PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Akan, I; Love, DC; Harwood, KR; Bond, MR; Hanover, JA				Akan, Ilhan; Love, Dona C.; Harwood, Katryn R.; Bond, Michelle R.; Hanover, John A.			Drosophila O-GlcNAcase Deletion Globally Perturbs Chromatin O-GlcNAcylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINE; GROUP PROTEINS; TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; TRANSFERASE OGT; GENE ENCODES; POLYCOMB; GLYCOSYLATION; REPRESSION; PHOSPHORYLATION	Gene expression during Drosophila development is subject to regulation by the Polycomb (Pc), Trithorax (Trx), and Compass chromatin modifier complexes. O-GlcNAc transferase (OGT/SXC) is essential for Pc repression suggesting that the O-GlcNAcylation of proteins plays a key role in regulating development. OGT transfers O-GlcNAc onto serine and threonine residues in intrinsically disordered domains of key transcriptional regulators; O-GlcNAcase (OGA) removes the modification. To pinpoint genomic regions that are regulated by O-GlcNAc levels, we performed ChIP-chip and microarray analysis after OGT or OGA RNAi knockdown in S2 cells. After OGA RNAi, we observed a genome-wide increase in the intensity of most O-GlcNAc-occupied regions including genes linked to cell cycle, ubiquitin, and steroid response. In contrast, O-GlcNAc levels were strikingly insensitive to OGA RNAi at sites of polycomb repression such as the Hox and NK homeobox gene clusters. Microarray analysis suggested that altered O-GlcNAc cycling perturbed the expression of genes associated with morphogenesis and cell cycle regulation. We then produced a viable null allele of oga (oga(del.1)) in Drosophila allowing visualization of altered O-GlcNAc cycling on polytene chromosomes. We found that trithorax (TRX), absent small or homeotic discs 1 (ASH1), and Compass member SET1 histone methyltransferases were O-GlcNAc-modified in oga(del.1) mutants. The oga(del.1) mutants displayed altered expression of a distinct set of cell cycle-related genes. Our results show that the loss of OGA in Drosophila globally impacts the epigenetic machinery allowing O-GlcNAc accumulation on RNA polymerase II and numerous chromatin factors including TRX, ASH1, and SET1.	[Akan, Ilhan; Harwood, Katryn R.; Bond, Michelle R.; Hanover, John A.] NIDDK, Bethesda, MD 20892 USA; [Love, Dona C.] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hanover, JA (corresponding author), NIDDK, LCBB, NIH, 8 Ctr Dr, Bethesda, MD 20892 USA.	jah@helix.nih.gov			NIDDK, National Institutes of Health Intramural Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060101, ZIADK060103] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health Intramural Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by an NIDDK, National Institutes of Health Intramural Grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article	Ardehali MB, 2011, EMBO J, V30, P2817, DOI 10.1038/emboj.2011.194; Ashburner M., 2004, DROSOPHILA LAB HDB; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dorighi KM, 2013, DEVELOPMENT, V140, P4182, DOI 10.1242/dev.095786; Feller C, 2015, MOL CELL, V57, P559, DOI 10.1016/j.molcel.2014.12.008; Gagnon J, 2015, EPIGENETICS-US, V10, P677, DOI 10.1080/15592294.2015.1060387; Gambetta MC, 2014, DEV CELL, V31, P629, DOI 10.1016/j.devcel.2014.10.020; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Howerton CL, 2013, P NATL ACAD SCI USA, V110, P5169, DOI 10.1073/pnas.1300065110; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; Iovino N, 2013, DEV CELL, V26, P431, DOI 10.1016/j.devcel.2013.06.021; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; Kaasik K, 2013, CELL METAB, V17, P291, DOI 10.1016/j.cmet.2012.12.017; Keembiyehetty C, 2015, J BIOL CHEM, V290, P7097, DOI 10.1074/jbc.M114.617779; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; Kim EJ, 2006, CARBOHYD RES, V341, P971, DOI 10.1016/j.carres.2006.03.004; KUZIN B, 1994, GENE DEV, V8, P2478, DOI 10.1101/gad.8.20.2478; Lavrov S, 2004, METH MOL B, V247, P289; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Martinez AM, 2006, CELL CYCLE, V5, P1189, DOI 10.4161/cc.5.11.2781; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; Rodriguez-Jato S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027479; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; XU T, 1993, DEVELOPMENT, V117, P1223; Xuan T, 2013, DEV BIOL, V379, P167, DOI 10.1016/j.ydbio.2013.04.015; Yan D, 2014, DEV CELL, V28, P459, DOI 10.1016/j.devcel.2014.01.020; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885	56	27	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9906	9919		10.1074/jbc.M115.704783	http://dx.doi.org/10.1074/jbc.M115.704783			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26957542	Green Published, hybrid			2022-12-28	WOS:000375602800005
J	Peverelli, MG; da Costa, TPS; Kirby, N; Perugini, MA				Peverelli, Martin G.; da Costa, Tatiana P. Soares; Kirby, Nigel; Perugini, Matthew A.			Dimerization of Bacterial Diaminopimelate Decarboxylase Is Essential for Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; SCATTERING DATA-ANALYSIS; RAY SOLUTION SCATTERING; ORNITHINE-DECARBOXYLASE; BIOLOGICAL MACROMOLECULES; PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DRUG DISCOVERY; ENZYME	Diaminopimelate decarboxylase (DAPDC) catalyzes the final step in the diaminopimelate biosynthesis pathway of bacteria. The product of the reaction is the essential amino acid L-lysine, which is an important precursor for the synthesis of the peptidoglycan cell wall, housekeeping proteins, and virulence factors of bacteria. Accordingly, the enzyme is a promising antibacterial target. Previous structural studies demonstrate that DAPDC exists as monomers, dimers, and tetramers in the crystal state. However, the active oligomeric form has not yet been determined. We show using analytical ultracentrifugation, small angle x-ray scattering, and enzyme kinetic analyses in solution that the active form of DAPDC from Bacillus anthracis, Escherichia coli, Mycobacterium tuberculosis, and Vibrio cholerae is a dimer. The importance of dimerization was probed further by generating dimerization interface mutants (N381A and R385A) of V. cholerae DAPDC. Our studies indicate that N381A and R385A are significantly attenuated in catalytic activity, thus confirming that dimerization of DAPDC is essential for function. These findings provide scope for the development of new antibacterial agents that prevent DAPDC dimerization.	[Peverelli, Martin G.; da Costa, Tatiana P. Soares; Perugini, Matthew A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Peverelli, Martin G.; Perugini, Matthew A.] Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Kirby, Nigel] Australian Synchrotron, 800 Blackburn Rd, Clayton, Vic 3168, Australia	La Trobe University	Perugini, MA (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia.	M.Perugini@latrobe.edu.au	Kirby, Nigel/AAC-3846-2021	Soares da Costa, Tatiana P./0000-0002-6275-7485; Kirby, Nigel/0000-0002-2791-4684; Perugini, Matthew/0000-0001-8052-5584	Australian Research Council (ARC) [DP150103313]; National Health and Medical Research Council of Australia [APP1091976]	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Australian Research Council (ARC) Discovery Project DP150103313. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by National Health and Medical Research Council of Australia Grant APP1091976 for fellowship support.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; ASADA Y, 1981, BIOCHEMISTRY-US, V20, P6881, DOI 10.1021/bi00527a022; Atkinson SC, 2014, PROTEINS, V82, P1869, DOI 10.1002/prot.24539; Atkinson SC, 2013, PLANT MOL BIOL, V81, P431, DOI 10.1007/s11103-013-0014-7; Atkinson SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038318; Brand IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039248; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; COLEMAN CS, 1993, J BIOL CHEM, V268, P24572; da Costa TPS, 2015, METHOD ENZYMOL, V562, P205, DOI 10.1016/bs.mie.2015.06.020; DEWEY DL, 1952, NATURE, V169, P533, DOI 10.1038/169533a0; Dogovski C., 2009, BIOTECHNOLOGY, P116; Dogovski C, 2012, BIOCHEMISTRY-US, P225, DOI DOI 10.85772/34121; Dogovski C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083419; Gerrard JA, 2007, MINI-REV MED CHEM, V7, P151, DOI 10.2174/138955707779802561; Gokulan K, 2003, J BIOL CHEM, V278, P18588, DOI 10.1074/jbc.M301549200; Hor L, 2013, J BIOL CHEM, V288, P9238, DOI 10.1074/jbc.M113.450148; Hu TC, 2008, J BIOL CHEM, V283, P21284, DOI 10.1074/jbc.M801823200; Hutton CA, 2003, MINI-REV MED CHEM, V3, P115, DOI 10.2174/1389557033405359; KELLAND JG, 1985, BIOCHEMISTRY-US, V24, P3263, DOI 10.1021/bi00334a028; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LABER B, 1989, ANAL BIOCHEM, V181, P297, DOI 10.1016/0003-2697(89)90246-7; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Momany C, 2002, ACTA CRYSTALLOGR D, V58, P549, DOI 10.1107/S0907444902000148; Myers DP, 2001, BIOCHEMISTRY-US, V40, P13230, DOI 10.1021/bi0155908; OSTERMAN A, 1994, BIOCHEMISTRY-US, V33, P13662, DOI 10.1021/bi00250a016; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Peverelli MG, 2015, BIOCHIMIE, V115, P78, DOI 10.1016/j.biochi.2015.05.004; Ray SS, 2002, STRUCTURE, V10, P1499, DOI 10.1016/S0969-2126(02)00880-8; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TSIRKA S, 1992, J BIOL CHEM, V267, P23057; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Voss JE, 2010, J BIOL CHEM, V285, P5188, DOI 10.1074/jbc.M109.038166; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Weyand Simone, 2009, Journal of Structural and Functional Genomics, V10, P209, DOI 10.1007/s10969-009-9065-z; WHITE PJ, 1965, BIOCHEM J, V96, P75, DOI 10.1042/bj0960075	43	25	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9785	9795		10.1074/jbc.M115.696591	http://dx.doi.org/10.1074/jbc.M115.696591			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26921318	Green Published, hybrid			2022-12-28	WOS:000375602300035
J	Cohen, A; Kupiec, M; Weisman, R				Cohen, Adiel; Kupiec, Martin; Weisman, Ronit			Gad8 Protein Is Found in the Nucleus Where It Interacts with the MluI Cell Cycle Box-binding Factor (MBF) Transcriptional Complex to Regulate the Response to DNA Replication Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; NITROGEN STARVATION; GENOME STABILITY; S-PHASE; G(1)/S TRANSCRIPTION; MAMMALIAN TARGET; KINASE PATHWAY; TOR	The target of rapamycin (TOR) kinase is found at the core of two evolutionarily conserved complexes known as TOR complexes 1 and 2 (TORC1 and TORC2). In fission yeast, TORC2 is dispensable for proliferation under optimal growth conditions but is required for starvation and stress responses. We have previously reported that loss of function of TORC2 renders cells highly sensitive to DNA replication stress; however, the mechanism underlying this sensitivity is unknown. TORC2 has one known direct substrate, the kinase Gad8, which is related to AKT in human cells. Here we show that both TORC2 and its substrate Gad8 are found in the nucleus and are bound to the chromatin. We also demonstrate that Gad8 physically interacts with the MluI cell cycle box-binding factor (MBF) transcription complex that regulates the G(1)/S progression and the response to DNA stress. In mutant cells lacking TORC2 or Gad8, the binding of the MBF complex to its cognate promoters is compromised, and the induction of MBF target genes in response to DNA replication stress is reduced. Consistently, the protein levels of Cdt2 and Cig2, two MBF target genes, are reduced in the absence of TORC2-Gad8 signaling. Taken together, our findings highlight critical functions of TORC2 in the nucleus and suggest a role in surviving DNA replication stress via transcriptional regulation of MBF target genes.	[Cohen, Adiel; Weisman, Ronit] Open Univ Israel, Dept Nat & Life Sci, Univ Rd 1, IL-4353701 Raanana, Israel; [Kupiec, Martin] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Open University Israel; Tel Aviv University	Weisman, R (corresponding author), Open Univ Israel, Dept Nat & Life Sci, Univ Rd 1, IL-4353701 Raanana, Israel.	ronitwe@openu.ac.il	weisman, ronit/R-6969-2016		Israel Science Foundation [688/14]; Open University of Israel Grant [31040]	Israel Science Foundation(Israel Science Foundation); Open University of Israel Grant	This work was supported by Israel Science Foundation Grant 688/14 and Open University of Israel Grant 31040) (to R. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Aligianni S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000626; Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Bachmann RA, 2006, J BIOL CHEM, V281, P7357, DOI 10.1074/jbc.M512218200; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Caetano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017211; Cohen A, 2014, J BIOL CHEM, V289, P21727, DOI 10.1074/jbc.M114.573824; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Davie E, 2015, CURR BIOL, V25, P445, DOI 10.1016/j.cub.2014.12.034; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; de Bruin RAM, 2009, CELL CYCLE, V8, P214, DOI 10.4161/cc.8.2.7412; Dutta C, 2008, MOL CELL BIOL, V28, P5977, DOI 10.1128/MCB.00596-08; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Hatano T, 2015, CELL CYCLE, V14, P848, DOI 10.1080/15384101.2014.1000215; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Ikeda K, 2008, CELL CYCLE, V7, P358, DOI 10.4161/cc.7.3.5245; Ivanova T, 2013, MOL BIOL CELL, V24, P3350, DOI 10.1091/mbc.E13-05-0257; Ivanova T, 2011, CELL CYCLE, V10, P912, DOI 10.4161/cc.10.6.14963; Kawai M, 2001, CURR GENET, V39, P166; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Laor D, 2015, MBIO, V6, DOI 10.1128/mBio.00959-15; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Loewith R, 2011, BIOCHEM SOC T, V39, P437, DOI 10.1042/BST0390437; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malik AR, 2013, BBA-PROTEINS PROTEOM, V1834, P1434, DOI 10.1016/j.bbapap.2012.12.010; Martelli AM, 2012, BBA-MOL CELL RES, V1823, P2168, DOI 10.1016/j.bbamcr.2012.08.017; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Purtill FS, 2011, CELL CYCLE, V10, P664, DOI 10.4161/cc.10.4.14824; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Rosner M, 2012, METHODS MOL BIOL, V821, P105, DOI 10.1007/978-1-61779-430-8_8; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Schonbrun M, 2013, J BIOL CHEM, V288, P19649, DOI 10.1074/jbc.M113.464974; Schonbrun M, 2009, MOL CELL BIOL, V29, P4584, DOI 10.1128/MCB.01879-08; Shimada K, 2013, MOL CELL, V51, P829, DOI 10.1016/j.molcel.2013.08.019; Stevens C, 2004, DNA REPAIR, V3, P1071, DOI 10.1016/j.dnarep.2004.03.034; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; Vazquez-Martin A, 2011, CELL CYCLE, V10, P3140, DOI 10.4161/cc.10.18.17376; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; Weisman R, 2014, EMBO MOL MED, V6, P995, DOI 10.15252/emmm.201403959; Workman JJ, 2014, CELL CYCLE, V13, P714, DOI 10.4161/cc.28112; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	54	20	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9371	9381		10.1074/jbc.M115.705251	http://dx.doi.org/10.1074/jbc.M115.705251			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26912660	hybrid, Green Published			2022-12-28	WOS:000374849000044
J	Filograna, R; Godena, VK; Sanchez-Martinez, A; Ferrari, E; Casella, L; Beltramini, M; Bubacco, L; Whitworth, AJ; Bisaglia, M				Filograna, Roberta; Godena, Vinay K.; Sanchez-Martinez, Alvaro; Ferrari, Emanuele; Casella, Luigi; Beltramini, Mariano; Bubacco, Luigi; Whitworth, Alexander J.; Bisaglia, Marco			Superoxide Dismutase (SOD)-mimetic M40403 Is Protective in Cell and Fly Models of Paraquat Toxicity IMPLICATIONS FOR PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED GENE-EXPRESSION; OXIDATIVE STRESS; SUBSTANTIA-NIGRA; PESTICIDES; MITOCHONDRIA; TRANSPORTER; MIMETICS; RESISTANCE; MORTALITY; RISK	Parkinson disease is a debilitating and incurable neurodegenerative disorder affecting similar to 1-2% of people over 65 years of age. Oxidative damage is considered to play a central role in the progression of Parkinson disease and strong evidence links chronic exposure to the pesticide paraquat with the incidence of the disease, most probably through the generation of oxidative damage. In this work, we demonstrated in human SH-SY5Y neuroblastoma cells the beneficial role of superoxide dismutase (SOD) enzymes against paraquat-induced toxicity, as well as the therapeutic potential of the SOD-mimetic compound M40403. Having verified the beneficial effects of superoxide dismutation in cells, we then evaluated the effects using Drosophila melanogaster as an in vivo model. Besides protecting against the oxidative damage induced by paraquat treatment, our data demonstrated that in Drosophila M40403 was able to compensate for the loss of endogenous SOD enzymes, acting both at a cytosolic and mitochondrial level. Because previous clinical trials have indicated that the M40403 molecule is well tolerated in humans, this study may have important implication for the treatment of Parkinson disease.	[Beltramini, Mariano; Bubacco, Luigi; Bisaglia, Marco] Univ Padua, Dept Biol, Mol Physiol & Biophys Unit, I-35121 Padua, Italy; [Godena, Vinay K.; Sanchez-Martinez, Alvaro; Whitworth, Alexander J.] Univ Sheffield, Dept Biomed Sci, MRC Ctr Dev & Biomed Genet, Sheffield S10 2TN, S Yorkshire, England; [Sanchez-Martinez, Alvaro; Whitworth, Alexander J.] MRC Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge CB2 2LY, England; [Ferrari, Emanuele; Casella, Luigi] Univ Pavia, Dept Chem, I-27100 Pavia, Italy	University of Padua; University of Sheffield; University of Pavia	Bisaglia, M (corresponding author), Univ Padua, Dept Biol, Mol Physiol & Biophys Unit, I-35121 Padua, Italy.; Whitworth, AJ (corresponding author), MRC Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge CB2 2LY, England.	a.whitworth@mrc-mbu.cam.ac.uk; marco.bisaglia@unipd.it	Sanchez-Martinez, Alvaro/L-3851-2019; Ferrari, Emanuele/O-2883-2015; Bubacco, Luigi/B-5602-2012	Sanchez-Martinez, Alvaro/0000-0002-2728-6251; Ferrari, Emanuele/0000-0002-3154-6714; Bubacco, Luigi/0000-0001-7927-9208	Italian Ministry of Education, University, and Research [PRIN2010-M2JARJ]; University of Padova [PRAT2010-CPDA103503, PRAT2012-124045]; Wellcome/MRC Parkinson Disease Consortium grant; University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee [WT089698]; ERC [309742]; MRC [MC-A070-5PSB0]; MRC [MC_UP_1501/1] Funding Source: UKRI; Medical Research Council [MC_UP_1501/1] Funding Source: researchfish	Italian Ministry of Education, University, and Research(Ministry of Education, Universities and Research (MIUR)); University of Padova; Wellcome/MRC Parkinson Disease Consortium grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Italian Ministry of Education, University, and Research (PRIN2010-M2JARJ), and from the University of Padova (PRAT2010-CPDA103503; PRAT2012-124045). The work was also supported by a Wellcome/MRC Parkinson Disease Consortium grant (to U. C. L./I. o. N.), the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee (WT089698), an ERC Starting Grant (no. 309742), and MRC core funding (MC-A070-5PSB0). The authors declare that they have no conflicts of interest with the contents of this article.	Alam ZI, 1997, J NEUROCHEM, V69, P1326; Aston K, 2001, INORG CHEM, V40, P1779, DOI 10.1021/ic000958v; Bisaglia M, 2014, AGEING RES REV, V13, P107, DOI 10.1016/j.arr.2013.12.009; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; BRAND AH, 1993, DEVELOPMENT, V118, P401; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Floor E, 1998, J NEUROCHEM, V70, P268; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Fujimori K, 2012, J NEUROCHEM, V120, P279, DOI 10.1111/j.1471-4159.2011.07570.x; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Jin H, 2014, BBA-MOL BASIS DIS, V1842, P1282, DOI 10.1016/j.bbadis.2013.09.007; Kamel F, 2013, SCIENCE, V341, P722, DOI 10.1126/science.1243619; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Lawal HO, 2010, NEUROBIOL DIS, V40, P102, DOI 10.1016/j.nbd.2010.05.008; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Lohr KM, 2014, P NATL ACAD SCI USA, V111, P9977, DOI 10.1073/pnas.1402134111; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Murphy CK, 2008, CLIN CANCER RES, V14, P4292, DOI 10.1158/1078-0432.CCR-07-4669; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; ORR WC, 1993, ARCH BIOCHEM BIOPHYS, V301, P34, DOI 10.1006/abbi.1993.1111; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rappold PM, 2011, P NATL ACAD SCI USA, V108, P20766, DOI 10.1073/pnas.1115141108; Rodriguez-Rocha H, 2013, FREE RADICAL BIO MED, V61, P370, DOI 10.1016/j.freeradbiomed.2013.04.021; Salvemini D, 1999, SCIENCE, V286, P304, DOI 10.1126/science.286.5438.304; Salvemini D, 2002, NAT REV DRUG DISCOV, V1, P367, DOI 10.1038/nrd796; Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tieu K, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a009316; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van der Mark M, 2012, ENVIRON HEALTH PERSP, V120, P340, DOI 10.1289/ehp.1103881; Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wicks S, 2009, FREE RADICAL BIO MED, V46, P176, DOI 10.1016/j.freeradbiomed.2008.09.036; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Yang W, 2010, TOXICOL LETT, V199, P239, DOI 10.1016/j.toxlet.2010.09.005; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023	46	43	47	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9257	9267		10.1074/jbc.M115.708057	http://dx.doi.org/10.1074/jbc.M115.708057			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26953346	Green Published, hybrid			2022-12-28	WOS:000374849000035
J	Liu, YL; Tempel, W; Zhang, Q; Liang, X; Loppnau, P; Qin, S; Min, JR				Liu, Yanli; Tempel, Wolfram; Zhang, Qi; Liang, Xiao; Loppnau, Peter; Qin, Su; Min, Jinrong			Family-wide Characterization of Histone Binding Abilities of Human CW Domain-containing Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-BINDING; PLANT HOMEODOMAIN; STRUCTURAL BASIS; MOLECULAR-BASIS; PZP DOMAIN; RECOGNITION; METHYLATION; MODEL; PHD; MECHANISM	Covalent modifications of histone N-terminal tails play a critical role in regulating chromatin structure and controlling gene expression. These modifications are controlled by histone-modifying enzymes and read out by histone-binding proteins. Numerous proteins have been identified as histone modification readers. Here we report the family-wide characterization of histone binding abilities of human CW domain-containing proteins. We demonstrate that the CW domains in ZCWPW2 and MORC3/4 selectively recognize histone H3 trimethylated at Lys-4, similar to ZCWPW1 reported previously, while the MORC1/2 and LSD2 lack histone H3 Lys-4 binding ability. Our crystal structures of the CW domains of ZCWPW2 and MORC3 in complex with the histone H3 trimethylated at Lys-4 peptide reveal the molecular basis of this interaction. In each complex, two tryptophan residues in the CW domain form the "floor" and "right wall," respectively, of the methyllysine recognition cage. Our mutation results based on ZCWPW2 reveal that the right wall tryptophan residue is essential for binding, and the floor tryptophan residue enhances binding affinity. Our structural and mutational analysis highlights the conserved roles of the cage residues of CW domain across the histone methyllysine binders but also suggests why some CW domains lack histone binding ability.	[Liu, Yanli; Tempel, Wolfram; Zhang, Qi; Loppnau, Peter; Qin, Su; Min, Jinrong] Univ Toronto, Struct Genom Consortium, 101 Coll St, Toronto, ON M5G 1L7, Canada; [Liu, Yanli; Liang, Xiao; Min, Jinrong] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China; [Qin, Su] South Univ Sci & Technol China, Life Sci Res Ctr, Shenzhen 518055, Peoples R China; [Min, Jinrong] Univ Toronto, Dept Physiol, Med Sci Bldg, Toronto, ON M5S 1A8, Canada	University of Toronto; Structural Genomics Consortium; Central China Normal University; Southern University of Science & Technology; University of Toronto	Qin, S; Min, JR (corresponding author), Univ Toronto, Struct Genom Consortium, 101 Coll St, Toronto, ON M5G 1L7, Canada.	qinsu08@gmail.com; jr.min@utoronto.ca	Qin, Su/Y-3750-2019; QIN, SU/H-8735-2015; Liu, Yanli/AAA-3283-2019; Min, Jinrong/G-3449-2011	Qin, Su/0000-0001-9437-6292; Liu, Yanli/0000-0003-0197-7617; Min, Jinrong/0000-0001-5210-3130; Zhang, Qi/0000-0003-1121-8817	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	We thank Aiping Dong for reviewing the ZCWPW2 and MORC3 crystallographic models. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Ali M, 2013, P NATL ACAD SCI USA, V110, P11296, DOI 10.1073/pnas.1310156110; Argentaro A, 2007, P NATL ACAD SCI USA, V104, P11939, DOI 10.1073/pnas.0704057104; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Chen SD, 2015, MOL CELL, V60, P319, DOI 10.1016/j.molcel.2015.08.019; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fang R, 2013, MOL CELL, V49, P558, DOI 10.1016/j.molcel.2012.11.019; Gildea RJ, 2011, J APPL CRYSTALLOGR, V44, P1259, DOI 10.1107/S0021889811041161; Hake SB, 2004, BRIT J CANCER, V90, P761, DOI 10.1038/sj.bjc.6601575; He FH, 2010, STRUCTURE, V18, P1127, DOI 10.1016/j.str.2010.06.012; Hoppmann V, 2011, EMBO J, V30, P1939, DOI 10.1038/emboj.2011.108; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klein BJ, 2016, NUCLEIC ACIDS RES, V44, P472, DOI 10.1093/nar/gkv1321; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li X, 2012, J AM CHEM SOC, V134, P1982, DOI 10.1021/ja210528v; Liu YL, 2016, CURR PROTEIN PEPT SC, V17, P497, DOI 10.2174/1389203717666160125115130; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Perry J, 2003, TRENDS BIOCHEM SCI, V28, P576, DOI 10.1016/j.tibs.2003.09.007; Qin S, 2014, TRENDS BIOCHEM SCI, V39, P536, DOI 10.1016/j.tibs.2014.09.001; Qin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4952; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaquero Alejandro, 2003, Sci Aging Knowledge Environ, V2003, pRE4, DOI 10.1126/sageke.2003.14.re4; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zhang Q, 2013, CELL RES, V23, P225, DOI 10.1038/cr.2012.177; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	48	36	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9000	9013		10.1074/jbc.M116.718973	http://dx.doi.org/10.1074/jbc.M116.718973			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26933034	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000374849000015
J	Prior, SH; Byrne, TS; Tokmina-Roszyk, D; Fields, GB; Van Doren, SR				Prior, Stephen H.; Byrne, Todd S.; Tokmina-Roszyk, Dorota; Fields, Gregg B.; Van Doren, Steven R.			Path to Collagenolysis: COLLAGEN V TRIPLE-HELIX MODEL BOUND PRODUCTIVELY AND IN ENCOUNTERS BY MATRIX METALLOPROTEINASE-12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; docking; matrix metalloproteinase (MMP); nuclear magnetic resonance (NMR); protein-protein interaction; encounter complex; paramagnetic relaxation enhancement (PRE)	PROTEIN-PROTEIN ASSOCIATION; MOLECULAR-DYNAMICS SIMULATIONS; CHEMICAL-SHIFT PERTURBATION; PEPTIDE-BOND HYDROLYSIS; CANCER-CELL INVASION; CATALYTIC DOMAIN; MAMMALIAN COLLAGENASES; METALLOPROTEINASE 1; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY	Collagenolysis is essential in extracellular matrix homeostasis, but its structural basis has long been shrouded in mystery. We have developed a novel docking strategy guided by paramagnetic NMR that positions a triple-helical collagen V mimic (synthesized with nitroxide spin labels) in the active site of the catalytic domain of matrix metalloproteinase-12 (MMP-12 or macrophage metalloelastase) primed for catalysis. The collagenolytically productive complex forms by utilizing seven distinct subsites that traverse the entire length of the active site. These subsites bury approximate to 1,080 (2) of surface area, over half of which is contributed by the trailing strand of the synthetic collagen V mimic, which also appears to ligate the catalytic zinc through the glycine carbonyl oxygen of its scissile G approximate to VV triplet. Notably, the middle strand also occupies the full length of the active site where it contributes extensive interfacial contacts with five subsites. This work identifies, for the first time, the productive and specific interactions of a collagen triple helix with an MMP catalytic site. The results uniquely demonstrate that the active site of the MMPs is wide enough to accommodate two strands from collagen triple helices. Paramagnetic relaxation enhancements also reveal an extensive array of encounter complexes that form over a large part of the catalytic domain. These transient complexes could possibly facilitate the formation of collagenolytically active complexes via directional Brownian tumbling.	[Prior, Stephen H.; Byrne, Todd S.; Van Doren, Steven R.] Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA; [Tokmina-Roszyk, Dorota; Fields, Gregg B.] Florida Atlantic Univ, Dept Chem & Biochem, Jupiter, FL 33458 USA; [Fields, Gregg B.] Scripps Res Inst, Scripps Florida, Jupiter, FL 33458 USA	University of Missouri System; University of Missouri Columbia; State University System of Florida; Florida Atlantic University; Scripps Research Institute; State University System of Florida; University of Florida	Van Doren, SR (corresponding author), Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA.	vandorens@missouri.edu		Van Doren, Steven/0000-0003-2838-4598; Prior, Steve/0000-0002-6133-0607	National Institutes of Health [R01 GM057289, R01 CA098799, T32 GM008396, S10 RR022341]; American Heart Association [0855714G]; University of Missouri; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008396, R01GM057289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Missouri; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM057289 and R01 CA098799 and Grant T32 GM008396 and American Heart Association Grant 0855714G. The 800 MHz NMR spectrometer was purchased with funds from National Institutes of Health Grant S10 RR022341 and the University of Missouri. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar JA, 2012, CHEM COMMUN, V48, P811, DOI 10.1039/c1cc16699a; Akaike H, 1973, P 2 INT S INF THEOR, P267, DOI DOI 10.2307/2334537; Arnold LH, 2011, J BIOL CHEM, V286, P45073, DOI 10.1074/jbc.M111.285213; Bashir Q, 2010, J AM CHEM SOC, V132, P241, DOI 10.1021/ja9064574; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Bhaskaran R, 2008, J BIOL CHEM, V283, P21779, DOI 10.1074/jbc.M709966200; Bhaskaran R, 2007, J MOL BIOL, V374, P1333, DOI 10.1016/j.jmb.2007.10.028; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Clore GM, 2015, METHOD ENZYMOL, V564, P485, DOI 10.1016/bs.mie.2015.06.032; Diaz N, 2013, BIOCHEMISTRY-US, V52, P8556, DOI 10.1021/bi401144p; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eckhard U, 2016, MATRIX BIOL, V49, P37, DOI 10.1016/j.matbio.2015.09.003; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; Fields GB, 2010, ORG BIOMOL CHEM, V8, P1237, DOI 10.1039/b920670a; FlippenAnderson JL, 1996, INT J PEPT PROT RES, V47, P231; Fu JY, 2001, PROTEIN EXPRES PURIF, V21, P268, DOI 10.1006/prep.2000.1376; Fulcher YG, 2011, BIOCHEMISTRY-US, V50, P9488, DOI 10.1021/bi2009807; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; Hubbard S. J., 1993, NACCESS; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105; Koppisetti RK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6552; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Krugh T. R., 1976, SPIN LABELING THEORY, P339; Kukreja M, 2015, CHEM BIOL, V22, P1122, DOI 10.1016/j.chembiol.2015.07.008; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Liang XY, 2010, BIOPHYS J, V99, P273, DOI 10.1016/j.bpj.2010.04.002; Libby P, 2008, J INTERN MED, V263, P517, DOI 10.1111/j.1365-2796.2008.01965.x; Lindsey ML, 2015, J AM COLL CARDIOL, V66, P1364, DOI 10.1016/j.jacc.2015.07.035; Madhan B, 2008, J AM CHEM SOC, V130, P13520, DOI 10.1021/ja805496v; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Nerenberg PS, 2008, J MOL BIOL, V382, P246, DOI 10.1016/j.jmb.2008.07.009; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Palmier MO, 2010, J BIOL CHEM, V285, P30918, DOI 10.1074/jbc.M110.136903; Park S, 2005, J COMPUT CHEM, V26, P1612, DOI 10.1002/jcc.20301; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; Prior SH, 2015, STRUCTURE, V23, P2099, DOI 10.1016/j.str.2015.08.013; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; Scanu S, 2013, J AM CHEM SOC, V135, P7681, DOI 10.1021/ja4015452; Schilder J, 2013, CURR OPIN STRUC BIOL, V23, P911, DOI 10.1016/j.sbi.2013.07.009; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Stura EA, 2013, FASEB J, V27, P4395, DOI 10.1096/fj.13-233601; Taddese S, 2010, BBA-PROTEINS PROTEOM, V1804, P731, DOI 10.1016/j.bbapap.2009.11.014; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020; Van Doren SR, 2015, MATRIX BIOL, V44-46, P224, DOI 10.1016/j.matbio.2015.01.005; Volkov AN, 2010, J AM CHEM SOC, V132, P11487, DOI 10.1021/ja100867c; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Woskowicz AM, 2013, J BIOL CHEM, V288, P35126, DOI 10.1074/jbc.M113.496067; Zhao YC, 2015, STRUCTURE, V23, P257, DOI 10.1016/j.str.2014.11.021; Zhen EY, 2008, ARTHRITIS RHEUM-US, V58, P2420, DOI 10.1002/art.23654	74	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7888	7901		10.1074/jbc.M115.703124	http://dx.doi.org/10.1074/jbc.M115.703124			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26887942	Green Published, hybrid			2022-12-28	WOS:000374056700012
J	Bensing, BA; Loukachevitch, LV; McCulloch, KM; Yu, H; Vann, KR; Wawrzak, Z; Anderson, S; Chen, X; Sullam, PM; Iverson, TM				Bensing, Barbara A.; Loukachevitch, Lioudmila V.; McCulloch, Kathryn M.; Yu, Hai; Vann, Kendra R.; Wawrzak, Zdzislaw; Anderson, Spencer; Chen, Xi; Sullam, Paul M.; Iverson, T. M.			Structural Basis for Sialoglycan Binding by the Streptococcus sanguinis SrpA Adhesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE GLYCOPROTEINS GSPB; INFECTIVE ENDOCARDITIS; GORDONII; HSA; SIALYLTRANSFERASE; PLATELETS; SYSTEM; DOMAIN; PHENIX	Streptococcus sanguinis is a leading cause of infective endocarditis, a life-threatening infection of the cardiovascular system. An important interaction in the pathogenesis of infective endocarditis is attachment of the organisms to host platelets. S. sanguinis expresses a serine-rich repeat adhesin, SrpA, similar in sequence to platelet-binding adhesins associated with increased virulence in this disease. In this study, we determined the first crystal structure of the putative binding region of SrpA (SrpA(BR)) both unliganded and in complex with a synthetic disaccharide ligand at 1.8 and 2.0 angstrom resolution, respectively. We identified a conserved Thr-Arg motif that orients the sialic acid moiety and is required for binding to platelet monolayers. Furthermore, we propose that sequence insertions in closely related family members contribute to the modulation of structural and functional properties, including the quaternary structure, the tertiary structure, and the ligand-binding site.	[Bensing, Barbara A.; Sullam, Paul M.] Univ Calif San Francisco, Dept Med, Vet Affairs Med Ctr, Div Infect Dis, San Francisco, CA 94121 USA; [Bensing, Barbara A.; Sullam, Paul M.] Northern Calif Inst Res & Educ, San Francisco, CA 94121 USA; [Loukachevitch, Lioudmila V.; McCulloch, Kathryn M.; Iverson, T. M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Vann, Kendra R.; Iverson, T. M.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Yu, Hai; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Wawrzak, Zdzislaw; Anderson, Spencer] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Argonne, IL 60439 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Northern California Institute for Research & Education; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California Davis; Northwestern University	Iverson, TM (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.; Iverson, TM (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.; Iverson, TM (corresponding author), Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA.; Iverson, TM (corresponding author), Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA.	tina.iverson@vanderbilt.edu	chen, xi/GXH-3653-2022; Chen, Xi/H-1811-2018	Chen, Xi/0000-0002-3160-614X; McCulloch, Kathryn/0000-0001-9077-3821; Vann, Kendra R./0000-0002-6366-6112	United States Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant [085P1000817]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026915] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041513, R01AI106987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE025826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, R25GM062459] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor Grant 085P1000817.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bensing BA, 2004, INFECT IMMUN, V72, P6528, DOI 10.1128/IAI.72.11.6528-6537.2004; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Deng LQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004540; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Li YH, 2008, APPL MICROBIOL BIOT, V79, P963, DOI 10.1007/s00253-008-1506-2; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Pyburn TM, 2010, ACTA CRYSTALLOGR F, V66, P1503, DOI 10.1107/S1744309110036535; Ramboarina S, 2010, J BIOL CHEM, V285, P32446, DOI 10.1074/jbc.M110.128165; Schulte T, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130090; Seo HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064204; Sugiarto G, 2012, ACS CHEM BIOL, V7, P1232, DOI 10.1021/cb300125k; SULLAM PM, 1992, J LAB CLIN MED, V120, P507; Sundaresan R, 2015, INT J BIOL MACROMOL, V75, P97, DOI 10.1016/j.ijbiomac.2014.12.048; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thornhill Martin H, 2011, BMJ, V342, pd2392, DOI 10.1136/bmj.d2392; Tleyjeh IM, 2005, JAMA-J AM MED ASSOC, V293, P3022, DOI 10.1001/jama.293.24.3022; Turner LS, 2009, INFECT IMMUN, V77, P4966, DOI 10.1128/IAI.00760-09; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004; Yang Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/145641; Yu H, 2005, J AM CHEM SOC, V127, P17618, DOI 10.1021/ja0561690; Yu H, 2004, BIOORGAN MED CHEM, V12, P6427, DOI 10.1016/j.bmc.2004.09.030; Yu H, 2006, NAT PROTOC, V1, P2485, DOI 10.1038/nprot.2006.401	33	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7230	7240		10.1074/jbc.M115.701425	http://dx.doi.org/10.1074/jbc.M115.701425			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26833566	Green Published, hybrid			2022-12-28	WOS:000383447600003
J	Reynolds, AL; Alvarez, Y; Sasore, T; Waghorne, N; Butler, CT; Kilty, C; Smith, AJ; McVicar, C; Wong, VHY; Galvin, O; Merrigan, S; Osman, J; Grebnev, G; Sjolander, A; Stitt, AW; Kennedy, BN				Reynolds, Alison L.; Alvarez, Yolanda; Sasore, Temitope; Waghorne, Nora; Butler, Clare T.; Kilty, Claire; Smith, Andrew J.; McVicar, Carmel; Wong, Vickie H. Y.; Galvin, Orla; Merrigan, Stephanie; Osman, Janina; Grebnev, Gleb; Sjolander, Anita; Stitt, Alan W.; Kennedy, Breandan N.			Phenotype-based Discovery of 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol as a Novel Regulator of Ocular Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINYL LEUKOTRIENE RECEPTOR; OXYGEN-INDUCED RETINOPATHY; ENDOTHELIAL GROWTH-FACTOR; PATHOLOGICAL NEOVASCULARIZATION; RETINAL ANGIOGENESIS; ZEBRAFISH; MOUSE; D-4; RANIBIZUMAB; VASCULATURE	Retinal angiogenesis is tightly regulated to meet oxygenation and nutritional requirements. In diseases such as proliferative diabetic retinopathy and neovascular age-related macular degeneration, uncontrolled angiogenesis can lead to blindness. Our goal is to better understand the molecular processes controlling retinal angiogenesis and discover novel drugs that inhibit retinal neovascularization. Phenotype-based chemical screens were performed using the ChemBridge Diverset (TM) library and inhibition of hyaloid vessel angiogenesis in Tg(fli1: EGFP) zebrafish. 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol, (quininib) robustly inhibits developmental angiogenesis at 4-10 mu M in zebrafish and significantly inhibits angiogenic tubule formation in HMEC-1 cells, angiogenic sprouting in aortic ring explants, and retinal revascularization in oxygen-induced retinopathy mice. Quininib is well tolerated in zebrafish, human cell lines, and murine eyes. Profiling screens of 153 angiogenic and inflammatory targets revealed that quininib does not directly target VEGF receptors but antagonizes cysteinyl leukotriene receptors 1 and 2 (CysLT1-2) at micromolar IC50 values. In summary, quininib is a novel anti-angiogenic small-molecule CysLT receptor antagonist. Quininib inhibits angiogenesis in a range of cell and tissue systems, revealing novel physiological roles for CysLT signaling. Quininib has potential as a novel therapeutic agent to treat ocular neovascular pathologies and may complement current anti-VEGF biological agents.	[Reynolds, Alison L.; Alvarez, Yolanda; Sasore, Temitope; Waghorne, Nora; Butler, Clare T.; Kilty, Claire; Smith, Andrew J.; Galvin, Orla; Merrigan, Stephanie; Grebnev, Gleb; Kennedy, Breandan N.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst, Dublin 4, Ireland; [McVicar, Carmel; Wong, Vickie H. Y.; Stitt, Alan W.] Queens Univ Belfast, Ctr Med Expt, Wellcome Wolfson Bldg,97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Osman, Janina; Sjolander, Anita] Lund Univ, Skane Univ Hosp, Dept Translat Med, Div Cell & Expt Pathol, S-20502 Malmo, Sweden	University College Dublin; Queens University Belfast; Lund University; Skane University Hospital	Kennedy, BN (corresponding author), Univ Coll Dublin, Conway Inst, UCD Sch Biomol & Biomed Sci, UCD Conway Inst F062, Dublin 4, Ireland.	brendan.kennedy@ucd.ie	Wong, Vickie/AAL-5158-2020; kennedy, Breandan/H-5643-2019; Stitt, Alan/A-9842-2009	Wong, Vickie/0000-0001-9356-7556; kennedy, Breandan/0000-0001-7991-4689; Stitt, Alan/0000-0002-8647-9918; Reynolds, Alison/0000-0002-3147-0094	Enterprise Ireland; Health Research Board Ireland; Science Foundation Ireland; MRC [G0801962] Funding Source: UKRI; Medical Research Council [G0801962] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [10JTA] Funding Source: researchfish	Enterprise Ireland; Health Research Board Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust	This work was supported by funding from an Enterprise Ireland proof of concept award, an Enterprise Ireland Commercialisation Fund award, a Health Research Board Ireland Health Research Award, and a Science Foundation Ireland Technology innovation development award. B. N. K. and Y. A. are authors on granted patent WO2012095836 A1. A. R., C. K., and B. N. K. are authors on patent filing WO2014012889 A1.	Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Alvarez Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007867; Back M, 2014, BRIT J PHARMACOL, V171, P3551, DOI 10.1111/bph.12665; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Balantic M, 2012, MOL DIAGN THER, V16, P173, DOI 10.2165/11631710-000000000-00000; Barajas-Espinosa A, 2012, FASEB J, V26, P1100, DOI 10.1096/fj.11-195792; Brockerhoff SE, 2006, NAT PROTOC, V1, P2448, DOI 10.1038/nprot.2006.255; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dhakal S, 2013, INVEST OPHTH VIS SCI, V54; Dhakal S, 2015, DEV DYNAM, V244, P1439, DOI 10.1002/dvdy.24322; Duah E, 2013, SCI REP-UK, V3, DOI 10.1038/srep03274; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Folkman J, 1997, EXS, V79, P1; Frost & Sullivan, 2010, M4AC52 FROST SULL; Frost & Sullivan, 2011, NC7752 FROST SULL; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gagnidze K, 2008, J MED CHEM, V51, P3378, DOI 10.1021/jm7015478; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Hartsock A, 2014, DEV BIOL, V394, P327, DOI 10.1016/j.ydbio.2014.07.024; Hellstrom A, 2013, LANCET, V382, P1445, DOI 10.1016/S0140-6736(13)60178-6; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jiang Y, 2007, BLOOD, V110, P3263, DOI 10.1182/blood-2007-07-100453; Kalen M, 2009, CHEM BIOL, V16, P432, DOI 10.1016/j.chembiol.2009.02.010; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kanaoka Y, 2014, ALLERGY ASTHMA IMMUN, V6, P288, DOI 10.4168/aair.2014.6.4.288; Kanaoka Y, 2013, J BIOL CHEM, V288, P10967, DOI 10.1074/jbc.C113.453704; KANAYASU T, 1989, BIOCHEM BIOPH RES CO, V159, P572, DOI 10.1016/0006-291X(89)90032-6; Kim MH, 2010, J CELL BIOCHEM, V111, P686, DOI 10.1002/jcb.22755; Kitambi SS, 2009, MECH DEVELOP, V126, P464, DOI 10.1016/j.mod.2009.01.002; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee KS, 2004, J ALLERGY CLIN IMMUN, V114, P1093, DOI 10.1016/j.jaci.2004.07.039; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; LoRusso PM, 2011, J CLIN ONCOL, V29, P2952, DOI 10.1200/JCO.2011.36.1311; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; Marschallinger J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9466; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Meltzer EO, 2000, J ALLERGY CLIN IMMUN, V105, P917, DOI 10.1067/mai.2000.106040; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Qian XD, 2006, EUR J PHARMACOL, V549, P35, DOI 10.1016/j.ejphar.2006.07.056; Rehak M, 2010, J THROMB HAEMOST, V8, P1886, DOI 10.1111/j.1538-7836.2010.03909.x; Reiss TF, 1996, J ALLERGY CLIN IMMUN, V98, P528, DOI 10.1016/S0091-6749(96)70086-6; Rennekamp AJ, 2015, CURR OPIN CHEM BIOL, V24, P58, DOI 10.1016/j.cbpa.2014.10.025; Reynolds AL, 2014, ADV EXP MED BIOL, V801, P797, DOI 10.1007/978-1-4614-3209-8_100; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Salim T, 2014, EXP CELL RES, V321, P255, DOI 10.1016/j.yexcr.2013.10.021; Sasore T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105280; Savari S, 2014, WORLD J GASTROENTERO, V20, P968, DOI 10.3748/wjg.v20.i4.968; Savari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073466; Shastry BS, 2009, CLIN EXP OPHTHALMOL, V37, P884, DOI 10.1111/j.1442-9071.2009.02150.x; Sidman RL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4882; Singh RK, 2010, PHARMACOLOGY, V85, P336, DOI 10.1159/000312669; Smith GA, 2004, PHARM RES, V21, P1539, DOI 10.1023/B:PHAM.0000041445.76931.27; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; TSOPANOGLOU NE, 1994, EUR J PHARMACOL, V258, P151, DOI 10.1016/0014-2999(94)90068-X; Wang XY, 2013, NEUROCHEM INT, V62, P340, DOI 10.1016/j.neuint.2013.01.002; Wangsa-Wirawan ND, 2003, ARCH OPHTHALMOL-CHIC, V121, P547, DOI 10.1001/archopht.121.4.547; Xu L, 2010, PHARMAZIE, V65, P750, DOI 10.1691/ph.2010.9810; Yuan YM, 2009, J PHARMACOL SCI, V109, P285, DOI 10.1254/jphs.08321FP; ZAMBONI R, 1992, J MED CHEM, V35, P3832, DOI 10.1021/jm00099a011	67	26	26	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7242	7255		10.1074/jbc.M115.710665	http://dx.doi.org/10.1074/jbc.M115.710665			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26846851	Green Published, hybrid			2022-12-28	WOS:000383447600004
J	Wang, J; Sevier, CS				Wang, Jie; Sevier, Carolyn S.			Formation and Reversibility of BiP Protein Cysteine Oxidation Facilitate Cell Survival during and post Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-REGULATED PROTEIN; INDUCED S-GLUTATHIONYLATION; ENDOPLASMIC-RETICULUM; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; DISULFIDE-ISOMERASE; ADP-RIBOSYLATION; SACCHAROMYCES-CEREVISIAE; THIOL/DISULFIDE EXCHANGE; MONOTHIOL GLUTAREDOXINS; PROTEOMIC ANALYSIS	Redox fluctuations within cells can be detrimental to cell function. To gain insight into how cells normally buffer against redox changes to maintain cell function, we have focused on elucidating the signaling pathways that serve to sense and respond to oxidative redox stress within the endoplasmic reticulum (ER) using yeast as a model system. Previously, we have shown that a cysteine in the molecular chaperone BiP, a Hsp70 molecular chaperone within the ER, is susceptible to oxidation by peroxide during ER-derived oxidative stress, forming a sulfenic acid (-SOH) moiety. Here, we demonstrate that this same conserved BiP cysteine is susceptible also to glutathione modification (-SSG). Glutathionylated BiP is detected both as a consequence of enhanced levels of cellular peroxide and also as a by-product of increased levels of oxidized glutathione (GSSG). Similar to sulfenylation, we observe glutathionylation decouples BiP ATPase and peptide binding activities, turning BiP from an ATP-dependent foldase into an ATP-independent holdase. We show glutathionylation enhances cell proliferation during oxidative stress, which we suggest relates to modified BiP's increased ability to limit polypeptide aggregation. We propose the susceptibility of BiP to modification with glutathione may serve also to prevent irreversible oxidation of BiP by peroxide.	[Wang, Jie; Sevier, Carolyn S.] Cornell Univ, Dept Mol Med, VMC C4-141, Ithaca, NY 14853 USA	Cornell University	Sevier, CS (corresponding author), Cornell Univ, Dept Mol Med, VMC C4-141, Ithaca, NY 14853 USA.	css224@cornell.edu	Wang, Jie/GPT-0245-2022	Wang, Jie/0000-0002-4974-9587; Sevier, Carolyn/0000-0003-3245-6988	National Institutes of Health [1S10OD017992-01]; NATIONAL CANCER INSTITUTE [R01CA081554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK094309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105958] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD017992] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank John O'Donnell and Heather Sickles for assistance with plasmid construction and technical expertise. We also thank Dante Lepore for help with fluorescence microscopy and Dr. Ruth Collins for the use of her lab microscope. We acknowledge the Cornell Proteomics and Mass Spectrometry Core Facility for processing and analysis of samples, and we thank the director of the core facility, Dr. Sheng Zhang, for providing the methods describing the mass spectrometry procedures. The proteomics core facility was supported by National Institutes of Health Grant 1S10OD017992-01, which provided instrument support.	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Ayer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044278; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Berndt C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00168; Birk J, 2013, J CELL SCI, V126, P1604, DOI 10.1242/jcs.117218; CARLSSON L, 1983, P NATL ACAD SCI-BIOL, V80, P4664, DOI 10.1073/pnas.80.15.4664; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; Chambers JE, 2012, J CELL BIOL, V198, P371, DOI 10.1083/jcb.201202005; Charles RL, 2007, MOL CELL PROTEOMICS, V6, P1473, DOI 10.1074/mcp.M700065-MCP200; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Devarie-Baez NO, 2016, FREE RADICAL RES, V50, P172, DOI 10.3109/10715762.2015.1090571; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Galligan JJ, 2014, FREE RADICAL BIO MED, V73, P411, DOI 10.1016/j.freeradbiomed.2014.06.002; Grant CM, 1999, MOL CELL BIOL, V19, P2650; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Halloran M, 2013, Int J Cell Biol, V2013, P797914, DOI 10.1155/2013/797914; Ham H, 2014, J BIOL CHEM, V289, P36059, DOI 10.1074/jbc.M114.612515; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; HENDERSHOT LM, 1988, MOL CELL BIOL, V8, P4250, DOI 10.1128/MCB.8.10.4250; Hildebrandt T, 2015, BIOL CHEM, V396, P523, DOI 10.1515/hsz-2014-0295; Hochrainer K, 2012, CELL MOL LIFE SCI, V69, P2057, DOI 10.1007/s00018-011-0912-2; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; Hoppe G, 2004, EXP EYE RES, V78, P1085, DOI 10.1016/j.exer.2004.02.001; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Izquierdo A, 2008, EUKARYOT CELL, V7, P1415, DOI 10.1128/EC.00133-08; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kettenhofen NJ, 2010, CHEM RES TOXICOL, V23, P1633, DOI 10.1021/tx100237w; Kim S, 2012, J CELL BIOL, V196, P713, DOI 10.1083/jcb.201110090; LEDFORD BE, 1994, MOL CELL BIOCHEM, V138, P141, DOI 10.1007/BF00928456; LENO GH, 1989, EUR J BIOCHEM, V186, P205, DOI 10.1111/j.1432-1033.1989.tb15196.x; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lillig CH, 2013, ANTIOXID REDOX SIGN, V18, P1654, DOI 10.1089/ars.2012.5007; Lind C, 1998, BIOCHEM BIOPH RES CO, V247, P481, DOI 10.1006/bbrc.1998.8695; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Lohman JR, 2008, BIOCHEMISTRY-US, V47, P8678, DOI 10.1021/bi800498g; Lundstrom-Ljung J, 1999, FEBS LETT, V443, P85, DOI 10.1016/S0014-5793(98)01698-6; Maller C, 2011, ANTIOXID REDOX SIGN, V14, P49, DOI 10.1089/ars.2010.3149; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Mesecke N, 2008, BIOCHEMISTRY-US, V47, P1452, DOI 10.1021/bi7017865; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Sanyal A, 2015, J BIOL CHEM, V290, P8482, DOI 10.1074/jbc.M114.618348; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; SIKORSKI RS, 1989, GENETICS, V122, P19; Uys JD, 2011, METHOD ENZYMOL, V490, P321, DOI 10.1016/B978-0-12-385114-7.00018-0; VEDIA LM, 1992, J BIOL CHEM, V267, P24929; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Wei PC, 2012, MOL CELL, V48, P747, DOI 10.1016/j.molcel.2012.10.007; WELCH WJ, 1983, J BIOL CHEM, V258, P7102; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Xiao RY, 2005, J BIOL CHEM, V280, P21099, DOI 10.1074/jbc.M411476200; Xiong Y., 2012, INT J CELL BIOL, V2012, P273549, DOI 10.1155/2012/273549; Yan M, 2011, BIOCHEM J, V438, P447, DOI 10.1042/BJ20110500; Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524; Yang Y, 2011, J PROTEOME RES, V10, P4647, DOI 10.1021/pr200455s	68	36	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7541	7557		10.1074/jbc.M115.694810	http://dx.doi.org/10.1074/jbc.M115.694810			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26865632	Green Published, hybrid			2022-12-28	WOS:000383447600028
J	Vuorenpaa, A; Jorgensen, TN; Newman, AH; Madsen, KL; Scheinin, M; Gether, U				Vuorenpaeaa, Anne; Jorgensen, Trine N.; Newman, Amy H.; Madsen, Kenneth L.; Scheinin, Mika; Gether, Ulrik			Differential Internalization Rates and Postendocytic Sorting of the Norepinephrine and Dopamine Transporters Are Controlled by Structural Elements in the N Termini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dopamine transporter; monoamine transporter; neurotransmitter transport; protein chimera; trafficking; internalization; norepinephrine transporter; recycling; transporter regulation	PROTEIN-KINASE-C; ENDOCYTIC RECYCLING SIGNAL; GAMMA-AMINOBUTYRIC-ACID; TRANS-GOLGI NETWORK; SURFACE EXPRESSION; CELL-LINES; SUBCELLULAR-LOCALIZATION; MEDIATED INTERNALIZATION; ORTHOSTATIC INTOLERANCE; LYSOSOMAL DEGRADATION	The norepinephrine transporter (NET) mediates reuptake of synaptically released norepinephrine in central and peripheral noradrenergic neurons. The molecular processes governing availability of NET in the plasma membrane are poorly understood. Here we use the fluorescent cocaine analogue JHC 1-64, as well as several other approaches, to investigate the trafficking itinerary of NET in live noradrenergic neurons. Confocal imaging revealed extensive constitutive internalization of JHC 1-64-labeled NET in the neuronal somata, proximal extensions and presynaptic boutons. Phorbol 12-myristate 13-acetate increased intracellular accumulation of JHC 1-64-labeled NET and caused a parallel reduction in uptake capacity. Internalized NET strongly colocalized with the long loop recycling marker Rab11, whereas less overlap was seen with the short loop recycling marker Rab4 and the late endosomal marker Rab7. Moreover, mitigating Rab11 function by overexpression of dominant negative Rab11 impaired NET function. Sorting of NET to the Rab11 recycling compartment was further supported by confocal imaging and reversible biotinylation experiments in transfected differentiated CATH.a cells. In contrast to NET, the dopamine transporter displayed markedly less constitutive internalization and limited sorting to the Rab11 recycling compartment in the differentiated CATH.a cells. Exchange of domains between the two homologous transporters revealed that this difference was determined by non-conserved structural elements in the intracellular N terminus. We conclude that NET displays a distinct trafficking itinerary characterized by continuous shuffling between the plasma membrane and the Rab11 recycling compartment and that the functional integrity of the Rab11 compartment is critical for maintaining proper presynaptic NET function.	[Vuorenpaeaa, Anne; Jorgensen, Trine N.; Madsen, Kenneth L.; Gether, Ulrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Neuropharmacol & Genet Lab,Panum Inst 18 6, DK-2200 Copenhagen N, Denmark; [Vuorenpaeaa, Anne; Scheinin, Mika] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, FI-20014 Turku, Finland; [Vuorenpaeaa, Anne; Scheinin, Mika] Turku Univ Hosp, Clin Pharmacol Unit, FI-20520 Turku, Finland; [Newman, Amy H.] NIDA, Med Chem Sect, Intramural Res Program, NIH, Baltimore, MD 21224 USA	University of Copenhagen; University of Turku; University of Turku; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Gether, U (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Neuropharmacol & Genet Lab,Panum Inst 18 6, DK-2200 Copenhagen N, Denmark.	gether@sund.ku.dk	Madsen, Kenneth/C-7778-2012	Madsen, Kenneth/0000-0001-9274-6691; Scheinin, Mika/0000-0001-7579-9126; Gether, Ulrik/0000-0002-0020-3807	FinPharma Doctoral program; National Institutes of Health [P01 DA 12408]; Danish Council for Independent Research-Medical Sciences; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000610, P01DA012408] Funding Source: NIH RePORTER	FinPharma Doctoral program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation Center for Biomembranes in Nanomedicine; Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the FinPharma Doctoral program (to A. V.), National Institutes of Health Grant P01 DA 12408 (to U. G.), the Danish Council for Independent Research-Medical Sciences (to U. G.), the Lundbeck Foundation Center for Biomembranes in Nanomedicine (to U. G.), and the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health (to A. H. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P733; Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P744; Arapulisamy O, 2013, J BIOL CHEM, V288, P28599, DOI 10.1074/jbc.M113.472878; Axelrod J, 1969, Prog Brain Res, V31, P21; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Biber K, 1997, J NEUROSCI, V17, P4956; Block ER, 2015, J NEUROSCI, V35, P12845, DOI 10.1523/JNEUROSCI.1391-15.2015; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Brown A, 2004, AM J PHYSIOL-CELL PH, V286, pC1071, DOI 10.1152/ajpcell.00291.2003; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; BUCK KJ, 1994, P NATL ACAD SCI USA, V91, P12584, DOI 10.1073/pnas.91.26.12584; Cha JH, 2005, J MED CHEM, V48, P7513, DOI 10.1021/jm050431y; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Ding YS, 2010, SYNAPSE, V64, P30, DOI 10.1002/syn.20696; Dipace C, 2007, MOL PHARMACOL, V71, P230, DOI 10.1124/mol.106.026690; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Fornes A, 2008, BIOCHEM J, V412, P495, DOI 10.1042/BJ20071018; Furman CA, 2009, NEUROSCI LETT, V463, P78, DOI 10.1016/j.neulet.2009.07.049; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; GEFFEN LB, 1971, PHYSIOL REV, V51, P98, DOI 10.1152/physrev.1971.51.1.98; GIROS B, 1994, J BIOL CHEM, V269, P15985; Gonzalez MI, 2007, J NEUROCHEM, V103, P1917, DOI 10.1111/j.1471-4159.2007.04881.x; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gu HH, 2001, MOL BIOL CELL, V12, P3797, DOI 10.1091/mbc.12.12.3797; Hahn MK, 2003, J NEUROSCI, V23, P4470; Holst B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001542; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Kim CH, 2006, P NATL ACAD SCI USA, V103, P19164, DOI 10.1073/pnas.0510836103; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; LIVETT BG, 1973, BRIT MED BULL, V29, P93, DOI 10.1093/oxfordjournals.bmb.a071003; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Mannangatti P, 2011, J BIOL CHEM, V286, P20239, DOI 10.1074/jbc.M111.226811; Matthies HJG, 2010, J NEUROSCI, V30, P7863, DOI 10.1523/JNEUROSCI.4574-09.2010; Matthies HJG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-65; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McCann UD, 1998, J NEUROSCI, V18, P8417; Miner LH, 2003, J COMP NEUROL, V466, P478, DOI 10.1002/cne.10898; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Muth TR, 1998, J BIOL CHEM, V273, P25616, DOI 10.1074/jbc.273.40.25616; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; Perego C, 1997, J BIOL CHEM, V272, P6584, DOI 10.1074/jbc.272.10.6584; Qi YP, 1997, J NEUROSCI, V17, P1217; Rahbek-Clemmensen T, 2014, J BIOL CHEM, V289, P23004, DOI 10.1074/jbc.M113.495754; RAITERI M, 1977, EUR J PHARMACOL, V41, P133, DOI 10.1016/0014-2999(77)90202-3; Rajamanickam J, 2015, BIOCHEM J, V468, P177, DOI 10.1042/BJ20140826; Rickhag M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2568; Rumantir MS, 2000, HYPERTENSION, V36, P824, DOI 10.1161/01.HYP.36.5.824; Savchenko V, 2003, MOL CELL NEUROSCI, V24, P1131, DOI 10.1016/S1044-7431(03)00235-5; Schramm NL, 1999, J BIOL CHEM, V274, P24935, DOI 10.1074/jbc.274.35.24935; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sung U, 2003, J NEUROSCI, V23, P1697; SURI C, 1993, J NEUROSCI, V13, P1280; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; Vina-Vilaseca A, 2010, J BIOL CHEM, V285, P7645, DOI 10.1074/jbc.M109.058990; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Yamamoto BK, 1998, J NEUROCHEM, V71, P274; Zhang K, 2013, J NEUROSCI, V33, P7451, DOI 10.1523/JNEUROSCI.4322-12.2013; Zoli M, 1999, TRENDS PHARMACOL SCI, V20, P142, DOI 10.1016/S0165-6147(99)01343-7	78	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5634	5651		10.1074/jbc.M115.702050	http://dx.doi.org/10.1074/jbc.M115.702050			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786096	Green Published, hybrid			2022-12-28	WOS:000372551800016
J	Booy, EP; McRae, EKS; Howard, R; Deo, SR; Ariyo, EO; Dzananovic, E; Meier, M; Stetefeld, J; McKenna, SA				Booy, Evan P.; McRae, Ewan K. S.; Howard, Ryan; Deo, Soumya R.; Ariyo, Emmanuel O.; Dzananovic, Edis; Meier, Markus; Stetefeld, Joerg; McKenna, Sean A.			RNA Helicase Associated with AU-rich Element (RHAU/DHX36) Interacts with the 3 '-Tail of the Long Non-coding RNA BC200 (BCYRN1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-quadruplex; long noncoding RNA (long ncRNA; lncRNA); RNA helicase; RNA structure; RNA-protein interaction; BC200; BCYRN1; DHX36; RHAU; telomerase RNA	G-QUADRUPLEX STRUCTURES; CIRCULAR-DICHROISM; MESSENGER-RNA; TETRAMOLECULAR QUADRUPLEX; SECONDARY STRUCTURE; RESOLVING ACTIVITY; HIGH-AFFINITY; MAJOR SOURCE; DNA; EXPRESSION	RNA helicase associated with AU-rich element (RHAU) is an ATP-dependent RNA helicase that demonstrates high affinity for quadruplex structures in DNA and RNA. To elucidate the significance of these quadruplex-RHAU interactions, we have performed RNA co-immunoprecipitation screens to identify novel RNAs bound to RHAU and characterize their function. In the course of this study, we have identified the non-coding RNA BC200 (BCYRN1) as specifically enriched upon RHAU immunoprecipitation. Although BC200 does not adopt a quadruplex structure and does not bind the quadruplex-interacting motif of RHAU, it has direct affinity for RHAU in vitro. Specifically designed BC200 truncations and RNase footprinting assays demonstrate that RHAU binds to an adenosine-rich region near the 3-end of the RNA. RHAU truncations support binding that is dependent upon a region within the C terminus and is specific to RHAU isoform 1. Tests performed to assess whether BC200 interferes with RHAU helicase activity have demonstrated the ability of BC200 to act as an acceptor of unwound quadruplexes via a cytosine-rich region near the 3-end of the RNA. Furthermore, an interaction between BC200 and the quadruplex-containing telomerase RNA was confirmed by pull-down assays of the endogenous RNAs. This leads to the possibility that RHAU may direct BC200 to bind and exert regulatory functions at quadruplex-containing RNA or DNA sequences.	[Booy, Evan P.; McRae, Ewan K. S.; Howard, Ryan; Deo, Soumya R.; Ariyo, Emmanuel O.; Dzananovic, Edis; Meier, Markus; Stetefeld, Joerg; McKenna, Sean A.] Univ Manitoba, Dept Chem, Rm 380 Parker Bldg,144 Dysart Rd, Winnipeg, MB R3T 2N2, Canada; [Stetefeld, Joerg; McKenna, Sean A.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba	McKenna, SA (corresponding author), Univ Manitoba, Dept Chem, Rm 380 Parker Bldg,144 Dysart Rd, Winnipeg, MB R3T 2N2, Canada.	sean.mckenna@umanitoba.ca	Meier, Markus/F-2798-2011; Stetefeld, Joerg/H-7630-2017	Meier, Markus/0000-0003-1068-746X; Stetefeld, Joerg/0000-0003-1478-3248; McKenna, Sean/0000-0002-9407-7257	Cancer Research Society; University of Manitoba Faculty of Science; Manitoba Graduate Scholarship; Faculty of Graduate Studies at the University of Manitoba; Research Manitoba; Canada Research Chair program	Cancer Research Society; University of Manitoba Faculty of Science; Manitoba Graduate Scholarship; Faculty of Graduate Studies at the University of Manitoba; Research Manitoba; Canada Research Chair program(Canada Research Chairs)	This work was supported by a grant from the Cancer Research Society.; Supported by the University of Manitoba Faculty of Science.; Supported by a University of Manitoba undergraduate student research award.; Supported by the University of Manitoba Graduate Fellowship and Manitoba Graduate Scholarship.; Supported by the Faculty of Graduate Studies at the University of Manitoba.; Supported by a Research Manitoba graduate student fellowship.; Supported by the Canada Research Chair program.	Ariyo EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144510; Arthanari H, 1998, NUCLEIC ACIDS RES, V26, P3724, DOI 10.1093/nar/26.16.3724; Beaudoin JD, 2014, NUCLEIC ACIDS RES, V42, P1209, DOI 10.1093/nar/gkt904; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Bicker S, 2013, GENE DEV, V27, P991, DOI 10.1101/gad.211243.112; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Blice-Baum AC, 2014, RNA, V20, P103, DOI 10.1261/rna.041442.113; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bole M, 2008, MOL BIOSYST, V4, P1212, DOI 10.1039/b812537f; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Booy Evan P, 2015, Methods Mol Biol, V1259, P125, DOI 10.1007/978-1-4939-2214-7_9; Booy EP, 2014, NUCLEIC ACIDS RES, V42, P3346, DOI 10.1093/nar/gkt1340; Booy Evan P, 2012, Methods Mol Biol, V941, P69, DOI 10.1007/978-1-62703-113-4_6; Bosch PC, 2014, EMBO J, V33, P2521, DOI 10.15252/embj.201488663; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Bugaut A, 2010, ORG BIOMOL CHEM, V8, P2771, DOI 10.1039/c002418j; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Chen MC, 2015, NUCLEIC ACIDS RES, V43, P2223, DOI 10.1093/nar/gkv051; Chen W, 1997, J PATHOL, V183, P345, DOI 10.1002/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Gao X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.571; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Gros J, 2008, CHEMBIOCHEM, V9, P2075, DOI 10.1002/cbic.200800300; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Iacoangeli A, 2004, CARCINOGENESIS, V25, P2125, DOI 10.1093/carcin/bgh228; Iwamoto F, 2008, EXP CELL RES, V314, P1378, DOI 10.1016/j.yexcr.2008.01.006; Jodoin R, 2014, RNA, V20, P1129, DOI 10.1261/rna.044578.114; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; LABUDA D, 1994, J MOL EVOL, V39, P506; Lai JC, 2012, BLOOD, V119, P4291, DOI 10.1182/blood-2011-08-362954; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lattmann S, 2011, NUCLEIC ACIDS RES, V39, P9390, DOI 10.1093/nar/gkr630; Lattmann S, 2010, NUCLEIC ACIDS RES, V38, P6219, DOI 10.1093/nar/gkq372; Li Xianglan, 2005, Nucleic Acids Symp Ser (Oxf), P313; LUKIW WJ, 1992, NEUROCHEM RES, V17, P591, DOI 10.1007/BF00968788; Meier M, 2013, J BIOL CHEM, V288, P35014, DOI 10.1074/jbc.M113.512970; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Mus E, 2007, P NATL ACAD SCI USA, V104, P10679, DOI 10.1073/pnas.0701532104; OLSTHOORN CSM, 1981, EUR J BIOCHEM, V115, P309, DOI 10.1111/j.1432-1033.1981.tb05240.x; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Perez DS, 2008, HUM MOL GENET, V17, P642, DOI 10.1093/hmg/ddm336; Raiber EA, 2012, NUCLEIC ACIDS RES, V40, P1499, DOI 10.1093/nar/gkr882; Sexton AN, 2011, MOL CELL BIOL, V31, P736, DOI 10.1128/MCB.01033-10; Shahid R, 2010, BIOCHEMISTRY-US, V49, P8300, DOI 10.1021/bi100957h; Simonsson T, 2001, BIOL CHEM, V382, P621, DOI 10.1515/BC.2001.073; Skryabin BV, 1998, J MOL EVOL, V47, P677, DOI 10.1007/PL00006426; Suhl JA, 2014, HUM MOL GENET, V23, P5479, DOI 10.1093/hmg/ddu272; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Vorlickova M, 2012, METHODS, V57, P64, DOI 10.1016/j.ymeth.2012.03.011; WATSON JB, 1987, MOL CELL BIOL, V7, P3324, DOI 10.1128/MCB.7.9.3324; Wu P, 2013, BRAIN RES BULL, V97, P69, DOI 10.1016/j.brainresbull.2013.06.001; Yoo JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004012; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200; Zhang Y, 2014, RNA BIOL, V11, P1364, DOI 10.1080/15476286.2014.996464	63	31	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5355	5372		10.1074/jbc.M115.711499	http://dx.doi.org/10.1074/jbc.M115.711499			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26740632	Green Published, hybrid			2022-12-28	WOS:000371640600044
J	Liu, Q; Tao, B; Liu, GZ; Chen, GL; Zhu, QA; Yu, Y; Yu, Y; Xiong, H				Liu, Qian; Tao, Bo; Liu, Guizhu; Chen, Guilin; Zhu, Qian; Yu, Ying; Yu, Yu; Xiong, Hong			Thromboxane A(2) Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase ( MAPK)mediated G(2)/M Progression Delay and Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOOXYGENASE-2 COX-2; CYCLE PROGRESSION; CARCINOMA CELLS; ERK ACTIVATION; ARREST; EXPRESSION; GROWTH; SIGNAL; MAPK; PHOSPHORYLATION	Multiple myeloma (MM) is a plasma cell malignancy without effective therapeutics. Thromboxane A(2) (TxA(2))/TxA(2) receptor (T prostanoid receptor (TP)) modulates the progression of some carcinomas; however, its effects on MM cell proliferation remain unclear. In this study, we evaluated cyclooxygenase (COX) enzymes and downstream prostaglandin profiles in human myeloma cell lines RPMI-8226 and U-266 and analyzed the effects of COX-1/-2 inhibitors SC-560 and NS-398 on MM cell proliferation. Our observations implicate COX-2 as being involved in modulating cell proliferation. We further incubated MM cells with prostaglandin receptor antagonists or agonists and found that only the TP antagonist, SQ29548, suppressed MM cell proliferation. TP silencing and the TP agonist, U46619, further confirmed this finding. Moreover, SQ29548 and TP silencing promoted MM cell G(2)/M phase delay accompanied by reducing cyclin B1/cyclin-dependent kinase-1 (CDK1) mRNA and protein expression. Notably, cyclin B1 overexpression rescued MM cells from G2/M arrest. We also found that the TP agonist activated JNK and p38 MAPK phosphorylation, and inhibitors of JNK and p38 MAPK depressed U46619-induced proliferation and cyclin B1/CDK1 protein expression. In addition, SQ29548 and TP silencing led to the MM cell apoptotic rate increasing with improving caspase 3 activity. The knockdown of caspase 3 reversed the apoptotic rate. Taken together, our results suggest that TxA2/TP promotes MM cell proliferation by reducing cell delay at G2/M phase via elevating p38 MAPK/JNK-mediated cyclin B1/CDK1 expression and hindering cell apoptosis. The TP inhibitor has potential as a novel agent to target kinase cascades for MM therapy.	[Liu, Qian; Tao, Bo; Liu, Guizhu; Chen, Guilin; Zhu, Qian; Yu, Ying; Yu, Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, 294 Taiyuan Rd, Shanghai 200031, Peoples R China; [Liu, Qian; Xiong, Hong] Shanghai Xuhui Dist Cent Hosp, 966 Middle Huaihai Rd, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yu, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.; Xiong, H (corresponding author), Shanghai Xuhui Dist Cent Hosp, 966 Middle Huaihai Rd, Shanghai 200031, Peoples R China.	yuyu@sibs.ac.cn; hxiong@scrc.ac.cn		Yu, Yu/0000-0003-2291-0606	Ministry of Science and Technology of China [2012CB945100]; National Natural Science Foundation of China [91439204, 31371154, 81470366]; Science and Technology Commission of Shanghai Municipality [14JC1407400, 13ZR1438800]; Science and Technology Service Network Initiative [KFJ-EW-STS-099]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Service Network Initiative	This work was supported by Ministry of Science and Technology of China Grant 2012CB945100; National Natural Science Foundation of China Grants 91439204, 31371154, and 81470366; Science and Technology Commission of Shanghai Municipality Grants 14JC1407400 and 13ZR1438800; and Science and Technology Service Network Initiative Grant KFJ-EW-STS-099. The authors declare that they have no conflicts of interest with the contents of this article.	Baek SH, 2015, IMMUNOPHARM IMMUNOT, V37, P265, DOI 10.3109/08923973.2015.1027916; Bolla M, 2002, J VASC RES, V39, P353, DOI 10.1159/000065547; Brenner H, 2008, BLOOD, V111, P2521, DOI 10.1182/blood-2007-08-104984; Brown NR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7769; Chien CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099729; Ding J, 2006, MOL CARCINOGEN, V45, P250, DOI 10.1002/mc.20175; Du LH, 2004, J BIOL CHEM, V279, P11957, DOI 10.1074/jbc.M304935200; Ekambaram P, 2011, CANCER METAST REV, V30, P397, DOI 10.1007/s10555-011-9297-9; Elder DJE, 2002, INT J CANCER, V99, P323, DOI 10.1002/ijc.10330; Feng YM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1137-9; Gao YL, 2001, J PHARMACOL EXP THER, V296, P426; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gustafsson A, 2007, ACTA ONCOL, V46, P1107, DOI 10.1080/02841860701403061; Hatashita M, 2014, INT J MOL MED, V33, P406, DOI 10.3892/ijmm.2013.1568; Hermenegildo C, 2005, J PHARMACOL EXP THER, V315, P722, DOI 10.1124/jpet.105.090456; Hideshima T, 2003, ONCOGENE, V22, P8797, DOI 10.1038/sj.onc.1206919; Huang RY, 2014, J CANCER RES CLIN, V140, P375, DOI 10.1007/s00432-013-1573-3; Kharaziha P, 2012, CANCER RES, V72, P5348, DOI 10.1158/0008-5472.CAN-12-0658; Ladetto M, 2005, BLOOD, V105, P4784, DOI 10.1182/blood-2004-11-4201; Lei Y, 2011, EUR J PHARMACOL, V650, P629, DOI 10.1016/j.ejphar.2010.10.038; Li JP, 2015, DRUG DES DEV THER, V9, P1627, DOI 10.2147/DDDT.S75378; Li QB, 2007, ACTA PHARMACOL SIN, V28, P1031, DOI 10.1111/j.1745-7254.2007.00550.x; Li XL, 2009, CARCINOGENESIS, V30, P1606, DOI 10.1093/carcin/bgp161; Lin X, 2005, J NEUROCHEM, V93, P257, DOI 10.1111/j.1471-4159.2004.02969.x; Liu LF, 2012, J PINEAL RES, V53, P60, DOI 10.1111/j.1600-079X.2011.00971.x; Liu X, 2006, ANTI-CANCER DRUG, V17, P173, DOI 10.1097/00001813-200602000-00008; LOHKA MJ, 1988, P NATL ACAD SCI USA, V85, P3009, DOI 10.1073/pnas.85.9.3009; Lv CT, 2013, MAR DRUGS, V11, P316, DOI 10.3390/md11020316; Ma YY, 2014, LEUKEMIA LYMPHOMA, V55, P2597, DOI 10.3109/10428194.2013.879128; Medicherla S, 2008, ANTICANCER RES, V28, P3827; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; MORINELLI TA, 1994, J BIOL CHEM, V269, P5693; Moussa O, 2008, ONCOGENE, V27, P55, DOI 10.1038/sj.onc.1210629; Moussa O, 2008, CANCER RES, V68, P4097, DOI 10.1158/0008-5472.CAN-07-6560; Nakanishi Y, 2001, EUR J CANCER, V37, P1570, DOI 10.1016/S0959-8049(01)00160-5; Nie D, 2002, CELL MOL LIFE SCI, V59, P799, DOI 10.1007/s00018-002-8468-9; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; RAYCHOWDHURY MK, 1994, J BIOL CHEM, V269, P19256; Sheu ML, 2005, ARTERIOSCL THROM VAS, V25, P539, DOI 10.1161/01.ATV.0000155462.24263.e4; Strillacci A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/828045; Su CC, 2014, ANTICANCER RES, V34, P7097; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Trojan A, 2006, SWISS MED WKLY, V136, P400; Wei JY, 2010, LUNG CANCER, V69, P26, DOI 10.1016/j.lungcan.2009.09.009; Yuan J, 2006, ONCOGENE, V25, P1753, DOI 10.1038/sj.onc.1209202; Zhang J, 2013, CIRC RES, V113, P104, DOI 10.1161/CIRCRESAHA.113.301033; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140772	50	23	25	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4779	4792		10.1074/jbc.M115.683052	http://dx.doi.org/10.1074/jbc.M115.683052			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26724804	Green Published, hybrid			2022-12-28	WOS:000371604600043
J	Tian, YF; Gawlak, G; O'Donnell, JJ; Birukova, AA; Birukov, KG				Tian, Yufeng; Gawlak, Grzegorz; O'Donnell, James J., III; Birukova, Anna A.; Birukov, Konstantin G.			Activation of Vascular Endothelial Growth Factor ( VEGF) Receptor 2 Mediates Endothelial Permeability Caused by Cyclic Stretch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED LUNG INJURY; BARRIER-PROTECTIVE RESPONSE; OXIDIZED PHOSPHOLIPIDS; SHEAR-STRESS; CELL JUNCTIONS; MECHANOSENSORY COMPLEX; TIGHT JUNCTIONS; BETA-CATENIN; CADHERIN; RHO	High tidal volume mechanical ventilation and the resultant excessive mechanical forces experienced by lung vascular endothelium are known to lead to increased vascular endothelial leak, but the underlying molecular mechanisms remain incompletely understood. One reported mechanotransduction pathway of increased endothelial cell (EC) permeability caused by high magnitude cyclic stretch (18% CS) involves CS-induced activation of the focal adhesion associated signalosome, which triggers Rho GTPase signaling. This study identified an alternative pathway of CS-induced EC permeability. We show here that high magnitude cyclic stretch (18% CS) rapidly activates VEGF receptor 2 (VEGFR2) signaling by dissociating VEGFR2 from VE-cadherin at the cell junctions. This results in VEGFR2 activation, Src-dependent VE-cadherin tyrosine phosphorylation, and internalization leading to increased endothelial permeability. This process is also accompanied by CS-induced phosphorylation and internalization of PECAM1. Importantly, CS-induced endothelial barrier disruption was attenuated by VEGFR2 inhibition. 18% CS-induced EC permeability was linked to dissociation of cell junction scaffold afadin from the adherens junctions. Forced expression of recombinant afadin in pulmonary endothelium attenuated CS-induced VEGFR2 and VE-cadherin phosphorylation, preserved adherens junction integrity and VEGFR2.VE-cadherin complex, and suppressed CS-induced EC permeability. This study shows for the first time a mechanism whereby VEGFR2 activation mediates EC permeability induced by pathologically relevant cyclic stretch. In this mechanism, CS induces dissociation of the VE-cadherin.VEGFR2 complex localized at the adherens juctions, causing activation of VEGFR2, VEGFR2-mediated Src-dependent phosphorylation of VE-cadherin, disassembly of adherens junctions, and EC barrier failure.	Univ Chicago, Lung Injury Ctr, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Birukov, KG (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Med, Lung Injury Ctr, 5841 S Maryland Ave,Off N-611, Chicago, IL 60637 USA.	kbirukov@medicine.bsd.uchicago.edu	Birukov, Konstantin/FJB-5755-2022		NHLBI, National Institutes of Health [HL87823, HL076259, HL107920, GM114171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL107920, R01HL076259, R01HL107920, R01HL087823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114171] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NHLBI, National Institutes of Health Grants HL87823, HL076259, HL107920, and GM114171. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdulnour REE, 2006, AM J PHYSIOL-LUNG C, V291, pL345, DOI 10.1152/ajplung.00453.2005; Amado-Azevedo J, 2014, CELL TISSUE RES, V355, P557, DOI 10.1007/s00441-014-1828-6; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725; Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2007, J CELL PHYSIOL, V211, P608, DOI 10.1002/jcp.20966; Birukova AA, 2013, MOL BIOL CELL, V24, P2678, DOI 10.1091/mbc.E13-02-0098; Birukova AA, 2012, J CELL PHYSIOL, V227, P3405, DOI 10.1002/jcp.24041; Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011; Birukova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030957; Birukova AA, 2012, J CELL PHYSIOL, V227, P1883, DOI 10.1002/jcp.22916; Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Birukova AA, 2010, TRANSL RES, V155, P44, DOI 10.1016/j.trsl.2009.09.002; Birukova AA, 2009, J APPL PHYSIOL, V107, P1900, DOI 10.1152/japplphysiol.00462.2009; Birukova AA, 2008, EXP CELL RES, V314, P3466, DOI 10.1016/j.yexcr.2008.09.003; Cavanaugh KJ, 2002, AM J PHYSIOL-CELL PH, V283, pC1801, DOI 10.1152/ajpcell.00341.2002; Chiu YJ, 2008, J CELL BIOL, V182, P753, DOI 10.1083/jcb.200801062; Cohen TS, 2008, EUR RESPIR J, V32, P854, DOI 10.1183/09031936.00141007; Conway Daniel, 2012, F1000 Biol Rep, V4, P1, DOI 10.3410/B4-1; Coon BG, 2015, J CELL BIOL, V208, P975, DOI 10.1083/jcb.201408103; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; DiPaolo BC, 2012, AM J PHYSIOL-LUNG C, V302, pL992, DOI 10.1152/ajplung.00175.2011; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Eggers CT, 2009, J BIOL CHEM, V284, P32869, DOI 10.1074/jbc.M109.022582; Frank JA, 2003, CRIT CARE, V7, P233, DOI 10.1186/cc1829; Fujiwara K, 2006, J INTERN MED, V259, P373, DOI 10.1111/j.1365-2796.2006.01623.x; Gavard Julie, 2014, Cell Adh Migr, V8, P158; Gawlak G, 2014, FASEB J, V28, P3249, DOI 10.1096/fj.13-245142; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Iwaki M, 2009, BIOCHEM BIOPH RES CO, V389, P531, DOI 10.1016/j.bbrc.2009.09.020; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Lambeng N, 2005, CIRC RES, V96, P384, DOI 10.1161/01.RES.0000156652.99586.9f; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Matsuzaki I, 2005, AM J PHYSIOL-HEART C, V288, pH336, DOI 10.1152/ajpheart.00025.2004; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Peng FF, 2010, CELL SIGNAL, V22, P34, DOI 10.1016/j.cellsig.2009.09.003; Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012; Privratsky JR, 2014, CELL TISSUE RES, V355, P607, DOI 10.1007/s00441-013-1779-3; Sarelius IH, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.985954; Schlegel N, 2014, CELL TISSUE RES, V355, P587, DOI 10.1007/s00441-013-1755-y; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001; Singh AJ, 2005, MOL BIOL CELL, V16, P2106, DOI 10.1091/mbc.E04-08-0749; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Sun HR, 2006, MICROCIRCULATION, V13, P237, DOI 10.1080/10739680600556944; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Tawa H, 2010, CIRC RES, V106, P1731, DOI 10.1161/CIRCRESAHA.110.216747; Tschumperlin DJ, 2000, AM J RESP CRIT CARE, V162, P357, DOI 10.1164/ajrccm.162.2.9807003; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Uhlig S, 2002, AM J PHYSIOL-LUNG C, V282, pL892, DOI 10.1152/ajplung.00124.2001; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Zimman A, 2007, ARTERIOSCL THROM VAS, V27, P332, DOI 10.1161/01.ATV.0000252842.57585.df	72	42	42	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10032	10045		10.1074/jbc.M115.690487	http://dx.doi.org/10.1074/jbc.M115.690487			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26884340	Green Published, hybrid			2022-12-28	WOS:000375602800016
J	Malecki, J; Dahl, HA; Moen, A; Davydova, E; Falnes, PO				Malecki, Jedrzej; Dahl, Helge-Andre; Moen, Anders; Davydova, Erna; Falnes, Pal O.			The METTL20 Homologue from Agrobacterium tumefaciens Is a Dual Specificity Protein-lysine Methyltransferase That Targets Ribosomal Protein L7/L12 and the beta Subunit of Electron Transfer Flavoprotein (ETF beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; COA DEHYDROGENASE; GTPASE ACTIVATION; MASS-SPECTROMETRY; ESCHERICHIA-COLI; MEDIUM-CHAIN; EF-G; METHYLATION; MITOCHONDRIA; TRANSLATION	Human METTL20 is a mitochondrial, lysine-specific methyltransferase that methylates the beta-subunit of electron transfer flavoprotein (ETF beta). Interestingly, putative METTL20 orthologues are found in a subset of alpha-proteobacteria, including Agrobacterium tumefaciens. Using an activity-based approach, we identified in bacterial extracts two substrates of recombinant METTL20 from A. tumefaciens (AtMETTL20), namely ETF beta and the ribosomal protein RpL7/L12. We show that AtMETTL20, analogous to the human enzyme, methylates ETF beta on Lys-193 and Lys-196 both in vitro and in vivo. ETF plays a key role in mediating electron transfer from various dehydrogenases, and we found that its electron transferring ability was diminished by AtMETTL20-mediated methylation of ETF beta. Somewhat surprisingly, AtMETTL20 also catalyzed monomethylation of RpL7/L12 on Lys-86, a common modification also found in many bacteria that lack METTL20. Thus, we here identify AtMETTL20 as the first enzyme catalyzing RpL7/L12 methylation. In summary, here we have identified and characterized a novel bacterial lysine-specific methyltransferase with unprecedented dual substrate specificity within the seven beta-strand class of lysine-specific methyltransferases, as it targets two apparently unrelated substrates, ETF beta and RpL7/L12. Moreover, the present work establishes METTL20-mediated methylation of ETF beta as the first lysine methylation event occurring in both bacteria and humans.	[Malecki, Jedrzej; Dahl, Helge-Andre; Moen, Anders; Davydova, Erna; Falnes, Pal O.] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway	University of Oslo	Falnes, PO (corresponding author), Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway.	pal.falnes@ibv.uio.no	Falnes, Pål Ø./AAA-4581-2020	Davydova, Erna/0000-0001-7072-4539; Falnes, Pal/0000-0001-8114-6025; Malecki, Jedrzej/0000-0003-0825-7962	University of Oslo; Norwegian Cancer Society; Research Council of Norway	University of Oslo; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway)	This work was supported by the University of Oslo and grants from the Norwegian Cancer Society and the Research Council of Norway. The authors declare that they have no conflicts of interest with the contents of this article.	Abeykoon A, 2014, J BIOL CHEM, V289, P7691, DOI 10.1074/jbc.M113.535567; Abeykoon AH, 2012, J BACTERIOL, V194, P6410, DOI 10.1128/JB.01379-12; Alvarez-Venegas R, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00065; Arnold RJ, 1999, ANAL BIOCHEM, V269, P105, DOI 10.1006/abio.1998.3077; Barbier M, 2013, MBIO, V4, DOI 10.1128/mBio.00207-13; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bujnicki Janusz M., 2000, Acta Microbiologica Polonica, V49, P19; CHANG FN, 1978, J BACTERIOL, V135, P1165, DOI 10.1128/JB.135.3.1165-1166.1978; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; Demirci H, 2008, STRUCTURE, V16, P1059, DOI 10.1016/j.str.2008.03.016; Deroo S, 2012, ACS CHEM BIOL, V7, P1120, DOI 10.1021/cb300081s; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Fato R, 1996, BIOCHEMISTRY-US, V35, P2705, DOI 10.1021/bi9516034; Helgstrand M, 2007, J MOL BIOL, V365, P468, DOI 10.1016/j.jmb.2006.10.025; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Lauber MA, 2009, J PROTEOME RES, V8, P4193, DOI 10.1021/pr801114k; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Malecki J, 2015, J BIOL CHEM, V290, P423, DOI 10.1074/jbc.M114.614115; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Moore KE, 2014, BBA-GENE REGUL MECH, V1839, P1395, DOI 10.1016/j.bbagrm.2014.02.008; Moore SD, 2008, P NATL ACAD SCI USA, V105, P11685, DOI 10.1073/pnas.0805633105; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Running WE, 2007, J PROTEOME RES, V6, P337, DOI 10.1021/pr060306q; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; STEENKAMP DJ, 1982, BIOCHEM J, V203, P707, DOI 10.1042/bj2030707; Strader MB, 2004, J PROTEOME RES, V3, P965, DOI 10.1021/pr049940z; Suh MJ, 2005, PROTEOMICS, V5, P4818, DOI 10.1002/pmic.200402111; Tiffany KA, 1997, BIOCHEMISTRY-US, V36, P8455, DOI 10.1021/bi970422u; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; TSAI MH, 1995, RES MICROBIOL, V146, P397, DOI 10.1016/0923-2508(96)80285-3; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06	44	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9581	9595		10.1074/jbc.M115.709261	http://dx.doi.org/10.1074/jbc.M115.709261			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26929405	Green Published, hybrid			2022-12-28	WOS:000375602300017
J	Habisov, S; Huber, J; Ichimura, Y; Akutsu, M; Rogova, N; Loehr, F; McEwan, DG; Johansen, T; Dikic, I; Doetsch, V; Komatsu, M; Rogov, VV; Kirkin, V				Habisov, Sabrina; Huber, Jessica; Ichimura, Yoshinobu; Akutsu, Masato; Rogova, Natalia; Loehr, Frank; McEwan, David G.; Johansen, Terje; Dikic, Ivan; Doetsch, Volker; Komatsu, Masaaki; Rogov, Vladimir V.; Kirkin, Vladimir			Structural and Functional Analysis of a Novel Interaction Motif within UFM1-activating Enzyme 5 (UBA5) Required for Binding to Ubiquitin-like Proteins and Ufmylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE AUTOPHAGY; FOLD MODIFIER; LIR MOTIF; UFM1; UBIQUITIN-FOLD-MODIFIER-1; DEGRADATION; INSIGHTS; LIGASE; ATG8; NBR1	The covalent conjugation of ubiquitin-fold modifier 1 (UFM1) to proteins generates a signal that regulates transcription, response to cell stress, and differentiation. Ufmylation is initiated by ubiquitin-like modifier activating enzyme 5 (UBA5), which activates and transfers UFM1 to ubiquitin-fold modifier-conjugating enzyme 1 (UFC1). The details of the interaction between UFM1 and UBA5 required for UFM1 activation and its downstream transfer are however unclear. In this study, we described and characterized a combined linear LC3-interacting region/UFM1-interacting motif (LIR/UFIM) within the C terminus of UBA5. This single motif ensures that UBA5 binds both UFM1 and light chain 3/gamma-aminobutyric acid receptor-associated proteins (LC3/GABARAP), two ubiquitin (Ub)-like proteins. We demonstrated that LIR/UFIM is required for the full biological activity of UBA5 and for the effective transfer of UFM1 onto UFC1 and a downstream protein substrate both in vitro and in cells. Taken together, our study provides important structural and functional insights into the interaction between UBA5 and Ub-like modifiers, improving the understanding of the biology of the ufmylation pathway.	[Habisov, Sabrina; Kirkin, Vladimir] Merck KGaA, Translat Innovat Platform Oncol, Frankfurter Str 250, D-64293 Darmstadt, Germany; [Habisov, Sabrina; Akutsu, Masato; McEwan, David G.; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Habisov, Sabrina; Akutsu, Masato; Dikic, Ivan] Goethe Univ Frankfurt, BMLS Buchmann Inst Mol Life Sci, Riedberg Campus,Max Von Laue Str 15, D-60438 Frankfurt, Germany; [Huber, Jessica; Rogova, Natalia; Loehr, Frank; Doetsch, Volker; Rogov, Vladimir V.] Goethe Univ Frankfurt, Inst Biophys Chem, Max Von Laue Str 9, D-60438 Frankfurt, Germany; [Huber, Jessica; Rogova, Natalia; Loehr, Frank; Doetsch, Volker; Rogov, Vladimir V.] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Max Von Laue Str 9, D-60438 Frankfurt, Germany; [Ichimura, Yoshinobu; Komatsu, Masaaki] Niigata Univ, Sch Med, Dept Biochem, Chuo Ku, Niigata 9518510, Japan; [McEwan, David G.] Univ Dundee, Sch Life Sci, Div Cell Signaling & Immunol, Dundee DD1 4HN, Scotland; [Johansen, Terje] Arctic Univ Norway, Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway	Merck KGaA; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Niigata University; University of Dundee; UiT The Arctic University of Tromso	Kirkin, V (corresponding author), Merck KGaA, Translat Innovat Platform Oncol, Frankfurter Str 250, D-64293 Darmstadt, Germany.; Rogov, VV (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, Max Von Laue Str 9, D-60438 Frankfurt, Germany.	rogov@bpc.uni-frankfurt.de; vladimir.kirkin@merckgroup.com	McEwan, David/AAY-6264-2020; Johansen, Terje/N-2971-2015; Dikic, Ivan/O-4650-2015; Johansen, Terje/AAY-1753-2021; Komatsu, Masaaki/B-8321-2011; akutsu, masato/L-4095-2016; McEwan, David G/A-3754-2015	Johansen, Terje/0000-0003-1451-9578; Dikic, Ivan/0000-0001-8156-9511; Johansen, Terje/0000-0003-1451-9578; Komatsu, Masaaki/0000-0001-7672-7722; akutsu, masato/0000-0002-9839-3345; Kirkin, Vladimir/0000-0002-8049-3663; Dotsch, Volker/0000-0001-5720-212X; Huber, Jessica/0000-0003-4269-5720; McEwan, David G/0000-0003-0353-6532	European Community [283570]	European Community(European Commission)	We acknowledge the Paul Scherrer Institut, Villigen, Switzerland, for providing synchrotron radiation beam time at beamlines PX and PXIII of the Swiss Light Source and thank Meitian Wang and Vincent Olieric for assistance. The research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (Grant 283570). We thank Sagar Bhogaraju for help with protein purification and Gry Evjen for help with the peptide array analysis of full-length UBA5. We acknowledge members of the Translational Innovation Platform Oncology, Merck KGaA, Andree Blaukat, Matthias Grell, Christiane Amendt, Ralph Lindemann, and Richard Schneider for supporting this work and for critical discussion of the data.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Cai YF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005643; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Genau HM, 2015, MOL CELL, V57, P995, DOI 10.1016/j.molcel.2014.12.040; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hu XL, 2014, INT J MOL MED, V33, P1539, DOI 10.3892/ijmm.2014.1728; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Lystad AH, 2014, EMBO REP, V15, P557, DOI 10.1002/embr.201338003; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Namanja AT, 2012, J BIOL CHEM, V287, P3231, DOI 10.1074/jbc.M111.293118; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rogov VV, 2012, CHEMBIOCHEM, V13, P959, DOI 10.1002/cbic.201200045; Rozenknop A, 2011, J MOL BIOL, V410, P477, DOI 10.1016/j.jmb.2011.05.003; Sasakawa H, 2006, BIOCHEM BIOPH RES CO, V343, P21, DOI 10.1016/j.bbrc.2006.02.107; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Weiergraber OH, 2008, J MOL BIOL, V381, P1320, DOI 10.1016/j.jmb.2008.06.086; Xie ST, 2014, ACTA CRYSTALLOGR F, V70, P765, DOI 10.1107/S2053230X14008826; Yoo HM, 2014, MOL CELL, V56, P261, DOI 10.1016/j.molcel.2014.08.007; Zhang M, 2015, CELL DEATH DIFFER, V22, P1922, DOI 10.1038/cdd.2015.51; Zhang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048587	37	39	40	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9025	9041		10.1074/jbc.M116.715474	http://dx.doi.org/10.1074/jbc.M116.715474			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26929408	hybrid, Green Published			2022-12-28	WOS:000374849000017
J	Zhou, N; Pan, T; Zhang, JS; Li, QW; Zhang, X; Bai, C; Huang, F; Peng, T; Zhang, JH; Liu, C; Tao, L; Zhang, H				Zhou, Nan; Pan, Ting; Zhang, Junsong; Li, Qianwen; Zhang, Xue; Bai, Chuan; Huang, Feng; Peng, Tao; Zhang, Jianhua; Liu, Chao; Tao, Liang; Zhang, Hui			Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEICHOMYCETICUS-NOV-SP; SEMISYNTHETIC DERIVATIVES; NONHUMAN-PRIMATES; CELLULAR ENTRY; TEICOPLANIN; RECEPTOR; MARBURG; GLYCOPROTEIN; PATHOGENESIS; PROTECTION	Ebola virus infection can cause severe hemorrhagic fever with a high mortality in humans. The outbreaks of Ebola viruses in 2014 represented the most serious Ebola epidemics in history and greatly threatened public health worldwide. The development of additional effective anti-Ebola therapeutic agents is therefore quite urgent. In this study, via high throughput screening of Food and Drug Administration-approved drugs, we identified that teicoplanin, a glycopeptide antibiotic, potently prevents the entry of Ebola envelope pseudotyped viruses into the cytoplasm. Furthermore, teicoplanin also has an inhibitory effect on transcription-and replication-competent virus-like particles, with an IC50 as low as 330 nM. Comparative analysis further demonstrated that teicoplanin is able to block the entry of Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) envelope pseudotyped viruses as well. Teicoplanin derivatives such as dalbavancin, oritavancin, and telavancin can also inhibit the entry of Ebola, MERS, and SARS viruses. Mechanistic studies showed that teicoplanin blocks Ebola virus entry by specifically inhibiting the activity of cathepsin L, opening a novel avenue for the development of additional glycopeptides as potential inhibitors of cathepsin L-dependent viruses. Notably, given that teicoplanin has routinely been used in the clinic with low toxicity, our work provides a promising prospect for the prophylaxis and treatment of Ebola, MERS, and SARS virus infection.	[Zhou, Nan; Pan, Ting; Zhang, Junsong; Li, Qianwen; Zhang, Xue; Bai, Chuan; Huang, Feng; Liu, Chao; Zhang, Hui] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China; [Tao, Liang] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510080, Guangdong, Peoples R China; [Zhou, Nan; Pan, Ting; Zhang, Junsong; Li, Qianwen; Zhang, Xue; Bai, Chuan; Huang, Feng; Liu, Chao; Zhang, Hui] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China; [Zhou, Nan; Pan, Ting; Zhang, Junsong; Li, Qianwen; Zhang, Xue; Bai, Chuan; Huang, Feng; Liu, Chao; Zhang, Hui] Sun Yat Sen Univ, Guangdong Engn Res Ctr Antimicrobial Agent & Immu, Guangzhou 510080, Guangdong, Peoples R China; [Peng, Tao] Guangzhou Med Univ, Sinofrench Hoffmann Inst, Guangzhou 510182, Guangdong, Peoples R China; [Zhang, Jianhua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol, Beijing 100101, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Zhang, H (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China.; Zhang, H (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China.; Zhang, H (corresponding author), Sun Yat Sen Univ, Guangdong Engn Res Ctr Antimicrobial Agent & Immu, Guangzhou 510080, Guangdong, Peoples R China.	zhangh92@mail.sysu.edu.cn	Pan, Ting/AAX-1933-2021	Peng, Tao/0000-0001-5260-7128	National Special Research Program for the Important Infectious Diseases [2013ZX10001004]; Guangdong Innovative Research Team Program Grant [2009010058]; National Natural Science Foundation [81590765]	National Special Research Program for the Important Infectious Diseases; Guangdong Innovative Research Team Program Grant; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Special Research Program for the Important Infectious Diseases Grant 2013ZX10001004, Guangdong Innovative Research Team Program Grant 2009010058, and National Natural Science Foundation of Key Projects Grant 81590765 (to H. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Andrault PM, 2015, BIOCHEMISTRY-US, V54, P2785, DOI 10.1021/acs.biochem.5b00231; [Anonymous], 1978, Bull World Health Organ, V56, P247; Balzarini J, 2003, J MED CHEM, V46, P2755, DOI 10.1021/jm0300882; Balzarini J, 2006, ANTIVIR RES, V72, P20, DOI 10.1016/j.antiviral.2006.03.005; Bereczki I, 2014, BIOORG MED CHEM LETT, V24, P3251, DOI 10.1016/j.bmcl.2014.06.018; BORGHI A, 1984, J ANTIBIOT, V37, P615, DOI 10.7164/antibiotics.37.615; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; BROGDEN RN, 1994, DRUGS, V47, P823, DOI 10.2165/00003495-199447050-00008; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Cavalcanti AB, 2010, COCHRANE DB SYST REV, V16; Chan SY, 2001, CELL, V106, P117, DOI 10.1016/S0092-8674(01)00418-4; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Corry J, 2016, J VIROL, V90, P1311, DOI 10.1128/JVI.02351-15; CORTI A, 1985, Journal of Applied Biochemistry, V7, P133; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; De Burghgraeve T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037244; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Gehring G, 2014, J ANTIMICROB CHEMOTH, V69, P2123, DOI 10.1093/jac/dku091; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Geisbert TW, 2003, AM J PATHOL, V163, P2371, DOI 10.1016/S0002-9440(10)63592-4; Gramberg T, 2005, VIROLOGY, V340, P224, DOI 10.1016/j.virol.2005.06.026; JAHRLING PB, 1990, LANCET, V335, P502, DOI 10.1016/0140-6736(90)90737-P; KILEY MP, 1982, INTERVIROLOGY, V18, P24, DOI 10.1159/000149300; Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108; LEGUENNO B, 1995, LANCET, V345, P1271, DOI 10.1016/S0140-6736(95)90925-7; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Maieron A, 2012, J ANTIMICROB CHEMOTH, V67, P2537, DOI 10.1093/jac/dks217; Mingo RM, 2015, J VIROL, V89, P2931, DOI 10.1128/JVI.03398-14; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; O'Hearn A, 2015, J VIROL, V89, P5441, DOI 10.1128/JVI.03689-14; Obeid S, 2011, J ANTIMICROB CHEMOTH, V66, P1287, DOI 10.1093/jac/dkr104; PARENTI F, 1978, J ANTIBIOT, V31, P276, DOI 10.7164/antibiotics.31.276; Pols MS, 2013, TRAFFIC, V14, P219, DOI 10.1111/tra.12027; Preobrazhenskaya MN, 2006, ANTIVIR RES, V71, P227, DOI 10.1016/j.antiviral.2006.04.008; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Rampling T, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1411627, DOI 10.1056/NEJMOA1411627, 10.1056/NEJMoa1411627.]; Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216; Ryabchikova EI, 1999, J INFECT DIS, V179, pS199, DOI 10.1086/514293; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06; Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Takada A, 2000, VIROLOGY, V278, P20, DOI 10.1006/viro.2000.0601; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Wang YZ, 2016, ANTIVIR RES, V125, P1, DOI 10.1016/j.antiviral.2015.11.003; Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027; Watt A, 2014, J VIROL, V88, P10511, DOI 10.1128/JVI.01272-14; Wolf MC, 2010, P NATL ACAD SCI USA, V107, P3157, DOI 10.1073/pnas.0909587107; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	52	181	194	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9218	9232		10.1074/jbc.M116.716100	http://dx.doi.org/10.1074/jbc.M116.716100			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26953343	hybrid, Green Published			2022-12-28	WOS:000374849000032
J	Ballottari, M; Truong, TB; De Re, E; Erickson, E; Stella, GR; Fleming, GR; Bassi, R; Niyogi, KK				Ballottari, Matteo; Truong, Thuy B.; De Re, Eleonora; Erickson, Erika; Stella, Giulio R.; Fleming, Graham R.; Bassi, Roberto; Niyogi, Krishna K.			Identification of pH-sensing Sites in the Light Harvesting Complex Stress-related 3 Protein Essential for Triggering Non-photochemical Quenching in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOPROTECTIVE ENERGY-DISSIPATION; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; XANTHOPHYLL CYCLE; CHLOROPLAST MEMBRANES; THERMAL DISSIPATION; CATION FORMATION; IN-VIVO; STATE; PSBS	Light harvesting complex stress-related 3 (LHCSR3) is the protein essential for photoprotective excess energy dissipation (non-photochemical quenching, NPQ) in the model green alga Chlamydomonas reinhardtii. Activation of NPQ requires low pH in the thylakoid lumen, which is induced in excess light conditions and sensed by lumen-exposed acidic residues. In this work we have used site-specific mutagenesis in vivo and in vitro for identification of the residues in LHCSR3 that are responsible for sensing lumen pH. Lumen-exposed protonatable residues, aspartate and glutamate, were mutated to asparagine and glutamine, respectively. By expression in a mutant lacking all LHCSR isoforms, residues Asp(117), Glu(221), and Glu(224) were shown to be essential for LHCSR3-dependent NPQ induction in C. reinhardtii. Analysis of recombinant proteins carrying the same mutations refolded in vitro with pigments showed that the capacity of responding to low pH by decreasing the fluorescence life time, present in the wild-type protein, was lost. Consistent with a role in pH sensing, the mutations led to a substantial reduction in binding the NPQ inhibitor dicyclohexylcarbodiimide.	[Ballottari, Matteo; Stella, Giulio R.; Bassi, Roberto] Univ Verona, Dept Biotechnol, Str Le Grazie, I-37134 Verona, Italy; [Truong, Thuy B.; Erickson, Erika; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Fleming, Graham R.] Univ Calif Berkeley, Dept Chem, Hildebrand B77, Berkeley, CA 94720 USA; [Stella, Giulio R.] Univ Paris 06, Sorbonne Univ, CNRS, Lab Biol Computat & Quantitat,UMR 7238, 15 Rue Ecole Med, F-75006 Paris, France; [De Re, Eleonora; Erickson, Erika; Fleming, Graham R.; Niyogi, Krishna K.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [De Re, Eleonora; Fleming, Graham R.] Univ Calif Berkeley, Grad Grp Appl Sci & Technol, Berkeley, CA 94720 USA; [Truong, Thuy B.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	University of Verona; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Donald Danforth Plant Science Center	Bassi, R (corresponding author), Univ Verona, Dept Biotechnol, Str Le Grazie, I-37134 Verona, Italy.; Niyogi, KK (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	roberto.bassi@univr.it; niyogi@berkeley.edu	Ballottari, Matteo/N-1916-2019	Ballottari, Matteo/0000-0001-8410-3397; Erickson, Erika/0000-0001-7806-9348; bassi, roberto/0000-0002-4140-8446	U.S. Department of Energy, Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division [449B]; Italian Ministry of Education, University and Research through PRIN ("Progetti di Ricerca di Interesse Nazionale") [2012XSAWYM]; National Science Foundation; Marie Curie Actions Initial Training Networks ACCLIPHOT [PITN-GA-2012-316427]	U.S. Department of Energy, Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division(United States Department of Energy (DOE)); Italian Ministry of Education, University and Research through PRIN ("Progetti di Ricerca di Interesse Nazionale"); National Science Foundation(National Science Foundation (NSF)); Marie Curie Actions Initial Training Networks ACCLIPHOT	This work was supported in part by the U.S. Department of Energy, Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division under field work proposal 449B. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Italian Ministry of Education, University and Research through PRIN ("Progetti di Ricerca di Interesse Nazionale") project 2012XSAWYM.r Supported by a National Science Foundation Graduate Research Fellowship.r Supported by Marie Curie Actions Initial Training Networks ACCLIPHOT Grant PITN-GA-2012-316427.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alboresi A, 2010, P NATL ACAD SCI USA, V107, P11128, DOI 10.1073/pnas.1002873107; Amarnath K, 2012, P NATL ACAD SCI USA, V109, P8405, DOI 10.1073/pnas.1205303109; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Ballottari M, 2004, EUR J BIOCHEM, V271, P4659, DOI 10.1111/j.1432-1033.2004.04426.x; Ballottari M, 2013, J PHYS CHEM B, V117, P11337, DOI 10.1021/jp402977y; Ballottari M, 2012, BBA-BIOENERGETICS, V1817, P143, DOI 10.1016/j.bbabio.2011.06.005; Ballottari M, 2010, J BIOL CHEM, V285, P28309, DOI 10.1074/jbc.M110.124115; Ballottari M, 2009, J BIOL CHEM, V284, P8103, DOI 10.1074/jbc.M808326200; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; Belgio E, 2013, PHYS CHEM CHEM PHYS, V15, P12253, DOI 10.1039/c3cp51925b; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; Cellini B, 2006, BIOCHEMISTRY-US, V45, P14140, DOI 10.1021/bi061496l; Cruz JA, 2005, PHOTOSYNTH RES, V85, P221, DOI 10.1007/s11120-005-4731-x; Dall'Osto L, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0221; de Bianchi S, 2010, BIOCHEM SOC T, V38, P651, DOI 10.1042/BST0380651; DEMMIG B, 1987, PLANT PHYSIOL, V84, P218, DOI 10.1104/pp.84.2.218; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Fan MR, 2015, NAT STRUCT MOL BIOL, V22, P729, DOI 10.1038/nsmb.3068; Ferrante P, 2012, J BIOL CHEM, V287, P16276, DOI 10.1074/jbc.M111.316729; Finazzi G, 1998, BIOCHEMISTRY-US, V37, P9999, DOI 10.1021/bi980320j; Gerotto C, 2011, PLANT CELL ENVIRON, V34, P922, DOI 10.1111/j.1365-3040.2011.02294.x; Ginsberg NS, 2011, P NATL ACAD SCI USA, V108, P3848, DOI 10.1073/pnas.1012054108; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; Gwizdala M, 2013, BBA-BIOENERGETICS, V1827, P348, DOI 10.1016/j.bbabio.2012.11.001; Holleboom CP, 2015, PHOTOSYNTH RES, V124, P171, DOI 10.1007/s11120-015-0113-1; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; HORTON P, 1994, PLANT PHYSIOL, V106, P415, DOI 10.1104/pp.106.2.415; Johnson MP, 2012, PLANTA, V235, P193, DOI 10.1007/s00425-011-1502-0; Kirilovsky D, 2013, PHOTOCH PHOTOBIO SCI, V12, P1135, DOI 10.1039/c3pp25406b; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lepetit B, 2013, PLANT PHYSIOL, V161, P853, DOI 10.1104/pp.112.207811; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Mou SL, 2012, EXTREMOPHILES, V16, P193, DOI 10.1007/s00792-011-0419-7; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; Pandit A, 2013, BBA-BIOENERGETICS, V1827, P738, DOI 10.1016/j.bbabio.2013.02.015; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Pesaresi P, 1997, FEBS LETT, V402, P151, DOI 10.1016/S0014-5793(96)01518-9; Petrou K, 2014, BBA-BIOENERGETICS, V1837, P1533, DOI 10.1016/j.bbabio.2013.11.018; Pinnola A, 2015, J BIOL CHEM, V290, P24340, DOI 10.1074/jbc.M115.668798; Pinnola A, 2013, PLANT CELL, V25, P3519, DOI 10.1105/tpc.113.114538; REES D, 1992, PHOTOSYNTH RES, V31, P11, DOI 10.1007/BF00049532; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Ruban AV, 1999, PLANT PHYSIOL, V119, P531, DOI 10.1104/pp.119.2.531; Ruban AV, 1996, BIOCHEMISTRY-US, V35, P674, DOI 10.1021/bi9524878; RUBAN AV, 1992, FEBS LETT, V309, P175, DOI 10.1016/0014-5793(92)81089-5; RUBAN AV, 1993, PLANT PHYSIOL, V102, P741, DOI 10.1104/pp.102.3.741; SUELTEMEYER DF, 1986, PLANT PHYSIOL, V81, P372, DOI 10.1104/pp.81.2.372; Tokutsu R, 2004, PLANT CELL PHYSIOL, V45, P138, DOI 10.1093/pcp/pch013; Tokutsu R, 2013, P NATL ACAD SCI USA, V110, P10016, DOI 10.1073/pnas.1222606110; Truong T. N, 2011, THESIS; van Oort B, 2007, FEBS LETT, V581, P3528, DOI 10.1016/j.febslet.2007.06.070; Walters RG, 1996, P NATL ACAD SCI USA, V93, P14204, DOI 10.1073/pnas.93.24.14204; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	73	66	68	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7334	7346		10.1074/jbc.M115.704601	http://dx.doi.org/10.1074/jbc.M115.704601			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26817847	Green Published, hybrid			2022-12-28	WOS:000383447600011
J	Fontana, C; Conde-Alvarez, R; Stahle, J; Holst, O; Iriarte, M; Zhao, Y; Arce-Gorvel, V; Hanniffy, S; Gorvel, JP; Moriyon, I; Widmalm, G				Fontana, Carolina; Conde-Alvarez, Raquel; Stahle, Jonas; Holst, Otto; Iriarte, Maite; Zhao, Yun; Arce-Gorvel, Vilma; Hanniffy, Sean; Gorvel, Jean-Pierre; Moriyon, Ignacio; Widmalm, Goran			Structural Studies of Lipopolysaccharide-defective Mutants from Brucella melitensis Identify a Core Oligosaccharide Critical in Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENUS-SPECIFIC EPITOPE; ESCHERICHIA-COLI K-12; CHLAMYDIA LIPOPOLYSACCHARIDE; PEROSAMINE SYNTHETASE; SALMONELLA-MINNESOTA; LIPID-A; NMR; SMOOTH; SPECTROSCOPY; ABORTUS	The structures of the lipooligosaccharides from Brucella melitensis mutants affected in the WbkD and ManB(core) proteins have been fully characterized using NMR spectroscopy. The results revealed that disruption of wbkD gives rise to a rough lipopolysaccharide (R-LPS) with a complete core structure (beta-D-Glcp-(1 -> 4)-alpha-Kdop-(2 -> 4)[beta-D-GlcpN-(1 -> 6)-beta-D-GlcpN-(1 -> 4)[beta-D-GlcpN-(1 -> 6)]-beta-D-GlcpN-(1 -> 3)-alpha-D-Manp-(1 -> 5)]-alpha-Kdop-(2 -> 6)-beta-D-GlcpN3N4P-(1 -> 6)-alpha-D-GlcpN3N1P), in addition to components lacking one of the terminal beta-D-GlcpN and/or the beta-D-Glcp residues (48 and 17%, respectively). These structures were identical to those of the R-LPS from B. melitensis EP, a strain simultaneously expressing both smooth and R-LPS, also studied herein. In contrast, disruption of man-B-core gives rise to a deep-rough pentasaccharide core (beta-D-Glcp-(1 -> 4)-alpha-Kdop-(2 -> 4)-alpha-Kdop-(2 -> 6)-beta-D-GlcpN3N4P-(1 -> 6)-alpha-D-GlcpN3N1P) as the major component (63%), as well as a minor tetrasaccharide component lacking the terminal beta-D-Glcp residue (37%). These results are in agreement with the predicted functions of the WbkD (glycosyltransferase involved in the biosynthesis of the O-antigen) and ManB(core) proteins (phosphomannomutase involved in the biosynthesis of a mannosyl precursor needed for the biosynthesis of the core and O-antigen). We also report that deletion of B. melitensis wadC removes the core oligosaccharide branch not linked to the O-antigen causing an increase in overall negative charge of the remaining LPS inner section. This is in agreement with the mannosyltransferase role predicted for WadC and the lack of GlcpN residues in the defective core oligosaccharide. Despite carrying the O-antigen essential in B. melitensis virulence, the core deficiency in the wadC mutant structure resulted in a more efficient detection by innate immunity and attenuation, proving the role of the beta-D-GlcpN-(1 -> 6)-beta-D-GlcpN-(1 -> 4)[beta-D-GlcpN-(1 -> 6)]-beta-D-GlcpN-(1 -> 3)-alpha-D-Manp-(1 -> 5) structure in virulence.	[Fontana, Carolina; Stahle, Jonas; Widmalm, Goran] Stockholm Univ, Dept Organ Chem, Arrhenius Lab, S-10691 Stockholm, Sweden; [Conde-Alvarez, Raquel; Iriarte, Maite; Moriyon, Ignacio] Univ Navarra, Inst Salud Trop, Inst Invest Sanitaria Navarra, C Irunlarrea 1, Pamplona 31008, Spain; [Conde-Alvarez, Raquel; Iriarte, Maite; Moriyon, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, C Irunlarrea 1, Pamplona 31008, Spain; [Holst, Otto] Airway Res Ctr North, Div Struct Biochem, Leibniz Ctr Med & Biosci, Prior Area Asthma & Allergy,Res Ctr Borstel, D-23845 Borstel, Germany; [Holst, Otto] German Ctr Lung Res, D-23845 Borstel, Germany; [Zhao, Yun; Arce-Gorvel, Vilma; Hanniffy, Sean; Gorvel, Jean-Pierre] Aix Marseille Univ, UM2, Ctr Immunol Marseille Luminy, Marseille, France; [Arce-Gorvel, Vilma; Hanniffy, Sean; Gorvel, Jean-Pierre] INSERM, U1104, Marseille, France; [Arce-Gorvel, Vilma; Hanniffy, Sean; Gorvel, Jean-Pierre] CNRS, UMR7280, Marseille, France	Stockholm University; University of Navarra; University of Navarra; Forschungszentrum Borstel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Widmalm, G (corresponding author), Stockholm Univ, Dept Organ Chem, Arrhenius Lab, S-10691 Stockholm, Sweden.	goran.widmalm@su.se	IRIARTE, MAITE/L-9460-2014; Moriyon, Ignacio/N-4764-2016; Conde-Álvarez, Raquel/K-5854-2014; Gorvel, Jean-Pierre/O-1332-2018; Fontana, Carolina/AAA-3564-2022	IRIARTE, MAITE/0000-0002-6726-8920; Moriyon, Ignacio/0000-0002-4288-0195; Conde-Álvarez, Raquel/0000-0003-0046-3577; Gorvel, Jean-Pierre/0000-0002-2829-9804; Fontana, Carolina/0000-0002-7362-2180; Arce-Gorvel, Vilma/0000-0003-0090-837X; Widmalm, Goran/0000-0001-8303-4481	Swedish Research Council; Knut and Alice Wallenberg Foundation; Ministerio de Economia y Competitividad [AGL2011-30453-C04, AGL2014-58795-C4-1-R]; European Commission [215536]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ministerio de Economia y Competitividad(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Swedish Research Council, the Knut and Alice Wallenberg Foundation, and Ministerio de Economia y Competitividad Grants AGL2011-30453-C04 and AGL2014-58795-C4-1-R; the research that led to these results received funding from the European Commission's Seventh Framework Programme FP7/2007-2013 under Grant Agreement 215536. The authors declare that they have no conflicts of interest with the contents of this article.	Aragon V, 1996, J BACTERIOL, V178, P1070, DOI 10.1128/jb.178.4.1070-1079.1996; Ariza J, 1999, REV MED MICROBIOL, V10, P125; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; BOHLEN JM, 1993, J MAGN RESON SER A, V102, P293, DOI 10.1006/jmra.1993.1107; BOWDEN RA, 1993, J MED MICROBIOL, V39, P363, DOI 10.1099/00222615-39-5-363; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Claridge TDW, 2003, ORG BIOMOL CHEM, V1, P3632, DOI 10.1039/b307122g; Conde-Alvarez R, 2013, MICROB PATHOGENESIS, V58, P29, DOI 10.1016/j.micpath.2012.11.011; Conde-Alvarez R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002675; Dean AS, 2012, PLOS NEGLECT TROP D, V6, DOI [10.1371/journal.pntd.0001929, 10.1371/journal.pntd.0001865]; DEBOER WR, 1976, EUR J BIOCHEM, V62, P1; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Godfroid F, 1998, INFECT IMMUN, V66, P5485, DOI 10.1128/IAI.66.11.5485-5493.1998; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; Grillo MJ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-29; HOLST O, 1990, CARBOHYD RES, V204, P93, DOI 10.1016/0008-6215(90)84024-O; HOLST O, 1993, EUR J BIOCHEM, V214, P703, DOI 10.1111/j.1432-1033.1993.tb17971.x; HOLST O, 1994, EUR J BIOCHEM, V222, P183, DOI 10.1111/j.1432-1033.1994.tb18856.x; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iriarte M., 2004, Brucella: molecular and cellular biology, P159; KELLOGG GW, 1992, J MAGN RESON, V98, P176, DOI 10.1016/0022-2364(92)90122-N; Knirel YA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P41, DOI 10.1007/978-3-7091-0733-1_3; Kubler-Kielb J, 2013, CARBOHYD RES, V366, P33, DOI 10.1016/j.carres.2012.11.004; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Kupce E, 2001, METHOD ENZYMOL, V338, P82; Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003; Mancilla M, 2012, J BACTERIOL, V194, P1860, DOI 10.1128/JB.06561-11; Mancilla M, 2010, J BACTERIOL, V192, P6346, DOI 10.1128/JB.00838-10; McDermott J, 2013, REV SCI TECH OIE, V32, P249; MUHLRADT PF, 1977, EUR J BIOCHEM, V81, P193, DOI 10.1111/j.1432-1033.1977.tb11941.x; Nyberg NT, 2005, J AM CHEM SOC, V127, P6154, DOI 10.1021/ja050878w; Posch G, 2013, CLIN VACCINE IMMUNOL, V20, P945, DOI 10.1128/CVI.00139-13; QURESHI N, 1994, J ENDOTOXIN RES, V1, P137; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Stewart A, 1998, CARBOHYD RES, V313, P193, DOI 10.1016/S0008-6215(98)00271-7; Tannus A, 1997, NMR BIOMED, V10, P423, DOI 10.1002/(SICI)1099-1492(199712)10:8<423::AID-NBM488>3.0.CO;2-X; Turse JE, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00054; Valvano MA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P275, DOI 10.1007/978-3-7091-0733-1_9; Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Zaccheus MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053941; Zartler ER, 2011, J BIOMOL NMR, V51, P357, DOI 10.1007/s10858-011-9563-8; Zhao G, 2007, BIOCHEM BIOPH RES CO, V363, P525, DOI 10.1016/j.bbrc.2007.08.184; Zygmunt MS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-92	47	32	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7727	7741		10.1074/jbc.M115.701540	http://dx.doi.org/10.1074/jbc.M115.701540			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26867577	Green Published, hybrid			2022-12-28	WOS:000383447600042
J	Qi, HL; Prabakaran, S; Cantrelle, FX; Chambraud, B; Gunawardena, J; Lippens, G; Landrieu, I				Qi, Haoling; Prabakaran, Sudhakaran; Cantrelle, Francois-Xavier; Chambraud, Beatrice; Gunawardena, Jeremy; Lippens, Guy; Landrieu, Isabelle			Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; CYCLIN-DEPENDENT KINASES; ALZHEIMER-LIKE STATE; MAP KINASE; ABNORMAL PHOSPHORYLATION; DOCKING INTERACTIONS; MICROTUBULE-BINDING; STRUCTURAL BASIS; HUMAN BRAIN; DISEASE	Tau neuronal protein has a central role in neurodegeneration and is implicated in Alzheimer disease development. Abnormal phosphorylation of Tau impairs its interaction with other proteins and is associated with its dysregulation in pathological conditions. Molecular mechanisms leading to hyperphosphorylation of Tau in pathological conditions are unknown. Here, we characterize phosphorylation of Tau by extracellular-regulated kinase (ERK2), a mitogen-activated kinase (MAPK) that responds to extracellular signals. Analysis of in vitro phosphorylated Tau by activated recombinant ERK2 with nuclear magnetic resonance spectroscopy (NMR) reveals phosphorylation of 15 Ser/Thr sites. In vitro phosphorylation of Tau using rat brain extract and subsequent NMR analysis identifies the same sites. Phosphorylation with rat brain extract is known to transform Tau into an Alzheimer disease-like state. Our results indicate that phosphorylation of Tau by ERK2 alone is sufficient to produce the same characteristics. We further investigate the mechanism of ERK2 phosphorylation of Tau. Kinases are known to recognize their protein substrates not only by their specificity for a targeted Ser or Thr phosphorylation site but also by binding to linear-peptide motifs called docking sites. We identify two main ERK2 docking sites in Tau sequence using NMR. Our results suggest that ERK2 dysregulation in Alzheimer disease could lead to abnormal phosphorylation of Tau resulting in the pathology of the disease.	[Qi, Haoling; Cantrelle, Francois-Xavier; Lippens, Guy; Landrieu, Isabelle] Univ Lille, CNRS, UMR8576, F-59000 Lille, France; [Prabakaran, Sudhakaran; Gunawardena, Jeremy] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Chambraud, Beatrice] Univ Paris 11, INSERM, UMR1195, F-94276 Le Kremlin Bicetre, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Landrieu, I (corresponding author), CNRS, RMN, IRI Bldg,Parc Sci Haute Borne 50,Ave Halley, F-59650 Villeneuve Dascq, France.	isabelle.landrieu@univ-lille1.fr	Landrieu, Isabelle/AAF-8495-2019	Landrieu, Isabelle/0000-0002-4883-2637; Lippens, Guy/0000-0002-8236-0901; Prabakaran, Sudhakaran/0000-0002-6527-1085; cantrelle, francois-xavier/0000-0002-3413-5443	TGE RMN THC (France) [FR-3050]; FRABio (Lille University, CNRS) [FR 3688]; LabEx (Laboratory of Excellence); DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease); French government funding agency Agence Nationale de la Recherche TAF; National Institutes of Health [R01 GM081578]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081578] Funding Source: NIH RePORTER	TGE RMN THC (France); FRABio (Lille University, CNRS); LabEx (Laboratory of Excellence); DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease); French government funding agency Agence Nationale de la Recherche TAF(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by TGE RMN THC (FR-3050, France) and FRABio (Lille University, CNRS, FR 3688) and also by a grant from the LabEx (Laboratory of Excellence), DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease), and in part by the French government funding agency Agence Nationale de la Recherche TAF. This work was supported by National Institutes of Health Grant R01 GM081578 (to S. P. and J. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; ARENDT T, 1995, NEUROSCIENCE, V68, P5, DOI 10.1016/0306-4522(95)00146-A; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Bienkiewicz EA, 1999, J BIOMOL NMR, V15, P203, DOI 10.1023/A:1008375029746; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Courcelles M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.25; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; Fernandes N, 2007, ACS CHEM BIOL, V2, P665, DOI 10.1021/cb700158q; Ferreira A, 1997, MOL CELL NEUROSCI, V9, P220, DOI 10.1006/mcne.1997.0615; Ferrer I, 2001, BRAIN PATHOL, V11, P144; Funk KE, 2014, BIOCHEM J, V462, P77, DOI 10.1042/BJ20140372; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Gotz J, 2010, BBA-MOL BASIS DIS, V1802, P860, DOI 10.1016/j.bbadis.2009.09.008; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; Ho DT, 2006, J BIOL CHEM, V281, P13169, DOI 10.1074/jbc.M601010200; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; KOBAYASHI S, 1993, FEBS LETT, V335, P171, DOI 10.1016/0014-5793(93)80723-8; Kragelj J, 2015, P NATL ACAD SCI USA, V112, P3409, DOI 10.1073/pnas.1419528112; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Leroy A, 2010, J BIOL CHEM, V285, P33435, DOI 10.1074/jbc.M110.149419; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; Lippens G, 2012, BIOCHEM SOC T, V40, P698, DOI 10.1042/BST20120050; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Luna-Vargas MPA, 2011, J STRUCT BIOL, V175, P113, DOI 10.1016/j.jsb.2011.03.017; Ma WF, 2010, STRUCTURE, V18, P1502, DOI 10.1016/j.str.2010.08.011; Mace PD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2687; Marsh ENG, 2014, ACS CHEM BIOL, V9, P1242, DOI 10.1021/cb500111u; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Mittag T, 2010, STRUCTURE, V18, P494, DOI 10.1016/j.str.2010.01.020; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Pei JJ, 2002, MOL BRAIN RES, V109, P45, DOI 10.1016/S0169-328X(02)00488-6; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; Prabakaran S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.15; Reynolds CH, 1997, J NEUROCHEM, V69, P191; Reynolds CH, 1997, J NEUROCHEM, V68, P1736; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; Smet C, 2004, CHEMBIOCHEM, V5, P1639, DOI 10.1002/cbic.200400145; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Stygelbout V, 2014, BRAIN, V137, P537, DOI 10.1093/brain/awt344; Swatton JE, 2004, EUR J NEUROSCI, V19, P2711, DOI 10.1111/j.0953-816X.2004.03365.x; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tepper K, 2014, J BIOL CHEM, V289, P34389, DOI 10.1074/jbc.M114.611368; Theillet FX, 2013, NAT PROTOC, V8, P1416, DOI 10.1038/nprot.2013.083; Theillet FX, 2012, J BIOMOL NMR, V54, P217, DOI 10.1007/s10858-012-9674-x; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; WEISEMANN R, 1993, J BIOMOL NMR, V3, P113; WISCHIK CM, 1985, J CELL BIOL, V100, P1905, DOI 10.1083/jcb.100.6.1905; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	70	41	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7742	7753		10.1074/jbc.M115.700914	http://dx.doi.org/10.1074/jbc.M115.700914			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26858248	Green Published, hybrid			2022-12-28	WOS:000383447600043
J	Dyson, HJ; Wright, PE				Dyson, H. Jane; Wright, Peter E.			Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cAMP response element-binding protein (CREB); hypoxia-inducible factor (HIF); intrinsically disordered protein; protein-protein interaction; STAT transcription factor; structure-function; transcriptional coactivator; coupled folding and binding; intrinsically disordered region; viral oncoprotein; IDP; IDR; transcriptional activation	P53 TRANSACTIVATION DOMAIN; KIX DOMAIN; STRUCTURAL BASIS; ACTIVATION DOMAIN; TAZ2 DOMAIN; C-MYB; UNSTRUCTURED PROTEINS; COMPLEX-FORMATION; VIRAL-PROTEINS; PEPTIDE MOTIFS	The transcriptional coactivators CREB-binding protein (CBP) and p300 undergo a particularly rich set of interactions with disordered and partly ordered partners, as a part of their ubiquitous role in facilitating transcription of genes. CBP and p300 contain a number of small structured domains that provide scaffolds for the interaction of disordered transactivation domains from a wide variety of partners, including p53, hypoxia-inducible factor 1 (HIF-1), NF-B, and STAT proteins, and are the targets for the interactions of disordered viral proteins that compete with cellular factors to disrupt signaling and subvert the cell cycle. The functional diversity of the CBP/p300 interactome provides an excellent example of the power of intrinsic disorder to facilitate the complexity of living systems.	[Dyson, H. Jane; Wright, Peter E.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Dyson, HJ; Wright, PE (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	dyson@scripps.edu; wright@scripps.edu	Dyson, Jane/D-4160-2011	Dyson, Jane/0000-0001-6855-3398; Wright, Peter/0000-0002-1368-0223	National Institutes of Health [GM113251, CA096865]; NATIONAL CANCER INSTITUTE [R01CA096865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants GM113251 (to H. J. D.) and CA096865 (to P. E. W.) from the National Institutes of Health. This is the fifth article in the Thematic Minireview series "Intrinsically Disordered Proteins." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arai M, 2015, P NATL ACAD SCI USA, V112, P9614, DOI 10.1073/pnas.1512799112; Arai M, 2012, J AM CHEM SOC, V134, P3792, DOI 10.1021/ja209936u; Arai M, 2010, FEBS LETT, V584, P4500, DOI 10.1016/j.febslet.2010.10.024; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Bhaumik P, 2014, ACTA CRYSTALLOGR D, V70, P1914, DOI 10.1107/S1399004714009262; Bruschweiler S, 2013, ACS CHEM BIOL, V8, P1600, DOI 10.1021/cb4002188; Calcada EO, 2013, CHEMBIOCHEM, V14, P1876, DOI 10.1002/cbic.201300172; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cook PR, 2011, J MOL BIOL, V409, P384, DOI 10.1016/j.jmb.2011.04.003; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Dancy BM, 2015, CHEM REV, V115, P2419, DOI 10.1021/cr500452k; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; De Guzman RN, 2005, BIOCHEMISTRY-US, V44, P490, DOI 10.1021/bi048161t; Delvecchio M, 2013, NAT STRUCT MOL BIOL, V20, P1040, DOI 10.1038/nsmb.2642; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Demers JP, 2009, J AM CHEM SOC, V131, P4355, DOI 10.1021/ja808255d; Denis CM, 2012, BLOOD, V120, P3968, DOI 10.1182/blood-2012-02-411397; Dogan J, 2014, PHYS CHEM CHEM PHYS, V16, P6323, DOI 10.1039/c3cp54226b; Dogan J, 2012, J BIOL CHEM, V287, P34316, DOI 10.1074/jbc.M112.399436; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ebert MO, 2008, BIOCHEMISTRY-US, V47, P1299, DOI 10.1021/bi701767j; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Feng HQ, 2009, STRUCTURE, V17, P202, DOI 10.1016/j.str.2008.12.009; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Fuxreiter M, 2012, MOL BIOSYST, V8, P168, DOI 10.1039/c1mb05234a; Ganguly D, 2011, PROTEINS, V79, P1251, DOI 10.1002/prot.22960; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P10405, DOI 10.1021/bi7007917; Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112; Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110; Goodman RH, 2000, GENE DEV, V14, P1553; Goto NK, 2002, J BIOL CHEM, V277, P43168, DOI 10.1074/jbc.M207660200; Hagai T, 2014, CELL REP, V7, P1729, DOI 10.1016/j.celrep.2014.04.052; Hottiger MO, 2000, TRENDS MICROBIOL, V8, P560, DOI 10.1016/S0966-842X(00)01874-6; Iesmantavicius V, 2014, ANGEW CHEM INT EDIT, V53, P1548, DOI 10.1002/anie.201307712; Jansma AL, 2014, J MOL BIOL, V426, P4030, DOI 10.1016/j.jmb.2014.10.021; Jenkins LMM, 2015, BIOCHEMISTRY-US, V54, P2001, DOI 10.1021/acs.biochem.5b00044; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kjaergaard M, 2013, BIOCHEMISTRY-US, V52, P1686, DOI 10.1021/bi4001062; Knott M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002605; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Law SM, 2014, P NATL ACAD SCI USA, V111, P12067, DOI 10.1073/pnas.1405831111; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Lee CW, 2009, BIOCHEMISTRY-US, V48, P2115, DOI 10.1021/bi802055v; Legge GB, 2004, J MOL BIOL, V343, P1081, DOI 10.1016/j.jmb.2004.08.087; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Miller M, 2009, ACTA CRYSTALLOGR D, V65, P1301, DOI 10.1107/S0907444909040153; Minezaki Y, 2006, J MOL BIOL, V359, P1137, DOI 10.1016/j.jmb.2006.04.016; Mukherjee SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001647; Naganathan AN, 2011, J AM CHEM SOC, V133, P12154, DOI 10.1021/ja204053n; Ohlenschlager O, 2006, ONCOGENE, V25, P5953, DOI 10.1038/sj.onc.1209584; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Parker D, 1999, MOL CELL BIOL, V19, P5601; Parker D, 1996, MOL CELL BIOL, V16, P694; Pelka P, 2008, J VIROL, V82, P7252, DOI 10.1128/JVI.00104-08; Plotnikov AN, 2014, STRUCTURE, V22, P353, DOI 10.1016/j.str.2013.10.021; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Radhakrishnan I, 1998, FEBS LETT, V430, P317, DOI 10.1016/S0014-5793(98)00680-2; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; Schmid T, 2004, BIOCHEM J, V380, P289, DOI 10.1042/BJ20031299; Shammas SL, 2014, P NATL ACAD SCI USA, V111, P12055, DOI 10.1073/pnas.1405815111; Shammas SL, 2013, J PHYS CHEM B, V117, P13346, DOI 10.1021/jp404267e; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; Smith JL, 2004, P NATL ACAD SCI USA, V101, P11554, DOI 10.1073/pnas.0402156101; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Turjanski AG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000060; Van Orden K, 1999, ONCOGENE, V18, P3766, DOI 10.1038/sj.onc.1202703; Vendel AC, 2004, BIOCHEMISTRY-US, V43, P904, DOI 10.1021/bi035612l; Vendel AC, 2003, BIOCHEMISTRY-US, V42, P12481, DOI 10.1021/bi0353023; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang F, 2012, P NATL ACAD SCI USA, V109, P6078, DOI 10.1073/pnas.1119073109; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; White E, 2001, ONCOGENE, V20, P7836, DOI 10.1038/sj.onc.1204861; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984; Yi P, 2015, MOL CELL, V57, P1047, DOI 10.1016/j.molcel.2015.01.025; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zhang WH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002353; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200	100	163	170	3	65	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6714	6722		10.1074/jbc.R115.692020	http://dx.doi.org/10.1074/jbc.R115.692020			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26851278	hybrid, Green Published			2022-12-28	WOS:000373299700011
J	Gosejacob, D; Jager, PS; vom Dorp, K; Frejno, M; Carstensen, AC; Kohnke, M; Degen, J; Dormann, P; Hoch, M				Gosejacob, Dominic; Jaeger, Philipp S.; vom Dorp, Katharina; Frejno, Martin; Carstensen, Anne C.; Koehnke, Monika; Degen, Joachim; Doermann, Peter; Hoch, Michael			Ceramide Synthase 5 Is Essential to Maintain C-16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose tissue metabolism; ceramide; ceramide synthase; diabetes; gene knockout; insulin resistance; lipid metabolism; metabolism; obesity; sphingolipid	INDUCED INSULIN-RESISTANCE; HEPATIC STEATOSIS; CHAIN LENGTH; PPAR-GAMMA; FAT; METABOLISM; INHIBITION; INFLAMMATION; HOMEOSTASIS; ACTIVATION	Ceramides are bioactive sphingolipids, which are composed of sphingoid bases carrying acyl chains of various lengths. Ceramides are synthesized by a family of six ceramide synthases (CerS) in mammals, which produce ceramides with different N-linked acyl chains. Increased ceramide levels are known to contribute to the development of obesity and insulin resistance. Recently, it has been demonstrated that the ceramide acylation pattern is of particular importance for an organism to maintain energy homeostasis. However, which of the CerS family members are involved in this process is not yet completely known. Using newly developed CerS5 knock-out mice, we show here that CerS5 is essential to maintain cellular C-16:0 sphingolipid pools in lung, spleen, muscle, liver, and white adipose tissue. Glycerophospholipid levels in CerS5-deficient mice were not altered. We found a strong impact of CerS5-dependent ceramide synthesis in white adipose tissue after high fat diet feeding. In skeletal muscle, liver, and spleen, C-16:0-ceramide levels were altered independent of feeding conditions. The loss of CerS5 is associated with reduced weight gain and improved systemic health, including maintenance of glucose homeostasis and reduced white adipose tissue inflammation after high fat diet challenge. Our findings indicate that reduction of endogenous C-16:0-ceramide by genetic inhibition of CerS5 is sufficient to ameliorate obesity and its comorbidities.	[Gosejacob, Dominic; Jaeger, Philipp S.; Frejno, Martin; Carstensen, Anne C.; Koehnke, Monika; Degen, Joachim; Hoch, Michael] Univ Bonn, LIMES Inst, Program Unit Dev Genet & Mol Physiol, Mol Dev Biol, Carl Troll Str 31, D-53115 Bonn, Germany; [vom Dorp, Katharina; Doermann, Peter] Univ Bonn, IMBIO, Mol Biotechnol, Karlrobert Kreiten Str 13, D-53115 Bonn, Germany; [Jaeger, Philipp S.] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Frejno, Martin] Univ Oxford, Chem Biol Unit, NDM Res Bldg,Old Rd Campus, Headington OX3 7FZ, England; [Carstensen, Anne C.] Univ Wurzburg, Lehrstuhl Biochem & Mol Biol, D-97074 Wurzburg, Germany	University of Bonn; University of Bonn; Max Planck Society; University of Oxford; University of Wurzburg	Hoch, M (corresponding author), Univ Bonn, LIMES Inst, Program Unit Dev Genet & Mol Physiol, Mol Dev Biol, Carl Troll Str 31, D-53115 Bonn, Germany.	m.hoch@uni-bonn.de			Deutsche Forschungsgemeinschaft DFG [SFB 645, SFB TR83]; Bayer-Schering scholarship	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Bayer-Schering scholarship	This work was supported in part by Deutsche Forschungsgemeinschaft DFG Grants SFB 645, TP B1 and SFB TR83, TP A7 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Bayer-Schering scholarship.	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauer R, 2009, EMBO J, V28, P3706, DOI 10.1038/emboj.2009.305; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bruce CR, 2012, DIABETES, V61, P3148, DOI 10.2337/db12-0029; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chen JB, 2016, BBA-MOL CELL BIOL L, V1861, P138, DOI 10.1016/j.bbalip.2015.11.006; Ebel P, 2014, BIOCHEM J, V461, P147, DOI 10.1042/BJ20131242; Ebel P, 2013, J BIOL CHEM, V288, P21433, DOI 10.1074/jbc.M113.479907; Gaebler A, 2013, J LIPID RES, V54, P2282, DOI 10.1194/jlr.D038653; Gasulla F, 2013, PLANT J, V75, P726, DOI 10.1111/tpj.12241; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Kim HJ, 2012, J LIPID RES, V53, P1701, DOI 10.1194/jlr.D025627; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Markham JE, 2007, RAPID COMMUN MASS SP, V21, P1304, DOI 10.1002/rcm.2962; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Mesika A, 2007, J BIOL CHEM, V282, P27366, DOI 10.1074/jbc.M703487200; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Park WJ, 2015, BIOL CHEM, V396, P693, DOI 10.1515/hsz-2014-0310; Peters F, 2015, J INVEST DERMATOL, V135, P1501, DOI 10.1038/jid.2015.60; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Rabionet M, 2015, HUM MOL GENET, V24, P4792, DOI 10.1093/hmg/ddv204; Rinaldo P, 2008, GENET MED, V10, P151, DOI 10.1097/GIM.0b013e3181614289; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888; Schiffmann S, 2012, BIOCHIMIE, V94, P558, DOI 10.1016/j.biochi.2011.09.007; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Shah C, 2008, J BIOL CHEM, V283, P13538, DOI 10.1074/jbc.M709950200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Stratford S, 2001, BIOCHEM J, V354, P359, DOI 10.1042/0264-6021:3540359; Tidhar R, 2012, J BIOL CHEM, V287, P3197, DOI 10.1074/jbc.M111.280271; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vazquez AI, 2010, J ANIM SCI, V88, P497, DOI 10.2527/jas.2009-1952; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wewer V, 2011, J LIPID RES, V52, P1039, DOI 10.1194/jlr.D013987; WILLIAMS MA, 1980, J NEUROCHEM, V35, P266, DOI 10.1111/j.1471-4159.1980.tb12515.x; Xia JY, 2015, CELL METAB, V22, P266, DOI 10.1016/j.cmet.2015.06.007; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu ZW, 2005, J LIPID RES, V46, P1229, DOI 10.1194/jlr.M500001-JLR200; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063	70	74	77	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6989	7003		10.1074/jbc.M115.691212	http://dx.doi.org/10.1074/jbc.M115.691212			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26853464	Green Published, hybrid			2022-12-28	WOS:000373299700035
J	Huang, HR; Yang, XJ; Bao, ML; Cao, HH; Miao, XP; Zhang, XY; Gan, L; Qiu, MS; Zhang, ZY				Huang, Huarong; Yang, Xiaojuan; Bao, Meiling; Cao, Huanhuan; Miao, Xiaoping; Zhang, Xiaoyun; Gan, Lin; Qiu, Mengsheng; Zhang, Zunyi			Ablation of the Sox11 Gene Results in Clefting of the Secondary Palate Resembling the Pierre Robin Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; craniofacial development; FGF; gene regulation; mouse; micrognathia; Pierre Robin sequence; cleft palate; Sox11	CRANIAL NEURAL CREST; ABNORMAL TONGUE DEVELOPMENT; GROWTH-FACTOR RECEPTOR; TRANSCRIPTION FACTORS; MUTANT MICE; EPITHELIAL DIFFERENTIATION; SHELF ELEVATION; BINDING-SITE; MOUSE; PALATOGENESIS	Mouse gene inactivation has shown that the transcription factor Sox11 is required for mouse palatogenesis. However, whether Sox11 is primarily involved in the regulation of palatogenesis still remains elusive. In this study, we explored the role of Sox11 in palatogenesis by analyzing the developmental mechanism in cleft palate formation in mutants deficient in Sox11. Sox11 is expressed both in the developing palatal shelf and in the surrounding structures, including the mandible. We found that cleft palate occurs only in the mutant in which Sox11 is directly deleted. As in the wild type, the palatal shelves in the Sox11 mutant undergo outgrowth in a downward direction and exhibit potential for fusion and elevation. However, mutant palatal shelves encounter clefting, which is associated with a malpositioned tongue that results in physical obstruction of palatal shelf elevation at embryonic day 14.5 (E14.5). We found that loss of Sox11 led to reduced cell proliferation in the developing mandibular mesenchyme via Cyclin D1, leading to mandibular hypoplasia, which blocks tongue descent. Extensive analyses of gene expression in Sox11 deficiency identified FGF9 as a potential candidate target of Sox11 in the modulation of cell proliferation both in the mandible and the palatal shelf between E12.5 and E13.5. Finally we show, using in vitro assays, that Sox11 directly regulates the expression of Fgf9 and that application of FGF9 protein to Sox11-deficient palatal shelves restores the rate of BrdU incorporation. Taken together, the palate defects presented in the Sox11 loss mutant mimic the clefting in the Pierre Robin sequence in humans.	[Huang, Huarong; Yang, Xiaojuan; Bao, Meiling; Cao, Huanhuan; Miao, Xiaoping; Zhang, Xiaoyun; Gan, Lin; Qiu, Mengsheng; Zhang, Zunyi] Hangzhou Normal Univ, Coll Biol & Environm Sci, Inst Dev & Regenerat Biol, Zhejiang Key Lab Mammalian Organogenesis & Regene, 16 Xuelin St, Hangzhou 310036, Zhejiang, Peoples R China	Hangzhou Normal University	Zhang, ZY (corresponding author), Hangzhou Normal Univ, 16 Xuelin St, Hangzhou 310036, Zhejiang, Peoples R China.	zunyi_zhang@idrbio.org			Natural Science Foundation of China [31071287, 31101046]; Natural Science Foundation of Zhejiang Province [LZ12C12002, LY15C070005]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by Natural Science Foundation of China Grant 31071287 and Natural Science Foundation of Zhejiang Province Grant LZ12C12002 (to Z.Z) and Natural Science Foundation of China Grant 31101046 and Natural Science Foundation of Zhejiang Province Grant LY15C070005 (to H.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alappat SR, 2005, DEV BIOL, V277, P102, DOI 10.1016/j.ydbio.2004.09.010; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Blavier L, 2001, MOL BIOL CELL, V12, P1457, DOI 10.1091/mbc.12.5.1457; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Casey LM, 2006, DEV DYNAM, V235, P1830, DOI 10.1002/dvdy.20821; Chew LJ, 2009, J NEUROSCI RES, V87, P3277, DOI 10.1002/jnr.22128; Cinaroglu A, 2005, J NEUROSCI RES, V79, P329, DOI 10.1002/jnr.20363; Cizelsky W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069372; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Donner AL, 2006, DEV DYNAM, V235, P1358, DOI 10.1002/dvdy.20722; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; FERGUSON MWJ, 1977, VIRCHOWS ARCH A, V375, P97, DOI 10.1007/BF00428098; Gadi J, 2013, J BIOL CHEM, V288, P25400, DOI 10.1074/jbc.M112.413377; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Han J, 2009, DEVELOPMENT, V136, P4225, DOI 10.1242/dev.036723; Hargrave M, 1997, DEV DYNAM, V210, P79, DOI 10.1002/(SICI)1097-0177(199710)210:2<79::AID-AJA1>3.0.CO;2-6; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Hoser M, 2008, MOL CELL BIOL, V28, P4675, DOI 10.1128/MCB.00338-08; Huang X, 2008, DEV DYNAM, V237, P3079, DOI 10.1002/dvdy.21714; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Jiang Y, 2013, J BIOL CHEM, V288, P18429, DOI 10.1074/jbc.M113.478503; Jin JZ, 2008, CELL TISSUE RES, V333, P29, DOI 10.1007/s00441-008-0612-x; Juriloff DM, 2008, BIRTH DEFECTS RES A, V82, P63, DOI 10.1002/bdra.20430; Liu WJ, 2008, DEVELOPMENT, V135, P3959, DOI 10.1242/dev.025304; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Moreno LM, 2004, AM J MED GENET A, V125A, P135, DOI 10.1002/ajmg.a.20425; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Parada C, 2015, CURR TOP DEV BIOL, V115, P31, DOI 10.1016/bs.ctdb.2015.07.023; Parada C, 2015, DEVELOPMENT, V142, P3734, DOI 10.1242/dev.125328; Paul MH, 2014, CELL MOL LIFE SCI, V71, P2931, DOI 10.1007/s00018-013-1523-x; Penzo-Mendez AI, 2010, INT J BIOCHEM CELL B, V42, P425, DOI 10.1016/j.biocel.2009.07.018; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; Ramaesh T, 2003, J ANAT, V203, P213, DOI 10.1046/j.1469-7580.2003.00210.x; Scapoli L, 1997, GENOMICS, V43, P216, DOI 10.1006/geno.1997.4798; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schmahl J, 2004, DEVELOPMENT, V131, P3627, DOI 10.1242/dev.01239; Schultz RE, 2004, AM J MED GENET A, V125A, P17, DOI 10.1002/ajmg.a.20424; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Song ZC, 2013, J BIOL CHEM, V288, P10440, DOI 10.1074/jbc.M112.432286; Tan TY, 2013, AM J MED GENET C, V163, P295, DOI 10.1002/ajmg.c.31374; Wang C, 2013, J BIOL CHEM, V288, P22174, DOI 10.1074/jbc.M113.463620; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Yu K, 2015, DEV DYNAM, V244, P1427, DOI 10.1002/dvdy.24319; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	54	18	20	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7107	7118		10.1074/jbc.M115.690875	http://dx.doi.org/10.1074/jbc.M115.690875			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26826126	hybrid, Green Published			2022-12-28	WOS:000373299700044
J	Lahaie, N; Kralikova, M; Prezeau, L; Blahos, J; Bouvier, M				Lahaie, Nicolas; Kralikova, Michaela; Prezeau, Laurent; Blahos, Jaroslav; Bouvier, Michel			Post-endocytotic Deubiquitination and Degradation of the Metabotropic -Aminobutyric Acid Receptor by the Ubiquitin-specific Protease 14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioluminescence resonance energy transfer (BRET); biosensor; deubiquitylation (deubiquitination); G protein-coupled receptor (GPCR); GABA receptor; protein degradation; receptor endocytosis; ubiquitylation (ubiquitination)	RESONANCE ENERGY-TRANSFER; GABA(B) RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; ENZYME USP14; B RECEPTORS; MEDIATES UBIQUITINATION; LYSOSOMAL DEGRADATION; PROTEINS ACTIVATE; DOWN-REGULATION; PHOSPHORYLATION	Mechanisms controlling the metabotropic -aminobutyric acid receptor (GABA(B)) cell surface stability are still poorly understood. In contrast with many other G protein-coupled receptors (GPCR), it is not subject to agonist-promoted internalization, but is constitutively internalized and rapidly down-regulated. In search of novel interacting proteins regulating receptor fate, we report that the ubiquitin-specific protease 14 (USP14) interacts with the GABA(B(1b)) subunit's second intracellular loop. Probing the receptor for ubiquitination using bioluminescence resonance energy transfer (BRET), we detected a constitutive and phorbol 12-myristate 13-acetate (PMA)-induced ubiquitination of the receptor at the cell surface. PMA also increased internalization and accelerated receptor degradation. Overexpression of USP14 decreased ubiquitination while treatment with a small molecule inhibitor of the deubiquitinase (IU1) increased receptor ubiquitination. Treatment with the internalization inhibitor Dynasore blunted both USP14 and IU1 effects on the receptor ubiquitination state, suggesting a post-endocytic site of action. Overexpression of USP14 also led to an accelerated degradation of GABA(B) in a catalytically independent fashion. We thus propose a model whereby cell surface ubiquitination precedes endocytosis, after which USP14 acts as an ubiquitin-binding protein that targets the ubiquitinated receptor to lysosomal degradation and promotes its deubiquitination.	[Lahaie, Nicolas; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Lahaie, Nicolas; Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3T 1J4, Canada; [Kralikova, Michaela; Blahos, Jaroslav] Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CR-14220 Prague 4, Czech Republic; [Prezeau, Laurent] Univ Montpellier I, Inst Genom Fonct, F-34090 Montpellier, France; [Prezeau, Laurent] Univ Montpellier 2, F-34090 Montpellier, France	Universite de Montreal; Universite de Montreal; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Universite de Montpellier; Universite de Montpellier	Blahos, J (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CR-14220 Prague 4, Czech Republic.; Bouvier, M (corresponding author), Univ Montreal, IRIC, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	blahos@img.cas.cz; michel.bouvier@umontreal.ca	Bouvier, Michel/H-2758-2014; Kralikova, Michaela/H-2588-2014; Blahos, Jaroslav/G-8325-2017	Bouvier, Michel/0000-0003-1128-0100; Blahos, Jaroslav/0000-0003-3355-1469; Blahos, Jaroslav/0000-0001-9803-0061	Canadian Institutes of Health Research (CIHR) [MOP 10501]; Czech Science Foundation [GACR P303/12/2408]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Czech Science Foundation(Grant Agency of the Czech Republic)	These studies were supported by the Canadian Institutes of Health Research (CIHR) (MOP 10501) and the Czech Science Foundation (GACR P303/12/2408). The authors declare that they have no conflicts of interest with the contents of this article.	Berlin I, 2010, J BIOL CHEM, V285, P37895, DOI 10.1074/jbc.M110.129411; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bhattacharyya BJ, 2012, AM J PHYSIOL-CELL PH, V302, pC698, DOI 10.1152/ajpcell.00326.2010; Breton B, 2010, FASEB J, V24, P4733, DOI 10.1096/fj.10-164061; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; DUTAR P, 1988, NEURON, V1, P585, DOI 10.1016/0896-6273(88)90108-0; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Guetg N, 2010, P NATL ACAD SCI USA, V107, P13924, DOI 10.1073/pnas.1000909107; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Kanaide M, 2007, J CELL PHYSIOL, V210, P237, DOI 10.1002/jcp.20863; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Kuramoto N, 2013, NEUROCHEM INT, V62, P137, DOI 10.1016/j.neuint.2012.12.003; Lappe-Siefke C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000631; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Li SS, 2013, MOL PHARMACOL, V84, P139, DOI 10.1124/mol.113.086769; Luttrell LM, 2002, J CELL SCI, V115, P455; Maier PJ, 2010, J BIOL CHEM, V285, P35606, DOI 10.1074/jbc.M110.142406; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mines MA, 2009, J BIOL CHEM, V284, P5742, DOI 10.1074/jbc.M808507200; Mukherjee RS, 2006, MOL PHARMACOL, V70, P1406, DOI 10.1124/mol.106.024463; Na CH, 2012, J PROTEOME RES, V11, P4722, DOI 10.1021/pr300536k; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nagai A, 2009, BIOCHEM BIOPH RES CO, V379, P995, DOI 10.1016/j.bbrc.2008.12.182; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Pontier SM, 2006, EMBO J, V25, P2698, DOI 10.1038/sj.emboj.7601157; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Sarker Subhodeep, 2011, Commun Integr Biol, V4, P528, DOI 10.4161/cib.4.5.16458; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Walters BJ, 2014, J PHYSIOL-LONDON, V592, P571, DOI 10.1113/jphysiol.2013.266015; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Zemoura K, 2014, J BIOL CHEM, V289, P7738, DOI 10.1074/jbc.M113.541987; Zemoura K, 2013, J BIOL CHEM, V288, P34897, DOI 10.1074/jbc.M113.514745	54	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7156	7170		10.1074/jbc.M115.686907	http://dx.doi.org/10.1074/jbc.M115.686907			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26817839	Green Published, hybrid			2022-12-28	WOS:000373299700048
J	Moriwaki, K; Chan, FKM				Moriwaki, Kenta; Chan, Francis Ka-Ming			Regulation of RIPK3-and RHIM-dependent Necroptosis by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; apoptosis; cell death; necrosis (necrotic death); proteasome; ubiquitylation (ubiquitination)	MIXED LINEAGE KINASE; RECEPTOR-INTERACTING PROTEIN; DOMAIN-LIKE PROTEIN; MULTIPLE-MYELOMA CELLS; NF-KAPPA-B; PROGRAMMED NECROSIS; APOPTOSIS; RIP3; DEATH; MLKL	Receptor-interacting protein kinase 3 (RIPK3) is a serine/threonine kinase with essential function in necroptosis. The activity of RIPK3 is controlled by phosphorylation. Once activated, RIPK3 phosphorylates and activates the downstream effector mixed lineage kinase domain-like (MLKL) to induce necroptosis. In certain situations, RIPK3 has also been shown to promote apoptosis or cytokine expression in a necroptosis and kinase-independent manner. The ubiquitin-proteasome system is the major pathway for selective degradation of cellular proteins and thus has a critical role in many cellular processes such as cell survival and cell death. Clinically, proteasome inhibition has shown promise as an anti-cancer agent. Here we show that the proteasome inhibitors MG132 and bortezomib activate the RIPK3-MLKL necroptotic pathway in mouse fibroblasts as well as human leukemia cells. Unlike necroptosis induced by classical TNF-like cytokines, necroptosis induced by proteasome inhibitors does not require caspase inhibition. However, an intact RIP homotypic interaction motif (RHIM) is essential. Surprisingly, when recruitment of MLKL to RIPK3 is restricted, proteasome inhibitors induced RIPK3-dependent apoptosis. Proteasome inhibition led to accumulation of K48-linked ubiquitinated RIPK3, which was partially reduced when Lys-264 was mutated. Taken together, these results reveal the ubiquitin-proteasome system as a novel regulatory mechanism for RIPK3-dependent necroptosis.	[Moriwaki, Kenta; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Dept Pathol, Immunol & Microbiol Program, 368 Plantat St, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Chan, FKM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, 368 Plantat St, Worcester, MA 01605 USA.	francis.chan@umassmed.edu	Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis/ABB-1895-2021	Chan, Francis Ka-Ming/0000-0002-4803-8353; Moriwaki, Kenta/0000-0002-8724-4715	National Institutes of Health [AI083497]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI119030, R01AI083497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI083497. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bertrand MJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022356; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chan FKM, 2015, ANNU REV IMMUNOL, V33, P79, DOI 10.1146/annurev-immunol-032414-112248; Chen WZ, 2013, J BIOL CHEM, V288, P16247, DOI 10.1074/jbc.M112.435545; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Choo Yeun Su, 2009, J Vis Exp, DOI 10.3791/1293; Cook WD, 2014, CELL DEATH DIFFER, V21, P1600, DOI 10.1038/cdd.2014.70; de Almagro MC, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.158; Dick LR, 2010, DRUG DISCOV TODAY, V15, P243, DOI 10.1016/j.drudis.2010.01.008; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Feng X, 2015, NEOPLASMA, V62, P592, DOI 10.4149/neo_2015_071; Geserick P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.240; Gonzalvez F, 2012, MOL CELL, V48, P888, DOI 10.1016/j.molcel.2012.09.031; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hideshima T, 2001, CANCER RES, V61, P3071; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Koo GB, 2015, CELL RES, V25, P707, DOI 10.1038/cr.2015.56; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Moriwaki K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.16; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Nugues AL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.347; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Palombella VJ, 1998, P NATL ACAD SCI USA, V95, P15671, DOI 10.1073/pnas.95.26.15671; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Weinlich R, 2014, MOL CELL, V56, P469, DOI 10.1016/j.molcel.2014.11.001; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	46	36	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5948	5959		10.1074/jbc.M115.700997	http://dx.doi.org/10.1074/jbc.M115.700997			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786097	Green Published, hybrid			2022-12-28	WOS:000372551800040
J	Slomnicki, LP; Pietrzak, M; Vashishta, A; Jones, J; Lynch, N; Elliot, S; Poulos, E; Malicote, D; Morris, BE; Hallgren, J; Hetman, M				Slomnicki, Lukasz P.; Pietrzak, Maciej; Vashishta, Aruna; Jones, James; Lynch, Nicholas; Elliot, Shane; Poulos, Eric; Malicote, David; Morris, Bridgit E.; Hallgren, Justin; Hetman, Michal			Requirement of Neuronal Ribosome Synthesis for Growth and Maintenance of the Dendritic Tree	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurite outgrowth; neurodegeneration; neurodevelopment; neurotrophin; nucleolus; ribosome	DNA-BINDING PROTEIN; RAT-BRAIN; NUCLEOLAR DISRUPTION; RNA LOCALIZATION; STRESS GRANULES; N-MYC; TRANSCRIPTION; BIOGENESIS; INHIBITION; TRANSLATION	The nucleolus serves as a principal site of ribosome biogenesis but is also implicated in various non-ribosomal functions, including negative regulation of the pro-apoptotic transcription factor p53. Although disruption of the nucleolus may trigger the p53-dependent neuronal death, neurotoxic consequences of a selective impairment of ribosome production are unclear. Here, we report that in rat forebrain neuronal maturation is associated with a remarkable expansion of ribosomes despite postnatal down-regulation of ribosomal biogenesis. In cultured rat hippocampal neurons, inhibition of the latter process by knockdowns of ribosomal proteins S6, S14, or L4 reduced ribosome content without disrupting nucleolar integrity, cell survival, and signaling responses to the neurotrophin brain-derived neurotrophic factor. Moreover, reduced general protein synthesis and/or formation of RNA stress granules suggested diminished ribosome recruitment to at least some mRNAs. Such a translational insufficiency was accompanied by impairment of brain-derived neurotrophic factor-mediated dendritic growth. Finally, RNA stress granules and smaller dendritic trees were also observed when ribosomal proteins were depleted from neurons with established dendrites. Thus, a robust ribosomal apparatus is required to carry out protein synthesis that supports dendritic growth and maintenance. Consequently, deficits of ribosomal biogenesis may disturb neurodevelopment by reducing neuronal connectivity. Finally, as stress granule formation and dendritic loss occur early in neurodegenerative diseases, disrupted homeostasis of ribosomes may initiate and/or amplify neurodegeneration-associated disconnection of neuronal circuitries.	[Slomnicki, Lukasz P.; Pietrzak, Maciej; Vashishta, Aruna; Jones, James; Lynch, Nicholas; Elliot, Shane; Poulos, Eric; Malicote, David; Morris, Bridgit E.; Hallgren, Justin; Hetman, Michal] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, 511 S Floyd St,MDR616, Louisville, KY 40292 USA; [Slomnicki, Lukasz P.; Pietrzak, Maciej; Vashishta, Aruna; Jones, James; Lynch, Nicholas; Elliot, Shane; Poulos, Eric; Malicote, David; Morris, Bridgit E.; Hallgren, Justin; Hetman, Michal] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA; [Hetman, Michal] Univ Louisville, Dept Pharmacol, Louisville, KY 40292 USA; [Hetman, Michal] Univ Louisville, Dept Toxicol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Hetman, M (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, 511 S Floyd St,MDR616, Louisville, KY 40292 USA.	michal.hetman@louisville.edu	Pietrzak, Maciej/GNH-5768-2022	Pietrzak, Maciej/0000-0001-5768-7884	National Institutes of Health [NS073584, 8P30GM103507]; National Science Foundation [IOS1021860]; Commonwealth of Kentucky Challenge for Excellence Fund; Kentucky Biomedical Research Infrastructure Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Commonwealth of Kentucky Challenge for Excellence Fund; Kentucky Biomedical Research Infrastructure Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS073584 and 8P30GM103507 ( to M. H.), National Science Foundation Grant IOS1021860 ( to M. H.), the Commonwealth of Kentucky Challenge for Excellence Fund ( to M. H.), and the summer undergraduate research fellowships of the Kentucky Biomedical Research Infrastructure Network ( to S. E., B. E. M., and D. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Armistead J, 2009, AM J HUM GENET, V84, P728, DOI 10.1016/j.ajhg.2009.04.017; Barna M, 2013, P NATL ACAD SCI USA, V110, P9, DOI 10.1073/pnas.1218764110; BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; Bentmann E, 2013, FEBS J, V280, P4348, DOI 10.1111/febs.12287; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Bose T, 2010, J CELL BIOL, V189, P201, DOI 10.1083/jcb.200912129; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brooks SS, 2014, GENETICS, V198, P723, DOI 10.1534/genetics.114.168211; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Dabrowski M, 2003, J NEUROCHEM, V85, P1279, DOI 10.1046/j.1471-4159.2003.01753.x; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; Ding QX, 2005, J NEUROSCI, V25, P9171, DOI 10.1523/JNEUROSCI.3040-05.2005; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; GOLDSPINK DF, 1988, J NEUROCHEM, V50, P1364, DOI 10.1111/j.1471-4159.1988.tb03017.x; Gomes C, 2011, J BIOL CHEM, V286, P4357, DOI 10.1074/jbc.M110.170134; Habas A, 2006, J NEUROCHEM, V96, P335, DOI 10.1111/j.1471-4159.2005.03543.x; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Kang H, 2015, NEUROBIOL DIS, V73, P220, DOI 10.1016/j.nbd.2014.10.003; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kreiner G, 2013, CELL DEATH DIFFER, V20, P1455, DOI 10.1038/cdd.2013.66; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kruger T, 2007, J CELL BIOL, V177, P573, DOI 10.1083/jcb.200612048; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Kwon M, 2011, J NEUROSCI, V31, P9735, DOI 10.1523/JNEUROSCI.6785-10.2011; Lee J, 2011, CELL DEATH DIFFER, V18, P1726, DOI 10.1038/cdd.2011.38; Lesiak A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064658; Leung KN, 2009, HUM MOL GENET, V18, P4227, DOI 10.1093/hmg/ddp373; Lewis JD, 2000, SCIENCE, V288, P1385, DOI 10.1126/science.288.5470.1385; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Meyer-Luehmann M, 2009, J NEUROSCI, V29, P12636, DOI 10.1523/JNEUROSCI.1948-09.2009; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; Neumuller RA, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004145; Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008; Pietrzak M, 2011, J NEUROCHEM, V117, P1033, DOI 10.1111/j.1471-4159.2011.07279.x; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Rieker C, 2011, J NEUROSCI, V31, P453, DOI 10.1523/JNEUROSCI.0590-10.2011; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Shiina N, 2010, J NEUROSCI, V30, P12816, DOI 10.1523/JNEUROSCI.6386-09.2010; Singleton MK, 2011, NEUROBIOL DIS, V43, P190, DOI 10.1016/j.nbd.2011.03.011; STOYKOVA AS, 1979, J NEUROCHEM, V33, P931, DOI 10.1111/j.1471-4159.1979.tb09923.x; STOYKOVA AS, 1983, J NEUROCHEM, V41, P942, DOI 10.1111/j.1471-4159.1983.tb09038.x; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Tsoi H, 2013, CEREBELLUM, V12, P310, DOI 10.1007/s12311-012-0447-6; Vilotti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035051; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Wild T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000522; Withers GS, 2011, DEV PSYCHOBIOL, V53, P443, DOI 10.1002/dev.20560; Wolozin B, 2014, DISCOV MED, V17, P47; Xu BS, 2015, HUM MOL GENET, V24, P1540, DOI 10.1093/hmg/ddu565; Xu BS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003857; YAMAGAMI S, 1970, J NEUROCHEM, V17, P721, DOI 10.1111/j.1471-4159.1970.tb03342.x; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	74	50	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5721	5739		10.1074/jbc.M115.682161	http://dx.doi.org/10.1074/jbc.M115.682161			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26757818	hybrid, Green Published			2022-12-28	WOS:000372551800022
J	Cho, CC; Lin, MH; Chuang, CY; Hsu, CH				Cho, Chao-Cheng; Lin, Meng-Hsuan; Chuang, Chien-Ying; Hsu, Chun-Hua			Macro Domain from Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Is an Efficient ADP-ribose Binding Module: CRYSTAL STRUCTURE AND BIOCHEMICAL STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; biophysics; crystal structure; RNA virus; viral protein	SARS-CORONAVIRUS; POLY(ADP-RIBOSE); PROTEASE; HISTONE; ADP-RIBOSE-1''-MONOPHOSPHATASE; ADP-RIBOSE-1''-PHOSPHATASE; IDENTIFICATION; METABOLITE; MECHANISM; INSIGHTS	The newly emerging Middle East respiratory syndrome coronavirus (MERS-CoV) encodes the conserved macro domain within non-structural protein 3. However, the precise biochemical function and structure of the macro domain is unclear. Using differential scanning fluorimetry and isothermal titration calorimetry, we characterized the MERS-CoV macro domain as a more efficient adenosine diphosphate (ADP)-ribose binding module than macro domains from other CoVs. Furthermore, the crystal structure of the MERS-CoV macro domain was determined at 1.43- resolution in complex with ADP-ribose. Comparison of macro domains from MERS-CoV and other human CoVs revealed structural differences in the 1 helix alters how the conserved Asp-20 interacts with ADP-ribose and may explain the efficient binding of the MERS-CoV macro domain to ADP-ribose. This study provides structural and biophysical bases to further evaluate the role of the MERS-CoV macro domain in the host response via ADP-ribose binding but also as a potential target for drug design.	[Cho, Chao-Cheng; Lin, Meng-Hsuan; Hsu, Chun-Hua] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10617, Taiwan; [Cho, Chao-Cheng; Lin, Meng-Hsuan; Hsu, Chun-Hua] Acad Sinica, Taipei 10617, Taiwan; [Chuang, Chien-Ying; Hsu, Chun-Hua] Natl Taiwan Univ, Dept Agr Chem, Taipei 10617, Taiwan; [Chuang, Chien-Ying; Hsu, Chun-Hua] Natl Taiwan Univ, Ctr Syst Biol, Taipei 10617, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Hsu, CH (corresponding author), Natl Taiwan Univ, Dept Agr Chem, Taipei 10617, Taiwan.	andyhsu@ntu.edu.tw	HSU, CHUN-HUA/W-4554-2019	HSU, CHUN-HUA/0000-0002-0008-7383	National Core Facility Program for Biotechnology; National Science Council of Taiwan	National Core Facility Program for Biotechnology; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	We thank the Technology Commons, College of Life Science and Center for Systems Biology, National Taiwan University, for instrument support for protein crystallization. Portions of this research were carried out at the National Synchrotron Radiation Research Center, a national user facility supported by the National Science Council of Taiwan. The Synchrotron Radiation Protein Crystallography Facility is supported by the National Core Facility Program for Biotechnology. We also thank Laura Smales for copyediting the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen MD, 2003, J MOL BIOL, V330, P503, DOI 10.1016/S0022-2836(03)00473-X; Banik GR, 2015, PAEDIATR RESPIR REV, V16, P197, DOI 10.1016/j.prrv.2015.04.002; Chakravarthy S, 2005, MOL CELL BIOL, V25, P7616, DOI 10.1128/MCB.25.17.7616-7624.2005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; Dyer O, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3095; Egloff MP, 2006, J VIROL, V80, P8493, DOI 10.1128/JVI.00713-06; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eriksson KK, 2008, J VIROL, V82, P12325, DOI 10.1128/JVI.02082-08; Geng HY, 2013, SCI CHINA LIFE SCI, V56, P683, DOI 10.1007/s11427-013-4519-8; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Han HJ, 2015, VIRUS RES, V205, P1, DOI 10.1016/j.virusres.2015.05.006; Haq I, 2002, ARCH BIOCHEM BIOPHYS, V403, P1, DOI 10.1016/S0003-9861(02)00202-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hui DS, 2015, LANCET RESP MED, V3, P509, DOI 10.1016/S2213-2600(15)00238-6; Hui DSC, 2004, POSTGRAD MED J, V80, P373, DOI 10.1136/pgmj.2004.020263; Jalal S, 2015, J PAK MED ASSOC, V65, P310; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kossyvakis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125809; Kumaran D, 2005, PROTEIN SCI, V14, P719, DOI 10.1110/ps.041132005; Kuri T, 2011, J GEN VIROL, V92, P1899, DOI 10.1099/vir.0.031856-0; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lei J, 2014, ANTIVIR RES, V109, P72, DOI 10.1016/j.antiviral.2014.06.011; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; MIWA M, 1971, J BIOL CHEM, V246, P6362; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Needle D, 2015, ACTA CRYSTALLOGR D, V71, P1102, DOI 10.1107/S1399004715003521; Neuman BW, 2008, J VIROL, V82, P5279, DOI 10.1128/JVI.02631-07; Neuvonen M, 2009, J MOL BIOL, V385, P212, DOI 10.1016/j.jmb.2008.10.045; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2015, J THORAC DIS, V7, P356, DOI 10.3978/j.issn.2072-1439.2014.12.49; Parvez MK, 2015, GENE, V566, P47, DOI 10.1016/j.gene.2015.04.026; PEHRSON JR, 1992, SCIENCE, V257, P1398; Piotrowski Y, 2009, PROTEIN SCI, V18, P6, DOI 10.1002/pro.15; Putics A, 2006, J GEN VIROL, V87, P651, DOI 10.1099/vir.0.81596-0; Putics A, 2005, J VIROL, V79, P12721, DOI 10.1128/JVI.79.20.12721-12731.2005; Putics A, 2006, ADV EXP MED BIOL, V581, P93; Rasmussen SA, 2015, CLIN INFECT DIS, V60, P1686, DOI 10.1093/cid/civ118; Saikatendu KS, 2005, STRUCTURE, V13, P1665, DOI 10.1016/j.str.2005.07.022; Shaw K, 2006, PUBLIC HEALTH, V120, P8, DOI 10.1016/j.puhe.2005.10.002; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shull NP, 2005, NUCLEIC ACIDS RES, V33, P650, DOI 10.1093/nar/gki211; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Thabet F, 2015, SAUDI MED J, V36, P484, DOI 10.15537/smj.2015.4.10243; UEDA K, 1972, BIOCHEM BIOPH RES CO, V46, P516, DOI 10.1016/S0006-291X(72)80169-4; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wojdyla JA, 2009, ACTA CRYSTALLOGR D, V65, P1292, DOI 10.1107/S0907444909040074; Xu YY, 2009, J VIROL, V83, P1083, DOI 10.1128/JVI.01862-08; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	56	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4894	4902		10.1074/jbc.M115.700542	http://dx.doi.org/10.1074/jbc.M115.700542			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26740631	Green Published, hybrid			2022-12-28	WOS:000371640600005
J	Horenstein, NA; Papke, RL; Kulkarni, AR; Chaturbhuj, GU; Stokes, C; Manther, K; Thakur, GA				Horenstein, Nicole A.; Papke, Roger L.; Kulkarni, Abhijit R.; Chaturbhuj, Ganesh U.; Stokes, Clare; Manther, Khan; Thakur, Ganesh A.			Critical Molecular Determinants of alpha 7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; ion channel; nicotinic acetylcholine receptors (nAChR); receptor desensitization; Xenopus	LIGAND-BINDING DOMAIN; FUNCTIONAL-CHARACTERIZATION; EXTRACELLULAR DOMAIN; TRANSMEMBRANE SITE; PAIN MODELS; IN-VITRO; AGONIST; NACHR; DESENSITIZATION; SUBTYPES	The 7 nicotinic acetylcholine receptors (nAChRs) are uniquely sensitive to selective positive allosteric modulators (PAMs), which increase the efficiency of channel activation to a level greater than that of other nAChRs. Although PAMs must work in concert with orthosteric agonists, compounds such as GAT107 ((3aR,4S,9bS)-4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide) have the combined properties of agonists and PAMs (ago-PAM) and produce very effective channel activation (direct allosteric activation (DAA)) by operating at two distinct sites in the absence of added agonist. One site is likely to be the same transmembrane site where PAMs like PNU-120596 function. We show that the other site, required for direct activation, is likely to be solvent-accessible at the extracellular domain vestibule. We identify key attributes of molecules in this family that are able to act at the DAA site through variation at the aryl ring substituent of the tetrahydroquinoline ring system and with two different classes of competitive antagonists of DAA. Analyses of molecular features of effective allosteric agonists allow us to propose a binding model for the DAA site, featuring a largely non-polar pocket accessed from the extracellular vestibule with an important role for Asp-101. This hypothesis is supported with data from site-directed mutants. Future refinement of the model and the characterization of specific GAT107 analogs will allow us to define critical structural elements that can be mapped onto the receptor surface for an improved understanding of this novel way to target 7 nAChR therapeutically.	[Horenstein, Nicole A.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Papke, Roger L.; Stokes, Clare; Manther, Khan] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Kulkarni, Abhijit R.; Chaturbhuj, Ganesh U.; Thakur, Ganesh A.] Northeastern Univ, Sch Pharm, Dept Pharmaceut Sci, Bouve Coll Hlth Sci, 140 Fenway, Boston, MA 02115 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Northeastern University	Thakur, GA (corresponding author), Northeastern Univ, Sch Pharm, Dept Pharmaceut Sci, Bouve Coll Hlth Sci, 140 Fenway, Boston, MA 02115 USA.	g.thakur@neu.edu	Chaturbhuj, Ganesh/N-2391-2016; Chaturbhuj, Ganesh/M-6716-2017	Chaturbhuj, Ganesh/0000-0002-6263-8777; Chaturbhuj, Ganesh/0000-0002-6263-8777	National Institutes of Health [GM57481, EY024717]; NATIONAL EYE INSTITUTE [R01EY024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM57481 (to R. L. P.) and EY024717 (to G. A. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AlSharari SD, 2013, BIOCHEM PHARMACOL, V86, P1201, DOI 10.1016/j.bcp.2013.06.018; Bertrand D, 2008, MOL PHARMACOL, V74, P1407, DOI 10.1124/mol.107.042820; Bertrand D, 2015, PHARMACOL REV, V67, P1025, DOI 10.1124/pr.113.008581; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bisson WH, 2008, J MOL MODEL, V14, P891, DOI 10.1007/s00894-008-0340-x; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; Briggs CA, 2009, BRIT J PHARMACOL, V158, P1486, DOI 10.1111/j.1476-5381.2009.00426.x; Cannon CE, 2013, NEUROPHARMACOLOGY, V64, P191, DOI 10.1016/j.neuropharm.2012.05.003; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chatterjee PK, 2009, AM J PHYSIOL-CELL PH, V297, pC1294, DOI 10.1152/ajpcell.00160.2009; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; DEFIEBRE CM, 1995, MOL PHARMACOL, V47, P164; Freitas K, 2013, J PHARMACOL EXP THER, V344, P264, DOI 10.1124/jpet.112.197871; Freitas K, 2013, NEUROPHARMACOLOGY, V65, P156, DOI 10.1016/j.neuropharm.2012.08.022; Gill JK, 2012, MOL PHARMACOL, V81, P710, DOI 10.1124/mol.111.076026; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gill-Thind JK, 2015, J BIOL CHEM, V290, P3552, DOI 10.1074/jbc.M114.619221; Halevi S, 2003, J BIOL CHEM, V278, P34411, DOI 10.1074/jbc.M300170200; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Horenstein NA, 2008, MOL PHARMACOL, V74, P1496, DOI 10.1124/mol.108.048892; Hu YP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/325875; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Kabbani N, 2013, BIOESSAYS, V35, P1025, DOI 10.1002/bies.201300082; KAO PN, 1984, J BIOL CHEM, V259, P1662; King JR, 2015, J BIOL CHEM, V290, P20060, DOI 10.1074/jbc.M115.647040; Kong FJ, 2015, J SURG RES, V194, P255, DOI 10.1016/j.jss.2014.09.043; Kox M, 2009, BIOCHEM PHARMACOL, V78, P863, DOI 10.1016/j.bcp.2009.06.096; Kulkarni AR, 2013, TETRAHEDRON LETT, V54, P6592, DOI 10.1016/j.tetlet.2013.09.107; Lewis AS, 2015, BIOCHEM PHARMACOL, V97, P488, DOI 10.1016/j.bcp.2015.07.019; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; Meyer EM, 1998, J PHARMACOL EXP THER, V287, P918; Mulcahy MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134409; Palma E, 1996, J PHYSIOL-LONDON, V491, P151, DOI 10.1113/jphysiol.1996.sp021203; Papke RL, 1996, NEUROSCI LETT, V213, P201; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Papke RL, 2015, NEUROPHARMACOLOGY, V91, P34, DOI 10.1016/j.neuropharm.2014.12.002; Papke RL, 2014, J PHARMACOL EXP THER, V350, P665, DOI 10.1124/jpet.114.215236; Papke RL, 2014, BIOCHEM PHARMACOL, V89, P1, DOI 10.1016/j.bcp.2014.01.029; Papke RL, 2014, J BIOL CHEM, V289, P4515, DOI 10.1074/jbc.M113.524603; Papke RL, 2011, NEUROPHARMACOLOGY, V60, P159, DOI 10.1016/j.neuropharm.2010.07.014; Papke RL, 2010, METHODS, V51, P121, DOI 10.1016/j.ymeth.2010.01.012; Papke RL, 2010, J MOL NEUROSCI, V40, P77, DOI 10.1007/s12031-009-9261-0; Papke RL, 2009, J PHARMACOL EXP THER, V329, P791, DOI 10.1124/jpet.108.150151; Parthiban M, 2009, J BIOMOL STRUCT DYN, V26, P535, DOI 10.1080/07391102.2009.10507269; Paulo JA, 2009, J PROTEOME RES, V8, P1849, DOI 10.1021/pr800731z; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Spurny R, 2015, P NATL ACAD SCI USA, V112, pE2543, DOI 10.1073/pnas.1418289112; Stokes C, 2015, TRENDS PHARMACOL SCI, V36, P514, DOI 10.1016/j.tips.2015.05.002; Thakur GA, 2013, J MED CHEM, V56, P8943, DOI 10.1021/jm401267t; Thomsen MS, 2012, J NEUROIMMUNOL, V251, P65, DOI 10.1016/j.jneuroim.2012.07.006; Wang JY, 2010, MOL PHARMACOL, V78, P1012, DOI 10.1124/mol.110.066662; Williams DK, 2012, MOL PHARMACOL, V82, P746, DOI 10.1124/mol.112.080317; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Williams DK, 2011, J GEN PHYSIOL, V137, P369, DOI 10.1085/jgp.201010587; Williams DK, 2009, J PHARMACOL EXP THER, V330, P40, DOI 10.1124/jpet.109.151225; Wu SY, 2014, EXP THER MED, V8, P557, DOI 10.3892/etm.2014.1754; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Yue Y., 2015, INT IMMUNOPHARMACOL, V15, P1	63	34	34	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5049	5067		10.1074/jbc.M115.692392	http://dx.doi.org/10.1074/jbc.M115.692392			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26742843	Green Published, hybrid			2022-12-28	WOS:000371640600019
J	Ren, XX; Wang, HB; Li, C; Jiang, JF; Xiong, SD; Jin, X; Wu, L; Wang, JH				Ren, Xiao-Xin; Wang, Hai-Bo; Li, Chuan; Jiang, Jin-Feng; Xiong, Si-Dong; Jin, Xia; Wu, Li; Wang, Jian-Hua			HIV-1 Nef-associated Factor 1 Enhances Viral Production by Interacting with CRM1 to Promote Nuclear Export of Unspliced HIV-1 gag mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; REV ACTIVATION DOMAIN; MAMMARY-TUMOR VIRUS; HTLV-I REX; A20-BINDING INHIBITOR; CELLULAR COFACTOR; RESPONSE ELEMENTS; GENE-EXPRESSION; TYPE-1 REV; PROTEIN	HIV-1 depends on host-cell-encoded factors to complete its life cycle. A comprehensive understanding of how HIV-1 manipulates host machineries during viral infection can facilitate the identification of host targets for antiviral drugs or gene therapy. The cellular protein Naf1 (HIV-1 Nef-associated factor 1) is a CRM1-dependent nucleo-cytoplasmic shuttling protein, and has been identified to regulate multiple receptor-mediated signal pathways in inflammation. The cytoplasm-located Naf1 can inhibit NF-kappa B activation through binding to A20, and the loss of Naf1 controlled NF-kappa B activation is associated with multiple autoimmune diseases. However, the effect of Naf1 on HIV-1 mRNA expression has not been characterized. In this study we found that the nucleus-located Naf1 could promote nuclear export of unspliced HIV-1 gag mRNA. We demonstrated that the association between Naf1 and CRM1 was required for this function as the inhibition or knockdown of CRM1 expression significantly impaired Naf1-promoted HIV-1 production. The mutation of Naf1 nuclear export signals (NESs) that account for CRM1 recruitment for nuclear export decreased Naf1 function. Additionally, the mutation of the nuclear localization signal (NLS) of Naf1 diminished its ability to promote HIV-1 production, demonstrating that the shuttling property of Naf1 is required for this function. Our results reveal a novel role of Naf1 in enhancing HIV-1 production, and provide a potential therapeutic target for controlling HIV-1 infection.	[Ren, Xiao-Xin; Xiong, Si-Dong] Soochow Univ, Jiangsu Key Lab Infect & Immun, Inst Biol & Med Sci, Suzhou 215123, Peoples R China; [Ren, Xiao-Xin; Wang, Hai-Bo; Li, Chuan; Jiang, Jin-Feng; Jin, Xia; Wang, Jian-Hua] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai 200031, Peoples R China; [Wu, Li] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	Soochow University - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University System of Ohio; Ohio State University	Wang, JH (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	jh_wang@sibs.ac.cn	Wu, Li/ABB-2813-2020; Wu, Li/E-4330-2011	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Ren, Xiaoxin/0000-0002-2371-3658	Chinese Academy of Sciences; Natural Science Foundation of China [81572001]; National Basic Research Program of China (973 Program) [2012CB519004]; National Grant Program on Key Infectious Disease [2014ZX10001003]; NSFC-NIH [81561128009]; NIH/NIAID [AI120209, AI104483]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120209, R01AI104483] Funding Source: NIH RePORTER	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Grant Program on Key Infectious Disease; NSFC-NIH; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants (to J.-H. W.) from the Interdisciplinary and Collaboration Team of the Chinese Academy of Sciences, the Natural Science Foundation of China (No. 81572001), the National Basic Research Program of China (973 Program) (2012CB519004), the National Grant Program on Key Infectious Disease (2014ZX10001003), the NSFC-NIH Joint Grant (81561128009), and Grants AI120209 and AI104483 (to L. W.) from the NIH/NIAID. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AHMED YF, 1990, GENE DEV, V4, P1014, DOI 10.1101/gad.4.6.1014; Arhel N, 2010, BBA-MOL BASIS DIS, V1802, P313, DOI 10.1016/j.bbadis.2009.12.003; Bai Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03656; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cohen S, 2009, BIOCHEM BIOPH RES CO, V389, P205, DOI 10.1016/j.bbrc.2009.08.074; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Edgcomb SP, 2012, J MOL BIOL, V415, P61, DOI 10.1016/j.jmb.2011.10.032; EMERMAN M, 1989, CELL, V57, P1155, DOI 10.1016/0092-8674(89)90053-6; Fang JH, 2004, VIROLOGY, V330, P471, DOI 10.1016/j.virol.2004.09.039; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukushi M, 1999, FEBS LETT, V442, P83, DOI 10.1016/S0014-5793(98)01631-7; Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007; Gupta K, 2000, J VIROL, V74, P11811, DOI 10.1128/JVI.74.24.11811-11824.2000; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; HANLY SM, 1989, GENE DEV, V3, P1534, DOI 10.1101/gad.3.10.1534; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Indik S, 2005, VIROLOGY, V337, P1, DOI 10.1016/j.virol.2005.03.040; Jager S, 2011, METHODS, V53, P13, DOI 10.1016/j.ymeth.2010.08.007; Jayappa Kallesh Danappa, 2012, Int J Biochem Mol Biol, V3, P70; Kaminski R, 2008, J CELL BIOCHEM, V103, P1231, DOI 10.1002/jcb.21503; Kiernan RE, 1998, J VIROL, V72, P4116, DOI 10.1128/JVI.72.5.4116-4126.1998; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kok KH, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-78; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Li JH, 2001, BIOORG MED CHEM LETT, V11, P1687, DOI 10.1016/S0960-894X(01)00281-5; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; Mullner M, 2008, NUCLEIC ACIDS RES, V36, P6284, DOI 10.1093/nar/gkn608; Naghavi MH, 2007, CURR OPIN IMMUNOL, V19, P402, DOI 10.1016/j.coi.2007.07.003; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Popa I, 2002, MOL CELL BIOL, V22, P2057, DOI 10.1128/MCB.22.7.2057-2067.2002; Ramirez VP, 2012, CYTOKINE GROWTH F R, V23, P109, DOI 10.1016/j.cytogfr.2012.04.002; Robertson-Anderson RM, 2011, J MOL BIOL, V410, P959, DOI 10.1016/j.jmb.2011.04.026; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; St Gelais C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034521; Sullenger BA, 2002, NATURE, V418, P252, DOI 10.1038/418252a; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Van den Bergh R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-53; Van Huffel S, 2001, J BIOL CHEM, V276, P30216, DOI 10.1074/jbc.M100048200; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang JH, 2002, FEBS LETT, V531, P295, DOI 10.1016/S0014-5793(02)03539-1; Wullaert A, 2007, J BIOL CHEM, V282, P81, DOI 10.1074/jbc.M607481200; Yasuda-Inoue M, 2013, BIOCHEM BIOPH RES CO, V441, P607, DOI 10.1016/j.bbrc.2013.10.107; Yasuda-Inoue M, 2013, BIOCHEM BIOPH RES CO, V434, P803, DOI 10.1016/j.bbrc.2013.04.016; Yi R, 2002, J VIROL, V76, P2036, DOI 10.1128/JVI.76.5.2036-2042.2002; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhou XX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065040, 10.1371/journal.pone.0062245]; Zolotukhin AS, 1999, J VIROL, V73, P120, DOI 10.1128/JVI.73.1.120-127.1999	59	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4580	4588		10.1074/jbc.M115.706135	http://dx.doi.org/10.1074/jbc.M115.706135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26733199	Green Published, hybrid			2022-12-28	WOS:000371604600026
J	Wang, ZF; Liu, N; Shi, S; Liu, SH; Lin, HF				Wang, Zifeng; Liu, Na; Shi, Shuo; Liu, Sanhong; Lin, Haifan			The Role of PIWIL4, an Argonaute Family Protein, in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMLINE STEM-CELLS; CLASS-II EXPRESSION; SMALL RNAS; INTERACTING RNAS; GENE-EXPRESSION; OVARIAN-CANCER; PIRNA PATHWAY; SUBTYPES; SPERMATOGENESIS; OVEREXPRESSION	P-element-induced wimpy testis (PIWI) proteins bind to PIWI-interacting RNAs and play key roles in the biogenesis and functions of PIWI-interacting RNAs. It has been reported that PIWI proteins are essential for stem cell self-renewal and germline development in diverse organisms and that they are ectopically expressed in multiple forms of cancer. However, the role of PIWI in cancer remains elusive. Here we report that one of the four PIWI proteins in humans, PIWIL4, is highly expressed in both breast cancer tissues and the cytoplasm of MDA-MB-231 cells derived from breast cancer. Reducing PIWIL4 expression drastically impairs the migration ability of MDA-MB-231 cells, significantly increases their apoptosis, and mildly affects their proliferation. Our transcriptome and proteome analysis reveal that these functions are at least partially achieved via the PIWIL4 regulation of TGF-beta and FGF signaling pathways and MHC class II proteins. These findings suggest that PIWIL4 may serve as a potential therapeutic target for breast cancer.	[Wang, Zifeng; Lin, Haifan] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Wang, Zifeng; Shi, Shuo; Liu, Sanhong; Lin, Haifan] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China; [Liu, Na; Lin, Haifan] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Liu, Na; Lin, Haifan] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	ShanghaiTech University; ShanghaiTech University; Yale University; Yale University	Lin, HF (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.; Liu, SH; Lin, HF (corresponding author), ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China.; Lin, HF (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA.; Lin, HF (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA.	liush@shanghaitech.edu.cn; haifan.lin@yale.edu		Liu, Sanhong/0000-0002-8695-0343; Wang, Zifeng/0000-0002-8316-4988	Shanghai Institute for Advanced Immunochemical Studies at ShanghaiTech University; School of Life Science and Technology at ShanghaiTech University; Mathers Award; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER	Shanghai Institute for Advanced Immunochemical Studies at ShanghaiTech University; School of Life Science and Technology at ShanghaiTech University; Mathers Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Shanghai Institute for Advanced Immunochemical Studies at ShanghaiTech University (to H. L.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the School of Life Science and Technology at ShanghaiTech University.r Supported by a Mathers Award (to H. L.).	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen C, 2013, CANCER BIOMARK, V13, P315, DOI 10.3233/CBM-130360; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gonzalez J, 2015, CELL REP, V12, P150, DOI 10.1016/j.celrep.2015.06.004; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kwon C, 2014, BIOCHEM BIOPH RES CO, V446, P218, DOI 10.1016/j.bbrc.2014.02.112; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lin HF, 1997, DEVELOPMENT, V124, P2463; Linn Sabine C, 2009, Eur J Cancer, V45 Suppl 1, P11, DOI 10.1016/S0959-8049(09)70012-7; Marek L, 2009, MOL PHARMACOL, V75, P196, DOI 10.1124/mol.108.049544; Meazza R, 2003, EUR J IMMUNOL, V33, P1183, DOI 10.1002/eji.200323712; Mottok A, 2015, CELL REP, V13, P1418, DOI 10.1016/j.celrep.2015.10.008; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Rakha EA, 2009, PATHOLOGY, V41, P40, DOI 10.1080/00313020802563510; Ross RJ, 2014, NATURE, V505, P353, DOI 10.1038/nature12987; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Siddiqi S, 2012, J CELL BIOCHEM, V113, P373, DOI 10.1002/jcb.23363; Soufla G, 2005, CANCER LETT, V221, P105, DOI 10.1016/j.canlet.2004.08.021; Suzuki Ryusuke, 2012, Frontiers in Genetics, V3, P204, DOI 10.3389/fgene.2012.00204; Sytnikova YA, 2014, GENOME RES, V24, P1977, DOI 10.1101/gr.178129.114; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Wang Y, 2012, INT J CLIN EXP PATHO, V5, P315; Watanabe T, 2015, GENOME RES, V25, P368, DOI 10.1101/gr.180802.114; Watanabe T, 2014, MOL CELL, V56, P18, DOI 10.1016/j.molcel.2014.09.012; Yan H, 2015, LEUKEMIA, V29, P196, DOI 10.1038/leu.2014.135; Yasuda K, 2014, LAB INVEST, V94, P1355, DOI 10.1038/labinvest.2014.122; Ye Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013406; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	43	43	47	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10646	10658		10.1074/jbc.M116.723239	http://dx.doi.org/10.1074/jbc.M116.723239			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26957540	hybrid, Green Published			2022-12-28	WOS:000377042600018
J	Mann, E; Mallette, E; Clarke, BR; Kimber, MS; Whitfield, C				Mann, Evan; Mallette, Evan; Clarke, Bradley R.; Kimber, Matthew S.; Whitfield, Chris			The Klebsiella pneumoniae O12 ATP-binding Cassette (ABC) Transporter Recognizes the Terminal Residue of Its O-antigen Polysaccharide Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI O9A; CHAIN-LENGTH; NONREDUCING TERMINI; POLYACRYLAMIDE GELS; LIPOPOLYSACCHARIDE; MODULES; EXPORT; DOMAIN; SPECIFICITY; BIOSYNTHESIS	Export of the Escherichia coli serotype O9a O-antigenic polysaccharides (O-PS) involves an ATP-binding cassette (ABC) transporter. The process requires a non-reducing terminal residue, which is recognized by a carbohydrate-binding module (CBM) appended to the C terminus of the nucleotide-binding domain of the transporter. Here, we investigate the process in Klebsiella pneumoniae serotype O12 (and Raoultella terrigena ATCC 33257). The O12 polysaccharide is terminated at the non-reducing end by a beta-linked 3-deoxy-D-manno-oct-2ulosonic acid (Kdo) residue. The O12 ABC transporter also binds its cognate O-PS via a CBM, and export is dependent on the presence of the terminal beta-Kdo residue. The overall structural architecture of the O12 CBM resembles the O9a prototype, but they share only weak sequence similarity, and the putative binding pocket for the O12 glycan is different. Removal of the CBM abrogated O-PS transport, but export was restored when the CBM was expressed in trans with the mutant CBM-deficient ABC transporter. These results demonstrate that the CBM-mediated substrate-recognition mechanism is evolutionarily conserved and can operate with glycans of widely differing structures.	[Mann, Evan; Mallette, Evan; Clarke, Bradley R.; Kimber, Matthew S.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada	University of Guelph	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Kimber, Matthew/0000-0001-9454-5586; Whitfield, Chris/0000-0002-5267-7027; Mann, Evan/0000-0003-4685-7264	Canadian Institutes of Health Research [MOP 62877]; National Science and Engineering Research Council of Canada [327280, 2015-04622]; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research Grant MOP 62877 (to C. W.) and Discovery Grants 327280 (to M. S. K.) and 2015-04622 (to C. W.) from the National Science and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alderwick LJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001299; Beis K, 2015, BIOCHEM SOC T, V43, P889, DOI 10.1042/BST20150047; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2011, J BIOL CHEM, V286, P41391, DOI 10.1074/jbc.M111.295857; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Davidson AL, 1997, J BACTERIOL, V179, P5458, DOI 10.1128/jb.179.17.5458-5464.1997; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hagelueken G, 2015, NAT STRUCT MOL BIOL, V22, P50, DOI 10.1038/nsmb.2935; Hagelueken G, 2012, MOL MICROBIOL, V86, P730, DOI 10.1111/mmi.12014; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; King JD, 2014, P NATL ACAD SCI USA, V111, P6407, DOI 10.1073/pnas.1400814111; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mann E, 2015, J BIOL CHEM, V290, P25561, DOI 10.1074/jbc.M115.660803; May JM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0027; Mertens K, 2010, INNATE IMMUN-LONDON, V16, P366, DOI 10.1177/1753425909350057; Murray GL, 2006, J BACTERIOL, V188, P2735, DOI 10.1128/JB.188.7.2735-2739.2006; Nsahlai CJ, 2003, FEMS MICROBIOL LETT, V224, P113, DOI 10.1016/S0378-1097(03)00428-2; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Perez C, 2015, NATURE, V524, P433, DOI 10.1038/nature14953; Phillips Kevin, 2011, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1028s94; Polissi A, 2014, MAR DRUGS, V12, P1023, DOI 10.3390/md12021023; REINIKAINEN T, 1992, PROTEINS, V14, P475, DOI 10.1002/prot.340140408; Simpson BW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0029; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tal N, 2013, P NATL ACAD SCI USA, V110, P5434, DOI 10.1073/pnas.1209644110; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; Varnai A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-30; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Wang ZS, 2014, BIOCHEM BIOPH RES CO, V452, P443, DOI 10.1016/j.bbrc.2014.08.094; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Willis LM, 2013, P NATL ACAD SCI USA, V110, P7868, DOI 10.1073/pnas.1222317110	49	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9748	9761		10.1074/jbc.M116.719344	http://dx.doi.org/10.1074/jbc.M116.719344			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26934919	Green Published, hybrid			2022-12-28	WOS:000375602300032
J	Van Audenhove, I; Denert, M; Boucherie, C; Pieters, L; Cornelissen, M; Gettemans, J				Van Audenhove, Isabel; Denert, Majken; Boucherie, Ciska; Pieters, Leen; Cornelissen, Maria; Gettemans, Jan			Fascin Rigidity and L-plastin Flexibility Cooperate in Cancer Cell Invadopodia and Filopodia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BUNDLING PROTEINS; PHOSPHORYLATION; NANOBODIES; MECHANISM; ADHESION; BINDING; ARCHITECTURE; DEGRADATION; MACROPHAGES; PROGRESSION	Invadopodia and filopodia are dynamic, actin-based protrusions contributing to cancer cell migration, invasion, and metastasis. The force of actin bundles is essential for their protrusive activity. The bundling protein fascin is known to play a role in both invadopodia and filopodia. As it is more and more acknowledged that functionally related proteins cooperate, it is unlikely that only fascin bundles actin in these protrusions. Another interesting candidate is L-plastin, normally expressed in hematopoietic cells, but considered a common marker of many cancer types. We identified L-plastin as a new component of invadopodia, where it contributes to degradation and invasiveness. By means of specific, high-affinity nanobodies inhibiting bundling of fascin or L-plastin, we further unraveled their cooperative mode of action. We show that the bundlers cannot compensate for each other due to strikingly different bundling characteristics: L-plastin bundles are much thinner and less tightly packed. Composite bundles adopt an intermediate phenotype, with fascin delivering the rigidity and strength for protrusive force and structural stability, whereas L-plastin accounts for the flexibility needed for elongation. Consistent with this, elevated L-plastin expression promotes elongation and reduces protrusion density in cells with relatively lower L-plastin than fascin levels.	[Van Audenhove, Isabel; Denert, Majken; Boucherie, Ciska; Gettemans, Jan] Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, Albert Baertsoenkaai 3, B-9000 Ghent, Belgium; [Pieters, Leen; Cornelissen, Maria] Univ Ghent, Fac Med & Hlth Sci, Dept Basic Med Sci, Albert Baertsoenkaai 3, B-9000 Ghent, Belgium	Ghent University; Ghent University	Gettemans, J (corresponding author), Univ Ghent, Albert Baertsoenkaai 3, B-9000 Ghent, Belgium.	jan.gettemans@ugent.be			research Foundation Flanders (Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen); League against Cancer (Stichting tegen Kanker, Belgium); Ghent University (BOF-GOA); Interuniversity Attraction Poles Programme of the Belgian State, Federal Office for Scientific, Technical and Cultural Affairs [IUAP P7/13]; FWO-Flanders	research Foundation Flanders (Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen)(FWO); League against Cancer (Stichting tegen Kanker, Belgium); Ghent University (BOF-GOA)(Ghent University); Interuniversity Attraction Poles Programme of the Belgian State, Federal Office for Scientific, Technical and Cultural Affairs; FWO-Flanders(FWO)	This work was supported in part by grants from the research Foundation Flanders (Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen), the League against Cancer (Stichting tegen Kanker, Belgium), Ghent University (BOF-GOA), and the Interuniversity Attraction Poles Programme of the Belgian State, Federal Office for Scientific, Technical and Cultural Affairs (IUAP P7/13). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by FWO-Flanders.	Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Barzik M, 2014, MOL BIOL CELL, V25, P2604, DOI 10.1091/mbc.E14-02-0712; Bethuyne J, 2014, NUCLEIC ACIDS RES, V42, P12928, DOI 10.1093/nar/gku962; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Cant K, 1998, J CELL SCI, V111, P213; Cervero P, 2012, EUR J CELL BIOL, V91, P908, DOI 10.1016/j.ejcb.2012.05.005; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; De Clercq S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078108; De Clercq S, 2013, CELL MOL LIFE SCI, V70, P909, DOI 10.1007/s00018-012-1169-0; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; Delanote V, 2010, FASEB J, V24, P105, DOI 10.1096/fj.09-134304; Desai B, 2008, J BIOL CHEM, V283, P13856, DOI 10.1074/jbc.M709401200; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Huang FK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8465; Jaiswal R, 2013, CURR BIOL, V23, P1373, DOI 10.1016/j.cub.2013.06.013; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Jansen S, 2011, J BIOL CHEM, V286, P30087, DOI 10.1074/jbc.M111.251439; Jones SL, 1996, J BIOL CHEM, V271, P14623, DOI 10.1074/jbc.271.24.14623; Khurana S, 2011, CELL ADHES MIGR, V5, P409, DOI 10.4161/cam.5.5.17644; Leong HS, 2014, CELL REP, V8, P1558, DOI 10.1016/j.celrep.2014.07.050; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; LIN CS, 1993, J BIOL CHEM, V268, P2781; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Ma YF, 2015, INT J CANCER, V137, P2534, DOI 10.1002/ijc.29260; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Morley S. C., 2012, INT J CELL BIOL, V2012; PARK TS, 1994, CANCER RES, V54, P1775; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Shibue T, 2012, CANCER DISCOV, V2, P706, DOI 10.1158/2159-8290.CD-11-0239; Shinomiya Hiroto, 2012, Int J Cell Biol, V2012, P213492, DOI 10.1155/2012/213492; Skoble J, 2001, J CELL BIOL, V155, P89, DOI 10.1083/jcb.200106061; Stevenson RP, 2012, J CELL SCI, V125, P1073, DOI 10.1242/jcs.093799; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Tan VY, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-52; Tilney LG, 1998, J CELL BIOL, V143, P121, DOI 10.1083/jcb.143.1.121; Van Audenhove I, 2015, BBA-MOL CELL RES, V1853, P940, DOI 10.1016/j.bbamcr.2015.01.003; Van Audenhove I, 2014, FASEB J, V28, P1805, DOI 10.1096/fj.13-242537; Van Audenhove I, 2013, CYTOSKELETON, V70, P604, DOI 10.1002/cm.21122; Van Impe K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3585; Van Overbeke W, 2015, HUM MOL GENET, V24, P2492, DOI 10.1093/hmg/ddv010; Van Overbeke W, 2014, MOL THER, V22, P1768, DOI 10.1038/mt.2014.132; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Winkelman JD, 2014, P NATL ACAD SCI USA, V111, P4121, DOI 10.1073/pnas.1322093111; Yamaguchi H, 2012, EUR J CELL BIOL, V91, P902, DOI 10.1016/j.ejcb.2012.04.005; Yamakita Y, 1996, J BIOL CHEM, V271, P12632, DOI 10.1074/jbc.271.21.12632; Yang SY, 2013, J BIOL CHEM, V288, P274, DOI 10.1074/jbc.M112.427971	54	36	36	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9148	9160		10.1074/jbc.M115.706937	http://dx.doi.org/10.1074/jbc.M115.706937			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26945069	Green Published, hybrid			2022-12-28	WOS:000374849000026
J	Westwell-Roper, C; Denroche, HC; Ehses, JA; Verchere, CB				Westwell-Roper, Clara; Denroche, Heather C.; Ehses, Jan A.; Verchere, C. Bruce			Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELLS; NLRP3 INFLAMMASOME; RECEPTOR 2; DYSFUNCTION; MACROPHAGES; EXPRESSION; TLR2; CYTOTOXICITY; PATHOGENESIS; LANGERHANS	Aggregation of islet amyloid polypeptide (IAPP) contributes to beta cell dysfunction in type 2 diabetes and islet transplantation. Like other amyloidogenic peptides, human IAPP induces macrophage IL-1 beta secretion by stimulating both the synthesis and processing of proIL-1 beta, a pro-inflammatory cytokine that (when chronically elevated) impairs beta cell insulin secretion. We sought to determine the specific mechanism of IAPP-induced proIL-1 beta synthesis. Soluble IAPP species produced early during IAPP aggregation provided a Toll-like-receptor-2-(TLR2-) dependent stimulus for NF-kappa B activation in HEK 293 cells and bone marrow-derived macrophages (BMDMs). Non-amyloidogenic rodent IAPP and thioflavin-T-positive fibrillar amyloid produced by human IAPP aggregation failed to activate TLR2. Blockade of TLR6 but not TLR1 prevented hIAPP-induced TLR2 activation, consistent with stimulation of a TLR2/6 heterodimer. TLR2 and its downstream adaptor protein MyD88 were required for IAPP-induced cytokine production by BMDMs, a process that is partially dependent on autoinduction by IL-1. BMDMs treated with soluble but not fibrillar IAPP provided a TLR2-dependent priming stimulus for ATP-induced IL-1 beta secretion, whereas late IAPP aggregates induced NLRP3-dependent IL-1 beta secretion by LPS-primed macrophages. Moreover, inhibition of TLR2 and depletion of islet macrophages prevented up-regulation of Il1b and Tnf expression in human IAPP-expressing transgenic mouse islets. These data suggest participation by both soluble and fibrillar aggregates in IAPP-induced islet inflammation. IAPP-induced activation of TLR2 and secretion of IL-1 may be important therapeutic targets to prevent amyloid-associated beta cell dysfunction.	[Westwell-Roper, Clara; Verchere, C. Bruce] Univ British Columbia, Child & Family Res Inst, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Denroche, Heather C.; Ehses, Jan A.; Verchere, C. Bruce] Univ British Columbia, Child & Family Res Inst, Dept Surg, Vancouver, BC V5Z 4H4, Canada	Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia	Verchere, CB (corresponding author), Child & Family Res Inst, A4-181 950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	bverchere@cfri.ca	Ehses, Jan/AAK-1635-2020	Verchere, Cameron Bruce/0000-0002-9262-0586; Westwell-Roper, Clara/0000-0003-4416-3912; Denroche, Heather/0000-0002-0976-2656; Ehses, Jan/0000-0001-9066-7607	Canadian Institutes of Health Research (CIHR) [MOP-123338]; BC Children's Hospital Foundation; Canucks for Kids Fund Childhood Diabetes Laboratories; Vanier Canada Graduate Studentship; Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship Award; Juvenile Diabetes Research Foundation; Canadian Diabetes Association; CFRI; Irving K. Barber Chair in Diabetes Research at the University of British Columbia	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); BC Children's Hospital Foundation; Canucks for Kids Fund Childhood Diabetes Laboratories; Vanier Canada Graduate Studentship; Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship Award; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Diabetes Association; CFRI; Irving K. Barber Chair in Diabetes Research at the University of British Columbia	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR; MOP-123338) and by core support to the Child & Family Research Institute (CFRI) from the BC Children's Hospital Foundation and Canucks for Kids Fund Childhood Diabetes Laboratories. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Vanier Canada Graduate Studentship and a Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship Award.; Supported by Postdoctoral Fellowships from the Juvenile Diabetes Research Foundation and Canadian Diabetes Association.; Supported by a scholar award from the Canadian Diabetes Association and an investigator award from the CFRI.; Supported by the Irving K. Barber Chair in Diabetes Research at the University of British Columbia and an investigator award from the CFRI.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Chang YC, 2009, FASEB J, V23, P3078, DOI 10.1096/fj.09-129312; Cheng K, 2012, ANGEW CHEM INT EDIT, V51, P12246, DOI 10.1002/anie.201204910; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Fassbender K, 2004, FASEB J, V18, P203, DOI 10.1096/fj.03-0364fje; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Gustot A, 2013, CELL MOL LIFE SCI, V70, P2999, DOI 10.1007/s00018-012-1245-5; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2534; Konarkowska B, 2006, FEBS J, V273, P3614, DOI 10.1111/j.1742-4658.2006.05367.x; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Mahdi T, 2012, CELL METAB, V16, P625, DOI 10.1016/j.cmet.2012.10.009; Masters SL, 2011, TRENDS MOL MED, V17, P276, DOI 10.1016/j.molmed.2011.01.005; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Novotny GW, 2012, ARCH BIOCHEM BIOPHYS, V528, P171, DOI 10.1016/j.abb.2012.09.014; Rapsinski GJ, 2013, J BIOL CHEM, V288, P14178, DOI 10.1074/jbc.M112.447060; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tukel C, 2009, CELL HOST MICROBE, V6, P45, DOI 10.1016/j.chom.2009.05.020; van Bergenhenegouwen J, 2013, J LEUKOCYTE BIOL, V94, P885, DOI 10.1189/jlb.0113003; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; Westwell-Roper Clara, 2013, Methods Mol Biol, V1040, P9, DOI 10.1007/978-1-62703-523-1_2; Westwell-Roper C, 2011, J IMMUNOL, V187, P2755, DOI 10.4049/jimmunol.1002854; Westwell-Roper CY, 2015, DIABETOLOGIA, V58, P575, DOI 10.1007/s00125-014-3447-x; Westwell-Roper CY, 2014, DIABETES, V63, P1698, DOI 10.2337/db13-0863; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6	39	28	28	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8908	8917		10.1074/jbc.M115.712455	http://dx.doi.org/10.1074/jbc.M115.712455			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26786104	Green Published, hybrid			2022-12-28	WOS:000374849000005
J	de Albuquerque, CP; Liang, J; Gaut, NJ; Zhou, HL				de Albuquerque, Claudio Ponte; Liang, Jason; Gaut, Nathaniel James; Zhou, Huilin			Molecular Circuitry of the SUMO (Small Ubiquitin-like Modifier) Pathway in Controlling Sumoylation Homeostasis and Suppressing Genome Rearrangements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine protease; DNA helicase; DNA recombination; DNA replication; small ubiquitin-like modifier (SUMO)	CELL-CYCLE PROGRESSION; DNA-DAMAGE; PROTEASE; REPLICATION; ENCODES; COMPLEX; LOCALIZATION; ACCUMULATION; ISOPEPTIDASE; DOMAINS	Small ubiquitin-like modifier (SUMO) E3 ligases are known to have a major role in preventing gross chromosomal rearrangements (GCRs); however, relatively little is known about the role of SUMO isopeptidases in genome maintenance and their role in controlling intracellular sumoylation homeostasis. Here we show the SUMO isopeptidase Ulp2 in Saccharomyces cerevisiae does not prevent the accumulation of GCRs, and interestingly, its loss causes subunit-specific changes of sumoylated minichromosome maintenance (MCM) helicase in addition to drastic accumulation of sumoylated nucleolar RENT and inner kinetochore complexes. In contrast, loss of Ulp1 or its mis-localization from the nuclear periphery causes substantial accumulations of GCRs and elevated sumoylation of most proteins except for Ulp2 targets. Interestingly, the E3 ligase Mms21, which has a major role in genome maintenance, preferentially controls the sumoylation of Mcm3 during DNA replication. These findings reveal distinct roles for Ulp1 and Ulp2 in controlling homeostasis of intracellular sumoylation and show that sumoylation of MCM is controlled in a subunit-specific and cell cycle dependent manner.	[de Albuquerque, Claudio Ponte; Liang, Jason; Gaut, Nathaniel James; Zhou, Huilin] Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr,CMM-East 2055, La Jolla, CA 92093 USA; [Liang, Jason] Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr,CMM-East 2055, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr,CMM-East 2055, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Moores Canc Ctr, 9500 Gilman Dr,CMM-East 2055, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhou, HL (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr,CMM-East 2055, La Jolla, CA 92093 USA.	huzhou@ucsd.edu		Liang, Jason/0000-0001-8742-8824; Zhou, Huilin/0000-0002-1350-4430	National Institutes of Health [T32 CA009523, GM116897]; Ludwig Cancer Research; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Training Grant T32 CA009523 (NCI; to J. L.) and GM116897 (NIGMS; to H. Z.). This work was also supported by Ludwig Cancer Research. We declare that there is no conflict of interest for this study.	Albuquerque CP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003670; Bell SD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012807; Boos D, 2012, CURR OPIN CELL BIOL, V24, P423, DOI 10.1016/j.ceb.2012.01.011; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Chen XL, 2005, MOL CELL BIOL, V25, P4311, DOI 10.1128/MCB.25.10.4311-4320.2005; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hornung P, 2014, J CELL BIOL, V206, P509, DOI 10.1083/jcb.201403081; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kroetz MB, 2009, MOL BIOL CELL, V20, P2196, DOI 10.1091/mbc.E08-10-1090; Lewis A, 2007, J CELL BIOL, V178, P813, DOI 10.1083/jcb.200702154; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; MAINE GT, 1984, GENETICS, V106, P365; Matson DR, 2012, GENE DEV, V26, P542, DOI 10.1101/gad.184184.111; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; Palancade B, 2007, MOL BIOL CELL, V18, P2912, DOI 10.1091/mbc.E07-02-0123; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; Pelisch F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6485; Putnam CD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004277; Putnam Christopher D, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5492; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Srikumar T, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.23; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Strunnikov AV, 2001, GENETICS, V158, P95; Takahashi Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000215; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168	39	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8825	8835		10.1074/jbc.M116.716399	http://dx.doi.org/10.1074/jbc.M116.716399			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26921322	Green Published, hybrid			2022-12-28	WOS:000374773200043
J	Koh, S; Hwang, J; Guchhait, K; Lee, EG; Kim, SY; Kim, S; Lee, S; Chung, JM; Jung, HS; Lee, SJ; Ryu, CM; Lee, SG; Oh, TK; Kwon, O; Kim, MH				Koh, Serry; Hwang, Jungwon; Guchhait, Koushik; Lee, Eun-Gyeong; Kim, Sang-Yoon; Kim, Sujin; Lee, Sangmin; Chung, Jeong Min; Jung, Hyun Suk; Lee, Sang Jun; Ryu, Choong-Min; Lee, Seung-Goo; Oh, Tae-Kwang; Kwon, Ohsuk; Kim, Myung Hee			Molecular Insights into Toluene Sensing in the TodS/TodT Signal Transduction System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; biodegradation; histidine kinase; Pseudomonas; x-ray crystallography	PSEUDOMONAS-PUTIDA F1; SENSOR KINASE TODS; BETA-GALACTOSIDASE ACTIVITY; 2-COMPONENT SYSTEM; EXPRESSION VECTORS; ESCHERICHIA-COLI; STRUCTURAL BASIS; CLONING VECTORS; OPERON PROMOTER; PAS DOMAINS	TodS is a sensor kinase that responds to various monoaromatic compounds, which either cause an agonistic or antagonistic effect on phosphorylation of its cognate response regulator TodT, and controls tod operon expression in Pseudomonas putida strains. We describe a molecular sensing mechanism of TodS that is activated in response to toluene. The crystal structures of the TodS Per-Arnt-Sim (PAS) 1 sensor domain (residues 43-164) and its complex with toluene (agonist) or 1,2,4-trimethylbenzene (antagonist) show a typical 233 PAS fold structure (residues 45-149), forming a hydrophobic ligand-binding site. A signal transfer region (residues 150-163) located immediately after the canonical PAS fold may be intrinsically flexible and disordered in both apo-PAS1 and antagonist-bound forms and dramatically adapt an -helix upon toluene binding. This structural change in the signal transfer region is proposed to result in signal transmission to activate the TodS/TodT two-component signal transduction system. Site-directed mutagenesis and -galactosidase assays using a P. putida reporter strain system verified the essential residues involved in ligand sensing and signal transfer and suggest that the Phe(46) residue acts as a ligand-specific switch.	[Koh, Serry; Hwang, Jungwon; Guchhait, Koushik; Lee, Sang Jun; Oh, Tae-Kwang; Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Infect & Immun Res Ctr, Daejeon 305806, South Korea; [Lee, Eun-Gyeong; Kim, Sang-Yoon; Kim, Sujin; Lee, Seung-Goo; Kwon, Ohsuk] Korea Res Inst Biosci & Biotechnol, Biochem & Synthet Biol Res Ctr, Daejeon 305806, South Korea; [Ryu, Choong-Min] Korea Res Inst Biosci & Biotechnol, Mol Phytobacteriol Lab, Daejeon 305806, South Korea; [Lee, Sangmin; Chung, Jeong Min; Jung, Hyun Suk] Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon 200701, Gangwon Do, South Korea; [Guchhait, Koushik; Lee, Eun-Gyeong; Lee, Sang Jun; Ryu, Choong-Min; Lee, Seung-Goo; Oh, Tae-Kwang; Kwon, Ohsuk; Kim, Myung Hee] Univ Sci & Technol, Biosyst & Bioengn Program, Daejeon 305350, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kangwon National University; University of Science & Technology (UST)	Koh, S; Kim, MH (corresponding author), Korea Res Inst Biosci & Biotechnol, Infect & Immun Res Ctr, Daejeon 305806, South Korea.; Kwon, O (corresponding author), Korea Res Inst Biosci & Biotechnol, Biochem & Synthet Biol Res Ctr, Daejeon 305806, South Korea.; Kwon, O; Kim, MH (corresponding author), Univ Sci & Technol, Biosyst & Bioengn Program, Daejeon 305350, South Korea.	skohtn@kribb.re.kr; oskwon@kribb.re.kr; mhk8n@kribb.re.kr	Lee, Seung-Goo/AAS-1613-2021; Kim, Sang-Yoon/Q-1259-2015; Lee, Seung-Goo/AAR-9823-2021	Kim, Sang-Yoon/0000-0002-6918-0607; Lee, Seung-Goo/0000-0003-4539-9812; Ryu, Choong-Min/0000-0002-7276-1189; Lee, Sang Jun/0000-0002-2803-753X	Rural Development Administration, Korea [PJ00817002, PJ00952403, PJ011118]; Korea Research Institute of Bioscience and Biotechnology Research Initiative [KGM4541622, KGM2111622]	Rural Development Administration, Korea(Rural Development Administration (RDA), Republic of Korea); Korea Research Institute of Bioscience and Biotechnology Research Initiative	This work was supported by Next-Generation Biogreen 21 Program Grants PJ00817002, PJ00952403, and PJ011118, Rural Development Administration, Korea; and Korea Research Institute of Bioscience and Biotechnology Research Initiative Grants KGM4541622 and KGM2111622. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; Busch A, 2007, P NATL ACAD SCI USA, V104, P13774, DOI 10.1073/pnas.0701547104; Busch A, 2010, J BACTERIOL, V192, P4246, DOI 10.1128/JB.00379-10; Busch A, 2009, J BIOL CHEM, V284, P10353, DOI 10.1074/jbc.M900521200; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Cohen J, 1997, HUM REPROD, V12, P1742, DOI 10.1093/humrep/12.8.1742; Diaz LF, 2008, BIODEGRADATION, V19, P197, DOI 10.1007/s10532-007-9126-6; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Griffith KL, 2002, BIOCHEM BIOPH RES CO, V290, P397, DOI 10.1006/bbrc.2001.6152; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lacal J, 2008, J MOL BIOL, V376, P325, DOI 10.1016/j.jmb.2007.12.004; Lacal J, 2006, P NATL ACAD SCI USA, V103, P8191, DOI 10.1073/pnas.0602902103; Lacal J, 2008, J MOL BIOL, V384, P1037, DOI 10.1016/j.jmb.2008.10.011; Lau PCK, 1997, P NATL ACAD SCI USA, V94, P1453, DOI 10.1073/pnas.94.4.1453; Lee J, 2008, BIOCHEMISTRY-US, V47, P4051, DOI 10.1021/bi7021156; LEE JY, 1994, BIOTECHNOL BIOENG, V43, P1146, DOI 10.1002/bit.260431120; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Mosqueda G, 1999, GENE, V232, P69, DOI 10.1016/S0378-1119(99)00113-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; RAMOS JL, 1995, J BACTERIOL, V177, P3911, DOI 10.1128/jb.177.14.3911-3916.1995; Ramos-Gonzalez MI, 2002, J BACTERIOL, V184, P7062, DOI 10.1128/JB.184.24.7062-7067.2002; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Silva-Jimenez H, 2015, MICROB BIOTECHNOL, V8, P103, DOI 10.1111/1751-7915.12142; Silva-Jimenez H, 2012, MICROB BIOTECHNOL, V5, P489, DOI 10.1111/j.1751-7915.2011.00322.x; Silva-Jimenez H, 2012, PROTEIN ENG DES SEL, V25, P159, DOI 10.1093/protein/gzs001; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Thibodeau SA, 2004, BIOTECHNIQUES, V36, P410, DOI 10.2144/04363BM07; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vick JE, 2011, APPL MICROBIOL BIOT, V92, P1275, DOI 10.1007/s00253-011-3633-4; Vidal-Aroca F, 2006, BIOTECHNIQUES, V40, P433, DOI 10.2144/000112145; Winnen B, 2013, J BACTERIOL, V195, P2349, DOI 10.1128/JB.00096-13; Wu DL, 2013, MOL CELL BIOL, V33, P4346, DOI 10.1128/MCB.00698-13; Yu HB, 2001, BIODEGRADATION, V12, P465, DOI 10.1023/A:1015012913426; ZYLSTRA GJ, 1989, APPL ENVIRON MICROB, V55, P3162, DOI 10.1128/AEM.55.12.3162-3166.1989; ZYLSTRA GJ, 1988, APPL ENVIRON MICROB, V54, P1498, DOI 10.1128/AEM.54.6.1498-1503.1988	47	14	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8575	8590		10.1074/jbc.M116.718841	http://dx.doi.org/10.1074/jbc.M116.718841			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26903514	hybrid, Green Published			2022-12-28	WOS:000374773200022
J	Silvaroli, JA; Arne, JM; Chelstowska, S; Kiser, PD; Banerjee, S; Golczak, M				Silvaroli, Josie A.; Arne, Jason M.; Chelstowska, Sylwia; Kiser, Philip D.; Banerjee, Surajit; Golczak, Marcin			Ligand Binding Induces Conformational Changes in Human Cellular Retinol-binding Protein 1 (CRBP1) Revealed by Atomic Resolution Crystal Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid transport; retinal metabolism; retinoid-binding protein; retinol; vitamin A	ESCHERICHIA-COLI; VITAMIN-A; MASS-SPECTROMETRY; RAT-LIVER; HOLO; APO; DYNAMICS; FAMILY; POTENT; ACYLTRANSFERASE	Important in regulating the uptake, storage, and metabolism of retinoids, cellular retinol-binding protein 1 (CRBP1) is essential for trafficking vitamin A through the cytoplasm. However, the molecular details of ligand uptake and targeted release by CRBP1 remain unclear. Here we report the first structure of CRBP1 in a ligand-free form as well as ultra-high resolution structures of this protein bound to either all-trans-retinol or retinylamine, the latter a therapeutic retinoid that prevents light-induced retinal degeneration. Superpositioning of human apo- and holo-CRBP1 revealed major differences within segments surrounding the entrance to the retinoid-binding site. These included -helix II and hairpin turns between -strands C-D and E-F as well as several side chains, such as Phe-57, Tyr-60, and Ile-77, that change their orientations to accommodate the ligand. Additionally, we mapped hydrogen bond networks inside the retinoid-binding cavity and demonstrated their significance for the ligand affinity. Analyses of the crystallographic B-factors indicated several regions with higher backbone mobility in the apoprotein that became more rigid upon retinoid binding. This conformational flexibility of human apo-CRBP1 facilitates interaction with the ligands, whereas the more rigid holoprotein structure protects the labile retinoid moiety during vitamin A transport. These findings suggest a mechanism of induced fit upon ligand binding by mammalian cellular retinol-binding proteins.	[Silvaroli, Josie A.; Arne, Jason M.; Chelstowska, Sylwia; Kiser, Philip D.; Golczak, Marcin] Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA; [Golczak, Marcin] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Chelstowska, Sylwia] Mil Inst Med, Dept Hematol, Lab Hematol & Flow Cytometry, PL-04141 Warsaw, Poland; [Kiser, Philip D.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Banerjee, Surajit] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA; [Banerjee, Surajit] Argonne Natl Lab, Northeastern Collaborat Access Team, 9700 S Cass Ave, Argonne, IL 60439 USA	Case Western Reserve University; Case Western Reserve University; Military Institute of Aviation Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Golczak, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	mxg149@case.edu		Silvaroli, Josie/0000-0002-4505-3670	NIGMS, National Institutes of Health (NIH) [P41 GM103403]; NIH-ORIP HEI [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; DOE Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NIGMS, NIH [P41GM103393]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P41GM103403] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002683] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP HEI; DOE Office of Science(United States Department of Energy (DOE)); DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank L. T. Webster, Jr. for help in editing the manuscript. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by NIGMS, National Institutes of Health (NIH), Grant P41 GM103403. The Pilatus 6M detector on the 24-ID-C beamline is funded by NIH-ORIP HEI Grant S10 RR029205. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. We also thank the staff of the SLAC National Accelerator Laboratory (Menlo Park, CA), operated by Stanford University for the DOE Office of Science. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the DOE Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIGMS, NIH, Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Alvarez R, 2014, CHEM REV, V114, P1, DOI 10.1021/cr400126u; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; BRIDGES CDB, 1975, VISION RES, V15, P1311, DOI 10.1016/0042-6989(75)90183-2; BURGER A, 1993, FEBS LETT, V329, P25, DOI 10.1016/0014-5793(93)80185-W; Calderone V, 2002, J MOL BIOL, V321, P527, DOI 10.1016/S0022-2836(02)00628-9; Careri M, 2006, RAPID COMMUN MASS SP, V20, P1973, DOI 10.1002/rcm.2547; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHYTIL F, 1983, ADV NUTR RES, V5, P13; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERIKSSON U, 1984, J BIOL CHEM, V259, P3464; Folli C, 2002, J BIOL CHEM, V277, P41970, DOI 10.1074/jbc.M207124200; Folli C, 2001, P NATL ACAD SCI USA, V98, P3710, DOI 10.1073/pnas.061455898; Franzoni L, 2002, J BIOL CHEM, V277, P21983, DOI 10.1074/jbc.M201994200; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Golczak M, 2015, NAT CHEM BIOL, V11, P26, DOI 10.1038/nchembio.1687; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P2278, DOI 10.1021/bi962018l; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; KATO M, 1984, J CELL BIOL, V98, P1696, DOI 10.1083/jcb.98.5.1696; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Kono N, 2015, TRAFFIC, V16, P19, DOI 10.1111/tra.12231; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P53; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LEVIN MS, 1988, J BIOL CHEM, V263, P17715; LI E, 1986, P NATL ACAD SCI USA, V83, P5779, DOI 10.1073/pnas.83.16.5779; LI E, 1990, J BIOL CHEM, V265, P11549; Lu JY, 2003, J MOL BIOL, V330, P799, DOI 10.1016/S0022-2836(03)00629-6; Lu JY, 1999, J MOL BIOL, V286, P1179, DOI 10.1006/jmbi.1999.2544; MACDONALD PN, 1987, J BIOL CHEM, V262, P10550; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1997, DOI 10.1107/S0907444999011853; NEWCOMER ME, 1981, J BIOL CHEM, V256, P8162; Nossoni Z, 2014, ACTA CRYSTALLOGR D, V70, P3226, DOI 10.1107/S1399004714023839; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; ONG DE, 1978, J BIOL CHEM, V253, P828; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROSENFIELD RE, 1978, ACTA CRYSTALLOGR A, V34, P828, DOI 10.1107/S0567739478001692; SAARI JC, 1984, VISION RES, V24, P1595, DOI 10.1016/0042-6989(84)90317-1; Saari JC, 2002, INVEST OPHTH VIS SCI, V43, P1730; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; SACCHETTINI JC, 1989, P NATL ACAD SCI USA, V86, P7736, DOI 10.1073/pnas.86.20.7736; Schaap FG, 2002, MOL CELL BIOCHEM, V239, P69, DOI 10.1023/A:1020519011939; Schneider B, 2014, ACTA CRYSTALLOGR D, V70, P2413, DOI 10.1107/S1399004714014631; Tarter M, 2008, PROTEINS, V70, P1626, DOI 10.1002/prot.21848; Torta F, 2004, BBA-PROTEINS PROTEOM, V1703, P21, DOI 10.1016/j.bbapap.2004.09.004; Trueblood KN, 1996, ACTA CRYSTALLOGR A, V52, P770, DOI 10.1107/S0108767396005697; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WINTER NS, 1993, J MOL BIOL, V230, P1247, DOI 10.1006/jmbi.1993.1239; Xiao H, 2005, J AM SOC MASS SPECTR, V16, P869, DOI 10.1016/j.jasms.2005.02.020; Zhang JY, 2015, MOL PHARMACOL, V87, P477, DOI 10.1124/mol.114.096560	61	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8528	8540		10.1074/jbc.M116.714535	http://dx.doi.org/10.1074/jbc.M116.714535			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26900151	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000374773200018
J	Baratchian, M; Davis, CA; Shimizu, A; Escors, D; Bagneris, C; Barrett, T; Collins, MK				Baratchian, Mehdi; Davis, Christopher A.; Shimizu, Akira; Escors, David; Bagneris, Claire; Barrett, Tracey; Collins, Mary K.			Distinct Activation Mechanisms of NF-kappa B Regulator Inhibitor of NF-kappa B Kinase (IKK) by Isoforms of the Cell Death Regulator Cellular FLICE-like Inhibitory Protein (cFLIP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KSHV VFLIP; C-FLIPR; COMPLEX; EXPRESSION; APOPTOSIS; GAMMA; LYMPHOMAS; PATHWAY; TAK1	The viral FLICE-like inhibitory protein (FLIP) protein from Kaposi sarcoma-associated herpesvirus activates the NF-kappa B pathway by forming a stable complex with a central region (amino acids 150-272) of the inhibitor of NF-kappa B kinase (IKK)gamma subunits, thereby activating IKK. Cellular FLIP (cFLIP) forms are also known to activate the NF-kappa B pathway via IKK activation. Here we demonstrate that cFLIP(L), cFLIP(S), and their proteolytic product p22-FLIP all require the C-terminal region of NEMO/IKK gamma (amino acids 272-419) and its ubiquitin binding function for activation of the IKK kinase (or kinase complex), but none form a stable complex with IKK gamma. Our results further reveal that cFLIPL requires the linear ubiquitin chain assembly complex and the kinase TAK1 for activation of the IKK kinase. Similarly, cFLIPS and p22-FLIP also require TAK1 but do not require LUBAC. In contrast, these isoforms are both components of complexes that incorporate Fas-associated death domain and RIP1, which appear essential for kinase activation. This conservation of IKK activation among the cFLIP family using different mechanisms suggests that the mechanism plays a critical role in their function.	[Baratchian, Mehdi; Davis, Christopher A.; Shimizu, Akira; Escors, David; Collins, Mary K.] UCL, Div Infect & Immun, MRC, Ctr Med Mol Virol, London WC1E 6BT, England; [Baratchian, Mehdi; Collins, Mary K.] Natl Inst Biol Stand & Controls, Div Adv Therapies, Blanche Lane, Potters Bar EN6 3QG, Herts, England; [Bagneris, Claire; Barrett, Tracey] Birkbeck Coll, Sch Biol Sci, Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England	University of London; University College London; National Institute for Biological Standards & Control; University of London; Birkbeck University London	Collins, MK (corresponding author), UCL, Infect & Immun, Gower St, London WC1E 6BT, England.	mary.collins@ucl.ac.uk	Escors-Murugarren, David/ABG-1930-2020; Escors, David/C-1549-2008	Escors-Murugarren, David/0000-0003-2828-4458; Escors, David/0000-0003-2828-4458; davis, chris/0000-0002-7317-3266; Bagneris, Claire/0000-0002-0561-7574	Cancer Research UK; University College London Graduate School; MRC [G0701236] Funding Source: UKRI; Cancer Research UK [12595] Funding Source: researchfish; Medical Research Council [G0701236] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); University College London Graduate School; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a project grant from Cancer Research UK (to M. K. C and T. B.) and a scholarship from the University College London Graduate School (to M. B.). The authors declare they have no conflicts of interest with the contents of this article.	Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Keller SA, 2000, BLOOD, V96, P2537; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lavrik IN, 2008, J BIOL CHEM, V283, P26401, DOI 10.1074/jbc.M800823200; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Matta H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036601; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mukherjee S, 2008, J BIOL CHEM, V283, P15127, DOI 10.1074/jbc.M704831200; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; O'Donnell MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041238; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Park YH, 2013, BBA-PROTEINS PROTEOM, V1834, P292, DOI 10.1016/j.bbapap.2012.08.013; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Safa Ahmad R, 2011, Cancers (Basel), V3, P1639, DOI 10.3390/cancers3021639; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shimizu A, 2011, J VIROL, V85, P7444, DOI 10.1128/JVI.02337-10; Suzuki S, 2007, J BIOL CHEM, V282, P25177, DOI 10.1074/jbc.C700065200; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tolani B, 2014, J VIROL, V88, P6345, DOI 10.1128/JVI.00028-14; Ueffing N, 2008, CELL DEATH DIFFER, V15, P773, DOI 10.1038/sj.cdd.4402314; Ullenhag GJ, 2007, CLIN CANCER RES, V13, P5070, DOI 10.1158/1078-0432.CCR-06-2547; Valente G, 2006, BRIT J HAEMATOL, V132, P560, DOI 10.1111/j.1365-2141.2005.05898.x; Valnet-Rabier MB, 2005, BRIT J HAEMATOL, V128, P767, DOI 10.1111/j.1365-2141.2005.05378.x; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu XF, 2007, EMBO REP, V8, P510, DOI 10.1038/sj.embor.7400931; Xiao GT, 2000, J BIOL CHEM, V275, P34060, DOI 10.1074/jbc.M002970200; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769	49	17	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7608	7620		10.1074/jbc.M116.718122	http://dx.doi.org/10.1074/jbc.M116.718122			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26865630	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000383447600033
J	Qu, CS; Bian, DD; Li, X; Xiao, J; Wu, CP; Li, Y; Jiang, T; Zhou, XT; Qu, J; Chen, JG				Qu, Chunsheng; Bian, Dandan; Li, Xue; Xiao, Jian; Wu, Chunping; Li, Yue; Jiang, Tian; Zhou, Xiangtian; Qu, Jia; Chen, Jie-Guang			Transient Expression of Fez Family Zinc Finger 2 Protein Regulates the Brn3b Gene in Developing Retinal Ganglion Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN FACTOR BRN-3B; TRANSCRIPTION FACTOR; FATE SPECIFICATION; COMPETENCE STATE; CEREBRAL-CORTEX; STEM-CELLS; MATH5; DIFFERENTIATION; NEURONS; LAYER	Retinal ganglion cells (RGCs) are projection neurons in the neural retina that relay visual information from the environment to the central nervous system. The early expression of MATH5 endows the post-mitotic precursors with RGC competence and leads to the activation of Brn3b that marks committed RGCs. Nevertheless, this fate commitment process and, specifically, regulation of Brn3b remain elusive. To explore the molecular mechanisms underlying RGC generation in the mouse retina, we analyzed the expression and function of Fez family zinc finger 2 (FEZF2), a transcription factor critical for the development of projection neurons in the cerebral cortex. Fezf2 mRNA and protein were transiently expressed at embryonic day 16.5 in the inner neuroblast layer and the prospective ganglion cell layer of the retina, respectively. Knockout of Fezf2 in the developing retina reduced BRN3B+ cells and increased apoptotic cell markers. Fezf2 knockdown by retinal in utero electroporation diminished BRN3B but not the coexpressed ISLET1 and BRN3A, indicating that the BRN3B decrease was the cause, not the result, of the overall reduction of BRN3B+ RGCs in the Fezf2 knockout retina. Moreover, the mRNA and promoter activity of Brn3b were increased in vitro by FEZF2, which bound to a 5' regulatory fragment in the Brn3b genomic locus. These results indicate that transient expression of Fezf2 in the retina modulates the transcription of Brn3b and the survival of RGCs. This study improves our understanding of the transcriptional cascade required for the specification of RGCs and provides novel insights into the molecular basis of retinal development.	[Qu, Chunsheng; Bian, Dandan; Li, Xue; Xiao, Jian; Wu, Chunping; Jiang, Tian; Zhou, Xiangtian; Qu, Jia; Chen, Jie-Guang] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou 325000, Zhejiang, Peoples R China; [Qu, Chunsheng; Bian, Dandan; Li, Xue; Xiao, Jian; Wu, Chunping; Jiang, Tian; Zhou, Xiangtian; Qu, Jia; Chen, Jie-Guang] Wenzhou Med Univ, Hosp Eye, Wenzhou 325000, Zhejiang, Peoples R China; [Qu, Chunsheng; Bian, Dandan; Li, Xue; Xiao, Jian; Wu, Chunping; Jiang, Tian; Zhou, Xiangtian; Qu, Jia; Chen, Jie-Guang] Minist Hlth China, China State Key Lab Cultivat Base, Wenzhou 325000, Zhejiang, Peoples R China; [Qu, Chunsheng; Bian, Dandan; Li, Xue; Xiao, Jian; Wu, Chunping; Jiang, Tian; Zhou, Xiangtian; Qu, Jia; Chen, Jie-Guang] Minist Hlth China, Key Lab Vis Sci, Wenzhou 325000, Zhejiang, Peoples R China; [Qu, Chunsheng; Bian, Dandan; Li, Xue; Xiao, Jian; Wu, Chunping; Jiang, Tian; Zhou, Xiangtian; Qu, Jia; Chen, Jie-Guang] Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou 325000, Zhejiang, Peoples R China; [Li, Yue] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Qu, Chunsheng] Wenzhou Med Univ, Affiliated Hosp 6, LiShui Peoples Hosp, Clin Lab, Lishui 323000, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Yale University; Wenzhou Medical University	Chen, JG (corresponding author), Wenzhou Med Univ, Key Lab Visual Sci, 270 Xueyuan Rd, Wenzhou 325003, Zhejiang, Peoples R China.; Chen, JG (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, 270 Xueyuan Rd, Wenzhou 325003, Zhejiang, Peoples R China.	jgchen@mail.eye.ac.cn	Xiao, Jian/GYU-4351-2022; zhou, xt/GWZ-9212-2022		National Natural Science Foundation of China [31500850, 81571096]; Zhejiang Provincial Natural Science Foundation of China [LQ16H120001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The work was supported by National Natural Science Foundation of China Grants 31500850 (to C. Q.) and 81571096 (to J. G. C.) and Zhejiang Provincial Natural Science Foundation of China Grant LQ16H120001 (to C. Q.). The authors declare that they have no conflicts of interest with the contents of this article.	Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2012, DEV BIOL, V365, P395, DOI 10.1016/j.ydbio.2012.03.006; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Chen LS, 2011, J BIOL CHEM, V286, P18641, DOI 10.1074/jbc.M111.236471; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Farah MH, 2005, J COMP NEUROL, V489, P120, DOI 10.1002/cne.20615; Farah MH, 2006, BRAIN RES REV, V52, P264, DOI 10.1016/j.brainresrev.2006.04.002; Feng L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-36; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Garcia-Frigola C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-103; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Hutcheson DA, 2001, DEV BIOL, V232, P327, DOI 10.1006/dbio.2001.0178; Jiang Y, 2013, J BIOL CHEM, V288, P18429, DOI 10.1074/jbc.M113.478503; Liu W, 2001, P NATL ACAD SCI USA, V98, P1649, DOI 10.1073/pnas.98.4.1649; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Mu XQ, 2008, P NATL ACAD SCI USA, V105, P6942, DOI 10.1073/pnas.0802627105; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Qiu F, 2008, J NEUROSCI, V28, P3392, DOI 10.1523/JNEUROSCI.0043-08.2008; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Shimizu T, 2010, DEVELOPMENT, V137, P1875, DOI 10.1242/dev.047167; Shu XS, 2013, CARCINOGENESIS, V34, P1984, DOI 10.1093/carcin/bgt165; Wagner KD, 2002, EMBO J, V21, P1398, DOI 10.1093/emboj/21.6.1398; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang ZB, 2011, CEREB CORTEX, V21, P2177, DOI 10.1093/cercor/bhr006; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005	34	1	1	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7661	7668		10.1074/jbc.M115.689448	http://dx.doi.org/10.1074/jbc.M115.689448			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26861874	Green Published, hybrid			2022-12-28	WOS:000383447600037
J	Ramirez-Escudero, M; Gimeno-Perez, M; Gonzalez, B; Linde, D; Merdzo, Z; Fernandez-Lobato, M; Sanz-Aparicio, J				Ramirez-Escudero, Mercedes; Gimeno-Perez, Maria; Gonzalez, Beatriz; Linde, Dolores; Merdzo, Zoran; Fernandez-Lobato, Maria; Sanz-Aparicio, Julia			Structural Analysis of -Fructofuranosidase from Xanthophyllomyces dendrorhous Reveals Unique Features and the Crucial Role of N-Glycosylation in Oligomerization and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; enzyme structure; glycoside hydrolase; glycosylation; kinetics; oligomerization; X-ray crystallography	CELL-WALL INVERTASE; BETA-FRUCTOFURANOSIDASE; CRYSTAL-STRUCTURE; SCHWANNIOMYCES-OCCIDENTALIS; SUBSTRATE; COMPLEX; ENZYME; DOMAIN; SITE; TRISACCHARIDE	Xanthophyllomyces dendrorhous -fructofuranosidase (XdINV)is a highly glycosylated dimeric enzyme that hydrolyzes sucrose and releases fructose from various fructooligosaccharides (FOS) and fructans. It also catalyzes the synthesis of FOS, prebiotics that stimulate the growth of beneficial bacteria in human gut. In contrast to most fructosylating enzymes, XdINV produces neo-FOS, which makes it an interesting biotechnology target. We present here its three-dimensional structure, which shows the expected bimodular arrangement and also a long extension of its C terminus that together with an N-linked glycan mediate the formation of an unusual dimer. The two active sites of the dimer are connected by a long crevice, which might indicate its potential ability to accommodate branched fructans. This arrangement could be representative of a group of GH32 yeast enzymes having the traits observed in XdINV. The inactive D80A mutant was used to obtain complexes with relevant substrates and products, with their crystals structures showing at least four binding subsites at each active site. Moreover, two different positions are observed from subsite +2 depending on the substrate, and thus, a flexible loop (Glu-334-His-343) is essential in binding sucrose and (2-1)-linked oligosaccharides. Conversely, (2-6) and neo-type substrates are accommodated mainly by stacking to Trp-105, explaining the production of neokestose and the efficient fructosylating activity of XdINV on -glucosides. The role of relevant residues has been investigated by mutagenesis and kinetics measurements, and a model for the transfructosylating reaction has been proposed. The plasticity of its active site makes XdINV a valuable and flexible biocatalyst to produce novel bioconjugates.	[Ramirez-Escudero, Mercedes; Gonzalez, Beatriz; Sanz-Aparicio, Julia] CSIC, Inst Phys Chem Rocasolano, Dept Crystallog & Struct Biol, Serrano 119, E-28006 Madrid, Spain; [Gimeno-Perez, Maria; Linde, Dolores; Merdzo, Zoran; Fernandez-Lobato, Maria] Univ Autonoma Madrid, CSIC, Ctr Mol Biol Severo Ochoa, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Sanz-Aparicio, J (corresponding author), CSIC, Inst Phys Chem Rocasolano, Dept Crystallog & Struct Biol, Serrano 119, E-28006 Madrid, Spain.; Fernandez-Lobato, M (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Mol Biol Severo Ochoa, E-28049 Madrid, Spain.	mfernandez@cbm.csic.es; xjulia@iqfr.csic.es	ESCUDERO, MERCEDES RAMIREZ/Q-3965-2018; Lobato, Maria Fernandez/F-1338-2016; Sanz-Aparicio, Julia/F-6201-2013; Escudero, Mercedes Ramirez/O-1690-2019; Gonzalez, Beatriz/M-1219-2014; Gimeno, Maria/AAN-1908-2020	ESCUDERO, MERCEDES RAMIREZ/0000-0001-7253-9572; Lobato, Maria Fernandez/0000-0003-0778-7443; Sanz-Aparicio, Julia/0000-0002-6849-8621; Escudero, Mercedes Ramirez/0000-0001-7253-9572; Gonzalez, Beatriz/0000-0002-0710-0202; Linde, Dolores/0000-0002-0359-0566; Gimeno-Perez, Maria/0000-0002-2663-7339	Spanish Ministry of Economy and Competitiveness [BIO2010-20508-C04-03/-04, BIO2013-48779-C4-3/-4]; European Community; Fundacion Ramon Areces institutional grant; Ministry of Education, Culture and Sports	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Community(European Commission); Fundacion Ramon Areces institutional grant; Ministry of Education, Culture and Sports	This work was supported in part by Spanish Ministry of Economy and Competitiveness Grants BIO2010-20508-C04-03/-04 and BIO2013-48779-C4-3/-4, BioStruct-X Program from the European Community's Seventh Framework Programme Grant FP7/2007-2013, and a Fundacion Ramon Areces institutional grant (to the Centro de Biologia Molecular "Severo Ochoa"). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Spanish doctoral fellowship from the Ministry of Education, Culture and Sports.	Alberto F, 2006, BIOCHEM J, V395, P457, DOI [10.1042/BJ20051936, 10.1042/Bj20051936]; Alvaro-Benito M, 2007, J BIOTECHNOL, V132, P75, DOI 10.1016/j.jbiotec.2007.07.939; Alvaro-Benito M, 2012, J BIOL CHEM, V287, P19674, DOI 10.1074/jbc.M112.355503; Alvaro-Benito M, 2010, J BIOL CHEM, V285, P13930, DOI 10.1074/jbc.M109.095430; Sainz-Polo MA, 2013, J BIOL CHEM, V288, P9755, DOI 10.1074/jbc.M112.446435; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bujacz A, 2011, FEBS J, V278, P1728, DOI 10.1111/j.1742-4658.2011.08098.x; Chuankhayan P, 2010, J BIOL CHEM, V285, P23249, DOI 10.1074/jbc.M110.113027; Cimini S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00089; DeLano W.L, PYMOL MOL GRAPHICS S; Rodriguez-Alegria ME, 2010, BIOCATAL BIOTRANSFOR, V28, P51, DOI 10.3109/10242420903388819; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franco-Robles Elena, 2015, ScientificWorldJournal, V2015, P289267, DOI 10.1155/2015/289267; Gimeno-Perez M, 2014, PROCESS BIOCHEM, V49, P423, DOI 10.1016/j.procbio.2013.12.018; Gimeno-Perez M, 2015, APPL MICROBIOL BIOT, V99, P3459, DOI 10.1007/s00253-014-6145-1; Henrissat B, 2008, CURR OPIN STRUC BIOL, V18, P527, DOI 10.1016/j.sbi.2008.09.003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kilian S, 2002, WORLD J MICROB BIOT, V18, P637, DOI 10.1023/A:1016808015630; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lammens W, 2008, J MOL BIOL, V377, P378, DOI 10.1016/j.jmb.2007.12.074; Lammens W, 2012, PLANT J, V70, P205, DOI 10.1111/j.1365-313X.2011.04858.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Roy K, 2007, PLANT PHYSIOL, V145, P616, DOI 10.1104/pp.107.105049; Lim JS, 2007, EUR FOOD RES TECHNOL, V225, P457, DOI 10.1007/s00217-006-0440-8; Linde D, 2012, BIORESOURCE TECHNOL, V109, P123, DOI 10.1016/j.biortech.2012.01.023; Linde D, 2009, APPL ENVIRON MICROB, V75, P1065, DOI 10.1128/AEM.02061-08; Lopez MG, 2003, J AGR FOOD CHEM, V51, P7835, DOI 10.1021/jf030383v; Marx SP, 2000, FEMS MICROBIOL LETT, V182, P163, DOI 10.1016/S0378-1097(99)00584-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Polo A, 2010, ACTA CRYSTALLOGR F, V66, P1441, DOI [10.1107/S1744309110029192, 10.1107/S17443091100291]; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; Pouyez J, 2012, BIOCHIMIE, V94, P2423, DOI 10.1016/j.biochi.2012.06.020; Ritsema T, 2003, CURR OPIN PLANT BIOL, V6, P223, DOI 10.1016/S1369-5266(03)00034-7; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tian F, 2012, J MOL CATAL B-ENZYM, V82, P71, DOI 10.1016/j.molcatb.2012.06.005; Trollope KM, 2015, FEBS J, V282, P4782, DOI 10.1111/febs.13536; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Velazquez-Hernandez ML, 2009, J APPL MICROBIOL, V106, P1763, DOI 10.1111/j.1365-2672.2008.04120.x; Verhaest M, 2007, NEW PHYTOL, V174, P90, DOI 10.1111/j.1469-8137.2007.01988.x; Verhaest M, 2006, ACTA CRYSTALLOGR D, V62, P1555, DOI 10.1107/S0907444906044489; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	45	31	31	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6843	6857		10.1074/jbc.M115.708495	http://dx.doi.org/10.1074/jbc.M115.708495			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26823463	Green Published, hybrid			2022-12-28	WOS:000373299700023
J	Zhao, YH; Luo, AP; Li, S; Zhang, W; Chen, HY; Li, Y; Ding, F; Huang, FR; Liu, ZH				Zhao, Yahui; Luo, Aiping; Li, Sheng; Zhang, Wei; Chen, Hongyan; Li, Yi; Ding, Fang; Huang, Furong; Liu, Zhihua			Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP-1 transcription factor (AP-1); apoptosis; c-Fos; chemoresistance; promoter; ID1; c-Jun; etoposide	SQUAMOUS-CELL CARCINOMA; ESOPHAGEAL CANCER-CELLS; TRANSCRIPTION FACTOR; EXPRESSION; AP-1; PATHWAY; P53; ACTIVATION; GENES; CHEMORESISTANCE	ID1 (inhibitor of differentiation/DNA binding 1) acts an important role in metastasis, tumorigenesis, and maintenance of cell viability. It has been shown that the up-regulation of ID1 is correlated with poor prognosis and the resistance to chemotherapy of human cancers. However, the underlying molecular mechanism remains elusive. Here, we determined for the first time that up-regulating ID1 upon etoposide activation was mediated through AP-1 binding sites within the ID1 promoter and confirmed that ID1 enhanced cell resistance to DNA damage-induced apoptosis in esophageal squamous cell carcinoma cells. Ablation of c-Jun/c-Fos or ID1 expression enhanced etoposide-mediated apoptosis through increasing activity of caspase 3 and PARP cleavage. Moreover, c-Jun/c-Fos and ID1 were positively correlated in human cancers. More importantly, simultaneous high expression of ID1 and c-Jun or c-Fos was correlated with poor survival in cancer patients. Collectively, we demonstrate the importance of c-Jun/c-Fos-ID1 signaling pathway in chemoresistance of esophageal cancer cells and provide considerable insight into understanding the underlying molecular mechanisms in esophageal squamous cell carcinoma cell biology.	[Zhao, Yahui; Luo, Aiping; Zhang, Wei; Chen, Hongyan; Li, Yi; Ding, Fang; Huang, Furong; Liu, Zhihua] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Zhao, Yahui; Luo, Aiping; Zhang, Wei; Chen, Hongyan; Li, Yi; Ding, Fang; Huang, Furong; Liu, Zhihua] Peking Union Med Coll, Collaborat Innovat Ctr Canc Med, Beijing 100021, Peoples R China; [Li, Sheng] Peking Univ, Canc Hosp & Inst, Ctr Mol & Translat Med,Minist Educ, Dept Cell Biol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University	Liu, ZH (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.; Liu, ZH (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn		Li, Sheng/0000-0001-8080-9712; Zhao, Yahui/0000-0002-9613-1384	National Basic Research Program of China [2013CB911004]; National Natural Science Foundation of China [81130043, 81420108025, 81472791]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2013CB911004 and National Natural Science Foundation of China Grants 81130043, 81420108025, and 81472791. The authors declare that they have no conflicts of interest with the contents of this article.	Birkenkamp KU, 2007, J BIOL CHEM, V282, P2211, DOI 10.1074/jbc.M606669200; Boeckx C, 2015, AM J CANCER RES, V5, P1921; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Castanon E, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-13; Chen HY, 2013, MOL CANCER RES, V11, P1542, DOI 10.1158/1541-7786.MCR-13-0317; di Pietro A, 2012, CELL CYCLE, V11, P4552, DOI 10.4161/cc.22803; Dutton SJ, 2014, LANCET ONCOL, V15, P894, DOI 10.1016/S1470-2045(14)70024-5; Goswami CP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-970; He H, 2015, J BIOL CHEM, V290, P13567, DOI 10.1074/jbc.M114.629717; He H, 2014, J BIOL CHEM, V289, P9089, DOI 10.1074/jbc.M113.534271; Hernandez-Vargas H, 2006, INT J CANCER, V119, P1164, DOI 10.1002/ijc.21938; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hu YC, 2001, CLIN CANCER RES, V7, P3519; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Li B, 2016, CLIN CANCER RES, V22, P1243, DOI 10.1158/1078-0432.CCR-15-1196; Li B, 2014, CLIN CANCER RES, V20, P2651, DOI 10.1158/1078-0432.CCR-13-2735; Li B, 2009, INT J CANCER, V125, P2576, DOI 10.1002/ijc.24675; Li S, 2013, J BIOL CHEM, V288, P4076, DOI 10.1074/jbc.M111.317487; Ling F, 2014, CURR TOP DEV BIOL, V110, P189, DOI 10.1016/B978-0-12-405943-6.00005-1; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Liu JG, 2010, CANCER BIOMARK, V8, P67, DOI 10.3233/DMA-2011-0831; Luo AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096610; Luo AP, 2013, MOL ONCOL, V7, P955, DOI 10.1016/j.molonc.2013.05.005; Ma J, 2013, INT J ONCOL, V43, P1052, DOI 10.3892/ijo.2013.2043; McNeely SC, 2006, ENVIRON HEALTH PERSP, V114, P1401, DOI 10.1289/ehp.8969; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Qian YJ, 2008, J BIOL CHEM, V283, P22410, DOI 10.1074/jbc.M800643200; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Subramanian D, 2015, J BIOL CHEM, V290, P18636, DOI 10.1074/jbc.M115.636548; Sun NK, 2015, ONCOTARGET, V6, P27065, DOI 10.18632/oncotarget.4824; Trevino JG, 2012, NEOPLASIA, V14, P1102, DOI 10.1593/neo.121044; Wu YZ, 2003, ONCOGENE, V22, P8891, DOI 10.1038/sj.onc.1206898; Yang H, 2015, ONCOTARGET, V6, P26079, DOI 10.18632/oncotarget.4581; Yap WN, 2010, CANCER LETT, V291, P187, DOI 10.1016/j.canlet.2009.10.012; Yu H. H., 2014, LASER PHOTONICS REV, V1, P1, DOI DOI 10.1080/09670874.2014.986560; Yu XF, 2006, BIOCHEM BIOPH RES CO, V342, P286, DOI 10.1016/j.bbrc.2006.01.147; Zhang S, 2014, ONCOTARGET, V5, P7183, DOI 10.18632/oncotarget.2293; Zhang XP, 2009, INT J CANCER, V124, P1980, DOI 10.1002/ijc.24139	40	25	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6831	6842		10.1074/jbc.M115.704361	http://dx.doi.org/10.1074/jbc.M115.704361			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26858249	Green Published, hybrid			2022-12-28	WOS:000373299700022
J	Bitto, D; Halldorsson, S; Caputo, A; Huiskonen, JT				Bitto, David; Halldorsson, Steinar; Caputo, Alessandro; Huiskonen, Juha T.			Low pH and Anionic Lipid-dependent Fusion of Uukuniemi Phlebovirus to Liposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron tomography; membrane; membrane fusion; virus entry; virus structure; bis(monoacylglycero)phosphate; bunyavirus; phlebovirus	SEMLIKI-FOREST-VIRUS; BORNE ENCEPHALITIS-VIRUS; MEMBRANE-FUSION; ELECTRON CRYOTOMOGRAPHY; SPONTANEOUS CURVATURE; SINDBIS VIRUS; FEVER; CHOLESTEROL; GLYCOPROTEIN; PROTEIN	Many phleboviruses (family Bunyaviridae) are emerging as medically important viruses. These viruses enter target cells by endocytosis and low pH-dependent membrane fusion in late endosomes. However, the necessary and sufficient factors for fusion have not been fully characterized. We have studied the minimal fusion requirements of a prototypic phlebovirus, Uukuniemi virus, in an in vitro virus-liposome assay. We show that efficient lipid mixing between viral and liposome membranes requires close to physiological temperatures and phospholipids with negatively charged headgroups, such as the late endosomal phospholipid bis(monoacylglycero)phosphate. We further demonstrate that bis(monoacylglycero)phosphate increases Uukuniemi virus fusion beyond the lipid mixing stage. By using electron cryotomography of viral particles in the presence or absence of liposomes, we observed that the conformation of phlebovirus glycoprotein capsomers changes from the native conformation toward a more elongated conformation at a fusion permissive pH. Our results suggest a rationale for phlebovirus entry in late endosomes.	[Bitto, David; Halldorsson, Steinar; Caputo, Alessandro; Huiskonen, Juha T.] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England; [Caputo, Alessandro] Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Huiskonen, JT (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.	juha@strubi.ox.ac.uk	Caputo, Alessandro/AFM-4954-2022; Huiskonen, Juha T/C-3043-2008	Caputo, Alessandro/0000-0001-5007-6896; Huiskonen, Juha T/0000-0002-0348-7323; Bitto, David/0000-0003-3530-4947; Halldorsson, Steinar/0000-0003-1810-6607	Wellcome Trust JIF [060208/Z/00/Z]	Wellcome Trust JIF	We thank A. Siebert for electron microscopy support, K. Grunewald for helpful suggestions, and T. Bowden for critically reading the manuscript. Oxford Particle Imaging Centre electron microscopy facility was founded by a Wellcome Trust JIF award 060208/Z/00/Z.	Alley SH, 2008, CHEM PHYS LIPIDS, V154, P64, DOI 10.1016/j.chemphyslip.2008.03.007; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Bowden TA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003374; BRATT MA, 1969, P NATL ACAD SCI USA, V64, P536, DOI 10.1073/pnas.64.2.536; BRON R, 1993, EMBO J, V12, P693, DOI 10.1002/j.1460-2075.1993.tb05703.x; Cao S, 2013, P NATL ACAD SCI USA, V110, P13362, DOI 10.1073/pnas.1301911110; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; CORVER J, 1995, J VIROL, V69, P3220, DOI 10.1128/JVI.69.5.3220-3223.1995; Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172; CYRKLAFF M, 1994, J MICROSC-OXFORD, V175, P135, DOI 10.1111/j.1365-2818.1994.tb03476.x; de Boer SM, 2012, J VIROL, V86, P13642, DOI 10.1128/JVI.01973-12; Dessau M, 2013, P NATL ACAD SCI USA, V110, P1696, DOI 10.1073/pnas.1217780110; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; Freiberg AN, 2008, J VIROL, V82, P10341, DOI 10.1128/JVI.01191-08; Fuller N, 2003, BIOPHYS J, V85, P1667, DOI 10.1016/S0006-3495(03)74596-2; Gallala HD, 2011, NEUROCHEM RES, V36, P1594, DOI 10.1007/s11064-010-0337-6; Garigliany MM, 2012, ANTIVIR RES, V95, P82, DOI 10.1016/j.antiviral.2012.05.014; Harmon B, 2012, J VIROL, V86, P12954, DOI 10.1128/JVI.02242-12; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; Huiskonen JT, 2014, JOVE-J VIS EXP, DOI 10.3791/51714; Huiskonen JT, 2010, J VIROL, V84, P4889, DOI 10.1128/JVI.00057-10; Huiskonen JT, 2009, J VIROL, V83, P3762, DOI 10.1128/JVI.02483-08; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; KUISMANEN E, 1982, MOL CELL BIOL, V2, P1444, DOI 10.1128/MCB.2.11.1444; Kyoung M, 2011, P NATL ACAD SCI USA, V108, pE304, DOI 10.1073/pnas.1107900108; Lee KK, 2010, EMBO J, V29, P1299, DOI 10.1038/emboj.2010.13; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Lozach PY, 2010, CELL HOST MICROBE, V7, P488, DOI 10.1016/j.chom.2010.05.007; MARSH M, 1980, J MOL BIOL, V142, P439, DOI 10.1016/0022-2836(80)90281-8; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mobius W, 2003, TRAFFIC, V4, P222; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; NIEVA JL, 1994, EMBO J, V13, P2797, DOI 10.1002/j.1460-2075.1994.tb06573.x; Overby AK, 2008, P NATL ACAD SCI USA, V105, P2375, DOI 10.1073/pnas.0708738105; PAL R, 1988, BIOCHEMISTRY-US, V27, P30, DOI 10.1021/bi00401a006; Prins M, 1998, TRENDS MICROBIOL, V6, P31, DOI 10.1016/S0966-842X(97)01173-6; RENKONEN O, 1972, VIROLOGY, V50, P899, DOI 10.1016/0042-6822(72)90443-6; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Sherman MB, 2009, VIROLOGY, V387, P11, DOI 10.1016/j.virol.2009.02.038; Smit JM, 1999, J VIROL, V73, P8476, DOI 10.1128/JVI.73.10.8476-8484.1999; Umashankar M, 2008, J VIROL, V82, P9245, DOI 10.1128/JVI.00975-08; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Waarts BL, 2005, J VIROL, V79, P7942, DOI 10.1128/JVI.79.12.7942-7948.2005; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131	60	24	24	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6412	6422		10.1074/jbc.M115.691113	http://dx.doi.org/10.1074/jbc.M115.691113			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26811337	Green Published, hybrid			2022-12-28	WOS:000372894200029
J	Burana, D; Yoshihara, H; Tanno, H; Yamamoto, A; Saeki, Y; Tanaka, K; Komada, M				Burana, Daocharad; Yoshihara, Hidehito; Tanno, Hidetaka; Yamamoto, Akitsugu; Saeki, Yasushi; Tanaka, Keiji; Komada, Masayuki			The Ankrd13 Family of Ubiquitin-interacting Motif-bearing Proteins Regulates Valosin-containing Protein/p97 Protein-mediated Lysosomal Trafficking of Caveolin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolin; cell surface protein; endocytosis; endosome; membrane trafficking; protein degradation; ubiquitin; ubiquitylation (ubiquitination); VCP; p97; ubiquitin-interacting motif	VCP/P97 AAA-ATPASE; RECEPTOR ENDOCYTOSIS; PLASMA-MEMBRANE; DEGRADATION; P97; PATHWAY; DOMAIN; VCP; QUANTIFICATION; MUTATIONS	Caveolin 1 (Cav-1) is an oligomeric protein that forms flask-shaped, lipid-rich pits, termed caveolae, on the plasma membrane. Cav-1 is targeted for lysosomal degradation in ubiquitination- and valosin-containing protein (VCP)-dependent manners. VCP, an ATPase associated with diverse cellular activities that remodels or segregates ubiquitinated protein complexes, has been proposed to disassemble Cav-1 oligomers on the endosomal membrane, facilitating the trafficking of Cav-1 to the lysosome. Genetic mutations in VCP compromise the lysosomal trafficking of Cav-1, leading to a disease called inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia (IBMPFD). Here we identified the Ankrd13 family of ubiquitin-interacting motif (UIM)-containing proteins as novel VCP-interacting molecules on the endosome. Ankrd13 proteins formed a ternary complex with VCP and Cav-1 and exhibited high binding affinity for ubiquitinated Cav-1 oligomers in an UIM-dependent manner. Mass spectrometric analyses revealed that Cav-1 undergoes Lys-63-linked polyubiquitination, which serves as a lysosomal trafficking signal, and that the UIMs of Ankrd13 proteins bind preferentially to this ubiquitin chain type. The overexpression of Ankrd13 caused enlarged hollow late endosomes, which was reminiscent of the phenotype of the VCP mutations in IBMPFD. Overexpression of Ankrd13 proteins also stabilized ubiquitinated Cav-1 oligomers on the limiting membrane of enlarged endosomes. The interaction with Ankrd13 was abrogated in IMBPFD-associated VCP mutants. Collectively, our results suggest that Ankrd13 proteins cooperate with VCP to regulate the lysosomal trafficking of ubiquitinated Cav-1.	[Burana, Daocharad; Tanno, Hidetaka; Komada, Masayuki] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 2268501, Japan; [Yoshihara, Hidehito; Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama 5260829, Japan	Tokyo Institute of Technology; Tokyo Metropolitan Institute of Medical Science	Komada, M (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259-B16 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	makomada@bio.titech.ac.jp	Saeki, Yasushi/AAR-8198-2021	Saeki, Yasushi/0000-0002-9202-5453; Tanno, Hidetaka/0000-0001-6749-0938	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24112003, 24112008, 21000012]; Grants-in-Aid for Scientific Research [26000014] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants-in-Aid 24112003 (to M. K.), 24112008 (to Y. S.), and 21000012 (to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Fujimuro M, 2005, METHOD ENZYMOL, V399, P75, DOI 10.1016/S0076-6879(05)99006-X; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kirchner P, 2013, J BIOL CHEM, V288, P7363, DOI 10.1074/jbc.M112.429076; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Nagahama M, 2009, BIOCHEM BIOPH RES CO, V382, P303, DOI 10.1016/j.bbrc.2009.03.012; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Spina S, 2013, EUR J NEUROL, V20, P251, DOI 10.1111/j.1468-1331.2012.03831.x; Tang WK, 2013, J BIOL CHEM, V288, P36624, DOI 10.1074/jbc.M113.488924; Tanno H, 2013, J BIOCHEM, V153, P497, DOI 10.1093/jb/mvt028; Tanno H, 2012, MOL BIOL CELL, V23, P1343, DOI 10.1091/mbc.E11-09-0817; Tsuchiya H, 2013, BIOCHEM BIOPH RES CO, V436, P223, DOI 10.1016/j.bbrc.2013.05.080; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002	31	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6218	6231		10.1074/jbc.M115.710707	http://dx.doi.org/10.1074/jbc.M115.710707			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797118	hybrid, Green Published			2022-12-28	WOS:000372894200014
J	Rubio-Marrero, EN; Vincelli, G; Jeffries, CM; Shaikh, TR; Pakos, IS; Ranaivoson, FM; von Daake, S; Demeler, B; De Jaco, A; Perkins, G; Ellisman, MH; Trewhella, J; Comoletti, D				Rubio-Marrero, Eva N.; Vincelli, Gabriele; Jeffries, Cy M.; Shaikh, Tanvir R.; Pakos, Irene S.; Ranaivoson, Fanomezana M.; von Daake, Sventja; Demeler, Borries; De Jaco, Antonella; Perkins, Guy; Ellisman, Mark H.; Trewhella, Jill; Comoletti, Davide			Structural Characterization of the Extracellular Domain of CASPR2 and Insights into Its Association with the Novel Ligand Contactin1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						analytical ultracentrifugation; ligand-binding protein; molecular cell biology; protein structure; small-angle x-ray scattering (SAXS)	SEDIMENTATION-VELOCITY; X-RAY; JUXTAPARANODAL REGIONS; CRYSTAL-STRUCTURE; MYELINATED AXONS; COMPLEX; ADHESION; REVEALS; ORGANIZATION; F3/CONTACTIN	Contactin-associated protein-like 2 (CNTNAP2) encodes for CASPR2, a multidomain single transmembrane protein belonging to the neurexin superfamily that has been implicated in a broad range of human phenotypes including autism and language impairment. Using a combination of biophysical techniques, including small angle x-ray scattering, single particle electron microscopy, analytical ultracentrifugation, and bio-layer interferometry, we present novel structural and functional data that relate the architecture of the extracellular domain of CASPR2 to a previously unknown ligand, Contactin1 (CNTN1). Structurally, CASPR2 is highly glycosylated and has an overall compact architecture. Functionally, we show that CASPR2 associates with micromolar affinity with CNTN1 but, under the same conditions, it does not interact with any of the other members of the contactin family. Moreover, by using dissociated hippocampal neurons we show that microbeads loaded with CASPR2, but not with a deletion mutant, co-localize with transfected CNTN1, suggesting that CNTN1 is an endogenous ligand for CASPR2. These data provide novel insights into the structure and function of CASPR2, suggesting a complex role of CASPR2 in the nervous system.	[Rubio-Marrero, Eva N.; Vincelli, Gabriele; Pakos, Irene S.; Ranaivoson, Fanomezana M.; von Daake, Sventja; Comoletti, Davide] Rutgers State Univ, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, Dept Neurosci & Cell Biol, New Brunswick, NJ 08901 USA; [Comoletti, Davide] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08901 USA; [Jeffries, Cy M.; Trewhella, Jill] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Shaikh, Tanvir R.] Masaryk Univ, Cent European Inst Technol, Struct Biol Programme, Brno 62500, Czech Republic; [Demeler, Borries] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [De Jaco, Antonella] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [De Jaco, Antonella] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Inst Pasteur, I-00185 Rome, Italy; [Perkins, Guy; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Trewhella, Jill] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Vincelli, Gabriele] Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, 195 Little Albany St, New Brunswick, NJ 08903 USA; [Jeffries, Cy M.] DESY, European Mol Biol Lab, Hamburg Outstn, Notkestr 85, D-22607 Hamburg, Germany	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Sydney; Masaryk University Brno; University of Texas System; University of Texas Health San Antonio; Fondazione Cenci Bolognetti; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Comoletti, D (corresponding author), 89 French St, New Brunswick, NJ 08901 USA.	comoleda@rwjms.rutgers.edu		Trewhella, Jill/0000-0002-8555-6766; Ranaivoson, Fanomezana Moutse/0000-0001-5599-2682; Perkins, Guy/0000-0002-1834-6646; /0000-0002-8718-7343; Demeler, Borries/0000-0002-2414-9518; DE JACO, Antonella/0000-0002-9394-0207	National Institutes of Health [P41 RR004050, P41GM103412]; National Science Foundation [ACI-1339649, TG-MCB070039N]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055145, P41GM103412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge the superb support provided by the staff at the Texas Advanced Computing Center at the University of Texas at Austin. We thank Dr. Woj Wojtowicz, University of California, Berkeley, for generously providing the CNTN 3, 4, and 6 clones. Electron microscopy employed the facilities of the National Center for Imaging and Microscopy (NCMIR) at UCSD supported by National Institutes of Health P41 RR004050 and P41GM103412 (to M. H. E.). The development of the UltraScan software is supported by National Science Foundation Grant ACI-1339649 (to B. D.). Supercomputer time allocations were provided by National Science Foundation Grant TG-MCB070039N (to B. D.).	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Brookes E, 2008, COLLOID POLYM SCI, V286, P139, DOI 10.1007/s00396-007-1714-9; Brookes E, 2006, PROG COLL POL SCI S, V131, P33, DOI 10.1007/2882_004; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Brookes EH, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P361; Chen F, 2011, STRUCTURE, V19, P779, DOI 10.1016/j.str.2011.03.012; CColakoglu G, 2014, P NATL ACAD SCI USA, V111, pE394, DOI 10.1073/pnas.1313769110; Comoletti D, 2007, STRUCTURE, V15, P693, DOI 10.1016/j.str.2007.04.010; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Comoletti D, 2010, STRUCTURE, V18, P1044, DOI 10.1016/j.str.2010.06.005; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B., 2016, ANAL ULTRAC IN PRESS; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Demeler Borries, 2010, Curr Protoc Protein Sci, VChapter 7, DOI 10.1002/0471140864.ps0713s60; Demeler B, 2010, MACROMOL BIOSCI, V10, P775, DOI 10.1002/mabi.200900481; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P45; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; Falivelli G, 2012, HUM MOL GENET, V21, P4761, DOI 10.1093/hmg/dds320; Finci LI, 2014, NEURON, V83, P839, DOI 10.1016/j.neuron.2014.07.010; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Franke D, 2015, NAT METHODS, V12, P419, DOI [10.1038/NMETH.3358, 10.1038/nmeth.3358]; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Jackman C, 2009, PEDIATR NEUROL, V40, P310, DOI 10.1016/j.pediatrneurol.2008.10.013; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Kastriti ME, 2015, MOL CELL NEUROSCI, V67, P93, DOI 10.1016/j.mcn.2015.06.005; Koch T, 1997, GLIA, V19, P199, DOI 10.1002/(SICI)1098-1136(199703)19:3<199::AID-GLIA3>3.0.CO;2-V; KRIGBAUM WR, 1970, BIOCHEMISTRY-US, V9, P1216, DOI 10.1021/bi00807a024; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Parent AS, 2007, J NEUROENDOCRINOL, V19, P847, DOI 10.1111/j.1365-2826.2007.01597.x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Poliak S, 2001, J NEUROSCI, V21, P7568, DOI 10.1523/JNEUROSCI.21-19-07568.2001; Puzzo D, 2013, HIPPOCAMPUS, V23, P1367, DOI 10.1002/hipo.22186; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Tzimourakas Alexandros, 2007, Biotechnology Journal, V2, P577, DOI 10.1002/biot.200700023; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268	50	22	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5788	5802		10.1074/jbc.M115.705681	http://dx.doi.org/10.1074/jbc.M115.705681			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26721881	Green Published, hybrid			2022-12-28	WOS:000372551800027
J	Yan, LY; Guo, HS; Hu, BQ; Li, R; Yong, J; Zhao, YY; Zhi, X; Fan, XY; Guo, F; Wang, XY; Wang, W; Wei, Y; Wang, Y; Wen, L; Qiao, J; Tang, FC				Yan, Liying; Guo, Hongshan; Hu, Boqiang; Li, Rong; Yong, Jun; Zhao, Yangyu; Zhi, Xu; Fan, Xiaoying; Guo, Fan; Wang, Xiaoye; Wang, Wei; Wei, Yuan; Wang, Yan; Wen, Lu; Qiao, Jie; Tang, Fuchou			Epigenomic Landscape of Human Fetal Brain, Heart, and Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; CHROMATIN STATE; HUMAN GENOME; HISTONE MODIFICATIONS; SUPER-ENHANCERS; TRANSCRIPTION FACTORS; INTEGRATIVE ANALYSIS; DNA ELEMENTS; RNA-SEQ; IN-VIVO	The epigenetic regulation of spatiotemporal gene expression is crucial for human development. Here, we present whole-genome chromatin immunoprecipitation followed by high throughput DNA sequencing (ChIP-seq) analyses of a wide variety of histone markers in the brain, heart, and liver of early human embryos shortly after their formation. We identified 40,181 active enhancers, with a large portion showing tissue-specific and developmental stage-specific patterns, pointing to their roles in controlling the ordered spatiotemporal expression of the developmental genes in early human embryos. Moreover, using sequential ChIP-seq, we showed that all three organs have hundreds to thousands of bivalent domains that are marked by both H3K4me3 and H3K27me3, probably to keep the progenitor cells in these organs ready for immediate differentiation into diverse cell types during subsequent developmental processes. Our work illustrates the potentially critical roles of tissue-specific and developmental stage-specific epigenomes in regulating the spatiotemporal expression of developmental genes during early human embryonic development.	[Yan, Liying; Guo, Hongshan; Hu, Boqiang; Li, Rong; Yong, Jun; Zhao, Yangyu; Zhi, Xu; Fan, Xiaoying; Guo, Fan; Wang, Xiaoye; Wang, Wei; Wei, Yuan; Wang, Yan; Wen, Lu; Qiao, Jie; Tang, Fuchou] Peking Univ, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Yan, Liying; Guo, Hongshan; Hu, Boqiang; Li, Rong; Yong, Jun; Zhao, Yangyu; Zhi, Xu; Fan, Xiaoying; Guo, Fan; Wang, Xiaoye; Wang, Wei; Wei, Yuan; Wang, Yan; Wen, Lu; Qiao, Jie; Tang, Fuchou] Peking Univ, Ctr Reprod Med, Coll Life Sci, Dept Obstet & Gynecol,Hosp 3, Beijing 100871, Peoples R China; [Qiao, Jie; Tang, Fuchou] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Yan, Liying; Li, Rong; Zhao, Yangyu; Fan, Xiaoying; Guo, Fan; Wang, Xiaoye; Wang, Wei; Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing 100191, Peoples R China; [Wen, Lu; Tang, Fuchou] Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Qiao, Jie] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing 100871, Peoples R China; [Wen, Lu; Tang, Fuchou] Peking Univ, Hlth Sci Ctr, Ctr Mol & Translat Med, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University; Peking University	Qiao, J; Tang, FC (corresponding author), Peking Univ, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China.; Qiao, J; Tang, FC (corresponding author), Peking Univ, Ctr Reprod Med, Coll Life Sci, Dept Obstet & Gynecol,Hosp 3, Beijing 100871, Peoples R China.; Qiao, J; Tang, FC (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.; Qiao, J (corresponding author), Minist Educ, Key Lab Assisted Reprod, Beijing 100191, Peoples R China.; Tang, FC (corresponding author), Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China.; Qiao, J (corresponding author), Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing 100871, Peoples R China.; Tang, FC (corresponding author), Peking Univ, Hlth Sci Ctr, Ctr Mol & Translat Med, Beijing 100191, Peoples R China.	jie.qiao@263.net; tangfuchou@pku.edu.cn	Guo, Fan/AAX-4952-2021; Guo, Fan/J-1857-2019	Guo, Fan/0000-0002-0165-073X	Center for Molecular and Translational Medicine; National Natural Science Foundation of China [31440063, 31230047, 31322037, 31271543, 81170538]; National Basic Research Program of China [2011CB944503, 2011CB944504, 2014CB943200, 2012CB966704, 2011CB966303]; National Key Technologies Research and Development Program [2012BAI32B01]; Beijing Municipal Science and Technology Commission [Z131100005213006]	Center for Molecular and Translational Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Key Technologies Research and Development Program(National Key Technology R&D Program); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported in part by a collaborative grant from the Center for Molecular and Translational Medicine. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Natural Science Foundation of China Grant 31440063 and National Basic Research Program of China Grant 2011CB944503.; Supported by National Key Technologies Research and Development Program Grant 2012BAI32B01.; Supported by National Basic Research Program of China Grants 2011CB944504, 2014CB943200, 2012CB966704, and 2011CB966303, National Natural Science Foundation of China Grants 31230047, 31322037, 31271543, and 81170538, and Beijing Municipal Science and Technology Commission Grant Z131100005213006.	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bogdanovic O, 2012, GENOME RES, V22, P2043, DOI 10.1101/gr.134833.111; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gilad Yoav, 2015, F1000Res, V4, P121, DOI 10.12688/f1000research.6536.1; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hong SH, 2011, CELL STEM CELL, V9, P24, DOI 10.1016/j.stem.2011.06.002; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Leung D, 2015, NATURE, V518, P350, DOI 10.1038/nature14217; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ng JH, 2013, DEV CELL, V24, P324, DOI 10.1016/j.devcel.2012.12.011; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reilly SK, 2015, SCIENCE, V347, P1155, DOI 10.1126/science.1260943; Sachs M, 2013, CELL REP, V3, P1777, DOI 10.1016/j.celrep.2013.04.032; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004610; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	53	33	33	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4386	4398		10.1074/jbc.M115.672931	http://dx.doi.org/10.1074/jbc.M115.672931			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26719341	hybrid, Green Published			2022-12-28	WOS:000371604600011
J	Sepuru, KM; Rajarathnam, K				Sepuru, Krishna Mohan; Rajarathnam, Krishna			CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; chemokine; G protein-coupled receptor (GPCR); glycobiology; glycosaminoglycan; heparin; immunology; NMR; CXC chemokines; CXCL1; MGSA	SOLUTION NMR CHARACTERIZATION; GROWTH-STIMULATORY ACTIVITY; N-TERMINAL DOMAIN; HEPARAN-SULFATE; CXC CHEMOKINES; NEUTROPHIL TRAFFICKING; LIGAND SELECTIVITY; DIMER BINDING; RECEPTOR; OLIGOMERIZATION	In humans, the chemokine CXCL1/MGSA (hCXCL1) plays fundamental and diverse roles in pathophysiology, from microbial killing to cancer progression, by orchestrating the directed migration of immune and non-immune cells. Cellular trafficking is highly regulated and requires concentration gradients that are achieved by interactions with sulfated glycosaminoglycans (GAGs). However, very little is known regarding the structural basis underlying hCXCL1-GAG interactions. We addressed this by characterizing the binding of GAG heparin oligosaccharides to hCXCL1 using NMR spectroscopy. Binding experiments under conditions at which hCXCL1 exists as monomers and dimers indicate that the dimer is the high-affinity GAG ligand. NMR experiments and modeling studies indicate that lysine and arginine residues mediate binding and that they are located in two non-overlapping domains. One domain, consisting of N-loop and C-helical residues (defined as -domain) has also been identified previously as the GAG-binding domain for the related chemokine CXCL8/IL-8. The second domain, consisting of residues from the N terminus, 40s turn, and third -strand (defined as -domain) is novel. Eliminating -domain binding by mutagenesis does not perturb -domain binding, indicating two independent GAG-binding sites. It is known that N-loop and N-terminal residues mediate receptor activation, and we show that these residues are also involved in extensive GAG interactions. We also show that the GAG-bound hCXCL1 completely occlude receptor binding. We conclude that hCXCL1-GAG interactions provide stringent control over regulating chemokine levels and receptor accessibility and activation, and that chemotactic gradients mediate cellular trafficking to the target site.	[Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Rajarathnam, K (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	krrajara@utmb.edu	Sepuru, Krishna Mohan/K-5321-2014	Sepuru, Krishna Mohan/0000-0002-3675-6294	National Institutes of Health [P01 HL107152]; Sealy and Smith Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy and Smith Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant P01 HL107152 (to K. R.) and a Sealy and Smith Foundation grant to the Sealy Center for Structural Biology and Molecular Biophysics. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Balamayooran G, 2010, AM J RESP CELL MOL, V43, P5, DOI 10.1165/rcmb.2009-0047TR; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FAIRBROTHER WJ, 1994, J MOL BIOL, V242, P252, DOI 10.1006/jmbi.1994.1577; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Frevert CW, 2003, AM J RESP CELL MOL, V28, P464, DOI 10.1165/rcmb.2002-0084OC; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Jansma AL, 2010, J BIOL CHEM, V285, P14424, DOI 10.1074/jbc.M109.091108; Joseph PRB, 2015, BIOCHEM J, V472, P121, DOI 10.1042/BJ20150059; Joseph PRB, 2015, PROTEIN SCI, V24, P81, DOI 10.1002/pro.2590; Joseph PRB, 2013, BIOCHEM J, V456, P241, DOI 10.1042/BJ20130148; KIM KS, 1994, J BIOL CHEM, V269, P32909; Kurupati P, 2010, MOL MICROBIOL, V76, P1387, DOI 10.1111/j.1365-2958.2010.07065.x; Li LY, 2012, MOL BIOSYST, V8, P1613, DOI 10.1039/c2mb25021g; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Luan J, 1997, J LEUKOCYTE BIOL, V62, P588, DOI 10.1002/jlb.62.5.588; Migliorini E, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150046; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; Poluri KM, 2013, J BIOL CHEM, V288, P25143, DOI 10.1074/jbc.M113.492579; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rajasekaran D, 2012, BIOCHEMISTRY-US, V51, P5642, DOI 10.1021/bi3001566; Ravindran A, 2013, J BIOL CHEM, V288, P12244, DOI 10.1074/jbc.M112.443762; RICHMOND A, 1986, J CELL PHYSIOL, V129, P375, DOI 10.1002/jcp.1041290316; Ritzman AM, 2010, INFECT IMMUN, V78, P4593, DOI 10.1128/IAI.00798-10; Rohde G, 2014, CLIN EXP ALLERGY, V44, P930, DOI 10.1111/cea.12313; Salanga CL, 2014, J BIOL CHEM, V289, P14896, DOI 10.1074/jbc.M114.547737; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Sawant KV, 2015, J INNATE IMMUN, V7, P647, DOI 10.1159/000430914; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wolf M, 2008, INT J BIOCHEM CELL B, V40, P1185, DOI 10.1016/j.biocel.2007.12.009; Wuyts A, 1999, EUR J BIOCHEM, V260, P421, DOI 10.1046/j.1432-1327.1999.00166.x; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064	46	38	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4247	4255		10.1074/jbc.M115.697888	http://dx.doi.org/10.1074/jbc.M115.697888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26721883	hybrid, Green Published			2022-12-28	WOS:000371338400047
J	Zhang, Y; Halder, S; Kerr, RA; Parrell, D; Ruotolo, B; Kroos, L				Zhang, Yang; Halder, Sabyasachi; Kerr, Richard A.; Parrell, Daniel; Ruotolo, Brandon; Kroos, Lee			Complex Formed between Intramembrane Metalloprotease SpoIVFB and Its Substrate, Pro-sigma(K)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS SPORULATION; MEMBRANE-PROTEIN COMPLEXES; SITE-2 PROTEASE; REGULATED PROTEOLYSIS; TRANSCRIPTION FACTOR; MASS-SPECTROMETRY; SUBCELLULAR-LOCALIZATION; BIOLOGICAL FUNCTIONS; RHOMBOID PROTEASES; CRYSTAL-STRUCTURE	Intramembrane metalloproteases (IMMPs) are conserved from bacteria to humans and control many important signaling pathways, but little is known about how IMMPs interact with their substrates. SpoIVFB is an IMMP that cleaves Pro-sigma(K) during Bacillus subtilis endospore formation. When catalytically inactive SpoIVFB was coexpressed with C-terminally truncated Pro-sigma(K)(1-126) (which can be cleaved by active SpoIVFB) in Escherichia soli, the substrate dramatically improved solubilization of the enzyme from membranes with mild detergents. Both the Pro(1-20) and sigma(K)(21-126) parts contributed to improving SpoIVFB solubilization from membranes, but only the sigma(K) part was needed to form a stable complex with SpoIVFB in a pull down assay. The last 10 residues of SpoIVFB were required for improved solubilization from membranes by Pro-sigma(K)(1-126) and for normal interaction with the substrate. The inactive SpoIVFB.Pro-sigma(K)(1-126)-His(6) complex was stable during affinity purification and gel filtration chromatography. Disulfide cross-linking of the purified complex indicated that it resembled the complex formed in vivo. Ion mobility-mass spectrometry analysis resulted in an observed mass consistent with a 4:2 SpoINTB.Pro-sigma(K)(1-126)-His(6) complex. Stepwise photobleaching of SpoIVFB fused to a fluorescent protein supported the notion that the enzyme is tetrameric during B. subtilis sporulation. The results provide the first evidence that an IMMP acts as a tetramer, give new insights into how SpoIVFB interacts with its substrate, and lay the foundation for further biochemical analysis of the enzyme.substrate complex and future structural studies.	[Zhang, Yang; Halder, Sabyasachi; Parrell, Daniel; Kroos, Lee] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Kerr, Richard A.; Ruotolo, Brandon] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Michigan State University; University of Michigan System; University of Michigan	Kroos, L (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	kroos@msu.edu	; Ruotolo, Brandon/F-2669-2013	Chang, Yong/0000-0003-4355-9755; Ruotolo, Brandon/0000-0002-6084-2328	National Institutes of Health [GM43585, GM105942]; Michigan State University AgBioResearch; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105942, R01GM043585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University AgBioResearch; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM43585 (to L. K.) and GM105942 (to B. R.) and by Michigan State University AgBioResearch. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Bai F, 2014, SCI REP-UK, V4, DOI 10.1038/srep06528; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; Bergbold N, 2013, BBA-BIOMEMBRANES, V1828, P2840, DOI 10.1016/j.bbamem.2013.03.025; Blaylock B, 2004, GENE DEV, V18, P2916, DOI 10.1101/gad.1252704; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Camp AH, 2008, MOL MICROBIOL, V69, P402, DOI 10.1111/j.1365-2958.2008.06289.x; Camp AH, 2009, GENE DEV, V23, P1014, DOI 10.1101/gad.1781709; Campo N, 2006, MOL CELL, V23, P25, DOI 10.1016/j.molcel.2006.05.019; Chiba S, 2007, J BIOL CHEM, V282, P2576, DOI 10.1074/jbc.M606056200; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Doan T, 2005, MOL MICROBIOL, V55, P1767, DOI 10.1111/j.1365-2958.2005.04501.x; Doan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000566; Dong TC, 2003, MOL MICROBIOL, V49, P1425, DOI 10.1046/j.1365-2958.2003.03651.x; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Freeman M, 2014, ANNU REV CELL DEV BI, V30, P235, DOI 10.1146/annurev-cellbio-100913-012944; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; Green DH, 2000, J BACTERIOL, V182, P278, DOI 10.1128/JB.182.2.278-285.2000; Ha Y, 2013, J BIOL CHEM, V288, P15430, DOI 10.1074/jbc.R112.422378; Hines KE, 2013, J GEN PHYSIOL, V141, P737, DOI 10.1085/jgp.201310988; Hoadlund-Hyzer CS, 2000, ANAL CHEM, V72, P2737; Hoaglund-Hyzer CS, 2001, ANAL CHEM, V73, P177, DOI 10.1021/ac0007783; Hu J, 2011, NATURE, V475, P528, DOI 10.1038/nature10218; Jiang X, 2005, MOL MICROBIOL, V58, P102, DOI 10.1111/j.1365-2958.2005.04811.x; Jurisch-Yaksi N, 2013, BBA-BIOMEMBRANES, V1828, P2815, DOI 10.1016/j.bbamem.2013.04.016; Kinch LN, 2006, PROTEIN SCI, V15, P84, DOI 10.1110/ps.051766506; Koide K, 2008, J BIOL CHEM, V283, P9562, DOI 10.1074/jbc.M709984200; Konovalova A, 2014, FEMS MICROBIOL REV, V38, P493, DOI 10.1111/1574-6976.12050; Kroos L, 2002, J BACTERIOL, V184, P5393, DOI 10.1128/JB.184.19.5393-5401.2002; KROOS L, 1989, SCIENCE, V243, P526, DOI 10.1126/science.2492118; Kroos L, 2013, BBA-BIOMEMBRANES, V1828, P2873, DOI 10.1016/j.bbamem.2013.03.032; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Laganowsky A, 2013, NAT PROTOC, V8, P639, DOI 10.1038/nprot.2013.024; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li Y, 2014, STRUCTURE, V22, P125, DOI 10.1016/j.str.2013.09.018; Mckay AR, 2006, J AM CHEM SOC, V128, P11433, DOI 10.1021/ja061468q; Meisner J, 2008, P NATL ACAD SCI USA, V105, P15100, DOI 10.1073/pnas.0806301105; Plant LD, 2014, P NATL ACAD SCI USA, V111, pE1438, DOI 10.1073/pnas.1323548111; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Prince H, 2005, J BACTERIOL, V187, P961, DOI 10.1128/JB.187.3.961-971.2005; Rasband W., 2006, IMAGEJ; Rather P, 2013, BBA-BIOMEMBRANES, V1828, P2849, DOI 10.1016/j.bbamem.2013.03.012; Rawson RB, 2013, BBA-BIOMEMBRANES, V1828, P2801, DOI 10.1016/j.bbamem.2013.03.031; Reading E, 2015, CHEM BIOL, V22, P593, DOI 10.1016/j.chembiol.2015.04.016; Reuel NF, 2012, BIOINFORMATICS, V28, P296, DOI 10.1093/bioinformatics/btr632; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Rudner DZ, 2002, GENE DEV, V16, P1007, DOI 10.1101/gad.977702; Sambrook J., 1989, MOL CLONING, pA1; Saribas AS, 2001, PROTEIN EXPRES PURIF, V21, P303, DOI 10.1006/prep.2000.1377; Schneider JS, 2013, P NATL ACAD SCI USA, V110, P19543, DOI 10.1073/pnas.1305934110; Schneider JS, 2013, BBA-BIOMEMBRANES, V1828, P2808, DOI 10.1016/j.bbamem.2013.04.019; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shepherd DA, 2015, INT J MASS SPECTROM, V377, P663, DOI 10.1016/j.ijms.2014.09.007; Stone E, 2001, ANAL CHEM, V73, P2233, DOI 10.1021/ac001430a; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Urban S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-231; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wolfe MS, 2010, BIOL CHEM, V391, P839, DOI 10.1515/BC.2010.086; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Yu YTN, 2000, J BACTERIOL, V182, P3305, DOI 10.1128/JB.182.11.3305-3309.2000; Zhang B, 1998, J BACTERIOL, V180, P2434, DOI 10.1128/JB.180.9.2434-2441.1998; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang Y, 2013, J BACTERIOL, V195, P4936, DOI 10.1128/JB.00807-13; Zhou RB, 2005, MOL MICROBIOL, V58, P835, DOI 10.1111/j.1365-2958.2005.04870.x; Zhou RB, 2004, P NATL ACAD SCI USA, V101, P6385, DOI 10.1073/pnas.0307709101; Zhou RB, 2013, J BACTERIOL, V195, P2793, DOI 10.1128/JB.00229-13; Zhou RB, 2009, P NATL ACAD SCI USA, V106, P16174, DOI 10.1073/pnas.0901455106; Zoll S, 2014, EMBO J, V33, P2408, DOI 10.15252/embj.201489367	77	6	6	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10347	10362		10.1074/jbc.M116.715508	http://dx.doi.org/10.1074/jbc.M116.715508			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26953342	hybrid, Green Published			2022-12-28	WOS:000375602800040
J	Erokhova, L; Horner, A; Ollinger, N; Siligan, C; Pohl, P				Erokhova, Liudmila; Horner, Andreas; Ollinger, Nicole; Siligan, Christine; Pohl, Peter			The Sodium Glucose Cotransporter SGLT1 Is an Extremely Efficient Facilitator of Passive Water Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; KIDNEY MDCK CELLS; NA+/GLUCOSE COTRANSPORTER; FUNCTIONAL EXPRESSION; PERMEABILITY; CHANNELS; CLONING; PERMEATION; BINDING; AQP10	The small intestine is void of aquaporins adept at facilitating vectorial water transport, and yet it reabsorbs similar to 8 liters of fluid daily. Implications of the sodium glucose cotransporter SGLT1 in either pumping water or passively channeling water contrast with its reported water transporting capacity, which lags behind that of aquaporin-1 by 3 orders of magnitude. Here we overexpressed SGLT1 in MDCK cell monolayers and reconstituted the purified transporter into proteoliposomes. We observed the rate of osmotic proteoliposome deflation by light scattering. Fluorescence correlation spectroscopy served to assess (i) SGLT1 abundance in both vesicles and plasma membranes and (ii) flow-mediated dilution of an aqueous dye adjacent to the cell monolayer. Calculation of the unitary water channel permeability, p(f), yielded similar values for cell and proteoliposome experiments. Neither the absence of glucose or Na+, nor the lack of membrane voltage in vesicles, nor the directionality of water flow grossly altered p(f). Such weak dependence on protein conformation indicates that a water-impermeable occluded state (glucose and Na+ in their binding pockets) lasts for only a minor fraction of the transport cycle or, alternatively, that occlusion of the substrate does not render the transporter water-impermeable as was suggested by computational studies of the bacterial homologue vSGLT. Although the similarity between the p(f) values of SGLT1 and aquaporin-1 makes a transcellular pathway plausible, it renders water pumping physiologically negligible because the passive flux would be orders of magnitude larger.	[Erokhova, Liudmila; Horner, Andreas; Ollinger, Nicole; Siligan, Christine; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4020 Linz, Austria	Johannes Kepler University Linz	Pohl, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, A-4020 Linz, Austria.	peter.pohl@jku.at	Horner, Andreas/F-6427-2013; Pohl, Peter/A-5361-2008	Horner, Andreas/0000-0002-5328-1745; Pohl, Peter/0000-0002-1792-2314; Ollinger, Nicole/0000-0003-2659-6968	Austrian Science Fund [P23574]; Austrian Science Fund (FWF) [P 23574] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The project was supported by Grant P23574 from the Austrian Science Fund (to P. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Adelman JL, 2014, BIOPHYS J, V106, P1280, DOI 10.1016/j.bpj.2014.01.006; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Duquette PP, 2001, P NATL ACAD SCI USA, V98, P3796, DOI 10.1073/pnas.071245198; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Erokhova L, 2011, J BIOL CHEM, V286, P39926, DOI 10.1074/jbc.M111.291864; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gagnon MP, 2004, BIOPHYS J, V86, P125, DOI 10.1016/S0006-3495(04)74090-4; Hatakeyama S, 2001, BIOCHEM BIOPH RES CO, V287, P814, DOI 10.1006/bbrc.2001.5661; Hoomann T, 2013, P NATL ACAD SCI USA, V110, P10842, DOI 10.1073/pnas.1304714110; Horner A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400083; HWANG ES, 1991, BIOCHEM BIOPH RES CO, V181, P1208, DOI 10.1016/0006-291X(91)92067-T; Ishibashi K, 2002, BBA-GENE STRUCT EXPR, V1576, P335, DOI 10.1016/S0167-4781(02)00393-7; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; Knyazev DG, 2013, J BIOL CHEM, V288, P17941, DOI 10.1074/jbc.M113.477893; Kovbasnjuk O, 1998, P NATL ACAD SCI USA, V95, P6526, DOI 10.1073/pnas.95.11.6526; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Krylov AV, 2001, J GEN PHYSIOL, V118, P333, DOI 10.1085/jgp.118.4.333; Laforenza U, 2010, BIOL CELL, V102, P457, DOI 10.1042/BC20100023; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; LIEBL B, 1992, ANALYST, V117, P681, DOI 10.1039/an9921700681; Loike JD, 1996, AM J PHYSIOL-CELL PH, V271, pC1774, DOI 10.1152/ajpcell.1996.271.5.C1774; Longpre JP, 2010, BIOPHYS J, V98, P231, DOI 10.1016/j.bpj.2009.10.015; Loo DDF, 1996, P NATL ACAD SCI USA, V93, P13367, DOI 10.1073/pnas.93.23.13367; Ma TH, 1999, J PHYSIOL-LONDON, V517, P317, DOI 10.1111/j.1469-7793.1999.0317t.x; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Saparov SM, 2005, BIOL CELL, V97, P545; Sasseville LJ, 2011, BIOPHYS J, V101, P1887, DOI 10.1016/j.bpj.2011.09.019; Spring KR, 1999, NEWS PHYSIOL SCI, V14, P92; Tyagi NK, 2005, BIOCHEMISTRY-US, V44, P15514, DOI 10.1021/bi051377q; VONBONSDORFF CH, 1985, EMBO J, V4, P2781, DOI 10.1002/j.1460-2075.1985.tb04004.x; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Yakata K, 2011, J STRUCT BIOL, V174, P315, DOI 10.1016/j.jsb.2011.01.003; ZAMPIGHI GA, 1995, J MEMBRANE BIOL, V148, P65; Zeuthen T, 2010, J MEMBRANE BIOL, V234, P57, DOI 10.1007/s00232-009-9216-y	36	28	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9712	9720		10.1074/jbc.M115.706986	http://dx.doi.org/10.1074/jbc.M115.706986			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26945065	Green Published, hybrid			2022-12-28	WOS:000375602300029
J	Qin, JY; Wang, ZZ; Hoogeveen-Westerveld, M; Shen, GB; Gong, WM; Nellist, M; Xu, WQ				Qin, Jiayue; Wang, Zhizhi; Hoogeveen-Westerveld, Marianne; Shen, Guobo; Gong, Weimin; Nellist, Mark; Xu, Wenqing			Structural Basis of the Interaction between Tuberous Sclerosis Complex 1 (TSC1) and Tre2-Bub2-Cdc16 Domain Family Member 7 (TBC1D7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; isothermal titration calorimetry (ITC); mTOR complex (mTORC); protein complex; tuberous sclerosis complex (TSC); TBC1D7; TSC1	INTELLECTUAL DISABILITY; PROTEIN COMPLEX; GENE-PRODUCTS; DIRECT TARGET; RHEB; HAMARTIN; MTOR; ACTIVATION; IDENTIFICATION; PREDICTION	Mutations in TSC1 or TSC2 cause tuberous sclerosis complex (TSC), an autosomal dominant disorder characterized by the occurrence of benign tumors in various vital organs and tissues. TSC1 and TSC2, the TSC1 and TSC2 gene products, form the TSC protein complex that senses specific cellular growth conditions to control mTORC1 signaling. TBC1D7 is the third subunit of the TSC complex, and helps to stabilize the TSC1-TSC2 complex through its direct interaction with TSC1. Homozygous inactivation of TBC1D7 causes intellectual disability and megaencephaly. Here we report the crystal structure of a TSC1-TBC1D7 complex and biochemical characterization of the TSC1-TBC1D7 interaction. TBC1D7 interacts with the C-terminal region of the predicted coiled-coil domain of TSC1. The TSC1-TBC1D7 interface is largely hydrophobic, involving the 4 helix of TBC1D7. Each TBC1D7 molecule interacts simultaneously with two parallel TSC1 helices from two TSC1 molecules, suggesting that TBC1D7 may stabilize the TSC complex by tethering the C-terminal ends of two TSC1 coiled-coils.	[Qin, Jiayue; Gong, Weimin; Xu, Wenqing] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Qin, Jiayue; Wang, Zhizhi; Shen, Guobo; Xu, Wenqing] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Qin, Jiayue] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Hoogeveen-Westerveld, Marianne; Nellist, Mark] Erasmus MC, Dept Clin Genet, NL-3015 CN Rotterdam, Netherlands; [Gong, Weimin] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Washington; University of Washington Seattle; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Erasmus University Rotterdam; Erasmus MC; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Gong, WM (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.; Xu, WQ (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.; Nellist, M (corresponding author), Erasmus MC, Dept Clin Genet, NL-3015 CN Rotterdam, Netherlands.	wgong@ibp.ac.cn; m.nellist@erasmusmc.nl; wxu@uw.edu	Qin, Jiayue/X-5590-2019; Qin, Jiayue/CAA-1134-2022; Wang, Zhizhi/K-3271-2016	Qin, Jiayue/0000-0003-4721-0016; Qin, Jiayue/0000-0003-4721-0016; Wang, Zhizhi/0000-0003-4948-925X; Xu, Wenqing/0000-0002-2884-3101	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	We are grateful to the staff at ALS beamlines BL 8.2.1 and 8.2.2 for assistance with synchrotron data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alfaiz AA, 2014, HUM MUTAT, V35, P447, DOI 10.1002/humu.22529; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Apostolovic B, 2010, CHEM SOC REV, V39, P3541, DOI 10.1039/b914339b; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Capo-Chichi JM, 2013, J MED GENET, V50, P740, DOI 10.1136/jmedgenet-2013-101680; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Curatolo Paolo, 2002, Eur J Paediatr Neurol, V6, P15, DOI 10.1053/ejpn.2001.0538; de Vries PJ, 2007, TRENDS MOL MED, V13, P319, DOI 10.1016/j.molmed.2007.06.003; DELANO WL, 1994, PROTEINS, V20, P105, DOI 10.1002/prot.340200202; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Han JM, 2011, FEBS LETT, V585, P973, DOI 10.1016/j.febslet.2011.02.001; Hoogeveen-Westerveld M, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-18; Hoogeveen-Westerveld M, 2010, BBA-MOL BASIS DIS, V1802, P774, DOI 10.1016/j.bbadis.2010.06.004; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Khwaja OS, 2011, CURR OPIN PEDIATR, V23, P633, DOI 10.1097/MOP.0b013e32834c9251; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Lima AJS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093940; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Mozaffari M, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-88; Nakashima A, 2007, BIOCHEM BIOPH RES CO, V361, P218, DOI 10.1016/j.bbrc.2007.07.011; Nellist M, 2005, EUR J HUM GENET, V13, P59, DOI 10.1038/sj.ejhg.5201276; Neuman NA, 2011, EMBO MOL MED, V3, P189, DOI 10.1002/emmm.201100131; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Rosner M, 2008, MUTAT RES-REV MUTAT, V658, P234, DOI 10.1016/j.mrrev.2008.01.001; Sahin M, 2012, CURR OPIN NEUROBIOL, V22, P895, DOI 10.1016/j.conb.2012.04.008; Sato N, 2010, GENE CHROMOSOME CANC, V49, P353, DOI 10.1002/gcc.20747; Sun W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3135; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Thien A, 2015, DEV CELL, V32, P617, DOI 10.1016/j.devcel.2015.01.026; Tomasoni R, 2011, BIOCHEM SOC T, V39, P466, DOI 10.1042/BST0390466; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; Woolfson DN, 2012, CURR OPIN STRUC BIOL, V22, P432, DOI 10.1016/j.sbi.2012.03.002; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	46	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8591	8601		10.1074/jbc.M115.701870	http://dx.doi.org/10.1074/jbc.M115.701870			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26893383	Green Published, hybrid			2022-12-28	WOS:000374773200023
J	Randles, L; Anchoori, RK; Roden, RBS; Walters, KJ				Randles, Leah; Anchoori, Ravi K.; Roden, Richard B. S.; Walters, Kylie J.			The Proteasome Ubiquitin Receptor hRpn13 and Its Interacting Deubiquitinating Enzyme Uch37 Are Required for Proper Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell proliferation; proteasome; ubiquitin; ubiquitylation (ubiquitination); RA190; Uch37; cell cycle progression; hRpn13; p27Kip1	CDK INHIBITOR P27; 26S PROTEASOME; BORTEZOMIB RESISTANCE; REGULATORY PARTICLE; ANTICANCER THERAPY; MULTIPLE-MYELOMA; SUBUNIT; CANCER; RPN13; ACTIVATION	Recently, we reported that bisbenzylidine piperidone RA190 adducts to Cys-88 of the proteasome ubiquitin receptor hRpn13, triggering accumulation of ubiquitinated proteins and endoplasmic reticulum stress-related apoptosis in various cancer cell lines. hRpn13 contains an N-terminal pleckstrin-like receptor for ubiquitin domain that binds ubiquitin and docks it into the proteasome as well as a C-terminal deubiquitinase adaptor (DEUBAD) domain that binds the deubiquitinating enzyme Uch37. Here we report that hRpn13 and Uch37 are required for proper cell cycle progression and that their protein knockdown leads to stalling at G(0)/G(1). Moreover, serum-starved cells display reduced hRpn13 and Uch37 protein levels with hallmarks of G(0)/G(1) stalling and recovery to their steady-state protein levels following release from nutrient deprivation. Interestingly, loss of hRpn13 correlates with a small but statistically significant reduction in Uch37 protein levels, suggesting that hRpn13 interaction may stabilize this deubiquitinating enzyme in human cells. We also find that RA190 treatment leads to a loss of S phase, suggesting a block of DNA replication, and G(2) arrest by using fluorescence-activated cell sorting. Uch37 deprivation further indicated a reduction of DNA replication and G(0)/G(1) stalling. Overall, this work implicates hRpn13 and Uch37 in cell cycle progression, providing a rationale for their function in cellular proliferation and for the apoptotic effect of the hRpn13-targeting molecule RA190.	[Randles, Leah; Walters, Kylie J.] NCI, Prot Proc Sect, Struct Biophys Lab, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Anchoori, Ravi K.; Roden, Richard B. S.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21231 USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD 21231 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Walters, KJ (corresponding author), NCI, Prot Proc Sect, Struct Biophys Lab, Ctr Canc Res, Ft Detrick, MD 21702 USA.	kylie.walters@nih.gov			NCI, National Institutes of Health Center for Cancer Research; NCI, National Institutes of Health [P50 CA098252]; Alleghany Health Network-Johns Hopkins Cancer Research Fund; PI therapeutics; NATIONAL CANCER INSTITUTE [P50CA098252, ZIABC011490] Funding Source: NIH RePORTER	NCI, National Institutes of Health Center for Cancer Research; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alleghany Health Network-Johns Hopkins Cancer Research Fund; PI therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the NCI, National Institutes of Health Center for Cancer Research (to K. J. W.), NCI, National Institutes of Health Grant P50 CA098252 (to R. B. S. R.), and the Alleghany Health Network-Johns Hopkins Cancer Research Fund (to R. B. S. R.). R. K. A. and R. B. S. R. are inventors of intellectual property licensed to Pontifax/PI therapeutics and have received research funding from PI therapeutics. Under a licensing agreement between Pontifax/PI therapeutics and the Johns Hopkins University, Drs. Roden and Anchoori are entitled to a share of royalty received by the University on an invention described in this article. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Anchoori RK, 2013, CANCER CELL, V24, P791, DOI 10.1016/j.ccr.2013.11.001; Asano S, 2015, SCIENCE, V347, P439, DOI 10.1126/science.1261197; Berko D, 2014, J BIOL CHEM, V289, P5609, DOI 10.1074/jbc.M113.509380; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Chen W, 2009, ONCOL REP, V21, P531, DOI 10.3892/or_00000254; Chen X, 2015, MOL CELL, V57, P767, DOI 10.1016/j.molcel.2015.02.025; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; Chen YJ, 2012, DIGEST DIS SCI, V57, P2310, DOI 10.1007/s10620-012-2181-9; Choudhury S, 2013, CELL STEM CELL, V13, P117, DOI 10.1016/j.stem.2013.05.004; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cuddihy AR, 2003, INT REV CYTOL, V222, P99; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; Ehlinger A, 2013, BIOCHEMISTRY-US, V52, P3618, DOI 10.1021/bi400417a; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Fejzo MS, 2013, INT J MOL SCI, V14, P3094, DOI 10.3390/ijms14023094; Finley D, 2016, TRENDS BIOCHEM SCI, V41, P77, DOI 10.1016/j.tibs.2015.10.009; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Grigoreva TA, 2015, ONCOTARGET, V6, P24733, DOI 10.18632/oncotarget.4619; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jacobson AD, 2014, MOL BIOL CELL, V25, P1824, DOI 10.1091/mbc.E13-10-0585; Jang SH, 2014, CLIN EXP METASTAS, V31, P727, DOI 10.1007/s10585-014-9663-4; Karisson-Rosenthal C, 2006, TRENDS CELL BIOL, V16, P285, DOI 10.1016/j.tcb.2006.04.002; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lu XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140518; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Paraskevopoulos K, 2014, MOL CELL, V56, P453, DOI 10.1016/j.molcel.2014.09.008; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Randles L, 2012, FRONT BIOSCI-LANDMRK, V17, P2140, DOI 10.2741/4042; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Ryu H, 2014, CELL REP, V7, P1842, DOI 10.1016/j.celrep.2014.05.009; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Sahtoe DD, 2015, MOL CELL, V57, P887, DOI 10.1016/j.molcel.2014.12.039; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Schorl C, 2007, METHODS, V41, P143, DOI 10.1016/j.ymeth.2006.07.022; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Shirley M, 2016, DRUGS, V76, P405, DOI 10.1007/s40265-016-0548-5; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Stewart ZA, 2003, TRENDS PHARMACOL SCI, V24, P139, DOI 10.1016/S0165-6147(03)00026-9; Tian Z, 2014, BLOOD, V123, P706, DOI 10.1182/blood-2013-05-500033; Trader DJ, 2015, J AM CHEM SOC, V137, P6312, DOI 10.1021/jacs.5b02069; VanderLinden RT, 2015, MOL CELL, V57, P901, DOI 10.1016/j.molcel.2015.01.016; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yoon MK, 2012, BIOCHEM SOC T, V40, P981, DOI 10.1042/BST20120092; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010; Zheng XH, 2015, ACTA HAEMATOL-BASEL, V134, P88, DOI 10.1159/000369916; Zhou BB, 1998, P NATL ACAD SCI USA, V95, P6785, DOI 10.1073/pnas.95.12.6785	77	38	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8773	8783		10.1074/jbc.M115.694588	http://dx.doi.org/10.1074/jbc.M115.694588			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26907685	hybrid, Green Published			2022-12-28	WOS:000374773200038
J	Liu, C; Song, XM; Nisbet, R; Gotz, J				Liu, Chang; Song, Xiaomin; Nisbet, Rebecca; Goetz, Juergen			Co-immunoprecipitation with Tau Isoform-specific Antibodies Reveals Distinct Protein Interactions and Highlights a Putative Role for 2N Tau in Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; apolipoprotein; protein; protein interaction; Tau protein (Tau); Tauopathy	MICROTUBULE-ASSOCIATED PROTEINS; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; PHOSPHORYLATED TAU; ALPHA-SYNUCLEIN; AMYLOID-BETA; MOUSE MODEL; ASSOCIATION; COMPLEXES; TRANSPORT	Alternative splicing generates multiple isoforms of the microtubule-associated protein Tau, but little is known about their specific function. In the adult mouse brain, three Tau isoforms are expressed that contain either 0, 1, or 2 N-terminal inserts (0N, 1N, and 2N). We generated Tau isoform-specific antibodies and performed co-immunoprecipitations followed by tandem mass tag multiplexed quantitative mass spectrometry. We identified novel Tau-interacting proteins of which one-half comprised membrane-bound proteins, localized to the plasma membrane, mitochondria, and other organelles. Tau was also found to interact with proteins involved in presynaptic signal transduction. MetaCore analysis revealed one major Tau interaction cluster that contained 33 Tau pulldown proteins. To explore the pathways in which these proteins are involved, we conducted an ingenuity pathway analysis that revealed two significant overlapping pathways, cell-to-cell signaling and interaction and neurological disease. The functional enrichment tool DAVID showed that in particular the 2N Tau-interacting proteins were specifically associated with neurological disease. Finally, for a subset of Tau interactions (apolipoprotein A1 (apoA1), apoE, mitochondrial creatine kinase U-type, -synuclein, synaptogyrin-3, synaptophysin, syntaxin 1B, synaptotagmin, and synapsin 1), we performed reverse co-immunoprecipitations, confirming the preferential interaction of specific isoforms. For example, apoA1 displayed a 5-fold preference for the interaction with 2N, whereas -synuclein showed preference for 0N. Remarkably, a reverse immunoprecipitation with apoA1 detected only the 2N isoform. This highlights distinct protein interactions of the different Tau isoforms, suggesting that they execute different functions in brain tissue.	[Liu, Chang] Univ Sydney, Brain & Mind Res Inst, Sydney Med Sch, Camperdown, NSW 2050, Australia; [Song, Xiaomin] Macquarie Univ Sydney, Australian Proteome Anal Facil, Sydney, NSW 2109, Australia; [Nisbet, Rebecca; Goetz, Juergen] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, St. Lucia Campus Brisbane, Brisbane, Qld 4072, Australia	University of Sydney; Macquarie University; University of Queensland	Gotz, J (corresponding author), Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, St. Lucia Campus Brisbane, Brisbane, Qld 4072, Australia.	j.goetz@uq.edu.au	Nisbet, Rebecca/P-6492-2017; Götz, Jürgen/C-2448-2014	Nisbet, Rebecca/0000-0002-3751-9119; Götz, Jürgen/0000-0001-8501-7896	Estate of Dr. Clem Jones, Order of Australia; State Government of Queensland; Federal Government of Australia [ACT900116]; Australian Research Council [DP13300101932]; National Health and Medical Research Council of Australia [APP1037746, APP1003150]	Estate of Dr. Clem Jones, Order of Australia; State Government of Queensland; Federal Government of Australia; Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Estate of Dr. Clem Jones, Order of Australia, the State Government of Queensland, Federal Government of Australia Grant ACT900116, Australian Research Council Grant DP13300101932, and National Health and Medical Research Council of Australia Grants APP1037746 and APP1003150 (to J. G.). The authors declare that they have no conflicts of interest with the contents of this article.	ALLEN RD, 1985, J CELL BIOL, V100, P1736, DOI 10.1083/jcb.100.5.1736; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Badiola N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026609; Benussi L, 2005, EXP CELL RES, V308, P78, DOI 10.1016/j.yexcr.2005.04.021; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Brandt Roland, 2004, Current Alzheimer Research, V1, P255, DOI 10.2174/1567205043332054; Chen BS, 2009, NEURON, V62, P471, DOI 10.1016/j.neuron.2009.04.015; Chen F, 2004, CURR DRUG TARGETS, V5, P503, DOI 10.2174/1389450043345236; David S, 1998, MOL BRAIN RES, V54, P276, DOI 10.1016/S0169-328X(97)00343-4; Dayon Loic, 2012, Methods Mol Biol, V893, P115, DOI 10.1007/978-1-61779-885-6_9; Dehmelt L, 2005, GENOME BIOL, V6; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Farah CA, 2005, J BIOL CHEM, V280, P9439, DOI 10.1074/jbc.M412304200; Farah CA, 2006, CELL MOTIL CYTOSKEL, V63, P710, DOI 10.1002/cm.20157; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Galas MC, 2000, J NEUROCHEM, V75, P1511, DOI 10.1046/j.1471-4159.2000.0751511.x; Garringer HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056426; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gotz J, 2007, BRAIN PATHOL, V17, P91, DOI 10.1111/j.1750-3639.2007.00051.x; Gotz J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00072; Gotz J, 2001, EUR J NEUROSCI, V13, P2131, DOI 10.1046/j.0953-816x.2001.01604.x; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iijima-Ando K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002918; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; Li JY, 2002, NEUROSCIENCE, V113, P463, DOI 10.1016/S0306-4522(02)00143-4; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084849; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; MATUS A, 1990, J PHYSIOL-PARIS, V84, P134; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; McVicker DP, 2011, J BIOL CHEM, V286, P42873, DOI 10.1074/jbc.M111.292987; Mishima T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090004; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Pooler AM, 2010, BIOCHEM SOC T, V38, P1012, DOI 10.1042/BST0381012; Reddy PH, 2014, BBA-MOL BASIS DIS, V1842, P1167, DOI 10.1016/j.bbadis.2014.03.012; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Roher AE, 2009, BIOMARKERS, V14, P493, DOI 10.3109/13547500903108423; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Salminen A, 2011, PROG NEUROBIOL, V93, P99, DOI 10.1016/j.pneurobio.2010.10.006; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Savitski MM, 2013, J PROTEOME RES, V12, P3586, DOI 10.1021/pr400098r; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Sontag JM, 2012, J BIOL CHEM, V287, P14984, DOI 10.1074/jbc.M111.338681; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; Tashiro K, 1997, NEUROREPORT, V8, P2797, DOI 10.1097/00001756-199708180-00029; Trinczek B, 1999, J CELL SCI, V112, P2355; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Ullrich M, 2014, NAT PROTOC, V9, P2237, DOI 10.1038/nprot.2014.150; VALE RD, 1985, CELL, V40, P559, DOI 10.1016/0092-8674(85)90204-1; Xia D, 2015, BBA-MOL BASIS DIS, V1852, P913, DOI 10.1016/j.bbadis.2014.12.017; Xia D, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00040; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yoshiyama Y, 2013, J NEUROL NEUROSUR PS, V84, P784, DOI 10.1136/jnnp-2012-303144; Zempell H, 2014, TRENDS NEUROSCI, V37, P721, DOI 10.1016/j.tins.2014.08.004	66	83	84	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8173	8188		10.1074/jbc.M115.641902	http://dx.doi.org/10.1074/jbc.M115.641902			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26861879	Green Published, hybrid			2022-12-28	WOS:000374056700034
J	Ong, TH; Romanova, EV; Roberts-Galbraith, RH; Yang, N; Zimmerman, TA; Collins, JJ; Lee, JE; Kelleher, NL; Newmark, PA; Sweedler, JV				Ong, Ta-Hsuan; Romanova, Elena V.; Roberts-Galbraith, Rachel H.; Yang, Ning; Zimmerman, Tyler A.; Collins, James J., III; Lee, Ji Eun; Kelleher, Neil L.; Newmark, Phillip A.; Sweedler, Jonathan V.			Mass Spectrometry Imaging and Identification of Peptides Associated with Cephalic Ganglia Regeneration in Schmidtea mediterranea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						imaging; mass spectrometry (MS); neurogenesis; neuropeptide; regeneration	PLURIPOTENT STEM-CELLS; HEAD-REGENERATION; PLANARIAN BRAIN; ANIMAL REGENERATION; MOLECULAR ANALYSIS; NEUROPEPTIDES; PEPTIDOMICS; EXPRESSION; DISCOVERY; SYSTEM	Tissue regeneration is a complex process that involves a mosaic of molecules that vary spatially and temporally. Insights into the chemical signaling underlying this process can be achieved with a multiplex and untargeted chemical imaging method such as mass spectrometry imaging (MSI), which can enable de novo studies of nervous system regeneration. A combination of MSI and multivariate statistics was used to differentiate peptide dynamics in the freshwater planarian flatworm Schmidtea mediterranea at different time points during cephalic ganglia regeneration. A protocol was developed to make S. mediterranea tissues amenable for MSI. MS ion images of planarian tissue sections allow changes in peptides and unknown compounds to be followed as a function of cephalic ganglia regeneration. In conjunction with fluorescence imaging, our results suggest that even though the cephalic ganglia structure is visible after 6 days of regeneration, the original chemical composition of these regenerated structures is regained only after 12 days. Differences were observed in many peptides, such as those derived from secreted peptide 4 and EYE53-1. Peptidomic analysis further identified multiple peptides from various known prohormones, histone proteins, and DNA- and RNA-binding proteins as being associated with the regeneration process. Mass spectrometry data also facilitated the identification of a new prohormone, which we have named secreted peptide prohormone 20 (SPP-20), and is up-regulated during regeneration in planarians.	[Ong, Ta-Hsuan; Romanova, Elena V.; Yang, Ning; Zimmerman, Tyler A.; Lee, Ji Eun; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Ong, Ta-Hsuan; Romanova, Elena V.; Yang, Ning; Zimmerman, Tyler A.; Lee, Ji Eun; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Roberts-Galbraith, Rachel H.; Collins, James J., III; Newmark, Phillip A.] Univ Illinois, Dept Cell & Dev Biol, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Kelleher, Neil L.] Northwestern Univ, Prote Ctr Excellence, Dept Chem, Evanston, IL 60611 USA; [Kelleher, Neil L.] Northwestern Univ, Prote Ctr Excellence, Dept Mol Biosci, Evanston, IL 60611 USA; [Zimmerman, Tyler A.] NIST, Mass Spectrometry Data Ctr Grp, Gaithersburg, MD 20899 USA; [Collins, James J., III] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Lee, Ji Eun] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul 136791, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University; National Institute of Standards & Technology (NIST) - USA; University of Texas System; University of Texas Southwestern Medical Center Dallas; Korea Institute of Science & Technology (KIST)	Sweedler, JV (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.	jsweedle@illinois.edu	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Newmark, Phillip/0000-0003-0793-022X; Romanova, Elena/0000-0002-2040-3312; Zimmerman, Tyler/0000-0002-5408-9771	National Institutes of Health NINDS [RO1 NS031609]; NICHD [R01 HD043403]; National Institute on Drug Abuse [P30 DA018310]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD043403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by the National Institutes of Health NINDS Grant RO1 NS031609, NICHD Grant R01 HD043403, and National Institute on Drug Abuse Grant P30 DA018310. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The authors have no conflicts of interest to declare.	Agata K, 2008, PHILOS T R SOC B, V363, P2071, DOI 10.1098/rstb.2008.2260; BAGUNA J, 1989, International Journal of Developmental Biology, V33, P261; Boser A, 2013, CELL REP, V5, P1142, DOI 10.1016/j.celrep.2013.10.035; Brandl H, 2016, NUCLEIC ACIDS RES, V44, pD764, DOI 10.1093/nar/gkv1148; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Bruand J, 2011, J PROTEOME RES, V10, P1915, DOI 10.1021/pr101159e; Brubacher JL, 2014, NAT PROTOC, V9, P661, DOI 10.1038/nprot.2014.041; Buchberger A, 2015, ANNU REV ANAL CHEM, V8, P485, DOI 10.1146/annurev-anchem-071114-040210; Casadonte R, 2011, NAT PROTOC, V6, P1695, DOI 10.1038/nprot.2011.388; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Chen XG, 2015, DEV GENES EVOL, V225, P79, DOI 10.1007/s00427-015-0494-3; Collins JJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000509; Deininger SO, 2010, METHODS MOL BIOL, V656, P385, DOI 10.1007/978-1-60761-746-4_22; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Elliott SA, 2013, WIRES DEV BIOL, V2, P301, DOI 10.1002/wdev.82; Fernandez-Taboada E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-133; Fraguas S, 2012, INT J DEV BIOL, V56, P143, DOI 10.1387/ijdb.113428sf; Fricker LD, 2007, ENDOCRINOLOGY, V148, P4185, DOI 10.1210/en.2007-0123; Gessel MM, 2014, J PROTEOMICS, V107, P71, DOI 10.1016/j.jprot.2014.03.021; Goldstein AL, 2012, EXPERT OPIN BIOL TH, V12, P37, DOI 10.1517/14712598.2012.634793; HALL JD, 1990, J NEUROBIOL, V21, P858, DOI 10.1002/neu.480210604; Hori I, 1997, J SUBMICR CYTOL PATH, V29, P91; Iglesias M, 2011, DEV BIOL, V358, P68, DOI 10.1016/j.ydbio.2011.07.013; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; King RS, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-8; King RS, 2012, J CELL BIOL, V196, P553, DOI 10.1083/jcb.201105099; Kreshchenko ND, 2014, BIOCHEM MOSC SUPPL S, V8, P89, DOI 10.1134/S1990747813050097; Kreshchenko N D, 2009, Ontogenez, V40, P3; Kreshchenko ND, 2008, ACTA BIOL HUNG, V59, P199, DOI 10.1556/ABiol.59.2008.Suppl.29; Kumar A, 2012, TRENDS NEUROSCI, V35, P691, DOI 10.1016/j.tins.2012.08.003; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Lanni EJ, 2012, J PROTEOMICS, V75, P5036, DOI 10.1016/j.jprot.2012.03.017; Lapan SW, 2012, CELL REP, V2, P294, DOI 10.1016/j.celrep.2012.06.018; Maezawa T, 2014, MECH DEVELOP, V132, P69, DOI 10.1016/j.mod.2013.12.003; Masyuko RN, 2014, ANALYST, V139, P5700, DOI 10.1039/c4an00435c; McVeigh P, 2005, PARASITOLOGY, V131, pS41, DOI 10.1017/S0031182005008851; Meriaux C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018359; Mineta K, 2003, P NATL ACAD SCI USA, V100, P7666, DOI 10.1073/pnas.1332513100; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Nishimura K, 2011, J NEUROCHEM, V119, P1217, DOI 10.1111/j.1471-4159.2011.07518.x; Okamoto K, 2005, ZOOL SCI, V22, P535, DOI 10.2108/zsj.22.535; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rangiah K, 2013, RAPID COMMUN MASS SP, V27, P2439, DOI 10.1002/rcm.6706; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Robb SMC, 2014, CURR TOP DEV BIOL, V108, P71, DOI 10.1016/B978-0-12-391498-9.00004-8; Roberts-Galbraith RH, 2015, CURR OPIN GENET DEV, V32, P37, DOI 10.1016/j.gde.2015.01.009; Roberts-Galbraith RH, 2013, P NATL ACAD SCI USA, V110, P1363, DOI 10.1073/pnas.1214053110; Romanova EV, 2015, J NEUROCHEM, V135, P1038, DOI 10.1111/jnc.13265; Romanova EV, 2015, TRENDS PHARMACOL SCI, V36, P579, DOI 10.1016/j.tips.2015.05.009; Romanova EV, 2013, CURR OPIN CHEM BIOL, V17, P801, DOI 10.1016/j.cbpa.2013.05.030; Romanova EV, 2012, J NEUROCHEM, V123, P276, DOI 10.1111/j.1471-4159.2012.07912.x; Rouhana L, 2014, DEVELOPMENT, V141, P2592, DOI 10.1242/dev.101618; Rowinska-Zyrek M, 2015, COORDIN CHEM REV, V284, P298, DOI 10.1016/j.ccr.2014.03.026; Rubakhin SS, 2010, METHODS MOL BIOL, V656, P21, DOI 10.1007/978-1-60761-746-4_2; Sandmann T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r76; Seeley EH, 2011, TRENDS BIOTECHNOL, V29, P136, DOI 10.1016/j.tibtech.2010.12.002; Sheman I. M., 2010, ONTOGENEZ, V41, P114; Sikes JM, 2013, NATURE, V500, P77, DOI 10.1038/nature12403; Solana J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r19; Southey BR, 2014, ANAL CHEM, V86, P443, DOI 10.1021/ac4023378; Spengler B, 2015, ANAL CHEM, V87, P64, DOI 10.1021/ac504543v; Strand FL, 1999, NEUROPEPTIDES REGULA; Umesono Y, 2009, DEV GROWTH DIFFER, V51, P185, DOI 10.1111/j.1440-169X.2009.01099.x; van Wolfswinkel JC, 2014, CELL STEM CELL, V15, P326, DOI 10.1016/j.stem.2014.06.007; Vasquez-Doorman C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004452; Wagner DE, 2012, CELL STEM CELL, V10, P299, DOI 10.1016/j.stem.2012.01.016; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Yang JH, 2011, ANAL CHEM, V83, P5728, DOI 10.1021/ac200998a; Yang Yong, 2007, J Biomol Tech, V18, P226; Zamdborg L, 2007, NUCLEIC ACIDS RES, V35, pW701, DOI 10.1093/nar/gkm371	71	19	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8109	8120		10.1074/jbc.M115.709196	http://dx.doi.org/10.1074/jbc.M115.709196			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26884331	Green Published, hybrid			2022-12-28	WOS:000374056700028
J	Rizzetto, L; Ifrim, DC; Moretti, S; Tocci, N; Cheng, SC; Quintin, J; Renga, G; Oikonomou, V; De Filippo, C; Weil, T; Blok, BA; Lenucci, MS; Santos, MAS; Romani, L; Netea, MG; Cavalieri, D				Rizzetto, Lisa; Ifrim, Daniela C.; Moretti, Silvia; Tocci, Noemi; Cheng, Shih-Chin; Quintin, Jessica; Renga, Giorgia; Oikonomou, Vasilis; De Filippo, Carlotta; Weil, Tobias; Blok, Bastiaan A.; Lenucci, Marcello S.; Santos, Manuel A. S.; Romani, Luigina; Netea, Mihai G.; Cavalieri, Duccio			Fungal Chitin Induces Trained Immunity in Human Monocytes during Cross-talk of the Host with Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell wall; cellular immune response; fungi; host-pathogen interaction; phagocytosis	CANDIDA-ALBICANS; DENDRITIC CELLS; IN-VIVO; IL-17 PRODUCTION; HUMAN SKIN; DEFENSE; MEMORY; METABOLISM; STRAINS; YEAST	The immune system is essential to maintain the mutualistic homeostatic interaction between the host and its micro- and mycobiota. Living as a commensal, Saccharomyces cerevisiae could potentially shape the immune response in a significant way. We observed that S. cerevisiae cells induce trained immunity in monocytes in a strain-dependent manner through enhanced TNF and IL-6 production upon secondary stimulation with TLR ligands, as well as bacterial and fungal commensals. Differential chitin content accounts for the differences in training properties observed among strains, driving induction of trained immunity by increasing cytokine production and direct antimicrobial activity both in vitro and in vivo. These chitin-induced protective properties are intimately associated with its internalization, identifying a critical role of phagosome acidification to facilitate microbial digestion. This study reveals how commensal and passenger microorganisms could be important in promoting health and preventing mucosal diseases by modulating host defense toward pathogens and thus influencing the host microbiota-immune system interactions.	[Rizzetto, Lisa; Tocci, Noemi; De Filippo, Carlotta; Weil, Tobias; Cavalieri, Duccio] Fdn Edmund Mach, Res & Innovat Ctr, I-38010 San Michele All Adige, TN, Italy; [Ifrim, Daniela C.; Cheng, Shih-Chin; Quintin, Jessica; Blok, Bastiaan A.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Div Expt Internal Med, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands; [Moretti, Silvia; Oikonomou, Vasilis; Romani, Luigina] Univ Perugia, Polo Unico StAndrea Fratte, Dept Expt Med, I-06123 Perugia, PG, Italy; [De Filippo, Carlotta; Cavalieri, Duccio] CNR, Inst Biometeorol, I-50145 Florence, Italy; [Lenucci, Marcello S.] Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali, I-73100 Lecce, LE, Italy; [Santos, Manuel A. S.] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Santos, Manuel A. S.] Univ Aveiro, CESAM Ctr Estudos Ambiente & Mar, P-3810193 Aveiro, Portugal; [Cavalieri, Duccio] Univ Florence, Dept Biol, Via Madonna Piano 6, I-50019 Sesto Fiorentino, FI, Italy; [Quintin, Jessica] Inst Pasteur, Dept Mycol, Immunol Fungal Infect Grp, F-75724 Paris 15, France	Fondazione Edmund Mach; Radboud University Nijmegen; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); University of Salento; Universidade de Aveiro; Universidade de Aveiro; University of Florence; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cavalieri, D (corresponding author), Univ Florence, Dept Biol, Via Madonna Piano 6, I-50019 Sesto Fiorentino, FI, Italy.	duccio.cavalieri@unifi.it	Netea, Mihai/N-5155-2014; De Filippo, Carlotta/AAB-5805-2019; Romani, Luigina/O-9987-2018; CHENG, SHIH-CHIN/M-3773-2019; Rizzetto, Lisa/C-7304-2016; De Filippo, Carlotta/AAE-4683-2021; Cheng, Shih-Chin/H-4567-2015; CAVALIERI, DUCCIO/T-3097-2017	De Filippo, Carlotta/0000-0002-2222-6524; CHENG, SHIH-CHIN/0000-0003-1251-8774; Rizzetto, Lisa/0000-0002-2170-9276; Cheng, Shih-Chin/0000-0003-1251-8774; CAVALIERI, DUCCIO/0000-0001-6426-5719; Romani, Luigina/0000-0002-1356-525X; MORETTI, Silvia/0000-0002-8177-7254; Renga, Giorgia/0000-0002-9762-6493; Oikonomou, Vasileios/0000-0002-7553-0159; Santos, Manuel/0000-0002-0437-1146	European Union [HEALTH-2010-242220, HEALTH-2010-260338]; Vici grant from the Netherlands Organization for Scientific Research; ERC [310372]; MetafoodbookLabs grant from Provincia Autonoma di Trento and UNIFARM	European Union(European Commission); Vici grant from the Netherlands Organization for Scientific Research; ERC(European Research Council (ERC)European Commission); MetafoodbookLabs grant from Provincia Autonoma di Trento and UNIFARM	This work was supported from the European Union's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement HEALTH-2010-242220 ("SYBARIS"; to D. C), by a Vici grant from the Netherlands Organization for Scientific Research (to J. Q., S.-C. C., and M. G. N.), by ERC Consolidator Grant 310372 (to M. G. N.), by European Union's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement HEALTH-2010-260338 ("ALLFUN"; to D. C. I. and M. G. N.), and by the MetafoodbookLabs grant from Provincia Autonoma di Trento and UNIFARM (to D. C., L. R., N. T., and T. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez FJ, 2014, MOLECULES, V19, P4433, DOI 10.3390/molecules19044433; Angebault C, 2013, J INFECT DIS, V208, P1705, DOI 10.1093/infdis/jit389; Bonifazi P, 2009, MUCOSAL IMMUNOL, V2, P362, DOI 10.1038/mi.2009.17; Brachmann CB, 1998, YEAST, V14, P115; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Cheng SC, 2010, J IMMUNOL, V185, P2450, DOI 10.4049/jimmunol.1000756; Chien MW, 2015, J BIOL CHEM, V290, P29329, DOI 10.1074/jbc.M115.674671; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113; Dallies N, 1998, YEAST, V14, P1297, DOI 10.1002/(SICI)1097-0061(1998100)14:14<1297::AID-YEA310>3.0.CO;2-L; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eloe-Fadrosh EA, 2015, MBIO, V6, DOI 10.1128/mBio.00231-15; Ferreira C, 2006, FEMS YEAST RES, V6, P1027, DOI 10.1111/j.1567-1364.2006.00110.x; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Foligne B, 2010, APPL ENVIRON MICROB, V76, P8259, DOI 10.1128/AEM.01976-10; Foligne B, 2010, WORLD J GASTROENTERO, V16, P2134, DOI 10.3748/wjg.v16.i17.2134; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Ifrim DC, 2013, J IMMUNOL, V190, P4129, DOI 10.4049/jimmunol.1202611; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Landry CR, 2006, MOL ECOL, V15, P575, DOI 10.1111/j.1365-294X.2006.02778.x; Lowman DW, 2011, CARBOHYD RES, V346, P2752, DOI 10.1016/j.carres.2011.09.029; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; Mora-Montes HM, 2011, INFECT IMMUN, V79, P1961, DOI 10.1128/IAI.01282-10; Mukherjee PK, 2015, NAT REV GASTRO HEPAT, V12, P77, DOI 10.1038/nrgastro.2014.188; Muller A, 1996, J IMMUNOL, V156, P3418; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Oh J, 2013, GENOME RES, V23, P2103, DOI 10.1101/gr.159467.113; Poulain D, 2009, DIGEST DIS, V27, P104, DOI 10.1159/000268129; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rizzetto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056651; Rizzetto L, 2010, J IMMUNOL, V184, P4258, DOI 10.4049/jimmunol.0902972; Romani L, 2015, SEMIN IMMUNOPATHOL, V37, P163, DOI 10.1007/s00281-014-0464-2; Romani L, 2014, EUR J IMMUNOL, V44, P3192, DOI 10.1002/eji.201344406; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Tan Z, 2015, J IMMUNOL, V194, P6082, DOI 10.4049/jimmunol.1402469; Wagener J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004050; Xu JP, 1999, J CLIN MICROBIOL, V37, P3835, DOI 10.1128/JCM.37.12.3835-3843.1999; Yoshida K, 2015, NAT IMMUNOL, V16, P1034, DOI 10.1038/ni.3257	48	56	57	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7961	7972		10.1074/jbc.M115.699645	http://dx.doi.org/10.1074/jbc.M115.699645			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26887946	Green Published, hybrid			2022-12-28	WOS:000374056700018
J	He, JS; Zhu, QZ; Wani, G; Sharma, N; Wani, AA				He, Jinshan; Zhu, Qianzheng; Wani, Gulzar; Sharma, Nidhi; Wani, Altaf A.			Valosin-containing Protein (VCP)/p97 Segregase Mediates Proteolytic Processing of Cockayne Syndrome Group B (CSB) in Damaged Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; NUCLEOTIDE EXCISION-REPAIR; UV-SENSITIVE SYNDROME; DOUBLE-STRAND BREAKS; DNA-DAMAGE; AAA-ATPASE; IN-VIVO; UBIQUITIN; XPC	Cockayne syndrome group A and B (CSB) proteins act in transcription-coupled repair, a subpathway of nucleotide excision repair. Here we demonstrate that valosin-containing protein (VCP)/p97 segregase functions in ultraviolet radiation (UVR)induced ubiquitin-mediated CSB degradation. We show that VCP/p97 inhibition and siRNA-mediated ablation of VCP/p97 and its cofactors UFD1 and UBXD7 impair CSB degradation. VCP/p97 inhibition also results in the accumulation of CSB in chromatin. Moreover, VCP/p97 interacts with both native and ubiquitin-conjugated forms of CSB. The localized cellular UVR exposures lead to VCP/p97 accumulation at DNA damage spots, forming distinct UVR-induced foci. However, manifestation of VCP/p97 foci is independent of CSB and UBXD7. Furthermore, VCP/p97 and UBXD7 associate with the Cockayne syndrome group A-DDB1-Cul4A complex, an E3 ligase responsible for CSB ubiquitination. Compromising proteasome and VCP/p97 function allows accumulation of both native and ubiquitinated CSB and results in an increase of UBXD7, proteasomal RPN2, and Sug1 in the chromatin compartment. Surprisingly, both biochemical inhibition and genetic defect of VCP/p97 enhance the recovery of RNA synthesis following UVR, whereas both VCP/p97 and proteasome inhibitions decrease cell viability. Our findings reveal a new role of VCP/p97 segregase in the timely processing of ubiquitinated CSB from damaged chromatin.	[He, Jinshan; Zhu, Qianzheng; Wani, Gulzar; Sharma, Nidhi; Wani, Altaf A.] Ohio State Univ, Dept Radiol, 1036 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Zhu, QZ; Wani, AA (corresponding author), Ohio State Univ, Dept Radiol, 1036 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	zhu.49@osu.edu; wani.2@osu.edu			National Institute of Health [ES002388, ES012991]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012991, R01ES002388] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Health Grants ES002388 and ES012991 (to A. A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Cho I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003407; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Citterio E, 1998, J BIOL CHEM, V273, P11844, DOI 10.1074/jbc.273.19.11844; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; den Besten W, 2012, NAT STRUCT MOL BIOL, V19, P511, DOI 10.1038/nsmb.2269; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Fei J, 2012, J BIOL CHEM, V287, P35118, DOI 10.1074/jbc.M112.398131; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Ford JM, 1997, CURR TOP MICROBIOL, V221, P47; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Fuss JO, 2011, DNA REPAIR, V10, P697, DOI 10.1016/j.dnarep.2011.04.028; Gool AJ, 1997, EMBO J, V16, P5955; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; He JS, 2014, J BIOL CHEM, V289, P27278, DOI 10.1074/jbc.M114.589812; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meyer H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-48; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Newman JC, 2006, P NATL ACAD SCI USA, V103, P9613, DOI 10.1073/pnas.0510909103; Puumalainen MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4695; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Sharma N, 2014, CELL CYCLE, V13, P106, DOI 10.4161/cc.26814; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Wang YM, 2014, P NATL ACAD SCI USA, V111, P14454, DOI 10.1073/pnas.1412569111; Wei LZ, 2011, CANCER SCI, V102, P1840, DOI 10.1111/j.1349-7006.2011.02037.x; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228; Zhu QZ, 2015, CELL CYCLE, V14, P1413, DOI 10.1080/15384101.2015.1007785	49	20	20	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7396	7408		10.1074/jbc.M115.705350	http://dx.doi.org/10.1074/jbc.M115.705350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26826127	hybrid, Green Published			2022-12-28	WOS:000383447600016
J	Kolesar, P; Altmannova, V; Silva, S; Lisby, M; Krejci, L				Kolesar, Peter; Altmannova, Veronika; Silva, Sonia; Lisby, Michael; Krejci, Lumir			Pro-recombination Role of Srs2 Protein Requires SUMO (Small Ubiquitin-like Modifier) but Is Independent of PCNA (Proliferating Cell Nuclear Antigen) Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; YEAST SACCHAROMYCES-CEREVISIAE; RAD51 PRESYNAPTIC FILAMENT; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; ELEVATED RECOMBINATION; MITOTIC RECOMBINATION; MOLECULAR DISSECTION; CONJUGATING ENZYME; IN-VITRO	Srs2 plays many roles in DNA repair, the proper regulation and coordination of which is essential. Post-translational modification by small ubiquitin-like modifier (SUMO) is one such possible mechanism. Here, we investigate the role of SUMO in Srs2 regulation and show that the SUMO-interacting motif (SIM) of Srs2 is important for the interaction with several recombination factors. Lack of SIM, but not proliferating cell nuclear antigen (PCNA)-interacting motif (PIM), leads to increased cell death under circumstances requiring homologous recombination for DNA repair. Simultaneous mutation of SIM in a srs2 Delta PIM strain leads to a decrease in recombination, indicating a pro-recombination role of SUMO. Thus SIM has an ambivalent function in Srs2 regulation; it not only mediates interaction with SUMO-PCNA to promote the anti-recombination function but it also plays a PCNA-independent pro-recombination role, probably by stimulating the formation of recombination complexes. The fact that deletion of PIM suppresses the phenotypes of Srs2 lacking SIM suggests that proper balance between the anti-recombination PCNA-bound and pro-recombination pools of Srs2 is crucial. Notably, sumoylation of Srs2 itself specifically stimulates recombination at the rDNA locus.	[Kolesar, Peter; Altmannova, Veronika; Krejci, Lumir] Masaryk Univ, Dept Biol, Brno 62500, Czech Republic; [Kolesar, Peter; Krejci, Lumir] Masaryk Univ, Natl Ctr Biomol Res, Brno 62500, Czech Republic; [Silva, Sonia; Lisby, Michael] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Krejci, Lumir] St Annes Univ Hosp Brno, Ctr Biomol & Cellular Engn, Int Clin Res Ctr, Brno 60200, Czech Republic; [Kolesar, Peter] Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Masaryk University Brno; Masaryk University Brno; University of Copenhagen; St Anne's University Hospital Brno (FNUSA-ICRC); University of Sussex	Krejci, L (corresponding author), Masaryk Univ, Dept Biol, Brno 62500, Czech Republic.; Krejci, L (corresponding author), Masaryk Univ, Natl Ctr Biomol Res, Brno 62500, Czech Republic.; Krejci, L (corresponding author), St Annes Univ Hosp Brno, Ctr Biomol & Cellular Engn, Int Clin Res Ctr, Brno 60200, Czech Republic.	lkrejci@chemi.muni.cz	da Silva, Sonia C Pinela/F-2447-2016; Krejci, Lumir/B-7842-2009; Kolesar, Peter/B-2580-2015; Lisby, Michael/K-9814-2014	da Silva, Sonia C Pinela/0000-0003-3700-3072; Krejci, Lumir/0000-0002-4732-1405; Kolesar, Peter/0000-0002-3315-3586; Lisby, Michael/0000-0002-4830-5247	Czech Science Foundation [GACR 13-26629S, P207/12/2323]; European Regional Development Fund-Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; Research Support Programme "Employment of Newly Graduated Doctors of Science for Scientific Excellence" - European Social Fund [GAMU-MUNI/M/1894/2014, CZ.1.07/2.3.00/30.0009, CZ.1.07/2.3.00/30.0037]; Faculty of Medicine, Masaryk University; Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation; Lundbeck Foundation; European Research Council (ERC); Fundacao para a Ciencia e Tecnologia (FCT); Villum Fonden [00011407] Funding Source: researchfish	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund-Project FNUSA-ICRC; Research Support Programme "Employment of Newly Graduated Doctors of Science for Scientific Excellence" - European Social Fund; Faculty of Medicine, Masaryk University; Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation(Villum Fonden); Lundbeck Foundation(Lundbeckfonden); European Research Council (ERC)(European Research Council (ERC)European Commission); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Villum Fonden(Villum Fonden)	This work was supported by the Czech Science Foundation (GACR 13-26629S and P207/12/2323; to L. K.), European Regional Development Fund-Project FNUSA-ICRC (CZ.1.05/1.1.00/02.0123; to L. K.) and Research Support Programme (GAMU-MUNI/M/1894/2014; to L. K), "Employment of Newly Graduated Doctors of Science for Scientific Excellence" co-financed from the European Social Fund (CZ.1.07/2.3.00/30.0009 (to V. A.) and CZ.1.07/2.3.00/30.0037 (to P. K.), funds from the Faculty of Medicine, Masaryk University to junior researcher (to V. A.), the Danish Agency for Science, Technology and Innovation, the Villum Kann Rasmussen Foundation, the Lundbeck Foundation, European Research Council (ERC) (to M. L.), and Fundacao para a Ciencia e Tecnologia (FCT; to S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; AGUILERA A, 1988, GENETICS, V119, P779; Altmannova V, 2012, BIOMOLECULES, V2, P350, DOI 10.3390/biom2030350; Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Aylon Y, 2003, MOL CELL BIOL, V23, P1403, DOI 10.1128/MCB.23.4.1403-1417.2003; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Burgess RC, 2009, J CELL BIOL, V185, P969, DOI 10.1083/jcb.200810055; Burkovics P, 2016, NUCLEIC ACIDS RES, V44, P3176, DOI 10.1093/nar/gkw024; Carter SD, 2009, P NATL ACAD SCI USA, V106, P12037, DOI 10.1073/pnas.0903869106; Chamankhah M, 1999, NUCLEIC ACIDS RES, V27, P2072, DOI 10.1093/nar/27.10.2072; Chanet R, 1996, MOL CELL BIOL, V16, P4782; Chavdarova M, 2015, NUCLEIC ACIDS RES, V43, P3626, DOI 10.1093/nar/gkv198; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Davis AP, 2001, GENETICS, V159, P515; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Eckert-Boulet N, 2009, DNA REPAIR, V8, P507, DOI 10.1016/j.dnarep.2009.01.015; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Friedl AA, 2001, MUTAT RES-DNA REPAIR, V486, P137, DOI 10.1016/S0921-8777(01)00086-6; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hegde V, 2000, NUCLEIC ACIDS RES, V28, P2779, DOI 10.1093/nar/28.14.2779; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang ME, 2000, CURR GENET, V38, P178, DOI 10.1007/s002940000149; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kim SO, 2012, J MOL CELL BIOL, V4, P258, DOI 10.1093/jmcb/mjs026; Klein H, 2001, GENETICS, V157, P557; Kolesar P, 2012, NUCLEIC ACIDS RES, V40, P7831, DOI 10.1093/nar/gks484; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2004, J BIOL CHEM, V279, P23193, DOI 10.1074/jbc.M402586200; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Le Breton C, 2008, NUCLEIC ACIDS RES, V36, P4964, DOI 10.1093/nar/gkn441; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Marini V, 2012, DNA REPAIR, V11, P789, DOI 10.1016/j.dnarep.2012.05.007; Marini V, 2010, DNA REPAIR, V9, P268, DOI 10.1016/j.dnarep.2010.01.007; Merker RJ, 2002, MOL CELL BIOL, V22, P421, DOI 10.1128/MCB.22.2.421-429.2002; Miura T, 2013, P NATL ACAD SCI USA, V110, P16067, DOI 10.1073/pnas.1303111110; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Mortensen UH, 2002, GENETICS, V161, P549; Paliwal S, 2014, NUCLEIC ACIDS RES, V42, P2380, DOI 10.1093/nar/gkt1263; PALLADINO F, 1992, GENETICS, V132, P23; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Paques F, 1997, MOL CELL BIOL, V17, P6765, DOI 10.1128/MCB.17.11.6765; Burkovics P, 2013, EMBO J, V32, P742, DOI 10.1038/emboj.2013.9; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; RONG L, 1991, GENETICS, V127, P75; RONG L, 1993, J BIOL CHEM, V268, P1252; Ruiz JF, 2009, MOL CELL BIOL, V29, P5441, DOI 10.1128/MCB.00256-09; Saponaro M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000858; SCHIESTL RH, 1990, GENETICS, V124, P817; Sebesta M, 2011, DNA REPAIR, V10, P567, DOI 10.1016/j.dnarep.2011.03.003; Sherman F., 1989, LAB COURSE MANUAL ME; Shi I, 2009, J BIOL CHEM, V284, P33275, DOI 10.1074/jbc.M109.057752; SMITH J, 1995, MOL CELL BIOL, V15, P1632; Smith J, 1999, GENETICS, V151, P447; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Takahashi Y, 2003, J BIOCHEM, V133, P415, DOI 10.1093/jb/mvg054; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wilson TE, 2002, GENETICS, V162, P677; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	80	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7594	7607		10.1074/jbc.M115.685891	http://dx.doi.org/10.1074/jbc.M115.685891			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26861880	hybrid, Green Published			2022-12-28	WOS:000383447600032
J	Burger, VM; Nolasco, DO; Stultz, CM				Burger, Virginia M.; Nolasco, Diego O.; Stultz, Collin M.			Expanding the Range of Protein Function at the Far End of the Order-Structure Continuum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						biophysics; conformational change; intrinsically disordered protein; protein folding; protein structure	INTRINSICALLY DISORDERED PROTEINS; COACTIVATOR BINDING DOMAIN; DEPENDENT TRANSLATION INITIATION; FLY-CASTING MECHANISM; MOLTEN-GLOBULE STATE; OUTER-MEMBRANE; COMPETITIVE RECRUITMENT; UNSTRUCTURED PROTEINS; UNFOLDED PROTEINS; ACTIVATION DOMAIN	The traditional view of the structure-function paradigm is that a protein's function is inextricably linked to a well defined, three-dimensional structure, which is determined by the protein's primary amino acid sequence. However, it is now accepted that a number of proteins do not adopt a unique tertiary structure in solution and that some degree of disorder is required for many proteins to perform their prescribed functions. In this review, we highlight how a number of protein functions are facilitated by intrinsic disorder and introduce a new protein structure taxonomy that is based on quantifiable metrics of a protein's disorder.	[Burger, Virginia M.; Nolasco, Diego O.; Stultz, Collin M.] MIT, Dept Elect Engn & Comp Sci, Elect Res Lab, Cambridge, MA 02138 USA; [Stultz, Collin M.] MIT, Inst Med Engn & Sci, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Stultz, CM (corresponding author), MIT, Dept Elect Engn & Comp Sci, Elect Res Lab, Cambridge, MA 02138 USA.; Stultz, CM (corresponding author), MIT, Inst Med Engn & Sci, Cambridge, MA 02138 USA.	cmstultz@mit.edu	Nolasco, Diego O/O-6743-2014; Nolasco, Diego O./D-1241-2017	Nolasco, Diego O/0000-0001-7931-5475; Nolasco, Diego O./0000-0001-7931-5475	National Science Foundation; Federal Agency for Support and Evaluation of Graduate Education of Brazil and Science without Borders (CAPES/CSF); Lemann Foundation; Steven G. and Renee Finn Research Innovation Fellowship; Div Of Biological Infrastructure [1309247] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Federal Agency for Support and Evaluation of Graduate Education of Brazil and Science without Borders (CAPES/CSF); Lemann Foundation; Steven G. and Renee Finn Research Innovation Fellowship; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in part, by the National Science Foundation (Post-doctoral Research Fellowship in Biology (to V. M. B.)), the Federal Agency for Support and Evaluation of Graduate Education of Brazil and Science without Borders (CAPES/CSF), the Lemann Foundation, and a Steven G. and Renee Finn Research Innovation Fellowship. This is the fourth article in the Thematic Minireview series "Intrinsically Disordered Proteins." The authors declare that they have no conflicts of interest with the contents of this article.	Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Bonsor DA, 2007, J AM CHEM SOC, V129, P4800, DOI 10.1021/ja070153n; Burger VM, 2014, POLYMERS-BASEL, V6, P2684, DOI 10.3390/polym6102684; Burger VM, 2012, BIOCOMPUT-PAC SYM, P70; Chavez LL, 2004, J AM CHEM SOC, V126, P8426, DOI 10.1021/ja049510+; Collins ES, 2002, J MOL BIOL, V318, P787, DOI 10.1016/S0022-2836(02)00036-0; Daly NL, 1999, J MOL BIOL, V285, P333, DOI 10.1006/jmbi.1998.2276; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dunker AK, 2015, SEMIN CELL DEV BIOL, V37, P44, DOI 10.1016/j.semcdb.2014.09.025; Dunker A Keith, 2013, Intrinsically Disord Proteins, V1, pe24157, DOI 10.4161/idp.24157; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ebert MO, 2008, BIOCHEMISTRY-US, V47, P1299, DOI 10.1021/bi701767j; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Fisher CK, 2011, J AM CHEM SOC, V133, P10022, DOI 10.1021/ja203075p; Fletcher CM, 1998, BIOCHEMISTRY-US, V37, P9, DOI 10.1021/bi972494r; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gosselin P, 2011, NUCLEIC ACIDS RES, V39, P3496, DOI 10.1093/nar/gkq1306; Gratia A, 1925, CR SOC BIOL, V93, P1040; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; Housden NG, 2013, SCIENCE, V340, P1570, DOI 10.1126/science.1237864; Housden NG, 2010, P NATL ACAD SCI USA, V107, P21412, DOI 10.1073/pnas.1010780107; HU CB, 1994, P NATL ACAD SCI USA, V91, P3730, DOI 10.1073/pnas.91.9.3730; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Keedy DA, 2014, STRUCTURE, V22, P899, DOI 10.1016/j.str.2014.04.016; Kjaergaard M, 2013, BIOCHEMISTRY-US, V52, P1686, DOI 10.1021/bi4001062; Kjaergaard M, 2012, BIOPHYS J, V102, P1627, DOI 10.1016/j.bpj.2012.02.014; Kjaergaard M, 2010, P NATL ACAD SCI USA, V107, P12535, DOI 10.1073/pnas.1001693107; Klages J, 2008, BIOCHEMISTRY-US, V47, P11930, DOI 10.1021/bi801059j; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Knott M, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4873710; Kumar Satish, 2013, Genomics & Informatics, V11, P289, DOI 10.5808/GI.2013.11.4.289; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Loftus SR, 2006, P NATL ACAD SCI USA, V103, P12353, DOI 10.1073/pnas.0603433103; Lotti M, 2012, MOL BIOSYST, V8, P105, DOI 10.1039/c1mb05244f; Lukhele S, 2013, STRUCTURE, V21, P2186, DOI 10.1016/j.str.2013.08.030; Lyle N, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4812791; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marsh JA, 2012, CURR OPIN STRUC BIOL, V22, P643, DOI 10.1016/j.sbi.2012.08.008; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Mittag T, 2010, STRUCTURE, V18, P494, DOI 10.1016/j.str.2010.01.020; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Olabode AS, 2015, VIROLOGY, V482, P202, DOI 10.1016/j.virol.2015.03.029; Otieno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047177; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Peter D, 2015, MOL CELL, V57, P1074, DOI 10.1016/j.molcel.2015.01.017; PTITSYN OB, 1987, J PROTEIN CHEM, V6, P273; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Rauscher S, 2015, J CHEM THEORY COMPUT, V11, P5513, DOI 10.1021/acs.jctc.5b00736; Rauscher S, 2010, BIOCHEM CELL BIOL, V88, P269, DOI [10.1139/O09-169, 10.1139/o09-169]; Savarin P, 1998, BIOCHEMISTRY-US, V37, P5407, DOI 10.1021/bi9730341; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Singh GP, 2015, PEERJ, V3, DOI 10.7717/peerj.724; SKELTON NJ, 1994, BIOCHEMISTRY-US, V33, P13581, DOI 10.1021/bi00250a010; Spector J, 2010, BIOPHYS J, V99, P3880, DOI 10.1016/j.bpj.2010.10.029; Srinivasan N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6145; Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257; Tompa P, 2014, STRUCTURE, V22, P177, DOI 10.1016/j.str.2014.01.003; Tonelli M, 2001, FEBS LETT, V509, P161, DOI 10.1016/S0014-5793(01)03086-1; Uversky VN, 2006, J PROTEOME RES, V5, P1829, DOI 10.1021/pr0602388; Uversky VN, 2014, CHEM REV, V114, P6844, DOI 10.1021/cr400713r; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; van den Bedem H, 2015, NAT METHODS, V12, P307, DOI 10.1038/nmeth.3324; Varadi M, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00045; Varadi M, 2014, NUCLEIC ACIDS RES, V42, pD326, DOI 10.1093/nar/gkt960; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; Weeks SD, 2014, J STRUCT BIOL, V185, P342, DOI 10.1016/j.jsb.2013.12.009; WOOD SP, 1986, SCIENCE, V232, P633, DOI 10.1126/science.3008332; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yadav LR, 2015, J BIOMOL STRUCT DYN, V33, P2469, DOI 10.1080/07391102.2014.1000973; Zakharov SD, 2012, BIOCHEM SOC T, V40, P1463, DOI 10.1042/BST20120211	84	11	11	4	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6706	6713		10.1074/jbc.R115.692590	http://dx.doi.org/10.1074/jbc.R115.692590			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26851282	Green Published, hybrid			2022-12-28	WOS:000373299700010
J	Dahl, JM; Lieberman, KR; Wang, HY				Dahl, Joseph M.; Lieberman, Kate R.; Wang, Hongyun			Modulation of DNA Polymerase Noncovalent Kinetic Transitions by Divalent Cations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; DNA replication; enzyme kinetics; enzyme mechanism; single-molecule biophysics	CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVE-SITE; COMPLEXES; MECHANISM; REPLICATION; TRANSLOCATION; PHI-29; SUBSTRATE; DYNAMICS	Replicative DNA polymerases (DNAPs) require divalent metal cations for phosphodiester bond formation in the polymerase site and for hydrolytic editing in the exonuclease site. Me2+ ions are intimate architectural components of each active site, where they are coordinated by a conserved set of amino acids and functional groups of the reaction substrates. Therefore Me2+ ions can influence the noncovalent transitions that occur during each nucleotide addition cycle. Using a nanopore, transitions in individual phi 29 DNAP complexes are resolved with single-nucleotide spatial precision and sub-millisecond temporal resolution. We studied Mg2+ and Mn2+, which support catalysis, and Ca2+, which supports deoxynucleoside triphosphate (dNTP) binding but not catalysis. We examined their effects on translocation, dNTP binding, and primer strand transfer between the polymerase and exonuclease sites. All three metals cause a concentration-dependent shift in the translocation equilibrium, predominantly by decreasing the forward translocation rate. Me2+ also promotes an increase in the backward translocation rate that is dependent upon the primer terminal 3-OH group. Me2+ modulates the translocation rates but not their response to force, suggesting that Me2+ does not affect the distance to the transition state of translocation. Absent Me2+, the primer strand transfer pathway between the polymerase and exonuclease sites displays additional kinetic states not observed at >1 mm Me2+. Complementary dNTP binding is affected by Me2+ identity, with Ca2+ affording the highest affinity, followed by Mn2+, and then Mg2+. Both Ca2+ and Mn2+ substantially decrease the dNTP dissociation rate relative to Mg2+, while Ca2+ also increases the dNTP association rate.	[Dahl, Joseph M.; Lieberman, Kate R.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Wang, Hongyun] Univ Calif Santa Cruz, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Wang, HY (corresponding author), Univ Calif Santa Cruz, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA.; Lieberman, KR (corresponding author), Baskin Sch Engn, 1156 High St, Santa Cruz, CA 95064 USA.	krlieberman@gmail.com; hongwang@soe.ucsc.edu			National Institutes of Health from NIGMS [R01GM087484]; National Science Foundation [DGE 1339067]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R25HG006836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087484] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM087484 from NIGMS (to K. R. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an National Science Foundation Graduate Research Fellowship DGE 1339067.	Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Bakhtina M, 2005, BIOCHEMISTRY-US, V44, P5177, DOI 10.1021/bi047664w; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Benner S, 2007, NAT NANOTECHNOL, V2, P718, DOI 10.1038/nnano.2007.344; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Blanco L, 1996, J BIOL CHEM, V271, P8509, DOI 10.1074/jbc.271.15.8509; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Dahl JM, 2014, BIOCHEMISTRY-US, V53, P8061, DOI 10.1021/bi501216a; Dahl JM, 2014, J BIOL CHEM, V289, P6350, DOI 10.1074/jbc.M113.535666; Dahl JM, 2012, J BIOL CHEM, V287, P13407, DOI 10.1074/jbc.M111.338418; de Vega M, 1999, J MOL BIOL, V292, P39, DOI 10.1006/jmbi.1999.3052; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; ESTEBAN JA, 1992, BIOCHEMISTRY-US, V31, P350, DOI 10.1021/bi00117a006; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; Fersht A., 1985, ENZYME STRUCTURE MEC; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garalde DR, 2011, J BIOL CHEM, V286, P14480, DOI 10.1074/jbc.M111.218750; GARMENDIA C, 1992, J BIOL CHEM, V267, P2594; Hogg M, 2014, NAT STRUCT MOL BIOL, V21, P49, DOI 10.1038/nsmb.2712; Johansson E, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012799; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; Kirby TW, 2012, NUCLEIC ACIDS RES, V40, P2974, DOI 10.1093/nar/gkr1218; Kunkel TA, 2009, COLD SH Q B, V74, P91, DOI 10.1101/sqb.2009.74.027; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; Lieberman KR, 2014, J AM CHEM SOC, V136, P7117, DOI 10.1021/ja5026408; Lieberman KR, 2013, J AM CHEM SOC, V135, P9149, DOI 10.1021/ja403640b; Lieberman KR, 2012, J AM CHEM SOC, V134, P18816, DOI 10.1021/ja3090302; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Miyabe I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002407; Morin JA, 2012, P NATL ACAD SCI USA, V109, P8115, DOI 10.1073/pnas.1204759109; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Salas M, 2008, IUBMB LIFE, V60, P82, DOI 10.1002/iub.19; STEITZ TA, 1993, CURR OPIN STRUC BIOL, V3, P31, DOI 10.1016/0959-440X(93)90198-T; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wang MN, 2011, BIOCHEMISTRY-US, V50, P581, DOI 10.1021/bi101192f; Wang M, 2009, BIOCHEMISTRY-US, V48, P2075, DOI 10.1021/bi801627h; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	48	4	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6456	6470		10.1074/jbc.M115.701797	http://dx.doi.org/10.1074/jbc.M115.701797			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797125	hybrid, Green Published			2022-12-28	WOS:000372894200033
J	Dunshee, DR; Bainbridge, TW; Kljavin, NM; Zavala-Solorio, J; Schroeder, AC; Chan, R; Corpuz, R; Wong, M; Zhou, W; Deshmukh, G; Ly, J; Sutherlin, DP; Ernst, JA; Sonoda, J				Dunshee, Diana Ronai; Bainbridge, Travis W.; Kljavin, Noelyn M.; Zavala-Solorio, Jose; Schroeder, Amy C.; Chan, Ruby; Corpuz, Racquel; Wong, Manda; Zhou, Wei; Deshmukh, Gauri; Ly, Justin; Sutherlin, Daniel P.; Ernst, James A.; Sonoda, Junichiro			Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FGF; metabolic disease; protease inhibitor; proteolytic enzyme; serine protease; FGF21; dipeptidyl peptidase IV (DPPIV); fibroblast activation protein (FAP)	DIPEPTIDYL PEPTIDASE-4 INHIBITORS; ENDOPLASMIC-RETICULUM STRESS; SERUM FGF21 LEVELS; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; METABOLIC SYNDROME; HEPATIC STEATOSIS; MICE; OBESITY; EXPRESSION	FGF21 is a stress-induced hormone with potent anti-obesity, insulin-sensitizing, and hepatoprotective properties. Although proteolytic cleavage of recombinant human FGF21 in preclinical species has been observed previously, the regulation of endogenously produced FGF21 is not well understood. Here we identify fibroblast activation protein (FAP) as the enzyme that cleaves and inactivates human FGF21. A selective chemical inhibitor, immunodepletion, or genetic deletion of Fap stabilized recombinant human FGF21 in serum. In addition, administration of a selective FAP inhibitor acutely increased circulating intact FGF21 levels in cynomolgus monkeys. On the basis of our findings, we propose selective FAP inhibition as a potential therapeutic approach to increase endogenous FGF21 activity for the treatment of obesity, type 2 diabetes, non-alcoholic steatohepatitis, and related metabolic disorders.	[Dunshee, Diana Ronai; Zavala-Solorio, Jose; Schroeder, Amy C.; Sonoda, Junichiro] Genentech Inc, Mol Biol, San Francisco, CA 94080 USA; [Bainbridge, Travis W.; Chan, Ruby; Corpuz, Racquel; Wong, Manda; Ernst, James A.] Genentech Inc, Prot Chem, San Francisco, CA 94080 USA; [Kljavin, Noelyn M.] Genentech Inc, Mol Oncol, San Francisco, CA 94080 USA; [Zhou, Wei] Genentech Inc, Translat Oncol, San Francisco, CA 94080 USA; [Deshmukh, Gauri; Ly, Justin] Genentech Inc, Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA; [Sutherlin, Daniel P.] Genentech Inc, Discovery Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Sonoda, J (corresponding author), Genentech Inc, Mol Biol, San Francisco, CA 94080 USA.	junichis@gene.com		Wong, Manda/0000-0001-5830-1517	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This work was funded by Genentech, Inc. All authors are present or former paid employees of Genentech with no further conflict of interest.	Agusti-Cobos E, 2011, J THROMB HAEMOST, V9, P1266, DOI 10.1111/j.1538-7836.2011.04294.x; Belouski E. J. C., 2014, U. S. Patent, Patent No. [8,835,385, 8835385]; Bobbert T, 2013, DIABETES CARE, V36, P145, DOI 10.2337/dc12-0703; Chen WW, 2008, EXP CLIN ENDOCR DIAB, V116, P65, DOI 10.1055/s-2007-985148; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dong JQ, 2015, BRIT J CLIN PHARMACO, V80, P1051, DOI 10.1111/bcp.12676; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Edosada CY, 2006, FEBS LETT, V580, P1581, DOI 10.1016/j.febslet.2006.01.087; Fisher FM, 2014, GASTROENTEROLOGY, V147, P1073, DOI 10.1053/j.gastro.2014.07.044; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Gimeno RE, 2014, TRENDS ENDOCRIN MET, V25, P303, DOI 10.1016/j.tem.2014.03.001; Hamson EJ, 2014, PROTEOM CLIN APPL, V8, P454, DOI 10.1002/prca.201300095; Hanssen MJW, 2015, SCI REP-UK, V5, DOI 10.1038/srep10275; Hecht R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049345; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Huang CH, 2011, J BIOCHEM, V149, P685, DOI 10.1093/jb/mvr017; Jansen K, 2014, J MED CHEM, V57, P3053, DOI 10.1021/jm500031w; Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960; Keane FM, 2014, FEBS OPEN BIO, V4, P43, DOI 10.1016/j.fob.2013.12.001; Kharitonenkov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058575; Kim SH, 2015, DIABETOLOGIA, V58, P809, DOI 10.1007/s00125-014-3475-6; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Laverman P, 2015, J NUCL MED, V56, P778, DOI 10.2967/jnumed.114.152959; Lee KN, 2006, BLOOD, V107, P1397, DOI 10.1182/blood-2005-08-3452; Levy MT, 2002, LIVER, V22, P93, DOI 10.1034/j.1600-0676.2002.01503.x; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Liu R, 2012, CANCER BIOL THER, V13, P123, DOI 10.4161/cbt.13.3.18696; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Migoya EM, 2010, CLIN PHARMACOL THER, V88, P801, DOI 10.1038/clpt.2010.184; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Niedermeyer J, 2000, MOL CELL BIOL, V20, P1089, DOI 10.1128/MCB.20.3.1089-1094.2000; Ong KL, 2012, J CLIN ENDOCR METAB, V97, P4701, DOI 10.1210/jc.2012-2267; Osborne B, 2014, BBA-PROTEINS PROTEOM, V1844, P1248, DOI 10.1016/j.bbapap.2014.03.015; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; Patel R, 2015, MOL ENDOCRINOL, V29, P213, DOI 10.1210/me.2014-1259; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Tanaka N, 2015, BBA-MOL BASIS DIS, V1852, P1242, DOI 10.1016/j.bbadis.2015.02.012; Umberger TS, 2014, BIOANALYSIS, V6, P3283, DOI 10.4155/bio.14.241; Waldele S, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0524-6; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yan HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024895; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zhen EY, 2016, BIOCHEM J, V473, P605, DOI 10.1042/BJ20151085	52	86	86	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5986	5996		10.1074/jbc.M115.710582	http://dx.doi.org/10.1074/jbc.M115.710582			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26797127	Green Published, hybrid			2022-12-28	WOS:000372551800043
J	Ronan, T; Macdonald-Obermann, JL; Huelsmann, L; Bessman, NJ; Naegle, KM; Pike, LJ				Ronan, Tom; Macdonald-Obermann, Jennifer L.; Huelsmann, Lorel; Bessman, Nicholas J.; Naegle, Kristen M.; Pike, Linda J.			Different Epidermal Growth Factor Receptor (EGFR) Agonists Produce Unique Signatures for the Recruitment of Downstream Signaling Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; epidermal growth factor (EGF); epidermal growth factor receptor (EGFR); growth factor; receptor tyrosine kinase; systems biology	SITE-SPECIFIC PHOSPHORYLATION; POSITIVE FEEDBACK LOOP; TYROSINE PHOSPHORYLATION; CRYSTAL-STRUCTURE; DOCKING PROTEIN; ACTIVATION; AMPHIREGULIN; LIGANDS; COMPLEX; CANCER	The EGF receptor can bind seven different agonist ligands. Although each agonist appears to stimulate the same suite of downstream signaling proteins, different agonists are capable of inducing distinct responses in the same cell. To determine the basis for these differences, we used luciferase fragment complementation imaging to monitor the recruitment of Cbl, CrkL, Gab1, Grb2, PI3K, p52 Shc, p66 Shc, and Shp2 to the EGF receptor when stimulated by the seven EGF receptor ligands. Recruitment of all eight proteins was rapid, dose-dependent, and inhibited by erlotinib and lapatinib, although to differing extents. Comparison of the time course of recruitment of the eight proteins in response to a fixed concentration of each growth factor revealed differences among the growth factors that could contribute to their differing biological effects. Principal component analysis of the resulting data set confirmed that the recruitment of these proteins differed between agonists and also between different doses of the same agonist. Ensemble clustering of the overall response to the different growth factors suggests that these EGF receptor ligands fall into two major groups as follows: (i) EGF, amphiregulin, and EPR; and (ii) betacellulin, TGF, and epigen. Heparin-binding EGF is distantly related to both clusters. Our data identify differences in network utilization by different EGF receptor agonists and highlight the need to characterize network interactions under conditions other than high dose EGF.	[Ronan, Tom; Naegle, Kristen M.] Washington Univ, Dept Biomed Engn, Sch Med, St Louis, MO 63110 USA; [Ronan, Tom; Naegle, Kristen M.] Washington Univ, Ctr Biol Syst Engn, Sch Med, St Louis, MO 63110 USA; [Macdonald-Obermann, Jennifer L.; Huelsmann, Lorel; Pike, Linda J.] Washington Univ, Dept Biochem & Mol Biophys, Sch Med, St Louis, MO 63110 USA; [Bessman, Nicholas J.] Univ Penn, Dept Biochem & Biophys, Grad Grp Biochem & Mol Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Huelsmann, Lorel] Univ Texas Southwestern, Sch Med, Dallas, TX 75390 USA; [Bessman, Nicholas J.] Cornell Univ, Joan & Sanford I Weill Dept Med, New York, NY 10065 USA; [Bessman, Nicholas J.] Cornell Univ, Joan & Sanford I Weill Dept Microbiol & Immunol, New York, NY 10065 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University; Cornell University	Naegle, KM (corresponding author), Washington Univ, Dept Biomed Engn, Sch Med, St Louis, MO 63110 USA.; Naegle, KM (corresponding author), Washington Univ, Ctr Biol Syst Engn, Sch Med, St Louis, MO 63110 USA.; Pike, LJ (corresponding author), Washington Univ, Dept Biochem & Mol Biophys, Sch Med, St Louis, MO 63110 USA.	knaegle@wustl.edu; pike@biochem.wustl.edu		Naegle, Kristen/0000-0001-7146-9592	National Institutes of Health [RO1GM099695, RO1-CA079992]; Center for Biological Systems Engineering, Washington University, St. Louis, MO; NATIONAL CANCER INSTITUTE [R01CA079992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Biological Systems Engineering, Washington University, St. Louis, MO; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant RO1GM099695 ( to L. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the Center for Biological Systems Engineering, Washington University, St. Louis, MO.; Supported by National Institutes of Health Grant RO1-CA079992 ( to Mark Lemmon). Present address: Joan and Sanford I. Weill Depts. of Medicine and Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, NY 10065.	BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Curran TG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6924; Dengjel J, 2007, NAT BIOTECHNOL, V25, P566, DOI 10.1038/nbt1301; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gilmore JL, 2008, BREAST CANCER RES TR, V110, P493, DOI 10.1007/s10549-007-9748-8; GRAYSON LS, 1993, BURNS, V19, P401, DOI 10.1016/0305-4179(93)90061-C; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Guo L, 2003, J AM SOC MASS SPECTR, V14, P1022, DOI 10.1016/S1044-0305(03)00206-X; Hofman EG, 2010, J BIOL CHEM, V285, P39481, DOI 10.1074/jbc.M110.164731; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Ingham RJ, 1998, J BIOL CHEM, V273, P30630, DOI 10.1074/jbc.273.46.30630; Knudsen SLJ, 2014, GROWTH FACTORS, V32, P155, DOI 10.3109/08977194.2014.952410; Kyono WT, 1998, J IMMUNOL, V161, P5555; Lecoq-Lafon C, 1999, BLOOD, V93, P2578, DOI 10.1182/blood.V93.8.2578.408k24_2578_2585; Lemos-Gonzalez Y, 2007, BRIT J CANCER, V96, P1569, DOI 10.1038/sj.bjc.6603770; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Macdonald-Obermann JL, 2013, J BIOL CHEM, V288, P30773, DOI 10.1074/jbc.M113.489534; MARTI U, 1989, HEPATOLOGY, V9, P126, DOI 10.1002/hep.1840090122; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Saito T, 2004, ENDOCRINOLOGY, V145, P4232, DOI 10.1210/en.2004-0401; Sattler M, 1997, J BIOL CHEM, V272, P14320, DOI 10.1074/jbc.272.22.14320; Shin HS, 2003, CIRC RES, V93, P302, DOI 10.1161/01.RES.0000086803.64109.9E; Simister PC, 2012, MOL BIOSYST, V8, P33, DOI 10.1039/c1mb05272a; Steen H, 2002, J BIOL CHEM, V277, P1031, DOI 10.1074/jbc.M109992200; Streicher KL, 2007, MOL CANCER RES, V5, P847, DOI 10.1158/1541-7786.MCR-06-0427; Wang W., 2015, EUR POLYM J, V1, P1, DOI DOI 10.1016/J.IJCARD.2014.10.148; Wilson KJ, 2012, GROWTH FACTORS, V30, P107, DOI 10.3109/08977194.2011.649918; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	44	29	30	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5528	5540		10.1074/jbc.M115.710087	http://dx.doi.org/10.1074/jbc.M115.710087			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786109	Green Published, hybrid			2022-12-28	WOS:000372551800008
J	Farwell, SLN; Kanyi, D; Hamel, M; Slee, JB; Miller, EA; Cipolle, MD; Lowe-Krentz, LJ				Farwell, Sara Lynn N.; Kanyi, Daniela; Hamel, Marianne; Slee, Joshua B.; Miller, Elizabeth A.; Cipolle, Mark D.; Lowe-Krentz, Linda J.			Heparin Decreases in Tumor Necrosis Factor (TNF)-induced Endothelial Stress Responses Require Transmembrane Protein 184A and Induction of Dual Specificity Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; JNK; endothelial cell; heparin-binding protein; inflammation; p38 MAPK	SMOOTH-MUSCLE-CELLS; KAPPA-B ACTIVATION; FLUID SHEAR-STRESS; P38 MAP KINASE; ACTIN POLYMERIZATION; VASCULAR LEAK; CROSS-TALK; EXPRESSION; PERMEABILITY; RECEPTOR	Despite the large number of heparin and heparan sulfate binding proteins, the molecular mechanism(s) by which heparin alters vascular cell physiology is not well understood. Studies with vascular smooth muscle cells (VSMCs) indicate a role for induction of dual specificity phosphatase 1 (DUSP1) that decreases ERK activity and results in decreased cell proliferation, which depends on specific heparin binding. The hypothesis that unfractionated heparin functions to decrease inflammatory signal transduction in endothelial cells (ECs) through heparin-induced expression of DUSP1 was tested. In addition, the expectation that the heparin response includes a decrease in cytokine-induced cytoskeletal changes was examined. Heparin pretreatment of ECs resulted in decreased TNF-induced JNK and p38 activity and downstream target phosphorylation, as identified through Western blotting and immunofluorescence microscopy. Through knockdown strategies, the importance of heparin-induced DUSP1 expression in these effects was confirmed. Quantitative fluorescence microscopy indicated that heparin treatment of ECs reduced TNF-induced increases in stress fibers. Monoclonal antibodies that mimic heparin-induced changes in VSMCs were employed to support the hypothesis that heparin was functioning through interactions with a receptor. Knockdown of transmembrane protein 184A (TMEM184A) confirmed its involvement in heparin-induced signaling as seen in VSMCs. Therefore, TMEM184A functions as a heparin receptor and mediates anti-inflammatory responses of ECs involving decreased JNK and p38 activity.	[Farwell, Sara Lynn N.; Kanyi, Daniela; Hamel, Marianne; Slee, Joshua B.; Miller, Elizabeth A.; Lowe-Krentz, Linda J.] Lehigh Univ, Dept Biol Sci, 111 Res Dr,Rm B217, Bethlehem, PA 18015 USA; [Kanyi, Daniela] Lehigh Univ, Dept Chem, Allentown, PA 18103 USA; [Cipolle, Mark D.] Lehigh Valley Hosp Ctr, Dept Surg, Allentown, PA 18103 USA; [Slee, Joshua B.] DeSales Univ, Dept Nat Sci, Center Valley, PA 18034 USA; [Cipolle, Mark D.] Christiana Care Hlth Syst, Trauma Program, Newark, DE 19718 USA	Lehigh University; Lehigh University; Lehigh Valley Hospital; Christiana Care Health System	Lowe-Krentz, LJ (corresponding author), Lehigh Univ, Dept Biol Sci, 111 Res Dr,Rm B217, Bethlehem, PA 18015 USA.	LJL0@lehigh.edu			National Institutes of Health [HL54269]; Lehigh Valley Hospital Department of Surgery and Division of Surgical Critical Care; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL054269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lehigh Valley Hospital Department of Surgery and Division of Surgical Critical Care; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Contract Grant HL54269 (to L. J. L. K.). It was initiated with funding from Lehigh Valley Hospital Department of Surgery and Division of Surgical Critical Care (to M. D. C. and L. J. L. K.).	Amini N, 2014, ATHEROSCLEROSIS, V235, P613, DOI 10.1016/j.atherosclerosis.2014.05.950; Azuma N, 2001, AM J PHYSIOL-HEART C, V280, pH189, DOI 10.1152/ajpheart.2001.280.1.H189; Baeyens N, 2014, P NATL ACAD SCI USA, V111, P17308, DOI 10.1073/pnas.1413725111; BARZU T, 1985, BIOCHIM BIOPHYS ACTA, V845, P196, DOI 10.1016/0167-4889(85)90177-6; Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Blaukovitch CI, 2010, J CELL BIOCHEM, V110, P382, DOI 10.1002/jcb.22543; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; CASTELLOT JJ, 1985, J CELL PHYSIOL, V124, P13, DOI 10.1002/jcp.1041240104; Chang E, 2011, BLOOD, V117, P2527, DOI 10.1182/blood-2010-08-302281; Chaudhury H, 2010, ARTERIOSCL THROM VAS, V30, P546, DOI 10.1161/ATVBAHA.109.201368; Chen KY, 2013, J BIOL CHEM, V288, P13988, DOI 10.1074/jbc.M112.444737; Chiodelli P, 2015, MOLECULES, V20, P6342, DOI 10.3390/molecules20046342; Couchman JR, 2015, INT J EXP PATHOL, V96, P1, DOI 10.1111/iep.12112; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Damarla M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004600; Dougherty CS, 1998, J VASC RES, V35, P437, DOI 10.1159/000025615; Ebong EE, 2014, INTEGR BIOL-UK, V6, P338, DOI 10.1039/c3ib40199e; Engelberg H, 2001, ATHEROSCLEROSIS, V159, P253, DOI 10.1016/S0021-9150(01)00650-5; Ettelaie C, 2011, BBA-MOL BASIS DIS, V1812, P1591, DOI 10.1016/j.bbadis.2011.09.007; Gilotti AC, 2014, J CELL PHYSIOL, V229, P2142, DOI 10.1002/jcp.24677; Gonzales JN, 2014, VASC PHARMACOL, V62, P63, DOI 10.1016/j.vph.2014.01.005; Hamel M, 2006, ENDOTHELIUM-J ENDOTH, V13, P157, DOI 10.1080/10623320600760191; Han JL, 2013, THROMB RES, V132, pE42, DOI 10.1016/j.thromres.2013.03.010; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Li X, 2012, CYTOKINE, V60, P114, DOI 10.1016/j.cyto.2012.06.008; Liu HB, 2013, J CARDIOVASC PHARM, V61, P461, DOI 10.1097/FJC.0b013e31828c0933; Manduteanu I, 2007, PHARMACOLOGY, V79, P154, DOI 10.1159/000098952; Mengistu M, 2012, ACTIN STRUCTURE FUNC, P177; Mengistu M, 2011, J CELL PHYSIOL, V226, P110, DOI 10.1002/jcp.22311; OTTLINGER ME, 1993, J BIOL CHEM, V268, P19173; PATTON WA, 1995, BIOCHEM J, V311, P461, DOI 10.1042/bj3110461; Pugh RJ, 2016, J BIOL CHEM, V291, P5326, DOI 10.1074/jbc.M115.681122; PUKAC LA, 1990, CELL REGUL, V1, P435, DOI 10.1091/mbc.1.5.435; Pukac LA, 1997, J CELL PHYSIOL, V172, P69, DOI 10.1002/(SICI)1097-4652(199707)172:1<69::AID-JCP8>3.0.CO;2-B; Rapraeger AC, 2013, FEBS J, V280, P2194, DOI 10.1111/febs.12134; Rath G, 2009, J PHYSIOL PHARMACOL, V60, P105; REILLY CF, 1989, J BIOL CHEM, V264, P6990; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Savage JM, 2001, J CELL PHYSIOL, V187, P283, DOI 10.1002/jcp.1076; Sen A, 2014, FEBS LETT, V588, P906, DOI 10.1016/j.febslet.2014.01.033; Sowa G, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00120; Thourani VH, 2000, AM J PHYSIOL-HEART C, V278, pH2084, DOI 10.1152/ajpheart.2000.278.6.H2084; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Vlodavsky I, 2013, MATRIX BIOL, V32, P241, DOI 10.1016/j.matbio.2013.03.002; Voyvodic PL, 2014, J BIOL CHEM, V289, P9547, DOI 10.1074/jbc.M113.541573; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yang D, 2010, CARDIOVASC RES, V85, P520, DOI 10.1093/cvr/cvp323; Zakkar M, 2008, CIRC RES, V103, P726, DOI 10.1161/CIRCRESAHA.108.183913; Zeng Z, 2014, INT J MOL SCI, V15, P10185, DOI 10.3390/ijms150610185	57	14	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5342	5354		10.1074/jbc.M115.681288	http://dx.doi.org/10.1074/jbc.M115.681288			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26769965	Green Published, hybrid			2022-12-28	WOS:000371640600043
J	Shafirovich, V; Kropachev, K; Anderson, T; Liu, Z; Kolbanovskiy, M; Martin, BD; Sugden, K; Shim, Y; Chen, XJ; Min, JH; Geacintov, NE				Shafirovich, Vladimir; Kropachev, Konstantin; Anderson, Thomas; Liu, Zhi; Kolbanovskiy, Marina; Martin, Brooke D.; Sugden, Kent; Shim, Yoonjung; Chen, Xuejing; Min, Jung-Hyun; Geacintov, Nicholas E.			Base and Nucleotide Excision Repair of Oxidatively Generated Guanine Lesions in DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						base excision repair (BER); DNA damage; DNA repair; nucleotide excision repair; oxidative stress	ONE-ELECTRON OXIDATION; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; HYDANTOIN PRODUCTS; DAMAGED DNA; DIOL EPOXIDE; DUPLEX DNA; IN-VITRO; 5-GUANIDINO-4-NITROIMIDAZOLE LESION; GLYCOSYLASE ACTIVITY	The well known biomarker of oxidative stress, 8-oxo-7,8-dihydroguanine, is more susceptible to further oxidation than the parent guanine base and can be oxidatively transformed to the genotoxic spiroiminodihydantoin (Sp) and 5-guanidinohydantoin (Gh) lesions. Incubation of 135-mer duplexes with single Sp or Gh lesions in human cell extracts yields a characteristic nucleotide excision repair (NER)-induced ladder of short dual incision oligonucleotide fragments in addition to base excision repair (BER) incision products. The ladders were not observed when NER was inhibited either by mouse monoclonal antibody (5F12) to human XPA or in XPC-/- fibroblast cell extracts. However, normal NER activity appeared when the XPC-/- cell extracts were complemented with XPC-RAD23B proteins. The Sp and Gh lesions are excellent substrates of both BER and NER. In contrast, 5-guanidino-4-nitroimidazole, a product of the oxidation of guanine in DNA by peroxynitrite, is an excellent substrate of BER only. In the case of mouse embryonic fibroblasts, BER of the Sp lesion is strongly reduced in NEIL1(-/-) relative to NEIL1(+/+) extracts. In summary, in human cell extracts, BER and NER activities co-exist and excise Gh and Sp DNA lesions, suggesting that the relative NER/BER product ratios may depend on competitive BER and NER protein binding to these lesions.	[Shafirovich, Vladimir; Kropachev, Konstantin; Anderson, Thomas; Liu, Zhi; Kolbanovskiy, Marina; Geacintov, Nicholas E.] New York Univ, Dept Chem, 31 Washington Pl, New York, NY 10003 USA; [Martin, Brooke D.; Sugden, Kent] Univ Montana, Dept Chem, Missoula, MT 59812 USA; [Shim, Yoonjung; Chen, Xuejing; Min, Jung-Hyun] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	New York University; University of Montana System; University of Montana; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shafirovich, V; Geacintov, NE (corresponding author), New York Univ, Dept Chem, 31 Washington Pl, New York, NY 10003 USA.	vs5@nyu.edu; ng1@nyu.edu		Anderson, Thomas/0000-0002-5682-8929; Min, Jung-Hyun/0000-0002-4221-9321; Shafirovich, Vladimir/0000-0001-8225-6509	National Science Foundation [CHE-0958457]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014872, R01ES011589] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1412692] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Acquisition of the MALDI-TOF mass spectrometer was supported by the National Science Foundation (CHE-0958457).	Aamann MD, 2014, MECH AGEING DEV, V135, P1, DOI 10.1016/j.mad.2013.12.008; Aller P, 2010, BIOCHEMISTRY-US, V49, P2502, DOI 10.1021/bi902195p; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; Burrows CJ, 2002, ENVIRON HEALTH PERSP, V110, P713, DOI 10.1289/ehp.02110s5713; Cadet J, 2008, ACCOUNTS CHEM RES, V41, P1075, DOI 10.1021/ar700245e; Cadet J, 2010, FREE RADICAL BIO MED, V49, P9, DOI 10.1016/j.freeradbiomed.2010.03.025; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cui L, 2013, CHEM RES TOXICOL, V26, P195, DOI 10.1021/tx300294d; Dimitri A, 2008, DNA REPAIR, V7, P1276, DOI 10.1016/j.dnarep.2008.04.007; Dobson CJ, 2006, NUCLEIC ACIDS RES, V34, P2230, DOI 10.1093/nar/gkl275; Duarte V, 1999, NUCLEIC ACIDS RES, V27, P496, DOI 10.1093/nar/27.2.496; Eckenroth BE, 2014, BIOCHEMISTRY-US, V53, P2075, DOI 10.1021/bi500270e; Fleming AM, 2013, J AM CHEM SOC, V135, P18191, DOI 10.1021/ja409254z; Fleming AM, 2012, J AM CHEM SOC, V134, P15091, DOI 10.1021/ja306077b; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Goldstein S, 2005, CHEM REV, V105, P2457, DOI 10.1021/cr0307087; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gu F, 2002, BIOCHEMISTRY-US, V41, P7508, DOI 10.1021/bi020148q; Hailer MK, 2005, CHEM RES TOXICOL, V18, P1378, DOI 10.1021/tx0501379; Hailer MK, 2005, DNA REPAIR, V4, P41, DOI 10.1016/j.dnarep.2004.07.006; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hazra TK, 2001, NUCLEIC ACIDS RES, V29, P1967, DOI 10.1093/nar/29.9.1967; Henderson PT, 2003, BIOCHEMISTRY-US, V42, P9257, DOI 10.1021/bi0347252; Hess MT, 1997, MOL CELL BIOL, V17, P7069, DOI 10.1128/MCB.17.12.7069; HUANG JC, 1994, J BIOL CHEM, V269, P19034; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P12213, DOI 10.1073/pnas.91.25.12213; Jia L, 2005, BIOCHEMISTRY-US, V44, P13342, DOI 10.1021/bi050790v; Jia L, 2006, BIOCHEMISTRY-US, V45, P6644, DOI 10.1021/bi0601757; Jin Q, 2013, BIOCHEMISTRY-US, V52, P7870, DOI 10.1021/bi4009825; Joffe A, 2003, CHEM RES TOXICOL, V16, P966, DOI 10.1021/tx025578w; Khutsishvili I, 2013, BIOCHEMISTRY-US, V52, P1354, DOI 10.1021/bi301566v; Kidane D, 2014, CRIT REV BIOCHEM MOL, V49, P116, DOI 10.3109/10409238.2013.875514; Kornyushyna O, 2002, BIOCHEMISTRY-US, V41, P15304, DOI 10.1021/bi0264925; Krishnamurthy N, 2008, BIOCHEMISTRY-US, V47, P7137, DOI 10.1021/bi800160s; Krokeide SZ, 2013, DNA REPAIR, V12, P1159, DOI 10.1016/j.dnarep.2013.04.026; Kropachev K, 2009, J MOL BIOL, V386, P1193, DOI 10.1016/j.jmb.2008.12.082; Kuraoka I, 2000, P NATL ACAD SCI USA, V97, P3832, DOI 10.1073/pnas.070471597; Lee YC, 2014, DNA REPAIR, V19, P55, DOI 10.1016/j.dnarep.2014.03.026; Leipold MD, 2003, BIOCHEMISTRY-US, V42, P11373, DOI 10.1021/bi034951b; Leipold MD, 2000, BIOCHEMISTRY-US, V39, P14984, DOI 10.1021/bi0017982; Liu MM, 2013, MUTAT RES-FUND MOL M, V743, P4, DOI 10.1016/j.mrfmmm.2012.12.003; Liu MM, 2013, STRUCTURE, V21, P247, DOI 10.1016/j.str.2012.12.008; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Lonkar P, 2011, INT J CANCER, V128, P1999, DOI 10.1002/ijc.25815; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; Luo WC, 2001, CHEM RES TOXICOL, V14, P927, DOI 10.1021/tx010072j; Luo WC, 2000, ORG LETT, V2, P613, DOI 10.1021/ol9913643; Maher RL, 2013, DNA REPAIR, V12, P964, DOI 10.1016/j.dnarep.2013.08.010; Maiti AK, 2008, DNA REPAIR, V7, P1213, DOI 10.1016/j.dnarep.2008.03.025; Mangerich A, 2012, P NATL ACAD SCI USA, V109, pE1820, DOI 10.1073/pnas.1207829109; MAO B, 1995, CARCINOGENESIS, V16, P357, DOI 10.1093/carcin/16.2.357; MAO B, 1993, BIOCHEMISTRY-US, V32, P11785, DOI 10.1021/bi00095a006; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; McKibbin PL, 2013, J AM CHEM SOC, V135, P13851, DOI 10.1021/ja4059469; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; MIURA N, 1991, J BIOL CHEM, V266, P19786; Mocquet V, 2007, EMBO J, V26, P2923, DOI 10.1038/sj.emboj.7601730; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Muftuoglu M, 2009, J BIOL CHEM, V284, P9270, DOI 10.1074/jbc.M807006200; Naegeli H, 2011, DNA REPAIR, V10, P673, DOI 10.1016/j.dnarep.2011.04.019; Neeley WL, 2004, ORG LETT, V6, P245, DOI 10.1021/ol036188j; Niles JC, 2001, J AM CHEM SOC, V123, P12147, DOI 10.1021/ja004296k; Niles JC, 2001, ORG LETT, V3, P963, DOI 10.1021/ol006993n; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; RAVANAT JL, 1995, CHEM RES TOXICOL, V8, P379, DOI 10.1021/tx00045a009; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Rolseth V, 2013, BBA-MOL CELL RES, V1833, P1157, DOI 10.1016/j.bbamcr.2012.12.024; Rosenquist TA, 2003, DNA REPAIR, V2, P581, DOI 10.1016/S1568-7864(03)00025-9; Saijo M, 2004, BIOCHEM BIOPH RES CO, V321, P815, DOI 10.1016/j.bbrc.2004.07.030; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Sejersted Y, 2011, P NATL ACAD SCI USA, V108, P18802, DOI 10.1073/pnas.1106880108; Shen JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04894; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Steenken S, 2000, J AM CHEM SOC, V122, P2373, DOI 10.1021/ja993508e; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Sugden KD, 2001, CHEM RES TOXICOL, V14, P1315, DOI 10.1021/tx010088+; Talhaoui I, 2015, J BIOL CHEM, V290, P14610, DOI 10.1074/jbc.M115.647487; Wallace SS, 2012, CANCER LETT, V327, P73, DOI 10.1016/j.canlet.2011.12.038; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6; Ye Y, 2003, J AM CHEM SOC, V125, P13926, DOI 10.1021/ja0378660; Yennie CJ, 2012, CHEM RES TOXICOL, V25, P1732, DOI 10.1021/tx300190a; Yun BH, 2011, CHEM RES TOXICOL, V24, P1144, DOI 10.1021/tx200139c; Zhao XB, 2010, BIOCHEMISTRY-US, V49, P1658, DOI 10.1021/bi901852q	88	43	43	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5309	5319		10.1074/jbc.M115.693218	http://dx.doi.org/10.1074/jbc.M115.693218			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26733197	Green Published, hybrid			2022-12-28	WOS:000371640600040
J	Dotson, D; Woodruff, EA; Villalta, F; Dong, XH				Dotson, Dominique; Woodruff, Elvin A.; Villalta, Fernando; Dong, Xinhong			Filamin A Is Involved in HIV-1 Vpu-mediated Evasion of Host Restriction by Modulating Tetherin Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; filamin; lipid raft; protein turnover; trafficking; HIV-1 Vpu; tetherin	INTRACELLULAR TRAFFICKING; DOWN-REGULATION; CELL-SURFACE; PROTEIN; RELEASE; BST-2/TETHERIN; BINDING; INTERACTS; BST-2; CD317/TETHERIN	Tetherin, also known as bone marrow stromal antigen 2 (BST-2), inhibits the release of a wide range of enveloped viruses, including human immunodeficiency virus, type 1 (HIV-1) by directly tethering nascent virions to the surface of infected cells. The HIV-1 accessary protein Vpu counteracts tetherin restriction via sequestration, down-regulation, and/or displacement mechanisms to remove tetherin from sites of virus budding. However, the exact mechanism of Vpu-mediated antagonism of tetherin restriction remains to be fully understood. Here we report a novel role for the actin cross-linking regulator filamin A (FLNa) in Vpu anti-tetherin activities. We demonstrate that FLNa associates with tetherin and that FLNa modulates tetherin turnover. FLNa deficiency was found to enhance cell surface and steady-state levels of tetherin expression. In contrast, we observed that overexpression of FLNa reduced tetherin expression levels both on the plasma membrane and in intracellular compartments. Although FLNb shows high amino acid sequence similarity with FLNa, we reveal that only FLNa, but not FLNb, plays an essential role in tetherin turnover. We further showed that FLNa deficiency inhibited Vpu-mediated enhancement of virus release through interfering with the activity of Vpu to down-regulate cellular tetherin. Taken together, our studies suggest that Vpu hijacks the FLNa function in the modulation of tetherin to neutralize the antiviral factor tetherin. These findings may provide novel strategies for the treatment of HIV-1 infection.	[Dotson, Dominique; Woodruff, Elvin A.; Villalta, Fernando; Dong, Xinhong] Meharry Med Coll, Sch Med, Dept Microbiol & Immunol, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA; [Dotson, Dominique; Woodruff, Elvin A.; Villalta, Fernando; Dong, Xinhong] Meharry Med Coll, Sch Med, Ctr AIDS Hlth Dispar Res, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA	Meharry Medical College; Meharry Medical College	Dong, XH (corresponding author), Meharry Med Coll, Sch Med, Dept Microbiol & Immunol, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA.; Dong, XH (corresponding author), Meharry Med Coll, Sch Med, Ctr AIDS Hlth Dispar Res, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA.	xdong@mmc.edu		Villalta, Fernando/0000-0002-6232-0574	National Institutes of Health [AI089330, MD007586, MD007593, AI080580, HL007737, GM059994]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI080580, P30AI110527, R21AI089330, T32AI007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007593, G12MD007586, U54MD007586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grants AI089330, MD007586, and MD007593 (to X. D.), AI080580 (to F. V.), and HL007737 and GM059994 (to D. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Agromayor M, 2012, STRUCTURE, V20, P414, DOI 10.1016/j.str.2011.12.013; Andrew A, 2011, J INTERF CYTOK RES, V31, P137, DOI 10.1089/jir.2010.0108; Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Arias JF, 2012, CURR HIV RES, V10, P283, DOI 10.2174/157016212800792423; Billcliff PG, 2013, BIOL OPEN, V2, P1253, DOI 10.1242/bio.20135793; Billcliff PG, 2013, J CELL SCI, V126, P1553, DOI 10.1242/jcs.112953; Caillet M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002347; Cho EY, 2007, MOL ENDOCRINOL, V21, P2242, DOI 10.1210/me.2007-0202; Cooper J, 2011, J BIOL CHEM, V286, P28498, DOI 10.1074/jbc.M111.239053; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2011, TRAFFIC, V12, P1714, DOI 10.1111/j.1600-0854.2011.01277.x; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Feng SJ, 2005, J BIOL CHEM, V280, P6709, DOI 10.1074/jbc.M413590200; Fiori JL, 2009, ENDOCRINOLOGY, V150, P2551, DOI 10.1210/en.2008-1344; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Janvier K, 2012, CURR HIV RES, V10, P315, DOI 10.2174/157016212800792414; Janvier K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001265; Jia XF, 2014, ELIFE, V3, DOI 10.7554/eLife.02362; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kesner BA, 2010, MOL BIOL EVOL, V27, P283, DOI 10.1093/molbev/msp236; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lehmann M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002456; Lewinski MK, 2015, J BIOL CHEM, V290, P10919, DOI 10.1074/jbc.M114.630095; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; McNatt MW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003299; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Muriel O, 2011, J CELL SCI, V124, P2763, DOI 10.1242/jcs.080804; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Noam Y, 2014, J BIOL CHEM, V289, P5889, DOI 10.1074/jbc.M113.522060; Ono A, 2010, BIOL CELL, V102, P335, DOI 10.1042/BC20090165; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rafizadeh S, 2014, P NATL ACAD SCI USA, V111, P9989, DOI 10.1073/pnas.1323541111; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Roy N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00177; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sauter D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00163; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Skasko M, 2012, J BIOL CHEM, V287, P58, DOI 10.1074/jbc.M111.296772; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Stefani F, 2011, CURR BIOL, V21, P1245, DOI 10.1016/j.cub.2011.06.028; Strebel K, 2014, BBA-BIOMEMBRANES, V1838, P1074, DOI 10.1016/j.bbamem.2013.06.029; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Takafuta T, 1998, J BIOL CHEM, V273, P17531, DOI 10.1074/jbc.273.28.17531; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Venkatesh S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003483; Vigan R, 2010, J VIROL, V84, P12958, DOI 10.1128/JVI.01699-10; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Yang HT, 2010, P NATL ACAD SCI USA, V107, P18428, DOI 10.1073/pnas.1011485107; Yang SJ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-78	76	6	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4236	4246		10.1074/jbc.M115.708123	http://dx.doi.org/10.1074/jbc.M115.708123			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26742839	hybrid, Green Published			2022-12-28	WOS:000371338400046
J	Park, AC; Huang, G; Jankowska-Gan, E; Massoudi, D; Kernien, JF; Vignali, DA; Sullivan, JA; Wilkes, DS; Burlingham, WJ; Greenspan, DS				Park, Arick C.; Huang, Guorui; Jankowska-Gan, Ewa; Massoudi, Dawiyat; Kernien, John F.; Vignali, Dario A.; Sullivan, Jeremy A.; Wilkes, David S.; Burlingham, William J.; Greenspan, Daniel S.			Mucosal Administration of Collagen V Ameliorates the Atherosclerotic Plaque Burden by Inducing Interleukin 35-dependent Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; autoimmune disease; autoimmunity; immunotherapy; vascular smooth muscle cells; collagen type V; IL-35	REGULATORY T-CELLS; RECEPTOR-DEFICIENT MICE; REDUCES ATHEROSCLEROSIS; ACCELERATES ATHEROSCLEROSIS; DECREASES ATHEROSCLEROSIS; ORAL TOLERANCE; AUTOIMMUNITY; SUPPRESSION; IL-35; INFLAMMATION	We have shown previously that collagen V (col(V)) autoimmunity is a consistent feature of atherosclerosis in human coronary artery disease and in the Apoe(-/-) mouse model. We have also shown sensitization of Apoe(-/-) mice with col(V) to markedly increase the atherosclerotic burden, providing evidence of a causative role for col(V) autoimmunity in atherosclerotic pathogenesis. Here we sought to determine whether induction of immune tolerance to col(V) might ameliorate atherosclerosis, providing further evidence for a causal role for col(V) autoimmunity in atherogenesis and providing insights into the potential for immunomodulatory therapeutic interventions. Mucosal inoculation successfully induced immune tolerance to col(V) with an accompanying reduction in plaque burden in Ldlr(-/-) mice on a high-cholesterol diet. The results therefore demonstrate that inoculation with col(V) can successfully ameliorate the atherosclerotic burden, suggesting novel approaches for therapeutic interventions. Surprisingly, tolerance and reduced atherosclerotic burden were both dependent on the recently described IL-35 and not on IL-10, the immunosuppressive cytokine usually studied in the context of induced tolerance and amelioration of atherosclerotic symptoms. In addition to the above, using recombinant protein fragments, we were able to localize two epitopes of the 1(V) chain involved in col(V) autoimmunity in atherosclerotic Ldlr(-/-) mice, suggesting future courses of experimentation for the characterization of such epitopes.	[Park, Arick C.; Huang, Guorui; Massoudi, Dawiyat; Kernien, John F.; Greenspan, Daniel S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, 4503 WIMRII,L4 1111 Highland Ave, Madison, WI 53705 USA; [Jankowska-Gan, Ewa; Sullivan, Jeremy A.; Burlingham, William J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, 4503 WIMRII,L4 1111 Highland Ave, Madison, WI 53705 USA; [Vignali, Dario A.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15261 USA; [Vignali, Dario A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Wilkes, David S.] Indiana Univ Sch Med, Dept Med, Ctr Immunobiol, Indianapolis, IN 46202 USA; [Wilkes, David S.; Greenspan, Daniel S.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St Jude Children's Research Hospital; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Greenspan, DS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, 4503 WIMRII,L4 1111 Highland Ave, Madison, WI 53705 USA.	dsgreens@wisc.edu		Park, Arick/0000-0001-5668-0701; Greenspan, Daniel/0000-0001-8096-7446	American Heart Association [14PRE20390026]; National Institutes of Health [R01 AI091977, PO1AI084853, R01AR047746]; NATIONAL CANCER INSTITUTE [R01CA203689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI084853, R01AI091977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Fellowship 14PRE20390026 (to A. C. P.) and by National Institutes of Health Grants R01 AI091977 (to D. A. V.), PO1AI084853 (to D. S. W., D. S. G., and W. J. B.), and R01AR047746 (to D. S. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Benagiano M, 2005, J IMMUNOL, V174, P6509, DOI 10.4049/jimmunol.174.10.6509; Blasi C, 2008, ATHEROSCLEROSIS, V201, P17, DOI 10.1016/j.atherosclerosis.2008.05.025; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Businaro R, 2009, ATHEROSCLEROSIS, V207, P74, DOI 10.1016/j.atherosclerosis.2009.04.026; Chanut-Delalande H, 2001, J BIOL CHEM, V276, P24352, DOI 10.1074/jbc.M101182200; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Dart ML, 2010, CIRC RES, V107, P1106, DOI 10.1161/CIRCRESAHA.110.221069; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; FICHARD A, 1995, MATRIX BIOL, V14, P515, DOI 10.1016/S0945-053X(05)80001-0; Franco C, 2008, CIRC RES, V102, P1202, DOI 10.1161/CIRCRESAHA.107.170662; George J, 2004, CARDIOVASC RES, V62, P603, DOI 10.1016/j.cardiores.2004.01.028; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; HARALSON MA, 1980, P NATL ACAD SCI-BIOL, V77, P5206, DOI 10.1073/pnas.77.9.5206; Hermansson A, 2010, J EXP MED, V207, P1081, DOI 10.1084/jem.20092243; Huang Y, 2013, PHARMAZIE, V68, P793, DOI 10.1691/ph.2013.2928; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; Inoue S, 2002, CIRCULATION, V106, P2700, DOI 10.1161/01.CIR.0000038140.80105.AD; KATSUDA S, 1992, ARTERIOSCLER THROMB, V12, P494, DOI 10.1161/01.ATV.12.4.494; Keller MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079601; Kempe S, 2009, AM J PATHOL, V175, P440, DOI 10.2353/ajpath.2009.080752; Ketelhuth DFJ, 2015, CIRC J, V79, P924, DOI 10.1253/circj.CJ-15-0167; Ketelhuth DFJ, 2013, CURR PHARM DESIGN, V19, P5850; Klingenberg R, 2012, IMMUNOBIOLOGY, V217, P540, DOI 10.1016/j.imbio.2011.06.006; Klingenberg R, 2010, ARTERIOSCL THROM VAS, V30, P946, DOI 10.1161/ATVBAHA.109.202671; Koltsova EK, 2012, CIRC RES, V111, P1274, DOI 10.1161/CIRCRESAHA.112.277525; Lin YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052490; Maron R, 2002, CIRCULATION, V106, P1708, DOI 10.1161/01.CIR.0000029750.99462.30; Molitor-Dart ML, 2007, J IMMUNOL, V179, P6749, DOI 10.4049/jimmunol.179.10.6749; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Olson BM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00315; OOSHIMA A, 1981, SCIENCE, V213, P666, DOI 10.1126/science.7256267; Rose N, 2003, NAT MED, V9, P641, DOI 10.1038/nm0603-641; Sawant DV, 2015, J INTERF CYTOK RES, V35, P499, DOI 10.1089/jir.2015.0015; SMITH EB, 1965, J ATHEROSCLER RES, V5, P241, DOI 10.1016/S0368-1319(65)80065-5; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; van Puijvelde GHM, 2006, CIRCULATION, V114, P1968, DOI 10.1161/CIRCULATIONAHA.106.615609; Wigren M, 2011, J INTERN MED, V269, P546, DOI 10.1111/j.1365-2796.2010.02311.x; Zhou XH, 2006, ARTERIOSCL THROM VAS, V26, P864, DOI 10.1161/01.ATV.0000206122.61591.ff	42	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3359	3370		10.1074/jbc.M115.681882	http://dx.doi.org/10.1074/jbc.M115.681882			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26721885	hybrid, Green Published			2022-12-28	WOS:000370854500020
J	Leroy, C; Belkina, NV; Long, T; Deruy, E; Dissous, C; Shaw, S; Tulasne, D				Leroy, Catherine; Belkina, Natalya V.; Long, Thavy; Deruy, Emeric; Dissous, Colette; Shaw, Stephen; Tulasne, David			Caspase Cleavages of the Lymphocyte-oriented Kinase Prevent Ezrin, Radixin, and Moesin Phosphorylation during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STE20-RELATED KINASE; PROTEIN-KINASE; ROCK-I; ACTIVATION; FAMILY; STK10; CELLS; LOK; SLK; POLARIZATION	The lymphocyte-oriented kinase (LOK), also called serine threonine kinase 10 (SiK10), is synthesized mainly in lymphocytes. It is involved in lymphocyte migration and polarization and can phosphorylate ezrin, radixin, and moesin (the ERM proteins). In a T lymphocyte cell line and in purified human lymphocytes, we found LOK to be cleaved by caspases during apoptosis. The first cleavage occurs at aspartic residue 332, located between the kinase domain and the coiled-coil regulation domain. This cleavage generates an N-terminal fragment, p50 N-LOK, containing the kinase domain and a C-terminal fragment, which is further cleaved during apoptosis. Although these cleavages preserve the entire kinase domain, p50 N-LOK displays no kinase activity. In apoptotic lymphocytes, caspase cleavages of LOK are concomitant with a decrease in ERN phosphorylation. When non-apoptotic lymphocytes from mice with homozygous and heterozygous LOK knockout were compared, the latter showed a higher level of ERM phosphorylation, but when apoptosis was induced, LOK-/- and LOK+/- lymphocytes showed the same low level, confirming in vivo that LOK-induced ERM phosphorylation is prevented during lymphocyte apoptosis. Our results demonstrate that cleavage of LOK during apoptosis abolishes its kinase activity, causing a decrease in ERM phosphorylation, crucial to the role of the ERM proteins in linking the plasma membrane to actin filaments.	[Leroy, Catherine; Tulasne, David] Univ Lille, CNRS, Inst Pasteur Lille, UMR 8161,Mech Tumorigenesis & Target Therapies, 1 Rue Pr Calmette, F-59000 Lille, France; [Belkina, Natalya V.] NCI, Thorac & Gastrointestinal Oncol, NIH, Bethesda, MD 20892 USA; [Shaw, Stephen] NCI, Expt Immunol Branch Branches, NIH, Bethesda, MD 20892 USA; [Long, Thavy; Deruy, Emeric; Dissous, Colette] Univ Lille, Ctr Hosp Reg Univ Lille,Inst Pasteur Lille, CNRS,INSERM,U1019,UMR 8204, Ctr Infect & Immun Lille, F-59000 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille	Tulasne, D (corresponding author), Univ Lille, CNRS, Inst Pasteur Lille, UMR 8161,Mech Tumorigenesis & Target Therapies, 1 Rue Pr Calmette, F-59000 Lille, France.		Tulasne, David/A-8705-2008; Tulasne, David/AAR-5287-2020	Tulasne, David/0000-0002-6764-7242; Dissous, Colette/0000-0002-5003-8205	CNRS; Institut Pasteur de Lille; INSERM; Ligue contre le Cancer, Comite Nord; Association pour la Recherche sur le Cancer; Institut National du Cancer; Canceropole Nord-Ouest; Site de Recherche Integree sur le Cancer SIRIC ONCOLiIIe	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur de Lille; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue contre le Cancer, Comite Nord(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France); Canceropole Nord-Ouest; Site de Recherche Integree sur le Cancer SIRIC ONCOLiIIe	This work was supported by the CNRS, the Institut Pasteur de Lille, and INSERM, and by grants from the Ligue contre le Cancer, Comite Nord, the Association pour la Recherche sur le Cancer, the Institut National du Cancer, the Canceropole Nord-Ouest, and the Site de Recherche Integree sur le Cancer SIRIC ONCOLiIIe. The authors declare that they have no conflicts of interest with the contents of this article.	Arora S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-218; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Bignell G, 2006, GENE CHROMOSOME CANC, V45, P42, DOI 10.1002/gcc.20265; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Bulut G, 2012, ONCOGENE, V31, P269, DOI 10.1038/onc.2011.245; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Chauvier D, 2007, CELL DEATH DIFFER, V14, P387, DOI 10.1038/sj.cdd.4402044; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Endo J, 2000, FEBS LETT, V468, P234, DOI 10.1016/S0014-5793(00)01219-9; Fukumura K, 2013, ONCOL REP, V30, P1542, DOI 10.3892/or.2013.2605; Kuramochi S, 1999, IMMUNOGENETICS, V49, P369, DOI 10.1007/s002510050509; Kuramochi S, 1997, J BIOL CHEM, V272, P22679, DOI 10.1074/jbc.272.36.22679; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lefebvre J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.377; Machicoane M, 2014, J CELL BIOL, V205, P791, DOI 10.1083/jcb.201401049; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Parameswaran N, 2013, IMMUNOL REV, V256, P63, DOI 10.1111/imr.12104; Paumelle R, 2002, ONCOGENE, V21, P2309, DOI 10.1038/sj.onc.1205297; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Pore D, 2015, LEUKEMIA, V29, P1857, DOI 10.1038/leu.2015.86; Sabourin LA, 2000, MOL CELL BIOL, V20, P684, DOI 10.1128/MCB.20.2.684-696.2000; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Viswanatha R, 2012, J CELL BIOL, V199, P969, DOI 10.1083/jcb.201207047; Walter SA, 2003, J BIOL CHEM, V278, P18221, DOI 10.1074/jbc.M212556200; Wen WH, 2010, J BIOL CHEM, V285, P39108, DOI 10.1074/jbc.M110.151753	28	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10148	10161		10.1074/jbc.M116.721365	http://dx.doi.org/10.1074/jbc.M116.721365			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26945071	hybrid, Green Published			2022-12-28	WOS:000375602800025
J	de la Ballina, LR; Cano-Crespo, S; Gonzalez-Munoz, E; Bial, S; Estrach, S; Cailleteau, L; Tissot, F; Daniel, H; Zorzano, A; Ginsberg, MH; Palacin, M; Feral, CC				de la Ballina, Laura R.; Cano-Crespo, Sara; Gonzalez-Munoz, Elena; Bial, Susanna; Estrach, Soline; Cailleteau, Laurence; Tissot, Floriane; Daniel, Hannelore; Zorzano, Antonio; Ginsberg, Mark H.; Palacin, Manuel; Feral, Chloe C.			Amino Acid Transport Associated to Cluster of Differentiation 98 Heavy Chain (CD98hc) Is at the Cross-road of Oxidative Stress and Amino Acid Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; SYSTEM X(C)(-); CELL GROWTH; CANCER; ACTIVATION; MTORC1; FAMILY; METABOLISM; EXPRESSION; DEATH	CD98hc functions as an amino acid (AA) transporter (together with another subunit) and integrin signaling enhancer. It is overexpressed in highly proliferative cells in both physiological and pathological conditions. CD98hc deletion induces strong impairment of cell proliferation in vivo and in vitro. Here, we investigate CD98hc-associated AA transport in cell survival and proliferation. By using chimeric versions of CD98hc, the two functions of the protein can be uncoupled. Although recovering the CD98hc AA transport capacity restores the in vivo and in vitro proliferation of CD98hc-null cells, reconstitution of the integrin signaling function of CD98hc is unable to restore in vitro proliferation of those cells. CD98hc-associated transporters (i.e. xCT, LAT1, and y(+)LAT2 in wild-type cells) are crucial to control reactive oxygen species and intracellular AA levels, thus sustaining cell survival and proliferation. Moreover, in CD98hc-null cells the deficiency of CD98hc/xCT cannot be compensated, leading to cell death by ferroptosis. Supplementation of culture media with beta-mercaptoethanol rescues CD98hc-deficient cell survival. Under such conditions null cells show oxidative stress and intracellular AA imbalance and, consequently, limited proliferation. CD98hcnull cells also present reduced intracellular levels of branchedchain and aromatic amino acids (BCAAs and ARO AAs, respectively) and induced expression of peptide transporter 1 (PEPT1). Interestingly, external supply of dipeptides containing BCAAs and ARO AAs rescues cell proliferation and compensates for impaired uptake of CD98hc/LAT1 and CD98hc/y(+) LAT2. Our data establish CD98hc as a master protective gene at the cross-road of redox control and AA availability, making it a relevant therapeutic target in cancer.	[de la Ballina, Laura R.; Cano-Crespo, Sara; Gonzalez-Munoz, Elena; Bial, Susanna; Zorzano, Antonio; Palacin, Manuel] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; [de la Ballina, Laura R.; Cano-Crespo, Sara; Gonzalez-Munoz, Elena; Bial, Susanna; Zorzano, Antonio; Palacin, Manuel] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [de la Ballina, Laura R.; Estrach, Soline; Cailleteau, Laurence; Tissot, Floriane; Feral, Chloe C.] Univ Nice Sophia Antipolis, CNRS UMR 7284, Inst Res Canc & Aging,Nice IRCAN, INSERM,U1081, F-06107 Nice, France; [Cano-Crespo, Sara; Bial, Susanna; Palacin, Manuel] Spanish Biomed Res Network Rare Dis CIBERER U 731, Barcelona 08028, Spain; [Gonzalez-Munoz, Elena] Fdn Progreso & Salud, Andalusian Cellular Reprogramming Lab LARCEL, Seville 41092, Spain; [Daniel, Hannelore] Tech Univ Munich, Mol Nutr & Biochem Unit, ZIEL Res Ctr Nutr & Food Sci, Gregor Mendel Str 2, D-85350 Freising Weihenstephan, Germany; [Zorzano, Antonio] Spanish Biomed Res Network Diabet & Associated Me, Barcelona 08028, Spain; [Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Technical University of Munich; University of California System; University of California San Diego	de la Ballina, LR; Palacin, M (corresponding author), Inst Res Biomed IRB Barcelona, Parc Cient Barcelona,Baldiri Reixac 10, E-08028 Barcelona, Spain.; Feral, CC (corresponding author), Univ Nice Sophia Antipolis, INSERM, U1081, IRCAN, 28 Ave Valombrose, F-06107 Nice, France.	larual_rb@yahoo.es; manuel.palacin@irbbarcelona.org; chloe.feral@inserm.fr	Estrach, Soline/GYA-4499-2022; FERAL, Chloe/AAB-6111-2020; Feral, Chloe C/O-5781-2016; Zorzano, Antonio/R-5479-2018; gonzalez-munoz, elena/K-6610-2014; Gonzalez-Munoz, Elena/AAY-4658-2020; Palacín, Manuel/G-9786-2015; Estrach, Soline/D-4226-2017	FERAL, Chloe/0000-0001-9756-2082; Feral, Chloe C/0000-0001-9756-2082; gonzalez-munoz, elena/0000-0001-8291-1518; Gonzalez-Munoz, Elena/0000-0001-8291-1518; Rodriguez de la Ballina, Laura/0000-0001-5363-7433; cano, sara/0000-0003-2224-3276; Palacin, Manuel/0000-0002-8670-293X; estrach, soline/0000-0003-2088-5988	le Conseil General 06; FEDER; le Ministere de l'Enseignement Superieur; la Region Provence Alpes-Cote d'Azur; INSERM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117807, P01HL078784] Funding Source: NIH RePORTER	le Conseil General 06(Region Provence-Alpes-Cote d'Azur); FEDER(European Commission); le Ministere de l'Enseignement Superieur; la Region Provence Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'Azur); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We greatly acknowledge the IRCAN core facilities (supported by le Conseil General 06, FEDER, le Ministere de l'Enseignement Superieur, la Region Provence Alpes-Cote d'Azur and INSERM) and the Synthesis of Peptides Unit (U3) of the CIBER in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) at the Barcelona Science Park. We thank Dr. Juan Pablo Munoz and Dr. Sonia R. Veiga for technical advice, constructive comments, and enlightening discussions.	Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Balza E, 2013, CARCINOGENESIS, V34, P620, DOI 10.1093/carcin/bgs360; Bodoy S, 2013, MOL ASPECTS MED, V34, P638, DOI 10.1016/j.mam.2012.12.006; Bror S, 2014, PFLUG ARCH EUR J PHY, V466, P155, DOI 10.1007/s00424-013-1393-y; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Cantor JM, 2012, J CELL SCI, V125, P1373, DOI 10.1242/jcs.096040; Cargnello M, 2015, MUTAGENESIS, V30, P169, DOI 10.1093/mutage/geu045; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DEVES R, 1993, J PHYSIOL-LONDON, V468, P753, DOI 10.1113/jphysiol.1993.sp019799; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Dinkova-Kostova AT, 2015, BIOCHEM SOC T, V43, P602, DOI 10.1042/BST20150003; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017; Estrach S, 2014, CANCER RES, V74, P6878, DOI 10.1158/0008-5472.CAN-14-0579; Evstafieva AG, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.469; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Fenczik CA, 2001, J BIOL CHEM, V276, P8746, DOI 10.1074/jbc.M011239200; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hang TTN, 2011, J CLIN INVEST, V121, P1733, DOI 10.1172/JCI44631; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Ito K, 1997, J BIOL CHEM, V272, P26780, DOI 10.1074/jbc.272.42.26780; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kim CS, 2008, BIOL PHARM BULL, V31, P1096, DOI 10.1248/bpb.31.1096; Kumar R, 2003, J CEREBR BLOOD F MET, V23, P462, DOI 10.1097/01.WCB.0000056064.25434.CA; Lau A, 2013, ANTIOXID REDOX SIGN, V18, P91, DOI 10.1089/ars.2012.4754; McCracken AN, 2013, TRENDS ENDOCRIN MET, V24, P200, DOI 10.1016/j.tem.2013.01.002; Milkereit R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8250; Millard M, 2011, THERANOSTICS, V1, P154, DOI 10.7150/thno/v01p0154; Mitsuoka K, 2010, EUR J PHARM SCI, V40, P202, DOI 10.1016/j.ejps.2010.03.010; Nicholson B, 1998, J BIOL CHEM, V273, P14663, DOI 10.1074/jbc.273.24.14663; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Oda K, 2010, CANCER SCI, V101, P173, DOI 10.1111/j.1349-7006.2009.01386.x; Palacin M, 2004, PFLUG ARCH EUR J PHY, V447, P490, DOI 10.1007/s00424-003-1062-7; Pfeiffer R, 1998, FEBS LETT, V439, P157, DOI 10.1016/S0014-5793(98)01359-3; Poncet N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089547; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Reig N, 2002, EMBO J, V21, P4906, DOI 10.1093/emboj/cdf500; Rosell A, 2014, P NATL ACAD SCI USA, V111, P2966, DOI 10.1073/pnas.1323779111; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sato H, 2000, ANTIOXID REDOX SIGN, V2, P665, DOI 10.1089/ars.2000.2.4-665; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Wuensch T, 2014, INFLAMM BOWEL DIS, V20, P671, DOI 10.1097/01.MIB.0000443336.71488.08; Wuensch T, 2013, AM J PHYSIOL-GASTR L, V305, pG66, DOI 10.1152/ajpgi.00491.2012	55	35	35	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9700	9711		10.1074/jbc.M115.704254	http://dx.doi.org/10.1074/jbc.M115.704254			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26945935	Green Published, hybrid			2022-12-28	WOS:000375602300028
J	Sanchez-Fernandez, G; Cabezudo, S; Caballero, A; Garcia-Hoz, C; Tall, GG; Klett, J; Michnick, SW; Mayor, F; Ribas, C				Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Caballero, Alvaro; Garcia-Hoz, Carlota; Tall, Gregory G.; Klett, Javier; Michnick, Stephen W.; Mayor, Federico, Jr.; Ribas, Catalina			Protein Kinase C zeta Interacts with a Novel Binding Region of G alpha q to Act as a Functional Effector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR KINASE; STRUCTURAL BASIS; ACTIVATION; DOMAIN; PATHWAY; COMPLEX; PKC; REGULATOR	Heterotrimeric G proteins play an essential role in the initiation of G protein-coupled receptor (GPCR) signaling through specific interactions with a variety of cellular effectors. We have recently reported that GPCR activation promotes a direct interaction between G alpha q and protein kinase C zeta (PKC zeta), leading to the stimulation of the ERK5 pathway independent of the canonical effector PLC beta. We report herein that the activation-dependent G alpha q/PKC zeta complex involves the basic PB1-type II domain of PKC zeta and a novel interaction module in G alpha q different from the classical effector-binding site. Point mutations in this G alpha q region completely abrogate ERK5 phosphorylation, indicating that G alpha q/PKC zeta association is required for the activation of the pathway. Indeed, PKC zeta was demonstrated to directly bind ERK5 thus acting as a scaffold between G alpha q and ERK5 upon GPCR activation. The inhibition of these protein complexes by G protein-coupled receptor kinase 2, a known G alpha q modulator, led to a complete abrogation of ERK5 stimulation. Finally, we reveal that G alpha q/PKC zeta complexes link G alpha q to apoptotic cell death pathways. Our data suggest that the interaction between this novel region in G alpha q and the effector PKC zeta is a key event in G alpha q signaling.	[Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Caballero, Alvaro; Garcia-Hoz, Carlota; Klett, Javier; Mayor, Federico, Jr.; Ribas, Catalina] Univ Autonoma Madrid, Dept Mol Biol, CSIC UAM, E-28049 Madrid, Spain; [Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Caballero, Alvaro; Garcia-Hoz, Carlota; Klett, Javier; Mayor, Federico, Jr.; Ribas, Catalina] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC UAM, E-28049 Madrid, Spain; [Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Caballero, Alvaro; Garcia-Hoz, Carlota; Mayor, Federico, Jr.; Ribas, Catalina] Inst Invest Sanitaria La Princesa, Madrid 29006, Spain; [Sanchez-Fernandez, Guzman] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany; [Tall, Gregory G.] Univ Rochester, Med Ctr, Dept Pharmacol, Rochester, NY 14642 USA; [Tall, Gregory G.] Univ Rochester, Med Ctr, Dept Physiol, Rochester, NY 14642 USA; [Michnick, Stephen W.] Univ Montreal, Dept Biochim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Max Planck Society; University of Rochester; University of Rochester; Universite de Montreal	Mayor, F; Ribas, C (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	fmayor@cbm.csic.es; cribas@cbm.csic.es	Cabezudo, Sofia/AAA-6434-2020; Mayor, Federico/N-7644-2016; Klett, Javier/L-4595-2014	Klett, Javier/0000-0001-8495-6568; Garcia-Hoz, Carlota/0000-0001-8268-4159; Cabezudo, Sofia/0000-0001-5675-458X	Ministerio de Educacion y Ciencia [SAF2011-23800, SAF2014-55511-R]; Fundacion Ramon Areces; Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III [RD12/0042/0012]; Comunidad de Madrid [S-2011/BMD-2332]; Instituto de Salud Carlos III [PI11/00126, PI14/00201]; NIGMS, National Institutes of Health [R01-GM088242]; Canadian Institutes of Health Research (CIHR) [MOP-GMX-231013]; EMBO; Fondo Europeo de Desarrollo Regional (FEDER, European Union); Spanish Ministry of Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088242] Funding Source: NIH RePORTER	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Ramon Areces; Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III; Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); EMBO(European Molecular Biology Organization (EMBO)); Fondo Europeo de Desarrollo Regional (FEDER, European Union); Spanish Ministry of Education(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Ministerio de Educacion y Ciencia (SAF2011-23800, SAF2014-55511-R), Fundacion Ramon Areces, The Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III (RD12/0042/0012), Comunidad de Madrid (S-2011/BMD-2332), and Instituto de Salud Carlos III (PI11/00126, PI14/00201) (to F. M. and C. R.). This work was also supported in part by the NIGMS, National Institutes of Health Grant R01-GM088242 (to G. T.), the Canadian Institutes of Health Research (CIHR) (MOP-GMX-231013) (to S. M.), an EMBO Short Fellowship (to G. S. F.), and Fondo Europeo de Desarrollo Regional (FEDER, European Union). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipients of FPU fellowships from the Spanish Ministry of Education.	Adams JW, 2000, CIRC RES, V87, P1180, DOI 10.1161/01.RES.87.12.1180; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Diaz-Meco MT, 2012, IMMUNOL REV, V246, P154, DOI 10.1111/j.1600-065X.2012.01093.x; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Fan GF, 2003, J BIOL CHEM, V278, P52432, DOI 10.1074/jbc.M310982200; Garcia-Hoz C, 2012, J BIOL CHEM, V287, P7792, DOI 10.1074/jbc.M111.282210; Garcia-Hoz C, 2010, J BIOL CHEM, V285, P13480, DOI 10.1074/jbc.M109.098699; Graybill C, 2012, J BIOL CHEM, V287, P21003, DOI 10.1074/jbc.M112.360495; Hirano Y, 2005, J BIOL CHEM, V280, P9653, DOI 10.1074/jbc.M409823200; Hirano Y, 2004, J BIOL CHEM, V279, P31883, DOI 10.1074/jbc.M403092200; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kim JY, 2013, P NATL ACAD SCI USA, V110, P6418, DOI 10.1073/pnas.1221799110; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Medina R, 1996, J BIOL CHEM, V271, P24720, DOI 10.1074/jbc.271.40.24720; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Nazarenko I, 2010, MOL CANCER RES, V8, P919, DOI 10.1158/1541-7786.MCR-09-0358; Nigro P, 2010, BLOOD, V116, P1971, DOI 10.1182/blood-2010-02-269134; Nithianandarajah-Jones GN, 2012, CELL SIGNAL, V24, P2187, DOI 10.1016/j.cellsig.2012.07.007; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Peavy RD, 2005, MOL PHARMACOL, V67, P2102, DOI 10.1124/mol.104.007799; Penela P, 2010, BRIT J PHARMACOL, V160, P821, DOI 10.1111/j.1476-5381.2010.00727.x; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Remy Ingrid, 2004, Methods Mol Biol, V261, P411; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Sanchez-Fernandez G, 2014, CELL SIGNAL, V26, P833, DOI 10.1016/j.cellsig.2014.01.010; Sanchez-Fernandez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084174; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Shankaranarayanan A, 2008, J BIOL CHEM, V283, P34923, DOI 10.1074/jbc.M805860200; Sohn SJ, 2008, EMBO J, V27, P1896, DOI 10.1038/emboj.2008.114; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Sturla LM, 2005, CANCER RES, V65, P5683, DOI 10.1158/0008-5472.CAN-04-2283; Sumimoto Hideki, 2007, Sci STKE, V2007, pre6, DOI 10.1126/stke.4012007re6; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Zhang XM, 2012, NAT CELL BIOL, V14, P850, DOI 10.1038/ncb2529	42	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9513	9525		10.1074/jbc.M115.684308	http://dx.doi.org/10.1074/jbc.M115.684308			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26887939	Green Published, hybrid			2022-12-28	WOS:000375602300012
J	Zhao, CG; Brown, RSH; Tang, CHA; Hu, CCA; Schlieker, C				Zhao, Chenguang; Brown, Rebecca S. H.; Tang, Chih-Hang Anthony; Hu, Chih-Chi Andrew; Schlieker, Christian			Site-specific Proteolysis Mobilizes TorsinA from the Membrane of the Endoplasmic Reticulum (ER) in Response to ER Stress and B Cell Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTONIA-ASSOCIATED PROTEIN; AAA PLUS PROTEIN; DEUBIQUITINATING ENZYME; NUCLEAR-ENVELOPE; ATPASES; XBP-1; GENE; GLYCOPROTEINS; DEGRADATION; SUPPRESSION	Torsin ATPases are the only representatives of the AAA+ ATPase family that reside in the lumen of the endoplasmic reticulum (ER) and nuclear envelope. Two of these, TorsinA and TorsinB, are anchored to the ER membrane by virtue of an N-terminal hydrophobic domain. Here we demonstrate that the imposition of ER stress leads to a proteolytic cleavage event that selectively removes the hydrophobic domain from the AAA+ domain of TorsinA, which retains catalytic activity. Both the pharmacological inhibition profile and the identified cleavage site between two juxtaposed cysteine residues are distinct from those of presently known proteases, suggesting that a hitherto uncharacterized, membrane-associated protease accounts for TorsinA processing. This processing occurs not only in stress-exposed cell lines but also in primary cells from distinct organisms including stimulated B cells, indicating that Torsin conversion in response to physiologically relevant stimuli is an evolutionarily conserved process. By establishing 5-nitroisatin as a cell-permeable inhibitor for Torsin processing, we provide the methodological framework for interfering with Torsin processing in a wide range of primary cells without the need for genetic manipulation.	[Zhao, Chenguang; Brown, Rebecca S. H.; Schlieker, Christian] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA; [Schlieker, Christian] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Tang, Chih-Hang Anthony; Hu, Chih-Chi Andrew] Wistar Inst Anat & Biol, Dept Translat Tumor Immunol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Brown, Rebecca S. H.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yale University; Yale University; The Wistar Institute; Yeshiva University; Albert Einstein College of Medicine	Schlieker, C (corresponding author), 266 Whitney Ave,POB 208114,Bass 236A, New Haven, CT 06520 USA.	christian.schlieker@yale.edu		Tang, Chih-hang/0000-0002-5097-5709; Hu, Chih-Chi/0000-0001-9024-2932	National Institutes of Health [DP2 OD008624-01, R01CA163910]; NATIONAL CANCER INSTITUTE [P30CA010815, R01CA163910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants DP2 OD008624-01 (to C. S.) and (R01CA163910 (to C. C. A. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Brown RSH, 2014, P NATL ACAD SCI USA, V111, pE4822, DOI 10.1073/pnas.1415271111; BRUSCA JS, 1994, METHOD ENZYMOL, V228, P182; Burdette AJ, 2010, CELL STRESS CHAPERON, V15, P605, DOI 10.1007/s12192-010-0173-2; Caldwell GA, 2003, HUM MOL GENET, V12, P307, DOI 10.1093/hmg/ddg027; Chen P, 2010, HUM MOL GENET, V19, P3502, DOI 10.1093/hmg/ddq266; Chen XP, 2010, NEUROCHEM RES, V35, P1214, DOI 10.1007/s11064-010-0177-4; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2015, J CELL SCI, V128, P2854, DOI 10.1242/jcs.167452; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Heyden ABV, 2011, EMBO J, V30, P3217, DOI 10.1038/emboj.2011.233; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Hu CCA, 2009, EMBO J, V28, P1624, DOI 10.1038/emboj.2009.117; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jungwirth M, 2010, HUM MOL GENET, V19, P888, DOI 10.1093/hmg/ddp557; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Korennykh A, 2012, ANNU REV CELL DEV BI, V28, P251, DOI 10.1146/annurev-cellbio-101011-155826; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Langosch D, 2015, TRENDS BIOCHEM SCI, V40, P318, DOI 10.1016/j.tibs.2015.04.001; Laudermilch E, 2016, CURR OPIN CELL BIOL, V40, P1, DOI 10.1016/j.ceb.2016.01.001; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; McGehee AM, 2009, J IMMUNOL, V183, P3690, DOI 10.4049/jimmunol.0900953; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Nery FC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1383; Neuwald AF, 1999, GENOME RES, V9, P27; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Rose AE, 2015, CRIT REV BIOCHEM MOL, V50, P532, DOI 10.3109/10409238.2015.1091804; Rose AE, 2014, J BIOL CHEM, V289, P552, DOI 10.1074/jbc.M113.515791; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sosa BA, 2014, ELIFE, V3, DOI 10.7554/eLife.03239; Tang CHA, 2014, J CLIN INVEST, V124, P2585, DOI 10.1172/JCI73448; Tirosh B, 2005, J EXP MED, V202, P505, DOI 10.1084/jem.20050575; Vander Heyden AB, 2009, MOL BIOL CELL, V20, P2661, DOI 10.1091/mbc.E09-01-0094; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zacchi LF, 2014, J BIOL CHEM, V289, P12727, DOI 10.1074/jbc.M113.529123; Zhao CG, 2013, P NATL ACAD SCI USA, V110, pE1545, DOI 10.1073/pnas.1300676110; Zhu L, 2008, MOL BIOL CELL, V19, P3599, DOI 10.1091/mbc.E08-01-0015; Zhu L, 2010, J BIOL CHEM, V285, P37271, DOI 10.1074/jbc.M110.123471	45	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9469	9481		10.1074/jbc.M115.709337	http://dx.doi.org/10.1074/jbc.M115.709337			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26953341	Green Published, hybrid			2022-12-28	WOS:000375602300008
J	Cvetesic, N; Dulic, M; Bilus, M; Sostaric, N; Lenhard, B; Gruic-Sovulj, I				Cvetesic, Nevena; Dulic, Morana; Bilus, Mirna; Sostaric, Nikolina; Lenhard, Boris; Gruic-Sovulj, Ita			Naturally Occurring Isoleucyl-tRNA Synthetase without tRNA-dependent Pre-transfer Editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; antibiotic resistance; protein evolution; protein synthesis; transfer RNA (tRNA); isoleucyl-tRNA synthetase; mupirocin; proofreading; tRNA-dependent pre-transfer editing	PSEUDOMONIC ACID; ESCHERICHIA-COLI; STRUCTURAL BASIS; QUALITY-CONTROL; GENETIC-CODE; MUPIROCIN RESISTANCE; AMINO-ACID; COMPLEX; RECOGNITION; MECHANISMS	Isoleucyl-tRNA synthetase (IleRS) is unusual among aminoacyl-tRNA synthetases in having a tRNA-dependent pre-transfer editing activity. Alongside the typical bacterial IleRS (such as Escherichia coli IleRS), some bacteria also have the enzymes (eukaryote-like) that cluster with eukaryotic IleRSs and exhibit low sensitivity to the antibiotic mupirocin. Our phylogenetic analysis suggests that the ileS1 and ileS2 genes of contemporary bacteria are the descendants of genes that might have arisen by an ancient duplication event before the separation of bacteria and archaea. We present the analysis of evolutionary constraints of the synthetic and editing reactions in eukaryotic/eukaryote-like IleRSs, which share a common origin but diverged through adaptation to different cell environments. The enzyme from the yeast cytosol exhibits tRNA-dependent pre-transfer editing analogous to E. coli IleRS. This argues for the presence of this proofreading in the common ancestor of both IleRS types and an ancient origin of the synthetic site-based quality control step. Yet surprisingly, the eukaryote-like enzyme from Streptomyces griseus IleRS lacks this capacity; at the same time, its synthetic site displays the 10(3)-fold drop in sensitivity to antibiotic mupirocin relative to the yeast enzyme. The discovery that pre-transfer editing is optional in IleRSs lends support to the notion that the conserved post-transfer editing domain is the main checkpoint in these enzymes. We substantiated this by showing that under error-prone conditions S. griseus IleRS is able to rescue the growth of an E. coli lacking functional IleRS, providing the first evidence that tRNA-dependent pre-transfer editing in IleRS is not essential for cell viability.	[Cvetesic, Nevena; Dulic, Morana; Bilus, Mirna; Sostaric, Nikolina; Gruic-Sovulj, Ita] Univ Zagreb, Fac Sci, Dept Chem, Horvatovac 102a, Zagreb 10000, Croatia; [Lenhard, Boris] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Computat Regulatory Genom Grp, London W12 0NN, England	University of Zagreb; Imperial College London	Gruic-Sovulj, I (corresponding author), Univ Zagreb, Fac Sci, Dept Chem, Horvatovac 102a, Zagreb 10000, Croatia.	gruic@chem.pmf.hr		Sostaric, Nikolina/0000-0002-1470-7846; Lenhard, Boris/0000-0002-1114-1509; Cvetesic, Nevena/0000-0002-1575-5612	Unity through Knowledge Fund [8/13]; Croatian Science Foundation [09.01/293]; European Community [315997]; MRC [MC_UP_1102/1] Funding Source: UKRI; Medical Research Council [MC_UP_1102/1] Funding Source: researchfish	Unity through Knowledge Fund; Croatian Science Foundation; European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Unity through Knowledge Fund Grant 8/13 (to I. G.-S.), in part by Croatian Science Foundation Grant 09.01/293 (to I. G.-S.), and the European Community's Seventh Framework Programme FP7RegPot/IntegraLife, Grant 315997. The authors declare that they have no conflicts of interest with the contents of this article.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bishop AC, 2002, P NATL ACAD SCI USA, V99, P585, DOI 10.1073/pnas.012611299; Brown JR, 2003, EMBO REP, V4, P692, DOI 10.1038/sj.embor.embor881; Brown JR, 1998, CURR BIOL, V8, pR365, DOI 10.1016/S0960-9822(98)70238-6; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Cvetesic N, 2015, J BIOL CHEM, V290, P13981, DOI 10.1074/jbc.M115.648568; Cvetesic N, 2014, EMBO J, V33, P1639, DOI 10.15252/embj.201488199; Cvetesic N, 2013, CROAT CHEM ACTA, V86, P73, DOI 10.5562/cca2173; Cvetesic N, 2012, J BIOL CHEM, V287, P25381, DOI 10.1074/jbc.M112.372151; Doolittle RF, 1998, CURR OPIN GENET DEV, V8, P630, DOI 10.1016/S0959-437X(98)80030-0; Dulic M, 2014, BIOCHEMISTRY-US, V53, P6189, DOI 10.1021/bi5007699; Dulic M, 2010, J BIOL CHEM, V285, P23799, DOI 10.1074/jbc.M110.133553; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2006, J MOL BIOL, V359, P901, DOI 10.1016/j.jmb.2006.04.025; FULLER AT, 1971, NATURE, V234, P416, DOI 10.1038/234416a0; Glasfeld E, 1996, BIOCHEMISTRY-US, V35, P4139, DOI 10.1021/bi9527810; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Hetem DJ, 2013, J HOSP INFECT, V85, P249, DOI 10.1016/j.jhin.2013.09.006; HUGHES J, 1980, BIOCHEM J, V191, P209, DOI 10.1042/bj1910209; Hussain T, 2006, EMBO J, V25, P4152, DOI 10.1038/sj.emboj.7601278; Jakubowski H, 2012, WIRES RNA, V3, P295, DOI 10.1002/wrna.122; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; Jones David T., 2005, P3, DOI 10.1201/9780203489819.pt1; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Novoa EM, 2015, J BIOL CHEM, V290, P10495, DOI 10.1074/jbc.M115.640060; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Nordin B. E., 2005, AMINOACYL TRNA SYNTH, P24; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paulander W, 2007, MOL MICROBIOL, V64, P1038, DOI 10.1111/j.1365-2958.2007.05713.x; Perona JJ, 2014, TOP CURR CHEM, V344, P1, DOI 10.1007/128_2013_456; RACHER KI, 1991, J BIOL CHEM, V266, P17158; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Sassanfar M, 1996, BIOCHEMISTRY-US, V35, P9995, DOI 10.1021/bi9603027; Serafini F, 2011, APPL ENVIRON MICROB, V77, P3141, DOI 10.1128/AEM.02540-10; Shiba K, 1997, TRENDS BIOCHEM SCI, V22, P453, DOI 10.1016/S0968-0004(97)01135-3; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; SternJohn J, 2007, P NATL ACAD SCI USA, V104, P2127, DOI 10.1073/pnas.0611110104; SUTHERLAND R, 1985, ANTIMICROB AGENTS CH, V27, P495, DOI 10.1128/AAC.27.4.495; Nguyen TH, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-12; Thomas CM, 2010, NAT REV MICROBIOL, V8, P281, DOI 10.1038/nrmicro2278; Vargas-Rodriguez O, 2013, J BIOL CHEM, V288, P14391, DOI 10.1074/jbc.M113.467795; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Yanagisawa T, 2003, J BIOL CHEM, V278, P25887, DOI 10.1074/jbc.M302633200; Yao P, 2008, J BIOL CHEM, V283, P22591, DOI 10.1074/jbc.M801181200; Yokogawa T, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1182	61	6	6	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8618	8631		10.1074/jbc.M115.698225	http://dx.doi.org/10.1074/jbc.M115.698225			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26921320	Green Published, hybrid			2022-12-28	WOS:000374773200025
J	Wang, SM; Lu, Y; Yin, MX; Wang, C; Wu, W; Li, JH; Wu, WQ; Ge, L; Hu, LX; Zhao, Y; Zhang, L				Wang, Shimin; Lu, Yi; Yin, Meng-Xin; Wang, Chao; Wu, Wei; Li, Jinhui; Wu, Wenqing; Ge, Ling; Hu, Lianxin; Zhao, Yun; Zhang, Lei			Importin 1 Mediates Yorkie Nuclear Import via an N-terminal Non-canonical Nuclear Localization Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hippo pathway; nuclear translocation; nuclear transport; oncogene; yes-associated protein (YAP); Importin; NLS; yorkie	ORGAN SIZE CONTROL; TUMOR-SUPPRESSOR PATHWAY; CELL-PROLIFERATION; PROMOTES APOPTOSIS; CRYSTALLOGRAPHIC ANALYSIS; KARYOPHERIN ALPHA; STRUCTURAL BASIS; TEAD/TEF FAMILY; BANTAM MICRORNA; PROTEIN IMPORT	The Hippo signaling pathway controls organ size by orchestrating cell proliferation and apoptosis. When the Hippo pathway was inactivated, the transcriptional co-activator Yorkie translocates into the nucleus and forms a complex with transcription factor Scalloped to promote the expression of Hippo pathway target genes. Therefore, the nuclear translocation of Yorkie is a critical step in Hippo signaling. Here, we provide evidence that the N-terminal 1-55 amino acids of Yorkie, especially Arg-15, were essential for its nuclear localization. By mass spectrometry and biochemical analyses, we found that Importin 1 can directly interact with the Yorkie N terminus and drive Yorkie into the nucleus. Further experiments show that the upstream component Hippo can inhibit Importin 1-mediated Yorkie nuclear import. Taken together, we identified a potential nuclear localization signal at the N-terminal end of Yorkie as well as a critical role for Importin 1 in Yorkie nuclear import.	[Wang, Shimin; Lu, Yi; Yin, Meng-Xin; Wang, Chao; Wu, Wei; Li, Jinhui; Wu, Wenqing; Ge, Ling; Hu, Lianxin; Zhao, Yun; Zhang, Lei] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Cell Biol,Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci,Innovat Ctr Cell, Shanghai 200031, Peoples R China; [Zhao, Yun; Zhang, Lei] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Zhang, L (corresponding author), Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	rayzhang@sibcb.ac.cn		Hu, Lianxin/0000-0001-5600-5634; Wang, Chao/0000-0001-6191-5261	National Basic Research Program of China (973 Program) [2012CB945001]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA01010406]; National Natural Science Foundation of China [31171394, 31371462]; State Key Program of National Natural Science of China [31530043]; "Cross and Cooperation in Science and Technology Innovation Team" project of the Chinese Academy of Sciences; CAS/SAFEA International Partnership Program for Creative Research Teams	National Basic Research Program of China (973 Program)(National Basic Research Program of China); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); "Cross and Cooperation in Science and Technology Innovation Team" project of the Chinese Academy of Sciences; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	This work was supported by grants from the National Basic Research Program of China (973 Program 2012CB945001), the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDA01010406), the National Natural Science Foundation of China (31171394, 31371462), supported by the State Key Program of National Natural Science of China (31530043), the "Cross and Cooperation in Science and Technology Innovation Team" project of the Chinese Academy of Sciences, and the CAS/SAFEA International Partnership Program for Creative Research Teams. The authors declare that they have no conflicts of interest with the contents of this article.	Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorjanacz M, 2002, DEV BIOL, V251, P271, DOI 10.1006/dbio.2002.0827; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Huang HL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001620; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; KUSSEL P, 1995, J CELL BIOL, V129, P1491, DOI 10.1083/jcb.129.6.1491; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Mason DA, 2002, GENETICS, V161, P157; Mathe E, 2000, DEV BIOL, V223, P307, DOI 10.1006/dbio.2000.9743; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Oh H, 2009, ONCOGENE, V28, P1916, DOI 10.1038/onc.2009.43; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Ren FF, 2010, DEV BIOL, V337, P303, DOI 10.1016/j.ydbio.2009.10.046; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; TOROK I, 1995, J CELL BIOL, V129, P1473, DOI 10.1083/jcb.129.6.1473; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XU TA, 1995, DEVELOPMENT, V121, P1053; Yin MX, 2015, ACTA BIOCH BIOPH SIN, V47, P39, DOI 10.1093/abbs/gmu111; Yin MX, 2011, J GENET GENOMICS, V38, P471, DOI 10.1016/j.jgg.2011.09.009; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	48	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7926	7937		10.1074/jbc.M115.700823	http://dx.doi.org/10.1074/jbc.M115.700823			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26887950	Green Published, hybrid			2022-12-28	WOS:000374056700015
J	Corradi, GR; Czysezon, NA; Mazzitelli, LR; Sarbia, N; Adamo, HP				Corradi, Gerardo R.; Czysezon, Nicolas A.; Mazzitelli, Luciana R.; Sarbia, Nicolas; Adamo, Hugo P.			Inhibition of the Formation of the Spf1p Phosphoenzyme by Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; TRANSPORT ATPASES; ATP13A2; CA2&-ATPASE; CALCIUM; PATHWAY; CYCLE; ADP	P5-ATPases are important for processes associated with the endosomal-lysosomal system of eukaryotic cells. In humans, the loss of function of P5-ATPases causes neurodegeneration. In the yeast Saccharomyces cerevisiae, deletion of P5-ATPase Spf1p gives rise to endoplasmic reticulum stress. The reaction cycle of P5-ATPases is poorly characterized. Here, we showed that the formation of the Spf1p catalytic phosphoenzyme was fast in a reaction medium containing ATP, Mg2+, and EGTA. Low concentrations of Ca2+ in the phosphorylation medium decreased the rate of phosphorylation and the maximal level of phosphoenzyme. Neither Mn2+ nor Mg2+ had an inhibitory effect on the formation of the phosphoenzyme similar to that of Ca2+. The K-m for ATP in the phosphorylation reaction was similar to 1 mu M and did not significantly change in the presence of Ca2+. Half-maximal phosphorylation was attained at 8 mu M Mg2+, but higher concentrations partially protected from Ca2+ inhibition. In conditions similar to those used for phosphorylation, Ca2+ had a small effect accelerating dephosphorylation and minimally affected ATPase activity, suggesting that the formation of the phosphoenzyme was not the limiting step of the ATP hydrolytic cycle.	[Corradi, Gerardo R.; Czysezon, Nicolas A.; Mazzitelli, Luciana R.; Sarbia, Nicolas; Adamo, Hugo P.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Adamo, HP (corresponding author), Fac Farm & Bioquim, IQUIFIB, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	hpadamo@qb.ffyb.uba.ar	Adamo, Hugo Pedro/ABB-8338-2021	Adamo, Hugo Pedro/0000-0002-1712-8049; Corradi, Gerardo Raul/0000-0003-0354-7709; Sarbia, Nicolas/0000-0003-3958-5803	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1240]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [PIP 1042]; Universidad de Buenos Aires	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas; Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by Grant PICT 1240 from Agencia Nacional de Promocion Cientifica y Tecnologica, by Grant PIP 1042 from Consejo Nacional de Investigaciones Cientificas y Tecnologicas, and by a research grant from Universidad de Buenos Aires. The authors declare that they have no conflicts of interest with the contents of this article.	ADAMO HP, 1988, J BIOL CHEM, V263, P17548; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bras J, 2012, HUM MOL GENET, V21, P2646, DOI 10.1093/hmg/dds089; CARIDE AJ, 1986, BIOCHIM BIOPHYS ACTA, V863, P165, DOI 10.1016/0005-2736(86)90256-7; Cohen Y., 2013, PLOS ONE, V8; Corradi GR, 2012, J BIOL CHEM, V287, P30477, DOI 10.1074/jbc.M112.363465; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Ekberg K, 2010, P NATL ACAD SCI USA, V107, P21400, DOI 10.1073/pnas.1010416107; GARRAHAN PJ, 1978, BIOCHIM BIOPHYS ACTA, V513, P59, DOI 10.1016/0005-2736(78)90111-6; HOBBS AS, 1985, J BIOL CHEM, V260, P2035; Holemans T, 2015, P NATL ACAD SCI USA, V112, P9040, DOI 10.1073/pnas.1508220112; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Lustoza ACDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027843; MENDLEIN J, 1989, J BIOL CHEM, V264, P18512; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; NAKAMURA Y, 1986, J BIOL CHEM, V261, P3090; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Perrett RM, 2015, MOL CELL NEUROSCI, V66, P21, DOI 10.1016/j.mcn.2015.02.009; Pinto F. de Tezanos, 2011, J LIFE SCI, V5, P1; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Sorensen DM, 2015, BBA-GEN SUBJECTS, V1850, P524, DOI 10.1016/j.bbagen.2014.05.008; Sorensen DM, 2012, J BIOL CHEM, V287, P28336, DOI 10.1074/jbc.M112.387191; Sorensen DM, 2010, BBA-BIOENERGETICS, V1797, P846, DOI 10.1016/j.bbabio.2010.04.010; Suzuki C, 1999, MOL MICROBIOL, V32, P813, DOI 10.1046/j.1365-2958.1999.01400.x; Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Vallipuram J, 2010, CELL MOL NEUROBIOL, V30, P233, DOI 10.1007/s10571-009-9445-8; van Veen S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00048; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111	36	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7767	7773		10.1074/jbc.M115.695122	http://dx.doi.org/10.1074/jbc.M115.695122			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26858246	Green Published, hybrid			2022-12-28	WOS:000383447600045
J	Golinelli-Cohen, MP; Lescop, E; Mons, C; Goncalves, S; Clemancey, M; Santolini, J; Guittet, E; Blondin, G; Latour, JM; Bouton, C				Golinelli-Cohen, Marie-Pierre; Lescop, Ewen; Mons, Cecile; Goncalves, Sergio; Clemancey, Martin; Santolini, Jerome; Guittet, Eric; Blondin, Genevieve; Latour, Jean-Marc; Bouton, Cecile			Redox Control of the Human Iron-Sulfur Repair Protein MitoNEET Activity via Its Iron-Sulfur Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-MEMBRANE PROTEIN; RESONANCE RAMAN-SPECTROSCOPY; DRUG TARGET MITONEET; FE-S CLUSTER; 2FE-2S CLUSTER; ELECTRON-TRANSFER; STAPHYLOCOCCUS-AUREUS; REGULATORY PROTEIN-1; 2-COMPONENT SYSTEM; ESCHERICHIA-COLI	Human mitoNEET (mNT) is the first identified Fe-S protein of the mammalian outer mitochondrial membrane. Recently, mNT has been implicated in cytosolic Fe-S repair of a key regulator of cellular iron homeostasis. Here, we aimed to decipher the mechanism by which mNT triggers its Fe-S repair capacity. By using tightly controlled reactions combined with complementary spectroscopic approaches, we have determined the differential roles played by both the redox state of the mNT cluster and dioxygen in cluster transfer and protein stability. We unambiguously demonstrated that only the oxidized state of them NT cluster triggers cluster transfer to a generic acceptor protein and that dioxygen is neither required for the cluster transfer reaction nor does it affect the transfer rate. In the absence of apo-acceptors, a large fraction of the oxidized holo-mNT form is converted back to reduced holo-mNT under low oxygen tension. Reduced holo-mNT, which holds a [2Fe-2S](+) with a global protein fold similar to that of the oxidized form is, by contrast, resistant in losing its cluster or in transferring it. Our findings thus demonstrate that mNT uses an iron-based redox switch mechanism to regulate the transfer of its cluster. The oxidized state is the "active state," which reacts promptly to initiate Fe-Stransfer independently of dioxygen, whereas the reduced state is a "dormant form." Finally, we propose that the redox-sensing function of mNT is a key component of the cellular adaptive response to help stress-sensitive Fe-S proteins recover from oxidative injury.	[Golinelli-Cohen, Marie-Pierre; Lescop, Ewen; Mons, Cecile; Goncalves, Sergio; Guittet, Eric; Bouton, Cecile] Univ Paris Saclay, Univ Paris 11, CNRS UPR 2301, ICSN, F-91190 Gif Sur Yvette, France; [Clemancey, Martin; Blondin, Genevieve; Latour, Jean-Marc] Univ Grenoble Alpes, LCBM, F-38054 Grenoble, France; [Clemancey, Martin; Blondin, Genevieve; Latour, Jean-Marc] CEA, DSV, IRTSV, LCBM,Equipe Physicochim Met Biol PMB, F-38054 Grenoble, France; [Clemancey, Martin; Blondin, Genevieve; Latour, Jean-Marc] CNRS, UMR 5249, LCBM, F-38054 Grenoble, France; [Santolini, Jerome] Univ Paris Saclay, Univ Paris 11, CNRS, CEA,Inst Integrat Biol Cell I2BC, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Golinelli-Cohen, MP; Bouton, C (corresponding author), CNRS, UPR 2301, Inst Chim Subst Nat, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	marie-pierre.golinelli@cnrs.fr; cecile.bouton@cnrs.fr	Golinelli, Marie-Pierre/K-4287-2013; Lescop, Ewen/AAA-8700-2019	Golinelli, Marie-Pierre/0000-0002-6738-8631; Lescop, Ewen/0000-0002-2623-9365; Santolini, Jerome/0000-0001-8919-112X; Guittet, Eric/0000-0002-8368-6719	Fondation pour la Recherche Medicale [ING20101220983]; Agence Nationale de la Recherche [ANR-13BSV8-0017-01]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; French Ministry of National Education, Research, and Technology	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI); French Ministry of National Education, Research, and Technology	This work was supported by the Fondation pour la Recherche Medicale (ING20101220983; to S. G.), the Agence Nationale de la Recherche (ANR-13BSV8-0017-01), and the French Infrastructure for Integrated Structural Biology (FRISBI) (ANR-10-INSB-05-01). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a doctoral grant from the French Ministry of National Education, Research, and Technology.	Bak DW, 2013, BIOCHEMISTRY-US, V52, P4687, DOI 10.1021/bi400540m; Bak DW, 2009, BIOCHEMISTRY-US, V48, P10193, DOI 10.1021/bi9016445; Boal AK, 2007, J INORG BIOCHEM, V101, P1913, DOI 10.1016/j.jinorgbio.2007.05.001; Bonomi F, 2005, J BIOL CHEM, V280, P29513, DOI 10.1074/jbc.M504344200; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Carboni M, 2012, INORG CHEM, V51, P10447, DOI 10.1021/ic301725z; Chahal HK, 2012, J INORG BIOCHEM, V116, P126, DOI 10.1016/j.jinorgbio.2012.06.008; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00259; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Ferecatu I, 2014, J BIOL CHEM, V289, P28070, DOI 10.1074/jbc.M114.548438; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; FU WG, 1992, J BIOL CHEM, V267, P15502; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gupta V, 2009, J AM CHEM SOC, V131, P6149, DOI 10.1021/ja807551e; Hall JW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00682; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; Hsueh KL, 2010, J AM CHEM SOC, V132, P7908, DOI 10.1021/ja1026387; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kobayashi K, 2011, BIOCHEMISTRY-US, V50, P9468, DOI 10.1021/bi201526y; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Landry AP, 2015, FREE RADICAL BIO MED, V81, P119, DOI 10.1016/j.freeradbiomed.2015.01.017; Landry AP, 2014, J BIOL CHEM, V289, P4307, DOI 10.1074/jbc.M113.542050; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Marchi Saverio, 2012, J Signal Transduct, V2012, P329635, DOI 10.1155/2012/329635; Meyer J, 2002, BIOCHEMISTRY-US, V41, P3096, DOI 10.1021/bi015981m; MOULIS JM, 1982, BIOCHEMISTRY-US, V21, P4762, DOI 10.1021/bi00262a037; MUNCK E, 1972, BIOCHEMISTRY-US, V11, P855; Nechushtai R, 2012, PLANT CELL, V24, P2139, DOI 10.1105/tpc.112.097634; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; PETERING D, 1971, J BIOL CHEM, V246, P643; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Saouma CT, 2014, INORG CHEM, V53, P3153, DOI 10.1021/ic403131p; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Stys A, 2011, J BIOL CHEM, V286, P22846, DOI 10.1074/jbc.M111.231902; Sun F, 2012, J AM CHEM SOC, V134, P305, DOI 10.1021/ja2071835; TA DT, 1992, J BIOL CHEM, V267, P11120; Tirrell TF, 2009, BIOCHEMISTRY-US, V48, P4747, DOI 10.1021/bi900028r; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wolfe MD, 2002, BIOCHEMISTRY-US, V41, P9611, DOI 10.1021/bi025912n; Wu Y, 2009, J BACTERIOL, V191, P1248, DOI 10.1128/JB.01086-08; Xiao YM, 2008, BIOCHEMISTRY-US, V47, P6612, DOI 10.1021/bi701433m; Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109; Zhou T, 2010, BIOCHEMISTRY-US, V49, P9604, DOI 10.1021/bi101168c; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	58	45	47	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7583	7593		10.1074/jbc.M115.711218	http://dx.doi.org/10.1074/jbc.M115.711218			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26887944	Green Published, hybrid			2022-12-28	WOS:000383447600031
J	Xiang, RF; Stack, D; Huston, SM; Li, SS; Ogbomo, H; Kyei, SK; Mody, CH				Xiang, Richard F.; Stack, Danuta; Huston, Shaunna M.; Li, Shu Shun; Ogbomo, Henry; Kyei, Stephen K.; Mody, Christopher H.			Ras-related C3 Botulinum Toxin Substrate (Rac) and Src Family Kinases (SFK) Are Proximal and Essential for Phosphatidylinositol 3-Kinase (PI3K) Activation in Natural Killer (NK) Cell-mediated Direct Cytotoxicity against Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; fungi; natural killer cells (NK cells); phosphatidylinositide 3-kinase (PI 3-kinase); Rac (Rac GTPase); Src; Cellular signaling; Cryptococcus	PHOSPHOINOSITIDE 3-KINASE; SMALL GTPASES; PLC-GAMMA; T-CELLS; RECEPTOR; PROTEINS; POLARIZATION; LYMPHOCYTES; IMMUNITY; SIGNALS	The activity of Rac in leukocytes is essential for immunity. However, its role in NK cell-mediated anti-microbial signaling remains unclear. In this study, we investigated the role of Rac in NK cell mediated anti-cryptococcal killing. We found that Cryptococcus neoformans independently activates both Rac and SFK pathways in NK cells, and unlike in tumor killing, Cryptococcus initiated a novel Rac PI3K Erk cytotoxicity cascade. Remarkably, Rac was not required for conjugate formation, despite its essential role in NK cytotoxicity against C. neoformans. Taken together, our data show that, unlike observations with tumor cells, NK cells use a novel Rac cytotoxicity pathway in conjunction with SFK, to kill C. neoformans.	[Xiang, Richard F.; Stack, Danuta; Huston, Shaunna M.; Li, Shu Shun; Ogbomo, Henry; Kyei, Stephen K.; Mody, Christopher H.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada; [Mody, Christopher H.] Univ Calgary, Dept Internal Med, Calgary, AB T2N 4N1, Canada; [Xiang, Richard F.; Stack, Danuta; Huston, Shaunna M.; Li, Shu Shun; Ogbomo, Henry; Kyei, Stephen K.; Mody, Christopher H.] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary	Mody, CH (corresponding author), Hlth Res Innovat Ctr, Jessie Boden Lloyd Prof Immunol, Rm 4AA14,3280 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	cmody@ucalgary.ca		Li, ShuShun/0000-0002-8725-4614; Mody, Christopher H./0000-0001-7264-3679	Canadian Institute for Health Research [247301]; Lung Association-Alberta and Northwest Territories	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Lung Association-Alberta and Northwest Territories	This work was supported by Canadian Institute for Health Research Grant 247301 (to C. H. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a studentship from the Lung Association-Alberta and Northwest Territories.	Amin ARMR, 2003, INT J ONCOL, V23, P1727; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Billadeau DD, 1998, J EXP MED, V188, P549, DOI 10.1084/jem.188.3.549; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Brown ACN, 2012, BLOOD, V120, P3729, DOI 10.1182/blood-2012-05-429977; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; BUHL AM, 1995, J BIOL CHEM, V270, P19828, DOI 10.1074/jbc.270.34.19828; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Diaz-Flores E, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004125; Djeu JY, 2002, CLIN CANCER RES, V8, P636; Emmer PM, 2000, HUM REPROD, V15, P1163, DOI 10.1093/humrep/15.5.1163; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Ferri N, 2009, J MED CHEM, V52, P4087, DOI 10.1021/jm8015987; Filbert EL, 2012, J IMMUNOL, V188, P5421, DOI 10.4049/jimmunol.1200242; Fraison Jean-Baptiste, 2013, J Crohns Colitis, V7, pe11, DOI 10.1016/j.crohns.2012.04.016; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Gibson JF, 2015, FUNGAL GENET BIOL, V78, P76, DOI 10.1016/j.fgb.2014.11.006; Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068; HIDORE MR, 1986, J IMMUNOL, V137, P3624; HIDORE MR, 1991, INFECT IMMUN, V59, P1747, DOI 10.1128/IAI.59.5.1747-1754.1991; Huston SM, 2013, J IMMUNOL, V191, P249, DOI 10.4049/jimmunol.1202707; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Inabe K, 2002, J EXP MED, V195, P189, DOI 10.1084/jem.20011571; Inukai K, 2000, BIOCHEM J, V346, P483, DOI 10.1042/0264-6021:3460483; Islam A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003439; James AM, 2013, BLOOD, V121, P2627, DOI 10.1182/blood-2012-06-437012; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Jones GJ, 2009, INT IMMUNOL, V21, P423, DOI 10.1093/intimm/dxp010; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Kwon Hyung-Joon, 2012, Immune Netw, V12, P240, DOI 10.4110/in.2012.12.6.240; LEVITZ SM, 1994, INFECT IMMUN, V62, P194, DOI 10.1128/IAI.62.1.194-202.1994; Li SS, 2013, CELL HOST MICROBE, V14, P387, DOI 10.1016/j.chom.2013.09.007; LIPSCOMB MF, 1987, AM J PATHOL, V128, P354; Lou ZK, 2000, J EXP MED, V191, P347, DOI 10.1084/jem.191.2.347; Ma LL, 2004, J IMMUNOL, V173, P3357, DOI 10.4049/jimmunol.173.5.3357; Maffucci T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008285; Malorni W, 2003, J IMMUNOL, V171, P4195, DOI 10.4049/jimmunol.171.8.4195; Marinkovic G, 2013, ARTERIOSCL THROM VAS, V33, P2380, DOI 10.1161/ATVBAHA.113.301394; Meng XB, 2007, J PROTEOME RES, V6, P744, DOI 10.1021/pr060382t; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; Morse RHA, 2001, J NEUROIMMUNOL, V116, P107, DOI 10.1016/S0165-5728(01)00289-2; MURPHY JW, 1991, INFECT IMMUN, V59, P1476, DOI 10.1128/IAI.59.4.1476-1488.1991; Neurath Markus, 2010, Gastroenterol Hepatol (N Y), V6, P435; Oykhman P, 2013, INFECT IMMUN, V81, P3912, DOI 10.1128/IAI.00533-13; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Perez-Villar JJ, 2002, BIOCHEMISTRY-US, V41, P10732, DOI 10.1021/bi025554o; Pfeifer M, 2013, P NATL ACAD SCI USA, V110, P12420, DOI 10.1073/pnas.1305656110; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Porter JC, 2002, J IMMUNOL, V168, P6330, DOI 10.4049/jimmunol.168.12.6330; Putney JW, 2002, NAT CELL BIOL, V4, pE280, DOI 10.1038/ncb1202-e280; Sethi NK, 2007, EUR J GASTROEN HEPAT, V19, P913, DOI 10.1097/MEG.0b013e3282cf4ed9; SHIRAKAWA F, 1986, J IMMUNOL, V137, P551; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tassi I, 2005, J IMMUNOL, V175, P7996, DOI 10.4049/jimmunol.175.12.7996; Vyas YM, 2001, J IMMUNOL, V167, P4358, DOI 10.4049/jimmunol.167.8.4358; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Wiseman JCD, 2007, J IMMUNOL, V178, P6456, DOI 10.4049/jimmunol.178.10.6456; Yang HW, 2012, MOL CELL, V47, P281, DOI 10.1016/j.molcel.2012.05.007	67	14	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6912	6922		10.1074/jbc.M115.681544	http://dx.doi.org/10.1074/jbc.M115.681544			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26867574	hybrid, Green Published			2022-12-28	WOS:000373299700028
J	Chaudhuri, AD; Choi, DC; Kabaria, S; Tran, A; Junn, E				Chaudhuri, Amrita Datta; Choi, Doo Chul; Kabaria, Savan; Tran, Alan; Junn, Eunsung			MicroRNA-7 Regulates the Function of Mitochondrial Permeability Transition Pore by Targeting VDAC1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); mitochondrial membrane potential; mitochondrial permeability transition (MPT); Parkinson disease; voltage-dependent anion channel (VDAC); 1-methyl-4-phenylpyridinium	1-METHYL-4-PHENYLPYRIDINIUM-INDUCED CELL-DEATH; ALPHA-SYNUCLEIN EXPRESSION; LARGE GENE LISTS; PARKINSONS-DISEASE; INHIBITS APOPTOSIS; ALZHEIMERS-DISEASE; ENERGY-METABOLISM; OXIDATIVE STRESS; COMPLEX-I; DYSFUNCTION	Mitochondrial dysfunction is one of the major contributors to neurodegenerative disorders including Parkinson disease. The mitochondrial permeability transition pore is a protein complex located on the mitochondrial membrane. Under cellular stress, the pore opens, increasing the release of pro-apoptotic proteins, and ultimately resulting in cell death. MicroRNA-7 (miR-7) is a small non-coding RNA that has been found to exhibit a protective role in the cellular models of Parkinson disease. In the present study, miR-7 was predicted to regulate the function of mitochondria, according to gene ontology analysis of proteins that are down-regulated by miR-7. Indeed, miR-7 overexpression inhibited mitochondrial fragmentation, mitochondrial depolarization, cytochrome c release, reactive oxygen species generation, and release of mitochondrial calcium in response to 1-methyl-4-phenylpyridinium (MPP+) in human neuroblastoma SH-SY5Y cells. In addition, several of these findings were confirmed in mouse primary neurons. Among the mitochondrial proteins identified by gene ontology analysis, the expression of voltage-dependent anion channel 1 (VDAC1), a constituent of the mitochondrial permeability transition pore, was down-regulated by miR-7 through targeting 3-untranslated region of VDAC1 mRNA. Similar to miR-7 overexpression, knockdown of VDAC1 also led to a decrease in intracellular reactive oxygen species generation and subsequent cellular protection against MPP+. Notably, overexpression of VDAC1 without the 3-UTR significantly abolished the protective effects of miR-7 against MPP+-induced cytotoxicity and mitochondrial dysfunction, suggesting that the protective effect of miR-7 is partly exerted through promoting mitochondrial function by targeting VDAC1 expression. These findings point to a novel mechanism by which miR-7 accomplishes neuroprotection by improving mitochondrial health.	[Chaudhuri, Amrita Datta; Choi, Doo Chul; Kabaria, Savan; Tran, Alan; Junn, Eunsung] Rutgers Robert Wood Johnson Med Sch, Dept Neurol, Ctr Neurodegenerat & Neuroimmunol Dis, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Junn, E (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurol, 683 Hoes Lane W,Rm 185, Piscataway, NJ 08854 USA.	junneu@rwjms.rutgers.edu		Junn, Eunsung/0000-0001-5694-2599	National Institutes of Health [NS070898]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS070898 (to E. J.). The following author has disclosed actual or potential conflicts: E. J. (patent). The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Burte F, 2011, J PROTEOME RES, V10, P1974, DOI 10.1021/pr101211k; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; Chaudhuri AD, 2015, J BIOL CHEM, V290, P12425, DOI 10.1074/jbc.M114.625962; Choi DC, 2014, J NEUROSCI, V34, P12725, DOI 10.1523/JNEUROSCI.0985-14.2014; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Ghosh T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001170; Gomez-Lazaro M, 2008, J NEUROCHEM, V104, P1599, DOI 10.1111/j.1471-4159.2007.05115.x; Hajnoczky G, 2002, CELL CALCIUM, V32, P363, DOI 10.1016/S0143416002001872; Harraz MM, 2011, J CHEM NEUROANAT, V42, P127, DOI 10.1016/j.jchemneu.2011.01.005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lessner G, 2010, J PROTEOME RES, V9, P4671, DOI 10.1021/pr100389u; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Manczak M, 2013, J ALZHEIMERS DIS, V37, P679, DOI 10.3233/JAD-130761; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; Pazarentzos E, 2014, EMBO J, V33, P2814, DOI 10.15252/embj.201488183; Periquet M, 2005, J NEUROCHEM, V95, P1259, DOI 10.1111/j.1471-4159.2005.03442.x; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004; Sun YN, 2015, J ALZHEIMERS DIS, V45, P269, DOI 10.3233/JAD-142805; Vyssokikh MY, 2003, ACTA BIOCHIM POL, V50, P389; Xiong YY, 2009, NEUROCHEM RES, V34, P746, DOI 10.1007/s11064-008-9844-0; Yelamanchili SV, 2010, J NEUROIMMUNE PHARM, V5, P63, DOI 10.1007/s11481-009-9172-4; Zhu JH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.46; Zhu M, 2014, CNS NEUROSCI THER, V20, P308, DOI 10.1111/cns.12217	39	80	81	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6483	6493		10.1074/jbc.M115.691352	http://dx.doi.org/10.1074/jbc.M115.691352			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26801612	Green Published, hybrid			2022-12-28	WOS:000372894200035
J	Yoon, PO; Park, JW; Lee, CM; Kim, SH; Kim, HN; Ko, Y; Bae, SJ; Yun, S; Park, JH; Kwon, T; Kim, WS; Lee, J; Lu, Q; Kang, HR; Cho, WK; Elias, JA; Yang, JS; Park, HO; Lee, K; Lee, CG				Yoon, Pyoung Oh; Park, Jin Wook; Lee, Chang-Min; Kim, Sung Hwan; Kim, Han-Na; Ko, Youngho; Bae, Seon Joo; Yun, Sungil; Park, Jun Hong; Kwon, Taewoo; Kim, Woo Seok; Lee, Jiyoung; Lu, Qing; Kang, Hye-Ryun; Cho, Won-Kyung; Elias, Jack A.; Yang, Joo-Sung; Park, Han-Oh; Lee, Kyuhong; Lee, Chun Geun			Self-assembled Micelle Interfering RNA for Effective and Safe Targeting of Dysregulated Genes in Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						connective tissue growth factor (CTGF); cytokine; fibrosis; pulmonary fibrosis; siRNA; amphiregulin	GROWTH-FACTOR-BETA; IN-VIVO; SIRNA DELIVERY; LUNG FIBROSIS; EPITHELIAL-CELLS; FACTOR RECEPTOR; TGF-BETA; RAT; THERAPEUTICS; NANOPARTICLES	The siRNA silencing approach has long been used as a method to regulate the expression of specific target genes in vitro and in vivo. However, the effectiveness of delivery and the nonspecific immune-stimulatory function of siRNA are the limiting factors for therapeutic applications of siRNAs. To overcome these limitations, we developed self-assembled micelle inhibitory RNA (SAMiRNA) nanoparticles made of individually biconjugated siRNAs with a hydrophilic polymer and lipid on their ends and characterized their stability, immune-stimulatory function, and in vivo silencing efficacy. SAMiRNAs form very stable nanoparticles with no significant degradation in size distribution and polydispersity index over 1 year. Overnight incubation of SAMiRNAs (3 m) on murine peripheral blood mononuclear cells did not cause any significant elaboration of innate immune cytokines such as TNF-, IL-12, or IL-6, whereas unmodified siRNAs or liposomes or liposome complexes significantly stimulated the expression of these cytokines. Last, the in vivo silencing efficacy of SAMiRNAs was evaluated by targeting amphiregulin and connective tissue growth factor in bleomycin or TGF- transgenic animal models of pulmonary fibrosis. Intratracheal or intravenous delivery two or three times of amphiregulin or connective tissue growth factor SAMiRNAs significantly reduced the bleomycin- or TGF--stimulated collagen accumulation in the lung and substantially restored the lung function of TGF- transgenic mice. This study demonstrates that SAMiRNA nanoparticle is a less toxic, stable siRNA silencing platform for efficient in vivo targeting of genes implicated in the pathogenesis of pulmonary fibrosis.	[Yoon, Pyoung Oh; Kim, Han-Na; Ko, Youngho; Bae, Seon Joo; Yun, Sungil; Park, Jun Hong; Kwon, Taewoo; Kim, Woo Seok; Lee, Jiyoung; Yang, Joo-Sung; Park, Han-Oh] Bioneer Corp, Daejeon 306220, South Korea; [Park, Jin Wook; Lee, Chang-Min; Elias, Jack A.; Lee, Chun Geun] Brown Univ, Alpert Med Sch, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Lu, Qing; Cho, Won-Kyung] Brown Univ, Alpert Med Sch, Dept Med, Providence, RI 02912 USA; [Kim, Sung Hwan; Lee, Kyuhong] Korea Inst Toxicol, Inhalat Toxicol Ctr, Jeongeup Campus, Jeollabuk Do 580185, South Korea; [Kang, Hye-Ryun] Seoul Natl Univ Hosp, Dept Internal Med, Div Allergy & Clin Immunol, Seoul 110744, South Korea	Brown University; Brown University; Korea Institute of Toxicology; Seoul National University (SNU); Seoul National University Hospital	Lee, CG (corresponding author), Brown Univ, Alpert Med Sch, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.; Lee, K (corresponding author), Korea Inst Toxicol, Inhalat Toxicol Ctr, Jeongeup Campus, Jeollabuk Do 580185, South Korea.	khlee@kitox.re.kr; chun_lee@brown.edu	Lee, Chun Geun/AAC-2838-2021	Lee, Chun Geun/0000-0002-9514-3658; Cho, Won-Kyung/0000-0003-1540-545X	National Institutes of Health [RO1-HL115813, PO1-HL114501]; Korea Drug Development Fund - Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare Republic of Korea [201312-11]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130230, R01HL115813, P01HL114501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Drug Development Fund - Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare Republic of Korea; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RO1-HL115813 (to C. G. L.) and PO1-HL114501 (to J. A. E.) and Korea Drug Development Fund Grant 201312-11 funded by the Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare Republic of Korea (to P. O. Y. and C. G. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barik S, 2005, J MOL MED, V83, P764, DOI 10.1007/s00109-005-0690-0; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; BOTTEGA R, 1992, BIOCHEMISTRY-US, V31, P9025, DOI 10.1021/bi00152a045; BUNDSCHUH DS, 1995, IN VITRO CELL DEV-AN, V31, P684; Falsini S, 2014, J MED CHEM, V57, P1138, DOI 10.1021/jm400791q; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Gunther M, 2011, EUR J PHARM BIOPHARM, V77, P438, DOI 10.1016/j.ejpb.2010.11.007; Huang YY, 2011, MOL THER, V19, P381, DOI 10.1038/mt.2010.266; Izumi S, 2014, NEW ENGL J MED, V371, P781, DOI 10.1056/NEJMc1407776; Jeong JH, 2003, J CONTROL RELEASE, V93, P183, DOI 10.1016/j.jconrel.2003.07.002; Jeong JH, 2009, BIOCONJUGATE CHEM, V20, P5, DOI 10.1021/bc800278e; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Kang Hye-Ryun, 2008, Expert Rev Clin Pharmacol, V1, P547, DOI 10.1586/17512433.1.4.547; Kelly M, 2003, CURR PHARM DESIGN, V9, P39, DOI 10.2174/1381612033392341; Kesharwani P, 2012, BIOMATERIALS, V33, P7138, DOI 10.1016/j.biomaterials.2012.06.068; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; Khalil N, 2001, THORAX, V56, P907, DOI 10.1136/thorax.56.12.907; Kim JS, 2010, LAB ANIM-UK, V44, P20, DOI 10.1258/la.2009.009003; Kim SN, 2010, TOX RESEARCH, V26, P217, DOI 10.5487/TR.2010.26.3.217; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Krein PM, 2002, CHEST, V122, p289S, DOI 10.1378/chest.122.6_suppl.289S; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Lee H, 2012, NAT NANOTECHNOL, V7, P389, DOI [10.1038/nnano.2012.73, 10.1038/NNANO.2012.73]; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Maeda H, 2010, BIOCONJUGATE CHEM, V21, P797, DOI 10.1021/bc100070g; Maurer N, 2001, BIOPHYS J, V80, P2310, DOI 10.1016/S0006-3495(01)76202-9; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Nguyen DN, 2012, P NATL ACAD SCI USA, V109, pE797, DOI 10.1073/pnas.1121423109; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Raghu G., 1998, FISHMANS PULMONARY D, P1037; Rayego-Mateos S, 2013, J MOL CELL BIOL, V5, P323, DOI 10.1093/jmcb/mjt030; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sohn MH, 2010, AM J RESP CRIT CARE, V182, P918, DOI 10.1164/rccm.200912-1793OC; Viel T, 2008, OLIGONUCLEOTIDES, V18, P201, DOI 10.1089/oli.2008.0133; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Watts JK, 2008, DRUG DISCOV TODAY, V13, P842, DOI 10.1016/j.drudis.2008.05.007; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Xu YD, 2003, AM J PHYSIOL-LUNG C, V285, pL527, DOI 10.1152/ajplung.00298.2002; Yehualaeshet T, 2000, AM J RESP CELL MOL, V23, P204, DOI 10.1165/ajrcmb.23.2.4089; Zhang SB, 2012, J DRUG TARGET, V20, P724, DOI 10.3109/1061186X.2012.719232; Zhou Y, 2012, J BIOL CHEM, V287, P41991, DOI 10.1074/jbc.M112.356824	48	29	30	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6433	6446		10.1074/jbc.M115.693671	http://dx.doi.org/10.1074/jbc.M115.693671			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26817844	hybrid, Green Published			2022-12-28	WOS:000372894200031
J	Bracher, S; Guerin, K; Polyhach, Y; Jeschke, G; Dittmer, S; Frey, S; Bohm, M; Jung, H				Bracher, Susanne; Guerin, Kamila; Polyhach, Yevhen; Jeschke, Gunnar; Dittmer, Sophie; Frey, Sabine; Boehm, Maret; Jung, Heinrich			Glu-311 in External Loop 4 of the Sodium/Proline Transporter PutP Is Crucial for External Gate Closure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid transport; electron paramagnetic resonance (EPR); membrane protein; protein chemistry; protein conformation; PutP; proline; secondary transport; solute; sodium symport; spin labeling	TRANSMEMBRANE DOMAIN-IX; NA+/PROLINE TRANSPORTER; ESCHERICHIA-COLI; ALTERNATING-ACCESS; CONFORMATIONAL DYNAMICS; BACTERIAL HOMOLOG; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; LIGAND-BINDING; MECHANISM	The available structural information on LeuT and structurally related transporters suggests that external loop 4 (eL4) and the outer end of transmembrane domain (TM) 10 participate in the reversible occlusion of the outer pathway to the solute binding sites. Here, the functional significance of eL4 and the outer region of TM10 are explored using the sodium/proline symporter PutP as a model. Glu-311 at the tip of eL4, and various amino acids around the outer end of TM10 are identified as particularly crucial for function. Substitutions at these sites inhibit the transport cycle, and affect in part ligand binding. In addition, changes at selected sites induce a global structural alteration in the direction of an outward-open conformation. It is suggested that interactions between the tip of eL4 and the peptide backbone at the end of TM10 participate in coordinating conformational alterations underlying the alternating access mechanism of transport. Together with the structural information on LeuT-like transporters, the results further specify the idea that common design and functional principles are maintained across different transport families.	[Bracher, Susanne; Dittmer, Sophie; Frey, Sabine; Boehm, Maret; Jung, Heinrich] Univ Munich, Div Microbiol, Dept Biol 1, D-82152 Martinsried, Germany; [Guerin, Kamila; Polyhach, Yevhen; Jeschke, Gunnar] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Boehm, Maret] Kinghorn Canc Ctr, Garvan Inst Med Res, Canc Div, Prostate Res Grp, Darlinghurst, NSW 2010, Australia; [Boehm, Maret] Kinghorn Canc Ctr, Garvan Inst Med Res, Canc Div, Ovarian Res Grp, Darlinghurst, NSW 2010, Australia	University of Munich; ETH Zurich; Garvan Institute of Medical Research; Garvan Institute of Medical Research	Jung, H (corresponding author), Univ Munich, Div Microbiol, Dept Biol 1, Grosshaderner Str 2-4, D-82152 Martinsried, Germany.	hjung@lmu.de	Jung, Heinrich/K-3790-2014	Jung, Heinrich/0000-0002-5450-3063; Jeschke, Gunnar/0000-0001-6853-8585	NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michelle Eder for excellent technical assistance, and Emil Tonon who participated in the analyses in a lab research course (H. J. group). We also thank the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, supported by NIGMS P41-GM103311.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carland JE, 2014, NEUROCHEM INT, V73, P211, DOI 10.1016/j.neuint.2013.08.012; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Crawford JM, 2010, CURR BIOL, V20, P69, DOI 10.1016/j.cub.2009.10.059; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2013, SCIENCE, V339, P399, DOI 10.1126/science.1228465; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Hilger D, 2008, J BIOL CHEM, V283, P4921, DOI 10.1074/jbc.M706741200; Hilger D, 2009, BIOPHYS J, V96, P217, DOI 10.1016/j.bpj.2008.09.030; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Jeschke G, 2013, EUR BIOPHYS J BIOPHY, V42, P181, DOI 10.1007/s00249-012-0802-z; Jung H, 1998, J BIOL CHEM, V273, P26400, DOI 10.1074/jbc.273.41.26400; Jung H, 1998, BIOCHEMISTRY-US, V37, P11083, DOI 10.1021/bi980684b; Jung H, 2002, FEBS LETT, V529, P73, DOI 10.1016/S0014-5793(02)03184-8; Jung H, 2012, FRONT BIOSCI-LANDMRK, V17, P745, DOI 10.2741/3955; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kaback HR, 2015, P NATL ACAD SCI USA, V112, P1259, DOI 10.1073/pnas.1419325112; Kazmier K, 2014, P NATL ACAD SCI USA, V111, P14752, DOI 10.1073/pnas.1410431111; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Li Z, 2015, J BIOL CHEM, V290, P127, DOI 10.1074/jbc.M114.584383; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Olkhova E, 2011, J MOL BIOL, V406, P59, DOI 10.1016/j.jmb.2010.11.045; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirch T, 2003, J BIOL CHEM, V278, P42942, DOI 10.1074/jbc.M308253200; Pirch T, 2002, J BIOL CHEM, V277, P8790, DOI 10.1074/jbc.M111008200; Quick M, 1996, EUR J BIOCHEM, V239, P732, DOI 10.1111/j.1432-1033.1996.0732u.x; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Raba M, 2008, J MOL BIOL, V382, P884, DOI 10.1016/j.jmb.2008.07.070; Raba M, 2014, STRUCTURE, V22, P769, DOI 10.1016/j.str.2014.03.011; Rivera-Ordaz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083576; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Sala-Rabanal M, 2012, AM J PHYSIOL-CELL PH, V302, pC1293, DOI 10.1152/ajpcell.00397.2011; Schwan WR, 2006, INFECT IMMUN, V74, P399, DOI 10.1128/IAI.74.1.399-409.2006; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STALMACH ME, 1983, J BACTERIOL, V156, P481, DOI 10.1128/JB.156.2.481-486.1983; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Vilchez S, 2000, J BACTERIOL, V182, P91, DOI 10.1128/JB.182.1.91-99.2000; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wegener C, 2000, BIOCHEMISTRY-US, V39, P4831, DOI 10.1021/bi992442x; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zaprasis A, 2015, APPL ENVIRON MICROB, V81, P250, DOI 10.1128/AEM.02797-14; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zomot E, 2003, J BIOL CHEM, V278, P42950, DOI 10.1074/jbc.M209307200	54	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4998	5008		10.1074/jbc.M115.675306	http://dx.doi.org/10.1074/jbc.M115.675306			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26728461	hybrid, Green Published			2022-12-28	WOS:000371640600015
J	Maass, T; Bayley, CP; Morgelin, M; Lettmann, S; Bonaldo, P; Paulsson, M; Baldock, C; Wagener, R				Maass, Tobias; Bayley, Christopher P.; Morgelin, Matthias; Lettmann, Sandra; Bonaldo, Paolo; Paulsson, Mats; Baldock, Clair; Wagener, Raimund			Heterogeneity of Collagen VI Microfibrils STRUCTURAL ANALYSIS OF NON-COLLAGENOUS REGIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; electron microscopy (EM); extracellular matrix; single particle analysis; small-angle x-ray scattering (SAXS); VWA domain; microfibrils	SMALL-ANGLE SCATTERING; BIOLOGICAL MACROMOLECULES; BETHLEM MYOPATHY; ALPHA-3 CHAIN; DOMAIN; RESOLUTION; PROTEOGLYCAN; DEFICIENCY; MUTATIONS; SECRETION	Collagen VI, a collagen with uncharacteristically large N- and C-terminal non-collagenous regions, forms a distinct microfibrillar network in most connective tissues. It was long considered to consist of three genetically distinct chains (1, 2, and 3). Intracellularly, heterotrimeric molecules associate to form dimers and tetramers, which are then secreted and assembled to microfibrils. The identification of three novel long collagen VI chains, 4, 5, and 6, led to the question if and how these may substitute for the long 3 chain in collagen VI assembly. Here, we studied structural features of the novel long chains and analyzed the assembly of these into tetramers and microfibrils. N- and C-terminal globular regions of collagen VI were recombinantly expressed and studied by small angle x-ray scattering (SAXS). Ab initio models of the N-terminal globular regions of the 4, 5, and 6 chains showed a C-shaped structure similar to that found for the 3 chain. Single particle EM nanostructure of the N-terminal globular region of the 4 chain confirmed the C-shaped structure revealed by SAXS. Immuno-EM of collagen VI extracted from tissue revealed that like the 3 chain the novel long chains assemble to homotetramers that are incorporated into mixed microfibrils. Moreover, SAXS models of the C-terminal globular regions of the 1, 2, 4, and 6 chains were generated. Interestingly, the 1, 2, and 4 C-terminal globular regions dimerize. These self-interactions may play a role in tetramer formation.	[Maass, Tobias; Lettmann, Sandra; Paulsson, Mats; Wagener, Raimund] Univ Cologne, Ctr Biochem, Fac Med, D-50931 Cologne, Germany; [Paulsson, Mats; Wagener, Raimund] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Paulsson, Mats] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Paulsson, Mats] Univ Cologne, Ctr Musculoskeletal Biomech, D-50931 Cologne, Germany; [Bayley, Christopher P.; Baldock, Clair] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Morgelin, Matthias] Lund Univ, Div Infect Med, Dept Clin Sci, SE-22184 Lund, Sweden; [Bonaldo, Paolo] Univ Padua, Dept Mol Med, I-35131 Padua, Italy	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Manchester; Lund University; University of Padua	Wagener, R (corresponding author), Univ Cologne, Ctr Biochem, Fac Med, D-50931 Cologne, Germany.; Wagener, R (corresponding author), Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany.; Baldock, C (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.; Baldock, C (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.; Wagener, R (corresponding author), Univ Cologne, Fac Med, Inst Biochem 2, D-50931 Cologne, Germany.	clair.baldock@manchester.ac.uk; raimund.wagener@uni-koeln.de		Bonaldo, Paolo/0000-0002-9571-8140; Baldock, Clair/0000-0003-3497-1959	Deutsche Forschungsgemeinschaft [SFB829/B2]; Biotechnology and Biological Sciences Research Council [BB/I012265/1]; Boehringer Ingelheim Fonds; Swedish Research Council [7480]; Swedish Foundation for Strategic Research; Foundation of Crafoord; Foundation of Johan and Greta Kock; Foundation of Alfred Osterlund; Foundation of King Gustav V Memorial Fund; Medical Faculty at Lund University; BBSRC [BB/I019286/1, BB/I012265/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I019286/1] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Foundation of Crafoord; Foundation of Johan and Greta Kock; Foundation of Alfred Osterlund; Foundation of King Gustav V Memorial Fund; Medical Faculty at Lund University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant SFB829/B2 (to the R. W. and M. P. laboratories), Biotechnology and Biological Sciences Research Council Grant BB/I012265/1 (to C. B.), Boehringer Ingelheim Fonds (to T. M.), Swedish Research Council Project 7480, the Swedish Foundation for Strategic Research, the Foundations of Crafoord, Johan and Greta Kock, Alfred Osterlund, King Gustav V Memorial Fund, and the Medical Faculty at Lund University.	Aigner T, 2002, BIOCHEM BIOPH RES CO, V290, P743, DOI 10.1006/bbrc.2001.6227; ARNOUX B, 1995, J MOL BIOL, V246, P609, DOI 10.1006/jmbi.1994.0112; Ball S, 2003, J BIOL CHEM, V278, P15326, DOI 10.1074/jbc.M209977200; Ball SG, 2001, J BIOL CHEM, V276, P7422, DOI 10.1074/jbc.M002816200; BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405; Becker AKA, 2014, STRUCTURE, V22, P199, DOI 10.1016/j.str.2013.06.028; Beecher N, 2011, J BIOL CHEM, V286, P40266, DOI 10.1074/jbc.M111.265595; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Bonnemann Carsten G, 2011, Handb Clin Neurol, V101, P81, DOI 10.1016/B978-0-08-045031-5.00005-0; Burg MA, 1996, J BIOL CHEM, V271, P26110, DOI 10.1074/jbc.271.42.26110; Bushby KMD, 2014, ADV EXP MED BIOL, V802, P185, DOI 10.1007/978-94-007-7893-1_12; Cescon M, 2015, J CELL SCI, V128, P3525, DOI 10.1242/jcs.169748; CHU ML, 1990, ANN NY ACAD SCI, V580, P55, DOI 10.1111/j.1749-6632.1990.tb17917.x; COLOMBATTI A, 1989, MATRIX, V9, P177, DOI 10.1016/S0934-8832(89)80048-4; ENGVALL E, 1986, J CELL BIOL, V102, P703, DOI 10.1083/jcb.102.3.703; Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817; Fitzgerald J, 2001, J BIOL CHEM, V276, P187, DOI 10.1074/jbc.M008173200; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Gebauer JM, 2016, MATRIX BIOL, V49, P106, DOI 10.1016/j.matbio.2015.07.001; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Hunter JM, 2015, MOL GENET GENOM MED, V3, P283, DOI 10.1002/mgg3.142; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Knupp C, 2001, EMBO J, V20, P372, DOI 10.1093/emboj/20.3.372; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Merlini L, 2008, NEUROLOGY, V71, P1245, DOI 10.1212/01.wnl.0000327611.01687.5e; PEACOCK AC, 1968, BIOCHEMISTRY-US, V7, P668, DOI 10.1021/bi00842a023; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; ROTH J, 1980, J HISTOCHEM CYTOCHEM, V28, P55, DOI 10.1177/28.1.6153194; Scacheri PC, 2002, NEUROLOGY, V58, P593, DOI 10.1212/WNL.58.4.593; SPISSINGER T, 1995, MATRIX BIOL, V14, P499, DOI 10.1016/0945-053X(95)90007-1; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tooley LD, 2010, J BIOL CHEM, V285, P33567, DOI 10.1074/jbc.M110.152520; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wagener R, 2009, MATRIX BIOL, V28, P307, DOI 10.1016/j.matbio.2009.05.003; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Zech M, 2015, AM J HUM GENET, V96, P883, DOI 10.1016/j.ajhg.2015.04.010	50	17	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5247	5258		10.1074/jbc.M115.705160	http://dx.doi.org/10.1074/jbc.M115.705160			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26742845	Green Published, hybrid			2022-12-28	WOS:000371640600035
J	Inoue, K; Nomura, Y; Kandori, H				Inoue, Keiichi; Nomura, Yurika; Kandori, Hideki			Asymmetric Functional Conversion of Eubacterial Light-driven Ion Pumps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON TRANSPORT; RHODOPSINS; CHLORIDE; BACTERIORHODOPSIN; TRANSLOCATION; HALORHODOPSIN; PHOTOCYCLE	In addition to the well-known light-driven outward proton pumps, novel ion-pumping rhodopsins functioning as outward Na+ and inward Cl- pumps have been recently found in eubacteria. They convert light energy into transmembrane electrochemical potential difference, similar to the prototypical archaeal H+ pump bacteriorhodopsin (BR) and Cl- pump halorhodopsin (HR). The H+, Na+, and Cl- pumps possess the conserved respective DTE, NDQ, and NTQ motifs in the helix C, which likely serve as their functional determinants. To verify this hypothesis, we attempted functional interconversion between selected pumps from each category by mutagenesis. Introduction of the proton-pumping motif resulted in successful Na+ -> H+ functional conversion. Introduction of the respective characteristic motifs with several additional mutations leads to successful Na+ -> Cl- and Cl- -> 3 H+ functional conversions, whereas remaining conversions (H+ -> Na+, H+ -> Cl-, Cl- -> Na+) were unsuccessful when mutagenesis of 4-6 residues was used. Phylogenetic analysis suggests that a H+ pump is the common ancestor of all of these rhodopsins, from which Cl- pumps emerged followed by Na+ pumps. We propose that successful functional conversions of these ion pumps are achieved exclusively when mutagenesis reverses the evolutionary amino acid sequence changes. Dependence of the observed functional conversions on the direction of evolution strongly suggests that the essential structural mechanism of an ancestral function is retained even after the gain of a new function during natural evolution, which can be evoked by a few mutations. By contrast, the gain of a new function needs accumulation of multiple mutations, which may not be easily reproduced by limited mutagenesis in vitro.	[Inoue, Keiichi; Nomura, Yurika; Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan; [Inoue, Keiichi] Japan Sci & Technol Agcy, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan	Nagoya Institute of Technology; Nagoya Institute of Technology; Japan Science & Technology Agency (JST)	Kandori, H (corresponding author), Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan.	kandori@nitech.ac.jp	Inoue, Keiichi/AEO-3337-2022	Inoue, Keiichi/0000-0002-6898-4347	Japanese Ministry of Education, Culture, Sports, Science, and Technology [26708001, 26115706, 26620005, 25104009, 15H02391]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to K. I.) (26708001, 26115706, 26620005) and to H.K. (25104009, 15H02391). The authors declare that they have no conflicts of interest with the contents of this article.	Balashov SP, 2014, BIOCHEMISTRY-US, V53, P7549, DOI 10.1021/bi501064n; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; da Silva GFZ, 2015, BIOCHEMISTRY-US, V54, P3950, DOI 10.1021/bi501386d; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gushchin I, 2015, NAT STRUCT MOL BIOL, V22, P390, DOI 10.1038/nsmb.3002; HAVELKA WA, 1995, J MOL BIOL, V247, P726, DOI 10.1006/jmbi.1995.0176; Hegemann P, 2011, NAT METHODS, V8, P39, DOI 10.1038/NMETH.F.327; Inoue K, 2015, TRENDS MICROBIOL, V23, P91, DOI 10.1016/j.tim.2014.10.009; Inoue K, 2014, J PHYS CHEM B, V118, P11190, DOI 10.1021/jp507219q; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; Miranda MRM, 2009, BIOPHYS J, V96, P1471, DOI 10.1016/j.bpj.2008.11.026; Muroda K, 2012, BIOCHEMISTRY-US, V51, P4677, DOI 10.1021/bi300485r; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SASAKI J, 1995, SCIENCE, V269, P73, DOI 10.1126/science.7604281; Sato M, 2005, BIOCHEMISTRY-US, V44, P4775, DOI 10.1021/bi047500f; SCHARF B, 1992, BIOCHEMISTRY-US, V31, P12486, DOI 10.1021/bi00164a027; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tittor J, 1997, J MOL BIOL, V271, P405, DOI 10.1006/jmbi.1997.1204; Varo G, 2003, BIOPHYS J, V84, P1202, DOI 10.1016/S0006-3495(03)74934-0; Varo G, 1996, BIOCHEMISTRY-US, V35, P6604, DOI 10.1021/bi9601159; VARO G, 1995, BIOPHYS J, V68, P2062, DOI 10.1016/S0006-3495(95)80385-1; Yoshizawa S, 2014, P NATL ACAD SCI USA, V111, P6732, DOI 10.1073/pnas.1403051111; ZUCKERKANDL EMILE, 1965, P97	30	34	34	5	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9883	9893		10.1074/jbc.M116.716498	http://dx.doi.org/10.1074/jbc.M116.716498			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26929409	Green Published, hybrid			2022-12-28	WOS:000375602800003
J	Greifenhagen, U; Frolov, A; Bluher, M; Hoffmann, R				Greifenhagen, Uta; Frolov, Andrej; Blueher, Matthias; Hoffmann, Ralf			Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOHISTOCHEMICAL DETECTION; PHYSIOLOGICAL CONDITIONS; MAILLARD REACTION; AMADORI COMPOUNDS; MASS-SPECTROMETRY; MOLECULAR-BASIS; IN-VIVO; DEGRADATION; METHYLGLYOXAL; PEPTIDES	Protein glycation refers to the reversible reaction between aldoses (or ketoses) and amino groups yielding relatively stable Amadori (or Heyns) products. Consecutive oxidative cleavage reactions of these products or the reaction of amino groups with other reactive substances (e.g. alpha-dicarbonyls) yield advanced glycation end products (AGEs) that can alter the structures and functions of proteins. AGEs have been identified in all organisms, and their contents appear to rise with some diseases, such as diabetes and obesity. Here, we report a pilot study using highly sensitive and specific proteomics approach to identify and quantify AGE modification sites in plasma proteins by reversed phase HPLC mass spectrometry in tryptic plasma digests. In total, 19 AGE modification sites corresponding to 11 proteins were identified in patients with type 2 diabetes mellitus under poor glycemic control. The modification degrees of 15 modification sites did not differ among cohorts of normoglycemic lean or obese and type 2 diabetes mellitus patients under good and poor glycemic control. The contents of two amide-AGEs in human serum albumin and apolipoprotein A-II were significantly higher in patients with poor glycemic control, although the plasma levels of both proteins were similar among all plasma samples. These two modification sites might be useful to predict long term, AGE-related complications in diabetic patients, such as impaired vision, increased arterial stiffness, or decreased kidney function.	[Greifenhagen, Uta; Frolov, Andrej; Hoffmann, Ralf] Univ Leipzig, Inst Bioanalyt Chem, Fac Chem & Mineral, D-04103 Leipzig, Germany; [Greifenhagen, Uta; Frolov, Andrej; Hoffmann, Ralf] Univ Leipzig, Ctr Biotechnol & Biomed, D-04103 Leipzig, Germany; [Blueher, Matthias] Univ Leipzig, Dept Med, Endocrinol, D-04103 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Hoffmann, R (corresponding author), Biotechnol Biomed Zentrum, Inst Bioanalyt Chem, Deutsch Pl 5, D-04103 Leipzig, Germany.	hoffmann@chemie.uni-leipzig.de	Frolov, Andrej A/V-5550-2018; Hoffmann, Ralf/ABD-8779-2020	Herfurth, Uta/0000-0002-3883-3230	Deutsche Forschungsgemeinschaft [HO-2222/7-1, SFB1052-B1]; Free State Saxony; Ernst Schering foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Free State Saxony; Ernst Schering foundation	This work was supported by Deutsche Forschungsgemeinschaft Grants HO-2222/7-1 (to R. H.) and SFB1052-B1 (to M. B.), funds from the Free State Saxony (to R. H.), and a Ph.D. fellowship of the Ernst Schering foundation (to U. G.). The authors declare that they have no conflicts of interest with the contents of this article.	AHMED MU, 1986, J BIOL CHEM, V261, P4889; Ahmed N, 2002, BIOCHEM J, V364, P1; Akira K, 2005, BIOL PHARM BULL, V28, P344, DOI 10.1248/bpb.28.344; Babaei-Jadidi R, 2003, DIABETES, V52, P2110, DOI 10.2337/diabetes.52.8.2110; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRON AJ, 1993, EYE, V7, P260, DOI 10.1038/eye.1993.60; Ceriello A, 2009, J CLIN ENDOCR METAB, V94, P410, DOI 10.1210/jc.2008-1824; Chetyrkin SV, 2008, FREE RADICAL BIO MED, V44, P1276, DOI 10.1016/j.freeradbiomed.2007.09.016; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Finamore F, 2015, J PROTEOMICS, V114, P125, DOI 10.1016/j.jprot.2014.11.005; Frolov A, 2014, ANAL BIOANAL CHEM, V406, P5755, DOI 10.1007/s00216-014-8018-y; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Gobert J, 2009, J AGR FOOD CHEM, V57, P8591, DOI 10.1021/jf9019085; Greifenhagen U, 2015, AMINO ACIDS, V47, P1065, DOI 10.1007/s00726-015-1940-2; Greifenhagen U, 2015, J PROTEOME RES, V14, P768, DOI 10.1021/pr500799m; Hasenkopf K, 2002, J AGR FOOD CHEM, V50, P5697, DOI 10.1021/jf020411u; Henning C, 2011, J BIOL CHEM, V286, P44350, DOI 10.1074/jbc.M111.282442; HIRSCH J, 1995, CARBOHYD RES, V273, P171, DOI 10.1016/0008-6215(95)00114-9; Hull GLJ, 2013, J CLIN BIOCHEM NUTR, V53, P129, DOI 10.3164/jcbn.13-5; Jakas A, 2008, J PEPT SCI, V14, P936, DOI 10.1002/psc.1029; Kilhovd BK, 2003, METABOLISM, V52, P163, DOI 10.1053/meta.2003.50035; Koito W, 2004, J BIOCHEM, V136, P831, DOI 10.1093/jb/mvh193; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liyasova MS, 2010, BIOCHEM PHARMACOL, V79, P784, DOI 10.1016/j.bcp.2009.10.007; Loidl-Stahlhofen A., 1994, BIOCHIM BIOPHYS ACTA, V1211, P156; MIYATA S, 1992, J CLIN INVEST, V89, P1102, DOI 10.1172/JCI115690; Miyazaki K, 2002, J BIOCHEM, V132, P543, DOI 10.1093/oxfordjournals.jbchem.a003255; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Niwa T, 1997, J CLIN INVEST, V99, P1272, DOI 10.1172/JCI119285; NIWA T, 1995, KIDNEY INT, V48, P771, DOI 10.1038/ki.1995.349; NIYATISHIRKHODAEE F, 1993, J AGR FOOD CHEM, V41, P227, DOI 10.1021/jf00026a016; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; RAY M, 1987, J BIOL CHEM, V262, P5974; Schalkwijk CG, 2004, DIABETES-METAB RES, V20, P369, DOI 10.1002/dmrr.488; Schmidt R, 2015, J MASS SPECTROM, V50, P613, DOI 10.1002/jms.3569; Sell DR, 2012, GERONTOLOGY, V58, P227, DOI 10.1159/000334668; SELL DR, 1989, J BIOL CHEM, V264, P21597; SMITH PR, 1992, EUR J BIOCHEM, V210, P729, DOI 10.1111/j.1432-1033.1992.tb17474.x; Smuda M, 2015, BIOCHEMISTRY-US, V54, P2500, DOI 10.1021/bi5013194; Smuda M, 2010, J AGR FOOD CHEM, V58, P6458, DOI 10.1021/jf100334r; Stitt AW, 2010, INVEST OPHTH VIS SCI, V51, P4867, DOI 10.1167/iovs.10-5881; THORNALLEY P, 1984, BIOCHIM BIOPHYS ACTA, V797, P276, DOI 10.1016/0304-4165(84)90131-4; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Uchida K, 1997, FEBS LETT, V410, P313, DOI 10.1016/S0014-5793(97)00610-8; UCHIYAMA A, 1991, J BIOCHEM, V110, P714, DOI 10.1093/oxfordjournals.jbchem.a123646; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; Venkatraman J, 2001, CHEM BIOL, V8, P611, DOI 10.1016/S1074-5521(01)00036-9; WALKER JE, 1976, FEBS LETT, V66, P173, DOI 10.1016/0014-5793(76)80496-6; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; YAN SD, 1994, P NATL ACAD SCI USA, V91, P7787, DOI 10.1073/pnas.91.16.7787; Zhang QB, 2008, J PROTEOME RES, V7, P2025, DOI 10.1021/pr700763r; Zhang QB, 2011, J PROTEOME RES, V10, P3076, DOI 10.1021/pr200040j; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29; ZYZAK DV, 1995, ARCH BIOCHEM BIOPHYS, V316, P547, DOI 10.1006/abbi.1995.1073	56	24	26	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9610	9616		10.1074/jbc.M115.702860	http://dx.doi.org/10.1074/jbc.M115.702860			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26933035	Green Published, hybrid			2022-12-28	WOS:000375602300019
J	Stempel, H; Jung, M; Perez-Gomez, A; Leinders-Zufall, T; Zufall, F; Bufe, B				Stempel, Hendrik; Jung, Martin; Perez-Gomez, Anabel; Leinders-Zufall, Trese; Zufall, Frank; Bufe, Bernd			Strain-specific Loss of Formyl Peptide Receptor 3 in the Murine Vomeronasal and Immune Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY NEURONS; MICROGLIAL CELLS; DENDRITIC CELLS; MHC PEPTIDES; MOUSE; RECOGNITION; NEUTROPHILS; ACTIVATION; BEHAVIOR; FAMILY	Formyl peptide receptor 3 (Fpr3, also known as Fpr-rs1) is aG protein-coupled receptor expressed in subsets of sensory neurons of the mouse vomeronasal organ, an olfactory substructure essential for social recognition. Fpr3 has been implicated in the sensing of infection-associated olfactory cues, but its expression pattern and function are incompletely understood. To facilitate visualization of Fpr3-expressing cells, we generated and validated two new anti-Fpr3 antibodies enabling us to analyze acute Fpr3 protein expression. Fpr3 is not only expressed in murine vomeronasal sensory neurons but also in bone marrow cells, the primary source for immune cell renewal, and in mature neutrophils. Consistent with the notion that Fpr3 functions as a pathogen sensor, Fpr3 expression in the immune system is up-regulated after stimulation with a bacterial endotoxin (lipopolysaccharide). These results strongly support a dual role for Fpr3 in both vomeronasal sensory neurons and immune cells. We also identify a large panel of mouse strains with severely altered expression and function of Fpr3, thus establishing the existence of natural Fpr3 knock-out strains. Weattribute distinct Fpr3 expression in these strains to the presence or absence of a 12-nucleotide in-frame deletion (Fpr3 Delta 424-435). In vitro calcium imaging and immunofluorescence analyses demonstrate that the lack of four amino acids leads to an unstable, truncated, and non-functional receptor protein. The genome of at least 19 strains encodes a non-functional Fpr3 variant, whereas at least 13 other strains express an intact receptor. These results provide a foundation for understanding the in vivo function of Fpr3.	[Stempel, Hendrik; Perez-Gomez, Anabel; Leinders-Zufall, Trese; Zufall, Frank; Bufe, Bernd] Univ Saarland, Sch Med, Ctr Integrat Physiol & Mol Med, Kirrbergerstr Bldg 48, D-66421 Homburg, Germany; [Jung, Martin] Univ Saarland, Sch Med, Dept Biochem, D-66421 Homburg, Germany	Saarland University; Saarland University	Bufe, B (corresponding author), Univ Saarland, Sch Med, Ctr Integrat Physiol & Mol Med, Kirrbergerstr Bldg 48, D-66421 Homburg, Germany.	bernd.bufe@uks.eu	Zufall, Frank/AAE-5290-2021; Leinders-Zufall, Trese/B-4103-2009; Jung, Martin/AAM-4547-2021; Leinders-Zufall, Trese/S-3664-2019; Jung, Martin/D-2207-2012	Zufall, Frank/0000-0002-4383-8618; Leinders-Zufall, Trese/0000-0002-0678-362X; Jung, Martin/0000-0002-1482-7020; Leinders-Zufall, Trese/0000-0002-0678-362X; Jung, Martin/0000-0002-1482-7020	Deutsche Forschungsgemeinschaft [INST 256/271-1 FUGG, Sonderforschungsbereich 894, Schwerpunktprogramm 1392]; Volkswagen Foundation; University of Saarland through HOMFORexcellence Grant	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); University of Saarland through HOMFORexcellence Grant	This work was supported by Deutsche Forschungsgemeinschaft Grant INST 256/271-1 FUGG (to F. Z. and B. B.), Sonderforschungsbereich 894 Projects A17 (to F. Z.) and P3 (to M. J.), Schwerpunktprogramm 1392 (to F. Z. and T. L.-Z.), the Volkswagen Foundation (to T. L.-Z.), and by the University of Saarland through HOMFORexcellence Grant 2011 (to B. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Arakawa H, 2012, BRAIN BEHAV IMMUN, V26, P40, DOI 10.1016/j.bbi.2011.07.231; Arakawa H, 2011, NEUROSCI BIOBEHAV R, V35, P1916, DOI 10.1016/j.neubiorev.2011.03.007; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bloes DA, 2015, NAT REV MICROBIOL, V13, P95, DOI 10.1038/nrmicro3390; Boehm T, 2006, TRENDS NEUROSCI, V29, P100, DOI 10.1016/j.tins.2005.11.006; Boillat M, 2015, CURR BIOL, V25, P251, DOI 10.1016/j.cub.2014.11.061; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2015, J BIOL CHEM, V290, P7369, DOI 10.1074/jbc.M114.626747; Bufe B, 2012, J BIOL CHEM, V287, P33644, DOI 10.1074/jbc.M112.375774; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Chamero P, 2012, TRENDS NEUROSCI, V35, P597, DOI 10.1016/j.tins.2012.04.011; Chamero P, 2011, P NATL ACAD SCI USA, V108, P12898, DOI 10.1073/pnas.1107770108; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cui YH, 2002, J IMMUNOL, V168, P434, DOI 10.4049/jimmunol.168.1.434; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Gao JL, 1998, GENOMICS, V51, P270, DOI 10.1006/geno.1998.5376; Gowen JW, 1943, P NATL ACAD SCI USA, V29, P144, DOI 10.1073/pnas.29.5.144; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Iribarren P, 2003, J IMMUNOL, V171, P5482, DOI 10.4049/jimmunol.171.10.5482; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Kavaliers M, 2005, NEUROSCI BIOBEHAV R, V29, P1347, DOI 10.1016/j.neubiorev.2005.04.011; Kavaliers M, 2005, TRENDS PARASITOL, V21, P423, DOI 10.1016/j.pt.2005.07.008; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lai L, 1998, J IMMUNOL, V160, P3861; Lee HY, 2004, EXP MOL MED, V36, P135, DOI 10.1038/emm.2004.20; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2014, J NEUROSCI, V34, P5121, DOI 10.1523/JNEUROSCI.0186-14.2014; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Li Q, 2015, CURR BIOL, V25, pR120, DOI 10.1016/j.cub.2014.11.044; Liberles SD, 2014, ANNU REV PHYSIOL, V76, P151, DOI 10.1146/annurev-physiol-021113-170334; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Margolis F L, 1982, Scand J Immunol Suppl, V9, P181; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Olsson MJ, 2014, PSYCHOL SCI, V25, P817, DOI 10.1177/0956797613515681; Perez-Gomez A, 2015, CURR BIOL, V25, P1340, DOI 10.1016/j.cub.2015.03.026; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P274, DOI 10.1016/j.conb.2010.02.013; Sturm T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2610; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang ZG, 2002, GENE, V299, P57, DOI 10.1016/S0378-1119(02)01012-0; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	54	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9762	9775		10.1074/jbc.M116.714493	http://dx.doi.org/10.1074/jbc.M116.714493			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26957543	hybrid, Green Published			2022-12-28	WOS:000375602300033
J	Kook, S; Wang, P; Young, LR; Schwake, M; Saftig, P; Weng, XL; Meng, Y; Neculai, D; Marks, MS; Gonzales, L; Beers, MF; Guttentag, S				Kook, Seunghyi; Wang, Ping; Young, Lisa R.; Schwake, Michael; Saftig, Paul; Weng, Xialian; Meng, Ying; Neculai, Dante; Marks, Michael S.; Gonzales, Linda; Beers, Michael F.; Guttentag, Susan			Impaired Lysosomal Integral Membrane Protein 2-dependent Peroxiredoxin 6 Delivery to Lamellar Bodies Accounts for Altered Alveolar Phospholipid Content in Adaptor Protein-3-deficient pearl Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; lung; peroxiredoxin; phospholipid metabolism; trafficking; AP-3; Hermansky Pudlak syndrome; alveolar epithelial type 2 cell; lamellar body; peroxiredoxin 6	HERMANSKY-PUDLAK-SYNDROME; CHEDIAK-HIGASHI-SYNDROME; PULMONARY SURFACTANT; LUNG SURFACTANT; AP-3 ADAPTER; MOUSE MODEL; 1-CYS PEROXIREDOXIN; BODY DEGENERATION; EPITHELIAL-CELLS; BETA-3A SUBUNIT	The Hermansky Pudlak syndromes (HPS) constitute a family of disorders characterized by oculocutaneous albinism and bleeding diathesis, often associated with lethal lung fibrosis. HPS results from mutations in genes of membrane trafficking complexes that facilitate delivery of cargo to lysosome-related organelles. Among the affected lysosome-related organelles are lamellar bodies (LB) within alveolar type 2 cells (AT2) in which surfactant components are assembled, modified, and stored. AT2 from HPS patients and mouse models of HPS exhibit enlarged LB with increased phospholipid content, but the mechanism underlying these defects is unknown. We now show that AT2 in the pearl mouse model of HPS type 2 lacking the adaptor protein 3 complex (AP-3) fails to accumulate the soluble enzyme peroxiredoxin 6 (PRDX6) in LB. This defect reflects impaired AP-3-dependent trafficking of PRDX6 to LB, because pearl mouse AT2 cells harbor a normal total PRDX6 content. AP-3-dependent targeting of PRDX6 to LB requires the transmembrane protein LIMP-2/SCARB2, a known AP-3-dependent cargo protein that functions as a carrier for lysosomal proteins in other cell types. Depletion of LB PRDX6 in AP-3- or LIMP-2/SCARB2-deficient mice correlates with phospholipid accumulation in lamellar bodies and with defective intraluminal degradation of LB disaturated phosphatidylcholine. Furthermore, AP-3-dependent LB targeting is facilitated by protein/protein interaction between LIMP-2/SCARB2 and PRDX6 in vitro and in vivo. Our data provide the first evidence for an AP-3-dependent cargo protein required for the maturation of LB in AT2 and suggest that the loss of PRDX6 activity contributes to the pathogenic changes in LB phospholipid homeostasis found HPS2 patients.	[Kook, Seunghyi; Wang, Ping; Guttentag, Susan] Vanderbilt Univ, Sch Med, Dept Pediat, Div Neonatol, Nashville, TN 37232 USA; [Young, Lisa R.] Vanderbilt Univ, Sch Med, Dept Pediat, Div Pediat Pulm Med, Nashville, TN 37232 USA; [Schwake, Michael] Univ Bielefeld, Dept Chem Biochem 3, D-33615 Bielefeld, Germany; [Saftig, Paul] Univ Kiel, Inst Biochem, Olshausenstr 40, D-24098 Kiel, Germany; [Weng, Xialian; Meng, Ying; Neculai, Dante] Zhejiang Univ, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China; [Marks, Michael S.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Marks, Michael S.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Marks, Michael S.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Gonzales, Linda; Beers, Michael F.] Univ Penn, Perelman Sch Med, Dept Med, Div Adult Pulm & Crit Care Med, Philadelphia, PA 19104 USA	Vanderbilt University; Vanderbilt University; University of Bielefeld; University of Kiel; Zhejiang University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Guttentag, S (corresponding author), 11111 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA.	susan.guttentag@vanderbilt.edu	Neculai, Dante/A-9923-2011; Saftig, Paul/A-7966-2010; Guttentag, Susan H/D-8705-2013; Guttentag, Susan/ABE-7405-2020; Marks, Michael S/Q-7223-2019	Neculai, Dante/0000-0001-8887-9168; Guttentag, Susan H/0000-0003-4420-5879; Guttentag, Susan/0000-0003-4420-5879; Marks, Michael S/0000-0001-7435-7262; Schwake, Michael/0000-0002-4173-2166	American Heart Association [12GRNT 12050265, 13GRNT17070104]; National Institutes of Health [HL059959, HL119503, HL119436, GM108807]; Department of Veterans Affairs Merit Award [BX001176]; Hermansky-Pudlak Syndrome Network; Deutsche Forschungsgemeinschaft [GRK1459]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119503, R01HL059959, R01HL119436, R56HL059959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108807] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001176] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); Hermansky-Pudlak Syndrome Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by American Heart Association Grants 12GRNT 12050265 (to S. G.) and 13GRNT17070104 (to M. F. B.), National Institutes of Health Grants HL059959 (to S. G.), HL119503 (to L. Y.), HL119436 (to M. F. B.), and GM108807 (to S. G. and M. M.), Department of Veterans Affairs Merit Award BX001176 (to M. F. B.), the Hermansky-Pudlak Syndrome Network, and Deutsche Forschungsgemeinschaft Grant GRK1459. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atochina-Vasserman EN, 2011, AM J RESP CRIT CARE, V184, P449, DOI 10.1164/rccm.201011-1882OC; Bachli EB, 2004, AM J MED GENET A, V127A, P201, DOI 10.1002/ajmg.a.20683; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; Bates SR, 2008, AM J PHYSIOL-LUNG C, V295, pL658, DOI 10.1152/ajplung.90233.2008; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; CHANDER A, 1986, J BIOL CHEM, V261, P6126; Chapuy B, 2008, TRAFFIC, V9, P1157, DOI 10.1111/j.1600-0854.2008.00745.x; Cheong N, 2007, J BIOL CHEM, V282, P23811, DOI 10.1074/jbc.M703927200; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; FISHER AB, 1987, J APPL PHYSIOL, V62, P2295, DOI 10.1152/jappl.1987.62.6.2295; FISHER AB, 1992, BIOCHEM J, V288, P407, DOI 10.1042/bj2880407; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V280, pL748, DOI 10.1152/ajplung.2001.280.4.L748; Fisher AB, 2006, BBA-MOL CELL BIOL L, V1761, P785, DOI 10.1016/j.bbalip.2006.05.009; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; Fitzgerald ML, 2007, J LIPID RES, V48, P621, DOI 10.1194/jlr.M600449-JLR200; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Gochuico BR, 2012, MOL MED, V18, P56, DOI 10.2119/molmed.2011.00198; Guttentag SH, 2005, AM J RESP CELL MOL, V33, P14, DOI 10.1165/rcmb.2004-0293OC; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Kakihana T, 2013, J BIOL CHEM, V288, P29586, DOI 10.1074/jbc.M113.467845; Kim TS, 1998, AM J PHYSIOL-LUNG C, V274, pL750, DOI 10.1152/ajplung.1998.274.5.L750; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Li ZJ, 2013, P NATL ACAD SCI USA, V110, P5004, DOI 10.1073/pnas.1218620110; Lyerla TA, 2003, AM J PHYSIOL-LUNG C, V285, pL643, DOI 10.1152/ajplung.00024.2003; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Manevich Y, 2002, P NATL ACAD SCI USA, V99, P11599, DOI 10.1073/pnas.182384499; Manevich Y, 2007, J LIPID RES, V48, P2306, DOI 10.1194/jlr.M700299-JLR200; Manevich Y, 2009, ARCH BIOCHEM BIOPHYS, V485, P139, DOI 10.1016/j.abb.2009.02.008; MARINETTI GV, 1962, BIOCHEMISTRY-US, V1, P350, DOI 10.1021/bi00908a024; Marks MS, 2013, CURR OPIN CELL BIOL, V25, P495, DOI 10.1016/j.ceb.2013.04.008; McGarry MP, 1999, P SOC EXP BIOL MED, V220, P162, DOI 10.1046/j.1525-1373.1999.d01-24.x; Meng RH, 2010, EXP HEMATOL, V38, P104, DOI 10.1016/j.exphem.2009.09.010; Nakatani Y, 2000, VIRCHOWS ARCH, V437, P304, DOI 10.1007/s004280000241; Neculai D, 2013, NATURE, V504, P172, DOI 10.1038/nature12684; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; Osanai K, 2008, AM J PATHOL, V173, P1265, DOI 10.2353/ajpath.2008.080056; Osanai K, 2010, AM J PHYSIOL-LUNG C, V298, pL243, DOI 10.1152/ajplung.00242.2009; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Postle AD, 2011, CHEM PHYS LIPIDS, V164, P549, DOI 10.1016/j.chemphyslip.2011.04.004; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Ridsdale R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016482; ROONEY SA, 1994, FASEB J, V8, P957, DOI 10.1096/fasebj.8.12.8088461; Salazar G, 2004, J BIOL CHEM, V279, P25430, DOI 10.1074/jbc.M402331200; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Sitaram A, 2012, MOL BIOL CELL, V23, P3178, DOI 10.1091/mbc.E11-06-0509; Sitaram A, 2012, PHYSIOLOGY, V27, P85, DOI 10.1152/physiol.00043.2011; Sorokina EM, 2011, AM J PHYSIOL-CELL PH, V300, pC1430, DOI 10.1152/ajpcell.00285.2010; Sorokina EM, 2009, AM J PHYSIOL-LUNG C, V297, pL871, DOI 10.1152/ajplung.00052.2009; Tang XY, 2005, PATHOL INT, V55, P137, DOI 10.1111/j.1440-1827.2005.01811.x; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016/S1084952102000551; Wei AH, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12051; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Whitsett JA, 2015, ANNU REV PATHOL-MECH, V10, P371, DOI 10.1146/annurev-pathol-012513-104644; Yang W, 2000, J CELL SCI, V113, P4077; Young LR, 2012, AM J RESP CRIT CARE, V186, P1014, DOI 10.1164/rccm.201207-1206OC; Zhang LH, 2011, AM J PHYSIOL-LUNG C, V301, pL461, DOI 10.1152/ajplung.00056.2011	67	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8414	8427		10.1074/jbc.M116.720201	http://dx.doi.org/10.1074/jbc.M116.720201			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26907692	Green Published, hybrid			2022-12-28	WOS:000374773200009
J	Tsukagoshi, Y; Suzuki, H; Seki, H; Muranaka, T; Ohyama, K; Fujimoto, Y				Tsukagoshi, Yuki; Suzuki, Hideyuki; Seki, Hikaru; Muranaka, Toshiya; Ohyama, Kiyoshi; Fujimoto, Yoshinori			Ajuga 24-Sterol Reductase Catalyzes the Direct Reductive Conversion of 24-Methylenecholesterol to Campesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; enzyme mechanism; plant biochemistry; reductase; sterol	REPTANS VAR ATROPURPUREA; HAIRY ROOTS; HIGHER-PLANTS; SITOSTEROL BIOSYNTHESIS; AMSONIA-ELLIPTICA; CULTURED-CELLS; DOUBLE-BOND; CHOLESTEROL; STEROLS; MECHANISM	Dimunito/Dwarf1 (DWF1) is an oxidoreductase enzyme that is responsible for the conversion of C-28- and C-29-(24(28))-olefinic sterols to 24-methyl- and 24-ethylcholesterols. Generally, the reaction proceeds in two steps via the (24(25)) intermediate. In this study, we characterized the ArDWF1 gene from an expression sequence tag library of Ajuga reptans var. atropurpurea hairy roots. The gene was functionally expressed in the yeast T21 strain. The in vivo and in vitro study of the transformed yeast indicated that ArDWF1 catalyzes the conversion of 24-methylenecholesterol to campesterol. A labeling study followed by GC-MS analysis suggested that the reaction proceeded with retention of the C-25 hydrogen. The 25-H retention was established by the incubation of the enzyme with (23,23,25-H-2(3),28-C-13)-24-methylenecholesterol, followed by C-13 NMR analysis of the resulting campesterol. Thus, it has been concluded that ArDWF1 directly reduces 24-methylenecholesterol to produce campesterol without passing through a (24(25)) intermediate. This is the first characterization of such a unique DWF1 enzyme. For comparison purposes, Oryza sativa DWF1 (OsDWF1) was similarly expressed in yeast. An in vivo assay of OsDWF1 supported the generally accepted two-step mechanism because the C-25 hydrogen of 24-methylenecholesterol was eliminated during its conversion to 24-methylcholesterol. As expected, the 24-methylcholesterol produced by OsDWF1 was a mixture of campesterol and dihydrobrassicasterol. Furthermore, the 24-methylcholesterol contained in the Ajuga hairy roots was determined to be solely campesterol through its analysis using chiral GC-MS. Therefore, ArDWF1 has another unique property in that only campesterol is formed by the direct reduction catalyzed by the enzyme.	[Tsukagoshi, Yuki; Ohyama, Kiyoshi; Fujimoto, Yoshinori] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan; [Suzuki, Hideyuki] Kazusa DNA Res Inst, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 2920818, Japan; [Seki, Hikaru; Muranaka, Toshiya] Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan	Tokyo Institute of Technology; Kazusa DNA Research Institute; Osaka University	Fujimoto, Y (corresponding author), Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan.	fujimoto.y.aa@gmail.com	Muranaka, Toshiya/D-4351-2016; Suzuki, Hideyuki/J-7571-2016; Seki, Hikaru/C-9730-2017	Muranaka, Toshiya/0000-0003-1058-2473; 	Ministry of Education, Culture, Sports, Science, and Technology [26450138]; Grants-in-Aid for Scientific Research [26350967] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (C) 26450138 (to K. O.) from the Ministry of Education, Culture, Sports, Science, and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	CAMPS F, 1983, AN QUIM C-ORG BIOQ, V79, P228; Du LQ, 2005, NATURE, V437, P741, DOI 10.1038/nature03973; FONTENEAU P, 1977, PLANT SCI LETT, V10, P147, DOI 10.1016/0304-4211(77)90122-5; Fujimoto Y, 1998, BIOORG MED CHEM LETT, V8, P205, DOI 10.1016/S0960-894X(97)10220-7; FUJIMOTO Y, 1990, J CHEM SOC PERK T 1, P2041, DOI 10.1039/p19900002041; FUJIMOTO Y, 1984, CHEM PHARM BULL, V32, P4372; Fujimoto Y, 2000, LIPIDS, V35, P279, DOI 10.1007/s11745-000-0524-z; Fujimoto Y, 1997, CHEM COMMUN, P681, DOI 10.1039/a700492c; Fujimoto Y, 2015, PHYTOCHEMISTRY, V111, P59, DOI 10.1016/j.phytochem.2014.12.019; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; Hyodo R, 2000, PHYTOCHEMISTRY, V53, P733, DOI 10.1016/S0031-9422(00)00018-2; Klahre U, 1998, PLANT CELL, V10, P1677, DOI 10.1105/tpc.10.10.1677; LAI MH, 1994, GENE, V140, P41; LENTON JR, 1975, PHYTOCHEMISTRY, V14, P1523, DOI 10.1016/0031-9422(75)85344-1; MALHOTRA HC, 1971, J BIOL CHEM, V246, P4934; MARUYAMA S, 1982, TETRAHEDRON LETT, V23, P1701, DOI 10.1016/S0040-4039(00)87194-4; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; MULHEIRN LJ, 1973, TETRAHEDRON LETT, P3175; NAGAKARI M, 1994, PHYTOCHEMISTRY, V36, P907, DOI 10.1016/S0031-9422(00)90461-8; Nes WD, 2003, J BIOL CHEM, V278, P34505, DOI 10.1074/jbc.M303359200; NES WD, 1991, J BIOL CHEM, V266, P15202; NES WR, 1977, BIOCH STEROIDS OTHER, P325; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Okuzumi K, 2003, TETRAHEDRON LETT, V44, P323, DOI 10.1016/S0040-4039(02)02565-0; Okuzumi T, 1999, TETRAHEDRON LETT, V40, P8863, DOI 10.1016/S0040-4039(99)01862-6; Patterson G. W., 1991, PHYSL BIOCH STEROLS, P83; Sawai S, 2014, PLANT CELL, V26, P3763, DOI 10.1105/tpc.114.130096; Schaller H, 2004, PLANT PHYSIOL BIOCH, V42, P465, DOI 10.1016/j.plaphy.2004.05.012; SEO S, 1992, J CHEM SOC PERK T 1, P569, DOI 10.1039/p19920000569; Takahashi K, 2003, TETRAHEDRON LETT, V44, P341, DOI 10.1016/S0040-4039(02)02567-4; TAKAHASHI T, 1995, GENE DEV, V9, P97, DOI 10.1101/gad.9.1.97; Tsukagoshi Y., 2016, FUNCTIONAL CHARACTER; UOMORI A, 1992, PHYTOCHEMISTRY, V31, P1569, DOI 10.1016/0031-9422(92)83108-B; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Yagi T, 1996, PHYTOCHEMISTRY, V41, P1057, DOI 10.1016/0031-9422(95)00766-0; Yamada J, 1997, TETRAHEDRON, V53, P877, DOI 10.1016/S0040-4020(96)01008-3	36	12	14	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8189	8198		10.1074/jbc.M115.703470	http://dx.doi.org/10.1074/jbc.M115.703470			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26872973	Green Published, hybrid			2022-12-28	WOS:000374056700035
J	Kumar, DP; Asgharpour, A; Mirshahi, F; Park, SH; Liu, SC; Imai, YM; Nadler, JL; Grider, JR; Murthy, KS; Sanyal, AJ				Kumar, Divya P.; Asgharpour, Amon; Mirshahi, Faridoddin; Park, So Hyun; Liu, Sichen; Imai, Yumi; Nadler, Jerry L.; Grider, John R.; Murthy, Karnam S.; Sanyal, Arun J.			Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet Cells to Promote Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bile acid; cell signaling; G protein-coupled receptor; metabolic syndrome; pancreatic islet; reprogramming	GLUCAGON-LIKE PEPTIDE-1; ALPHA-CELLS; INSULIN-SECRETION; BETA-CELLS; ALPHA-TC1-6 CELLS; INCRETIN HORMONES; NUCLEAR RECEPTOR; GASTRIC BYPASS; SMOOTH-MUSCLE; GLP-1	The physiological role of the TGR5 receptor in the pancreas is not fully understood. We previously showed that activation of TGR5 in pancreatic cells by bile acids induces insulin secretion. Glucagon released from pancreatic cells and glucagon-like peptide 1 (GLP-1) released from intestinal L cells regulate insulin secretion. Both glucagon and GLP-1 are derived from alternate splicing of a common precursor, proglucagon by PC2 and PC1, respectively. We investigated whether TGR5 activation in pancreatic cells enhances hyperglycemia-induced PC1 expression thereby releasing GLP-1, which in turn increases cell mass and function in a paracrine manner. TGR5 activation augmented a hyperglycemia-induced switch from glucagon to GLP-1 synthesis in human and mouse islet cells by G(S)/cAMP/PKA/cAMP-response element-binding protein-dependent activation of PC1. Furthermore, TGR5-induced GLP-1 release from cells was via an Epac-mediated PKA-independent mechanism. Administration of the TGR5 agonist, INT-777, to db/db mice attenuated the increase in body weight and improved glucose tolerance and insulin sensitivity. INT-777 augmented PC1 expression in cells and stimulated GLP-1 release from islets of db/db mice compared with control. INT-777 also increased pancreatic cell proliferation and insulin synthesis. The effect of TGR5-mediated GLP-1 from cells on insulin release from islets could be blocked by GLP-1 receptor antagonist. These results suggest that TGR5 activation mediates cross-talk between and cells by switching from glucagon to GLP-1 to restore cell mass and function under hyperglycemic conditions. Thus, INT-777-mediated TGR5 activation could be leveraged as a novel way to treat type 2 diabetes mellitus.	[Asgharpour, Amon; Mirshahi, Faridoddin; Sanyal, Arun J.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Richmond, VA 23298 USA; [Kumar, Divya P.; Grider, John R.; Murthy, Karnam S.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Park, So Hyun; Liu, Sichen; Imai, Yumi; Nadler, Jerry L.] Eastern Virginia Med Sch, Strelitz Diabet Ctr, Dept Internal Med, Norfolk, VA 23507 USA	Virginia Commonwealth University; Virginia Commonwealth University; Eastern Virginia Medical School	Murthy, KS (corresponding author), Dept Phys & Biophys, MCV Box 980551, Richmond, VA 23298 USA.; Sanyal, AJ (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, MCV Box 980342, Richmond, VA 23298 USA.	srinivasa.karnam@vcuhealth.org; arun.sanyal@vcuhealth.org	Prasanna Kumar, Divya/P-2759-2019; Rajagopal, Senthilkumar/B-5404-2012	Prasanna Kumar, Divya/0000-0001-5935-379X; Rajagopal, Senthilkumar/0000-0002-8404-8209; Liu, Sichen/0000-0003-4476-3387; Imai, Yumi/0000-0001-5046-4223	National Institutes of Health [RO1 DK081450, RO1 DK28300]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081410, R01DK028300, R03DK081450, T32DK007150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants RO1 DK081450 (to A. J. S.) and RO1 DK28300 (to K. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahren B, 1998, BIOESSAYS, V20, P642, DOI 10.1002/(SICI)1521-1878(199808)20:8<642::AID-BIES7>3.0.CO;2-K; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Boden G, 1999, P ASSOC AM PHYSICIAN, V111, P241, DOI 10.1046/j.1525-1381.1999.99220.x; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; Donath MY, 2013, DIABETES CARE, V36, pS145, DOI 10.2337/dcS13-2015; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; GOKE R, 1993, J BIOL CHEM, V268, P19650; Grzesik WJ, 2015, J CLIN ENDOCR METAB, V100, pE387, DOI 10.1210/jc.2014-3630; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Hansen AMK, 2011, DIABETOLOGIA, V54, P1379, DOI 10.1007/s00125-011-2080-1; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Hu WH, 2009, AM J PHYSIOL-CELL PH, V296, pC1310, DOI 10.1152/ajpcell.00573.2008; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Imai Y, 2013, DIABETES OBES METAB, V15, P117, DOI 10.1111/dom.12161; JANSEN E, 1995, J BIOL CHEM, V270, P15391, DOI 10.1074/jbc.270.25.15391; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kilimnik G, 2010, ISLETS, V2, P149, DOI 10.4161/isl.2.3.11396; Kumar DP, 2012, BIOCHEM BIOPH RES CO, V427, P600, DOI 10.1016/j.bbrc.2012.09.104; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Lieu T, 2014, BRIT J PHARMACOL, V171, P1156, DOI 10.1111/bph.12426; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Mather K, 2009, AM J PHYSIOL-ENDOC M, V296, pE398, DOI 10.1152/ajpendo.90889.2008; McGirr R, 2005, ENDOCRINOLOGY, V146, P4514, DOI 10.1210/en.2005-0402; Meier JJ, 2005, DIABETES-METAB RES, V21, P91, DOI 10.1002/dmrr.538; Moffett R. C., 2014, PLOS ONE, V9; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; MURTHY KS, 1991, AM J PHYSIOL, V261, pG945, DOI 10.1152/ajpgi.1991.261.6.G945; Nakatani H, 2009, METABOLISM, V58, P1400, DOI 10.1016/j.metabol.2009.05.006; Nie Y, 2000, J CLIN INVEST, V105, P955, DOI 10.1172/JCI7456; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Pellicciari R, 2009, J MED CHEM, V52, P7958, DOI 10.1021/jm901390p; Pournaras DJ, 2012, ENDOCRINOLOGY, V153, P3613, DOI 10.1210/en.2011-2145; Prawitt J, 2011, CURR DIABETES REP, V11, P160, DOI 10.1007/s11892-011-0187-x; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; ROUILLE Y, 1994, P NATL ACAD SCI USA, V91, P3242, DOI 10.1073/pnas.91.8.3242; ROUILLE Y, 1995, J BIOL CHEM, V270, P26488, DOI 10.1074/jbc.270.44.26488; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Tucker JD, 1996, REGUL PEPTIDES, V62, P29, DOI 10.1016/0167-0115(95)00167-0; Vincent RP, 2013, ANN CLIN BIOCHEM, V50, P360, DOI 10.1177/0004563212473450; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wewalka M, 2014, J CLIN ENDOCR METAB, V99, P1442, DOI 10.1210/jc.2013-3367; Whalley NM, 2011, J ENDOCRINOL, V211, P99, DOI 10.1530/JOE-11-0094; Wideman RD, 2007, DIABETES, V56, P2744, DOI 10.2337/db07-0563; Wideman RD, 2009, MOL THER, V17, P191, DOI 10.1038/mt.2008.219; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010	53	73	88	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6626	6640		10.1074/jbc.M115.699504	http://dx.doi.org/10.1074/jbc.M115.699504			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26757816	Green Published, hybrid			2022-12-28	WOS:000373299700002
J	Krick, S; Wang, JJ; St-Pierre, M; Gonzalez, C; Dahl, G; Salathe, M				Krick, Stefanie; Wang, Junjie; St-Pierre, Melissa; Gonzalez, Carlos; Dahl, Gerhard; Salathe, Matthias			Dual Oxidase 2 (Duox2) Regulates Pannexin 1-mediated ATP Release in Primary Human Airway Epithelial Cells via Changes in Intracellular pH and Not H2O2 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acidosis; ATP; epithelial cell; hydrogen peroxide; pannexin; dual oxidase 2	GAP-JUNCTION HEMICHANNELS; CILIARY BEAT FREQUENCY; CYSTIC-FIBROSIS; CHRONIC-BRONCHITIS; CHLORIDE CURRENTS; LARGE-CONDUCTANCE; INTERFERON-GAMMA; XENOPUS OOCYTES; UP-REGULATION; CHANNELS	Human airway epithelial cells express pannexin 1 (Panx1) channels to release ATP, which regulates mucociliary clearance. Airway inflammation causes mucociliary dysfunction. Exposure of primary human airway epithelial cell cultures to IFN- for 48 h did not alter Panx1 protein expression but significantly decreased ATP release in response to hypotonic stress. The IFN--induced functional down-regulation of Panx1 was due to the up-regulation of dual oxidase 2 (Duox2). Duox2 suppression by siRNA led to an increase in ATP release in control cells and restoration of ATP release in cells treated with IFN-. Both effects were reduced by the pannexin inhibitor probenecid. Duox2 up-regulation stoichiometrically increases H2O2 and proton production. H2O2 inhibited Panx1 function temporarily by formation of disulfide bonds at the thiol group of its terminal cysteine. Long-term exposure to H2O2, however, had no inhibitory effect. To assess the role of cellular acidification upon IFN- treatment, fully differentiated airway epithelial cells were exposed to ammonium chloride to alkalinize the cytosol. This led to a 2-fold increase in ATP release in cells treated with IFN- that was also inhibited by probenecid. Duox2 knockdown also partially corrected IFN--mediated acidification. The direct correlation between intracellular pH and Panx1 open probability was shown in oocytes. Therefore, airway epithelial cells release less ATP in response to hypotonic stress in an inflammatory environment (IFN- exposure). Decreased Panx1 function is a response to cell acidification mediated by IFN--induced up-regulation of Duox2, representing a novel mechanism for mucociliary dysfunction in inflammatory airway diseases.	[Krick, Stefanie; St-Pierre, Melissa; Salathe, Matthias] Univ Miami, Div Pulm Allergy Crit Care & Sleep Med, Miami, FL 33136 USA; [Wang, Junjie; Dahl, Gerhard] Univ Miami, Dept Physiol & Biophys, Miami, FL 33136 USA; [Gonzalez, Carlos] Univ Valparaiso, Interdisciplinary Ctr Neurosci Valparaiso, Valparaiso 2362735, Chile	University of Miami; University of Miami; Universidad de Valparaiso	Salathe, M (corresponding author), Univ Miami, Miller Sch Med, Div Pulm Allergy Crit Care & Sleep Med, 1600 NW 10th Ave,RMSB 7061 R-47, Miami, FL 33136 USA.	msalathe@med.miami.edu	Gonzalez, Carlos/V-7628-2019	Salathe, Matthias/0000-0001-9092-4861	National Institutes of Health [R01 HL-89399, R01 HL-60644]; Flight Attendant Medical Research Institute [CIA103027, CIA13033]; Cystic Fibrosis Foundation [SALATH14G0]; Chilean [1120802, ACT1104]; Millennium Initiative [P09-022-F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089399, R01HL060644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Chilean; Millennium Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL-89399 and R01 HL-60644, the Flight Attendant Medical Research Institute (CIA103027 and CIA13033), the Cystic Fibrosis Foundation (SALATH14G0; to M. S.), and Chilean Grants 1120802 and ACT1104 and Millennium Initiative P09-022-F (to C. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson WH, 2015, AM J RESP CRIT CARE, V192, P182, DOI 10.1164/rccm.201412-2230OC; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Beckel JM, 2014, GLIA, V62, P1486, DOI 10.1002/glia.22695; Bienert GP, 2014, BBA-GEN SUBJECTS, V1840, P1596, DOI 10.1016/j.bbagen.2013.09.017; Braiman A, 2001, CELL CALCIUM, V30, P361, DOI 10.1054/ceca.2001.0245; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Button B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003755; Conner GE, 2013, AM J RESP CELL MOL, V49, P672, DOI 10.1165/rcmb.2013-0156OC; DAVIS CW, 1992, AM J PHYSIOL, V262, pC1313, DOI 10.1152/ajpcell.1992.262.5.C1313; Duffy HS, 2004, CIRC RES, V94, P215, DOI 10.1161/01.RES.0000113924.06926.11; Fragoso MA, 2004, J PHYSIOL-LONDON, V561, P183, DOI 10.1113/jphysiol.2004.071548; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gattas MV, 2009, FREE RADICAL BIO MED, V47, P1450, DOI 10.1016/j.freeradbiomed.2009.08.017; GEARY CA, 1995, AM J PHYSIOL-LUNG C, V268, pL1021, DOI 10.1152/ajplung.1995.268.6.L1021; Gonzalez-Nieto D, 2008, P NATL ACAD SCI USA, V105, P17169, DOI 10.1073/pnas.0804189105; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Hua DP, 2012, PLANT CELL, V24, P2546, DOI 10.1105/tpc.112.100107; Isakson BE, 2014, CHANNELS, V8, P118, DOI 10.4161/chan.27978; Kim DY, 1999, J BIOL CHEM, V274, P5581, DOI 10.1074/jbc.274.9.5581; Kumar Rakesh K., 2006, Inflammation & Allergy Drug Targets, V5, P253, DOI 10.2174/187152806779010909; Kumar Rakesh K., 2012, Inflammation & Allergy Drug Targets, V11, P292; LETHEM MI, 1993, AM J RESP CELL MOL, V9, P315, DOI 10.1165/ajrcmb/9.3.315; Li A, 1998, J NEUROSCI, V18, P6740; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Manzanares D, 2015, J BIOL CHEM, V290, P25710, DOI 10.1074/jbc.M115.670885; Manzanares D, 2014, AM J PHYSIOL-LUNG C, V306, pL453, DOI 10.1152/ajplung.00247.2013; Manzanares D, 2011, J BIOL CHEM, V286, P19830, DOI 10.1074/jbc.M110.185074; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Murali S, 2014, J PHYSIOL-LONDON, V592, P4747, DOI 10.1113/jphysiol.2014.279299; Nagai K, 2008, ANTIOXID REDOX SIGN, V10, P705, DOI 10.1089/ars.2007.1941; Negoro H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106269; Nlend MC, 2007, FEBS LETT, V581, P3241, DOI 10.1016/j.febslet.2007.06.015; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Panzner P, 2003, CHEST, V124, P1909, DOI 10.1378/chest.124.5.1909; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Pfahnl A, 1998, BIOPHYS J, V75, P2323, DOI 10.1016/S0006-3495(98)77676-3; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; SCHLIEF T, 1995, J PHYSIOL-LONDON, V486, P123, DOI 10.1113/jphysiol.1995.sp020796; Schmid A, 2011, SUBCELL BIOCHEM, V55, P95, DOI 10.1007/978-94-007-1217-1_5; Schwarzer C, 2004, J BIOL CHEM, V279, P36454, DOI 10.1074/jbc.M404983200; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Sutto Z, 2004, J PHYSIOL-LONDON, V560, P519, DOI 10.1113/jphysiol.2004.068171; Tarran R, 1998, AM J PHYSIOL-CELL PH, V274, pC904, DOI 10.1152/ajpcell.1998.274.4.C904; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440	53	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6423	6432		10.1074/jbc.M115.664854	http://dx.doi.org/10.1074/jbc.M115.664854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26823467	hybrid, Green Published			2022-12-28	WOS:000372894200030
J	Sethna, S; Chamakkala, T; Gu, XW; Thompson, TC; Cao, GW; Elliott, MH; Finnemann, SC				Sethna, Saumil; Chamakkala, Tess; Gu, Xiaowu; Thompson, Timothy C.; Cao, Guangwen; Elliott, Michael H.; Finnemann, Silvia C.			Regulation of Phagolysosomal Digestion by Caveolin-1 of the Retinal Pigment Epithelium Is Essential for Vision	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolin; lysosomal acidification; lysosome; phagocytosis; retina; clearance; digestion; retinal pigment epithelium	AGE-RELATED-CHANGES; OUTER SEGMENTS; PHAGOSOME MATURATION; VISUAL CYCLE; RPE CELLS; PHAGOCYTOSIS; DEGRADATION; RHODOPSIN; RECEPTOR; PROTEIN	Caveolin-1 associates with the endo/lysosomal machinery of cells in culture, suggesting that it functions at these organelles independently of its contribution to cell surface caveolae. Here we explored mice lacking caveolin-1 specifically in the retinal pigment epithelium (RPE). The RPE supports neighboring photoreceptors via diurnal phagocytosis of spent photoreceptor outer segment fragments. Like mice lacking caveolin-1 globally, (RPE)CAV1(-/-) mice developed a normal RPE and neural retina but showed reduced rod photoreceptor light responses, indicating that lack of caveolin-1 affects photoreceptor function in a non-cell-autonomous manner. (RPE)CAV1(-/-) RPE in situ showed normal particle engulfment but delayed phagosome clearance and reversed diurnal profiles of levels and activities of lysosomal enzymes. Therefore, eliminating caveolin-1 specifically impairs phagolysosomal degradation by the RPE in vivo. Endogenous caveolin-1 was recruited to maturing phagolysosomes in RPE cells in culture. Consistent with these in vivo data, a moderate increase (to approximate to 2.5-fold) or decrease (by half) of caveolin-1 protein levels in RPE cells in culture was sufficient to accelerate or impair phagolysosomal digestion, respectively. A mutant form of caveolin-1 that fails to reach the cell surface augmented degradation like wild-type caveolin-1. Acidic lysosomal pH and increased protease activity are essential for digestion. We show that halving caveolin-1 protein levels significantly alkalinized lysosomal pH and decreased lysosomal enzyme activities. Taken together, our results reveal a novel role for intracellular caveolin-1 in modulating phagolysosomal function. Moreover, they show, for the first time, that organellar caveolin-1 significantly affects tissue functionality in vivo.	[Sethna, Saumil; Chamakkala, Tess; Finnemann, Silvia C.] Fordham Univ, Dept Biol Sci, Ctr Canc Genet Dis & Gene Regulat, 441 East Fordham Rd, Bronx, NY 10458 USA; [Gu, Xiaowu; Elliott, Michael H.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Thompson, Timothy C.; Cao, Guangwen] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai 200433, Peoples R China	Fordham University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; UTMD Anderson Cancer Center; Naval Medical University	Finnemann, SC (corresponding author), Fordham Univ, Dept Biol Sci, Ctr Canc Genet Dis & Gene Regulat, 441 East Fordham Rd, Bronx, NY 10458 USA.; Elliott, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, 608 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	michael-elliott@ouhsc.edu; finnemann@fordham.edu		GU, XIAOWU/0000-0003-2266-5516; Cao, Guangwen/0000-0002-8094-1278	National Institutes of Health [R01EY013295, R01 EY019494, P3OEY021725]; Research to Prevent Blindness, Inc.; Fordham Graduate School of Arts and Sciences; NATIONAL EYE INSTITUTE [R01EY013295, R01EY019494, P30EY021725] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Fordham Graduate School of Arts and Sciences; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health Grants R01EY013295 (to S. C. F.) and R01 EY019494 (to M. H. E.) and Core Grant P3OEY021725 and by an unrestricted grant from Research to Prevent Blindness, Inc. (to the Department of Ophthalmology, University of Oklahoma Health Science Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Fordham Graduate School of Arts and Sciences alumni dissertation fellowship.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; BOSCH E, 1993, J HISTOCHEM CYTOCHEM, V41, P253, DOI 10.1177/41.2.8419462; Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3; Bulloj A, 2013, EXP EYE RES, V113, P9, DOI 10.1016/j.exer.2013.05.002; Cao GW, 2003, AM J PATHOL, V162, P1241, DOI 10.1016/S0002-9440(10)63920-X; Chang YG, 2007, J CELL SCI, V120, P3053, DOI 10.1242/jcs.006361; Chucair-Elliott AJ, 2012, J BIOL CHEM, V287, P24092, DOI 10.1074/jbc.M112.378240; Cingle KA, 1996, CURR EYE RES, V15, P433, DOI 10.3109/02713689608995834; Damek-Poprawa M, 2009, J BIOL CHEM, V284, P10877, DOI 10.1074/jbc.M808857200; DEGUCHI J, 1994, INVEST OPHTH VIS SCI, V35, P568; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Esteve-Rudd J, 2014, ADV EXP MED BIOL, V801, P85, DOI 10.1007/978-1-4614-3209-8_11; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Fridolfsson HN, 2014, FASEB J, V28, P3823, DOI 10.1096/fj.14-252320; Gu XW, 2014, ADV EXP MED BIOL, V801, P15, DOI 10.1007/978-1-4614-3209-8_3; Gu XW, 2014, AM J PATHOL, V184, P541, DOI 10.1016/j.ajpath.2013.10.022; Guha S, 2014, EXP EYE RES, V126, P68, DOI 10.1016/j.exer.2014.05.013; He KM, 2015, CELL RES, V25, P738, DOI 10.1038/cr.2015.60; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; KURZCHALIA TV, 1994, FEBS LETT, V346, P88, DOI 10.1016/0014-5793(94)00466-8; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Laniosz V, 2008, J VIROL, V82, P6288, DOI 10.1128/JVI.00569-08; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; Li JW, 2005, CELL CYCLE, V4, P1599, DOI 10.4161/cc.4.11.2117; Li XM, 2012, J BIOL CHEM, V287, P16424, DOI 10.1074/jbc.M112.353763; Mandal MNA, 2011, J BIOL CHEM, V286, P32491, DOI 10.1074/jbc.M111.255877; Mao Yingyu, 2013, Methods Mol Biol, V935, P285, DOI 10.1007/978-1-62703-080-9_20; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Matsui T, 2014, METHOD ENZYMOL, V534, P195, DOI 10.1016/B978-0-12-397926-1.00011-1; Matsui T, 2011, TRAFFIC, V12, P1432, DOI 10.1111/j.1600-0854.2011.01240.x; Mora RC, 2006, AM J PHYSIOL-CELL PH, V290, pC832, DOI 10.1152/ajpcell.00405.2005; Mundy DI, 2012, MOL BIOL CELL, V23, P864, DOI 10.1091/mbc.E11-07-0598; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Parinot C, 2014, JOVE-J VIS EXP, DOI 10.3791/52100; PLANTNER JJ, 1991, EXP EYE RES, V53, P269, DOI 10.1016/0014-4835(91)90083-Q; Querbes W, 2006, J VIROL, V80, P9402, DOI 10.1128/JVI.01086-06; Rakoczy PE, 1997, BIOCHEM J, V324, P935, DOI 10.1042/bj3240935; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Reagan A, 2016, ADV EXP MED BIOL, V854, P411, DOI 10.1007/978-3-319-17121-0_54; REGAN CM, 1980, EXP EYE RES, V30, P183, DOI 10.1016/0014-4835(80)90112-8; Sethna Saumil, 2013, Methods Mol Biol, V935, P245, DOI 10.1007/978-1-62703-080-9_17; Shelby SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053964; Shi Y, 2015, AUTOPHAGY, V11, P769, DOI 10.1080/15548627.2015.1034411; Shiroto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087871; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strick DJ, 2009, INVEST OPHTH VIS SCI, V50, P2427, DOI 10.1167/iovs.08-3058; Valapala M, 2014, AUTOPHAGY, V10, P480, DOI 10.4161/auto.27292; Wavre-Shapton ST, 2014, J CELL SCI, V127, P3852, DOI 10.1242/jcs.154757; Yao JY, 2014, INVEST OPHTH VIS SCI, V55, P3237, DOI 10.1167/iovs.13-13336; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	55	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6494	6506		10.1074/jbc.M115.687004	http://dx.doi.org/10.1074/jbc.M115.687004			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26814131	Green Published, hybrid			2022-12-28	WOS:000372894200036
J	Reale, C; Iervolino, A; Scudiero, I; Ferravante, A; D'Andrea, LE; Mazzone, P; Zotti, T; Leonardi, A; Roberto, L; Zannini, M; de Cristofaro, T; Shanmugakonar, M; Capasso, G; Pasparakis, M; Vito, P; Stilo, R				Reale, Carla; Iervolino, Anna; Scudiero, Ivan; Ferravante, Angela; D'Andrea, Luca Egildo; Mazzone, Pellegrino; Zotti, Tiziana; Leonardi, Antonio; Roberto, Luca; Zannini, Mariastella; de Cristofaro, Tiziana; Shanmugakonar, Muralitharan; Capasso, Giovambattista; Pasparakis, Manolis; Vito, Pasquale; Stilo, Romania			NF-B Essential Modulator (NEMO) Is Critical for Thyroid Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; NF-kappaB; NF-kappaB transcription factor; signal transduction; thyroid; thyroid hormone	HYPOHIDROTIC ECTODERMAL DYSPLASIA; SEVERE LIVER DEGENERATION; ALPHA-INDUCED APOPTOSIS; GAMMA-DEFICIENT MICE; KAPPA-B; EMBRYONIC LETHALITY; GENE-EXPRESSION; CELL-DEATH; C-FLIP; ACTIVATION	The I-B kinase (IKK) subunit NEMO/IKK (NEMO) is an adapter molecule that is critical for canonical activation of NF-B, a pleiotropic transcription factor controlling immunity, differentiation, cell growth, tumorigenesis, and apoptosis. To explore the functional role of canonical NF-B signaling in thyroid gland differentiation and function, we have generated a murine strain bearing a genetic deletion of the NEMO locus in thyroid. Here we show that thyrocyte-specific NEMO knock-out mice gradually develop hypothyroidism after birth, which leads to reduced body weight and shortened life span. Histological and molecular analysis indicate that absence of NEMO in thyrocytes results in a dramatic loss of the thyroid gland cellularity, associated with down-regulation of thyroid differentiation markers and ongoing apoptosis. Thus, NEMO-dependent signaling is essential for normal thyroid physiology.	[Reale, Carla; Iervolino, Anna; Scudiero, Ivan; Ferravante, Angela; D'Andrea, Luca Egildo; Mazzone, Pellegrino; Roberto, Luca; Capasso, Giovambattista; Vito, Pasquale] Biogem Consortium, Via Camporeale, I-83031 Ariano Irpino, Italy; [Zotti, Tiziana; Vito, Pasquale; Stilo, Romania] Univ Sannio, Dipartimento Sci & Tecnol, Via Port Arsa 11, I-82100 Benevento, Italy; [Leonardi, Antonio; Stilo, Romania] Univ Napoli, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy; [Zannini, Mariastella; de Cristofaro, Tiziana] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Capasso, Giovambattista] Univ Naples 2, Dipartimento Sci Cardiotoraciche & Resp, Naples, Italy; [Pasparakis, Manolis] Univ Cologne, Inst Genet, D-50923 Cologne, Germany; [Shanmugakonar, Muralitharan] Qatar Univ, Anim Lab, Res Ctr, POB 2713, Doha, Qatar	University of Sannio; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Universita della Campania Vanvitelli; University of Cologne; Qatar University	Vito, P (corresponding author), Biogem Consortium, Via Camporeale, I-83031 Ariano Irpino, Italy.; Vito, P (corresponding author), Univ Sannio, Dipartimento Sci & Tecnol, Via Port Arsa 11, I-82100 Benevento, Italy.	vito@unisannio.it	leonardi, antonio/A-2887-2009; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; Mazzone, Pellegrino/AAC-6576-2020; De+Cristofaro, Tiziana/AAX-4405-2020; Zotti, Tiziana/AAV-6768-2021; vito, pasquale/ABF-5505-2020; Zannini, Mariastella/I-1735-2012; Reale, Carla/AAB-7939-2020	leonardi, antonio/0000-0001-8636-9623; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Mazzone, Pellegrino/0000-0002-6217-1505; Zotti, Tiziana/0000-0003-4753-116X; Reale, Carla/0000-0001-7682-4784; ZANNINI, MARIASTELLA/0000-0002-5740-9769; Iervolino, Anna/0000-0003-0450-9587; Capasso, Giovambattista/0000-0003-3469-8614; SHANMUGAKONAR, MURALITHARAN/0000-0002-2766-817X; DECRISTOFARO, TIZIANA/0000-0003-0121-0002; scudiero, ivan/0000-0001-5559-5548; ferravante, angela/0000-0002-4932-3877; vito, pasquale/0000-0002-5721-7716				BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Bouchard M, 2004, GENESIS, V38, P105, DOI 10.1002/gene.20008; Brahler S, 2012, AM J PHYSIOL-RENAL, V303, pF1473, DOI 10.1152/ajprenal.00031.2012; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; D' Andrea EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116062; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; FRYNS JP, 1989, J MED GENET, V26, P520, DOI 10.1136/jmg.26.8.520; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Iervolino A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119142; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kratsios P, 2010, CIRC RES, V106, P133, DOI 10.1161/CIRCRESAHA.109.202200; Legarda-Addison D, 2009, CELL DEATH DIFFER, V16, P1279, DOI 10.1038/cdd.2009.41; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nicola JP, 2010, MOL ENDOCRINOL, V24, P1846, DOI 10.1210/me.2010-0102; PABST HF, 1981, J PEDIATR-US, V98, P223, DOI 10.1016/S0022-3476(81)80639-7; Pacifico F, 2004, J BIOL CHEM, V279, P54610, DOI 10.1074/jbc.M403492200; Pacifico F, 2010, MOL CELL ENDOCRINOL, V321, P29, DOI 10.1016/j.mce.2009.10.010; PIKE MG, 1986, J PEDIATR-US, V108, P109, DOI 10.1016/S0022-3476(86)80782-X; Rudolph D, 2000, GENE DEV, V14, P854; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Shifera AS, 2010, J CELL PHYSIOL, V223, P558, DOI 10.1002/jcp.22105; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Stilo R, 2003, BIOCHEM BIOPH RES CO, V303, P1034, DOI 10.1016/S0006-291X(03)00487-X; Sundaravalli P A, 1980, Indian Pediatr, V17, P566; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Visconti R, 1997, ONCOGENE, V15, P1987, DOI 10.1038/sj.onc.1201373; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382; Zotti T, 2014, MOL IMMUNOL, V58, P27, DOI 10.1016/j.molimm.2013.10.015; Zotti T, 2011, J BIOL CHEM, V286, P22924, DOI 10.1074/jbc.M110.215426	41	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5765	5773		10.1074/jbc.M115.711697	http://dx.doi.org/10.1074/jbc.M115.711697			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786105	hybrid, Green Published			2022-12-28	WOS:000372551800025
J	Black, JC; Zhang, HL; Kim, J; Getz, G; Whetstine, JR				Black, Joshua C.; Zhang, Hailei; Kim, Jaegil; Getz, Gad; Whetstine, Johnathan R.			Regulation of Transient Site-specific Copy Gain by MicroRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; drug resistance; genomic instability; histone demethylase; microRNA (miRNA); CKS1B; JMJD2A; KDM4A; TSSG; cisplatin	CLINICAL-RELEVANCE; DEMETHYLASE KDM4A; CKS1B EXPRESSION; CANCER CELLS; OVEREXPRESSION; PROTEIN; 1Q21	Intra-tumor copy number heterogeneity is commonly observed in cancer; however, the molecular mechanisms that contribute to heterogeneity remain poorly understood. Up-regulation of the histone demethylase KDM4A promotes transient site-specific copy gain (TSSG) in cells; therefore, uncovering how KDM4A levels are controlled is important for understanding the regulation of copy number heterogeneity. Here, we demonstrate that KDM4A is regulated by hsa-mir-23a-3p, hsa-mir-23b-3p, and hsa-mir-137. Altering expression of these microRNAs (miRNAs) regulates KDM4A-dependent TSSG. miRNA inhibition promoted copy gains and increased expression of the drug-resistant oncogene CKS1B, which was further substantiated in primary breast tumors. Consistent with increased CKS1B expression, miRNA inhibition reduced breast cancer cell sensitivity to cisplatin. Our data identify these miRNAs as regulators of TSSG and copy gains of a drug resistance gene.	Massachusetts Gen Hosp, Ctr Canc, Rm 7-213,Bldg 149,13th St, Charlestown, MA 02129 USA; [Black, Joshua C.; Whetstine, Johnathan R.] Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA; [Getz, Gad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02129 USA; [Zhang, Hailei; Kim, Jaegil; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Whetstine, JR (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Rm 7-213,Bldg 149,13th St, Charlestown, MA 02129 USA.; Whetstine, JR (corresponding author), Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA.	jwhetstine@hms.harvard.edu		Black, Joshua/0000-0002-2491-8815	American Cancer Society Grant [RSG-13-115-01-CCG]; National Institutes of Health Grants [CA059267, R01GM097360, U24CA143845]; Jane Coffin Childs Memorial Fund; Massachusetts General Hospital Executive Committee on Research Tosteson Postdoctoral Fellowship; American Lung Association Lung Cancer Discovery Award; Alex Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE [C06CA059267, U24CA143845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097360] Funding Source: NIH RePORTER	American Cancer Society Grant(American Cancer Society); National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; Massachusetts General Hospital Executive Committee on Research Tosteson Postdoctoral Fellowship; American Lung Association Lung Cancer Discovery Award; Alex Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by American Cancer Society Grant RSG-13-115-01-CCG, National Institutes of Health Grants CA059267 and R01GM097360, and a grant from The Jane Coffin Childs Memorial Fund for Medical Research. J. R. W. is a consultant for QSonica. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Fellow of The Jane Coffin Childs Memorial Fund for Medical Research and supported by Massachusetts General Hospital Executive Committee on Research Tosteson Postdoctoral Fellowship.; Supported by National Institutes of Health Grant U24CA143845.; Tepper Family Massachusetts General Hospital Research Scholar and Leukemia and Lymphoma Society Scholar and recipient of an American Lung Association Lung Cancer Discovery Award and an Innovation Award from Alex Lemonade Stand Foundation. To whom correspondence should be addressed: Dept. of Medicine, Harvard Medical School and Massachusetts General Hospital Cancer Center, Rm. 7-213, Bldg. 149, 13th St., Charlestown, MA 02129. Tel.: 617-643-4347; Fax: 617-724-9648; E-mail: jwhetstine@hms.harvard.edu.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; An Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.123; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Black JC, 2015, CELL CYCLE, V14, P2869, DOI 10.1080/15384101.2015.1076659; Black JC, 2015, GENE DEV, V29, P1018, DOI 10.1101/gad.259796.115; Black JC, 2013, CELL, V154, P541, DOI 10.1016/j.cell.2013.06.051; Black JC, 2010, MOL CELL, V40, P736, DOI 10.1016/j.molcel.2010.11.008; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Dimova I, 2009, BALK J MED GENET, V12, P29, DOI 10.2478/v10034-010-0009-5; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Fonseca R, 2006, LEUKEMIA, V20, P2034, DOI 10.1038/sj.leu.2404403; Fujita Y, 2015, MOL THER, V23, P717, DOI 10.1038/mt.2015.10; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Giulino-Roth L, 2012, BLOOD, V120, P5181, DOI 10.1182/blood-2012-06-437624; Goeze A, 2002, J PATHOL, V196, P8, DOI 10.1002/path.1009; Guo JL, 2013, BIOCHEM BIOPH RES CO, V441, P357, DOI 10.1016/j.bbrc.2013.10.052; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Inoue J, 2004, AM J PATHOL, V165, P71, DOI 10.1016/S0002-9440(10)63276-2; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Khattar Vinayak, 2013, J Cancer Ther, V4, P1341; Lembo A., 2012, PLOS ONE, V7; Lestini BJ, 2009, CANCER BIOL THER, V8, P1587, DOI 10.4161/cbt.8.16.8964; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li PP, 2014, BIOMED PHARMACOTHER, V68, P7, DOI 10.1016/j.biopha.2013.12.002; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Martin-Ezquerra G, 2011, HISTOL HISTOPATHOL, V26, P71, DOI 10.14670/HH-26.71; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mishra S, 2016, MOL CELL BIOL, V36, P1050, DOI 10.1128/MCB.00652-15; Shaughnessy J, 2005, HEMATOLOGY, V10, P117, DOI 10.1080/10245330512331390140; Shi L, 2010, ONCOTARGET, V1, P22, DOI 10.18632/oncotarget.105; Smith AR, 2015, ONCOTARGET, V6, P12558, DOI 10.18632/oncotarget.3726; Tan MKM, 2011, MOL CELL BIOL, V31, P3687, DOI 10.1128/MCB.05746-11; Van Rechem C, 2015, CANCER DISCOV, V5, P245, DOI 10.1158/2159-8290.CD-14-1159; Van Rechem C, 2011, J BIOL CHEM, V286, P30462, DOI 10.1074/jbc.M111.273508; Vrana JA, 2002, CANCER RES, V62, P892; Wang XC, 2009, BIOCHEM BIOPH RES CO, V379, P1107, DOI 10.1016/j.bbrc.2009.01.028; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050203; Zhu XL, 2013, FEBS LETT, V587, P73, DOI 10.1016/j.febslet.2012.11.004	43	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4862	4871		10.1074/jbc.M115.711648	http://dx.doi.org/10.1074/jbc.M115.711648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26755726	hybrid, Green Published			2022-12-28	WOS:000371640600002
J	Tien, NT; Karaca, I; Tamboli, IY; Walter, J				Tien, Nguyen T.; Karaca, Ilker; Tamboli, Irfan Y.; Walter, Jochen			Trehalose Alters Subcellular Trafficking and the Metabolism of the Alzheimer-associated Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATHEPSIN-D; ALPHA-SYNUCLEIN; STRESS-RESPONSE; MOUSE MODEL; IN-VITRO; AUTOPHAGY; DISEASE; DEGRADATION; HOMEOSTASIS; LYSOSOMES	The disaccharide trehalose is commonly considered to stimulate autophagy. Cell treatment with trehalose could decrease cytosolic aggregates of potentially pathogenic proteins, including mutant huntingtin, alpha-synuclein, and phosphorylated tau that are associated with neurodegenerative diseases. Here, we demonstrate that trehalose also alters the metabolism of the Alzheimer disease-related amyloid precursor protein (APP). Cell treatment with trehalose decreased the degradation of full-length APP and its C-terminal fragments. Trehalose also reduced the secretion of the amyloid-beta peptide. Biochemical and cell biological experiments revealed that trehalose alters the subcellular distribution and decreases the degradation of APP C-terminal fragments in endolysosomal compartments. Trehalose also led to strong accumulation of the autophagic marker proteins LC3-II and p62, and decreased the proteolytic activation of the lysosomal hydrolase cathepsin D. The combined data indicate that trehalose decreases the lysosomal metabolism of APP by altering its endocytic vesicular transport.	[Tien, Nguyen T.; Karaca, Ilker; Tamboli, Irfan Y.; Walter, Jochen] Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53127 Bonn, Germany; [Tien, Nguyen T.] Leiden Univ, Med Ctr, Dept Radiol & Human Genet, NL-2333 ZC Leiden, Netherlands; [Karaca, Ilker] Univ Bonn, Dept Psychiat & Psychotherapy, D-53127 Bonn, Germany; [Tamboli, Irfan Y.] Georgetown Univ, Dept Neurosci, Washington, DC 20007 USA	University of Bonn; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bonn; Georgetown University	Walter, J (corresponding author), Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	jochen.walter@ukb.uni-bonn.de	Karaca, Ilker/J-6484-2016; Wang, Caihong/T-5837-2019; Walter, Jochen/B-3677-2014	Karaca, Ilker/0000-0002-2139-0015; Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912	Deutsche Forschungsgemeinschaft [SFB645, KFO177]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB645 and KFO177 (to J. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Casarejos MJ, 2011, NEUROCHEM INT, V58, P512, DOI 10.1016/j.neuint.2011.01.008; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Ejlerskov P, 2013, J BIOL CHEM, V288, P17313, DOI 10.1074/jbc.M112.401174; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Karaca I, 2014, J BIOL CHEM, V289, P16761, DOI 10.1074/jbc.M113.535500; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Magazu S, 2007, EUR BIOPHYS J BIOPHY, V36, P163, DOI 10.1007/s00249-006-0108-0; Mathews PM, 2002, J BIOL CHEM, V277, P5299, DOI 10.1074/jbc.M108161200; METCALF P, 1993, EMBO J, V12, P1293, DOI 10.1002/j.1460-2075.1993.tb05774.x; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Mohamed NV, 2014, SCI REP-UK, V4, DOI 10.1038/srep05715; Nyabi O, 2002, NAT CELL BIOL, V4, pE164, DOI 10.1038/ncb0702-e164a; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Popiel HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051069; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; RICHO GR, 1994, J BIOL CHEM, V269, P14806; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; Tamboli IY, 2011, J NEUROSCI, V31, P1837, DOI 10.1523/JNEUROSCI.2954-10.2011; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tian Y, 2013, P NATL ACAD SCI USA, V110, P17071, DOI 10.1073/pnas.1315110110; Torres Manuel, 2012, Mol Neurodegener, V7, P59, DOI 10.1186/1750-1326-7-59; Venables MC, 2008, MED SCI SPORT EXER, V40, P1653, DOI 10.1249/mss.0b013e318175716c; Walter J, 2001, CURR OPIN NEUROBIOL, V11, P585, DOI 10.1016/S0959-4388(00)00253-1; Walter J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-34; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010	54	45	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10528	10540		10.1074/jbc.M116.719286	http://dx.doi.org/10.1074/jbc.M116.719286			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26957541	Green Published, hybrid			2022-12-28	WOS:000377042600008
J	Hemmann, JL; Saurel, O; Ochsner, AM; Stodden, BK; Kiefer, P; Milon, A; Vorholt, JA				Hemmann, Jethro L.; Saurel, Olivier; Ochsner, Andrea M.; Stodden, Barbara K.; Kiefer, Patrick; Milon, Alain; Vorholt, Julia A.			The One-carbon Carrier Methylofuran from Methylobacterium extorquens AM1 Contains a Large Number of alpha- and gamma-Linked Glutamic Acid Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIOXIDE REDUCTION FACTOR; METHYLOTROPHIC BACTERIA; METHANOBACTERIUM-THERMOAUTOTROPHICUM; METHANOCALDOCOCCUS-JANNASCHII; NONMETHYLOTROPHIC CONDITIONS; METHANOFURAN BIOSYNTHESIS; TETRAHYDROMETHANOPTERIN; IDENTIFICATION; COENZYMES; ENZYMES	Methylobacterium extorquens AM1 uses dedicated cofactors for one-carbon unit conversion. Based on the sequence identities of enzymes and activity determinations, a methanofuran analog was proposed to be involved in formaldehyde oxidation in Alphaproteobacteria. Here, we report the structure of the cofactor, which we termed methylofuran. Using an in vitro enzyme assay and LC-MS, methylofuran was identified in cell extracts and further purified. From the exact mass and MS-MS fragmentation pattern, the structure of the cofactor was determined to consist of a polyglutamic acid side chain linked to a core structure similar to the one present in archaeal methanofuran variants. NMR analyses showed that the core structure contains a furan ring. However, instead of the tyramine moiety that is present in methanofuran cofactors, a tyrosine residue is present in methylofuran, which was further confirmed by MS through the incorporation of a C-13-labeled precursor. Methylofuran was present as a mixture of different species with varying numbers of glutamic acid residues in the side chain ranging from 12 to 24. Notably, the glutamic acid residues were not solely gamma-linked, as is the case for all known methanofurans, but were identified by NMR as a mixture of alpha- and gamma-linked amino acids. Considering the unusual peptide chain, the elucidation of the structure presented here sets the basis for further research on this cofactor, which is probably the largest cofactor known so far.	[Hemmann, Jethro L.; Ochsner, Andrea M.; Kiefer, Patrick; Vorholt, Julia A.] ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland; [Saurel, Olivier; Milon, Alain] CNRS, Inst Pharmacol & Struct Biol, F-31077 Toulouse, France; [Saurel, Olivier; Milon, Alain] Univ Toulouse 3, F-31077 Toulouse, France; [Stodden, Barbara K.] INRA CNRS 441 2594, Lab Interact Plantes Microorganismes, Castanet Tolosan, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Vorholt, JA (corresponding author), ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	jvorholt@ethz.ch	Hemmann, Jethro L/GPP-3825-2022; Olivier, Saurel/AAQ-7007-2020; Vorholt, Julia/K-3514-2016	Hemmann, Jethro L/0000-0003-4687-5577; Vorholt, Julia/0000-0002-6011-4910; Saurel, Olivier/0000-0003-1439-4103; Ochsner, Andrea/0000-0002-5170-5022	Ibisa; Region Midi-Pyrenees; European structural funds	Ibisa; Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur); European structural funds	We thank Philipp Christen, ETH Zurich, for support in running fed-batch cultures. The IPBS (Institute of Pharmacology and Structural Biology) NMR equipment belonged to the Genotoul-PICT platform and received specific funding by Ibisa, the Region Midi-Pyrenees and European structural funds.	Allen KD, 2014, BIOCHEMISTRY-US, V53, P6199, DOI 10.1021/bi500973h; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony C, 1982, BIOCH METHYLOTROPHS, P95; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BOBIK TA, 1987, ARCH BIOCHEM BIOPHYS, V254, P430, DOI 10.1016/0003-9861(87)90121-4; Bosch G, 2008, PROTEOMICS, V8, P3494, DOI 10.1002/pmic.200800152; Chistoserdova L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-208; Chistoserdova L, 2004, MOL BIOL EVOL, V21, P1234, DOI 10.1093/molbev/msh113; Chistoserdova L, 2004, J BACTERIOL, V186, P22, DOI 10.1128/JB.186.1.22-28.2004; Chistoserdova L, 1998, SCIENCE, V281, P99, DOI 10.1126/science.281.5373.99; DEROME AE, 1990, J MAGN RESON, V88, P177, DOI 10.1016/0022-2364(90)90123-Q; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; ESCALANTESEMERENA JC, 1984, J BIOL CHEM, V259, P9447; Hagemeier CH, 2000, EUR J BIOCHEM, V267, P3762, DOI 10.1046/j.1432-1327.2000.01413.x; HOUCK DR, 1991, J AM CHEM SOC, V113, P3162, DOI 10.1021/ja00008a053; KASAI T, 1973, AGR BIOL CHEM TOKYO, V37, P685, DOI 10.1080/00021369.1973.10860731; KELTJENS JT, 1983, EUR J BIOCHEM, V130, P537, DOI 10.1111/j.1432-1033.1983.tb07183.x; Kezmarsky ND, 2005, BBA-GEN SUBJECTS, V1722, P175, DOI 10.1016/j.bbagen.2004.12.003; Kiefer P, 2013, BIOINFORMATICS, V29, P963, DOI 10.1093/bioinformatics/btt080; LARGE PJ, 1961, BIOCHEM J, V81, P470, DOI 10.1042/bj0810470; Laukel M, 2004, PROTEOMICS, V4, P1247, DOI 10.1002/pmic.200300713; LEIGH JA, 1984, J AM CHEM SOC, V106, P3636, DOI 10.1021/ja00324a037; LEIGH JA, 1983, J BIOL CHEM, V258, P7536; Marx CJ, 2003, J BACTERIOL, V185, P7169, DOI 10.1128/JB.185.24.7169-7175.2003; Miller D, 2014, BIOCHEMISTRY-US, V53, P4635, DOI 10.1021/bi500615p; Pomper BK, 2002, FEBS LETT, V523, P133, DOI 10.1016/S0014-5793(02)02962-9; Pomper BK, 1999, EUR J BIOCHEM, V261, P475, DOI 10.1046/j.1432-1327.1999.00291.x; Pomper BK, 2001, EUR J BIOCHEM, V268, P4769, DOI 10.1046/j.1432-1327.2001.02401.x; Shima S, 2001, METHOD ENZYMOL, V331, P317; TAYLOR CD, 1974, J BIOL CHEM, V249, P4879; Vorholt JA, 2002, ARCH MICROBIOL, V178, P239, DOI 10.1007/s00203-002-0450-2; Vorholt JA, 1999, J BACTERIOL, V181, P5750, DOI 10.1128/JB.181.18.5750-5757.1999; Vorholt JA, 2000, J BACTERIOL, V182, P6645, DOI 10.1128/JB.182.23.6645-6650.2000; Wang Y, 2015, J BACTERIOL, V197, P2850, DOI 10.1128/JB.00401-15; Wang Y, 2014, BIOCHEMISTRY-US, V53, P6220, DOI 10.1021/bi500879h; WHITE RH, 1988, J BACTERIOL, V170, P4594, DOI 10.1128/jb.170.10.4594-4597.1988	36	6	8	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9042	9051		10.1074/jbc.M116.714741	http://dx.doi.org/10.1074/jbc.M116.714741			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26895963	Green Published, hybrid			2022-12-28	WOS:000374849000018
J	Mayorga, JP; Camacho-Villasana, Y; Shingu-Vazquez, M; Garcia-Villegas, R; Zamudio-Ochoa, A; Garcia-Guerrero, AE; Hernandez, G; Perez-Martinez, X				Pablo Mayorga, Juan; Camacho-Villasana, Yolanda; Shingu-Vazquez, Miguel; Garcia-Villegas, Rodolfo; Zamudio-Ochoa, Angelica; Garcia-Guerrero, Aldo E.; Hernandez, Greco; Perez-Martinez, Xochitl			A Novel Function of Pet54 in Regulation of Cox1 Synthesis in Saccharomyces cerevisiae Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-OXIDASE BIOGENESIS; MESSENGER-RNA; TRANSLATIONAL REGULATION; ASSEMBLY FACTOR; YEAST; PROTEIN; GENE; BINDING; STABILITY; EXPRESSION	Cytochrome c oxidase assembly requires the synthesis of the mitochondria-encoded core subunits, Cox1, Cox2, and Cox3. In yeast, Pet54 protein is required to activate translation of the COX3 mRNA and to process the aI5 beta intron on the COX1 transcript. Here we report a third, novel function of Pet54 on Cox1 synthesis. We observed that Pet54 is necessary to achieve an efficient Cox1 synthesis. Translation of the COX1 mRNA is coupled to the assembly of cytochrome c oxidase by a mechanism that involves Mss51. This protein activates translation of the COX1 mRNA by acting on the COX1 5'-UTR, and, in addition, it interacts with the newly synthesized Cox1 protein in high molecular weight complexes that include the factors Coa3 and Cox14. Deletion of Pet54 decreased Cox1 synthesis, and, in contrast to what is commonly observed for other assembly mutants, double deletion of cox14 or coa3 did not recover Cox1 synthesis. Our results show that Pet54 is a positive regulator of Cox1 synthesis that renders Mss51 competent as a translational activator of the COX1 mRNA and that this role is independent of the assembly feedback regulatory loop of Cox1 synthesis. Pet54 may play a role in Mss51 hemylation/conformational change necessary for translational activity. Moreover, Pet54 physically interacts with the COX1 mRNA, and this binding was independent of the presence of Mss51.	[Pablo Mayorga, Juan; Camacho-Villasana, Yolanda; Garcia-Villegas, Rodolfo; Zamudio-Ochoa, Angelica; Garcia-Guerrero, Aldo E.; Perez-Martinez, Xochitl] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Mexico City 04510, DF, Mexico; [Shingu-Vazquez, Miguel] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Hernandez, Greco] Natl Inst Canc INCan, Basic Res Div, Mexico City 14080, DF, Mexico	Universidad Nacional Autonoma de Mexico; Monash University; Instituto Nacional de Cancerologia (INCAN)	Perez-Martinez, X (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Mexico City 04510, DF, Mexico.	xperez@ifc.unam.mx	Zamudio-Ochoa, Angelica/AAC-3684-2020	Zamudio-Ochoa, Angelica/0000-0002-6347-5789	Consejo Nacional de Ciencia y Tecnologia [47514, 238399, 298954, 255917, 250726]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica; Universidad Nacional Autonoma de Mexico [IN208711, IN204414]; Fundacion Miguel Aleman, A.C.; National Institute of Cancer	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Fundacion Miguel Aleman, A.C.; National Institute of Cancer	This work was supported by Consejo Nacional de Ciencia y Tecnologia Grant 47514 (to X. P.-M.) and Fellowships 238399 (to J. P. M.), 298954 (to A. Z.-O.), 255917 (to A. E. G.-G.), and 250726 (to R. G.-V.); the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica; Universidad Nacional Autonoma de Mexico Grants IN208711 and IN204414 (to X. P.-M.); the Fundacion Miguel Aleman, A.C. (to X. P.-M.); and the National Institute of Cancer (to G. H.). This manuscript is part of the Ph.D. thesis of J. P. M. from the Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico. The authors declare that they have no conflicts of interest with the contents of this article.	Bareth B, 2013, MOL CELL BIOL, V33, P4128, DOI 10.1128/MCB.00747-13; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; BROWN NG, 1994, MOL CELL BIOL, V14, P1045, DOI 10.1128/MCB.14.2.1045; Burke D., 2000, METHODS YEAST GENETI; CABRAL F, 1978, J BIOL CHEM, V253, P4396; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Chuang TW, 2013, MOL BIOL CELL, V24, P1, DOI 10.1091/mbc.E12-03-0217; COSTANZO MC, 1986, EMBO J, V5, P3637, DOI 10.1002/j.1460-2075.1986.tb04693.x; COSTANZO MC, 1986, MOL CELL BIOL, V6, P3694, DOI 10.1128/MCB.6.11.3694; de Jong L, 2000, FEBS LETT, V483, P62, DOI 10.1016/S0014-5793(00)02086-X; DEKKER PJT, 1992, NUCLEIC ACIDS RES, V20, P2647, DOI 10.1093/nar/20.11.2647; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; ELZINGA SDJ, 1993, NUCLEIC ACIDS RES, V21, P5328, DOI 10.1093/nar/21.23.5328; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; GOLIK P, 1995, CURR GENET, V28, P217, DOI 10.1007/BF00309780; Guo XE, 2011, J BIOL CHEM, V286, P38783, DOI 10.1074/jbc.M111.257956; Herrmann JM, 2013, BBA-MOL CELL RES, V1833, P286, DOI 10.1016/j.bbamcr.2012.03.007; James P, 1996, GENETICS, V144, P1425; Kaspar BJ, 2008, NUCLEIC ACIDS RES, V36, P2958, DOI 10.1093/nar/gkn045; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P26715, DOI 10.1074/jbc.M112.377200; KLOECKENERGRUISSEM B, 1988, J BACTERIOL, V170, P1399, DOI 10.1128/jb.170.3.1399-1402.1988; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau CK, 2003, CURR BIOL, V13, P933, DOI 10.1016/S0960-9822(03)00328-2; Leung GP, 2011, J BIOL CHEM, V286, P26250, DOI 10.1074/jbc.M111.235200; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; McStay GP, 2013, J BIOL CHEM, V288, P26546, DOI 10.1074/jbc.M113.498592; McStay GP, 2013, FEBS LETT, V587, P943, DOI 10.1016/j.febslet.2013.02.022; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; MULERO JJ, 1993, GENETICS, V133, P509; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; PAPADOPOULOU B, 1990, EMBO J, V9, P4135, DOI 10.1002/j.1460-2075.1990.tb07636.x; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; POUTRE CG, 1987, GENETICS, V115, P637; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; Siep M, 2000, CURR GENET, V37, P213, DOI 10.1007/s002940050522; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Soto IC, 2016, ANTIOXID REDOX SIGN, V24, P281, DOI 10.1089/ars.2015.6429; Soto IC, 2012, CELL METAB, V16, P801, DOI 10.1016/j.cmet.2012.10.018; Su CH, 2014, MOL BIOL CELL, V25, P965, DOI [10.1091/mbc.E13-0-0575, 10.1091/mbc.E13-10-0575]; Tavares-Carreon F, 2008, J BIOL CHEM, V283, P1472, DOI 10.1074/jbc.M708437200; Turk EM, 2010, J BIOL CHEM, V285, P8585, DOI 10.1074/jbc.M109.090761; VALENCIK ML, 1989, EMBO J, V8, P3899, DOI 10.1002/j.1460-2075.1989.tb08569.x; VALENCIK ML, 1991, MOL CELL BIOL, V11, P2399, DOI 10.1128/MCB.11.5.2399; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zambrano A, 2007, MOL BIOL CELL, V18, P523, DOI 10.1091/mbc.E06-09-0803; Zamudio-Ochoa A, 2014, RNA BIOL, V11, P953, DOI 10.4161/rna.29780; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	60	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9343	9355		10.1074/jbc.M116.721985	http://dx.doi.org/10.1074/jbc.M116.721985			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26929411	hybrid, Green Published			2022-12-28	WOS:000374849000042
J	Hamon, Y; Legowska, M; Herve, V; Dallet-Choisy, S; Marchand-Adam, S; Vanderlynden, L; Demonte, M; Williams, R; Scott, CJ; Si-Tahar, M; Heuze-Vourc'h, N; Lalmanach, G; Jenne, DE; Lesner, A; Gauthier, F; Korkmaz, B				Hamon, Yveline; Legowska, Monika; Herve, Virginie; Dallet-Choisy, Sandrine; Marchand-Adam, Sylvain; Vanderlynden, Lise; Demonte, Michele; Williams, Rich; Scott, Christopher J.; Si-Tahar, Mustapha; Heuze-Vourc'h, Nathalie; Lalmanach, Gilles; Jenne, Dieter E.; Lesner, Adam; Gauthier, Francis; Korkmaz, Brice			Neutrophilic Cathepsin C Is Maturated by a Multistep Proteolytic Process and Secreted by Activated Cells during Inflammatory Lung Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL-PEPTIDASE-I; PAPILLON-LEFEVRE-SYNDROME; SERINE PROTEASES; INHIBITION; EXPRESSION; REQUIRES; GRANULES; PROTEINASE-3; GENE; VIVO	The cysteine protease cathepsin C (CatC) activates granule-associated proinflammatory serine proteases in hematopoietic precursor cells. Its early inhibition in the bone marrow is regarded as a new therapeutic strategy for treating proteolysis-driven chronic inflammatory diseases, but its complete inhibition is elusive in vivo. Controlling the activity of CatC may be achieved by directly inhibiting its activity with a specific inhibitor or/and by preventing its maturation. We have investigated immunochemically and kinetically the occurrence of CatC and its proform in human hematopoietic precursor cells and in differentiated mature immune cells in lung secretions. The maturation of proCatC obeys a multistep mechanism that can be entirely managed by CatS in neutrophilic precursor cells. CatS inhibition by a cell-permeable inhibitor abrogated the release of the heavy and light chains from proCatC and blocked similar to 80% of CatC activity. Under these conditions the activity of neutrophil serine proteases, however, was not abolished in precursor cell cultures. In patients with neutrophilic lung inflammation, mature CatC is found in large amounts in sputa. It is secreted by activated neutrophils as confirmed through lipopolysaccharide administration in a nonhuman primate model. CatS inhibitors currently in clinical trials are expected to decrease the activity of neutrophilic CatC without affecting those of elastase-like serine proteases.	[Hamon, Yveline; Herve, Virginie; Dallet-Choisy, Sandrine; Marchand-Adam, Sylvain; Vanderlynden, Lise; Demonte, Michele; Si-Tahar, Mustapha; Heuze-Vourc'h, Nathalie; Lalmanach, Gilles; Gauthier, Francis; Korkmaz, Brice] INSERM, U1100, Ctr Etud Pathol Resp, F-37032 Tours, France; [Hamon, Yveline; Herve, Virginie; Dallet-Choisy, Sandrine; Marchand-Adam, Sylvain; Vanderlynden, Lise; Demonte, Michele; Si-Tahar, Mustapha; Heuze-Vourc'h, Nathalie; Lalmanach, Gilles; Gauthier, Francis; Korkmaz, Brice] Univ Tours, F-37032 Tours, France; [Legowska, Monika; Lesner, Adam] Univ Gdansk, Fac Chem, Wita Stwosza 63, PL-80308 Gdansk, Poland; [Williams, Rich; Scott, Christopher J.] Queens Univ Belfast, Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Hamon, Yveline; Jenne, Dieter E.] German Ctr Lung Res DZL, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, D-81377 Munich, Germany; [Hamon, Yveline; Jenne, Dieter E.] Max Planck Inst Neurobiol, D-82152 Planegg Martinsried, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Fahrenheit Universities; University of Gdansk; Queens University Belfast; Max Planck Society	Korkmaz, B (corresponding author), Univ Tours, INSERM U1100, Ctr Etud Pathol Resp, Fac Med, F-37032 Tours, France.	brice.korkmaz@inserm.fr	Jenne, Dieter Erich/AAP-1414-2020; SI-TAHAR, Mustapha/L-4149-2014; HEUZE-VOURC'H, Nathalie/P-8081-2016; Lesner, Adam/M-2732-2019; Si-Tahar, Mustapha/W-8034-2019	SI-TAHAR, Mustapha/0000-0002-5792-7742; Si-Tahar, Mustapha/0000-0002-5792-7742; marchand-adam, sylvain/0000-0002-9522-3738; Williams, Rich/0000-0002-7710-2975; Dallet-Choisy, Sandrine/0000-0002-6530-4107; Heuze-Vourc'h, Nathalie/0000-0003-4929-5068; KORKMAZ, BRICE/0000-0002-5159-8706; Lesner, Adam/0000-0001-8335-3431; Lalmanach, Gilles/0000-0001-8562-4821	Association Vaincre la Mucoviscidose (VLM) [RF20130500913]; INSERM (ITMO Immunology, Hematology, Pneumology); Region Centre-Val de Loire (Project BPCOlyse); "National Science Centre" in Poland [UMO-2012/07/N/ST5/00128]; European Union's Horizon research and innovation program [668036]; Alexandre von Humboldt Foundation	Association Vaincre la Mucoviscidose (VLM); INSERM (ITMO Immunology, Hematology, Pneumology); Region Centre-Val de Loire (Project BPCOlyse)(Region Centre-Val de Loire); "National Science Centre" in Poland; European Union's Horizon research and innovation program; Alexandre von Humboldt Foundation	This work was supported by the "Association Vaincre la Mucoviscidose (VLM)" (RF20130500913), INSERM (ITMO Immunology, Hematology, Pneumology), "Region Centre-Val de Loire (Project BPCOlyse)," and the "National Science Centre" in Poland (UMO-2012/07/N/ST5/00128). In addition, this project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement 668036 (RELENT). The authors declare that they have no conflicts of interest in the research.; Recipient of a short term institutional research training grant from the Alexandre von Humboldt Foundation.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Andoniou CE, 2011, IMMUNOL CELL BIOL, V89, P540, DOI 10.1038/icb.2010.115; Attucci S, 2002, BIOCHEM J, V366, P965, DOI 10.1042/BJ20020321; BROWN GR, 1993, J IMMUNOL, V150, P4733; Cigic B, 1999, EUR J BIOCHEM, V264, P944, DOI 10.1046/j.1432-1327.1999.00697.x; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Clair JMS, 2006, BIOL CHEM, V387, P1143, DOI 10.1515/BC.2006.141; D'Angelo ME, 2010, J BIOL CHEM, V285, P20514, DOI 10.1074/jbc.M109.094573; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; DOLENC I, 1995, J BIOL CHEM, V270, P21626, DOI 10.1074/jbc.270.37.21626; Dubois AV, 2013, AM J RESP CRIT CARE, V188, P703, DOI 10.1164/rccm.201305-0912OC; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Firatli E, 1996, J PERIODONTOL, V67, P617, DOI 10.1902/jop.1996.67.6.617; Gauthier JY, 2007, BIOORG MED CHEM LETT, V17, P4929, DOI 10.1016/j.bmcl.2007.06.023; Guarino C, 2014, J BIOL CHEM, V289, P31777, DOI 10.1074/jbc.M114.591339; Guay D, 2009, BIOORG MED CHEM LETT, V19, P5392, DOI 10.1016/j.bmcl.2009.07.114; HANEKE E, 1979, HUM GENET, V51, P1, DOI 10.1007/BF00278288; Hart TC, 1999, J MED GENET, V36, P881; Koike M, 2013, EUR J NEUROSCI, V37, P816, DOI 10.1111/ejn.12096; Kono H, 2012, J IMMUNOL, V189, P3734, DOI 10.4049/jimmunol.1200136; Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63; Korkmaz B, 2013, SEMIN IMMUNOPATHOL, V35, P411, DOI 10.1007/s00281-013-0362-z; Korkmaz B, 2011, FEBS J, V278, P2635, DOI 10.1111/j.1742-4658.2011.08189.x; Laine DI, 2010, EXPERT OPIN THER PAT, V20, P497, DOI 10.1517/13543771003657172; Liu RK, 2000, J CLIN PERIODONTOL, V27, P69, DOI 10.1034/j.1600-051x.2000.027001069.x; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; MACH L, 1994, J BIOL CHEM, V269, P13030; Maubach G, 1997, EUR J BIOCHEM, V250, P745, DOI 10.1111/j.1432-1033.1997.00745.x; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; Methot N, 2008, MOL PHARMACOL, V73, P1857, DOI 10.1124/mol.108.045682; Methot N, 2007, J BIOL CHEM, V282, P20836, DOI 10.1074/jbc.M702615200; Papillon MM, 1924, B SOC FRANCAISE DERM, V31, P82; Perera NC, 2013, J IMMUNOL, V191, P2700, DOI 10.4049/jimmunol.1301293; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Pham CTN, 1997, J BIOL CHEM, V272, P10695, DOI 10.1074/jbc.272.16.10695; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Rao NV, 1997, J BIOL CHEM, V272, P10260; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Ruffell B, 2013, GENE DEV, V27, P2086, DOI 10.1101/gad.224899.113; Sorensen OE, 2014, J CLIN INVEST, V124, P4539, DOI 10.1172/JCI76009; Sutherland RE, 2014, BIOCHEM BIOPH RES CO, V450, P818, DOI 10.1016/j.bbrc.2014.06.062; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; Tran TV, 2002, ARCH BIOCHEM BIOPHYS, V403, P160, DOI 10.1016/S0003-9861(02)00217-5; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Wilkinson RDA, 2015, BIOL CHEM, V396, P867, DOI 10.1515/hsz-2015-0114; Wolters PJ, 1998, J BIOL CHEM, V273, P15514, DOI 10.1074/jbc.273.25.15514; Wolters PJ, 2000, AM J RESP CELL MOL, V22, P183, DOI 10.1165/ajrcmb.22.2.3767; Wolters PJ, 2001, J BIOL CHEM, V276, P18551, DOI 10.1074/jbc.M100223200	49	35	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8486	8499		10.1074/jbc.M115.707109	http://dx.doi.org/10.1074/jbc.M115.707109			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26884336	Green Published, hybrid			2022-12-28	WOS:000374773200015
J	Vega, M; Riera, A; Fernandez-Cid, A; Herrero, P; Moreno, F				Vega, Montserrat; Riera, Alberto; Fernandez-Cid, Alejandra; Herrero, Pilar; Moreno, Fernando			Hexokinase 2 Is an Intracellular Glucose Sensor of Yeast Cells That Maintains the Structure and Activity of Mig1 Protein Repressor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REPRESSION; CATABOLITE REPRESSION; SUBCELLULAR-LOCALIZATION; REGULATORY MECHANISMS; NUCLEAR-LOCALIZATION; CRYSTAL-STRUCTURE; UPSTREAM KINASES; SNF1 KINASE; SUC2 GENE	Hexokinase 2 (Hxk2) from Saccharomyces cerevisiae is a bifunctional enzyme, being both a catalyst in the cytosol and an important regulator of the glucose repression signal in the nucleus. Despite considerable recent progress, little is known about the regulatory mechanism that controls nuclear Hxk2 association with the SUC2 promoter chromatin and how this association is necessary for SUC2 gene repression. Our data indicate that in the SUC2 promoter context, Hxk2 functions through a variety of structurally unrelated factors, mainly the DNA-binding Mig1 and Mig2 repressors and the regulatory Snf1 and Reg1 factors. Hxk2 sustains the repressor complex architecture maintaining transcriptional repression at the SUC2 gene. Using chromatin immunoprecipitation assays, we discovered that the Hxk2 in its open configuration, at low glucose conditions, leaves the repressor complex that induces its dissociation and promotes SUC2 gene expression. In high glucose conditions, Hxk2 adopts a close conformation that promotes Hxk2 binding to the Mig1 protein and the reassembly of the SUC2 repressor complex. Additional findings highlight the possibility that Hxk2 constitutes an intracellular glucose sensor that operates by changing its conformation in response to cytoplasmic glucose levels that regulate its interaction with Mig1 and thus its recruitment to the repressor complex of the SUC2 promoter. Thus, our data indicate that Hxk2 is more intimately involved in gene regulation than previously thought.	[Vega, Montserrat; Riera, Alberto; Fernandez-Cid, Alejandra; Herrero, Pilar; Moreno, Fernando] Univ Oviedo, Dept Biochem & Mol Biol, E-33006 Oviedo, Spain; [Riera, Alberto; Fernandez-Cid, Alejandra] MRC, Ctr Clin Sci, Imperial Coll, Fac Med, Hammersmith Hosp Campus, London W12 ONN, England	University of Oviedo; Imperial College London	Moreno, F (corresponding author), Univ Oviedo, Dept Bioquim & Biol Mol, Campus El Cristo, E-33006 Oviedo, Spain.	fmoreno@uniovi.es	Vega, Montserrat/ABE-7870-2021	Fernandez-Cid, Alejandra/0000-0002-6746-6791; Vega, Montserrat/0000-0002-4837-0671	Ministerio de Ciencia e Innovacion (Spain) [BFU2007-66063-C02-02, BFU2010-19628-C02-01]; Formacion Personal Investigador FPI fellowship [BFU2010-19628-C02-01]; Ministerio de Ciencia e Innovacion (Spain)	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Formacion Personal Investigador FPI fellowship; Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported in whole or part by Ministerio de Ciencia e Innovacion (Spain) Grants BFU2007-66063-C02-02 and BFU2010-19628-C02-01 (to F. M.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Formacion Personal Investigador FPI fellowship associated with Grant BFU2010-19628-C02-01 and provided by the Ministerio de Ciencia e Innovacion (Spain).	Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Aleshin AE, 1998, STRUCTURE, V6, P39, DOI 10.1016/S0969-2126(98)00006-9; Alms GR, 1999, EMBO J, V18, P4157, DOI 10.1093/emboj/18.15.4157; Barrett L, 2012, EUKARYOT CELL, V11, P119, DOI 10.1128/EC.05061-11; Bermejo C, 2011, NAT PROTOC, V6, P1806, DOI 10.1038/nprot.2011.391; Bu Y, 1998, NUCLEIC ACIDS RES, V26, P1002, DOI 10.1093/nar/26.4.1002; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; DELAFUENTE G, 1970, EUR J BIOCHEM, V16, P240, DOI 10.1111/j.1432-1033.1970.tb01077.x; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Dombek KM, 1999, MOL CELL BIOL, V19, P6029; FERNANDEZ R, 1985, J GEN MICROBIOL, V131, P2705; FERNANDEZ R, 1986, J GEN MICROBIOL, V132, P3467; Fernandez-Cid A, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-31; Fernandez-Garcia P, 2012, J BIOL CHEM, V287, P42151, DOI 10.1074/jbc.M112.401679; Flores-Saaib RD, 2000, NUCLEIC ACIDS RES, V28, P4189, DOI 10.1093/nar/28.21.4189; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; GASCON S, 1968, J BIOL CHEM, V243, P1567; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Hammell CM, 2002, MOL CELL BIOL, V22, P6441, DOI 10.1128/MCB.22.18.6441-6457.2002; Hecht A, 1999, METH MOL B, V119, P469; Heidrich K, 1997, BIOCHEMISTRY-US, V36, P1960, DOI 10.1021/bi9623643; Herrero P, 1998, FEBS LETT, V434, P71, DOI 10.1016/S0014-5793(98)00872-2; HERRERO P, 1995, YEAST, V11, P137, DOI 10.1002/yea.320110205; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; Liu Y, 2011, EUKARYOT CELL, V10, P313, DOI 10.1128/EC.00291-10; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Lutfiyya LL, 1996, MOL CELL BIOL, V16, P4790; Lutfiyya LL, 1998, GENETICS, V150, P1377; MA H, 1986, MOL CELL BIOL, V6, P4046, DOI 10.1128/MCB.6.11.4046; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; Mayordomo I, 2002, J BIOL CHEM, V277, P35650, DOI 10.1074/jbc.M204198200; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; MERCADO JJ, 1991, FEBS LETT, V291, P97, DOI 10.1016/0014-5793(91)81112-L; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Moreno F, 2002, FEMS MICROBIOL REV, V26, P83, DOI 10.1111/j.1574-6976.2002.tb00600.x; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; NEIGEBORN L, 1984, GENETICS, V108, P845; Noubhani A, 2009, J BIOL CHEM, V284, P27229, DOI 10.1074/jbc.M109.029454; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Palomino A, 2006, NUCLEIC ACIDS RES, V34, P1427, DOI 10.1093/nar/gkl028; Palomino A, 2005, BIOCHEM J, V388, P697, DOI 10.1042/BJ20050160; Pelaez R, 2012, J BIOL CHEM, V287, P3518, DOI 10.1074/jbc.M111.317230; Pelaez R, 2010, BIOCHEM J, V432, P181, DOI 10.1042/BJ20100663; Pelaez R, 2009, J BIOL CHEM, V284, P20548, DOI 10.1074/jbc.M109.013730; Randez-Gil F, 1998, FEBS LETT, V425, P475, DOI 10.1016/S0014-5793(98)00289-0; Redd MJ, 1997, J BIOL CHEM, V272, P11193; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; ROTH SY, 1995, CURR OPIN GENET DEV, V5, P168, DOI 10.1016/0959-437X(95)80004-2; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Schuurmans JM, 2008, FEMS YEAST RES, V8, P26, DOI 10.1111/j.1567-1364.2007.00309.x; Schuurmans JM, 2008, FEMS YEAST RES, V8, P195, DOI 10.1111/j.1567-1364.2007.00319.x; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Tabba S, 2010, CELL SIGNAL, V22, P1013, DOI 10.1016/j.cellsig.2010.02.003; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; Varanasi US, 1996, MOL CELL BIOL, V16, P6707; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Zhang Z, 2004, J BIOL CHEM, V279, P39240, DOI 10.1074/jbc.M407159200; Zhang Z, 2004, EMBO J, V23, P2246, DOI 10.1038/sj.emboj.7600227	70	44	45	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7267	7285		10.1074/jbc.M115.711408	http://dx.doi.org/10.1074/jbc.M115.711408			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26865637	Green Published, hybrid			2022-12-28	WOS:000383447600006
J	Bashiri, G; Rehan, AM; Sreebhavan, S; Baker, HM; Baker, EN; Squire, CJ				Bashiri, Ghader; Rehan, Aisyah M.; Sreebhavan, Sreevalsan; Baker, Heather M.; Baker, Edward N.; Squire, Christopher J.			Elongation of the Poly--glutamate Tail of F-420 Requires Both Domains of the F-420:-Glutamyl Ligase (FbiB) of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; high-performance liquid chromatography (HPLC); mass spectrometry (MS); Mycobacterium tuberculosis; x-ray crystallography; FbiB; cofactor F420; gamma-glutamyl ligase; poly-gamma-glutamate tail	COENZYME F-420; METHANOCOCCUS-JANNASCHII; CRYSTAL-STRUCTURES; BOVIS BCG; X-RAY; BIOSYNTHESIS; CRYSTALLIZATION; EXPRESSION; IDENTIFICATION; PURIFICATION	Cofactor F-420 is an electron carrier with a major role in the oxidoreductive reactions of Mycobacterium tuberculosis, the causative agent of tuberculosis. A -glutamyl ligase catalyzes the final steps of the F-420 biosynthesis pathway by successive additions of l-glutamate residues to F-420-0, producing a poly--glutamate tail. The enzyme responsible for this reaction in archaea (CofE) comprises a single domain and produces F-420-2 as the major species. The homologous M. tuberculosis enzyme, FbiB, is a two-domain protein and produces F-420 with predominantly 5-7 l-glutamate residues in the poly--glutamate tail. The N-terminal domain of FbiB is homologous to CofE with an annotated -glutamyl ligase activity, whereas the C-terminal domain has sequence similarity to an FMN-dependent family of nitroreductase enzymes. Here we demonstrate that full-length FbiB adds multiple l-glutamate residues to F-420-0 in vitro to produce F-420-5 after 24 h; communication between the two domains is critical for full -glutamyl ligase activity. We also present crystal structures of the C-terminal domain of FbiB in apo-, F-420-0-, and FMN-bound states, displaying distinct sites for F-420-0 and FMN ligands that partially overlap. Finally, we discuss the features of a full-length structural model produced by small angle x-ray scattering and its implications for the role of N- and C-terminal domains in catalysis.	[Bashiri, Ghader; Rehan, Aisyah M.; Baker, Heather M.; Baker, Edward N.; Squire, Christopher J.] Univ Auckland, Sch Biol Sci, Struct Biol Lab, Private Bag 92019, Auckland 1010, New Zealand; [Bashiri, Ghader; Rehan, Aisyah M.; Baker, Heather M.; Baker, Edward N.; Squire, Christopher J.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1010, New Zealand; [Sreebhavan, Sreevalsan] Univ Auckland, Fac Med & Hlth Sci, Private Bag 92019, Auckland 1010, New Zealand	University of Auckland; University of Auckland; University of Auckland	Squire, CJ (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1010, New Zealand.	c.squire@auckland.ac.nz	Rehan, Aisyah Mohamed/N-6806-2019; Bashiri, Ghader/R-4957-2017	Rehan, Aisyah Mohamed/0000-0001-7841-1705; Bashiri, Ghader/0000-0002-5092-3749; Squire, Christopher/0000-0001-9212-0461; Baker, Edward/0000-0003-2456-7661	Health Research Council of New Zealand; New Zealand Synchrotron Group Ltd.; IPTA Academic Training Scheme from the Ministry of Higher Education, Malaysia; International Islamic University Malaysia	Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Synchrotron Group Ltd.; IPTA Academic Training Scheme from the Ministry of Higher Education, Malaysia; International Islamic University Malaysia	This work was supported by the Health Research Council of New Zealand, and access to the Australian Synchrotron was supported by the New Zealand Synchrotron Group Ltd. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Ph.D. scholarship from the IPTA Academic Training Scheme from the Ministry of Higher Education, Malaysia, and the International Islamic University Malaysia. Present address: Dept. of Biotechnology, Kulliyyah of Science, International Islamic University Malaysia Kuantan Campus, Jalan Sultan Ahmad Shah, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Ahmed FH, 2015, J MOL BIOL, V427, P3554, DOI 10.1016/j.jmb.2015.09.021; Bair TB, 2001, ARCH MICROBIOL, V176, P37, DOI 10.1007/s002030100290; Bashiri G, 2008, J BIOL CHEM, V283, P17531, DOI 10.1074/jbc.M801854200; Bashiri G, 2007, PROTEIN EXPRES PURIF, V54, P38, DOI 10.1016/j.pep.2007.01.014; Bashiri G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045003; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G., 2011, BUSTER; Choi KP, 2002, J BACTERIOL, V184, P2420, DOI 10.1128/JB.184.9.2420-2428.2002; Choi KP, 2001, J BACTERIOL, V183, P7058, DOI 10.1128/JB.183.24.7058-7066.2001; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Dauter Z, 1999, J MOL BIOL, V289, P93, DOI 10.1006/jmbi.1999.2744; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; EIRICH LD, 1978, BIOCHEMISTRY-US, V17, P4583, DOI 10.1021/bi00615a002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Goldstone RM, 2008, PROTEIN EXPRES PURIF, V57, P81, DOI 10.1016/j.pep.2007.08.015; Graham DE, 2003, ARCH MICROBIOL, V180, P455, DOI 10.1007/s00203-003-0614-8; Graupner M, 2002, BIOCHEMISTRY-US, V41, P3754, DOI 10.1021/bi011937v; Gurumurthy M, 2013, MOL MICROBIOL, V87, P744, DOI 10.1111/mmi.12127; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lapalikar GV, 2012, CATAL SCI TECHNOL, V2, P1560, DOI 10.1039/c2cy20129a; Li H, 2003, BIOCHEMISTRY-US, V42, P9771, DOI 10.1021/bi034779b; Mashalidis EH, 2015, PROTEIN SCI, V24, P729, DOI 10.1002/pro.2645; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nocek B, 2007, J MOL BIOL, V372, P456, DOI 10.1016/j.jmb.2007.06.063; Ogunleye A, 2015, MICROBIOL-SGM, V161, P1, DOI 10.1099/mic.0.081448-0; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Purwantini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081985; Purwantini E, 2009, P NATL ACAD SCI USA, V106, P6333, DOI 10.1073/pnas.0812883106; Rehan AM, 2011, ACTA CRYSTALLOGR F, V67, P1274, DOI 10.1107/S1744309111028958; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seedorf H, 2007, FEBS J, V274, P1588, DOI 10.1111/j.1742-4658.2007.05706.x; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Taylor MC, 2010, MOL MICROBIOL, V78, P561, DOI 10.1111/j.1365-2958.2010.07356.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang F, 2010, ANTIMICROB AGENTS CH, V54, P3776, DOI 10.1128/AAC.00453-10; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	48	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6882	6894		10.1074/jbc.M115.689026	http://dx.doi.org/10.1074/jbc.M115.689026			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26861878	Green Published, hybrid			2022-12-28	WOS:000373299700026
J	Green, BR; Gajewiak, J; Chhabra, S; Skalicky, JJ; Zhang, MM; Rivier, JE; Bulaj, G; Olivera, BM; Yoshikami, D; Norton, RS				Green, Brad R.; Gajewiak, Joanna; Chhabra, Sandeep; Skalicky, Jack J.; Zhang, Min-Min; Rivier, Jean E.; Bulaj, Grzegorz; Olivera, Baldomero M.; Yoshikami, Doju; Norton, Raymond S.			Structural Basis for the Inhibition of Voltage-gated Sodium Channels by Conotoxin O-GVIIJ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						disulfide; high performance liquid chromatography (HPLC); nuclear magnetic resonance (NMR); peptide chemical synthesis; sodium channel; conotoxin; cysteine; structure-activity relationship studies; two-electrode voltage clamp electrophysiology	NMR CHEMICAL-SHIFTS; MU-CONOTOXIN; CYSTINE KNOT; PROTEIN STRUCTURES; TETRODOTOXIN; POLYPEPTIDES; IDENTIFY; PROGRAM; PEPTIDE; TOXINS	Cone snail toxins are well known blockers of voltage-gated sodium channels, a property that is of broad interest in biology and therapeutically in treating neuropathic pain and neurological disorders. Although most conotoxin channel blockers function by direct binding to a channel and disrupting its normal ion movement, conotoxin O -GVIIJ channel blocking is unique, using both favorable binding interactions with the channel and a direct tether via an intermolecular disulfide bond. Disulfide exchange is possible because conotoxin O -GVIIJ contains an S-cysteinylated Cys-24 residue that is capable of exchanging with a free cysteine thiol on the channel surface. Here, we present the solution structure of an analog of O -GVIIJ (GVIIJ[C24S]) and the results of structure-activity studies with synthetic O -GVIIJ variants. GVIIJ[C24S] adopts an inhibitor cystine knot structure, with two antiparallel -strands stabilized by three disulfide bridges. The loop region linking the -strands (loop 4) presents residue 24 in a configuration where it could bind to the proposed free cysteine of the channel (Cys-910, rat Na(V)1.2 numbering; at site 8). The structure-activity study shows that three residues (Lys-12, Arg-14, and Tyr-16) located in loop 2 and spatially close to residue 24 were also important for functional activity. We propose that the interaction of O -GVIIJ with the channel depends on not only disulfide tethering via Cys-24 to a free cysteine at site 8 on the channel but also the participation of key residues of O -GVIIJ on a distinct surface of the peptide.	[Green, Brad R.; Chhabra, Sandeep; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia; [Green, Brad R.; Gajewiak, Joanna; Zhang, Min-Min; Olivera, Baldomero M.; Yoshikami, Doju] Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA; [Skalicky, Jack J.] Univ Utah, Coll Pharm, Dept Biochem, Salt Lake City, UT 84108 USA; [Bulaj, Grzegorz] Univ Utah, Coll Pharm, Dept Med Chem, Salt Lake City, UT 84108 USA; [Rivier, Jean E.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Monash University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Salk Institute	Yoshikami, D (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.; Norton, RS (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	yoshikami@bioscience.utah.edu; ray.norton@monash.edu	Chhabra, Sandeep/T-5468-2018; chhabra, sandeep/R-9942-2017	Chhabra, Sandeep/0000-0002-5225-1333; Olivera, Baldomero/0000-0003-4556-1410; Norton, Raymond/0000-0001-8893-0584	National Institutes of Health [GM 048677]; Janssen Research and Development, LLC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janssen Research and Development, LLC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM 048677. Syntheses of GVIIJ analogs were also supported in part by funds from Janssen Research and Development, LLC. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Chahine M, 2008, CNS NEUROL DISORD-DR, V7, P144, DOI 10.2174/187152708784083830; Chen CL, 2012, J BIOL CHEM, V287, P39061, DOI 10.1074/jbc.M112.397646; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; Fiedler B, 2008, BIOCHEM PHARMACOL, V75, P2334, DOI 10.1016/j.bcp.2008.03.019; Gajewiak J, 2014, P NATL ACAD SCI USA, V111, P2758, DOI 10.1073/pnas.1324189111; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leipold E, 2007, CHANNELS, V1, P253, DOI 10.4161/chan.4847; McArthur JR, 2011, BIOCHEMISTRY-US, V50, P116, DOI 10.1021/bi101316y; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Robinson SD, 2014, MAR DRUGS, V12, P6058, DOI 10.3390/md12126058; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shon KJ, 1998, J NEUROSCI, V18, P4473; SIBANDA BL, 1989, J MOL BIOL, V206, P759, DOI 10.1016/0022-2836(89)90583-4; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Waxman SG, 2002, J REHABIL RES DEV, V39, P233; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; Wilson MJ, 2011, P NATL ACAD SCI USA, V108, P10302, DOI 10.1073/pnas.1107027108; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2015, BIOCHEMISTRY-US, V54, P3911, DOI 10.1021/acs.biochem.5b00390; Zhang MM, 2010, J NEUROPHYSIOL, V104, P88, DOI 10.1152/jn.00145.2010; Zhang MM, 2010, BIOCHEMISTRY-US, V49, P4804, DOI 10.1021/bi100207k; Zhang MM, 2009, CHANNELS, V3, P32, DOI 10.4161/chan.3.1.7500	37	4	6	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7205	7220		10.1074/jbc.M115.697672	http://dx.doi.org/10.1074/jbc.M115.697672			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26817840	Green Published, hybrid			2022-12-28	WOS:000373299700052
J	Kitchen, P; Conner, MT; Bill, RM; Conner, AC				Kitchen, Philip; Conner, Matthew T.; Bill, Roslyn M.; Conner, Alex C.			Structural Determinants of Oligomerization of the Aquaporin-4 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aquaporin; cellular regulation; oligomerization; protein translocation; water channel	MOLECULAR-DYNAMICS SIMULATIONS; WATER PERMEABILITY; MEMBRANE-DIFFUSION; PROTEIN; TETRAMERIZATION; TRAFFICKING; EXPRESSION; MECHANISM; HYDRATION; DOMAINS	The aquaporin (AQP) family of integral membrane protein channels mediate cellular water and solute flow. Although qualitative and quantitative differences in channel permeability, selectivity, subcellular localization, and trafficking responses have been observed for different members of the AQP family, the signature homotetrameric quaternary structure is conserved. Using a variety of biophysical techniques, we show that mutations to an intracellular loop (loop D) of human AQP4 reduce oligomerization. Non-tetrameric AQP4 mutants are unable to relocalize to the plasma membrane in response to changes in extracellular tonicity, despite equivalent constitutive surface expression levels and water permeability to wild-type AQP4. A network of AQP4 loop D hydrogen bonding interactions, identified using molecular dynamics simulations and based on a comparative mutagenic analysis of AQPs 1, 3, and 4, suggest that loop D interactions may provide a general structural framework for tetrameric assembly within the AQP family.	[Kitchen, Philip] Univ Warwick, Mol Assembly & Org Cells Doctoral Training Ctr, Coventry CV4 7AL, W Midlands, England; [Conner, Matthew T.] Wolverhampton Univ, Fac Sci & Engn, Sch Biol Chem & Forens Sci, Wolverhampton WV1 1LY, W Midlands, England; [Kitchen, Philip; Bill, Roslyn M.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Kitchen, Philip; Bill, Roslyn M.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England; [Conner, Alex C.] Univ Birmingham, Inst Clin Sci, Birmingham B15 2TT, W Midlands, England	University of Warwick; University of Wolverhampton; Aston University; Aston University; University of Birmingham	Bill, RM (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.; Bill, RM (corresponding author), Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England.; Conner, AC (corresponding author), Univ Birmingham, Inst Clin Sci, Birmingham B15 2TT, W Midlands, England.	r.m.bill@aston.ac.uk; a.c.conner@bham.ac.uk	Bill, Roslyn M/D-4554-2012; Kitchen, Philip/J-6936-2019	Bill, Roslyn M/0000-0003-1331-0852; Kitchen, Philip/0000-0002-1558-4673	Science Research Investment Fund; Biotechnology and Biological Sciences Research Council [BB/I019960/1, BB/K013319/1, BB/L502194/1]; Innovative Medicines Joint Undertaking [115583]; BBSRC [BB/I019960/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1091578] Funding Source: researchfish	Science Research Investment Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Innovative Medicines Joint Undertaking; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The computing facilities were provided by the Centre for Scientific Computing of the University of Warwick with support from the Science Research Investment Fund.; Supported by Biotechnology and Biological Sciences Research Council Grants BB/I019960/1, BB/K013319/1, and BB/L502194/1 and Innovative Medicines Joint Undertaking under Grant Agreement 115583 to the ND4BB ENABLE Consortium. Towhomcorrespondence may be addressed. E-mail: r.m.bill@aston.ac.uk.	Alberga D, 2014, BBA-BIOMEMBRANES, V1838, P3052, DOI 10.1016/j.bbamem.2014.08.015; Atochina-Vasserman EN, 2012, BBA-GEN SUBJECTS, V1820, P763, DOI 10.1016/j.bbagen.2011.12.006; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Buck TM, 2007, NAT STRUCT MOL BIOL, V14, P762, DOI 10.1038/nsmb1275; Chevalier AS, 2015, PLANT CELL PHYSIOL, V56, P819, DOI 10.1093/pcp/pcu203; Cho G, 2015, BBA-GEN SUBJECTS, V1850, P784, DOI 10.1016/j.bbagen.2015.01.009; Cho MR, 1999, BIOPHYS J, V76, P1136, DOI 10.1016/S0006-3495(99)77278-4; Conner MT, 2012, J BIOL CHEM, V287, P11516, DOI 10.1074/jbc.M111.329219; Duchesne L, 2002, J BIOL CHEM, V277, P20598, DOI 10.1074/jbc.M201179200; Duchesne L, 2001, KIDNEY INT, V60, P422, DOI 10.1046/j.1523-1755.2001.060002422.x; Felber LM, 2004, BIOTECHNIQUES, V36, P878, DOI 10.2144/04365PT04; Fenton RA, 2010, AM J PHYSIOL-RENAL, V298, pF224, DOI 10.1152/ajprenal.00463.2009; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Horner A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400083; Hub Jochen S, 2009, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-540-79885-9_3; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kaldenhoff R, 2014, BBA-GEN SUBJECTS, V1840, P1592, DOI 10.1016/j.bbagen.2013.09.037; Kamsteeg EJ, 1999, EMBO J, V18, P2394, DOI 10.1093/emboj/18.9.2394; Kang M, 2012, TRAFFIC, V13, P1589, DOI 10.1111/tra.12008; Kaptan S, 2015, STRUCTURE, V23, P2309, DOI 10.1016/j.str.2015.08.020; Kishida K, 2000, J BIOL CHEM, V275, P20896, DOI 10.1074/jbc.M001119200; Kitchen P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143027; Kitchen P, 2015, J BIOL CHEM, V290, P16873, DOI 10.1074/jbc.M115.646034; Lagree V, 1998, J BIOL CHEM, V273, P33949, DOI 10.1074/jbc.273.51.33949; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; Mazzaferri J, 2013, BIOPHYS J, V105, P328, DOI 10.1016/j.bpj.2013.06.010; Mitsuma T, 2010, J MOL BIOL, V402, P669, DOI 10.1016/j.jmb.2010.07.060; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Potokar M, 2013, GLIA, V61, P917, DOI 10.1002/glia.22485; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Roudier N, 2002, J BIOL CHEM, V277, P7664, DOI 10.1074/jbc.M105411200; Sachdeva R, 2014, J BIOMOL STRUCT DYN, V32, P555, DOI 10.1080/07391102.2013.780981; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Schmidt TH, 2012, J CHEM INF MODEL, V52, P2657, DOI [10.1021/ci3000453, 10.1021/ci30006531]; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sjohamn J, 2014, BBA-GEN SUBJECTS, V1840, P1614, DOI 10.1016/j.bbagen.2013.11.012; Tani K, 2009, J MOL BIOL, V389, P694, DOI 10.1016/j.jmb.2009.04.049; Umenishi F, 2000, BIOPHYS J, V78, P1024, DOI 10.1016/S0006-3495(00)76661-6; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Yu J, 2006, STRUCTURE, V14, P1411, DOI 10.1016/j.str.2006.07.006; Zelenina M, 2002, AM J PHYSIOL-RENAL, V283, pF309, DOI 10.1152/ajprenal.00260.2001	42	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6858	6871		10.1074/jbc.M115.694729	http://dx.doi.org/10.1074/jbc.M115.694729			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26786101	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000373299700024
J	Wada, T; Sunaga, H; Miyata, K; Shirasaki, H; Uchiyama, Y; Shimba, S				Wada, Taira; Sunaga, Hiroshi; Miyata, Kazuki; Shirasaki, Haruno; Uchiyama, Yuki; Shimba, Shigeki			Aryl Hydrocarbon Receptor Plays Protective Roles against High Fat Diet (HFD)-induced Hepatic Steatosis and the Subsequent Lipotoxicity via Direct Transcriptional Regulation of Socs3 Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; lipid metabolism; liver; liver injury; liver metabolism; aryl hydrocarbon receptor (AhR); suppressor of cytokine signal 3 (Socs3)	NECROSIS-FACTOR-ALPHA; AH-RECEPTOR; INSULIN-RESISTANCE; SIGNALING PATHWAYS; DIOXIN RECEPTOR; SKELETAL-MUSCLE; ADIPOSE-TISSUE; MOUSE-LIVER; MICE; ACTIVATION	Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor regulating the expression of genes involved in xenobiotic response. Recent studies have suggested that AhR plays essential roles not only in xenobiotic detoxification but also energy metabolism. Thus, in this study, we studied the roles of AhR in lipid metabolism. Under high fat diet (HFD) challenge, liver-specific AhR knock-out (AhR LKO) mice exhibited severe steatosis, inflammation, and injury in the liver. Gene expression analysis and biochemical study revealed that de novo lipogenesis activity was significantly increased in AhR LKO mice. In contrast, induction of suppressor of cytokine signal 3 (Socs3) expression by HFD was attenuated in the livers of AhR LKO mice. Rescue of the Socs3 gene in the liver of AhR LKO mice cancelled the HFD-induced hepatic lipotoxicities. Promoter analysis established Socs3 as novel transcriptional target of AhR. These results indicated that AhR plays a protective role against HFD-induced hepatic steatosis and the subsequent lipotoxicity effects, such as inflammation, and that the mechanism of protection involves the direct transcriptional regulation of Socs3 expression by AhR.	[Wada, Taira; Sunaga, Hiroshi; Miyata, Kazuki; Shirasaki, Haruno; Uchiyama, Yuki; Shimba, Shigeki] Nihon Univ, Sch Pharm, Dept Hlth Sci, Funabashi, Chiba 2748555, Japan	Nihon University	Shimba, S (corresponding author), Nihon Univ, Sch Pharm, Dept Hlth Sci, Funabashi, Chiba 2748555, Japan.	shimba.shigeki@nihon-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; "High-Tech Research Center" Project for Private Universities; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [26670066] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "High-Tech Research Center" Project for Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology, Japan (to S. S. and T. W), and the "High-Tech Research Center" Project for Private Universities, and a matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology 2007. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott BD, 1999, TOXICOL APPL PHARM, V155, P62, DOI 10.1006/taap.1998.8601; Adachi J, 2001, J BIOL CHEM, V276, P31475, DOI 10.1074/jbc.C100238200; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brant F, 2014, INFECT IMMUN, V82, P3127, DOI 10.1128/IAI.01733-14; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; Carson L. A., 1963, J ATHEROSCLER RES, V3, P334; Ciolino HP, 1999, BIOCHEM J, V340, P715, DOI 10.1042/0264-6021:3400715; Dabir P, 2008, CIRC RES, V102, P1558, DOI 10.1161/CIRCRESAHA.108.176990; Di Meglio P, 2014, IMMUNITY, V40, P989, DOI 10.1016/j.immuni.2014.04.019; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FOLCH J, 1957, J BIOL CHEM, V226, P497; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12; Huang YL, 2013, MOLECULES, V18, P12987, DOI 10.3390/molecules181012987; JAMDAR SC, 1978, BIOCHEM J, V170, P153, DOI 10.1042/bj1700153; Jorgensen SB, 2013, DIABETES, V62, P56, DOI 10.2337/db12-0443; La Merrill M, 2009, ENVIRON HEALTH PERSP, V117, P1414, DOI 10.1289/ehp.0800530; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Lee JH, 2010, GASTROENTEROLOGY, V139, P653, DOI 10.1053/j.gastro.2010.03.033; Lu PP, 2015, HEPATOLOGY, V61, P1908, DOI 10.1002/hep.27719; McMillan BJ, 2007, P NATL ACAD SCI USA, V104, P1412, DOI 10.1073/pnas.0607296104; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Oesch-Bartlomowicz B, 2005, P NATL ACAD SCI USA, V102, P9218, DOI 10.1073/pnas.0503488102; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Palanivel R, 2012, DIABETOLOGIA, V55, P3083, DOI 10.1007/s00125-012-2665-3; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Sato S, 2008, TOXICOL APPL PHARM, V229, P10, DOI 10.1016/j.taap.2007.12.029; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Seidel SD, 2001, J BIOCHEM MOL TOXIC, V15, P187; Sekine H, 2009, MOL CELL BIOL, V29, P6391, DOI 10.1128/MCB.00337-09; Sinal CJ, 1997, MOL PHARMACOL, V52, P590, DOI 10.1124/mol.52.4.590; Steinberg GR, 2004, AM J PHYSIOL-ENDOC M, V286, pE57, DOI 10.1152/ajpendo.00302.2003; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Wada T, 2008, MOL PHARMACOL, V73, P891, DOI 10.1124/mol.107.040741; Wada T, 2013, MOL PHARMACOL, V83, P1133, DOI 10.1124/mol.112.083303; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Watabe Y, 2010, BIOL PHARM BULL, V33, P389, DOI 10.1248/bpb.33.389; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Wong PKK, 2006, J CLIN INVEST, V116, P1571, DOI 10.1172/JCI25660; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Xu JL, 2012, DRUG METAB DISPOS, V40, P259, DOI 10.1124/dmd.111.039925; Yan CG, 2013, FASEB J, V27, P2967, DOI 10.1096/fj.12-225797; Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9; Zhang S, 2003, ENVIRON HEALTH PERSP, V111, P1877, DOI 10.1289/ehp.6322; Zhu BM, 2008, J INVEST DERMATOL, V128, P1821, DOI 10.1038/sj.jid.5701224	56	46	48	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7004	7016		10.1074/jbc.M115.693655	http://dx.doi.org/10.1074/jbc.M115.693655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26865635	hybrid, Green Published			2022-12-28	WOS:000373299700036
J	Becker-Kettern, J; Paczia, N; Conrotte, JF; Kay, DP; Guignard, C; Jung, PP; Linster, CL				Becker-Kettern, Julia; Paczia, Nicole; Conrotte, Jean-Francois; Kay, Daniel P.; Guignard, Cedric; Jung, Paul P.; Linster, Carole L.			Saccharomyces cerevisiae Forms d-2-Hydroxyglutarate and Couples Its Degradation to d-Lactate Formation via a Cytosolic Transhydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dehydrogenase; enzyme kinetics; flavoprotein; inborn error of metabolism; yeast metabolism; 2-hydroxyglutarate; transhydrogenase	ALPHA-HYDROXYGLUTARIC ACID; GRAPHICAL USER-INTERFACE; L-2-HYDROXYGLUTARIC ACIDURIA; HISTONE DEMETHYLASES; MASS ISOTOPOMER; GENE-EXPRESSION; IDH2 MUTATIONS; DEHYDROGENASE; YEAST; 2-HYDROXYGLUTARATE	The d or l form of 2-hydroxyglutarate (2HG) accumulates in certain rare neurometabolic disorders, and high d-2-hydroxyglutarate (d-2HG) levels are also found in several types of cancer. Although 2HG has been detected in Saccharomyces cerevisiae, its metabolism in yeast has remained largely unexplored. Here, we show that S. cerevisiae actively forms the d enantiomer of 2HG. Accordingly, the S. cerevisiae genome encodes two homologs of the human d-2HG dehydrogenase: Dld2, which, as its human homolog, is a mitochondrial protein, and the cytosolic protein Dld3. Intriguingly, we found that a dld3 knock-out strain accumulates millimolar levels of d-2HG, whereas a dld2 knock-out strain displayed only very moderate increases in d-2HG. Recombinant Dld2 and Dld3, both currently annotated as d-lactate dehydrogenases, efficiently oxidized d-2HG to -ketoglutarate. Depletion of d-lactate levels in the dld3, but not in the dld2 mutant, led to the discovery of a new type of enzymatic activity, carried by Dld3, to convert d-2HG to -ketoglutarate, namely an FAD-dependent transhydrogenase activity using pyruvate as a hydrogen acceptor. We also provide evidence that Ser3 and Ser33, which are primarily known for oxidizing 3-phosphoglycerate in the main serine biosynthesis pathway, in addition reduce -ketoglutarate to d-2HG using NADH and represent major intracellular sources of d-2HG in yeast. Based on our observations, we propose that d-2HG is mainly formed and degraded in the cytosol of S. cerevisiae cells in a process that couples d-2HG metabolism to the shuttling of reducing equivalents from cytosolic NADH to the mitochondrial respiratory chain via the d-lactate dehydrogenase Dld1.	[Becker-Kettern, Julia; Paczia, Nicole; Conrotte, Jean-Francois; Kay, Daniel P.; Jung, Paul P.; Linster, Carole L.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, 6 Ave Swing, L-4367 Belvaux, Luxembourg; [Guignard, Cedric] Luxembourg Inst Sci & Technol, 41 Rue Brill, L-4422 Belvaux, Luxembourg	University of Luxembourg; Luxembourg Institute of Science & Technology	Linster, CL (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, 6 Ave Swing, L-4367 Belvaux, Luxembourg.	carole.linster@uni.lu		Linster, Carole/0000-0001-7143-0719; Jung, Paul/0000-0001-5960-1327; Paczia, Nicole/0000-0003-3859-8186; Guignard, Cedric/0000-0001-9925-5932	Fonds National de la Recherche Luxembourg Grant CORE [C13/BM/5773107]; AFR Ph.D. Fellowship [4044610]; Fondation du Pelican de Mie et Pierre Hippert-Faber scholarship	Fonds National de la Recherche Luxembourg Grant CORE(Luxembourg National Research Fund); AFR Ph.D. Fellowship(Luxembourg National Research Fund); Fondation du Pelican de Mie et Pierre Hippert-Faber scholarship	This work was supported by the Fonds National de la Recherche Luxembourg Grant CORE C13/BM/5773107, AFR Ph.D. Fellowship 4044610 (to J. B. K.), and a Fondation du Pelican de Mie et Pierre Hippert-Faber scholarship (to J. B. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; Achouri Y, 2004, BIOCHEM J, V381, P35, DOI 10.1042/BJ20031933; Albers E, 2003, J BIOL CHEM, V278, P10264, DOI 10.1074/jbc.M211692200; Albers E, 1998, MICROBIOL-UK, V144, P1683, DOI 10.1099/00221287-144-6-1683; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; ALLEN SHG, 1972, J BIOL CHEM, V247, P909; BLEIWEIS AS, 1967, J BACTERIOL, V94, P1560, DOI 10.1128/JB.94.5.1560-1564.1967; Brachmann CB, 1998, YEAST, V14, P115; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Chalmers R A, 1980, J Inherit Metab Dis, V3, P11, DOI 10.1007/BF02312516; Chelstowska A, 1999, YEAST, V15, P1377, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1377::AID-YEA473>3.0.CO;2-0; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cristescu ME, 2009, J MOL EVOL, V69, P276, DOI 10.1007/s00239-009-9274-x; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dujon B, 2010, NAT REV GENET, V11, P512, DOI 10.1038/nrg2811; DULEY J, 1975, ANAL BIOCHEM, V69, P164, DOI 10.1016/0003-2697(75)90577-1; Duran M, 1980, J Inherit Metab Dis, V3, P109, DOI 10.1007/BF02312543; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Engqvist M, 2009, J BIOL CHEM, V284, P25026, DOI 10.1074/jbc.M109.021253; Fan J, 2015, ACS CHEM BIOL, V10, P510, DOI 10.1021/cb500683c; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Fu XD, 2015, CELL METAB, V22, P508, DOI 10.1016/j.cmet.2015.06.009; GIBSON KM, 1993, PEDIATR RES, V34, P277, DOI 10.1203/00006450-199309000-00007; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GREGERSEN N, 1977, ACTA PAEDIATR SCAND, V66, P85, DOI 10.1111/j.1651-2227.1977.tb07812.x; GREGOLIN C, 1963, BIOCHIM BIOPHYS ACTA, V67, P201; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Hudig M, 2015, PLANT CELL PHYSIOL, V56, P1820, DOI 10.1093/pcp/pcv108; Intlekofer AM, 2015, CELL METAB, V22, P304, DOI 10.1016/j.cmet.2015.06.023; Kardon T, 2006, FEBS LETT, V580, P2347, DOI 10.1016/j.febslet.2006.02.082; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Koh JLY, 2015, G3-GENES GENOM GENET, V5, P1223, DOI 10.1534/g3.115.017830; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kwon DW, 2011, BIOCHEM BIOPH RES CO, V410, P614, DOI 10.1016/j.bbrc.2011.06.039; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JY, 2015, BIOTECHNOL BIOENG, V112, P751, DOI 10.1002/bit.25488; Lin ZG, 2011, MOL BIOL EVOL, V28, P131, DOI 10.1093/molbev/msq184; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/nchembio.1141, 10.1038/NCHEMBIO.1141]; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; LODI T, 1993, MOL GEN GENET, V238, P315, DOI 10.1007/BF00291989; Lodi T, 1999, MOL GEN GENET, V262, P623, DOI 10.1007/s004380051125; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Luo ZL, 2009, MICROBIOL-SGM, V155, P4036, DOI 10.1099/mic.0.030726-0; Luttik MAH, 2000, J BACTERIOL, V182, P7007, DOI 10.1128/JB.182.24.7007-7013.2000; Matsunaga H, 2012, BIOCHEM BIOPH RES CO, V423, P553, DOI 10.1016/j.bbrc.2012.06.002; Muntau AC, 2000, NEUROPEDIATRICS, V31, P137, DOI 10.1055/s-2000-7497; Nota B, 2013, AM J HUM GENET, V92, P627, DOI 10.1016/j.ajhg.2013.03.009; Palmieri L, 2001, J BIOL CHEM, V276, P1916, DOI 10.1074/jbc.M004332200; Patiny L, 2013, J CHEM INF MODEL, V53, P1223, DOI 10.1021/ci300563h; Petersen S, 2001, METAB ENG, V3, P344, DOI 10.1006/mben.2001.0198; PRONK JT, 1994, MICROBIOL-UK, V140, P717, DOI 10.1099/00221287-140-4-717; Reed DW, 1999, J BACTERIOL, V181, P7580, DOI 10.1128/JB.181.24.7580-7587.1999; REEVES HC, 1962, J BACTERIOL, V84, P186, DOI 10.1128/JB.84.1.186-187.1962; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Rudolph J, 2010, BIOCHEMISTRY-US, V49, P9249, DOI 10.1021/bi101291d; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; Rzem R, 2006, BIOCHIMIE, V88, P113, DOI 10.1016/j.biochi.2005.06.005; Rzem R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119540; Stewart BJ, 2013, YEAST, V30, P81, DOI 10.1002/yea.2942; Struys EA, 2007, J INHERIT METAB DIS, V30, P690, DOI 10.1007/s10545-007-0697-5; Struys EA, 2004, CLIN CHEM, V50, P1391, DOI 10.1373/clinchem.2004.033399; Struys EA, 2004, FEBS LETT, V557, P115, DOI 10.1016/S0014-5793(03)01459-5; Tate JJ, 2003, J BIOL CHEM, V278, P36924, DOI 10.1074/jbc.M301829200; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; ULANE R, 1972, J BACTERIOL, V109, P34, DOI 10.1128/JB.109.1.34-43.1972; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; Vissers LELM, 2011, AM J MED GENET A, V155A, P2609, DOI 10.1002/ajmg.a.34325; Wapinski I, 2010, P NATL ACAD SCI USA, V107, P5505, DOI 10.1073/pnas.0911905107; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; ZACHARIOU M, 1986, J BACTERIOL, V167, P863, DOI 10.1128/jb.167.3.863-869.1986; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996	82	34	36	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6036	6058		10.1074/jbc.M115.704494	http://dx.doi.org/10.1074/jbc.M115.704494			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26774271	Green Published, hybrid			2022-12-28	WOS:000372894200001
J	Wang, XL; Wang, Q; Wang, JJ; Bai, P; Shi, L; Shen, W; Zhou, M; Zhou, XS; Zhang, YX; Cai, MH				Wang, Xiaolong; Wang, Qi; Wang, Jinjia; Bai, Peng; Shi, Lei; Shen, Wei; Zhou, Mian; Zhou, Xiangshan; Zhang, Yuanxing; Cai, Menghao			Mit1 Transcription Factor Mediates Methanol Signaling and Regulates the Alcohol Oxidase 1 (AOX1) Promoter in Pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-protein interaction; protein domain; signal transduction; transcription coactivator; transcription regulation; AOX1 promoter; Mit1; Pichia pastoris; glycerol repression; methanol induction	YEAST CANDIDA-BOIDINII; RECOMBINANT PROTEIN-PRODUCTION; SACCHAROMYCES-CEREVISIAE; UTILIZATION PATHWAY; HANSENULA-POLYMORPHA; METHYLOTROPHIC YEASTS; HETEROLOGOUS PROTEIN; MASTER REGULATOR; GENE ACTIVATION; EXPRESSION	The alcohol oxidase 1 (AOX1) promoter (P-AOX1) of Pichia pastoris is the most powerful and commonly used promoter for driving protein expression. However, mechanisms regulating its transcriptional activity are unclear. Here, we identified a Zn(II)(2)Cys(6)-type methanol-induced transcription factor 1 (Mit1) and elucidated its roles in regulating P-AOX1 activity in response to glycerol and methanol. Mit1 regulated the expression of many genes involved in methanol utilization pathway, including AOX1, but did not participate in peroxisome proliferation and transportation of peroxisomal proteins during methanol metabolism. Structural analysis of Mit1 by performing domain deletions confirmed its specific and critical role in the strict repression of P-AOX1 in glycerol medium. Importantly, Mit1, Mxr1, and Prm1, which positively regulated P-AOX1 in response to methanol, were bound to P-AOX1 at different sites and did not interact with each other. However, these factors cooperatively activated P-AOX1 through a cascade. Mxr1 mainly functioned during carbon derepression, whereas Mit1 and Prm1 functioned during methanol induction, with Prm1 transmitting methanol signal to Mit1 by binding to the MIT1 promoter (P-MIT1), thus increasingly expressing Mit1 and subsequently activating P-AOX1.	[Wang, Xiaolong; Wang, Qi; Wang, Jinjia; Bai, Peng; Shi, Lei; Shen, Wei; Zhou, Mian; Zhou, Xiangshan; Zhang, Yuanxing; Cai, Menghao] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, 130 Meilong Rd, Shanghai 200237, Peoples R China; [Zhang, Yuanxing] SCICB, Shanghai 200237, Peoples R China	East China University of Science & Technology	Cai, MH (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, 130 Meilong Rd, Shanghai 200237, Peoples R China.	cmh022199@ecust.edu.cn			National Special Fund for State Key Laboratory of Bioreactor Engineering [2060204]; Chinese National High Technology Research and Development Program [2014AA093501]	National Special Fund for State Key Laboratory of Bioreactor Engineering; Chinese National High Technology Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by Grant 2060204 from the National Special Fund for State Key Laboratory of Bioreactor Engineering and Grant 2014AA093501 from the Chinese National High Technology Research and Development Program. The authors declare that they have no conflicts of interest with the contents of this article.	Cregg J., 1988, DEV IND MICROBIOL, P33; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; FABER KN, 1995, YEAST, V11, P1331, DOI 10.1002/yea.320111402; Gellissen G, 2000, APPL MICROBIOL BIOT, V54, P741, DOI 10.1007/s002530000464; Gurvitz A, 2001, J BIOL CHEM, V276, P31825, DOI 10.1074/jbc.M105989200; Hartner FS, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-39; Karpichev IV, 2008, J BIOL CHEM, V283, P10264, DOI 10.1074/jbc.M708215200; Kranthi BV, 2010, YEAST, V27, P705, DOI 10.1002/yea.1766; Kranthi BV, 2009, BBA-GENE REGUL MECH, V1789, P460, DOI 10.1016/j.bbagrm.2009.05.004; Leao-Helder AN, 2003, J BIOL CHEM, V278, P40749, DOI 10.1074/jbc.M304029200; Liang SL, 2013, BIOTECHNOL LETT, V35, P1865, DOI 10.1007/s10529-013-1265-8; Lin-Cereghino GP, 2006, MOL CELL BIOL, V26, P883, DOI 10.1128/MCB.26.3.883-897.2006; Parua PK, 2012, MOL MICROBIOL, V85, P282, DOI 10.1111/j.1365-2958.2012.08112.x; Phelps C, 2006, P NATL ACAD SCI USA, V103, P7077, DOI 10.1073/pnas.0510080103; Porro D, 2005, MOL BIOTECHNOL, V31, P245, DOI 10.1385/MB:31:3:245; Raschke WC, 1996, GENE, V177, P163, DOI 10.1016/0378-1119(96)00293-4; Ratnakumar S, 2010, J BIOL CHEM, V285, P10703, DOI 10.1074/jbc.M109.079848; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rottensteiner H, 1997, EUR J BIOCHEM, V247, P776, DOI 10.1111/j.1432-1033.1997.00776.x; Sahu U, 2016, J BIOL CHEM, V291, P3648, DOI 10.1074/jbc.M115.673640; Sahu U, 2014, BIOCHEM BIOPH RES CO, V451, P158, DOI 10.1016/j.bbrc.2014.07.094; Sakai Y, 1999, FEBS LETT, V459, P233, DOI 10.1016/S0014-5793(99)01245-4; Sasano Y, 2008, EUKARYOT CELL, V7, P527, DOI 10.1128/EC.00403-07; Sasano Y, 2010, FEMS YEAST RES, V10, P535, DOI 10.1111/j.1567-1364.2010.00640.x; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Stasyk OV, 2008, METHOD ENZYMOL, V451, P229, DOI 10.1016/S0076-6879(08)03216-3; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Takagi S, 2012, United States patent, Patent No. [US 8,143,023, 8143023]; Vallini V, 2000, CURR GENET, V38, P163, DOI 10.1007/s002940000142; VERDUYN C, 1984, J MICROBIOL METH, V2, P15, DOI 10.1016/0167-7012(84)90027-7; Vogl T, 2013, NEW BIOTECHNOL, V30, P385, DOI 10.1016/j.nbt.2012.11.010; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02; Xuan YJ, 2009, FEMS YEAST RES, V9, P1271, DOI 10.1111/j.1567-1364.2009.00571.x; Yurimoto H, 2000, BBA-GENE STRUCT EXPR, V1493, P56, DOI 10.1016/S0167-4781(00)00157-3; Yurimoto H., 2011, INT J MICROBIOL, V2011; Zhang P, 2010, APPL ENVIRON MICROB, V76, P6108, DOI 10.1128/AEM.00607-10; Zianni Michael, 2006, J Biomol Tech, V17, P103	38	60	65	6	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6245	6261		10.1074/jbc.M115.692053	http://dx.doi.org/10.1074/jbc.M115.692053			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26828066	Green Published, hybrid			2022-12-28	WOS:000372894200016
J	Alonso-Rodriguez, E; Fernandez-Pinar, P; Sacristan-Reviriego, A; Molina, M; Martin, H				Alonso-Rodriguez, Esmeralda; Fernandez-Pinar, Pablo; Sacristan-Reviriego, Almudena; Molina, Maria; Martin, Humberto			An Analog-sensitive Version of the Protein Kinase Slt2 Allows Identification of Novel Targets of the Yeast Cell Wall Integrity Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell wall; mitogen-activated protein kinase (MAPK); phosphorylation; signaling; yeast; ATPS analog; Slt2; cell wall integrity	CAP-DEPENDENT TRANSLATION; SACCHAROMYCES-CEREVISIAE; MAP KINASE; TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; SHUTTLE VECTORS; FUSION PROTEINS; PHOSPHORYLATION; SPECIFICITY; MECHANISMS	The yeast cell wall integrity MAPK Slt2 mediates the transcriptional response to cell wall alterations through phosphorylation of transcription factors Rlm1 and SBF. However, the variety of cellular functions regulated by Slt2 suggests the existence of a significant number of still unknown substrates for this kinase. To identify novel Slt2 targets, we generated and characterized an analog-sensitive mutant of Slt2 (Slt2-as) that can be specifically inhibited by bulky kinase inhibitor analogs. We demonstrated that Slt2-as is able to use adenosine 5-[-thio]triphosphate analogs to thiophosphorylate its substrates in yeast cell extracts as well as when produced as recombinant proteins in Escherichia coli. Taking advantage of this chemical-genetic approach, we found that Slt2 phosphorylates the MAPK phosphatase Msg5 both in the N-terminal regulatory and C-terminal catalytic domains. Moreover, we identified the calcineurin regulator Rcn2, the 4E-BP (translation initiation factor eIF4E-binding protein) translation repressor protein Caf20, and the Golgi-associated adaptor Gga1 as novel targets for Slt2. The Slt2 phosphorylation sites on Rcn2 and Caf20 were determined. We also demonstrated that, in the absence of SLT2, the GGA1 paralog GGA2 is essential for cells to survive under cell wall stress and for proper protein sorting through the carboxypeptidase Y pathway. Therefore, Slt2-as provides a powerful tool that can expand our knowledge of the outputs of the cell wall integrity MAPK pathway.	[Molina, Maria] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Plaza Ramon & Cajal S-N, E-28040 Madrid, Spain; IRYCIS, Madrid 28040, Spain	Complutense University of Madrid	Molina, M (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Plaza Ramon & Cajal S-N, E-28040 Madrid, Spain.	molmifa@ucm.es	Brieva, Humberto Martin/E-9254-2016; Molina, Maria/ABE-7186-2021; Martín, Humberto/Z-3423-2019	Brieva, Humberto Martin/0000-0002-6736-3602; Molina, Maria/0000-0003-0074-3309; Martín, Humberto/0000-0002-6736-3602	Ministerio de Ciencia e Innovacion [BIO2010-22369-C02-01]; Ministerio de Economia y Competitividad (Spain) [BIO2013-44112-P]; Comunidad Autonoma de Madrid (Spain) [S2011/BMD-2414]; Formacion de Personal Investigador (FPI) fellowship from Ministerio de Ciencia e Innovacion (Spain)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad (Spain)(Spanish Government); Comunidad Autonoma de Madrid (Spain)(Comunidad de Madrid); Formacion de Personal Investigador (FPI) fellowship from Ministerio de Ciencia e Innovacion (Spain)	This work was supported by Grants BIO2010-22369-C02-01 and BIO2013-44112-P from Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad (Spain), respectively, and S2011/BMD-2414 from Comunidad Autonoma de Madrid (Spain). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Formacion de Personal Investigador (FPI) fellowship from Ministerio de Ciencia e Innovacion (Spain).	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Arias P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-390; Sanz AB, 2012, MOL BIOL CELL, V23, P2805, DOI 10.1091/mbc.E12-04-0278; Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Copic A, 2007, MOL BIOL CELL, V18, P1803, DOI 10.1091/mbc.E06-11-1000; Cramer JF, 2010, TRAFFIC, V11, P259, DOI 10.1111/j.1600-0854.2009.01017.x; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; Doray B, 2002, P NATL ACAD SCI USA, V99, P8072, DOI 10.1073/pnas.082235699; Emrick MA, 2006, P NATL ACAD SCI USA, V103, P18101, DOI 10.1073/pnas.0608849103; Engelberg D, 2014, CELL SIGNAL, V26, P2865, DOI 10.1016/j.cellsig.2014.09.003; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Garcia R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1879-4; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Ghosh P, 2003, J BIOL CHEM, V278, P14543, DOI 10.1074/jbc.M212543200; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hertz Nicholas T, 2010, Curr Protoc Chem Biol, V2, P15, DOI 10.1002/9780470559277.ch090201; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jin CY, 2014, MOL BIOL CELL, V25, P1396, DOI 10.1091/mbc.E13-09-0550; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Koch A, 2010, EUR J CELL BIOL, V89, P184, DOI 10.1016/j.ejcb.2009.11.024; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Mao K, 2011, AUTOPHAGY, V7, P1564, DOI 10.4161/auto.7.12.17971; Marin MJ, 2009, MOL GENET GENOMICS, V281, P345, DOI 10.1007/s00438-008-0415-5; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MARTIN H, 1993, MOL GEN GENET, V241, P177, DOI 10.1007/BF00280215; Martin H, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145606; Mascaraque V, 2013, MOL CELL PROTEOMICS, V12, P557, DOI 10.1074/mcp.M112.020438; McKay MM, 2004, TRAFFIC, V5, P102, DOI 10.1111/j.1600-0854.2004.00160.x; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Miller GJ, 2003, NAT STRUCT BIOL, V10, P599, DOI 10.1038/nsb953; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Molina M, 2010, YEAST, V27, P503, DOI 10.1002/yea.1791; Paczkowski JE, 2015, TRENDS CELL BIOL, V25, P408, DOI 10.1016/j.tcb.2015.02.005; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Ray A, 2003, NAT GENET, V33, P522, DOI 10.1038/ng1132; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; SIKORSKI RS, 1989, GENETICS, V122, P19; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Thingholm TE, 2009, PROTEOMICS, V9, P1451, DOI 10.1002/pmic.200800454; TORRES L, 1991, MOL MICROBIOL, V5, P2845, DOI 10.1111/j.1365-2958.1991.tb01993.x; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006; Willett R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2535; Zhang C, 2013, ACS CHEM BIOL, V8, P1931, DOI 10.1021/cb400376p; Zhao C, 1998, MOL CELL BIOL, V18, P1013, DOI 10.1128/MCB.18.2.1013	65	10	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5461	5472		10.1074/jbc.M115.683680	http://dx.doi.org/10.1074/jbc.M115.683680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786099	Green Published, hybrid			2022-12-28	WOS:000372551800002
J	Cassady-Cain, RL; Blackburn, EA; Alsarraf, H; Dedic, E; Bease, AG; Bottcher, B; Jorgensen, R; Wear, M; Stevens, MP				Cassady-Cain, Robin L.; Blackburn, Elizabeth A.; Alsarraf, Husam; Dedic, Emil; Bease, Andrew G.; Boettcher, Bettina; Jorgensen, Rene; Wear, Martin; Stevens, Mark P.			Biophysical Characterization and Activity of Lymphostatin, a Multifunctional Virulence Factor of Attaching and Effacing Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; circular dichroism (CD); electron microscopy (EM); Escherichia coli (E; coli); glycosyltransferase; small-angle X-ray scattering (SAXS); structural biology; T-cell; LifA; lymphostatin	CLOSTRIDIUM-DIFFICILE TOXIN; PROTEIN SECONDARY STRUCTURE; COMPLETE GENOME SEQUENCE; X-RAY SOLUTION; STRUCTURE PREDICTION; NEW-GENERATION; UDP-GLUCOSE; WEB; COLONIZATION; EFFECTOR	Attaching and effacing Escherichia coli cause diarrhea and typically produce lymphostatin (LifA), an inhibitor of mitogen-activated proliferation of lymphocytes and pro-inflammatory cytokine synthesis. A near-identical factor (Efa1) has been reported to mediate adherence of E. coli to epithelial cells. An amino-terminal region of LifA shares homology with the catalytic domain of the large clostridial toxins, which are retaining glycosyltransferases with a DXD motif involved in binding of a metal ion. Understanding the mode(s) of action of lymphostatin has been constrained by difficulties obtaining a stably transformed plasmid expression clone. We constructed a tightly inducible clone of enteropathogenic E. coli O127:H6 lifA for affinity purification of lymphostatin. The purified protein inhibited mitogen-activated proliferation of bovine T lymphocytes in the femtomolar range. It is a monomer in solution and the molecular envelope was determined using both transmission electron microscopy and small-angle x-ray scattering. Domain architecture was further studied by limited proteolysis. The largest proteolytic fragment containing the putative glycosyltransferase domain was tested in isolation for activity against T cells, and was not sufficient for activity. Tryptophan fluorescence studies indicated thatlymphostatin binds uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc) but not UDP-glucose (UDP-Glc). Substitution of the predicted DXD glycosyltransferase motif with alanine residues abolished UDP-GlcNAc binding and lymphostatin activity, although other biophysical properties were unchanged. The data indicate that lymphostatin has UDP-sugar binding potential that is critical for activity, and is a major leap toward identifying the nature and consequences of modifications of host cell factors.	[Cassady-Cain, Robin L.; Bease, Andrew G.; Stevens, Mark P.] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Cassady-Cain, Robin L.; Bease, Andrew G.; Stevens, Mark P.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush EH25 9RG, Midlothian, Scotland; [Blackburn, Elizabeth A.; Boettcher, Bettina; Wear, Martin] Univ Edinburgh, CTCB, Michael Swann Bldg,Kings Bldg, Edinburgh EH9 3BF, Midlothian, Scotland; [Alsarraf, Husam; Dedic, Emil; Jorgensen, Rene] Statens Serum Inst, Dept Microbiol & Infect Control, Artillerivej 5, DK-2300 Copenhagen S, Denmark; [Dedic, Emil] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; Statens Serum Institut; Swiss Federal Institutes of Technology Domain; ETH Zurich	Stevens, MP (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland.	Mark.Stevens@roslin.ed.ac.uk	Bottcher, Bettina/E-9397-2010; Jørgensen, René/P-5619-2014; Alsarraf, Husam/G-2918-2017	Bottcher, Bettina/0000-0002-7962-4849; Jørgensen, René/0000-0003-0672-466X; Blackburn, Elizabeth A/0000-0003-1325-9575; Alsarraf, Husam/0000-0001-8147-9647; Stevens, Mark/0000-0003-2174-5039	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J004227/1]; Wellcome Trust Multi-User Equipment Grant [101527/Z/13/Z]; Wellcome-UoE ISSF award; DFF-Sapere Aude Starting Grant from the Danish Council for Independent Research Grant [11-104831/FSS]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust Multi-User Equipment Grant(Wellcome Trust); Wellcome-UoE ISSF award; DFF-Sapere Aude Starting Grant from the Danish Council for Independent Research Grant	This work was supported, in whole or in part, by core strategic funding from Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/J004227/1 ( to R. L. C. C. and M. P. S.), Wellcome Trust Multi-User Equipment Grant 101527/Z/13/Z and Wellcome-UoE ISSF award ( to E. A. B., M. W., and B. B.), and the DFF-Sapere Aude Starting Grant from the Danish Council for Independent Research Grant 11-104831/FSS) ( to H. A., E. D., and R. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Median AB, 2006, FEMS MICROBIOL LETT, V258, P43, DOI 10.1111/j.1574-6968.2006.00198.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2010, MIN 17 STAT SOFTW; Badea L, 2003, MICROB PATHOGENESIS, V34, P205, DOI 10.1016/S0882-4010(03)00026-3; Belland RJ, 2001, P NATL ACAD SCI USA, V98, P13984, DOI 10.1073/pnas.241377698; Belyi Y, 2010, BBA-GEN SUBJECTS, V1800, P134, DOI 10.1016/j.bbagen.2009.07.022; Bhattacharyya S, 2002, EUR J BIOCHEM, V269, P3425, DOI 10.1046/j.1432-1033.2002.03013.x; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burland V, 1998, NUCLEIC ACIDS RES, V26, P4196, DOI 10.1093/nar/26.18.4196; ChavesOlarte E, 1997, J CLIN INVEST, V100, P1734, DOI 10.1172/JCI119698; Ciesla WP, 1998, J BIOL CHEM, V273, P16021, DOI 10.1074/jbc.273.26.16021; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; D'Urzo N, 2012, FEBS J, V279, P3085, DOI 10.1111/j.1742-4658.2012.08688.x; Deacon V, 2010, MICROBIOL-SGM, V156, P2527, DOI 10.1099/mic.0.039685-0; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Deng WY, 2012, MOL CELL PROTEOMICS, V11, P692, DOI 10.1074/mcp.M111.013672; Egerer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000942; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Grossmann EM, 2000, J SURG RES, V88, P165, DOI 10.1006/jsre.1999.5736; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2015, CELL MICROBIOL, V17, P1752, DOI 10.1111/cmi.12533; Janka A, 2002, INT J MED MICROBIOL, V292, P207, DOI 10.1078/1438-4221-00206; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klapproth JA, 2000, INFECT IMMUN, V68, P2148, DOI 10.1128/IAI.68.4.2148-2155.2000; Klapproth JM, 1996, AM J PHYSIOL-GASTR L, V271, pG841, DOI 10.1152/ajpgi.1996.271.5.G841; Klapproth JMA, 2005, INFECT IMMUN, V73, P1441, DOI 10.1128/IAI.73.3.1441-1451.2005; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Makino K, 1998, DNA Res, V5, P1, DOI 10.1093/dnares/5.1.1; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nicholls L, 2000, MOL MICROBIOL, V35, P275, DOI 10.1046/j.1365-2958.2000.01690.x; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Peri S, 2001, TRENDS BIOCHEM SCI, V26, P687, DOI 10.1016/S0968-0004(01)01954-5; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; R Development Core Team, 2014, R LANG ENV STAT COMP; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Solomon K, 2005, INFECT IMMUN, V73, P1625, DOI 10.1128/IAI.73.3.1625-1634.2005; Stevens MP, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0007-2013; Stevens MP, 2002, INFECT IMMUN, V70, P5158, DOI 10.1128/IAI.70.9.5158-5166.2002; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3	67	7	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5803	5816		10.1074/jbc.M115.709600	http://dx.doi.org/10.1074/jbc.M115.709600			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786100	Green Published, hybrid			2022-12-28	WOS:000372551800028
J	Coughlan, KA; Valentine, RJ; Sudit, BS; Allen, K; Dagon, Y; Kahn, BB; Ruderman, NB; Saha, AK				Coughlan, Kimberly A.; Valentine, Rudy J.; Sudit, Bella S.; Allen, Katherine; Dagon, Yossi; Kahn, Barbara B.; Ruderman, Neil B.; Saha, Asish K.			PKD1 Inhibits AMPK2 through Phosphorylation of Serine 491 and Impairs Insulin Signaling in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; AMP-activated kinase (AMPK); insulin resistance; protein kinase C (PKC); protein kinase D (PKD); skeletal muscle; Serine485; 491	ACTIVATED PROTEIN-KINASE; METABOLISM; EXERCISE; AKT; SER(485/491); RESISTANCE; DISEASE; STRESS; HEALTH; HEART	Background: Diminished activity of the enzyme AMP-activated protein kinase (AMPK) is associated with impaired insulin signaling. Results: Protein Kinase (PK)C/D1 activation inhibits AMPK2 via Ser(491) phosphorylation; PKD1 inhibition prevents this in skeletal muscle cells. Conclusion: PKD1 is a novel upstream AMPK-kinase that phosphorylates AMPK on Ser(491) and regulates insulin signaling. Significance: PKD1 inhibition may be a novel strategy for improving insulin sensitivity. AMP-activated protein kinase (AMPK) is an energy-sensing enzyme whose activity is inhibited in settings of insulin resistance. Exposure to a high glucose concentration has recently been shown to increase phosphorylation of AMPK at Ser(485/491) of its 1/2 subunit; however, the mechanism by which it does so is not known. Diacylglycerol (DAG), which is also increased in muscle exposed to high glucose, activates a number of signaling molecules including protein kinase (PK)C and PKD1. We sought to determine whether PKC or PKD1 is involved in inhibition of AMPK by causing Ser(485/491) phosphorylation in skeletal muscle cells. C2C12 myotubes were treated with the PKC/D1 activator phorbol 12-myristate 13-acetate (PMA), which acts as a DAG mimetic. This caused dose- and time-dependent increases in AMPK Ser(485/491) phosphorylation, which was associated with a approximate to 60% decrease in AMPK2 activity. Expression of a phosphodefective AMPK2 mutant (S491A) prevented the PMA-induced reduction in AMPK activity. Serine phosphorylation and inhibition of AMPK activity were partially prevented by the broad PKC inhibitor Go6983 and fully prevented by the specific PKD1 inhibitor CRT0066101. Genetic knockdown of PKD1 also prevented Ser(485/491) phosphorylation of AMPK. Inhibition of previously identified kinases that phosphorylate AMPK at this site (Akt, S6K, and ERK) did not prevent these events. PMA treatment also caused impairments in insulin-signaling through Akt, which were prevented by PKD1 inhibition. Finally, recombinant PKD1 phosphorylated AMPK2 at Ser(491) in cell-free conditions. These results identify PKD1 as a novel upstream kinase of AMPK2 Ser(491) that plays a negative role in insulin signaling in muscle cells.	[Coughlan, Kimberly A.; Sudit, Bella S.; Allen, Katherine; Ruderman, Neil B.; Saha, Asish K.] Boston Univ, Sch Med, Dept Med, Endocrinol Diabet & Nutr Sect, Boston, MA 02118 USA; [Valentine, Rudy J.] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA; [Dagon, Yossi; Kahn, Barbara B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA	Boston University; Iowa State University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Saha, AK (corresponding author), 650 Albany St,Room 820, Boston, MA 02118 USA.	aksaha@bu.edu	Dagon, Yossi/AAI-5882-2020		USPHS [RO1DK19514, RO1DK67509]; NIH [NHLBI 2 T32 HL07969-06A1, 5T32HL007224, R01 DK098002]; JPB foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007969, T32HL007224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019514, R01DK098002, R01DK067509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by USPHS Grants RO1DK19514, RO1DK67509 ( to N. B. R. and A. K. S.), NIH Training Grants NHLBI 2 T32 HL07969-06A1 ( to K. A. C.) and 5T32HL007224 ( to R. J. V.) NIH Grant R01 DK098002 and a Grant from the JPB foundation ( to B. B. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amati F, 2012, OBES REV, V13, P40, DOI 10.1111/j.1467-789X.2012.01036.x; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Berggreen C, 2009, AM J PHYSIOL-ENDOC M, V296, pE635, DOI 10.1152/ajpendo.90596.2008; BOLLAG GE, 1986, P NATL ACAD SCI USA, V83, P5822, DOI 10.1073/pnas.83.16.5822; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Coughlan KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127388; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; Ellwanger K, 2011, BIOCHEM J, V440, P327, DOI 10.1042/BJ20101980; Garcia-Haro L, 2012, FEBS LETT, V586, P4241, DOI 10.1016/j.febslet.2012.10.032; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; IDF, 2014, INT DIAB FED DIAB AT; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim MS, 2008, MOL CELL BIOL, V28, P3600, DOI 10.1128/MCB.00189-08; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; Lopez-Cotarelo P, 2015, J BIOL CHEM, V290, P827, DOI 10.1074/jbc.M114.596551; McGee SL, 2014, FASEB J, V28, P3384, DOI 10.1096/fj.14-249359; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Park DW, 2014, AM J PHYSIOL-LUNG C, V307, pL735, DOI 10.1152/ajplung.00165.2014; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; Rhim JH, 2008, REJUV RES, V11, P781, DOI 10.1089/rej.2008.0709; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870; Tsuchiya Y, 2012, BIOSCIENCE REP, V32, P197, DOI 10.1042/BSR20110076; Valentine RJ, 2014, ARCH BIOCHEM BIOPHYS, V562, P62, DOI 10.1016/j.abb.2014.08.013	29	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5664	5675		10.1074/jbc.M115.696849	http://dx.doi.org/10.1074/jbc.M115.696849			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26797128	Green Published, hybrid			2022-12-28	WOS:000372551800018
J	Sun, L; Dutta, RK; Xie, P; Kanwar, YS				Sun, Lin; Dutta, Rajesh K.; Xie, Ping; Kanwar, Yashpal S.			RETRACTED: myo-Inositol Oxygenase Overexpression Accentuates Generation of Reactive Oxygen Species and Exacerbates Cellular Injury following High Glucose Ambience: A NEW MECHANISM RELEVANT TO THE PATHOGENESIS OF DIABETIC NEPHROPATHY (Retracted article. See vol. 294, pg. 10380, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication						diabetes; diabetic nephropathy; extracellular matrix; kidney; reactive oxygen species (ROS); myo-inositol oxygenase (MIOX)	PROTEIN-KINASE-C; INTRACELLULAR HYALURONAN SYNTHESIS; OXIDATIVE STRESS; AUTOPHAGY RESPONSES; SIGNALING PATHWAY; MOLECULAR-CLONING; MESANGIAL CELLS; UP-REGULATION; ACTIVATION; GLUTATHIONE	Diabetic nephropathy (DN) is characterized by perturbations in metabolic/cellular signaling pathways with generation of reactive oxygen species (ROS). The ROS are regarded as a common denominator of various pathways, and they inflict injury on renal glomerular cells. Recent studies indicate that tubular pathobiology also plays a role in the progression of DN. However, the mechanism(s) for how high (25 mm) glucose (HG) ambience induces tubular damage remains enigmatic. myo-Inositol oxygenase (MIOX) is a tubular enzyme that catabolizes myo-inositol to d-glucuronate via the glucuronate-xylulose (G-X) pathway. In this study, we demonstrated that G-X pathway enzymes are expressed in the kidney, and MIOX expression/bioactivity was up-regulated under HG ambience in LLC-PK1 cells, a tubular cell line. We further investigated whether MIOX overexpression leads to accentuation of tubulo-interstitial injury, as gauged by some of the parameters relevant to the progression of DN. Under HG ambience, MIOX overexpression accentuated redox imbalance, perturbed NAD(+)/NADH ratios, increased ROS generation, depleted reduced glutathione, reduced GSH/GSSG ratio, and enhanced adaptive changes in the profile of the antioxidant defense system. These changes were also accompanied by mitochondrial dysfunctions, DNA damage and induction of apoptosis, accentuated activity of profibrogenic cytokine, and expression of fibronectin, the latter two being the major hallmarks of DN. These perturbations were largely blocked by various ROS inhibitors (Mito Q, diphenyleneiodonium chloride, and N-acetylcysteine) and MIOX/NOX4 siRNA. In conclusion, this study highlights a novel mechanism where MIOX under HG ambience exacerbates renal injury during the progression of diabetic nephropathy following the generation of excessive ROS via an unexplored G-X pathway.	[Sun, Lin] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China; [Sun, Lin] Cent S Univ, Xiangya Hosp 2, Renal Inst, Changsha 410011, Hunan, Peoples R China; [Dutta, Rajesh K.; Xie, Ping; Kanwar, Yashpal S.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Dutta, Rajesh K.; Xie, Ping; Kanwar, Yashpal S.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA	Central South University; Central South University; Northwestern University; Northwestern University	Kanwar, YS (corresponding author), Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA.; Kanwar, YS (corresponding author), Northwestern Univ, Dept Med, Chicago, IL 60611 USA.; Kanwar, YS (corresponding author), Northwestern Univ, Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	y-kanwar@northwestern.edu		Dutta, Rajesh Kumar/0000-0002-1394-0961	National Institutes of Health [DK60635]; National Natural Science Foundation of China [81270812, 81470960]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK60635 and National Natural Science Foundation of China Grants 81270812 and 81470960. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Allen DA, 2003, FASEB J, V17, P908, DOI 10.1096/fj.02-0130fje; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; Arner RJ, 2004, BIOCHEM BIOPH RES CO, V324, P1386, DOI 10.1016/j.bbrc.2004.09.209; Arner RJ, 2001, BIOCHEM J, V360, P313, DOI 10.1042/bj3600313; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Bansal S, 2010, J BIOL CHEM, V285, P24609, DOI 10.1074/jbc.M110.121822; Bhaskar A, 2015, J BIOL CHEM, V290, P1020, DOI 10.1074/jbc.M114.588913; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Bollinger JM, 2009, DALTON T, P905, DOI 10.1039/b811885j; Bonventre JV, 2012, SEMIN NEPHROL, V32, P452, DOI 10.1016/j.semnephrol.2012.07.008; Brezniceanu ML, 2008, DIABETES, V57, P451, DOI 10.2337/db07-0013; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Castilho AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042428; CHARALAMPOUS FC, 1957, J BIOL CHEM, V228, P1; Cheresh P, 2013, BBA-MOL BASIS DIS, V1832, P1028, DOI 10.1016/j.bbadis.2012.11.021; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Danesh FR, 2002, P NATL ACAD SCI USA, V99, P8301, DOI 10.1073/pnas.122228799; Dunlop M, 2000, KIDNEY INT, V58, pS3, DOI 10.1046/j.1523-1755.2000.07702.x; Ferraresi R, 2005, FREE RADICAL RES, V39, P1249, DOI 10.1080/10715760500306935; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Goode D, 1996, FEBS LETT, V395, P174, DOI 10.1016/0014-5793(96)01012-5; Grimm S, 2007, APOPTOSIS, V12, P841, DOI 10.1007/s10495-007-0747-3; HANKES LV, 1969, ANN NY ACAD SCI, V165, P564; Hernandez-Mijares A, 2013, DIABETES CARE, V36, P1695, DOI 10.2337/dc12-1224; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; KASHIHARA N, 1992, P NATL ACAD SCI USA, V89, P6309, DOI 10.1073/pnas.89.14.6309; Krstic J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/654594; Li J, 2006, NEPHROLOGY, V11, P428, DOI 10.1111/j.1440-1797.2006.00673.x; Lin S, 2002, J BIOL CHEM, V277, P41725, DOI 10.1074/jbc.M203957200; Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Miyata T, 2010, NAT REV NEPHROL, V6, P83, DOI 10.1038/nrneph.2009.211; Nayak B, 2005, P NATL ACAD SCI USA, V102, P17952, DOI 10.1073/pnas.0509089102; Nayak B, 2011, J BIOL CHEM, V286, P27594, DOI 10.1074/jbc.M110.217141; Phillips Aled O, 2003, Curr Diab Rep, V3, P491, DOI 10.1007/s11892-003-0013-1; Prabhu KS, 2005, J BIOL CHEM, V280, P19895, DOI 10.1074/jbc.M502621200; Pullar JM, 2002, J BIOL CHEM, V277, P19402, DOI 10.1074/jbc.M111053200; REDDY CC, 1981, J BIOL CHEM, V256, P8510; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Safar MM, 2015, PHARMACOL REP, V67, P17, DOI 10.1016/j.pharep.2014.08.001; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Sebastia J, 2003, CYTOM PART A, V51A, P16, DOI 10.1002/cyto.a.10003; Sun L, 2008, J AM SOC NEPHROL, V19, P2293, DOI 10.1681/ASN.2008030336; Thallas-Bonke V, 2008, DIABETES, V57, P460, DOI 10.2337/db07-1119; Wang A, 2015, MATRIX BIOL, V48, P36, DOI 10.1016/j.matbio.2015.04.003; Wang AM, 2014, J BIOL CHEM, V289, P9418, DOI 10.1074/jbc.M113.541441; Whiteside CI, 2002, AM J PHYSIOL-RENAL, V282, pF975, DOI 10.1152/ajprenal.00014.2002; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Xie P, 2011, J BIOL CHEM, V286, P34131, DOI 10.1074/jbc.M111.241778; Yang B, 2001, KIDNEY INT, V60, P1765, DOI 10.1046/j.1523-1755.2001.00013.x; Yang QW, 2000, P NATL ACAD SCI USA, V97, P9896, DOI 10.1073/pnas.160266197; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zeng LX, 2004, J AM SOC NEPHROL, V15, P1711, DOI 10.1097/01.ASN.0000129839.91567.68; ZIYADEH FN, 1991, J AM SOC NEPHROL, V1, P1220; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B	64	26	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5688	5707		10.1074/jbc.M115.669952	http://dx.doi.org/10.1074/jbc.M115.669952			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26792859	Green Published, hybrid			2022-12-28	WOS:000372551800020
J	Wangkanont, K; Wesener, DA; Vidani, JA; Kiessling, LL; Forest, KT				Wangkanont, Kittikhun; Wesener, Darryl A.; Vidani, Jack A.; Kiessling, Laura L.; Forest, Katrina T.			Structures of Xenopus Embryonic Epidermal Lectin Reveal a Conserved Mechanism of Microbial Glycan Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; galactofuranose; innate immunity; lectin; protein cross-linking; X-ray crystallography; bacterial agglutination; glycerol phosphate; intelectin; omentin	LAEVIS OOCYTE LECTIN; PROTEIN; INTELECTIN; EXPRESSION; IDENTIFICATION; FAMILY; CLONING; BINDING; PURIFICATION; SCATTERING	Intelectins (X-type lectins), broadly distributed throughout chordates, have been implicated in innate immunity. Xenopus laevis embryonic epidermal lectin (XEEL), an intelectin secreted into environmental water by the X. laevis embryo, is postulated to function as a defense against microbes. XEEL is homologous (64% identical) to human intelectin-1 (hIntL-1), which is also implicated in innate immune defense. We showed previously that hIntL-1 binds microbial glycans bearing exocyclic vicinal diol groups. It is unknown whether XEEL has the same ligand specificity. Also unclear is whether XEEL and hIntL-1 have similar quaternary structures, as XEEL lacks the corresponding cysteine residues in hIntL-1 that stabilize the disulfide-linked trimer. These observations prompted us to further characterize XEEL. We found that hIntL-1 and XEEL have similar structural features. Even without the corresponding intermolecular disulfide bonds present in hIntL-1, the carbohydrate recognition domain of XEEL (XEELCRD) forms a stable trimer in solution. The structure of XEELCRD in complex with d-glycerol-1-phosphate, a residue present in microbe-specific glycans, indicated that the exocyclic vicinal diol coordinates to a protein-bound calcium ion. This ligand-binding mode is conserved between XEEL and hIntL-1. The domain architecture of full-length XEEL is reminiscent of a barbell, with two sets of three glycan-binding sites oriented in opposite directions. This orientation is consistent with our observation that XEEL can promote the agglutination of specific serotypes of Streptococcus pneumoniae. These data support a role for XEEL in innate immunity, and they highlight structural and functional conservation of X-type lectins among chordates.	[Wangkanont, Kittikhun; Kiessling, Laura L.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Wesener, Darryl A.; Vidani, Jack A.; Kiessling, Laura L.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Forest, Katrina T.] Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kiessling, LL (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.; Forest, KT (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	kiessling@chem.wisc.edu; forest@bact.wisc.edu	Wangkanont, Kittikhun/AAF-8664-2019	Wangkanont, Kittikhun/0000-0002-7190-2955; Wesener, Darryl/0000-0002-8132-7018; Kiessling, Laura/0000-0001-6829-1500	DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor [085P1000817]; DOE Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health from NIGMS [P41GM103393]; National Science Foundation [BIR-9512577]; National Institutes of Health [S10 RR13790]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, T32GM008505, R01GM055984] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1353674] Funding Source: National Science Foundation	DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor; DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	For access to equipment and technical assistance, we gratefully acknowledge E. Kondrashkina (LS-CAT), M. M. Benning (Bruker AXS, Madison, WI), D. R. McCaslin (University of Wisconsin (UW)-Madison, Biophysics Instrumentation Facility (BIF)), and G. Sabat, M. Rajendarm, G. Auer, L. Zarling, and D. B. Weibel (UW-Madison). We thank R. A. Brown and A. W. Baker (UW-Madison) for critical feedback. This research used the resources of the Advanced Photon Source, a United States Dept. of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor (Grant 085P1000817). Use of the Stanford Synchrotron Radiation Lightsource (SSRL) (SLAC National Accelerator Laboratory) is supported by the DOE Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by National Institutes of Health Grant P41GM103393 from NIGMS. SPR and analytical ultracentrifugation experiments were conducted at the UW-Madison Biophysics Instrumentation Facility supported by UW-Madison, National Science Foundation Grant BIR-9512577, and National Institutes of Health Grant S10 RR13790.	Abe Y, 1999, EUR J BIOCHEM, V261, P33, DOI 10.1046/j.1432-1327.1999.00238.x; Afonine PV, 2005, CCP4 NEWSL, V42; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Chang SG, 2003, MOL CELLS, V16, P323; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Datta R, 2005, INFECT IMMUN, V73, P4025, DOI 10.1128/IAI.73.7.4025-4033.2005; DeLano W.L., PYMOL MOL GRAPHICS S; Dubaissi E, 2014, DEVELOPMENT, V141, P1514, DOI 10.1242/dev.102426; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058; French AT, 2008, INT J PARASITOL, V38, P467, DOI 10.1016/j.ijpara.2007.08.015; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Fullerton SWB, 2003, BIOCHEMISTRY-US, V42, P2104, DOI 10.1021/bi027077f; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Hudson KL, 2015, J AM CHEM SOC, V137, P15152, DOI 10.1021/jacs.5b08424; Ishino T, 2007, J BIOCHEM, V141, P479, DOI 10.1093/jb/mvm048; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Laue TM, 1995, METHOD ENZYMOL, V259, P427; Lee JK, 2004, GLYCOCONJUGATE J, V21, P443, DOI 10.1007/s10719-004-5534-6; Lee JK, 1997, GLYCOBIOLOGY, V7, P367, DOI 10.1093/glycob/7.3.367; Lee JK, 2001, GLYCOBIOLOGY, V11, P65, DOI 10.1093/glycob/11.1.65; Lin B, 2009, FISH SHELLFISH IMMUN, V26, P396, DOI 10.1016/j.fsi.2008.11.019; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Malashkevich VN, 1998, P NATL ACAD SCI USA, V95, P9134, DOI 10.1073/pnas.95.16.9134; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mooij WTM, 2009, NUCLEIC ACIDS RES, V37, pW402, DOI 10.1093/nar/gkp256; Nagata S, 2005, GLYCOBIOLOGY, V15, P281, DOI 10.1093/glycob/cwi010; Nagata S, 2003, DEV GENES EVOL, V213, P368, DOI 10.1007/s00427-003-0341-9; Nagata S, 2013, DEV COMP IMMUNOL, V40, P94, DOI 10.1016/j.dci.2013.02.008; NISHIHARA T, 1986, BIOCHEMISTRY-US, V25, P6013, DOI 10.1021/bi00368a027; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pemberton AD, 2004, J IMMUNOL, V173, P1894, DOI 10.4049/jimmunol.173.3.1894; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; ROBERSON MM, 1982, J BIOL CHEM, V257, P7520; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Russell S, 2008, FISH SHELLFISH IMMUN, V25, P91, DOI 10.1016/j.fsi.2008.02.018; Russell S, 2009, FISH SHELLFISH IMMUN, V26, P154, DOI 10.1016/j.fsi.2008.03.001; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shoji H, 2005, GLYCOBIOLOGY, V15, P709, DOI 10.1093/glycob/cwi051; Stivala A, 2011, BIOINFORMATICS, V27, P3315, DOI 10.1093/bioinformatics/btr575; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Tsuji S, 2007, GLYCOBIOLOGY, V17, P1045, DOI 10.1093/glycob/cwm075; Tsuji S, 2009, GLYCOBIOLOGY, V19, P518, DOI 10.1093/glycob/cwp013; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wesener DA, 2015, NAT STRUCT MOL BIOL, V22, P603, DOI 10.1038/nsmb.3053; Wong JWH, 2011, MOL BIOL EVOL, V28, P327, DOI 10.1093/molbev/msq194; Yan J, 2013, DEV COMP IMMUNOL, V41, P189, DOI 10.1016/j.dci.2013.04.016; Yan J, 2013, FISH SHELLFISH IMMUN, V34, P1139, DOI 10.1016/j.fsi.2013.01.017; Yan J, 2012, FISH SHELLFISH IMMUN, V33, P11, DOI 10.1016/j.fsi.2012.03.023; Zuniga JE, 2005, J MOL BIOL, V354, P1052, DOI 10.1016/j.jmb.2005.10.014	63	27	28	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5596	5610		10.1074/jbc.M115.709212	http://dx.doi.org/10.1074/jbc.M115.709212			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26755729	hybrid, Green Published			2022-12-28	WOS:000372551800013
J	Kuhn, BM; Errafi, S; Bucher, R; Dobrev, P; Geisler, M; Bigler, L; Zazimalova, E; Ringli, C				Kuhn, Benjamin M.; Errafi, Sanae; Bucher, Rahel; Dobrev, Petre; Geisler, Markus; Bigler, Laurent; Zazimalova, Eva; Ringli, Christoph			7-Rhamnosylated Flavonols Modulate Homeostasis of the Plant Hormone Auxin and Affect Plant Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; auxin; flavonoid; metabolism; transport; UGT89C1; auxin transport; auxin turnover; flavonols; rol1-2; flavonol glycosides; rhamnose*	TRANSCRIPTOME COEXPRESSION ANALYSIS; CRYSTAL-STRUCTURES; ARABIDOPSIS ROOTS; TWISTED DWARF1; TRANSPORT; MUTANTS; EFFLUX; BIOSYNTHESIS; EXPRESSION; PATHWAYS	Flavonols are a group of secondary metabolites that affect diverse cellular processes. They are considered putative negative regulators of the transport of the phytohormone auxin, by which they influence auxin distribution and concomitantly take part in the control of plant organ development. Flavonols are accumulating in a large number of glycosidic forms. Whether these have distinct functions and diverse cellular targets is not well understood. The rol1-2 mutant of Arabidopsis thaliana is characterized by a modified flavonol glycosylation profile that is inducing changes in auxin transport and growth defects in shoot tissues. To determine whether specific flavonol glycosides are responsible for these phenotypes, a suppressor screen was performed on the rol1-2 mutant, resulting in the identification of an allelic series of UGT89C1, a gene encoding a flavonol 7-O-rhamnosyltransferase. A detailed analysis revealed that interfering with flavonol rhamnosylation increases the concentration of auxin precursors and auxin metabolites, whereas auxin transport is not affected. This finding provides an additional level of complexity to the possible ways by which flavonols influence auxin distribution and suggests that flavonol glycosides play an important role in regulating plant development.	[Kuhn, Benjamin M.; Errafi, Sanae; Ringli, Christoph] Univ Zurich, Dept Plant & Microbial Biol, CH-8008 Zurich, Switzerland; [Bucher, Rahel; Bigler, Laurent] Univ Zurich, Dept Chem, CH-8057 Zurich, Switzerland; [Dobrev, Petre; Zazimalova, Eva] Acad Sci Czech Republ, Inst Expt Bot, CR-16502 Prague 6, Czech Republic; [Geisler, Markus] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Kuhn, Benjamin M.] Borer Chem AG, CH-4528 Zuchwil, Switzerland	University of Zurich; University of Zurich; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Fribourg	Ringli, C (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	chringli@botinst.uzh.ch	Geisler, Markus M/B-3921-2012; Bigler, Laurent/AAP-3799-2020; Eva, Zazimalova/G-7432-2014	Geisler, Markus M/0000-0002-6641-5810; Bigler, Laurent/0000-0003-3548-3594; Eva, Zazimalova/0000-0002-8325-7092	Swiss National Science Foundation [122157, 138472, 31003A_144223]; Forschungskredit of the University of Zurich; Czech Science Foundation [P305/11/0797]; Novartis foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungskredit of the University of Zurich; Czech Science Foundation(Grant Agency of the Czech Republic); Novartis foundation(Novartis)	This work was supported the Swiss National Science Foundation (Grants 122157 and 138472) and by the Forschungskredit of the University of Zurich (to B. M. K., S. E., and C. R.); by the Czech Science Foundation (Grant P305/11/0797) (to P. D. and E. Z.); and the Swiss National Science Foundation (Grant 31003A_144223) and the Novartis foundation (to M. G.).	Bailly A, 2008, J BIOL CHEM, V283, P21817, DOI 10.1074/jbc.M709655200; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Brown JE, 1998, BIOCHEM J, V330, P1173; Buer CS, 2013, PLANTA, V238, P171, DOI 10.1007/s00425-013-1883-3; Buer CS, 2004, PLANT CELL, V16, P1191, DOI 10.1105/tpc.020313; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Costa D, 2015, TETRAHEDRON, V71, P3157, DOI 10.1016/j.tet.2014.06.092; Diet A, 2006, PLANT CELL, V18, P1630, DOI 10.1105/tpc.105.038653; Dobrev Petre I, 2012, Methods Mol Biol, V913, P251, DOI 10.1007/978-1-61779-986-0_17; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698; Habets MEJ, 2014, NEW PHYTOL, V203, P362, DOI 10.1111/nph.12831; Henrichs S, 2012, EMBO J, V31, P2965, DOI 10.1038/emboj.2012.120; Horiguchi G, 2006, PLANT J, V48, P638, DOI 10.1111/j.1365-313X.2006.02896.x; JACOBS M, 1988, SCIENCE, V241, P346, DOI 10.1126/science.241.4863.346; Jones P, 2003, J BIOL CHEM, V278, P43910, DOI 10.1074/jbc.M303523200; Kai K, 2007, PHYTOCHEMISTRY, V68, P1651, DOI 10.1016/j.phytochem.2007.04.030; Koornneef M., 1982, ARABIDOPSIS INFORMAT, V19, P113; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Kuhn BM, 2011, PLANT PHYSIOL, V156, P585, DOI 10.1104/pp.111.175976; Leiber RM, 2010, PLANT CELL, V22, P1898, DOI 10.1105/tpc.109.073007; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Lewis DR, 2011, PLANT PHYSIOL, V156, P144, DOI 10.1104/pp.111.172502; Lewis DR, 2009, NAT PROTOC, V4, P437, DOI 10.1038/nprot.2009.1; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; MO YY, 1992, P NATL ACAD SCI USA, V89, P7213, DOI 10.1073/pnas.89.15.7213; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Novak O, 2012, PLANT J, V72, P523, DOI 10.1111/j.1365-313X.2012.05085.x; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Ostin A, 1998, PLANT PHYSIOL, V118, P285, DOI 10.1104/pp.118.1.285; Peer W.A., 2006, SCI FLAVONOIDS, P239, DOI [10.1007/978-0-387-28822-2_9, DOI 10.1007/978-0-387-28822-2_9]; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Peer WA, 2013, J EXP BOT, V64, P2629, DOI 10.1093/jxb/ert152; Peer WA, 2011, MOL PLANT, V4, P487, DOI 10.1093/mp/ssr034; Pencik A, 2013, PLANT CELL, V25, P3858, DOI 10.1105/tpc.113.114421; Rampey RA, 2004, PLANT PHYSIOL, V135, P978, DOI 10.1104/pp.104.039677; Reemer J., 2014, AUXIN ITS ROLE PLANT, P75; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; Ringli C, 2008, PLANT CELL, V20, P1470, DOI 10.1105/tpc.107.053249; Routaboul JM, 2006, PLANTA, V224, P96, DOI 10.1007/s00425-005-0197-5; Runions A, 2014, AUXIN ITS ROLE PLANT, P315, DOI [10.1007/978-3-7091-1526-8_15, DOI 10.1007/978-3-7091-1526-8_15]; Santelia D, 2008, J BIOL CHEM, V283, P31218, DOI 10.1074/jbc.M710122200; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Spiess GM, 2014, PLANT PHYSIOL, V165, P1092, DOI 10.1104/pp.114.236026; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Tam YY, 2000, PLANT PHYSIOL, V123, P589, DOI 10.1104/pp.123.2.589; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yin RH, 2014, NEW PHYTOL, V201, P466, DOI 10.1111/nph.12558; Yin R, 2012, J EXP BOT, V63, P2465, DOI 10.1093/jxb/err416; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; Yonekura-Sakakibara K, 2007, J BIOL CHEM, V282, P14932, DOI 10.1074/jbc.M611498200; Zazimalova E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001552; Zhang J, 2009, PLANT J, V57, P171, DOI 10.1111/j.1365-313X.2008.03676.x	62	42	43	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5385	5395		10.1074/jbc.M115.701565	http://dx.doi.org/10.1074/jbc.M115.701565			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26742840	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000371640600046
J	Joshi, P; Maidji, E; Stoddart, CA				Joshi, Pheroze; Maidji, Ekaterina; Stoddart, Cheryl A.			Inhibition of Heat Shock Protein 90 Prevents HIV Rebound	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS-FACTOR-ALPHA; CONFORMATIONAL DYNAMICS; HSP90 INHIBITORS; INFECTION; CELLS; TRANSCRIPTION; GELDANAMYCIN; REPLICATION; EXPRESSION	HIV evades eradication because transcriptionally dormant proviral genomes persist in long-lived reservoirs of resting CD4(+) T cells and myeloid cells, which are the source of viral rebound after cessation of antiretroviral therapy. Dormant HIV genomes readily produce infectious virus upon cellular activation because host transcription factors activated specifically by cell stress and heat shock mediate full-length HIV transcription. The molecular chaperone heat shock protein 90 (Hsp90) is over expressed during heat shock and activates inducible cellular transcription factors. Here we show that heat shock accelerates HIV transcription through induction of Hsp90 activity, which activates essential HIV-specific cellular transcription factors (NF-kappa B, NFAT, and STAT5), and that inhibition of Hsp90 greatly reduces gene expression mediated by these factors. More importantly, we show that Hsp90 controls virus transcription in vivo by specific Hsp90 inhibitors in clinical development, tanespimycin (17-(allylarnino)-17-demethoxygeldanamycin) and AUY922, which durably prevented viral rebound in HIV-infected humanized NOD scid IL-2R gamma(-/-) bone marrow-liver-thymus mice up to 11 weeks after treatment cessation, Despite the absence of rebound viremia, we were able to recover infectious HIV from PBMC with heat shock. Replication-competent virus was detected in spleen cells from these nonviremic Hsp90 inhibitor-treated mice, indicating the presence of a tissue reservoir of persistent infection. Our novel findings provide in vivo evidence that inhibition of Hsp90 activity prevents HIV gene expression in replication-competent cellular reservoirs that would typically cause rebound in plasma viremia after antiretroviral therapy cessation. Alternating or supplementing Hsp90 inhibitors with current antiretroviral therapy regimens could conceivably suppress rebound viremia from persistent HIV reservoirs.	[Joshi, Pheroze; Maidji, Ekaterina; Stoddart, Cheryl A.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Expt Med, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Stoddart, CA (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Expt Med, San Francisco, CA 94110 USA.	cheryl.stoddart@ucsf.edu			NIAID, National Institutes of Health [AI108398, HHSN272201400002C]; AIDS Research Institute at the University of California San Francisco; Harvey V. Berneking Living Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R21AI108398] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AIDS Research Institute at the University of California San Francisco; Harvey V. Berneking Living Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported mainly by NIAID, National Institutes of Health, Grant AI108398 (to C. A. S.) and Contract HHSN272201400002C. This work was also supported in part by the AIDS Research Institute at the University of California San Francisco and the Harvey V. Berneking Living Trust. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Anderson I, 2014, P NATL ACAD SCI USA, V111, pE1528, DOI 10.1073/pnas.1320178111; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Bae J, 2013, J IMMUNOL, V190, P1360, DOI 10.4049/jimmunol.1200593; BISWAS P, 1994, J VIROL, V68, P2598, DOI 10.1128/JVI.68.4.2598-2604.1994; CANN AJ, 1990, J VIROL, V64, P4735, DOI 10.1128/JVI.64.10.4735-4742.1990; Chakalova L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000729; Chun TW, 2013, CURR OPIN HIV AIDS, V8, P111, DOI 10.1097/COH.0b013e32835d6e1c; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; GEELEN JLMC, 1988, J GEN VIROL, V69, P2913, DOI 10.1099/0022-1317-69-11-2913; Geller R, 2012, BBA-MOL CELL RES, V1823, P698, DOI 10.1016/j.bbamcr.2011.11.007; GENDELMAN HE, 1987, VIROLOGY, V160, P323, DOI 10.1016/0042-6822(87)90002-X; Gooljarsingh LT, 2006, P NATL ACAD SCI USA, V103, P7625, DOI 10.1073/pnas.0602650103; Graham B, 2012, CANCER SCI, V103, P522, DOI 10.1111/j.1349-7006.2011.02191.x; HALTINER M, 1985, NUCLEIC ACIDS RES, V13, P1015, DOI 10.1093/nar/13.3.1015; Hashimoto K, 1996, ARCH VIROL, V141, P439, DOI 10.1007/BF01718308; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Ikebe E, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.30; Iordanskiy S, 2015, VIROLOGY, V485, P1, DOI 10.1016/j.virol.2015.06.021; JACQUIERSARLIN MR, 1995, J BIOL CHEM, V270, P14094, DOI 10.1074/jbc.270.23.14094; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Joshi P, 2013, VIROLOGY, V436, P162, DOI 10.1016/j.virol.2012.11.005; Joshi P, 2011, J BIOL CHEM, V286, P24581, DOI 10.1074/jbc.M111.248021; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Kretz-Remy C, 2001, J BIOL CHEM, V276, P43723, DOI 10.1074/jbc.M010821200; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Mbonye U, 2014, VIROLOGY, V454, P328, DOI 10.1016/j.virol.2014.02.008; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; PAL R, 1991, AIDS RES HUM RETROV, V7, P707, DOI 10.1089/aid.1991.7.707; Palmer S, 2011, J INTERN MED, V270, P550, DOI 10.1111/j.1365-2796.2011.02457.x; Perrier NA, 2005, J NEUROCHEM, V94, P629, DOI 10.1111/j.1471-4159.2005.03140.x; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Rabin L, 1996, ANTIMICROB AGENTS CH, V40, P755, DOI 10.1128/AAC.40.3.755; Rahman SA, 2014, J VIROL, V88, P7904, DOI 10.1128/JVI.00431-14; Roesch F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002792; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Santos S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-65; SASAKI H, 1995, P NATL ACAD SCI USA, V92, P2026, DOI 10.1073/pnas.92.6.2026; Schnaider T, 2000, CELL STRESS CHAPERON, V5, P52, DOI 10.1379/1466-1268(2000)005<0052:THSIGS>2.0.CO;2; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shandilya J, 2012, BBA-GENE REGUL MECH, V1819, P391, DOI 10.1016/j.bbagrm.2012.01.010; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; STANLEY SK, 1990, J IMMUNOL, V145, P1120; Stoddart CA, 2015, ANTIMICROB AGENTS CH, V59, P4190, DOI 10.1128/AAC.05036-14; Stoddart CA, 2011, VIROLOGY, V417, P154, DOI 10.1016/j.virol.2011.05.013; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; TALBOT SJ, 1995, J VIROL, V69, P3399, DOI 10.1128/JVI.69.6.3399-3406.1995; Travers J, 2012, DRUG DISCOV TODAY, V17, P242, DOI 10.1016/j.drudis.2011.12.021; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Vozzolo L, 2010, J BIOL CHEM, V285, P39314, DOI 10.1074/jbc.M110.155275; Wilk T, 2001, J VIROL, V75, P759, DOI 10.1128/JVI.75.2.759-771.2001; Xu WJ, 2004, J CELL PHYSIOL, V198, P188, DOI 10.1002/jcp.10403; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575	69	33	35	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10332	10346		10.1074/jbc.M116.717538	http://dx.doi.org/10.1074/jbc.M116.717538			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26957545	hybrid, Green Published			2022-12-28	WOS:000375602800039
J	Li, JW; Johnson, KA				Li, Jiawen; Johnson, Kenneth A.			Thumb Site 2 Inhibitors of Hepatitis C Viral RNA-dependent RNA Polymerase Allosterically Block the Transition from Initiation to Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-INFECTION; MECHANISM; DISCRIMINATION; EXPLORER; COMPLEX; AZT; HCV	Replication of the hepatitis C viral genome is catalyzed by the NS5B (nonstructural protein 5B) RNA-dependent RNA polymerase, which is a major target of antiviral drugs currently in the clinic. Prior studies established that initiation of RNA replication could be facilitated by starting with a dinucleotide (pGG). Here we establish conditions for efficient initiation from GTP to form the dinucleotide and subsequent intermediates leading to highly processive elongation, and we examined the effects of four classes of nonnucleoside inhibitors on each step of the reaction. We show that palm site inhibitors block initiation starting from GTP but not when starting from pGG. In addition we show that nonnucleoside inhibitors binding to thumb site-2 (NNI2) lead to the accumulation of abortive intermediates three-five nucleotides in length. Our kinetic analysis shows that NNI2 do not significantly block initiation or elongation of RNA synthesis; rather, they block the transition from initiation to elongation, which is thought to proceed with significant structural rearrangement of the enzyme-RNA complex including displacement of the beta-loop from the active site. Direct measurement in single turnover kinetic studies show that pyrophosphate release is faster than the chemistry step, which appears to be rate-limiting during processive synthesis. These results reveal important new details to define the steps involved in initiation and elongation during viral RNA replication, establish the allosteric mechanisms by which NNI2 inhibitors act, and point the way to the design of more effective allosteric inhibitors that exploit this new information.	[Li, Jiawen; Johnson, Kenneth A.] Univ Texas Austin, Inst Cell & Mol Biol, Dept Mol Biosci, 4800,2500 Speedway,MBB 3-122, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Dept Mol Biosci, 4800,2500 Speedway,MBB 3-122, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu			National Institutes of Health [1R01AI110577]; Welch Foundation [F-1604]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI110577 (NIAID; to K. A. J.) and the Welch Foundation (F-1604 to K. A. J.). K. A. J. is the president of KinTek, which provided the RQF-3 rapid quench-flow instrument and KinTek Explorer software used in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Deredge D, 2016, J BIOL CHEM, V291, P10078, DOI 10.1074/jbc.M115.708370; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Hanes JW, 2008, ANAL BIOCHEM, V372, P125, DOI 10.1016/j.ab.2007.08.004; Jin ZN, 2013, P NATL ACAD SCI USA, V110, pE348, DOI 10.1073/pnas.1214924110; Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kellinger MW, 2011, BIOCHEMISTRY-US, V50, P5008, DOI 10.1021/bi200204m; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Muir AJ, 2015, CLIN GASTROENTEROL H, V13, P2166, DOI 10.1016/j.cgh.2015.07.015; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Watkins WJ, 2010, CURR OPIN DRUG DISC, V13, P441; Wilder JM, 2016, HEPATOLOGY, V63, P437, DOI 10.1002/hep.28334; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	22	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10067	10077		10.1074/jbc.M115.708354	http://dx.doi.org/10.1074/jbc.M115.708354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26851276	Green Published, hybrid			2022-12-28	WOS:000375602800019
J	Qian, XL; Hamid, FM; El Sahili, A; Darwis, DA; Wong, YH; Bhushan, S; Makeyev, EV; Lescar, J				Qian, Xinlei; Hamid, Fursham M.; El Sahili, Abbas; Darwis, Dina Amallia; Wong, Yee Hwa; Bhushan, Shashi; Makeyev, Eugene V.; Lescar, Julien			Functional Evolution in Orthologous Cell-encoded RNA-dependent RNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSIC ANTIVIRAL IMMUNITY; SMALL INTERFERING RNAS; SECONDARY; BIOGENESIS; NEUROSPORA; MECHANISMS; CRYSTALLIZATION; TRANSCRIPTION; POPULATIONS; INITIATION	Many eukaryotic organisms encode more than one RNA-dependent RNA polymerase (RdRP) that probably emerged as a result of gene duplication. Such RdRP paralogs often participate in distinct RNA silencing pathways and show characteristic repertoires of enzymatic activities in vitro. However, to what extent members of individual paralogous groups can undergo functional changes during speciation remains an open question. We show that orthologs of QDE-1, an RdRP component of the quelling pathway in Neurospora crassa, have rapidly diverged in evolution at the amino acid sequence level. Analyses of purified QDE-1 polymerases from N. crassa (QDE-1(Ncr)) and related fungi, Thielavia terrestris (QDE-1(Tte)) and Myceliophthora thermophila (QDE-1(Mth)), show that all three enzymes can synthesize RNA, but the precise modes of their action differ considerably. Unlike their QDE-1(Ncr) counterpart favoring processive RNA synthesis, QDE-1(Tte) and QDE-1(Mth) produce predominantly short RNA copies via primer-independent initiation. Surprisingly, a 3.19 angstrom resolution crystal structure of QDE-1(Tte) reveals a quasisymmetric dimer similar to QDE-1(Ncr). Further electron microscopy analyses confirm that QDE-1(Tte) occurs as a dimer in solution and retains this status upon interaction with a template. We conclude that divergence of orthologous RdRPs can result in functional innovation while retaining overall protein fold and quaternary structure.	[Qian, Xinlei; Hamid, Fursham M.; El Sahili, Abbas; Darwis, Dina Amallia; Wong, Yee Hwa; Bhushan, Shashi; Makeyev, Eugene V.; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 138673, Singapore; [Makeyev, Eugene V.] Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England; [Lescar, Julien] CHU Pitie Salpetriere, UPMC, UMRS CNRS ERL INSERM U1135 8255 CR7, Ctr Immunol & Malad Infect,Fac Med Pierre & Marie, F-75031 Paris, France; [Qian, Xinlei] Singapore MIT Alliance Res & Technol, Singapore 138602, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Makeyev, EV; Lescar, J (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 138673, Singapore.; Makeyev, EV (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England.; Lescar, J (corresponding author), CHU Pitie Salpetriere, UPMC, UMRS CNRS ERL INSERM U1135 8255 CR7, Ctr Immunol & Malad Infect,Fac Med Pierre & Marie, F-75031 Paris, France.	eugene.makeyev@kcl.ac.uk; julien@ntu.edu.sg		Wong, Yee Hwa/0000-0002-2751-9721; qian, xinlei/0000-0002-2032-0736; Makeyev, Eugene/0000-0001-6034-6896; El Sahili, Abbas/0000-0003-3973-686X; Bhushan, Shashi/0000-0002-8514-5959	Ministry of Education Singapore Academic Research Fund Tier 1 [RG62/12, RGC2/14]; National Medical Research Council [NMRC/CBRG/0028/2013]; Biotechnology and Biological Sciences Research Council [BB/M001199/1, BB/M007103/1]; Nanyang President Graduate Scholarship; BBSRC [BB/M001199/1, BB/M007103/1] Funding Source: UKRI	Ministry of Education Singapore Academic Research Fund Tier 1(Ministry of Education, Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nanyang President Graduate Scholarship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Ministry of Education Singapore Academic Research Fund Tier 1 Grants RG62/12 and RGC2/14 (to J. L.), National Medical Research Council Grant NMRC/CBRG/0028/2013 (to E. V. M.), Biotechnology and Biological Sciences Research Council Grants BB/M001199/1 and BB/M007103/1 (to E. V. M.), and the Nanyang President Graduate Scholarship (to F. M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aalto AP, 2010, J BIOL CHEM, V285, P29367, DOI 10.1074/jbc.M110.139121; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Berka RM, 2011, NAT BIOTECHNOL, V29, P922, DOI 10.1038/nbt.1976; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Burroughs AM, 2014, WIRES RNA, V5, P141, DOI 10.1002/wrna.1210; Calo S, 2014, NATURE, V513, P555, DOI 10.1038/nature13575; Calo S, 2012, MOL MICROBIOL, V83, P379, DOI 10.1111/j.1365-2958.2011.07939.x; Carradec Q, 2015, NUCLEIC ACIDS RES, V43, P1818, DOI 10.1093/nar/gku1331; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chen SD, 2013, NAT REV GENET, V14, P645, DOI 10.1038/nrg3521; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Devert A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120100; Dumesic PA, 2014, TRENDS BIOCHEM SCI, V39, P25, DOI 10.1016/j.tibs.2013.10.003; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; GOTTLIEB P, 1992, J VIROL, V66, P2611, DOI 10.1128/JVI.66.5.2611-2616.1992; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Haag JR, 2012, MOL CELL, V48, P811, DOI 10.1016/j.molcel.2012.09.027; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Ipsaro JJ, 2015, NAT STRUCT MOL BIOL, V22, P20, DOI 10.1038/nsmb.2931; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kriventseva EV, 2015, NUCLEIC ACIDS RES, V43, pD250, DOI 10.1093/nar/gku1220; Kuo HC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05135; Lee HC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000496; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lee SR, 2007, NAT STRUCT MOL BIOL, V14, P604, DOI 10.1038/nsmb1262; Long MY, 2013, ANNU REV GENET, V47, P307, DOI 10.1146/annurev-genet-111212-133301; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nayak A, 2013, CURR TOP MICROBIOL, V371, P183, DOI 10.1007/978-3-642-37765-5_7; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Santos SP, 2012, PROTEIN EXPRES PURIF, V81, P193, DOI 10.1016/j.pep.2011.10.001; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Shrestha Binesh, 2008, V439, P269, DOI 10.1007/978-1-59745-188-8_19; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Studer RA, 2009, TRENDS GENET, V25, P210, DOI 10.1016/j.tig.2009.03.004; Szittya G, 2013, CURR TOP MICROBIOL, V371, P153, DOI 10.1007/978-3-642-37765-5_6; Talsky KB, 2010, J BIOL CHEM, V285, P27614, DOI 10.1074/jbc.M110.142273; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Toth-Petroczy A, 2014, CURR OPIN STRUC BIOL, V26, P131, DOI 10.1016/j.sbi.2014.06.007; Turner BC, 2001, FUNGAL GENET BIOL, V32, P67, DOI 10.1006/fgbi.2001.1247; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Yang QY, 2015, GENE DEV, V29, P526, DOI 10.1101/gad.255828.114; Zhou R, 2013, IMMUNOL REV, V253, P97, DOI 10.1111/imr.12053; Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004	65	9	9	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9295	9309		10.1074/jbc.M115.685933	http://dx.doi.org/10.1074/jbc.M115.685933			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26907693	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000374849000038
J	Ristic, G; Tsou, WL; Guzi, E; Kanack, AJ; Scaglione, KM; Todi, SV				Ristic, Gorica; Tsou, Wei-Ling; Guzi, Ermal; Kanack, Adam J.; Scaglione, Kenneth Matthew; Todi, Sokol V.			USP5 Is Dispensable for Monoubiquitin Maintenance in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; ISOPEPTIDASE-T; DEUBIQUITINATING ENZYMES; UNANCHORED UBIQUITIN; POLYUBIQUITIN CHAINS; GENE-EXPRESSION; NERVOUS-SYSTEM; ATAXIA MICE; IN-VITRO; DEGRADATION	Ubiquitination is a post-translational modification that regulates most cellular pathways and processes, including degradation of proteins by the proteasome. Substrate ubiquitination is controlled at various stages, including through its reversal by deubiquitinases (DUBs). Acritical outcome of this process is the recycling of monoubiquitin. One DUB whose function has been proposed to include monoubiquitin recycling is USP5. Here, we investigated whether Drosophila USP5 is important for maintaining monoubiquitin in vivo. We found that the fruit fly orthologue of USP5 has catalytic preferences similar to its human counterpart and that this DUB is necessary during fly development. Our biochemical and genetic experiments indicate that reduction of USP5 does not lead to monoubiquitin depletion in developing flies. Also, introduction of exogenous ubiquitin does not suppress developmental lethality caused by loss of endogenous USP5. Our work indicates that a primary physiological role of USP5 is not to recycle monoubiquitin for reutilization, but that it may involve disassembly of conjugated ubiquitin to maintain proteasome function.	[Ristic, Gorica; Tsou, Wei-Ling; Guzi, Ermal; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Kanack, Adam J.; Scaglione, Kenneth Matthew] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Kanack, Adam J.; Scaglione, Kenneth Matthew] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA	Wayne State University; Wayne State University; Medical College of Wisconsin; Medical College of Wisconsin	Todi, SV (corresponding author), 540 E Canfield,Scott Hall,Rm 3108, Detroit, MI 48201 USA.	stodi@med.wayne.edu	Tsou, Wei-Ling/AAI-2655-2021	Tsou, Wei-Ling/0000-0001-9136-2581; Scaglione, Kenneth/0000-0002-3858-9418; TODI, SOKOL/0000-0003-4399-5549	National Institutes of Health [P40OD018537, R01GM084947]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086778, R00NS073936] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Udai Pandey (University of Pittsburgh), Daniel Eberl (University of Iowa), and R. J. Wessells (Wayne State University) for fly stocks, as well as Dr. Lori Pile (Wayne State University) for the anti-Sin3 antibody. We also thank the Bloomington Drosophila Stock Center (funded by National Institutes of Health Grant P40OD018537), the Vienna Drosophila RNAi Center, the FlyORF, and the TRiP at Harvard Medical School (funded by National Institutes of Health Grant R01GM084947) for transgenic stocks.	Amerik AY, 1997, EMBO J, V16, P4826; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Avvakumov GV, 2012, BIOCHEMISTRY-US, V51, P1188, DOI 10.1021/bi200854q; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Blount JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5638; Blount JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036542; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen PC, 2011, J NEUROSCI, V31, P17505, DOI 10.1523/JNEUROSCI.2922-11.2011; Chen PC, 2009, J NEUROSCI, V29, P10909, DOI 10.1523/JNEUROSCI.2635-09.2009; Chen W, 2004, CANCER RES, V64, P3949, DOI 10.1158/0008-5472.CAN-03-3906; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FALQUET L, 1995, FEBS LETT, V359, P73, DOI 10.1016/0014-5793(94)01451-6; Garcia-Caballero A, 2014, NEURON, V83, P1144, DOI 10.1016/j.neuron.2014.07.036; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Grou CP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12836; Hallengren J, 2013, CELL BIOCHEM BIOPHYS, V67, P67, DOI 10.1007/s12013-013-9634-4; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kong QH, 2010, BIOCHEM BIOPH RES CO, V393, P708, DOI 10.1016/j.bbrc.2010.02.066; Kovacs L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120875; Lee FKM, 2009, J NEUROCHEM, V110, P208, DOI 10.1111/j.1471-4159.2009.06124.x; Lu CG, 2013, DEVELOPMENT, V140, P3522, DOI 10.1242/dev.098947; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Oh C, 2013, ANAL BIOCHEM, V443, P153, DOI 10.1016/j.ab.2013.09.011; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pile LA, 2000, EMBO J, V19, P6131, DOI 10.1093/emboj/19.22.6131; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Ristic G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00072; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Scaglione KM, 2013, J BIOL CHEM, V288, P18784, DOI 10.1074/jbc.C113.477596; Shabek N, 2010, CELL CYCLE, V9, P523, DOI 10.4161/cc.9.3.11152; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Tsou WL, 2015, NEUROBIOL DIS, V82, P12, DOI 10.1016/j.nbd.2015.05.010; Tsou WL, 2015, HUM MOL GENET, V24, P4385, DOI 10.1093/hmg/ddv174; Tsou WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043112; Wang CH, 2014, BIOCHEM BIOPH RES CO, V452, P369, DOI 10.1016/j.bbrc.2014.08.069; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032	50	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9161	9172		10.1074/jbc.M115.703504	http://dx.doi.org/10.1074/jbc.M115.703504			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26917723	Green Published, hybrid			2022-12-28	WOS:000374849000027
J	Berezhnov, AV; Soutar, MPM; Fedotova, EI; Frolova, MS; Plun-Favreau, H; Zinchenko, VP; Abramov, AY				Berezhnov, Alexey V.; Soutar, Marc P. M.; Fedotova, Evgeniya I.; Frolova, Maria S.; Plun-Favreau, Helene; Zinchenko, Valery P.; Abramov, Andrey Y.			Intracellular pH Modulates Autophagy and Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; lysosome; mitochondria; mitophagy; neurodegeneration; intracellular pH	MITOCHONDRIA; PARKIN; LYSOSOME; RELEASE; CELLS	The specific autophagic elimination of mitochondria (mitophagy) plays the role of quality control for this organelle. Deregulation of mitophagy leads to an increased number of damaged mitochondria and triggers cell death. The deterioration of mitophagy has been hypothesized to underlie the pathogenesis of several neurodegenerative diseases, most notably Parkinson disease. Although some of the biochemical and molecular mechanisms of mitochondrial quality control are described in detail, physiological or pathological triggers of mitophagy are still not fully characterized. Here we show that the induction of mitophagy by the mitochondrial uncoupler FCCP is independent of the effect of mitochondrial membrane potential but dependent on acidification of the cytosol by FCCP. The ionophore nigericin also reduces cytosolic pH and induces PINK1/PARKIN-dependent and -independent mitophagy. The increase of intracellular pH with monensin suppresses the effects of FCCP and nigericin on mitochondrial degradation. Thus, a change in intracellular pH is a regulator of mitochondrial quality control.	[Berezhnov, Alexey V.; Fedotova, Evgeniya I.; Frolova, Maria S.; Zinchenko, Valery P.] Russian Acad Sci, Inst Cell Biophys, Dept Intracellular Signaling, Pushchino 142290, Moscow Region, Russia; [Soutar, Marc P. M.; Plun-Favreau, Helene; Abramov, Andrey Y.] UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; University of London; University College London	Abramov, AY (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England.	a.abramov@ucl.ac.uk	Abramov, Andrey Y/H-9053-2012; Abramov, Andrey/AAC-6712-2019; Fedotova, Evgeniya/R-8947-2016; Soutar, Marc P M/G-3637-2011; Plun-Favreau, Helene/Q-4111-2016; Berezhnov, Alexey/C-7479-2015	Abramov, Andrey Y/0000-0002-7646-7235; Abramov, Andrey/0000-0002-7646-7235; Soutar, Marc P M/0000-0003-0008-9423; Plun-Favreau, Helene/0000-0002-1401-9656; Fedotova, Evgeniya/0000-0001-6619-4563; Berezhnov, Alexey/0000-0003-0271-6179	Russian Foundation for Basic Research [14-04-31870]; Leverhulme Trust [RPG-2012-447]; MRC [G0700183] Funding Source: UKRI; Medical Research Council [G0700183] Funding Source: researchfish	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Leverhulme Trust(Leverhulme Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Russian Foundation for Basic Research (Grant No. 14-04-31870) and The Leverhulme Trust (RPG-2012-447). The authors declare that they have no conflicts of interest with the contents of this article.	Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; BERG TO, 1994, BIOCHEM J, V300, P229, DOI 10.1042/bj3000229; Bevensee MO, 2008, BRAIN RES, V1193, P143, DOI 10.1016/j.brainres.2007.12.002; Burchell VS, 2013, NAT NEUROSCI, V16, P1257, DOI 10.1038/nn.3489; Chu CT, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/789431; Cookson MR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009415; Deas E, 2011, BBA-MOL CELL RES, V1813, P623, DOI 10.1016/j.bbamcr.2010.08.007; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; GRINDE B, 1983, EXP CELL RES, V149, P27, DOI 10.1016/0014-4827(83)90377-4; HARTLEY Z, 1993, J NEUROSCI, V13, P4690; Kockskamper J, 2005, J PHYSIOL-LONDON, V564, P697, DOI 10.1113/jphysiol.2004.078782; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004; Marino ML, 2012, J BIOL CHEM, V287, P30664, DOI 10.1074/jbc.M112.339127; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Owens LM, 1996, CIRCULATION, V94, P10, DOI 10.1161/01.CIR.94.1.10; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Strappazzon F, 2015, CELL DEATH DIFFER, V22, P419, DOI 10.1038/cdd.2014.139; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Togashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081313; Yao Z, 2011, J CELL SCI, V124, P4194, DOI 10.1242/jcs.088260; ZIEGELSTEIN RC, 1994, CARDIOVASC RES, V28, P1433, DOI 10.1093/cvr/28.9.1433	31	64	64	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8701	8708		10.1074/jbc.M115.691774	http://dx.doi.org/10.1074/jbc.M115.691774			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26893374	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000374773200032
J	Copps, KD; Hancer, NJ; Qiu, W; White, MF				Copps, Kyle D.; Hancer, Nancy J.; Qiu, Wei; White, Morris F.			Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin receptor substrate 1 (IRS-1); insulin resistance; mammalian target of rapamycin (mTOR); S6 kinase; tuberous sclerosis complex (TSC); amino acids; gene knock-in; insulin signaling; serine; threonine phosphorylation	SKELETAL-MUSCLE CELLS; SERINE/THREONINE PHOSPHORYLATION; MAMMALIAN TARGET; TYROSINE PHOSPHORYLATION; METABOLIC-REGULATION; TUBEROUS SCLEROSIS; AMINO-ACID; RESISTANCE; DEGRADATION; PATHWAY	Constitutive activation of the mammalian target of rapamycin complex 1 and S6 kinase (mTORC1 S6K) attenuates insulin-stimulated Akt activity in certain tumors in part through feedback phosphorylation of the upstream insulin receptor substrate 1 (IRS1). However, the significance of this mechanism for regulating insulin sensitivity in normal tissue remains unclear. We investigated the function of Ser-302 in mouse IRS1, the major site of its phosphorylation by S6K in vitro, through genetic knock-in of a serine-to-alanine mutation (A302). Although insulin rapidly stimulated feedback phosphorylation of Ser-302 in mouse liver and muscle, homozygous A302 mice (A/A) and their knock-in controls (S/S) exhibited similar glucose homeostasis and muscle insulin signaling. Furthermore, both A302 and control primary hepatocytes from which Irs2 was deleted showed marked inhibition of insulin-stimulated IRS1 tyrosine phosphorylation and PI3K binding after emetine treatment to raise intracellular amino acids and activate mTORC1 S6K signaling. To specifically activate mTORC1 in mouse tissue, we deleted hepatic Tsc1 using Cre adenovirus. Although it moderately decreased IRS1/PI3K association and Akt phosphorylation in liver, Tsc1 deletion failed to cause glucose intolerance or promote hyperinsulinemia in mixed background A/A or S/S mice. Moreover, Tsc1 deletion failed to stimulate phospho-Ser-302 or other putative S6K sites within IRS1, whereas ribosomal S6 protein was constitutively phosphorylated. Following acute Tsc1 deletion from hepatocytes, Akt phosphorylation, but not IRS1/PI3K association, was rapidly restored by treatment with the mTORC1 inhibitor rapamycin. Thus, within the hepatic compartment, mTORC1 S6K signaling regulates Akt largely through IRS-independent means with little effect upon physiologic insulin sensitivity.	[Copps, Kyle D.; Hancer, Nancy J.; Qiu, Wei; White, Morris F.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Med,Div Endocrinol, Rm 16020,3 Blackfan Circle, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	White, MF (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Ctr Life Sci,Dept Med,Div Endocrinol, Rm 16020,3 Blackfan Circle, Boston, MA 02115 USA.	morris.white@childrens.harvard.edu			National Institutes of Health [DK38712, DK55326, DK098655, GM021700]; Juvenile Diabetes Foundation International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038712, R29DK038712, R55DK038712, R01DK098655, R01DK055326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021700] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Foundation International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK38712, DK55326, DK098655, and GM021700 (to M. F. W.) with further support by an award from the Juvenile Diabetes Foundation International (to M. F. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bergsten P, 2002, DIABETES, V51, P699, DOI 10.2337/diabetes.51.3.699; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Danielsson A, 2006, BIOCHEM BIOPH RES CO, V342, P1183, DOI 10.1016/j.bbrc.2006.02.075; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; HELLERHARRISON RA, 1995, J BIOL CHEM, V270, P24442, DOI 10.1074/jbc.270.41.24442; Herrema H, 2014, BIOCHEM BIOPH RES CO, V443, P689, DOI 10.1016/j.bbrc.2013.12.023; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Pollizzi K, 2009, HUM MOL GENET, V18, P2378, DOI 10.1093/hmg/ddp176; Rajan MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059725; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schlottmann SA, 2006, J IMMUNOL METHODS, V309, P75, DOI 10.1016/j.jim.2005.11.019; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Sopasakis VR, 2010, CELL METAB, V11, P220, DOI 10.1016/j.cmet.2010.02.002; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; White MF, 2010, ENDOCRINOLOGY, P636; Wick KR, 2003, J BIOL CHEM, V278, P8460, DOI 10.1074/jbc.M208518200; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200	46	21	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8602	8617		10.1074/jbc.M116.714915	http://dx.doi.org/10.1074/jbc.M116.714915			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26846849	Green Published, hybrid			2022-12-28	WOS:000374773200024
J	Ding, XQ; Thapa, A; Ma, HW; Xu, JH; Elliott, MH; Rodgers, KK; Smith, ML; Wang, JS; Pittler, SJ; Kefalov, VJ				Ding, Xi-Qin; Thapa, Arjun; Ma, Hongwei; Xu, Jianhua; Elliott, Michael H.; Rodgers, Karla K.; Smith, Marci L.; Wang, Jin-Shan; Pittler, Steven J.; Kefalov, Vladimir J.			The B3 Subunit of the Cone Cyclic Nucleotide-gated Channel Regulates the Light Responses of Cones and Contributes to the Channel Structural Flexibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; photoreceptor; phototransduction; retina; vision; achromatopsia; cng channel; cone	ENDOPLASMIC-RETICULUM STRESS; CNG CHANNEL; ION CHANNELS; PHOTORECEPTOR DEGENERATION; RETINAL DEGENERATION; BETA-SUBUNIT; FLICKER ERG; MOUSE MODEL; ROD; MUTATIONS	Cone photoreceptor cyclic nucleotide-gated (CNG) channels play a pivotal role in cone phototransduction, which is a process essential for daylight vision, color vision, and visual acuity. Mutations in the cone channel subunits CNGA3 and CNGB3 are associated with human cone diseases, including achromatopsia, cone dystrophies, and early onset macular degeneration. Mutations in CNGB3 alone account for 50% of reported cases of achromatopsia. This work investigated the role of CNGB3 in cone light response and cone channel structural stability. As cones comprise only 2-3% of the total photoreceptor population in the wild-type mouse retina, we used Cngb3(-/-)/Nrl(-/-) mice with CNGB3 deficiency on a cone-dominant background in our study. We found that, in the absence of CNGB3, CNGA3 was able to travel to the outer segments, co-localize with cone opsin, and form tetrameric complexes. Electroretinogram analyses revealed reduced cone light response amplitude/sensitivity and slower response recovery in Cngb3(-/-)/Nrl(-/-) mice compared with Nrl(-/-) mice. Absence of CNGB3 expression altered the adaptation capacity of cones and severely compromised function in bright light. Biochemical analysis demonstrated that CNGA3 channels lacking CNGB3 were more resilient to proteolysis than CNGA3/CNGB3 channels, suggesting a hindered structural flexibility. Thus, CNGB3 regulates cone light response kinetics and the channel structural flexibility. This work advances our understanding of the biochemical and functional role of CNGB3 in cone photoreceptors.	[Ding, Xi-Qin; Thapa, Arjun; Ma, Hongwei; Xu, Jianhua] Univ Oklahoma, Dept Cell Biol, Hlth Sci Ctr, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA; [Elliott, Michael H.] Univ Oklahoma, Dept Ophthalmol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Rodgers, Karla K.] Univ Oklahoma, Dept Biochem, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Elliott, Michael H.] Dean McGee Eye Inst, Oklahoma City, OK USA; [Smith, Marci L.; Pittler, Steven J.] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35924 USA; [Wang, Jin-Shan] Washington Univ, Dept Ophthalmol & Visual Sci, Sch Med, St Louis, MO 63110 USA; [Thapa, Arjun] Univ New Mexico, Dept Chem & Nucl Engn, Ctr Biomed Engn, Albuquerque, NM 87131 USA; [Xu, Jianhua] Fudan Univ, Inst Biomed Sci, Inst Reprod & Dev, 2140 Xietu Rd, Shanghai 200032, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); University of New Mexico; Fudan University	Ding, XQ (corresponding author), Univ Oklahoma, Dept Cell Biol, Hlth Sci Ctr, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu	; Pittler, Steven/J-7091-2013	Rodgers, Karla/0000-0002-7338-0281; Kefalov, Vladimir/0000-0002-1659-008X; Pittler, Steven/0000-0002-8464-9303	National Center for Research Resources [P20RR017703]; National Eye Institute [P30EY021725, T32EY023202, EY019490, EY019494, AI-094141, EY018143, EY003039, EY019312, EY021126, EY002687]; Research to Prevent Blindness; Oklahoma Center for the Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY021126, P30EY021725, R01EY019490, P30EY002687, R01EY019312, R01EY019494, R01EY018143, P30EY003039, T32EY023202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094141] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Oklahoma Center for the Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Center for Research Resources (P20RR017703), the National Eye Institute (P30EY021725, T32EY023202, EY019490 (X. Q. D.), EY019494 (M. H. E.), AI-094141 (K. K. R.), EY018143 (S. J. P.), EY003039 (S. J. P.), EY019312 (V. J. K.), EY021126 (V. J. K.), and EY002687 to the Department of Ophthalmology and Visual Sciences at Washington University), the Research to Prevent Blindness, and the Oklahoma Center for the Advancement of Science and Technology. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biel Martin, 2009, V191, P111, DOI 10.1007/978-3-540-68964-5_7; Biel M, 2009, J BIOL CHEM, V284, P9017, DOI 10.1074/jbc.R800075200; Bradley J, 2005, CURR OPIN NEUROBIOL, V15, P343, DOI 10.1016/j.conb.2005.05.014; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; COOK NJ, 1989, J BIOL CHEM, V264, P6996; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Ding XQ, 2008, BIOCHEMISTRY-US, V47, P3677, DOI 10.1021/bi7019645; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Ding XQ, 2002, MOL PHARMACOL, V61, P1041, DOI 10.1124/mol.61.5.1041; Faillace MP, 2004, J BIOL CHEM, V279, P22643, DOI 10.1074/jbc.M400035200; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Gerstner A, 2000, J NEUROSCI, V20, P1324; Goldberg AFX, 2001, J BIOL CHEM, V276, P42700, DOI 10.1074/jbc.M107511200; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Johnson S, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011437; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Kohl S, 2005, EUR J HUM GENET, V13, P302, DOI 10.1038/sj.ejhg.5201269; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Kolandaivelu S, 2011, J BIOL CHEM, V286, P33252, DOI 10.1074/jbc.M111.259101; Kolesnikov AV, 2012, JOVE-J VIS EXP, DOI 10.3791/3424; Kondo M, 2001, INVEST OPHTH VIS SCI, V42, P305; Korenbrot JI, 2013, J NEUROSCI, V33, P17763, DOI 10.1523/JNEUROSCI.2659-13.2013; Kunchithapautham K, 2009, INVEST OPHTH VIS SCI, V50, P4858, DOI 10.1167/iovs.08-3008; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Matveev AV, 2008, J NEUROCHEM, V106, P2042, DOI 10.1111/j.1471-4159.2008.05548.x; Matveev AV, 2010, BIOCHEMISTRY-US, V49, P1628, DOI 10.1021/bi901960u; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Michalakis S, 2006, J BIOL CHEM, V281, P35156, DOI 10.1074/jbc.M606409200; Nakamoto RK, 1998, J BIOL CHEM, V273, P7338, DOI 10.1074/jbc.273.13.7338; Nishiguchi KM, 2005, HUM MUTAT, V25, P248, DOI 10.1002/humu.20142; Okada A, 2004, INVEST OPHTH VIS SCI, V45, P2324, DOI 10.1167/iovs.03-1094; Parker R, 2011, J NEUROSCI, V31, P4714, DOI 10.1523/JNEUROSCI.3722-10.2011; PEACHEY NS, 1993, NEUROSCI LETT, V162, P9, DOI 10.1016/0304-3940(93)90547-X; Peng CH, 2003, J BIOL CHEM, V278, P24617, DOI 10.1074/jbc.M301699200; PICONES A, 1995, BIOPHYS J, V69, P120, DOI 10.1016/S0006-3495(95)79881-2; Qian H, 2008, EXP EYE RES, V87, P71, DOI 10.1016/j.exer.2008.04.011; Raz-Prag D, 2006, INVEST OPHTH VIS SCI, V47, P3603, DOI 10.1167/iovs.05-1527; Rebrik TI, 2012, J NEUROSCI, V32, P3142, DOI 10.1523/JNEUROSCI.5518-11.2012; Rebrik TI, 1998, J GEN PHYSIOL, V112, P537, DOI 10.1085/jgp.112.5.537; Roger JE, 2012, J NEUROSCI, V32, P528, DOI 10.1523/JNEUROSCI.3591-11.2012; Schon C, 2013, MOL GENET GENOMICS, V288, P459, DOI 10.1007/s00438-013-0766-4; Seddon JM, 2006, ANIM GENET, V37, P407, DOI 10.1111/j.1365-2052.2006.01484.x; Shuart NG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1466; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; Siligardi G, 1998, ENANTIOMER, V3, P77; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Trudeau MC, 2004, J GEN PHYSIOL, V124, P211, DOI 10.1085/jgp.200409101; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Vinberg F, 2014, VISION RES, V101, P108, DOI 10.1016/j.visres.2014.06.003; Wang JS, 2014, J NEUROSCI, V34, P11212, DOI 10.1523/JNEUROSCI.1245-14.2014; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; Weitz D, 1998, EMBO J, V17, P2273, DOI 10.1093/emboj/17.8.2273; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Xu JH, 2011, INVEST OPHTH VIS SCI, V52, P3557, DOI 10.1167/iovs.10-6358; Yeh CY, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-27; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	66	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8721	8734		10.1074/jbc.M115.696138	http://dx.doi.org/10.1074/jbc.M115.696138			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26893377	Green Published, hybrid			2022-12-28	WOS:000374773200034
J	Siu, KL; Gao, L; Cai, H				Siu, Kin Lung; Gao, Ling; Cai, Hua			Differential Roles of Protein Complexes NOX1-NOXO1 and NOX2-p47phox in Mediating Endothelial Redox Responses to Oscillatory and Unidirectional Laminar Shear Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NADPH oxidase; nitric oxide; nitric oxide synthase; oxidative stress; shear stress; signal transduction	NITRIC-OXIDE SYNTHASE; NADPH OXIDASE; HYDROGEN-PEROXIDE; UP-REGULATION; SUPEROXIDE-PRODUCTION; DIABETES-MELLITUS; MONOCYTE ADHESION; NAD(P)H OXIDASES; CHRONIC EXERCISE; ANGIOTENSIN-II	The endothelium is exposed to various flow patterns such as vasoprotective unidirectional laminar shear stress (LSS) and atherogenic oscillatory shear stress (OSS). A software-controlled, valve-operated OsciFlow device with parallel chambers was used to apply LSS and OSS to endothelial cells. Although LSS inhibited superoxide over time, OSS time-dependently increased superoxide production from endothelial cells. Immunocytochemical staining revealed that, at resting state, p47phox colocalizes with NOX2, whereas NOXO1 colocalizes with NOX1. RNAi of p47phox had no effects on superoxide or NO production in response to OSS but significantly reduced NO production in LSS, implicating a p47phox-bound NADPH oxidase (NOX) in mediating basal NO production. Indeed, RNAi of p47phox inhibited endothelial nitric oxide synthase (eNOS) serine 1179 phosphorylation, whereas PEG-catalase scavenging of intracellular hydrogen peroxide or RNAi of NOX2 produced similar results, indicating a role of NOX2/p47phox-derived hydrogen peroxide in mediating the basal activity of NO production from eNOS. In contrast, RNAi of NOXO1 resulted in no significant changes in NO and superoxide levels in response to LSS but significantly reduced superoxide while increasing NO in response to OSS. Furthermore, we identified, for the first time, that OSS uncouples eNOS, which was corrected by RNAi of NOXO1. In summary, LSS activates the NOX2-p47phox complex to activate eNOS phosphorylation and NO production. OSS instead activates the NOX1-NOXO1 complex to uncouple eNOS. These results demonstrate differential roles of NOXs in modulating the redox state in response to different shear stresses, which may promote the development of novel therapeutic agents to mimic the protective effects of LSS while inhibiting the injurious effects of OSS.	[Cai, Hua] Univ Calif Los Angeles, Div Mol Med, Dept Anesthesiol, Cardiovasc Res Labs,David Geffen Sch Med, 650 Charles E Young Dr, Los Angeles, CA 90095 USA; [Cai, Hua] Univ Calif Los Angeles, Div Cardiol, Dept Med, Cardiovasc Res Labs,David Geffen Sch Med, 650 Charles E Young Dr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cai, H (corresponding author), Univ Calif Los Angeles, Div Mol Med, Dept Anesthesiol, Cardiovasc Res Labs,David Geffen Sch Med, 650 Charles E Young Dr, Los Angeles, CA 90095 USA.; Cai, H (corresponding author), Univ Calif Los Angeles, Div Cardiol, Dept Med, Cardiovasc Res Labs,David Geffen Sch Med, 650 Charles E Young Dr, Los Angeles, CA 90095 USA.	hcai@mednet.ucla.edu			NHLBI/National Institutes of Health [HL077440, HL088975, HL108701, HL119968]; American Heart Association Established Investigator Award [12EIA8990025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077440, R01HL119968, R01HL108701, R01HL088975] Funding Source: NIH RePORTER	NHLBI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Established Investigator Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NHLBI/National Institutes of Health Grants HL077440 (to H. C.), HL088975 (to H. C.), HL108701 (to H. C. and D. G. H.), and HL119968 (to H. C.) and American Heart Association Established Investigator Award 12EIA8990025 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altenhofer S, 2012, CELL MOL LIFE SCI, V69, P2327, DOI 10.1007/s00018-012-1010-9; BERLINER JA, 1990, J CLIN INVEST, V85, P1260, DOI 10.1172/JCI114562; Cai H, 2004, J MOL CELL CARDIOL, V37, P121, DOI 10.1016/j.yjmcc.2004.04.012; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Cai H, 2001, ARTERIOSCL THROM VAS, V21, P1571, DOI 10.1161/hq1001.097028; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Craige SM, 2011, CIRCULATION, V124, P731, DOI 10.1161/CIRCULATIONAHA.111.030775; Davis ME, 2003, AM J PHYSIOL-HEART C, V284, pH1449, DOI 10.1152/ajpheart.00918.2002; Davis ME, 2001, CIRC RES, V89, P1073, DOI 10.1161/hh2301.100806; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Dikalova AE, 2010, AM J PHYSIOL-HEART C, V299, pH673, DOI 10.1152/ajpheart.00242.2010; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Drummond GR, 2000, CIRC RES, V86, P347, DOI 10.1161/01.RES.86.3.347; Duerrschmidt N, 2006, J PHYSIOL-LONDON, V576, P557, DOI 10.1113/jphysiol.2006.111070; Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551; Gao L, 2009, J MOL CELL CARDIOL, V47, P752, DOI 10.1016/j.yjmcc.2009.07.025; Goettsch C, 2011, BASIC RES CARDIOL, V106, P551, DOI 10.1007/s00395-011-0170-3; Gray SP, 2013, CIRCULATION, V127, P1888, DOI 10.1161/CIRCULATIONAHA.112.132159; Harrison DG, 2003, J RENIN-ANGIO-ALDO S, V4, P51, DOI 10.3317/jraas.2003.014; Heitzer T, 2000, DIABETOLOGIA, V43, P1435, DOI 10.1007/s001250051551; Higashi Y, 2002, AM J HYPERTENS, V15, P326, DOI 10.1016/S0895-7061(01)02317-2; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hsiai TK, 2007, FREE RADICAL BIO MED, V42, P519, DOI 10.1016/j.freeradbiomed.2006.11.017; Hwang J, 2003, J BIOL CHEM, V278, P47291, DOI 10.1074/jbc.M305150200; Hwang J, 2003, CIRC RES, V93, P1225, DOI 10.1161/01.RES.0000104087.29395.66; Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, pH24, DOI 10.1152/ajpheart.00799.2009; Kirk EA, 2000, ARTERIOSCL THROM VAS, V20, P1529, DOI 10.1161/01.ATV.20.6.1529; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Laude K, 2005, AM J PHYSIOL-HEART C, V288, pH7, DOI 10.1152/ajpheart.00637.2004; Lauer N, 2005, CARDIOVASC RES, V65, P254, DOI 10.1016/j.cardiores.2004.09.010; Laursen JB, 2001, CIRCULATION, V103, P1282; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Lehoux S, 2006, CARDIOVASC RES, V71, P269, DOI 10.1016/j.cardiores.2006.05.008; Li HG, 2006, J AM COLL CARDIOL, V47, P2536, DOI 10.1016/j.jacc.2006.01.071; Lu X, 2004, J PHYSIOL-LONDON, V561, P575, DOI 10.1113/jphysiol.2004.075218; Montezano AC, 2014, ANTIOXID REDOX SIGN, V20, P164, DOI 10.1089/ars.2013.5302; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Peshavariya H, 2009, N-S ARCH PHARMACOL, V380, P193, DOI 10.1007/s00210-009-0413-0; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; SESSA WC, 1994, CIRC RES, V74, P349, DOI 10.1161/01.RES.74.2.349; Sheehan AL, 2011, ATHEROSCLEROSIS, V216, P321, DOI 10.1016/j.atherosclerosis.2011.02.028; Siu KL, 2015, J MOL CELL CARDIOL, V78, P174, DOI 10.1016/j.yjmcc.2014.07.005; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Stroes E, 1997, J CLIN INVEST, V99, P41, DOI 10.1172/JCI119131; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; WANG J, 1993, CIRC RES, V73, P829, DOI 10.1161/01.RES.73.5.829; White SJ, 2011, J CELL PHYSIOL, V226, P2841, DOI 10.1002/jcp.22629; Woodman CR, 1997, AM J PHYSIOL-HEART C, V273, pH2575, DOI 10.1152/ajpheart.1997.273.6.H2575; Youn JY, 2012, DIABETOLOGIA, V55, P2069, DOI 10.1007/s00125-012-2557-6	56	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8653	8662		10.1074/jbc.M115.713149	http://dx.doi.org/10.1074/jbc.M115.713149			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26826128	Green Published, hybrid			2022-12-28	WOS:000374773200028
J	Bilova, T; Lukasheva, E; Brauch, D; Greifenhagen, U; Paudel, G; Tarakhovskaya, E; Frolova, N; Mittasch, J; Balcke, GU; Tissier, A; Osmolovskaya, N; Vogt, T; Wessjohann, LA; Birkemeyer, C; Milkowski, C; Frolov, A				Bilova, Tatiana; Lukasheva, Elena; Brauch, Dominic; Greifenhagen, Uta; Paudel, Gagan; Tarakhovskaya, Elena; Frolova, Nadezhda; Mittasch, Juliane; Balcke, Gerd Ulrich; Tissier, Alain; Osmolovskaya, Natalia; Vogt, Thomas; Wessjohann, Ludger A.; Birkemeyer, Claudia; Milkowski, Carsten; Frolov, Andrej			A Snapshot of the Plant Glycated Proteome STRUCTURAL, FUNCTIONAL, AND MECHANISTIC ASPECTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; END-PRODUCTS; HUMAN PLASMA; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; AUTOXIDATIVE GLYCOSYLATION; ARGININE RESIDUES; SKELETAL-MUSCLE; IN-VITRO; PROTEINS; IDENTIFICATION	Glycation is the reaction of carbonyl compounds (reducing sugars and alpha-dicarbonyls) with amino acids, lipids, and proteins, yielding early and advanced glycation end products (AGEs). The AGEs can be formed via degradation of early glycation intermediates (glycoxidation) and by interaction with the products of monosaccharide autoxidation (autoxidative glycosylation). Although formation of these potentially deleterious compounds is well characterized in animal systems and thermally treated foods, only a little information about advanced glycation in plants is available. Thus, the knowledge of the plant AGE patterns and the underlying pathways of their formation are completely missing. To fill this gap, we describe the AGE-modified proteome of Brassica napus and characterize individual sites of advanced glycation by the methods of liquid chromatography-based bottom-up proteomics. The modification patterns were complex but reproducible: 789 AGE-modified peptides in 772 proteins were detected in two independent experiments. In contrast, only 168 polypeptides contained early glycated lysines, which did not resemble the sites of advanced glycation. Similar observations were made with Arabidopsis thaliana. The absence of the early glycated precursors of the AGE-modified protein residues indicated autoxidative glycosylation, but not glycoxidation, as the major pathway of AGE formation. To prove this assumption and to identify the potential modifying agents, we estimated the reactivity and glycative potential of plant-derived sugars using a model peptide approach and liquid chromatography-mass spectrometry-based techniques. Evaluation of these data sets together with the assessed tissue carbohydrate contents revealed dihydroxyacetone phosphate, glyceraldehyde 3-phosphate, ribulose, erythrose, and sucrose as potential precursors of plant AGEs.	[Bilova, Tatiana; Paudel, Gagan; Wessjohann, Ludger A.; Frolov, Andrej] Leibniz Inst Plant Biochem IPB, Dept Bioorgan Chem, D-06120 Halle, Saale, Germany; [Balcke, Gerd Ulrich; Tissier, Alain; Vogt, Thomas] Leibniz Inst Plant Biochem IPB, Dept Cell & Metab Biol, D-06120 Halle, Saale, Germany; [Bilova, Tatiana; Brauch, Dominic; Greifenhagen, Uta; Paudel, Gagan; Birkemeyer, Claudia; Frolov, Andrej] Univ Leipzig, Fac Chem & Mineral, D-04103 Leipzig, Germany; [Lukasheva, Elena] St Petersburg State Univ, Fac Biol, Dept Biochem, St Petersburg 199034, Russia; [Lukasheva, Elena; Tarakhovskaya, Elena; Osmolovskaya, Natalia] St Petersburg State Univ, Fac Biol, Dept Plant Physiol & Biochem, St Petersburg 199034, Russia; [Brauch, Dominic] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Stadt Seeland, Germany; [Frolova, Nadezhda; Mittasch, Juliane; Milkowski, Carsten] Univ Halle Wittenberg, Interdisciplinary Ctr Crop Plant Res IZN, D-06120 Halle, Saale, Germany	Leibniz Institut fur Pflanzenbiochemie; Leibniz Institut fur Pflanzenbiochemie; Leipzig University; Saint Petersburg State University; Saint Petersburg State University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Martin Luther University Halle Wittenberg	Frolov, A (corresponding author), Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Weinberg 3, D-06120 Halle, Saale, Germany.	afrolov@ipb-halle.de	Osmolovskaya, Natalia G./G-2226-2015; Lukasheva, Elena/V-1195-2019; Tissier, Alain F/B-2108-2017; Frolova, Nadezhda/AAT-5791-2020; Wessjohann, Ludger/AAZ-3838-2021; Tarakhovskaya, Elena/Y-8165-2019; Frolov, Andrej A/V-5550-2018; Lukasheva, Elena/U-4334-2017; Tarakhovskaya, Elena R./I-7458-2013; Bilova, Tatiana E./M-2405-2015; Birkemeyer, Claudia/L-8687-2015	Osmolovskaya, Natalia G./0000-0001-8764-8552; Lukasheva, Elena/0000-0002-0889-2395; Tissier, Alain F/0000-0002-9406-4245; Tarakhovskaya, Elena/0000-0002-5341-2813; Lukasheva, Elena/0000-0002-0889-2395; Tarakhovskaya, Elena R./0000-0002-5341-2813; Bilova, Tatiana E./0000-0002-6024-3667; Herfurth, Uta/0000-0002-3883-3230; Frolova, Nadezhda/0000-0002-1895-1133; Birkemeyer, Claudia/0000-0002-8538-8838; Wessjohann, Ludger A./0000-0003-2060-8235; Milkowski, Carsten/0000-0001-9758-6789	Deutsche Forschungsgemeinschaft [FR-3117/2-1]; Ernst-Schering Foundation; Deutscher Akademischer Austauschdienst DAAD; St. Petersburg University [1.38.233.2014]; Leibniz Association	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst-Schering Foundation; Deutscher Akademischer Austauschdienst DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); St. Petersburg University; Leibniz Association	This work was supported by Deutsche Forschungsgemeinschaft Grant FR-3117/2-1 (to A. F., G. P., and T. B.), the Ernst-Schering Foundation (to U. G.), the Deutscher Akademischer Austauschdienst DAAD Program "Dmitry Mendeleev" (to E. T. and E. L.), and St. Petersburg University Grant 1.38.233.2014 (to E. L.). The publication of this article was funded by the Open Access fund of the Leibniz Association. The authors declare that they have no conflicts of interest with the contents of this article.	Abordo EA, 1999, BIOCHEM PHARMACOL, V58, P641, DOI 10.1016/S0006-2952(99)00132-X; Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; AHMED MU, 1986, J BIOL CHEM, V261, P4889; Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Ahmed N, 2005, DIABETES CARE, V28, P2465, DOI 10.2337/diacare.28.10.2465; Baraka-Vidot J, 2012, BIOCHIMIE, V94, P1960, DOI 10.1016/j.biochi.2012.05.017; Bechtold U, 2009, PLANT J, V59, P661, DOI 10.1111/j.1365-313X.2009.03898.x; Bollineni RC, 2014, J PROTEOME RES, V13, P5081, DOI 10.1021/pr500324y; Bou R, 2008, ANAL BIOCHEM, V377, P1, DOI 10.1016/j.ab.2008.02.029; Cellar NA, 2008, J CHROMATOGR B, V861, P29, DOI 10.1016/j.jchromb.2007.11.024; Chew O, 2003, J BIOL CHEM, V278, P46869, DOI 10.1074/jbc.M307525200; Fortpied J, 2005, BIOCHEM J, V388, P795, DOI 10.1042/BJ20041976; Frolov A, 2008, ANN NY ACAD SCI, V1126, P253, DOI 10.1196/annals.1433.060; Frolov A, 2014, ANAL BIOANAL CHEM, V406, P5755, DOI 10.1007/s00216-014-8018-y; Frolov A, 2014, J AGR FOOD CHEM, V62, P3626, DOI 10.1021/jf4050183; Frolov A, 2010, ANAL BIOANAL CHEM, V397, P2349, DOI 10.1007/s00216-010-3810-9; Greifenhagen U, 2015, AMINO ACIDS, V47, P1065, DOI 10.1007/s00726-015-1940-2; Greifenhagen U, 2015, J PROTEOME RES, V14, P768, DOI 10.1021/pr500799m; Griffiths G, 2000, J EXP BOT, V51, P1363, DOI 10.1093/jexbot/51.349.1363; Grillo MA, 2008, AMINO ACIDS, V35, P29, DOI 10.1007/s00726-007-0606-0; Hamada Y, 1996, BIOCHEM BIOPH RES CO, V228, P539, DOI 10.1006/bbrc.1996.1695; HAYASHI T, 1980, AGR BIOL CHEM TOKYO, V44, P2575, DOI 10.1080/00021369.1980.10864377; HENLE T, 1994, Z LEBENSM UNTERS FOR, V199, P55, DOI 10.1007/BF01192954; Herold K, 2007, J LEUKOCYTE BIOL, V82, P204, DOI 10.1189/jlb.1206751; HEYNS K, 1962, CHEM BER-RECL, V95, P720, DOI 10.1002/cber.19620950323; HODGE JE, 1955, ADV CARBOHYD CHEM, V10, P169, DOI 10.1016/S0096-5332(08)60392-6; Hori M, 2012, ANTIAGING MED, V9, P125; Huang CH, 2005, J EXP BOT, V56, P3041, DOI 10.1093/jxb/eri301; Luevano-Contreras C, 2010, NUTRIENTS, V2, P1247, DOI 10.3390/nu2121247; Manini P, 2006, CARBOHYD RES, V341, P1828, DOI 10.1016/j.carres.2006.03.027; Miele C, 2003, J BIOL CHEM, V278, P47376, DOI 10.1074/jbc.M301088200; Milkovska-Stamenova S, 2015, J AGR FOOD CHEM, V63, P5911, DOI 10.1021/jf505757m; Morgan F, 1999, INT J FOOD SCI TECH, V34, P429, DOI 10.1046/j.1365-2621.1999.00318.x; Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052; Rabbani N, 2008, ANN NY ACAD SCI, V1126, P124, DOI 10.1196/annals.1433.043; Rich D.H., 1979, PEPTIDES ANAL SYNTHE, V1, P241, DOI [10.1016/B978-0-12-304201-9.50011-4, DOI 10.1016/B978-0-12-304201-9.50011-4]; Schmidt R, 2015, J MASS SPECTROM, V50, P613, DOI 10.1002/jms.3569; Schwarzenbolz U, 1997, Z LEBENSM UNTERS F A, V205, P121, DOI 10.1007/s002170050137; Sebekova K, 1998, CELL MOL BIOL, V44, P1051; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Singer D, 2010, ANAL CHEM, V82, P6409, DOI 10.1021/ac100473k; Singla-Pareek SL, 2008, TRANSGENIC RES, V17, P171, DOI 10.1007/s11248-007-9082-2; Snow LM, 2007, J GERONTOL A-BIOL, V62, P1204, DOI 10.1093/gerona/62.11.1204; SYROVY I, 1994, J BIOCHEM BIOPH METH, V28, P115, DOI 10.1016/0165-022X(94)90025-6; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; Weiss MF, 2000, KIDNEY INT, V57, P2571, DOI 10.1046/j.1523-1755.2000.00117.x; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243; WOLFF SP, 1988, BIOCHEM J, V249, P618, DOI 10.1042/bj2490618; Yamauchi Y, 2003, J BIOCHEM, V134, P251, DOI 10.1093/jb/mvg138; Yamauchi Y, 2002, PLANT CELL PHYSIOL, V43, P1334, DOI 10.1093/pcp/pcf162; Yan H, 1997, BIOCHEM J, V328, P599, DOI 10.1042/bj3280599; Zhang QB, 2008, J PROTEOME RES, V7, P2025, DOI 10.1021/pr700763r; Zhang QB, 2011, J PROTEOME RES, V10, P3076, DOI 10.1021/pr200040j; Zoccali C, 2000, NEPHROL DIAL TRANSPL, V15, P7, DOI 10.1093/ndt/15.suppl_1.7	55	32	37	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7621	7636		10.1074/jbc.M115.678581	http://dx.doi.org/10.1074/jbc.M115.678581			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26786108	Green Published, hybrid			2022-12-28	WOS:000383447600034
J	Albarran, L; Lopez, JJ; Woodard, GE; Salido, GM; Rosado, JA				Albarran, Letizia; Lopez, Jose J.; Woodard, Geoffrey E.; Salido, Gines M.; Rosado, Juan A.			Store-operated Ca2+ Entry-associated Regulatory factor (SARAF) Plays an Important Role in the Regulation of Arachidonate-regulated Ca2+ (ARC) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arachidonic acid (AA) (ARA); calcium channel; calcium release-activated calcium channel protein 1 (ORAI1); protein-protein interaction; stromal interaction molecule 1 (STIM1); ARC channels; SARAF	MEDIATED CALCIUM-ENTRY; ACTIN CYTOSKELETON; HUMAN PLATELETS; RETINOIC ACID; STIM1; ACTIVATION; APOPTOSIS; DEPLETION; SURVIVAL; DEATH	The store-operated Ca2+ entry-associated regulatory factor (SARAF) has recently been identified as a STIM1 regulatory protein that facilitates slow Ca2+-dependent inactivation of store-operated Ca2+ entry (SOCE). Both the store-operated channels and the store-independent arachidonate-regulated Ca2+ (ARC) channels are regulated by STIM1. In the present study, we show that, in addition to its location in the endoplasmic reticulum, SARAF is constitutively expressed in the plasma membrane, where it can interact with plasma membrane (PM)-resident ARC forming subunits in the neuroblastoma cell line SH-SY5Y. Using siRNA-based and overexpression approaches we report that SARAF negatively regulates store-independent Ca2+ entry via the ARC channels. Arachidonic acid (AA) increases the association of PM-resident SARAF with Orai1. Finally, our results indicate that SARAF modulates the ability of AA to promote cell survival in neuroblastoma cells. In addition to revealing new insight into the biology of ARC channels in neuroblastoma cells, these findings provide evidence for an unprecedented location of SARAF in the plasma membrane.	[Albarran, Letizia; Lopez, Jose J.; Salido, Gines M.; Rosado, Juan A.] Univ Extremadura, Dept Physiol, Cellular Physiol Res Grp, Caceres 10003, Spain; [Woodard, Geoffrey E.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA	Universidad de Extremadura; Uniformed Services University of the Health Sciences - USA	Rosado, JA (corresponding author), Univ Extremadura, Dept Physiol, Caceres 10071, Spain.	jarosado@unex.es	Lopez, Jose J/F-4602-2016; Salido, Gines M/A-4292-2009; Rosado, Juan A/H-3488-2015	Lopez, Jose J/0000-0002-5234-1478; Salido, Gines M/0000-0002-8687-2445; Rosado, Juan A/0000-0002-9749-2325	MINECO (Ministerio de Economia y Competitividad) [BFU2013-45564-C2-1-P]; Junta de Extremadura-FEDER [GR15029]; MINECO [BES-2011-043356]; Juan de la Cierva Program	MINECO (Ministerio de Economia y Competitividad)(Spanish Government); Junta de Extremadura-FEDER(European Commission); MINECO(Spanish Government); Juan de la Cierva Program	This work was supported by MINECO (Ministerio de Economia y Competitividad) (Grant BFU2013-45564-C2-1-P) and Junta de Extremadura-FEDER (GR15029). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by MINECO Fellowship BES-2011-043356.; Supported by the Juan de la Cierva Program.	Albarran L, 2014, BBA-MOL CELL RES, V1843, P789, DOI 10.1016/j.bbamcr.2014.01.014; Bell E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068859; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Csutora P, 2008, J BIOL CHEM, V283, P14524, DOI 10.1074/jbc.M709575200; Fisher JN, 2015, ONCOTARGET, V6, P13176, DOI 10.18632/oncotarget.3759; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Jha A, 2013, J CELL BIOL, V202, P71, DOI 10.1083/jcb.201301148; Kerper LE, 1997, TOXICOL APPL PHARM, V146, P127, DOI 10.1006/taap.1997.8234; Lopez E, 2015, THROMB HAEMOSTASIS, V114, P969, DOI 10.1160/TH14-09-0727; Lovat PE, 2003, J CELL BIOCHEM, V89, P698, DOI 10.1002/jcb.10551; Luo DL, 2001, J BIOL CHEM, V276, P20186, DOI 10.1074/jbc.M100327200; Mignen O, 2000, J BIOL CHEM, V275, P9114, DOI 10.1074/jbc.275.13.9114; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Mignen O, 2009, J PHYSIOL-LONDON, V587, P4181, DOI 10.1113/jphysiol.2009.174193; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Redondo PC, 2005, CELL SIGNAL, V17, P1011, DOI 10.1016/j.cellsig.2004.11.019; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Shuttleworth TJ, 2004, PHYSIOLOGY, V19, P355, DOI 10.1152/physiol.00018.2004; Shuttleworth TJ, 1996, J BIOL CHEM, V271, P21720, DOI 10.1074/jbc.271.36.21720; Thompson JL, 2015, J PHYSIOL-LONDON, V593, P559, DOI 10.1113/jphysiol.2014.284182; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Zhang XX, 2014, J GEN PHYSIOL, V143, P345, DOI 10.1085/jgp.201311084	26	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6982	6988		10.1074/jbc.M115.704940	http://dx.doi.org/10.1074/jbc.M115.704940			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26817842	Green Published, hybrid			2022-12-28	WOS:000373299700034
J	Bischof, LF; Friedrich, C; Harms, A; Sogaard-Andersen, L; van der Does, C				Bischof, Lisa Franziska; Friedrich, Carmen; Harms, Andrea; Sogaard-Andersen, Lotte; van der Does, Chris			The Type IV Pilus Assembly ATPase PilB of Myxococcus xanthus Interacts with the Inner Membrane Platform Protein PilC and the Nucleotide-binding Protein PilM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; cell motility; membrane reconstitution; membrane transport; secretion; type IV pili; Myxococcus xanthus	II SECRETION SYSTEM; N-TERMINAL DOMAIN; PSEUDOMONAS-AERUGINOSA; VIBRIO-CHOLERAE; NEISSERIA-MENINGITIDIS; CYTOPLASMIC DOMAIN; BIOGENESIS PROTEIN; THERMUS-THERMOPHILUS; TWITCHING MOTILITY; CRYSTAL-STRUCTURE	Type IV pili (T4P) are ubiquitous bacterial cell surface structures, involved in processes such as twitching motility, biofilm formation, bacteriophage infection, surface attachment, virulence, and natural transformation. T4P are assembled by machinery that can be divided into the outer membrane pore complex, the alignment complex that connects components in the inner and outer membrane, and the motor complex in the inner membrane and cytoplasm. Here, we characterize the inner membrane platform protein PilC, the cytosolic assembly ATPase PilB of the motor complex, and the cytosolic nucleotide-binding protein PilM of the alignment complex of the T4P machinery of Myxococcus xanthus. PilC was purified as a dimer and reconstituted into liposomes. PilB was isolated as a monomer and bound ATP in a non-cooperative manner, but PilB fused to Hcp1 of Pseudomonas aeruginosa formed a hexamer and bound ATP in a cooperative manner. Hexameric but not monomeric PilB bound to PilC reconstituted in liposomes, and this binding stimulated PilB ATPase activity. PilM could only be purified when it was stabilized by a fusion with a peptide corresponding to the first 16 amino acids of PilN, supporting an interaction between PilM and PilN(1-16). PilM-N(1-16) was isolated as a monomer that bound but did not hydrolyze ATP. PilM interacted directly with PilB, but only with PilC in the presence of PilB, suggesting an indirect interaction. We propose that PilB interacts with PilC and with PilM, thus establishing the connection between the alignment and the motor complex.	[Bischof, Lisa Franziska; Friedrich, Carmen; Harms, Andrea; Sogaard-Andersen, Lotte; van der Does, Chris] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Bischof, Lisa Franziska; van der Does, Chris] Univ Freiburg, Inst Biol 2, Mol Biol Archaea, Schaenzlestr 1, D-79104 Freiburg, Germany	Max Planck Society; University of Freiburg	van der Does, C (corresponding author), Univ Freiburg, Inst Biol, Schaenzlestr 1, D-79104 Freiburg, Germany.	chris.van.der.does@biologie.uni-freiburg.de		Sogaard-Andersen, Lotte/0000-0002-0674-0013	German Research Council within the framework of the Collaborative Research Center "Microbial Diversity in Environmental Signal Response" [SFB987]; Max Planck Society; International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology; Collaborative Research Center "Functional Specificity by Coupling and Modification of Proteins" [SFB746]	German Research Council within the framework of the Collaborative Research Center "Microbial Diversity in Environmental Signal Response"; Max Planck Society(Max Planck Society); International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology; Collaborative Research Center "Functional Specificity by Coupling and Modification of Proteins"	This work was supported in part by the German Research Council within the framework of the Collaborative Research Center SFB987 "Microbial Diversity in Environmental Signal Response," intramural funding of the Max Planck Society, and by a fellowship from the International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology (to C. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Collaborative Research Center SFB746 "Functional Specificity by Coupling and Modification of Proteins."	Abendroth J, 2005, J MOL BIOL, V348, P845, DOI 10.1016/j.jmb.2005.02.061; Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Albers SV, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00023; Arts J, 2007, MICROBIOL-SGM, V153, P1582, DOI 10.1099/mic.0.2006/002840-0; Ayers M, 2010, FUTURE MICROBIOL, V5, P1203, DOI 10.2217/FMB.10.76; Balasingham SV, 2007, J BACTERIOL, V189, P5716, DOI 10.1128/JB.00060-07; Banerjee A, 2013, FEBS J, V280, P6141, DOI 10.1111/febs.12534; Banerjee A, 2012, J BIOL CHEM, V287, P43322, DOI 10.1074/jbc.M112.414383; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; BLACKHART BD, 1985, P NATL ACAD SCI USA, V82, P8767, DOI 10.1073/pnas.82.24.8767; Bulyha I, 2009, MOL MICROBIOL, V74, P691, DOI 10.1111/j.1365-2958.2009.06891.x; Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen Y, 2005, J BIOL CHEM, V280, P42356, DOI 10.1074/jbc.M506843200; Chiang P, 2005, J BACTERIOL, V187, P829, DOI 10.1128/JB.187.3.829-839.2005; Claeys D, 2005, ELECTROPHORESIS, V26, P1189, DOI 10.1002/elps.200406196; Clausen M, 2009, J BACTERIOL, V191, P4633, DOI 10.1128/JB.00396-09; Collins RF, 2007, J BACTERIOL, V189, P6389, DOI 10.1128/JB.00648-07; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Friedrich C, 2014, J BACTERIOL, V196, P378, DOI 10.1128/JB.01094-13; Georgiadou M, 2012, MOL MICROBIOL, V84, P857, DOI 10.1111/j.1365-2958.2012.08062.x; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jakovljevic V, 2008, J BACTERIOL, V190, P2411, DOI 10.1128/JB.01793-07; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Karuppiah V, 2010, PROTEINS, V78, P2049, DOI 10.1002/prot.22720; Knol J, 1996, J BIOL CHEM, V271, P15358, DOI 10.1074/jbc.271.26.15358; Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08; Leviatan S, 2010, J BIOL CHEM, V285, P23548, DOI 10.1074/jbc.M110.125492; Li CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070144; Lu C, 2014, J STRUCT BIOL, V187, P223, DOI 10.1016/j.jsb.2014.07.006; Lu C, 2013, STRUCTURE, V21, P1707, DOI 10.1016/j.str.2013.06.027; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Mignot T, 2005, SCIENCE, V310, P855, DOI 10.1126/science.1119052; Misic AM, 2010, J MOL BIOL, V400, P1011, DOI 10.1016/j.jmb.2010.05.066; Morand PC, 2004, EMBO J, V23, P2009, DOI 10.1038/sj.emboj.7600200; Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281; Planet PJ, 2001, P NATL ACAD SCI USA, V98, P2503, DOI 10.1073/pnas.051436598; Pohlschroder M, 2011, CURR OPIN MICROBIOL, V14, P357, DOI 10.1016/j.mib.2011.03.002; Possot OM, 2000, J BACTERIOL, V182, P2142, DOI 10.1128/JB.182.8.2142-2152.2000; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Reindl S, 2013, MOL CELL, V49, P1069, DOI 10.1016/j.molcel.2013.01.014; Robert V, 2005, FEMS MICROBIOL LETT, V252, P43, DOI 10.1016/j.femsle.2005.08.029; Robien MA, 2003, J MOL BIOL, V333, P657, DOI 10.1016/j.jmb.2003.07.015; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; SANDKVIST M, 1995, EMBO J, V14, P1664, DOI 10.1002/j.1460-2075.1995.tb07155.x; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Shiue SJ, 2006, EMBO J, V25, P1426, DOI 10.1038/sj.emboj.7601036; Siewering K, 2014, P NATL ACAD SCI USA, V111, pE953, DOI 10.1073/pnas.1322889111; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; SPORMANN AM, 1995, J BACTERIOL, V177, P5846, DOI 10.1128/jb.177.20.5846-5852.1995; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; Tammam S, 2011, MOL MICROBIOL, V82, P1496, DOI 10.1111/j.1365-2958.2011.07903.x; Tammam S, 2013, J BACTERIOL, V195, P2126, DOI 10.1128/JB.00032-13; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Laan M, 2013, METHODS MOL BIOL, V1033, P325, DOI 10.1007/978-1-62703-487-6_21; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544; Yamagata A, 2012, J MOL BIOL, V419, P110, DOI 10.1016/j.jmb.2012.02.041	69	37	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6946	6957		10.1074/jbc.M115.701284	http://dx.doi.org/10.1074/jbc.M115.701284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26851283	Green Published, hybrid			2022-12-28	WOS:000373299700031
J	Lum, MA; Barger, CJ; Hsu, AH; Leontieva, OV; Black, AR; Black, JD				Lum, Michelle A.; Barger, Carter J.; Hsu, Alice H.; Leontieva, Olga V.; Black, Adrian R.; Black, Jennifer D.			Protein Kinase C (PKC) Is Resistant to Long Term Desensitization/Down-regulation by Prolonged Diacylglycerol Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); diacylglycerol; heat shock protein 90 (Hsp90); lipid raft; protein degradation; protein kinase C (PKC); protein phosphorylation; signal transduction; PKC; desensitization	INTESTINAL EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; DOWN-REGULATION; PLASMA-MEMBRANE; LIPID RAFTS; PHOSPHOLIPASE-D; DIFFERENTIAL REGULATION; TUMOR-FORMATION; LIVING CELLS; CYCLE ARREST	Sustained activation of PKC is required for long term physiological responses, such as growth arrest and differentiation. However, studies with pharmacological agonists (e.g. phorbol 12-myristate 13-acetate (PMA)) indicate that prolonged stimulation leads to PKC desensitization via dephosphorylation and/or degradation. The current study analyzed effects of chronic stimulation with the physiological agonist diacylglycerol. Repeated addition of 1,2-dioctanoyl-sn-glycerol (DiC(8)) resulted in sustained plasma membrane association of PKC in a pattern comparable with that induced by PMA. However, although PMA potently down-regulated PKC, prolonged activation by DiC(8) failed to engage known desensitization mechanisms, with the enzyme remaining membrane-associated and able to support sustained downstream signaling. DiC(8)-activated PKC did not undergo dephosphorylation, ubiquitination, or internalization, early events in PKC desensitization. Although DiC(8) efficiently down-regulated novel PKCs PKC and PKCE, differences in Ca2+ sensitivity and diacylglycerol affinity were excluded as mediators of the selective resistance of PKC. Roles for Hsp/Hsc70 and Hsp90 were also excluded. PMA, but not DiC(8), targeted PKC to detergent-resistant membranes, and disruption of these domains with cholesterol-binding agents demonstrated a role for differential membrane compartmentalization in selective agonist-induced degradation. Chronic DiC(8) treatment failed to desensitize PKC in several cell types and did not affect PKCI; thus, conventional PKCs appear generally insensitive to desensitization by sustained diacylglycerol stimulation. Consistent with this conclusion, prolonged (several-day) membrane association/activation of PKC is seen in self-renewing epithelium of the intestine, cervix, and skin. PKC deficiency affects gene expression, differentiation, and tumorigenesis in these tissues, highlighting the importance of mechanisms that protect PKC from desensitization in vivo.	[Lum, Michelle A.; Barger, Carter J.; Hsu, Alice H.; Black, Adrian R.; Black, Jennifer D.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Lum, Michelle A.; Barger, Carter J.; Hsu, Alice H.; Black, Adrian R.; Black, Jennifer D.] Univ Nebraska, Med Ctr, Fred & Pamela Buffet Canc Ctr, Omaha, NE 68198 USA; [Lum, Michelle A.; Leontieva, Olga V.; Black, Adrian R.; Black, Jennifer D.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Roswell Park Cancer Institute	Black, JD (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	jennifer.black@unmc.edu		Barger, Carter/0000-0002-1508-0504	National Institutes of Health [DK060632, DK054909, CA191894, CA016056, CA036727, CA009476]; NATIONAL CANCER INSTITUTE [R21CA191894, T32CA009476, P30CA016056, P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060632, R56DK060632, R01DK054909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants DK060632, DK054909, CA191894, CA016056, and CA036727 and T32 Award CA009476 (to C. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrahamsen H, 2012, J BIOL CHEM, V287, P13262, DOI 10.1074/jbc.M112.349753; Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Antal CE, 2014, BIOCHEM SOC T, V42, P1477, DOI 10.1042/BST20140172; Antal CE, 2014, CHEM BIOL, V21, P459, DOI 10.1016/j.chembiol.2014.02.008; ASAOKA Y, 1991, P NATL ACAD SCI USA, V88, P8681, DOI 10.1073/pnas.88.19.8681; Assender JW, 1996, ACTA PHYSIOL SCAND, V157, P451, DOI 10.1046/j.1365-201X.1996.511285000.x; Becker KP, 2005, CELL MOL LIFE SCI, V62, P1448, DOI 10.1007/s00018-005-4531-7; BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; BERRY N, 1990, P NATL ACAD SCI USA, V87, P2294, DOI 10.1073/pnas.87.6.2294; BISHOP WR, 1986, J BIOL CHEM, V261, P2513; Black AR, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00423; Black JD, 2001, GASTROENTEROLOGY, V120, P1868, DOI 10.1053/gast.2001.25287; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Black JD, 2010, PROTEIN KINASE C IN CANCER SIGNALING AND THERAPY, P155, DOI 10.1007/978-1-60761-543-9_8; Botto L, 2007, J NEUROSCI RES, V85, P443, DOI 10.1002/jnr.21111; Cheng W, 2012, J BIOL CHEM, V287, P26126, DOI 10.1074/jbc.M112.342170; Chiosis G, 2003, MOL CANCER THER, V2, P123; Chiu T, 2003, AM J PHYSIOL-GASTR L, V285, pG1, DOI 10.1152/ajpgi.00419.2002; Clark JA, 2004, J BIOL CHEM, V279, P9233, DOI 10.1074/jbc.M312268200; Diaz O, 2005, J IMMUNOL, V175, P8077, DOI 10.4049/jimmunol.175.12.8077; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; EBELING JG, 1985, P NATL ACAD SCI USA, V82, P815, DOI 10.1073/pnas.82.3.815; Egea-Jimenez AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069041; Eichmann TO, 2015, CELL MOL LIFE SCI, V72, P3931, DOI 10.1007/s00018-015-1982-3; Farah CA, 2012, ADV EXP MED BIOL, V740, P663, DOI 10.1007/978-94-007-2888-2_29; Feng X, 2000, J BIOL CHEM, V275, P17024, DOI 10.1074/jbc.275.22.17024; FLORINCHRISTENSEN J, 1992, J BIOL CHEM, V267, P14783; Foster DA, 2003, MOL CANCER RES, V1, P789; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Frey MR, 2000, J CELL BIOL, V151, P763, DOI 10.1083/jcb.151.4.763; Frey MR, 1997, J BIOL CHEM, V272, P9424; Gao TY, 2006, J BIOL CHEM, V281, P32461, DOI 10.1074/jbc.M604076200; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Goodell AL, 1996, J INVEST DERMATOL, V107, P354, DOI 10.1111/1523-1747.ep12363325; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Hao F, 2011, J BIOL CHEM, V286, P18104, DOI 10.1074/jbc.M110.208488; Hara T, 2005, CANCER RES, V65, P7356, DOI 10.1158/0008-5472.CAN-04-4241; Hizli AA, 2006, J BIOL CHEM, V281, P14596, DOI 10.1074/jbc.M601959200; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; Hu TH, 2005, BIOCHEM BIOPH RES CO, V327, P1047, DOI 10.1016/j.bbrc.2004.12.117; Igumenova TI, 2015, BIOCHEMISTRY-US, V54, P4953, DOI 10.1021/acs.biochem.5b00565; Jerome-Morais A, 2009, J INVEST DERMATOL, V129, P2365, DOI 10.1038/jid.2009.74; Kazanietz MG, 2010, PROTEIN KINASE C IN CANCER SIGNALING AND THERAPY, P1, DOI 10.1007/978-1-60761-543-9; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; KHALIL RA, 1994, AM J PHYSIOL, V266, pC1544, DOI 10.1152/ajpcell.1994.266.6.C1544; Kozak SL, 2002, J VIROL, V76, P1802, DOI 10.1128/JVI.76.4.1802-1815.2002; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Lenz JC, 2002, J CELL BIOL, V159, P291, DOI 10.1083/jcb.200203048; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li JN, 2014, J AM CHEM SOC, V136, P11757, DOI 10.1021/ja505369r; Lum MA, 2013, J BIOL CHEM, V288, P27112, DOI 10.1074/jbc.M112.437095; Lum MA, 2013, J BIOL CHEM, V288, P13093, DOI 10.1074/jbc.M112.437061; Magee AI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-234; Manzow S, 2000, INT J CANCER, V85, P503, DOI 10.1002/(SICI)1097-0215(20000215)85:4<503::AID-IJC10>3.0.CO;2-L; Mateos MV, 2010, BBA-BIOMEMBRANES, V1798, P624, DOI 10.1016/j.bbamem.2009.12.008; MAYOR S, 1995, MOL BIOL CELL, V6, P929, DOI 10.1091/mbc.6.7.929; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; Neill GW, 2003, CANCER RES, V63, P4692; Newton AC, 2010, PROTEIN KINASE C IN CANCER SIGNALING AND THERAPY, P9, DOI 10.1007/978-1-60761-543-9_2; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Nowicki S, 2000, AM J PHYSIOL-CELL PH, V279, pC1812, DOI 10.1152/ajpcell.2000.279.6.C1812; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Parolini I, 1999, J BIOL CHEM, V274, P14176, DOI 10.1074/jbc.274.20.14176; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; PRESTA M, 1991, CELL REGUL, V2, P719, DOI 10.1091/mbc.2.9.719; Pysz MA, 2014, J BIOL CHEM, V289, P22268, DOI 10.1074/jbc.M114.571554; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Rybin VO, 1999, CIRC RES, V84, P980, DOI 10.1161/01.RES.84.9.980; Santiskulvong C, 2007, CELL SIGNAL, V19, P1348, DOI 10.1016/j.cellsig.2007.01.006; SEVERSON DL, 1989, AM J PHYSIOL, V256, pC11, DOI 10.1152/ajpcell.1989.256.1.C11; Slater SJ, 2002, J BIOL CHEM, V277, P15277, DOI 10.1074/jbc.M112207200; Stahelin RV, 2005, J BIOL CHEM, V280, P36452, DOI 10.1074/jbc.M506224200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; STENSON WF, 1993, AM J PHYSIOL, V265, pG955, DOI 10.1152/ajpgi.1993.265.5.G955; SZALLASI Z, 1994, J BIOL CHEM, V269, P2118; Wang XQ, 2006, J INVEST DERMATOL, V126, P951, DOI 10.1038/sj.jid.5700282; Yen CLE, 2015, J LIPID RES, V56, P489, DOI 10.1194/jlr.R052902; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	88	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6331	6346		10.1074/jbc.M115.696211	http://dx.doi.org/10.1074/jbc.M115.696211			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26769967	Green Published, hybrid			2022-12-28	WOS:000372894200023
J	Pan, DX; Barber, MA; Hornigold, K; Baker, MJ; Toth, JM; Oxley, D; Welch, HCE				Pan, Dingxin; Barber, Mark A.; Hornigold, Kirsti; Baker, Martin J.; Toth, Judit M.; Oxley, David; Welch, Heidi C. E.			Norbin Stimulates the Catalytic Activity and Plasma Membrane Localization of the Guanine-Nucleotide Exchange Factor P-Rex1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; G protein-coupled receptor (GPCR); guanine nucleotide exchange factor (GEF); protein complex; Rac (Rac GTPase); Rho (Rho GTPase); small GTPase; Neurochondrin (NCDN); PREX1; PREX2	BETA-GAMMA-SUBUNITS; OUTGROWTH-RELATED PROTEIN; BREAST-CANCER CELLS; NEURITE-OUTGROWTH; NEUTROPHIL FUNCTION; RHO GTPASES; RAC; NEUROCHONDRIN; ACTIVATION; MIGRATION	P-Rex1 is a guanine-nucleotide exchange factor (GEF) that activates the small G protein (GTPase) Rac1 to control Rac1-dependent cytoskeletal dynamics, and thus cell morphology. Three mechanisms of P-Rex1 regulation are currently known: (i) binding of the phosphoinositide second messenger PIP3, (ii) binding of the G subunits of heterotrimeric G proteins, and (iii) phosphorylation of various serine residues. Using recombinant P-Rex1 protein to search for new binding partners, we isolated the G-protein-coupled receptor (GPCR)-adaptor protein Norbin (Neurochondrin, NCDN) from mouse brain fractions. Coimmunoprecipitation confirmed the interaction between overexpressed P-Rex1 and Norbin in COS-7 cells, as well as between endogenous P-Rex1 and Norbin in HEK-293 cells. Binding assays with purified recombinant proteins showed that their interaction is direct, and mutational analysis revealed that the pleckstrin homology domain of P-Rex1 is required. Rac-GEF activity assays with purified recombinant proteins showed that direct interaction with Norbin increases the basal, PIP3- and G-stimulated Rac-GEF activity of P-Rex1. Pak-CRIB pulldown assays demonstrated that Norbin promotes the P-Rex1-mediated activation of endogenous Rac1 upon stimulation of HEK-293 cells with lysophosphatidic acid. Finally, immunofluorescence microscopy and subcellular fractionation showed that coexpression of P-Rex1 and Norbin induces a robust translocation of both proteins from the cytosol to the plasma membrane, as well as promoting cell spreading, lamellipodia formation, and membrane ruffling, cell morphologies generated by active Rac1. In summary, we have identified a novel mechanism of P-Rex1 regulation through the GPCR-adaptor protein Norbin, a direct P-Rex1 interacting protein that promotes the Rac-GEF activity and membrane localization of P-Rex1.	[Pan, Dingxin; Barber, Mark A.; Hornigold, Kirsti; Baker, Martin J.; Toth, Judit M.; Welch, Heidi C. E.] Babraham Inst, Signalling Programme, Babraham Res Campus, Cambridge CB22 3AT, England; [Oxley, David] Babraham Inst, Mass Spectrometry Facil, Babraham Res Campus, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Welch, HCE (corresponding author), Babraham Inst, Signalling Programme, Babraham Res Campus, Cambridge CB22 3AT, England.	heidi.welch@babraham.ac.uk	Baker, Martin James/AAO-1650-2020; Baker, Martin/AAM-8426-2020; Pan, Dingxin/AAE-1205-2021	Baker, Martin/0000-0002-9743-6294; 	Cambridge Overseas Trust; Cambridge Commonwealth Trust; Biotechnology and Biological Sciences Research Council; United Kindom Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/I02154X/1, 1104302, BBS/E/B/000C0411] Funding Source: researchfish; BBSRC [BB/I02154X/1, BBS/E/B/000C0411] Funding Source: UKRI	Cambridge Overseas Trust; Cambridge Commonwealth Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kindom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by graduate studentships from the Cambridge Overseas Trust (to D. P.), the Cambridge Commonwealth Trust (to M. A. B.), and the Biotechnology and Biological Sciences Research Council (to M. J. B.), as well as by a Strategic Core grant from the United Kindom Biotechnology and Biological Sciences Research Council to the Babraham Institute Signaling Programme. The authors declare that they have no conflicts of interest with the contents of this article.	Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Barber MA, 2012, BIOCHEM J, V443, P173, DOI 10.1042/BJ20112078; Campbell AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053982; Montero JC, 2013, CELL SIGNAL, V25, P2281, DOI 10.1016/j.cellsig.2013.07.018; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Damoulakis G, 2014, J CELL SCI, V127, P2589, DOI 10.1242/jcs.153049; Dateki M, 2005, J BIOL CHEM, V280, P20503, DOI 10.1074/jbc.M414033200; Donald S, 2008, P NATL ACAD SCI USA, V105, P4483, DOI 10.1073/pnas.0712324105; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Francke F, 2006, J BIOL CHEM, V281, P32496, DOI 10.1074/jbc.M602889200; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Herter JM, 2013, BLOOD, V121, P2301, DOI 10.1182/blood-2012-09-457085; Hill K, 2006, METHOD ENZYMOL, V406, P26, DOI 10.1016/S0076-6879(06)06003-4; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Hodakoski C, 2014, P NATL ACAD SCI USA, V111, P155, DOI 10.1073/pnas.1213773111; Ishizuka Y, 1999, BBA-MOL CELL RES, V1450, P92, DOI 10.1016/S0167-4889(99)00039-7; Istvanffy R, 2004, DEV GENES EVOL, V214, P206, DOI 10.1007/s00427-004-0396-2; Jackson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011962; Ktistakis NT, 2003, BIOCHEM SOC T, V31, P94, DOI 10.1042/bst0310094; Lawson CD, 2011, J IMMUNOL, V186, P1467, DOI 10.4049/jimmunol.1002738; Li J, 2015, P NATL ACAD SCI USA, V112, pE6964, DOI 10.1073/pnas.1512913112; Lindsay CR, 2015, J INVEST DERMATOL, V135, P314, DOI 10.1038/jid.2014.323; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Lucato CM, 2015, J BIOL CHEM, V290, P20827, DOI 10.1074/jbc.M115.660456; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1913, DOI 10.1074/jbc.M506034200; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1921, DOI 10.1074/jbc.M506035200; Mense SM, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005840; Mochizuki R, 2003, BIOCHEM BIOPH RES CO, V310, P1219, DOI 10.1016/j.bbrc.2003.09.153; Mochizuki R, 1999, BBA-GENE STRUCT EXPR, V1446, P397, DOI 10.1016/S0167-4781(99)00120-7; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Ohoka Y, 2001, BIOCHEM BIOPH RES CO, V280, P237, DOI 10.1006/bbrc.2000.4080; Oku S, 2013, J BIOL CHEM, V288, P19816, DOI 10.1074/jbc.M112.431676; Pan DX, 2015, BLOOD, V125, P1146, DOI 10.1182/blood-2014-07-591040; Qian F, 2012, ARTERIOSCL THROM VAS, V32, P768, DOI 10.1161/ATVBAHA.111.243675; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schwaibold EMC, 2008, BIOCHEM BIOPH RES CO, V373, P366, DOI 10.1016/j.bbrc.2008.06.042; Shinozaki K, 1999, MOL BRAIN RES, V71, P364, DOI 10.1016/S0169-328X(99)00181-3; Shinozaki K, 1997, BIOCHEM BIOPH RES CO, V240, P766, DOI 10.1006/bbrc.1997.7660; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Urano D, 2008, CELL SIGNAL, V20, P1545, DOI 10.1016/j.cellsig.2008.04.009; Wang H, 2015, P NATL ACAD SCI USA, V112, P9745, DOI 10.1073/pnas.1510291112; Wang Hong, 2010, Commun Integr Biol, V3, P487, DOI 10.4161/cib.3.6.12844; Wang H, 2009, SCIENCE, V326, P1554, DOI 10.1126/science.1178496; Ward RJ, 2009, J NEUROCHEM, V109, P182, DOI 10.1111/j.1471-4159.2009.05918.x; Welch H, 1998, J BIOL CHEM, V273, P11248, DOI 10.1074/jbc.273.18.11248; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Welch Heidi C E, 2015, Small GTPases, V6, P49, DOI 10.4161/21541248.2014.973770; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005; Zhao TM, 2007, J LEUKOCYTE BIOL, V81, P1127, DOI 10.1189/jlb.0406251	55	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6359	6375		10.1074/jbc.M115.686592	http://dx.doi.org/10.1074/jbc.M115.686592			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26792863	Green Published, hybrid			2022-12-28	WOS:000372894200025
J	Li, FF; Wu, R; Cui, X; Zha, L; Yu, LQ; Shi, H; Xue, BZ				Li, Fenfen; Wu, Rui; Cui, Xin; Zha, Lin; Yu, Liqing; Shi, Hang; Xue, Bingzhong			Histone Deacetylase 1 (HDAC1) Negatively Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone H3 Lysine 27 (H3K27) Deacetylation and Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; EPIGENETIC REGULATION; WHITE FAT; UPSTREAM ENHANCER; PROTEIN; BEIGE; GENE; TRANSCRIPTION; EXPRESSION; MICE	Inhibiting class I histone deacetylases (HDACs) increases energy expenditure, reduces adiposity, and improves insulin sensitivity in obese mice. However, the precise mechanism is poorly understood. Here, we demonstrate that HDAC1 is a negative regulator of the brown adipocyte thermogenic program. The Hdac1 level is lower in mouse brown fat (BAT) than white fat, is suppressed in mouse BAT during cold exposure or beta(3)-adrenergic stimulation, and is down-regulated during brown adipocyte differentiation. Remarkably, overexpressing Hdac1 profoundly blocks, whereas deleting Hdac1 significantly enhances, alpha-adrenergic activation-induced BAT-specific gene expression in brown adipocytes. beta-Adrenergic activation in brown adipocytes results in a dissociation of HDAC1 from promoters of BAT-specific genes, including uncoupling protein 1 (Ucp1) and peroxisome proliferator-activated receptor gamma co-activator 1 alpha (Pgc1 alpha), leading to increased acetylation of histone H3 lysine 27 (H3K27), an epigenetic mark of gene activation. This is followed by dissociation of the polycomb repressive complexes, including the H3K27 methyltransferase enhancer of zeste homologue (EZH2), suppressor of zeste 12 (SUZ12), and ring finger protein 2 (RNF2) from (and concomitant recruitment of H3K27 demethylase ubiquitously transcribed tetratricopeptide repeat on chromosome X (UTX) to) Ucp1 and Pgc1 alpha promoters, leading to decreased H3K27 trimethylation, a histone transcriptional repression mark. Thus, HDAC1 negatively regulates the brown adipocyte thermogenic program, and inhibiting Hdac1 promotes BAT-specific gene expression through a coordinated control of increased acetylation and decreased methylation of H3K27, thereby switching the transcriptional repressive state to the active state at the promoters of Ucp1 and Pgc1 alpha. Targeting HDAC1 may be beneficial in prevention and treatment of obesity by enhancing BAT thermogenesis.	[Li, Fenfen; Wu, Rui; Cui, Xin; Zha, Lin; Shi, Hang; Xue, Bingzhong] Georgia State Univ, Dept Biol, Ctr Obes Reversal, 24 Peachtree Ctr Ave, Atlanta, GA 30303 USA; [Yu, Liqing] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	University System of Georgia; Georgia State University; University System of Maryland; University of Maryland College Park	Shi, H; Xue, BZ (corresponding author), Georgia State Univ, Dept Biol, Ctr Obes Reversal, 24 Peachtree Ctr Ave, Atlanta, GA 30303 USA.	hshi3@gsu.edu; bxue@gsu.edu	Cui, Xin/N-4841-2015	Cui, Xin/0000-0002-2141-4400; Xue, Bingzhong/0000-0002-7857-1343	National Institutes of Health [R01HL107500, R01DK084172, R01DK085176]; American Heart Association [10SDG3900046]; American Diabetes Association [7-13-BS-159]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085176, R01DK084172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01HL107500 (to B. X.), R01DK084172 (to H. S.), and R01DK085176 (to L. Y.); American Heart Association Grant 10SDG3900046 (to B. X.); and American Diabetes Association Grant 7-13-BS-159 (to H. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An Woojin, 2007, Subcell Biochem, V41, P351; Backdahl L, 2009, INT J BIOCHEM CELL B, V41, P176, DOI 10.1016/j.biocel.2008.08.023; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Campion J, 2009, OBES REV, V10, P383, DOI 10.1111/j.1467-789X.2009.00595.x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CANNON B, 1985, ESSAYS BIOCHEM, V20, P110; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cassard-Doulcier AM, 1998, BIOCHEM J, V333, P243, DOI 10.1042/bj3330243; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chavan AV, 2010, MINI-REV MED CHEM, V10, P1263; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dambacher S, 2010, HEREDITY, V105, P24, DOI 10.1038/hdy.2010.49; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Galmozzi A, 2013, DIABETES, V62, P732, DOI 10.2337/db12-0548; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Ge K, 2012, BBA-GENE REGUL MECH, V1819, P727, DOI 10.1016/j.bbagrm.2011.12.008; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; HIMMSHAGEN J, 1989, PROG LIPID RES, V28, P67, DOI 10.1016/0163-7827(89)90009-X; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Holness MJ, 2006, CURR OPIN CLIN NUTR, V9, P482, DOI 10.1097/01.mco.0000232912.69236.e0; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; KLAUS S, 1994, J CELL SCI, V107, P313; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Maier S, 2002, J NUTR, V132, p2440S, DOI 10.1093/jn/132.8.2440S; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Nebbioso A, 2010, J MOL ENDOCRINOL, V45, P219, DOI 10.1677/JME-10-0043; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Rim JS, 2002, J BIOL CHEM, V277, P34589, DOI 10.1074/jbc.M108866200; ROSS SR, 1992, P NATL ACAD SCI USA, V89, P7561, DOI 10.1073/pnas.89.16.7561; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Segre CV, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/690848; Sharma BK, 2014, J CELL PHYSIOL, V229, P1901, DOI 10.1002/jcp.24664; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shinoda K, 2015, CELL METAB, V22, P997, DOI 10.1016/j.cmet.2015.09.029; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Shore A, 2010, DIABETOLOGIA, V53, P1164, DOI 10.1007/s00125-010-1701-4; Szic KSV, 2010, BIOCHEM PHARMACOL, V80, P1816, DOI 10.1016/j.bcp.2010.07.029; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang XF, 2011, ENDOCRINOLOGY, V152, P836, DOI 10.1210/en.2010-0855; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue B, 2007, J BIOL CHEM, V282, P23829, DOI 10.1074/jbc.M609680200; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue B, 2009, MOL CELL BIOL, V29, P4563, DOI 10.1128/MCB.01914-08; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yang XS, 2014, MOL ENDOCRINOL, V28, P565, DOI 10.1210/me.2013-1293; Ye JP, 2013, DIABETES, V62, P685, DOI 10.2337/db12-1354	68	68	72	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4523	4536		10.1074/jbc.M115.677930	http://dx.doi.org/10.1074/jbc.M115.677930			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26733201	hybrid, Green Published			2022-12-28	WOS:000371604600022
J	Estrada, DF; Laurence, JS; Scott, EE				Estrada, D. Fernando; Laurence, Jennifer S.; Scott, Emily E.			Cytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; nuclear magnetic resonance (NMR); protein conformation; protein-protein interaction; steroidogenesis	P450 OXIDOREDUCTASE; 17,20-LYASE ACTIVITY; NADPH-CYTOCHROME-P450 REDUCTASE; ABIRATERONE ACETATE; ELECTRON-TRANSFER; STRUCTURAL BASIS; BINDING DOMAIN; B(5); MUTAGENESIS; RESIDUES	To accomplish key physiological processes ranging from drug metabolism to steroidogenesis, human microsomal cytochrome P450 enzymes require the sequential input of two electrons delivered by the FMN domain of NADPH-cytochrome P450 reductase. Although some human microsomal P450 enzymes can instead accept the second electron from cytochrome b(5), for human steroidogenic CYP17A1, the cytochrome P450 reductase FMN domain delivers both electrons, and b(5) is an allosteric modulator. The structural basis of these key but poorly understood protein interactions was probed by solution NMR using the catalytically competent soluble domains of each protein. Formation of the CYP17A1FMN domain complex induced differential line broadening of the NMR signal for each protein. Alterations in the exchange dynamics generally occurred for residues near the surface of the flavin mononucleotide, including 87-90 (loop 1), and for key CYP17A1 active site residues. These interactions were modulated by the identity of the substrate in the buried CYP17A1 active site and by b(5). The FMN domain outcompetes b(5) for binding to CYP17A1 in the three-component system. These results and comparison with previous NMR studies of the CYP17A1b(5) complex suggest a model of CYP17A1 enzyme regulation.	[Estrada, D. Fernando; Scott, Emily E.] Univ Kansas, Dept Med Chem, 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA; [Laurence, Jennifer S.] Univ Kansas, Dept Pharmaceut Chem, MRB,2030 Becker Dr, Lawrence, KS 66047 USA	University of Kansas; University of Kansas	Scott, EE (corresponding author), Univ Kansas, Dept Med Chem, 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.; Laurence, JS (corresponding author), Univ Kansas, Dept Pharmaceut Chem, MRB,2030 Becker Dr, Lawrence, KS 66047 USA.	laurencj@ku.edu; eescott@ku.edu	Chadwick, Jennifer/N-8027-2013	Chadwick, Jennifer/0000-0002-1686-5979	Center of Biomedical Research Excellence in Protein Structure and Function, National Institutes of Health [RR01778, GM103420]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103420, F32GM103069, R01GM102505] Funding Source: NIH RePORTER	Center of Biomedical Research Excellence in Protein Structure and Function, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	E. coli strain NCM533 was a gift from Tom Pochapsky at Brandeis University. NMR data were collected at the University of Kansas Biomolecular NMR Laboratory, supported in part by Center of Biomedical Research Excellence in Protein Structure and Function, National Institutes of Health Grants RR01778 and GM103420, or the Brandeis University Nuclear Magnetic Resonance Facility, with the assistance of Director Dr. Susan Sondej Pochapsky.	Ahuja S, 2013, J BIOL CHEM, V288, P22080, DOI 10.1074/jbc.M112.448225; Akhtar MK, 2005, J ENDOCRINOL, V187, P267, DOI 10.1677/joe.1.06375; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Barsukov I, 1997, J BIOMOL NMR, V10, P63, DOI 10.1023/A:1018313830207; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; ENOCH HG, 1979, J BIOL CHEM, V254, P8976; Estabrook RW, 1996, ARCH BIOCHEM BIOPHYS, V333, P308, DOI 10.1006/abbi.1996.0395; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Gay SC, 2010, FUTURE MED CHEM, V2, P1451, DOI 10.4155/FMC.10.229; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; HALL PF, 1991, J STEROID BIOCHEM, V40, P527, DOI 10.1016/0960-0760(91)90272-7; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; Iyanagi T, 2012, ARCH BIOCHEM BIOPHYS, V528, P72, DOI 10.1016/j.abb.2012.09.002; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kenaan C, 2011, BIOCHEMISTRY-US, V50, P3957, DOI 10.1021/bi1020748; Kumar S, 2005, DRUG METAB DISPOS, V33, P1131, DOI 10.1124/dmd.105.004606; Laursen T, 2011, BBA-PROTEINS PROTEOM, V1814, P132, DOI 10.1016/j.bbapap.2010.07.003; Lee YT, 2011, BIOCHEMISTRY-US, V50, P693, DOI 10.1021/bi101726d; Lee-Robichaud P, 2004, J STEROID BIOCHEM, V92, P119, DOI 10.1016/j.jsbmb.2004.07.005; Mulrooney SB, 2000, PROTEIN EXPRES PURIF, V19, P173, DOI 10.1006/prep.2000.1228; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Naffin-Olivos JL, 2006, BIOCHEMISTRY-US, V45, P755, DOI 10.1021/bi051623y; Nunez M, 2010, J BIOMOL NMR, V47, P289, DOI 10.1007/s10858-010-9428-6; O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879; Pandey AV, 2013, PHARMACOL THERAPEUT, V138, P229, DOI 10.1016/j.pharmthera.2013.01.010; Pandey AV, 2005, J BIOL CHEM, V280, P13265, DOI 10.1074/jbc.M414673200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Petrunak EM, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.610998; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Sandee D, 2011, ENDOCRINOLOGY, V152, P2904, DOI 10.1210/en.2011-0230; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; SHIMIZU T, 1991, J BIOL CHEM, V266, P3372; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; Storbeck KH, 2015, J STEROID BIOCHEM, V151, P66, DOI 10.1016/j.jsbmb.2014.11.024; Swart AC, 2010, J STEROID BIOCHEM, V119, P112, DOI 10.1016/j.jsbmb.2009.12.014; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Waskell L., 2005, CYTOCHROME P450 STRU, P33; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; Zhang HM, 2008, J BIOL CHEM, V283, P5217, DOI 10.1074/jbc.M709094200; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r; Zhao Q, 1999, PROTEIN SCI, V8, P298; Zhao Q, 1996, J STRUCT BIOL, V116, P320, DOI 10.1006/jsbi.1996.0048	58	32	32	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3990	4003		10.1074/jbc.M115.677294	http://dx.doi.org/10.1074/jbc.M115.677294			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26719338	Green Published, hybrid			2022-12-28	WOS:000371338400026
J	Rahmanto, YS; Jung, JG; Wu, RC; Kobayashi, Y; Heaphy, CM; Meeker, AK; Wang, TL; Shih, IM				Rahmanto, Yohan Suryo; Jung, Jin-Gyoung; Wu, Ren-Chin; Kobayashi, Yusuke; Heaphy, Christopher M.; Meeker, Alan K.; Wang, Tian-Li; Shih, Ie-Ming			Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEXES; PROMOTER MUTATIONS; CLEAR-CELL; REGULATORY MECHANISMS; SOMATIC MUTATIONS; GENOME STABILITY; CARCINOMA; GENE; EXPRESSION; KRAS	ARID1A is a tumor suppressor gene that belongs to the switch/sucrose non-fermentable chromatin remodeling gene family. It is mutated in many types of human cancer with the highest frequency in endometrium-related ovarian and uterine neoplasms including ovarian clear cell, ovarian endometrioid, and uterine endometrioid carcinomas. We have previously reported that mutations in the promoter of human telomerase reverse transcriptase (TERT) rarely co-occur with the loss of ARID1A protein expression, suggesting a potential role of ARID1A in telomere biology. In this study, we demonstrate that ARID1A negatively regulates TERT transcriptional regulation and activity via binding to the regulatory element of TERT and promotes a repressive histone mode. Induction of ARID1A expression was associated with increased occupancy of SIN3A and H3K9me3, known transcription repressor and histone repressor marks, respectively. Thus, loss of ARID1A protein expression caused by inactivating mutations reactivates TERT transcriptional activity and confers a survival advantage of tumor cells by maintaining their telomeres.	[Rahmanto, Yohan Suryo; Jung, Jin-Gyoung; Wu, Ren-Chin; Kobayashi, Yusuke; Heaphy, Christopher M.; Meeker, Alan K.; Wang, Tian-Li; Shih, Ie-Ming] Johns Hopkins Univ, Sch Med, Dept Pathol, 1550 Orleans St,CRB2,Rm 376, Baltimore, MD 21231 USA; [Rahmanto, Yohan Suryo; Jung, Jin-Gyoung; Wu, Ren-Chin; Kobayashi, Yusuke; Heaphy, Christopher M.; Meeker, Alan K.; Wang, Tian-Li; Shih, Ie-Ming] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1550 Orleans St,CRB2,Rm 305, Baltimore, MD 21231 USA; [Wang, Tian-Li; Shih, Ie-Ming] Johns Hopkins Univ, Sch Med, Dept Obstet Gynecol, Baltimore, MD 21231 USA; [Wu, Ren-Chin] Chang Gung Mem Hosp, Dept Pathol, Taoyuan 333, Taiwan; [Wu, Ren-Chin] Chang Gung Univ, Taoyuan 333, Taiwan; [Kobayashi, Yusuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1608582, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Chang Gung Memorial Hospital; Chang Gung University; Keio University	Rahmanto, YS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 1550 Orleans St,CRB2,Rm 376, Baltimore, MD 21231 USA.; Rahmanto, YS; Shih, IM (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1550 Orleans St,CRB2,Rm 305, Baltimore, MD 21231 USA.; Shih, IM (corresponding author), Johns Hopkins Med Inst, Dept Gynecol & Obstet, 1550 Orleans St,CRB2,Rm-305, Baltimore, MD 21231 USA.	suryoysr@gmail.com; shihie@yahoo.com	sdsd, shihieih/ABE-6190-2020; Kobayashi, Yusuke/M-5174-2019; Suryo Rahmanto, Yohan/K-8043-2018	Kobayashi, Yusuke/0000-0002-4503-2845; Suryo Rahmanto, Yohan/0000-0003-1453-7872; Heaphy, Christopher/0000-0003-4264-1810; Wu, Ren-Chin/0000-0003-1439-0874	NCI, National Institutes of Health [CA165807, CA129080, CA148826, CA187512]; DoD [W81XWH-11-2-0230, W81XWH-14-1-0221]; Katie Oppo Research Fund; Ephraim and Wilma Shaw Roseman Foundation; HERA Women's Cancer Foundation OSB Grant; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [R01CA148826, R21CA187512, R21CA165807, R01CA129080] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DoD(United States Department of Defense); Katie Oppo Research Fund; Ephraim and Wilma Shaw Roseman Foundation; HERA Women's Cancer Foundation OSB Grant; Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health grants CA165807 and CA129080 (to I. M. S.), CA148826 (to T. L. W.), CA187512 (to T. L. W.); DoD grants W81XWH-11-2-0230 (to I. M. S. and T. L. W.) and W81XWH-14-1-0221 (to T. L. W.); Katie Oppo Research Fund (to I. M. S.); The Ephraim and Wilma Shaw Roseman Foundation (to I. M. S.); HERA Women's Cancer Foundation OSB Grant (to Y. S. R.); and Research Fellowship from the Uehara Memorial Foundation (to Y. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ardighieri L, 2014, J PATHOL, V232, P16, DOI 10.1002/path.4293; Ayhan A, 2012, INT J GYNECOL CANCER, V22, P1310, DOI 10.1097/IGC.0b013e31826b5dcc; Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015; Borah S, 2015, SCIENCE, V347, P1006, DOI 10.1126/science.1260200; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chan TL, 2003, CANCER RES, V63, P4878; Chandler RL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7118; Chen XS, 2014, SEMIN CANCER BIOL, V26, P43, DOI 10.1016/j.semcancer.2014.01.006; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clynes D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8538; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Guan B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju146; Guan B, 2012, NEOPLASIA, V14, P986, DOI 10.1593/neo.121218; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Gunes C, 2013, CELL, V152, P390, DOI 10.1016/j.cell.2013.01.010; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Koh CM, 2015, J CLIN INVEST, V125, P2109, DOI 10.1172/JCI79134; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Kyo S, 2002, ONCOGENE, V21, P688, DOI 10.1038/sj.onc.1205163; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Min JN, 2013, CELL RES, V23, P1396, DOI 10.1038/cr.2013.113; Moore Chris B, 2013, Methods Mol Biol, V1031, P65, DOI 10.1007/978-1-62703-481-4_8; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Nair SS, 2012, MOL ONCOL, V6, P611, DOI 10.1016/j.molonc.2012.09.005; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shen JF, 2015, CANCER DISCOV, V5, P752, DOI 10.1158/2159-8290.CD-14-0849; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Stern JL, 2015, GENE DEV, V29, P2219, DOI 10.1101/gad.269498.115; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Wahlstrom T, 2013, EXP CELL RES, V319, P3160, DOI 10.1016/j.yexcr.2013.07.004; Watanabe R, 2014, CANCER RES, V74, P2465, DOI 10.1158/0008-5472.CAN-13-3608; Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Wu RC, 2014, CANCER BIOL THER, V15, P655, DOI 10.4161/cbt.28411; Wu RC, 2014, J PATHOL, V232, P473, DOI 10.1002/path.4315; Wu S, 2014, CELL CYCLE, V13, P2869, DOI 10.4161/15384101.2014.946834; Xu M, 2008, MOL CELL BIOL, V28, P4819, DOI 10.1128/MCB.01969-07	50	33	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9690	9699		10.1074/jbc.M115.707612	http://dx.doi.org/10.1074/jbc.M115.707612			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26953344	Green Published, hybrid			2022-12-28	WOS:000375602300027
J	Collazo, L; Klinman, JP				Collazo, Lara; Klinman, Judith P.			Control of the Position of Oxygen Delivery in Soybean Lipoxygenase-1 by Amino Acid Side Chains within a Gas Migration Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; ENZYME STRUCTURE; ACTIVE-SITE; DIFFUSION; PATHWAYS; DIOXYGEN; BINDING; OXIDASE; O-2; HYDROGENASE	Understanding gas migration pathways is critical to unraveling structure-function relationships in enzymes that process gaseous substrates such as O-2, H-2, and N-2. This work investigates the role of a defined pathway for O-2 in regulating the peroxidation of linoleic acid by soybean lipoxygenase 1. Computational and mutagenesis studies provide strong support for a dominant delivery channel that shuttles molecular oxygen to a specific region of the active site, thereby ensuring the regio- and stereospecificity of product. Analysis of reaction kinetics and product distribution in channel mutants also reveals a plasticity to the gas migration pathway. The findings show that a single site mutation (I553W) limits oxygen accessibility to the active site, greatly increasing the fraction of substrate that reacts with oxygen free in solution. They also show how a neighboring site mutation (L496W) can result in a redirection of oxygen toward an alternate position of the substrate, changing the regio- and stereospecificity of peroxidation. The present data indicate that modest changes in a protein scaffold may modulate the access of small gaseous molecules to enzyme-bound substrates.	[Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Collazo, Lara] Genentech Inc, One DNA Way, San Francisco, CA 94080 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Roche Holding; Genentech	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	klinman@berkeley.edu			National Science Foundation GRFP [DGE-1106400, CHE-0840505]; National Institutes of Health [GM025765]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025765, R35GM118117, R01GM025765] Funding Source: NIH RePORTER	National Science Foundation GRFP(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation GRFP Grants DGE-1106400 (to L. C.) and CHE-0840505 and the National Institutes of Health Grant GM025765 (to J. P. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Berry H, 1998, J BIOL CHEM, V273, P2769, DOI 10.1074/jbc.273.5.2769; Brodkin HR, 2015, PROTEIN SCI, V24, P762, DOI 10.1002/pro.2648; Case D., 2010, AMBER 11, P142; Chen L, 2008, BIOCHEMISTRY-US, V47, P5368, DOI 10.1021/bi800228w; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Cohen J, 2005, STRUCTURE, V13, P1321, DOI 10.1016/j.str.2005.05.013; Cohen J, 2008, METHOD ENZYMOL, V437, P439, DOI 10.1016/S0076-6879(07)37022-5; Dementin S, 2009, J AM CHEM SOC, V131, P10156, DOI 10.1021/ja9018258; Edwards SJ, 2010, J PHYS CHEM B, V114, P6653, DOI 10.1021/jp100133p; GIAMMONA DA, 1984, THESIS U CALIFORNIA; Glickman MH, 1996, BIOCHEMISTRY-US, V35, P12882, DOI 10.1021/bi960985q; Hatcher E, 2007, J AM CHEM SOC, V129, P187, DOI 10.1021/ja0667211; Hu SS, 2014, J AM CHEM SOC, V136, P8157, DOI 10.1021/ja502726s; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Johnson BJ, 2007, J BIOL CHEM, V282, P17767, DOI 10.1074/jbc.M701308200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; Lee J, 2011, CHEM REV, V111, P7595, DOI 10.1021/cr100042n; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; Liebgott PP, 2010, NAT CHEM BIOL, V6, P63, DOI [10.1038/NCHEMBIO.276, 10.1038/nchembio.276]; Luna VM, 2008, BIOCHEMISTRY-US, V47, P4657, DOI 10.1021/bi800045y; Meyer MP, 2008, P NATL ACAD SCI USA, V105, P1146, DOI 10.1073/pnas.0710643105; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Mullins LS, 1999, J AM CHEM SOC, V121, P3803, DOI 10.1021/ja990063l; Rickert KW, 1999, BIOCHEMISTRY-US, V38, P12218, DOI 10.1021/bi990834y; Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104; Saam J, 2010, J BIOL CHEM, V285, P24439, DOI 10.1074/jbc.M110.131193; Scorciapino MA, 2009, J AM CHEM SOC, V131, P11825, DOI 10.1021/ja9028473; Song WJ, 2011, P NATL ACAD SCI USA, V108, P14795, DOI 10.1073/pnas.1106514108; Tomita A, 2009, P NATL ACAD SCI USA, V106, P2612, DOI 10.1073/pnas.0807774106; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang PH, 2012, P NATL ACAD SCI USA, V109, P6399, DOI 10.1073/pnas.1121176109; Winter MB, 2011, P NATL ACAD SCI USA, V108, pE881, DOI 10.1073/pnas.1114038108	37	26	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9052	9059		10.1074/jbc.M115.709154	http://dx.doi.org/10.1074/jbc.M115.709154			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26867580	Green Published, hybrid			2022-12-28	WOS:000374849000019
J	Yalley, A; Schill, D; Hatta, M; Johnson, N; Cirillo, LA				Yalley, Akua; Schill, Daniel; Hatta, Mitsutoki; Johnson, Nicole; Cirillo, Lisa Ann			Loss of Interdependent Binding by the FoxO1 and FoxA1/A2 Forkhead Transcription Factors Culminates in Perturbation of Active Chromatin Marks and Binding of Transcriptional Regulators at Insulin-sensitive Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; gene regulation; histone modification; insulin; nucleosome; FoxA1; FoxA2; FoxO1	PROTEIN-KINASE-B; FACTOR FKHR; RESPONSE SEQUENCE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; CRYSTAL-STRUCTURE; MMTV PROMOTER; POSTTRANSLATIONAL MODIFICATION; MEDIATED PHOSPHORYLATION; COMPACTED CHROMATIN; GLUCOSE-PRODUCTION	FoxO1 binds to insulin response elements located in the promoters of insulin-like growth factor-binding protein 1 (IGFBP1) and glucose-6-phosphatase (G6Pase), activating their expression. Insulin-mediated phosphorylation of FoxO1 promotes cytoplasmic translocation, inhibiting FoxO1-mediated transactivation. We have previously demonstrated that FoxO1 opens and remodels chromatin assembled from the IGFBP1 promoter via a highly conserved winged helix motif. This finding, which established FoxO1 as a pioneer factor, suggested a model whereby FoxO1 chromatin remodeling at regulatory targets facilitates binding and recruitment of additional regulatory factors. However, the impact of FoxO1 phosphorylation on its ability to bind chromatin and the effect of FoxO1 loss on recruitment of neighboring transcription factors at its regulatory targets in liver chromatin is unknown. In this study, we demonstrate that an amino acid substitution that mimics insulin-mediated phosphorylation of a serine in the winged helix DNA binding motif curtails FoxO1 nucleosome binding. We also demonstrate that shRNA-mediated loss of FoxO1 binding to the IGFBP1 and G6Pase promoters in HepG2 cells significantly reduces binding of RNA polymerase II and the pioneer factors FoxA1/A2. Knockdown of FoxA1 similarly reduced binding of RNA polymerase II and FoxO1. Reduction in acetylation of histone H3 Lys-27 accompanies loss of FoxO1 and FoxA1/A2 binding. Interdependent binding of FoxO1 and FoxA1/A2 possibly entails cooperative binding because FoxO1 and FoxA1/A2 facilitate one another's binding to IGFPB1 promoter DNA. These results illustrate how transcription factors can nucleate transcriptional events in chromatin in response to signaling events and suggest a model for regulation of hepatic glucose metabolism through interdependent FoxO/FoxA binding.	[Yalley, Akua; Schill, Daniel; Hatta, Mitsutoki; Johnson, Nicole; Cirillo, Lisa Ann] Dept Cell Biol, Med Coll Wisconsin, Neurobiol, & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Cirillo, LA (corresponding author), whom correspondence should be addressed Dept Cell, Med Coll Wisconsin, Neurobiol & Anat, Milwaukee, WI 53226 USA.	lcirillo@mcw.edu	yalley, akua/GVR-9401-2022; HATTA, MOCHAMMAD/D-3742-2019	yalley, akua/0000-0002-7429-1707; HATTA, MOCHAMMAD/0000-0002-8456-4203; Zwifelhofer, Nicole/0000-0001-9577-3994	National Institutes of Health [R01 DK093763]; American Diabetes Association [1-04-IN-09, 1-06-RA-30]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by National Institutes of Health Grant R01 DK093763 and American Diabetes Association Grants 1-04-IN-09 and 1-06-RA-30 (to L. A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allander SV, 1997, ENDOCRINOLOGY, V138, P4291, DOI 10.1210/en.138.10.4291; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Belikov S, 2001, EMBO J, V20, P2802, DOI 10.1093/emboj/20.11.2802; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Boura E, 2007, J BIOL CHEM, V282, P8265, DOI 10.1074/jbc.M605682200; Boyes J, 1998, J MOL BIOL, V279, P529, DOI 10.1006/jmbi.1998.1783; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; Cuesta I, 2007, MOL CELL BIOL, V27, P7302, DOI 10.1128/MCB.00758-07; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gautier-Stein A, 2005, MOL ENDOCRINOL, V19, P163, DOI 10.1210/me.2004-0105; Ghosh AK, 2001, J BIOL CHEM, V276, P8507, DOI 10.1074/jbc.M008541200; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hall RK, 2007, MOL ENDOCRINOL, V21, P550, DOI 10.1210/me.2006-0307; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hatta M, 2009, BIOCHEM BIOPH RES CO, V379, P1005, DOI 10.1016/j.bbrc.2009.01.014; Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kohler S, 2010, J BIOL CHEM, V285, P464, DOI 10.1074/jbc.M109.063149; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnani L, 2011, TRENDS GENET, V27, P465, DOI 10.1016/j.tig.2011.07.002; Mahmud DL, 2002, ONCOGENE, V21, P1556, DOI 10.1038/sj.onc.1205230; Martelli AM, 2012, BBA-MOL CELL RES, V1823, P2168, DOI 10.1016/j.bbamcr.2012.08.017; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; Oduro AK, 2008, EXP CELL RES, V314, P2796, DOI 10.1016/j.yexcr.2008.07.006; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Streeper RS, 1997, J BIOL CHEM, V272, P11698, DOI 10.1074/jbc.272.18.11698; SVAREN J, 1994, EMBO J, V13, P4856, DOI 10.1002/j.1460-2075.1994.tb06812.x; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tomizawa M, 2000, J BIOL CHEM, V275, P7289, DOI 10.1074/jbc.275.10.7289; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; UNTERMAN TG, 1994, BIOCHEM BIOPH RES CO, V203, P1835, DOI 10.1006/bbrc.1994.2401; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Wang RH, 2013, INT J BIOL SCI, V9, P934, DOI 10.7150/ijbs.7529; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Yeagley D, 2001, J BIOL CHEM, V276, P33705, DOI 10.1074/jbc.M101215200; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527; Zhang WJ, 2001, MOL CELL BIOL, V21, P2413, DOI 10.1128/MCB.21.7.2413-2422.2001; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	73	17	19	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8848	8861		10.1074/jbc.M115.677583	http://dx.doi.org/10.1074/jbc.M115.677583			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26929406	Green Published, hybrid			2022-12-28	WOS:000374773200045
J	Guillet, V; Galandrin, S; Maveyraud, L; Ladeveze, S; Mariaule, V; Bon, C; Eynard, N; Daffe, M; Marrakchi, H; Mourey, L				Guillet, Valerie; Galandrin, Segolene; Maveyraud, Laurent; Ladeveze, Simon; Mariaule, Vincent; Bon, Cecile; Eynard, Nathalie; Daffe, Mamadou; Marrakchi, Hedia; Mourey, Lionel			Insight into Structure-Function Relationships and Inhibition of the Fatty Acyl-AMP Ligase (FadD32) Orthologs from Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; drug design; enzyme inhibitor; mycobacteria; tuberculosis; fatty acyl ACP-synthase; fatty acyl-AMP ligase	MYCOLIC ACID BIOSYNTHESIS; CRYSTAL-STRUCTURE; TUBERCULOSIS; SYNTHETASE; ACTIVATION; ENVELOPE; PROGRAM; ENZYMES; KEY	Mycolic acids are essential components of the mycobacterial cell envelope, and their biosynthetic pathway is one of the targets of first-line antituberculous drugs. This pathway contains a number of potential targets, including some that have been identified only recently and have yet to be explored. One such target, FadD32, is required for activation of the long meromycolic chain and is essential for mycobacterial growth. We report here an in-depth biochemical, biophysical, and structural characterization of four FadD32 orthologs, including the very homologous enzymes from Mycobacterium tuberculosis and Mycobacterium marinum. Determination of the structures of two complexes with alkyl adenylate inhibitors has provided direct information, with unprecedented detail, about the active site of the enzyme and the associated hydrophobic tunnel, shedding new light on structure-function relationships and inhibition mechanisms by alkyl adenylates and diarylated coumarins. This work should pave the way for the rational design of inhibitors of FadD32, a highly promising drug target.	[Guillet, Valerie; Galandrin, Segolene; Maveyraud, Laurent; Ladeveze, Simon; Mariaule, Vincent; Bon, Cecile; Eynard, Nathalie; Daffe, Mamadou; Marrakchi, Hedia; Mourey, Lionel] Univ Toulouse, Inst Pharmacol & Biol Struct, CNRS, UPS, F-31077 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Guillet, V; Marrakchi, H (corresponding author), Inst Pharmacol & Biol Struct, 205 Route Narbonne,BP 64182, F-31077 Toulouse 4, France.	valerie.guillet@ipbs.fr; hedia.marrakchi@ipbs.fr	Mourey, Lionel/B-5662-2009; Marrakchi, Hedia/AAF-2657-2020; Maveyraud, Laurent/C-6066-2011; BON, cecile C/F-9231-2018	Mourey, Lionel/0000-0002-8259-1259; Maveyraud, Laurent/0000-0003-4610-8319; Marrakchi, Hedia/0000-0003-2749-5966; Mariaule, Vincent/0000-0003-2655-0580; Bon, Cecile/0000-0002-3700-2646	European Community New Medicines for Tuberculosis Program [LSHP-CT-2005-018923]	European Community New Medicines for Tuberculosis Program	This work was supported by European Community New Medicines for Tuberculosis Program Grant LSHP-CT-2005-018923. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersson CS, 2012, STRUCTURE, V20, P1062, DOI 10.1016/j.str.2012.03.012; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bains J, 2007, J MOL BIOL, V373, P965, DOI 10.1016/j.jmb.2007.08.008; Bricogne G., 2011, BUSTER VERSION 2 10; Carroll P, 2011, APPL ENVIRON MICROB, V77, P5040, DOI 10.1128/AEM.02880-10; Chalut C, 2006, P NATL ACAD SCI USA, V103, P8511, DOI 10.1073/pnas.0511129103; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crosby HA, 2012, APPL ENVIRON MICROB, V78, P6619, DOI 10.1128/AEM.01733-12; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Daffe M, 2014, BACTERIAL MEMBRANES, P179; Daffe M, 2015, TUBERCULOSIS, V95, pS155, DOI 10.1016/j.tube.2015.02.024; DeLano W.L, PYMOL MOL GRAPHICS S; Duckworth BP, 2012, CURR TOP MED CHEM, V12, P766; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Galandrin S, 2013, J BIOMOL SCREEN, V18, P576, DOI 10.1177/1087057112474691; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Goyal A, 2012, J MOL BIOL, V416, P221, DOI 10.1016/j.jmb.2011.12.031; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leger M, 2009, CHEM BIOL, V16, P510, DOI 10.1016/j.chembiol.2009.03.012; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15493; Liu Z, 2013, J BIOL CHEM, V288, P18473, DOI 10.1074/jbc.M113.466912; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; Smart O. S., 2011, GRADE VERSION 1 1 1; Stanley SA, 2013, P NATL ACAD SCI USA, V110, P11565, DOI 10.1073/pnas.1302114110; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Zhang ZN, 2011, J MOL BIOL, V406, P313, DOI 10.1016/j.jmb.2010.12.011	54	15	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7973	7989		10.1074/jbc.M115.712612	http://dx.doi.org/10.1074/jbc.M115.712612			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26900152	Green Published, hybrid			2022-12-28	WOS:000374056700019
J	Kabir, I; Li, ZQ; Bui, HH; Kuo, MS; Gao, GP; Jiang, XC				Kabir, Inamul; Li, Zhiqiang; Bui, Hai H.; Kuo, Ming-Shang; Gao, Guangping; Jiang, Xian-Cheng			Small Intestine but Not Liver Lysophosphatidylcholine Acyltransferase 3 (Lpcat3) Deficiency Has a Dominant Effect on Plasma Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; PHOSPHOLIPID-TRANSFER PROTEIN; FATTY-ACID; ABSORPTION; IDENTIFICATION; MICE; ATHEROSCLEROSIS; TRANSPORT; GENE; LKB1	Lysophosphatidylcholine acyltransferase 3 (Lpcat3) is involved in phosphatidylcholine remodeling in the small intestine and liver. We investigated lipid metabolism in inducible intestine-specific and liver-specific Lpcat3 gene knock-out mice. We produced Lpcat3-Flox/villin-Cre-ERT2 mice, which were treated with tamoxifen (at days 1, 3, 5, and 7), to delete Lpcat3 specifically in the small intestine. At day 9 after the treatment, we found that Lpcat3 deficiency in enterocytes significantly reduced polyunsaturated phosphatidylcholines in the enterocyte plasma membrane and reduced Niemann-Pick C1-like 1 (NPC1L1), CD36, ATP-binding cassette transporter 1 (ABCA1), and ABCG8 levels on the membrane, thus significantly reducing lipid absorption, cholesterol secretion through apoB-dependent and apoB-independent pathways, and plasma triglyceride, cholesterol, and phospholipid levels, as well as body weight. Moreover, Lpcat3 deficiency does not cause significant lipid accumulation in the small intestine. We also utilized adenovirus-associated virus-Cre to deplete Lpcat3 in the liver. We found that liver deficiency only reduces plasma triglyceride levels but not other lipid levels. Furthermore, there is no significant lipid accumulation in the liver. Importantly, small intestine Lpcat3 deficiency has a much bigger effect on plasma lipid levels than that of liver deficiency. Thus, inhibition of small intestine Lpcat3 might constitute a novel approach for treating hyperlipidemia.	[Kabir, Inamul; Li, Zhiqiang; Jiang, Xian-Cheng] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Li, Zhiqiang; Jiang, Xian-Cheng] Vet Affairs New York Harbor Healthcare Syst, Mol & Cellular Cardiol Program, Brooklyn, NY 11209 USA; [Bui, Hai H.; Kuo, Ming-Shang] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Gao, Guangping] Univ Massachusetts, Sch Med, Horae Gene Therapy Ctr, Worcester, MA 01605 USA; [Gao, Guangping] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Eli Lilly; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Jiang, XC (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.; Jiang, XC (corresponding author), Vet Affairs New York Harbor Healthcare Syst, Mol & Cellular Cardiol Program, Brooklyn, NY 11209 USA.	xjiang@downstate.edu		Kabir, Inamul/0000-0001-6207-1785	Veterans Affairs Merit Grant [000900-01]; National Institutes of Health [R56HL121409]; National Natural Scientific Foundation (NSF) of China [31371190]; American Heart Association [10SDG4040054]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL121409] Funding Source: NIH RePORTER	Veterans Affairs Merit Grant(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Scientific Foundation (NSF) of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Veterans Affairs Merit Grant 000900-01 (to X. C. J.), National Institutes of Health Grant R56HL121409 (to X. C. J.), National Natural Scientific Foundation (NSF) of China Grant 31371190 (to X. C. J.), and Scientist Development Grant 10SDG4040054 from the American Heart Association (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; GLICKMAN RM, 1977, P NATL ACAD SCI USA, V74, P2569, DOI 10.1073/pnas.74.6.2569; GLICKMAN RM, 1973, J CLIN INVEST, V52, P2910, DOI 10.1172/JCI107487; GLICKMAN RM, 1978, NEW ENGL J MED, V299, P1424, DOI 10.1056/NEJM197812282992602; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; HAYASHI Y, 1993, MOL ENDOCRINOL, V7, P1049, DOI 10.1210/me.7.8.1049; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hussain MM, 2014, CURR OPIN LIPIDOL, V25, P200, DOI 10.1097/MOL.0000000000000084; Iqbal J, 2005, J LIPID RES, V46, P1491, DOI 10.1194/jlr.M500023-JLR200; Iqbal J, 2013, J BIOL CHEM, V288, P30432, DOI 10.1074/jbc.M113.501247; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; Kitajima K, 2006, ARTERIOSCL THROM VAS, V26, P1852, DOI 10.1161/01.ATV.0000231520.26490.54; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Li PS, 2014, NAT MED, V20, P80, DOI 10.1038/nm.3417; Li ZQ, 2015, GASTROENTEROLOGY, V149, P1519, DOI 10.1053/j.gastro.2015.07.012; Li ZQ, 2012, J BIOL CHEM, V287, P20122, DOI 10.1074/jbc.M111.334664; Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11; Liu R, 2007, ARTERIOSCL THROM VAS, V27, P2014, DOI 10.1161/ATVBAHA.107.149914; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Pan XY, 2012, BBA-MOL CELL BIOL L, V1821, P727, DOI 10.1016/j.bbalip.2011.09.013; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rong X, 2015, ELIFE, V4, DOI 10.7554/eLife.06557; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Schiller J, 2001, J LIPID RES, V42, P1501; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; STREMMEL W, 1985, J CLIN INVEST, V75, P1068, DOI 10.1172/JCI111769; TALL AR, 1979, J CLIN INVEST, V64, P977, DOI 10.1172/JCI109564; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANCE DE, 2002, PHOSPHOLIPID BIOSYNT; Woods A, 2011, BIOCHEM J, V434, P49, DOI 10.1042/BJ20101721; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	37	29	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7651	7660		10.1074/jbc.M115.697011	http://dx.doi.org/10.1074/jbc.M115.697011			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26828064	hybrid, Green Published			2022-12-28	WOS:000383447600036
J	Banerjee, R				Banerjee, Ruma			Introduction to the Thematic Minireview Series on Intrinsically Disordered Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						conformational change; intrinsically disordered protein; post-translational modification (PTM); protein folding; signaling		In this thematic minireview series, the JBC presents six exciting articles on low complexity or intrinsically disordered proteins (IDPs). The dynamical and fluctuating structures of IDPs or of disordered regions within proteins result in virtually all of their primary sequence being exposed, at least at some time, to potential interacting partners. Their structural versatility underlies their often wide functional repertoires, which is further expanded by post-translational modifications. Given these characteristics, it is not surprising that IDPs serve as important hubs in signaling networks, scaffolding multivalent interactions. They are also important for organizing membrane-less protein organelles. This collection of reviews discusses biophysical approaches for studying IDPs and illuminates their importance to critical functions such as cell cycle control, transcription, and translation, as well as their regulation via cellular input signals.	[Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, 4220C MSRB III,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB III,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [DK45776, HL58984, GM112455]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK45776, HL58984, and GM112455 (to R. B.). The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Burger VM, 2016, J BIOL CHEM, V291, P6706, DOI 10.1074/jbc.R115.692590; Dyson HJ, 2016, J BIOL CHEM, V291, P6714, DOI 10.1074/jbc.R115.692020; Guharoy M, 2016, J BIOL CHEM, V291, P6723, DOI 10.1074/jbc.R115.692665; Shammas SL, 2016, J BIOL CHEM, V291, P6689, DOI 10.1074/jbc.R115.692715; Uversky VN, 2016, J BIOL CHEM, V291, P6681, DOI 10.1074/jbc.R115.685859	6	2	3	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6679	6680		10.1074/jbc.R116.719930	http://dx.doi.org/10.1074/jbc.R116.719930			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26851284	Green Published, hybrid			2022-12-28	WOS:000373299700006
J	Conway, JM; Pierce, WS; Le, JH; Harper, GW; Wright, JH; Tucker, AL; Zurawski, JV; Lee, LL; Blumer-Schuette, SE; Kelly, RM				Conway, Jonathan M.; Pierce, William S.; Le, Jaycee H.; Harper, George W.; Wright, John H.; Tucker, Allyson L.; Zurawski, Jeffrey V.; Lee, Laura L.; Blumer-Schuette, Sara E.; Kelly, Robert M.			Multidomain, Surface Layer-associated Glycoside Hydrolases Contribute to Plant Polysaccharide Degradation by Caldicellulosiruptor Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biofuel; cell surface; cell surface enzyme; enzyme; glycoside hydrolase; plant cell wall; Caldicellulosiruptor; S-layer; lignocellulose	THERMOANAEROBACTERIUM-THERMOSULFURIGENES EM1; HIGH-MOLECULAR-WEIGHT; S-LAYER; CELL-WALL; CLOSTRIDIUM-THERMOCELLUM; DOMAIN PROTEINS; GENOME SEQUENCE; XYLANASE; GENE; CLONING	The genome of the extremely thermophilic bacterium Caldicellulosiruptor kronotskyensis encodes 19 surface layer (S-layer) homology (SLH) domain-containing proteins, the most in any Caldicellulosiruptor species genome sequenced to date. These SLH proteins include five glycoside hydrolases (GHs) and one polysaccharide lyase, the genes for which were transcribed at high levels during growth on plant biomass. The largest GH identified so far in this genus, Calkro_0111 (2,435 amino acids), is completely unique to C. kronotskyensis and contains SLH domains. Calkro_0111 was produced recombinantly in Escherichia coli as two pieces, containing the GH16 and GH55 domains, respectively, as well as putative binding and spacer domains. These displayed endo- and exoglucanase activity on the -1,3-1,6-glucan laminarin. A series of additional truncation mutants of Calkro_0111 revealed the essential architectural features required for catalytic function. Calkro_0402, another of the SLH domain GHs in C. kronotskyensis, when produced in E. coli, was active on a variety of xylans and -glucans. Unlike Calkro_0111, Calkro_0402 is highly conserved in the genus Caldicellulosiruptor and among other biomass-degrading Firmicutes but missing from Caldicellulosiruptor bescii. As such, the gene encoding Calkro_0402 was inserted into the C. bescii genome, creating a mutant strain with its S-layer extensively decorated with Calkro_0402. This strain consequently degraded xylans more extensively than wild-type C. bescii. The results here provide new insights into the architecture and role of SLH domain GHs and demonstrate that hemicellulose degradation can be enhanced through non-native SLH domain GHs engineered into the genomes of Caldicellulosiruptor species.	[Conway, Jonathan M.; Pierce, William S.; Le, Jaycee H.; Harper, George W.; Wright, John H.; Tucker, Allyson L.; Zurawski, Jeffrey V.; Lee, Laura L.; Blumer-Schuette, Sara E.; Kelly, Robert M.] N Carolina State Univ, Dept Chem & Biomol Engn, EB-1,911 Partners Way, Raleigh, NC 27695 USA; [Blumer-Schuette, Sara E.] Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA	University of North Carolina; North Carolina State University; Oakland University	Kelly, RM (corresponding author), N Carolina State Univ, Dept Chem & Biomol Engn, EB-1,911 Partners Way, Raleigh, NC 27695 USA.	rmkelly@ncsu.edu	Blumer-Schuette, Sara/H-4081-2019	Blumer-Schuette, Sara/0000-0001-9522-4266; Conway, Jonathan/0000-0002-2715-2149; Kelly, Robert/0000-0002-0639-3592	BioEnergy Science Center, a United States Department of Energy Bioenergy Research Center - Office of Biological and Environmental Research in the Department of Energy Office of Science; United States Department of Education GAANN Fellowship [P200A100004-12]; National Institutes of Health Biotechnology Traineeship (National Institutes of Health) [T32 GM008776-11]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008776] Funding Source: NIH RePORTER	BioEnergy Science Center, a United States Department of Energy Bioenergy Research Center - Office of Biological and Environmental Research in the Department of Energy Office of Science; United States Department of Education GAANN Fellowship; National Institutes of Health Biotechnology Traineeship (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the BioEnergy Science Center, a United States Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by United States Department of Education GAANN Fellowship P200A100004-12.; Supported by a National Institutes of Health Biotechnology Traineeship (National Institutes of Health Grant T32 GM008776-11) and National Science Foundation graduate fellowship.	Abdul Halim MF, 2013, MOL MICROBIOL, V88, P1164, DOI 10.1111/mmi.12248; Adelsberger H, 2004, MICROBIOL-SGM, V150, P2257, DOI 10.1099/mic.0.27066-0; Albers SV, 2011, NAT REV MICROBIOL, V9, P414, DOI 10.1038/nrmicro2576; Ali E, 2005, BIOSCI BIOTECH BIOCH, V69, P2389, DOI 10.1271/bbb.69.2389; Ali MK, 2001, FEMS MICROBIOL LETT, V198, P79; Ali MK, 2001, BIOSCI BIOTECH BIOCH, V65, P41, DOI 10.1271/bbb.65.41; Ali MK, 1999, BIOSCI BIOTECH BIOCH, V63, P1596, DOI 10.1271/bbb.63.1596; Anderson VJ, 2011, MOL MICROBIOL, V81, P192, DOI 10.1111/j.1365-2958.2011.07688.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bergquist PL, 1999, FEMS MICROBIOL ECOL, V28, P99, DOI 10.1016/S0168-6496(98)00078-6; Blumer-Schuette SE, 2015, J BIOL CHEM, V290, P10645, DOI 10.1074/jbc.M115.641480; Blumer-Schuette SE, 2014, FEMS MICROBIOL REV, V38, P393, DOI 10.1111/1574-6976.12044; Blumer-Schuette SE, 2012, J BACTERIOL, V194, P4015, DOI 10.1128/JB.00266-12; Blumer-Schuette SE, 2011, J BACTERIOL, V193, P1483, DOI 10.1128/JB.01515-10; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; BOOT HJ, 1995, J BACTERIOL, V177, P7222, DOI 10.1128/jb.177.24.7222-7230.1995; Brahamsha B, 1996, P NATL ACAD SCI USA, V93, P6504, DOI 10.1073/pnas.93.13.6504; Brechtel E, 1999, ARCH MICROBIOL, V171, P159, DOI 10.1007/s002030050694; Brunecky R, 2012, ACTA CRYSTALLOGR D, V68, P292, DOI 10.1107/S0907444912001680; Cha M, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-85; Charrier B, 2012, TRENDS PLANT SCI, V17, P468, DOI 10.1016/j.tplants.2012.03.003; Cheng YM, 2009, APPL MICROBIOL BIOT, V81, P1051, DOI 10.1007/s00253-008-1617-9; Chung DW, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-82; Conway JM, 2015, THERMOPHILIC MICROORGANISMS, P91; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; de la Riva L, 2011, J BACTERIOL, V193, P3276, DOI 10.1128/JB.00248-11; DUMAS C, 1983, THEOR APPL GENET, V67, P1, DOI 10.1007/BF00303914; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EGELSEER E, 1995, J BACTERIOL, V177, P1444, DOI 10.1128/jb.177.6.1444-1451.1995; Elkins JG, 2010, J BACTERIOL, V192, P6099, DOI 10.1128/JB.00950-10; Fagan RP, 2014, NAT REV MICROBIOL, V12, P211, DOI 10.1038/nrmicro3213; Fagan RP, 2011, J MED MICROBIOL, V60, P1225, DOI 10.1099/jmm.0.028472-0; Farkas J, 2013, J IND MICROBIOL BIOT, V40, P41, DOI 10.1007/s10295-012-1202-1; Feng JX, 2000, BIOSCI BIOTECH BIOCH, V64, P2614, DOI 10.1271/bbb.64.2614; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Fuchs KP, 2003, MICROBIOL-SGM, V149, P1021, DOI 10.1099/mic.0.26153-0; FUJINO T, 1993, J BACTERIOL, V175, P1891, DOI 10.1128/JB.175.7.1891-1899.1993; Geslin C, 2003, J BACTERIOL, V185, P3888, DOI 10.1128/JB.185.13.3888-3894.2003; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Gibbs MD, 2000, CURR MICROBIOL, V40, P333, DOI 10.1007/s002849910066; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Halim MFA, 2016, J BACTERIOL, V198, P808, DOI 10.1128/JB.00849-15; Han YJ, 2012, J BIOL CHEM, V287, P34946, DOI 10.1074/jbc.M112.391532; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; HARADA T, 1992, TRENDS GLYCOSCI GLYC, V4, P309; Honma K, 2007, MICROB PATHOGENESIS, V42, P156, DOI 10.1016/j.micpath.2007.01.003; Huang XL, 2015, J AGR FOOD CHEM, V63, P6430, DOI 10.1021/acs.jafc.5b01259; Hung KS, 2011, BIOTECHNOL LETT, V33, P1441, DOI 10.1007/s10529-011-0579-7; Ito Y, 2003, APPL ENVIRON MICROB, V69, P6969, DOI 10.1128/AEM.69.12.6969-6978.2003; Itoh T, 2014, BIOSCI BIOTECH BIOCH, V78, P624, DOI 10.1080/09168451.2014.891935; Johnson BR, 2016, APPL ENVIRON MICROB, V82, P134, DOI 10.1128/AEM.01968-15; Kataeva IA, 2009, J BACTERIOL, V191, P3760, DOI 10.1128/JB.00256-09; Kern J, 2011, J BIOL CHEM, V286, P26042, DOI 10.1074/jbc.M111.248070; Kim H, 2000, APPL MICROBIOL BIOT, V54, P521, DOI 10.1007/s002530000412; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Lee LL, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00440-15; LEE SP, 1994, APPL ENVIRON MICROB, V60, P3764, DOI 10.1128/AEM.60.10.3764-3773.1994; LEMAIRE M, 1995, J BACTERIOL, V177, P2451, DOI 10.1128/jb.177.9.2451-2459.1995; Liebl WG, 2008, J BACTERIOL, V190, P1350, DOI 10.1128/JB.01149-07; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Liu SY, 1996, J BACTERIOL, V178, P1539, DOI 10.1128/jb.178.6.1539-1547.1996; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Matuschek M, 1996, MOL GEN GENET, V252, P493, DOI 10.1007/BF02173016; MATUSCHEK M, 1994, J BACTERIOL, V176, P3295, DOI 10.1128/jb.176.11.3295-3302.1994; McCarren J, 2007, J BACTERIOL, V189, P1158, DOI 10.1128/JB.01500-06; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Morris DD, 1999, EXTREMOPHILES, V3, P103, DOI 10.1007/s007920050105; Ozdemir I, 2012, APPL ENVIRON MICROB, V78, P768, DOI 10.1128/AEM.07031-11; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pham TK, 2010, PROTEOMICS, V10, P3130, DOI 10.1002/pmic.200900448; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; SHAO WL, 1995, APPL ENVIRON MICROB, V61, P937, DOI 10.1128/AEM.61.3.937-940.1995; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; St John FJ, 2006, APPL ENVIRON MICROB, V72, P1496, DOI 10.1128/AEM.72.2.1496-1506.2006; St John FJ, 2012, J STRUCT BIOL, V180, P303, DOI 10.1016/j.jsb.2012.09.007; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun ZL, 2013, APPL MICROBIOL BIOT, V97, P1941, DOI 10.1007/s00253-012-4044-x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas C, 2009, CELL MOTIL CYTOSKEL, V66, P940, DOI 10.1002/cm.20389; van de Werken HJG, 2008, APPL ENVIRON MICROB, V74, P6720, DOI 10.1128/AEM.00968-08; VanFossen AL, 2011, BIOTECHNOL BIOENG, V108, P1559, DOI 10.1002/bit.23093; VanFossen AL, 2009, APPL ENVIRON MICROB, V75, P7718, DOI 10.1128/AEM.01959-09; Veith A, 2009, MOL MICROBIOL, V73, P58, DOI 10.1111/j.1365-2958.2009.06746.x; Verma DPS, 2001, PLANT MOL BIOL, V47, P693, DOI 10.1023/A:1013679111111; Waeonukul R, 2009, J MICROBIOL BIOTECHN, V19, P277, DOI 10.4014/jmb.0804.293; Xiao ZZ, 2005, ANAL BIOCHEM, V342, P176, DOI 10.1016/j.ab.2005.01.052; Xiao ZZ, 2004, BIOTECHNOL BIOENG, V88, P832, DOI 10.1002/bit.20286; Ye LB, 2012, APPL ENVIRON MICROB, V78, P7048, DOI 10.1128/AEM.02009-12; Yi Z., 2013, PLOS ONE, V8; Zhao YY, 2013, WORLD J MICROB BIOT, V29, P327, DOI 10.1007/s11274-012-1186-z; Zurawski JV, 2015, APPL ENVIRON MICROB, V81, P7159, DOI 10.1128/AEM.01622-15	96	31	31	1	36	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6732	6747		10.1074/jbc.M115.707810	http://dx.doi.org/10.1074/jbc.M115.707810			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26814128	Green Published, hybrid			2022-12-28	WOS:000373299700013
J	Rossi, P; Sterlini, B; Castroflorio, E; Marte, A; Onofri, F; Valtorta, F; Maragliano, L; Corradi, A; Benfenati, F				Rossi, Pia; Sterlini, Bruno; Castroflorio, Enrico; Marte, Antonella; Onofri, Franco; Valtorta, Flavia; Maragliano, Luca; Corradi, Anna; Benfenati, Fabio			A Novel Topology of Proline-rich Transmembrane Protein 2 (PRRT2): HINTS FOR AN INTRACELLULAR FUNCTION AT THE SYNAPSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; molecular dynamics; neurological disease; SNARE proteins; synapse	PAROXYSMAL DYSKINESIA; INFANTILE CONVULSIONS; MOLECULAR-DYNAMICS; MUTATIONS; GENE; SIMULATION; DISORDERS; SRC	Proline-rich transmembrane protein 2 (PRRT2) has been identified as the single causative gene for a group of paroxysmal syndromes of infancy, including epilepsy, paroxysmal movement disorders, and migraine. On the basis of topology predictions, PRRT2 has been assigned to the recently characterized family of Dispanins, whose members share the two-transmembrane domain topology with a large N terminus and short C terminus oriented toward the outside of the cell. Because PRRT2 plays a role at the synapse, it is important to confirm the exact orientation of its N and C termini with respect to the plasma membrane to get clues regarding its possible function. Using a combination of different experimental approaches, including live immunolabeling, immunogold electron microscopy, surface biotinylation and computational modeling, we demonstrate a novel topology for this protein. PRRT2 is a type II transmembrane protein in which only the second hydrophobic segment spans the plasma membrane, whereas the first one is associated with the internal surface of the membrane and forms a helix-loop-helix structure without crossing it. Most importantly, the large proline-rich N-terminal domain is not exposed to the extracellular space but is localized intracellularly, and only the short C terminus is extracellular (N-cyt/C-exo topology). Accordingly, we show that PRRT2 interacts with the Src homology 3 domain-bearing protein Intersectin 1, an intracellular protein involved in synaptic vesicle cycling. These findings will contribute to the clarification of the role of PRRT2 at the synapse and the understanding of pathogenic mechanisms on the basis of PRRT2-related neurological disorders.	[Corradi, Anna; Benfenati, Fabio] Univ Genoa, Dept Expt Med, Viale Benedetto 15,3, I-16132 Genoa, Italy; [Sterlini, Bruno; Castroflorio, Enrico; Maragliano, Luca; Benfenati, Fabio] Fdn Ist Italiano Tecnol, Ctr Synapt Neurosci & Technol, Largo Rosanna Benzi 10, I-16132 Genoa, Italy; [Valtorta, Flavia] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Via Olgettina 58, I-20132 Milan, Italy	University of Genoa; Istituto Italiano di Tecnologia - IIT; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Benfenati, F (corresponding author), Fdn Ist Italiano Tecnol, Ctr Synapt Neurosci & Technol, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.	fabio.benfenati@iit.it	Maragliano, Luca/A-8294-2010; Flavia, Valtorta/F-3450-2012; CASTROFLORIO, ENRICO/I-6767-2019; Corradi, Anna/AAC-5209-2022; Marte, Antonella/AAA-8072-2019	Maragliano, Luca/0000-0002-5705-6967; Flavia, Valtorta/0000-0001-9556-4746; CASTROFLORIO, ENRICO/0000-0002-6953-5420; Marte, Antonella/0000-0001-9842-2663; Sterlini, Bruno/0000-0001-8247-4709	Italian Ministry of University and Research; EU [602531]; EU ITN "ECMED" Grant [642881]; Telethon-Italy Grant [GGP13033]; CARIPLO Foundation [2013 0879]; Italian Ministry of Health Ricerca Finalizzata	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); EU(European Commission); EU ITN "ECMED" Grant; Telethon-Italy Grant(Fondazione Telethon); CARIPLO Foundation(Fondazione Cariplo); Italian Ministry of Health Ricerca Finalizzata(Ministry of Health, Italy)	This study was supported by Italian Ministry of University and Research Grants PRIN 2009 (to A. C.) and PRIN 2010/11 (to F. B. and F. O.), EU FP7 Integrating Project "Desire" Grant Agreement 602531 (to F. B.), EU ITN "ECMED" Grant Agreement 642881 (to F. B.), Telethon-Italy Grant GGP13033 (to F. B. and F. V.), CARIPLO Foundation Grant 2013 0879 (to F. V. and F. B.), and Italian Ministry of Health Ricerca Finalizzata 2013 (to F. V. and F. B.). The authors declare that they have no conflict of interest with the contents of this article.	Almen MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031961; Bailey CC, 2013, J BIOL CHEM, V288, P32184, DOI 10.1074/jbc.M113.514356; Becker F, 2013, J NEUROL, V260, P1234, DOI 10.1007/s00415-012-6777-y; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Cloarec R, 2012, NEUROLOGY, V79, P2097, DOI 10.1212/WNL.0b013e3182752c46; Corradi A, 2014, HUM MOL GENET, V23, P90, DOI 10.1093/hmg/ddt401; Cowell JK, 2014, PROG BRAIN RES, V213, P159, DOI 10.1016/B978-0-444-63326-2.00009-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Vries B, 2012, NEUROLOGY, V79, P2154, DOI 10.1212/WNL.0b013e3182752c30; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gardiner AR, 2012, NEUROLOGY, V79, P2115, DOI 10.1212/WNL.0b013e3182752c5a; Guerrini R, 2012, NEUROLOGY, V79, P2086, DOI 10.1212/WNL.0b013e3182752edd; Heron SE, 2013, J MED GENET, V50, P133, DOI 10.1136/jmedgenet-2012-101406; Heron SE, 2012, AM J HUM GENET, V90, P152, DOI 10.1016/j.ajhg.2011.12.003; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jacob J, 1999, BIOPHYS J, V76, P1367, DOI 10.1016/S0006-3495(99)77298-X; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee HY, 2012, CELL REP, V1, P2, DOI 10.1016/j.celrep.2011.11.001; Li M, 2015, INT J MOL SCI, V16, P9134, DOI 10.3390/ijms16059134; Marini C, 2012, NEUROLOGY, V79, P2109, DOI 10.1212/WNL.0b013e3182752ca2; Mattingly RR, 1996, NATURE, V382, P268, DOI 10.1038/382268a0; MCPHERSON PS, 1994, J BIOL CHEM, V269, P30132; Meneret A, 2013, EUR J NEUROL, V20, P872, DOI 10.1111/ene.12104; Onofri F, 2000, J BIOL CHEM, V275, P29857, DOI 10.1074/jbc.M006018200; Onofri F, 1997, P NATL ACAD SCI USA, V94, P12168, DOI 10.1073/pnas.94.22.12168; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Riant F, 2012, NEUROLOGY, V79, P2122, DOI 10.1212/WNL.0b013e3182752cb8; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Scheffer IE, 2012, NEUROLOGY, V79, P2104, DOI 10.1212/WNL.0b013e3182752c6c; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Weston S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104341; Wood Heather, 2012, Nat Rev Neurol, V8, P657, DOI 10.1038/nrneurol.2012.240; Wu L, 2014, PARKINSONISM RELAT D, V20, P1399, DOI 10.1016/j.parkreldis.2014.10.012	44	43	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6111	6123		10.1074/jbc.M115.683888	http://dx.doi.org/10.1074/jbc.M115.683888			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797119	Green Published, hybrid			2022-12-28	WOS:000372894200006
J	Uhrig, RG; Labandera, AM; Muhammad, J; Samuel, M; Moorhead, GB				Uhrig, R. Glen; Labandera, Anne-Marie; Muhammad, Jamshed; Samuel, Marcus; Moorhead, Greg B.			Rhizobiales-like Phosphatase 2 from Arabidopsis thaliana Is a Novel Phospho-tyrosine-specific Phospho-protein Phosphatase (PPP) Family Protein Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; Phosphoprotein phosphatase; protein phosphatase; protein phosphorylation; protein serine; threonine phosphatase (PSP); tyrosine-protein phosphatase (tyrosine phosphatase); serine; threonine phosphatase	PLANTS; PHOSPHORYLATION; EUKARYOTES; KINASE; PP2A; AUTOPHOSPHORYLATION; REGULATORS; COMPLEXES; REVEALS; ENZYME	Cellular signaling through protein tyrosine phosphorylation is well established in mammalian cells. Although lacking the classic tyrosine kinases present in humans, plants have a tyrosine phospho-proteome that rivals human cells. Here we report a novel plant tyrosine phosphatase from Arabidopsis thaliana (AtRLPH2) that, surprisingly, has the sequence hallmarks of a phospho-serine/threonine phosphatase belonging to the PPP family. Rhizobiales/Rhodobacterales/Rhodospirillaceae-like phosphatases (RLPHs) are conserved in plants and several other eukaryotes, but not in animals. We demonstrate that AtRLPH2 is localized to the plant cell cytosol, is resistant to the classic serine/threonine phosphatase inhibitors okadaic acid and microcystin, but is inhibited by the tyrosine phosphatase inhibitor orthovanadate and is particularly sensitive to inhibition by the adenylates, ATP and ADP. AtRLPH2 displays remarkable selectivity toward tyrosine-phosphorylated peptides versus serine/threonine phospho-peptides and readily dephosphorylates a classic tyrosine phosphatase protein substrate, suggesting that in vivo it is a tyrosine phosphatase. To date, only one other tyrosine phosphatase is known in plants; thus AtRLPH2 represents one of the missing pieces in the plant tyrosine phosphatase repertoire and supports the concept of protein tyrosine phosphorylation as a key regulatory event in plants.	[Uhrig, R. Glen; Labandera, Anne-Marie; Muhammad, Jamshed; Samuel, Marcus; Moorhead, Greg B.] Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Uhrig, R. Glen] Swiss Fed Inst Technol Zurich ETHZ, Dept Biol, CH-8092 Zurich, Switzerland	University of Calgary; Swiss Federal Institutes of Technology Domain; ETH Zurich	Moorhead, GB (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	moorhead@ucalgary.ca		Labandera, Anne-Marie/0000-0002-0593-4166; Uhrig, R Glen/0000-0003-2773-4381	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Andreeva AV, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-47; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; DEANA AD, 1990, BIOCHIM BIOPHYS ACTA, V1051, P199, DOI 10.1016/0167-4889(90)90194-I; Donella-Deana A, 2003, METHOD ENZYMOL, V366, P3; DONELLADEANA A, 1991, BIOCHIM BIOPHYS ACTA, V1094, P130, DOI 10.1016/0167-4889(91)90034-U; Fernandez-Pol S, 2013, EUKARYOT CELL, V12, P1179, DOI 10.1128/EC.00027-13; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Huang YF, 2000, PLANT PHYSIOL, V122, P1301, DOI 10.1104/pp.122.4.1301; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Kerk D, 2008, PLANT PHYSIOL, V146, P351, DOI 10.1104/pp.107.111393; Labandera AM, 2015, BIOCHEM BIOPH RES CO, V458, P739, DOI 10.1016/j.bbrc.2015.01.123; Luan S, 2003, ANNU REV PLANT BIOL, V54, P63, DOI 10.1146/annurev.arplant.54.031902.134743; Meng TC, 2003, METHOD ENZYMOL, V366, P304; Mithoe SC, 2012, J PROTEOME RES, V11, P438, DOI 10.1021/pr200893k; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Nemoto K, 2015, J BIOL CHEM, V290, P16665, DOI 10.1074/jbc.M114.617274; Oh MH, 2012, FEBS LETT, V586, P4070, DOI 10.1016/j.febslet.2012.09.040; Patzewitz EM, 2013, CELL REP, V3, P622, DOI 10.1016/j.celrep.2013.01.032; RUZZENE M, 1993, EUR J BIOCHEM, V211, P289, DOI 10.1111/j.1432-1033.1993.tb19897.x; Samajova O, 2014, METHODS MOL BIOL, V1171, P107, DOI 10.1007/978-1-4939-0922-3_9; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Silver DM, 2013, FEBS J, V280, P538, DOI 10.1111/j.1742-4658.2012.08546.x; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Templeton GW, 2011, BIOCHEM J, V435, P73, DOI 10.1042/BJ20101035; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Tran HNN, 2012, MOL CELL PROTEOMICS, V11, P1140, DOI 10.1074/mcp.M112.018028; Tran HT, 2004, MOL CELL PROTEOMICS, V3, P257, DOI 10.1074/mcp.M300115-MCP200; Tran HT, 2012, PLANT J, V71, P263, DOI 10.1111/j.1365-313X.2012.04984.x; Tsuruta H, 2005, J BIOCHEM, V137, P69, DOI 10.1093/jb/mvi010; Uhrig RG, 2013, PLANT PHYSIOL, V163, P1829, DOI 10.1104/pp.113.224378; Uhrig RG, 2013, TRENDS PLANT SCI, V18, P505, DOI 10.1016/j.tplants.2013.05.004; Uhrig RG, 2011, PLANT PHYSIOL, V157, P1778, DOI 10.1104/pp.111.182493; Ulke-Lemee A, 2007, BBA-PROTEINS PROTEOM, V1774, P1339, DOI 10.1016/j.bbapap.2007.07.015; Xu Q, 1998, PLANT CELL, V10, P849, DOI 10.1105/tpc.10.5.849; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446	39	7	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5926	5934		10.1074/jbc.M115.683656	http://dx.doi.org/10.1074/jbc.M115.683656			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26742850	hybrid, Green Published			2022-12-28	WOS:000372551800038
J	Zheng, ZL; Blum, A; Banerjee, T; Wang, QY; Dantis, V; Oliver, D				Zheng, Zeliang; Blum, Amy; Banerjee, Tithi; Wang, Qianyu; Dantis, Virginia; Oliver, Donald			Determination of the Oligomeric State of SecYEG Protein Secretion Channel Complex Using in Vivo Photo- and Disulfide Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine-mediated cross-linking; membrane protein; oligomer; protein chimera; protein translocation; SecY; photo-cross-linking; translocon jamming	ESCHERICHIA-COLI; TRANSLOCATION CHANNEL; PREPROTEIN TRANSLOCATION; SECA ATPASE; BACTERIAL TRANSLOCON; CONDUCTING CHANNEL; DIMERIC SECA; MEMBRANE; BINDING; EXPORT	SecYEG protein of bacteria or Sec61 of eukaryotes is a universally conserved heterotrimeric protein channel complex that accommodates the partitioning of membrane proteins into the lipid bilayer as well as the secretion of proteins to the trans side of the plasma or endoplasmic reticular membrane, respectively. SecYEG function is facilitated by cytosolic partners, mainly a nascent chain-ribosome complex or the SecA ATPase motor protein. Extensive efforts utilizing both biochemical and biophysical approaches have been made to determine whether SecYEG functions as a monomer or a dimer, but such approaches have often generated conflicting results. Here we have employed site-specific in vivo photo-cross-linking or cysteine cross-linking, along with co-immunoprecipitation or SecA footprinting techniques to readdress this issue. Our findings show that the SecY dimer to monomer ratio is relatively constant regardless of whether translocons are actively engaged with protein substrate or not. Under the former conditions the SecY dimer can be captured associated with a translocon-jammed substrate, indicative of SecY dimer function. Furthermore, SecA ATPase can be cross-linked to two copies of SecY when the complex contains a translocation intermediate. Collectively, our results suggest that SecYEG dimers are functional units of the translocon.	[Zheng, Zeliang; Blum, Amy; Banerjee, Tithi; Wang, Qianyu; Dantis, Virginia; Oliver, Donald] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA	Wesleyan University	Oliver, D (corresponding author), Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA.	doliver@wesleyan.edu	Banerjee, Tithi/ABB-7530-2021	Blum, Amy/0000-0002-1450-909X	National Institutes of Health [GM110552]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110552] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM110552 (to D. O.). The authors declare that they have no conflict of interest with the content of this article.	Bauer BW, 2014, CELL, V157, P1416, DOI 10.1016/j.cell.2014.03.063; Bessonneau P, 2002, EMBO J, V21, P995, DOI 10.1093/emboj/21.5.995; Bonardi F, 2011, P NATL ACAD SCI USA, V108, P7775, DOI 10.1073/pnas.1101705108; Bunn MW, 2003, J MOL BIOL, V331, P941, DOI 10.1016/S0022-2836(03)00834-9; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cymer F, 2013, P NATL ACAD SCI USA, V110, P14640, DOI 10.1073/pnas.1306787110; Dalal K, 2012, P NATL ACAD SCI USA, V109, P4104, DOI 10.1073/pnas.1117783109; Dapic V, 2000, J BIOL CHEM, V275, P25000, DOI 10.1074/jbc.M001100200; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; Deville K, 2011, J BIOL CHEM, V286, P4659, DOI 10.1074/jbc.M110.175638; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gold VAM, 2010, P NATL ACAD SCI USA, V107, P10044, DOI 10.1073/pnas.0914680107; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hizlan D, 2012, CELL REPORTS, V1, P21, DOI 10.1016/j.celrep.2011.11.003; ITO K, 1984, MOL GEN GENET, V197, P204, DOI 10.1007/BF00330964; ITO K, 1986, J BACTERIOL, V167, P201, DOI 10.1128/jb.167.1.201-204.1986; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Kedrov A, 2011, EMBO J, V30, P4387, DOI 10.1038/emboj.2011.314; KIM YJ, 1994, CELL, V78, P845; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; Mao CF, 2013, P NATL ACAD SCI USA, V110, P11815, DOI 10.1073/pnas.1303289110; Meyer TH, 1999, J MOL BIOL, V285, P1789, DOI 10.1006/jmbi.1998.2413; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park E, 2012, J CELL BIOL, V198, P881, DOI 10.1083/jcb.201205140; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; Scheuring J, 2005, J MOL BIOL, V354, P258, DOI 10.1016/j.jmb.2005.09.058; Schluenzen F, 2006, NAT STRUCT MOL BIOL, V13, P871, DOI 10.1038/nsmb1145; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; Veenendaal AKJ, 2002, J BIOL CHEM, V277, P36640, DOI 10.1074/jbc.M205713200; Veenendaal AKJ, 2001, J BIOL CHEM, V276, P32559, DOI 10.1074/jbc.M103912200; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	49	7	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5997	6010		10.1074/jbc.M115.694844	http://dx.doi.org/10.1074/jbc.M115.694844			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26747607	hybrid, Green Published			2022-12-28	WOS:000372551800044
J	Chang, YJ; Jeng, US; Chiang, YL; Hwang, IS; Chen, YR				Chang, Yu-Jen; Jeng, U-Ser; Chiang, Ya-Ling; Hwang, Ing-Shouh; Chen, Yun-Ru			The Glycine-Alanine Dipeptide Repeat from C9orf72 Hexanucleotide Expansions Forms Toxic Amyloids Possessing Cell-to-Cell Transmission Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aggregation; amyloid; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); fibril; toxicity; C9orf72; GA; dipeptide repeat; fibril	GGGGCC REPEAT; RNA FOCI; PROTEINS; TRANSCRIPTS; C9FTD/ALS; POLY(GA); ALS	Hexanucleotide expansions, GGGGCC, in the non-coding regions of the C9orf72 gene were found in major frontotemporal lobar dementia and amyotrophic lateral sclerosis patients (C9FTD/ALS). In addition to possible RNA toxicity, several dipeptide repeats (DPRs) are translated through repeat-associated non-ATG-initiated translation. The DPRs, including poly(GA), poly(GR), poly(GP), poly(PR), and poly(PA), were found in the brains and spinal cords of C9FTD/ALS patients. Among the DPRs, poly(GA) is highly susceptible to form cytoplasmic inclusions, which is a characteristic of C9FTD/ALS. To elucidate DPR aggregation, we used synthetic (GA)(15) DPR as a model system to examine the aggregation and structural properties in vitro. We found that (GA)(15) with 15 repeats fibrillates rapidly and ultimately forms flat, ribbon-type fibrils evidenced by transmission electron microscopy and atomic force microscopy. The fibrils are capable of amyloid dye binding and contain a characteristic cross- sheet structure, as revealed by x-ray scattering. Furthermore, using neuroblastoma cells, we demonstrated the neurotoxicity and cell-to-cell transmission property of (GA)(15) DPR. Overall, our results show the structural and toxicity properties of GA DPR to facilitate future DPR-related therapeutic development.	[Chang, Yu-Jen; Chen, Yun-Ru] Acad Sinica, Genom Res Ctr, Acad Rd,Sect 2, Taipei 115, Taiwan; [Chiang, Ya-Ling; Hwang, Ing-Shouh] Acad Sinica, Inst Phys, Acad Rd,Sect 2, Taipei 115, Taiwan; [Jeng, U-Ser] Natl Synchrotron Radiat Res Ctr, 101 Hsin Ann Rd,Sci Pk, Hsinchu 30076, Taiwan; [Jeng, U-Ser] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan; [Chiang, Ya-Ling; Hwang, Ing-Shouh] Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu 30013, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Synchrotron Radiation Research Center; National Tsing Hua University; National Tsing Hua University	Chen, YR (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	yrchen@gate.sinica.edu.tw	Chen, Yun-Ru/C-9304-2014; Hwang, Ing-Shouh/AAP-3963-2021	Chen, Yun-Ru/0000-0002-6596-6338; Hwang, Ing-Shouh/0000-0002-7670-1212	Ministry of Science and Technology, Taiwan Grants [MOST 103-2113-M-001-015, MOST 104-2627-M-001-005]	Ministry of Science and Technology, Taiwan Grants	This work was supported by Ministry of Science and Technology, Taiwan Grants MOST 103-2113-M-001-015 and MOST 104-2627-M-001-005). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Belzil VV, 2013, ACTA NEUROPATHOL, V126, P895, DOI 10.1007/s00401-013-1199-1; Bongiovanni MN, 2013, SOFT MATTER, V9, P3315, DOI 10.1039/c3sm27244c; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Fratta P, 2013, ACTA NEUROPATHOL, V126, P401, DOI 10.1007/s00401-013-1147-0; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hane F, 2014, BIOMOLECULES, V4, P101, DOI 10.3390/biom4010101; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Lin JM, 2009, SOFT MATTER, V5, P3913, DOI 10.1039/b908203d; Mann DMA, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-68; Martel A, 2008, J AM CHEM SOC, V130, P17070, DOI 10.1021/ja806654t; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rohrer JD, 2015, LANCET NEUROL, V14, P291, DOI 10.1016/S1474-4422(14)70233-9; Schludi MH, 2015, ACTA NEUROPATHOL, V130, P537, DOI 10.1007/s00401-015-1450-z; Waite AJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.016; Wen XM, 2014, NEURON, V84, P1213, DOI 10.1016/j.neuron.2014.12.010; Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5; Xu CF, 2010, J APPL CRYSTALLOGR, V43, P33, DOI 10.1107/S0021889809050936; Yang DJ, 2015, ACTA NEUROPATHOL, V130, P525, DOI 10.1007/s00401-015-1448-6; Zhang YJ, 2014, ACTA NEUROPATHOL, V128, P505, DOI 10.1007/s00401-014-1336-5; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	31	53	54	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4903	4911		10.1074/jbc.M115.694273	http://dx.doi.org/10.1074/jbc.M115.694273			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26769963	Green Published, hybrid			2022-12-28	WOS:000371640600006
J	Nomura, K; Hayakawa, K; Tatsumi, H; Ono, S				Nomura, Kazumi; Hayakawa, Kimihide; Tatsumi, Hitoshi; Ono, Shoichiro			Actin-interacting Protein 1 Promotes Disassembly of Actin-depolymerizing Factor/Cofilin-bound Actin Filaments in a pH-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cofilin; cytoskeleton; pH regulation; severing; AIP1; actin dynamics; actin turnover; depolymerization	BODY-WALL MUSCLE; CAENORHABDITIS-ELEGANS; F-ACTIN; KINETIC-ANALYSIS; SOMATIC GONAD; GENE ENCODES; HUMAN FASCIN; UNC-60 GENE; COFILIN; ADF/COFILIN	Actin-interacting protein 1 (AIP1) is a conserved WD repeat protein that promotes disassembly of actin filaments when actin-depolymerizing factor (ADF)/cofilin is present. Although AIP1 is known to be essential for a number of cellular events involving dynamic rearrangement of the actin cytoskeleton, the regulatory mechanism of the function of AIP1 is unknown. In this study, we report that two AIP1 isoforms from the nematode Caenorhabditis elegans, known as UNC-78 and AIPL-1, are pH-sensitive in enhancement of actin filament disassembly. Both AIP1 isoforms only weakly enhance disassembly of ADF/cofilin-bound actin filaments at an acidic pH but show stronger disassembly activity at neutral and basic pH values. However, a severing-defective mutant of UNC-78 shows pH-insensitive binding to ADF/cofilin-decorated actin filaments, suggesting that the process of filament severing or disassembly, but not filament binding, is pH-dependent. His-60 of AIP1 is located near the predicted binding surface for the ADF/cofilin-actin complex, and an H60K mutation of AIP1 partially impairs its pH sensitivity, suggesting that His-60 is involved in the pH sensor for AIP1. These biochemical results suggest that pH-dependent changes in AIP1 activity might be a novel regulatory mechanism of actin filament dynamics.	[Nomura, Kazumi; Ono, Shoichiro] Emory Univ, Dept Pathol, 615 Michael St,Whitehead Res Bldg,Rm 105N, Atlanta, GA 30322 USA; [Nomura, Kazumi; Ono, Shoichiro] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Hayakawa, Kimihide] Nagoya Univ, Grad Sch Med, Mechanobiol Lab, Nagoya, Aichi 4668550, Japan; [Tatsumi, Hitoshi] Nagoya Univ, Grad Sch Med, Dept Physiol, Nagoya, Aichi 4668550, Japan; [Tatsumi, Hitoshi] Kanazawa Inst Technol, Dept Appl Biosci, Kanazawa, Ishikawa 9240838, Japan	Emory University; Emory University; Nagoya University; Nagoya University; Kanazawa Institute of Technology	Ono, S (corresponding author), Emory Univ, Dept Pathol, 615 Michael St,Whitehead Res Bldg,Rm 105N, Atlanta, GA 30322 USA.	sono@emory.edu	Sokabe, Masahiro/I-1565-2012; Ono, Shoichiro/A-6475-2015	Ono, Shoichiro/0000-0002-4763-0398	National Institutes of Health [R01 AR048615]; Ministry of Education, Culture, Sports, Science, and Technology Japan [15K07025]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant R01 AR048615 (to S. O.) and Grant-in-Aid 15K07025 from the Ministry of Education, Culture, Sports, Science, and Technology Japan (to H. T.).	ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bernstein BW, 2000, CELL MOTIL CYTOSKEL, V47, P319, DOI 10.1002/1097-0169(200012)47:4<319::AID-CM6>3.0.CO;2-I; Brieher W, 2013, MOL BIOL CELL, V24, P2299, DOI 10.1091/mbc.E12-09-0694; Chen H, 2004, BIOCHEMISTRY-US, V43, P7127, DOI 10.1021/bi049797n; Chen Q, 2015, J BIOL CHEM, V290, P2289, DOI 10.1074/jbc.M114.612978; Clark MG, 2006, MOL BIOL CELL, V17, P1971, DOI 10.1091/mbc.E05-10-0956; Damaghi M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00370; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Galkin VE, 2003, J CELL BIOL, V163, P1057, DOI 10.1083/jcb.200308144; Goldmann WH, 1999, EUR J BIOCHEM, V260, P439, DOI 10.1046/j.1432-1327.1999.00177.x; Gressin L, 2015, CURR BIOL, V25, P1437, DOI 10.1016/j.cub.2015.04.011; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; Hayakawa K, 2014, P NATL ACAD SCI USA, V111, P9810, DOI 10.1073/pnas.1321451111; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; Jansen S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8202; Kudryashov DS, 2006, J MOL BIOL, V358, P785, DOI 10.1016/j.jmb.2006.02.029; LAMB JA, 1993, J BIOL CHEM, V268, P8999; Liu ZM, 2010, BIOCHEMISTRY-US, V49, P4349, DOI 10.1021/bi100215b; Lueck A, 2000, BIOCHEMISTRY-US, V39, P5274, DOI 10.1021/bi992871v; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; Martin C, 2011, AM J PHYSIOL-CELL PH, V300, pC490, DOI 10.1152/ajpcell.00280.2010; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; MCKIM KS, 1994, MOL GEN GENET, V242, P346, DOI 10.1007/BF00280425; Michelot A, 2013, DEV CELL, V24, P182, DOI 10.1016/j.devcel.2012.12.008; Mohri K, 2006, MOL BIOL CELL, V17, P2190, DOI 10.1091/mbc.E05-11-1016; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; Mohri K, 2003, J CELL SCI, V116, P4107, DOI 10.1242/jcs.00717; Nadkarni AV, 2014, CURR BIOL, V24, P2749, DOI 10.1016/j.cub.2014.09.048; Normoyle KPM, 2012, J BIOL CHEM, V287, P35722, DOI 10.1074/jbc.M112.396051; Okada K, 1999, J CELL SCI, V112, P1553; Okada K, 2002, J BIOL CHEM, V277, P43011, DOI 10.1074/jbc.M203111200; Okreglak V, 2010, J CELL BIOL, V188, P769, DOI 10.1083/jcb.200909176; Ono K, 2003, J CELL SCI, V116, P2073, DOI 10.1242/jcs.00421; Ono K, 2008, J CELL SCI, V121, P2662, DOI 10.1242/jcs.034215; Ono K, 2014, CYTOSKELETON, V71, P36, DOI 10.1002/cm.21152; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; Ono S, 1998, J BIOL CHEM, V273, P3778, DOI 10.1074/jbc.273.6.3778; Ono S, 1997, J BIOL CHEM, V272, P2527; Ono S, 2001, J CELL BIOL, V152, P1313, DOI 10.1083/jcb.152.6.1313; Ono S, 2001, J BIOL CHEM, V276, P5952, DOI 10.1074/jbc.M007563200; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Ono S, 2011, MOL BIOL CELL, V22, P2258, DOI 10.1091/mbc.E10-12-0934; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; SCHEEL J, 1989, J BIOL CHEM, V264, P2832; Schmidt JM, 1999, ARCH BIOCHEM BIOPHYS, V366, P139, DOI 10.1006/abbi.1999.1204; Schonichen A, 2013, ANNU REV BIOPHYS, V42, P289, DOI 10.1146/annurev-biophys-050511-102349; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSUBOI KK, 1965, ARCH BIOCHEM BIOPHYS, V112, P82, DOI 10.1016/0003-9861(65)90013-5; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Yamakita Y, 1996, J BIOL CHEM, V271, P12632, DOI 10.1074/jbc.271.21.12632; Yamashiro S, 2005, BIOCHEMISTRY-US, V44, P14238, DOI 10.1021/bi050933d; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410; Zhao HX, 2010, BIOPHYS J, V98, P2327, DOI 10.1016/j.bpj.2010.01.046	62	16	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5146	5156		10.1074/jbc.M115.713495	http://dx.doi.org/10.1074/jbc.M115.713495			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26747606	hybrid, Green Published			2022-12-28	WOS:000371640600027
J	Taylor, VG; Bommarito, PA; Tesmer, JJG				Taylor, Veronica G.; Bommarito, Paige A.; Tesmer, John J. G.			Structure of the Regulator of G Protein Signaling 8 (RGS8)-G alpha(q) Complex MOLECULAR BASIS FOR G alpha SELECTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; GTPase-activating protein (GAP); heterotrimeric G protein; regulator of G protein signaling (RGS); structure-function; X-ray crystallography; G alpha q; RGS10; RGS8; selectivity; cell signaling; protein structure; cardiovascular disease; protein complex; GTPase activation assays; G alpha q	GTPASE-ACTIVATING PROTEINS; RGS; INHIBITION; DOMAIN; ASSOCIATION; HYPERTENSION; SUBUNITS; CONFERS; G(Z)	Regulator of G protein signaling (RGS) proteins interact with activated G subunits via their RGS domains and accelerate the hydrolysis of GTP. Although the R4 subfamily of RGS proteins generally accepts both G(i/o) and G(q/11) subunits as substrates, the R7 and R12 subfamilies select against G(q/11). In contrast, only one RGS protein, RGS2, is known to be selective for G(q/11). The molecular basis for this selectivity is not clear. Previously, the crystal structure of RGS2 in complex with G(q) revealed a non-canonical interaction that could be due to interfacial differences imposed by RGS2, the G subunit, or both. To resolve this ambiguity, the 2.6 crystal structure of RGS8, an R4 subfamily member, was determined in complex with G(q). RGS8 adopts the same pose on G(q) as it does when bound to G(i3), indicating that the non-canonical interaction of RGS2 with G(q) is due to unique features of RGS2. Based on the RGS8-G(q) structure, residues in RGS8 that contact a unique -helical domain loop of G(q) were converted to those typically found in R12 subfamily members, and the reverse substitutions were introduced into RGS10, an R12 subfamily member. Although these substitutions perturbed their ability to stimulate GTP hydrolysis, they did not reverse selectivity. Instead, selectivity for G(q) seems more likely determined by whether strong contacts can be maintained between 6 of the RGS domain and Switch III of G(q), regions of high sequence and conformational diversity in both protein families.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Sci, Ann Arbor, MI 48109 USA; [Taylor, Veronica G.] Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan		tesmerjj@umich.edu		Tesmer, John/0000-0003-1125-3727	U. S. DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; DNA Sequencing Core of the Michigan Diabetes Research and Training Center [DK20572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086865, R01HL122416, R01HL071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008270] Funding Source: NIH RePORTER	U. S. DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; DNA Sequencing Core of the Michigan Diabetes Research and Training Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source, an Office of Science User Facility operated for the U. S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U. S. DOE under Contract Number DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). This research used the DNA Sequencing Core of the Michigan Diabetes Research and Training Center supported by DK20572. We thank the LS CAT staff members at Argonne Photon Source for their help with data collection and Dr. Jennifer Cash for assistance with crystal structure determination.	ARSHAVSKY VY, 1989, FEBS LETT, V250, P353, DOI 10.1016/0014-5793(89)80754-9; Calo LA, 2004, J CLIN ENDOCR METAB, V89, P4153, DOI 10.1210/jc.2004-0498; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Gu S, 2008, MOL PHARMACOL, V73, P1037, DOI 10.1124/mol.107.044214; Hague C, 2005, J BIOL CHEM, V280, P27289, DOI 10.1074/jbc.M502365200; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Kosloff M, 2011, NAT STRUCT MOL BIOL, V18, P846, DOI 10.1038/nsmb.2068; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEE E, 1994, METHOD ENZYMOL, V237, P146; Mao H, 2004, J BIOL CHEM, V279, P26314, DOI 10.1074/jbc.M401800200; Nance MR, 2013, STRUCTURE, V21, P438, DOI 10.1016/j.str.2012.12.016; Natochin M, 1998, BIOCHEMISTRY-US, V37, P13776, DOI 10.1021/bi981155a; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Posner BA, 1999, BIOCHEMISTRY-US, V38, P7773, DOI 10.1021/bi9906367; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Santhappan R, 2015, J NEUROCHEM, V135, P76, DOI 10.1111/jnc.13222; Shankaranarayanan A, 2008, J BIOL CHEM, V283, P34923, DOI 10.1074/jbc.M805860200; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687	35	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5138	5145		10.1074/jbc.M115.712075	http://dx.doi.org/10.1074/jbc.M115.712075			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26755720	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000371640600026
J	Haji-Ghassemi, O; Muller-Loennies, S; Rodriguez, T; Brade, L; Grimmecke, HD; Brade, H; Evans, SV				Haji-Ghassemi, Omid; Mueller-Loennies, Sven; Rodriguez, Teresa; Brade, Lore; Grimmecke, Hans-Dieter; Brade, Helmut; Evans, Stephen V.			The Combining Sites of Anti-lipid A Antibodies Reveal a Widely Utilized Motif Specific for Negatively Charged Groups	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENUS-SPECIFIC EPITOPE; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; ESCHERICHIA-COLI; CROSS-REACTIVITY; SEVERE SEPSIS; INDUCED FIT; V-J; RECOGNITION; LIPOPOLYSACCHARIDE	Lipopolysaccharide dispersed in the blood by Gram-negative bacteria can be a potent inducer of septic shock. One research focus has been based on antibody sequestration of lipid A (the endotoxic principle of LPS); however, none have been successfully developed into a clinical treatment. Comparison of a panel of anti-lipid A antibodies reveals highly specific antibodies produced through distinct germ line precursors. The structures of antigen-binding fragments for two homologous mAbs specific for lipid A, 555-3 and 555-5, have been determined both in complex with lipid A disaccharide backbone and unliganded. These high resolution structures reveal a conserved positively charged pocket formed within the complementarity determining region H2 loops that binds the terminal phosphates of lipid A. Significantly, this motif occurs in unrelated antibodies where it mediates binding to negatively charged moieties through a range of epitopes, including phosphorylated peptides used in diagnostics and therapeutics. S55-3 and 555-5 have combining sites distinct from anti-lipid A antibodies previously described (as a result of their separate germ line origin), which are nevertheless complementary both in shape and charge to the antigen. S55-3 and S55-5 display similar avidity toward lipid A despite possessing a number of different amino acid residues in their combining sites. Binding of lipid A occurs independent of the acyl chains, although the GIcN-O6 attachment point for the core oligosaccharide is buried in the combining site, which explains their inability to recognize LPS. Despite their lack of therapeutic potential, the observed motif may have significant immunological implications as a tool for engineering recombinant antibodies.	[Haji-Ghassemi, Omid; Rodriguez, Teresa; Evans, Stephen V.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 3P6, Canada; [Mueller-Loennies, Sven; Brade, Lore; Grimmecke, Hans-Dieter; Brade, Helmut] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Parkallee 22, D-23845 Borstel, Germany; [Grimmecke, Hans-Dieter] Laves Arzneimittel GmbH, Lavesstr, CH-6247 Schotz Luzern, Switzerland	University of Victoria; Forschungszentrum Borstel	Evans, SV (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 3P6, Canada.; Muller-Loennies, S (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Parkallee 22, D-23845 Borstel, Germany.	sml@fz-borstel.de; d.grimmecke@laves-pharma.ch; svevans@uvic.ca	Martín, Teresa Rodríguez/GZL-1938-2022	Evans, Stephen/0000-0002-0366-4027; Haji-Ghassemi, Omid/0000-0003-0116-005X	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We gratefully acknowledge the technical assistance of Lite Agge, Veronika Susott, Christine Schneider, and Nadine Harmel at the Research Center, Borstel, Germany. Research described in this paper was performed at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	Adhikary R, 2015, BIOCHEMISTRY-US, V54, P2085, DOI 10.1021/bi501417q; Alejandria MM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001090.pub2; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; APPELMELK BJ, 1988, J MED MICROBIOL, V26, P107, DOI 10.1099/00222615-26-2-107; Baek DS, 2015, BIOCHEM BIOPH RES CO, V463, P414, DOI 10.1016/j.bbrc.2015.05.086; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blackler R. J., 2012, ANTICARBOHYDRATE ANT, P75; BRADE L, 1985, INFECT IMMUN, V48, P776, DOI 10.1128/IAI.48.3.776-781.1985; Brade L, 1997, INFECT IMMUN, V65, P3961, DOI 10.1128/IAI.65.9.3961-3965.1997; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Buttenschoen K, 2010, LANGENBECK ARCH SURG, V395, P597, DOI 10.1007/s00423-010-0658-6; CATON AJ, 1986, EMBO J, V5, P1577, DOI 10.1002/j.1460-2075.1986.tb04399.x; Cross AS, 2014, VIRULENCE, V5, P219, DOI 10.4161/viru.25965; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; Deng L, 2013, P NATL ACAD SCI USA, V110, P7418, DOI 10.1073/pnas.1305306110; DIPADOVA FE, 1993, INFECT IMMUN, V61, P3863, DOI 10.1128/IAI.61.9.3863-3872.1993; ElSamalouti VT, 1997, EUR J BIOCHEM, V250, P418, DOI 10.1111/j.1432-1033.1997.0418a.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Franklin MC, 2011, STRUCTURE, V19, P1097, DOI 10.1016/j.str.2011.01.019; FU YC, 1992, INFECT IMMUN, V60, P1314, DOI 10.1128/IAI.60.4.1314-1321.1992; FUJIHARA Y, 1993, J INFECT DIS, V168, P1429, DOI 10.1093/infdis/168.6.1429; GALANOS C, 1971, EUR J BIOCHEM, V24, P116; Garcia-Ojeda PA, 2000, INFECT IMMUN, V68, P239, DOI 10.1128/IAI.68.1.239-246.2000; Gomery K, 2012, P NATL ACAD SCI USA, V109, P20877, DOI 10.1073/pnas.1209253109; Haji-Ghassemi O, 2015, J BIOL CHEM, V290, P19629, DOI 10.1074/jbc.M115.657874; Haji-Ghassemi O, 2015, GLYCOBIOLOGY, V25, P920, DOI 10.1093/glycob/cwv037; Haji-Ghassemi O, 2014, J BIOL CHEM, V289, P16644, DOI 10.1074/jbc.M113.528224; Helmerhorst EJ, 1998, INFECT IMMUN, V66, P870, DOI 10.1128/IAI.66.2.870-873.1998; HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302; Hold GL, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P371, DOI 10.1007/978-3-7091-0733-1_12; HOLST O, 1993, EUR J BIOCHEM, V214, P695, DOI 10.1111/j.1432-1033.1993.tb17970.x; HOLST O, 1994, EUR J BIOCHEM, V222, P183, DOI 10.1111/j.1432-1033.1994.tb18856.x; HOUEN G, 1995, J IMMUNOL METHODS, V181, P187, DOI 10.1016/0022-1759(94)00345-W; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Ianaro A, 2009, MINI-REV MED CHEM, V9, P306, DOI 10.2174/1389557510909030306; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; KABAT EA, 1957, J CELL COMPAR PHYSL, V50, P79, DOI 10.1002/jcp.1030500406; KABURAKI J, 1992, Keio Journal of Medicine, V41, P10; Kawasaki Kiyoshi, 2009, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V9, P224; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Koerber JT, 2013, NAT BIOTECHNOL, V31, P916, DOI 10.1038/nbt.2672; Krishnan MR, 1996, J IMMUNOL, V157, P2430; KUHN HM, 1993, INFECTION, V21, P179, DOI 10.1007/BF01710544; KUHN HM, 1992, INFECT IMMUN, V60, P2201, DOI 10.1128/IAI.60.6.2201-2210.1992; LAFER EM, 1981, J EXP MED, V153, P897, DOI 10.1084/jem.153.4.897; LEWIS PN, 1973, BIOCHIM BIOPHYS ACTA, V303, P211, DOI 10.1016/0005-2795(73)90350-4; Li Joan, 2011, Hosp Pract (1995), V39, P99, DOI 10.3810/hp.2011.08.585; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKinstry WJ, 2009, J BIOL CHEM, V284, P15557, DOI 10.1074/jbc.M900044200; Mertens NMJ, 2000, MOL IMMUNOL, V37, P901, DOI 10.1016/S0161-5890(01)00007-4; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Muller-Loennies S, 2007, INT J MED MICROBIOL, V297, P321, DOI 10.1016/j.ijmm.2007.04.002; Muller-Loennies S, 2006, GLYCOBIOLOGY, V16, P184, DOI 10.1093/glycob/cwj055; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Ou ZH, 2007, J MOL BIOL, V374, P1029, DOI 10.1016/j.jmb.2007.09.084; Parker MJ, 2014, GLYCOBIOLOGY, V24, P442, DOI 10.1093/glycob/cwu009; PASCUAL V, 1992, J IMMUNOL, V149, P2337; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POKKULURI PR, 1994, J MOL BIOL, V243, P283, DOI 10.1006/jmbi.1994.1654; Pollack M, 1997, J IMMUNOL, V159, P3519; Rietschel E T, 1987, Prog Clin Biol Res, V231, P25; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; Rynkiewicz MJ, 2012, BIOCHEMISTRY-US, V51, P5684, DOI 10.1021/bi201711m; Sanguineti S, 2007, J MOL BIOL, V370, P183, DOI 10.1016/j.jmb.2007.04.046; SCHULZEGAHMEN U, 1993, J MOL BIOL, V234, P1098, DOI 10.1006/jmbi.1993.1663; Shih HH, 2012, J BIOL CHEM, V287, P44425, DOI 10.1074/jbc.M112.415935; Sonkaria S, 2004, BIOCHEM J, V381, P125, DOI 10.1042/BJ20031966; Spellerberg M, 1995, ANN NY ACAD SCI, V764, P427; VENKATACHALAM CM, 1968, BIOPOLYMERS, V6, P1425, DOI 10.1002/bip.1968.360061006; Vulliez-Le Normand B, 2008, P NATL ACAD SCI USA, V105, P9976, DOI 10.1073/pnas.0801711105; Wang W, 2013, J PHYS CHEM B, V117, P4912, DOI 10.1021/jp4010967; Watson JD, 2002, J MOL BIOL, V315, P171, DOI 10.1006/jmbi.2001.5227; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Yokota S, 1996, FEMS IMMUNOL MED MIC, V14, P31, DOI 10.1111/j.1574-695X.1996.tb00264.x; Zweigner J, 2001, BLOOD, V98, P3800, DOI 10.1182/blood.V98.13.3800	83	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10104	10118		10.1074/jbc.M115.712448	http://dx.doi.org/10.1074/jbc.M115.712448			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26933033	Green Published, hybrid			2022-12-28	WOS:000375602800022
J	Ratner, D; Orning, MPA; Starheim, KK; Marty-Roix, R; Proulx, MK; Goguen, JD; Lien, E				Ratner, Dmitry; Orning, M. Pontus A.; Starheim, Kristian K.; Marty-Roix, Robyn; Proulx, Megan K.; Goguen, Jon D.; Lien, Egil			Manipulation of Interleukin-1 beta and Interleukin-18 Production by Yersinia pestis Effectors YopJ and YopM and Redundant Impact on Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; III SECRETION SYSTEM; INFLAMMASOME ACTIVATION; CELL-DEATH; EPITHELIAL-CELLS; BUBONIC PLAGUE; IMMUNE CELLS; CASPASE-1; INFECTION; EXPRESSION	Innate immunity plays a central role in resolving infections by pathogens. Host survival during plague, caused by the Gram-negative bacterium Yersinia pestis, is favored by a robust early innate immune response initiated by IL-1 beta and IL-18. These cytokines are produced by a two-step mechanism involving NF-kappa B-mediated pro-cytokine production and inflammasome-driven maturation into bioactive inflammatory mediators. Because of the anti-microbial effects induced by IL-1 beta/IL-18, it may be desirable for pathogens to manipulate their production. Y. pestis type III secretion system effectors YopJ and YopM can interfere with different parts of this process. Both effectors have been reported to influence inflammasome caspase-1 activity; YopJ promotes caspase-8-dependent cell death and caspase-1 cleavage, whereas YopM inhibits caspase-1 activity via an incompletely understood mechanism. However, neither effector appears essential for full virulence in vivo. Here we report that the sum of influences by YopJ and YopM on IL-1 beta/IL-18 release is suppressive. In the absence of YopM, YopJ minimally affects caspase-1 cleavage but suppresses IL-1 beta, IL-18, and other cytokines and chemokines. Importantly, we find that Y. pestis containing combined deletions of YopJ and YopM induces elevated levels of IL-1 beta/IL-18 in vitro and in vivo and is significantly attenuated in a mouse model of bubonic plague. The reduced virulence of the YopJ-YopM mutant is dependent on the presence of IL-1 beta, IL-18, and caspase-1. Thus, we conclude that Y. pestis YopJ and YopM can both exert a tight control of host IL-1 beta/IL-18 production to benefit the bacteria, resulting in a redundant impact on virulence.	[Ratner, Dmitry; Orning, M. Pontus A.; Starheim, Kristian K.; Marty-Roix, Robyn; Lien, Egil] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol,Program Innate Immun, Worcester, MA 01605 USA; [Orning, M. Pontus A.; Starheim, Kristian K.; Lien, Egil] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway; [Proulx, Megan K.; Goguen, Jon D.] Univ Massachusetts, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; Norwegian University of Science & Technology (NTNU); University of Massachusetts System; University of Massachusetts Worcester	Lien, E (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol,Program Innate Immun, Worcester, MA 01605 USA.; Lien, E (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway.	egil.lien@umassmed.edu		Proulx, Megan/0000-0002-9524-8302	National Institutes of Health [AI07538, AI095213]; Norwegian Cancer Society; Research Council of Norway Center of Excellence Funding Scheme Project [223255/F50]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007538, T32AI095213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway Center of Excellence Funding Scheme Project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health Grants AI07538 (to E. L.) and AI095213 (to D. R.), the Norwegian Cancer Society, and Research Council of Norway Center of Excellence Funding Scheme Project 223255/F50. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alli M, 2008, INT J MED MICROBIOL, V298, P183, DOI 10.1016/j.ijmm.2007.04.007; Autenrieth SE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001212; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Brodsky IE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000067; Broz P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003144; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Caulfield AJ, 2014, CELL HOST MICROBE, V15, P424, DOI 10.1016/j.chom.2014.03.005; Chung LK, 2014, MBIO, V5, DOI 10.1128/mBio.01402-14; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Gurung P, 2015, AM J PATHOL, V185, P17, DOI 10.1016/j.ajpath.2014.08.025; Hentschke M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013165; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lemaitre N, 2006, INFECT IMMUN, V74, P5126, DOI 10.1128/IAI.00219-06; Lenz JD, 2011, J BACTERIOL, V193, P5936, DOI 10.1128/JB.05877-11; LEUNG KY, 1990, INFECT IMMUN, V58, P3262, DOI 10.1128/IAI.58.10.3262-3271.1990; Lilo S, 2008, INFECT IMMUN, V76, P3911, DOI 10.1128/IAI.01695-07; Lindner I, 2007, EUR J IMMUNOL, V37, P2450, DOI 10.1002/eji.200635947; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; McCoy MW, 2010, INFECT IMMUN, V78, P2584, DOI 10.1128/IAI.00141-10; McPhee JB, 2010, INFECT IMMUN, V78, P3529, DOI 10.1128/IAI.00269-10; Meinzer U, 2012, CELL HOST MICROBE, V11, P337, DOI 10.1016/j.chom.2012.02.009; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mombaerts P, 1995, Int Rev Immunol, V13, P43, DOI 10.3109/08830189509061737; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Mukherjee S, 2008, METHOD ENZYMOL, V438, P343, DOI 10.1016/S0076-6879(07)38024-5; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Palace SG, 2014, MBIO, V5, DOI 10.1128/mBio.01385-14; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Philipovskiy AV, 2007, INFECT IMMUN, V75, P878, DOI 10.1128/IAI.01529-06; Rosadini CV, 2015, CELL HOST MICROBE, V18, P682, DOI 10.1016/j.chom.2015.11.006; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Szaba FM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004142; Szaba FM, 2009, INFECT IMMUN, V77, P4295, DOI 10.1128/IAI.00273-09; Thinwa J, 2014, J IMMUNOL, V193, P1373, DOI 10.4049/jimmunol.1400145; Uittenbogaard AM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00155; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Vladimer GI, 2013, CURR OPIN MICROBIOL, V16, P23, DOI 10.1016/j.mib.2012.11.008; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Ye Z, 2011, INFECT IMMUN, V79, P674, DOI 10.1128/IAI.00808-10; Ye Z, 2009, INFECT IMMUN, V77, P3791, DOI 10.1128/IAI.00284-09; Zauberman A, 2006, INFECT IMMUN, V74, P3239, DOI 10.1128/IAI.00097-06; Zauberman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005938; Zheng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036019; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194; Zhou LM, 2004, RESP PHYSIOL NEUROBI, V140, P89, DOI 10.1016/j.resp.2003.12.003; Zwack EE, 2015, MBIO, V6, DOI 10.1128/mBio.02095-14	60	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9894	9905		10.1074/jbc.M115.697698	http://dx.doi.org/10.1074/jbc.M115.697698			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26884330	Green Published, hybrid			2022-12-28	WOS:000375602800004
J	Macias-Garcia, A; Heizmann, B; Sellars, M; Marchal, P; Dali, H; Pasquali, JL; Muller, S; Kastner, P; Chan, SS				Macias-Garcia, Alejandra; Heizmann, Beate; Sellars, MacLean; Marchal, Patricia; Dali, Hayet; Pasquali, Jean-Louis; Muller, Sylviane; Kastner, Philippe; Chan, Susan			Ikaros Is a Negative Regulator of B1 Cell Development and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEINS; TUMOR-SUPPRESSOR; B-1; DIFFERENTIATION; EXPRESSION; RECEPTOR; GENE; IDENTIFICATION; ACTIVATION; FETAL	B1 B cells secrete most of the circulating natural antibodies and are considered key effector cells of the innate immune response. However, B1 cell-associated antibodies often cross-react with self-antigens, which leads to autoimmunity, and B1 cells have been implicated in cancer. How B1 cell activity is regulated remains unclear. We show that the Ikaros transcription factor is a major negative regulator of B1 cell development and function. Using conditional knock-out mouse models to delete Ikaros at different locations, we show that Ikaros-deficient mice exhibit specific and significant increases in splenic and bone marrow B1 cell numbers, and that the B1 progenitor cell pool is increased similar to 10-fold in the bone marrow. Ikaros-null B1 cells resemble WT B1 cells at the molecular and cellular levels, but show a down-regulation of signaling components important for inhibiting proliferation and immunoglobulin production. Ikaros-null B1 cells hyper-react to TLR4 stimulation and secrete high amounts of IgM autoantibodies. These results indicate that Ikaros is required to limit B1 cell homeostasis in the adult.	[Macias-Garcia, Alejandra; Heizmann, Beate; Sellars, MacLean; Marchal, Patricia; Pasquali, Jean-Louis; Kastner, Philippe; Chan, Susan] Univ Strasbourg, CNRS UMR 7104, INSERM U964, IGBMC, F-67404 Illkirch Graffenstaden, France; [Dali, Hayet; Pasquali, Jean-Louis; Muller, Sylviane] IBMC, CNRS UPR3572, F-67000 Strasbourg, France; [Pasquali, Jean-Louis] Univ Strasbourg, UFR Med, F-67000 Strasbourg, France; Hop Univ Strasbourg, Dept Clin Immunol, F-67000 Strasbourg, France; [Muller, Sylviane] Univ Strasbourg, Inst Etud Avancees, F-67000 Strasbourg, France; [Kastner, Philippe] Univ Strasbourg, Fac Med, F-67000 Strasbourg, France; [Macias-Garcia, Alejandra] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Heizmann, Beate] IGBMC, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France; [Sellars, MacLean] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Massachusetts Institute of Technology (MIT); Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chan, SS (corresponding author), Univ Strasbourg, CNRS UMR 7104, INSERM U964, IGBMC, F-67404 Illkirch Graffenstaden, France.	scpk@igbmc.fr	Beate, HEIZMANN/G-6157-2017		Agence Nationale de la Recherche [ANR-11-BSV3-018]; Institut National du Cancer (INCa) [2011-144]; Ligue Nationale Contre le Cancer (Equipe labellisee); Fondation Arthritis Courtin; Fondation ARC [PJA20141201922]; Fondation de France [201400047508]; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Hopitaux Universitaires de Strasbourg; Laboratory of Excellence Medalis [ANR-10-LABX-0034]; EquipEx program I2MC [ANR-11-EQPX-022]; Initiative of Excellence (IdEx), University of Strasbourg; Conacyt Association of Mexico; Fondation ARC; Fondation de France; Fondation pour la Recherche Medicale;  [ANR-10-LABX-0030-INRT]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Nationale Contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Fondation Arthritis Courtin; Fondation ARC; Fondation de France(Fondation de France); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Hopitaux Universitaires de Strasbourg; Laboratory of Excellence Medalis; EquipEx program I2MC; Initiative of Excellence (IdEx), University of Strasbourg; Conacyt Association of Mexico; Fondation ARC; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); 	This work was supported by the Agence Nationale de la Recherche (ANR-11-BSV3-018), the Institut National du Cancer (INCa #2011-144), the Ligue Nationale Contre le Cancer (Equipe labellisee 2006-2012, 2015-2017, to S. C. and P. K.), Fondation Arthritis Courtin (2013), Fondation ARC (#PJA20141201922), Fondation de France (#201400047508), and institutional funds from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), the Hopitaux Universitaires de Strasbourg, the ANR-10-LABX-0030-INRT, the Laboratory of Excellence Medalis (ANR-10-LABX-0034), the EquipEx program I2MC (ANR-11-EQPX-022), the Initiative of Excellence (IdEx), University of Strasbourg. The authors declare that they have no competing financial interests.r Received predoctoral fellowships from the Conacyt Association of Mexico and the Fondation ARC.r Received post-doctoral fellowships from the Fondation ARC and Fondation de France.r Received a predoctoral fellowship from the Fondation pour la Recherche Medicale.	Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Arita K, 2011, J IMMUNOL, V186, P7050, DOI 10.4049/jimmunol.1001302; Badea TC, 2003, J NEUROSCI, V23, P2314; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; Ferreiros-Vidal I, 2013, BLOOD, V121, P1769, DOI 10.1182/blood-2012-08-450114; Geimer Le Lay AS, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004545; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Grandoch M, 2009, CELL SIGNAL, V21, P609, DOI 10.1016/j.cellsig.2009.01.002; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; Hayakawa K, 2015, ANN NY ACAD SCI, V1362, P250, DOI 10.1111/nyas.12768; Heizmann B, 2013, J EXP MED, V210, P2823, DOI 10.1084/jem.20131735; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Holodick NE, 2010, EUR J IMMUNOL, V40, P3007, DOI 10.1002/eji.201040545; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Hwang IY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060139; Johnson EN, 2002, J BIOL CHEM, V277, P16768, DOI 10.1074/jbc.M200751200; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Kastner P, 2013, AM J BLOOD RES, V3, P1; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; Kleinmann E, 2008, MOL CELL BIOL, V28, P7465, DOI 10.1128/MCB.00715-08; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kubo T, 2009, J EXP MED, V206, P1971, DOI 10.1084/jem.20082392; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; LEVENSON R, 1982, CELL, V28, P855, DOI 10.1016/0092-8674(82)90064-2; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu Z, 2006, IMMUNITY, V24, P405, DOI 10.1016/j.immuni.2006.02.001; Mabbott NA, 2014, IMMUNOLOGY, V141, P79, DOI 10.1111/imm.12171; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; MANOHAR V, 1982, J IMMUNOL, V129, P532; MCINTYRE TM, 1991, J IMMUNOL, V146, P3639; Milpied P, 2009, EUR J IMMUNOL, V39, P1466, DOI 10.1002/eji.200839040; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Montecino-Rodriguez E, 2014, J IMMUNOL, V192, P5171, DOI 10.4049/jimmunol.1303170; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; MORRIS DL, 1993, J EXP MED, V177, P857, DOI 10.1084/jem.177.3.857; Nakamura A, 2003, J EXP MED, V197, P669, DOI 10.1084/jem.20021824; Nakano-Yokomizo T, 2011, J EXP MED, V208, P1661, DOI 10.1084/jem.20101623; Oliveira VC, 2015, IMMUNOBIOLOGY, V220, P1232, DOI 10.1016/j.imbio.2015.06.010; Oravecz A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9823; PARRY SL, 1994, J IMMUNOL, V152, P2821; Pedersen GK, 2015, ANN NY ACAD SCI, V1362, P39, DOI 10.1111/nyas.12800; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Savitsky D, 2006, J EXP MED, V203, P2305, DOI 10.1084/jem.20060411; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Sellars M, 2009, J EXP MED, V206, P1073, DOI 10.1084/jem.20082311; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Weigelt K, 2007, J LEUKOCYTE BIOL, V82, P1564, DOI 10.1189/jlb.0707447; Wojcik H, 2007, EUR J IMMUNOL, V37, P1022, DOI 10.1002/eji.200637026; Yang Y, 2007, P NATL ACAD SCI USA, V104, P4542, DOI 10.1073/pnas.0700001104; Ye M, 2005, J EXP MED, V202, P1411, DOI 10.1084/jem.20051089; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhou Y., 2015, MOL BIOL B CELLS; Zhou Y, 2015, J EXP MED, V212, P569, DOI 10.1084/jem.20141510; Zuccolo J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00195	66	13	13	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9073	9086		10.1074/jbc.M115.704239	http://dx.doi.org/10.1074/jbc.M115.704239			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26841869	Green Published, hybrid			2022-12-28	WOS:000374849000021
J	Dermentzaki, G; Paschalidis, N; Politis, PK; Stefanis, L				Dermentzaki, Georgia; Paschalidis, Nikolaos; Politis, Panagiotis K.; Stefanis, Leonidas			Complex Effects of the ZSCAN21 Transcription Factor on Transcriptional Regulation of -Synuclein in Primary Neuronal Cultures and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-synuclein; neuron; Parkinson disease; rat; transcription regulation; zinc finger and SCAN domain containing 21 transcription factor	CHAPERONE-MEDIATED AUTOPHAGY; MESSENGER-RNA EXPRESSION; GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; ALLELIC VARIATION; SUBSTANTIA-NIGRA; BETA-SYNUCLEIN; RISK-FACTORS; LEWY BODY	-Synuclein, a presynaptic neuronal protein encoded by the SNCA gene, is strongly implicated in Parkinson disease (PD). PD pathogenesis is linked to increased SNCA levels; however, the transcriptional elements that control SNCA expression are still elusive. Previous experiments in PC12 cells demonstrated that the transcription factor zinc finger and SCAN domain containing 21 (ZSCAN21) plays an important regulatory role in SNCA transcription. Currently, we characterized the role of ZSCAN21 in SNCA transcription in primary neuronal cultures and in vivo. We found that ZSCAN21 is developmentally expressed in neurons in different rat brain regions. We confirmed its binding in the intron 1 region of SNCA in rat cortical cultures. Lentivirus-mediated silencing of ZSCAN21 increased significantly SNCA promoter activity, mRNA, and protein levels in such cultures. In contrast, ZSCAN21 silencing reduced SNCA in neurosphere cultures. Interestingly, ZSCAN21 overexpression in cortical neurons led to robust mRNA but negligible protein expression, suggesting that ZSCAN21 protein levels are tightly regulated post-transcriptionally and/or post-translationally in primary neurons. Efficient adeno-associated virus-mediated knockdown of ZSCAN21 in the postnatal and adult hippocampus, an area linked with non-motor PD symptoms, revealed no significant alterations in SNCA levels. Overall, our study demonstrates that ZSCAN21 is involved in the transcriptional regulation of SNCA in primary neuronal cultures, but the direction of the effect is variable, likely depending on neuronal maturation. However, the unaltered SNCA levels observed following ZSCAN21 down-regulation in the rat brain, possibly due to compensatory mechanisms, imply that ZSCAN21 is not a master regulator of SNCA in vivo.	[Dermentzaki, Georgia; Paschalidis, Nikolaos; Politis, Panagiotis K.; Stefanis, Leonidas] Acad Athens, Biomed Res Fdn, Athens 11527, Greece; [Stefanis, Leonidas] Natl & Kapodistrian Univ Athens, Hosp Attikon, Sch Med, Dept Neurol 2, Athens 12462, Greece	Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon	Stefanis, L (corresponding author), Acad Athens, Biomed Res Fdn, Athens 11527, Greece.	lstefanis@bioacademy.gr	Politis, Panagiotis/AAO-2423-2020; Stefanis, Leonidas/AAD-7192-2019	Politis, Panagiotis/0000-0002-2556-2857; Paschalidis, Nikolaos/0000-0001-6278-4144	European Union; Greek National Funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: Heracleitus II, Investing in Knowledge Society through the European Social Fund	European Union(European Commission); Greek National Funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: Heracleitus II, Investing in Knowledge Society through the European Social Fund	This work was supported in part by the European Union (European Social Fund) and Greek National Funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: Heracleitus II, Investing in Knowledge Society through the European Social Fund. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott RD, 2001, NEUROLOGY, V57, P456, DOI 10.1212/WNL.57.3.456; Ai SX, 2014, J NEUROL SCI, V337, P123, DOI 10.1016/j.jns.2013.11.033; Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Bayer TA, 1999, NEUROREPORT, V10, P2799, DOI 10.1097/00001756-199909090-00019; Brenner S, 2015, NEUROSCI LETT, V599, P140, DOI 10.1016/j.neulet.2015.05.029; Calabresi P, 2013, LANCET NEUROL, V12, P811, DOI 10.1016/S1474-4422(13)70118-2; Chiba-Falek O, 2005, AM J HUM GENET, V76, P478, DOI 10.1086/428655; Chiba-Falek O, 2003, HUM GENET, V113, P426, DOI 10.1007/s00439-003-1002-9; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Clough RL, 2007, FASEB J, V21, P596, DOI 10.1096/fj.06-7111com; Clough RL, 2011, J NEUROCHEM, V117, P275, DOI 10.1111/j.1471-4159.2011.07199.x; Clough RL, 2009, J NEUROCHEM, V110, P1479, DOI 10.1111/j.1471-4159.2009.06250.x; Dachsel JC, 2007, MOVEMENT DISORD, V22, P293, DOI 10.1002/mds.21223; Deng H, 2014, AGEING RES REV, V15, P161, DOI 10.1016/j.arr.2014.04.002; Dietrich P, 2003, MOL CELL NEUROSCI, V24, P430, DOI 10.1016/S1044-7431(03)00201-X; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Galvin JE, 2001, EXP NEUROL, V168, P347, DOI 10.1006/exnr.2000.7615; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Guez-Barber D, 2012, J NEUROSCI METH, V203, P10, DOI 10.1016/j.jneumeth.2011.08.045; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jowaed A, 2010, J NEUROSCI, V30, P6355, DOI 10.1523/JNEUROSCI.6119-09.2010; Kaltezioti V, 2014, J NEUROSCI, V34, P15816, DOI 10.1523/JNEUROSCI.1865-14.2014; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Kim JY, 2013, EUR J NEUROSCI, V37, P1203, DOI 10.1111/ejn.12126; Kingsbury AE, 2004, MOVEMENT DISORD, V19, P162, DOI 10.1002/mds.10683; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lim Y, 2011, J NEUROSCI, V31, P10076, DOI 10.1523/JNEUROSCI.0618-11.2011; Linnertz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007480; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz M, 2015, ALZHEIMERS DEMENT, V11, P1133, DOI 10.1016/j.jalz.2015.05.011; Matsumoto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015522; Mizuta I, 2013, J HUM GENET, V58, P711, DOI 10.1038/jhg.2013.90; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Neystat M, 1999, MOVEMENT DISORD, V14, P417, DOI 10.1002/1531-8257(199905)14:3<417::AID-MDS1005>3.0.CO;2-X; Nuber S, 2008, J NEUROSCI, V28, P2471, DOI 10.1523/JNEUROSCI.3040-07.2008; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Papapetropoulos S, 2007, MOVEMENT DISORD, V22, P1057, DOI 10.1002/mds.21466; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petersen K, 1999, NEUROSCIENCE, V91, P651, DOI 10.1016/S0306-4522(98)00596-X; Pihlstrom L, 2015, MOVEMENT DISORD, V30, P577, DOI 10.1002/mds.26073; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Raghavan R, 2004, PEDIATR DEVEL PATHOL, V7, P506, DOI 10.1007/s10024-003-7080-9; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Saleh H, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0026-0; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Stefanis L, 2001, J NEUROCHEM, V76, P1165, DOI 10.1046/j.1471-4159.2001.00114.x; Sterling Lori, 2014, F1000Res, V3, P259, DOI 10.12688/f1000research.3281.2; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tan YY, 2014, PARKINSONISM RELAT D, V20, P308, DOI 10.1016/j.parkreldis.2013.12.002; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang Y, 2013, CNS NEUROSCI THER, V19, P183, DOI 10.1111/cns.12059; Woods NT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002255; Wright JA, 2013, MOL CELL NEUROSCI, V57, P33, DOI 10.1016/j.mcn.2013.09.002; Xilouri M, 2013, BRAIN, V136, P2130, DOI 10.1093/brain/awt131; Xilouri M, 2012, HUM MOL GENET, V21, P874, DOI 10.1093/hmg/ddr521; Yamamoto T, 2008, CURR GENE THER, V8, P1, DOI 10.2174/156652308783688536; Yang XW, 1999, NAT GENET, V22, P327, DOI 10.1038/11896; Yang XW, 1996, DEVELOPMENT, V122, P555; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	71	14	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8756	8772		10.1074/jbc.M115.704973	http://dx.doi.org/10.1074/jbc.M115.704973			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26907683	Green Published, hybrid			2022-12-28	WOS:000374773200037
J	Prabhu, AV; Luu, W; Sharpe, LJ; Brown, AJ				Prabhu, Anika V.; Luu, Winnie; Sharpe, Laura J.; Brown, Andrew J.			Cholesterol-mediated Degradation of 7-Dehydrocholesterol Reductase Switches the Balance from Cholesterol to Vitamin D Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cholesterol regulation; enzyme degradation; genetic disease; vitamin D; 7-dehydrocholesterol; DHCR7	LEMLI-OPITZ-SYNDROME; HMG-COA REDUCTASE; GENOME-WIDE ASSOCIATION; STEROL-SENSING DOMAIN; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; SYNDROME SLOS; MENDELIAN RANDOMIZATION; SQUALENE MONOOXYGENASE; UBIQUITIN LIGASE; PROTEIN	Cholesterol is detrimental to human health in excess but is also essential for normal embryogenesis. Hence, enzymes involved in its synthesis possess many layers of regulation to achieve balanced cholesterol levels. 7-Dehydrocholesterol reductase (DHCR7) is the terminal enzyme of cholesterol synthesis in the Kandutsch-Russell pathway, converting 7-dehydrocholesterol (7DHC) to cholesterol. In the absence of functional DHCR7, accumulation of 7DHC and a lack of cholesterol production leads to the devastating developmental disorder, Smith-Lemli-Opitz syndrome. This study identifies that statin treatment can ameliorate the low DHCR7 expression seen with common Smith-Lemli-Opitz syndrome mutations. Furthermore, we show that wild-type DHCR7 is also relatively labile. In an example of end-product inhibition, cholesterol accelerates the proteasomal degradation of DHCR7, resulting in decreased protein levels and activity. The loss of enzymatic activity results in the accumulation of the substrate 7DHC, which leads to an increased production of vitamin D. Thus, these findings highlight DHCR7 as an important regulatory switch between cholesterol and vitamin D synthesis.	[Prabhu, Anika V.; Luu, Winnie; Sharpe, Laura J.; Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Biol Sci Bldg D26, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Brown, AJ (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Biol Sci Bldg D26, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au		Prabhu, Anika/0000-0002-3809-1716; Sharpe, Laura/0000-0002-9896-294X	University of New South Wales Goldstar Award; National Health and Medical Research Council [1060515]	University of New South Wales Goldstar Award; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by The University of New South Wales Goldstar Award and National Health and Medical Research Council Grant 1060515. The authors declare that they have no conflicts of interest with the contents of this article.	Afzal S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6330; Afzal S, 2014, LANCET DIABETES ENDO, V2, P298, DOI 10.1016/S2213-8587(13)70200-6; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Bae SH, 1999, J BIOL CHEM, V274, P14624, DOI 10.1074/jbc.274.21.14624; BLOCH K, 1965, SCIENCE, V150, P19, DOI 10.1126/science.150.3692.19; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Correa-Cerro LS, 2006, HUM MOL GENET, V15, P839, DOI 10.1093/hmg/ddl003; Cross JL, 2015, CLIN GENET, V87, P570, DOI 10.1111/cge.12425; DeLuca HF, 2008, NUTR REV, V66, pS73, DOI 10.1111/j.1753-4887.2008.00105.x; Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094; Elias ER, 1997, AM J MED GENET, V68, P305, DOI 10.1002/(SICI)1096-8628(19970131)68:3<305::AID-AJMG11>3.0.CO;2-X; Faulkner RA, 2013, J LIPID RES, V54, P1011, DOI 10.1194/jlr.M033639; FEINGOLD KR, 1983, METABOLISM, V32, P75, DOI 10.1016/0026-0495(83)90160-9; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Haas D, 2007, J INHERIT METAB DIS, V30, P375, DOI 10.1007/s10545-007-0537-7; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Holmer L, 1998, GENOMICS, V54, P469, DOI 10.1006/geno.1998.5615; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; KANDUTSCH AA, 1960, J BIOL CHEM, V235, P2256; Kielar D, 2001, CLIN CHEM, V47, P2089; Kuan V, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-144; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lanthaler B, 2014, GENE, V550, P136, DOI 10.1016/j.gene.2014.08.016; Lehmann B, 1997, J INVEST DERMATOL, V108, P78, DOI 10.1111/1523-1747.ep12285640; Li XC, 2015, NATURE, V517, P104, DOI 10.1038/nature13797; Luu W, 2015, J LIPID RES, V56, P888, DOI 10.1194/jlr.M056986; Luu W, 2014, J LIPID RES, V55, P410, DOI 10.1194/jlr.M043257; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; McDonald JG, 2012, J LIPID RES, V53, P1399, DOI 10.1194/jlr.D022285; Meyer HE, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h321; Mitsche MA, 2015, ELIFE, V4, DOI 10.7554/eLife.07999; Oregon Health and Science University, 2012, SMITH LEML OP SYNDR; Pasta S, 2015, MOL GENET METAB REP, V4, P92, DOI 10.1016/j.ymgmr.2015.07.006; Porter F. D., 2014, INVESTIGATION SIMVAS; Prabhu AV, 2014, BBA-MOL CELL BIOL L, V1841, P1431, DOI 10.1016/j.bbalip.2014.07.006; Prasad C, 2002, AM J MED GENET, V108, P64, DOI 10.1002/ajmg.10211; Rodwell V W, 1976, Adv Lipid Res, V14, P1; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Shinkyo R, 2011, J BIOL CHEM, V286, P33021, DOI 10.1074/jbc.M111.282434; Sikora DM, 2004, J PEDIATR-US, V144, P783, DOI 10.1016/j.jpeds.2004.02.036; SMITH DW, 1964, J PEDIATR-US, V64, P210, DOI 10.1016/S0022-3476(64)80264-X; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Tierney E, 2010, AM J MED GENET A, V152A, P91, DOI 10.1002/ajmg.a.33148; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Waterham HR, 2012, AM J MED GENET C, V160C, P263, DOI 10.1002/ajmg.c.31346; Waterham HR, 2000, BBA-MOL CELL BIOL L, V1529, P340, DOI 10.1016/S1388-1981(00)00159-1; Witsch-Baumgartner M, 2008, J MED GENET, V45, P200, DOI 10.1136/jmg.2007.053520; Xu LB, 2009, J AM CHEM SOC, V131, P13037, DOI 10.1021/ja9029076; YANG JX, 1994, GENE DEV, V8, P1910, DOI 10.1101/gad.8.16.1910; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1269, DOI 10.1016/j.bbalip.2011.11.009; Zou L, 2015, J STEROID BIOCHEM, V148, P64, DOI 10.1016/j.jsbmb.2014.12.001	58	67	68	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8363	8373		10.1074/jbc.M115.699546	http://dx.doi.org/10.1074/jbc.M115.699546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26887953	hybrid, Green Published			2022-12-28	WOS:000374773200005
J	Qayyum, MZ; Dey, D; Sen, R				Qayyum, M. Zuhaib; Dey, Debashish; Sen, Ranjan			Transcription Elongation Factor NusA Is a General Antagonist of Rho-dependent Termination in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); gene regulation; microarray; RNA polymerase; transcription termination; NusA; Rho; nut site; rut site	RNA-EXIT CHANNEL; DEFECTIVE-MUTANTS; NASCENT RNA; PROTEIN PSU; IN-VITRO; POLYMERASE; ANTITERMINATION; COMPLEX; MECHANISM; TRANSLATION	NusA is an essential protein that binds to RNA polymerase and also to the nascent RNA and influences transcription by inducing pausing and facilitating the process of transcription termination/antitermination. Its participation in Rho-dependent transcription termination has been perceived, but the molecular nature of this involvement is not known. We hypothesized that, because both Rho and NusA are RNA-binding proteins and have the potential to target the same RNA, the latter is likely to influence the global pattern of the Rho-dependent termination. Analyses of the nascent RNA binding properties and consequent effects on the Rho-dependent termination functions of specific NusA-RNA binding domain mutants revealed an existence of Rho-NusA direct competition for the overlapping nut (NusA-binding site) and rut (Rho-binding site) sites on the RNA. This leads to delayed entry of Rho at the rut site that inhibits the latter's RNA release process. High density tiling microarray profiles of these NusA mutants revealed that a significant number of genes, together with transcripts from intergenic regions, are up-regulated. Interestingly, the majority of these genes were also up-regulated when the Rho function was compromised. These results provide strong evidence for the existence of NusA-binding sites in different operons that are also the targets of Rho-dependent terminations. Our data strongly argue in favor of a direct competition between NusA and Rho for the access of specific sites on the nascent transcripts in different parts of the genome. We propose that this competition enables NusA to function as a global antagonist of the Rho function, which is unlike its role as a facilitator of hairpin-dependent termination.	[Qayyum, M. Zuhaib; Dey, Debashish; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Transcript Lab, Tuljaguda Complex,4-1-714 Mozamjahi Rd, Hyderabad 500001, Andhra Pradesh, India; [Qayyum, M. Zuhaib] Manipal Univ, Grad Studies, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Sen, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Transcript Lab, Tuljaguda Complex,4-1-714 Mozamjahi Rd, Hyderabad 500001, Andhra Pradesh, India.	rsen@cdfd.org.in	Qayyum, Mohammad Zuhaib/AAD-8672-2022	Qayyum, Mohammad Zuhaib/0000-0003-2442-4812	Department of Biotechnology, Government of India [BT/PR13297/BRB/10/746/2009]; Center for DNA Fingerprinting and Diagnostics	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Center for DNA Fingerprinting and Diagnostics	This work was supported by Department of Biotechnology, Government of India, Grant BT/PR13297/BRB/10/746/2009 and the intramural grant of the Center for DNA Fingerprinting and Diagnostics. The authors declare that they have no conflicts of interest with the contents of this article.	ALBRECHTSEN B, 1990, J MOL BIOL, V213, P123, DOI 10.1016/S0022-2836(05)80125-1; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Banerjee S, 2006, J MICROBIOL, V44, P11; BARIK S, 1985, J MOL BIOL, V182, P495, DOI 10.1016/0022-2836(85)90236-0; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Burns CM, 1998, J MOL BIOL, V278, P307, DOI 10.1006/jmbi.1998.1691; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; Chalissery J, 2011, J MOL BIOL, V405, P49, DOI 10.1016/j.jmb.2010.10.044; Cheeran A, 2005, J MOL BIOL, V352, P28, DOI 10.1016/j.jmb.2005.06.052; Dutta D, 2008, J BIOL CHEM, V283, P20243, DOI 10.1074/jbc.M801926200; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Gusarov I, 2001, CELL, V107, P437, DOI 10.1016/S0092-8674(01)00582-7; Gutierrrez P, 2007, J BIOL CHEM, V282, P23348, DOI 10.1074/jbc.M702010200; Ha KS, 2010, J MOL BIOL, V401, P708, DOI 10.1016/j.jmb.2010.06.036; Harinarayanan R, 2003, J MOL BIOL, V332, P31, DOI 10.1016/S0022-2836(03)00753-8; Hollands K, 2012, P NATL ACAD SCI USA, V109, P5376, DOI 10.1073/pnas.1112211109; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; Kalyani BS, 2011, J MOL BIOL, V413, P548, DOI 10.1016/j.jmb.2011.08.053; Kolb KE, 2014, J BIOL CHEM, V289, P1151, DOI 10.1074/jbc.M113.521393; LI J, 1993, GENE DEV, V7, P161, DOI 10.1101/gad.7.1.161; Menouni R, 2013, P NATL ACAD SCI USA, V110, P14414, DOI 10.1073/pnas.1303400110; Mishra S, 2013, J BIOL CHEM, V288, P28089, DOI 10.1074/jbc.M113.472209; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Muteeb G, 2012, NUCLEIC ACIDS RES, V40, P11213, DOI 10.1093/nar/gks872; Muteeb G, 2010, METHODS MOL BIOL, V634, P411, DOI 10.1007/978-1-60761-652-8_29; Pani B, 2006, J BIOL CHEM, V281, P26491, DOI 10.1074/jbc.M603982200; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; Peters JM, 2012, GENE DEV, V26, P2621, DOI 10.1101/gad.196741.112; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Pichoff S, 1998, MOL MICROBIOL, V29, P859, DOI 10.1046/j.1365-2958.1998.00981.x; Prasch S, 2009, NUCLEIC ACIDS RES, V37, P4736, DOI 10.1093/nar/gkp452; Rabhi M, 2011, EMBO J, V30, P2805, DOI 10.1038/emboj.2011.192; Ranjan A, 2013, NUCLEIC ACIDS RES, V41, P6839, DOI 10.1093/nar/gkt336; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Saxena S, 2011, J BACTERIOL, V193, P3842, DOI 10.1128/JB.00221-11; SCHMIDT MC, 1987, J MOL BIOL, V195, P809, DOI 10.1016/0022-2836(87)90486-4; Schweimer K, 2011, STRUCTURE, V19, P945, DOI 10.1016/j.str.2011.03.024; Sen Ranjan, 2008, EcoSal Plus, V3, DOI 10.1128/ecosalplus.4.5.3.1; Sevostyanova A, 2015, P NATL ACAD SCI USA, V112, pE6835, DOI 10.1073/pnas.1515383112; Shashni R, 2014, NUCLEIC ACIDS RES, V42, P9677, DOI 10.1093/nar/gku690; Shashni R, 2012, MICROBIOL-SGM, V158, P1468, DOI 10.1099/mic.0.056804-0; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Squires CL, 2000, ANNU REV MICROBIOL, V54, P775, DOI 10.1146/annurev.micro.54.1.775; SQUIRES CL, 1993, P NATL ACAD SCI USA, V90, P970, DOI 10.1073/pnas.90.3.970; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Worbs M, 2001, MOL CELL, V7, P1177, DOI 10.1016/S1097-2765(01)00262-3; ZHENG CH, 1994, P NATL ACAD SCI USA, V91, P7543, DOI 10.1073/pnas.91.16.7543	50	22	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8090	8108		10.1074/jbc.M115.701268	http://dx.doi.org/10.1074/jbc.M115.701268			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26872975	Green Published, hybrid			2022-12-28	WOS:000374056700027
J	Zhao, RB; Najmi, M; Fiser, A; Goldman, ID				Zhao, Rongbao; Najmi, Mitra; Fiser, Andras; Goldman, I. David			Identification of an Extracellular Gate for the Proton-coupled Folate Transporter (PCFT-SLC46A1) by Cysteine Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine-mediated cross-linking; folate; homology modeling; membrane transport; transporter	TRANSMEMBRANE CONDUCTANCE REGULATOR; HELA-CELLS LACKING; ACCESSIBILITY METHOD; FUNCTIONAL ROLES; MOLECULAR-BASIS; PHARMACOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; LINING RESIDUES; AMINO-ACID; MALABSORPTION	The proton-coupled folate transporter (PCFT, SLC46A1) is required for intestinal folate absorption and folate homeostasis in humans. A homology model of PCFT, based upon the Escherichia coli glycerol 3-phosphate transporter structure, predicted that PCFT transmembrane domains (TMDs) 1, 2, 7, and 11 form an extracellular gate in the inward-open conformation. To assess this model, five residues (Gln(45)-TMD1, Asn(90)-TMD2, Leu(290)-TMD7, Ser(407)-TMD11 and Asn(411)-TMD11) in the predicted gate were substituted with Cys to generate single and nine double mutants. Transport function of the mutants was assayed in transient transfectants by measurement of [H-3]substrate influx as was accessibility of the Cys residues to biotinylation. Pairs of Cys residues were assessed for spontaneous formation of a disulfide bond, induction of a disulfide bond by oxidization with dichloro(1,10-phenanthroline)copper (II) (CuPh), or the formation of a Cd2+ complex. The data were consistent with the formation of a spontaneous disulfide bond between the N90C/S407C pair and a CuPh- and Cd2+-induced disulfide bond and complex, respectively, for the Q45C/L290C and L290C/N411C pairs. The decrease in activity induced by cross-linkage of the Cys residue pairs was due to a decrease in the influx V-max consistent with restriction in the mobility of the transporter. The presence of folate substrate decreased the CuPh-induced inhibition of transport. Hence, the data support the glycerol 3-phosphate transporter-based homology model of PCFT and the presence of an extracellular gate formed by TMDs 1, 2, 7, and 11.	[Zhao, Rongbao; Najmi, Mitra; Goldman, I. David] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Zhao, Rongbao; Goldman, I. David] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Fiser, Andras] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Fiser, Andras] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Goldman, ID (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	i.david.goldman@einstein.yu.edu			National Cancer Institute, National Institutes of Health [CA082621]; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA082621] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute, National Institutes of Health Grant CA082621. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benitah JP, 1996, P NATL ACAD SCI USA, V93, P7392, DOI 10.1073/pnas.93.14.7392; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Diop-Bove N, 2014, GENEREVIEWS; Diop-Bove NK, 2009, MOL CANCER THER, V8, P2424, DOI 10.1158/1535-7163.MCT-08-0938; Duddempudi PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078301; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; Fernandez-Fuentes N, 2007, BIOINFORMATICS, V23, P2558, DOI 10.1093/bioinformatics/btm377; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hilwi M, 2014, J BIOL CHEM, V289, P34258, DOI 10.1074/jbc.M114.593061; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lasry I, 2009, BIOCHEM BIOPH RES CO, V386, P426, DOI 10.1016/j.bbrc.2009.06.007; Liu XH, 2006, J BIOL CHEM, V281, P8275, DOI 10.1074/jbc.M512458200; Liu XH, 2008, BIOMETALS, V21, P277, DOI 10.1007/s10534-007-9117-4; Loo TW, 2014, J BIOL CHEM, V289, P24749, DOI 10.1074/jbc.M114.583021; Mahadeo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1153, DOI 10.1152/ajpcell.00113.2010; Mueckler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031412; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; Rai BK, 2006, BIOINFORMATICS, V22, P2691, DOI 10.1093/bioinformatics/btl449; Shabaneh M, 2014, J BIOL CHEM, V289, P11175, DOI 10.1074/jbc.M114.550277; Shin DS, 2013, AM J PHYSIOL-CELL PH, V304, pC1159, DOI 10.1152/ajpcell.00353.2012; Shin DS, 2012, AM J PHYSIOL-CELL PH, V303, pC834, DOI 10.1152/ajpcell.00171.2012; Shin DS, 2012, AM J PHYSIOL-CELL PH, V302, pC1405, DOI 10.1152/ajpcell.00435.2011; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sun J, 2014, NATURE, V507, P73, DOI 10.1038/nature13074; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Umapathy NS, 2007, INVEST OPHTH VIS SCI, V48, P5299, DOI 10.1167/iovs.07-0288; Unal ES, 2009, AM J PHYSIOL-CELL PH, V297, pC66, DOI 10.1152/ajpcell.00096.2009; Unal ES, 2009, J BIOL CHEM, V284, P17846, DOI 10.1074/jbc.M109.008060; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; Valdes R, 2014, J BIOL CHEM, V289, P8799, DOI 10.1074/jbc.M113.546960; Valdes R, 2012, J BIOL CHEM, V287, P44036, DOI 10.1074/jbc.M112.414433; Visentin M, 2015, AM J PHYSIOL-CELL PH, V308, pC631, DOI 10.1152/ajpcell.00238.2014; Visentin M, 2014, ANNU REV PHYSIOL, V76, P251, DOI 10.1146/annurev-physiol-020911-153251; Wilson MR, 2014, J BIOL CHEM, V289, P25287, DOI 10.1074/jbc.M114.578252; Yang Y, 2014, ANTIOXID REDOX SIGN, V20, P937, DOI 10.1089/ars.2013.5483; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2004, CANCER RES, V64, P3313, DOI 10.1158/0008-5472.CAN-03-3953; Zhao RB, 2004, CLIN CANCER RES, V10, P718, DOI 10.1158/1078-0432.CCR-1066-03; Zhao RB, 2008, MOL PHARMACOL, V74, P854, DOI 10.1124/mol.108.045443; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2012, AM J PHYSIOL-CELL PH, V303, pC673, DOI 10.1152/ajpcell.00123.2012; Zhao RB, 2011, BBA-BIOMEMBRANES, V1808, P1140, DOI 10.1016/j.bbamem.2011.01.008; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439	51	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8162	8172		10.1074/jbc.M115.693929	http://dx.doi.org/10.1074/jbc.M115.693929			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26884338	Green Published, hybrid			2022-12-28	WOS:000374056700033
J	Li, M; Kandror, O; Akopian, T; Dharkar, P; Wlodawer, A; Maurizi, MR; Goldberg, AL				Li, Mi; Kandror, Olga; Akopian, Tatos; Dharkar, Poorva; Wlodawer, Alexander; Maurizi, Michael R.; Goldberg, Alfred L.			Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; COLI CLPAP PROTEASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; AXIAL CHANNEL; TRANSLOCATION; DEGRADATION; MECHANISM; PEPTIDE; BINDING	The ClpP protease complex and its regulatory ATPases, ClpC1 and ClpX, in Mycobacterium tuberculosis (Mtb) are essential and, therefore, promising drug targets. The Mtb ClpP protease consists of two heptameric rings, one composed of ClpP1 and the other of ClpP2 subunits. Formation of the enzymatically active ClpP1P2 complex requires binding of N-blocked dipeptide activators. We have found a new potent activator, benzoyl-leucine-leucine (Bz-LL), that binds with higher affinity and promotes 3-4-fold higher peptidase activity than previous activators. Bz-LL-activated ClpP1P2 specifically stimulates the ATPase activity of Mtb ClpC1 and ClpX. The ClpC1P1P2 and ClpXP1P2 complexes exhibit 2-3-fold enhanced ATPase activity, peptide cleavage, and ATP-dependent protein degradation. The crystal structure of ClpP1P2 with bound Bz-LL was determined at a resolution of 3.07 angstrom and with benzyloxycarbonyl-Leu-Leu (Z-LL) bound at 2.9 angstrom. Bz-LL was present in all 14 active sites, whereas Z-LL density was not resolved. Surprisingly, Bz-LL adopts opposite orientations in ClpP1 and ClpP2. In ClpP1, Bz-LL binds with the C-terminal leucine side chain in the S1 pocket. One C-terminal oxygen is close to the catalytic serine, whereas the other contacts backbone amides in the oxyanion hole. In ClpP2, Bz-LL binds with the benzoyl group in the S1 pocket, and the peptide hydrogen bonded between parallel beta-strands. The ClpP2 axial loops are extended, forming an open axial channel as has been observed with bound ADEP antibiotics. Thus occupancy of the active sites of ClpP allosterically alters sites on the surfaces thereby affecting the association of ClpP1 and ClpP2 rings, interactions with regulatory ATPases, and entry of protein substrates.	[Li, Mi; Wlodawer, Alexander] NCI, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA; [Li, Mi] Frederick Natl Lab, Leidos Biomed Res, Basic Res Program, Frederick, MD 21702 USA; [Kandror, Olga; Akopian, Tatos; Goldberg, Alfred L.] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Dharkar, Poorva; Maurizi, Michael R.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Goldberg, AL (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.; Maurizi, MR (corresponding author), NCI, Bldg 37,Rm 2128,37 Convent Dr, Bethesda, MD 20892 USA.	mmaurizi@helix.nih.gov; Alfred_Goldberg@hms.harvard.edu	Dharkar, Poorva/E-3367-2012		United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Diffraction data were collected on the SER-CAT 22ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract W-31-109-Eng-38.	Akopian T, 2015, J BIOL CHEM, V290, P11008, DOI 10.1074/jbc.M114.625640; Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Alexopoulos J, 2013, MOL MICROBIOL, V90, P167, DOI 10.1111/mmi.12356; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Benaroudj N, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-61; Bewley MC, 2009, J STRUCT BIOL, V165, P118, DOI 10.1016/j.jsb.2008.10.005; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Butler SM, 2006, MOL MICROBIOL, V60, P553, DOI 10.1111/j.1365-2958.2006.05128.x; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Dahmen M, 2015, ANGEW CHEM INT EDIT, V54, P3598, DOI 10.1002/anie.201409325; Effantin G, 2010, J BIOL CHEM, V285, P14834, DOI 10.1074/jbc.M109.090498; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; Gao W, 2015, ANTIMICROB AGENTS CH, V59, P880, DOI 10.1128/AAC.04054-14; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Gersch M, 2012, J BIOL CHEM, V287, P9484, DOI 10.1074/jbc.M111.336222; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; HWANG BJ, 1987, P NATL ACAD SCI USA, V84, P5550, DOI 10.1073/pnas.84.16.5550; Ingvarsson H, 2007, ACTA CRYSTALLOGR D, V63, P249, DOI 10.1107/S0907444906050530; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajfasz JK, 2011, MICROBIOL-SGM, V157, P2880, DOI 10.1099/mic.0.052407-0; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Kirstein J, 2009, EMBO MOL MED, V1, P37, DOI 10.1002/emmm.200900002; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Lee JW, 2009, J BIOL CHEM, V284, P33475, DOI 10.1074/jbc.M109.045807; Leodolter J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125345; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ollinger J, 2012, J BACTERIOL, V194, P663, DOI 10.1128/JB.06142-11; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Ryan KR, 2002, J MOL BIOL, V324, P443, DOI 10.1016/S0022-2836(02)01042-2; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schmitz KR, 2014, P NATL ACAD SCI USA, V111, pE4587, DOI 10.1073/pnas.1417120111; Singh SK, 1999, BIOCHEMISTRY-US, V38, P14906, DOI 10.1021/bi991615f; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Szyk A, 2006, J STRUCT BIOL, V156, P165, DOI 10.1016/j.jsb.2006.03.013; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; Turgay K, 1998, EMBO J, V17, P6730; Ye F, 2013, J BIOL CHEM, V288, P17643, DOI 10.1074/jbc.M113.452714; Zhang J, 2011, J BIOL CHEM, V286, P37590, DOI 10.1074/jbc.M111.277848	56	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7465	7476		10.1074/jbc.M115.700344	http://dx.doi.org/10.1074/jbc.M115.700344			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26858247	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000383447600022
J	Sassa, T; Hirayama, T; Kihara, A				Sassa, Takayuki; Hirayama, Taisuke; Kihara, Akio			Enzyme Activities of the Ceramide Synthases CERS2-6 Are Regulated by Phosphorylation in the C-terminal Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; SPHINGOSINE 1-PHOSPHATE; CASEIN KINASE; PERMEABILITY BARRIER; SPHINGOLIPIDS; METABOLISM; SUSCEPTIBILITY; DEHYDROGENASE; EXPRESSION; INHIBITOR	Ceramide and complex sphingolipids regulate important cellular functions including cell growth, apoptosis, and signaling. Dysregulation of sphingolipid metabolism leads to pathological consequences such as sphingolipidoses and insulin resistance. Ceramides in mammals vary greatly in their acyl-chain composition: six different ceramide synthase isozymes (CERS1-6) that exhibit distinct substrate specificity and tissue distribution account for this diversity. In the present study, we demonstrated that CERS2-6 were phosphorylated at the cytoplasmic C-terminal regions. Most of the phosphorylated residues conformed to a consensus motif for phosphorylation by casein kinase 2 (CK2), and treatment of cells with the CK2-specific inhibitor CX-4945 lowered the phosphorylation levels of CERS2, -4, -5, and -6. Phosphorylation of CERS2 was especially important for its catalytic activity, acting mainly by increasing its V-max value. Phosphorylation modestly increased the catalytic activities of CERS4 and -5 and mildly increased those of CERS3 and -6. Dephosphorylation of endogenous ceramide synthases in the mouse brain led to severely reduced activity toward the Cers2 substrates C22:0/C24:0-CoAs and modestly reduced activity toward the Cers5/6 substrate C16:0-CoA. These results suggest that the phosphorylation of ceramide synthases may be a key regulatory point in the control of the distribution and levels of sphingolipids of various acyl-chain lengths.	[Sassa, Takayuki; Hirayama, Taisuke; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	SASSA, Takayuki/B-2519-2012; KIHARA, AKIO/A-3802-2012	SASSA, Takayuki/0000-0003-3145-9829; KIHARA, AKIO/0000-0001-5889-0788	Advanced Research and Development Programs for Medical Innovation (AMED-CREST) from the Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science [26251010, 24590073]; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [26251010, 16K08220] Funding Source: KAKEN	Advanced Research and Development Programs for Medical Innovation (AMED-CREST) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Advanced Research and Development Programs for Medical Innovation (AMED-CREST) (to A. K.) from the Japan Agency for Medical Research and Development (AMED), by Grants-in-Aid for Scientific Research (A) 26251010 (to A. K.) and (C) 24590073 (to T. S.) from the Japan Society for the Promotion of Science, and funding from Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program (to A. K.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest with the content of this article.	Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; Breiden B, 2014, BBA-MOL CELL BIOL L, V1841, P441, DOI 10.1016/j.bbalip.2013.08.010; Chon HJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00070; Eckl KM, 2013, J INVEST DERMATOL, V133, P2202, DOI 10.1038/jid.2013.153; Ferguson AD, 2011, FEBS LETT, V585, P104, DOI 10.1016/j.febslet.2010.11.019; Fresques T, 2015, J BIOL CHEM, V290, P1395, DOI 10.1074/jbc.M114.621086; Gangoiti P, 2010, PROG LIPID RES, V49, P316, DOI 10.1016/j.plipres.2010.02.004; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Harrer H, 2013, MOL NUTR FOOD RES, V57, P516, DOI 10.1002/mnfr.201200465; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2014, BBA-MOL CELL BIOL L, V1841, P766, DOI 10.1016/j.bbalip.2013.08.014; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mizutani Y, 2009, BIOCHIMIE, V91, P784, DOI 10.1016/j.biochi.2009.04.001; Muir A, 2014, ELIFE, V3, DOI 10.7554/eLife.03779; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Rabionet M, 2015, HUM MOL GENET, V24, P4792, DOI 10.1093/hmg/ddv204; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018; Sassa T, 2014, BIOMOL THER, V22, P83, DOI 10.4062/biomolther.2014.017; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Sassa T, 2012, BBA-MOL CELL BIOL L, V1821, P1031, DOI 10.1016/j.bbalip.2012.04.008; Schulze H, 2014, BBA-MOL CELL BIOL L, V1841, P799, DOI 10.1016/j.bbalip.2013.10.015; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Sridevi P, 2009, BBA-MOL CELL RES, V1793, P1218, DOI 10.1016/j.bbamcr.2009.04.006; Sugimoto M, 2015, BBA-MOL CELL BIOL L, V1851, P1554, DOI 10.1016/j.bbalip.2015.09.004; Truman JP, 2014, BBA-MOL CELL BIOL L, V1841, P1174, DOI 10.1016/j.bbalip.2013.12.013; Turpin S. M., 2014, OBESITY INDUCED CERS; Vanni N, 2014, ANN NEUROL, V76, P206, DOI 10.1002/ana.24170; Venerando A, 2014, BIOCHEM J, V460, P141, DOI 10.1042/BJ20140178; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063	45	38	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7477	7487		10.1074/jbc.M115.695858	http://dx.doi.org/10.1074/jbc.M115.695858			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26887952	Green Published, hybrid			2022-12-28	WOS:000383447600023
J	Pack, LR; Yamamoto, KR; Fujimori, DG				Pack, Lindsey R.; Yamamoto, Keith R.; Fujimori, Danica Galonic			Opposing Chromatin Signals Direct and Regulate the Activity of Lysine Demethylase 4C (KDM4C)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin regulation; enzyme kinetics; histone demethylase; nucleosome; post-translational modification (PTM); substrate specificity; lysine demethylase 4C (KDM4C)	HISTONE H3 METHYLATION; BINDING MODULES; TUDOR DOMAIN; DNA-DAMAGE; FAMILY; RECOGNITION; RECRUITMENT; MECHANISM; DISTINCT; HP1	Histone H3 lysine 4 trimethylation (H3K4me3) and histone H3 lysine 9 trimethylation (H3K9me3) are epigenetic marks with opposing roles in transcription regulation. Whereas colocalization of these modifications is generally excluded in the genome, how this preclusion is established remains poorly understood. Lysine demethylase 4C (KDM4C), an H3K9me3 demethylase, localizes predominantly to H3K4me3-containing promoters through its hybrid tandem tudor domain (TTD) (1, 2), providing a model for how these modifications might be excluded. We quantitatively investigated the contribution of the TTD to the catalysis of H3K9me3 demethylation by KDM4C and demonstrated that TTD-mediated recognition of H3K4me3 stimulates demethylation of H3K9me3 in cis on peptide and mononucleosome substrates. Our findings support a multivalent interaction mechanism, by which an activating mark, H3K4me3, recruits and stimulates KDM4C to remove the repressive H3K9me3 mark, thus facilitating exclusion. In addition, our work suggests that differential TTD binding properties across the KDM4 demethylase family may differentiate their targets in the genome.	[Pack, Lindsey R.; Yamamoto, Keith R.; Fujimori, Danica Galonic] Univ San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Pack, Lindsey R.] Univ San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA; [Fujimori, Danica Galonic] Univ San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of San Francisco; University of San Francisco; University of San Francisco	Yamamoto, KR (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, S572D Genentech Hall,600 16th St, San Francisco, CA 94143 USA.; Fujimori, DG (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, N572E Genentech Hall,600 16th St, San Francisco, CA 94143 USA.	Yamamoto@ucsf.edu; Danica.Fujimori@ucsf.edu			National Science Foundation Graduate Research Fellowship; National Institutes of Health (NIH) [R01 CA020535]; NIH [R01 GM114044]; University of California San Francisco Nina Ireland Program for Lung Health; NATIONAL CANCER INSTITUTE [R01CA020535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK098722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114044] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Nina Ireland Program for Lung Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by a National Science Foundation Graduate Research Fellowship (to L. R. P.), National Institutes of Health (NIH) Grant R01 CA020535 (to K. R. Y.), and NIH Grant R01 GM114044, Searle Scholar, and University of California San Francisco Nina Ireland Program for Lung Health awards (to D. G. F.). The authors declare that they have no conflict of interest with the contents of this article.	Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Binda O, 2010, EPIGENETICS-US, V5, P767, DOI 10.4161/epi.5.8.13278; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Das PP, 2014, MOL CELL, V53, P32, DOI 10.1016/j.molcel.2013.11.011; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hillringhaus L, 2011, J BIOL CHEM, V286, P41616, DOI 10.1074/jbc.M111.283689; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Huang H, 2014, CELL, V159, P458, DOI 10.1016/j.cell.2014.09.037; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Johansson C, 2014, EPIGENOMICS-UK, V6, P89, DOI 10.2217/epi.13.79; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krishnan S, 2013, STRUCTURE, V21, P98, DOI 10.1016/j.str.2012.10.018; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Lin CH, 2008, MOL CELL, V32, P696, DOI 10.1016/j.molcel.2008.11.008; Lohse B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067653; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Rubenstein EM, 2007, EUKARYOT CELL, V6, P571, DOI 10.1128/EC.00026-07; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Shiau C, 2013, CHEM BIOL, V20, P494, DOI 10.1016/j.chembiol.2013.03.008; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Terndrup M, 2014, MOL CELL BIOL, V34, P1031, DOI 10.1128/MCB.00864-13; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Tong Q, 2015, STRUCTURE, V23, P312, DOI 10.1016/j.str.2014.11.013; Torres IO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7204; Wan Q, 2007, ANGEW CHEM INT EDIT, V46, P9248, DOI 10.1002/anie.200704195; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]	53	22	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6060	6070		10.1074/jbc.M115.696864	http://dx.doi.org/10.1074/jbc.M115.696864			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26747609	Green Published, hybrid			2022-12-28	WOS:000372894200002
J	Moore, SPG; Kruchten, J; Toomire, KJ; Strauss, PR				Moore, Stephen P. G.; Kruchten, Joshua; Toomire, Kimberly J.; Strauss, Phyllis R.			Transcription Factors and DNA Repair Enzymes Compete for Damaged Promoter Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						8-Oxoguanine (8-oxoG); 8-Oxoguanine glycosylase (OGG1); cAMP-response element-binding protein (CREB); development; DNA repair; embryo; transcription; zebrafish; G; U mispair; uracil DNA glycosylase; DNA base excision repair; CREB1 transcription factor; glycosylase; transcription factor competition; DNA damage repair	BASE EXCISION-REPAIR; HUMAN 8-OXOGUANINE-DNA GLYCOSYLASE; FACTOR DECOY OLIGONUCLEOTIDE; INDUCED CYTIDINE DEAMINASE; ELEMENT-BINDING PROTEIN; GENOME-WIDE ANALYSIS; NF-KAPPA-B; SUBSTRATE-SPECIFICITY; AP-ENDONUCLEASE; CREB	Transcriptional regulation is a tightly regulated, vital process. The transcription factor cyclic AMP-response element-binding protein 1 (CREB1) controls approximate to 25% of the mammalian transcriptome by binding the CREB1 binding site consensus sequence (CRE) sequence (TGACGTCA). DNA lesions within CRE modulate CREB1 binding negatively and positively. Because appropriate DNA lesions also interact with base excision repair proteins, we investigated whether CREB1 and repair glycosylases compete with each other. We incubated 39-mer CRE-containing double-stranded oligonucleotides with recombinant CREB1 alone or with UNG2 or OGG1, followed by EMSA. The CpG islet within CRE was modified to contain a G/U or 8-oxoG (degrees G)/C mispair. OGG1 and CREB1 reversibly competed for CRE containing an degrees G/C pair. Also, OGG1 blocked CREB1 from dimerizing by 69%, even when total CREB1 binding was reduced only by 20-30%. In contrast, bound CREB1 completely prevented access to G/U-containing CRE by UNG2 and, therefore, to base excision repair, whereas UNG2 exposure prevented CREB1 binding. CREB1 dimerization was unaffected by UNG2 when CREB1 bound to CRE, but was greatly reduced by prior UNG2 exposure. To explore physiological relevance, we microinjected zebrafish embryos with the same oligonucleotides, as a sink for endogenous CREB1. As predicted, microinjection with unmodified or lesion-containing CRE, but not scrambled CRE or scrambled CRE with a G/U mispair, resulted in increased embryo death. However, only the G/U mispair in native CRE resulted in substantial developmental abnormalities, thus confirming the danger of unrepaired G/U mispairs in promoters. In summary, CREB1 and DNA glycosylases compete for damaged CRE in vitro and in vivo, thus blocking DNA repair and resulting in transcriptional misregulation leading to abnormal development.	[Moore, Stephen P. G.; Kruchten, Joshua; Toomire, Kimberly J.; Strauss, Phyllis R.] Northeastern Univ, Dept Biol, 134 Mugar Hall,360 Huntington Ave, Boston, MA 02115 USA	Northeastern University	Strauss, PR (corresponding author), Northeastern Univ, Dept Biol, 134 Mugar Hall,360 Huntington Ave, Boston, MA 02115 USA.	p.strauss@neu.edu		Moore, Stephen/0000-0002-3311-4472	G. Harold and Leila Y. Mathers Foundation, Aid for Cancer Research; Northeastern University	G. Harold and Leila Y. Mathers Foundation, Aid for Cancer Research; Northeastern University	This work was supported by the G. Harold and Leila Y. Mathers Foundation, Aid for Cancer Research, and funds from Northeastern University. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham J, 2011, ENVIRON MOL MUTAGEN, V52, P287, DOI 10.1002/em.20619; Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Chen LW, 2002, CHEM BIOL, V9, P345, DOI 10.1016/S1074-5521(02)00120-5; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Dominguez PM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00642; Dworkin S, 2007, DEV BIOL, V307, P127, DOI 10.1016/j.ydbio.2007.04.026; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Fortier S, 2009, BIOCHEMISTRY-US, V48, P5396, DOI 10.1021/bi900253d; Ghosh R, 1999, NUCLEIC ACIDS RES, V27, P3213, DOI 10.1093/nar/27.15.3213; Hailer-Morrison MK, 2003, BIOCHEMISTRY-US, V42, P9761, DOI 10.1021/bi034546k; Hara T, 2003, J NEUROCHEM, V86, P805, DOI 10.1046/j.1471-4159.2003.01847.x; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; Lee YN, 2000, BIOCHEMISTRY-US, V39, P4863, DOI 10.1021/bi992272o; Li JF, 2013, ANTIOXID REDOX SIGN, V18, P2429, DOI 10.1089/ars.2012.5107; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lopez DI, 2007, PROTEIN EXPRES PURIF, V55, P406, DOI 10.1016/j.pep.2007.06.011; Martin LJ, 2008, J NEUROPATH EXP NEUR, V67, P377, DOI 10.1097/NEN.0b013e31816ff780; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moore SPG, 2013, DNA REPAIR, V12, P1152, DOI 10.1016/j.dnarep.2013.10.002; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Park YG, 1999, J BIOL CHEM, V274, P1573, DOI 10.1074/jbc.274.3.1573; Pei DS, 2011, NUCLEIC ACIDS RES, V39, P3156, DOI 10.1093/nar/gkq1142; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Ramiro AR, 2015, TRENDS BIOCHEM SCI, V40, P172, DOI 10.1016/j.tibs.2015.01.006; Ramon O, 1999, FREE RADICAL RES, V31, P217, DOI 10.1080/10715769900300781; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sidorenko VS, 2009, FEBS J, V276, P5149, DOI 10.1111/j.1742-4658.2009.07212.x; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Sundaram N, 2003, DEV BIOL, V261, P337, DOI 10.1016/S0012-1606(03)00303-8; Wang Y, 2006, MOL CELL BIOL, V26, P9083, DOI 10.1128/MCB.01216-06; Wu D, 2014, J BIOL CHEM, V289, P15463, DOI 10.1074/jbc.M114.561019; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	40	16	17	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5452	5460		10.1074/jbc.M115.672733	http://dx.doi.org/10.1074/jbc.M115.672733			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26757817	hybrid, Green Published			2022-12-28	WOS:000372551800001
J	Ernst, WL; Shome, K; Wu, CC; Gong, XY; Frizzell, RA; Aridor, M				Ernst, Wayne L.; Shome, Kuntala; Wu, Christine C.; Gong, Xiaoyan; Frizzell, Raymond A.; Aridor, Meir			VAMP-associated Proteins (VAP) as Receptors That Couple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Proteostasis with Lipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); cholesterol regulation; cystic fibrosis transmembrane conductance regulator (CFTR); ER-associated degradation; proteostasis	ENDOPLASMIC-RETICULUM STRESS; AMYOTROPHIC-LATERAL-SCLEROSIS; OXYSTEROL-BINDING-PROTEIN; TRANSCRIPTION FACTOR ATF6; OSBP-RELATED PROTEINS; PICK-C CELLS; MEMBRANE-PROTEIN; QUALITY-CONTROL; PLASMA-MEMBRANE; GOLGI-APPARATUS	Unesterified cholesterol accumulates in late endosomes in cells expressing the misfolded cystic fibrosis transmembrane conductance regulator (CFTR). CFTR misfolding in the endoplasmic reticulum (ER) or general activation of ER stress led to dynein-mediated clustering of cholesterol-loaded late endosomes at the Golgi region, a process regulated by ER-localized VAMP-associated proteins (VAPs). We hypothesized that VAPs serve as intracellular receptors that couple lipid homeostasis through interactions with two phenylalanines in an acidic track (FFAT) binding signals (found in lipid sorting and sensing proteins, LSS) with proteostasis regulation. VAPB inhibited the degradation of F508-CFTR. The activity was mapped to the ligand-binding major sperm protein (MSP) domain, which was sufficient in regulating CFTR biogenesis. We identified mutations in an unstructured loop within the MSP that uncoupled VAPB-regulated CFTR biogenesis from basic interactions with FFAT. Using this information, we defined functional and physical interactions between VAPB and proteostasis regulators (ligands), including the unfolded protein response sensor ATF6 and the ER degradation cluster that included FAF1, VCP, BAP31, and Derlin-1. VAPB inhibited the degradation of F508-CFTR in the ER through interactions with the RMA1-Derlin-BAP31-VCP pathway. Analysis of pseudoligands containing tandem FFAT signals supports a competitive model for VAP interactions that direct CFTR biogenesis. The results suggest a model in which VAP-ligand binding couples proteostasis and lipid homeostasis leading to observed phenotypes of lipid abnormalities in protein folding diseases.	[Ernst, Wayne L.; Shome, Kuntala; Wu, Christine C.; Gong, Xiaoyan; Frizzell, Raymond A.; Aridor, Meir] Univ Pittsburgh, Sch Med, Dept Cell Biol, 3500 Terrace St, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Aridor, M (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, 3500 Terrace St, Pittsburgh, PA 15261 USA.	aridor@pitt.edu		Frizzell, Raymond/0000-0003-0167-4421	Cystic Fibrosis Foundation (CFF) [FRIZZE05XX0]; National Institutes of Health [5R01DK092807, 5P30DK072506]; CFF Postdoctoral Fellowship [ERNST10F0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092807, R01DK068196, P30DK072506] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation (CFF); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFF Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Cystic Fibrosis Foundation (CFF) Grant FRIZZE05XX0 (to R. A. F.), National Institutes of Health Grants 5R01DK092807 (to M. A.) and 5P30DK072506 (to R. A. F.), and CFF Postdoctoral Fellowship ERNST10F0 (to W. L. E.).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Baron Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-39; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Chai A, 2008, HUM MOL GENET, V17, P266, DOI 10.1093/hmg/ddm303; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Cianciola NL, 2011, ARCH BIOCHEM BIOPHYS, V515, P54, DOI 10.1016/j.abb.2011.08.012; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Cutler RG, 2002, ANN NEUROL, V52, P448, DOI 10.1002/ana.10312; Delaunay A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001609; Forrest S, 2013, HUM MOL GENET, V22, P2689, DOI 10.1093/hmg/ddt118; Gentzsch M, 2007, J CELL SCI, V120, P447, DOI 10.1242/jcs.03350; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Goto A, 2012, MOL BIOL CELL, V23, P3624, DOI 10.1091/mbc.E12-04-0283; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Han SM, 2012, DEV CELL, V22, P348, DOI 10.1016/j.devcel.2011.12.009; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hantan Degejirihu, 2014, Kobe J Med Sci, V60, pE48; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; Kim AJ, 2005, J CELL SCI, V118, P89, DOI 10.1242/jcs.01562; Kim H, 2013, J LIPID RES, V54, P2144, DOI 10.1194/jlr.M037218; Kim KH, 2011, PROTEINS, V79, P2583, DOI 10.1002/prot.23073; Kim S, 2010, J BIOL CHEM, V285, P13839, DOI 10.1074/jbc.M109.097345; Kim YJ, 2015, DEV CELL, V33, P549, DOI 10.1016/j.devcel.2015.04.028; Krahmer N, 2013, MOL CELL PROTEOMICS, V12, P1115, DOI 10.1074/mcp.M112.020230; Kuijpers M, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-24; Kuijpers M, 2013, EMBO J, V32, P2056, DOI 10.1038/emboj.2013.131; Kukihara H, 2009, J VIROL, V83, P7959, DOI 10.1128/JVI.00889-09; Lambert G, 2001, J BIOL CHEM, V276, P20340, DOI 10.1074/jbc.M011209200; Lee JJ, 2013, J BIOL CHEM, V288, P6998, DOI 10.1074/jbc.M112.417576; Lehto M, 2001, J LIPID RES, V42, P1203; Lim CH, 2007, CELL PHYSIOL BIOCHEM, V20, P473, DOI 10.1159/000107531; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maiuolo J, 2011, P NATL ACAD SCI USA, V108, P7832, DOI 10.1073/pnas.1101379108; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Mikitova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030455; Moldavski O, 2015, DEV CELL, V33, P603, DOI 10.1016/j.devcel.2015.04.015; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Moumen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026066; Moustaqim-Barrette A, 2014, HUM MOL GENET, V23, P1975, DOI 10.1093/hmg/ddt594; Narita K, 2005, FASEB J, V19, P1558, DOI 10.1096/fj.04-2714fje; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Olkkonen VM, 2013, MOLECULES, V18, P13666, DOI 10.3390/molecules181113666; Olzmann JA, 2013, P NATL ACAD SCI USA, V110, P1345, DOI 10.1073/pnas.1213738110; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; Prosser DC, 2008, J CELL SCI, V121, P3052, DOI 10.1242/jcs.028696; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Ron I, 2008, MOL GENET METAB, V93, P426, DOI 10.1016/j.ymgme.2007.10.132; Sage AT, 2010, AM J PHYSIOL-ENDOC M, V298, pE499, DOI 10.1152/ajpendo.00507.2009; Sanhueza M, 2014, BIOL OPEN, V3, P59, DOI 10.1242/bio.20137070; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Sul JW, 2013, HUM MOL GENET, V22, P1558, DOI 10.1093/hmg/ddt006; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang Y, 2000, J BIOL CHEM, V275, P27013; Weber-Boyvat M, 2013, BIOCHEM PHARMACOL, V86, P89, DOI 10.1016/j.bcp.2013.02.016; White NM, 2007, AM J PHYSIOL-LUNG C, V292, pL476, DOI 10.1152/ajplung.00262.2006; Wilson JD, 2011, MOL BIOL CELL, V22, P1430, DOI 10.1091/mbc.E10-07-0559; Worgall TS, 2009, CURR OPIN CLIN NUTR, V12, P105, DOI 10.1097/MCO.0b013e32832595b7; Xu YQ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-26; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	82	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5206	5220		10.1074/jbc.M115.692749	http://dx.doi.org/10.1074/jbc.M115.692749			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26740627	hybrid, Green Published			2022-12-28	WOS:000371640600032
J	Bohm, S; Szakal, B; Herken, BW; Sullivan, MR; Mihalevic, MJ; Kabbinavar, FF; Branzei, D; Clark, NL; Bernstein, KA				Boehm, Stefanie; Szakal, Barnabas; Herken, Benjamin W.; Sullivan, Meghan R.; Mihalevic, Michael J.; Kabbinavar, Faiz F.; Branzei, Dana; Clark, Nathan L.; Bernstein, Kara A.			The Budding Yeast Ubiquitin Protease Ubp7 Is a Novel Component Involved in S Phase Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; EVOLUTIONARY RATE COVARIATION; HISTONE H2B UBIQUITINATION; DNA-REPLICATION STRESS; SACCHAROMYCES-CEREVISIAE; DISTINCT ROLES; PROTEINS; GENES; COMPLEX; DAMAGE	DNAdamage must be repaired in an accurate and timely fashion to preserve genome stability. Cellular mechanisms preventing genome instability are crucial to human health because genome instability is considered a hallmark of cancer. Collectively referred to as the DNA damage response, conserved pathways ensure proper DNA damage recognition and repair. The function of numerous DNA damage response components is fine-tuned by posttranslational modifications, including ubiquitination. This not only involves the enzyme cascade responsible for conjugating ubiquitin to substrates but also requires enzymes that mediate directed removal of ubiquitin. Deubiquitinases remove ubiquitin from substrates to prevent degradation or to mediate signaling functions. The Saccharomyces cerevisiae deubiquitinase Ubp7 has been characterized previously as an endocytic factor. However, here we identify Ubp7 as a novel factor affecting S phase progression after hydroxyurea treatment and demonstrate an evolutionary and genetic interaction of Ubp7 with DNA damage repair pathways of homologous recombination and nucleotide excision repair. We find that deletion of UBP7 sensitizes cells to hydroxyurea and cisplatin and demonstrate that factors that stabilize replication forks are critical under these conditions. Furthermore, ubp7 Delta cells exhibit an S phase progression defect upon checkpoint activation by hydroxyurea treatment. ubp7 Delta mutants are epistatic to factors involved in histone maintenance and modification, and we find that a subset of Ubp7 is chromatin-associated. In summary, our results suggest that Ubp7 contributes to S phase progression by affecting the chromatin state at replication forks, and we propose histone H2B ubiquitination as a potential substrate of Ubp7.	[Boehm, Stefanie; Herken, Benjamin W.; Sullivan, Meghan R.; Mihalevic, Michael J.; Kabbinavar, Faiz F.; Bernstein, Kara A.] Univ Pittsburgh, Sch Med, Inst Canc, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Clark, Nathan L.] Univ Pittsburgh, Sch Med, Dept Commun & Syst Biol, Pittsburgh, PA 15213 USA; [Szakal, Barnabas; Branzei, Dana] Fdn Ist Fdn Italiana Ric Canc Oncol Mol, Dept Mol Oncol, I-20139 Milan, Italy; [Boehm, Stefanie] Univ Cologne, Mol Pathol & Dept Translat Genom, D-50931 Cologne, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Cologne	Clark, NL (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	karab@pitt.edu	Bernstein, Kara Anne/S-4943-2016; Clark, Nathan/P-4855-2014; Branzei, Dana/GOG-9093-2022	Bernstein, Kara Anne/0000-0003-2247-6459; Clark, Nathan/0000-0003-0006-8374; Branzei, Dana/0000-0002-0544-4888; Szakal, Barnabas/0000-0001-6888-1383	National Institutes of Health [ES024872, GM088413, P30CA047904]; Ellison Medical Foundation [AG-NS-0935-12]; Charles E. Kaufman Award through Pittsburgh Foundation [KA2014-73920]; CURE grant from Pennsylvania Department of Health; Center for Causal Discovery (National Institutes of Health) [U54HG008540]; Associazione Italiana per la Ricerca sul Cancro Italian Association for Cancer Research Grant [IG14171]; Fondazione Telethon Grant [GGP12160]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG008540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM088413, R00GM088413] Funding Source: NIH RePORTER	National Institutes of Health; Ellison Medical Foundation(Lawrence Ellison Foundation); Charles E. Kaufman Award through Pittsburgh Foundation; CURE grant from Pennsylvania Department of Health; Center for Causal Discovery (National Institutes of Health); Associazione Italiana per la Ricerca sul Cancro Italian Association for Cancer Research Grant(Fondazione AIRC per la ricerca sul cancro); Fondazione Telethon Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants ES024872 and GM088413) and Ellison Medical Foundation Grant AG-NS-0935-12 (to K. A. B.), by Charles E. Kaufman Award KA2014-73920 through The Pittsburgh Foundation, by a CURE grant from the Pennsylvania Department of Health, by the Center for Causal Discovery (National Institutes of Health Grant U54HG008540) (to N. L. C.), by Associazione Italiana per la Ricerca sul Cancro Italian Association for Cancer Research Grant IG14171, and by Fondazione Telethon Grant GGP12160 (to D. B.). This project used the University of Pittsburgh Cancer Institute Cytometry Facility that is supported in part by National Institutes of Health Award P30CA047904. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Balakrishnan R, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar062; BANKMANN M, 1992, NATURE, V355, P555, DOI 10.1038/355555a0; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602; Bjergbaek L, 2005, EMBO J, V24, P405, DOI 10.1038/sj.emboj.7600511; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Clark NL, 2013, GENETICS, V193, P529, DOI 10.1534/genetics.112.145979; Clark NL, 2012, GENOME RES, V22, P714, DOI 10.1101/gr.132647.111; Clark NL, 2010, MOL BIOL EVOL, V27, P1152, DOI 10.1093/molbev/msp324; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; COX BS, 1968, MUTAT RES, V6, P37, DOI 10.1016/0027-5107(68)90101-2; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Franco AA, 2005, GENE DEV, V19, P1365, DOI 10.1101/gad.1305005; Gallego-Sanchez A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002826; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Gazy I, 2013, G3-GENES GENOM GENET, V3, P917, DOI 10.1534/g3.113.005561; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Giannattasio M, 2014, NAT STRUCT MOL BIOL, V21, P884, DOI 10.1038/nsmb.2888; Godin S, 2013, NUCLEIC ACIDS RES, V41, P4525, DOI 10.1093/nar/gkt138; Godin SK, 2015, GENETICS, V199, P1023, DOI 10.1534/genetics.114.173518; Guzder SN, 1998, J BIOL CHEM, V273, P31541, DOI 10.1074/jbc.273.47.31541; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; Hegnauer AM, 2012, EMBO J, V31, P3768, DOI 10.1038/emboj.2012.195; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Hustedt N, 2013, GENES-BASEL, V4, P388, DOI 10.3390/genes4030388; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jansen LET, 1998, J BIOL CHEM, V273, P33111, DOI 10.1074/jbc.273.50.33111; Johnsen SA, 2012, FEBS LETT, V586, P1592, DOI 10.1016/j.febslet.2012.04.002; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lin CY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004667; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; McHugh PJ, 2012, CELL CYCLE, V11, P3739, DOI 10.4161/cc.21727; Nishi R, 2014, NAT CELL BIOL, V16, P1016, DOI 10.1038/ncb3028; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Pepe A, 2014, CELL REP, V7, P1048, DOI 10.1016/j.celrep.2014.04.007; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Qin S, 2009, NUCLEIC ACIDS RES, V37, P1843, DOI 10.1093/nar/gkn1049; Reed SH, 1998, J BIOL CHEM, V273, P29481, DOI 10.1074/jbc.273.45.29481; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rhie BH, 2013, BIOCHEM BIOPH RES CO, V439, P570, DOI 10.1016/j.bbrc.2013.09.017; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sherman F., 1986, METHODS YEAST GENETI; Song YH, 2010, J BIOL CHEM, V285, P2361, DOI 10.1074/jbc.M109.039255; Swanson RL, 1999, MOL CELL BIOL, V19, P2929; Szakal B, 2013, EMBO J, V32, P1155, DOI 10.1038/emboj.2013.67; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Wang AY, 2009, P NATL ACAD SCI USA, V106, P21573, DOI 10.1073/pnas.0906539106; Weinberg JS, 2014, CURR BIOL, V24, P951, DOI 10.1016/j.cub.2014.03.038; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	67	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4442	4452		10.1074/jbc.M115.671057	http://dx.doi.org/10.1074/jbc.M115.671057			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26740628	Green Published, hybrid			2022-12-28	WOS:000371604600016
J	Yu, SH; Zhao, P; Sun, TT; Gao, ZW; Moremen, KW; Boons, GJ; Wells, L; Steet, R				Yu, Seok-Ho; Zhao, Peng; Sun, Tiantian; Gao, Zhongwei; Moremen, Kelley W.; Boons, Geert-Jan; Wells, Lance; Steet, Richard			Selective Exo-Enzymatic Labeling Detects Increased Cell Surface Sialoglycoprotein Expression upon Megakaryocytic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-galactoside-2; 6-sialyltransferase 1 (ST6GAL1); cell differentiation; click chemistry; glycosyltransferase; proteomics; sialic acid	LIVING CELLS; SIALYLATED GLYCOPROTEINS; GLYCANS; LEUKOSIALIN; PHENOTYPE; ADHESION; FEATURES; MEDIATE	Selective exo-enzymatic labeling (or SEEL) uses recombinant glycosyltransferases and nucleotide-sugar analogues to allow efficient labeling of cell surface glycans. SEEL can circumvent many of the possible issues associated with metabolic labeling, including low incorporation of sugar precursors, and allows for sugars to be added selectively to different types of glycans by virtue of the inherent specificity of the glycosyltransferases. Here we compare the labeling of sialoglycoproteins in undifferentiated and differentiated human erythroleukemia cells (HEL) using SEEL using the sialyltransferases ST6Gal1 and ST3Gal1, which label N- and O-glycans, respectively. Our results show that the profile of glycoproteins detected varies between undifferentiated HEL cells and those differentiated to megakaryocytes, with a shift to more N-linked sialoglycoproteins in the differentiated cells. The efficiency of SEEL for both sialyltransferases in HEL cells was greatly increased with prior neuraminidase treatment highlighting the necessity for the presence of available acceptors with this labeling method. Following metabolic labeling or SEEL, tagged glycoproteins were enriched by immunoprecipitation and identified using mass spectrometry. The proteomic findings demonstrated that the detection of many glycoproteins is markedly improved by SEEL labeling, and that unique glycoproteins can be identified using either ST6Gal1 or ST3Gal1. Furthermore, this analysis enabled the identification of increased surface expression of several sialylated cell adhesion molecules, including the known megakaryocytic markers integrin3 and CD44, upon differentiation of HEL cells to adherent megakaryocytes.	[Yu, Seok-Ho; Zhao, Peng; Sun, Tiantian; Gao, Zhongwei; Moremen, Kelley W.; Boons, Geert-Jan; Wells, Lance; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	lwell@ccrc.uga.edu; rsteet@ccrc.uga.edu	Boons, Geert-Jan P H/J-3211-2016; Moremen, Kelley/AAD-4661-2019	Boons, Geert-Jan P H/0000-0003-3111-5954; Yu, Seok-Ho/0000-0002-8372-1094; Wells, Lance/0000-0003-4956-5363; Zhao, Peng/0000-0002-9296-5293	National Institutes of Health from NIGMS [GM-107012]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490, P01GM107012] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health P01 Grant GM-107012 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almaraz RT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.017558; Barnes J, 2012, J BIOL CHEM, V287, P7526, DOI 10.1074/jbc.M111.308825; Baskin JM, 2010, P NATL ACAD SCI USA, V107, P10360, DOI 10.1073/pnas.0912081107; Bilyy RO, 2012, J BIOL CHEM, V287, P496, DOI 10.1074/jbc.M111.273144; Boons GJ, 2010, SPR CARB CH, V36, P152, DOI 10.1039/9781849730891-00152; Chang PV, 2009, ANGEW CHEM INT EDIT, V48, P4030, DOI 10.1002/anie.200806319; Cook BN, 2002, BIOORGAN MED CHEM, V10, P829, DOI 10.1016/S0968-0896(01)00376-5; Dehnert KW, 2012, CHEMBIOCHEM, V13, P353, DOI 10.1002/cbic.201100649; Franz S, 2007, CELL DEATH DIFFER, V14, P733, DOI 10.1038/sj.cdd.4402066; Friscourt F, 2012, J AM CHEM SOC, V134, P5381, DOI 10.1021/ja3002666; FUKUDA M, 1986, MED BIOL, V64, P335; Hagiwara T, 1996, EXP HEMATOL, V24, P690; Henne WM, 2015, CURR OPIN CELL BIOL, V35, P123, DOI 10.1016/j.ceb.2015.05.001; Jiang H, 2011, JOVE-J VIS EXP, DOI 10.3791/2686; Kiwamoto T, 2014, J ALLERGY CLIN IMMUN, V133, P240, DOI 10.1016/j.jaci.2013.05.018; KOSHIISHI I, 1994, BLOOD, V84, P390; LONG MW, 1990, J CLIN INVEST, V85, P1072, DOI 10.1172/JCI114538; Luchansky SJ, 2004, BIOCHEMISTRY-US, V43, P12358, DOI 10.1021/bi049274f; MAEMURA K, 1992, J BIOL CHEM, V267, P24379; Mbua NE, 2013, ANGEW CHEM INT EDIT, V52, P13012, DOI 10.1002/anie.201307095; Mbua NE, 2013, P NATL ACAD SCI USA, V110, P10207, DOI 10.1073/pnas.1221105110; Mbua NE, 2011, CHEMBIOCHEM, V12, P1911, DOI 10.1002/cbic.201100117; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; MOLLA A, 1995, BIOCHEM J, V309, P491, DOI 10.1042/bj3090491; Phillips M. J., 2015, NATURE REV IN PRESS; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Tian Y, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9083-8; WHITEHEART SW, 1987, ANAL BIOCHEM, V163, P123, DOI 10.1016/0003-2697(87)90102-3; Zauli G, 1996, BRIT J HAEMATOL, V92, P530, DOI 10.1046/j.1365-2141.1996.00384.x; Zeng Y, 2009, NAT METHODS, V6, P207, DOI [10.1038/NMETH.1305, 10.1038/nmeth.1305]	30	36	38	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3982	3989		10.1074/jbc.M115.700369	http://dx.doi.org/10.1074/jbc.M115.700369			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26733198	Green Published, hybrid			2022-12-28	WOS:000371338400025
J	Coke, CJ; Scarlett, KA; Chetram, MA; Jones, KJ; Sandifer, BJ; Davis, AS; Marcus, AI; Hinton, CV				Coke, Christopher J.; Scarlett, Kisha A.; Chetram, Mahandranauth A.; Jones, Kia J.; Sandifer, Brittney J.; Davis, Ahriea S.; Marcus, Adam I.; Hinton, Cimona V.			Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELL-MIGRATION; ADENYLATE-CYCLASE; HUMAN BREAST; PC-3 CELLS; FACTOR-I; EXPRESSION; PROTEIN; METASTASIS; INHIBITION; LIGAND	The G-protein-coupled chemokine receptor CXCR4 generates signals that lead to cell migration, cell proliferation, and other survival mechanisms that result in the metastatic spread of primary tumor cells to distal organs. Numerous studies have demonstrated that CXCR4 can form homodimers or can heterodimerize with other G-protein-coupled receptors to form receptor complexes that can amplify or decrease the signaling capacity of each individual receptor. Using biophysical and biochemical approaches, we found that CXCR4 can form an induced heterodimer with cannabinoid receptor 2 (CB2) in human breast and prostate cancer cells. Simultaneous, agonist-dependent activation of CXCR4 and CB2 resulted in reduced CXCR4-mediated expression of phosphorylated ERK1/2 and ultimately reduced cancer cell functions such as calcium mobilization and cellular chemotaxis. Given that treatment with cannabinoids has been shown to reduce invasiveness of cancer cells as well as CXCR4-mediated migration of immune cells, it is plausible that CXCR4 signaling can be silenced through a physical heterodimeric association with CB2, thereby inhibiting subsequent functions of CXCR4. Taken together, the data illustrate a mechanism by which the cannabinoid system can negatively modulate CXCR4 receptor function and perhaps tumor progression.	[Coke, Christopher J.; Scarlett, Kisha A.; Jones, Kia J.; Sandifer, Brittney J.; Davis, Ahriea S.; Hinton, Cimona V.] Clark Atlanta Univ, Dept Biol Sci, 223 James P Brawley Dr SW, Atlanta, GA 30314 USA; [Coke, Christopher J.; Scarlett, Kisha A.; Jones, Kia J.; Sandifer, Brittney J.; Davis, Ahriea S.; Hinton, Cimona V.] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, 223 James P Brawley Dr SW, Atlanta, GA 30314 USA; [Chetram, Mahandranauth A.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Mol Oncol Program, Washington, DC USA; [Marcus, Adam I.] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Clark Atlanta University; Clark Atlanta University; Georgetown University; Emory University	Hinton, CV (corresponding author), Clark Atlanta Univ, Dept Biol Sci, 223 James P Brawley Dr SW, Atlanta, GA 30314 USA.; Hinton, CV (corresponding author), Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, 223 James P Brawley Dr SW, Atlanta, GA 30314 USA.	chinton@cau.edu		Hinton, Cimona/0000-0002-5724-1804	National Institutes of Health from the NIGMS [1R01GM106020, 3R01GM106020, R25GM060414]; Research Centers in Minority Institutions Program [5G12MD007590]; NATIONAL CANCER INSTITUTE [T32CA009686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060414, R01GM106020] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007590] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research Centers in Minority Institutions Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grants 1R01GM106020, 3R01GM106020, and R25GM060414 from the NIGMS and Grant 5G12MD007590 from the Research Centers in Minority Institutions Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agle KA, 2010, J BIOL CHEM, V285, P16066, DOI 10.1074/jbc.M109.061416; Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/NCHEMBIO.396, 10.1038/nchembio.396]; Ali H, 1997, MED CLIN N AM, V81, P1, DOI 10.1016/S0025-7125(05)70503-4; Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Benamar K, 2008, J PHARMACOL EXP THER, V325, P641, DOI 10.1124/jpet.107.135053; Blazquez C, 2003, FASEB J, V17, P529, DOI 10.1096/fj.02-0795fje; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; Callen L, 2012, J BIOL CHEM, V287, P20851, DOI 10.1074/jbc.M111.335273; Chen CG, 2004, EUR J PHARMACOL, V483, P175, DOI 10.1016/j.ejphar.2003.10.033; Chetram MA, 2011, BIOCHEM BIOPH RES CO, V410, P195, DOI 10.1016/j.bbrc.2011.05.074; Chetram MA, 2011, MOL CANCER RES, V9, P90, DOI 10.1158/1541-7786.MCR-10-0235; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Chinni SR, 2008, MOL CANCER RES, V6, P446, DOI 10.1158/1541-7786.MCR-07-0117; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Correa F, 2005, BRIT J PHARMACOL, V145, P441, DOI 10.1038/sj.bjp.0706215; Costantino CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033961; Croci T, 1998, BRIT J PHARMACOL, V125, P1393, DOI 10.1038/sj.bjp.0702190; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Dias J, 2014, AM J PHYSIOL-RENAL, V306, pF855, DOI 10.1152/ajprenal.00488.2013; Don-Salu-Hewage AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057194; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Engl T, 2006, NEOPLASIA, V8, P290, DOI 10.1593/neo.05694; Franco Rafael, 2007, ScientificWorldJournal, V7, P48; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; GERARD C, 1994, CURR OPIN IMMUNOL, V6, P140, DOI 10.1016/0952-7915(94)90045-0; Ghosh S, 2006, MOL IMMUNOL, V43, P2169, DOI 10.1016/j.molimm.2006.01.005; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Guzman M, 2001, J MOL MED-JMM, V78, P613, DOI 10.1007/s001090000177; Haack KKV, 2011, PHARMACEUTICALS, V4, P509, DOI 10.3390/ph4030509; Hamada T, 1996, GENE, V176, P211, DOI 10.1016/0378-1119(96)00251-X; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hereld D, 2008, EUR J IMMUNOL, V38, P334, DOI 10.1002/eji.200738101; HOWLETT AC, 1984, LIFE SCI, V35, P1803, DOI 10.1016/0024-3205(84)90278-9; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; HOWLETT AC, 1985, MOL PHARMACOL, V27, P429; Humblet Valerie, 2005, Mol Imaging, V4, P448; Hurst Dow P., 2009, P235, DOI 10.1007/978-1-59745-503-9_9; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; Jorda MA, 2002, BLOOD, V99, P2786; Joseph J, 2004, CANCER IMMUNOL IMMUN, V53, P723, DOI 10.1007/s00262-004-0509-9; Karnoub Antoine E, 2006, Breast Dis, V26, P75; Kato M, 2003, BREAST CANCER RES, V5, pR144, DOI 10.1186/bcr627; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Lee BC, 2004, MOL CANCER RES, V2, P327; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Munoz LM, 2011, PHARMACOL THERAPEUT, V131, P351, DOI 10.1016/j.pharmthera.2011.05.002; McKallip RJ, 2005, J IMMUNOL, V174, P3281, DOI 10.4049/jimmunol.174.6.3281; Melck D, 2000, ENDOCRINOLOGY, V141, P118, DOI 10.1210/en.141.1.118; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Rodriguez-Frade JM, 2009, METHOD ENZYMOL, V461, P105, DOI 10.1016/S0076-6879(09)05405-6; Misra P, 2008, J NUCL MED, V49, P963, DOI 10.2967/jnumed.107.050054; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nasser MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023901; Ohtani Y, 1998, NEUROSCI LETT, V249, P163, DOI 10.1016/S0304-3940(98)00425-X; Pello OM, 2008, EUR J IMMUNOL, V38, P537, DOI 10.1002/eji.200737630; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Pertwee R. G., 1995, CANNABINOIDS; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pertwee RG, 2001, PROG NEUROBIOL, V63, P569, DOI 10.1016/S0301-0082(00)00031-9; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pisanti S, 2009, BEST PRACT RES CL EN, V23, P117, DOI 10.1016/j.beem.2009.02.001; Prasad A, 2007, J LEUKOCYTE BIOL, V82, P465, DOI 10.1189/jlb.1106678; Premack BA, 1996, NAT MED, V2, P1174, DOI 10.1038/nm1196-1174; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Qamri Z, 2009, MOL CANCER THER, V8, P3117, DOI 10.1158/1535-7163.MCT-09-0448; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Ruiz L, 1999, FEBS LETT, V458, P400, DOI 10.1016/S0014-5793(99)01073-X; Sarfaraz S, 2008, CANCER RES, V68, P339, DOI 10.1158/0008-5472.CAN-07-2785; Satake H, 2008, PROTEIN PEPTIDE LETT, V15, P300, DOI 10.2174/092986608783744207; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Steele AD, 2002, CYTOKINE GROWTH F R, V13, P209, DOI 10.1016/S1359-6101(02)00007-2; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Szabo B, 2001, J PHARMACOL EXP THER, V297, P819; Taichman RS, 2002, CANCER RES, V62, P1832; Taub D D, 1994, Ther Immunol, V1, P229; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wagner JA, 2001, EUR J PHARMACOL, V423, P203, DOI 10.1016/S0014-2999(01)01112-8; Wang JH, 2005, CELL SIGNAL, V17, P1578, DOI 10.1016/j.cellsig.2005.03.022; Wang JH, 2004, J CELL BIOCHEM, V93, P753, DOI 10.1002/jcb.20161; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Wang JH, 2006, MOL CANCER THER, V5, P2474, DOI 10.1158/1535-7163.MCT-05-0261; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	92	62	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9991	10005		10.1074/jbc.M115.712661	http://dx.doi.org/10.1074/jbc.M115.712661			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26841863	hybrid, Green Published			2022-12-28	WOS:000375602800013
J	Brown, KM; Lourido, S; Sibley, LD				Brown, Kevin M.; Lourido, Sebastian; Sibley, L. David			Serum Albumin Stimulates Protein Kinase G-dependent Microneme Secretion in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; INTRACELLULAR CA2+; GAUSSIA LUCIFERASE; CELL INVASION; HOST-CELLS; INHIBITORS; MOTILITY; IDENTIFICATION; EXOCYTOSIS; EXPRESSION	Microneme secretion is essential for motility, invasion, and egress in apicomplexan parasites. Although previous studies indicate that Ca2+ and cGMP control microneme secretion, little is known about how these pathways are naturally activated. Here we have developed genetically encoded indicators for Ca2+ and microneme secretion to better define the signaling pathways that regulate these processes in Toxoplasma gondii. We found that microneme secretion was triggered in vitro by exposure to a single host protein, serum albumin. The natural agonist serum albumin induced microneme secretion in a protein kinase G-dependent manner that correlated with increased cGMP levels. Surprisingly, serum albumin acted independently of elevated Ca2+ and yet it was augmented by artificial agonists that raise Ca2+, such as ethanol. Furthermore, although ethanol elevated intracellular Ca2+, it alone was unable to trigger secretion without the presence of serum or serum albumin. This dichotomy was recapitulated by zaprinast, a phosphodiesterase inhibitor that elevated cGMP and separately increased Ca2+ in a protein kinase G-independent manner leading to microneme secretion. Taken together, these findings reveal that microneme secretion is centrally controlled by protein kinase G and that this pathway is further augmented by elevation of intracellular Ca2+.	[Brown, Kevin M.; Lourido, Sebastian; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Lourido, Sebastian] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA	Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Whitehead Institute	Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	sibley@wusm.wustl.edu		Lourido, Sebastian/0000-0002-5237-1095	National Institutes of Health [AI034036]; American Heart Association [15POST22130001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094098, R01AI034036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI034036 (to L. D. S.) and American Heart Association Postdoctoral Fellowship 15POST22130001 (to K. M. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflict of interest with the contents of this article.	Alam MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8285; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; Bumstead J, 2000, MOL BIOCHEM PARASIT, V110, P311, DOI 10.1016/S0166-6851(00)00280-2; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers Vern B., 2008, V47, P33; Charron AJ, 2002, J CELL SCI, V115, P3049; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Donald RGK, 2002, EUKARYOT CELL, V1, P317, DOI 10.1128/EC.1.3.317-328.2002; Donald RGK, 2002, MOL BIOCHEM PARASIT, V120, P165, DOI 10.1016/S0166-6851(01)00451-0; Donald RGK, 2006, MOL BIOCHEM PARASIT, V149, P86, DOI 10.1016/j.molbiopara.2006.05.003; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Etheridge RD, 2014, CELL HOST MICROBE, V15, P537, DOI 10.1016/j.chom.2014.04.002; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Gould MK, 2011, FEMS MICROBIOL REV, V35, P515, DOI 10.1111/j.1574-6976.2010.00262.x; Hall CI, 2011, P NATL ACAD SCI USA, V108, P10568, DOI 10.1073/pnas.1105622108; Hoff EF, 2001, EXP PARASITOL, V97, P77, DOI 10.1006/expr.2000.4585; Howard BL, 2015, ACS CHEM BIOL, V10, P1145, DOI 10.1021/cb501004q; Hui R, 2015, TRENDS PHARMACOL SCI, V36, P452, DOI 10.1016/j.tips.2015.04.011; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kappe S, 1999, J CELL BIOL, V147, P937, DOI 10.1083/jcb.147.5.937; Kebaier C, 2010, INT J PARASITOL, V40, P25, DOI 10.1016/j.ijpara.2009.06.011; Lourido S, 2015, CELL CALCIUM, V57, P186, DOI 10.1016/j.ceca.2014.12.010; Lourido S, 2013, ACS CHEM BIOL, V8, P1155, DOI 10.1021/cb400115y; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Lucet IS, 2012, FUTURE MED CHEM, V4, P2295, DOI [10.4155/FMC.12.183, 10.4155/fmc.12.183]; Matthiesen SH, 2003, CELL MICROBIOL, V5, P613, DOI 10.1046/j.1462-5822.2003.00305.x; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Sibley LD, 2010, CURR OPIN BIOTECH, V21, P592, DOI 10.1016/j.copbio.2010.05.009; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; Sugi T, 2010, EUKARYOT CELL, V9, P667, DOI 10.1128/EC.00351-09; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; UPTON SJ, 1992, J PARASITOL, V78, P329, DOI 10.2307/3283483; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Wan KL, 1997, MOL BIOCHEM PARASIT, V84, P203, DOI 10.1016/S0166-6851(96)02796-X; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019	47	44	46	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9554	9565		10.1074/jbc.M115.700518	http://dx.doi.org/10.1074/jbc.M115.700518			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26933037	hybrid, Green Published			2022-12-28	WOS:000375602300015
J	Quek, DQY; Nguyen, LN; Fan, H; Silver, DL				Quek, Debra Q. Y.; Nguyen, Long N.; Fan, Hao; Silver, David L.			Structural Insights into the Transport Mechanism of the Human Sodium-dependent Lysophosphatidylcholine Transporter MFSD2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR FACILITATOR SUPERFAMILY; MEMBRANE-SPANNING SEGMENTS; BLOOD-BRAIN-BARRIER; ESCHERICHIA-COLI; MELIBIOSE PERMEASE; DOCOSAHEXAENOIC ACID; MICROCEPHALY SYNDROME; SUGAR-TRANSPORT; HELIX-II; PROTEIN	Major facilitator superfamily domain containing 2A (MFSD2A) was recently characterized as a sodium-dependent lysophosphatidylcholine transporter expressed at the blood-brain barrier endothelium. It is the primary route for importation of docosohexaenoic acid and other long-chain fatty acids into fetal and adult brain and is essential for mouse and human brain growth and function. Remarkably, MFSD2A is the first identified major facilitator superfamily member that uniquely transports lipids, implying that MFSD2A harbors unique structural features and transport mechanism. Here, we present three three-dimensional structural models of human MFSD2A derived by homology modeling using MelB-and LacY-based crystal structures and refined by biochemical analysis. All models revealed 12 transmembrane helices and connecting loops and represented the partially outward-open, outward-partially occluded, and inward-open states of the transport cycle. In addition to a conserved sodium-binding site, three unique structural features were identified as follows: a phosphate headgroup binding site, a hydrophobic cleft to accommodate a hydrophobic hydrocarbon tail, and three sets of ionic locks that stabilize the outward-open conformation. Ligand docking studies and biochemical assays identified Lys-436 as a key residue for transport. It is seen forming a salt bridge with the negative charge on the phosphate headgroup. Importantly, MFSD2A transported structurally related acylcarnitines but not a lysolipid without a negative charge, demonstrating the necessity of a negatively charged headgroup interaction with Lys-436 for transport. These findings support a novel transport mechanism by which lysophosphatidylcholines are "flipped" within the transporter cavity by pivoting about Lys-436 leading to net transport from the outer to the inner leaflet of the plasma membrane.	[Quek, Debra Q. Y.; Silver, David L.] Duke Natl Univ Singapore, Grad Sch Med, Signature Res Program Cardiovasc & Metab Disorder, Singapore 169857, Singapore; [Nguyen, Long N.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117545, Singapore; [Fan, Hao] Natl Univ Singapore, Dept Biol Sci, Singapore 117545, Singapore; [Fan, Hao] ASTAR, Bioinformat Inst, 30 Biopolis St,Matrix 07-01, Singapore 138671, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Fan, H (corresponding author), ASTAR, Bioinformat Inst, 30 Biopolis St,Matrix 07-01, Singapore 138671, Singapore.; Silver, DL (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 16985, Japan.	fanh@bii.a-star.edu.sg; david.silver@duke-nus.edu.sg	Nguyen, Long/AAY-6172-2021	Nguyen, Long N/0000-0002-9857-2239	Singapore Ministry of Health National Medical Research Council [CBRG/069/2014]; Singapore Ministry of Education Tier2 Grant [MOE2014-T2-2-018]; Biomedical Research Council of A*STAR; National University of Singapore	Singapore Ministry of Health National Medical Research Council(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Singapore Ministry of Education Tier2 Grant(Ministry of Education, Singapore); Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore)	This work was supported by Singapore Ministry of Health National Medical Research Council Grant CBRG/069/2014, Singapore Ministry of Education Tier2 Grant MOE2014-T2-2-018 (to D. L. S.), Biomedical Research Council of A*STAR (to H. F.), and the President's Graduate Fellowship Award from National University of Singapore (to D. Q. Y. Q.). The authors declare that they have no conflicts of interest with the contents of this article.	Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angers M, 2008, BIOCHEM J, V416, P347, DOI 10.1042/BJ20080165; BAISTED DJ, 1988, BIOCHEM J, V253, P693, DOI 10.1042/bj2530693; BARTON PG, 1975, J BIOL CHEM, V250, P4470; Bazan NG, 2009, J LIPID RES, V50, pS400, DOI 10.1194/jlr.R800068-JLR200; Betsholtz C, 2014, NATURE, V509, P432, DOI 10.1038/nature13339; BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0005-2736(72)90365-3; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clark MR, 2011, NAT IMMUNOL, V12, P373, DOI 10.1038/ni.2024; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edmond J, 1998, J NEUROCHEM, V70, P1227; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Franco PJ, 1999, J BACTERIOL, V181, P6377, DOI 10.1128/JB.181.20.6377-6386.1999; Franco PJ, 2001, BBA-BIOMEMBRANES, V1510, P231, DOI 10.1016/S0005-2736(00)00353-9; Fuerst O, 2015, J BIOL CHEM, V290, P16261, DOI 10.1074/jbc.M115.642678; Gomes P, 1999, BRAIN RES, V829, P143, DOI 10.1016/S0006-8993(99)01387-6; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; HAMA H, 1994, J BIOL CHEM, V269, P1063; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lagarde M, 2001, J MOL NEUROSCI, V16, P201, DOI 10.1385/JMN:16:2-3:201; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lemieux MJ, 2003, PROTEIN SCI, V12, P2748, DOI 10.1110/ps.03276603; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matsuzaki S, 1999, BBA-BIOMEMBRANES, V1420, P63, DOI 10.1016/S0005-2736(99)00087-5; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Nomura N, 2015, NATURE, V526, P397, DOI 10.1038/nature14909; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; POURCHER T, 1991, BIOCHEM BIOPH RES CO, V178, P1176, DOI 10.1016/0006-291X(91)91016-6; POURCHER T, 1993, J BIOL CHEM, V268, P3209; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Yousef MS, 2009, P NATL ACAD SCI USA, V106, P15291, DOI 10.1073/pnas.0905516106; ZANI ML, 1993, J BIOL CHEM, V268, P3216; ZANI ML, 1994, J BIOL CHEM, V269, P24883	51	49	51	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9383	9394		10.1074/jbc.M116.721035	http://dx.doi.org/10.1074/jbc.M116.721035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26945070	Green Published, hybrid			2022-12-28	WOS:000375602300001
J	Vilanova, E; Santos, GRC; Aquino, RS; Valle-Delgado, JJ; Anselmetti, D; Fernandez-Busquets, X; Mourao, PAS				Vilanova, Eduardo; Santos, Gustavo R. C.; Aquino, Rafael S.; Valle-Delgado, Juan J.; Anselmetti, Dario; Fernandez-Busquets, Xavier; Mourao, Paulo A. S.			Carbohydrate-Carbohydrate Interactions Mediated by Sulfate Esters and Calcium Provide the Cell Adhesion Required for the Emergence of Early Metazoans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR PROTEOGLYCANS; FORCE; RECOGNITION; GLYCOSAMINOGLYCANS; POLYSACCHARIDES; GALACTAN; CHONDROITIN; RECEPTOR; PORIFERA; SPONGES	Early metazoans had to evolve the first cell adhesion mechanism addressed to maintain a distinctive multicellular morphology. As the oldest extant animals, sponges are good candidates for possessing remnants of the molecules responsible for this crucial evolutionary innovation. Cell adhesion in sponges is mediated by the calcium-dependent multivalent self-interactions of sulfated polysaccharides components of extracellular membrane-bound proteoglycans, namely aggregation factors. Here, we used atomic force microscopy to demonstrate that the aggregation factor of the sponge Desmapsamma anchorata has a circular supramolecular structure and that it thus belongs to the spongican family. Its sulfated polysaccharide units, which were characterized via nuclear magnetic resonance analysis, consist preponderantly of a central backbone composed of 3-alpha-Glc1 units partially sulfated at 2-and 4-positions and branches of Pyr(4,6)alpha-Gal1 -> 3-alpha-Fuc2(SO3)1 -> 3-alpha-Glc4(SO3) 1 -> 3-alpha-Glc -> 4-linked to the central alpha-Glc units. Single-molecule force measurements of self-binding forces of this sulfated polysaccharide and their chemically desulfated and carboxyl-reduced derivatives revealed that the sulfate epitopes and extracellular calcium are essential for providing the strength and stability necessary to sustain cell adhesion in sponges. We further discuss these findings within the framework of the role of molecular structures in the early evolution of metazoans.	[Vilanova, Eduardo; Santos, Gustavo R. C.; Aquino, Rafael S.; Mourao, Paulo A. S.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, BR-21941913 Rio de Janeiro, Brazil; [Vilanova, Eduardo; Santos, Gustavo R. C.; Aquino, Rafael S.; Mourao, Paulo A. S.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, BR-21941913 Rio de Janeiro, Brazil; [Valle-Delgado, Juan J.; Fernandez-Busquets, Xavier] Inst Bioengn Catalonia IBEC, Nanomalaria Grp, Barcelona 08028, Spain; [Valle-Delgado, Juan J.; Fernandez-Busquets, Xavier] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, E-08036 Barcelona, Spain; [Valle-Delgado, Juan J.; Fernandez-Busquets, Xavier] Univ Barcelona, Nanosci & Nanotechnol Inst IN2UB, E-08028 Barcelona, Spain; [Anselmetti, Dario] Univ Bielefeld, Fac Phys, Expt Biophys & Appl Nanosci, D-33615 Bielefeld, Germany; [Valle-Delgado, Juan J.] Aalto Univ, Sch Chem Technol, Dept Forest Prod Technol, Aalto 00076, Finland	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Bielefeld; Aalto University	Fernandez-Busquets, X (corresponding author), Ctr Esther Koplowitz, Barcelona Ctr Int Hlth Res ISGlobal, Planta 1,Rossello 149-153, Barcelona 08036, Spain.; Mourao, PAS (corresponding author), Hosp Univ Clementino Fraga Filho, Rua Prof Paulo Rocco 255,Sala 4a01, BR-21941913 Rio De Janeiro, Brazil.	xfernandez_busquets@ub.edu; pmourao@hucff.ufrj.br	Mourao, Paulo/AAA-5386-2020; Anselmetti, Dario/F-1664-2011; Valle-Delgado, Juan Jose/H-8857-2013	Anselmetti, Dario/0000-0002-8720-4369; Valle-Delgado, Juan Jose/0000-0002-4808-1730	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES), Brazil; Fundacion Carolina, Spain; Ministerio de Economia y Competitividad [BIO2011-25039, BIO2014-52872-R]; Generalitat de Catalunya, Spain [2014-SGR-938]; FEDER funds, Spain	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacion Carolina, Spain; Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya, Spain(Generalitat de Catalunya); FEDER funds, Spain(Spanish Government)	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES), Brazil; Fundacion Carolina, Spain; BIO2011-25039 and BIO2014-52872-R from the Ministerio de Economia y Competitividad, including FEDER funds, Spain and 2014-SGR-938 from the Generalitat de Catalunya, Spain. The authors declare that they have no conflicts of interest with the contents of this article.	Abedin M, 2010, TRENDS CELL BIOL, V20, P734, DOI 10.1016/j.tcb.2010.08.002; Alves AP, 1997, J BIOL CHEM, V272, P6965, DOI 10.1074/jbc.272.11.6965; Alves AP, 1998, GLYCOBIOLOGY, V8, P939, DOI 10.1093/glycob/8.9.939; Aquino RS, 2010, THROMB HAEMOSTASIS, V103, P1005, DOI 10.1160/TH09-11-0761; Bao XF, 2001, CARBOHYD RES, V336, P127, DOI 10.1016/S0008-6215(01)00238-5; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Bilan MI, 2007, CARBOHYD RES, V342, P586, DOI 10.1016/j.carres.2006.11.008; Blumbach B, 1998, J CELL SCI, V111, P2635; Bucior I, 2004, GLYCOCONJUGATE J, V21, P111, DOI 10.1023/B:GLYC.0000044843.72595.7d; Bucior I, 2004, CURR OPIN STRUC BIOL, V14, P631, DOI 10.1016/j.sbi.2004.08.006; Bucior I, 2004, J CELL BIOL, V165, P529, DOI 10.1083/jcb.200309005; DAMMER U, 1995, SCIENCE, V267, P1173, DOI 10.1126/science.7855599; EGGENS I, 1989, J BIOL CHEM, V264, P9476; Farias EHC, 2008, GLYCOBIOLOGY, V18, P250, DOI 10.1093/glycob/cwm139; Fernandez-Busquets X, 2003, CELL MOL LIFE SCI, V60, P88, DOI 10.1007/s000180300006; Fernandez-Busquets X, 1998, J BIOL CHEM, V273, P29545, DOI 10.1074/jbc.273.45.29545; Fernandez-Busquets X., 2010, ENCY LIFE SCI, P1; Fernandez-Busquets X, 2009, MOL BIOL EVOL, V26, P2551, DOI 10.1093/molbev/msp170; FernandezBusquets X, 1997, J BIOL CHEM, V272, P27839, DOI 10.1074/jbc.272.44.27839; Garcia-Manyes S, 2006, J BIOL CHEM, V281, P5992, DOI 10.1074/jbc.M507878200; Guerardel Y, 2004, J BIOL CHEM, V279, P15591, DOI 10.1074/jbc.M308928200; Haseley SR, 2001, P NATL ACAD SCI USA, V98, P9419, DOI 10.1073/pnas.151111298; HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4; Huang QL, 2005, BIOPOLYMERS, V79, P28, DOI 10.1002/bip.20332; Jarchow J, 2000, J STRUCT BIOL, V132, P95, DOI 10.1006/jsbi.2000.4309; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; KOJIMA N, 1991, J BIOL CHEM, V266, P17552; Koshy KM, 1996, J BIOL CHEM, V271, P3496; Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; Lorenz B, 2012, J AM CHEM SOC, V134, P3326, DOI 10.1021/ja210304j; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; Maloof AC, 2010, NAT GEOSCI, V3, P653, DOI 10.1038/NGEO934; Mathews C.K., 1990, BIOCHEMISTRY-US, V3d; Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9; Mills DB, 2014, P NATL ACAD SCI USA, V111, P4168, DOI 10.1073/pnas.1400547111; Misevic GN, 2004, J BIOL CHEM, V279, P15579, DOI 10.1074/jbc.M308927200; Morrow C, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0099-8; NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3; Ori A, 2011, J BIOL CHEM, V286, P19892, DOI 10.1074/jbc.M111.228114; PAVAO MSG, 1990, CARBOHYD RES, V208, P153, DOI 10.1016/0008-6215(90)80095-K; Pereira MS, 2002, CARBOHYD RES, V337, P2231, DOI 10.1016/S0008-6215(02)00215-X; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Popescu O, 2003, BIOCHIMIE, V85, P181, DOI 10.1016/S0300-9084(03)00063-4; Sabella C, 2007, J IMMUNOL, V179, P5927, DOI 10.4049/jimmunol.179.9.5927; Santos GRC, 2015, GLYCOBIOLOGY, V25, P1043, DOI 10.1093/glycob/cwv044; Spillmann D, 1996, J CELL BIOCHEM, V61, P562, DOI 10.1002/(SICI)1097-4644(19960616)61:4<562::AID-JCB9>3.0.CO;2-M; Spillmann D., 2000, CARBOHYDRATES CHEM B, P1061; Taylor R. L., 1976, METHODS CARBOHYDRATE, V7, P149; Nguyen TH, 2015, NANOSCALE, V7, P10130, DOI 10.1039/c5nr02132d; Vilanova E, 2010, CELL TISSUE RES, V340, P523, DOI 10.1007/s00441-010-0963-y; Vilanova E, 2009, GLYCOBIOLOGY, V19, P860, DOI 10.1093/glycob/cwp059; Vilanova Eduardo, 2007, V28, P653; Vilela-Silva ACES, 2002, J BIOL CHEM, V277, P379, DOI 10.1074/jbc.M108496200; Wang B, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4876603; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204; Yamada S, 2007, GLYCOBIOLOGY, V17, P886, DOI 10.1093/glycob/cwm051; Zierer MS, 2000, CARBOHYD RES, V328, P209, DOI 10.1016/S0008-6215(00)00076-8	61	19	19	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9425	9437		10.1074/jbc.M115.708958	http://dx.doi.org/10.1074/jbc.M115.708958			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26917726	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000375602300004
J	Fu, WQ; Liu, N; Qiao, Q; Wang, MZ; Min, JR; Zhu, B; Xu, RM; Yang, N				Fu, Weiqi; Liu, Nan; Qiao, Qi; Wang, Mingzhu; Min, Jinrong; Zhu, Bing; Xu, Rui-Ming; Yang, Na			Structural Basis for Substrate Preference of SMYD3, a SET Domain-containing Protein Lysine Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE; METHYLATION; GROWTH; HETEROCHROMATIN; TRANSCRIPTION; ACTIVATION; EXPRESSION; INTERPLAY; RECEPTOR; REGION	SMYD3 is a SET domain-containing N-lysine methyltransferase associated with multiple cancers. Its reported substrates include histones (H3K4 and H4K5), vascular endothelial growth factor receptor 1 (VEGFR1 Lys(831)) and MAP3 kinase kinase (MAP3K2 Lys(260)). To reveal the structural basis for substrate preference and the catalytic mechanism of SMYD3, we have solved its co-crystal structures with VEGFR1 and MAP3K2 peptides. Our structural and biochemical analyses show that MAP3K2 serves as a robust substrate of SMYD3 because of the presence of a phenylalanine residue at the -2 position. A shallow hydrophobic pocket on SMYD3 accommodates the binding of the phenylalanine and promotes efficient catalytic activities of SMYD3. By contrast, SMYD3 displayed a weak activity toward a VEGFR1 peptide, and the location of the acceptor lysine in the folded kinase domain of VEGFR1 requires drastic conformational rearrangements for juxtaposition of the acceptor lysine with the enzymatic active site. Our results clearly revealed structural determinants for the substrate preference of SMYD3 and provided mechanistic insights into lysine methylation of MAP3K2. The knowledge should be useful for the development of SMYD3 inhibitors in the fight against MAP3K2 and Ras-driven cancer.	[Fu, Weiqi; Liu, Nan; Qiao, Qi; Wang, Mingzhu; Zhu, Bing; Xu, Rui-Ming; Yang, Na] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China; [Fu, Weiqi; Qiao, Qi; Zhu, Bing; Xu, Rui-Ming; Yang, Na] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Qiao, Qi] Harvard Univ, Boston, MA 02115 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Toronto; Structural Genomics Consortium; Harvard University	Zhu, B; Xu, RM; Yang, N (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	bingzhu@sun5.ibp.ac.cn; rmxu@sun5.ibp.ac.cn; yangna@moon.ibp.ac.cn	xu, rui/GRX-5734-2022; Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130	Chinese Ministry of Science and Technology [2015CB856200, 2012CB910702]; Natural Science Foundation of China [31521002, 31430018, 31370734]; Chinese Academy of Sciences Strategic Priority Research Program [XDB08010100]; National Key New Drug Creation and Manufacturing Program of China [2014ZX09507002]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Strategic Priority Research Program; National Key New Drug Creation and Manufacturing Program of China	This work was supported by Chinese Ministry of Science and Technology Grants 2015CB856200 and 2012CB910702, Natural Science Foundation of China Grants 31521002, 31430018, and 31370734, Chinese Academy of Sciences Strategic Priority Research Program Grant XDB08010100, and the National Key New Drug Creation and Manufacturing Program of China Grant 2014ZX09507002. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Colon-Bolea P, 2014, BIOESSAYS, V36, P1162, DOI 10.1002/bies.201400120; Dales JP, 2003, ANN PATHOL, V23, P297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foreman KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022290; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Kunizaki M, 2007, CANCER RES, V67, P10759, DOI 10.1158/0008-5472.CAN-07-1132; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Silva FP, 2008, ONCOGENE, V27, P2686, DOI 10.1038/sj.onc.1210929; Sirinupong N, 2011, J MOL BIOL, V406, P149, DOI 10.1016/j.jmb.2010.12.014; Starovasnik MA, 1999, J MOL BIOL, V293, P531, DOI 10.1006/jmbi.1999.3134; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Tsuge M, 2005, NAT GENET, V37, P1104, DOI 10.1038/ng1638; Van Aller GS, 2012, EPIGENETICS-US, V7, P340, DOI 10.4161/epi.19506; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865; Xu ST, 2011, NUCLEIC ACIDS RES, V39, P4438, DOI 10.1093/nar/gkr019; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Zhang X, 2013, P NATL ACAD SCI USA, V110, P17284, DOI 10.1073/pnas.1307959110; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zou JN, 2009, CANCER LETT, V280, P78, DOI 10.1016/j.canlet.2009.02.015	34	27	27	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9173	9180		10.1074/jbc.M115.709832	http://dx.doi.org/10.1074/jbc.M115.709832			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26929412	Green Published, hybrid			2022-12-28	WOS:000374849000028
J	Bachmann, AS; Opoku-Ansah, J; Ibarra-Rivera, TR; Yco, LP; Ambadi, S; Roberts, CC; Chang, CEA; Pirrung, MC				Bachmann, Andre S.; Opoku-Ansah, John; Ibarra-Rivera, Tannya R.; Yco, Lisette P.; Ambadi, Sudhakar; Roberts, Christopher C.; Chang, Chia-en A.; Pirrung, Michael C.			Syrbactin Structural Analog TIR-199 Blocks Proteasome Activity and Induces Tumor Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						computer modeling; multiple myeloma; natural product; neuroblastoma; proteasome; TIR-199; anti-tumor activity; chemical synthesis; hollow fiber assays; syringolin A	RELAPSED MULTIPLE-MYELOMA; BIOLOGICAL-ACTIVITY; SYRINGOLIN; BORTEZOMIB; DISEASE; LINES; NEUROBLASTOMA; INHIBITORS; IMMUNOPROTEASOME; GLIDOBACTIN	Multiple myeloma is an aggressive hematopoietic cancer of plasma cells. The recent emergence of three effective FDA-approved proteasome-inhibiting drugs, bortezomib (Velcade (R)), carfilzomib (Kyprolis (R)), and ixazomib (Ninlaro (R)), confirms that proteasome inhibitors are therapeutically useful against neoplastic disease, in particular refractory multiple myeloma and mantle cell lymphoma. This study describes the synthesis, computational affinity assessment, and preclinical evaluation of TIR-199, a natural product-derived syrbactin structural analog. Molecular modeling and simulation suggested that TIR-199 covalently binds each of the three catalytic subunits (beta 1, beta 2, and beta 5) and revealed key interaction sites. In vitro and cell culture-based proteasome activity measurements confirmed that TIR-199 inhibits the proteasome in a dose-dependent manner and induces tumor cell death in multiple myeloma and neuroblastoma cells as well as other cancer types in the NCI-60 cell panel. It is particularly effective against kidney tumor cell lines, with >250-fold higher anti-tumor activities than observed with the natural product syringolin A. In vivo studies in mice revealed a maximum tolerated dose of TIR-199 at 25 mg/kg. The anti-tumor activity of TIR-199 was confirmed in hollow fiber assays in mice. Adverse drug reaction screens in a kidney panel revealed no off-targets of concern. This is the first study to examine the efficacy of a syrbactin in animals. Taken together, the results suggest that TIR-199 is a potent new proteasome inhibitor with promise for further development into a clinical drug for the treatment of multiple myeloma and other forms of cancer.	[Bachmann, Andre S.; Yco, Lisette P.] Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, 301 Michigan St,NE, Grand Rapids, MI 49503 USA; [Bachmann, Andre S.; Opoku-Ansah, John; Yco, Lisette P.] Univ Hawaii, Daniel K Inouye Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA; [Bachmann, Andre S.; Yco, Lisette P.] Univ Hawaii Manoa, Coll Trop Agr & Human Resources, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Ibarra-Rivera, Tannya R.; Ambadi, Sudhakar; Roberts, Christopher C.; Chang, Chia-en A.; Pirrung, Michael C.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Pirrung, Michael C.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Ibarra-Rivera, Tannya R.] Univ Autonoma Nuevo Leon, Fac Med, Monterrey 64460, Nuevo Leon, Mexico	Michigan State University; Michigan State University College of Human Medicine; University of Hawaii System; University Hawaii Hilo; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California Riverside; University of California System; University of California Irvine; Universidad Autonoma de Nuevo Leon	Bachmann, AS (corresponding author), Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, 301 Michigan St,NE, Grand Rapids, MI 49503 USA.; Pirrung, MC (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	andre.bachmann@hc.msu.edu; Michael.pirrung@ucr.edu			Robert C. Perry Fund of the Hawaii Community Foundation (HCF) [09ADVC-45411]; Daniel K. Inouye College of Pharmacy; University of California Cancer Research Coordinating Committee; UC-MEXUS; CONACYT	Robert C. Perry Fund of the Hawaii Community Foundation (HCF); Daniel K. Inouye College of Pharmacy; University of California Cancer Research Coordinating Committee(University of California System); UC-MEXUS; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by funding from the Robert C. Perry Fund of the Hawaii Community Foundation (HCF 09ADVC-45411) (to A. S. B.) and internal funds from the Daniel K. Inouye College of Pharmacy (to A. S. B.). Further support was provided by the University of California Cancer Research Coordinating Committee (to M. C. P.) and postdoctoral fellowships from UC-MEXUS and CONACYT (to T. R. I.-R.). This work was also supported by contributions via experiment.com from Francois Souchay, Yong Rok Lee, Bruce Liu, Ann Adenbaum, Alan Schramm, and Robert Patton. A. S. B. is a named inventor of a United States patent (US 8,597,904, December 3, 2013) that relates to pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition. This patent is assigned to PONO Pharma Inc. (Honolulu, HI), for which A. S. B. currently serves as an independent agent. M. C. P. is a named inventor on a United States patent application (US 2015-0141392 A1) assigned to the University of California concerning synthetic macrocyclic compounds having proteasome inhibitory activity.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Anshu A, 2011, BIOCHEM PHARMACOL, V82, P600, DOI 10.1016/j.bcp.2011.06.031; Archer CR, 2012, BIOCHEMISTRY-US, V51, P6880, DOI 10.1021/bi300841r; Archer CR, 2010, BIOCHEM PHARMACOL, V80, P170, DOI 10.1016/j.bcp.2010.03.031; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Bross PF, 2004, CLIN CANCER RES, V10, P3954, DOI 10.1158/1078-0432.CCR-03-0781; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chiba T, 2015, BIOORG MED CHEM LETT, V25, P4872, DOI 10.1016/j.bmcl.2015.06.015; Chiba T, 2014, ANGEW CHEM INT EDIT, V53, P4836, DOI 10.1002/anie.201402428; Clerc J, 2011, CHEM COMMUN, V47, P385, DOI 10.1039/c0cc02238a; Clerc J, 2010, EUR J ORG CHEM, V2010, P3991, DOI 10.1002/ejoc.201000317; Clerc J, 2009, CHEMBIOCHEM, V10, P2638, DOI 10.1002/cbic.200900411; Clerc J, 2009, P NATL ACAD SCI USA, V106, P6507, DOI 10.1073/pnas.0901982106; Coleman CS, 2006, CELL PROLIFERAT, V39, P599, DOI 10.1111/j.1365-2184.2006.00402.x; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Egerer T, 2006, ARTHRITIS RHEUM-US, V54, P1501, DOI 10.1002/art.21782; Ethen CM, 2007, FEBS LETT, V581, P885, DOI 10.1016/j.febslet.2007.01.061; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Fitzpatrick LR, 2007, DIS COLON RECTUM, V50, P337, DOI 10.1007/s10350-006-0796-7; Greenstein S, 2003, EXP HEMATOL, V31, P271, DOI 10.1016/S0301-472X(03)00023-7; Groll M, 2008, NATURE, V452, P755, DOI 10.1038/nature06782; Herndon TM, 2013, CLIN CANCER RES, V19, P4559, DOI 10.1158/1078-0432.CCR-13-0755; HOLLINGSHEAD MG, 1995, LIFE SCI, V57, P131, DOI 10.1016/0024-3205(95)00254-4; Hopkins AL, 2014, NAT REV DRUG DISCOV, V13, P105, DOI 10.1038/nrd4163; Ibarra-Rivera TR, 2011, TETRAHEDRON, V67, P9950, DOI 10.1016/j.tet.2011.09.048; Lu SQ, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-13; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; OKA M, 1988, J ANTIBIOT, V41, P1812, DOI 10.7164/antibiotics.41.1812; OKA M, 1988, J ANTIBIOT, V41, P1331, DOI 10.7164/antibiotics.41.1331; Opoku-Ansah J, 2012, PHARM BIOL, V50, P25, DOI 10.3109/13880209.2011.626784; Pirrung MC, 2010, ORG LETT, V12, P2402, DOI 10.1021/ol100761z; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Richardson PG, 2007, BLOOD, V110, P3557, DOI 10.1182/blood-2006-08-036947; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Strauss SJ, 2006, J CLIN ONCOL, V24, P2105, DOI 10.1200/JCO.2005.04.6789; Totaro KA, 2015, BIOORGAN MED CHEM, V23, P6218, DOI 10.1016/j.bmc.2015.07.041; Trivella DBB, 2014, CHEM BIOL, V21, P782, DOI 10.1016/j.chembiol.2014.04.010; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	47	11	12	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8350	8362		10.1074/jbc.M115.710053	http://dx.doi.org/10.1074/jbc.M115.710053			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26907687	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000374773200004
J	Hirasawa, M; Takubo, K; Osada, H; Miyake, S; Toda, E; Endo, M; Umezawa, K; Tsubota, K; Oike, Y; Ozawa, Y				Hirasawa, Manabu; Takubo, Keiyo; Osada, Hideto; Miyake, Seiji; Toda, Eriko; Endo, Motoyoshi; Umezawa, Kazuo; Tsubota, Kazuo; Oike, Yuichi; Ozawa, Yoko			Angiopoietin-like Protein 2 Is a Multistep Regulator of Inflammatory Neovascularization in a Murine Model of Age-related Macular Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION; GENERAL JAPANESE POPULATION; INTEGRIN ALPHA-5-BETA-1; INSULIN-RESISTANCE; METABOLIC SYNDROME; IN-VITRO; MACROPHAGE; EXPRESSION; MICE; METASTASIS	Choroidal neovascularization (CNV) is a pathogenic process of age-related macular degeneration, a vision-threatening disease. The retinal pigment epithelium and macrophages both influence CNV development. However, the underlying mechanisms remain obscure. Here, we focus on Angptl2 (angiopoietin-like protein 2), a cytokine involved in age-related systemic diseases. Angptl2 was originally identified as an adipocytokine and is also expressed in the eye. Using a laser-induced CNV model, we found that Angptl2 KO mice exhibited suppressed CNV development with reduced macrophage recruitment and inflammatory mediator induction. The mediators monocyte chemotactic protein-1, interleukin-1 beta (Il-1 beta), Il-6, matrix metalloprotease-9 (Mmp-9), and transforming growth factor-beta 1 (Tgf-beta 1) that were upregulated during CNV development were all suppressed in the retinal pigment epithelium-choroid of CNV models generated in the Angptl2 KO mice. Bone marrow transplantation using wild-type and KO mice suggested that both bone marrow-derived and host-derived Angptl2 were responsible for macrophage recruitment and CNV development. Peritoneal macrophages derived from Angptl2 KO mice expressed lower levels of the inflammatory mediators. In the wild-type peritoneal macrophages and RAW264.7 cells, Angptl2 induced the mediators via integrins alpha 4 and beta 2, followed by the downstream activation of NF-kappa B and ERK. The activation of NF-kappa B and ERK by Angptl2 also promoted macrophage migration. Therefore, Angptl2 from focal tissue might trigger macrophage recruitment, and that from recruited macrophages might promote expression of inflammatory mediators including Angptl2 in an autocrine and/or paracrine fashion to facilitate CNV development. Angptl2 might therefore represent a multistep regulator of CNV pathogenesis and serve as a new therapeutic target for age-related macular degeneration.	[Hirasawa, Manabu; Osada, Hideto; Miyake, Seiji; Toda, Eriko; Ozawa, Yoko] Keio Univ, Sch Med, Lab Retinal Cell Biol, Tokyo 1608582, Japan; [Hirasawa, Manabu; Tsubota, Kazuo; Ozawa, Yoko] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan; [Hirasawa, Manabu] Tokyo Dent Coll, Suidobashi Hosp, Dept Ophthalmol, Tokyo 1010061, Japan; [Endo, Motoyoshi; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8608555, Japan; [Umezawa, Kazuo] Aichi Med Univ, Sch Med, Dept Mol Target Med Screening, Nagakute, Aichi 4801195, Japan; [Oike, Yuichi] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Tokyo 1000004, Japan; [Takubo, Keiyo] Natl Ctr Global Hlth & Med, Res Inst, Dept Stem Cell Biol, Tokyo 1628655, Japan	Keio University; Keio University; Tokyo Dental College; Kumamoto University; Aichi Medical University; Japan Science & Technology Agency (JST); National Center for Global Health & Medicine - Japan	Ozawa, Y (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Lab Retinal Cell Biol,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	ozawa@a5.keio.jp	Endo, Motoyoshi/T-5840-2019; Ozawa, Yoko/AAH-9888-2020; Takubo, Keiyo/AAX-5546-2020	Takubo, Keiyo/0000-0002-1736-7592; Osada, Hideto/0000-0001-9971-8992	Japan Society for the Promotion of Science KAKENHI [80365345, 25462734]; Grants-in-Aid for Scientific Research [25462734] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 80365345 and 25462734. The authors declare that they have no conflicts of interest with the contents of this article.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; AMIN R, 1994, INVEST OPHTH VIS SCI, V35, P3178; Aoi J, 2014, MOL CANCER RES, V12, P239, DOI 10.1158/1541-7786.MCR-13-0336; Aoi J, 2011, CANCER RES, V71, P7502, DOI 10.1158/0008-5472.CAN-11-1758; Belotti D, 2008, MOL CANCER RES, V6, P525, DOI 10.1158/1541-7786.MCR-07-0366; Campa C, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/546826; Doi Y, 2013, DIABETES CARE, V36, P98, DOI 10.2337/dc12-0166; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Du HJ, 2013, P NATL ACAD SCI USA, V110, P2377, DOI 10.1073/pnas.1221729110; Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Espinosa-Heidmann DG, 2013, INVEST OPHTH VIS SCI, V54, P7439, DOI 10.1167/iovs.13-12546; Farhat N, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000201; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Fu ZY, 2013, BIOCHEM BIOPH RES CO, V430, P1126, DOI 10.1016/j.bbrc.2012.12.025; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Grossniklaus HE, 2002, MOL VIS, V8, P119; Honda S, 2009, GRAEF ARCH CLIN EXP, V247, P515, DOI 10.1007/s00417-008-1010-5; Horio E, 2014, ARTERIOSCL THROM VAS, V34, P790, DOI 10.1161/ATVBAHA.113.303116; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Kamizuru H, 2001, INVEST OPHTH VIS SCI, V42, P2664; Kamoshita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103013; Kanda A, 2012, LAB INVEST, V92, P1553, DOI 10.1038/labinvest.2012.111; Kim I, 1999, J BIOL CHEM, V274, P26523, DOI 10.1074/jbc.274.37.26523; Koto T, 2007, INVEST OPHTH VIS SCI, V48, P4328, DOI 10.1167/iovs.06-1148; Lambert V, 2002, AM J PATHOL, V161, P1247, DOI 10.1016/S0002-9440(10)64401-X; Lavalette S, 2011, AM J PATHOL, V178, P2416, DOI 10.1016/j.ajpath.2011.01.013; Lee HJ, 2013, BIOCHEM BIOPH RES CO, V430, P981, DOI 10.1016/j.bbrc.2012.11.127; Mangione CM, 1999, AM J OPHTHALMOL, V128, P45, DOI 10.1016/S0002-9394(99)00169-5; Meng QX, 2013, EXP THER MED, V5, P1631, DOI 10.3892/etm.2013.1045; Nagai N, 2007, INVEST OPHTH VIS SCI, V48, P2321, DOI 10.1167/iovs.06-1296; Nagai T, 2007, INVEST OPHTH VIS SCI, V48, P5716, DOI 10.1167/iovs.07-1023; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Odagiri H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004612; Oike Y, 2004, INT J HEMATOL, V80, P21, DOI 10.1532/ijh97.04034; Oike Y, 2009, CIRC J, V73, P2192, DOI 10.1253/circj.CJ-09-0710; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; Ozawa Y, 2012, CURR PHARM DESIGN, V18, P51, DOI 10.2174/138161212798919101; Parmeggiani F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/435607; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Sene A, 2013, CELL METAB, V17, P549, DOI 10.1016/j.cmet.2013.03.009; Suzuki M, 2012, J CELL SCI, V125, P2407, DOI 10.1242/jcs.097683; Suzuki M, 2014, BRIT J OPHTHALMOL, V98, P1186, DOI 10.1136/bjophthalmol-2013-304670; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Tian Z, 2013, J MOL CELL CARDIOL, V57, P1, DOI 10.1016/j.yjmcc.2013.01.004; Toyono T, 2013, INVEST OPHTH VIS SCI, V54, P4278, DOI 10.1167/iovs.12-11497; Usui T, 2013, CIRC J, V77, P2311, DOI 10.1253/circj.CJ-12-1548; Wang WQ, 2011, INVEST OPHTH VIS SCI, V52, P7213, DOI 10.1167/iovs.10-7097; Watanabe M, 2008, BIOCHEM BIOPH RES CO, V376, P310, DOI 10.1016/j.bbrc.2008.08.148; Xu J, 2012, ANGIOGENESIS, V15, P213, DOI 10.1007/s10456-012-9254-4; Yasukawa T, 2004, CURR EYE RES, V28, P359, DOI 10.1076/ceyr.28.5.359.28678; Zarbin Marco A, 2003, Trans Am Ophthalmol Soc, V101, P499; Zarranz-Ventura J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065434	56	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7373	7385		10.1074/jbc.M115.710186	http://dx.doi.org/10.1074/jbc.M115.710186			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26839315	Green Published, hybrid			2022-12-28	WOS:000383447600014
J	Madsen, AS; Andersen, C; Daoud, M; Anderson, KA; Laursen, JS; Chakladar, S; Huynh, FK; Colaco, AR; Backos, DS; Fristrup, P; Hirschey, MD; Olsen, CA				Madsen, Andreas S.; Andersen, Christian; Daoud, Mohammad; Anderson, Kristin A.; Laursen, Jonas S.; Chakladar, Saswati; Huynh, Frank K.; Colaco, Ana R.; Backos, Donald S.; Fristrup, Peter; Hirschey, Matthew D.; Olsen, Christian A.			Investigating the Sensitivity of NAD(+)-dependent Sirtuin Deacylation Activities to NADH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; fatty acid; histone deacetylase (HDAC); nicotinamide adenine dinucleotide (NADH); protein acylation; sirtuin; lysine myristoylation; lysine palmitoylation; nicotinamide adenine dinucleotide (NAD plus ); post-translational modification (PTM)	NICOTINAMIDE-ADENINE-DINUCLEOTIDE; HISTONE DEACETYLASE INHIBITORS; LIFE-SPAN EXTENSION; REDOX STATE; CALORIE RESTRICTION; LYSINE ACETYLATION; DNA-DAMAGE; POSTTRANSLATIONAL MODIFICATION; HISTONE/PROTEIN DEACETYLASES; PROTEIN ACETYLATION	Protein lysine posttranslational modification by an increasing number of different acyl groups is becoming appreciated as a regulatory mechanism in cellular biology. Sirtuins are class III histone deacylases that use NAD(+) as a co-substrate during amide bond hydrolysis. Several studies have described the sirtuins as sensors of the NAD(+)/NADH ratio, but it has not been formally tested for all the mammalian sirtuins in vitro. To address this problem, we first synthesized a wide variety of peptide-based probes, which were used to identify the range of hydrolytic activities of human sirtuins. These probes included aliphatic E-N-acyllysine modifications with hydrocarbon lengths ranging from formyl (C-1) to palmitoyl (C-16) as well as negatively charged dicarboxyl-derived modifications. In addition to the well established activities of the sirtuins, long chain acyllysine modifications were also shown to be prone to hydrolytic cleavage by SIRT1-3 and SIRT6, supporting recent findings. We then tested the ability of NADH, ADP-ribose, and nicotinamide to inhibit these NAD(+)-dependent deacylase activities of the sirtuins. In the commonly used 7-amino-4-methylcoumarin-coupled fluorescence-based assay, the fluorophore has significant spectral overlap with NADH and therefore cannot be used to measure inhibition by NADH. Therefore, we turned to an HPLC-MS-based assay to directly monitor the conversion of acylated peptides to their deacylated forms. All tested sirtuin deacylase activities showed sensitivity to NADH in this assay. However, the inhibitory concentrations of NADH in these assays are far greater than the predicted concentrations of NADH in cells; therefore, our data indicate that NADH is unlikely to inhibit sirtuins in vivo. These data suggest a re-evaluation of the sirtuins as direct sensors of the NAD(+)/NADH ratio.	[Madsen, Andreas S.; Laursen, Jonas S.; Chakladar, Saswati; Olsen, Christian A.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Biopharmaceut, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Madsen, Andreas S.; Andersen, Christian; Daoud, Mohammad; Colaco, Ana R.; Fristrup, Peter; Olsen, Christian A.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; [Anderson, Kristin A.; Huynh, Frank K.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, 300 N Duke St, Durham, NC 27701 USA; [Backos, Donald S.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Computat Chem & Biol Core Facil, Anschutz Med Campus, Aurora, CO 80045 USA	University of Copenhagen; Technical University of Denmark; Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus	Madsen, AS; Olsen, CA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Biopharmaceut, Univ Pk 2, DK-2100 Copenhagen, Denmark.; Hirschey, MD (corresponding author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, 300 N Duke St, Durham, NC 27701 USA.	andreas.madsen@sund.ku.dk; matthew.hirschey@duke.edu; cao@sund.ku.dk	Backos, Donald/Q-4791-2018; Backos, Donald/N-5265-2019; Fristrup, Peter/A-7211-2008; Huynh, Frank/AAK-9575-2020	Backos, Donald/0000-0001-6735-6210; Backos, Donald/0000-0001-6735-6210; Fristrup, Peter/0000-0001-7175-3796; Huynh, Frank/0000-0002-4764-9558; Olsen, Christian Adam/0000-0002-2953-8942; Madsen, Andreas Stahl/0000-0001-7283-2090; Hirschey, Matthew/0000-0003-4541-5376	National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science [UL1TR001082]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022146] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF15OC0017334] Funding Source: researchfish	National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank the reviewers for valuable input. We thank Tina Gustafsson (DTU Chemistry) for technical assistance. The University of Colorado Computational Chemistry and Biology Core Facility is supported partly by National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Award Grant UL1TR001082.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Baeza J, 2014, J BIOL CHEM, V289, P21326, DOI 10.1074/jbc.M114.581843; Bao XC, 2014, ELIFE, V3, DOI 10.7554/eLife.02999; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Beis K, 2003, J AM CHEM SOC, V125, P11872, DOI 10.1021/ja035796r; Biel M, 2005, ANGEW CHEM INT EDIT, V44, P3186, DOI 10.1002/anie.200461346; Bilan DS, 2014, BBA-GEN SUBJECTS, V1840, P951, DOI 10.1016/j.bbagen.2013.11.018; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Brandl A, 2012, J MOL CELL BIOL, V4, P284, DOI 10.1093/jmcb/mjs013; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Chiang YL, 2016, ORG BIOMOL CHEM, V14, P2186, DOI 10.1039/c5ob02609a; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Christensen CE, 2014, J BIOL CHEM, V289, P2344, DOI 10.1074/jbc.M113.498626; Dai LZ, 2014, NAT CHEM BIOL, V10, P365, DOI [10.1038/NCHEMBIO.1497, 10.1038/nchembio.1497]; Davenport AM, 2014, J MOL BIOL, V426, P526, DOI 10.1016/j.jmb.2013.10.009; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200; Edrissi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003328; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Feldman JL, 2015, BIOCHEMISTRY-US, V54, P3037, DOI 10.1021/acs.biochem.5b00150; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Fischer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045098; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Galleano I, 2016, J MED CHEM, V59, P1021, DOI 10.1021/acs.jmedchem.5b01532; Gambini J, 2011, ARCH BIOCHEM BIOPHYS, V512, P24, DOI 10.1016/j.abb.2011.04.020; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Hirschey MD, 2011, CELL METAB, V14, P718, DOI 10.1016/j.cmet.2011.10.006; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hu J, 2013, ORG BIOMOL CHEM, V11, P5213, DOI 10.1039/c3ob41138a; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Jang SY, 2012, J BIOL CHEM, V287, P19304, DOI 10.1074/jbc.M112.363747; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Jiang T, 2007, P NATL ACAD SCI USA, V104, P60, DOI 10.1073/pnas.0606775103; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; Jing H, 2015, CHEM REV, V115, P2350, DOI 10.1021/cr500457h; Jones P, 2008, BIOORG MED CHEM LETT, V18, P1814, DOI 10.1016/j.bmcl.2008.02.025; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Liu L, 1999, MOL CELL BIOL, V19, P1202; Madsen AS, 2012, ANGEW CHEM INT EDIT, V51, P9083, DOI 10.1002/anie.201203754; Madsen AS, 2012, J MED CHEM, V55, P5582, DOI 10.1021/jm300526r; Marcu R, 2014, MOL CELL BIOL, V34, P2890, DOI 10.1128/MCB.00068-14; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Moellering RE, 2013, SCIENCE, V341, P549, DOI 10.1126/science.1238327; Moniot S, 2013, J STRUCT BIOL, V182, P136, DOI 10.1016/j.jsb.2013.02.012; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Olsen CA, 2014, CHEMMEDCHEM, V9, P434, DOI 10.1002/cmdc.201300421; Olsen CA, 2012, ANGEW CHEM INT EDIT, V51, P3755, DOI 10.1002/anie.201200316; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Schemies J, 2010, MED RES REV, V30, P861, DOI 10.1002/med.20178; Schmidt MT, 2004, J BIOL CHEM, V279, P40122, DOI 10.1074/jbc.M407484200; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; STEVENSON FT, 1993, P NATL ACAD SCI USA, V90, P7245, DOI 10.1073/pnas.90.15.7245; STEVENSON FT, 1992, J EXP MED, V176, P1053, DOI 10.1084/jem.176.4.1053; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Teng YB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08529; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Vogelauer M, 2012, J BIOL CHEM, V287, P32006, DOI 10.1074/jbc.M112.362467; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wilhelm F, 2011, J NEUROSCI RES, V89, P1956, DOI 10.1002/jnr.22638; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; WU YD, 1991, J AM CHEM SOC, V113, P2353, DOI 10.1021/ja00007a002; WU YD, 1993, J ORG CHEM, V58, P2043, DOI 10.1021/jo00060a017; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Yu QR, 2009, J PHOTOCH PHOTOBIO B, V95, P46, DOI 10.1016/j.jphotobiol.2008.12.010; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhao X, 2013, J MED CHEM, V56, P963, DOI 10.1021/jm301431y; Zhao YZ, 2011, CELL METAB, V14, P555, DOI 10.1016/j.cmet.2011.09.004	102	68	69	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7128	7141		10.1074/jbc.M115.668699	http://dx.doi.org/10.1074/jbc.M115.668699			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26861872	Green Published, hybrid			2022-12-28	WOS:000373299700046
J	Meng, LX; Xie, ZL; Zhang, Q; Li, Y; Yang, F; Chen, ZY; Li, WX; Cao, ZJ; Wu, YL				Meng, Lanxia; Xie, Zili; Zhang, Qian; Li, Yang; Yang, Fan; Chen, Zongyun; Li, Wenxin; Cao, Zhijian; Wu, Yingliang			Scorpion Potassium Channel-blocking Defensin Highlights a Functional Link with Neurotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; defensin; neurotoxin; potassium channel; structure-function	K+ CHANNELS; PROTEOMIC ANALYSIS; INSECT DEFENSINS; STRUCTURAL BASIS; FUNGAL DEFENSIN; KV1.3 CHANNEL; TOXIN; INHIBITOR; PLECTASIN; PEPTIDES	The structural similarity between defensins and scorpion neurotoxins suggests that they might have evolved from a common ancestor. However, there is no direct experimental evidence demonstrating a functional link between scorpion neurotoxins and defensins. The scorpion defensin BmKDfsin4 from Mesobuthus martensii Karsch contains 37 amino acid residues and a conserved cystine-stabilized / structural fold. The recombinant BmKDfsin4, a classical defensin, has been found to have inhibitory activity against Gram-positive bacteria such as Staphylococcus aureus, Bacillus subtilis, and Micrococcus luteus as well as methicillin-resistant Staphylococcus aureus. Interestingly, electrophysiological experiments showed that BmKDfsin4,like scorpion potassium channel neurotoxins, could effectively inhibit Kv1.1, Kv1.2, and Kv1.3 channel currents, and its IC50 value for the Kv1.3 channel was 510.2 nm. Similar to the structure-function relationships of classical scorpion potassium channel-blocking toxins, basic residues (Lys-13 and Arg-19) of BmKDfsin4 play critical roles in peptide-Kv1.3 channel interactions. Furthermore, mutagenesis and electrophysiological experiments demonstrated that the channel extracellular pore region is the binding site of BmKDfsin4, indicating that BmKDfsin4adopts the same mechanism for blocking potassium channel currents as classical scorpion toxins. Taken together, our work identifies scorpion BmKDfsin4 as the first invertebrate defensin to block potassium channels. These findings not only demonstrate that defensins from invertebrate animals are a novel type of potassium channel blockers but also provide evidence of a functional link between defensins and neurotoxins.	[Meng, Lanxia; Xie, Zili; Zhang, Qian; Li, Yang; Yang, Fan; Chen, Zongyun; Li, Wenxin; Cao, Zhijian; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Li, Wenxin; Cao, Zhijian; Wu, Yingliang] Wuhan Univ, Ctr BioDrug Res, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Cao, ZJ; Wu, YL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	zjcao@whu.edu.cn; ylwu@whu.edu.cn			National Natural Sciences Foundation of China [31470812, 31170789]; National Science Fund for Excellent Young Scholars [31422049]; Hubei Science Fund for Excellent Scholars [2015CFA042]; Wuhan University Natural Sciences Foundation [2042015kf0168]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Excellent Young Scholars; Hubei Science Fund for Excellent Scholars; Wuhan University Natural Sciences Foundation	This work was supported by National Natural Sciences Foundation of China Grants 31470812 and 31170789, National Science Fund for Excellent Young Scholars Grant 31422049, Hubei Science Fund for Excellent Scholars Grant 2015CFA042, and Wuhan University Natural Sciences Foundation Grant 2042015kf0168. The authors declare that they have no conflicts of interest with the contents of this article.	Batista CVF, 2006, PROTEOMICS, V6, P3718, DOI 10.1002/pmic.200500525; BONTEMS F, 1991, EUR J BIOCHEM, V196, P19, DOI 10.1111/j.1432-1033.1991.tb15780.x; Cao ZJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3602; CHALK R, 1995, P ROY SOC B-BIOL SCI, V261, P217, DOI 10.1098/rspb.1995.0139; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; Chen ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09881; Chen ZY, 2014, BIOCHEM BIOPH RES CO, V447, P70, DOI 10.1016/j.bbrc.2014.03.101; COCIANCICH S, 1993, BIOCHEM BIOPH RES CO, V194, P17, DOI 10.1006/bbrc.1993.1778; CREST M, 1992, J BIOL CHEM, V267, P1640; de la Vega RCR, 2005, TRENDS GENET, V21, P330, DOI 10.1016/j.tig.2005.03.009; de Oliveira UC, 2015, TOXICON, V95, P52, DOI 10.1016/j.toxicon.2014.12.013; Dunlop JA, 2007, ARTHROPOD STRUCT DEV, V36, P245, DOI 10.1016/j.asd.2006.09.003; EhretSabatier L, 1996, J BIOL CHEM, V271, P29537, DOI 10.1074/jbc.271.47.29537; Felix JP, 1999, BIOCHEMISTRY-US, V38, P4922, DOI 10.1021/bi982954w; Feng J, 2015, J BIOL CHEM, V290, P15487, DOI 10.1074/jbc.M115.639500; Feng J, 2013, J BIOL CHEM, V288, P12544, DOI 10.1074/jbc.M112.433888; Froy O, 2004, J PEPT SCI, V10, P714, DOI 10.1002/psc.578; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gan GL, 2008, J BIOL CHEM, V283, P24177, DOI 10.1074/jbc.M800179200; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Goyffon Max, 1998, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V192, P445; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Han S, 2010, J PROTEOME RES, V9, P3118, DOI 10.1021/pr100027k; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; MagetDana R, 1997, BIOPHYS J, V73, P2527, DOI 10.1016/S0006-3495(97)78281-X; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Ng TB, 2013, CURR PROTEIN PEPT SC, V14, P515, DOI 10.2174/13892037113149990068; ROMI R, 1993, J BIOL CHEM, V268, P26302; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Xiang F, 2015, TOXINS, V7, P34, DOI 10.3390/toxins7010034; Xie ZL, 2015, FASEB J, V29, P4324, DOI 10.1096/fj.15-274787; Xu XB, 2014, J PROTEOMICS, V106, P162, DOI 10.1016/j.jprot.2014.04.032; Yang WS, 2015, CELL MOL LIFE SCI, V72, P845, DOI 10.1007/s00018-014-1715-z; Yi H, 2008, PROTEINS, V70, P844, DOI 10.1002/prot.21706; Zhu S, 2005, CELL MOL LIFE SCI, V62, P2257, DOI 10.1007/s00018-005-5200-6; Zhu S, 2004, CELL MOL LIFE SCI, V61, P1751, DOI 10.1007/s00018-004-4149-1; Zhu SY, 2014, MOL BIOL EVOL, V31, P546, DOI 10.1093/molbev/msu038; Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109	42	35	39	2	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7097	7106		10.1074/jbc.M115.680611	http://dx.doi.org/10.1074/jbc.M115.680611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26817841	Green Published, hybrid			2022-12-28	WOS:000373299700043
J	Seaayfan, E; Defontaine, N; Demaretz, S; Zaarour, N; Laghmani, K				Seaayfan, Elie; Defontaine, Nadia; Demaretz, Sylvie; Zaarour, Nancy; Laghmani, Kamel			OS9 Protein Interacts with Na-K-2Cl Co-transporter (NKCC2) and Targets Its Immature Form for the Endoplasmic Reticulum-associated Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; THICK ASCENDING LIMB; CATION-CHLORIDE COTRANSPORTERS; DOMAIN-CONTAINING LECTINS; MISFOLDED GLYCOPROTEINS; SECRETORY PATHWAY; CYSTIC-FIBROSIS; QUALITY-CONTROL; MOLECULAR CHAPERONES; SURFACE EXPRESSION	Mutations in the renal specific Na-K-2Cl co-transporter (NKCC2) lead to type I Bartter syndrome, a life-threatening kidney disease featuring arterial hypotension along with electrolyte abnormalities. We have previously shown that NKCC2 and its disease-causing mutants are subject to regulation by endoplasmic reticulum-associated degradation (ERAD). The aim of the present study was to identify the protein partners specifically involved in ERAD of NKCC2. To this end, we screened a kidney cDNA library through a yeast two-hybrid assay using NKCC2 C terminus as bait. We identified OS9 (amplified in osteosarcomas) as a novel and specific binding partner of NKCC2. Coimmunoprecipitation assays in renal cells revealed that OS9 association involves mainly the immature form of NKCC2. Accordingly, immunocytochemistry analysis showed that NKCC2 and OS9 co-localize at the endoplasmic reticulum. In cells overexpressing OS9, total cellular NKCC2 protein levels were markedly decreased, an effect blocked by the proteasome inhibitor MG132. Pulse-chase and cycloheximide-chase assays demonstrated that the marked reduction in the co-transporter protein levels was essentially due to increased protein degradation of the immature form of NKCC2. Conversely, knockdown of OS9 by small interfering RNA increased NKCC2 expression by increasing the co-transporter stability. Inactivation of the mannose 6-phosphate receptor homology domain of OS9 had no effect on its action on NKCC2. In contrast, mutations of NKCC2 N-glycosylation sites abolished the effects of OS9, indicating that OS9-induced protein degradation is N-glycan-dependent. In summary, our results demonstrate the presence of an OS9-mediated ERAD pathway in renal cells that degrades immature NKCC2 proteins. The identification and selective modulation of ERAD components specific to NKCC2 and its disease-causing mutants might provide novel therapeutic strategies for the treatment of type I Bartter syndrome.	Ctr Rech Cordeliers, INSERM, U1138, F-75006 Paris, France; CNRS, ERL8228, F-75006 Paris, France; Univ Paris 06, F-75006 Paris, France; Univ Paris 05, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Laghmani, K (corresponding author), INSERM UPMC CNRS, U1138, ERL8228, Team 3, 15 Rue Ecole Med, F-75270 Paris 06, France.	Kamel.Laghmani@crc.jussieu.frx	Laghmani, Kamel/AIE-9621-2022	Laghmani, Kamel/0000-0002-2167-5766; Seaayfan, Elie/0000-0003-4839-9834	INSERM, Paris, France; Fondation pour la Recherche Medicale; Societe de Nephrologie	INSERM, Paris, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Societe de Nephrologie	This work was supported in part by grants from INSERM, Paris, France. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a thesis fellowship from Fondation pour la Recherche Medicale and la Societe de Nephrologie.	Acuna R, 2011, J HYPERTENS, V29, P475, DOI 10.1097/HJH.0b013e328341d0fd; Ahner A, 2013, FEBS J, V280, P4430, DOI 10.1111/febs.12415; Alcock F, 2009, J MOL BIOL, V385, P1032, DOI 10.1016/j.jmb.2008.11.045; Amaral MD, 2011, CURR DRUG TARGETS, V12, P683; Amlal H, 1996, AM J PHYSIOL-CELL PH, V271, pC455, DOI 10.1152/ajpcell.1996.271.2.C455; AMLAL H, 1994, J BIOL CHEM, V269, P21962; Ares GR, 2011, AM J PHYSIOL-RENAL, V301, pF1143, DOI 10.1152/ajprenal.00396.2011; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Benziane B, 2007, J BIOL CHEM, V282, P33817, DOI 10.1074/jbc.M700195200; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Caplan MJ, 1997, AM J PHYSIOL-RENAL, V272, pF425, DOI 10.1152/ajprenal.1997.272.4.F425; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chaari A, 2013, INT J BIOL MACROMOL, V60, P196, DOI 10.1016/j.ijbiomac.2013.05.032; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cormier JH, 2005, MOL CELL, V19, P717, DOI 10.1016/j.molcel.2005.08.029; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Donnelly BF, 2013, J BIOL CHEM, V288, P13124, DOI 10.1074/jbc.M113.455394; Friedmann E, 2002, J BIOL CHEM, V277, P35274, DOI 10.1074/jbc.M201044200; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gamba G, 1999, KIDNEY INT, V56, P1606, DOI 10.1046/j.1523-1755.1999.00712.x; GREGER R, 1987, KIDNEY INT, V31, P590, DOI 10.1038/ki.1987.39; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hosokawa N, 2010, METHOD ENZYMOL, V480, P181, DOI 10.1016/S0076-6879(10)80010-2; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P651, DOI 10.1093/glycob/cwq013; Huttner S, 2012, PLANT MOL BIOL, V79, P21, DOI 10.1007/s11103-012-9891-4; Jansen BJH, 2009, MOL IMMUNOL, V46, P505, DOI 10.1016/j.molimm.2008.06.032; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kim DG, 2004, AM J PHYSIOL-RENAL, V286, pF760, DOI 10.1152/ajprenal.00369.2003; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kimura Y, 1998, J BIOCHEM-TOKYO, V123, P876; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Litovchick L, 2002, J BIOL CHEM, V277, P34413, DOI 10.1074/jbc.M203986200; Monette MY, 2011, AM J PHYSIOL-RENAL, V300, pF840, DOI 10.1152/ajprenal.00552.2010; Mori T, 2004, HYPERTENSION, V43, P341, DOI 10.1161/01.HYP.0000113295.31481.36; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; Riazi S, 2006, AM J NEPHROL, V26, P245, DOI 10.1159/000093783; Rizzo F, 2015, CURR OPIN NEPHROL HY, V24, P111, DOI 10.1097/MNH.0000000000000097; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stolz A, 2010, BBA-MOL CELL RES, V1803, P694, DOI 10.1016/j.bbamcr.2010.02.005; Su W, 2012, MOL PLANT, V5, P929, DOI 10.1093/mp/sss042; Su YA, 1996, MOL CARCINOGEN, V15, P270, DOI 10.1002/(SICI)1098-2744(199604)15:4<270::AID-MC4>3.0.CO;2-K; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Tian Y, 2006, KIDNEY INT, V69, P304, DOI 10.1038/sj.ki.5000076; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vitale A, 1999, PLANT CELL, V11, P615, DOI 10.1105/tpc.11.4.615; Wang Y, 2007, J BIOL CHEM, V282, P36561, DOI 10.1074/jbc.M703903200; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Welling PA, 2014, CURR OPIN NEPHROL HY, V23, P1, DOI 10.1097/01.mnh.0000437204.84826.99; Wu JJ, 2013, HUM GENET, V132, P179, DOI 10.1007/s00439-012-1238-3; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Zaarour N, 2012, J BIOL CHEM, V287, P42642, DOI 10.1074/jbc.M112.399162; Zaarour N, 2011, J BIOL CHEM, V286, P9489, DOI 10.1074/jbc.M110.166546; Zaarour N, 2009, J BIOL CHEM, V284, P21752, DOI 10.1074/jbc.M109.000679	68	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4487	4502		10.1074/jbc.M115.702514	http://dx.doi.org/10.1074/jbc.M115.702514			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26721884	Green Published, hybrid			2022-12-28	WOS:000371604600020
J	Di, XJ; Wang, YJ; Han, DY; Fu, YL; Duerfeldt, AS; Blagg, BSJ; Mu, TW				Di, Xiao-Jing; Wang, Ya-Juan; Han, Dong-Yun; Fu, Yan-Lin; Duerfeldt, Adam S.; Blagg, Brian S. J.; Mu, Ting-Wei			Grp94 Protein Delivers gamma-Aminobutyric Acid Type A (GABA(A)) Receptors to Hrd1 Protein-mediated Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; JUVENILE MYOCLONIC EPILEPSY; TOLL-LIKE RECEPTORS; CYS-LOOP RECEPTORS; N-LINKED GLYCANS; MISFOLDED GLYCOPROTEINS; QUALITY-CONTROL; PROTEOSTASIS; UBIQUITIN; SUBUNITS	Proteostasis maintenance of gamma-aminobutyric acid type A (GABA(A)) receptors dictates their function in controlling neuronal inhibition in mammalian central nervous systems. However, as a multisubunit, multispan, integral membrane protein, even wild type subunits of GABA(A) receptors fold and assemble inefficiently in the endoplasmic reticulum (ER). Unassembled and misfolded subunits undergo ER-associated degradation (ERAD), but this degradation process remains poorly understood for GABA(A) receptors. Here, using the alpha 1 subunits of GABA(A) receptors as a model substrate, we demonstrated that Grp94, a metazoan-specific Hsp90 in the ER lumen, uses its middle domain to interact with the alpha 1 subunits and positively regulates their ERAD. OS-9, an ER-resident lectin, acts downstream of Grp94 to further recognize misfolded alpha 1 subunits in a glycan-dependent manner. This delivers misfolded alpha 1 subunits to the Hrd1-mediated ubiquitination and the valosin-containing protein-mediated extraction pathway. Repressing the initial ERAD recognition step by inhibiting Grp94 enhances the functional surface expression of misfolding-prone alpha 1(A322D) subunits, which causes autosomal dominant juvenile myoclonic epilepsy. This study clarifies a Grp94-mediated ERAD pathway for GABA(A) receptors, which provides a novel way to finely tune their function in physiological and pathophysiological conditions.	[Di, Xiao-Jing; Han, Dong-Yun; Fu, Yan-Lin; Mu, Ting-Wei] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Wang, Ya-Juan] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Wang, Ya-Juan] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Duerfeldt, Adam S.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Blagg, Brian S. J.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Oklahoma System; University of Oklahoma - Norman; University of Kansas	Mu, TW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	tingwei.mu@case.edu	blagg, brian s j/X-7770-2018; Mu, Tingwei/AAU-8596-2020	blagg, brian s j/0000-0002-6200-3480; Mu, Tingwei/0000-0002-6419-9296; Wang, Yajuan (Megan)/0000-0002-3284-9012	Case Western Reserve University School of Medicine; Epilepsy Foundation of America [225243]; Clinical Translational Science Collaborative of Cleveland (CTSA) National Institutes of Health from the NCRR [UL1RR024989]; National Center for Advancing Translational Sciences; National Institutes of Health from NCI [T32 HL007567, CA109265]; NATIONAL CANCER INSTITUTE [U01CA109265] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007567] Funding Source: NIH RePORTER	Case Western Reserve University School of Medicine; Epilepsy Foundation of America; Clinical Translational Science Collaborative of Cleveland (CTSA) National Institutes of Health from the NCRR; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Research Startup Fund from Case Western Reserve University School of Medicine (to T. W. M.), Epilepsy Foundation of America Grant 225243 (to T. W. M.), Clinical Translational Science Collaborative of Cleveland (CTSA) National Institutes of Health Grant UL1RR024989 from the NCRR and National Center for Advancing Translational Sciences (to T. W. M.), and National Institutes of Health Grants T32 HL007567 (to Y. J. W.) and CA109265 from NCI (to B. S. J. B.).	Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barnes EM, 2001, INT REV NEUROBIOL, V48, P1, DOI 10.1016/S0074-7742(01)48012-3; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Dersh D, 2014, MOL BIOL CELL, V25, P2220, DOI 10.1091/mbc.E14-03-0805; Di XJ, 2013, CHEM BIOL, V20, P1456, DOI 10.1016/j.chembiol.2013.09.020; Ding L, 2010, J BIOL CHEM, V285, P26390, DOI 10.1074/jbc.M110.142299; Duerfeldt AS, 2012, J AM CHEM SOC, V134, P9796, DOI 10.1021/ja303477g; Eletto D, 2012, J CELL SCI, V125, P4865, DOI 10.1242/jcs.108928; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Fu YL, 2016, ADV PROTEIN CHEM STR, V103, P1, DOI 10.1016/bs.apcsb.2015.11.002; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gorrie GH, 1997, J NEUROSCI, V17, P6587; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Han DY, 2015, ACS CHEM BIOL, V10, P2135, DOI 10.1021/acschembio.5b00479; Han DY, 2015, J BIOL CHEM, V290, P325, DOI 10.1074/jbc.M114.580324; Hebert DN, 2014, NAT CHEM BIOL, V10, P902, DOI 10.1038/nchembio.1651; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hines RM, 2012, CURR OPIN NEUROBIOL, V22, P552, DOI 10.1016/j.conb.2011.10.007; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hirose S, 2014, PROG BRAIN RES, V213, P55, DOI 10.1016/B978-0-444-63326-2.00003-X; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jin HB, 2014, J BIOL CHEM, V289, P29420, DOI 10.1074/jbc.M114.603068; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2013, P NATL ACAD SCI USA, V110, P6877, DOI 10.1073/pnas.1302933110; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Mowrey DD, 2015, BBA-BIOMEMBRANES, V1848, P307, DOI 10.1016/j.bbamem.2014.03.014; Nakatsukasa K, 2014, CURR OPIN CELL BIOL, V29, P82, DOI 10.1016/j.ceb.2014.04.008; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Ong DST, 2013, CHEM BIOL, V20, P403, DOI 10.1016/j.chembiol.2012.11.014; Pareek S, 1997, J NEUROSCI, V17, P7754; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Steinlein OK, 2012, CHEM REV, V112, P6334, DOI 10.1021/cr300044d; Suntharalingam A, 2012, J BIOL CHEM, V287, P40661, DOI 10.1074/jbc.M112.384800; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang YJ, 2014, PHARMACOL RES, V83, P3, DOI 10.1016/j.phrs.2014.04.002; Wang YJ, 2013, J PROTEOME RES, V12, P5570, DOI 10.1021/pr400535z; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhang T, 2015, MOL BIOL CELL, V26, P4438, DOI 10.1091/mbc.E15-06-0354; Zhong YW, 2015, BIOCHEM BIOPH RES CO, V458, P424, DOI 10.1016/j.bbrc.2015.01.133	68	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9526	9539		10.1074/jbc.M115.705004	http://dx.doi.org/10.1074/jbc.M115.705004			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26945068	Green Published, hybrid			2022-12-28	WOS:000375602300013
J	Tatler, AL; Habgood, A; Porte, J; John, AE; Stavrou, A; Hodge, E; Kerama-Likoko, C; Violette, SM; Weinreb, PH; Knox, AJ; Laurent, G; Parfrey, H; Wolters, PJ; Wallace, W; Alberti, S; Nordheim, A; Jenkins, G				Tatler, Amanda L.; Habgood, Anthony; Porte, Joanne; John, Alison E.; Stavrou, Anastasios; Hodge, Emily; Kerama-Likoko, Cheryl; Violette, Shelia M.; Weinreb, Paul H.; Knox, Alan J.; Laurent, Geoffrey; Parfrey, Helen; Wolters, Paul John; Wallace, William; Alberti, Siegfried; Nordheim, Alfred; Jenkins, Gisli			Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin alpha v beta 6 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; LUNG EPITHELIAL-CELLS; TRANSCRIPTIONAL ACTIVATION; LIVER FIBROSIS; INTEGRIN-ALPHA-V-BETA-6; INFLAMMATION; RECEPTOR; DIFFERENTIATION; DEGRADATION; INHIBITION	Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with high mortality. Active TGF beta 1 is considered central to the pathogenesis of IPF. A major mechanism of TGF beta 1 activation in the lung involves the epithelially restricted alpha v beta 6 integrin. Expression of the alpha v beta 6 integrin is dramatically increased in IPF. How alpha v beta 6 integrin expression is regulated in the pulmonary epithelium is unknown. Here we identify a region in the beta 6 subunit gene(ITGB6) promoter acting to markedly repress basal gene transcription, which responds to both the Ets domain-containing protein Elk1 (Elk1) and the glucocorticoid receptor (GR). Both Elk1 and GR can regulate alpha v beta 6 integrin expression in vitro. We demonstrate Elk1 binding to the ITGB6 promoter basally and that manipulation of Elk1 or Elk1 binding alters ITGB6 promoter activity, gene transcription, and alpha v beta 6 integrin expression. Crucially, we find that loss of Elk1 causes enhanced Itgb6 expression and exaggerated lung fibrosis in an in vivo model of fibrosis, whereas the GR agonist dexamethasone inhibits Itgb6 expression. Moreover, Elk1 dysregulation is present in epithelium from patients with IPF. These data reveal a novel role for Elk1 regulating ITGB6 expression and highlight how dysregulation of Elk1 can contribute to human disease.	[Tatler, Amanda L.; Habgood, Anthony; Porte, Joanne; John, Alison E.; Stavrou, Anastasios; Hodge, Emily; Kerama-Likoko, Cheryl; Knox, Alan J.; Jenkins, Gisli] Univ Nottingham, Univ Nottingham Hosp, Div Resp Med, City Campus, Nottingham NG5 1PB, England; [Violette, Shelia M.; Weinreb, Paul H.] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA; [Laurent, Geoffrey] UCL, Ctr Resp Res, London WC1E 6JF, England; [Laurent, Geoffrey] Univ Western Australia, Ctr Cell Therapy & Regenerat Med, Crawley, WA 6009, Australia; [Parfrey, Helen] Univ Cambridge, Dept Med, Cambridge CB2 0SP, England; [Parfrey, Helen] Papworth Hosp NHSFT, Cambridge CB2 0SP, England; [Wolters, Paul John] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Wallace, William] Univ Edinburgh, Div Pathol, Edinburgh EH4 2XR, Midlothian, Scotland; [Alberti, Siegfried; Nordheim, Alfred] Univ Tubingen, Interfac Inst Cell Biol, D-72076 Tubingen, Germany	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Biogen; University of London; University College London; University of Western Australia; University of Cambridge; Papworth Hospital; University of California System; University of California San Francisco; University of Edinburgh; Eberhard Karls University of Tubingen	Tatler, AL (corresponding author), Univ Nottingham Hosp, Div Resp Med, City Campus,Hucknall Rd, Nottingham NG5 1PB, England.	amanda.tatler@nottingham.ac.uk	Jenkins, Gisli/R-8143-2017; tatler, amanda/I-2620-2019	Jenkins, Gisli/0000-0002-7929-2119; tatler, amanda/0000-0002-4644-4614; John, Alison/0000-0002-0453-3221; Weinreb, Paul/0000-0002-0802-0052; Knox, Alan/0000-0002-5906-4143	Wellcome Trust [085350]; National Centre for the Replacement, Refinement, and Reduction of Animals in Research Grant [G110564]; German Cancer Aid Grant [109886]; NC3Rs David Sainsbury fellowship; GlaxoSmithKline; Intermune; Boehringer Ingelheim; Biogen; PharmAkea; Medimmune; Roche; Novartis; Medical Research Council [MR/N005953/1] Funding Source: researchfish; Medical Research Foundation [MRF-091-0004-RG-TATLE] Funding Source: researchfish; National Centre for the Replacement [G1100564/1, NC/K500501/1] Funding Source: researchfish; MRC [MR/N005953/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Centre for the Replacement, Refinement, and Reduction of Animals in Research Grant(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); German Cancer Aid Grant; NC3Rs David Sainsbury fellowship; GlaxoSmithKline(GlaxoSmithKline); Intermune; Boehringer Ingelheim(Boehringer Ingelheim); Biogen(Biogen); PharmAkea; Medimmune(AstraZenecaMedimmune); Roche(Roche Holding); Novartis(Novartis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 085350 (to G. J.), the National Centre for the Replacement, Refinement, and Reduction of Animals in Research Grant G110564 (to G. J.), German Cancer Aid Grant 109886 (to A. N.), and an NC3Rs David Sainsbury fellowship (to A. T.). S. M. V. and P. H. W. are shareholders of Biogen Idec. G. J. has received consultancy fees from GlaxoSmithKline, Intermune, Boehringer Ingelheim, Biogen, and PharmAkea and lecture fees from Intermune, Medimmune, Roche, and Boehringer Ingelheim and has sponsored research agreements with GlaxoSmithKline, Novartis, and Biogen.	Adcock IM, 1996, AM J RESP CRIT CARE, V154, P771, DOI 10.1164/ajrccm.154.3.8810618; Aigner A, 2006, J BIOTECHNOL, V124, P12, DOI 10.1016/j.jbiotec.2005.12.003; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; Carreras I, 2001, AM J PHYSIOL-LUNG C, V281, pL766, DOI 10.1152/ajplung.2001.281.4.L766; Castelbaum AJ, 1997, J CLIN ENDOCR METAB, V82, P136, DOI 10.1210/jc.82.1.136; Cesari F, 2004, GENESIS, V38, P87, DOI 10.1002/gene.20003; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; Hagimoto N, 2002, J IMMUNOL, V168, P6470, DOI 10.4049/jimmunol.168.12.6470; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Horan GS, 2008, AM J RESP CRIT CARE, V177, P56, DOI 10.1164/rccm.200706-805OC; Jenkins RG, 2015, LANCET RESP MED, V3, P462, DOI 10.1016/S2213-2600(15)00048-X; Ji HL, 2011, REPROD SCI, V18, P156, DOI 10.1177/1933719110382305; John AE, 2013, J NUCL MED, V54, P2146, DOI 10.2967/jnumed.113.120592; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; Oak SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021253; Popov Y, 2008, J HEPATOL, V48, P453, DOI 10.1016/j.jhep.2007.11.021; Puthawala K, 2008, AM J RESP CRIT CARE, V177, P82, DOI 10.1164/rccm.200706-806OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rock K, 2011, J BIOL CHEM, V286, P18268, DOI 10.1074/jbc.M110.201665; Saini G, 2015, EUR RESPIR J, V46, P486, DOI 10.1183/09031936.00210414; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; SHEPPARD D, 1992, J BIOL CHEM, V267, P17409; Song CZ, 1999, P NATL ACAD SCI USA, V96, P11776, DOI 10.1073/pnas.96.21.11776; Stabile LP, 2011, CLIN CANCER RES, V17, P154, DOI 10.1158/1078-0432.CCR-10-0992; Sullivan BP, 2010, AM J PATHOL, V177, P2837, DOI 10.2353/ajpath.2010.100425; Tanswell AK, 1998, AM J PHYSIOL-LUNG C, V275, pL452, DOI 10.1152/ajplung.1998.275.3.L452; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; Wang B, 2007, HEPATOLOGY, V46, P1404, DOI 10.1002/hep.21849; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Yang SH, 2002, MOL CELL BIOL, V22, P5036, DOI 10.1128/MCB.22.14.5036-5046.2002; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zoz DF, 2011, AM J MED SCI, V341, P435, DOI 10.1097/MAJ.0b013e31821a9d8e	40	19	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9540	9553		10.1074/jbc.M115.692368	http://dx.doi.org/10.1074/jbc.M115.692368			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26861876	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000375602300014
J	Wang, HR; Wang, XH; Xu, XP; Kyba, M; Cooney, AJ				Wang, Hongran; Wang, Xiaohong; Xu, Xueping; Kyba, Michael; Cooney, Austin J.			Germ Cell Nuclear Factor (GCNF) Represses Oct4 Expression and Globally Modulates Gene Expression in Human Embryonic Stem (hES) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell differentiation; embryonic stem cell; gene expression; gene regulation; pluripotency; Germ cell nuclear factor; Oct4	TRANSCRIPTION FACTOR; MOUSE EMBRYOS; SELF-RENEWAL; DIFFERENTIATION; ESTABLISHMENT; PLURIPOTENCY; OCT-3/4; KNOCKDOWN; ENDODERM; LINEAGES	Oct4 is considered a key transcription factor for pluripotent stem cell self-renewal. It binds to specific regions within target genes to regulate their expression and is downregulated upon induction of differentiation of pluripotent stem cells; however, the mechanisms that regulate the levels of human Oct4 expression remain poorly understood. Here we show that expression of human Oct4 is directly repressed by germ cell nuclear factor (GCNF), an orphan nuclear receptor, in hES cells. Knockdown of GCNF by siRNA resulted in maintenance of Oct4 expression during RA-induced hES cell differentiation. While overexpression of GCNF promoted repression of Oct4 expression in both undifferentiated and differentiated hES cells. The level of Oct4 repression was dependent on the level of GCNF expression in a dose-dependent manner. mRNA microarray analysis demonstrated that overexpression of GCNF globally regulates gene expression in undifferentiated and differentiated hES cells. Within the group of altered genes, GCNF down-regulated 36% of the genes, and up-regulated 64% in undifferentiated hES cells. In addition, GCNF also showed a regulatory gene pattern that is different from RA treatment during hES cell differentiation. These findings increase our understanding of the mechanisms that maintain hES cell pluripotency and regulate gene expression during the differentiation process.	[Wang, Hongran; Cooney, Austin J.] Univ Texas Austin, Dept Pediat, Dell Pediat Res Inst, Dell Med Sch, 1400 Barbara Jordan Blvd, Austin, TX 78723 USA; [Wang, Xiaohong] Texas Heart Inst, Stem Cell Ctr, Houston, TX 77030 USA; [Wang, Xiaohong; Xu, Xueping] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Kyba, Michael] Univ Minnesota, Dept Pediat, Lillehei Heart Inst, Minneapolis, MN 55454 USA	University of Texas System; University of Texas Austin; Texas Heart Institute; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities	Cooney, AJ (corresponding author), Univ Texas Austin, Dept Pediat, Dell Pediat Res Inst, Dell Med Sch, 1400 Barbara Jordan Blvd, Austin, TX 78723 USA.	austin.cooney@austin.utexas.edu		Kyba, Michael/0000-0002-5579-7534	National Institutes of Health [P01 GM081627]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant P01 GM081627 (to A. J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agoulnik IY, 1998, FEBS LETT, V424, P73, DOI 10.1016/S0014-5793(98)00142-2; Akamatsu W, 2009, J NEUROSCI, V29, P2113, DOI 10.1523/JNEUROSCI.4527-08.2009; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chung ACK, 2006, DEV BIOL, V293, P13, DOI 10.1016/j.ydbio.2005.12.017; Chung ACK, 2001, MOL CELL BIOL, V21, P663, DOI 10.1128/MCB.21.2.663-677.2001; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; HIROSE T, 1995, GENE, V152, P247, DOI 10.1016/0378-1119(94)00656-D; Kapelle M, 1997, BBA-GENE STRUCT EXPR, V1352, P13, DOI 10.1016/S0167-4781(97)00043-2; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kim MH, 2002, BIOCHEM BIOPH RES CO, V296, P1372, DOI 10.1016/S0006-291X(02)02070-3; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Lan ZJ, 2002, J BIOL CHEM, V277, P50660, DOI 10.1074/jbc.M209586200; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma YH, 2010, RNA, V16, P2564, DOI 10.1261/rna.2350710; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nichols J, 1998, REPROD FERT DEVELOP, V10, P517, DOI 10.1071/RD98075; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oka M, 2013, J BIOL CHEM, V288, P15085, DOI 10.1074/jbc.M112.448837; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; PIKARSKY E, 1994, MOL CELL BIOL, V14, P1026, DOI 10.1128/MCB.14.2.1026; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Sato N, 2006, BIOCHEM BIOPH RES CO, V344, P845, DOI 10.1016/j.bbrc.2006.04.007; Shufaro Y, 2004, BEST PRACT RES CL OB, V18, P909, DOI 10.1016/j.bpobgyn.2004.07.002; Susens U, 1996, BBA-GENE STRUCT EXPR, V1309, P179, DOI 10.1016/S0167-4781(96)00157-1; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang HR, 2013, STEM CELLS, V31, P2659, DOI 10.1002/stem.1367; Yeom YI, 1996, DEVELOPMENT, V122, P881; Zafarana G, 2009, STEM CELLS, V27, P776, DOI 10.1002/stem.5	31	10	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8644	8652		10.1074/jbc.M115.694208	http://dx.doi.org/10.1074/jbc.M115.694208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26769970	hybrid, Green Published			2022-12-28	WOS:000374773200027
J	Alvaro, CG; Thorner, J				Alvaro, Christopher G.; Thorner, Jeremy			Heterotrimeric G Protein-coupled Receptor Signaling in Yeast Mating Pheromone Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						adaptor protein; cell differentiation; G protein; G protein-coupled receptor (GPCR); gene regulation; mitogen-activated protein kinase (MAPK); morphogenesis; post-translational modification (PTM); Saccharomyces cerevisiae; scaffold protein; signal transduction; gene regulation; protein phosphorylation; cell adhesion; cell cycle arrest; polarized morphogenesis; cell fusion; nuclear fusion	FUS3 MAP KINASE; SACCHAROMYCES-CEREVISIAE STE2P; CASCADE SCAFFOLD PROTEIN; CYCLIN-DEPENDENT KINASE; ALPHA-FACTOR RECEPTOR; PLASMA-MEMBRANE; NUCLEAR-FUSION; CELL-FUSION; POLARIZED MORPHOGENESIS; SPATIAL REGULATION	The DNAs encoding the receptors that respond to the peptide mating pheromones of the budding yeast Saccharomyces cerevisiae were isolated in 1985, and were the very first genes for agonist-binding heterotrimeric G protein-coupled receptors (GPCRs) to be cloned in any organism. Now, over 30 years later, this yeast and its receptors continue to provide a pathfinding experimental paradigm for investigating GPCR-initiated signaling and its regulation, as described in this retrospective overview.	[Alvaro, Christopher G.; Thorner, Jeremy] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem Biophys & Struct Biol, Rm 526,Barker Hall, Berkeley, CA 94720 USA; [Alvaro, Christopher G.] Univ Calif San Francisco, William J Rutter Community Ctr Mission Bay, STRIDE IRACDA Postdoctoral Program, Postdoc Off,UCSF Grad Div,Sch Med, Third Fl,1675 Owens St,Ste 310,Campus Box 0523, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Thorner, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem Biophys & Struct Biol, Rm 526,Barker Hall, Berkeley, CA 94720 USA.	jthorner@berkeley.edu	THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X	National Institutes of Health CBMS Predoctoral Traineeship [GM07232]; National Institutes of Health [GM21841]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021841, T32GM007232, R37GM021841] Funding Source: NIH RePORTER	National Institutes of Health CBMS Predoctoral Traineeship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health CBMS Predoctoral Traineeship GM07232 (to C. G. A) and by National Institutes of Health R01 Research Grant GM21841 (to J. T.). This is the first article in the Thematic Minireview series "Cell Signaling in Simple Organisms." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvaro CG, 2014, MOL CELL BIOL, V34, P2660, DOI 10.1128/MCB.00230-14; Apanovitch DM, 1998, BIOCHEMISTRY-US, V37, P4815, DOI 10.1021/bi9729965; Babu P, 2004, J BIOL CHEM, V279, P27138, DOI 10.1074/jbc.M403071200; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; Beh CT, 1997, J CELL BIOL, V139, P1063, DOI 10.1083/jcb.139.5.1063; BERLIN V, 1991, METHOD ENZYMOL, V194, P774; Bharucha JP, 2008, EUKARYOT CELL, V7, P1246, DOI 10.1128/EC.00024-08; Bidlingmaier S, 2004, J CELL BIOL, V164, P207, DOI 10.1083/jcb.200307065; BLUMER KJ, 1990, P NATL ACAD SCI USA, V87, P4363, DOI 10.1073/pnas.87.11.4363; BLUMER KJ, 1988, COLD SPRING HARB SYM, V53, P591, DOI 10.1101/SQB.1988.053.01.068; Bukusoglu G, 1996, MOL CELL BIOL, V16, P4818; Chapa-Y-Lazo B, 2011, FUNGAL BIOL-UK, V115, P547, DOI 10.1016/j.funbio.2011.02.001; Chen RE, 2010, MOL CELL BIOL, V30, P4293, DOI 10.1128/MCB.00361-10; COLE GM, 1990, MOL CELL BIOL, V10, P510, DOI 10.1128/MCB.10.2.510; David NE, 1997, J BIOL CHEM, V272, P15553, DOI 10.1074/jbc.272.24.15553; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; DOHLMAN HG, 1993, P NATL ACAD SCI USA, V90, P9688, DOI 10.1073/pnas.90.20.9688; Dosil M, 2010, METHOD ENZYMOL, V485, P329, DOI [10.1016/S0076-6879(10)85019-0, 10.1016/B978-0-12-381296-4.00019-1]; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; Elion EA, 2001, J CELL SCI, V114, P3967; ELION EA, 1995, J CELL BIOL, V130, P1283, DOI 10.1083/jcb.130.6.1283; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Follette PJ, 2009, METHODS MOL BIOL, V571, P99, DOI 10.1007/978-1-60761-198-1_6; Fracchiolla KE, 2015, J PEPT SCI, V21, P212, DOI 10.1002/psc.2750; Friesen H, 2003, MOL BIOL CELL, V14, P3027, DOI 10.1091/mbc.E02-09-0613; Garrenton LS, 2006, GENE DEV, V20, P1946, DOI 10.1101/gad.1413706; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; Gelin-Licht R, 2012, CELL REP, V1, P483, DOI 10.1016/j.celrep.2012.03.004; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Guo M, 2003, MOL CELL, V12, P517, DOI 10.1016/S1097-2765(03)00307-1; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; HARTWELL LH, 1980, J CELL BIOL, V85, P811, DOI 10.1083/jcb.85.3.811; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Hung W, 1997, EUR J BIOCHEM, V245, P241, DOI 10.1111/j.1432-1033.1997.00241.x; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kim J, 2012, GENE DEV, V26, P1110, DOI 10.1101/gad.187260.112; Klein S, 2000, P NATL ACAD SCI USA, V97, P3219, DOI 10.1073/pnas.050015797; Kwan JJ, 2006, J MOL BIOL, V356, P142, DOI 10.1016/j.jmb.2005.11.012; Lahav R, 2007, MOL CELL BIOL, V27, P818, DOI 10.1128/MCB.00439-06; Leberer E, 2000, BIOL CHEM, V381, P427, DOI 10.1515/BC.2000.055; Lee BK, 2007, PROTEIN EXPRES PURIF, V56, P62, DOI 10.1016/j.pep.2007.06.002; LEEUW T, 1995, SCIENCE, V270, P1210, DOI 10.1126/science.270.5239.1210; Liu DM, 2014, J CELL BIOL, V207, P59, DOI 10.1083/jcb.201404122; MACKAY VL, 1988, P NATL ACAD SCI USA, V85, P55, DOI 10.1073/pnas.85.1.55; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Manahan CL, 2000, MOL BIOL CELL, V11, P957, DOI 10.1091/mbc.11.3.957; Manfredi JP, 1996, MOL CELL BIOL, V16, P4700; Matheos D, 2004, J CELL BIOL, V165, P99, DOI 10.1083/jcb.200309089; Metodiev MV, 2002, SCIENCE, V296, P1483, DOI 10.1126/science.1070540; Muller EM, 2003, J BIOL CHEM, V278, P38461, DOI 10.1074/jbc.M304089200; Naider F, 2004, PEPTIDES, V25, P1441, DOI 10.1016/j.peptides.2003.11.028; NAKAYAMA N, 1985, EMBO J, V4, P2643, DOI 10.1002/j.1460-2075.1985.tb03982.x; Nern A, 1999, J CELL BIOL, V144, P1187, DOI 10.1083/jcb.144.6.1187; Ogura K, 2009, J BIOCHEM, V146, P317, DOI 10.1093/jb/mvp075; Overton MC, 2005, EUKARYOT CELL, V4, P1963, DOI 10.1128/EC.4.12.1963-1970.2005; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; Prosser DC, 2015, J CELL SCI, V128, P4220, DOI 10.1242/jcs.175372; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; Richman TJ, 2004, CURR GENET, V45, P339, DOI 10.1007/s00294-004-0505-9; Rivers DM, 2003, MOL GENET GENOMICS, V270, P225, DOI 10.1007/s00438-003-0914-3; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Rogers DW, 2015, CURR BIOL, V25, P1753, DOI 10.1016/j.cub.2015.05.023; Rose MD, 1996, ANNU REV CELL DEV BI, V12, P663, DOI 10.1146/annurev.cellbio.12.1.663; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rymer JK, 2015, BBA-BIOMEMBRANES, V1848, P916, DOI 10.1016/j.bbamem.2014.12.024; SCHANDEL KA, 1994, MOL CELL BIOL, V14, P7245, DOI 10.1128/MCB.14.11.7245; Shen S, 2009, MOL BIOL CELL, V20, P2438, DOI 10.1091/mbc.E08-10-0987; Shi CH, 2005, BIOCHEMISTRY-US, V44, P15705, DOI 10.1021/bi051292p; Shi C, 2009, BBA-GEN SUBJECTS, V1790, P1, DOI 10.1016/j.bbagen.2008.10.003; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Siekhaus DE, 2003, NAT CELL BIOL, V5, P231, DOI 10.1038/ncb941; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Smith ST, 2013, P I CIVIL ENG-STR B, V166, P1, DOI 10.1680/stbu.2012.166.1.1; Stahelin RV, 2007, J BIOL CHEM, V282, P25737, DOI 10.1074/jbc.M702861200; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Stein Richard A, 2015, G3 (Bethesda), V6, P337, DOI 10.1534/g3.115.023960; Takahashi S, 2007, MOL BIOL CELL, V18, P4945, DOI 10.1091/mbc.E07-07-0676; Takaku T, 2010, J BIOL CHEM, V285, P19346, DOI 10.1074/jbc.M110.116749; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Thorner J., 2006, LANDMARK PAPERS YEAS, P193; Toshima JY, 2009, MOL BIOL CELL, V20, P5039, DOI 10.1091/mbc.E09-07-0541; Truckses DM, 2006, MOL CELL BIOL, V26, P912, DOI 10.1128/MCB.26.3.912-928.2006; TRUEHEART J, 1989, P NATL ACAD SCI USA, V86, P9916, DOI 10.1073/pnas.86.24.9916; Uddin MS, 2012, J RECEPT SIG TRANSD, V32, P65, DOI 10.3109/10799893.2011.647352; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; Watson LJ, 2014, TRAFFIC, V15, P1330, DOI 10.1111/tra.12211; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Winters MJ, 2005, MOL CELL BIOL, V25, P2177, DOI 10.1128/MCB.25.6.2177-2190.2005; Yablonski D, 1996, P NATL ACAD SCI USA, V93, P13864, DOI 10.1073/pnas.93.24.13864; Yu L, 2008, MOL BIOL CELL, V19, P1739, DOI 10.1091/mbc.E07-08-0757; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690; Zhang NN, 2006, MOL BIOL CELL, V17, P3409, DOI 10.1091/mbc.E06-03-0177; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459; ZHOU ZQ, 1993, MOL CELL BIOL, V13, P2069, DOI 10.1128/MCB.13.4.2069; Zuber J, 2015, BIOCHEMISTRY-US, V54, P1787, DOI 10.1021/bi501314t	100	63	65	2	161	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7788	7795		10.1074/jbc.R116.714980	http://dx.doi.org/10.1074/jbc.R116.714980			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26907689	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000374056700002
J	Hossain, ST; Malhotra, A; Deutscher, MP				Hossain, Sk Tofajjen; Malhotra, Arun; Deutscher, Murray P.			How RNase R Degrades Structured RNA: ROLE OF THE HELICASE ACTIVITY AND THE S1 DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; conformational change; Escherichia coli (E; coli); RNA degradation; RNA helicase; P-loop domain; duplex RNA; ribonuclase	ESCHERICHIA-COLI; POLYNUCLEOTIDE PHOSPHORYLASE; NUCLEASE DOMAIN; RIBONUCLEASE R; RIBOSOMAL-RNA; BINDING; DEGRADOSOME; FLUORESCENCE; DEGRADATION; STABILITY	RNase R, a ubiquitous 3 exoribonuclease, plays an important role in many aspects of RNA metabolism. In contrast to other exoribonucleases, RNase R can efficiently degrade highly structured RNAs, but the mechanism by which this is accomplished has remained elusive. It is known that RNase R contains an unusual, intrinsic RNA helicase activity that facilitates degradation of duplex RNA, but how it stimulates the nuclease activity has also been unclear. Here, we have made use of specifically designed substrates to compare the nuclease and helicase activities of RNase R. We have also identified and mutated several residues in the S1 RNA-binding domain that are important for interacting with duplex RNA and have measured intrinsic tryptophan fluorescence to analyze the conformational changes that occur upon binding of structured RNA. Using these approaches, we have determined the relation of the RNA helicase, ATP binding, and nuclease activities of RNase R. This information has been combined with a structural analysis of RNase R, based on its homology to RNase II, whose structure has been determined, to develop a detailed model that explains how RNase R digests structured RNA and how this differs from its action on single-stranded RNA.	[Hossain, Sk Tofajjen; Malhotra, Arun; Deutscher, Murray P.] Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, POB 016129, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, POB 016129, Miami, FL 33101 USA.	m.deutscher@med.miami.edu	Malhotra, Arun/Z-5140-2019	Malhotra, Arun/0000-0001-6656-7841; Hossain, Sk Tofajjen/0000-0002-1448-1015	National Institutes of Health [GM 16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016317, R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM 16317 (to M.P.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Awano N, 2007, J BACTERIOL, V189, P5808, DOI 10.1128/JB.00655-07; Awano N, 2010, J BACTERIOL, V192, P1344, DOI 10.1128/JB.01368-09; BEECHEM JM, 1985, ANNU REV BIOCHEM, V54, P43, DOI 10.1146/annurev.biochem.54.1.43; Bhattacharya M, 2011, J FLUORESC, V21, P1083, DOI 10.1007/s10895-010-0781-3; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Hossain ST, 2015, J BIOL CHEM, V290, P15697, DOI 10.1074/jbc.M115.650176; Khemici V, 2004, MOL MICROBIOL, V51, P777, DOI 10.1046/j.1365-2958.2003.03862.x; Liang WX, 2012, J BIOL CHEM, V287, P33472, DOI 10.1074/jbc.M112.375287; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Liang WX, 2010, J BIOL CHEM, V285, P29054, DOI 10.1074/jbc.C110.168641; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Lustig B, 1997, NUCLEIC ACIDS RES, V25, P2562, DOI 10.1093/nar/25.13.2562; Matos RG, 2009, BIOCHEM J, V423, P291, DOI 10.1042/BJ20090839; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Sulthana S, 2013, J BIOL CHEM, V288, P12574, DOI 10.1074/jbc.C113.459172; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Vincent HA, 2009, J BIOL CHEM, V284, P486, DOI 10.1074/jbc.M806468200; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	26	33	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7877	7887		10.1074/jbc.M116.717991	http://dx.doi.org/10.1074/jbc.M116.717991			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26872969	hybrid, Green Published			2022-12-28	WOS:000374056700011
J	Parthasarathy, S; Parapatla, H; Nandavaram, A; Palmer, T; Siddavattam, D				Parthasarathy, Sunil; Parapatla, Hari; Nandavaram, Aparna; Palmer, Tracy; Siddavattam, Dayananda			Organophosphate Hydrolase Is a Lipoprotein and Interacts with P-i-specific Transport System to Facilitate Growth of Brevundimonas diminuta Using OP Insecticide as Source of Phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TWIN-ARGININE TRANSLOCASE; ESCHERICHIA-COLI; PSEUDOMONAS-DIMINUTA; FLAVOBACTERIUM SP; OUTER-MEMBRANE; STREPTOMYCES-COELICOLOR; CYTOPLASMIC MEMBRANE; PROTEIN EXPORT; NERVE AGENTS; PATHWAY	Organophosphate hydrolase (OPH), encoded by the organophosphate degradation (opd) island, hydrolyzes the triester bond found in a variety of organophosphate insecticides and nerve agents. OPH is targeted to the inner membrane of Brevundimonas diminuta in a pre-folded conformation by the twin arginine transport (Tat) pathway. The OPH signal peptide contains an invariant cysteine residue at the junction of the signal peptidase (Spase) cleavage site along with a well conserved lipobox motif. Treatment of cells producing native OPH with the signal peptidase II inhibitor globomycin resulted in accumulation of most of the pre-OPH in the cytoplasm with negligible processed OPH detected in the membrane. Substitution of the conserved lipobox cysteine to serine resulted in release of OPH into the periplasm, confirming that OPH is a lipoprotein. Analysis of purified OPH revealed that it was modified with the fatty acids palmitate and stearate. Membrane-bound OPH was shown to interact with the outer membrane efflux protein TolC and with PstS, the periplasmic component of the ABC transporter complex (PstSACB) involved in phosphate transport. Interaction of OPH with PstS appears to facilitate transport of Pi generated from organophosphates due to the combined action of OPH and periplasmically located phosphatases. Consistent with this model, opd null mutants of B. diminuta failed to grow using the organophosphate insecticide methyl parathion as sole source of phosphate.	[Parthasarathy, Sunil; Parapatla, Hari; Nandavaram, Aparna; Siddavattam, Dayananda] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India; [Palmer, Tracy] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee, Scotland	University of Hyderabad; University of Dundee	Siddavattam, D (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India.	sdsl@uohyd.ernet.in		Palmer, Tracy/0000-0001-9043-2592	Department of Biotechnology, Govt. of India; DST-FIST (Department of Science and Technology-Fund for Improvement of SAMP;T Infrastructure); School of Life Sciences, University of Hyderabad by DBT-CREBB/BUILDER (Department of Biotechnology-Centre for Research and Education in Biology and Biotechnology/Boost); Shantha Biotechnics Junior Research Fellowship (JRF); Commonwealth Split-Site Fellowships, British Council, UK; MRC [G117/519] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/0000A189] Funding Source: researchfish; Medical Research Council [G117/519] Funding Source: researchfish	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); DST-FIST (Department of Science and Technology-Fund for Improvement of SAMP;T Infrastructure); School of Life Sciences, University of Hyderabad by DBT-CREBB/BUILDER (Department of Biotechnology-Centre for Research and Education in Biology and Biotechnology/Boost); Shantha Biotechnics Junior Research Fellowship (JRF); Commonwealth Split-Site Fellowships, British Council, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Department of Biotechnology, Govt. of India (to D. S. Laboratory). Department of Animal Biology was supported by the DST-FIST (Department of Science and Technology-Fund for Improvement of S&T Infrastructure), and the School of Life Sciences, University of Hyderabad is supported by DBT-CREBB/BUILDER (Department of Biotechnology-Centre for Research and Education in Biology and Biotechnology/Boost to University Interdisciplinary Life Science Departments for Education and Research). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Shantha Biotechnics Junior Research Fellowship (JRF) and Commonwealth Split-Site Fellowships, British Council, UK.	Bachmann J, 2006, FEBS J, V273, P4817, DOI 10.1111/j.1742-4658.2006.05480.x; Benning MM, 2001, BIOCHEMISTRY-US, V40, P2712, DOI 10.1021/bi002661e; Beven L, 1996, CURR MICROBIOL, V33, P317, DOI 10.1007/s002849900121; Bigley AN, 2013, BBA-PROTEINS PROTEOM, V1834, P443, DOI 10.1016/j.bbapap.2012.04.004; BROWN KA, 1980, SOIL BIOL BIOCHEM, V12, P105, DOI 10.1016/0038-0717(80)90044-9; CHAUDHRY GR, 1988, APPL ENVIRON MICROB, V54, P288, DOI 10.1128/AEM.54.2.288-293.1988; Cho CMH, 2002, APPL ENVIRON MICROB, V68, P2026, DOI 10.1128/AEM.68.4.2026-2030.2002; DUMAS DP, 1989, J BIOL CHEM, V264, P19659; Efremenko EN, 2001, RUSS CHEM B+, V50, P1826, DOI 10.1023/A:1014377912147; Gimenez MI, 2007, MOL MICROBIOL, V66, P1597, DOI 10.1111/j.1365-2958.2007.06034.x; Gorla P, 2009, J BACTERIOL, V191, P6292, DOI 10.1128/JB.00824-09; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Hobbs EC, 2012, P NATL ACAD SCI USA, V109, P16696, DOI 10.1073/pnas.1210093109; Ichihara K, 2010, J LIPID RES, V51, P635, DOI 10.1194/jlr.D001065; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kanugula AK, 2011, INDIAN J BIOCHEM BIO, V48, P29; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Keller R, 2012, J CELL BIOL, V199, P303, DOI 10.1083/jcb.201204149; Kim MS, 2010, J AM SOC MASS SPECTR, V21, P1606, DOI 10.1016/j.jasms.2010.04.011; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Mullerova D, 2009, FEMS MICROBIOL LETT, V299, P74, DOI 10.1111/j.1574-6968.2009.01737.x; MULBRY WW, 1989, APPL ENVIRON MICROB, V55, P289, DOI 10.1128/AEM.55.2.289-293.1989; Nadeau O. W., 2007, CSH PROTOC, V2007; Narita S, 2006, FEBS LETT, V580, P1164, DOI 10.1016/j.febslet.2005.10.038; OMBURO GA, 1992, J BIOL CHEM, V267, P13278; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Pandeeti EVP, 2012, G3-GENES GENOM GENET, V2, P1541, DOI 10.1534/g3.112.004051; Pandeeti EVP, 2011, PLASMID, V65, P226, DOI 10.1016/j.plasmid.2011.02.003; Poole R K, 1993, Methods Mol Biol, V19, P109; RAO NN, 1990, MOL MICROBIOL, V4, P1083, DOI 10.1111/j.1365-2958.1990.tb00682.x; Sambrook, 2001, MOL CLONING LAB MANU, V3rd; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHNAITM.CA, 1970, J BACTERIOL, V104, P890, DOI 10.1128/JB.104.2.890-901.1970; SERDAR CM, 1982, APPL ENVIRON MICROB, V44, P246, DOI 10.1128/AEM.44.1.246-249.1982; Siddavattam D, 2003, APPL ENVIRON MICROB, V69, P2533, DOI 10.1128/AEM.69.5.2533-2539.2003; Siddavattam D, 2006, PESTIC BIOCHEM PHYS, V86, P146, DOI 10.1016/j.pestbp.2006.02.007; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Tanaka S, 2007, J BIOL CHEM, V282, P13379, DOI 10.1074/jbc.M611840200; Thompson BJ, 2010, MOL MICROBIOL, V77, P943, DOI 10.1111/j.1365-2958.2010.07261.x; Valente FMA, 2007, FEBS LETT, V581, P3341, DOI 10.1016/j.febslet.2007.06.020; vanGeest M, 1996, J BIOL CHEM, V271, P25582, DOI 10.1074/jbc.271.41.25582; WALKER CH, 1993, CHEM-BIOL INTERACT, V87, P17, DOI 10.1016/0009-2797(93)90021-P; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Widdick DA, 2011, MOL MICROBIOL, V80, P1395, DOI 10.1111/j.1365-2958.2011.07656.x; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181; ZWIEBEL LJ, 1981, J BACTERIOL, V145, P654, DOI 10.1128/JB.145.1.654-656.1981	54	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7774	7785		10.1074/jbc.M116.715110	http://dx.doi.org/10.1074/jbc.M116.715110			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26861877	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000383447600046
J	Beeg, M; Stravalaci, M; Romeo, M; Carra, AD; Cagnotto, A; Rossi, A; Diomede, L; Salmona, M; Gobbi, M				Beeg, Marten; Stravalaci, Matteo; Romeo, Margherita; Carra, Arianna Dorotea; Cagnotto, Alfredo; Rossi, Alessandro; Diomede, Luisa; Salmona, Mario; Gobbi, Marco			Clusterin Binds to A(1-42) Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid (A); Caenorhabditis elegans; chaperone; kinetics; surface plasmon resonance (SPR); clusterin; kinetics of fibril formation	AMYLOID-BETA-PEPTIDE; ABERRANT PROTEIN OLIGOMERS; A-BETA; ALZHEIMERS-DISEASE; EXTRACELLULAR CHAPERONES; CAENORHABDITIS-ELEGANS; MOLECULAR-MECHANISMS; IN-VITRO; TOXICITY; A-BETA(1-42)	The aggregation of amyloid protein (A) is a fundamental pathogenic mechanism leading to the neuronal damage present in Alzheimer disease, and soluble A oligomers are thought to be a major toxic culprit. Thus, better knowledge and specific targeting of the pathways that lead to these noxious species may result in valuable therapeutic strategies. We characterized some effects of the molecular chaperone clusterin, providing new and more detailed evidence of its potential neuroprotective effects. Using a classical thioflavin T assay, we observed a dose-dependent inhibition of the aggregation process. The global analysis of time courses under different conditions demonstrated that clusterin has no effect on the elongation rate but mainly interferes with the nucleation processes (both primary and secondary), reducing the number of nuclei available for further fibril growth. Then, using a recently developed immunoassay based on surface plasmon resonance, we obtained direct evidence of a high-affinity (K-D = 1 nm) interaction of clusterin with biologically relevant A(1-42) oligomers, selectively captured on the sensor chip. Moreover, with the same technology, we observed that substoichiometric concentrations of clusterin prevent oligomer interaction with the antibody 4G8, suggesting that the chaperone shields hydrophobic residues exposed on the oligomeric assemblies. Finally, we found that preincubation with clusterin antagonizes the toxic effects of A(1-42) oligomers, as evaluated in a recently developed in vivo model in Caenorhabditis elegans. These data substantiate the interaction of clusterin with biologically active regions exposed on nuclei/oligomers of A(1-42), providing a molecular basis for the neuroprotective effects of the chaperone.	[Beeg, Marten; Stravalaci, Matteo; Romeo, Margherita; Carra, Arianna Dorotea; Cagnotto, Alfredo; Rossi, Alessandro; Diomede, Luisa; Salmona, Mario; Gobbi, Marco] IRCCS, Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Via La Masa 19, I-20156 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Gobbi, M (corresponding author), IRCCS, Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Via La Masa 19, I-20156 Milan, Italy.	marco.gobbi@marionegri.it	Cagnotto, Alfredo/AAB-3083-2020; Stravalaci, Matteo/AAB-8963-2019; Diomede, Luisa/P-3417-2014; salmona, mario/AAA-7116-2020; Beeg, Marten/AAA-9269-2020; salmona, mario/ABI-4066-2020; Gobbi, Marco/J-2638-2016	Cagnotto, Alfredo/0000-0002-1390-8240; Stravalaci, Matteo/0000-0002-5636-4204; Diomede, Luisa/0000-0002-2258-0531; salmona, mario/0000-0002-9098-9873; Beeg, Marten/0000-0001-7201-6704; Gobbi, Marco/0000-0003-1014-6225; Romeo, Margherita/0000-0002-3020-8545	National Institutes of Health Office Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Flamma Spa (Bergamo, Italy) for providing Fmoc amino acids for peptide synthesis. Purified immunoglobulin light chain H7 was provided by Prof. G. Merlini and Dr. P. Rognoni (IRCCS Policlinico San Matteo, Pavia, Italy). C. elegans and OP50 E. coli were provided by the Caenorhabditis Genetics Center, funded by the National Institutes of Health Office Research Infrastructure Programs (P40 OD010440).	Bailey RW, 2001, BIOCHEMISTRY-US, V40, P11828, DOI 10.1021/bi010135x; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Beeg M, 2013, CURR OPIN PHARMACOL, V13, P797, DOI 10.1016/j.coph.2013.05.010; Beeg M, 2011, ANAL BIOCHEM, V411, P297, DOI 10.1016/j.ab.2010.12.032; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Boggs LN, 1996, J NEUROCHEM, V67, P1324; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Buell AK, 2012, ANGEW CHEM INT EDIT, V51, P5247, DOI 10.1002/anie.201108040; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cascella R, 2013, BBA-MOL BASIS DIS, V1832, P1217, DOI 10.1016/j.bbadis.2013.04.012; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Desikan RS, 2014, JAMA NEUROL, V71, P180, DOI 10.1001/jamaneurol.2013.4560; Diomede L, 2014, BLOOD, V123, P3543, DOI 10.1182/blood-2013-10-525634; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Ferrone FA, 2006, METHOD ENZYMOL, V412, P285, DOI 10.1016/S0076-6879(06)12017-0; Ferrone FA, 2015, J MOL BIOL, V427, P287, DOI 10.1016/j.jmb.2014.10.028; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hatters DM, 2002, EUR J BIOCHEM, V269, P2789, DOI 10.1046/j.1432-1033.2002.02957.x; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kuipers BJH, 2007, J AGR FOOD CHEM, V55, P5445, DOI 10.1021/jf070337l; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Ly S, 2013, J BIOL CHEM, V288, P11628, DOI 10.1074/jbc.M112.411900; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Matsubara E, 1996, BIOCHEM J, V316, P671, DOI 10.1042/bj3160671; McHattie S, 1999, BIOCHEM BIOPH RES CO, V259, P336, DOI 10.1006/bbrc.1999.0781; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Minati L, 2009, AM J ALZHEIMERS DIS, V24, P95, DOI 10.1177/1533317508328602; Murphy RM, 2002, ANNU REV BIOMED ENG, V4, P155, DOI 10.1146/annurev.bioeng.4.092801.094202; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Petrlova J, 2011, PROTEINS, V79, P402, DOI 10.1002/prot.22891; Sohma Y, 2006, CHEMBIOCHEM, V7, P1549, DOI 10.1002/cbic.200600112; Stravalaci M, 2012, J BIOL CHEM, V287, P27796, DOI 10.1074/jbc.M111.334979; Stravalaci M, 2011, BIOSENS BIOELECTRON, V26, P2772, DOI 10.1016/j.bios.2010.10.038; Taniguchi A, 2009, CHEMBIOCHEM, V10, P710, DOI 10.1002/cbic.200800765; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Wyatt AR, 2013, ANNU REV BIOCHEM, V82, P295, DOI 10.1146/annurev-biochem-072711-163904; Wyatt AR, 2012, J MOL BIOL, V421, P499, DOI 10.1016/j.jmb.2012.01.004; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com	49	74	76	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6958	6966		10.1074/jbc.M115.689539	http://dx.doi.org/10.1074/jbc.M115.689539			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26884339	Green Published, hybrid			2022-12-28	WOS:000373299700032
J	Shammas, SL; Crabtree, MD; Dahal, L; Wicky, BIM; Clarke, J				Shammas, Sarah L.; Crabtree, Michael D.; Dahal, Liza; Wicky, Basile I. M.; Clarke, Jane			Insights into Coupled Folding and Binding Mechanisms from Kinetic Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						biophysics; electrostatics; kinetics; protein dynamic; protein folding; signaling; coupled folding and binding; phi-value; protein-protein interactions; residual structure; IDP; protein electrostatics	INTRINSICALLY DISORDERED PROTEINS; LINEAGE LEUKEMIA PROTEIN; TRANSITION-STATE; KIX DOMAIN; INDUCED FIT; CONFORMATIONAL SELECTION; TRANSACTIVATION DOMAIN; MOLECULAR RECOGNITION; C-MYB; SEQUENCE	Intrinsically disordered proteins (IDPs) are characterized by a lack of persistent structure. Since their identification more than a decade ago, many questions regarding their functional relevance and interaction mechanisms remain unanswered. Although most experiments have taken equilibrium and structural perspectives, fewer studies have investigated the kinetics of their interactions. Here we review and highlight the type of information that can be gained from kinetic studies. In particular, we show how kinetic studies of coupled folding and binding reactions, an important class of signaling event, are needed to determine mechanisms.	[Shammas, Sarah L.; Crabtree, Michael D.; Dahal, Liza; Wicky, Basile I. M.; Clarke, Jane] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England	University of Cambridge	Shammas, SL; Clarke, J (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	sls42@cam.ac.uk; jc162@cam.ac.uk		Wicky, Basile I. M./0000-0002-2501-7875; Shammas, Sarah/0000-0003-4489-140X; Crabtree, Michael/0000-0003-1466-4011	Wellcome Trust [WT 095195MA]; Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council (EPSRC); Cambridge Trust; Biotechnology and Biological Sciences Research Council [1348064] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1510934] Funding Source: researchfish; MRC [MC_U105485808] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cambridge Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (WT 095195MA). This work was also supported by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship (to M. D. C.); an Engineering and Physical Sciences Research Council (EPSRC) studentship (to L. D.); and the Cambridge Trust (to B. I. M. W.). This is the second article in the Thematic Minireview series "Intrinsically Disordered Proteins." The authors declare that they have no conflicts of interest with the contents of this article.	Arai M, 2015, P NATL ACAD SCI USA, V112, P9614, DOI 10.1073/pnas.1512799112; Bachmann A, 2011, P NATL ACAD SCI USA, V108, P3952, DOI 10.1073/pnas.1012668108; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Borcherds W, 2014, NAT CHEM BIOL, V10, P1000, DOI 10.1038/nchembio.1668; Bruschweiler S, 2013, ACS CHEM BIOL, V8, P1600, DOI 10.1021/cb4002188; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Das RK, 2013, P NATL ACAD SCI USA, V110, P13392, DOI 10.1073/pnas.1304749110; Dogan J, 2015, BIOCHEMISTRY-US, V54, P4741, DOI 10.1021/acs.biochem.5b00520; Dogan J, 2014, BIOPHYS J, V107, P1997, DOI 10.1016/j.bpj.2014.08.037; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dogan J, 2012, J BIOL CHEM, V287, P34316, DOI 10.1074/jbc.M112.399436; Dosnon M, 2015, ACS CHEM BIOL, V10, P795, DOI 10.1021/cb5008579; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Ferguson N, 2003, CURR OPIN STRUC BIOL, V13, P75, DOI 10.1016/S0959-440X(02)00009-X; Fisher CK, 2011, CURR OPIN STRUC BIOL, V21, P426, DOI 10.1016/j.sbi.2011.04.001; Forman-Kay JD, 2013, STRUCTURE, V21, P1492, DOI 10.1016/j.str.2013.08.001; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112; Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110; Goodman RH, 2000, GENE DEV, V14, P1553; Goto NK, 2002, J BIOL CHEM, V277, P43168, DOI 10.1074/jbc.M207660200; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Hill SA, 2014, J MOL BIOL, V426, P21, DOI 10.1016/j.jmb.2013.08.027; Hofmann H, 2012, P NATL ACAD SCI USA, V109, P16155, DOI 10.1073/pnas.1207719109; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iesmantavicius V, 2014, ANGEW CHEM INT EDIT, V53, P1548, DOI 10.1002/anie.201307712; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jensen MR, 2013, CURR OPIN STRUC BIOL, V23, P426, DOI 10.1016/j.sbi.2013.02.007; Kiefhaber T, 2012, CURR OPIN STRUC BIOL, V22, P21, DOI 10.1016/j.sbi.2011.09.010; Krieger JM, 2014, BIOPHYS J, V106, P1771, DOI 10.1016/j.bpj.2014.03.004; Law SM, 2014, P NATL ACAD SCI USA, V111, P12067, DOI 10.1073/pnas.1405831111; Mao AH, 2010, P NATL ACAD SCI USA, V107, P8183, DOI 10.1073/pnas.0911107107; Markwick PRL, 2009, J AM CHEM SOC, V131, P16968, DOI 10.1021/ja907476w; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107; Pogliani L, 1996, J MATH CHEM, V20, P193, DOI 10.1007/BF01165164; Radnai L, 2010, J BIOL CHEM, V285, P38649, DOI 10.1074/jbc.M110.165894; Rogers JM, 2014, P NATL ACAD SCI USA, V111, P15420, DOI 10.1073/pnas.1409122111; Rogers JM, 2014, J AM CHEM SOC, V136, P5197, DOI 10.1021/ja4125065; Rogers JM, 2013, J AM CHEM SOC, V135, P1415, DOI 10.1021/ja309527h; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; SERRANO L, 1992, J MOL BIOL, V227, P544, DOI 10.1016/0022-2836(92)90906-Z; Shammas SL, 2012, BIOPHYS J, V103, P2203, DOI 10.1016/j.bpj.2012.10.012; Shammas SL, 2014, P NATL ACAD SCI USA, V111, P12055, DOI 10.1073/pnas.1405815111; Shammas SL, 2013, J PHYS CHEM B, V117, P13346, DOI 10.1021/jp404267e; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Soranno A, 2014, P NATL ACAD SCI USA, V111, P4874, DOI 10.1073/pnas.1322611111; Soranno A, 2012, P NATL ACAD SCI USA, V109, P17800, DOI 10.1073/pnas.1117368109; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Teilum K, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00040; Thakur JK, 2014, NUCLEIC ACIDS RES, V42, P2112, DOI 10.1093/nar/gkt1147; Toto A, 2014, PROTEIN SCI, V23, P962, DOI 10.1002/pro.2480; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Wang T, 2005, BIOPHYS J, V89, P4180, DOI 10.1529/biophysj.105.068809; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wuttke R, 2014, P NATL ACAD SCI USA, V111, P5213, DOI 10.1073/pnas.1313006111	62	102	102	2	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6689	6695		10.1074/jbc.R115.692715	http://dx.doi.org/10.1074/jbc.R115.692715			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26851275	Green Published, hybrid			2022-12-28	WOS:000373299700008
J	Gorelik, A; Illes, K; Superti-Furga, G; Nagar, B				Gorelik, Alexei; Illes, Katalin; Superti-Furga, Giulio; Nagar, Bhushan			Structural Basis for Nucleotide Hydrolysis by the Acid Sphingomyelinase-like Phosphodiesterase SMPDL3A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme catalysis; nucleoside; nucleotide metabolism; sphingomyelinase; zinc; SMPDL3A	LYSOSOMAL PROTEINS; PROTEOMIC ANALYSIS; INDUCTION; GENE; CALCINEURIN; MECHANISM; SYSTEM; SERUM; MODEL	Sphingomyelin phosphodiesterase, acid-like 3A (SMPDL3A) is a member of a small family of proteins founded by the well characterized lysosomal enzyme, acid sphingomyelinase (ASMase). ASMase converts sphingomyelin into the signaling lipid, ceramide. It was recently discovered that, in contrast to ASMase, SMPDL3A is inactive against sphingomyelin and, surprisingly, can instead hydrolyze nucleoside diphosphates and triphosphates, which may play a role in purinergic signaling. As none of the ASMase-like proteins has been structurally characterized to date, the molecular basis for their substrate preferences is unknown. Here we report crystal structures of murine SMPDL3A, which represent the first structures of an ASMase-like protein. The catalytic domain consists of a central mixed -sandwich surrounded by -helices. Additionally, SMPDL3A possesses a unique C-terminal domain formed from a cluster of four -helices that appears to distinguish this protein family from other phosphoesterases. We show that SMDPL3A is a di-zinc-dependent enzyme with an active site configuration that suggests a mechanism of phosphodiester hydrolysis by a metal-activated water molecule and protonation of the leaving group by a histidine residue. Co-crystal structures of SMPDL3A with AMP and ,-methylene ADP (AMPCP) reveal that the substrate binding site accommodates nucleotides by establishing interactions with their base, sugar, and phosphate moieties, with the latter the major contributor to binding affinity. Our study provides the structural basis for SMPDL3A substrate specificity and sheds new light on the function of ASMase-like proteins.	[Gorelik, Alexei; Illes, Katalin; Nagar, Bhushan] McGill Univ, Fac Med, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Gorelik, Alexei; Illes, Katalin; Nagar, Bhushan] McGill Univ, Fac Med, Grp Rech Axe Struct Proteines, Montreal, PQ H3G 0B1, Canada; [Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria	McGill University; McGill University; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Nagar, B (corresponding author), Rm 464,3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	bhushan.nagar@mcgill.ca	Superti-Furga, Giulio/AAE-5681-2019	Gorelik, Alexei/0000-0001-6236-4633	National Science Foundation; NIGMS, National Institutes of Health under National Science Foundation [DMR-1332208]; National Institutes of Health [GM-103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIGMS, National Institutes of Health under National Science Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is based upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation and the NIGMS, National Institutes of Health under National Science Foundation Grant DMR-1332208 using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by National Institutes of Health Grant GM-103485 (NIGMS). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ago H, 2006, J BIOL CHEM, V281, P16157, DOI 10.1074/jbc.M601089200; Airola MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105830; Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Antherieu S, 2011, HEPATOLOGY, V53, P1895, DOI 10.1002/hep.24290; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Castro BM, 2014, PROG LIPID RES, V54, P53, DOI 10.1016/j.plipres.2014.01.004; Cheng JJ, 2013, J BIOL CHEM, V288, P14863, DOI 10.1074/jbc.M113.466532; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Heinz LX, 2015, CELL REP, V11, P1919, DOI 10.1016/j.celrep.2015.05.006; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kornhuber J, 2015, BIOL CHEM, V396, P707, DOI 10.1515/hsz-2015-0109; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Lim JM, 2008, J PROTEOME RES, V7, P1251, DOI 10.1021/pr7006945; Masuishi Y, 2013, J PROTEOME RES, V12, P4617, DOI 10.1021/pr4004807; Noto PB, 2012, MOL PHARMACOL, V82, P719, DOI 10.1124/mol.112.078865; Ong WY, 2015, EXPERT OPIN THER TAR, V19, P1725, DOI 10.1517/14728222.2015.1071794; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padilla J, 2013, PHYSIOL GENOMICS, V45, P434, DOI 10.1152/physiolgenomics.00038.2013; Pehkonen P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-50; Perisic L, 2013, ARTERIOSCL THROM VAS, V33, P2432, DOI 10.1161/ATVBAHA.113.301743; Qian MQ, 2008, MOL CELL PROTEOMICS, V7, P58, DOI 10.1074/mcp.M700217-MCP200; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sawada H, 2005, TOXICOL SCI, V83, P282, DOI 10.1093/toxsci/kfh264; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sleat DE, 2007, PROTEOM CLIN APPL, V1, P1134, DOI 10.1002/prca.200700250; Sleat DE, 2012, PROTEOMICS, V12, P3499, DOI 10.1002/pmic.201200205; Traini M, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.612341; Veenstra TD, 2005, MOL CELL PROTEOMICS, V4, P409, DOI 10.1074/mcp.M500006-MCP200; Zampieri S, 2016, HUM MUTAT, V37, P139, DOI 10.1002/humu.22923; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	36	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6376	6385		10.1074/jbc.M115.711085	http://dx.doi.org/10.1074/jbc.M115.711085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26792860	Green Published, hybrid			2022-12-28	WOS:000372894200026
J	Lefoulon, C; Boeglin, M; Moreau, B; Very, AA; Szponarski, W; Dauzat, M; Michard, E; Gaillard, I; Cherel, I				Lefoulon, Cecile; Boeglin, Martin; Moreau, Bertrand; Very, Anne-Alienor; Szponarski, Wojciech; Dauzat, Myriam; Michard, Erwan; Gaillard, Isabelle; Cherel, Isabelle			The Arabidopsis AtPP2CA Protein Phosphatase Inhibits the GORK K+ Efflux Channel and Exerts a Dominant Suppressive Effect on Phosphomimetic-activating Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						abscisic acid (ABA); Arabidopsis thaliana; mutagenesis; phosphatase; plant molecular biology; plant physiology; potassium channel; potassium transport; protein-protein interaction; Xenopus	ACID SIGNAL-TRANSDUCTION; PLANT POTASSIUM CHANNEL; ABSCISIC-ACID; GUARD-CELL; PLASMA-MEMBRANE; XENOPUS OOCYTES; ANION CHANNEL; NEGATIVE REGULATOR; PP2C PHOSPHATASES; CRYSTAL-STRUCTURE	The regulation of the GORK (Guard Cell Outward Rectifying) Shaker channel mediating a massive K+ efflux in Arabidopsis guard cells by the phosphatase AtPP2CA was investigated. Unlike the gork mutant, the atpp2ca mutants displayed a phenotype of reduced transpiration. We found that AtPP2CA interacts physically with GORK and inhibits GORK activity in Xenopus oocytes. Several amino acid substitutions in the AtPP2CA active site, including the dominant interfering G145D mutation, disrupted the GORK-AtPP2CA interaction, meaning that the native conformation of the AtPP2CA active site is required for the GORK-AtPP2CA interaction. Furthermore, two serines in the GORK ankyrin domain that mimic phosphorylation (Ser to Glu) or dephosphorylation (Ser to Ala) were mutated. Mutations mimicking phosphorylation led to a significant increase in GORK activity, whereas mutations mimicking dephosphorylation had no effect on GORK. In Xenopus oocytes, the interaction of AtPP2CA with phosphorylated or dephosphorylated GORK systematically led to inhibition of the channel to the same baseline level. Single-channel recordings indicated that the GORK S722E mutation increases the open probability of the channel in the absence, but not in the presence, of AtPP2CA. The dephosphorylation-independent inactivation mechanism of GORK by AtPP2CA is discussed in relation with well known conformational changes in animal Shaker-like channels that lead to channel opening and closing. In plants, PP2C activity would control the stomatal aperture by regulating both GORK and SLAC1, the two main channels required for stomatal closure.	[Lefoulon, Cecile; Boeglin, Martin; Moreau, Bertrand; Very, Anne-Alienor; Szponarski, Wojciech; Michard, Erwan; Gaillard, Isabelle; Cherel, Isabelle] CNRS, INRA, SupAgro, Lab Biochim & Physiol Mol Plantes,UM2,UMR 5004, 2 Pl Viala, F-34060 Montpellier, France; [Dauzat, Myriam] INRA, SupAgro, UMR 759, Lab Ecophysiol Plantes Stress Environnementaux, 2 Pl Viala, F-34060 Montpellier, France; [Lefoulon, Cecile] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cellular & Syst Biol, Bower Bldg, Glasgow G12 8QQ, Lanark, Scotland; [Michard, Erwan] Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; INRAE; Institut Agro; Montpellier SupAgro; University of Glasgow; Instituto Gulbenkian de Ciencia	Cherel, I (corresponding author), Univ Montpellier, CNRS, INRA, Biochim & Physiol Mol Plantes,SupAgro, 2 Pl Viala, F-34060 Montpellier, France.	cherel@supagro.inra.fr	michard, erwan/GXH-1685-2022	Cecile, Lefoulon/0000-0002-1131-3710; Cherel, Isabelle/0000-0001-8007-7099; VERY, Anne-Alienor/0000-0003-1961-5243; Gaillard, Isabelle/0000-0002-7993-4046	Agence Nationale pour la Recherche [PUMPKin ANR-08-BLAN-01 312133, ANR-14-CE20-0002]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale pour la Recherche contracts PUMPKin ANR-08-BLAN-01 312133 and Sweetkaligrape ANR-14-CE20-0002. The authors declare that they have no conflicts of interest with the contents of this article.	Ache P, 2000, FEBS LETT, V486, P93, DOI 10.1016/S0014-5793(00)02248-1; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anschutz U, 2014, J PLANT PHYSIOL, V171, P670, DOI 10.1016/j.jplph.2014.01.009; ARMSTRONG F, 1995, P NATL ACAD SCI USA, V92, P9520, DOI 10.1073/pnas.92.21.9520; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Cherel I, 2002, PLANT CELL, V14, P1133, DOI 10.1105/tpc.000943; Cohen A, 2006, J NEUROSCI METH, V153, P62, DOI 10.1016/j.jneumeth.2005.10.005; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Curran A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00036; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Daram P, 1997, EMBO J, V16, P3455, DOI 10.1093/emboj/16.12.3455; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; Demidchik V, 2014, J PLANT PHYSIOL, V171, P696, DOI 10.1016/j.jplph.2014.01.015; Dreyer I, 2009, TRENDS PLANT SCI, V14, P383, DOI 10.1016/j.tplants.2009.04.001; Eisenach C, 2014, PLANT J, V78, P203, DOI 10.1111/tpj.12471; Garcia-Mata C, 2010, J BIOL CHEM, V285, P29286, DOI 10.1074/jbc.M110.141176; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Geiger D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001346; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Hill WG, 2005, AM J PHYSIOL-RENAL, V289, pF217, DOI 10.1152/ajprenal.00022.2005; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; Ivashikina N, 2005, J GEN PHYSIOL, V125, P483, DOI 10.1085/jgp.200409211; Jackson MD, 2003, BIOCHEMISTRY-US, V42, P8513, DOI 10.1021/bi034074+; Johansson I, 2006, PLANT J, V46, P269, DOI [10.1111/j.1365-313X.2006.02690.x, 10.1111/j.1365-313X.2006.02690.X]; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Joshi-Saha A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002164; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Kwan DCH, 2012, J GEN PHYSIOL, V140, P279, DOI 10.1085/jgp.201210838; Lacombe B, 2000, FEBS LETT, V466, P351, DOI 10.1016/S0014-5793(00)01093-0; Lacombe B, 2000, PLANT CELL, V12, P837, DOI 10.1105/tpc.12.6.837; Lan WZ, 2011, MOL PLANT, V4, P527, DOI 10.1093/mp/ssr031; Lebaudy A, 2008, P NATL ACAD SCI USA, V105, P5271, DOI 10.1073/pnas.0709732105; Lee SC, 2007, P NATL ACAD SCI USA, V104, P15959, DOI 10.1073/pnas.0707912104; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Maierhofer T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005703; Marten I, 1997, P NATL ACAD SCI USA, V94, P3448, DOI 10.1073/pnas.94.7.3448; MAUREL C, 1995, EMBO J, V14, P3028, DOI 10.1002/j.1460-2075.1995.tb07305.x; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Merilo E, 2013, PLANT PHYSIOL, V162, P1652, DOI 10.1104/pp.113.220608; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Michard E, 2005, PLANT J, V44, P783, DOI 10.1111/j.1365-313X.2005.02566.x; Miller AJ, 2000, BBA-BIOMEMBRANES, V1465, P343, DOI 10.1016/S0005-2736(00)00148-6; Nieves-Cordones M, 2014, PLANT PHYSIOL, V164, P1415, DOI 10.1104/pp.113.229757; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pilot G, 2003, J MOL EVOL, V56, P418, DOI 10.1007/s00239-002-2413-2; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Robert N, 2006, FEBS LETT, V580, P4691, DOI 10.1016/j.febslet.2006.07.047; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Sharma T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00224; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; Sirichandra C, 2009, J EXP BOT, V60, P1439, DOI 10.1093/jxb/ern340; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Szyroki A, 2001, P NATL ACAD SCI USA, V98, P2917, DOI 10.1073/pnas.051616698; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; VERY AA, 1995, PLANT J, V7, P321, DOI 10.1046/j.1365-313X.1995.7020321.x; Vlad F, 2008, PLANT J, V55, P104, DOI 10.1111/j.1365-313X.2008.03488.x; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Vranova E, 2001, J EXP BOT, V52, P181, DOI 10.1093/jexbot/52.354.181; YOSHIDA N, 1995, ZOOL SCI, V12, P599, DOI 10.2108/zsj.12.599; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou XE, 2012, PLANT SIGNAL BEHAV, V7, P581, DOI 10.4161/psb.19694	74	31	33	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6521	6533		10.1074/jbc.M115.711309	http://dx.doi.org/10.1074/jbc.M115.711309			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26801610	Green Published, hybrid			2022-12-28	WOS:000372894200038
J	Kitayama, M; Mizutani, K; Maruoka, M; Mandai, K; Sakakibara, S; Ueda, Y; Komori, T; Shimono, Y; Takai, Y				Kitayama, Midori; Mizutani, Kiyohito; Maruoka, Masahiro; Mandai, Kenji; Sakakibara, Shotaro; Ueda, Yuki; Komori, Takahide; Shimono, Yohei; Takai, Yoshimi			A Novel Nectin-mediated Cell Adhesion Apparatus That Is Implicated in Prolactin Receptor Signaling for Mammary Gland Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; cell-cell interaction; Janus kinase (JAK); mammary gland; prolactin; nectin-1; nectin-4	DYSPLASIA-SYNDACTYLY SYNDROME; BREAST-CANCER; ECTODERMAL-DYSPLASIA; ADHERENS JUNCTION; TYROSINE PHOSPHORYLATION; PVRL4 GENE; E-CADHERIN; V-DOMAIN; EXPRESSION; LOCALIZATION	Mammary gland development is induced by the actions of various hormones to form a structure consisting of collecting ducts and milk-secreting alveoli, which comprise two types of epithelial cells known as luminal and basal cells. These cells adhere to each other by cell adhesion apparatuses whose roles in hormone-dependent mammary gland development remain largely unknown. Here we identified a novel cell adhesion apparatus at the boundary between the luminal and basal cells in addition to desmosomes. This apparatus was formed by the trans-interaction between the cell adhesion molecules nectin-4 and nectin-1, which were expressed in the luminal and basal cells, respectively. Nectin-4 of this apparatus further cis-interacted with the prolactin receptor in the luminal cells to enhance the prolactin-induced prolactin receptor signaling for alveolar development with lactogenic differentiation. Thus, a novel nectin-mediated cell adhesion apparatus regulates the prolactin receptor signaling for mammary gland development.	[Kitayama, Midori; Mizutani, Kiyohito; Maruoka, Masahiro; Mandai, Kenji; Sakakibara, Shotaro; Ueda, Yuki; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling,Chuo Ku, 1-5-6 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan; [Kitayama, Midori; Mizutani, Kiyohito; Mandai, Kenji; Shimono, Yohei; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan; [Kitayama, Midori; Komori, Takahide] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan	Kobe University; Kobe University; Kobe University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling,Chuo Ku, 1-5-6 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	ytakai@med.kobe-u.ac.jp	Mizutani, Kiyohito/L-8474-2019	Mandai, Kenji/0000-0002-0115-6635; Maruoka, Masahiro/0000-0003-4625-8544; Shimono, Yohei/0000-0002-6256-4704	Japan Society for the Promotion of Science [21227005, 26251013, 23501268, 26860190]; Ministry of Education, Culture, Sports, Science, and Technology [26114007, 23130510, 25130707]; Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research [26114007, 15K14381] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 21227005 and 26251013 ( to Y. T.), 23501268 ( to Y. S.), and 26860190 ( to K. Mizutani) from the Japan Society for the Promotion of Science; Grants-in-aid for Scientific Research on Innovative Areas 26114007 ( to Y. T.) and 23130510 and 25130707 ( to Y. S.) from the Ministry of Education, Culture, Sports, Science, and Technology; and the Japan Foundation for Applied Enzymology ( to Y. T.). The authors declare no competing financial interests.	Ahonen TJ, 1999, ENDOCRINOLOGY, V140, P5412, DOI 10.1210/en.140.11.5412; Akhtar N, 2013, NAT CELL BIOL, V15, P17, DOI 10.1038/ncb2646; Amano H, 2008, GENES CELLS, V13, P269, DOI 10.1111/j.1365-2443.2008.01167.x; Athanassiadou AM, 2011, FOLIA HISTOCHEM CYTO, V49, P26, DOI 10.5603/FHC.2011.0005; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; Ballester M, 2012, HUM REPROD, V27, P3179, DOI 10.1093/humrep/des304; BERA TK, 1994, MOL CELL BIOCHEM, V132, P145, DOI 10.1007/BF00926923; Blackman B, 2005, BREAST CANCER RES, V7, pR248, DOI 10.1186/bcr988; Bojesen KB, 2012, J BIOL CHEM, V287, P37420, DOI 10.1074/jbc.M112.345215; Brancati F, 2010, AM J HUM GENET, V87, P265, DOI 10.1016/j.ajhg.2010.07.003; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Cowin P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003251; DANIEL CW, 1995, DEV BIOL, V169, P511, DOI 10.1006/dbio.1995.1165; DeRycke MS, 2010, AM J CLIN PATHOL, V134, P835, DOI 10.1309/AJCPGXK0FR4MHIHB; Fabre S, 2002, J BIOL CHEM, V277, P27006, DOI 10.1074/jbc.M203228200; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Fabre-Lafay S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-73; Fortugno P, 2014, J INVEST DERMATOL, V134, P2146, DOI 10.1038/jid.2014.119; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Guzman G, 2006, ARCH PATHOL LAB MED, V130, P1193; Harbaum L, 2010, MODERN PATHOL, V23, P961, DOI 10.1038/modpathol.2010.83; Harrison OJ, 2012, NAT STRUCT MOL BIOL, V19, P906, DOI 10.1038/nsmb.2366; Harvey Philip W, 2008, J Psychopharmacol, V22, P20, DOI 10.1177/0269881107082624; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Hung MC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013532; Inagaki M, 2005, DEVELOPMENT, V132, P1525, DOI 10.1242/dev.01697; Jelani M, 2011, J HUM GENET, V56, P352, DOI 10.1038/jhg.2011.18; Kalin M, 2011, EUR UROL, V60, P1235, DOI 10.1016/j.eururo.2011.06.038; Kanzaki N, 2008, J CELL SCI, V121, P2008, DOI 10.1242/jcs.024620; Kawano S, 2009, J BIOL CHEM, V284, P23793, DOI 10.1074/jbc.M109.025155; Kinugasa M, 2012, CIRC RES, V110, P716, DOI 10.1161/CIRCRESAHA.111.256834; Kurita S, 2011, J BIOL CHEM, V286, P36297, DOI 10.1074/jbc.M111.261768; Lanigan F, 2007, CELL MOL LIFE SCI, V64, P3161, DOI 10.1007/s00018-007-7386-2; Lattanzio R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.32; LEBRUN JJ, 1994, J BIOL CHEM, V269, P14021; Liu XW, 1996, MOL ENDOCRINOL, V10, P1496, DOI 10.1210/me.10.12.1496; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; Matsushima H, 2003, BRIT J DERMATOL, V148, P755, DOI 10.1046/j.1365-2133.2003.05225.x; McLachlan E, 2007, J MEMBRANE BIOL, V218, P107, DOI 10.1007/s00232-007-9052-x; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; MONAGHAN P, 1994, J HISTOCHEM CYTOCHEM, V42, P931, DOI 10.1177/42.7.8014476; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Muschler J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003202; Neradugomma NK, 2014, CARCINOGENESIS, V35, P795, DOI 10.1093/carcin/bgt379; Nishiwada S, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0144-7; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Oda H, 2011, J CELL BIOL, V193, P1137, DOI 10.1083/jcb.201008173; Pavlova NN, 2013, ELIFE, V2, DOI 10.7554/eLife.00358; PITELKA DR, 1973, J CELL BIOL, V56, P797, DOI 10.1083/jcb.56.3.797; Raza SI, 2015, ANN HUM GENET, V79, P92, DOI 10.1111/ahg.12094; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Russell DL, 1999, MOL ENDOCRINOL, V13, P2049, DOI 10.1210/me.13.12.2049; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Shimono Yohei, 2012, Subcell Biochem, V60, P137, DOI 10.1007/978-94-007-4186-7_7; Sugiyama H, 2013, GENES CELLS, V18, P519, DOI 10.1111/gtc.12056; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Takano A, 2009, CANCER RES, V69, P6694, DOI 10.1158/0008-5472.CAN-09-0016; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; Tworoger SS, 2007, J CLIN ONCOL, V25, P1482, DOI 10.1200/JCO.2006.07.6356; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Xu R, 2009, J CELL BIOL, V184, P57, DOI 10.1083/jcb.200807021; Yamana S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124259	67	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5817	5831		10.1074/jbc.M115.685917	http://dx.doi.org/10.1074/jbc.M115.685917			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26757815	Green Published, hybrid			2022-12-28	WOS:000372551800029
J	Coffey, RT; Shi, YT; Long, MJC; Marr, MT; Hedstrom, L				Coffey, Rory T.; Shi, Yuntao; Long, Marcus J. C.; Marr, Michael T., II; Hedstrom, Lizbeth			Ubiquilin-mediated Small Molecule Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eukaryotic translation initiation factor 4E-binding protein 1 (EIF4EBP1); mammalian target of rapamycin (mTOR); protein synthesis; S6 kinase; translation control; luciferase; rapamycin; ubiquilin	MESSENGER-RNA TRANSLATION; LIFE-SPAN; BINDING PARTNER; CELL-SURVIVAL; TOR PATHWAY; S6 KINASE; PROTEIN; PHOSPHORYLATION; ACTIVATION; AUTOPHAGY	Mammalian target of rapamycin complex 1 (mTORC1) is a master regulator of cellular metabolism, growth, and proliferation. mTORC1 has been implicated in many diseases such as cancer, diabetes, and neurodegeneration, and is a target to prolong lifespan. Here we report a small molecule inhibitor (Cbz-B3A) of mTORC1 signaling. Cbz-B3A inhibits the phosphorylation of eIF4E-binding protein 1 (4EBP1) and blocks 68% of translation. In contrast, rapamycin preferentially inhibits the phosphorylation of p70(S6k) and blocks 35% of translation. Cbz-B3A does not appear to bind directly to mTORC1, but instead binds to ubiquilins 1, 2, and 4. Knockdown of ubiquilin 2, but not ubiquilins 1 and 4, decreases the phosphorylation of 4EBP1, suggesting that ubiquilin 2 activates mTORC1. The knockdown of ubiquilins 2 and 4 decreases the effect of Cbz-B3A on 4EBP1 phosphorylation. Cbz-B3A slows cellular growth of some human leukemia cell lines, but is not cytotoxic. Thus Cbz-B3A exemplifies a novel strategy to inhibit mTORC1 signaling that might be exploited for treating many human diseases. We propose that Cbz-B3A reveals a previously unappreciated regulatory pathway coordinating cytosolic protein quality control and mTORC1 signaling.	[Coffey, Rory T.] Brandeis Univ, Grad Program Mol & Cellular Biol, MS008, Waltham, MA 02453 USA; [Shi, Yuntao] Brandeis Univ, Grad Program Chem, MS015, Waltham, MA 02453 USA; [Long, Marcus J. C.] Brandeis Univ, Grad Program Biochem & Biophys, MS009, Waltham, MA 02453 USA; [Marr, Michael T., II; Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, MS009, 415 South St, Waltham, MA 02453 USA; [Marr, Michael T., II] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, MS029, Waltham, MA 02453 USA; [Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, Waltham, MA 02453 USA; [Long, Marcus J. C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Brandeis University; Brandeis University; Brandeis University; Brandeis University; Brandeis University; Brandeis University; Cornell University	Hedstrom, L (corresponding author), Brandeis Univ, Dept Biol, MS009, 415 South St, Waltham, MA 02453 USA.	hedstrom@brandeis.edu		Long, marcus/0000-0002-0343-9671	National Institutes of Health [5 RO1 GM100921, 5 T32 GM007122]; Brandeis Sprout grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122, R01GM100921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brandeis Sprout grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 RO1 GM100921 (to L. H.) and 5 T32 GM007122 and a Brandeis Sprout grant (to R. T. C.).	Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; ALLEY MC, 1988, CANCER RES, V48, P589; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Davidson JD, 2000, HUM MOL GENET, V9, P2305, DOI 10.1093/oxfordjournals.hmg.a018922; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Deroo BJ, 2002, J BIOL CHEM, V277, P20120, DOI 10.1074/jbc.C200173200; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Edinger AL, 2003, CANCER RES, V63, P8451; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Houghton PJ, 2010, MOL CANCER THER, V9, P101, DOI 10.1158/1535-7163.MCT-09-0952; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee DY, 2013, EMBO REP, V14, P373, DOI 10.1038/embor.2013.22; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Livingstone Mark, 2012, F1000Res, V1, P4, DOI 10.12688/f1000research.1-4.v1; Long MJC, 2012, CHEM BIOL, V19, P629, DOI 10.1016/j.chembiol.2012.04.008; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Masui K, 2014, TRENDS ENDOCRIN MET, V25, P364, DOI 10.1016/j.tem.2014.04.002; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Pons B, 2012, ONCOL REP, V27, P225, DOI 10.3892/or.2011.1462; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Safren N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087513; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; SONENBERG N, 1979, P NATL ACAD SCI USA, V76, P4345, DOI 10.1073/pnas.76.9.4345; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Teilum K, 2011, BBA-PROTEINS PROTEOM, V1814, P969, DOI 10.1016/j.bbapap.2010.11.005; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Thorne N, 2012, CHEM BIOL, V19, P1060, DOI 10.1016/j.chembiol.2012.07.015; Wu SL, 2002, BBA-MOL CELL RES, V1542, P41, DOI 10.1016/S0167-4889(01)00164-1; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029	72	23	26	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5221	5233		10.1074/jbc.M115.691584	http://dx.doi.org/10.1074/jbc.M115.691584			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26740621	Green Published, hybrid			2022-12-28	WOS:000371640600033
J	Oh, CK; Lee, SJ; Park, SH; Moon, Y				Oh, Chang-Kyu; Lee, Seung Joon; Park, Seong-Hwan; Moon, Yuseok			Acquisition of Chemoresistance and Other Malignancy-related Features of Colorectal Cancer Cells Are Incremented by Ribosome-inactivating Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MACROPHAGE INHIBITORY CYTOKINE-1; ADAPTIVE-RESPONSE GENE; MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR-3; DRUG-RESISTANCE; STEM-CELLS; P53; APOPTOSIS; ATF3	Colorectal cancer (CRC) as an environmental disease is largely influenced by accumulated epithelial stress from diverse environmental causes. We are exposed to ribosome-related insults, including ribosome-inactivating stress (RIS), from the environment, dietary factors, and medicines, but their physiological impacts on the chemotherapy of CRC are not yet understood. Here we revealed the effects of RIS on chemosensitivity and other malignancy-related properties of CRC cells. First, RIS led to bidirectional inhibition of p53-macrophage inhibitory cytokine 1 (MIC-1)-mediated death responses in response to anticancer drugs by either enhancing ATF3-linked antiapoptotic signaling or intrinsically inhibiting MIC-1 and p53 expression, regardless of ATF3. Second, RIS enhanced the epithelial-mesenchymal transition and biogenesis of cancer stem-like cells in an ATF3-dependent manner. These findings indicate that gastrointestinal exposure to RIS interferes with the efficacy of chemotherapeutics, mechanistically implying that ATF3-linked malignancy and chemoresistance can be novel therapeutic targets for the treatment of environmentally aggravated cancers.	Pusan Natl Univ, Lab Mucosal Exposome & Biomodulat, Dept Biomed Sci, Sch Med, Yangsan 50612, South Korea; Pusan Natl Univ, Med Res Inst, Sch Med, Yangsan 50612, South Korea	Pusan National University; Pusan National University	Moon, Y (corresponding author), Pusan Natl Univ, Sch Med, Dept Biomed Sci, Yangsan 50612, South Korea.	moon@pnu.edu	Yuseok Moon, ATS/AAE-4364-2020	MOON, YUSEOK/0000-0001-8686-8166	Cooperative Research Program for Agriculture, Science, and Technology Development, Rural Development Administration, Republic of Korea [PJ01093206]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, information and communications technology (ICT), and Future Planning [NRF-2015R1A2A1A15056056]	Cooperative Research Program for Agriculture, Science, and Technology Development, Rural Development Administration, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, information and communications technology (ICT), and Future Planning	This work was supported by the Cooperative Research Program for Agriculture, Science, and Technology Development (Project PJ01093206), Rural Development Administration, Republic of Korea, and the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, information and communications technology (ICT), and Future Planning (Grant NRF-2015R1A2A1A15056056). The authors declare that they have no conflicts of interest with the contents of this article.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Agarwal MK, 2006, P NATL ACAD SCI USA, V103, P16278, DOI 10.1073/pnas.0607210103; Akram A, 2010, AM J RESP CRIT CARE, V182, P489, DOI 10.1164/rccm.200906-0925OC; Avner BS, 2012, BIOENGINEERED, V3, P262, DOI 10.4161/bioe.21130; Baek SJ, 2004, J BIOL CHEM, V279, P6883, DOI 10.1074/jbc.M305295200; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Choi HJ, 2013, ONCOGENE, V32, P4960, DOI 10.1038/onc.2012.508; Findlay VJ, 2014, CANCER GENE THER, V21, P181, DOI 10.1038/cgt.2014.15; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Islam Z, 2006, TOXICOL APPL PHARM, V213, P235, DOI 10.1016/j.taap.2005.11.001; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jin KT, 2012, ONCOL LETT, V3, P11, DOI 10.3892/ol.2011.432; Kadara H, 2006, CANCER BIOL THER, V5, P518, DOI 10.4161/cbt.5.5.2602; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kevans D, 2011, INT J SURG PATHOL, V19, P751, DOI 10.1177/1066896911414566; Kishi H, 2001, J BIOL CHEM, V276, P39115, DOI 10.1074/jbc.M105134200; Laskin JD, 2002, TOXICOL SCI, V69, P289, DOI 10.1093/toxsci/69.2.289; Li HF, 2010, J AM SOC NEPHROL, V21, P1003, DOI 10.1681/ASN.2009070690; Linda Hans, 2011, Front Neurol, V2, P30, DOI 10.3389/fneur.2011.00030; Liu T, 2003, CANCER RES, V63, P5034; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maresca M, 2010, TOXICON, V56, P282, DOI 10.1016/j.toxicon.2010.04.016; Mawji IA, 2007, CANCER RES, V67, P8307, DOI 10.1158/0008-5472.CAN-07-1687; Nita ME, 1998, BRIT J CANCER, V78, P986, DOI 10.1038/bjc.1998.617; Park SH, 2010, J IMMUNOL, V185, P5522, DOI 10.4049/jimmunol.1001315; Park SH, 2014, J BIOL CHEM, V289, P27118, DOI 10.1074/jbc.M114.568717; Park SH, 2013, J IMMUNOL, V191, P5170, DOI 10.4049/jimmunol.1301145; Scala F, 2016, ONCOGENE, V35, P977, DOI 10.1038/onc.2015.147; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shifrin VI, 1999, J BIOL CHEM, V274, P13985, DOI 10.1074/jbc.274.20.13985; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Yang H, 2003, MOL CANCER THER, V2, P1023; Yang H, 2009, BIOCHEM PHARMACOL, V78, P1205, DOI 10.1016/j.bcp.2009.06.012; Yang H, 2009, BIOCHEM PHARMACOL, V77, P1105, DOI 10.1016/j.bcp.2008.11.028; Ye X. C., 2012, CANC MED, V1, P5; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Yin X, 2010, J CELL SCI, V123, P3558, DOI 10.1242/jcs.064915; Yoder JM, 2007, INFECT IMMUN, V75, P1745, DOI 10.1128/IAI.01528-06; Zhou HR, 2003, TOXICOL SCI, V74, P335, DOI 10.1093/toxsci/kfg148	49	8	9	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10173	10183		10.1074/jbc.M115.696609	http://dx.doi.org/10.1074/jbc.M115.696609			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26961878	hybrid, Green Published			2022-12-28	WOS:000375602800027
J	Dohmen, LCT; Navas, A; Vargas, DA; Gregory, DJ; Kip, A; Dorlo, TPC; Gomez, MA				Dohmen, Luuk C. T.; Navas, Adriana; Vargas, Deninson Alejandro; Gregory, David J.; Kip, Anke; Dorlo, Thomas P. C.; Adelaida Gomez, Maria			Functional Validation of ABCA3 as a Miltefosine Transporter in Human Macrophages IMPACT ON INTRACELLULAR SURVIVAL OF LEISHMANIA (VIANNIA) PANAMENSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-LIKE TRANSPORTER; BINDING CASSETTE TRANSPORTER; CUTANEOUS LEISHMANIASIS; DRUG-RESISTANCE; METABOLIZING-ENZYMES; MULTIDRUG-RESISTANCE; TREATMENT FAILURE; LEUKEMIA-CELLS; SUSCEPTIBILITY; PHENOTYPE	Within its mammalian host, Leishmania resides and replicates as an intracellular parasite. The direct activity of antileishmanials must therefore depend on intracellular drug transport, metabolism, and accumulation within the host cell. In this study, we explored the role of human macrophage transporters in the intracellular accumulation and antileishmanial activity of miltefosine (MLF), the only oral drug available for the treatment of visceral and cutaneous leishmaniasis (CL). Membrane transporter gene expression in primary human macrophages infected in vitro with Leishmania Viannia panamensis and exposed to MLF showed modulation of ABC and solute liquid carrier transporters gene transcripts. Among these, ABCA3, a lipid transporter, was significantly induced after exposure to MLF, and this induction was confirmed in primary macrophages from CL patients. Functional validation of MLF as a substrate for ABCA3 was performed by shRNA gene knockdown (KD) in THP-1 monocytes. Intracellular accumulation of radiolabeled MLF was significantly higher in ABCA3KD macrophages. ABCA3KD resulted in increased cytotoxicity induced by MLF exposure. ABCA3 gene expression inversely correlated with intracellular MLF content in primary macrophages from CL patients. ABCA3KD reduced parasite survival during macrophage infection with an L. V. panamensis strain exhibiting low in vitro susceptibility to MLF. Confocal microscopy showed ABCA3 to be located in the cell membrane of resting macrophages and in intracellular compartments in L. V. panamensis-infected cells. These results provide evidence of ABCA3 as an MLF efflux transporter in human macrophages and support its role in the direct antileishmanial effect of this alkylphosphocholine drug.	[Adelaida Gomez, Maria] Ctr Int Entrenamiento & Invest Med, Cra 125 19-225, Cali, Colombia; [Dohmen, Luuk C. T.; Kip, Anke; Dorlo, Thomas P. C.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, NL-3508 TB Utrecht, Netherlands; [Gregory, David J.] Harvard Univ, TH Chan Sch Publ Hlth, Mol & Integrat Physiol Sci, Boston, MA 02115 USA; [Kip, Anke] Slotervaart Hosp, Antoni van Leeuwenhoek Hosp, Dept Pharm & Pharmacol, NL-1066 CX Amsterdam, Netherlands; [Dorlo, Thomas P. C.] Uppsala Univ, Dept Pharmaceut Biosci, S-75124 Uppsala, Sweden	Utrecht University; Harvard University; Harvard T.H. Chan School of Public Health; Slotervaart Hospital; Uppsala University	Gomez, MA (corresponding author), Ctr Int Entrenamiento & Invest Med, Cra 125 19-225, Cali, Colombia.	mgomez@cideim.org.co	Dorlo, Thomas/F-1339-2011; Navas, Adriana/ABC-7647-2020; Gregory, David/P-2582-2015	Dorlo, Thomas/0000-0003-3076-8435; Gregory, David/0000-0001-6534-7150; Gomez, Maria Adelaida/0000-0001-8792-1563	COLCIENCIAS [250-2010, 2229-519-28930, 738-2009, 2229-49326161]; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases Re-entry Grant [B00032]; NIAID, National Institutes of Health [R01AI104823]; FOGARTY INTERNATIONAL CENTER [D43TW006589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104823] Funding Source: NIH RePORTER	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases Re-entry Grant; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by COLCIENCIAS Grants 250-2010, Code 2229-519-28930, and 738-2009, Code 2229-49326161, the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases Re-entry Grant B00032, and NIAID, National Institutes of Health Grant R01AI104823. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Gomez MA, 2014, J ANTIMICROB CHEMOTH, V69, P139, DOI 10.1093/jac/dkt334; Agrawal A, 2012, PEDIATR RES, V71, P633, DOI 10.1038/pr.2012.21; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; Basu JM, 2008, ANTIMICROB AGENTS CH, V52, P1080, DOI 10.1128/AAC.01196-07; Bosch Tessa M., 2008, V448, P63, DOI 10.1007/978-1-59745-205-2_5; Castanys-Munoz E, 2008, ANTIMICROB AGENTS CH, V52, P3573, DOI 10.1128/AAC.00587-08; Castanys-Munoz E, 2007, MOL MICROBIOL, V64, P1141, DOI 10.1111/j.1365-2958.2007.05653.x; Chapuy B, 2008, LEUKEMIA, V22, P1576, DOI 10.1038/leu.2008.103; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; Cohen AL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.47; Rubiano LC, 2012, J INFECT DIS, V205, P684, DOI 10.1093/infdis/jir816; DAGOSTIN.R, 1973, BIOMETRIKA, V60, P613, DOI 10.1093/biomet/60.3.613; Dorlo TPC, 2014, J INFECT DIS, V210, P146, DOI 10.1093/infdis/jiu039; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Escobar P, 2002, ACTA TROP, V81, P151, DOI 10.1016/S0001-706X(01)00197-8; Kip AE, 2015, J CHROMATOGR B, V998, P57, DOI 10.1016/j.jchromb.2015.06.017; Fernandez OL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002871; Matsumura Y, 2007, FEBS LETT, V581, P3139, DOI 10.1016/j.febslet.2007.05.078; Menez C, 2007, LIPIDS, V42, P229, DOI 10.1007/s11745-007-3026-8; Menez C, 2007, PHARM RES-DORDR, V24, P546, DOI 10.1007/s11095-006-9170-7; Obonaga R, 2014, ANTIMICROB AGENTS CH, V58, P144, DOI 10.1128/AAC.01023-13; Overbeck TR, 2013, ONCOLOGY-BASEL, V84, P362, DOI 10.1159/000348884; Perez-Victoria JM, 2002, CURR DRUG TARGETS, V3, P311, DOI 10.2174/1389450023347588; Perez-Victoria JM, 2001, ANTIMICROB AGENTS CH, V45, P2468, DOI 10.1128/AAC.45.9.2468-2474.2001; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; Roy G, 2000, MOL BIOCHEM PARASIT, V110, P195, DOI 10.1016/S0166-6851(00)00270-X; Rybczynska M, 2001, BRIT J CANCER, V84, P1405, DOI 10.1054/bjoc.2001.1776; Seifert K, 2010, J ANTIMICROB CHEMOTH, V65, P508, DOI 10.1093/jac/dkp500; Song JH, 2008, INT J ONCOL, V32, P931; Soto J, 2004, CLIN INFECT DIS, V38, P1266, DOI 10.1086/383321; Soto J, 2008, AM J TROP MED HYG, V78, P210, DOI 10.4269/ajtmh.2008.78.210; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Vanaerschot M, 2014, EXPERT REV ANTI-INFE, V12, P937, DOI 10.1586/14787210.2014.916614; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Yardley V, 2005, AM J TROP MED HYG, V73, P272, DOI 10.4269/ajtmh.2005.73.272; Zhou HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031752	37	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9638	9647		10.1074/jbc.M115.688168	http://dx.doi.org/10.1074/jbc.M115.688168			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26903515	Green Published, hybrid			2022-12-28	WOS:000375602300022
J	Patel, D; Menon, D; Bernfeld, E; Mroz, V; Kalan, S; Loayza, D; Foster, DA				Patel, Deven; Menon, Deepak; Bernfeld, Elyssa; Mroz, Victoria; Kalan, Sampada; Loayza, Diego; Foster, David A.			Aspartate Rescues S-phase Arrest Caused by Suppression of Glutamine Utilization in KRas-driven Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS; REPLICATION; CHECKPOINT; PROTEIN; ATR; DNA	During G(1)-phase of the cell cycle, normal cells respond first to growth factors that indicate that it is appropriate to divide and then later in G(1) to the presence of nutrients that indicate sufficient raw material to generate two daughter cells. Dividing cells rely on the "conditionally essential" amino acid glutamine (Q) as an anaplerotic carbon source for TCA cycle intermediates and as a nitrogen source for nucleotide biosynthesis. We previously reported that while non-transformed cells arrest in the latter portion of G(1) upon Q deprivation, mutant KRas-driven cancer cells bypass the G(1) checkpoint, and instead, arrest in S-phase. In this study, we report that the arrest of KRas-driven cancer cells in S-phase upon Q deprivation is due to the lack of deoxynucleotides needed for DNA synthesis. The lack of deoxynucleotides causes replicative stress leading to activation of the ataxia telangiectasia and Rad3-related protein (ATR)-mediated DNA damage pathway, which arrests cells in S-phase. The key metabolite generated from Q utilization was aspartate, which is generated from a transaminase reaction whereby Q-derived glutamate is converted to alpha-ketoglutarate with the concomitant conversion of oxaloacetate to aspartate. Aspartate is a critical metabolite for both purine and pyrimidine nucleotide biosynthesis. This study identifies the molecular basis for the S-phase arrest caused by Q deprivation in KRas-driven cancer cells that arrest in S-phase in response to Q deprivation. Given that arresting cells in S-phase sensitizes cells to apoptotic insult, this study suggests novel therapeutic approaches to KRas-driven cancers.	[Patel, Deven; Menon, Deepak; Bernfeld, Elyssa; Mroz, Victoria; Kalan, Sampada; Loayza, Diego; Foster, David A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Patel, Deven; Menon, Deepak; Bernfeld, Elyssa; Loayza, Diego; Foster, David A.] CUNY, Grad Ctr, Biochem Program, New York, NY 10016 USA; [Kalan, Sampada; Loayza, Diego; Foster, David A.] CUNY, Grad Ctr, Biol Program, New York, NY 10016 USA; [Foster, David A.] Weill Cornell Coll Med, Dept Pharmacol, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 413 East 69th St, New York, NY 10021 USA.	foster@genectr.hunter.cuny.edu	Patel, Deven/J-4886-2019; Menon, Deepak/S-7899-2019	Menon, Deepak/0000-0002-6529-7859; Lehman, Elyssa/0000-0002-9869-1588	NCI, National Institutes of Health [R01-CA046677, R01-CA179542]; National Center for Research Resources of the National Institutes of Health [RR-03039]; NATIONAL CANCER INSTITUTE [R01CA046677, R01CA179542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM094071] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants R01-CA046677, R01-CA179542 from the NCI, National Institutes of Health. Research Centers in Minority Institutions Award RR-03039 from the National Center for Research Resources of the National Institutes of Health, which supports infrastructure and instrumentation in the Biological Sciences Dept. at Hunter College, is also acknowledged. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Boza JJ, 2000, EUR J NUTR, V39, P38, DOI 10.1007/s003940050074; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dai Y, 2013, MOL CANCER THER, V12, P878, DOI 10.1158/1535-7163.MCT-12-0902; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Goodarzi Aaron A, 2003, Prog Cell Cycle Res, V5, P393; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Rabinovich S, 2015, NATURE, V527, P379, DOI 10.1038/nature15529; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Saqcena M., ONCOGENE, V34, P2672; Saqcena M, 2015, CELL CYCLE, V14, P2285, DOI 10.1080/15384101.2015.1046653; Saqcena M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074157; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Van Vranken JG, 2015, CELL, V162, P471, DOI 10.1016/j.cell.2015.07.027; Wasa M, 1996, ANN SURG, V224, P189, DOI 10.1097/00000658-199608000-00012; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhang J, 2014, MOL CELL, V56, P205, DOI 10.1016/j.molcel.2014.08.018	26	45	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9322	9329		10.1074/jbc.M115.710145	http://dx.doi.org/10.1074/jbc.M115.710145			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26921316	Green Published, hybrid			2022-12-28	WOS:000374849000040
J	Liu, ZJ; Sneve, M; Haroldson, TA; Smith, JP; Drewes, LR				Liu, Zejian; Sneve, Mary; Haroldson, Thomas A.; Smith, Jeffrey P.; Drewes, Lester R.			Regulation of Monocarboxylic Acid Transporter 1 Trafficking by the Canonical Wnt/-Catenin Pathway in Rat Brain Endothelial Cells Requires Cross-talk with Notch Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; gene regulation; Notch pathway; ubiquitylation (ubiquitination); Wnt pathway; monocarboxylic acid transporter; RBE4; SLC16A1; blood-brain barrier; cross-talk	COLORECTAL-CANCER; COLON-CANCER; TARGET; EXPRESSION; GLUCOSE; PROTEIN; MOTIF; ACTIVATION; MECHANISMS; BARRIER	The transport of monocarboxylate fuels such as lactate, pyruvate, and ketone bodies across brain endothelial cells is mediated by monocarboxylic acid transporter 1 (MCT1). Although the canonical Wnt/-catenin pathway is required for rodent blood-brain barrier development and for the expression of associated nutrient transporters, the role of this pathway in the regulation of brain endothelial MCT1 is unknown. Here we report expression of nine members of the frizzled receptor family by the RBE4 rat brain endothelial cell line. Furthermore, activation of the canonical Wnt/-catenin pathway in RBE4 cells via nuclear -catenin signaling with LiCl does not alter brain endothelial Mct1 mRNA but increases the amount of MCT1 transporter protein. Plasma membrane biotinylation studies and confocal microscopic examination of mCherry-tagged MCT1 indicate that increased transporter results from reduced MCT1 trafficking from the plasma membrane via the endosomal/lysosomal pathway and is facilitated by decreased MCT1 ubiquitination following LiCl treatment. Inhibition of the Notch pathway by the -secretase inhibitor N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester negated the up-regulation of MCT1 by LiCl, demonstrating a cross-talk between the canonical Wnt/-catenin and Notch pathways. Our results are important because they show, for the first time, the regulation of MCT1 in cerebrovascular endothelial cells by the multifunctional canonical Wnt/-catenin and Notch signaling pathways.	[Liu, Zejian; Sneve, Mary; Haroldson, Thomas A.; Drewes, Lester R.] Univ Minnesota, Med Sch Duluth, Dept Biomed Sci, Duluth, MN 55812 USA; [Smith, Jeffrey P.] Colorado State Univ, Dept Biol, Pueblo, CO 81001 USA	University of Minnesota System; University of Minnesota Duluth; Colorado State University	Liu, ZJ (corresponding author), Yale Univ, Sch Med, Endocrinol Sect, Dept Internal Med, 300 Cedar St, New Haven, CT 06519 USA.; Drewes, LR (corresponding author), Univ Minnesota, Dept Biomed Sci, 1035 Univ Dr, Duluth, MN 55812 USA.	zejian.liu@yale.edu; ldrewes@d.umn.edu	Drewes, Lester R/X-9794-2018	Drewes, Lester R/0000-0002-7440-0387	American Heart Association [0855638G]; NINDS/National Institute of Health [1R15NS062404-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS062404] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NINDS/National Institute of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association Grant 0855638G (to L. R. D.) and NINDS/National Institute of Health Grant 1R15NS062404-01A2 (to J. P. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Becker HM, 2010, AM J PHYSIOL-RENAL, V299, pF141, DOI 10.1152/ajprenal.00488.2009; Bialer M, 2007, NEUROTHERAPEUTICS, V4, P130, DOI 10.1016/j.nurt.2006.11.007; Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Camps J, 2013, CANCER RES, V73, P2003, DOI 10.1158/0008-5472.CAN-12-3159; Chalamalasetty RB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1381; Chenal J, 2007, J NEUROCHEM, V102, P389, DOI 10.1111/j.1471-4159.2007.04495.x; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coon AL, 2006, AM J NEURORADIOL, V27, P1053; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; CORVERA S, 1994, J CELL BIOL, V126, P979, DOI 10.1083/jcb.126.4.979; Cuff M, 2005, GASTROENTEROLOGY, V128, P676, DOI 10.1053/j.gastro.2004.12.003; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; De Giorgis V, 2013, SEIZURE-EUR J EPILEP, V22, P803, DOI 10.1016/j.seizure.2013.07.003; DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Freeman J, 2006, EPILEPSY RES, V68, P145, DOI 10.1016/j.eplepsyres.2005.10.003; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerhart DZ, 1997, AM J PHYSIOL-ENDOC M, V273, pE207, DOI 10.1152/ajpendo.1997.273.1.E207; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kim HA, 2012, J CLIN INVEST, V122, P3248, DOI 10.1172/JCI61216; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krebs LT, 2000, GENE DEV, V14, P1343; Kwon C, 2011, NAT CELL BIOL, V13, P1244, DOI 10.1038/ncb2313; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Li CY, 2011, J CANCER RES CLIN, V137, P771, DOI 10.1007/s00432-010-0934-4; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lim JC, 2008, J NEUROCHEM, V106, P1855, DOI 10.1111/j.1471-4159.2008.05537.x; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; Matson Christian T, 2003, Methods Mol Med, V89, P479; McCullagh KJA, 1996, AM J PHYSIOL-ENDOC M, V271, pE143, DOI 10.1152/ajpendo.1996.271.1.E143; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Murray CM, 2005, NAT CHEM BIOL, V1, P371, DOI 10.1038/nchembio744; NEHLIG A, 1993, PROG NEUROBIOL, V40, P163, DOI 10.1016/0301-0082(93)90022-K; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Peignon G, 2011, GUT, V60, P166, DOI 10.1136/gut.2009.204719; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Reis M, 2012, J EXP MED, V209, P1611, DOI 10.1084/jem.20111580; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Roux F, 2005, CELL MOL NEUROBIOL, V25, P41, DOI 10.1007/s10571-004-1376-9; ROUX F, 1994, J CELL PHYSIOL, V159, P101, DOI 10.1002/jcp.1041590114; Saeki Y, 2008, NATURE, V453, P460, DOI 10.1038/453460a; Shewan AM, 2000, BIOCHEM J, V350, P99, DOI 10.1042/0264-6021:3500099; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Smith JK, 2012, PSYCHOL AESTHET CREA, V6, P1, DOI 10.1037/a0027241; Smith JP, 2006, J BIOL CHEM, V281, P2053, DOI 10.1074/jbc.M511577200; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Storch S, 2004, J BIOL CHEM, V279, P53625, DOI 10.1074/jbc.M410930200; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; Uhernik AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085957; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Xia S, 2008, P NATL ACAD SCI USA, V105, P5609, DOI 10.1073/pnas.0801456105	75	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8059	8069		10.1074/jbc.M115.710277	http://dx.doi.org/10.1074/jbc.M115.710277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26872974	hybrid, Green Published			2022-12-28	WOS:000374056700025
J	Brison, Y; Malbert, Y; Czaplicki, G; Mourey, L; Remaud-Simeon, M; Tranier, S				Brison, Yoann; Malbert, Yannick; Czaplicki, Georges; Mourey, Lionel; Remaud-Simeon, Magali; Tranier, Samuel			Structural Insights into the Carbohydrate Binding Ability of an alpha-(1 -> 2) Branching Sucrase from Glycoside Hydrolase Family 70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAN-BINDING; MOLECULAR CHARACTERIZATION; DSR-E; STREPTOCOCCAL GLUCOSYLTRANSFERASE; GLUCANSUCRASE GTF180; SUGAR-BINDING; DEXTRANSUCRASE; SEQUENCE; AMBER; DOMAIN	The alpha-(1 -> 2) branching sucrase Delta N-123-GBD-CD2 is a transglucosylase belonging to glycoside hydrolase family 70 (GH70) that catalyzes the transfer of D-glucosyl units from sucrose to dextrans or gluco-oligosaccharides via the formation of alpha-(1 -> 2) glucosidic linkages. The first structures of Delta N-123-GBD-CD2 in complex with D-glucose, isomaltosyl, or isomaltotriosyl residues were solved. The glucose complex revealed three glucose-binding sites in the catalytic gorge and six additional binding sites at the surface of domains B, IV, and V. Soaking with isomaltotriose or gluco-oligosaccharides led to structures in which isomaltosyl or isomaltotriosyl residues were found in glucan binding pockets located in domain V. One aromatic residue is systematically identified at the bottom of these pockets in stacking interaction with one glucosyl moiety. The carbohydrate is also maintained by a network of hydrogen bonds and van der Waals interactions. The sequence of these binding pockets is conserved and repeatedly present in domain V of several GH70 glucansucrases known to bind alpha-glucans. These findings provide the first structural evidence of the molecular interaction occurring between isomalto-oligosaccharides and domain V of the GH70 enzymes.	[Brison, Yoann; Malbert, Yannick; Remaud-Simeon, Magali] Univ Toulouse, INSA, UPS, INP,LISBP, 135 Ave Rangueil, F-31077 Toulouse, France; [Malbert, Yannick; Remaud-Simeon, Magali] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Remaud-Simeon, Magali] CNRS, UMR5504, F-31400 Toulouse, France; [Czaplicki, Georges; Mourey, Lionel; Tranier, Samuel] CNRS, IPBS, 205 Route Narbonne,BP 64182, F-31077 Toulouse, France; [Czaplicki, Georges; Mourey, Lionel; Tranier, Samuel] Univ Toulouse 3, Univ Toulouse, IPBS, F-31077 Toulouse, France; [Brison, Yoann] Toulouse White Biotechnol, INRA UMS1337, CNRS UMS3582, Parc Technol Canal,3 Rue Ariane, F-31520 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); INRAE	Remaud-Simeon, M (corresponding author), LISBP, 135 Ave Rangueil, F-31077 Toulouse, France.; Tranier, S (corresponding author), Inst Pharmacol & Biol Struct, 205 Route Narbonne,BP 64182, F-31077 Toulouse, France.	remaud@insa-toulouse.fr; samuel.tranier@ipbs.fr	Mourey, Lionel/B-5662-2009; Tranier, Samuel/C-6059-2011; Czaplicki, Georges/ABC-7047-2020	Mourey, Lionel/0000-0002-8259-1259; Czaplicki, Georges/0000-0001-5348-4107; Tranier, Samuel/0000-0001-9751-163X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105958] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM105958] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott DW, 2012, METHOD ENZYMOL, V510, P211, DOI 10.1016/B978-0-12-415931-0.00011-2; ABO H, 1991, J BACTERIOL, V173, P989, DOI 10.1128/jb.173.3.989-996.1991; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; BANAS JA, 1990, INFECT IMMUN, V58, P667, DOI 10.1128/IAI.58.3.667-673.1990; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Bozonnet S, 2002, J BACTERIOL, V184, P5753, DOI 10.1128/JB.184.20.5753-5761.2002; Brison Y, 2013, CARBOHYD POLYM, V94, P567, DOI 10.1016/j.carbpol.2013.01.064; Brison Y, 2012, J BIOL CHEM, V287, P7915, DOI 10.1074/jbc.M111.305078; Brison Y, 2010, APPL MICROBIOL BIOT, V86, P545, DOI 10.1007/s00253-009-2241-z; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cote GL, 2005, J IND MICROBIOL BIOT, V32, P53, DOI 10.1007/s10295-004-0194-x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fabre E, 2005, J BACTERIOL, V187, P296, DOI 10.1128/JB.187.1.296-303.2005; Falconer DJ, 2011, CARBOHYD RES, V346, P280, DOI 10.1016/j.carres.2010.10.024; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; FERRETTI JJ, 1987, J BACTERIOL, V169, P4271, DOI 10.1128/jb.169.9.4271-4278.1987; GIFFARD PM, 1991, J GEN MICROBIOL, V137, P2577, DOI 10.1099/00221287-137-11-2577; GIFFARD PM, 1993, J GEN MICROBIOL, V139, P1511, DOI 10.1099/00221287-139-7-1511; GIFFARD PM, 1994, J DENT RES, V73, P1133, DOI 10.1177/00220345940730060201; GILMORE KS, 1990, INFECT IMMUN, V58, P2452, DOI 10.1128/IAI.58.8.2452-2458.1990; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Jayaram B, 1998, J PHYS CHEM B, V102, P9571, DOI 10.1021/jp982007x; Joucla G, 2006, FEBS LETT, V580, P763, DOI 10.1016/j.febslet.2006.01.001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kingston KB, 2002, MICROBIOL-SGM, V148, P549, DOI 10.1099/00221287-148-2-549; Komatsu H, 2007, BIOCHEMISTRY-US, V46, P8436, DOI 10.1021/bi700282c; Kozlikova B, 2014, BIOINFORMATICS, V30, P2684, DOI 10.1093/bioinformatics/btu364; Kralj S, 2004, MICROBIOL-SGM, V150, P2099, DOI 10.1099/mic.0.27105-0; Leemhuis H, 2013, APPL MICROBIOL BIOT, V97, P181, DOI 10.1007/s00253-012-3943-1; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; LIS M, 1995, APPL ENVIRON MICROB, V61, P2040, DOI 10.1128/AEM.61.5.2040-2042.1995; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Maestro B, 2011, PROTEIN ENG DES SEL, V24, P113, DOI 10.1093/protein/gzq087; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng XF, 2015, APPL MICROBIOL BIOT, V99, P5885, DOI 10.1007/s00253-014-6361-8; MOOSER G, 1988, INFECT IMMUN, V56, P880, DOI 10.1128/IAI.56.4.880-884.1988; Mori T, 2011, J AM CHEM SOC, V133, P5701, DOI 10.1021/ja200094f; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naessens M, 2005, J CHEM TECHNOL BIOT, V80, P845, DOI 10.1002/jctb.1322; Nihira T, 2011, LANGMUIR, V27, P2107, DOI 10.1021/la104550m; Olvera C, 2007, MICROBIOL-SGM, V153, P3994, DOI 10.1099/mic.0.2007/008854-0; Passerini D, 2015, FEBS J, V282, P2115, DOI 10.1111/febs.13261; Pijning T, 2014, FEBS J, V281, P2159, DOI 10.1111/febs.12769; Pijning T, 2012, ACTA CRYSTALLOGR F, V68, P1448, DOI 10.1107/S1744309112044168; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Shah DSH, 2004, J BACTERIOL, V186, P8301, DOI 10.1128/JB.186.24.8301-8308.2004; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Suwannarangsee S, 2007, FEBS LETT, V581, P4675, DOI 10.1016/j.febslet.2007.08.062; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; TAKEO K, 1995, J CHROMATOGR A, V698, P89, DOI 10.1016/0021-9673(94)01265-G; Tomme P, 2000, ENZYME MICROB TECH, V27, P453, DOI 10.1016/S0141-0229(00)00246-5; Vettori M. H. P. B, 2012, DIALOGOS CIENC, V2012, P171, DOI [./10.7447/dc2012.018, DOI 10.7447/DC2012.018]; Vuillemin M, 2014, APPL MICROBIOL BIOT, V98, P5173, DOI 10.1007/s00253-014-5627-5; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	69	22	22	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7527	7540		10.1074/jbc.M115.688796	http://dx.doi.org/10.1074/jbc.M115.688796			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26865636	Green Published, hybrid			2022-12-28	WOS:000383447600027
J	Chen, PW; Jian, XY; Heissler, SM; Le, K; Luo, RH; Jenkins, LM; Nagy, A; Moss, J; Sellers, JR; Randazzo, PA				Chen, Pei-Wen; Jian, Xiaoying; Heissler, Sarah M.; Le, Kang; Luo, Ruibai; Jenkins, Lisa M.; Nagy, Attila; Moss, Joel; Sellers, James R.; Randazzo, Paul A.			The Arf GTPase-activating Protein, ASAP1, Binds Nonmuscle Myosin 2A to Control Remodeling of the Actomyosin Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR DORSAL RUFFLES; ACTIN CYTOSKELETON; CELL-MIGRATION; ANIONIC PHOSPHOLIPIDS; FOCAL ADHESIONS; PHOSPHORYLATION; DOMAIN; ASSOCIATION; EXPRESSION; PODOSOMES	ASAP1 regulates F-actin-based structures and functions, including focal adhesions (FAs) and circular dorsal ruffles (CDRs), cell spreading and migration. ASAP1 function requires its N-terminal BAR domain. We discovered that nonmuscle myosin 2A (NM2A) directly bound the BAR-PH tandem of ASAP1 in vitro. ASAP1 and NM2A co-immunoprecipitated and colocalized in cells. Knockdown of ASAP1 reduced colocalization of NM2A and F-actin in cells. Knockdown of ASAP1 or NM2A recapitulated each other's effects on FAs, cell migration, cell spreading, and CDRs. The NM2A-interacting BAR domain contributed to ASAP1 control of cell spreading and CDRs. Exogenous expression of NM2A rescued the effect of ASAP1 knockdown on CDRs but ASAP1 did not rescue NM2A knockdown defect in CDRs. Our results support the hypothesis that ASAP1 is a positive regulator of NM2A. Given other binding partners of ASAP1, ASAP1 may directly link signaling and the mechanical machinery of cell migration.	[Chen, Pei-Wen; Jian, Xiaoying; Luo, Ruibai; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, Bethesda, MD 20892 USA; [Jenkins, Lisa M.] NCI, Cell Biol Lab, Bethesda, MD 20892 USA; [Heissler, Sarah M.; Nagy, Attila; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Le, Kang; Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Chen, Pei-Wen] Grinnell Coll, Dept Biol, Grinnell, IA 50112 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, Bethesda, MD 20892 USA.	randazzp@mail.nih.gov	Jenkins, Lisa/AAI-2490-2021		NCI, National Institutes of Health [BC 007365]; NHLBI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZICBC011430, Z01BC007365] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000627, ZIAHL001786, ZIAHL000659] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the intramural program of the NCI, National Institutes of Health (to P. W. C., X. J., R. L., and P. R., Project BC 007365) and NHLBI, National Institutes of Health (to K. L., J. M., A. N., S. H., and J. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chen PW, 2013, J BIOL CHEM, V288, P5849, DOI 10.1074/jbc.M112.415778; Chen PW, 2010, CELL ADHES MIGR, V4, P527, DOI 10.4161/cam.4.4.12399; Chen P, 2012, INORG CHEM COMMUN, V17, P17, DOI 10.1016/j.inoche.2011.12.005; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; DANIEL JL, 1992, METHOD ENZYMOL, V215, P78; Doyle AD, 2012, J CELL SCI, V125, P2244, DOI 10.1242/jcs.098806; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Gu ZZ, 2011, J CELL BIOL, V193, P61, DOI 10.1083/jcb.201007003; Hoon JL, 2012, MOL CELL BIOL, V32, P4246, DOI 10.1128/MCB.00551-12; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Itoh T, 2013, J BIOCHEM, V153, P21, DOI 10.1093/jb/mvs138; Jian XY, 2015, STRUCTURE, V23, P1977, DOI 10.1016/j.str.2015.08.008; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; LI DQ, 1994, P NATL ACAD SCI USA, V91, P853, DOI 10.1073/pnas.91.3.853; Liu YH, 2005, J BIOL CHEM, V280, P8884, DOI 10.1074/jbc.M412200200; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Oda A, 2003, J BIOL CHEM, V278, P6456, DOI 10.1074/jbc.M210817200; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786	32	18	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7517	7526		10.1074/jbc.M115.701292	http://dx.doi.org/10.1074/jbc.M115.701292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26893376	Green Published, hybrid			2022-12-28	WOS:000383447600026
J	Crouch, LI; Labourel, A; Walton, PH; Davies, GJ; Gilbert, HJ				Crouch, Lucy I.; Labourel, Aurore; Walton, Paul H.; Davies, Gideon J.; Gilbert, Harry J.			The Contribution of Non-catalytic Carbohydrate Binding Modules to the Activity of Lytic Polysaccharide Monooxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL WALL DEGRADATION; CELLULOSE-BINDING; SUBSTRATE-SPECIFICITY; FUNCTIONAL-CHARACTERIZATION; SERRATIA-MARCESCENS; LIMITED PROTEOLYSIS; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; PROTEIN CBP21; FAMILY	Lignocellulosic biomass is a sustainable industrial substrate. Copper-dependent lytic polysaccharide monooxygenases (LPMOs) contribute to the degradation of lignocellulose and increase the efficiency of biofuel production. LPMOs can contain non-catalytic carbohydrate binding modules (CBMs), but their role in the activity of these enzymes is poorly understood. Here we explored the importance of CBMs in LPMO function. The family 2a CBMs of two monooxygenases, CfLPMO10 and TbLPMO10 from Cellulomonas fimi and Thermobispora bispora, respectively, were deleted and/or replaced with CBMs from other proteins. The data showed that the CBMs could potentiate and, surprisingly, inhibit LPMO activity, and that these effects were both enzyme-specific and substrate-specific. Removing the natural CBM or introducing CtCBM3a, from the Clostridium thermocellum cellulosome scaffoldin CipA, almost abolished the catalytic activity of the LPMOs against the cellulosic substrates. The deleterious effect of CBM removal likely reflects the importance of prolonged presentation of the enzyme on the surface of the substrate for efficient catalytic activity, as only LPMOs appended to CBMs bound tightly to cellulose. The negative impact of CtCBM3a is in sharp contrast with the capacity of this binding module to potentiate the activity of a range of glycoside hydrolases including cellulases. The deletion of the endogenous CBM from CfLPMO10 or the introduction of a family 10 CBM from Cellvibrio japonicus LPMO10B into TbLPMO10 influenced the quantity of non-oxidized products generated, demonstrating that CBMs can modulate the mode of action of LPMOs. This study demonstrates that engineered LPMO-CBM hybrids can display enhanced industrially relevant oxygenations.	[Crouch, Lucy I.; Labourel, Aurore; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Walton, Paul H.; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England	Newcastle University - UK; University of York - UK	Gilbert, HJ (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	harry.gilbert@ncl.ac.uk	Davies, Gideon J/A-9042-2011	Davies, Gideon J/0000-0002-7343-776X; Labourel, Aurore/0000-0002-4762-5804; Walton, Paul/0000-0002-1152-1480	Biotechnology and Biological Sciences Research Council [BB/K020358/1, BB/L021633/1, BB/K001949/1]; BBSRC [BB/K020358/1, BB/L021633/1, BB/K001949/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (Grants BB/K020358/1, BB/L021633/1, and BB/K001949/1). The authors declare that they have no conflicts of interest with the contents of this article.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Andersen N, 2008, ENZYME MICROB TECH, V42, P362, DOI 10.1016/j.enzmictec.2007.11.018; Arfi Y, 2014, P NATL ACAD SCI USA, V111, P9109, DOI 10.1073/pnas.1404148111; ATALLA RH, 1984, SCIENCE, V223, P283, DOI 10.1126/science.223.4633.283; Beeson WT, 2015, ANNU REV BIOCHEM, V84, P923, DOI 10.1146/annurev-biochem-060614-034439; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Book AJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-109; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2014, BIOCHEMISTRY-US, V53, P1647, DOI 10.1021/bi5000433; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Gardner JG, 2014, MOL MICROBIOL, V94, P1121, DOI 10.1111/mmi.12821; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Urbanowicz BR, 2012, P NATL ACAD SCI USA, V109, P14253, DOI 10.1073/pnas.1208097109; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; VANTILBEURGH H, 1986, FEBS LETT, V204, P223, DOI 10.1016/0014-5793(86)80816-X; Venditto I, 2015, J BIOL CHEM, V290, P10572, DOI 10.1074/jbc.M115.637827; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011; Zhang XY, 2014, J BIOL CHEM, V289, P2002, DOI 10.1074/jbc.M113.527770	49	74	77	2	65	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7439	7449		10.1074/jbc.M115.702365	http://dx.doi.org/10.1074/jbc.M115.702365			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26801613	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000383447600020
J	Mazurkewich, S; Brott, AS; Kimber, MS; Seah, SYK				Mazurkewich, Scott; Brott, Ashley S.; Kimber, Matthew S.; Seah, Stephen Y. K.			Structural and Kinetic Characterization of the 4-Carboxy-2-hydroxymuconate Hydratase from the Gallate and Protocatechuate 4,5-Cleavage Pathways of Pseudomonas putida KT2440	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOPROTOCATECHUATE DEGRADATION PATHWAY; LIGNIN-RELATED BIPHENYL; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; DEACETYLASE MSHB; 4-OXALOMESACONATE HYDRATASE; MOLECULAR CHARACTERIZATION; STRUCTURE REFINEMENT; AROMATIC-COMPOUNDS; GALLIC ACID	The bacterial catabolism of lignin and its breakdown products is of interest for applications in industrial processing of lignobiomass. The gallate degradation pathway of Pseudomonas putida KT2440 requires a 4-carboxy-2-hydroxymuconate (CHM) hydratase (GalB), which has a 12% sequence identity to a previously identified CHM hydratase (LigJ) from Sphingomonas sp. SYK-6. The structure of GalB was determined and found to be a member of the PIG-L N-acetylglucosamine deacetylase family; GalB is structurally distinct from the amidohydrolase fold of LigJ. LigJ has the same stereospecificity as GalB, providing an example of convergent evolution for catalytic conversion of a common metabolite in bacterial aromatic degradation pathways. Purified GalB contains a bound Zn2+ cofactor; however the enzyme is capable of using Fe2+ and Co2+ with similar efficiency. The general base aspartate in the PIG-L deacetylases is an alanine in GalB; replacement of the alanine with aspartate decreased the GalB catalytic efficiency for CHM by 9.5 x 10(4)-fold, and the variant enzyme did not have any detectable hydrolase activity. Kinetic analyses and pH dependence studies of the wild type and variant enzymes suggested roles for Glu-48 and His-164 in the catalytic mechanism. A comparison with the PIG-L deacetylases led to a proposed mechanism for GalB wherein Glu-48 positions and activates the metal-ligated water for the hydration reaction and His-164 acts as a catalytic acid.	[Mazurkewich, Scott; Brott, Ashley S.; Kimber, Matthew S.; Seah, Stephen Y. K.] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East,Sci Complex, Guelph, ON N1G 2W1, Canada	University of Guelph	Seah, SYK (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East,Sci Complex, Guelph, ON N1G 2W1, Canada.	sseah@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Kimber, Matthew/0000-0001-9454-5586; Mazurkewich, Scott/0000-0002-9238-0615	National Science and Engineering Research Council of Canada [2015-05366]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Grant 2015-05366 from the National Science and Engineering Research Council of Canada (to S. Y. K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALVAREZSANTOS S, 1994, CAN J CHEM, V72, P2077, DOI 10.1139/v94-264; Becker HM, 2014, SUBCELL BIOCHEM, V75, P105, DOI 10.1007/978-94-007-7359-2_7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadley SG, 2012, ACTA CRYSTALLOGR D, V68, P1450, DOI 10.1107/S090744491203449X; Burks EA, 1998, J AM CHEM SOC, V120, P7665, DOI 10.1021/ja9808402; Chan HC, 2011, MOL BIOSYST, V7, P1224, DOI 10.1039/c0mb00320d; DAGLEY S, 1960, NATURE, V188, P560, DOI 10.1038/188560a0; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fadouloglou VE, 2007, FEBS J, V274, P3044, DOI 10.1111/j.1742-4658.2007.05834.x; Fang Z, 2013, BIOCHEM J, V454, P239, DOI 10.1042/BJ20130415; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Hara H, 2000, J BACTERIOL, V182, P6950, DOI 10.1128/JB.182.24.6950-6957.2000; Hobbs ME, 2012, BIOCHEMISTRY-US, V51, P3497, DOI 10.1021/bi300307b; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HORN JM, 1991, MOL MICROBIOL, V5, P2459, DOI 10.1111/j.1365-2958.1991.tb02091.x; Huang XY, 2012, J BIOL CHEM, V287, P10424, DOI 10.1074/jbc.M111.320184; Huang XY, 2011, J BIOL CHEM, V286, P20275, DOI 10.1074/jbc.M111.234229; Izumi A, 2007, J MOL BIOL, V370, P899, DOI 10.1016/j.jmb.2007.05.006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamimura N, 2010, APPL ENVIRON MICROB, V76, P8093, DOI 10.1128/AEM.01863-10; KATAYAMA Y, 1988, FEBS LETT, V233, P129, DOI 10.1016/0014-5793(88)81369-3; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li SH, 2007, BIOSCI BIOTECH BIOCH, V71, P449, DOI 10.1271/bbb.60503; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; MARUYAMA K, 1990, J BIOCHEM-TOKYO, V108, P327, DOI 10.1093/oxfordjournals.jbchem.a123201; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P37, DOI 10.1038/newbio238037a0; Maynes JT, 2003, J BIOL CHEM, V278, P47166, DOI 10.1074/jbc.M308914200; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; McCarthy AA, 2004, J MOL BIOL, V335, P1131, DOI 10.1016/j.jmb.2003.11.034; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mine S, 2014, FEBS J, V281, P2584, DOI 10.1111/febs.12805; Ni B, 2013, APPL MICROBIOL BIOT, V97, P6031, DOI 10.1007/s00253-012-4402-8; Nogales J, 2005, J BIOL CHEM, V280, P35382, DOI 10.1074/jbc.M502585200; Nogales J, 2011, MOL MICROBIOL, V79, P359, DOI 10.1111/j.1365-2958.2010.07448.x; Pelmenschikov V, 2002, J BIOL INORG CHEM, V7, P284, DOI 10.1007/s007750100295; Peng X, 1999, APPL ENVIRON MICROB, V65, P2789; Peng X, 1998, APPL ENVIRON MICROB, V64, P2520; Pollard JR, 1998, EUR J BIOCHEM, V251, P98, DOI 10.1046/j.1432-1327.1998.2510098.x; Prieto MA, 1996, J BACTERIOL, V178, P111, DOI 10.1128/jb.178.1.111-120.1996; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Rea D, 2007, J MOL BIOL, V373, P866, DOI 10.1016/j.jmb.2007.06.048; REEKE GN, 1967, P NATL ACAD SCI USA, V58, P2220, DOI 10.1073/pnas.58.6.2220; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; RITTER CS, 1973, J BACTERIOL, V113, P1064, DOI 10.1128/JB.113.2.1064-1065.1973; SHANNON LM, 1962, J BIOL CHEM, V237, P3342; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TACK BF, 1972, J BIOL CHEM, V247, P6438; TACK BF, 1972, J BIOL CHEM, V247, P6444; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Volkamer A, 2010, J CHEM INF MODEL, V50, P2041, DOI 10.1021/ci100241y; Wang WJ, 2010, J BIOL CHEM, V285, P36608, DOI 10.1074/jbc.M110.159509; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu SS, 2010, J PHYS CHEM B, V114, P9259, DOI 10.1021/jp101448j; Yoshikata T, 2014, APPL ENVIRON MICROB, V80, P7142, DOI 10.1128/AEM.02236-14; Zou Y, 2008, CHEM BIOL, V15, P533, DOI 10.1016/j.chembiol.2008.05.009	63	9	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7669	7686		10.1074/jbc.M115.682054	http://dx.doi.org/10.1074/jbc.M115.682054			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26867578	hybrid, Green Published			2022-12-28	WOS:000383447600038
J	Ho, NAT; Dawes, SS; Crowe, AM; Casabon, I; Gao, C; Kendall, SL; Baker, EN; Eltis, LD; Lott, JS				Ngoc Anh Thu Ho; Dawes, Stephanie S.; Crowe, Adam M.; Casabon, Israel; Gao, Chen; Kendall, Sharon L.; Baker, Edward N.; Eltis, Lindsay D.; Lott, J. Shaun			The Structure of the Transcriptional Repressor KstR in Complex with CoA Thioester Cholesterol Metabolites Sheds Light on the Regulation of Cholesterol Catabolism in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; STRUCTURE REFINEMENT; PROTEIN-PRODUCTION; TETR FAMILY; FATTY-ACIDS; SIDE-CHAIN; CRYSTALLOGRAPHY; DEGRADATION; MACROPHAGES; INFECTION	Cholesterol can be a major carbon source for Mycobacterium tuberculosis during infection, both at an early stage in the macrophage phagosome and later within the necrotic granuloma. KstR is a highly conserved TetR family transcriptional repressor that regulates a large set of genes responsible for cholesterol catabolism. Many genes in this regulon, including kstR, are either induced during infection or are essential for survival of M. tuberculosis in vivo. In this study, we identified two ligands for KstR, both of which are CoA thioester cholesterol metabolites with four intact steroid rings. A metabolite in which one of the rings was cleaved was not a ligand. We confirmed the ligand-protein interactions using intrinsic tryptophan fluorescence and showed that ligand binding strongly inhibited KstR-DNA binding using surface plasmon resonance (IC50 for ligand = 25 nM). Crystal structures of the ligand-free form of KstR show variability in the position of the DNA-binding domain. In contrast, structures of KstR.ligand complexes are highly similar to each other and demonstrate a position of the DNA-binding domain that is unfavorable for DNA binding. Comparison of ligand-bound and ligand-free structures identifies residues involved in ligand specificity and reveals a distinctive mechanism by which the ligand-induced conformational change mediates DNA release.	[Ngoc Anh Thu Ho; Dawes, Stephanie S.; Casabon, Israel; Gao, Chen; Baker, Edward N.; Lott, J. Shaun] Univ Auckland, Sch Biol Sci, 3a Symonds St, Auckland 1142, New Zealand; [Ngoc Anh Thu Ho; Dawes, Stephanie S.; Casabon, Israel; Gao, Chen; Baker, Edward N.; Lott, J. Shaun] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, 3a Symonds St, Auckland 1142, New Zealand; [Kendall, Sharon L.] Royal Vet Coll, Dept Pathol & Pathogen Biol, Royal Coll St, London NW1 0TU, England; [Crowe, Adam M.; Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Casabon, Israel; Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Gao, Chen] St Vincents Inst Med Res, Struct Biol Grp, 9 Princes St, Fitzroy, Vic 3065, Australia	University of Auckland; University of Auckland; University of London; University of London Royal Veterinary College; University of British Columbia; University of British Columbia; St. Vincent's Institute of Medical Research	Eltis, LD (corresponding author), Univ British Columbia, Inst Life Sci, 2350 Hlth Sci Mall\, Vancouver, BC V6T 1Z3, Canada.; Lott, JS (corresponding author), Univ Auckland, Rm 110-424B,3 Symonds St,Private Bag 92019, Auckland 1142, New Zealand.	leltis@mail.ubc.ca; s.lott@auckland.ac.nz	; Eltis, Lindsay/J-8272-2015	Ho, Thu/0000-0001-9291-8860; Baker, Edward/0000-0003-2456-7661; Lott, Shaun/0000-0003-3660-452X; Eltis, Lindsay/0000-0002-6774-8158; Kendall, Sharon/0000-0003-3277-3035; Crowe, Adam/0000-0002-5487-2520	Health Research Council of New Zealand [12/1111]; Canadian Institutes for Health Research (CIHR) [MOP-133647]; University of Auckland; CIHR; Fonds de Recherche en Sante du Quebec; Michael Smith Foundation for Health Research	Health Research Council of New Zealand(Health Research Council of New Zealand); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of Auckland; CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported in part by Health Research Council of New Zealand Program Grant 12/1111 (to E. N. B. and J. S. L.) and Canadian Institutes for Health Research (CIHR) Operating Grant MOP-133647 (to L. D. E.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a doctoral scholarship from the University of Auckland.r Supported by a CIHR doctoral fellowship.r Supported by a postdoctoral fellowship from the Fonds de Recherche en Sante du Quebec and the Michael Smith Foundation for Health Research.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Balhana RJC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1696-9; Bricogne G., 2011, BUSTER VERSION 2 8 0; Brzostek A, 2007, FEMS MICROBIOL LETT, V275, P106, DOI 10.1111/j.1574-6968.2007.00865.x; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Capyk JK, 2011, J BIOL CHEM, V286, P40717, DOI 10.1074/jbc.M111.289975; Casabon I, 2014, J BACTERIOL, V196, P579, DOI 10.1128/JB.01012-13; Casabon I, 2013, MOL MICROBIOL, V89, P1201, DOI 10.1111/mmi.12340; Casabon I, 2013, MOL MICROBIOL, V87, P269, DOI 10.1111/mmi.12095; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crowe AM, 2015, J BIOL CHEM, V290, P872, DOI 10.1074/jbc.M114.607481; Dubnau E, 2002, INFECT IMMUN, V70, P2787, DOI 10.1128/IAI.70.6.2787-2795.2002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Fernandez E, 2014, J BIOL CHEM, V289, P17576, DOI 10.1074/jbc.M113.545715; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Grkovic S, 2003, BIOCHEMISTRY-US, V42, P15226, DOI 10.1021/bi035447+; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Itou H, 2010, J MOL BIOL, V403, P174, DOI 10.1016/j.jmb.2010.07.042; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Le TBK, 2011, J MOL BIOL, V408, P40, DOI 10.1016/j.jmb.2011.02.035; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Powell HR, 2013, ACTA CRYSTALLOGR D, V69, P1195, DOI 10.1107/S0907444912048524; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; VanderVen BC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004679; Willems AR, 2008, J MOL BIOL, V376, P1377, DOI 10.1016/j.jmb.2007.12.061; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2015, GLOB TUB REP 2015; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang M, 2015, ACS INFECT DIS, V1, P110, DOI 10.1021/id500033m	48	24	25	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7256	7266		10.1074/jbc.M115.707760	http://dx.doi.org/10.1074/jbc.M115.707760			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26858250	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000383447600005
J	Johnson, JJ; Miller, DL; Jiang, R; Liu, YY; Shi, ZG; Tarwater, L; Williams, R; Balsara, R; Sauter, ER; Stack, MS				Johnson, Jeff J.; Miller, Daniel L.; Jiang, Rong; Liu, Yueying; Shi, Zonggao; Tarwater, Laura; Williams, Russell; Balsara, Rashna; Sauter, Edward R.; Stack, M. Sharon			Protease-activated Receptor-2 (PAR-2)-mediated Nf-B Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; kallikrein; microRNA (miRNA); NF-B; protease; serine protease; oral cancer; protease-activated receptor	EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN KERATINOCYTES; UP-REGULATION; KAPPA-B; CANCER; EXPRESSION; HEAD; INVASION; LESIONS; DIFFERENTIATION	Oral cancer is the sixth most common cause of death from cancer with an estimated 400,000 deaths worldwide and a low (50%) 5-year survival rate. The most common form of oral cancer is oral squamous cell carcinoma (OSCC). OSCC is highly inflammatory and invasive, and the degree of inflammation correlates with tumor aggressiveness. The G protein-coupled receptor protease-activated receptor-2 (PAR-2) plays a key role in inflammation. PAR-2 is activated via proteolytic cleavage by trypsin-like serine proteases, including kallikrein-5 (KLK5), or by treatment with activating peptides. PAR-2 activation induces G protein--mediated signaling, mobilizing intracellular calcium and Nf-B signaling, leading to the increased expression of pro-inflammatory mRNAs. Little is known, however, about PAR-2 regulation of inflammation-related microRNAs. Here, we assess PAR-2 expression and function in OSCC cell lines and tissues. Stimulation of PAR-2 activates Nf-B signaling, resulting in RelA nuclear translocation and enhanced expression of pro-inflammatory mRNAs. Concomitantly, suppression of the anti-inflammatory tumor suppressor microRNAs let-7d, miR-23b, and miR-200c was observed following PAR-2 stimulation. Analysis of orthotopic oral tumors generated by cells with reduced KLK5 expression showed smaller, less aggressive lesions with reduced inflammatory infiltrate relative to tumors generated by KLK5-expressing control cells. Together, these data support a model wherein KLK5-mediated PAR-2 activation regulates the expression of inflammation-associated mRNAs and microRNAs, thereby modulating progression of oral tumors.	[Johnson, Jeff J.; Liu, Yueying; Shi, Zonggao; Tarwater, Laura; Stack, M. Sharon] Univ Notre Dame, Harper Canc Res Inst, 1234 Notre Dame Ave,A200E Harper Hall, South Bend, IN 46617 USA; [Johnson, Jeff J.; Liu, Yueying; Shi, Zonggao; Stack, M. Sharon] Univ Notre Dame, Dept Chem & Biochem, 1234 Notre Dame Ave,A200E Harper Hall, South Bend, IN 46617 USA; [Miller, Daniel L.] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Jiang, Rong] Emory Univ, Dept Human Genet, Atlanta, GA USA; [Williams, Russell] Indiana Univ, Dept Biol, South Bend, IN 46634 USA; [Balsara, Rashna] WM Keck Ctr Transgene Res, South Bend, IN 46617 USA; [Sauter, Edward R.] Univ Texas Tyler, Hlth Sci Ctr, Dept Surg, Tyler, TX 75799 USA	University of Notre Dame; University of Notre Dame; University of Missouri System; University of Missouri Columbia; Emory University; Indiana University System; Indiana University South Bend; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Stack, MS (corresponding author), Univ Notre Dame, 1234 Notre Dame Ave,A200E Harper Hall, South Bend, IN 46617 USA.	sstack@nd.edu		Shi, Zonggao/0000-0001-7503-2953	National Institutes of Health NCI Research Grant [RO1CA085870]; NIDCR Grant [F31DE021926]; NATIONAL CANCER INSTITUTE [R01CA085870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE021926] Funding Source: NIH RePORTER	National Institutes of Health NCI Research Grant; NIDCR Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health NCI Research Grant RO1CA085870 (to M. S. S.) and NIDCR Grant F31DE021926 (to D. L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Arwert EN, 2010, P NATL ACAD SCI USA, V107, P19903, DOI 10.1073/pnas.1007404107; Barland CO, 2004, J INVEST DERMATOL, V122, P330, DOI 10.1046/j.0022-202X.2004.22203.x; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Buddenkotte J, 2005, J INVEST DERMATOL, V124, P38, DOI 10.1111/j.0022-202X.2004.23539.x; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Chang CJ, 2011, ONCOL REP, V26, P1003, DOI 10.3892/or.2011.1360; Chang PY, 2013, CLIN CHEM LAB MED, V51, P1291, DOI 10.1515/cclm-2012-0504; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Christofakis EP, 2008, ORAL ONCOL, V44, P920, DOI 10.1016/j.oraloncology.2007.12.002; Chuang TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095370; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Elashoff D, 2012, CANCER EPIDEM BIOMAR, V21, P664, DOI 10.1158/1055-9965.EPI-11-1093; Fujita Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110378; Furio L, 2011, J INVEST DERMATOL, V131, P2169, DOI 10.1038/jid.2011.295; Ghosh S, 2010, MOL CANCER RES, V8, P145, DOI 10.1158/1541-7786.MCR-09-0045; Gonzalez HE, 2003, ARCH OTOLARYNGOL, V129, P754, DOI 10.1001/archotol.129.7.754; Gorenchtein M, 2012, J DENT RES, V91, P440, DOI 10.1177/0022034511431261; Inaba H, 2014, CELL MICROBIOL, V16, P131, DOI 10.1111/cmi.12211; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Jamali Z, 2015, ORAL ONCOL, V51, P321, DOI 10.1016/j.oraloncology.2015.01.008; Jayakumar A, 2005, ARCH BIOCHEM BIOPHYS, V435, P89, DOI 10.1016/j.abb.2004.12.012; Jian SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066133; Jiang R, 2011, J BIOL CHEM, V286, P9127, DOI 10.1074/jbc.M110.191361; Johnson J, 2014, ORAL ONCOL, V50, P468, DOI 10.1016/j.oraloncology.2014.02.004; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; KRAMER I R H, 1978, Oral Surgery Oral Medicine Oral Pathology, V46, P518; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Lee MC, 2008, NEUROGASTROENT MOTIL, V20, P385, DOI 10.1111/j.1365-2982.2007.01041.x; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; LUMERMAN H, 1995, ORAL SURG ORAL MED O, V79, P321, DOI 10.1016/S1079-2104(05)80226-4; Macfarlane SR, 2005, BRIT J PHARMACOL, V145, P535, DOI 10.1038/sj.bjp.0706204; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Myers JN, 2002, CLIN CANCER RES, V8, P293; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Oikonomopoulou K, 2006, BIOL CHEM, V387, P817, DOI 10.1515/BC.2006.104; Ono M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005231; Pellegrino L, 2013, NUCLEIC ACIDS RES, V41, P5400, DOI 10.1093/nar/gkt245; Perez-Sayans M, 2012, J ORAL PATHOL MED, V41, P433, DOI 10.1111/j.1600-0714.2011.01121.x; Pettus JR, 2009, HISTOL HISTOPATHOL, V24, P197, DOI 10.14670/HH-24.197; Rajkumar K, 2014, OR SURG OR MED OR PA, V118, P309, DOI 10.1016/j.oooo.2014.04.008; Rallabhandi P, 2008, J BIOL CHEM, V283, P24314, DOI 10.1074/jbc.M804800200; Ramdas L, 2009, HEAD NECK-J SCI SPEC, V31, P642, DOI 10.1002/hed.21017; Rao SK, 2010, J BIOL CHEM, V285, P32512, DOI 10.1074/jbc.M110.150490; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Sales KU, 2015, ONCOGENE, V34, P288, DOI 10.1038/onc.2013.563; Shi LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078344; Shi ZG, 2015, ARCH ORAL BIOL, V60, P1416, DOI 10.1016/j.archoralbio.2015.06.007; Suen JY, 2014, BRIT J PHARMACOL, V171, P4112, DOI 10.1111/bph.12757; Tanis T, 2014, ARCH ORAL BIOL, V59, P1155, DOI 10.1016/j.archoralbio.2014.07.005; VEDTOFTE P, 1987, INT J ORAL MAX SURG, V16, P656, DOI 10.1016/S0901-5027(87)80049-8; Vergnolle N, 2001, TRENDS PHARMACOL SCI, V22, P146, DOI 10.1016/S0165-6147(00)01634-5; Wagner S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/376326; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Wojtukiewicz MZ, 2015, CANCER METAST REV, V34, P775, DOI 10.1007/s10555-015-9599-4; World Health Organization, 2012, GLOBOCAN 2012 EST CA; Yau MK, 2013, J MED CHEM, V56, P7477, DOI 10.1021/jm400638v; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zidar N, 2011, HUM PATHOL, V42, P482, DOI 10.1016/j.humpath.2010.07.020	67	35	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6936	6945		10.1074/jbc.M115.692640	http://dx.doi.org/10.1074/jbc.M115.692640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26839311	hybrid, Green Published			2022-12-28	WOS:000373299700030
J	Salvo, E; Alabi, S; Liu, B; Schlessinger, A; Bechhofer, DH				Salvo, Elizabeth; Alabi, Shanique; Liu, Bo; Schlessinger, Avner; Bechhofer, David H.			Interaction of Bacillus subtilis Polynucleotide Phosphorylase and RNase Y: STRUCTURAL MAPPING AND EFFECT ON mRNA TURNOVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial genetics; endonuclease; mRNA decay; phosphorylase; RNA turnover; Bacillus subtilis; PNPase; RNase Y	BACTERIAL 2-HYBRID SYSTEM; ESCHERICHIA-COLI; DECAY; EXORIBONUCLEASES; ENDORIBONUCLEASE; IDENTIFICATION; DEGRADATION; DEGRADOSOME; INITIATION; SEQUENCE	Polynucleotide phosphorylase (PNPase), a 3-to-5 phosphorolytic exoribonuclease, is thought to be the primary enzyme responsible for turnover of Bacillus subtilis mRNA. The role of PNPase in B. subtilis mRNA decay has been analyzed previously by comparison of mRNA profiles in a wild-type strain versus a strain that is deleted for pnpA, the gene encoding PNPase. Recent studies have provided evidence for a degradosome-like complex in B. subtilis that is built around the major decay-initiating endonuclease, RNase Y, and there is ample evidence for a strong interaction between PNPase and RNase Y. The role of the PNPase-RNase Y interaction in the exonucleolytic function of PNPase needs to be clarified. We sought to construct a B. subtilis strain containing a catalytically active PNPase that could not interact with RNase Y. Mapping studies of the PNPase-RNase Y interaction were guided by a homology model of B. subtilis PNPase based on the known structure of the Escherichia coli PNPase in complex with an RNase E peptide. Mutations in B. subtilis residues predicted to be involved in RNase Y binding showed a loss of PNPase-RNase Y interaction. Two mRNAs whose decay is dependent on RNase Y and PNPase were examined in strains containing full-length PNPase that was either catalytically active but unable to interact with RNase Y, or catalytically inactive but able to interact with RNase Y. At least for these two mRNAs, disruption of the PNPase-RNase Y interaction did not appear to affect mRNA turnover.	[Salvo, Elizabeth; Alabi, Shanique; Liu, Bo; Schlessinger, Avner; Bechhofer, David H.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Alabi, Shanique] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Icahn School of Medicine at Mount Sinai; Yale University	Bechhofer, DH (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	david.bechhofer@mssm.edu	Liu, Bo/G-5317-2015	Liu, Bo/0000-0002-4511-6926	National Institutes of Health [R01 GM100137, R01 GM108911]; United States Department of Defense [W81XWH-15-1-0539]; Post-baccalaureate Research Education Program [R25 GM06118]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100137, R01GM108911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Post-baccalaureate Research Education Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM100137 (to D. H. B.) and R01 GM108911 (to A. S.) and United States Department of Defense Grant W81XWH-15-1-0539 (to A. S.) This work was also supported by Post-baccalaureate Research Education Program Grant R25 GM06118 (to S. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bechhofer DH, 2008, METHOD ENZYMOL, V447, P259, DOI 10.1016/S0076-6879(08)02214-3; Bechhofer DH, 1998, J BACTERIOL, V180, P5968, DOI 10.1128/JB.180.22.5968-5977.1998; BROSIUS J, 1992, METHOD ENZYMOL, V216, P469; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; DEUTSCHER MP, 1991, P NATL ACAD SCI USA, V88, P3277, DOI 10.1073/pnas.88.8.3277; DUFFY JJ, 1972, J MOL BIOL, V64, P565, DOI 10.1016/0022-2836(72)90083-6; Gerwig J, 2014, MOL MICROBIOL, V94, P5, DOI 10.1111/mmi.12769; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Jarrige AC, 2002, J MOL BIOL, V321, P397, DOI 10.1016/S0022-2836(02)00645-9; Kang SO, 2010, INFECT IMMUN, V78, P2754, DOI 10.1128/IAI.01370-09; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Laalami S, 2014, CELL MOL LIFE SCI, V71, P1799, DOI 10.1007/s00018-013-1472-4; Lehnik-Habrink M, 2012, MOL MICROBIOL, V84, P1005, DOI 10.1111/j.1365-2958.2012.08072.x; Lehnik-Habrink M, 2010, MOL MICROBIOL, V77, P958, DOI 10.1111/j.1365-2958.2010.07264.x; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Liu B, 2014, MOL MICROBIOL, V94, P41, DOI 10.1111/mmi.12748; Luttinger A, 1996, MOL MICROBIOL, V19, P343, DOI 10.1046/j.1365-2958.1996.380907.x; Newman JA, 2012, J MOL BIOL, V416, P121, DOI 10.1016/j.jmb.2011.12.024; Nurmohamed S, 2009, J MOL BIOL, V389, P17, DOI 10.1016/j.jmb.2009.03.051; Oussenko IA, 2005, J BACTERIOL, V187, P2758, DOI 10.1128/JB.187.8.2758-2767.2005; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Sharp JS, 2003, J BACTERIOL, V185, P5372, DOI 10.1128/JB.185.18.5372-5379.2003; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sulthana S, 2013, J BIOL CHEM, V288, P12574, DOI 10.1074/jbc.C113.459172; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Wang W, 1996, J BACTERIOL, V178, P2375, DOI 10.1128/jb.178.8.2375-2382.1996; Wu YH, 2012, ANAL BIOCHEM, V423, P15, DOI 10.1016/j.ab.2012.01.012; Yao SY, 2010, J BACTERIOL, V192, P3279, DOI 10.1128/JB.00230-10	37	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6655	6663		10.1074/jbc.M115.711044	http://dx.doi.org/10.1074/jbc.M115.711044			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26797123	Green Published, hybrid			2022-12-28	WOS:000373299700004
J	Rieger, ME; Zhou, BY; Solomon, N; Sunohara, M; Li, CG; Nguyen, C; Liu, YX; Pan, JH; Minoo, P; Crandall, ED; Brody, SL; Kahn, M; Borok, Z				Rieger, Megan E.; Zhou, Beiyun; Solomon, Nicola; Sunohara, Mitsuhiro; Li, Changgong; Cu Nguyen; Liu, Yixin; Pan, Jie-hong; Minoo, Parviz; Crandall, Edward D.; Brody, Steven L.; Kahn, Michael; Borok, Zea			p300/-Catenin Interactions Regulate Adult Progenitor Cell Differentiation Downstream of WNT5a/Protein Kinase C (PKC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-catenin (-catenin); differentiation; protein kinase C (PKC); protein-protein interaction; Wnt pathway; p300	IDIOPATHIC PULMONARY-FIBROSIS; PROTEIN-KINASE; BETA-CATENIN; EPITHELIAL-CELLS; PRIMARY CULTURE; STEM-CELLS; INHIBITION; P300; ACTIVATION; BINDING	Maintenance of stem/progenitor cell-progeny relationships is required for tissue homeostasis during normal turnover and repair. Wnt signaling is implicated in both maintenance and differentiation of adult stem/progenitor cells, yet how this pathway serves these dichotomous roles remains enigmatic. We previously proposed a model suggesting that specific interaction of -catenin with either of the homologous Kat3 co-activators, p300 or CREB-binding protein, differentially regulates maintenance versus differentiation of embryonic stem cells. Limited knowledge of endogenous mechanisms driving differential -catenin/co-activator interactions and their role in adult somatic stem/progenitor cell maintenance versus differentiation led us to explore this process in defined models of adult progenitor cell differentiation. We focused primarily on alveolar epithelial type II (AT2) cells, progenitors of distal lung epithelium, and identified a novel axis whereby WNT5a/protein kinase C (PKC) signaling regulates specific -catenin/co-activator interactions to promote adult progenitor cell differentiation. p300/-catenin but not CBP/-catenin interaction increases as AT2 cells differentiate to a type I (AT1) cell-like phenotype. Additionally, p300 transcriptionally activates AT1 cell-specific gene Aqp-5. IQ-1, a specific inhibitor of p300/-catenin interaction, prevents differentiation of not only primary AT2 cells, but also tracheal epithelial cells, and C2C12 myoblasts. p300 phosphorylation at Ser-89 enhances p300/-catenin interaction, concurrent with alveolar epithelial cell differentiation. WNT5a, a traditionally non-canonical WNT ligand regulates Ser-89 phosphorylation and p300/-catenin interactions in a PKC-dependent manner, likely involving PKC. These studies identify a novel intersection of canonical and non-canonical Wnt signaling in adult progenitor cell differentiation that has important implications for targeting -catenin to modulate adult progenitor cell behavior in disease.	[Rieger, Megan E.; Zhou, Beiyun; Solomon, Nicola; Sunohara, Mitsuhiro; Liu, Yixin; Crandall, Edward D.; Borok, Zea] Univ So Calif, Pulm Res Ctr, Will Rogers Inst, Div Pulm Crit Care & Sleep Med,Dept Med, Los Angeles, CA 90033 USA; [Li, Changgong; Minoo, Parviz] Univ So Calif, Div Neonatol, Dept Pediat, Los Angeles, CA 90033 USA; [Cu Nguyen; Kahn, Michael; Borok, Zea] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Crandall, Edward D.] Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA; [Kahn, Michael] Univ So Calif, Ctr Mol Pathways & Drug Discovery, Los Angeles, CA 90033 USA; [Zhou, Beiyun; Kahn, Michael; Borok, Zea] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Pan, Jie-hong; Brody, Steven L.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Crandall, Edward D.] Univ So Calif, Dept Chem Engn & Mat Sci, Viterbi Sch Engn, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Washington University (WUSTL); University of Southern California	Borok, Z (corresponding author), Univ So Calif, Will Rogers Inst, Pulm Res Ctr, Div Pulm Critical Care & Sleep Med,Keck Sch Med, IRD 723,M-C 9520, Los Angeles, CA 90089 USA.	zborok@med.usc.edu	CRANDALL, EDWARD/AAD-8382-2020		Hastings Foundation; Whittier Foundation; National Institutes of Health [CA148837, ES017034, HL056244, HL056590, HL062569, HL089445, HL095349, HL108364, HL112638, HL114959, HL122582, NS074392, T32 CA900320]; Children's Discovery Institute; University of Southern California Norris Comprehensive Cancer Center [P30 CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089445, R01HL062569, R29HL056244, R01HL095349, R37HL062569, R01HL056590, R01HL122582, R01HL114959, R01HL112638, R01HL056244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074392] Funding Source: NIH RePORTER	Hastings Foundation; Whittier Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; University of Southern California Norris Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Hastings Foundation, Whittier Foundation, National Institutes of Health Grants CA148837, ES017034, HL056244, HL056590, HL062569, HL089445, HL095349, HL108364, HL112638, HL114959, HL122582, and NS074392, National Institutes of Health postdoctoral fellowship T32 CA900320, Children's Discovery Institute for support of the Pulmonary Epithelial Cell Core at Washington University in St. Louis, and University of Southern California Norris Comprehensive Cancer Center Support Grant P30 CA014089. Content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare that they have no conflicts of interest with the contents of this article.	ADAMSON IYR, 1975, LAB INVEST, V32, P736; ADAMSON IYR, 1974, LAB INVEST, V30, P35; Andersson ER, 2013, P NATL ACAD SCI USA, V110, pE602, DOI 10.1073/pnas.1208524110; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Ballard PL, 2010, AM J PHYSIOL-LUNG C, V299, pL36, DOI 10.1152/ajplung.00427.2009; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Barok Z, 2000, J BIOL CHEM, V275, P26507, DOI 10.1074/jbc.M910007199; BOROK Z, 1994, IN VITRO CELL DEV-AN, V30A, P99; Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Cao YX, 2003, J CELL BIOCHEM, V89, P887, DOI 10.1002/jcb.10555; Chilosi M, 2002, LAB INVEST, V82, P1335, DOI 10.1097/01.LAB.0000032380.82232.67; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; DANTO SI, 1992, AM J RESP CELL MOL, V6, P296, DOI 10.1165/ajrcmb/6.3.296; DeMaio L, 2009, AM J PHYSIOL-LUNG C, V296, pL1051, DOI 10.1152/ajplung.00021.2009; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Endo M, 2012, J CELL SCI, V125, P2017, DOI 10.1242/jcs.097782; Flozak AS, 2010, J BIOL CHEM, V285, P3157, DOI 10.1074/jbc.M109.070326; Gang EJ, 2014, ONCOGENE, V33, P2169, DOI 10.1038/onc.2013.169; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Hasegawa K, 2012, STEM CELL TRANSL MED, V1, P18, DOI 10.5966/sctm.2011-0033; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Horani A, 2013, AM J RESP CELL MOL, V49, P341, DOI 10.1165/rcmb.2013-0046TE; Kahn M, 2011, FUTURE MED CHEM, V3, P1745, DOI [10.4155/FMC.11.126, 10.4155/fmc.11.126]; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Komiya Yuko, 2008, Organogenesis, V4, P68; Kung AL, 2000, GENE DEV, V14, P272; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lomas NJ, 2012, INT J CLIN EXP PATHO, V5, P58; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Mavila N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050401; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morrisey EE, 2003, AM J PATHOL, V162, P1393, DOI 10.1016/S0002-9440(10)64271-X; Nemoto E, 2012, BIOCHEM BIOPH RES CO, V422, P627, DOI 10.1016/j.bbrc.2012.05.039; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Nsair A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045603; Palpant NJ, 2007, J MOL CELL CARDIOL, V43, P362, DOI 10.1016/j.yjmcc.2007.06.012; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sasaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075010; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Tanjore H, 2013, AM J RESP CRIT CARE, V187, P630, DOI 10.1164/rccm.201205-0972OC; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Yang DH, 2009, CIRC RES, V104, P372, DOI 10.1161/CIRCRESAHA.108.185405; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200; Zemans RL, 2011, P NATL ACAD SCI USA, V108, P15990, DOI 10.1073/pnas.1110144108; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zhou B, 2008, AM J PHYSIOL-CELL PH, V295, pC111, DOI 10.1152/ajpcell.90620.2007; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou BY, 2008, AM J PHYSIOL-CELL PH, V295, pC1141, DOI 10.1152/ajpcell.00120.2008	64	52	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6569	6582		10.1074/jbc.M115.706416	http://dx.doi.org/10.1074/jbc.M115.706416			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26833564	Green Published, hybrid			2022-12-28	WOS:000372894200042
J	Tanaka, H; Muto, A; Shima, H; Katoh, Y; Sax, N; Tajima, S; Brydun, A; Ikura, T; Yoshizawa, N; Masai, H; Hoshikawa, Y; Noda, T; Nio, M; Ochiai, K; Igarashi, K				Tanaka, Hiromu; Muto, Akihiko; Shima, Hiroki; Katoh, Yasutake; Sax, Nicolas; Tajima, Shinya; Brydun, Andrey; Ikura, Tsuyoshi; Yoshizawa, Naoko; Masai, Hisao; Hoshikawa, Yutaka; Noda, Tetsuo; Nio, Masaki; Ochiai, Kyoko; Igarashi, Kazuhiko			Epigenetic Regulation of the Blimp-1 Gene (Prdm1) in B Cells Involves Bach2 and Histone Deacetylase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; epigenetics; gene regulation; histone; transcription factor; B cells; methylation; plasma cells	TRANSCRIPTION FACTOR BLIMP-1; SECRETING PLASMA-CELLS; T-CELLS; PROTEIN COMPLEXES; REPRESSOR BACH2; IN-VIVO; NETWORK; DIFFERENTIATION; HOMEOSTASIS; SMRT	B lymphocyte-induced maturation protein 1 (Blimp-1) encoded by Prdm1 is a master regulator of plasma cell differentiation. The transcription factor Bach2 represses Blimp-1 expression in B cells to stall terminal differentiation, by which it supports reactions such as class switch recombination of the antibody genes. We found that histones H3 and H4 around the Prdm1 intron 5 Maf recognition element were acetylated at higher levels in X63/0 plasma cells expressing Blimp-1 than in BAL17 mature B cells lacking its expression. Conversely, methylation of H3-K9 was lower in X63/0 cells than BAL17 cells. Purification of the Bach2 complex in BAL17 cells revealed its interaction with histone deacetylase 3 (HDAC3), nuclear co-repressors NCoR1 and NCoR2, transducin -like 1X-linked (Tbl1x), and RAP1-interacting factor homolog (Rif1). Chromatin immunoprecipitation confirmed the binding of HDAC3 and Rif1 to the Prdm1 locus. Reduction of HDAC3 or NCoR1 expression by RNA interference in B cells resulted in an increased Prdm1 mRNA expression. Bach2 is suggested to cooperate with HDAC3-containing co-repressor complexes in B cells to regulate the stage-specific expression of Prdm1 by writing epigenetic modifications at the Prdm1 locus.	[Tanaka, Hiromu; Muto, Akihiko; Shima, Hiroki; Katoh, Yasutake; Sax, Nicolas; Tajima, Shinya; Brydun, Andrey; Ochiai, Kyoko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Katoh, Yasutake; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Tanaka, Hiromu; Nio, Masaki] Tohoku Univ, Grad Sch Med, Dept Pediat Surg, Seiryo Machi 1-1, Sendai, Miyagi 9800874, Japan; [Muto, Akihiko; Shima, Hiroki; Sax, Nicolas; Ochiai, Kyoko; Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Ikura, Tsuyoshi] Kyoto Univ, Ctr Radiat Biol, Kyoto 6068501, Japan; [Yoshizawa, Naoko; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Kamikitazawa 1-6, Tokyo 1568506, Japan; [Hoshikawa, Yutaka; Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Ariake 3-10-6, Tokyo 1358550, Japan	Tohoku University; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); Kyoto University; Tokyo Metropolitan Institute of Medical Science; Japanese Foundation for Cancer Research	Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan.	igarashi@med.tohoku.ac.jp	Nio, Masaki/AAF-4406-2019	Yoshizawa-Sugata, Naoko/0000-0001-8792-8669; Igarashi, Kazuhiko/0000-0002-2470-2475	Japan Society for the Promotion of Science [15H02506, 24390066, 21249014, 17054028, 25460352, 24790271]; Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science and Technology of Japan; Takeda Foundation and Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [26251004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science and Technology of Japan; Takeda Foundation and Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid 15H02506, 24390066, 21249014, 17054028, 25460352, and 24790271 from Japan Society for the Promotion of Science and the Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science and Technology of Japan and The Takeda Foundation and Astellas Foundation for Research on Metabolic Disorders. Restoration of the laboratory from the damage due to the 2011 Tohoku earthquake was provided in part by the Astellas Foundation for Research on Metabolic Disorders, the Banyu Foundation, the Naito Foundation, A. Miyazaki, and A. Iida. The authors declare that they have no conflicts of interest with the contents of this article.	Calame K, 2008, CURR OPIN IMMUNOL, V20, P259, DOI 10.1016/j.coi.2008.04.010; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Dan JM, 2014, DEV CELL, V29, P7, DOI 10.1016/j.devcel.2014.03.004; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hoshino H, 2007, J BIOCHEM, V141, P719, DOI 10.1093/jb/mvm073; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Igarashi K, 2014, IMMUNOL REV, V261, P116, DOI 10.1111/imr.12201; Igarashi K, 2014, TOHOKU J EXP MED, V232, P229, DOI 10.1620/tjem.232.229; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kim EH, 2014, J IMMUNOL, V192, P985, DOI 10.4049/jimmunol.1302378; Kuwahara M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4555; Law IKM, 2009, PROTEOMICS, V9, P2444, DOI 10.1002/pmic.200800738; Lawrence Ann-Marie, 2009, J Vis Exp, DOI 10.3791/1350; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Minami J, 2014, LEUKEMIA, V28, P680, DOI 10.1038/leu.2013.231; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Ochiai K, 2008, INT IMMUNOL, V20, P453, DOI 10.1093/intimm/dxn005; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; Osakabe A, 2010, J BIOL CHEM, V285, P11913, DOI 10.1074/jbc.M109.083238; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sawado T, 2001, P NATL ACAD SCI USA, V98, P10226, DOI 10.1073/pnas.181344198; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Sciammas R, 2004, J IMMUNOL, V172, P5427, DOI 10.4049/jimmunol.172.9.5427; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Smith AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016206; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Tsukumo S, 2013, P NATL ACAD SCI USA, V110, P10735, DOI 10.1073/pnas.1306691110; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Yamasaki C, 2005, J BIOCHEM, V137, P287, DOI 10.1093/jb/mvi031; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	51	42	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6316	6330		10.1074/jbc.M116.713842	http://dx.doi.org/10.1074/jbc.M116.713842			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26786103	Green Published, hybrid			2022-12-28	WOS:000372894200022
J	Wang, Y; Zhou, XL; Ruan, ZR; Liu, RJ; Eriani, G; Wang, ED				Wang, Yong; Zhou, Xiao-Long; Ruan, Zhi-Rong; Liu, Ru-Juan; Eriani, Gilbert; Wang, En-Duo			A Human Disease-causing Point Mutation in Mitochondrial Threonyl-tRNA Synthetase Induces Both Structural and Functional Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; aminoacyl-tRNA synthetase; enzyme kinetics; mitochondria; mitochondrial disease; threonyl-tRNA synthetase	EDITING ACTIVITY; QUALITY-CONTROL; PROTEIN; DOMAIN; CODON; MISTRANSLATION; TRANSLATION; MECHANISM; ERRORS	Mitochondria require all translational components, including aminoacyl-tRNA synthetases (aaRSs), to complete organelle protein synthesis. Some aaRS mutations cause mitochondrial disorders, including human mitochondrial threonyl-tRNA synthetase (hmtThrRS) (encoded by TARS2), the P282L mutation of which causes mitochondrial encephalomyopathies. However, its catalytic and structural consequences remain unclear. Herein, we cloned TARS2 and purified the wild-type and P282L mutant hmtThrRS. hmtThrRS misactivates non-cognate Ser and uses post-transfer editing to clear erroneously synthesized products. In vitro and in vivo analyses revealed that the mutation induces a decrease in Thr activation, aminoacylation, and proofreading activities and a change in the protein structure and/or stability, which might cause reduced catalytic efficiency. We also identified a splicing variant of TARS2 mRNA lacking exons 8 and 9, the protein product of which is targeted into mitochondria. In HEK293T cells, the variant does not dimerize and cannot complement the ThrRS knock-out strain in yeast, suggesting that the truncated protein is inactive and might have a non-canonical function, as observed for other aaRS fragments. The present study describes the aminoacylation and editing properties of hmtThrRS, clarifies the molecular consequences of the P282L mutation, and shows that the yeast ThrRS-deletion model is suitable to test pathology-associated point mutations or alternative splicing variants of mammalian aaRS mRNAs.	[Wang, Yong; Zhou, Xiao-Long; Ruan, Zhi-Rong; Liu, Ru-Juan; Wang, En-Duo] Univ Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Chinese Acad Sci,Ctr Excellence Mol Cell Sci, Shanghai 200031, Peoples R China; [Wang, Yong; Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, 319 Yue Yang Rd, Shanghai 200031, Peoples R China; [Eriani, Gilbert] Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, Architecture & React ARN,UPR9002, 15 Rue Rene Descartes, F-67084 Strasbourg, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Zhou, XL; Wang, ED (corresponding author), Univ Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Chinese Acad Sci,Ctr Excellence Mol Cell Sci, Shanghai 200031, Peoples R China.; Wang, ED (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 319 Yue Yang Rd, Shanghai 200031, Peoples R China.	xlzhou@sibcb.ac.cn; edwang@sibcb.ac.cn	Ruan, Zhi-Rong/GYI-8935-2022	Eriani, Gilbert/0000-0002-8518-4675; , Yong/0000-0002-3698-123X; Ruan, Zhi-Rong/0000-0002-1806-2942; Liu, Ru-Juan/0000-0001-7459-3126	National Key Basic Research Foundation of China [2012CB911000]; Natural Science Foundation of China [31130064, 91440204]; Committee of Science and Technology in Shanghai [12JC1409700, 15ZR1446500]; Youth Innovation Promotion Association (Chinese Academy of Sciences)	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai(Shanghai Science & Technology Committee); Youth Innovation Promotion Association (Chinese Academy of Sciences)	This work was supported by Grant 2012CB911000 from the National Key Basic Research Foundation of China, Grants 31130064 and 91440204 from the Natural Science Foundation of China, and Grants 12JC1409700 and 15ZR1446500 from the Committee of Science and Technology in Shanghai. This work was also supported by the Youth Innovation Promotion Association (Chinese Academy of Sciences) (to X. L. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen JF, 1996, J MOL EVOL, V42, P482, DOI 10.1007/BF02352278; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; EDELMANN P, 1977, CELL, V10, P131, DOI 10.1016/0092-8674(77)90147-7; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Guitart T, 2010, J BIOL CHEM, V285, P38157, DOI 10.1074/jbc.M110.167486; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; HOLZWARTH G, 1965, J AM CHEM SOC, V87, P218, DOI 10.1021/ja01080a015; Hussain T, 2006, EMBO J, V25, P4152, DOI 10.1038/sj.emboj.7601278; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Ling JQ, 2012, P NATL ACAD SCI USA, V109, P3281, DOI 10.1073/pnas.1200109109; Liu Y, 2014, P NATL ACAD SCI USA, V111, P17570, DOI 10.1073/pnas.1420196111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Michel SLJ, 2003, BIOCHEMISTRY-US, V42, P4626, DOI 10.1021/bi034073h; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; NAMEKI N, 1995, NUCLEIC ACIDS RES, V23, P2831, DOI 10.1093/nar/23.15.2831; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Ross-Inta C, 2008, BIOSCIENCE REP, V28, P239, DOI 10.1042/BSR20080090; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Ruan ZR, 2015, J BIOL CHEM, V290, P1664, DOI 10.1074/jbc.M114.599886; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; YARUS M, 1970, ANAL BIOCHEM, V35, P450, DOI 10.1016/0003-2697(70)90207-1; Zhou XL, 2014, NUCLEIC ACIDS RES, V42, P13873, DOI 10.1093/nar/gku1218; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P302, DOI 10.1093/nar/gks982; Zhou XL, 2011, NUCLEIC ACIDS RES, V39, P8857, DOI 10.1093/nar/gkr595; Zhou XL, 2008, J BIOL CHEM, V283, P36608, DOI 10.1074/jbc.M806745200; Zhou XL, 2013, SCI CHINA LIFE SCI, V56, P921, DOI 10.1007/s11427-013-4542-9	47	29	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6507	6520		10.1074/jbc.M115.700849	http://dx.doi.org/10.1074/jbc.M115.700849			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26811336	Green Published, hybrid			2022-12-28	WOS:000372894200037
J	Roderer, D; Benke, S; Schuler, B; Glockshuber, R				Roderer, Daniel; Benke, Stephan; Schuler, Benjamin; Glockshuber, Rudi			Soluble Oligomers of the Pore-forming Toxin Cytolysin A from Escherichia coli Are Off-pathway Products of Pore Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial toxin; disulfide; protein assembly; protein conformation; redox regulation; cytolysin A; hemolysis	ENTERICA SEROVARS TYPHI; SALMONELLA-ENTERICA; CRYSTAL-STRUCTURE; PROTECTIVE ANTIGEN; ANTHRAX TOXIN; PARATYPHI-A; HEMOLYSIN-E; CLYA; CYTOTOXIN; PROTEIN	The -pore-forming toxin Cytolysin A (ClyA) is responsible for the hemolytic activity of various Escherichia coli and Salmonella enterica strains. Soluble ClyA monomers spontaneously assemble into annular dodecameric pore complexes upon contact with membranes or detergent. At ClyA monomer concentrations above approximate to 100 nm, the rate-limiting step in detergent- or membrane- induced pore assembly is the unimolecular reaction from the monomer to the assembly-competent protomer, which then oligomerizes rapidly to active pore complexes. In the absence of detergent, ClyA slowly forms soluble oligomers. Here we show that soluble ClyA oligomers cannot form dodecameric pore complexes after the addition of detergent and are hemolytically inactive. In addition, we demonstrate that the natural cysteine pair Cys-87/Cys-285 of ClyA forms a disulfide bond under oxidizing conditions and that both the oxidized and reduced ClyA monomers assemble to active pores via the same pathway in the presence of detergent, in which an unstructured, monomeric intermediate is transiently populated. The results show that the oxidized ClyA monomer assembles to pore complexes about one order of magnitude faster than the reduced monomer because the unstructured intermediate of oxidized ClyA is less stable and dissolves more rapidly than the reduced intermediate. Moreover, we show that oxidized ClyA forms soluble, inactive oligomers in the absence of detergent much faster than the reduced monomer, providing an explanation for several contradictory reports in which oxidized ClyA had been described as inactive.	[Roderer, Daniel; Glockshuber, Rudi] ETH, Inst Mol Biol & Biophys, Otto Stern Weg 5, CH-8093 Zurich, Switzerland; [Benke, Stephan; Schuler, Benjamin] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Roderer, D (corresponding author), Max Planck Inst Mol Physiol, Dept Struct Biochem, Otto Hahn Str 11, D-44227 Dortmund, Germany.	daniel.roderer@mpi-dortmund.mpg.de	Roderer, Daniel/AAI-9535-2021; Schuler, Benjamin/E-7342-2011	Roderer, Daniel/0000-0002-7276-3467; Schuler, Benjamin/0000-0002-5970-4251	Swiss National Science Foundation; National Center of Competence in Structural Biology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Structural Biology	This work was supported by grants from the Swiss National Science Foundation ( to R. G. and B. S.) and the National Center of Competence in Structural Biology ( to R. G. and B. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Atkins A, 2000, J BIOL CHEM, V275, P41150, DOI 10.1074/jbc.M005420200; Benke S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7198; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Crespo MD, 2012, NAT CHEM BIOL, V8, P707, DOI [10.1038/NCHEMBIO.1019, 10.1038/nchembio.1019]; Degiacomi MT, 2013, NAT CHEM BIOL, V9, P623, DOI [10.1038/NCHEMBIO.1312, 10.1038/nchembio.1312]; del Castillo FJ, 2001, FEMS MICROBIOL LETT, V204, P281, DOI 10.1016/S0378-1097(01)00413-X; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; delCastillo FJ, 1997, MOL MICROBIOL, V25, P107, DOI 10.1046/j.1365-2958.1997.4391813.x; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Fahie M, 2013, J BIOL CHEM, V288, P31042, DOI 10.1074/jbc.M113.475350; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Huang LJ, 2010, J MICROBIOL, V48, P663, DOI 10.1007/s12275-010-9268-9; Kim JY, 2008, J MOL BIOL, V380, P51, DOI 10.1016/j.jmb.2008.03.076; Ludwig A, 1999, MOL MICROBIOL, V31, P557, DOI 10.1046/j.1365-2958.1999.01196.x; Ludwig A, 2004, J BACTERIOL, V186, P5311, DOI 10.1128/JB.186.16.5311-5320.2004; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Oscarsson J, 2002, INFECT IMMUN, V70, P5759, DOI 10.1128/IAI.70.10.5759-5769.2002; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; RENNIE RP, 1974, J MED MICROBIOL, V7, P189, DOI 10.1099/00222615-7-2-189; Roderer D, 2014, BIOCHEMISTRY-US, V53, P6357, DOI 10.1021/bi5007578; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; von Rhein C, 2006, INFECT IMMUN, V74, P6505, DOI 10.1128/IAI.00779-06; von Rhein C, 2009, INT J MED MICROBIOL, V299, P21, DOI 10.1016/j.ijmm.2008.06.004; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Wunderlich B, 2013, NAT PROTOC, V8, P1459, DOI 10.1038/nprot.2013.082	32	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5652	5663		10.1074/jbc.M115.700757	http://dx.doi.org/10.1074/jbc.M115.700757			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26757820	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000372551800017
J	Dong, MQ; Lam, PCH; Orry, A; Sexton, PM; Christopoulos, A; Abagyan, R; Miller, LJ				Dong, Maoqing; Lam, Polo C. -H.; Orry, Andrew; Sexton, Patrick M.; Christopoulos, Arthur; Abagyan, Ruben; Miller, Laurence J.			Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface receptor; cyclic AMP (cAMP); G protein-coupled receptor (GPCR); gel electrophoresis; ligand-binding protein; membrane protein; molecular modeling; mutagenesis; peptides	PROTEIN-COUPLED RECEPTORS; 2ND TRANSMEMBRANE HELIX; GLUCAGON RECEPTOR; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; LIGAND-BINDING; AMINO-TERMINUS; MUTATIONAL ANALYSIS; AGONIST-BINDING; BASIC RESIDUES	Amino-terminal regions of secretin-family peptides contain key determinants for biological activity and binding specificity, although the nature of interactions with receptors is unclear. A helix N-capping motif within this region has been postulated to directly contribute to agonist activity while also stabilizing formation of a helix extending toward the peptide carboxyl terminus and docking within the receptor amino terminus. We used cysteine trapping to systematically explore spatial approximations between cysteines replacing each residue in this motif of secretin (sec), Phe(6), Thr(7), and Leu(10), and cysteines incorporated into the extracellular face of the receptor. Each peptide was a full agonist for cAMP, but had a lower binding affinity than natural hormone. These bound to COS cells expressing 61 receptor constructs incorporating cysteines in every position along each extracellular loop (ECL) and adjacent parts of transmembrane (TM) segments. Patterns of covalent labeling were distinct for each probe, with Cys(6)-sec labeling multiple residues in the carboxyl-terminal half of ECL2 and throughout ECL3, Cys(7)-sec predominantly labeling only single residues in the carboxyl-terminal end of ECL2 and the amino-terminal end of ECL3, and Cys(10)-sec not efficiently labeling any of these residues. These spatial constraints were used to refine our model of secretin bound to its receptor, now bringing ECL3 above the amino terminus of the ligand and revealing possible charge-charge interactions between this part of secretin and receptor residues in TM5, TM6, ECL2, and ECL3, which can orient and stabilize the peptide-receptor complex. This was validated by testing predicted approximations by mutagenesis and residue-residue complementation studies.	[Dong, Maoqing; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Lam, Polo C. -H.; Orry, Andrew; Abagyan, Ruben] Molsoft LLC, La Jolla, CA 92037 USA; [Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92037 USA; [Sexton, Patrick M.; Christopoulos, Arthur] Natl Hlth & Med Res Council Australia, Canberra, ACT, Australia	Mayo Clinic; Mayo Clinic Phoenix; Monash University; Monash University; University of California System; University of California San Diego	Miller, LJ (corresponding author), Mayo Clin, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu	Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473	NIDDK of the National Institutes of Health [DK046577]; National Health and Medical Research Council of Australia [1055134, 1061044]; Mayo Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046577, R56DK046577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071872] Funding Source: NIH RePORTER	NIDDK of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Mayo Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIDDK of the National Institutes of Health (Grant DK046577). This work was also supported by the National Health and Medical Research Council of Australia Program Grant 1055134 and Project Grant 1061044, and by the Mayo Clinic.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Behar V, 2000, J BIOL CHEM, V275, P9, DOI 10.1074/jbc.275.1.9; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Di Paolo E, 1999, RECEPTOR CHANNEL, V6, P309; Di Paolo E, 1998, FEBS LETT, V424, P207, DOI 10.1016/S0014-5793(98)00175-6; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong MQ, 2013, REGUL PEPTIDES, V180, P5, DOI 10.1016/j.regpep.2012.10.001; Dong MQ, 2012, FASEB J, V26, P5092, DOI 10.1096/fj.12-212399; Dong M, 2011, J BIOL CHEM, V286, P23888, DOI 10.1074/jbc.M111.245969; Dong MQ, 2011, BIOCHEMISTRY-US, V50, P2983, DOI 10.1021/bi200133u; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 1999, J BIOL CHEM, V274, P19161, DOI 10.1074/jbc.274.27.19161; Donnelly D, 1997, FEBS LETT, V409, P431, DOI 10.1016/S0014-5793(97)00546-2; Garcia GL, 2012, AM J PHYSIOL-CELL PH, V302, pC1202, DOI 10.1152/ajpcell.00273.2011; GARDNER JD, 1977, GASTROENTEROLOGY, V73, P52; Harikumar KG, 2007, J BIOL CHEM, V282, P32834, DOI 10.1074/jbc.M704563200; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; HEFFORD MA, 1989, BIOCHIM BIOPHYS ACTA, V998, P267, DOI 10.1016/0167-4838(89)90283-5; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Miller LJ, 2007, BIOCHEM SOC T, V35, P709, DOI 10.1042/BST0350709; Miller LJ, 2013, BIOCHEM SOC T, V41, P154, DOI 10.1042/BST20120204; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Neumann JM, 2008, TRENDS BIOCHEM SCI, V33, P314, DOI 10.1016/j.tibs.2008.05.001; Nolte WM, 2014, NAT CHEM BIOL, V10, P629, DOI 10.1038/nchembio.1581; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Perret J, 2002, BIOCHEM J, V362, P389, DOI 10.1042/0264-6021:3620389; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Solano RM, 2001, J BIOL CHEM, V276, P1084, DOI 10.1074/jbc.M007686200; Ulrich CD, 1998, GASTROENTEROLOGY, V114, P382, DOI 10.1016/S0016-5085(98)70491-3; Vertongen P, 2001, BRIT J PHARMACOL, V133, P1249, DOI 10.1038/sj.bjp.0704195; Vilardaga JP, 1996, BIOCHEM BIOPH RES CO, V218, P842, DOI 10.1006/bbrc.1996.0150; Watkins HA, 2012, DRUG DISCOV TODAY, V17, P1006, DOI 10.1016/j.drudis.2012.05.005; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Willard FS, 2012, EXP DIABETES RES, DOI 10.1155/2012/709893; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859	49	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5172	5184		10.1074/jbc.M115.706010	http://dx.doi.org/10.1074/jbc.M115.706010			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26740626	Green Published, hybrid			2022-12-28	WOS:000371640600029
J	Rahman, K; Zhao, P; Mandalasi, M; van der Wel, H; Wells, L; Blader, IJ; West, CM				Rahman, Kazi; Zhao, Peng; Mandalasi, Msano; van der Wel, Hanke; Wells, Lance; Blader, Ira J.; West, Christopher M.			The E3 Ubiquitin Ligase Adaptor Protein Skp1 Is Glycosylated by an Evolutionarily Conserved Pathway That Regulates Protist Growth and Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; PROLYL 4-HYDROXYLASE; GLCNAC-TRANSFERASE; CYTOPLASM; EXPRESSION; CLONING	Toxoplasma gondii is a protist parasite of warm-blooded animals that causes disease by proliferating intracellularly in muscle and the central nervous system. Previous studies showed that a prolyl 4-hydroxylase related to animal HIF alpha prolyl hydroxylases is required for optimal parasite proliferation, especially at low O-2. We also observed that Pro-154 of Skp1, a subunit of the Skp1/Cullin-1/F-box protein (SCF)-class of E3-ubiquitin ligases, is a natural substrate of this enzyme. In an unrelated protist, Dictyostelium discoideum, Skp1 hydroxyproline is modified by five sugars via the action of three glycosyltransferases, Gnt1, PgtA, and AgtA, which are required for optimal O-2-dependent development. We show here that TgSkp1 hydroxyproline is modified by a similar pentasaccharide, based on mass spectrometry, and that assembly of the first three sugars is dependent on Toxoplasma homologs of Gnt1 and PgtA. Reconstitution of the glycosyltransferase reactions in extracts with radioactive sugar nucleotide substrates and appropriate Skp1 glycoforms, followed by chromatographic analysis of acid hydrolysates of the reaction products, confirmed the predicted sugar identities as GlcNAc, Gal, and Fuc. Disruptions of gnt1 or pgtA resulted in decreased parasite growth. Off target effects were excluded based on restoration of the normal glycan chain and growth upon genetic complementation. By analogy to Dictyostelium Skp1, the mechanism may involve regulation of assembly of the SCF complex. Understanding the mechanism of Toxoplasma Skp1 glycosylation is expected to help develop it as a drug target for control of the pathogen, as the glycosyltransferases are absent from mammalian hosts.	[Rahman, Kazi; Mandalasi, Msano; van der Wel, Hanke; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem, Oklahoma City, OK 73104 USA; [Rahman, Kazi; Mandalasi, Msano; van der Wel, Hanke; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Mol Biol, Oklahoma City, OK 73104 USA; [Rahman, Kazi; Zhao, Peng; Mandalasi, Msano; van der Wel, Hanke; Wells, Lance; West, Christopher M.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Rahman, Kazi; Blader, Ira J.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Zhao, Peng; Wells, Lance] Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Blader, Ira J.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14214 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University System of Georgia; University of Georgia; University of Oklahoma System; University of Oklahoma Health Sciences Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	West, CM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem, Oklahoma City, OK 73104 USA.; West, CM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Mol Biol, Oklahoma City, OK 73104 USA.; West, CM (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	westcm@uga.edu		Zhao, Peng/0000-0002-9296-5293; Wells, Lance/0000-0003-4956-5363; Rahman, Kazi/0000-0003-2986-0007; Mandalasi, Msano/0000-0002-5906-7387	Mizutani Foundation for Glycoscience [14-140]; Oklahoma Center for the Advancement of Science and Technology Grant [HR10-0181]; National Institutes of Health [R01-GM084383, R01-AI069986]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084383] Funding Source: NIH RePORTER	Mizutani Foundation for Glycoscience; Oklahoma Center for the Advancement of Science and Technology Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant 14-140 from the Mizutani Foundation for Glycoscience (to C.M.W. and I.J.B.), Oklahoma Center for the Advancement of Science and Technology Grant HR10-0181 (to C.M.W.), and National Institutes of Health Grants R01-GM084383 (to C.M.W. and I.J.B.) and R01-AI069986 (to I.J.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Basu S, 2015, GENESIS, V53, P523, DOI 10.1002/dvg.22867; Figueras MJ, 2012, INT J BIOL MACROMOL, V50, P725, DOI 10.1016/j.ijbiomac.2011.12.012; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kimmel J, 2006, EUKARYOT CELL, V5, P1420, DOI 10.1128/EC.00078-06; Lambert H, 2010, CELL MICROBIOL, V12, P292, DOI 10.1111/j.1462-5822.2009.01417.x; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Pereira-Chioccola VL, 2009, FUTURE MICROBIOL, V4, P1363, DOI [10.2217/fmb.09.89, 10.2217/FMB.09.89]; Schafer CM, 2014, J BIOL CHEM, V289, P9076, DOI 10.1074/jbc.M113.528679; Sheikh MO, 2015, MOL CELL PROTEOMICS, V14, P66, DOI 10.1074/mcp.M114.044560; Sheikh MO, 2014, BIOCHEMISTRY-US, V53, P1657, DOI 10.1021/bi401707y; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Teng-umnuay P, 1999, J BIOL CHEM, V274, P36392, DOI 10.1074/jbc.274.51.36392; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; van der Wel H, 2002, J BIOL CHEM, V277, P46328, DOI 10.1074/jbc.M208024200; Vinayak S, 2014, MBIO, V5, DOI 10.1128/mBio.02021-14; Wang ZA, 2011, DEV BIOL, V349, P283, DOI 10.1016/j.ydbio.2010.10.013; West CM, 2006, METHOD ENZYMOL, V417, P389, DOI 10.1016/S0076-6879(06)17023-8; West CM, 2015, CURR OPIN MICROBIOL, V26, P41, DOI 10.1016/j.mib.2015.04.006; West CM, 2010, BBA-GEN SUBJECTS, V1800, P160, DOI 10.1016/j.bbagen.2009.11.006; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wojczyk BS, 2003, MOL BIOCHEM PARASIT, V131, P93, DOI 10.1016/S0166-6851(03)00196-8; Xu YC, 2012, J BIOL CHEM, V287, P25098, DOI 10.1074/jbc.M112.355446; Zhang DM, 2012, J BIOL CHEM, V287, P2006, DOI 10.1074/jbc.M111.314021	28	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4268	4280		10.1074/jbc.M115.703751	http://dx.doi.org/10.1074/jbc.M115.703751			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26719340	hybrid, Green Published			2022-12-28	WOS:000371604600001
J	Wang, X; Du, XY; Li, HY; Zhang, SC				Wang, Xia; Du, Xiaoyuan; Li, Hongyan; Zhang, Shicui			Identification of the Zinc Finger Protein ZRANB2 as a Novel Maternal Lipopolysaccharide-binding Protein That Protects Embryos of Zebrafish against Gram-negative Bacterial Infections	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; embryo; innate immunity; zebrafish; zinc; LPS-binding protein; ZRANB2	PATTERN-RECOGNITION RECEPTOR; IGM-BEARING CELLS; IMMUNOGLOBULIN PROTEIN; GENE TRANSCRIPTS; DANIO-RERIO; COMPLEMENT; IMMUNITY; EGG; EXPRESSION; LYSOZYME	Zinc finger ZRANB2 proteins are widespread in animals, but their functions and mechanisms remain poorly defined. Here we clearly demonstrate that ZRANB2 is a newly identified LPS-binding protein present abundantly in the eggs/embryos of zebrafish. We also show that recombinant ZRANB2 (rZRANB2) acts as a pattern recognition receptor capable of identifying the bacterial signature molecule LPS as well as binding the Gram-negative bacteria Escherichia coli, Vibrio anguilarum, and Aeromonas hydrophila and functions as an antibacterial effector molecule capable of directly killing the bacteria. Furthermore, we reveal that N-terminal residues 11-37 consisting of the first ZnF_RBZ domain are indispensable for ZRANB2 antimicrobial activity. Importantly, microinjection of rZRANB2 into early embryos significantly enhanced the resistance of the embryos against pathogenic A. hydrophila challenge, and this enhanced bacterial resistance was markedly reduced by co-injection of anti-ZRANB2 antibody. Moreover, precipitation of ZRANB2 in the embryo extracts by preincubation with anti-ZRANB2 antibody caused a marked decrease in the antibacterial activity of the extracts against the bacteria tested. In addition, the N-terminal peptide Z(1/37) or Z(11/37) with in vitro antibacterial activity also promoted the resistance of embryos against A. hydrophila, but the peptide Z(38/198) without in vitro antibacterial activity did not. Collectively, these results indicate that ZRANB2 is a maternal LPS-binding protein that can protect the early embryos of zebrafish against pathogenic attacks, a novel role ever assigned to ZRANB2 proteins. This work also provides new insights into the immunological function of the zinc finger proteins that are widely distributed in various animals.	[Wang, Xia; Du, Xiaoyuan; Li, Hongyan; Zhang, Shicui] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao 266003, Peoples R China; [Wang, Xia; Du, Xiaoyuan; Li, Hongyan; Zhang, Shicui] Ocean Univ China, Dept Marine Biol, Qingdao 266003, Peoples R China; [Zhang, Shicui] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266003, Peoples R China	Ocean University of China; Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Li, HY; Zhang, SC (corresponding author), Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao 266003, Peoples R China.; Li, HY; Zhang, SC (corresponding author), Ocean Univ China, Dept Marine Biol, Qingdao 266003, Peoples R China.	hongyanli@ouc.edu.cn; sczhang@ouc.edu.cn			National Natural Science Foundation of China [31372505, U1401211]; Fundamental Research Funds for Central Universities [201562029]; Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, China	This work was supported by Grants 31372505 and U1401211 from the National Natural Science Foundation of China, by Grant 201562029 from the Fundamental Research Funds for Central Universities, and by the Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, China. All experimental animals were treated in accordance with the guidelines of the Laboratory Animal Administration Law of China (permit number SD2007695) as approved by the Ethics Committee of the Laboratory Animal Administration of Shandong province. The authors declare that they have no conflicts of interest with the contents of this article.	Adams DJ, 2001, J CELL BIOL, V154, P25, DOI 10.1083/jcb.200010059; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; BILDFELL R J, 1992, Journal of Aquatic Animal Health, V4, P97, DOI 10.1577/1548-8667(1992)004&lt;0097:PAPCOA&gt;2.3.CO;2; BLY JE, 1986, COMP BIOCHEM PHYS A, V84, P309, DOI 10.1016/0300-9629(86)90620-1; Breuil G, 1997, FISH SHELLFISH IMMUN, V7, P29, DOI 10.1006/fsim.1996.0061; BROCK FV, 1995, J ATMOS OCEAN TECH, V12, P5, DOI 10.1175/1520-0426(1995)012<0005:TOMATO>2.0.CO;2; CASTILLO A, 1993, DEV COMP IMMUNOL, V17, P419, DOI 10.1016/0145-305X(93)90033-M; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chiou ST, 2000, J BIOL CHEM, V275, P1630, DOI 10.1074/jbc.275.3.1630; Choi S, 2011, MOL IMMUNOL, V48, P2207, DOI 10.1016/j.molimm.2011.06.434; Dong CH, 2004, DEV BIOL, V265, P341, DOI 10.1016/j.ydbio.2003.08.028; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; ELLIS AE, 1988, VET IMMUNOL IMMUNOP, V19, P153, DOI 10.1016/0165-2427(88)90006-2; FUDA H, 1992, DEV COMP IMMUNOL, V16, P415, DOI 10.1016/0145-305X(92)90043-C; Gao Z, 2014, EUR J IMMUNOL, V44, P3680, DOI 10.1002/eji.201444734; Haig SJ, 2011, VET MICROBIOL, V147, P155, DOI 10.1016/j.vetmic.2010.06.022; Hanif A, 2004, BIORESOURCE TECHNOL, V94, P311, DOI 10.1016/j.biortech.2003.12.013; Hasan Imtiaj, 2009, Journal of Bio-Science, V17, P35; Huttenhuis HBT, 2006, FISH SHELLFISH IMMUN, V21, P261, DOI 10.1016/j.fsi.2005.12.002; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Karginova EA, 1997, AM J PHYSIOL-RENAL, V273, pF731, DOI 10.1152/ajprenal.1997.273.5.F731; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Liang YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004234; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnadottir B, 2004, COMP BIOCHEM PHYS B, V139, P217, DOI 10.1016/j.cbpc.2004.07.009; Mangs AH, 2007, CURR GENOMICS, V8, P129, DOI 10.2174/138920207780368141; Minoda Y, 2006, BIOCHEM BIOPH RES CO, V344, P1023, DOI 10.1016/j.bbrc.2006.04.006; MOR A, 1990, J FISH BIOL, V37, P249, DOI 10.1111/j.1095-8649.1990.tb05856.x; Ohte S, 2012, J CELL BIOCHEM, V113, P808, DOI 10.1002/jcb.23408; Olsen YA, 1997, FISH SHELLFISH IMMUN, V7, P81, DOI 10.1006/fsim.1996.0064; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Picchietti S, 2006, FISH SHELLFISH IMMUN, V20, P398, DOI 10.1016/j.fsi.2005.06.001; Picchietti S, 2004, CELL TISSUE RES, V315, P259, DOI 10.1007/s00441-003-0819-9; Plumb J. A., 1994, HLTH MAINTENANCE CUL; PLUMB JA, 1978, US NMFS MAR FISH REV, V40, P26; Sun C, 2013, DEV COMP IMMUNOL, V40, P28, DOI 10.1016/j.dci.2012.12.009; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Tateno H, 2002, DEV COMP IMMUNOL, V26, P543, DOI 10.1016/S0145-305X(02)00007-1; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; VANLOON AM, 1981, J CLIN MICROBIOL, V13, P416, DOI 10.1128/JCM.13.3.416-422.1981; Wang FY, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/27; Wang SH, 2011, J BIOL CHEM, V286, P22653, DOI 10.1074/jbc.M111.247635; Wang ZP, 2008, FISH SHELLFISH IMMUN, V25, P264, DOI 10.1016/j.fsi.2008.05.010; Wang ZP, 2010, FISH SHELLFISH IMMUN, V29, P773, DOI 10.1016/j.fsi.2010.07.002; Wang ZP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004498; Yang YHJ, 2013, MOL BIOL REP, V40, P5381, DOI 10.1007/s11033-013-2637-9; Yao F, 2012, DEV COMP IMMUNOL, V38, P332, DOI 10.1016/j.dci.2012.07.009; YOUSIF AN, 1994, DIS AQUAT ORGAN, V19, P15, DOI 10.3354/dao019015; YOUSIF AN, 1991, DIS AQUAT ORGAN, V10, P45, DOI 10.3354/dao010045; Zhang J, 2011, MAR BIOTECHNOL, V13, P441, DOI 10.1007/s10126-010-9315-x; Zhang P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007844; Zhang SC, 2013, DEV COMP IMMUNOL, V39, P72, DOI 10.1016/j.dci.2012.02.009; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]	55	19	19	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4019	4034		10.1074/jbc.M115.679167	http://dx.doi.org/10.1074/jbc.M115.679167			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26740623	Green Published, hybrid			2022-12-28	WOS:000371338400028
J	Wietek, J; Broser, M; Krause, BS; Hegemann, P				Wietek, Jonas; Broser, Matthias; Krause, Benjamin S.; Hegemann, Peter			Identification of a Natural Green Light Absorbing Chloride Conducting Channelrhodopsin from Proteomonas sulcata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; biophysics; chloride channel; electrophysiology; optogenetics; patch clamp; photobiology; ultraviolet-visible spectroscopy (UV-Vis spectroscopy); channelrhodopsin	PLATYMONAS-SUBCORDIFORMIS; CHANNEL; OPTOGENETICS; PHOTOCYCLES; RHODOPSINS; PACKAGE	Chloride conducting channelrhodopsins (ChloCs) are new members of the optogenetic toolbox that enable neuronal inhibition in target cells. Originally, ChloCs have been engineered from cation conducting channelrhodopsins (ChRs), and later identified in a cryptophyte alga genome. We noticed that the sequence of a previously described Proteomonas sulcata ChR (PsChR1) was highly homologous to the naturally occurring and previously reported ChloCs GtACR1/2, but was not recognized as an anion conducting channel. Based on electrophysiological measurements obtained under various ionic conditions, we concluded that the PsChR1 photocurrent at physiological conditions is strongly inward rectifying and predominantly carried by chloride. The maximum activation was noted at excitation with light of 540 nm. An initial spectroscopic characterization of purified protein revealed that the photocycle and the transport mechanism of PsChR1 differ significantly from cation conducting ChRs. Hence, we concluded that PsChR1 is an anion conducting ChR, now renamed PsACR1, with a red-shifted absorption suited for multicolor optogenetic experiments in combination with blue light absorbing cation conducting ChRs.	[Wietek, Jonas; Broser, Matthias; Krause, Benjamin S.; Hegemann, Peter] Humboldt Univ, Inst Biol, Expt Biophys, Invalidenstr 42, D-10115 Berlin, Germany	Humboldt University of Berlin	Wietek, J (corresponding author), Humboldt Univ, Inst Biol, Expt Biophys, Invalidenstr 42, D-10115 Berlin, Germany.	jonas.wietek@gmail.com	Wietek, Jonas/AFQ-6404-2022	Wietek, Jonas/0000-0002-8079-7042	German Research Foundation (DFG) [SFB1078 B2, FOR1279 SPP1665]; Cluster of Excellence Unifying Concepts in Catalysis, UniCat, Project [E4/D4]	German Research Foundation (DFG)(German Research Foundation (DFG)); Cluster of Excellence Unifying Concepts in Catalysis, UniCat, Project	This work was supported by the German Research Foundation (DFG) (SFB1078 B2, FOR1279 SPP1665 and the Cluster of Excellence Unifying Concepts in Catalysis, UniCat, Project E4/D4 (to P. H.). The authors declare that they have no conflicts of interest with the contents of this article.	BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Clay BL, 1999, BOT J LINN SOC, V131, P131, DOI 10.1006/bojl.1999.0259; Dawydow A, 2014, P NATL ACAD SCI USA, V111, P13972, DOI 10.1073/pnas.1408269111; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; Govorunova EG, 2013, J BIOL CHEM, V288, P29911, DOI 10.1074/jbc.M113.505495; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Kianianmomeni A, 2009, PLANT PHYSIOL, V151, P347, DOI 10.1104/pp.109.143297; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Lorenz-Fonfria VA, 2014, BBA-BIOENERGETICS, V1837, P626, DOI 10.1016/j.bbabio.2013.10.014; Luck M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.401604; Mullen K.M., 2007, J STAT SOFTW, V18, P1, DOI DOI 10.18637/JSS.V018.I03; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Schneider F, 2015, ANNU REV BIOPHYS, V44, P167, DOI 10.1146/annurev-biophys-060414-034014; Schneider F, 2013, BIOPHYS J, V105, P91, DOI 10.1016/j.bpj.2013.05.042; Sineshchekov OA, 2013, BIOPHYS J, V104, P807, DOI 10.1016/j.bpj.2013.01.002; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Szundi I, 2015, J BIOL CHEM, V290, P16573, DOI 10.1074/jbc.M114.631614; Wietek J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14807; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	28	43	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4121	4127		10.1074/jbc.M115.699637	http://dx.doi.org/10.1074/jbc.M115.699637			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26740624	Green Published, hybrid			2022-12-28	WOS:000371338400036
J	Sidik, SM; Triana, MAH; Paul, AS; El Bakkouri, M; Hackett, CG; Tran, F; Westwood, NJ; Hui, R; Zuercher, WJ; Duraisingh, MT; Moreno, SNJ; Lourido, S				Sidik, Saima M.; Triana, Miryam A. Hortua; Paul, Aditya S.; El Bakkouri, Majida; Hackett, Caroline G.; Tran, Fanny; Westwood, Nicholas J.; Hui, Raymond; Zuercher, William J.; Duraisingh, Manoj T.; Moreno, Silvia N. J.; Lourido, Sebastian			Using a Genetically Encoded Sensor to Identify Inhibitors of Toxoplasma gondii Ca2+ Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; INTRACELLULAR CA2+; ARTEMISININ RESISTANCE; MICRONEME DISCHARGE; HUMAN-ERYTHROCYTES; CALCIUM STORAGE; INVASION; MALARIA; FALCIPARUM; EGRESS	The life cycles of apicomplexan parasites progress in accordance with fluxes in cytosolic Ca2+. Such fluxes are necessary for events like motility and egress from host cells. We used genetically encoded Ca2+ indicators (GCaMPs) to develop a cell-based phenotypic screen for compounds that modulate Ca2+ signaling in the model apicomplexan Toxoplasma gondii. In doing so, we took advantage of the phosphodiesterase inhibitor zaprinast, which we show acts in part through cGMP-dependent protein kinase (protein kinase G; PKG) to raise levels of cytosolic Ca2+. We define the pool of Ca2+ regulated by PKG to be a neutral store distinct from the endoplasmic reticulum. Screening a library of 823 ATP mimetics, we identify both inhibitors and enhancers of Ca2+ signaling. Two such compounds constitute novel PKG inhibitors and prevent zaprinast from increasing cytosolic Ca2+. The enhancers identified are capable of releasing intracellular Ca2+ stores independently of zaprinast or PKG. One of these enhancers blocks parasite egress and invasion and shows strong antiparasitic activity against T. gondii. The same compound inhibits invasion of the most lethal malaria parasite, Plasmodium falciparum. Inhibition of Ca2+-related phenotypes in these two apicomplexan parasites suggests that depletion of intracellular Ca2+ stores by the enhancer may be an effective antiparasitic strategy. These results establish a powerful new strategy for identifying compounds that modulate the essential parasite signaling pathways regulated by Ca2+, underscoring the importance of these pathways and the therapeutic potential of their inhibition.	[Sidik, Saima M.; Hackett, Caroline G.; Lourido, Sebastian] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Triana, Miryam A. Hortua; Moreno, Silvia N. J.] Univ Georgia, Dept Cellular Biol, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Paul, Aditya S.; Duraisingh, Manoj T.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [El Bakkouri, Majida; Hui, Raymond] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Tran, Fanny; Westwood, Nicholas J.] Univ St Andrews, Sch Chem & Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland; [Tran, Fanny; Westwood, Nicholas J.] EaStCHEM, St Andrews KY16 9ST, Fife, Scotland; [Zuercher, William J.] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University System of Georgia; University of Georgia; Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; Structural Genomics Consortium; University of St Andrews; University of St Andrews; University of North Carolina; University of North Carolina Chapel Hill	Lourido, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lourido@wi.mit.edu		Hortua Triana, Miryam Andrea/0000-0001-5964-8512; Lourido, Sebastian/0000-0002-5237-1095; Westwood, Nicholas/0000-0003-0630-0138	National Institutes of Health [AI-110027, AI-096836, 1DP5OD017892]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096836, R21AI110027] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants AI-110027 and AI-096836 (to S. N. J. M.) and 1DP5OD017892 (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Arrizabalaga G, 2004, INT J PARASITOL, V34, P361, DOI 10.1016/j.ijpara.2003.11.017; Arrizabalaga G, 2004, J CELL BIOL, V165, P653, DOI 10.1083/jcb.200309097; Bei AK, 2010, AM J HEMATOL, V85, P234, DOI 10.1002/ajh.21642; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Borges-Pereira L, 2015, J BIOL CHEM, V290, P26914, DOI 10.1074/jbc.M115.652511; Boyle JP, 2007, EXP PARASITOL, V116, P302, DOI 10.1016/j.exppara.2007.01.010; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Donald RGK, 2006, MOL BIOCHEM PARASIT, V149, P86, DOI 10.1016/j.molbiopara.2006.05.003; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Elkins JM, 2016, NAT BIOTECHNOL, V34, P95, DOI 10.1038/nbt.3374; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; English AR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013227; Farrell A, 2012, SCIENCE, V335, P218, DOI 10.1126/science.1210829; FASOLATO C, 1991, J BIOL CHEM, V266, P20159; Fox T, 1998, PROTEIN SCI, V7, P2249, DOI 10.1002/pro.5560071102; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Glushakova S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-41; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Howard BL, 2015, ACS CHEM BIOL, V10, P1145, DOI 10.1021/cb501004q; Islam I, 2007, BIOORG MED CHEM LETT, V17, P3814, DOI 10.1016/j.bmcl.2007.04.071; Johnson SM, 2012, J MED CHEM, V55, P2416, DOI 10.1021/jm201713h; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Kinoshita T, 2006, BIOORG MED CHEM LETT, V16, P55, DOI 10.1016/j.bmcl.2005.09.055; KOCH GLE, 1990, BIOESSAYS, V12, P527, DOI 10.1002/bies.950121105; Lim DC, 2012, INT J PARASITOL, V42, P21, DOI 10.1016/j.ijpara.2011.11.007; LIU CM, 1978, J BIOL CHEM, V253, P5892; Lourido S, 2013, J MED CHEM, V56, P3068, DOI 10.1021/jm4001314; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; MCCALLUMDEIGHTON N, 1992, MOL BIOCHEM PARASIT, V50, P317, DOI 10.1016/0166-6851(92)90229-D; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Moreno SNJ, 2011, ESSAYS BIOCHEM, V51, P97, DOI [10.1042/BSE0510097, 10.1042/bse0510097]; Moreno SNJ, 1996, BIOCHEM J, V313, P655, DOI 10.1042/bj3130655; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Naqvi S, 2012, BIOCHEM J, V441, P347, DOI 10.1042/BJ20110970; Pace DA, 2014, J BIOL CHEM, V289, P19637, DOI 10.1074/jbc.M114.565390; Paul AS, 2015, CELL HOST MICROBE, V18, P49, DOI 10.1016/j.chom.2015.06.003; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Plattner H, 1997, EUR J CELL BIOL, V72, P297; PRIGENT AF, 1988, BIOCHEM PHARMACOL, V37, P3671, DOI 10.1016/0006-2952(88)90400-5; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Simard JR, 2009, J AM CHEM SOC, V131, P13286, DOI 10.1021/ja902010p; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; SOLDATI D, 1995, MOL CELL BIOL, V15, P87, DOI 10.1128/MCB.15.1.87; STELLY N, 1991, J CELL BIOL, V113, P103, DOI 10.1083/jcb.113.1.103; Stevens KL, 2008, BIOORG MED CHEM LETT, V18, P5758, DOI 10.1016/j.bmcl.2008.09.069; Taylor HM, 2010, EUKARYOT CELL, V9, P37, DOI 10.1128/EC.00186-09; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WAHLGREN M, 1983, CLIN EXP IMMUNOL, V54, P127; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019; Yuasa K, 2005, BIOCHEM J, V392, P221, DOI 10.1042/BJ20050425; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zheng W, 2013, DRUG DISCOV TODAY, V18, P1067, DOI 10.1016/j.drudis.2013.07.001	72	37	37	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9566	9580		10.1074/jbc.M115.703546	http://dx.doi.org/10.1074/jbc.M115.703546			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26933036	Green Published, hybrid			2022-12-28	WOS:000375602300016
J	Terajima, M; Taga, Y; Chen, YL; Cabral, WA; Hou-Fu, G; Srisawasdi, S; Nagasawa, M; Sumida, N; Hattori, S; Kurie, JM; Marini, JC; Yamauchi, M				Terajima, Masahiko; Taga, Yuki; Chen, Yulong; Cabral, Wayne A.; Hou-Fu, Guo; Srisawasdi, Sirivimol; Nagasawa, Masako; Sumida, Noriko; Hattori, Shunji; Kurie, Jonathan M.; Marini, Joan C.; Yamauchi, Mitsuo			Cyclophilin-B Modulates Collagen Cross-linking by Differentially Affecting Lysine Hydroxylation in the Helical and Telopeptidyl Domains of Tendon Type I Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSYL HYDROXYLASE; OSTEOGENESIS IMPERFECTA; BRUCK-SYNDROME; NULL MICE; MUTATIONS; BONE; DEFICIENCY; PROTEIN; CELLS; EXPRESSION	Covalent intermolecular cross-linking provides collagen fibrils with stability. The cross-linking chemistry is tissue-specific and determined primarily by the state of lysine hydroxylation at specific sites. A recent study on cyclophilin B (CypB) null mice, a model of recessive osteogenesis imperfecta, demonstrated that lysine hydroxylation at the helical cross-linking site of bone type I collagen was diminished in these animals (Cabral, W. A., Perdivara, I., Weis, M., Terajima, M., Blissett, A. R., Chang, W., Perosky, J. E., Makareeva, E. N., Mertz, E. L., Leikin, S., Tomer, K. B., Kozloff, K. M., Eyre, D. R., Yamauchi, M., and Marini, J. C. (2014) PLoS Genet. 10, e1004465). However, the extent of decrease appears to be tissue-and molecular site-specific, the mechanism of which is unknown. Here we report that although CypB deficiency resulted in lower lysine hydroxylation in the helical cross-linking sites, it was increased in the telopeptide cross-linking sites in tendon type I collagen. This resulted in a decrease in the lysine aldehyde-derived cross-links but generation of hydroxylysine aldehyde-derived cross-links. The latter were absent from the wild type and heterozygous mice. Glycosylation of hydroxylysine residues was moderately increased in the CypB null tendon. Wefound that CypB interacted with all lysyl hydroxylase isoforms (isoforms 1-3) and a putative lysyl hydroxylase-2 chaperone, 65-kDa FK506-binding protein. Tendon collagen in CypB null mice showed severe size and organizational abnormalities. The data indicate that CypB modulates collagen cross-linking by differentially affecting lysine hydroxylation in a site-specific manner, possibly via its interaction with lysyl hydroxylases and associated molecules. This study underscores the critical importance of collagen post-translational modifications in connective tissue formation.	[Terajima, Masahiko; Sumida, Noriko; Yamauchi, Mitsuo] Univ N Carolina, Sch Dent, North Carolina Oral Hlth Inst, Chapel Hill, NC 27599 USA; [Taga, Yuki; Hattori, Shunji] Nippi Res Inst Biomatrix, Ibaraki 3020017, Japan; [Chen, Yulong; Hou-Fu, Guo; Kurie, Jonathan M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Cabral, Wayne A.; Marini, Joan C.] NICHD, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD 20892 USA; [Srisawasdi, Sirivimol] Chulalongkorn Univ, Dept Operat Dent, Bangkok 10330, Thailand; [Nagasawa, Masako] Niigata Univ, Grad Sch Med & Dent Sci, Div Bioprosthodont, Niigata 9518514, Japan	University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chulalongkorn University; Niigata University	Yamauchi, M (corresponding author), Univ N Carolina, Sch Dent, North Carolina Oral Hlth Inst, Chapel Hill, NC 27599 USA.	mitsuo_yamauchi@unc.edu	Taga, Yuki/I-2781-2019	Taga, Yuki/0000-0001-9100-758X; Guo, Hou-Fu/0000-0002-3659-9399	National Institute of Health Grants, National Institutes of Health-NIAMS [R21AR060978]; National Institute of Health Grants, National Institutes of Health-NCI [R01CA105155]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000408] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA105155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060978] Funding Source: NIH RePORTER	National Institute of Health Grants, National Institutes of Health-NIAMS; National Institute of Health Grants, National Institutes of Health-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institute of Health Grants, National Institutes of Health-NIAMS R21AR060978, NCI R01CA105155. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; Barnes AM, 2013, HUM MUTAT, V34, P1279, DOI 10.1002/humu.22362; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Cabral WA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004465; Chen YL, 2015, J CLIN INVEST, V125, P1147, DOI 10.1172/JCI74725; Choi JW, 2014, CANCER RES, V74, P484, DOI 10.1158/0008-5472.CAN-13-0771; Eisinger-Mathason TSK, 2013, CANCER DISCOV, V3, P1190, DOI 10.1158/2159-8290.CD-13-0118; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Grzesik WJ, 2000, J BONE MINER RES, V15, P52, DOI 10.1359/jbmr.2000.15.1.52; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Hudson DM, 2015, J BIOL CHEM, V290, P8613, DOI 10.1074/jbc.M114.634915; Hyry M., 2012, THESIS; Ishikawa Y, 2015, BBA-GEN SUBJECTS, V1850, P1983, DOI 10.1016/j.bbagen.2014.12.024; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Ishikawa Y, 2012, J BIOL CHEM, V287, P22253, DOI 10.1074/jbc.M111.333336; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Lietman CD, 2014, HUM MOL GENET, V23, P4822, DOI 10.1093/hmg/ddu197; Marcant A, 2012, J IMMUNOL, V189, P2023, DOI 10.4049/jimmunol.1102803; MECHANIC GL, 1987, EXP LUNG RES, V12, P109, DOI 10.3109/01902148709062835; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; Pornprasertsuk S, 2005, J BONE MINER RES, V20, P81, DOI 10.1359/JBMR.041026; Pornprasertsuk S, 2004, J BONE MINER RES, V19, P1349, DOI 10.1359/JBMR.040323; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; Shiiba M, 2002, J BONE MINER RES, V17, P1639, DOI 10.1359/jbmr.2002.17.9.1639; Sricholpech M, 2012, J BIOL CHEM, V287, P22998, DOI 10.1074/jbc.M112.343954; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; Taga Y, 2014, J PROTEOME RES, V13, P3671, DOI 10.1021/pr500213a; Taga Y, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010397; Takaluoma K, 2007, MATRIX BIOL, V26, P396, DOI 10.1016/j.matbio.2007.01.002; Terajima M, 2014, J BIOL CHEM, V289, P22636, DOI 10.1074/jbc.M113.528513; Teramura N, 2011, J BACTERIOL, V193, P3049, DOI 10.1128/JB.01528-10; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Witsch TJ, 2014, AM J PHYSIOL-LUNG C, V306, pL246, DOI 10.1152/ajplung.00109.2013; Yamauchi M, 1989, Connect Tissue Res, V21, P159, DOI 10.3109/03008208909050006; YAMAUCHI M, 1986, BIOCHEMISTRY-US, V25, P4907, DOI 10.1021/bi00365a027; Yamauchi M., 1989, CONNECT TISSUE RES, V21, P168; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/bse0520113, 10.1042/BSE0520113]; Yeowell HN, 2000, MOL GENET METAB, V71, P212, DOI 10.1006/mgme.2000.3076	50	34	34	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9501	9512		10.1074/jbc.M115.699470	http://dx.doi.org/10.1074/jbc.M115.699470			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26934917	Green Published, hybrid			2022-12-28	WOS:000375602300011
J	Bianchi, V; Bulek, A; Fuller, A; Lloyd, A; Attaf, M; Rizkallah, PJ; Dolton, G; Sewell, AK; Cole, DK				Bianchi, Valentina; Bulek, Anna; Fuller, Anna; Lloyd, Angharad; Attaf, Meriem; Rizkallah, Pierre J.; Dolton, Garry; Sewell, Andrew K.; Cole, David K.			A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; HETEROCLITIC PEPTIDES; STRUCTURAL BASIS; ANCHOR RESIDUES; REACTIVE CTL; GENE-THERAPY; ALPHA-BETA; BINDING; RECOGNITION; EPITOPES	Human CD8(+) cytotoxic T lymphocytes can mediate tumor regression in melanoma through the specific recognition of HLA-restricted peptides. Because of the relatively weak affinity of most anti-cancer T-cell receptors (TCRs), there is growing emphasis on immunizing melanoma patients with altered peptide ligands in order to induce strong anti-tumor immunity capable of breaking tolerance toward these self-antigens. However, previous studies have shown that these immunogenic designer peptides are not always effective. The melanocyte differentiation protein, glycoprotein 100 (gp100), encodes a naturally processed epitope that is an attractive target for melanoma immunotherapies, in particular peptide-based vaccines. Previous studies have shown that substitutions at peptide residue Glu(3) have a broad negative impact on polyclonal T-cell responses. Here, we describe the first atomic structure of a natural cognate TCR in complex with this gp100 epitope and highlight the relatively high affinity of the interaction. Alanine scan mutagenesis performed across the gp100(280-288) peptide showed that Glu(3) was critically important for TCR binding. Unexpectedly, structural analysis demonstrated that the Glu(3) -> Ala substitution resulted in a molecular switch that was transmitted to adjacent residues, abrogating TCR binding and T-cell recognition. These findings help to clarify the mechanism of T-cell recognition of gp100 during melanoma responses and could direct the development of altered peptides for vaccination.	[Cole, David K.] Cardiff Univ, Sch Med, Div Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; Cardiff Univ, Sch Med, Syst Immun Res Inst, Heath Pk, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University	Cole, DK (corresponding author), Cardiff Univ, Sch Med, Div Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	coledk@cf.ac.uk	Rizkallah, Pierre J/A-5367-2012; Sewell, Andrew/GPT-4220-2022	Rizkallah, Pierre J/0000-0002-9290-0369; Sewell, Andrew/0000-0003-3194-3135; Fuller, Anna/0000-0002-8655-6741; Cole, David/0000-0003-0028-9396	Cancer Research Wales Ph.D. studentship; Research Council UK fellowship; Wellcome Trust [WT095767]; BBSRC [BB/H001085/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish; Medical Research Council [1247762] Funding Source: researchfish; Wellcome Trust [100327/Z/12/Z] Funding Source: researchfish	Cancer Research Wales Ph.D. studentship; Research Council UK fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by a Cancer Research Wales Ph.D. studentship.; Supported by a Research Council UK fellowship.; A Wellcome Trust Research Career Development Fellow (Grant WT095767).	Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Armstrong KM, 2008, J MOL RECOGNIT, V21, P275, DOI 10.1002/jmr.896; Armstrong KM, 2007, BIOPHYS J, V93, P597, DOI 10.1529/biophysj.107.104570; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Bulek AM, 2012, J IMMUNOL METHODS, V382, P203, DOI 10.1016/j.jim.2012.06.007; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garboczi DN, 1996, J IMMUNOL, V157, P5403; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; KAWAKAMI Y, 1995, J IMMUNOL, V154, P3961; Kloverpris HN, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0149-5; Lesterhuis WJ, 2011, CANCER IMMUNOL IMMUN, V60, P249, DOI 10.1007/s00262-010-0942-x; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Madura F, 2015, EUR J IMMUNOL, V45, P584, DOI 10.1002/eji.201445114; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miles KM, 2011, MOL IMMUNOL, V48, P728, DOI 10.1016/j.molimm.2010.11.004; Motozono C, 2015, J BIOL CHEM, V290, P18924, DOI 10.1074/jbc.M114.622522; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PARKER KC, 1992, J IMMUNOL, V149, P3580; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; Salgaller ML, 1996, CANCER RES, V56, P4749; Schaft N, 2003, J IMMUNOL, V170, P2186, DOI 10.4049/jimmunol.170.4.2186; Schaft N, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00270; Skipper JCA, 1999, INT J CANCER, V82, P669, DOI 10.1002/(SICI)1097-0215(19990827)82:5<669::AID-IJC9>3.0.CO;2-#; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Wagner SN, 1997, CANCER IMMUNOL IMMUN, V44, P239, DOI 10.1007/s002620050379; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9	45	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8951	8959		10.1074/jbc.M115.707414	http://dx.doi.org/10.1074/jbc.M115.707414			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26917722	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000374849000008
J	Donovan, KA; Zhu, SL; Liuni, P; Peng, F; Kessans, SA; Wilson, DJ; Dobson, RCJ				Donovan, Katherine A.; Zhu, Shaolong; Liuni, Peter; Peng, Fen; Kessans, Sarah A.; Wilson, Derek J.; Dobson, Renwick C. J.			Conformational Dynamics and Allostery in Pyruvate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROSPRAY MASS-SPECTROMETRY; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; ENERGY LANDSCAPE; BINDING-SITE; CATALYSIS; PROTEINS; FRUCTOSE-1,6-BISPHOSPHATE; RECOGNITION; TRANSITIONS	Pyruvate kinase catalyzes the final step in glycolysis and is allosterically regulated to control flux through the pathway. Two models are proposed to explain how Escherichia coli pyruvate kinase type 1 is allosterically regulated: the "domain rotation model" suggests that both the domains within the monomer and the monomers within the tetramer reorient with respect to one another; the "rigid body reorientation model" proposes only a reorientation of the monomers within the tetramer causing rigidification of the active site. To test these hypotheses and elucidate the conformational and dynamic changes that drive allostery, we performed time-resolved electrospray ionization mass spectrometry coupled to hydrogen-deuterium exchange studies followed by mutagenic analysis to test the activation mechanism. Global exchange experiments, supported by thermostability studies, demonstrate that fructose 1,6-bisphosphate binding to the allosteric domain causes a shift toward a globally more dynamic ensemble of conformations. Mapping deuterium exchange to peptides within the enzyme highlight site-specific regions with altered conformational dynamics, many of which increase in conformational flexibility. Based upon these and mutagenic studies, we propose an allosteric mechanism whereby the binding of fructose 1,6-bisphosphate destabilizes an alpha-helix that bridges the allosteric and active site domains within the monomeric unit. This destabilizes the beta-strands within the (beta/alpha)(8)-barrel domain and the linked active site loops that are responsible for substrate binding. Our data are consistent with the domain rotation model but inconsistent with the rigid body reorientation model given the increased flexibility at the interdomain interface, and we can for the first time explain how fructose 1,6-bisphosphate affects the active site.	[Donovan, Katherine A.; Kessans, Sarah A.; Dobson, Renwick C. J.] Univ Canterbury, Biomol Interact Ctr, Private Bag 4800, Christchurch 8041, New Zealand; [Donovan, Katherine A.; Kessans, Sarah A.; Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8041, New Zealand; [Zhu, Shaolong; Liuni, Peter; Wilson, Derek J.] York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada; [Peng, Fen] Univ Houston, Biol & Biochem, Houston, TX 77204 USA; [Wilson, Derek J.] York Univ, Dept Chem, Ctr Res Mass Spectrometry, 4700 Keele St, Toronto, ON M3J 1P3, Canada; [Dobson, Renwick C. J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, 30 Flemington Rd, Parkville, Vic 3010, Australia	University of Canterbury; University of Canterbury; York University - Canada; University of Houston System; University of Houston; York University - Canada; University of Melbourne	Wilson, DJ (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada.; Wilson, DJ (corresponding author), York Univ, Dept Chem, Ctr Res Mass Spectrometry, 4700 Keele St, Toronto, ON M3J 1P3, Canada.; Dobson, RCJ (corresponding author), Univ Canterbury, Sch Biol Sci, Biomol Interact Ctr, Private Bag 4800, Christchurch 1, New Zealand.	dkwilson@yorku.ca; renwick.dobson@canterbury.ac.nz	Dobson, Renwick/AAZ-7020-2021; Donovan, Katherine Aleisha/R-7539-2018	Dobson, Renwick/0000-0002-5506-4939; Donovan, Katherine Aleisha/0000-0002-8539-5106	Maurice Wilkins Centre; Journal of Cell Science travel fellowship; Natural Sciences and Engineering Research Council of Canada; Ministry of Business, Innovation and Employment [UOCX1208]; New Zealand Royal Society Marsden Fund [UOC1013]; United States Army Research Laboratory; United States Army Research Office [W911NF-11-1-0481]	Maurice Wilkins Centre; Journal of Cell Science travel fellowship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); United States Army Research Laboratory; United States Army Research Office	Supported by Maurice Wilkins Centre flexible research funding and a Journal of Cell Science travel fellowship.; Supported by a Natural Sciences and Engineering Research Council of Canada discovery grant.; Supported in part by Ministry of Business, Innovation and Employment Contract UOCX1208, New Zealand Royal Society Marsden Fund Contract UOC1013, and United States Army Research Laboratory and United States Army Research Office Contract/Grant W911NF-11-1-0481.	Allen SC, 1996, ACTA CRYSTALLOGR D, V52, P499, DOI 10.1107/S0907444995016040; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; BOITEUX A, 1983, BIOCHEM J, V211, P631, DOI 10.1042/bj2110631; Changeux JP, 2013, NAT REV MOL CELL BIO, V14, P819, DOI 10.1038/nrm3695; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Donovan KA, 2016, ACTA CRYSTALLOGR D, V72, P512, DOI 10.1107/S205979831600142X; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Fenton AW, 2010, BIOCHEMISTRY-US, V49, P7202, DOI 10.1021/bi100147w; Fenton AW, 2002, ARCH BIOCHEM BIOPHYS, V397, P28, DOI 10.1006/abbi.2001.2634; FOTHERGILLGILMORE LA, 1993, PROG BIOPHYS MOL BIO, V59, P105, DOI 10.1016/0079-6107(93)90001-Z; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Hill A.V., 1910, J PHYSL, V40, pi, DOI DOI 10.1113/JPHYSIOL.1910.SP191040SUPPLTOC; Ishwar A, 2015, BIOCHEMISTRY-US, V54, P1516, DOI 10.1021/bi501426w; Jeoung NH, 2014, REV ENDOCR METAB DIS, V15, P99, DOI 10.1007/s11154-013-9284-2; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kerns SJ, 2015, NAT STRUCT MOL BIOL, V22, P124, DOI 10.1038/nsmb.2941; Kumar S, 2011, J PHYS CHEM B, V115, P6784, DOI 10.1021/jp201862a; LEVINE M, 1978, NATURE, V271, P626, DOI 10.1038/271626a0; Liuni P, 2012, ANGEW CHEM INT EDIT, V51, P9666, DOI 10.1002/anie.201204903; Lovell SC, 1998, J MOL BIOL, V276, P839, DOI 10.1006/jmbi.1997.1569; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; MALCOVATI M, 1982, METHOD ENZYMOL, V90, P170; Mattevi A, 1996, CURR OPIN STRUC BIOL, V6, P824, DOI 10.1016/S0959-440X(96)80013-3; Mattevi A, 1996, FEBS LETT, V389, P15, DOI 10.1016/0014-5793(96)00462-0; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Morgan HP, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140120; Morgan HP, 2011, J BIOL CHEM, V286, P31232, DOI 10.1074/jbc.M110.212613; Morgan HP, 2010, J BIOL CHEM, V285, P12892, DOI 10.1074/jbc.M109.079905; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; MUIRHEAD H, 1986, EMBO J, V5, P475, DOI 10.1002/j.1460-2075.1986.tb04236.x; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; Nussinov R, 2015, CURR OPIN STRUC BIOL, V30, P17, DOI 10.1016/j.sbi.2014.11.005; PONCE E, 1995, J BACTERIOL, V177, P5719, DOI 10.1128/jb.177.19.5719-5722.1995; Resetca D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.595454; Rob T, 2012, ANAL CHEM, V84, P3771, DOI 10.1021/ac300365u; Rob T, 2009, J AM SOC MASS SPECTR, V20, P124, DOI 10.1016/j.jasms.2008.09.005; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; URFER R, 1992, PROTEIN SCI, V1, P31; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; WALKER D, 1992, J MOL BIOL, V228, P265, DOI 10.1016/0022-2836(92)90505-E; WAYGOOD EB, 1975, CAN J BIOCHEM CELL B, V53, P444, DOI 10.1139/o75-061; Wilson DJ, 2003, ANAL CHEM, V75, P6408, DOI 10.1021/ac0346757; Yuan Y, 2015, CHEM REV, V115, P1702, DOI 10.1021/cr500495x; Zhong WH, 2014, BIOCHEM J, V458, P301, DOI 10.1042/BJ20130790; Zhu T, 2010, BIOCHIMIE, V92, P116, DOI 10.1016/j.biochi.2009.09.016	53	24	25	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9244	9256		10.1074/jbc.M115.676270	http://dx.doi.org/10.1074/jbc.M115.676270			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26879751	Green Published, hybrid			2022-12-28	WOS:000374849000034
J	McLaughlin, D; Coey, CT; Yang, WC; Drohat, AC; Matunis, MJ				McLaughlin, Dylan; Coey, Christopher T.; Yang, Wei-Chih; Drohat, Alexander C.; Matunis, Michael J.			Characterizing Requirements for Small Ubiquitin-like Modifier (SUMO) Modification and Binding on Base Excision Repair Activity of Thymine-DNA Glycosylase in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBNUCLEAR LOCALIZATION; CRYSTAL-STRUCTURE; TDG; RECEPTOR; TET; 5-CARBOXYLCYTOSINE; TRANSCRIPTION; SUMOYLATION; REPRESSION; COOPERATE	Thymine-DNA glycosylase (TDG) plays critical roles in DNA base excision repair and DNA demethylation. It has been proposed, based on structural studies and in vitro biochemistry, that sumoylation is required for efficient TDG enzymatic turnover following base excision. However, whether sumoylation is required for TDG activity in vivo has not previously been tested. We have developed an in vivo assay for TDG activity that takes advantage of its recently discovered role in DNA demethylation and selective recognition and repair of 5-carboxylcytosine. Using this assay, we investigated the role of sumoylation in regulating TDG activity through the use of TDG mutants defective for sumoylation and Small Ubiquitin-like Modifier (SUMO) binding and by altering TDG sumoylation through SUMO and SUMO protease overexpression experiments. Our findings indicate that sumoylation and SUMO binding are not essential for TDG-mediated excision and repair of 5-carboxylcytosine bases. Moreover, in vitro assays revealed that apurinic/apyrimidinic nuclease 1 provides nearly maximum stimulation of TDG processing of G.caC substrates. Thus, under our assay conditions, apurinic/apyrimidinic nuclease 1-mediated stimulation or other mechanisms sufficiently alleviate TDG product inhibition and promote its enzymatic turnover in vivo.	[McLaughlin, Dylan; Yang, Wei-Chih; Matunis, Michael J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Coey, Christopher T.; Drohat, Alexander C.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore	Matunis, MJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.; Drohat, AC (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	adrohat@som.umaryland.edu; mmatuni1@jhu.edu		Matunis, Michael/0000-0002-9350-6611; Drohat, Alex/0000-0002-7458-8770	National Institutes of Health [R01-GM72711, R01-GM060980]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072711, R01GM060980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01-GM72711 (to A. C. D.) and R01-GM060980 (to M. J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Baba D, 2006, J MOL BIOL, V359, P137, DOI 10.1016/j.jmb.2006.03.036; Baldwin MR, 2010, BIOCHEMISTRY-US, V49, P7879, DOI 10.1021/bi100889r; Bellacosa A, 2015, DNA REPAIR, V32, P33, DOI 10.1016/j.dnarep.2015.04.011; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Burrage PS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2564; Calini V, 2002, CELL BIOL TOXICOL, V18, P369, DOI 10.1023/A:1020811522100; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Coey CT, 2014, J BIOL CHEM, V289, P15810, DOI 10.1074/jbc.M114.572081; Cubenas-Potts C, 2013, MOL BIOL CELL, V24, P3483, DOI 10.1091/mbc.E13-05-0230; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goeres J, 2011, MOL BIOL CELL, V22, P4868, DOI 10.1091/mbc.E10-12-0953; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hardeland U, 2001, PROG NUCLEIC ACID RE, V68, P235; Hardeland U, 2007, NUCLEIC ACIDS RES, V35, P3859, DOI 10.1093/nar/gkm337; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Jia YY, 2014, J MOL CELL BIOL, V6, P231, DOI 10.1093/jmcb/mju014; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Malik SS, 2015, NUCLEIC ACIDS RES, V43, P9541, DOI 10.1093/nar/gkv890; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Mohan RD, 2007, MOL CELL BIOL, V27, P229, DOI 10.1128/MCB.00323-06; Morgan MT, 2011, NUCLEIC ACIDS RES, V39, P2319, DOI 10.1093/nar/gkq1164; Nayak A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0422-2; Raman N, 2013, CHROMOSOMA, V122, P475, DOI 10.1007/s00412-013-0429-6; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shibata E, 2014, J BIOL CHEM, V289, P23056, DOI 10.1074/jbc.M114.574210; Sjolund AB, 2013, MUTAT RES-FUND MOL M, V743, P12, DOI 10.1016/j.mrfmmm.2012.11.001; Slenn TJ, 2014, J BIOL CHEM, V289, P23043, DOI 10.1074/jbc.M114.574194; Smet-Nocca C, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-4; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]	45	14	14	4	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9014	9024		10.1074/jbc.M115.706325	http://dx.doi.org/10.1074/jbc.M115.706325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26917720	Green Published, hybrid			2022-12-28	WOS:000374849000016
J	Li, HY; Wang, J; Meng, F; Jia, ZK; Su, Y; Bai, QF; Lv, LL; Ma, FR; Potempa, LA; Yan, YB; Ji, SR; Wu, Y				Li, Hai-Yun; Wang, Jing; Meng, Fan; Jia, Zhe-Kun; Su, Yang; Bai, Qi-Feng; Lv, Ling-Ling; Ma, Fu-Rong; Potempa, Lawrence A.; Yan, Yong-Bin; Ji, Shang-Rong; Wu, Yi			An Intrinsically Disordered Motif Mediates Diverse Actions of Monomeric C-reactive Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; endothelial dysfunction; extracellular matrix; inflammation; protein motif; C-reactive protein; intrinsically disordered region	AMINO-ACID-SEQUENCE; ENDOTHELIAL-CELLS; SYNTHETIC PEPTIDE; COMPLEMENT ACTIVATION; NEUTROPHIL ADHESION; MOLECULAR-DYNAMICS; INFLAMMATION; ATHEROSCLEROSIS; PLATELETS; DISEASE	Most proinflammatory actions of C-reactive protein (CRP) are only expressed following dissociation of its native pentameric assembly into monomeric form (mCRP). However, little is known about what underlies the greatly enhanced activities of mCRP. Here we show that a single sequence motif, i.e. cholesterol binding sequence (CBS; a.a. 35-47), is responsible for mediating the interactions of mCRP with diverse ligands. The binding of mCRP to lipoprotein component ApoB, to complement component C1q, to extracellular matrix components fibronectin and collagen, to blood coagulation component fibrinogen, and to membrane lipid component cholesterol, are all found to be markedly inhibited by the synthetic CBS peptide but not by other CRP sequences tested. Likewise, mutating CBS in mCRP also greatly impairs these interactions. Functional experiments further reveal that CBS peptide significantly reduces the effects of mCRP on activation of endothelial cells in vitro and on acute induction of IL-6 in mice. The potency and specificity of CBS are critically determined by the N-terminal residues Cys-36, Leu-37, and His-38; while the versatility of CBS appears to originate from its intrinsically disordered conformation polymorphism. Together, these data unexpectedly identify CBS as the major recognition site of mCRP and suggest that this motif may be exploited to tune the proinflammatory actions of mCRP.	[Li, Hai-Yun; Wu, Yi] Xi An Jiao Tong Univ, Sch Basic Med Sci, MOE Key Lab Environm & Genes Related Dis, Xian 710061, Shaanxi, Peoples R China; [Li, Hai-Yun; Yan, Yong-Bin] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Wang, Jing; Meng, Fan; Jia, Zhe-Kun; Su, Yang; Lv, Ling-Ling; Ma, Fu-Rong; Ji, Shang-Rong; Wu, Yi] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China; [Bai, Qi-Feng] Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; [Potempa, Lawrence A.] Roosevelt Univ, Coll Pharm, Schaumburg, IL 60173 USA	Xi'an Jiaotong University; Tsinghua University; Lanzhou University; Lanzhou University	Wu, Y (corresponding author), Xi An Jiao Tong Univ, Sch Basic Med Sci, MOE Key Lab Environm & Genes Related Dis, Xian 710061, Shaanxi, Peoples R China.; Ji, SR; Wu, Y (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China.	jsr@lzu.edu.cn; wuy@lzu.edu.cn	Bai, Qifeng/A-2950-2019; Yan, Yong-Bin/A-4282-2008	Bai, Qifeng/0000-0001-7296-6187; Yan, Yong-Bin/0000-0002-8565-3558; Wu, Yi/0000-0003-0365-5590; Li, Haiyun/0000-0002-7458-7399; Ji, Shang-Rong/0000-0001-8595-3756	National Natural Science Foundation of China [31270813, 31222015, 30930024]; China Postdoctoral Science Foundation [2014M560075]; National Natural Science Foundation of China [31270813, 31222015, 30930024]; China Postdoctoral Science Foundation [2014M560075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (Grant Numbers, 31270813, 31222015, 30930024) and the China Postdoctoral Science Foundation (Grant Numbers 2014M560075). The authors declare that they have no conflicts of interest with the contents of this article.	BARNA BP, 1993, CANCER IMMUNOL IMMUN, V36, P171, DOI 10.1007/BF01741088; Braig D, 2014, INT IMMUNOL, V26, P467, DOI 10.1093/intimm/dxu056; De La Torre R, 2013, J THROMB HAEMOST, V11, P2048, DOI 10.1111/jth.12415; Du Clos Terry W, 2013, ISRN Inflamm, V2013, P379040, DOI 10.1155/2013/379040; EISCHEN A, 1994, BRIT J HAEMATOL, V88, P712, DOI 10.1111/j.1365-2141.1994.tb05109.x; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; El Kebir D, 2011, J LEUKOCYTE BIOL, V90, P1167, DOI 10.1189/jlb.0111032; Fujita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093738; Habersberger J, 2012, CARDIOVASC RES, V96, P64, DOI 10.1093/cvr/cvs237; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; Heuertz RM, 1996, J IMMUNOL, V156, P3412; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2009, FASEB J, V23, P1806, DOI 10.1096/fj.08-116962; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; KINOSHITA CM, 1989, BIOCHEMISTRY-US, V28, P9840, DOI 10.1021/bi00451a044; Lauer N, 2011, J IMMUNOL, V187, P4374, DOI 10.4049/jimmunol.1002488; Li HY, 2014, J BIOL CHEM, V289, P14283, DOI 10.1074/jbc.M114.555318; Ma X, 2013, CHINESE SCI BULL, V58, P1642, DOI 10.1007/s11434-012-5591-3; Mihlan M, 2011, FASEB J, V25, P4198, DOI 10.1096/fj.11-186460; Molins B, 2011, CARDIOVASC RES, V92, P328, DOI 10.1093/cvr/cvr226; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POTEMPA LA, 1983, MOL IMMUNOL, V20, P1165, DOI 10.1016/0161-5890(83)90140-2; Potempa Lawrence A, 2015, Biophys Rep, V1, P18; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SHEPHARD EG, 1992, IMMUNOLOGY, V76, P79; SHEPHARD EG, 1990, J IMMUNOL, V145, P1469; Singh SK, 2008, ANN MED, V40, P110, DOI 10.1080/07853890701749225; Strang F, 2012, BRAIN PATHOL, V22, P337, DOI 10.1111/j.1750-3639.2011.00539.x; Su HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102418; SWANSON SJ, 1990, MOL IMMUNOL, V27, P679, DOI 10.1016/0161-5890(90)90011-N; Thiele JR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/372432; Thiele JR, 2014, CIRCULATION, V130, P35, DOI 10.1161/CIRCULATIONAHA.113.007124; THOMASSEN MJ, 1993, J IMMUNOTHER, V13, P1, DOI 10.1097/00002371-199301000-00001; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Wang MS, 2012, SOFT MATTER, V8, P7909, DOI 10.1039/c2sm25779c; Wang MY, 2014, CELL RES, V24, P505, DOI 10.1038/cr.2014.7; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu Y, 2015, BIOL CHEM, V396, P1181, DOI 10.1515/hsz-2015-0149; Xu PC, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0077-0; YING SC, 1989, J IMMUNOL, V143, P221; Zhang L, 2015, J IMMUNOL, V194, P5243, DOI 10.4049/jimmunol.1402909; Zhang YJ, 2012, J BIOL CHEM, V287, P748, DOI 10.1074/jbc.M111.281295; Zhao J, 2010, CELL MOL BIOL LETT, V15, P485, DOI 10.2478/s11658-010-0022-4; Zhong WJ, 1998, J IMMUNOL, V161, P2533; Zouki C, 1997, J CLIN INVEST, V100, P522, DOI 10.1172/JCI119561	53	37	41	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8795	8804		10.1074/jbc.M115.695023	http://dx.doi.org/10.1074/jbc.M115.695023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26907682	hybrid, Green Published			2022-12-28	WOS:000374773200040
J	Liao, Y; Lu, B; Ma, Q; Wu, G; Lai, XR; Zang, JS; Shi, Y; Liu, DX; Han, F; Zhou, NM				Liao, Yuan; Lu, Bin; Ma, Qiang; Wu, Gang; Lai, Xiangru; Zang, Jiashu; Shi, Ying; Liu, Dongxiang; Han, Feng; Zhou, Naiming			Human Neuropeptide S Receptor Is Activated via a G alpha(q) Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL SELECTIVITY; SENSING RECEPTOR; FOOD-INTAKE; IDENTIFICATION; AGONISTS; PHARMACOLOGY; PEPTIDE; MICE; RATS; DELINEATION	Human neuropeptide S (NPS) and its cognate receptor regulate important biological functions in the brain and have emerged as a future therapeutic target for treatment of a variety of neurological and psychiatric diseases. The human NPS (hNPS) receptor has been shown to dually couple to G alpha(s)- and G alpha(q)-dependent signaling pathways. The human NPS analog hNPS-(1-10), lacking 10 residues from the C terminus, has been shown to stimulate Ca2+ mobilization in a manner comparable with full-length hNPS in vitro but seems to fail to induce biological activity in vivo. Here, results derived from a number of cell-based functional assays, including intracellular cAMP-response element (CRE)-driven luciferase activity, Ca2+ mobilization, and ERK1/2 phosphorylation, show that hNPS-(1-10) preferentially activates G alpha(q)-dependent Ca2+ mobilization while exhibiting less activity in triggering G alpha(s)-dependent CRE-driven luciferase activity. We further demonstrate that both G alpha(q)- and G alpha(s)-coupled signaling pathways contribute to full-length hNPS-mediated activation of ERK1/2, whereas hNPS-(1-10)promoted ERK1/2 activation is completely inhibited by the G alpha(q) inhibitor UBO-QIC but not by the PKA inhibitor H89. Moreover, the results of Ala-scanning mutagenesis of hNPS-(1-13) indicated that residues Lys(11) and Lys(12) are structurally crucial for the hNPS receptor to couple to G alpha(s)-dependent signaling. In conclusion, our findings demonstrate that hNPS-(1-10) is a biased agonist favoring G alpha(q)-dependent signaling. It may represent a valuable chemical probe for further investigation of the therapeutic potential of human NPS receptor-directed signaling in vivo.	[Liao, Yuan; Lu, Bin; Ma, Qiang; Lai, Xiangru; Zang, Jiashu; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China; [Wu, Gang; Han, Feng] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Dongxiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Han, F (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Zijingang Campus,866 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.; Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Zijingang Campus,866 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	changhuahan@zju.edu.cn; zhounaiming@zju.edu.cn	Zhou, Naiming/AHC-1121-2022		Ministry of Science and Technology of China [2012CB910402, 2012AA020303]; National Natural Science Foundation of China [81173106, 31200621]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K22AA020303] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Ministry of Science and Technology of China Grants 2012CB910402 and 2012AA020303 and National Natural Science Foundation of China Grants 81173106 and 31200621. The authors declare that they have no conflicts of interest with the contents of this article.	Alonso N, 2014, BIOCHEM J, V459, P117, DOI 10.1042/BJ20131226; Anedda F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029523; Arey BJ, 2011, REV ENDOCR METAB DIS, V12, P275, DOI 10.1007/s11154-011-9188-y; Badia-Elder NE, 2008, ALCOHOL CLIN EXP RES, V32, P1380, DOI 10.1111/j.1530-0277.2008.00713.x; Beck B, 2005, BIOCHEM BIOPH RES CO, V332, P859, DOI 10.1016/j.bbrc.2005.05.029; Bernier V, 2006, J BIOL CHEM, V281, P24704, DOI 10.1074/jbc.M603691200; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Brule C, 2014, FASEB J, V28, P5148, DOI 10.1096/fj.14-249771; Busnelli M, 2012, J BIOL CHEM, V287, P3617, DOI 10.1074/jbc.M111.277178; Ceraudo E, 2014, J BIOL CHEM, V289, P24599, DOI 10.1074/jbc.M113.541698; Charest PG, 2007, CELL SIGNAL, V19, P32, DOI 10.1016/j.cellsig.2006.05.020; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Clark SD, 2010, PEPTIDES, V31, P130, DOI 10.1016/j.peptides.2009.10.015; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; Davey AE, 2012, ENDOCRINOLOGY, V153, P1232, DOI 10.1210/en.2011-1426; Erdmann F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117319; Figueroa KW, 2009, J PHARMACOL EXP THER, V328, P331, DOI 10.1124/jpet.108.145219; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gesty-Palmer D, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000071; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Guerrini R, 2010, MED RES REV, V30, P751, DOI 10.1002/med.20180; Han RW, 2009, NEUROSCI LETT, V455, P74, DOI 10.1016/j.neulet.2009.03.023; He XB, 2015, BIOCHEM J, V466, P391, DOI 10.1042/BJ20141146; Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276; Karpinsky-Semper D, 2014, MOL PHARMACOL, V85, P758, DOI 10.1124/mol.114.091843; Lee HY, 2010, FEBS LETT, V584, P4102, DOI 10.1016/j.febslet.2010.08.036; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Leonard SK, 2011, NEUROSCIENCE, V172, P153, DOI 10.1016/j.neuroscience.2010.10.020; Leonard SK, 2008, PSYCHOPHARMACOLOGY, V197, P601, DOI 10.1007/s00213-008-1080-4; Makita N, 2007, P NATL ACAD SCI USA, V104, P5443, DOI 10.1073/pnas.0701290104; Maudsley S, 2015, MOL PHARMACOL, V87, P706, DOI 10.1124/mol.114.095224; Meis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002695; Mottola DM, 2002, J PHARMACOL EXP THER, V301, P1166, DOI 10.1124/jpet.301.3.1166; Okamura N, 2011, NEUROPSYCHOPHARMACOL, V36, P744, DOI 10.1038/npp.2010.207; Patel CB, 2010, MOL PHARMACOL, V78, P983, DOI 10.1124/mol.110.067066; Pietras CO, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-39; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reinscheid RK, 2007, PEPTIDES, V28, P830, DOI 10.1016/j.peptides.2007.01.008; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Rizzi A, 2008, BRIT J PHARMACOL, V154, P471, DOI 10.1038/bjp.2008.96; Roth AL, 2006, J BIOL CHEM, V281, P20809, DOI 10.1074/jbc.M601846200; Sato S, 2002, International Patent Application, Patent No. [WO2002072829 A1, 2002072829]; Sbai O, 2014, FASEB J, V28, P3734, DOI 10.1096/fj.13-243402; Smith KL, 2006, ENDOCRINOLOGY, V147, P3510, DOI 10.1210/en.2005-1280; Sroussi HY, 2012, MOL IMMUNOL, V50, P42, DOI 10.1016/j.molimm.2011.12.001; Thorsell A, 2013, J NEUROSCI, V33, P10132, DOI 10.1523/JNEUROSCI.4742-12.2013; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Watts AO, 2013, BRIT J PHARMACOL, V168, P1662, DOI 10.1111/bph.12064; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005	52	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7505	7516		10.1074/jbc.M115.704122	http://dx.doi.org/10.1074/jbc.M115.704122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26865629	hybrid, Green Published			2022-12-28	WOS:000383447600025
J	Ghosh, U; Adhya, S				Ghosh, Utpalendu; Adhya, Samit			Non-equivalent Roles of AGO1 and AGO2 in mRNA Turnover and Translation of Cyclin D1 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; cyclin D1; microRNA (miRNA); mRNA; myogenesis	COMPLEXES; EXPRESSION; REPRESSION; PROTEINS; PROVIDES; CELLS	Mammalian Argonaute proteins (AGO1-4), in combination with microRNAs (miRs), bind to target mRNAs to initiate degradation and/or translation repression, but the relationships between these two effects is unclear. Although the AGO isoforms of Drosophila and plants perform different functions, mammalian AGO isoforms are considered to be functionally degenerate in terms of miR loading and downstream silencing effects. However, we found that, in quiescent (G0) rat myoblasts transiting to the G1 phase, cyclin D1 (Ccnd1) mRNA was associated with two functionally distinct AGO-miR complexes. While AGO1-miR-1 down-regulated the mRNA level, AGO2-let-7 delayed the timing of translation. Knockdown (KD) of AGO2, or antisense-mediated depletion of Let-7, caused Ccnd1 translation to occur earlier, but had no significant effect on mRNA abundance. Conversely, down-regulation of either AGO1 or miR-1, resulted in elevated Ccnd1 mRNA levels at early times, but failed to affect the timing of translation. These results show that the two miR-mediated silencing effects, viz. mRNA decay and translation repression, are independent processes induced by individual AGO isoforms in association with specific miRs.	[Ghosh, Utpalendu; Adhya, Samit] CSIR, Indian Inst Chem Biol, Genet Engn Lab, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Adhya, S (corresponding author), CSIR, Indian Inst Chem Biol, Genet Engn Lab, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	nilugrandson@gmail.com			Project BEnD of CSIR-IICB [BSC0206]	Project BEnD of CSIR-IICB	This work was supported by Project BEnD (BSC0206) of CSIR-IICB. The authors declare that they have no conflicts of interest with the contents of this article.	Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Bakre A, 2012, J GEN VIROL, V93, P2346, DOI 10.1099/vir.0.044255-0; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fu X, 2014, ONCOGENE, V33, P4296, DOI 10.1038/onc.2013.385; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo Y, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-41; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Huang V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003821; Hur JK, 2013, J BIOL CHEM, V288, P7829, DOI 10.1074/jbc.M112.441030; Izaurralde E, 2015, SCIENCE, V349, P380, DOI 10.1126/science.1260969; Jash S, 2014, MOL CELL BIOL, V34, P3594, DOI 10.1128/MCB.00742-14; Jash S, 2012, FASEB J, V26, P4187, DOI 10.1096/fj.11-203232; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Ritchie W, 2014, BIOCHEM BIOPH RES CO, V445, P780, DOI 10.1016/j.bbrc.2014.01.181; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Wu PH, 2013, MOL CELL, V52, P113, DOI 10.1016/j.molcel.2013.08.023; Yamakawa N, 2014, NUCLEIC ACIDS RES, V42, P5289, DOI 10.1093/nar/gku137; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Zhang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041478	31	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7119	7127		10.1074/jbc.M115.696377	http://dx.doi.org/10.1074/jbc.M115.696377			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26846850	Green Published, hybrid			2022-12-28	WOS:000373299700045
J	Jang, KK; Gil, SY; Lim, JG; Choi, SH				Jang, Kyung Ku; Gil, So Yeon; Lim, Jong Gyu; Choi, Sang Ho			Regulatory Characteristics of Vibrio vulnificus gbpA Gene Encoding a Mucin-binding Protein Essential for Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial adhesion; gene regulation; mucin; oxidative stress; quorum sensing; CRP; GbpA; IscR; LuxR homologue; Vibrio vulnificus	AMP RECEPTOR PROTEIN; ESCHERICHIA-COLI; LUXR HOMOLOG; CYCLIC-AMP; ASSEMBLY PROTEINS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; SIALIC-ACID; HOST-CELLS; ISCR	Binding to mucin is the initial step for enteropathogens to establish pathogenesis. An open reading frame, gbpA, of Vibrio vulnificus was identified and characterized in this study. Compared with wild type, the gbpA mutant was impaired in binding to mucin-agar and the mucin-secreting HT29-methotrexate cells, and the impaired mucin binding was restored by the purified GbpA provided exogenously. The gbpA mutant had attenuated virulence and ability of intestinal colonization in a mouse model, indicating that GbpA is a mucin-binding protein and essential for pathogenesis of V. vulnificus. The gbpA transcription was growth phase-dependent, reaching a maximum during the exponential phase. The Fe-S cluster regulator (IscR) and the cyclic AMP receptor protein (CRP) coactivated, whereas SmcR, a LuxR homologue, repressed gbpA. The cellular levels of IscR, CRP, and SmcR were not significantly affected by one another, indicating that the regulator proteins function cooperatively to regulate gbpA rather than sequentially in a regulatory cascade. The regulatory proteins directly bind upstream of the gbpA promoter P-gbpA. DNase I protection assays, together with the deletion analyses of P-gbpA, demonstrated that IscR binds to two specific sequences centered at -164.5 and -106, and CRP and SmcR bind specifically to the sequences centered at -68 and -45, respectively. Furthermore, gbpA was induced by exposure to H2O2, and the induction appeared to be mediated by elevated intracellular levels of IscR. Consequently, the combined results indicated that IscR, CRP, and SmcR cooperate for precise regulation of gbpA during the V. vulnificus pathogenesis.	[Jang, Kyung Ku; Gil, So Yeon; Lim, Jong Gyu; Choi, Sang Ho] Seoul Natl Univ, Ctr Food Safety & Toxicol, Dept Agr Biotechnol, Natl Res Lab Mol Microbiol & Toxicol, Seoul 151921, South Korea	Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	choish@snu.ac.kr	Jang, Kyungku/GLT-4101-2022	Jang, Kyungku/0000-0002-0403-1256; Choi, Sang Ho/0000-0003-3865-1039	National Research Foundation - Ministry of Science, ICT, and Future Planning [2015R1A2A1A13001654]; R&D Convergence Center Support Program of the Ministry of Agriculture, Food and Rural Affairs; Ministry of Food and Drug Safety [14162MFDS972]	National Research Foundation - Ministry of Science, ICT, and Future Planning; R&D Convergence Center Support Program of the Ministry of Agriculture, Food and Rural Affairs; Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This work was supported by Mid-career Researcher Program Grant 2015R1A2A1A13001654 through the National Research Foundation funded by Ministry of Science, ICT, and Future Planning; the R&D Convergence Center Support Program of the Ministry of Agriculture, Food and Rural Affairs; and Ministry of Food and Drug Safety, Grant 14162MFDS972 ( to S. H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Bhowmick R, 2008, INFECT IMMUN, V76, P4968, DOI 10.1128/IAI.01615-07; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Cameron ADS, 2006, NUCLEIC ACIDS RES, V34, P6001, DOI 10.1093/nar/gkl734; Choi HK, 2002, J BIOL CHEM, V277, P47292, DOI 10.1074/jbc.M206893200; Froelich B, 2013, APPL ENVIRON MICROB, V79, P5208, DOI 10.1128/AEM.01110-13; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Green J, 2014, CURR OPIN MICROBIOL, V18, P1, DOI 10.1016/j.mib.2014.01.003; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Hwang J, 2013, P NATL ACAD SCI USA, V110, pE2829, DOI 10.1073/pnas.1302859110; Jeong HG, 2009, INFECT IMMUN, V77, P3209, DOI 10.1128/IAI.00109-09; Jeong HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002581; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Jeong HS, 2010, J BIOL CHEM, V285, P9357, DOI 10.1074/jbc.M109.089987; Jude BA, 2009, J BACTERIOL, V191, P6911, DOI 10.1128/JB.00747-09; Juge N, 2012, TRENDS MICROBIOL, V20, P30, DOI 10.1016/j.tim.2011.10.001; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Kim BS, 2011, J BIOL CHEM, V286, P40889, DOI 10.1074/jbc.M111.300988; Kim SM, 2013, INFECT IMMUN, V81, P3721, DOI 10.1128/IAI.00561-13; Kim SM, 2012, MICROBIOL-SGM, V158, P2017, DOI 10.1099/mic.0.059071-0; Kim S, 2014, MOL MICROBIOL, V93, P992, DOI 10.1111/mmi.12712; Kim YR, 2003, BIOCHEM BIOPH RES CO, V304, P405, DOI 10.1016/S0006-291X(03)00613-2; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Lee DH, 2008, J BIOL CHEM, V283, P23610, DOI 10.1074/jbc.M801480200; Lee JH, 2004, INFECT IMMUN, V72, P4905, DOI 10.1128/IAI.72.8.4905-4910.2004; Lee KJ, 2010, INFECT IMMUN, V78, P2408, DOI 10.1128/IAI.01194-09; Lee SJ, 2016, INT J MED MICROBIOL, V306, P10, DOI 10.1016/j.ijmm.2015.10.006; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; Lim JG, 2014, J BIOL CHEM, V289, P36263, DOI 10.1074/jbc.M114.611020; Lim JG, 2014, INFECT IMMUN, V82, P569, DOI 10.1128/IAI.01141-13; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Nesbit AD, 2009, J MOL BIOL, V387, P28, DOI 10.1016/j.jmb.2009.01.055; Neutra M., 1987, PHYSL GASTROINTESTIN, P975; Oh MH, 2009, INFECT IMMUN, V77, P1208, DOI 10.1128/IAI.01006-08; Paranjpye RN, 2005, INFECT IMMUN, V73, P1411, DOI 10.1128/IAI.73.3.1411-1422.2005; Paranjpye RN, 2007, APPL ENVIRON MICROB, V73, P5041, DOI 10.1128/AEM.00641-07; Park JH, 2011, J BACTERIOL, V193, P2062, DOI 10.1128/JB.00110-11; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Shao CP, 2011, J BACTERIOL, V193, P2557, DOI 10.1128/JB.01259-10; Shao CP, 2001, J BACTERIOL, V183, P1369, DOI 10.1128/JB.183.4.1369-1375.2001; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016; Vieira MAM, 2010, INFECT IMMUN, V78, P927, DOI 10.1128/IAI.01115-09; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; Wiggins R, 2001, SEX TRANSM INFECT, V77, P402, DOI 10.1136/sti.77.6.402; Wong E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002373; WRIGHT AC, 1990, INFECT IMMUN, V58, P1769, DOI 10.1128/IAI.58.6.1769-1773.1990; Wu Y, 2009, J BACTERIOL, V191, P1248, DOI 10.1128/JB.01086-08; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; Yeung ATY, 2012, MBIO, V3, DOI 10.1128/mBio.00073-12; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	61	17	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5774	5787		10.1074/jbc.M115.685321	http://dx.doi.org/10.1074/jbc.M115.685321			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26755724	hybrid, Green Published			2022-12-28	WOS:000372551800026
J	El Asmar, Z; Terrand, J; Jenty, M; Host, L; Mlih, M; Zerr, A; Justiniano, H; Matz, RL; Boudier, C; Scholler, E; Garnier, JM; Bertaccini, D; Thierse, D; Schaeffer, C; Van Dorsselaer, A; Herz, J; Bruban, V; Boucher, P				El Asmar, Zeina; Terrand, Jerome; Jenty, Marion; Host, Lionel; Mlih, Mohamed; Zerr, Aurelie; Justiniano, Helene; Matz, Rachel L.; Boudier, Christian; Scholler, Estelle; Garnier, Jean-Marie; Bertaccini, Diego; Thierse, Daniele; Schaeffer, Christine; Van Dorsselaer, Alain; Herz, Joachim; Bruban, Veronique; Boucher, Philippe			Convergent Signaling Pathways Controlled by LRP1 (Receptor-related Protein 1) Cytoplasmic and Extracellular Domains Limit Cellular Cholesterol Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; atherosclerosis; cholesterol regulation; transgenic mice; Wnt pathway; lipoprotein receptor-related protein 1 (LRP1)	BINDING CASSETTE TRANSPORTER; FATTY-ACID SYNTHESIS; VASCULAR WALL; TYROSINE PHOSPHORYLATION; ADIPOSE-TISSUE; TGF-BETA; ABCG1; EFFLUX; EXPRESSION; MEMBRANE	The low density lipoprotein receptor-related protein 1 (LRP1) is a ubiquitously expressed cell surface receptor that protects from intracellular cholesterol accumulation. However, the underlying mechanisms are unknown. Here we show that the extracellular () chain of LRP1 mediates TGF-induced enhancement of Wnt5a, which limits intracellular cholesterol accumulation by inhibiting cholesterol biosynthesis and by promoting cholesterol export. Moreover, we demonstrate that the cytoplasmic () chain of LRP1 suffices to limit cholesterol accumulation in LRP1(-/-) cells. Through binding of Erk2 to the second of its carboxyl-terminal NPXY motifs, LRP1 -chain positively regulates the expression of ATP binding cassette transporter A1 (ABCA1) and of neutral cholesterol ester hydrolase (NCEH1). These results highlight the unexpected functions of LRP1 and the canonical Wnt5a pathway and new therapeutic potential in cholesterol-associated disorders including cardiovascular diseases.	[El Asmar, Zeina; Terrand, Jerome; Jenty, Marion; Host, Lionel; Mlih, Mohamed; Zerr, Aurelie; Justiniano, Helene; Matz, Rachel L.; Boudier, Christian; Scholler, Estelle; Bruban, Veronique; Boucher, Philippe] Univ Strasbourg, UMR 7213, CNRS, 74 Route Rhin,CS 60024, F-67401 Illkirch Graffenstaden, France; [Garnier, Jean-Marie] Univ Strasbourg, CNRS UMR 7104, INSERM 964, IGBMC, F-67401 Illkirch Graffenstaden, France; [Bertaccini, Diego; Thierse, Daniele; Schaeffer, Christine; Van Dorsselaer, Alain] Univ Strasbourg, UMR 7178, CNRS, F-67087 Strasbourg, France; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dallas, TX 75390 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bruban, V; Boucher, P (corresponding author), Univ Strasbourg, UMR 7213, CNRS, 74 Route Rhin,CS 60024, F-67401 Illkirch Graffenstaden, France.	veronique.bruban@unistra.fr; philippe.boucher@unistra.fr	Asmar, Zeina El/AAR-7053-2021; Mlih, Mohamed/O-4834-2019; Boudier, Christian/N-3841-2018	Mlih, Mohamed/0000-0003-3491-9616; Boudier, Christian/0000-0002-5534-6389; Terrand, jerome/0000-0002-8169-7713; MATZ, Rachel/0000-0001-5832-7063; Boucher, Philippe/0000-0002-3928-9812	Fondation de France; Fondation pour la Recherche Medicale (FRM); Agence Nationale de la Recherche [ANR-06-Physio-032-01, ANR-09-BLAN-0121-01]; National Institutes of Health [HL63762]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093382] Funding Source: NIH RePORTER	Fondation de France(Fondation de France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from Fondation de France, Fondation pour la Recherche Medicale (FRM), and the Agence Nationale de la Recherche (ANR-06-Physio-032-01 and ANR-09-BLAN-0121-01). This work was also supported by National Institutes of Health Grant HL63762 (to J. H.).	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Argmann CA, 2001, ARTERIOSCL THROM VAS, V21, P2011, DOI 10.1161/hq1201.099426; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Buchmann J, 2007, ENDOCRINOLOGY, V148, P1561, DOI 10.1210/en.2006-1244; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Ghosh S, 2003, J LIPID RES, V44, P1833, DOI 10.1194/jlr.M300162-JLR200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Hu YW, 2010, J ATHEROSCLER THROMB, V17, P493, DOI 10.5551/jat.3152; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; KOVANEN PT, 1975, J LIPID RES, V16, P211; KRAUSE BR, 1984, J LIPID RES, V25, P97; Kumawat K, 2013, FASEB J, V27, P1631, DOI 10.1096/fj.12-217539; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lorkowski S, 2001, BIOCHEM BIOPH RES CO, V283, P821, DOI 10.1006/bbrc.2001.4863; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Malgor R, 2014, INFLAMM RES, V63, P277, DOI 10.1007/s00011-013-0697-x; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Oram JF, 2003, J BIOL CHEM, V278, P52379, DOI 10.1074/jbc.M310695200; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Phillips MC, 2014, J BIOL CHEM, V289, P24020, DOI 10.1074/jbc.R114.583658; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sekiya M, 2011, J ATHEROSCLER THROMB, V18, P359, DOI 10.5551/jat.7013; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Tarling EJ, 2012, BBA-MOL CELL BIOL L, V1821, P386, DOI 10.1016/j.bbalip.2011.07.011; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Tsaousi A, 2011, CURR OPIN LIPIDOL, V22, P350, DOI 10.1097/MOL.0b013e32834aa701; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, ARTERIOSCL THROM VAS, V27, P1603, DOI 10.1161/ATVBAHA.107.145789; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2006, ARTERIOSCL THROM VAS, V26, P1310, DOI 10.1161/01.ATV.0000218998.75963.02; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Woldt E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2087; Xie Q, 2006, ARTERIOSCL THROM VAS, V26, pE143, DOI 10.1161/01.ATV.0000245790.47112.b2; Xu DQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9100; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006853; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	51	25	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5116	5127		10.1074/jbc.M116.714485	http://dx.doi.org/10.1074/jbc.M116.714485			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26792864	hybrid, Green Published			2022-12-28	WOS:000371640600024
J	Li, Y; Li, JJ; Tian, ZH; Xu, Y; Zhang, JH; Liu, W; Tan, HR				Li, Yue; Li, Jingjing; Tian, Zhenhua; Xu, Yu; Zhang, Jihui; Liu, Wen; Tan, Huarong			Coordinative Modulation of Chlorothricin Biosynthesis by Binding of the Glycosylated Intermediates and End Product to a Responsive Regulator ChlF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotics; DNA-protein interaction; gene regulation; glycosylation; microbiology; chlorothricin; signaling molecule; TetR family regulator; Streptomyces antibioticus	GAMMA-BUTYROLACTONE RECEPTORS; ANTIBIOTIC BIOSYNTHESIS; POLYOXIN BIOSYNTHESIS; STREPTOMYCES-CACAOI; TETR FAMILY; GENE; ACTINOMADURA; THIOESTERASE; POLYKETIDE; MECHANISM	Chlorothricin, isolated from Streptomyces antibioticus, is a parent member of spirotetronate family of antibiotics that have long been appreciated for their remarkable biological activities. ChlF1 plays bifunctional roles in chlorothricin biosynthesis by binding to its target genes (chlJ, chlF1, chlG, and chlK). The dissociation constants of ChlF1 to these genes are approximate to 102-140 nm. A consensus sequence, 5-GTAANNATTTAC-3, was found in these binding sites. ChlF1 represses the transcription of chlF1, chlG, and chlK but activates chlJ, which encodes a key enzyme acyl-CoA carboxyl transferase involved in the chlorothricin biosynthesis. We demonstrate that the end product chlorothricin and likewise its biosynthetic intermediates (demethylsalicycloyl chlorothricin and deschloro-chlorothricin) can act as signaling molecules to modulate the binding of ChlF1 to its target genes. Intriguingly, a correlation between the antibacterial activity and binding ability of signaling molecules to the regulator ChlF1 is clearly observed. These features of the signaling molecules are associated with the glycosylation of spirotetronate macrolide aglycone. The findings provide new insights into the TetR family regulators responding to special structure of signaling molecules, and we reveal the regulatory mini-network mediated by ChlF1 in chlorothricin biosynthesis for the first time.	[Li, Yue; Li, Jingjing; Zhang, Jihui; Tan, Huarong] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Li, Yue; Li, Jingjing] Univ Chinese Acad Sci, Beijing 100101, Peoples R China; [Tian, Zhenhua; Xu, Yu; Liu, Wen] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Tan, HR (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China.; Liu, W (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China.	wliu@mail.sioc.ac.cn; tanhr@im.ac.cn		Li, Jingjing/0000-0002-7526-5308	Ministry of Science and Technology of China [2015CB150600, 2013CB734001]; National Natural Science Foundation of China [31270110, 31370097]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grants 2015CB150600 and 2013CB734001 and National Natural Science Foundation of China Grants 31270110 and 31370097.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; Cuthbertson L, 2013, CHEM BIOL, V20, P232, DOI 10.1016/j.chembiol.2012.11.011; Ding W, 2010, CHEM BIOL, V17, P495, DOI 10.1016/j.chembiol.2010.04.009; Hu ZH, 2003, MICROBIOL-SGM, V149, P2213, DOI 10.1099/mic.0.26015-0; Igarashi Y, 2012, J ANTIBIOT, V65, P355, DOI 10.1038/ja.2012.30; Jimenez JI, 2011, ENVIRON MICROBIOL, V13, P1718, DOI 10.1111/j.1462-2920.2011.02471.x; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jia XY, 2006, CHEM BIOL, V13, P575, DOI 10.1016/j.chembiol.2006.03.008; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kotowska M, 2009, APPL ENVIRON MICROB, V75, P887, DOI 10.1128/AEM.01371-08; Lacoske MH, 2015, J NAT PROD, V78, P562, DOI 10.1021/np500757w; Li R, 2010, MOL MICROBIOL, V75, P349, DOI 10.1111/j.1365-2958.2009.06968.x; Li R, 2009, MICROBIOL-SGM, V155, P1819, DOI 10.1099/mic.0.028639-0; Li SM, 2013, ORG LETT, V15, P1374, DOI 10.1021/ol400342e; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Liu TG, 2006, CHEM BIOL, V13, P945, DOI 10.1016/j.chembiol.2006.07.006; MORIMOTO M, 1982, J ANTIBIOT, V35, P1033, DOI 10.7164/antibiotics.35.1033; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Sambrook J., 2001, MOL CLONING LAB MANU; SCHINDLER PW, 1975, EUR J BIOCHEM, V51, P579, DOI 10.1111/j.1432-1033.1975.tb03959.x; Shao ZH, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0264-y; Tahlan K, 2007, MOL MICROBIOL, V63, P951, DOI 10.1111/j.1365-2958.2006.05559.x; Tian ZH, 2015, NAT CHEM BIOL, V11, P259, DOI [10.1038/NCHEMBIO.1769, 10.1038/nchembio.1769]; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; WAITZ JA, 1981, J ANTIBIOT, V34, P1101, DOI 10.7164/antibiotics.34.1101; Wang JL, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-35; Wang J, 2011, MOL MICROBIOL, V82, P236, DOI 10.1111/j.1365-2958.2011.07811.x; Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106; Xu GM, 2010, J BIOL CHEM, V285, P27440, DOI 10.1074/jbc.M110.143081; Xu Y, 2012, MBIO, V3, DOI 10.1128/mBio.00191-12; Zianni Michael, 2006, J Biomol Tech, V17, P103; Zou ZZ, 2014, MOL MICROBIOL, V94, P490, DOI 10.1111/mmi.12752	34	23	26	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5406	5417		10.1074/jbc.M115.695874	http://dx.doi.org/10.1074/jbc.M115.695874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26750095	Green Published, hybrid			2022-12-28	WOS:000371640600048
J	Panama, BK; Korogyi, AS; Aschar-Sobbi, R; Oh, Y; Gray, CBB; Gang, HY; Brown, JH; Kirshenbaum, LA; Backx, PH				Panama, Brian K.; Korogyi, Adam S.; Aschar-Sobbi, Roozbeh; Oh, Yena; Gray, Charles B. B.; Gang, Hongying; Brown, Joan Heller; Kirshenbaum, Lorrie A.; Backx, Peter H.			Reductions in the Cardiac Transient Outward K+ Current I-to Caused by Chronic beta-Adrenergic Receptor Stimulation Are Partly Rescued by Inhibition of Nuclear Factor kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adrenergic receptor; Ca2+; calmodulin-dependent protein kinase (CaMK); cardiomyocyte; potassium channel; transcription	CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; ACTION-POTENTIAL REPOLARIZATION; VENTRICULAR MYOCYTES; POTASSIUM CURRENT; GENE-EXPRESSION; MYOCARDIAL-INFARCTION; CA2+ RELEASE; HYPERTROPHY; PHOSPHORYLATION; OVEREXPRESSION	The fast transient outward potassium current (I-to,I-f) plays a critical role in the electrical and contractile properties of the myocardium. I-to,I-f channels are formed by the co-assembly of the pore-forming -subunits, Kv4.2 and Kv4.3, together with the accessory -subunit KChIP2. Reductions of I-to,I-f are common in the diseased heart, which is also associated with enhanced stimulation of -adrenergic receptors (-ARs). We used cultured neonatal rat ventricular myocytes to examine how chronic -AR stimulation decreases I-to,I-f. To determine which downstream pathways mediate these I-to,I-f changes, adenoviral infections were used to inhibit CaMKIIc, CaMKIIb, calcineurin, or nuclear factor B (NF-B). We observed that chronic -AR stimulation with isoproterenol (ISO) for 48 h reduced I-to,I-f along with mRNA expression of all three of its subunits (Kv4.2, Kv4.3, and KChIP2). Inhibiting either CaMKIIc nor CaMKIIb did not prevent the ISO-mediated I-to,I-f reductions, even though CaMKIIc and CaMKIIb clearly regulated I-to,I-f and the mRNA expression of its subunits. Likewise, calcineurin inhibition did not prevent the I-to,I-f reductions induced by -AR stimulation despite strongly modulating I-to,I-f and subunit mRNA expression. In contrast, NF-B inhibition partly rescued the ISO-mediated I-to,I-f reductions in association with restoration of KChIP2 mRNA expression. Consistent with these observations, KChIP2 promoter activity was reduced by p65 as well as -AR stimulation. In conclusion, NF-B, and not CaMKII or calcineurin, partly mediates the I-to,I-f reductions induced by chronic -AR stimulation. Both mRNA and KChIP2 promoter data suggest that the ISO-induced I-to,I-f reductions are, in part, mediated through reduced KChIP2 transcription caused by NF-B activation.	[Panama, Brian K.; Korogyi, Adam S.; Aschar-Sobbi, Roozbeh; Oh, Yena; Backx, Peter H.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Backx, Peter H.] Univ Toronto, Univ Hlth Network, Div Cardiol, Toronto, ON M5G 1L7, Canada; [Gray, Charles B. B.; Brown, Joan Heller] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92161 USA; [Panama, Brian K.] Masonic Med Res Lab, Dept Expt Cardiol, Utica, NY 13501 USA; [Gang, Hongying; Kirshenbaum, Lorrie A.] Univ Manitoba, Dept Physiol, Fac Med, Inst Cardiovasc Sci,St Boniface Gen Hosp Res Ctr, Winnipeg, MB R2H 2A6, Canada	York University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Diego; Masonic Medical Research Laboratory; University of Manitoba; Children's Hospital Research Institute of Manitoba	Backx, PH (corresponding author), 4700 Keele St,135A Farquharson Bldg, Toronto, ON M3J 1P3, Canada.	pbackx@yorku.ca		Ryplanski, Kairee/0000-0002-3737-7181	Canadian Institutes of Health Research [MOP185773, MOP74456]; National Institutes of Health [P01-HL080101]; HSF of Canada; H&SF/Richard Lewar Centre of Excellence; NIH [T32GM007752]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HSF of Canada; H&SF/Richard Lewar Centre of Excellence; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Canadian Institutes of Health Research Grant MOP185773 (to P. H. B.) and Grant MOP74456 (to L. A. K.) and by National Institutes of Health Grant P01-HL080101 (to J. H. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by fellowships from H&SF of Canada and the H&SF/Richard Lewar Centre of Excellence.; Supported by NIH Grant T32GM007752.	Baltas LG, 1997, FEBS LETT, V409, P131, DOI 10.1016/S0014-5793(97)00470-5; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calloe K, 2009, CARDIOVASC RES, V81, P686, DOI 10.1093/cvr/cvn339; Clark A L, 2000, Heart Fail Rev, V5, P101, DOI 10.1023/A:1009854325711; Dhingra R, 2013, CIRC-HEART FAIL, V6, P335, DOI 10.1161/CIRCHEARTFAILURE.112.000061; Foeger NC, 2013, J PHYSIOL-LONDON, V591, P4149, DOI 10.1113/jphysiol.2013.255836; Gong NL, 2006, J BIOL CHEM, V281, P38498, DOI 10.1074/jbc.M607774200; Grimm M, 2015, J MOL CELL CARDIOL, V85, P282, DOI 10.1016/j.yjmcc.2015.06.007; Hagemann D, 2001, MOL CELL BIOCHEM, V220, P69, DOI 10.1023/A:1010899724222; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hoch B, 1999, CIRC RES, V84, P713, DOI 10.1161/01.RES.84.6.713; Jia Y, 2006, CIRC RES, V98, P386, DOI 10.1161/01.RES.0000201956.86258.e1; Jin HW, 2010, J MOL CELL CARDIOL, V48, P1169, DOI 10.1016/j.yjmcc.2009.12.019; Kaprielian R, 2002, AM J PHYSIOL-HEART C, V283, pH1157, DOI 10.1152/ajpheart.00518.2001; Kassiri Z, 2002, J MOL MED, V80, P351, DOI 10.1007/s00109-002-0325-7; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; LI CCH, 1994, J BIOL CHEM, V269, P30089; Ling HY, 2013, CIRC RES, V112, P935, DOI 10.1161/CIRCRESAHA.112.276915; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonnell SM, 2009, CIRC RES, V105, P316, DOI 10.1161/CIRCRESAHA.109.194035; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Panama BK, 2011, CIRC RES, V108, P537, DOI 10.1161/CIRCRESAHA.110.229112; Regula KM, 2004, CIRCULATION, V110, P3795, DOI 10.1161/01.CIR.0000150537.59754.55; Rossow CF, 2004, CIRC RES, V94, P1340, DOI 10.1161/01.RES.0000128406.08418.34; Rossow CF, 2009, J MOL CELL CARDIOL, V46, P249, DOI 10.1016/j.yjmcc.2008.10.016; Sah R, 2003, J PHYSIOL-LONDON, V546, P5, DOI 10.1113/jphysiol.2002.026468; Sah R, 2002, CIRC RES, V90, P165, DOI 10.1161/hh0202.103315; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Sucharov CC, 2006, AM J PHYSIOL-HEART C, V291, pH1299, DOI 10.1152/ajpheart.00017.2006; Wagner S, 2009, CIRC-ARRHYTHMIA ELEC, V2, P285, DOI 10.1161/CIRCEP.108.842799; Wickenden AD, 1997, J PHYSIOL-LONDON, V504, P271, DOI 10.1111/j.1469-7793.1997.271be.x; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zobel C, 2002, CIRCULATION, V106, P2385, DOI 10.1161/01.CIR.0000033970.22130.93	34	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4156	4165		10.1074/jbc.M115.694984	http://dx.doi.org/10.1074/jbc.M115.694984			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26742842	hybrid, Green Published			2022-12-28	WOS:000371338400039
J	Aykul, S; Martinez-Hackert, E				Aykul, Senem; Martinez-Hackert, Erik			Transforming Growth Factor-beta Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MORPHOGENETIC PROTEIN; KINASE 1 ALK1; TGF-BETA; ACTIVIN-A; EXTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; SMAD1/5 PHOSPHORYLATION; CELL-PROLIFERATION; TISSUE-REPAIR; COMPLEX	Transforming growth factor-beta (TGT-beta) family ligands are pleiotropic cytokines. Their physiological activities are not determined by a simple coupling of stimulus and response, but depend critically on context, i.e. the interplay of receptors, ligands, and regulators that form the TGF-beta signal transduction system of a cell or tissue. How these different components combine to regulate signaling activities remains poorly understood. Here, we describe a ligand-mediated mechanism of signaling regulation. Based on the observation that the type II TGF-beta family receptors ActRIIA, ActRIIB, and BMPRII interact with a large group of overlapping ligands at overlapping epitopes, we hypothesized high affinity ligands compete with low affinity ligands for receptor binding and signaling. We show activin A and other high affinity ligands directly inhibited signaling by the low affinity ligands BMP-2, BMP-7, and BMP-9. We demonstrate activin A functions as a competitive inhibitor that blocks the ligand binding epitope on type II receptors. We propose binding competition and signaling antagonism are integral functions of the TGF-beta signal transduction system. These functions could help explain how activin A modulates physiological signaling during extraordinary cellular responses, such as injury and wound healing, and how activin A could elicit disease phenotypes such as cancer-related muscle wasting and fibrosis.	[Aykul, Senem; Martinez-Hackert, Erik] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Martinez-Hackert, E (corresponding author), Michigan State Univ, Biochem Rm 509,603 Wilson Rd, E Lansing, MI 48824 USA.	emh@msu.edu		AYKUL, SENEM/0000-0001-7250-2913; Martinez-Hackert, Erik/0000-0002-6182-7023	Michigan State University; Clinical and Translational Sciences Institute; National Institutes of Health [R41 AR068804-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R41AR068804] Funding Source: NIH RePORTER	Michigan State University; Clinical and Translational Sciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by Michigan State University, the Clinical and Translational Sciences Institute,and National Institutes of Health Grant R41 AR068804-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amthor H, 2002, DEV BIOL, V243, P115, DOI 10.1006/dbio.2001.0555; Antsiferova M, 2012, J CELL SCI, V125, P3929, DOI 10.1242/jcs.094789; Attisano L, 1996, MOL CELL BIOL, V16, P1066; Aykul S, 2016, J MOL BIOL, V428, P590, DOI 10.1016/j.jmb.2016.01.011; Aykul S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114954; Baardsnes J, 2009, BIOCHEMISTRY-US, V48, P2146, DOI 10.1021/bi8019004; Baker JM, 2014, JOVE-J VIS EXP, DOI 10.3791/50282; Caja L, 2012, CURR PHARM DESIGN, V18, P4072, DOI 10.2174/138161212802430459; Cash JN, 2009, EMBO J, V28, P2662, DOI 10.1038/emboj.2009.205; Chen JL, 2014, FASEB J, V28, P1711, DOI 10.1096/fj.13-245894; Chen YG, 2002, EXP BIOL MED, V227, P75, DOI 10.1177/153537020222700201; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; De Crescenzo G, 2003, J MOL BIOL, V328, P1173, DOI 10.1016/S0022-2836(03)00360-7; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; Gamer LW, 2005, DEV BIOL, V285, P156, DOI 10.1016/j.ydbio.2005.06.012; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Harada K, 1996, J CLIN ENDOCR METAB, V81, P2125, DOI 10.1210/jc.81.6.2125; Hatsell SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4358; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hinck AP, 2012, FEBS LETT, V586, P1860, DOI 10.1016/j.febslet.2012.05.028; HULLY JR, 1994, HEPATOLOGY, V20, P854, DOI 10.1002/hep.1840200413; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Klammert U, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0183-8; Kokabu S, 2012, MOL ENDOCRINOL, V26, P87, DOI 10.1210/me.2011-1168; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kropf J, 1997, CLIN CHEM, V43, P1965; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lebrun JJ, 1997, MOL CELL BIOL, V17, P1682, DOI 10.1128/MCB.17.3.1682; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Lowery JW, 2015, J CELL SCI, V128, P1308, DOI 10.1242/jcs.156737; Martens JWM, 1997, ENDOCRINOLOGY, V138, P2928, DOI 10.1210/en.138.7.2928; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Moura J, 2013, ARCH DERMATOL RES, V305, P557, DOI 10.1007/s00403-013-1381-2; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Olsen OE, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0104-z; Oshimori N, 2012, CELL STEM CELL, V11, P751, DOI 10.1016/j.stem.2012.11.001; Pearsall RS, 2008, P NATL ACAD SCI USA, V105, P7082, DOI 10.1073/pnas.0711263105; Phillips DJ, 2009, CYTOKINE GROWTH F R, V20, P153, DOI 10.1016/j.cytogfr.2009.02.007; Piek E, 1999, J CELL PHYSIOL, V180, P141, DOI 10.1002/(SICI)1097-4652(199908)180:2<141::AID-JCP1>3.0.CO;2-I; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Rejon CA, 2013, CELL SIGNAL, V25, P2717, DOI 10.1016/j.cellsig.2013.09.002; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Ruckle J, 2009, J BONE MINER RES, V24, P744, DOI 10.1359/JBMR.081208; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Saunier EF, 2006, CURR CANCER DRUG TAR, V6, P565, DOI 10.2174/156800906778742460; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Sebald W, 2004, BIOL CHEM, V385, P697, DOI 10.1515/BC.2004.086; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Werner S, 2006, CYTOKINE GROWTH F R, V17, P157, DOI 10.1016/j.cytogfr.2006.01.001; Wiater E, 2003, J BIOL CHEM, V278, P7934, DOI 10.1074/jbc.M209710200; Wrana JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011197; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	74	68	69	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10792	10804		10.1074/jbc.M115.713487	http://dx.doi.org/10.1074/jbc.M115.713487			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26961869	hybrid, Green Published			2022-12-28	WOS:000377042600030
J	Coleman, SK; Hou, Y; Willibald, M; Semenov, A; Moykkynen, T; Keinanen, K				Coleman, Sarah K.; Hou, Ying; Willibald, Marina; Semenov, Artur; Moykkynen, Tommi; Keinanen, Kari			Aggregation Limits Surface Expression of Homomeric GluA3 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA receptor; AMPAR); ionotropic glutamate receptor; protein aggregation; protein assembly; protein folding; protein trafficking; surface expression	N-TERMINAL DOMAIN; AMPA RECEPTOR; LIGAND-BINDING; ENDOPLASMIC-RETICULUM; ACID AMPA; SYNAPTIC PLASTICITY; GLUTAMATE-RECEPTOR; SUBUNIT; TRAFFICKING; BIOGENESIS	AMPA receptors are glutamate-gated cation channels assembled from GluA1-4 subunits and have properties that are strongly dependent on the subunit composition. The subunits have different propensities to form homomeric or various heteromeric receptors expressed on cell surface, but the underlying mechanisms are still poorly understood. Here, we examined the biochemical basis for the poor ability of GluA3 subunits to form homomeric receptors, linked previously to two amino acid residues, Tyr-454 and Arg-461, in its ligand binding domain (LBD). Surface expression of GluA3 was improved by co-assembly with GluA2 but not with stargazin, a trafficking chaperone and modulator of AMPA receptors. The secretion efficiency of GluA2 and GluA3 LBDs paralleled the transport difference between the respective full-length receptors and was similarly dependent on Tyr-454/Arg-461 but not on LBD stability. In comparison to GluA2, GluA3 homomeric receptors showed a strong and Tyr-454/Arg-461-dependent tendency to aggregate both in the macroscopic scale measured as lower solubility in nonionic detergent and in the microscopic scale evident as the preponderance of hydrodynamically large structures in density gradient centrifugation and native gel electrophoresis. We conclude that the impaired surface expression of homomeric GluA3 receptors is caused by nonproductive assembly and aggregation to which LBD residues Tyr-454 and Arg-461 strongly contribute. This aggregation inhibits the entry of newly synthesized GluA3 receptors to the secretory pathway.	[Coleman, Sarah K.; Hou, Ying; Willibald, Marina; Semenov, Artur; Moykkynen, Tommi; Keinanen, Kari] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, POB 56,Viikinkaari 9, FI-00014 Helsinki, Finland; [Coleman, Sarah K.] Univ Westminster, Dept Life Sci, London W1W 6UW, England; [Hou, Ying] Rm 11-1-602, Beijing 100176, Peoples R China; [Willibald, Marina] Forschungslabore Frauenklin Univ Klinikum, Life Sci Ctr, D-40225 Dusseldorf, Germany	University of Helsinki; University of Westminster	Keinanen, K (corresponding author), Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, POB 56,Viikinkaari 9, FI-00014 Helsinki, Finland.	kari.keinanen@helsinki.fi		Coleman, Sarah/0000-0002-1066-8296	Academy of Finland [137596]; Magnus Ehrnrooth Foundation	Academy of Finland(Academy of Finland); Magnus Ehrnrooth Foundation	This work was supported by grants from the Academy of Finland (137596; to K. K.) and from the Magnus Ehrnrooth Foundation (to S. K. C, A. S., and T. M). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Balasuriya D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.469205; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; Coleman SK, 2010, J BIOL CHEM, V285, P36032, DOI 10.1074/jbc.M110.156943; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; Coleman SK, 2003, J NEUROSCI, V23, P798; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Gan Q, 2015, J PHYSIOL-LONDON, V593, P39, DOI 10.1113/jphysiol.2014.273755; Gill MB, 2011, J NEUROSCI, V31, P6928, DOI 10.1523/JNEUROSCI.6271-10.2011; Gill MB, 2009, J BIOL CHEM, V284, P14503, DOI 10.1074/jbc.M900510200; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Grunwald ME, 2003, NEUROPHARMACOLOGY, V45, P768, DOI 10.1016/S0028-3908(03)00274-0; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Kim KS, 2010, J NEUROSCI, V30, P1064, DOI 10.1523/JNEUROSCI.3909-09.2010; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mayer ML, 2011, CURR OPIN NEUROBIOL, V21, P283, DOI 10.1016/j.conb.2011.02.001; Moykkynen T, 2014, J BIOL CHEM, V289, P13197, DOI 10.1074/jbc.M113.526301; Nakagawa T, 2010, MOL NEUROBIOL, V42, P161, DOI 10.1007/s12035-010-8149-x; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Pei WM, 2007, BIOCHEMISTRY-US, V46, P2027, DOI 10.1021/bi062213s; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; Shanks NF, 2010, J NEUROSCI, V30, P2728, DOI 10.1523/JNEUROSCI.5146-09.2010; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sukumaran M, 2012, ADV EXP MED BIOL, V970, P241, DOI 10.1007/978-3-7091-0932-8_11; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Zhao HY, 2012, J GEN PHYSIOL, V139, P371, DOI 10.1085/jgp.201210770	39	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8784	8794		10.1074/jbc.M115.689125	http://dx.doi.org/10.1074/jbc.M115.689125			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26912664	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000374773200039
J	Milovanovic, D; Platen, M; Junius, M; Diederichsen, U; Schaap, IAT; Honigmann, A; Jahn, R; van den Bogaart, G				Milovanovic, Dragomir; Platen, Mitja; Junius, Meike; Diederichsen, Ulf; Schaap, Iwan A. T.; Honigmann, Alf; Jahn, Reinhard; van den Bogaart, Geert			Calcium Promotes the Formation of Syntaxin 1 Mesoscale Domains through Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; membrane structure; plasma membrane; protein-lipid interaction; SNARE proteins; PI(4; 5)P-2; clustering; membrane domains; syntaxin 1	PLASMA-MEMBRANE; NEUROTRANSMITTER RELEASE; SECRETORY GRANULES; SYNAPTIC VESICLE; FORCE MICROSCOPY; T-SNARE; CLUSTERS; EXOCYTOSIS; MICRODOMAINS; SITES	Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) is a minor component of total plasma membrane lipids, but it has a substantial role in the regulation of many cellular functions, including exo- and endocytosis. Recently, it was shown that PI(4,5)P-2 and syntaxin 1, a SNARE protein that catalyzes regulated exocytosis, form domains in the plasma membrane that constitute recognition sites for vesicle docking. Also, calcium was shown to promote syntaxin 1 clustering in the plasma membrane, but the molecular mechanism was unknown. Here, using a combination of superresolution stimulated emission depletion microscopy, FRET, and atomic force microscopy, we show that Ca2+ acts as a charge bridge that specifically and reversibly connects multiple syntaxin 1/PI(4,5)P-2 complexes into larger mesoscale domains. This transient reorganization of the plasma membrane by physiological Ca2+ concentrations is likely to be important for Ca2+-regulated secretion.	[Milovanovic, Dragomir; Jahn, Reinhard; van den Bogaart, Geert] Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany; [Milovanovic, Dragomir] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci,Program Cellular Neurosci Neurodege, 333 Cedar St, New Haven, CT 06511 USA; [Platen, Mitja; Schaap, Iwan A. T.] Univ Gottingen, Fac Phys, Inst Phys 3, D-37077 Gottingen, Germany; [Junius, Meike; Diederichsen, Ulf] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; [Schaap, Iwan A. T.] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Honigmann, Alf] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [van den Bogaart, Geert] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands	Max Planck Society; Howard Hughes Medical Institute; Yale University; University of Gottingen; University of Gottingen; Heriot Watt University; Max Planck Society; Radboud University Nijmegen	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.; van den Bogaart, G (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands.	rjahn@gwdg.de; geert.vandenbogaart@radboudumc.ru.nl	van den Bogaart, Geert/A-1089-2014; Schaap, Iwan A. T./L-3177-2013; van den Bogaart, Geert/GLV-3283-2022; Honigmann, Alf/C-4832-2017	van den Bogaart, Geert/0000-0003-2180-6735; Schaap, Iwan A. T./0000-0001-6665-5104; van den Bogaart, Geert/0000-0003-2180-6735; Honigmann, Alf/0000-0003-0475-3790; Jahn, Reinhard/0000-0003-1542-3498; Diederichsen, Ulf/0000-0002-2654-9160; Milovanovic, Dragomir/0000-0002-6625-1879	Deutsche Forschungsgemeinschaft [SFB803]; National Institutes of Health [P01 GM072694]; Hypatia fellowship from the Radboud University Medical Center; European Research Council [FP7 336479]; Human Frontier Science Program, Netherlands Organization for Scientific Research [ALW VIDI 864.14.001]; Netherlands Organization for Scientific Research Gravitation Program [ICI-024.002.009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hypatia fellowship from the Radboud University Medical Center; European Research Council(European Research Council (ERC)European Commission); Human Frontier Science Program, Netherlands Organization for Scientific Research; Netherlands Organization for Scientific Research Gravitation Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB803 and National Institutes of Health Grant P01 GM072694 (to R. J.), a Hypatia fellowship from the Radboud University Medical Center, European Research Council Starting Grant FP7 336479, a career development award from the Human Frontier Science Program, Netherlands Organization for Scientific Research Grant ALW VIDI 864.14.001, and Netherlands Organization for Scientific Research Gravitation Program 2013 Grant ICI-024.002.009 (to G. v. d. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Barg S, 2010, P NATL ACAD SCI USA, V107, P20804, DOI 10.1073/pnas.1014823107; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Carvalho K, 2008, BIOPHYS J, V95, P4348, DOI 10.1529/biophysj.107.126912; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Davies JN, 2011, BIOCHEM BIOPH RES CO, V411, P562, DOI 10.1016/j.bbrc.2011.06.185; Ellenbroek WG, 2011, BIOPHYS J, V101, P2178, DOI 10.1016/j.bpj.2011.09.039; Gandasi NR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4914; Gottfert F, 2013, BIOPHYS J, V105, pL1, DOI 10.1016/j.bpj.2013.05.029; HESS P, 1982, J PHYSIOL-LONDON, V333, P173, DOI 10.1113/jphysiol.1982.sp014447; HEUMANN R, 1983, EXP CELL RES, V145, P179, DOI 10.1016/S0014-4827(83)80019-6; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Levental I, 2009, BIOCHEMISTRY-US, V48, P8241, DOI 10.1021/bi9007879; Lopez I, 2007, CELL CALCIUM, V41, P547, DOI 10.1016/j.ceca.2006.10.004; Milovanovic D, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00089; Milovanovic D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6984; Murray DH, 2011, BIOCHEMISTRY-US, V50, P9014, DOI 10.1021/bi201307u; Ortega-Esteban A, 2012, ULTRAMICROSCOPY, V114, P56, DOI 10.1016/j.ultramic.2012.01.007; Park Y, 2012, NAT STRUCT MOL BIOL, V19, P991, DOI 10.1038/nsmb.2375; Rickman C, 2010, J BIOL CHEM, V285, P13535, DOI 10.1074/jbc.M109.091058; Rizzoli SO, 2014, EMBO J, V33, P788, DOI 10.1002/embj.201386357; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sarmento MJ, 2014, BBA-BIOMEMBRANES, V1838, P822, DOI 10.1016/j.bbamem.2013.11.020; Schaap IAT, 2004, EUR BIOPHYS J BIOPHY, V33, P462, DOI 10.1007/s00249-003-0386-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Khuong TM, 2013, NEURON, V77, P1097, DOI 10.1016/j.neuron.2013.01.025; Torregrosa-Hetland CJ, 2011, J CELL SCI, V124, P727, DOI 10.1242/jcs.078600; van den Bogaart G, 2013, CURR TOP MEMBR, V72, P193, DOI 10.1016/B978-0-12-417027-8.00006-4; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Wang YH, 2012, J AM CHEM SOC, V134, P3387, DOI 10.1021/ja208640t; Weiss N, 2012, J BIOL CHEM, V287, P2810, DOI 10.1074/jbc.M111.290882; Williams D, 2009, MOL BIOL CELL, V20, P4910, DOI 10.1091/mbc.E09-04-0284; Zhang Li, 2012, Subcell Biochem, V59, P177, DOI 10.1007/978-94-007-3015-1_6; Zilly FE, 2011, EMBO J, V30, P1209, DOI 10.1038/emboj.2011.53	42	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7868	7876		10.1074/jbc.M116.716225	http://dx.doi.org/10.1074/jbc.M116.716225			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26884341	Green Published, hybrid			2022-12-28	WOS:000374056700010
J	Heir, P; Srikumar, T; Bikopoulos, G; Bunda, S; Poon, BP; Lee, JE; Raught, B; Ohh, M				Heir, Pardeep; Srikumar, Tharan; Bikopoulos, George; Bunda, Severa; Poon, Betty P.; Lee, Jeffrey E.; Raught, Brian; Ohh, Michael			Oxygen-dependent Regulation of Erythropoietin Receptor Turnover and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-HIPPEL-LINDAU; HYPOXIA-INDUCIBLE FACTOR; DIFFERENTIATED NEUROBLASTOMA SH-SY5Y; PROLYL HYDROXYLASE DOMAIN; TUMOR-SUPPRESSOR PROTEIN; CELL-SURFACE EXPRESSION; CONGENITAL POLYCYTHEMIA; MEDIATES UBIQUITINATION; PROLINE HYDROXYLATION; CHUVASH POLYCYTHEMIA	von Hippel-Lindau (VHL) disease is a rare familial cancer predisposition syndrome caused by a loss or mutation in a single gene, VHL, but it exhibits a wide phenotypic variability that can be categorized into distinct subtypes. The phenotypic variability has been largely argued to be attributable to the extent of deregulation of the alpha subunit of hypoxia-inducible factor alpha, a well established target of VHL E3 ubiquitin ligase, ECV (Elongins/Cul2/VHL). Here, we show that erythropoietin receptor (EPOR) is hydroxylated on proline 419 and 426 via prolyl hydroxylase 3. EPOR hydroxylation is required for binding to the beta domain of VHL and polyubiquitylation via ECV, leading to increased EPOR turnover. In addition, several type-specific VHL disease-causing mutants, including those that have retained proper binding and regulation of hypoxia-inducible factor alpha, showed a severe defect in binding prolyl hydroxylated EPOR peptides. These results identify EPOR as the second bona fide hydroxylation-dependent substrate of VHL that potentially influences oxygen homeostasis and contributes to the complex genotype-phenotype correlation in VHL disease.	[Heir, Pardeep; Bikopoulos, George; Bunda, Severa; Poon, Betty P.; Lee, Jeffrey E.; Ohh, Michael] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Poon, Betty P.; Ohh, Michael] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Srikumar, Tharan; Raught, Brian] Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Ohh, M (corresponding author), Univ Toronto, Dept Biochem, Dept Lab Med & Pathobiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	michael.ohh@utoronto.ca	Srikumar, Tharan/Q-5642-2016		Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from the Canadian Institutes of Health Research. The authors declare that they have no conflicts of interest with the contents of this article.	AKAHANE K, 1989, EXP HEMATOL, V17, P177; Ali N, 2009, BLOOD, V113, P3690, DOI 10.1182/blood-2008-10-176396; Anderson K, 2011, J BIOL CHEM, V286, P42027, DOI 10.1074/jbc.M111.303222; Arsenault PR, 2013, J BIOL CHEM, V288, P33571, DOI 10.1074/jbc.M113.482364; Astuti D, 2011, ENDOCR-RELAT CANCER, V18, P73, DOI 10.1677/ERC-10-0113; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Delhommeau F, 2006, CELL MOL LIFE SCI, V63, P2939, DOI 10.1007/s00018-006-6272-7; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; ERSLEV A, 1953, BLOOD, V8, P349, DOI 10.1182/blood.V8.4.349.349; Furlow PW, 2009, J BIOL CHEM, V284, P9050, DOI 10.1074/jbc.M808737200; Gopalakrishnan T V, 1979, Methods Enzymol, V58, P506; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hortner M, 2002, EUR J BIOCHEM, V269, P2516, DOI 10.1046/j.1432-1033.2002.02916.x; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Komatsu N, 1997, BLOOD, V89, P4021, DOI 10.1182/blood.V89.11.4021; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Lee FS, 2011, ANNU REV PATHOL-MECH, V6, P165, DOI 10.1146/annurev-pathol-011110-130321; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Motohashi T, 2001, EUR J HAEMATOL, V67, P88, DOI 10.1034/j.1600-0609.2001.t01-1-00446.x; Niu XM, 2009, AM J HEMATOL, V84, P74, DOI 10.1002/ajh.21327; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Pastore Y, 2003, AM J HUM GENET, V73, P412, DOI 10.1086/377108; Perrotta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012015; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Richard S, 2013, SEMIN CANCER BIOL, V23, P26, DOI 10.1016/j.semcancer.2012.05.005; Russell RC, 2011, NAT MED, V17, P845, DOI 10.1038/nm.2370; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shively SB, 2008, J PATHOL, V216, P514, DOI 10.1002/path.2435; STEIN AA, 1960, J NEUROSURG, V17, P751, DOI 10.3171/jns.1960.17.4.0751; Sulahian R, 2009, BLOOD, V113, P5287, DOI 10.1182/blood-2008-09-179572; Supino-Rosin L, 1999, EUR J BIOCHEM, V263, P410, DOI 10.1046/j.1432-1327.1999.00516.x; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Um M, 2006, J BIOL CHEM, V281, P5648, DOI 10.1074/jbc.M510943200; Um M, 2007, CELL SIGNAL, V19, P634, DOI 10.1016/j.cellsig.2006.08.014; Vortmeyer AO, 2003, CANCER RES, V63, P7051; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Zheng XN, 2014, GENE DEV, V28, P1429, DOI 10.1101/gad.242131.114	57	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7357	7372		10.1074/jbc.M115.694562	http://dx.doi.org/10.1074/jbc.M115.694562			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26846855	Green Published, hybrid			2022-12-28	WOS:000383447600013
J	Prior, KK; Wittig, I; Leisegang, MS; Groenendyk, J; Weissmann, N; Michalak, M; Jansen-Durr, P; Shah, AM; Brandes, RP				Prior, Kim-Kristin; Wittig, Ilka; Leisegang, Matthias S.; Groenendyk, Jody; Weissmann, Norbert; Michalak, Marek; Jansen-Duerr, Pidder; Shah, Ajay M.; Brandes, Ralf P.			The Endoplasmic Reticulum Chaperone Calnexin Is a NADPH Oxidase NOX4 Interacting Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); NADPH oxidase; protein-protein interaction; proteomics; reactive oxygen species (ROS); blue native PAGE	OXYGEN SPECIES GENERATION; NAD(P)H OXIDASE; SMOOTH-MUSCLE; QUALITY-CONTROL; IDENTIFICATION; REVEALS; FLAVOCYTOCHROME; GLYCOSYLATION; MITOCHONDRIA; DEGRADATION	Within the family of NADPH oxidases, NOX4 is unique as it is predominantly localized in the endoplasmic reticulum, has constitutive activity, and generates hydrogen peroxide (H2O2). We hypothesize that these features are consequences of a so far unidentified NOX4-interacting protein. Two-dimensional blue native (BN) electrophorese combined with SDS-PAGE yielded NOX4 to reside in macromolecular complexes. Interacting proteins were screened by quantitative SILAC (stable isotope labeling of amino acids in cell culture) co-immunoprecipitation (Co-IP) in HEK293 cells stably overexpressing NOX4. By this technique, several interacting proteins were identified with calnexin showing the most robust interaction. Calnexin also resided in NOX4-containing complexes as demonstrated by complexome profiling from BN-PAGE. The calnexin NOX4 interaction could be confirmed by reverse Co-IP and proximity ligation assay, whereas NOX1, NOX2, or NOX5 did not interact with calnexin. Calnexin deficiency as studied in mouse embryonic fibroblasts from calnexin(-/-) mice or in response to calnexin shRNA reduced cellular NOX4 protein expression and reactive oxygen species formation. Our results suggest that endogenous NOX4 forms macromolecular complexes with calnexin, which are needed for the proper maturation, processing, and function of NOX4 in the endoplasmic reticulum.	[Prior, Kim-Kristin; Leisegang, Matthias S.; Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Wittig, Ilka] Goethe Univ Frankfurt, Funct Prote, Core Unit SFB 815, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Wittig, Ilka] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60590 Frankfurt, Germany; [Groenendyk, Jody; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Weissmann, Norbert] Univ Giessen, Excellence Cluster Cardiopulm Syst, D-60590 Giessen, Germany; [Jansen-Duerr, Pidder] Univ Innsbruck, Inst Biomed Ageing Res, A-6020 Innsbruck, Austria; [Jansen-Duerr, Pidder] Univ Innsbruck, CMBI, A-6020 Innsbruck, Austria; [Shah, Ajay M.] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, London WC2R 2LS, England; [Prior, Kim-Kristin; Wittig, Ilka; Leisegang, Matthias S.; Brandes, Ralf P.] German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Theodor Stern Kai 7, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; University of Alberta; Justus Liebig University Giessen; University of Innsbruck; University of Innsbruck; University of London; King's College London; German Centre for Cardiovascular Research	Brandes, RP (corresponding author), Goethe Univ Frankfurt, Fachbereich Med, Inst Kardiovaskulare Physiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	brandes@vrc.uni-frankfurt.de	Leisegang, Matthias S./ABD-8062-2021; Jansen-Dürr, Pidder/ABG-2466-2020; Leisegang, Matthias S./P-6006-2017; Brandes, Ralf/L-3058-2017	Leisegang, Matthias S./0000-0002-6084-6484; Jansen-Dürr, Pidder/0000-0001-7771-3429; Leisegang, Matthias S./0000-0002-6084-6484; Brandes, Ralf/0000-0002-8035-0048; Weissmann, Norbert/0000-0003-2675-3871; Shah, Ajay/0000-0002-6547-0631	Deutsche Forschungsgemeinschaft Excellence Cluster "Cardiopulmonary System-ECCPS" [SFB 815 TP A1, TP Z1, SFB 834 TPA2]; Faculty of Medicine, Goethea-Universitat, Frankfurt am Main, Germany; Austrian Research Promoti Agency (FFG) [848474]; British Heart Foundation; British Heart Foundation [RG/13/11/30384] Funding Source: researchfish	Deutsche Forschungsgemeinschaft Excellence Cluster "Cardiopulmonary System-ECCPS"(German Research Foundation (DFG)); Faculty of Medicine, Goethea-Universitat, Frankfurt am Main, Germany; Austrian Research Promoti Agency (FFG); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	The work was supported in part by the Deutsche Forschungsgemeinschaft Excellence Cluster "Cardiopulmonary System-ECCPS," SFB 815 TP A1 (to R. P. B.) and TP Z1 (to I. W.) and SFB 834 TPA2 (to R. P. B.) and the Faculty of Medicine, Goethea-Universitat, Frankfurt am Main, Germany. The authors declare that they have no relevant financial, personal or professional relationships to disclose which could be perceived as a conflict of interest or as potentially influencing or biasing the authors' work.; Supported by the Austrian Research Promoti Agency (FFG) Grant 848474.; Supported by the British Heart Foundation.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; Anilkumar N, 2013, ARTERIOSCL THROM VAS, V33, pE104, DOI 10.1161/ATVBAHA.112.300956; Babelova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080328; Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; BAKSH S, 1995, FEBS LETT, V376, P53, DOI 10.1016/0014-5793(95)01246-4; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daiber A, 2010, BBA-BIOENERGETICS, V1797, P897, DOI 10.1016/j.bbabio.2010.01.032; Fontanini A, 2005, J BIOL CHEM, V280, P2378, DOI 10.1074/jbc.M405104200; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Giese H, 2015, BIOINFORMATICS, V31, P440, DOI 10.1093/bioinformatics/btu623; Lorenzo AFG, 2015, CELL PHYSIOL BIOCHEM, V36, P2183, DOI 10.1159/000430184; Goetz JG, 2007, J CELL SCI, V120, P3553, DOI 10.1242/jcs.03486; Hayee B, 2011, GLYCOBIOLOGY, V21, P914, DOI 10.1093/glycob/cwr023; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hu TS, 2005, AM J PHYSIOL-RENAL, V289, pF816, DOI 10.1152/ajprenal.00024.2005; Hubner NC, 2011, METHODS, V53, P453, DOI 10.1016/j.ymeth.2010.12.016; Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200; Konno T, 2015, J CELL BIOL, V211, P253, DOI 10.1083/jcb.201506123; Kruse C, 2015, ARTERIOSCL THROM VAS, V35, P1954, DOI 10.1161/ATVBAHA.115.305678; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Nisimoto Y, 2014, BIOCHEMISTRY-US, V53, P5111, DOI 10.1021/bi500331y; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; Rezende F, 2016, ANTIOXID REDOX SIGN, V24, P392, DOI 10.1089/ars.2015.6314; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Santos CXC, 2009, J LEUKOCYTE BIOL, V86, P989, DOI 10.1189/jlb.0608354; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Sun QA, 2011, P NATL ACAD SCI USA, V108, P16098, DOI 10.1073/pnas.1109546108; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tong XY, 2010, CIRC RES, V107, P975, DOI 10.1161/CIRCRESAHA.110.221242; VasquezVivar J, 1997, FEBS LETT, V403, P127, DOI 10.1016/S0014-5793(97)00036-7; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Wallach TM, 1997, BIOCHEM J, V321, P583, DOI 10.1042/bj3210583; Wilkins MR, 1999, METH MOL B, V112, P531; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xi G, 2013, J BIOL CHEM, V288, P15641, DOI 10.1074/jbc.M113.456046; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Zhu YM, 2006, J BIOL CHEM, V281, P30336, DOI 10.1074/jbc.M607191200	59	42	43	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7045	7059		10.1074/jbc.M115.710772	http://dx.doi.org/10.1074/jbc.M115.710772			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26861875	Green Published, hybrid			2022-12-28	WOS:000373299700039
J	Halpin, JC; Huang, B; Sun, M; Street, TO				Halpin, Jackson C.; Huang, Bin; Sun, Ming; Street, Timothy O.			Crowding Activates Heat Shock Protein 90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; chaperone; conformational change; heat shock protein 90 (Hsp90); macromolecular crowding	MOLECULAR CHAPERONE HSP90; ESCHERICHIA-COLI HSP90; CONFORMATIONAL-CHANGES; ENDOPLASMIC-RETICULUM; ATPASE CYCLE; STABILITY; NUCLEOTIDE; STATES; MECHANISM; DYNAMICS	Hsp90 is a dimeric ATP-dependent chaperone involved in the folding, maturation, and activation of diverse target proteins. Extensive in vitro structural analysis has led to a working model of Hsp90's ATP-driven conformational cycle. An implicit assumption is that dilute experimental conditions do not significantly perturb Hsp90 structure and function. However, Hsp90 undergoes a dramatic open/closed conformational change, which raises the possibility that this assumption may not be valid for this chaperone. Indeed, here we show that the ATPase activity of Hsp90 is highly sensitive to molecular crowding, whereas the ATPase activities of Hsp60 and Hsp70 chaperones are insensitive to crowding conditions. Polymer crowders activate Hsp90 in a non-saturable manner, with increasing efficacy at increasing concentration. Crowders exhibit a non-linear relationship between their radius of gyration and the extent to which they activate Hsp90. This experimental relationship can be qualitatively recapitulated with simple structure-based volume calculations comparing open/closed configurations of Hsp90. Thermodynamic analysis indicates that crowding activation of Hsp90 is entropically driven, which is consistent with a model in which excluded volume provides a driving force that favors the closed active state of Hsp90. Multiple Hsp90 homologs are activated by crowders, with the endoplasmic reticulum-specific Hsp90, Grp94, exhibiting the highest sensitivity. Finally, we find that crowding activation works by a different mechanism than co-chaperone activation and that these mechanisms are independent. We hypothesize that Hsp90 has a higher intrinsic activity in the cell than in vitro.	[Halpin, Jackson C.; Huang, Bin; Sun, Ming; Street, Timothy O.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Brandeis University	Street, TO (corresponding author), Brandeis Univ, 415 South St, Waltham, MA 02454 USA.	tstreet@brandeis.edu		Halpin, Jackson/0000-0003-4085-1064	National Institutes of Health [R01 GM115356]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM115356 ( to T. O. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; Benton LA, 2012, BIOCHEMISTRY-US, V51, P9773, DOI 10.1021/bi300909q; Bron P, 2008, BIOL CELL, V100, P413, DOI 10.1042/BC20070149; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Ghaemmaghami S, 2001, NAT STRUCT BIOL, V8, P879, DOI 10.1038/nsb1001-879; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Krukenberg KA, 2009, PROTEIN SCI, V18, P1815, DOI 10.1002/pro.191; Krukenberg KA, 2009, J MOL BIOL, V390, P278, DOI 10.1016/j.jmb.2009.04.080; Lavery LA, 2014, MOL CELL, V53, P330, DOI 10.1016/j.molcel.2013.12.023; Li J, 2013, NAT STRUCT MOL BIOL, V20, P326, DOI 10.1038/nsmb.2502; Mayer M, 2003, J MOL BIOL, V330, P137, DOI 10.1016/S0022-2836(03)00556-4; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Partridge JR, 2014, ELIFE, V3, DOI 10.7554/eLife.03487; Reid C, 1997, BIOPHYS J, V72, P1022, DOI 10.1016/S0006-3495(97)78754-X; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Sarkar M, 2013, P NATL ACAD SCI USA, V110, P19342, DOI 10.1073/pnas.1312678110; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Street TO, 2010, PROTEIN SCI, V19, P57, DOI 10.1002/pro.282; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wang Y, 2014, MOL PHARMACEUT, V11, P1391, DOI 10.1021/mp400521b; Wayne N, 2011, METHODS MOL BIOL, V787, P33, DOI 10.1007/978-1-61779-295-3_3; Wearsch PA, 1997, J BIOL CHEM, V272, P5152, DOI 10.1074/jbc.272.8.5152; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P11289, DOI 10.1021/bi0155504	34	14	14	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6447	6455		10.1074/jbc.M115.702928	http://dx.doi.org/10.1074/jbc.M115.702928			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797120	Green Published, hybrid			2022-12-28	WOS:000372894200032
J	Campbell, JC; Kim, JJ; Li, KY; Huang, GY; Reger, AS; Matsuda, S; Sankaran, B; Link, TM; Yuasa, K; Ladbury, JE; Casteel, DE; Kim, C				Campbell, James C.; Kim, Jeong Joo; Li, Kevin Y.; Huang, Gilbert Y.; Reger, Albert S.; Matsuda, Shinya; Sankaran, Banumathi; Link, Todd M.; Yuasa, Keizo; Ladbury, John E.; Casteel, Darren E.; Kim, Choel			Structural Basis of Cyclic Nucleotide Selectivity in cGMP-dependent Protein Kinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cyclic nucleotide; ligand-binding protein; protein kinase G (PKG); receptor structure-function; serine; threonine protein kinase; X-ray crystallography; NO-cGMP signaling; cGMP-dependent protein kinase; cyclic nucleotide-binding domain (CNB); second messenger	STRUCTURE REFINEMENT; MODEL; ACTIVATION; EXPRESSION; CLONING; PHENIX; GENE; CAMP	Membrane-bound cGMP-dependent protein kinase (PKG) II is a key regulator of bone growth, renin secretion, and memory formation. Despite its crucial physiological roles, little is known about its cyclic nucleotide selectivity mechanism due to a lack of structural information. Here, we find that the C-terminal cyclic nucleotide binding (CNB-B) domain of PKG II binds cGMP with higher affinity and selectivity when compared with its N-terminal CNB (CNB-A) domain. To understand the structural basis of cGMP selectivity, we solved co-crystal structures of the CNB domains with cyclic nucleotides. Our structures combined with mutagenesis demonstrate that the guanine-specific contacts at Asp-412 and Arg-415 of the C-helix of CNB-B are crucial for cGMP selectivity and activation of PKG II. Structural comparison with the cGMP selective CNB domains of human PKG I and Plasmodium falciparum PKG (PfPKG) shows different contacts with the guanine moiety, revealing a unique cGMP selectivity mechanism for PKG II.	[Campbell, James C.; Ladbury, John E.; Kim, Choel] Baylor Coll Med, Struct & Computat Biol & Mol Biophys Program, Houston, TX 77030 USA; [Kim, Jeong Joo; Reger, Albert S.; Kim, Choel] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Huang, Gilbert Y.; Kim, Choel] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kim, Jeong Joo] Univ Kassel, Dept Biochem, D-34132 Kassel, Hesse, Germany; [Li, Kevin Y.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Matsuda, Shinya; Yuasa, Keizo] Univ Tokushima, Dept Biol Sci & Technol, Grad Sch, Tokushima 7708506, Japan; [Sankaran, Banumathi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA; [Link, Todd M.; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Casteel, Darren E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ladbury, John E.] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Universitat Kassel; Rice University; Tokushima University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego; University of Leeds	Kim, C (corresponding author), Baylor Coll Med, Struct & Computat Biol & Mol Biophys Program, Houston, TX 77030 USA.; Kim, C (corresponding author), Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.; Kim, C (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	ckim@bcm.edu	Kim, Jeong Joo/GYJ-5589-2022	Link, Todd/0000-0003-1939-9755; Ladbury, John/0000-0002-6328-7200; Matsuda, Shinya/0000-0002-0169-1347	National Institutes of Health, NIGMS; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090161, T32GM089657, R25GM056929, T32GM008280] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Fields and H. Rehmann for critically reading the manuscript. We also thank M. Young and C. Zhao for their assistance with crystallization. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, NIGMS, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract Number DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BUTT E, 1993, NEUROCHEM RES, V18, P27, DOI 10.1007/BF00966920; CORBIN JD, 1986, J BIOL CHEM, V261, P1208; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Golin-Bisello F, 2005, AM J PHYSIOL-CELL PH, V289, pC708, DOI 10.1152/ajpcell.00544.2004; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Huang GY, 2014, BIOCHEMISTRY-US, V53, P6725, DOI 10.1021/bi501012v; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; JARCHAU T, 1994, P NATL ACAD SCI USA, V91, P9426, DOI 10.1073/pnas.91.20.9426; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kim JJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004639; Kim Jeong Joo, 2011, PLoS One, V6, pe18413, DOI 10.1371/journal.pone.0018413; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Rangaswami H, 2009, J BIOL CHEM, V284, P14796, DOI 10.1074/jbc.M806486200; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Russwurm M, 2007, BIOCHEM J, V407, P69, DOI 10.1042/BJ20070348; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Scheich C, 2004, PROTEIN SCI, V13, P370, DOI 10.1110/ps.03304604; Schlossmann J, 2005, DRUG DISCOV TODAY, V10, P627, DOI 10.1016/S1359-6446(05)03406-9; Schlossmann Jens, 2009, V191, P163, DOI 10.1007/978-3-540-68964-5_9; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Sprenger JU, 2013, INT J MOL SCI, V14, P8025, DOI 10.3390/ijms14048025; Taylor MK, 2000, J BIOL CHEM, V275, P28053; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thunemann Martin, 2013, Methods Mol Biol, V1020, P89, DOI 10.1007/978-1-62703-459-3_6; UHLER MD, 1993, J BIOL CHEM, V268, P13586; Vaandrager AB, 2005, FRONT BIOSCI-LANDMRK, V10, P2150, DOI 10.2741/1687; Vaandrager AB, 1998, P NATL ACAD SCI USA, V95, P1466, DOI 10.1073/pnas.95.4.1466; Vaandrager AB, 1997, J BIOL CHEM, V272, P11816, DOI 10.1074/jbc.272.18.11816; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOLFE L, 1989, J BIOL CHEM, V264, P7734; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172	37	15	16	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5623	5633		10.1074/jbc.M115.691303	http://dx.doi.org/10.1074/jbc.M115.691303			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26769964	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000372551800015
J	Nonaka, T; Suzuki, G; Tanaka, Y; Kametani, F; Hirai, S; Okado, H; Miyashita, T; Saitoe, M; Akiyama, H; Masai, H; Hasegawa, M				Nonaka, Takashi; Suzuki, Genjiro; Tanaka, Yoshinori; Kametani, Fuyuki; Hirai, Shinobu; Okado, Haruo; Miyashita, Tomoyuki; Saitoe, Minoru; Akiyama, Haruhiko; Masai, Hisao; Hasegawa, Masato			Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1 Triggers Mislocalization and Accumulation of TDP-43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ALS (Lou Gehrig disease); phosphorylation; protein aggregation; protein kinase; casein kinase 1; frontotemporal lobar degeneration (FTLD); TAR DNA-binding protein of 43 kDa (TDP-43)	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; PATHOLOGICAL ALPHA-SYNUCLEIN; NUCLEAR FACTOR TDP-43; NEURODEGENERATIVE-DISEASES; CFTR EXON-9; CDC7 KINASE; IN-VIVO; AGGREGATION; TOXICITY	Intracellular aggregates of phosphorylated TDP-43 are a major component of ubiquitin-positive inclusions in the brains of patients with frontotemporal lobar degeneration and ALS and are considered a pathological hallmark. Here, to gain insight into the mechanism of intracellular TDP-43 accumulation, we examined the relationship between phosphorylation and aggregation of TDP-43. We found that expression of a hyperactive form of casein kinase 1 (CK11-317, a C-terminally truncated form) promotes mislocalization and cytoplasmic accumulation of phosphorylated TDP-43 (ubiquitin- and p62-positive) in cultured neuroblastoma SH-SY5Y cells. Insoluble phosphorylated TDP-43 prepared from cells co-expressing TDP-43 and CK11-317 functioned as seeds for TDP-43 aggregation in cultured cells, indicating that CK11-317-induced aggregated TDP-43 has prion-like properties. A striking toxicity and alterations of TDP-43 were also observed in yeast expressing TDP-43 and CK11-317. Therefore, abnormal activation of CK1 causes phosphorylation of TDP-43, leading to the formation of cytoplasmic TDP-43 aggregates, which, in turn, may trigger neurodegeneration.	[Nonaka, Takashi; Suzuki, Genjiro; Tanaka, Yoshinori; Kametani, Fuyuki; Akiyama, Haruhiko; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dementia Res Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Hirai, Shinobu; Okado, Haruo] Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Miyashita, Tomoyuki; Saitoe, Minoru] Tokyo Metropolitan Inst Med Sci, Dept Sensory & Motor Syst, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science	Nonaka, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Dementia Res Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	nonaka-tk@igakuken.or.jp	Kametani, Fuyuki/G-4752-2011; Nonaka, Takashi/L-8572-2017	Kametani, Fuyuki/0000-0001-9125-7001; Saitoe, Minoru/0000-0001-9731-4214; Tanaka, Yoshinori/0000-0003-1428-0683; Nonaka, Takashi/0000-0002-0830-9403	MEXT KAKENHI [26111730, 26117005, 23240050]; JSPS KAKENHI [23228004]; MHLW [12946221]; Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis of the Japan Agency for Medical Research and Development; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25115006, 26251004, 14J03307] Funding Source: KAKEN	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MHLW(Ministry of Health, Labour and Welfare, Japan); Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT KAKENHI Grants 26111730 (to T. N.) and 26117005 and 23240050 (to M. H.), JSPS KAKENHI Grant 23228004 (to M. H.), MHLW Grant 12946221 (to M. H.), a grant-in-aid for research on rare and intractable diseases, the Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis of the Japan Agency for Medical Research and Development (to M. H.), and a grant from the Takeda Science Foundation (to T. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Carlomagno Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090452; Choksi DK, 2014, HUM MOL GENET, V23, P1025, DOI 10.1093/hmg/ddt498; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Kitamura R, 2011, J BIOL CHEM, V286, P23031, DOI 10.1074/jbc.M111.243311; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; Liachko NF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004803; Liachko NF, 2013, ANN NEUROL, V74, P39, DOI 10.1002/ana.23870; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Masuda-Suzukake M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0088-8; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yamada M, 2014, CELL CYCLE, V13, P1859, DOI 10.4161/cc.29251; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	43	74	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5473	5483		10.1074/jbc.M115.695379	http://dx.doi.org/10.1074/jbc.M115.695379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26769969	Green Published, hybrid			2022-12-28	WOS:000372551800003
J	Rahman, MH; Jha, MK; Kim, JH; Nam, Y; Lee, MG; Go, Y; Harris, RA; Park, DH; Kook, H; Lee, IK; Suk, K				Rahman, Md Habibur; Jha, Mithilesh Kumar; Kim, Jong-Heon; Nam, Youngpyo; Lee, Maan Gee; Go, Younghoon; Harris, Robert A.; Park, Dong Ho; Kook, Hyun; Lee, In-Kyu; Suk, Kyoungho			Pyruvate Dehydrogenase Kinase-mediated Glycolytic Metabolic Shift in the Dorsal Root Ganglion Drives Painful Diabetic Neuropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; dorsal root ganglia; lactic acid; metabolism; neuron; pyruvate dehydrogenase kinase (PDC kinase); glia; glycolytic metabolic shift; painful neuropathy	SATELLITE GLIAL-CELLS; SENSING ION CHANNELS; LACTIC-ACIDOSIS; OXIDATIVE STRESS; SPINAL-CORD; TACTILE ALLODYNIA; SENSORY NEURONS; SCIATIC-NERVE; IN-VITRO; LACTATE	The dorsal root ganglion (DRG) is a highly vulnerable site in diabetic neuropathy. Under diabetic conditions, the DRG is subjected to tissue ischemia or lower ambient oxygen tension that leads to aberrant metabolic functions. Metabolic dysfunctions have been documented to play a crucial role in the pathogenesis of diverse pain hypersensitivities. However, the contribution of diabetes-induced metabolic dysfunctions in the DRG to the pathogenesis of painful diabetic neuropathy remains ill-explored. In this study, we report that pyruvate dehydrogenase kinases (PDK2 and PDK4), key regulatory enzymes in glucose metabolism, mediate glycolytic metabolic shift in the DRG leading to painful diabetic neuropathy. Streptozotocin-induced diabetes substantially enhanced the expression and activity of the PDKs in the DRG, and the genetic ablation of Pdk2 and Pdk4 attenuated the hyperglycemia-induced pain hypersensitivity. Mechanistically, Pdk2/4 deficiency inhibited the diabetes-induced lactate surge, expression of pain-related ion channels, activation of satellite glial cells, and infiltration of macrophages in the DRG, in addition to reducing central sensitization and neuroinflammation hallmarks in the spinal cord, which probably accounts for the attenuated pain hypersensitivity. Pdk2/4-deficient mice were partly resistant to the diabetes-induced loss of peripheral nerve structure and function. Furthermore, in the experiments using DRG neuron cultures, lactic acid treatment enhanced the expression of the ion channels and compromised cell viability. Finally, the pharmacological inhibition of DRG PDKs or lactic acid production substantially attenuated diabetes-induced pain hypersensitivity. Taken together, PDK2/4 induction and the subsequent lactate surge induce the metabolic shift in the diabetic DRG, thereby contributing to the pathogenesis of painful diabetic neuropathy.	[Rahman, Md Habibur; Jha, Mithilesh Kumar; Kim, Jong-Heon; Nam, Youngpyo; Lee, Maan Gee; Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Brain Sci & Engn Inst, Dept Pharmacol,Plus KNU Biomed Convergence Progra, 680 Gukchaebosang St, Daegu 41944, South Korea; [Go, Younghoon; Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, 680 Gukchaebosang St, Daegu 41944, South Korea; [Park, Dong Ho] Kyungpook Natl Univ, Sch Med, Dept Ophthalmol, 680 Gukchaebosang St, Daegu 41944, South Korea; [Harris, Robert A.] Indiana Univ Sch Med, Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Kook, Hyun] Chonnam Natl Univ, Sch Med, Dept Pharmacol, Gwangju 501746, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington; Chonnam National University	Suk, K (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, 680 Gukchaebosang St, Daegu 41944, South Korea.	ksuk@knu.ac.kr	Kook, Hyun/AAR-5405-2021; Lee, In-Kyu/AAR-6374-2021	Kook, Hyun/0000-0002-0740-1806; Jha, Mithilesh Kumar/0000-0002-9526-0053; Maan-Gee, Lee/0000-0002-0172-1593	Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Republic of Korea [A111345]; Basic Science Research Program through the National Research Foundation - Korean Ministry of Education, Science, and Technology [2008-0062282, 2015R1A2A1A10051958]	Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through the National Research Foundation - Korean Ministry of Education, Science, and Technology	This work was supported by Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea, Grant A111345. This work was also supported by the Basic Science Research Program through the National Research Foundation funded by the Korean Ministry of Education, Science, and Technology, Grants 2008-0062282 and 2015R1A2A1A10051958. The authors declare that they have no conflicts of interest with the contents of this article.	Arumugam R, 2010, ENDOCRINOLOGY, V151, P3074, DOI 10.1210/en.2010-0049; Ashton RS, 2012, NAT NEUROSCI, V15, P1399, DOI 10.1038/nn.3212; Aslam A., 2014, PAIN RES TREAT, V2014, DOI DOI 10.1155/2014/412041; Baloh RH, 2008, NEUROSCIENTIST, V14, P12, DOI 10.1177/1073858407307354; Ton BHT, 2013, ACTA HISTOCHEM, V115, P840, DOI 10.1016/j.acthis.2013.04.007; Bishnoi M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-52; Bocarsly ME, 2015, P NATL ACAD SCI USA, V112, P15731, DOI 10.1073/pnas.1511593112; Brenneis C, 2013, J NEUROSCI, V33, P315, DOI 10.1523/JNEUROSCI.2804-12.2013; BROCK FE, 1990, SCHWEIZ MED WSCHR, V120, P1477; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Chopra K, 2010, J PAIN, V11, P950, DOI 10.1016/j.jpain.2010.01.006; Chu XP, 2013, ADV EXP MED BIOL, V961, P419, DOI 10.1007/978-1-4614-4756-6_36; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; Dienel GA, 2014, J CEREBR BLOOD F MET, V34, P1736, DOI 10.1038/jcbfm.2014.153; Doupis J, 2009, J CLIN ENDOCR METAB, V94, P2157, DOI 10.1210/jc.2008-2385; Fox A, 1999, PAIN, V81, P307, DOI 10.1016/S0304-3959(99)00024-X; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Galloway C, 2013, CYTOKINE, V63, P1, DOI 10.1016/j.cyto.2013.04.009; Gao Yong-Jing, 2009, Open Pain J, V2, P11; GEORGADZE AK, 1985, FARMAKOL TOKSIKOL, V48, P101; Gibbons CH, 2015, BRAIN, V138, P43, DOI 10.1093/brain/awu307; GREENE DA, 1979, J NEUROCHEM, V33, P1007, DOI 10.1111/j.1471-4159.1979.tb05237.x; Greig Marni, 2014, Handb Clin Neurol, V126, P559, DOI 10.1016/B978-0-444-53480-4.00037-0; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hanani M, 2014, J CELL MOL MED, V18, P2367, DOI 10.1111/jcmm.12406; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hayashi Toshihiro, 2011, Brain and Nerve (Tokyo), V63, P1307; Herbst EAF, 2014, AM J PHYSIOL-REG I, V306, pR102, DOI 10.1152/ajpregu.00150.2013; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Hwang Hye Suk, 2011, Exp Neurobiol, V20, P144, DOI 10.5607/en.2011.20.3.144; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Jasmin L, 2010, NEURON GLIA BIOL, V6, P63, DOI 10.1017/S1740925X10000098; Jeoung NH, 2012, BIOCHEM J, V443, P829, DOI 10.1042/BJ20112197; Jha Mithilesh Kumar, 2013, Brain Tumor Res Treat, V1, P57, DOI 10.14791/btrt.2013.1.2.57; Jha MK, 2014, EXP NEUROL, V254, P41, DOI 10.1016/j.expneurol.2014.01.009; Jha MK, 2014, PROTEOMICS, V14, P378, DOI 10.1002/pmic.201300236; Jha MK, 2012, CURR NEUROPHARMACOL, V10, P393, DOI 10.2174/157015912804143586; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; KADEKARO M, 1985, P NATL ACAD SCI USA, V82, P6010, DOI 10.1073/pnas.82.17.6010; Kadic AJ, 2014, NEUROSCIENCE, V256, P302, DOI 10.1016/j.neuroscience.2013.10.032; Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27; KEMPSKI O, 1988, STROKE, V19, P385, DOI 10.1161/01.STR.19.3.385; Kennedy JM, 2000, BRAIN, V123, P2118, DOI 10.1093/brain/123.10.2118; Kim SJ, 2011, P NATL ACAD SCI USA, V108, P3371, DOI 10.1073/pnas.1019755108; Kim TJ, 2007, J PAIN, V8, P59, DOI 10.1016/j.jpain.2006.06.003; Kishi M, 2002, DIABETES, V51, P819, DOI 10.2337/diabetes.51.3.819; KRAIG RP, 1987, J CEREBR BLOOD F MET, V7, P379, DOI 10.1038/jcbfm.1987.80; Krzymien J, 2013, POL ARCH MED WEWN, V123, P91, DOI 10.20452/pamw.1619; Kulkarni SS, 2012, METABOLISM, V61, P175, DOI 10.1016/j.metabol.2011.06.014; KURLEMANN G, 1995, EUR J PEDIATR, V154, P928, DOI 10.1007/BF01957508; Kwon MJ, 2013, J NEUROSCI, V33, P15095, DOI 10.1523/JNEUROSCI.0278-13.2013; Laferriere A, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-49; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lee Y, 2005, MOL CELLS, V20, P315; Liang HS, 2014, CYTOTHERAPY, V16, P523, DOI 10.1016/j.jcyt.2013.11.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOIKE JD, 1993, J IMMUNOL, V150, P1951; Luft FC, 2001, J AM SOC NEPHROL, V12, pS15; Macauley SL, 2015, J CLIN INVEST, V125, P2463, DOI 10.1172/JCI79742; Mansikka H, 2004, ANESTHESIOLOGY, V100, P912, DOI 10.1097/00000542-200404000-00022; Marshall J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015033; McGuire JF, 2009, DIABETES, V58, P2677, DOI 10.2337/db09-0594; Morten KJ, 1998, NEUROLOGY, V51, P1331, DOI 10.1212/WNL.51.5.1331; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naruse K, 2005, DIABETES, V54, P1823, DOI 10.2337/diabetes.54.6.1823; Naruse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027458; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c; Nukada H, 2011, BRAIN RES, V1373, P172, DOI 10.1016/j.brainres.2010.11.084; Ohashi T, 2013, INT J CANCER, V133, P1107, DOI 10.1002/ijc.28114; Ohtori S, 2004, SPINE, V29, P1082, DOI 10.1097/00007632-200405150-00006; Pabbidi RM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-9; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Phillips LK, 2015, NAT REV ENDOCRINOL, V11, P112, DOI 10.1038/nrendo.2014.202; Polonsky KS, 2012, NEW ENGL J MED, V367, P1332, DOI 10.1056/NEJMra1110560; Puljak L, 2009, J NEUROSCI METH, V177, P397, DOI 10.1016/j.jneumeth.2008.10.029; Qi J, 2011, J IMMUNOL, V186, P6417, DOI 10.4049/jimmunol.1001241; Radu BM, 2014, CELL BIOCHEM BIOPHYS, V68, P9, DOI 10.1007/s12013-013-9678-5; Rahman MH, 2016, CURR PHARM DESIGN, V22, P738, DOI 10.2174/1381612822666151204001234; Ramos-Nino Maria E, 2013, ISRN Oncol, V2013, P697521, DOI 10.1155/2013/697521; Rinnankoski-Tuikka R, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-53; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Rogatzki MJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00022; Sala F, 1999, ANN NY ACAD SCI, V890, P133, DOI 10.1111/j.1749-6632.1999.tb07989.x; Sasaki H, 1997, ACTA NEUROPATHOL, V93, P118, DOI 10.1007/s004010050592; Schmeichel AM, 2003, DIABETES, V52, P165, DOI 10.2337/diabetes.52.1.165; Shakeel M, 2015, DIABETES METAB SYND, V9, P373, DOI 10.1016/j.dsx.2014.04.029; SIESJO BK, 1985, J CEREBR BLOOD F MET, V5, P253, DOI 10.1038/jcbfm.1985.32; Sima AAF, 1999, DIABETOLOGIA, V42, P773, DOI 10.1007/s001250051227; Sotelo-Hitschfeld T, 2015, J NEUROSCI, V35, P4168, DOI 10.1523/JNEUROSCI.5036-14.2015; Stacpoole PW, 1998, DRUG METAB REV, V30, P499, DOI 10.3109/03602539808996323; Stacpoole PW, 1998, ENVIRON HEALTH PERSP, V106, P989, DOI 10.1289/ehp.98106s4989; STAUB F, 1993, J NEUROL SCI, V119, P79, DOI 10.1016/0022-510X(93)90194-4; Staub F, 1994, Anasthesiol Intensivmed Notfallmed Schmerzther, V29, P203, DOI 10.1055/s-2007-996719; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; Tao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071997; Tavee J, 2009, CLEV CLIN J MED, V76, P297, DOI 10.3949/ccjm.76a.08070; Tsuda M, 2008, GLIA, V56, P378, DOI 10.1002/glia.20623; Wang DM, 2014, EUR J PHARMACOL, V728, P59, DOI 10.1016/j.ejphar.2014.01.057; WATKINS PJ, 1969, BMJ-BRIT MED J, V1, P744, DOI 10.1136/bmj.1.5646.744; Weisberg LS, 2015, CLIN J AM SOC NEPHRO, V10, P1476, DOI 10.2215/CJN.10871014; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; YAGIHASHI S, 1995, DIABETES METAB REV, V11, P193, DOI 10.1002/dmr.5610110304; Zhao WC, 2014, NEUROSCI LETT, V560, P81, DOI 10.1016/j.neulet.2013.12.019; ZOCHODNE DW, 1991, BRAIN RES, V559, P89, DOI 10.1016/0006-8993(91)90290-C; Zochodne DW, 2001, BRAIN, V124, P2319, DOI 10.1093/brain/124.11.2319	112	39	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					6011	6025		10.1074/jbc.M115.699215	http://dx.doi.org/10.1074/jbc.M115.699215			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26769971	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000372551800045
J	Gu, SC; Liu, YJ; Zhu, BW; Ding, K; Yao, TP; Chen, FF; Zhan, LX; Xu, PL; Ehrlich, M; Liang, TB; Lin, X; Feng, XH				Gu, Shuchen; Liu, Yanjing; Zhu, Bowen; Ding, Ke; Yao, Tso-Pang; Chen, Fenfang; Zhan, Lixing; Xu, Pinglong; Ehrlich, Marcelo; Liang, Tingbo; Lin, Xia; Feng, Xin-Hua			Loss of alpha-Tubulin Acetylation Is Associated with TGF-beta-induced Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; epithelial-mesenchymal transition (EMT); histone deacetylase 6 (HDAC6); microtubule; transforming growth factor (TGF-beta)	CANCER-CELL-MIGRATION; GASTRIC-CANCER; MIR-200 FAMILY; MICROTUBULES; INVASION; DEACETYLATION; PROGRESSION; METASTASIS; MECHANISMS; DYNAMICS	The epithelial-to-mesenchymal transition (EMT) is a process by which differentiated epithelial cells reprogram gene expression, lose their junctions and polarity, reorganize their cytoskeleton, increase cell motility and assume a mesenchymal morphology. Despite the critical functions of the microtubule (MT) in cytoskeletal organization, how it participates in EMT induction and maintenance remains poorly understood. Here we report that acetylated -tubulin, which plays an important role in microtubule (MT) stabilization and cell morphology, can serve as a novel regulator and marker of EMT. A high level of acetylated -tubulin was correlated with epithelial morphology and it profoundly decreased during TGF--induced EMT. We found that TGF- increased the activity of HDAC6, a major deacetylase of -tubulin, without affecting its expression levels. Treatment with HDAC6 inhibitor tubacin or TGF- type I receptor inhibitor SB431542 restored the level of acetylated -tubulin and consequently blocked EMT. Our results demonstrate that acetylated -tubulin can serve as a marker of EMT and that HDAC6 represents an important regulator during EMT process.	[Gu, Shuchen; Liu, Yanjing; Zhu, Bowen; Ding, Ke; Chen, Fenfang; Xu, Pinglong; Feng, Xin-Hua] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Gu, Shuchen; Liu, Yanjing; Zhu, Bowen; Ding, Ke; Chen, Fenfang; Xu, Pinglong; Feng, Xin-Hua] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Yao, Tso-Pang] Duke Univ, Dept Pharmacol & Canc Biol, Sch Med, Durham, NC 27710 USA; [Zhan, Lixing] Chinese Acad Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [Ehrlich, Marcelo] Tel Aviv Univ, Dept Cell Res & Immunol, IL-6997801 Tel Aviv, Israel; [Liang, Tingbo] Zhejiang Univ, Sch Med, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310009, Zhejiang, Peoples R China; [Liang, Tingbo] Zhejiang Univ, Sch Med, Key Lab Canc Prevent & Intervent, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China; [Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Zhejiang University; Zhejiang University; Duke University; Chinese Academy of Sciences; Tel Aviv University; Zhejiang University; Zhejiang University; Baylor College of Medicine; Baylor College of Medicine	Feng, XH (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.; Feng, XH (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	xhfeng@zju.edu.cn	Xu, Pinglong/AAN-2506-2021; Xu, Pinglong/AAF-6838-2019	Xu, Pinglong/0000-0001-7726-5443; Ehrlich, Marcelo/0000-0002-2352-1808; Zhan, Lixing/0000-0003-4949-4358	Key Program of the Ministry of Sciences and Technology [2012CB966600]; National Natural Science Foundation of China [91540205, 31571447, 31401196]; Major Program of the National Natural Science Foundation of China [31090360]; China Post-doctoral Science Foundation [2014T70571]; Fundamental Research Funds for the Central Universities; National Institutes of Health [R01GM63773, R01AR053591, R01CA108454, R01DK073932]; NATIONAL CANCER INSTITUTE [R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	Key Program of the Ministry of Sciences and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Post-doctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Key Program of the Ministry of Sciences and Technology (2012CB966600), National Natural Science Foundation of China Grants (91540205, 31571447, 31401196), Major Program of the National Natural Science Foundation of China (31090360), and China Post-doctoral Science Foundation grant (2014T70571), the Fundamental Research Funds for the Central Universities, and National Institutes of Health grants (R01GM63773, R01AR053591, R01CA108454, and R01DK073932).	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; BLACK MM, 1987, J NEUROSCI, V7, P1833; CAMBRAYDEAKIN MA, 1987, CELL MOTIL CYTOSKEL, V8, P284, DOI 10.1002/cm.970080309; DASGUPTA D, 1983, FEBS LETT, V152, P101, DOI 10.1016/0014-5793(83)80491-8; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hay ED, 1995, ACTA ANAT, V154, P8; Hoj JP, 2014, EXP CELL RES, V326, P187, DOI 10.1016/j.yexcr.2014.04.011; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kitase Y, 2013, INT J DEV BIOL, V57, P55, DOI 10.1387/ijdb.120117yk; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; SASSE R, 1988, J CELL SCI, V90, P577; Schneider D, 2012, BIOCHEM BIOPH RES CO, V419, P221, DOI 10.1016/j.bbrc.2012.01.151; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; Shan B, 2008, J BIOL CHEM, V283, P21065, DOI 10.1074/jbc.M802786200; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu ZY, 2013, INT J BIOL SCI, V9, P587, DOI 10.7150/ijbs.6339; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Ying L, 2012, MOL BIOSYST, V8, P2289, DOI 10.1039/c2mb25070e; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhao Y, 2014, ONCOL REP, V31, P358, DOI 10.3892/or.2013.2850	37	64	66	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5396	5405		10.1074/jbc.M115.713123	http://dx.doi.org/10.1074/jbc.M115.713123			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26763233	Green Published, hybrid			2022-12-28	WOS:000371640600047
J	Jacob, RS; George, E; Singh, PK; Salot, S; Anoop, A; Jha, NN; Sen, S; Maji, SK				Jacob, Reeba S.; George, Edna; Singh, Pradeep K.; Salot, Shimul; Anoop, Arunagiri; Jha, Narendra Nath; Sen, Shamik; Maji, Samir K.			Cell Adhesion on Amyloid Fibrils Lacking Integrin Recognition Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; amyloid; focal adhesions; integrin; protein self-assembly	KINASE FAK EXPRESSION; FOCAL ADHESION; EXTRACELLULAR-MATRIX; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; AGGREGATION; PEPTIDES; DYNAMICS; PROTEINS; ROLES	Amyloids are highly ordered, cross--sheet-rich protein/peptide aggregates associated with both human diseases and native functions. Given the well established ability of amyloids in interacting with cell membranes, we hypothesize that amyloids can serve as universal cell-adhesive substrates. Here, we show that, similar to the extracellular matrix protein collagen, amyloids of various proteins/peptides support attachment and spreading of cells via robust stimulation of integrin expression and formation of integrin-based focal adhesions. Additionally, amyloid fibrils are also capable of immobilizing non-adherent red blood cells through charge-based interactions. Together, our results indicate that both active and passive mechanisms contribute to adhesion on amyloid fibrils. The present data may delineate the functional aspect of cell adhesion on amyloids by various organisms and its involvement in human diseases. Our results also raise the exciting possibility that cell adhesivity might be a generic property of amyloids.	[Jacob, Reeba S.; George, Edna; Singh, Pradeep K.; Salot, Shimul; Anoop, Arunagiri; Jha, Narendra Nath; Sen, Shamik; Maji, Samir K.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Sen, S; Maji, SK (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	shamiks@iitb.ac.in; samirmaji@iitb.ac.in	JHA, NARENDRA NATH/ABI-3727-2020; Maji, Samir K. K./B-9640-2019; Arunagiri, Anoop/P-2528-2018	JHA, NARENDRA NATH/0000-0002-1734-7663; Maji, Samir K. K./0000-0002-9110-1565; Arunagiri, Anoop/0000-0001-9839-1860; Singh, Pradeep/0000-0002-4625-9873; Jacob, Reeba/0000-0002-0676-834X; kumbara, arya/0000-0002-0395-1245; Sen, Shamik/0000-0002-8639-8659	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR9797/NNT/28/774/2014]; University Grants Commission, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); University Grants Commission, Government of India(University Grants Commission, India)	This work was supported by Department of Biotechnology, Ministry of Science and Technology, Government of India, Grant BT/PR9797/NNT/28/774/2014.; Recipient of a fellowship from the University Grants Commission, Government of India.	Alteri CJ, 2007, P NATL ACAD SCI USA, V104, P5145, DOI 10.1073/pnas.0602304104; Anoop A, 2014, J BIOL CHEM, V289, P16884, DOI 10.1074/jbc.M114.548354; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; ARNOTT S, 1967, J MOL BIOL, V30, P201, DOI 10.1016/0022-2836(67)90252-5; Barlow DE, 2010, LANGMUIR, V26, P6549, DOI 10.1021/la9041309; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bhattacharya M, 2011, J PHYS CHEM B, V115, P4195, DOI 10.1021/jp111528c; Blumenthal NR, 2014, P NATL ACAD SCI USA, V111, P16124, DOI 10.1073/pnas.1412740111; Bongiovanni MN, 2015, BIOMATERIALS, V46, P105, DOI 10.1016/j.biomaterials.2014.12.039; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Carny O, 2005, FASEB J, V19, P1051, DOI 10.1096/fj.04-3256hyp; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; EKBLOM P, 1986, ANNU REV CELL BIOL, V2, P27, DOI 10.1146/annurev.cb.02.110186.000331; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Fulara A, 2011, J PHYS CHEM B, V115, P11010, DOI 10.1021/jp206271e; Gallo G, 2004, EXP NEUROL, V189, P112, DOI 10.1016/j.expneurol.2004.05.019; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; Ghosh D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09228; Ghosh D, 2014, LANGMUIR, V30, P3775, DOI 10.1021/la404739f; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028; Gras SL, 2009, ADV CHEM ENG, V35, P161, DOI 10.1016/S0065-2377(08)00206-8; Greenwald J, 2012, J MOL BIOL, V421, P417, DOI 10.1016/j.jmb.2012.04.015; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hategan A, 2004, BIOPHYS J, V87, P3547, DOI 10.1529/biophysj.104.041475; HAYMAN EG, 1985, J CELL BIOL, V100, P1948, DOI 10.1083/jcb.100.6.1948; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jacob RS, 2015, BIOMATERIALS, V54, P97, DOI 10.1016/j.biomaterials.2015.03.002; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jha NN, 2013, BIOCHEMISTRY-US, V52, P8800, DOI 10.1021/bi401398k; Kim DH, 2013, CELL ADHES MIGR, V7, P293, DOI 10.4161/cam.24804; Kim SH, 2003, FEBS LETT, V553, P433, DOI 10.1016/S0014-5793(03)01047-0; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Kokkinos MI, 2007, MOL VIS, V13, P418; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li CX, 2014, ADV MATER, V26, P3207, DOI 10.1002/adma.201306198; LORD EM, 1992, DEV BIOL, V153, P16, DOI 10.1016/0012-1606(92)90088-X; Maji SK, 2009, FEBS LETT, V583, P2610, DOI 10.1016/j.febslet.2009.07.003; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mankar S, 2011, NANO REV EXP, V2, DOI 10.3402/nano.v2i0.6032; MAZIA D, 1975, J CELL BIOL, V66, P198, DOI 10.1083/jcb.66.1.198; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Mierke CT, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/065005; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mokhtar S. H., 2013, INT J ALZHEIMERS DIS, V2013, DOI DOI 10.1155/2013/910502; MOONEY DJ, 1995, J CELL SCI, V108, P2311; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Nilsson KPR, 2009, FEBS LETT, V583, P2593, DOI 10.1016/j.febslet.2009.04.016; Oh J, 2007, J BIOL CHEM, V282, P13601, DOI 10.1074/jbc.M602576200; Otzen D, 2008, CELL MOL LIFE SCI, V65, P910, DOI 10.1007/s00018-007-7404-4; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Pedersen JS, 2010, FEBS J, V277, P4591, DOI 10.1111/j.1742-4658.2010.07888.x; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Reynolds NP, 2015, BIOMACROMOLECULES, V16, P1556, DOI 10.1021/acs.biomac.5b00114; Reynolds NP, 2014, BIOMACROMOLECULES, V15, P599, DOI 10.1021/bm401646x; Reynolds NP, 2013, BIOMACROMOLECULES, V14, P2305, DOI 10.1021/bm400430t; Rufo CM, 2014, NAT CHEM, V6, P303, DOI [10.1038/NCHEM.1894, 10.1038/nchem.1894]; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Sabate R, 2008, J STRUCT BIOL, V162, P387, DOI 10.1016/j.jsb.2008.02.002; Sabate R, 2007, J MOL BIOL, V370, P768, DOI 10.1016/j.jmb.2007.05.014; Sanborn SL, 2002, BIOMATERIALS, V23, P1, DOI 10.1016/S0142-9612(01)00066-7; Sapir-Koren R, 2011, IBMS BONEKEY, V8, P286, DOI [10.1138/20110516, DOI 10.1138/20110516]; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Sen S, 2009, CELL MOL BIOENG, V2, P218, DOI 10.1007/s12195-009-0057-7; Serpell LC, 1999, METHOD ENZYMOL, V309, P526; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; Singh PK, 2012, CELL BIOCHEM BIOPHYS, V64, P29, DOI 10.1007/s12013-012-9364-z; Solomon JP, 2011, BIOCHEMISTRY-US, V50, P2486, DOI 10.1021/bi101905n; Stepanichev M Yu, 2005, Neurosci Behav Physiol, V35, P511, DOI 10.1007/s11055-005-0086-1; Stepanichev MYu, 1998, Neurosci Behav Physiol, V28, P564, DOI 10.1007/BF02463018; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Sullan RMA, 2009, BIOFOULING, V25, P263, DOI 10.1080/08927010802688095; Torsoni AS, 2003, CIRC RES, V93, P140, DOI 10.1161/01.RES.0000081595.25297.1B; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; TROMMLER A, 1985, BIOPHYS J, V48, P835, DOI 10.1016/S0006-3495(85)83842-X; Usov I, 2013, ACS NANO, V7, P10465, DOI 10.1021/nn404886k; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Watt FM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005124; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; Yan H, 2008, FARADAY DISCUSS, V139, P71, DOI 10.1039/b717748h	104	36	37	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5278	5298		10.1074/jbc.M115.678177	http://dx.doi.org/10.1074/jbc.M115.678177			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26742841	Green Published, hybrid			2022-12-28	WOS:000371640600038
J	Loeven, MA; Rops, AL; Lehtinen, MJ; van Kuppevelt, TH; Daha, MR; Smith, RJ; Bakker, M; Berden, JH; Rabelink, TJ; Jokiranta, TS; van der Vlag, J				Loeven, Markus A.; Rops, Angelique L.; Lehtinen, Markus J.; van Kuppevelt, Toin H.; Daha, Mohamed R.; Smith, Richard J.; Bakker, Marinka; Berden, Jo H.; Rabelink, Ton J.; Jokiranta, T. Sakari; van der Vlag, Johan			Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmune disease; complement system; endothelium; heparan sulfate; innate immunity; atypical hemolytic uremic syndrome; complement Factor H; endothelial glycocalyx	BINDING-SITES; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; C-3 CONVERTASE; 3RD COMPONENT; BOUND C3B; PROTEIN; PURIFICATION; DOMAINS; GLYCOSAMINOGLYCAN; IDENTIFICATION	Complement factor H (FH) inhibits complement activation and interacts with glomerular endothelium via its complement control protein domains 19 and 20, which also recognize heparan sulfate (HS). Abnormalities in FH are associated with the renal diseases atypical hemolytic uremic syndrome and dense deposit disease and the ocular disease age-related macular degeneration. Although FH systemically controls complement activation, clinical phenotypes selectively manifest in kidneys and eyes, suggesting the presence of tissue-specific determinants of disease development. Recent results imply the importance of tissue-specifically expressed, sulfated glycosaminoglycans (GAGs), like HS, in determining FH binding to and activity on host tissues. Therefore, we investigated which GAGs mediate human FH and recombinant human FH complement control proteins domains 19 and 20 (FH19-20) binding to mouse glomerular endothelial cells (mGEnCs) in ELISA. Furthermore, we evaluated the functional defects of FH19-20 mutants during complement activation by measuring C3b deposition on mGEnCs using flow cytometry. FH and FH19-20 bound dose-dependently to mGEnCs and TNF- treatment increased binding of both proteins, whereas heparinase digestion and competition with heparin/HS inhibited binding. Furthermore, 2-O-, and 6-O-, but not N-desulfation of heparin, significantly increased the inhibitory effect on FH19-20 binding to mGEnCs. Compared with wild type FH19-20, atypical hemolytic uremic syndrome-associated mutants were less able to compete with FH in normal human serum during complement activation on mGEnCs, confirming their potential glomerular pathogenicity. In conclusion, our study shows that FH and FH19-20 binding to glomerular endothelial cells is differentially mediated by HS but not other GAGs. Furthermore, we describe a novel, patient serum-independent competition assay for pathogenicity screening of FH19-20 mutants.	[Loeven, Markus A.; Rops, Angelique L.; Bakker, Marinka; Berden, Jo H.; van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Nephrol, NL-6525 GA Nijmegen, Netherlands; [Lehtinen, Markus J.; Jokiranta, T. Sakari] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00290 Helsinki, Finland; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [Daha, Mohamed R.; Rabelink, Ton J.] Leiden Univ, Med Ctr, Dept Nephrol, NL-2300 RC Leiden, Netherlands; [Smith, Richard J.] Univ Iowa, Carver Coll Med, Dept Internal Med & Otolaryngol, Iowa City, IA 52242 USA	Radboud University Nijmegen; University of Helsinki; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Iowa	van der Vlag, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nephrol Res Lab 480,Radboud Inst Mol Life Sci, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands.	johan.vandervlag@radboudumc.nl	Rabelink, Ton J./A-5316-2008; Loeven, Markus/F-7863-2016; Van der Vlag, Johan/E-4636-2010; Berden, J.H.M./H-8009-2014; van Kuppevelt, A.H.M.S.M./L-4463-2015	Rabelink, Ton J./0000-0001-6780-5186; Van der Vlag, Johan/0000-0001-7843-5918; Smith, Richard/0000-0003-1201-6731	Kidneeds; Dutch Kidney Foundation [KJPB 09.01]; Radboud University Medical Center; Sigrid Juselius Foundation; Academy of Finland [128646, 259793];  [CP09.03]	Kidneeds; Dutch Kidney Foundation; Radboud University Medical Center; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); 	This work was supported by Kidneeds, the Dutch Kidney Foundation, Grants KJPB 09.01 and Consortium Grant CP09.03 (GLYCOREN), the Radboud University Medical Center, the Sigrid Juselius Foundation, and the Academy of Finland (Projects 128646 and 259793). The authors declare that they have no conflicts of interest with the contents of this article.	Berger SP, 2007, SEMIN IMMUNOPATHOL, V29, P375, DOI 10.1007/s00281-007-0090-3; Boels MGS, 2013, EUR J INTERN MED, V24, P503, DOI 10.1016/j.ejim.2012.12.016; Clark SJ, 2013, J IMMUNOL, V190, P2049, DOI 10.4049/jimmunol.1201751; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; CONRAD DH, 1978, J EXP MED, V147, P1792, DOI 10.1084/jem.147.6.1792; DASILVA WD, 1967, J EXP MED, V126, P1027, DOI 10.1084/jem.126.6.1027; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fakhouri F, 2010, KIDNEY INT, V78, P279, DOI 10.1038/ki.2010.132; FEARON DT, 1973, J EXP MED, V138, P1305, DOI 10.1084/jem.138.6.1305; FEARON DT, 1979, P NATL ACAD SCI USA, V76, P5867, DOI 10.1073/pnas.76.11.5867; GORDON DL, 1995, J IMMUNOL, V155, P348; HARRISON RA, 1980, MOL IMMUNOL, V17, P9, DOI 10.1016/0161-5890(80)90119-4; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Hellwage J, 1997, BIOCHEM J, V326, P321, DOI 10.1042/bj3260321; HOGASEN K, 1995, J CLIN INVEST, V95, P1054, DOI 10.1172/JCI117751; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; KUHN S, 1995, J IMMUNOL, V155, P5663; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Langford-Smith A, 2014, J INNATE IMMUN, V6, P407, DOI 10.1159/000356513; LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Loeven MA, 2015, MOL IMMUNOL, V63, P203, DOI 10.1016/j.molimm.2014.08.005; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Nester CM, 2015, MOL IMMUNOL, V67, P31, DOI 10.1016/j.molimm.2015.03.246; NICHOLSONWELLER A, 1982, J IMMUNOL, V129, P184; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Recalde S, 2016, J AM SOC NEPHROL, V27, P1305, DOI 10.1681/ASN.2015050580; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Rodriguez E, 2014, BIOSCIENCE REP, V34, P635, DOI 10.1042/BSR20140117; Rops AL, 2008, KIDNEY INT, V73, P52, DOI 10.1038/sj.ki.5002573; Rops AL, 2004, KIDNEY INT, V66, P2193, DOI 10.1111/j.1523-1755.2004.66009.x; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Sanchez-Corral P, 2002, AM J HUM GENET, V71, P1285, DOI 10.1086/344515; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; SIM RB, 1982, BIOCHEM J, V205, P285, DOI 10.1042/bj2050285; Smetsers TFCM, 2004, J INVEST DERMATOL, V122, P707, DOI 10.1111/j.0022-202X.2004.22316.x; Vernon KA, 2016, J AM SOC NEPHROL, V27, P1334, DOI 10.1681/ASN.2015030295; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; WHALEY K, 1976, SCIENCE, V193, P1011, DOI 10.1126/science.948757	50	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4974	4981		10.1074/jbc.M115.702506	http://dx.doi.org/10.1074/jbc.M115.702506			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26728463	hybrid, Green Published			2022-12-28	WOS:000371640600013
J	Pugh, RJ; Slee, JB; Farwell, SLN; Li, YQ; Barthol, T; Patton, WA; Lowe-Krentz, LJ				Pugh, Raymond J.; Slee, Joshua B.; Farwell, Sara Lynn N.; Li, Yaqiu; Barthol, Trista; Patton, Walter A.; Lowe-Krentz, Linda J.			Transmembrane Protein 184A Is a Receptor Required for Vascular Smooth Muscle Cell Responses to Heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ERK; heparin-binding protein; receptor; signal transduction; vascular smooth muscle cells	CULTURED ENDOTHELIAL-CELLS; SULFATE PROTEOGLYCANS; KINASE ACTIVATION; PROLIFERATION; CAVEOLAE; SYNDECAN-1; BINDING; GROWTH; ATHEROSCLEROSIS; ENDOCYTOSIS	Vascular cell responses to exogenous heparin have been documented to include decreased vascular smooth muscle cell proliferation following decreased ERK pathway signaling. However, the molecular mechanism(s) by which heparin interacts with cells to induce those responses has remained unclear. Previously characterized monoclonal antibodies that block heparin binding to vascular cells have been found to mimic heparin effects. In this study, those antibodies were employed to isolate a heparin binding protein. MALDI mass spectrometry data provide evidence that the protein isolated is transmembrane protein 184A (TMEM184A). Commercial antibodies against three separate regions of the TMEM184A human protein were used to identify the TMEM184A protein in vascular smooth muscle cells and endothelial cells. A GFP-TMEM184A construct was employed to determine colocalization with heparin after endocytosis. Knockdown of TMEM184A eliminated the physiological responses to heparin, including effects on ERK pathway activity and BrdU incorporation. Isolated GFP-TMEM184A binds heparin, and overexpression results in additional heparin uptake. Together, these data support the identification of TMEM184A as a heparin receptor in vascular cells.	[Slee, Joshua B.; Farwell, Sara Lynn N.; Li, Yaqiu; Barthol, Trista; Lowe-Krentz, Linda J.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Pugh, Raymond J.] Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA; [Patton, Walter A.] Lebanon Valley Coll, Dept Chem, Annville, PA 17003 USA; [Slee, Joshua B.] DeSales Univ, Dept Nat Sci, Center Valley, PA 18034 USA; [Pugh, Raymond J.] Penn State Univ, 403 Wartik Lab, University Pk, PA 16802 USA	Lehigh University; Lehigh University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lowe-Krentz, LJ (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	ljl0@lehigh.edu	LI, Yaqiu/GRY-7432-2022		Public Health Service [HL54269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL054269] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Public Health Service Contract Grant HL54269 (to L. J. L. K.).	Baeyens N, 2014, P NATL ACAD SCI USA, V111, P17308, DOI 10.1073/pnas.1413725111; BARZU T, 1985, BIOCHIM BIOPHYS ACTA, V845, P196, DOI 10.1016/0167-4889(85)90177-6; Best D, 2008, DEVELOPMENT, V135, P1415, DOI 10.1242/dev.019497; Best D, 2009, DEV DYNAM, V238, P223, DOI 10.1002/dvdy.21827; Blaukovitch CI, 2010, J CELL BIOCHEM, V110, P382, DOI 10.1002/jcb.22543; BUSCH SJ, 1992, J CELL BIOL, V116, P31, DOI 10.1083/jcb.116.1.31; CASTELLOT JJ, 1985, J CELL PHYSIOL, V124, P13, DOI 10.1002/jcp.1041240104; CASTELLOT JJ, 1981, J CELL BIOL, V90, P372, DOI 10.1083/jcb.90.2.372; Chen KY, 2013, J BIOL CHEM, V288, P13988, DOI 10.1074/jbc.M112.444737; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Chiodelli P, 2015, MOLECULES, V20, P6342, DOI 10.3390/molecules20046342; CLOWES AW, 1977, NATURE, V265, P625, DOI 10.1038/265625a0; Couchman JR, 2015, INT J EXP PATHOL, V96, P1, DOI 10.1111/iep.12112; Ebong EE, 2014, INTEGR BIOL-UK, V6, P338, DOI 10.1039/c3ib40199e; Farwell SLN, 2016, J BIOL CHEM, V291, P5342, DOI 10.1074/jbc.M115.681288; Fasciano S, 2005, J BIOL CHEM, V280, P15682, DOI 10.1074/jbc.M411458200; Gilotti AC, 2014, J CELL PHYSIOL, V229, P2142, DOI 10.1002/jcp.24677; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Kalmes A, 2001, ANN NY ACAD SCI, V947, P42; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; Li X, 2012, THROMB RES, V129, pE223, DOI 10.1016/j.thromres.2012.03.003; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; Obunike JC, 2001, J BIOL CHEM, V276, P8934, DOI 10.1074/jbc.M008813200; Ori A, 2011, J BIOL CHEM, V286, P19892, DOI 10.1074/jbc.M111.228114; OTTLINGER ME, 1993, J BIOL CHEM, V268, P19173; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; PATTON WA, 1995, BIOCHEM J, V311, P461, DOI 10.1042/bj3110461; PUKAC LA, 1990, CELL REGUL, V1, P435, DOI 10.1091/mbc.1.5.435; Pukac LA, 1997, J CELL PHYSIOL, V172, P69, DOI 10.1002/(SICI)1097-4652(199707)172:1<69::AID-JCP8>3.0.CO;2-B; Rath G, 2009, J PHYSIOL PHARMACOL, V60, P105; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; REILLY CF, 1989, J BIOL CHEM, V264, P6990; Savage JM, 2001, J CELL PHYSIOL, V187, P283, DOI 10.1002/jcp.1076; Singh A, 2015, J BIOL CHEM, V290, P15421, DOI 10.1074/jbc.M115.655845; Slee J.B., 2012, HEPARIN PROPERTIES U, P59; Sowa G, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00120; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Stewart MD, 2015, J BIOL CHEM, V290, P941, DOI 10.1074/jbc.M114.608455; Thourani VH, 2000, AM J PHYSIOL-HEART C, V278, pH2084, DOI 10.1152/ajpheart.2000.278.6.H2084; Vlodavsky I, 2013, MATRIX BIOL, V32, P241, DOI 10.1016/j.matbio.2013.03.002; Voyvodic PL, 2014, J BIOL CHEM, V289, P9547, DOI 10.1074/jbc.M113.541573; Xie-Zukauskas H, 2013, VASC PHARMACOL, V58, P313, DOI 10.1016/j.vph.2012.12.003; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Zeng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086249; Zeng Y, 2013, AM J PHYSIOL-HEART C, V305, pH811, DOI 10.1152/ajpheart.00764.2012	45	14	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5326	5341		10.1074/jbc.M115.681122	http://dx.doi.org/10.1074/jbc.M115.681122			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26769966	Green Published, hybrid			2022-12-28	WOS:000371640600042
J	Izard, T; Brown, DT				Izard, Tina; Brown, David T.			Mechanisms and Functions of Vinculin Interactions with Phospholipids at Cell Adhesion Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							F-ACTIN-BINDING; FOCAL ADHESIONS; INTRAMOLECULAR ASSOCIATION; TAIL DOMAIN; NANOSCALE ARCHITECTURE; ACIDIC PHOSPHOLIPIDS; JUNCTIONAL COMPLEX; CRYSTAL-STRUCTURE; ALPHA-CATENIN; SMOOTH-MUSCLE	The cytoskeletal protein vinculin is a major regulator of cell adhesion and attaches to the cell surface by binding to specific phospholipids. Structural, biochemical, and biological studies provided much insight into how vinculin binds to membranes, what components it recognizes, and how lipid binding is regulated. Here we discuss the roles and mechanisms of phospholipids in regulating the structure and function of vinculin and of its muscle-specific metavinculin splice variant. A full appreciation of these processes is necessary for understanding how vinculin regulates cell motility, migration, and wound healing, and for understanding of its role in cancer and cardiovascular diseases.	[Izard, Tina] Scripps Res Inst, Dept Canc Biol, Cell Adhes Lab, Jupiter, FL 33458 USA; [Izard, Tina] Scripps Res Inst, Dept Immunol & Microbial Sci, Jupiter, FL 33458 USA; [Brown, David T.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	Scripps Research Institute; Scripps Research Institute; University of Mississippi; University of Mississippi Medical Center	Izard, T (corresponding author), Scripps Res Inst, Dept Canc Biol, Cell Adhes Lab, Jupiter, FL 33458 USA.; Izard, T (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, Jupiter, FL 33458 USA.	cmorrow@scripps.edu			United States Department of Defense; American Heart Association; State of Florida; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094483] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); American Heart Association(American Heart Association); State of Florida; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from United States Department of Defense and the American Heart Association, and by start-up funds provided to Scripps Florida from the State of Florida.	Atherton P, 2016, EXP CELL RES, V343, P21, DOI 10.1016/j.yexcr.2015.11.017; Atherton P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10038; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; BELKIN AM, 1988, J BIOL CHEM, V263, P6631; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Brown DT, 2015, ONCOTARGET, V6, P34043, DOI 10.18632/oncotarget.5868; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Case LB, 2015, NAT CELL BIOL, V17, P880, DOI 10.1038/ncb3180; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Chinthalapudi K, 2015, BIOCHEMISTRY-US, V54, P2758, DOI 10.1021/acs.biochem.5b00015; Chinthalapudi K, 2014, J CELL BIOL, V207, P643, DOI 10.1083/jcb.201404128; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; DeLeon-Pennell KY, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3391; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; DEPASQUALE JA, 1991, J CELL BIOL, V113, P1351, DOI 10.1083/jcb.113.6.1351; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Diez G, 2009, BIOPHYS J, V97, P3105, DOI 10.1016/j.bpj.2009.09.039; Dumbauld DW, 2013, P NATL ACAD SCI USA, V110, P9788, DOI 10.1073/pnas.1216209110; Durer ZAO, 2015, J MOL BIOL, V427, P2782, DOI 10.1016/j.jmb.2015.07.005; FERAMISCO JR, 1982, J BIOL CHEM, V257, P1024; FERNANDEZ JLR, 1993, J CELL BIOL, V122, P1285, DOI 10.1083/jcb.122.6.1285; Marquez M, 2008, AM J PHYSIOL-RENAL, V294, pF603, DOI 10.1152/ajprenal.00234.2007; Marquez MG, 2014, BBA-MOL CELL RES, V1843, P2991, DOI 10.1016/j.bbamcr.2014.09.014; Marquez MG, 2009, AM J PHYSIOL-RENAL, V297, pF1181, DOI 10.1152/ajprenal.00062.2009; Giannone G, 2015, NAT CELL BIOL, V17, P845, DOI 10.1038/ncb3196; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; GIMONA M, 1987, J MUSCLE RES CELL M, V8, P329, DOI 10.1007/BF01568889; Halstead JR, 2010, J CELL SCI, V123, P3535, DOI 10.1242/jcs.062679; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Huttelmaier S, 2001, J CELL BIOL, V155, P775, DOI 10.1083/jcb.200105044; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; Johnson RP, 2000, J BIOL CHEM, V275, P95, DOI 10.1074/jbc.275.1.95; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1995, BIOCHEM BIOPH RES CO, V210, P159, DOI 10.1006/bbrc.1995.1641; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kaushik G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5843; Kim LY, 2016, J MOL BIOL, V428, P10, DOI 10.1016/j.jmb.2015.09.031; KROEMKER M, 1994, FEBS LETT, V355, P259, DOI 10.1016/0014-5793(94)01216-4; Laine RO, 1997, J CELL BIOL, V138, P1255, DOI 10.1083/jcb.138.6.1255; Lavelin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073549; Lee JH, 2012, J MOL BIOL, V422, P697, DOI 10.1016/j.jmb.2012.06.015; Lee JH, 2009, STRUCTURE, V17, P833, DOI 10.1016/j.str.2009.04.010; Legate KR, 2011, EMBO J, V30, P4539, DOI 10.1038/emboj.2011.332; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Liu JR, 2015, P NATL ACAD SCI USA, V112, pE4864, DOI 10.1073/pnas.1512025112; Maeda M, 1997, CIRCULATION, V95, P17, DOI 10.1161/01.CIR.95.1.17; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Moulder GL, 1996, MOL BIOL CELL, V7, P1181, DOI 10.1091/mbc.7.8.1181; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Palmer SM, 2009, J BIOL CHEM, V284, P7223, DOI 10.1074/jbc.M807842200; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Rangarajan ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010679; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rubashkin MG, 2014, CANCER RES, V74, P4597, DOI 10.1158/0008-5472.CAN-13-3698; Rudiger M, 1998, FEBS LETT, V431, P49, DOI 10.1016/S0014-5793(98)00723-6; SAGA S, 1985, EXP CELL RES, V156, P45, DOI 10.1016/0014-4827(85)90260-5; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; SCHLESSINGER J, 1983, CELL MOTIL CYTOSKEL, V3, P399, DOI 10.1002/cm.970030508; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; TEMPEL M, 1995, BIOPHYS J, V69, P228, DOI 10.1016/S0006-3495(95)79894-0; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Thompson PM, 2014, STRUCTURE, V22, P697, DOI 10.1016/j.str.2014.03.002; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Wirth VF, 2010, BIOCHEM BIOPH RES CO, V398, P433, DOI 10.1016/j.bbrc.2010.06.094; Witt S, 2004, J BIOL CHEM, V279, P31533, DOI 10.1074/jbc.M314245200; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; Xu WM, 1998, DEVELOPMENT, V125, P327	77	33	36	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2548	2555		10.1074/jbc.R115.686493	http://dx.doi.org/10.1074/jbc.R115.686493			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26728462	hybrid, Green Published			2022-12-28	WOS:000369626900001
J	Franke, M; Schroder, J; Monhasery, N; Ackfeld, T; Hummel, TM; Rabe, B; Garbers, C; Becker-Pauly, C; Floss, DM; Scheller, J				Franke, Manuel; Schroeder, Jutta; Monhasery, Niloufar; Ackfeld, Theresa; Hummel, Thorben M.; Rabe, Bjoern; Garbers, Christoph; Becker-Pauly, Christoph; Floss, Doreen M.; Scheller, Juergen			Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; IL-23; CYTOKINE; PROTEINS; CELLS; IDENTIFICATION; INFLAMMATION; CLEAVAGE; IL-12R-BETA-1; ANTAGONIST	IL-23 (interleukin 23) regulates immune responses against pathogens and plays a major role in the differentiation and maintenance of T(H)17 cells and the development of autoimmune diseases and cancer. The IL-23 receptor (IL-23R) complex consists of the unique IL-23R and the common IL-12 receptor beta 1 (IL-12R beta 1). Differential splicing generates antagonistic soluble IL-23R (sIL-23R) variants, which might limit IL-23-mediated immune responses. Here, ectodomain shedding of human and murine IL-23R was identified as an alternative pathway for the generation of sIL-23R. Importantly, proteolytically released sIL-23R has IL-23 binding activity. Shedding of IL-23R was induced by stimulation with the phorbol ester phorbol 12-myristate 13-acetate (PMA), but not by ionomycin. PMA-induced shedding was abrogated by an ADAM(A disintegrin and metalloprotease) 10 and 17 selective inhibitor, but not by an ADAM10 selective inhibitor. ADAM17-deficient but not ADAM10-deficient HEK293 cells failed to shed IL-23R after PMA stimulation, demonstrating that ADAM17 but not ADAM10 cleaves the IL-23R. Constitutive shedding was, however, inhibited by an ADAM10 selective inhibitor. Using deletions and specific amino acid residue exchanges, we identified critical determinants of ectodomain shedding within the stalk region of the IL-23R. Finally, interaction studies identified domains 1 and 3 of the IL-23R as the main ADAM17 binding sites. In summary, we describe human and murine IL-23R as novel targets for protein ectodomain shedding by ADAM10 and ADAM17.	[Franke, Manuel; Schroeder, Jutta; Monhasery, Niloufar; Ackfeld, Theresa; Hummel, Thorben M.; Floss, Doreen M.; Scheller, Juergen] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Univ Str 1, D-40225 Dusseldorf, Germany; [Rabe, Bjoern; Garbers, Christoph; Becker-Pauly, Christoph] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany	Heinrich Heine University Dusseldorf; University of Kiel	Scheller, J (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Univ Str 1, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Becker-Pauly, Christoph/B-7569-2011; Scheller, Jürgen/K-5290-2015; Garbers, Christoph/D-9932-2015	Garbers, Christoph/0000-0003-4939-6950; Ackfeld, Theresa/0000-0003-0001-0981	Deutsche Forschungsgemeinschaft, Bonn, Germany [DFG SCHE907/3-1, SFB877]	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG))	This work was funded by grants from the Deutsche Forschungsgemeinschaft, Bonn, Germany (DFG SCHE907/3-1 to J. S., SFB877 project A9 to C. B.-P. and A10 to C. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Althoff K, 2000, EUR J BIOCHEM, V267, P2624, DOI 10.1046/j.1432-1327.2000.01278.x; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Cosmi L, 2014, CYTOM PART A, V85A, P36, DOI 10.1002/cyto.a.22348; de Paus RA, 2008, MOL IMMUNOL, V45, P3889, DOI 10.1016/j.molimm.2008.06.029; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Floss DM, 2015, CYTOKINE GROWTH F R, V26, P569, DOI 10.1016/j.cytogfr.2015.07.005; Floss DM, 2013, J BIOL CHEM, V288, P19386, DOI 10.1074/jbc.M112.432153; Garbers C, 2014, BBA-MOL BASIS DIS, V1842, P1485, DOI 10.1016/j.bbadis.2014.05.018; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Guo W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045625; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Kan SH, 2008, GENES IMMUN, V9, P631, DOI 10.1038/gene.2008.64; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Mancini G, 2008, GENES IMMUN, V9, P566, DOI 10.1038/gene.2008.51; Ngiow SF, 2013, TRENDS IMMUNOL, V34, P548, DOI 10.1016/j.it.2013.07.004; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schroder J, 2015, J BIOL CHEM, V290, P359, DOI 10.1074/jbc.M114.617597; Suthaus J, 2010, MOL BIOL CELL, V21, P2797, DOI 10.1091/mbc.E10-03-0240; Tucher J, 2014, J PROTEOME RES, V13, P2205, DOI 10.1021/pr401135u; van de Vosse E, 2005, HUM MOL GENET, V14, P3847, DOI 10.1093/hmg/ddi409; Yu RY, 2010, J IMMUNOL, V185, P7302, DOI 10.4049/jimmunol.1002410; Zhang XY, 2006, IMMUNOGENETICS, V57, P934, DOI 10.1007/s00251-005-0067-0	28	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10551	10561		10.1074/jbc.M115.710541	http://dx.doi.org/10.1074/jbc.M115.710541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26961870	Green Published, hybrid			2022-12-28	WOS:000377042600010
J	Gordillo, GM; Biswas, A; Khanna, S; Spieldenner, JM; Pan, XL; Sen, CK				Gordillo, Gayle M.; Biswas, Ayan; Khanna, Savita; Spieldenner, James M.; Pan, Xueliang; Sen, Chandan K.			Multidrug Resistance-associated Protein-1 (MRP-1)-dependent Glutathione Disulfide (GSSG) Efflux as a Critical Survival Factor for Oxidant-enriched Tumorigenic Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; AP-ENDONUCLEASE APE1/REF-1; FACTOR-KAPPA-B; OXIDATIVE STRESS; TUMOR-GROWTH; THIOREDOXIN REDUCTASE; CELLULAR GLUTATHIONE; LIPOIC ACID; X PUMP; EXPRESSION	Endothelial cell tumors are the most common soft tissue tumors in infants. Tumor-forming endothelial (EOMA) cells are able to escape cell death fate despite excessive nuclear oxidant burden. Our previous work recognized perinuclear Nox-4 as a key contributor to FOMA growth. The objective of this work was to characterize the mechanisms by which EOMA cells evade oxidant toxicity and thrive. In EOMA cells, compared with in the cytosol, the nuclear GSSG/GSH ratio was 5-fold higher. Compared to the ratio observed in healthy murine aortic endothelial (MAE) cells, GSSG/GSH was over twice as high in EOMA cells. Multidrug resistance-associated protein-1 (MRP-1), an active GSSG efflux mechanism, showed 2-fold increased activity in EOMA compared with MAE cells. Hyperactive YR-1 and Ape/Ref-1 were responsible for high MRP-1 expression in EOMA. Proximity ligand assay demonstrated MRP-1 and YR-1 binding. Such binding enabled the nuclear targeting of MRP-1 in EOMA in a leptomycin-B-sensitive manner. MRP-1 inhibition as well as knockdown trapped nuclear GSSG, causing cell death of EOMA. Disulfide loading of cells by inhibition of GSSG reductase (bischoloronitrosourea) or thioredoxin reductase (auranofin) was effective in causing EOMA death as well. In sum, EOMA cells survive a heavy oxidant burden by rapid efflux of GSSG, which is lethal if trapped within the cell. A hyperactive MRP-1 system for GSSG efflux acts as a critical survival factor for these cells, making it a potential target for EOMA therapeutics.	[Gordillo, Gayle M.; Biswas, Ayan] Ohio State Univ, Dept Plast Surg, Wexner Med Ctr, Columbus, OH 43212 USA; [Khanna, Savita; Spieldenner, James M.; Sen, Chandan K.] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43212 USA; [Gordillo, Gayle M.; Biswas, Ayan; Khanna, Savita; Spieldenner, James M.; Sen, Chandan K.] Ohio State Univ, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43212 USA; [Pan, Xueliang] Ohio State Univ, Ctr Biostat, Wexner Med Ctr, Columbus, OH 43212 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gordillo, GM (corresponding author), 915 Olentangy River Rd,Suite 2100, Columbus, OH 43212 USA.	gayle.gordillo@osumc.edu	Gordillo, Gayle M/E-3136-2011	Pan, Xueliang/0000-0002-2342-3212	National Institutes of Health/NIGMS [R01 GM095657, R01 GM108014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108014, R01GM095657] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/NIGMS Grants R01 GM095657 (to G. M. G) and R01 GM108014 (to C. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Bader AG, 2005, MOL CELL BIOL, V25, P2095, DOI 10.1128/MCB.25.6.2095-2106.2005; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Biswas A, 2015, AM J PHYSIOL-CELL PH, V309, pC296, DOI 10.1152/ajpcell.00022.2015; Busu C, 2013, REDOX BIOL, V1, P131, DOI 10.1016/j.redox.2013.01.003; Cai BL, 2011, ORAL ONCOL, V47, P1134, DOI 10.1016/j.oraloncology.2011.08.005; Chow AKM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078675; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; Cohen SB, 2010, ONCOGENE, V29, P403, DOI 10.1038/onc.2009.321; Dando I, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/425708; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Dirican N, 2016, REDOX REP, V21, P197, DOI 10.1179/1351000215Y.0000000027; Fan C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.132; Filomeni G, 2005, FREE RADICAL BIO MED, V39, P345, DOI 10.1016/j.freeradbiomed.2005.03.022; Filomeni G, 2002, FASEB J, V16, P64, DOI 10.1096/fj.02-0105fje; Friedrichs B, 1998, ARTERIOSCL THROM VAS, V18, P1829, DOI 10.1161/01.ATV.18.12.1829; Gordillo G, 2009, ANTIOXID REDOX SIGN, V11, P47, DOI 10.1089/ars.2008.2150; Gordillo G, 2010, ANTIOXID REDOX SIGN, V12, P933, DOI 10.1089/ars.2009.2917; Gordillo GM, 2014, J BIOL CHEM, V289, P9027, DOI 10.1074/jbc.M113.519264; Gordillo GM, 2004, AM J PHYSIOL-CELL PH, V287, pC866, DOI 10.1152/ajpcell.00238.2003; Gordillo GM, 2002, METHOD ENZYMOL, V352, P422; Gumireddy K., 2013, J CARCINOG MUTAGEN, V2013, pS7; Haber M, 2006, J CLIN ONCOL, V24, P1546, DOI 10.1200/JCO.2005.01.6196; Haggstrom AN, 2006, PEDIATRICS, V118, P882, DOI 10.1542/peds.2006-0413; Han D, 1997, AM J PHYSIOL-REG I, V273, pR1771, DOI 10.1152/ajpregu.1997.273.5.R1771; HEDLEY D, 1994, METHOD CELL BIOL, V42, P31; HEDLEY DW, 1994, CYTOMETRY, V15, P349, DOI 10.1002/cyto.990150411; Hlavac V, 2013, PHARMACOGENOMICS, V14, P515, DOI [10.2217/PGS.13.26, 10.2217/pgs.13.26]; Hsu TC, 2000, FREE RADICAL BIO MED, V28, P1338, DOI 10.1016/S0891-5849(00)00220-3; Huang EY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.120; Ishikawa T, 1996, J BIOL CHEM, V271, P14981, DOI 10.1074/jbc.271.25.14981; JACOBS AH, 1976, PEDIATRICS, V58, P218; Janiszewski M, 1998, CARDIOVASC RES, V39, P327, DOI 10.1016/S0008-6363(98)00082-0; Ji LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063404; KEHRER JP, 1983, TOXICOL LETT, V17, P63, DOI 10.1016/0378-4274(83)90036-X; Khanna S, 2005, STROKE, V36, pE144, DOI 10.1161/01.STR.0000181082.70763.22; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; Khanna S, 2009, ANTIOXID REDOX SIGN, V11, P449, DOI 10.1089/ARS.2008.2230; Khaperskyy DA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004217; KOSOWER EM, 1995, METHOD ENZYMOL, V251, P133, DOI 10.1016/0076-6879(95)51117-2; KOSOWER NS, 1987, METHOD ENZYMOL, V143, P76; Leier I, 1996, BIOCHEM J, V314, P433, DOI 10.1042/bj3140433; Liu CF, 2012, MOL CARCINOGEN, V51, P303, DOI 10.1002/mc.20781; Lokanga RA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005181; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Martinez-Gonzalez JJ, 2015, MOL BIOCHEM PARASIT, V201, P16, DOI 10.1016/j.molbiopara.2015.05.001; Mims J, 2015, RADIAT RES, V183, P291, DOI 10.1667/RR13828.1; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Mulliken JB, 1988, VASCULAR BIRTHMARKS, P41; Munoz M, 2007, IUBMB LIFE, V59, P752, DOI 10.1080/15216540701736285; Ohashi S, 2009, BIOCHEM BIOPH RES CO, V385, P545, DOI 10.1016/j.bbrc.2009.05.094; Ortega Angel L, 2011, Cancers (Basel), V3, P1285, DOI 10.3390/cancers3011285; Osseni RA, 2000, LIFE SCI, V68, P387, DOI 10.1016/S0024-3205(00)00955-3; Paller AS, 2000, J INVEST DERM SYMP P, V5, P83, DOI 10.1046/j.1087-0024.2000.00011.x; Park HA, 2009, CELL DEATH DIFFER, V16, P1167, DOI 10.1038/cdd.2009.37; Park HA, 2011, STROKE, V42, P2308, DOI 10.1161/STROKEAHA.110.608547; Radyuk SN, 2009, J BIOL CHEM, V284, P2266, DOI 10.1074/jbc.M805913200; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Ramos L, 2008, HUM REPROD, V23, P259, DOI 10.1093/humrep/dem365; Raninga Prahlad V, 2014, Oncoscience, V1, P95; Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5; RICE GC, 1986, CANCER RES, V46, P6105; Scheffer GL, 2000, CANCER RES, V60, P5269; Seco-Cervera M, 2014, AGING-US, V6, P231, DOI 10.18632/aging.100649; Sen CK, 1999, METHOD ENZYMOL, V299, P239; Sen CK, 2002, J BIOL CHEM, V277, P33284, DOI 10.1074/jbc.M203391200; Sen CK, 1997, FREE RADICAL BIO MED, V22, P1241, DOI 10.1016/S0891-5849(96)00552-7; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; Sharma-Walia N, 2010, J VIROL, V84, P12733, DOI 10.1128/JVI.01065-10; Sundin T, 2013, MOL CELL BIOCHEM, V375, P97, DOI 10.1007/s11010-012-1532-3; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Tobe R, 2012, BIOCHEM J, V445, P423, DOI 10.1042/BJ20120618; Tontonoz P, 2015, MOL CELL BIOL, V35, P1125, DOI 10.1128/MCB.00715-14; Traverso N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/972913; Van Luyn MJA, 1998, INT J CANCER, V76, P55, DOI 10.1002/(SICI)1097-0215(19980330)76:1<55::AID-IJC10>3.3.CO;2-O; Xu SL, 2014, DRUG DISCOV TODAY, V19, P222, DOI 10.1016/j.drudis.2013.10.017; Yamane Y, 1998, J BIOL CHEM, V273, P31075, DOI 10.1074/jbc.273.47.31075; Zhang HH, 2014, ANTIOXID REDOX SIGN, V21, P669, DOI 10.1089/ars.2013.5499; Zhang YW, 2014, WORLD J GASTROENTERO, V20, P584, DOI 10.3748/wjg.v20.i2.584; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897	84	21	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10089	10103		10.1074/jbc.M115.688879	http://dx.doi.org/10.1074/jbc.M115.688879			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26961872	Green Published, hybrid			2022-12-28	WOS:000375602800021
J	Striz, AC; Tuma, PL				Striz, Anneliese C.; Tuma, Pamela L.			The GTP-bound and Sumoylated Form of the rab17 Small Molecular Weight GTPase Selectively Binds Syntaxin 2 in Polarized Hepatic WIF-B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE PLASMA-MEMBRANE; EPITHELIAL-CELLS; RAT-LIVER; PROTEIN SUMOYLATION; RECYCLING ENDOSOMES; APICAL DOMAIN; IN-VIVO; SUMO; TRANSPORTERS; TRANSCYTOSIS	A major focus for our laboratory is identifying the molecules and mechanisms that regulate polarized apical protein sorting in hepatocytes, the major epithelial cells of the liver. These trafficking pathways are regulated, in part, by small molecular weight rab GTPases. We chose to investigate rab17, whose expression is restricted to polarized epithelial cells, is enriched in liver, and has been implicated in regulating basolateral to apical transcytosis. To initiate our studies, we generated three recombinant adenoviruses expressing wild type, constitutively active (GTP bound), or dominant-negative (GDP bound) rab17. Immunoblotting revealed rab17 immunoreactive species at 25 kDa (the predicted rab17 molecular mass) and 40 kDa. We determined that mono-sumoylation of the 25-kDa rab17 is responsible for the shift in molecular mass, and that rab17 prenylation is required for sumoylation. We further determined that sumoylation selectively promotes interactions with syntaxin 2 (but not syntaxins 3 or 4) and that these interactions are nucleotide dependent. Furthermore, a K68R-mutated rab17 led to the redistribution of syntaxin 2 and 5' nucleotidase from the apical membrane to subapical puncta, whereas multidrug resistance protein 2 distributions were not changed. Together these data are consistent with the proposed role of rab17 in vesicle fusion with the apical plasma membrane and further implicate sumoylation as an important mediator of protein-protein interactions. The selectivity in syntaxin binding and apical protein redistribution further suggests that rab17 and syntaxin 2 mediate fusion of transcytotic vesicles at the apical surface.	[Striz, Anneliese C.; Tuma, Pamela L.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	Catholic University of America	Tuma, PL (corresponding author), Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA.	tuma@cua.edu			National Institutes of Health [R01 DK082890]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK082890 (to P. L. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no have no conflicts of interest with the contents of this article.	BARTLES JR, 1988, TRENDS BIOCHEM SCI, V13, P181, DOI 10.1016/0968-0004(88)90147-8; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; Bastaki M, 2002, MOL BIOL CELL, V13, P225, DOI 10.1091/mbc.01-07-0376; Beaumont KA, 2011, TRAFFIC, V12, P627, DOI 10.1111/j.1600-0854.2011.01172.x; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Caron D, 2015, FEBS LETT, V589, P985, DOI 10.1016/j.febslet.2015.03.007; Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Datta S, 2014, MOL BIOL CELL, V25, P1202, DOI 10.1091/mbc.E13-07-0430; Fiordalisi JJ, 2001, METHOD ENZYMOL, V332, P3; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Fuhs SR, 2011, J BIOL CHEM, V286, P14830, DOI 10.1074/jbc.M110.214270; Fujita H, 1998, BIOCHEM J, V329, P527, DOI 10.1042/bj3290527; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; Gentile F, 2002, J BIOL CHEM, V277, P44050, DOI 10.1074/jbc.M206761200; Gonzalez-Santamaria J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.135; Hunziker W, 1998, J BIOL CHEM, V273, P15734, DOI 10.1074/jbc.273.25.15734; Ihrke G, 1998, J CELL BIOL, V141, P115, DOI 10.1083/jcb.141.1.115; IHRKE G, 1993, J CELL BIOL, V123, P1761, DOI 10.1083/jcb.123.6.1761; In JG, 2014, BIOCHEM J, V463, P201, DOI 10.1042/BJ20140468; Jin MJ, 1996, J BIOL CHEM, V271, P30105, DOI 10.1074/jbc.271.47.30105; Kipp H, 2000, J BIOL CHEM, V275, P15917, DOI 10.1074/jbc.M909875199; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehtonen S, 1999, INT J DEV BIOL, V43, P425; Li YJ, 2012, J CELL BIOL, V199, P589, DOI 10.1083/jcb.201203150; LUTCKE A, 1993, J CELL BIOL, V121, P553, DOI 10.1083/jcb.121.3.553; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Mori Y, 2012, J BIOL CHEM, V287, P8963, DOI 10.1074/jbc.M111.314385; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Peters PJ, 2001, METHOD ENZYMOL, V329, P210; Qu YY, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-95; Robibaro B, 2002, CELL MICROBIOL, V4, P139, DOI 10.1046/j.1462-5822.2002.00178.x; SCHELL MJ, 1992, J CELL BIOL, V119, P1173, DOI 10.1083/jcb.119.5.1173; SHANKS MR, 1994, J CELL SCI, V107, P813; Tokmakov AA, 2012, J BIOL CHEM, V287, P27106, DOI 10.1074/jbc.M112.366351; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Wasik U, 2014, BBA-MOL CELL RES, V1843, P2878, DOI 10.1016/j.bbamcr.2014.07.018; Xu Z, 2008, FASEB J, V22, P127, DOI 10.1096/fj.06-7871com; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039	41	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9721	9732		10.1074/jbc.M116.723353	http://dx.doi.org/10.1074/jbc.M116.723353			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26957544	Green Published, hybrid			2022-12-28	WOS:000375602300030
J	Aerbajinai, W; Liu, LH; Zhu, JQ; Kumkhaek, C; Chin, K; Rodgers, GP				Aerbajinai, Wulin; Liu, Lunhua; Zhu, Jianqiong; Kumkhaek, Chutima; Chin, Kyung; Rodgers, Griffin P.			Glia Maturation Factor- Regulates Monocyte Migration through Modulation of 1-Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; Arp2; 3 complex; cell migration; endocytosis; integrin; ubiquitylation (ubiquitination); glia maturation factor-gamma (GMFG)	STIMULATED GLUT4 TRANSLOCATION; CELL-MIGRATION; MEMBRANE-FUSION; FACTOR-GAMMA; NEUTROPHIL CHEMOTAXIS; LYSOSOMAL DEGRADATION; SYNIP PHOSPHORYLATION; ACTIN POLYMERIZATION; INTEGRIN TRAFFICKING; RECYCLING PATHWAYS	Monocyte migration requires the dynamic redistribution of integrins through a regulated endo-exocytosis cycle, but the complex molecular mechanisms underlying this process have not been fully elucidated. Glia maturation factor- (GMFG), a novel regulator of the Arp2/3 complex, has been shown to regulate directional migration of neutrophils and T-lymphocytes. In this study, we explored the important role of GMFG in monocyte chemotaxis, adhesion, and 1-integrin turnover. We found that knockdown of GMFG in monocytes resulted in impaired chemotactic migration toward formyl-Met-Leu-Phe (fMLP) and stromal cell-derived factor 1 (SDF-1) as well as decreased 51-integrin-mediated chemoattractant-stimulated adhesion. These GMFG knockdown impaired effects could be reversed by cotransfection of GFP-tagged full-length GMFG. GMFG knockdown cells reduced the cell surface and total protein levels of 51-integrin and increased its degradation. Importantly, we demonstrate that GMFG mediates the ubiquitination of 1-integrin through knockdown or overexpression of GMFG. Moreover, GMFG knockdown retarded the efficient recycling of 1-integrin back to the plasma membrane following normal endocytosis of 51-integrin, suggesting that the involvement of GMFG in maintaining 51-integrin stability may occur in part by preventing ubiquitin-mediated degradation and promoting 1-integrin recycling. Furthermore, we observed that GMFG interacted with syntaxin 4 (STX4) and syntaxin-binding protein 4 (STXBP4); however, only knockdown of STXBP4, but not STX4, reduced monocyte migration and decreased 1-integrin cell surface expression. Knockdown of STXBP4 also substantially inhibited 1-integrin recycling in human monocytes. These results indicate that the effects of GMFG on monocyte migration and adhesion probably occur through preventing ubiquitin-mediated proteasome degradation of 51-integrin and facilitating effective 1-integrin recycling back to the plasma membrane.	[Aerbajinai, Wulin; Zhu, Jianqiong; Kumkhaek, Chutima; Chin, Kyung; Rodgers, Griffin P.] NHLBI, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA; [Liu, Lunhua] NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rodgers, GP (corresponding author), NIH, Mol & Clin Hematol Branch, Bldg 10,Rm 9N-113A, Bethesda, MD 20892 USA.	gr5n@nih.gov			NIDDK, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006005] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of NIDDK, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aerbajinai W, 2011, J LEUKOCYTE BIOL, V90, P529, DOI 10.1189/jlb.0710424; Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Bennett MK, 1999, NAT CELL BIOL, V1, pE58, DOI 10.1038/11027; Boczkowska M, 2013, J BIOL CHEM, V288, P25683, DOI 10.1074/jbc.C113.493338; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Cera MR, 2009, J CELL SCI, V122, P268, DOI 10.1242/jcs.037127; Chang FS, 2003, CURR BIOL, V13, P455, DOI 10.1016/S0960-9822(03)00131-3; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; CHULUYAN HE, 1995, J LEUKOCYTE BIOL, V58, P71, DOI 10.1002/jlb.58.1.71; Day P, 2011, INT J ONCOL, V39, P863, DOI 10.3892/ijo.2011.1101; De Franceschi N, 2015, J CELL SCI, V128, P839, DOI 10.1242/jcs.161653; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Firat-Karalar EN, 2011, CURR OPIN CELL BIOL, V23, P4, DOI 10.1016/j.ceb.2010.10.007; Gandhi M, 2010, CURR BIOL, V20, P861, DOI 10.1016/j.cub.2010.03.026; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hao YH, 2013, CELL, V152, P1051, DOI 10.1016/j.cell.2013.01.051; Harrison MS, 2014, P NATL ACAD SCI USA, V111, P267, DOI 10.1073/pnas.1316482111; Herter J, 2013, J IMMUNOL, V190, P4451, DOI 10.4049/jimmunol.1203179; Hsu VW, 2010, CURR OPIN CELL BIOL, V22, P528, DOI 10.1016/j.ceb.2010.05.008; Ikeda K, 2006, CIRC RES, V99, P424, DOI 10.1161/01.RES.0000237662.23539.0b; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kawaguchi T, 2010, BIOCHEM BIOPH RES CO, V391, P1336, DOI 10.1016/j.bbrc.2009.12.045; Kharitidi D, 2015, CELL REP, V13, P599, DOI 10.1016/j.celrep.2015.09.024; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lippert DND, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-21; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; LUSCINSKAS FW, 1994, J CELL BIOL, V125, P1417, DOI 10.1083/jcb.125.6.1417; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; MEERSCHAERT J, 1995, J IMMUNOL, V154, P4099; Mellman I, 2000, J CELL BIOL, V149, P529, DOI 10.1083/jcb.149.3.529; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Okada S, 2007, BIOCHEM BIOPH RES CO, V356, P102, DOI 10.1016/j.bbrc.2007.02.095; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rankin CR, 2013, J BIOL CHEM, V288, P15229, DOI 10.1074/jbc.M112.440909; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shi Ying, 2006, Genomics Proteomics & Bioinformatics, V4, P145, DOI 10.1016/S1672-0229(06)60027-2; Stanley P, 2012, BIOL OPEN, V1, P1161, DOI 10.1242/bio.20122824; Steeber DA, 2000, IMMUNOL RES, V22, P299, DOI 10.1385/IR:22:2-3:299; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Tanabe Kenji, 2011, Commun Integr Biol, V4, P742; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Tiwari A, 2011, J BIOL CHEM, V286, P36749, DOI 10.1074/jbc.M111.260828; Veale KJ, 2011, EXP CELL RES, V317, P1817, DOI 10.1016/j.yexcr.2011.04.016; Veale Kelly J, 2011, Commun Integr Biol, V4, P44, DOI 10.4161/cib.4.1.13569; Wong CHY, 2010, CARDIOVASC RES, V86, P183, DOI 10.1093/cvr/cvq040; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182; Yamada E, 2014, ENDOCR J, V61, P523, DOI 10.1507/endocrj.EJ14-0099; Ydenberg CA, 2013, CURR BIOL, V23, P1037, DOI 10.1016/j.cub.2013.04.058; Yu HJ, 2013, J BIOL CHEM, V288, P18885, DOI 10.1074/jbc.M113.465450	62	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8549	8564		10.1074/jbc.M115.674200	http://dx.doi.org/10.1074/jbc.M115.674200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26895964	Green Published, hybrid			2022-12-28	WOS:000374773200020
J	Ha, SD; Reid, C; Meshkibaf, S; Kim, SO				Ha, Soon-Duck; Reid, Chantelle; Meshkibaf, Shahab; Kim, Sung Ouk			Inhibition of Interleukin 1 (IL-1) Expression by Anthrax Lethal Toxin (LeTx) Is Reversed by Histone Deacetylase 8 (HDAC8) Inhibition in Murine Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anthrax toxin; histone deacetylase (HDAC); interleukin 1 (IL-1); lipopolysaccharide (LPS); transcription enhancer	LONG NONCODING RNAS; NF-KAPPA-B; GENE-EXPRESSION; SIGNALING PATHWAYS; ENHANCER RNAS; PROINFLAMMATORY CYTOKINES; INFLAMMATORY RESPONSE; INHALATION ANTHRAX; PROTECTIVE ANTIGEN; ADAPTIVE IMMUNITY	Many pathogenic microbes often release toxins that subvert the host's immune responses to render the environment suitable for their survival and proliferation. LeTx is one of the toxins causing immune paralysis by cleaving and inactivating the mitogen-activated protein kinase (MAPK) kinases (MEKs). Here, we show that inhibition of the histone deacetylase 8 (HDAC8) by either the HDAC8-specific inhibitor PCI-34051 or small interference (si)RNAs rendered LeTx-exposed murine macrophages responsive to LPS in pro-IL-1 production. HDAC8 selectively targeted acetylated histone H3 lysine 27 (H3K27Ac), which is known to associate with active enhancers. LeTx induced HDAC8 expression, in part through inhibiting p38 MAPK, which resulted in a decrease of H3K27Ac levels. Inhibition of HDAC8 increased H3K27Ac levels and enhanced NF-B-mediated pro-IL-1 enhancer and messenger RNA production in LeTx-exposed macrophages. Collectively, this study demonstrates a novel role of HDAC8 in LeTx immunotoxicity and regulation of pro-IL-1 production likely through eRNAs. Targeting HDAC8 could be a strategy for enhancing immune responses in macrophages exposed to LeTx or other toxins that inhibit MAPKs.	Univ Western Ontario, Siebens Drake Res Inst, Dept Microbiol & Immunol, London, ON N6G 2V4, Canada; Univ Western Ontario, Siebens Drake Res Inst, Infect Dis Res Grp, London, ON N6G 2V4, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Kim, SO (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6G 2V4, Canada.	skim283@uwo.ca	KIM, Sung Ouk/A-1309-2008; Kim, Sung Ouk/AAO-1795-2020	Kim, Sung Ouk/0000-0002-0282-6661	Natural Sciences and Engineering Research of Canada [RGPIN 312482-2013]	Natural Sciences and Engineering Research of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research of Canada Grant RGPIN 312482-2013 (to S. O. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Ascenzi P, 2002, FEBS LETT, V531, P384, DOI 10.1016/S0014-5793(02)03609-8; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Boyer AE, 2009, INFECT IMMUN, V77, P3432, DOI 10.1128/IAI.00346-09; Buggy JJ, 2000, BIOCHEM J, V350, P199, DOI 10.1042/0264-6021:3500199; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Coggeshall KM, 2013, J CELL MOL MED, V17, P914, DOI 10.1111/jcmm.12075; Cote CK, 2015, TOXINS, V7, P3167, DOI 10.3390/toxins7083167; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; Erwin JL, 2001, INFECT IMMUN, V69, P1175, DOI 10.1128/IAI.69.2.1175-1177.2001; Fortier A, 2005, TRENDS MICROBIOL, V13, P328, DOI 10.1016/j.tim.2005.05.007; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fukao T, 2004, LANCET INFECT DIS, V4, P166, DOI 10.1016/S1473-3099(04)00940-5; Gao JX, 2009, BIOCHEM BIOPH RES CO, V379, P1, DOI 10.1016/j.bbrc.2008.11.135; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Ha SD, 2007, J BIOL CHEM, V282, P36230, DOI 10.1074/jbc.M707622200; Ha SD, 2007, J BIOL CHEM, V282, P26275, DOI 10.1074/jbc.M703668200; Ha SD, 2014, J IMMUNOL, V193, P1333, DOI 10.4049/jimmunol.1400420; Ha SD, 2012, MOL CELL BIOL, V32, P4846, DOI 10.1128/MCB.00494-12; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Herz HM, 2014, MOL CELL, V53, P859, DOI 10.1016/j.molcel.2014.02.033; Heward JA, 2015, FEBS LETT, V589, P396, DOI 10.1016/j.febslet.2014.12.026; Hicks CW, 2011, TOXINS, V3, P1185, DOI 10.3390/toxins3091185; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Karolczak-Bayatti M, 2011, J BIOL CHEM, V286, P34346, DOI 10.1074/jbc.M111.278549; Kassam A, 2005, CELL MICROBIOL, V7, P281, DOI 10.1111/j.1462-5822.2004.00458.x; Kim TK, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018622; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lee H, 2006, MOL CELL BIOL, V26, P5259, DOI 10.1128/MCB.01971-05; Li S, 2015, J BIOL CHEM, V290, P2368, DOI 10.1074/jbc.M114.618454; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; MILNE JC, 1993, MOL MICROBIOL, V10, P647, DOI 10.1111/j.1365-2958.1993.tb00936.x; Murko C, 2010, INT J DEV BIOL, V54, P1527, DOI 10.1387/ijdb.092971cm; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Olson DE, 2014, ACS CHEM BIOL, V9, P2210, DOI 10.1021/cb500492r; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Park S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057138; Pedra JHF, 2007, J IMMUNOL, V179, P4783, DOI 10.4049/jimmunol.179.7.4783; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Raymond B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000359; Ribot WJ, 2006, INFECT IMMUN, V74, P5029, DOI 10.1128/IAI.00275-06; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saha A, 2013, BIOORGAN MED CHEM, V21, P4201, DOI 10.1016/j.bmc.2013.05.002; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Scarpa M, 2012, INFLAMM BOWEL DIS, V18, P1982, DOI 10.1002/ibd.22934; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Terra JK, 2010, J IMMUNOL, V184, P17, DOI 10.4049/jimmunol.0903114; Tonello F, 2003, J BIOL CHEM, V278, P40075, DOI 10.1074/jbc.M306466200; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wang SA, 2014, BBA-MOL CELL RES, V1843, P1135, DOI 10.1016/j.bbamcr.2014.02.001; WARREN MK, 1985, J IMMUNOL, V134, P982; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Wolfson NA, 2013, BIOPOLYMERS, V99, P112, DOI 10.1002/bip.22135; Xu LX, 2008, J IMMUNOL, V180, P4139, DOI 10.4049/jimmunol.180.6.4139; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; Yasui T, 2011, J BONE MINER RES, V26, P2665, DOI 10.1002/jbmr.464; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhao BW, 2006, VIROLOGY, V352, P338, DOI 10.1016/j.virol.2006.04.036	89	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8745	8755		10.1074/jbc.M115.695809	http://dx.doi.org/10.1074/jbc.M115.695809			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26912657	Green Published, hybrid			2022-12-28	WOS:000374773200036
J	Liu, XH; Berry, CT; Ruthel, G; Madara, JJ; MacGillivray, K; Gray, CM; Madge, LA; McCorkell, KA; Beiting, DP; Hershberg, U; May, MJ; Freedman, BD				Liu, Xiaohong; Berry, Corbett T.; Ruthel, Gordon; Madara, Jonathan J.; MacGillivray, Katelyn; Gray, Carolyn M.; Madge, Lisa A.; McCorkell, Kelly A.; Beiting, Daniel P.; Hershberg, Uri; May, Michael J.; Freedman, Bruce D.			T Cell Receptor-induced Nuclear Factor kappa B (NF-kappa B) Signaling and Transcriptional Activation Are Regulated by STIM1-and Orai1-mediated Calcium Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FALSE DISCOVERY RATE; P65 PHOSPHORYLATION; GENE-EXPRESSION; DIFFERENTIAL REQUIREMENT; CA2+ SENSOR; PKC-THETA; LYMPHOCYTES; SUBUNIT; ALPHA	T cell activation following antigen binding to the T cell receptor (TCR) involves the mobilization of intracellular Ca2+ to activate the key transcription factors nuclear factor of activated T lymphocytes (NFAT) and NF-kappa B. The mechanism of NFAT activation by Ca2+ has been determined. However, the role of Ca2+ in controlling NF-kappa B signaling is poorly understood, and the source of Ca2+ required for NF-kappa B activation is unknown. We demonstrate that TCR- but not TNF-induced NF-kappa B signaling upstream of I kappa B kinase activation absolutely requires the influx of extracellular Ca2+ via STIM1-dependent Ca2+ release-activated Ca2+/Orai channels. We further show that Ca2+ influx controls phosphorylation of the NF-kappa B protein p65 on Ser-536 and that this posttranslational modification controls its nuclear localization and transcriptional activation. Notably, our data reveal that this role for Ca2+ is entirely separate from its upstream control of IB degradation, thereby identifying a novel Ca2+-dependent distal step in TCR-induced NF-kappa B activation. Finally, we demonstrate that this control of distal signaling occurs via Ca2+-dependent PKC-mediated phosphorylation of p65. Thus, we establish the source of Ca2+ required for TCR-induced NF-kappa B activation and define a new distal Ca2+-dependent checkpoint in TCR-induced NF-kappa B signaling that has broad implications for the control of immune cell development and T cell functional specificity.	[Liu, Xiaohong; Berry, Corbett T.; Ruthel, Gordon; Madara, Jonathan J.; MacGillivray, Katelyn; Beiting, Daniel P.; Freedman, Bruce D.] Univ Penn, Sch Vet Med, Dept Pathobiol, 3800 Spruce St, Philadelphia, PA 19104 USA; [Gray, Carolyn M.; Madge, Lisa A.; McCorkell, Kelly A.; May, Michael J.] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Berry, Corbett T.; Hershberg, Uri] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Drexel University	Freedman, BD (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, 3800 Spruce St, Philadelphia, PA 19104 USA.	bruce@vet.upenn.edu	Ruthel, Gordon/GYU-9133-2022; Hershberg, Uri/AAQ-6255-2020; Beiting, Daniel/AAG-6275-2019	Hershberg, Uri/0000-0002-6425-5980; Berry, Corbett/0000-0001-9348-2034; May, Michael/0000-0002-2485-3716	National Institutes of Health [RO1AI060921, RO1HL096642]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096642, R56HL096642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI125415, T32AI070077, R01AI060921] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD010919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by National Institutes of Health Grants RO1AI060921 (to B. F.) and RO1HL096642 (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTMAN A, 1992, IMMUNOLOGY, V76, P465; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Barouch-Bentov R, 2006, ADV EXP MED BIOL, V584, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Buss H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051847; Campbell KJ, 2006, BIOCHEM SOC SYMP, V73, P165, DOI 10.1042/bss0730165; Campbell KJ, 2004, BIOCHEM SOC T, V32, P1087, DOI 10.1042/BST0321087; Clavijo PE, 2012, J IMMUNOL, V188, P1213, DOI 10.4049/jimmunol.1100793; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Coutinho A, 2005, CURR TOP MICROBIOL, V293, P43, DOI 10.1007/3-540-27702-1_3; Deenick EK, 2010, EUR J IMMUNOL, V40, P677, DOI 10.1002/eji.201040298; DOLMETSCH RE, 1994, J GEN PHYSIOL, V103, P365, DOI 10.1085/jgp.103.3.365; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Frischbutter S, 2011, EUR J IMMUNOL, V41, P2349, DOI 10.1002/eji.201041052; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Gentleman R, 2005, LIMMA LINEAR MODELS; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Gilmore F., 2015, NF B TRANSCRIPTION F; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Gutierrez H, 2008, J NEUROSCI, V28, P8246, DOI 10.1523/JNEUROSCI.1941-08.2008; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Healy JI, 1998, CIBA F SYMP, V215, P137; Hochrainer K, 2013, J BIOL CHEM, V288, P285, DOI 10.1074/jbc.M112.385625; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hori S, 2010, EUR J IMMUNOL, V40, P664, DOI 10.1002/eji.201040372; Hu J, 2005, MOL CARCINOGEN, V44, P274, DOI 10.1002/mc.20142; Hu J, 2004, CARCINOGENESIS, V25, P1991, DOI 10.1093/carcin/bgh198; Ishiguro K, 2007, MOL IMMUNOL, V44, P2095, DOI 10.1016/j.molimm.2006.09.012; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Itatsu K, 2009, LIVER INT, V29, P291, DOI 10.1111/j.1478-3231.2008.01858.x; Jana S, 2009, EUR J IMMUNOL, V39, P2571, DOI 10.1002/eji.200939201; Jang MK, 2001, J BIOL CHEM, V276, P20005, DOI 10.1074/jbc.M010211200; Lee HM, 2011, ADV IMMUNOL, V112, P25, DOI 10.1016/B978-0-12-387827-4.00002-4; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Lio CWJ, 2011, CURR OPIN IMMUNOL, V23, P213, DOI 10.1016/j.coi.2010.11.010; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; Medoff BD, 2009, EUR J IMMUNOL, V39, P78, DOI 10.1002/eji.200838734; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Oruganti SR, 2011, MOL IMMUNOL, V48, P1448, DOI 10.1016/j.molimm.2011.03.020; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Podtschaske M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000935; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sanchez-Valdepenas C, 2007, CELL SIGNAL, V19, P528, DOI 10.1016/j.cellsig.2006.08.002; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Schmidt AM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004411; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; STEFFAN NM, 1995, J IMMUNOL, V155, P4685; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Takeuchi H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003326; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang BL, 2015, J BIOL CHEM, V290, P20336, DOI 10.1074/jbc.M115.639849; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028081; Wittwer T, 2008, BIOCHEM BIOPH RES CO, V371, P294, DOI 10.1016/j.bbrc.2008.04.069; Xing DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024021; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	81	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8440	8452		10.1074/jbc.M115.713008	http://dx.doi.org/10.1074/jbc.M115.713008			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26826124	Green Published, hybrid			2022-12-28	WOS:000374773200011
J	Rizvi, S; Yamada, D; Hirsova, P; Bronk, SF; Werneburg, NW; Krishnan, A; Salim, W; Zhang, L; Trushina, E; Truty, MJ; Gores, GJ				Rizvi, Sumera; Yamada, Daisaku; Hirsova, Petra; Bronk, Steven F.; Werneburg, Nathan W.; Krishnan, Anuradha; Salim, Warda; Zhang, Liang; Trushina, Eugenia; Truty, Mark J.; Gores, Gregory J.			A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; cancer biology; fibroblast growth factor receptor (FGFR); Hippo pathway; Yes-associated protein (YAP); BGJ398; mcl-1	YAP; LIVER; EXPRESSION; PHOSPHORYLATION; IDENTIFICATION; HOMEOSTASIS; ACTIVATION; GENERATION; DIAGNOSIS; ONCOGENE	Herein, we have identified cross-talk between the Hippo and fibroblast growth factor receptor (FGFR) oncogenic signaling pathways in cholangiocarcinoma (CCA). Yes-associated protein (YAP) nuclear localization and up-regulation of canonical target genes was observed in CCA cell lines and a patient-derived xenograft (PDX). Expression of FGFR1, -2, and -4 was identified in human CCA cell lines, driven, in part, by YAP coactivation of TBX5. In turn, FGFR signaling in a cell line with minimal basal YAP expression induced its cellular protein expression and nuclear localization. Treatment of YAP-positive CCA cell lines with BGJ398, a pan-FGFR inhibitor, resulted in a decrease in YAP activation. FGFR activation of YAP appears to be driven largely by FGF5 activation of FGFR2, as siRNA silencing of this ligand or receptor, respectively, inhibited YAP nuclear localization. BGJ398 treatment of YAP-expressing cells induced cell death due to Mcl-1 depletion. In a YAP-associated mouse model of CCA, expression of FGFR 1, 2, and 4 was also significantly increased. Accordingly, BGJ398 treatment was tumor-suppressive in this model and in a YAP-positive PDX model. These preclinical data suggest not only that the YAP and Hippo signaling pathways culminate in an Mcl-1-regulated tumor survival pathway but also that nuclear YAP expression may be a biomarker to employ in FGFR-directed therapy.	[Rizvi, Sumera; Yamada, Daisaku; Hirsova, Petra; Bronk, Steven F.; Werneburg, Nathan W.; Krishnan, Anuradha; Salim, Warda; Gores, Gregory J.] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St S-W, Rochester, MN 55905 USA; [Zhang, Liang; Trushina, Eugenia] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Trushina, Eugenia] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Truty, Mark J.] Mayo Clin, Dept Surg, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Gores, GJ (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 200 First St S-W, Rochester, MN 55905 USA.	gores.gregory@mayo.edu	Hirsova, Petra/B-8943-2018	Hirsova, Petra/0000-0003-0494-0924	National Institutes of Health [DK59427, T32DK007198, DK84567, ES020715]; Mayo Foundation; American Liver Foundation; International Liver Cancer Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007198, P30DK084567, R01DK059427, R56DK059427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; American Liver Foundation; International Liver Cancer Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants DK59427 (to G. J. G.), T32DK007198 (to S. R.), DK84567 (Optical Microscopy Core for the Mayo Center for Cell Signaling in Gastroenterology), and ES020715 (to E. T.) and by the Mayo Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the American Liver Foundation.; Supported by the International Liver Cancer Association.	Anan A, 2006, HEPATOLOGY, V43, P335, DOI 10.1002/hep.21036; Arai Y, 2014, HEPATOLOGY, V59, P1427, DOI 10.1002/hep.26890; Bae SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7314; Borad MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004135; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Ertel F, 2013, EMBO REP, V14, P328, DOI 10.1038/embor.2013.20; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; Gores GJ, 2012, GENE DEV, V26, P305, DOI 10.1101/gad.186189.111; Gradilone SA, 2013, CANCER RES, V73, P2259, DOI 10.1158/0008-5472.CAN-12-2938; Graham RP, 2014, HUM PATHOL, V45, P1630, DOI 10.1016/j.humpath.2014.03.014; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hata AN, 2015, CANCER DISCOV, V5, P475, DOI 10.1158/2159-8290.CD-15-0011; He C, 2015, ONCOGENE, V34, P6040, DOI 10.1038/onc.2015.52; Ishimura N, 2006, AM J PHYSIOL-GASTR L, V290, pG129, DOI 10.1152/ajpgi.00242.2005; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Khan SA, 2012, GUT, V61, P1657, DOI 10.1136/gutjnl-2011-301748; Kim MP, 2012, ANN SURG ONCOL, V19, pS395, DOI 10.1245/s10434-011-1839-4; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Lange Miranda, 2012, Front Neurol, V3, P175, DOI 10.3389/fneur.2012.00175; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Li H, 2012, LIVER INT, V32, P38, DOI 10.1111/j.1478-3231.2011.02646.x; Li J, 2014, J CLIN INVEST, V124, P3241, DOI 10.1172/JCI73742; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Marti P, 2015, HEPATOLOGY, V62, P1497, DOI 10.1002/hep.27992; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Mott JL, 2008, MOL CANCER THER, V7, P2339, DOI 10.1158/1535-7163.MCT-08-0285; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Pei TM, 2015, ONCOTARGET, V6, P17206, DOI 10.18632/oncotarget.4043; Perra A, 2014, J HEPATOL, V61, P1088, DOI 10.1016/j.jhep.2014.06.033; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Rizvi S, 2014, SEMIN LIVER DIS, V34, P456, DOI 10.1055/s-0034-1394144; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Sandhu DS, 2014, HEPATOLOGY, V59, P1166, DOI 10.1002/hep.26679; Schmidt C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv024; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Xu YF, 2014, BIOCHEM BIOPH RES CO, V446, P54, DOI 10.1016/j.bbrc.2014.02.050; Yamada D, 2015, HEPATOLOGY, V61, P1627, DOI 10.1002/hep.27687; YANO H, 1992, CANCER, V69, P1664, DOI 10.1002/1097-0142(19920401)69:7<1664::AID-CNCR2820690705>3.0.CO;2-P; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	49	66	67	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8031	8047		10.1074/jbc.M115.698472	http://dx.doi.org/10.1074/jbc.M115.698472			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26826125	hybrid, Green Published			2022-12-28	WOS:000374056700023
J	Guharoy, M; Bhowmick, P; Tompa, P				Guharoy, Mainak; Bhowmick, Pallab; Tompa, Peter			Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						E3 ubiquitin ligase; intrinsically disordered protein; proteasome; protein degradation; protein phosphorylation; ubiquitylation (ubiquitination); protein structural disorder; regulated degradation; E3 ligase	ANAPHASE PROMOTING COMPLEX/CYCLOSOME; E3 LIGASE; DEPENDENT DEGRADATION; STRUCTURAL BASIS; MULTISITE PHOSPHORYLATION; BETA-TRCP; C-CBL; ACTIVATION; NUCLEAR; CELL	The ubiquitin-proteasome system (UPS) regulates diverse cellular pathways by the timely removal (or processing) of proteins. Here we review the role of structural disorder and conformational flexibility in the different aspects of degradation. First, we discuss post-translational modifications within disordered regions that regulate E3 ligase localization, conformation, and enzymatic activity, and also the role of flexible linkers in mediating ubiquitin transfer and reaction processivity. Next we review well studied substrates and discuss that substrate elements (degrons) recognized by E3 ligases are highly disordered: short linear motifs recognized by many E3s constitute an important class of degrons, and these are almost always present in disordered regions. Substrate lysines targeted for ubiquitination are also often located in neighboring regions of the E3 docking motifs and are therefore part of the disordered segment. Finally, biochemical experiments and predictions show that initiation of degradation at the 26S proteasome requires a partially unfolded region to facilitate substrate entry into the proteasomal core.	[Guharoy, Mainak; Bhowmick, Pallab; Tompa, Peter] Vlaams Inst Biotechnol, VIB Struct Biol Res Ctr SBRC, B-1050 Brussels, Belgium; [Guharoy, Mainak; Bhowmick, Pallab; Tompa, Peter] Vrije Univ Brussel, SBB, B-1050 Brussels, Belgium; [Tompa, Peter] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1117 Budapest, Hungary	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Guharoy, M; Tompa, P (corresponding author), Vlaams Inst Biotechnol, VIB Struct Biol Res Ctr SBRC, B-1050 Brussels, Belgium.; Guharoy, M; Tompa, P (corresponding author), Vrije Univ Brussel, SBB, B-1050 Brussels, Belgium.; Tompa, P (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1117 Budapest, Hungary.	mainak.guharoy@vib-vub.be; ptompa@vub.ac.be	Bhowmick, Pallab/P-9871-2016	Bhowmick, Pallab/0000-0001-7267-8601; Guharoy, Mainak/0000-0003-1354-2872; Tompa, Peter/0000-0001-8042-9939	Research Foundation Flanders (FWO) [G.0029.12]; Marie Curie Initial Training Network (ITN) grant (IDPbyNMR)	Research Foundation Flanders (FWO)(FWO); Marie Curie Initial Training Network (ITN) grant (IDPbyNMR)	This work was supported by the Odysseus Grant G.0029.12 from Research Foundation Flanders (FWO) (to P. T.). This work was also supported by a Marie Curie Initial Training Network (ITN) grant (IDPbyNMR) (to P. B.). This is the sixth article in the Thematic Minireview series "Intrinsically Disordered Proteins." The authors declare that they have no conflicts of interest with the contents of this article.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bhat KP, 2011, BBA-GENE REGUL MECH, V1809, P150, DOI 10.1016/j.bbagrm.2010.11.006; Bhowmick P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065443; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Brown NG, 2015, P NATL ACAD SCI USA, V112, P5272, DOI 10.1073/pnas.1504161112; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Bui JM, 2014, STRUCTURE, V22, P1196, DOI 10.1016/j.str.2014.06.002; Bulatov E, 2015, BIOCHEM J, V467, P365, DOI 10.1042/BJ20141450; Byrd RA, 2013, EMBO J, V32, P2087, DOI 10.1038/emboj.2013.158; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Caulfield TR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003935; Cholbinski P, 2011, EUR J CELL BIOL, V90, P834, DOI 10.1016/j.ejcb.2011.06.008; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; Craney A, 2013, CURR OPIN CELL BIOL, V25, P704, DOI 10.1016/j.ceb.2013.07.004; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fishbain S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1194; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Guharoy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10239; Hagai T, 2011, J MOL BIOL, V412, P319, DOI 10.1016/j.jmb.2011.07.024; Hamilton MH, 2001, J BIOL CHEM, V276, P26324, DOI 10.1074/jbc.M101205200; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Holt LJ, 2012, FEBS LETT, V586, P2773, DOI 10.1016/j.febslet.2012.05.045; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Imamura T, 2013, J BIOCHEM, V154, P481, DOI 10.1093/jb/mvt097; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Julie LC, 2012, FEBS LETT, V586, P362, DOI 10.1016/j.febslet.2011.12.031; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Kim TY, 2015, MOL CELL BIOL, V35, P167, DOI 10.1128/MCB.00857-14; Koivomagi M, 2011, NATURE, V480, P128, DOI 10.1038/nature10560; Landre V, 2014, ONCOTARGET, V5, P7988, DOI 10.18632/oncotarget.2431; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Lau AW, 2012, FRONT BIOSCI-LANDMRK, V17, P2197, DOI 10.2741/4045; Lee KA, 2011, J BIOL CHEM, V286, P41530, DOI 10.1074/jbc.M111.248856; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lewis MD, 2003, ONCOGENE, V22, P3992, DOI 10.1038/sj.onc.1206683; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2015, BBA-REV CANCER, V1855, P50, DOI 10.1016/j.bbcan.2014.11.005; Liu J, 2011, J BIOL CHEM, V286, P40934, DOI 10.1074/jbc.M111.277236; Liu J, 2010, BIOPHYS J, V99, P736, DOI 10.1016/j.bpj.2010.05.021; Liu J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000527; Lorenz S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-65; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1250834; Mark WY, 2005, J MOL BIOL, V345, P275, DOI 10.1016/j.jmb.2004.10.045; Mattiroli F, 2014, NAT STRUCT MOL BIOL, V21, P308, DOI 10.1038/nsmb.2792; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Min MW, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130097; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; Ng C, 2008, EMBO J, V27, P804, DOI 10.1038/emboj.2008.18; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Qi JF, 2013, CELL BIOCHEM BIOPHYS, V67, P15, DOI 10.1007/s12013-013-9636-2; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Singh SA, 2014, EMBO J, V33, P385, DOI 10.1002/embj.201385876; Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Sowa ME, 2006, ACS CHEM BIOL, V1, P20, DOI 10.1021/cb0600020; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Tatematsu K, 2005, J BIOL CHEM, V280, P22937, DOI 10.1074/jbc.M413476200; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Thompson ME, 2010, FEBS J, V277, P3072, DOI 10.1111/j.1742-4658.2010.07733.x; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Tompa P, 2012, NAT CHEM BIOL, V8, P597, DOI 10.1038/nchembio.1009; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Yen CH, 2000, J IMMUNOL, V165, P6372, DOI 10.4049/jimmunol.165.11.6372; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yoshida Y, 2015, P NATL ACAD SCI USA, V112, P4630, DOI 10.1073/pnas.1422313112; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao ML, 2010, J BIOL CHEM, V285, P4771, DOI 10.1074/jbc.M109.060095; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhuang M, 2013, MOL CELL, V49, P273, DOI 10.1016/j.molcel.2012.10.022	99	32	35	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6723	6731		10.1074/jbc.R115.692665	http://dx.doi.org/10.1074/jbc.R115.692665			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26851277	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000373299700012
J	Uversky, VN				Uversky, Vladimir N.			Dancing Protein Clouds: The Strange Biology and Chaotic Physics of Intrinsically Disordered Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						intrinsically disordered protein; multifunctional protein; post-translational modification (PTM); protein folding; protein-protein interaction; complexity; dynamical system; structural heterogeneity; intrinsically disordered proteins; posttranslational modification	MOLECULAR RECOGNITION FEATURES; NATIVELY UNFOLDED PROTEINS; POSTTRANSLATIONAL MODIFICATIONS; FUZZY COMPLEXES; SACCHAROMYCES-CEREVISIAE; UNSTRUCTURED PROTEINS; INTERACTION NETWORKS; STRUCTURAL DISORDER; ESCHERICHIA-COLI; FLEXIBLE NETS	Biologically active but floppy proteins represent a new reality of modern protein science. These intrinsically disordered proteins (IDPs) and hybrid proteins containing ordered and intrinsically disordered protein regions (IDPRs) constitute a noticeable part of any given proteome. Functionally, they complement ordered proteins, and their conformational flexibility and structural plasticity allow them to perform impossible tricks and be engaged in biological activities that are inaccessible to well folded proteins with their unique structures. The major goals of this minireview are to show that, despite their simplified amino acid sequences, IDPs/IDPRs are complex entities often resembling chaotic systems, are structurally and functionally heterogeneous, and can be considered an important part of the structure-function continuum. Furthermore, IDPs/IDPRs are everywhere, and are ubiquitously engaged in various interactions characterized by a wide spectrum of binding scenarios and an even wider spectrum of structural and functional outputs.	[Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, USF Hlth Byrd Alzheimers Res Inst, Dept Mol Med, 12901 Bruce B Downs Blvd,MDC07, Tampa, FL 33612 USA; [Uversky, Vladimir N.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah 21589, Saudi Arabia; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia; [Uversky, Vladimir N.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia	State University System of Florida; University of South Florida; King Abdulaziz University; Russian Academy of Sciences; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Uversky, VN (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, 12901 Bruce B Downs Blvd,MDC07, Tampa, FL 33612 USA.	vuversky@health.usf.edu	Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857	Russian Science Foundation RSCF [14-24-00131]	Russian Science Foundation RSCF(Russian Science Foundation (RSF))	This work was supported in part by Russian Science Foundation RSCF Grant 14-24-00131. This is the first article in the Thematic Minireview series "Intrinsically Disordered Proteins." The author declares that he has no conflicts of interest with the contents of this article.	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barbar E, 2015, SEMIN CELL DEV BIOL, V37, P20, DOI 10.1016/j.semcdb.2014.09.016; Bardwell JCA, 2012, TRENDS BIOCHEM SCI, V37, P517, DOI 10.1016/j.tibs.2012.08.006; Baumann M, 2004, EXPERT REV PROTEOMIC, V1, P207, DOI 10.1586/14789450.1.2.207; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; Burra PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012069; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Choi UB, 2011, STRUCTURE, V19, P566, DOI 10.1016/j.str.2011.01.011; Creamer Trevor P, 2013, Intrinsically Disord Proteins, V1, pe26412, DOI 10.4161/idp.26412; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; De Biasio A, 2008, J PROTEOME RES, V7, P2496, DOI 10.1021/pr800063u; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker A K, 1998, Pac Symp Biocomput, P473; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Feng ZP, 2006, MOL BIOCHEM PARASIT, V150, P256, DOI 10.1016/j.molbiopara.2006.08.011; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; Fuxreiter M, 2012, MOL BIOSYST, V8, P168, DOI 10.1039/c1mb05234a; Galea CA, 2009, J PROTEOME RES, V8, P211, DOI 10.1021/pr800308v; Gunasekaran K, 2004, J MOL BIOL, V341, P1327, DOI 10.1016/j.jmb.2004.07.002; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hazy E, 2009, CHEMPHYSCHEM, V10, P1415, DOI 10.1002/cphc.200900205; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jakob U, 2014, CHEM REV, V114, P6779, DOI 10.1021/cr400459c; Kathiriya JJ, 2014, MOL BIOSYST, V10, P2876, DOI 10.1039/c4mb00224e; Kjaergaard M., 2015, INTRINSICALLY DISORD, V3, P1; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lacy ER, 2005, J MOL BIOL, V349, P764, DOI 10.1016/j.jmb.2005.04.019; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; LORENZ EN, 1963, T NEW YORK ACAD SCI, V25, P409, DOI 10.1111/j.2164-0947.1963.tb01464.x; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Mitrea DM, 2013, FEBS LETT, V587, P1081, DOI 10.1016/j.febslet.2013.02.024; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Pederson T, 2001, CELL, V104, P635, DOI 10.1016/S0092-8674(02)01455-1; Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494; Peng ZL, 2015, CELL MOL LIFE SCI, V72, P137, DOI 10.1007/s00018-014-1661-9; Peng ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094331; PERHAM RN, 1975, PHILOS T ROY SOC B, V272, P123, DOI 10.1098/rstb.1975.0075; Permyakov SE, 2003, PROTEINS, V53, P855, DOI 10.1002/prot.10481; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Schulz GE, 1979, MOL MECH BIOL RECOGN, P79; Sharma R, 2015, FEBS LETT, V589, P2533, DOI 10.1016/j.febslet.2015.07.022; Shibata N, 2007, ACTA CRYSTALLOGR F, V63, P529, DOI 10.1107/S1744309107022579; Sigalov A, 2004, BIOCHEMISTRY-US, V43, P2049, DOI 10.1021/bi035900h; Sigalov AB, 2007, BIOCHIMIE, V89, P419, DOI 10.1016/j.biochi.2006.11.003; Singh GP, 2006, PROTEINS, V62, P309, DOI 10.1002/prot.20746; Stewart I, 2011, PHILOS T R SOC A, V369, P4705, DOI 10.1098/rsta.2011.0113; Teschke Carolyn M., 1992, Current Opinion in Biotechnology, V3, P468, DOI 10.1016/0958-1669(92)90073-R; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tompa P, 2006, J PROTEOME RES, V5, P1996, DOI 10.1021/pr0600881; Trifonov EN, 2000, GENE, V261, P139, DOI 10.1016/S0378-1119(00)00476-5; Uversky VN, 2015, FEBS LETT, V589, P2498, DOI 10.1016/j.febslet.2015.06.004; Uversky VN, 2015, FEBS LETT, V589, P15, DOI 10.1016/j.febslet.2014.11.028; Uversky VN, 2013, CURR PHARM DESIGN, V19, P4191, DOI 10.2174/1381612811319230005; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Xu D, 1998, PROTEIN SCI, V7, P533; Xue B, 2013, FEBS LETT, V587, P1587, DOI 10.1016/j.febslet.2013.04.006; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Xue B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S1; Xue B, 2009, MOL BIOSYST, V5, P1688, DOI [10.1039/b905913j, 10.1039/B905913J]; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Zandany N, 2015, FEBS LETT, V589, P2441, DOI 10.1016/j.febslet.2015.06.010; Zhang Y, 2002, J BIOL CHEM, V277, P17706, DOI 10.1074/jbc.M111982200	98	122	122	6	88	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6681	6688		10.1074/jbc.R115.685859	http://dx.doi.org/10.1074/jbc.R115.685859			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26851286	Green Published, hybrid			2022-12-28	WOS:000373299700007
J	Broussard, TC; Miller, DJ; Jackson, P; Nourse, A; White, SW; Rock, CO				Broussard, Tyler C.; Miller, Darcie J.; Jackson, Pamela; Nourse, Amanda; White, Stephen W.; Rock, Charles O.			Biochemical Roles for Conserved Residues in the Bacterial Fatty Acid-binding Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; fatty acid; fatty acid-binding protein; site-directed mutagenesis; Staphylococcus aureus (S; aureus); fatty acid; fatty acid kinase	STAPHYLOCOCCUS-AUREUS; DIHYDROXYACETONE KINASE; ANALYTICAL ULTRACENTRIFUGATION; CRYSTAL-STRUCTURE; GENE-EXPRESSION; IDENTIFICATION; REVEALS; PATHWAY; COMPLEX; DOMAIN	Fatty acid kinase (Fak) is a ubiquitous Gram-positive bacterial enzyme consisting of an ATP-binding protein (FakA) that phosphorylates the fatty acid bound to FakB. In Staphylococcus aureus, Fak is a global regulator of virulence factor transcription and is essential for the activation of exogenous fatty acids for incorporation into phospholipids. The 1.2- x-ray structure of S. aureus FakB2, activity assays, solution studies, site-directed mutagenesis, and in vivo complementation were used to define the functions of the five conserved residues that define the FakB protein family (Pfam02645). The fatty acid tail is buried within the protein, and the exposed carboxyl group is bound by a Ser-93-fatty acid carboxyl-Thr-61-His-266 hydrogen bond network. The guanidinium of the invariant Arg-170 is positioned to potentially interact with a bound acylphosphate. The reduced thermal denaturation temperatures of the T61A, S93A, and H266A FakB2 mutants illustrate the importance of the hydrogen bond network in protein stability. The FakB2 T61A, S93A, and H266A mutants are 1000-fold less active in the Fak assay, and the R170A mutant is completely inactive. All FakB2 mutants form FakA(FakB2)(2) complexes except FakB2(R202A), which is deficient in FakA binding. Allelic replacement shows that strains expressing FakB2 mutants are defective in fatty acid incorporation into phospholipids and virulence gene transcription. These conserved residues are likely to perform the same critical functions in all bacterial fatty acid-binding proteins.	[Broussard, Tyler C.; Jackson, Pamela; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Miller, Darcie J.; Nourse, Amanda; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	Charles.rock@stjude.org	White, Stephen W/N-8164-2018	Nourse, Amanda/0000-0003-4595-5321	National Institutes of Health from NIGMS [GM034496]; NIAID [T32 AI106700]; Cancer Center Support [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI106700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Center Support; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM034496 (to C. O. R.) from NIGMS, Training Grant T32 AI106700 from NIAID (to T. C. B.), and Cancer Center Support Grant CA21765 and by the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Balbo A., 2007, CURR PROTOC IMMUNOL, V18; Bose JL, 2014, INFECT IMMUN, V82, P1813, DOI 10.1128/IAI.01655-13; Bose JL, 2013, APPL ENVIRON MICROB, V79, P2218, DOI 10.1128/AEM.00136-13; Brown P. H., 2008, CURR PROTOC IMMUNOL, V18; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghirlando R, 2014, ANAL BIOCHEM, V458, P37, DOI 10.1016/j.ab.2014.04.029; Kinch LN, 2005, PROTEIN SCI, V14, P360, DOI 10.1110/ps.041114805; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehman MK, 2016, METHODS MOL BIOL, V1373, P89, DOI 10.1007/7651_2014_187; Mihalek I, 2006, BIOINFORMATICS, V22, P1656, DOI 10.1093/bioinformatics/btl157; Nan J, 2009, ACTA CRYSTALLOGR D, V65, P440, DOI 10.1107/S0907444909007756; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111; Parsons JB, 2014, MOL MICROBIOL, V92, P234, DOI 10.1111/mmi.12556; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P2182, DOI 10.1128/AAC.02307-12; Sabirova JS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1956-8; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schulze-Gahmen U, 2003, PROTEINS, V50, P526, DOI 10.1002/prot.10305; Shi R, 2011, P NATL ACAD SCI USA, V108, P1302, DOI 10.1073/pnas.1012596108; Siebold C, 2003, J BIOL CHEM, V278, P48236, DOI 10.1074/jbc.M305942200; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Zhao H., 2013, Curr. Protoc. Protein Sci., DOI [10.1002/0471140864.ps2012s71, DOI 10.1002/0471140864.PS2012S71]; Zhao HY, 2013, ANAL BIOCHEM, V437, P104, DOI 10.1016/j.ab.2013.02.011; Zhao HY, 2012, ANAL CHEM, V84, P9513, DOI 10.1021/ac302357w; Zhong J, 2003, NUCLEIC ACIDS RES, V31, P1656, DOI 10.1093/nar/gkg248; Zurbriggen A, 2008, J BIOL CHEM, V283, P35789, DOI 10.1074/jbc.M804893200	33	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6292	6303		10.1074/jbc.M115.706820	http://dx.doi.org/10.1074/jbc.M115.706820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26774272	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000372894200020
J	Huang, LH; Melton, EM; Li, HB; Sohn, P; Rogers, MA; Mulligan-Kehoe, MJ; Fiering, SN; Hickey, WF; Chang, CCY; Chang, TY				Huang, Li-Hao; Melton, Elaina M.; Li, Haibo; Sohn, Paul; Rogers, Maximillian A.; Mulligan-Kehoe, Mary Jo; Fiering, Steven N.; Hickey, William F.; Chang, Catherine C. Y.; Chang, Ta-Yuan			Myeloid Acyl-CoA:Cholesterol Acyltransferase 1 Deficiency Reduces Lesion Macrophage Content and Suppresses Atherosclerosis Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acyltransferase; atherosclerosis; cholesterol; cholesterol metabolism; macrophage	COA-CHOLESTEROL ACYLTRANSFERASE; HAMSTER OVARY CELLS; MICE; COENZYME; EXPRESSION; MONOCYTES; PROLIFERATION; XANTHOMATOSIS; ACCUMULATION; DEGRADATION	Acyl-CoA:cholesterol acyltransferase 1 (Acat1) converts cellular cholesterol to cholesteryl esters and is considered a drug target for treating atherosclerosis. However, in mouse models for atherosclerosis, global Acat1 knockout (Acat1(-/-)) did not prevent lesion development. Acat1(-/-) increased apoptosis within lesions and led to several additional undesirable phenotypes, including hair loss, dry eye, leukocytosis, xanthomatosis, and a reduced life span. To determine the roles of Acat1 in monocytes/macrophages in atherosclerosis, we produced a myeloid-specific Acat1 knockout (Acat1(-M/-M)) mouse and showed that, in the Apoe knockout (Apoe(-/-)) mouse model for atherosclerosis, Acat1(-M/-M) decreased the plaque area and reduced lesion size without causing leukocytosis, dry eye, hair loss, or a reduced life span. Acat1(-M/-M) enhanced xanthomatosis in apoe(-/-) mice, a skin disease that is not associated with diet-induced atherosclerosis in humans. Analyses of atherosclerotic lesions showed that Acat1(-M/-M) reduced macrophage numbers and diminished the cholesterol and cholesteryl ester load without causing detectable apoptotic cell death. Leukocyte migration analysis in vivo showed that Acat1(-M/-M) caused much fewer leukocytes to appear at the activated endothelium. Studies in inflammatory (Ly6C(hi)-positive) monocytes and in cultured macrophages showed that inhibiting ACAT1 by gene knockout or by pharmacological inhibition caused a significant decrease in integrin 1 (CD29) expression in activated monocytes/macrophages. The sparse presence of lesion macrophages without Acat1 can therefore, in part, be attributed to decreased interaction between inflammatory monocytes/macrophages lacking Acat1 and the activated endothelium. We conclude that targeting ACAT1 in a myeloid cell lineage suppresses atherosclerosis progression while avoiding many of the undesirable side effects caused by global Acat1 inhibition.	[Huang, Li-Hao; Melton, Elaina M.; Li, Haibo; Sohn, Paul; Rogers, Maximillian A.; Chang, Catherine C. Y.; Chang, Ta-Yuan] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Mulligan-Kehoe, Mary Jo] Geisel Sch Med Dartmouth, Dept Surg, Vasc Sect, Lebanon, NH 03756 USA; [Fiering, Steven N.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA; [Hickey, William F.] Geisel Sch Med Dartmouth, Dept Pathol, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Chang, CCY; Chang, TY (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.	Catherine.Chang@Dartmouth.Edu; Ta.Yuan.Chang@Dartmouth.Edu		Melton, Elaina/0000-0002-4030-7766; Rogers, Maximillian/0000-0001-9277-3200	National Institutes of Health [RO1-HL060306, 1F32HL124953]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060306, F32HL124953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant RO1-HL060306 (to T. Y. C. and C. C. Y. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Postdoctoral Fellowship 1F32HL124953.	Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Chang CCY, 2000, J BIOL CHEM, V275, P28083; CHANG CCY, 1986, BIOCHEMISTRY-US, V25, P1700, DOI 10.1021/bi00355a039; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Clahsen T, 2008, J LEUKOCYTE BIOL, V84, P1521, DOI 10.1189/jlb.0308178; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Drinane M, 2009, CIRC RES, V104, P337, DOI 10.1161/CIRCRESAHA.108.184622; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Gaudreault N, 2012, ARTERIOSCL THROM VAS, V32, P264, DOI 10.1161/ATVBAHA.111.238964; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Huang LH, 2013, ARTERIOSCL THROM VAS, V33, P2081, DOI 10.1161/ATVBAHA.112.301080; Ikenoya M, 2007, ATHEROSCLEROSIS, V191, P290, DOI 10.1016/j.atherosclerosis.2006.05.048; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Kusunoki J, 2001, CIRCULATION, V103, P2604; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Rong JX, 2013, ARTERIOSCL THROM VAS, V33, P4, DOI 10.1161/ATVBAHA.112.252056; Sakashita N, 2010, J LIPID RES, V51, P1263, DOI [10.1194/jlr.M900288-JLR200, 10.1194/jlr.M900288]; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200	28	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6232	6244		10.1074/jbc.M116.713818	http://dx.doi.org/10.1074/jbc.M116.713818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26801614	Green Published, hybrid			2022-12-28	WOS:000372894200015
J	Chib, S; Byrd, AK; Raney, KD				Chib, Shubeena; Byrd, Alicia K.; Raney, Kevin D.			Yeast Helicase Pif1 Unwinds RNA:DNA Hybrids with Higher Processivity than DNA:DNA Duplexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA binding protein; DNA helicase; molecular motor; pre-steady state kinetics; RNA; yeast	SINGLE-STRANDED-DNA; BACTERIOPHAGE-T4 DDA HELICASE; COLI RECBC HELICASE; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL-DNA; G-QUADRUPLEX; GENOME INSTABILITY; BINDING-PROTEIN; TRANSLOCASE ACTIVITIES; REPLICATION	Saccharomyces cerevisiae Pif1, an SF1B helicase, has been implicated in both mitochondrial and nuclear functions. Here we have characterized the preference of Pif1 for RNA:DNA heteroduplexes in vitro by investigating several kinetic parameters associated with unwinding. We show that the preferential unwinding of RNA:DNA hybrids is due to neither specific binding nor differences in the rate of strand separation. Instead, Pif1 is capable of unwinding RNA:DNA heteroduplexes with moderately greater processivity compared with its duplex DNA:DNA counterparts. This higher processivity of Pif1 is attributed to slower dissociation from RNA:DNA hybrids. Biologically, this preferential role of the helicase may contribute to its functions at both telomeric and nontelomeric sites.	[Chib, Shubeena; Byrd, Alicia K.; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Raney, KD (corresponding author), 4301 W Markham St,Slot 516, Little Rock, AR 72205 USA.	raneykevind@uams.edu		Byrd, Alicia/0000-0001-5484-0759	National Institutes of Health [R01 GM098922]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM098922 ( to K. D. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarattuthodiyil S, 2014, NUCLEIC ACIDS RES, V42, P11707, DOI 10.1093/nar/gku845; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Bochman ML, 2014, CELL REP, V6, P346, DOI 10.1016/j.celrep.2013.12.037; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749; Byrd AK, 2012, J MOL BIOL, V420, P141, DOI 10.1016/j.jmb.2012.04.007; Cheng X, 2007, MITOCHONDRION, V7, P211, DOI 10.1016/j.mito.2006.11.023; Chung WH, 2014, J MICROBIOL, V52, P89, DOI 10.1007/s12275-014-3524-3; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; FOURY F, 1987, EMBO J, V6, P1441, DOI 10.1002/j.1460-2075.1987.tb02385.x; FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345; FOURY F, 1985, EMBO J, V4, P3525, DOI 10.1002/j.1460-2075.1985.tb04112.x; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Hamperl S, 2014, DNA REPAIR, V19, P84, DOI 10.1016/j.dnarep.2014.03.023; Houlard M, 2011, CELL CYCLE, V10, P108, DOI 10.4161/cc.10.1.14379; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Khan I, 2015, DNA REPAIR, V33, P43, DOI 10.1016/j.dnarep.2015.06.003; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; LAHAYE A, 1993, J BIOL CHEM, V268, P26155; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; MAINE IP, 1992, BIOCHEMISTRY-US, V31, P3968, DOI 10.1021/bi00131a012; Manthei KA, 2015, P NATL ACAD SCI USA, V112, P4292, DOI 10.1073/pnas.1416746112; MATSON SW, 1989, P NATL ACAD SCI USA, V86, P4430, DOI 10.1073/pnas.86.12.4430; Morris PD, 2001, J BIOL CHEM, V276, P19691, DOI 10.1074/jbc.M010928200; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Ramanagoudr-Bhojappa R, 2013, J BIOL CHEM, V288, P16185, DOI 10.1074/jbc.M113.470013; Ramanagoudr-Bhojappa R, 2013, NUCLEIC ACIDS RES, V41, P1029, DOI 10.1093/nar/gks1088; RANEY KD, 1995, J BIOL CHEM, V270, P22236, DOI 10.1074/jbc.270.38.22236; Raney KD, 2013, ADV EXP MED BIOL, V973, P17, DOI 10.1007/978-1-4614-5037-5_2; Reynolds KA, 2015, BIOCHEMISTRY-US, V54, P4248, DOI 10.1021/acs.biochem.5b00214; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Saini N, 2013, NATURE, V502, P389, DOI 10.1038/nature12584; Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Suhasini AN, 2012, J BIOL CHEM, V287, P19188, DOI 10.1074/jbc.M112.352757; Tackett AJ, 2001, BIOCHEMISTRY-US, V40, P543, DOI 10.1021/bi002122+; Tomko EJ, 2010, EMBO J, V29, P3826, DOI 10.1038/emboj.2010.242; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; Wilson MA, 2013, NATURE, V502, P393, DOI 10.1038/nature12585; Wu CG, 2012, J MOL BIOL, V423, P303, DOI 10.1016/j.jmb.2012.07.009; Wu CG, 2010, NAT STRUCT MOL BIOL, V17, P1210, DOI 10.1038/nsmb.1901; Xiao S, 2013, NUCLEIC ACIDS RES, V41, P10379, DOI 10.1093/nar/gkt781; Zheng KW, 2013, NUCLEIC ACIDS RES, V41, P5533, DOI 10.1093/nar/gkt264; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190	56	27	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5889	5901		10.1074/jbc.M115.688648	http://dx.doi.org/10.1074/jbc.M115.688648			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26733194	Green Published, hybrid			2022-12-28	WOS:000372551800035
J	Deng, XY; Qin, XJ; Chen, L; Jia, Q; Zhang, YH; Zhang, ZY; Lei, DS; Ren, G; Zhou, ZH; Wang, Z; Li, Q; Xie, W				Deng, Xiangyu; Qin, Xiangjing; Chen, Lei; Jia, Qian; Zhang, Yonghui; Zhang, Zhiyong; Lei, Dongsheng; Ren, Gang; Zhou, Zhihong; Wang, Zhong; Li, Qing; Xie, Wei			Large Conformational Changes of Insertion 3 in Human Glycyl-tRNA Synthetase (hGlyRS) during Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; Charcot-Marie-Tooth disease (CMT); conformational change; crystal structure; enzyme mechanism	MARIE-TOOTH-DISEASE; MUSCULAR-ATROPHY; GARS; MUTATIONS; NEUROPATHY; 2D; PURIFICATION; PHENOTYPES; SEQUENCE; DYNAMICS	Glycyl-tRNA synthetase (GlyRS) is the enzyme that covalently links glycine to cognate tRNA for translation. It is of great research interest because of its nonconserved quaternary structures, unique species-specific aminoacylation properties, and noncanonical functions in neurological diseases, but none of these is fully understood. We report two crystal structures of human GlyRS variants, in the free form and in complex with tRNA(Gly) respectively, and reveal new aspects of the glycylation mechanism. We discover that insertion 3 differs considerably in conformation in catalysis and that it acts like a switch and fully opens to allow tRNA to bind in a cross-subunit fashion. The flexibility of the protein is supported by molecular dynamics simulation, as well as enzymatic activity assays. The biophysical and biochemical studies suggest that human GlyRS may utilize its flexibility for both the traditional function (regulate tRNA binding) and alternative functions (roles in diseases).	[Deng, Xiangyu; Chen, Lei; Jia, Qian; Zhou, Zhihong; Xie, Wei] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, 135 West Xingang Rd, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Xiangyu; Chen, Lei; Jia, Qian; Zhou, Zhihong; Wang, Zhong; Li, Qing; Xie, Wei] Sun Yat Sen Univ, Ctr Cellular & Struct Biol, Guangzhou 510006, Guangdong, Peoples R China; [Wang, Zhong; Li, Qing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China; [Qin, Xiangjing] Chinese Acad Sci, South China Sea Inst, Guangzhou 510301, Guangdong, Peoples R China; [Zhang, Yonghui; Zhang, Zhiyong] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Zhang, Yonghui; Zhang, Zhiyong] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Lei, Dongsheng; Ren, Gang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Xie, W (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, 135 West Xingang Rd, Guangzhou 510275, Guangdong, Peoples R China.	xiewei6@mail.sysu.edu.cn	Ren, Gang/B-1567-2012; Lei, Dongsheng/K-3485-2012; Lei, Dongsheng/AAH-4177-2020	Ren, Gang/0000-0002-8036-2321; Lei, Dongsheng/0000-0003-1640-0693; Xie, Wei/0000-0003-2410-2135; Jia, Qian/0000-0002-1629-6622	National Sciences Foundation of China [31100579, 31270760]; Guangdong Innovative Research Team Program [2011Y038]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115153] Funding Source: NIH RePORTER	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative Research Team Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Sciences Foundation of China Grants 31100579 and 31270760 and Guangdong Innovative Research Team Program 2011Y038. The authors declare that they have no conflicts of interest with the contents of this article.	Achilli F, 2009, DIS MODEL MECH, V2, P359, DOI 10.1242/dmm.002527; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bienfait HME, 2007, NEUROLOGY, V68, P1658, DOI 10.1212/01.wnl.0000263479.97552.94; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CUSACK S, 1993, BIOCHIMIE, V75, P1077, DOI 10.1016/0300-9084(93)90006-E; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; Del Bo R, 2006, NEUROLOGY, V66, P752, DOI 10.1212/01.wnl.0000201275.18875.ac; DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007; Desarnaud F, 1998, J NEUROCHEM, V71, P1765; DIGNAM SS, 1984, J BIOL CHEM, V259, P4043; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Freist W, 1996, BIOL CHEM H-S, V377, P343; Griffin LB, 2014, HUM MUTAT, V35, P1363, DOI 10.1002/humu.22681; Guo RT, 2009, J BIOL CHEM, V284, P28968, DOI 10.1074/jbc.M109.030692; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; James PA, 2006, NEUROLOGY, V67, P1710, DOI 10.1212/01.wnl.0000242619.52335.bc; Jani-Acsadi A, 2008, SEMIN NEUROL, V28, P185, DOI 10.1055/s-2008-1062264; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KERN D, 1981, BIOCHEMISTRY-US, V20, P122, DOI 10.1021/bi00504a021; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; Lee HJ, 2012, J PERIPHER NERV SYST, V17, P418, DOI 10.1111/j.1529-8027.2012.00442.x; LOGAN DT, 1995, EMBO J, V14, P4156, DOI 10.1002/j.1460-2075.1995.tb00089.x; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mazauric MH, 1996, EUR J BIOCHEM, V241, P814, DOI 10.1111/j.1432-1033.1996.00814.x; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; McPherson A, 2006, J STRUCT BIOL, V156, P387, DOI 10.1016/j.jsb.2006.09.006; Motley WW, 2010, TRENDS NEUROSCI, V33, P59, DOI 10.1016/j.tins.2009.11.001; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perona JJ, 2014, TOP CURR CHEM, V344, P1, DOI 10.1007/128_2013_456; Qin XJ, 2014, J BIOL CHEM, V289, P20359, DOI 10.1074/jbc.M114.557249; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Saporta MA, 2013, NEUROL CLIN, V31, P597, DOI 10.1016/j.ncl.2013.01.009; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SCHIMMEL P, 1995, J MOL EVOL, V40, P531; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; Shi Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02349; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590; SKRE H, 1974, CLIN GENET, V6, P98; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; SURGUCHOV AP, 1975, EUR J BIOCHEM, V54, P175, DOI 10.1111/j.1432-1033.1975.tb04127.x; THOMAS PK, 1974, J NEUROL NEUROSUR PS, V37, P68, DOI 10.1136/jnnp.37.1.68; Vallat JM, 2013, CURR OPIN NEUROL, V26, P473, DOI 10.1097/WCO.0b013e328364c04b; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zhu XD, 2009, P NATL ACAD SCI USA, V106, P15944, DOI 10.1073/pnas.0901872106	60	10	11	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5740	5752		10.1074/jbc.M115.679126	http://dx.doi.org/10.1074/jbc.M115.679126			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26797133	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000372551800023
J	Kopel, M; Helbert, W; Belnik, Y; Buravenkov, V; Herman, A; Banin, E				Kopel, Moran; Helbert, William; Belnik, Yana; Buravenkov, Vitaliy; Herman, Asael; Banin, Ehud			New Family of Ulvan Lyases Identified in Three Isolates from the Alteromonadales Order	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; bacteria; enzyme degradation; glycoside hydrolase; polysaccharide; ulvan	POR SECRETION SYSTEM; GLIDING MOTILITY; PERSICIVIRGA-ULVANIVORANS; GLUCURONAN LYASE; SIGNAL PEPTIDES; GREEN SEAWEEDS; POLYSACCHARIDE; PURIFICATION; CELLULOSOME; DEGRADATION	Ulvan is the main polysaccharide component of the Ulvales (green seaweed) cell wall. It is composed of disaccharide building blocks comprising 3-sulfated rhamnose linked to d-glucuronic acid (GlcUA), l-iduronic acid (IdoUA), or d-xylose (Xyl). The degradation of ulvan requires ulvan lyase, which catalyzes the endolytic cleavage of the glycoside bond between 3-sulfated rhamnose and uronic acid according to a -elimination mechanism. The first characterized ulvan lyase was identified in Nonlabens ulvanivorans, an ulvanolytic bacterial isolate. In the current study, we have identified and biochemically characterized novel ulvan lyases from three Alteromonadales isolated bacteria. Two homologous ulvan lyases (long and short) were found in each of the bacterial genomes. The protein sequences have no homology to the previously reported ulvan lyases and therefore are the first representatives of a new family of polysaccharide lyases. The enzymes were heterologously expressed in Escherichia coli to determine their mode of action. The heterologous expressed enzymes were secreted into the milieu subsequent to their signal sequence cleavage. An endolytic mode of action was observed and studied using gel permeation chromatography and H-1 NMR. In contrast to N. ulvanivorans ulvan lyase, cleavage occurred specifically at the GlcUA residues. In light of the genomic context and modular structure of the ulvan lyase families identified to date, we propose that two ulvan degradation pathways evolved independently.	[Kopel, Moran; Belnik, Yana; Buravenkov, Vitaliy; Herman, Asael; Banin, Ehud] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Inst Nanotechnol & Adv Mat, IL-52900 Ramat Gan, Israel; [Helbert, William] Univ Grenoble 1, Ctr efRecherches Macromol Vegetales, UPR CNRS 5301, Grenoble 9, France; [Helbert, William] ICMG, FR CNRS 2607, Grenoble 9, France	Bar Ilan University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Banin, E (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Inst Nanotechnol & Adv Mat, IL-52900 Ramat Gan, Israel.; Helbert, W (corresponding author), Univ Grenoble 1, Ctr efRecherches Macromol Vegetales, UPR CNRS 5301, Grenoble 9, France.; Helbert, W (corresponding author), ICMG, FR CNRS 2607, Grenoble 9, France.	helbert@cermav.cnrs.fr; ehud.banin@biu.ac.il			Israel Ministry of Science, Technology and Space	Israel Ministry of Science, Technology and Space	This work was supported in part by an infrastructure grant from the Israel Ministry of Science, Technology and Space ( to E. B.) and by a Ph.D. fellowship ( to M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Barbeyron T, 2011, INT J SYST EVOL MICR, V61, P1899, DOI 10.1099/ijs.0.024489-0; Collen PN, 2014, J BIOL CHEM, V289, P6199, DOI 10.1074/jbc.M113.537480; Collen PN, 2011, J BIOL CHEM, V286, P42063, DOI 10.1074/jbc.M111.271825; Da Costa A, 2001, APPL ENVIRON MICROB, V67, P5197, DOI 10.1128/AEM.67.11.5197-5203.2001; Delattre C, 2006, APPL MICROBIOL BIOT, V70, P437, DOI 10.1007/s00253-005-0077-8; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Jindou S, 2004, BIOSCI BIOTECH BIOCH, V68, P924, DOI 10.1271/bbb.68.924; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kopel M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00793-14; Kopel M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01257-14; Kopel M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01081-14; Lahaye M, 1997, CARBOHYD RES, V304, P325, DOI 10.1016/S0008-6215(97)00270-X; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; Lane DJR, 2008, ANAL BIOCHEM, V373, P287, DOI 10.1016/j.ab.2007.09.009; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Robic A, 2009, BIOPOLYMERS, V91, P652, DOI 10.1002/bip.21195; Sato K, 2013, FEMS MICROBIOL LETT, V338, P68, DOI 10.1111/1574-6968.12028; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Shrivastava A, 2013, J BACTERIOL, V195, P3201, DOI 10.1128/JB.00333-13; Smith SP, 2013, CURR OPIN STRUC BIOL, V23, P686, DOI 10.1016/j.sbi.2013.09.002; Yi H, 2012, SYST APPL MICROBIOL, V35, P150, DOI 10.1016/j.syapm.2011.12.002	26	28	33	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5871	5878		10.1074/jbc.M115.673947	http://dx.doi.org/10.1074/jbc.M115.673947			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26763234	hybrid, Green Published			2022-12-28	WOS:000372551800033
J	Walker, A; Chung, CW; Neu, M; Burman, M; Batuwangala, T; Jones, G; Tang, CM; Steward, M; Mullin, M; Tournier, N; Lewis, A; Korczynska, J; Chung, V; Catchpole, I				Walker, Adam; Chung, Chun-Wa; Neu, Margarete; Burman, Manish; Batuwangala, Thil; Jones, Gavin; Tang, Chi-Man; Steward, Michael; Mullin, Michael; Tournier, Nadia; Lewis, Alan; Korczynska, Justyna; Chung, Vicky; Catchpole, Ian			Novel Interaction Mechanism of a Domain Antibody-based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency than Ranibizumab and Bevacizumab and Improved Capacity over Aflibercept	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; antibody engineering; drug action; protein-protein interaction; retinal degeneration; single-domain antibody (sdAb; nanobody); vascular endothelial growth factor (VEGF)	VEGF-TRAP; MACULAR DEGENERATION; CRYSTAL-STRUCTURE; FC-RECEPTORS; BINDING; THERAPY; CELLS; ANGIOGENESIS; IGG	A potent VEGF inhibitor with novel antibody architecture and antigen binding mode has been developed. The molecule, hereafter referred to as VEGF dual dAb (domain antibody), was evaluated in vitro for binding to VEGF and for potency in VEGF-driven models and compared with other anti-VEGF biologics that have been used in ocular anti-angiogenic therapeutic regimes. VEGF dual dAb is more potent than bevacizumab and ranibizumab for VEGF binding, inhibition of VEGF receptor binding assays (RBAs), and VEGF-driven in vitro models of angiogenesis and displays comparable inhibition to aflibercept (Eylea). VEGF dual dAb is dimeric, and each monomer contains two distinct anti-VEGF domain antibodies attached via linkers to a human IgG1 Fc domain. Mechanistically, the enhanced in vitro potency of VEGF dual dAb, in comparison to other anti-VEGF biologics, can be explained by increased binding stoichiometry. A consistent model of the target engagement has been built based on the x-ray complexes of each of the two isolated domain antibodies with the VEGF antigen.	[Walker, Adam; Burman, Manish; Batuwangala, Thil; Jones, Gavin; Tang, Chi-Man; Steward, Michael; Korczynska, Justyna; Catchpole, Ian] GSK Med Res Ctr, BioPharm Innovat, Stevenage SG1 2NY, Herts, England; [Chung, Chun-Wa; Neu, Margarete] GSK Med Res Ctr, Mol Discovery Res, Stevenage SG1 2NY, Herts, England; [Mullin, Michael; Tournier, Nadia; Lewis, Alan; Korczynska, Justyna] GSK Med Res Ctr, BioPharm Discovery, Stevenage SG1 2NY, Herts, England; [Chung, Vicky] GSK Med Res Ctr, BioPharm Proc Res, Stevenage SG1 2NY, Herts, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Catchpole, I (corresponding author), GSK Med Res Ctr, BioPharm Innovat, Stevenage SG1 2NY, Herts, England.	ian.r.catchpole@gsk.com		Jones, Gavin/0000-0001-9798-7566				Cheung N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2970; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; de Haas M, 2001, WIEN KLIN WOCHENSCHR, V113, P825; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; DISALVO J, 1995, J BIOL CHEM, V270, P7717, DOI 10.1074/jbc.270.13.7717; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enever C, 2015, PROTEIN ENG DES SEL, V28, P59, DOI 10.1093/protein/gzu057; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Ferrara N, 2010, NAT MED, V16, P1107, DOI 10.1038/nm1010-1107; Freund KB, 2013, EXPERT OPIN PHARMACO, V14, P1017, DOI 10.1517/14656566.2013.787410; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Grimmond S, 1996, GENOME RES, V6, P124, DOI 10.1101/gr.6.2.124; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim YC, 2014, J CONTROL RELEASE, V190, P172, DOI 10.1016/j.jconrel.2014.06.043; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Loignon M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-65; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; PAULY RR, 1992, CIRCULATION, V86, P68; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Spitzer MS, 2007, GRAEF ARCH CLIN EXP, V245, P1837, DOI 10.1007/s00417-007-0568-7; Tugues S, 2011, MOL ASPECTS MED, V32, P88, DOI 10.1016/j.mam.2011.04.004; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Xu D, 2011, J BIOL CHEM, V286, P737, DOI 10.1074/jbc.M110.177006; Yang JH, 2014, MOL PHARMACEUT, V11, P3421, DOI 10.1021/mp500160v; Yang J, 2014, CELL MOL IMMUNOL, V11, P285, DOI 10.1038/cmi.2014.6; Yang LPH, 2014, DRUG AGING, V31, P395, DOI 10.1007/s40266-014-0176-2	39	15	15	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5500	5511		10.1074/jbc.M115.691162	http://dx.doi.org/10.1074/jbc.M115.691162			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26728464	Green Published, hybrid			2022-12-28	WOS:000372551800005
J	Becker, A; Zhang, P; Allmann, L; Meilinger, D; Bertulat, B; Eck, D; Hofstaetter, M; Bartolomei, G; Hottiger, MO; Schreiber, V; Leonhardt, H; Cardoso, MC				Becker, Annette; Zhang, Peng; Allmann, Lena; Meilinger, Daniela; Bertulat, Bianca; Eck, Daniel; Hofstaetter, Maria; Bartolomei, Giody; Hottiger, Michael O.; Schreiber, Valerie; Leonhardt, Heinrich; Cardoso, M. Cristina			Poly(ADP-ribosyl)ation of Methyl CpG Binding Domain Protein 2 Regulates Chromatin Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						5-methylcytosine; chromatin remodeling; DNA methylation; heterochromatin; post-translational modification (PTM); MeCP2; PARP-1; chromatin binding and organization; poly(ADP-ribosyl)ation	RETT-SYNDROME; DNA-REPAIR; HISTONE DEACETYLASE; BDNF TRANSCRIPTION; MECP2; MUTATIONS; PHOSPHORYLATION; ASSOCIATION; CELLS; DIFFERENTIATION	The epigenetic information encoded in the genomic DNA methylation pattern is translated by methylcytosine binding proteins like MeCP2 into chromatin topology and structure and gene activity states. We have shown previously that the MeCP2 level increases during differentiation and that it causes large-scale chromatin reorganization, which is disturbed by MeCP2 Rett syndrome mutations. Phosphorylation and other posttranslational modifications of MeCP2 have been described recently to modulate its function. Here we show poly(ADP-ribosyl)ation of endogenous MeCP2 in mouse brain tissue. Consequently, we found that MeCP2 induced aggregation of pericentric heterochromatin and that its chromatin accumulation was enhanced in poly(ADP-ribose) polymerase (PARP) 1(-/-) compared with wild-type cells. We mapped the poly(ADP-ribosyl)ation domains and engineered MeCP2 mutation constructs to further analyze potential effects on DNA binding affinity and large-scale chromatin remodeling. Single or double deletion of the poly(ADP-ribosyl)ated regions and PARP inhibition increased the heterochromatin clustering ability of MeCP2. Increased chromatin clustering may reflect increased binding affinity. In agreement with this hypothesis, we found that PARP-1 deficiency significantly increased the chromatin binding affinity of MeCP2 in vivo. These data provide novel mechanistic insights into the regulation of MeCP2-mediated, higher-order chromatin architecture and suggest therapeutic opportunities to manipulate MeCP2 function.	[Becker, Annette; Zhang, Peng; Allmann, Lena; Bertulat, Bianca; Eck, Daniel; Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, Schnittspahnstr 10, D-64287 Darmstadt, Germany; [Meilinger, Daniela; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci, Dept Biol, D-82152 Planegg Martinsried, Germany; [Hofstaetter, Maria] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bartolomei, Giody; Hottiger, Michael O.] Univ Zurich, Dept Mol Mech Dis, CH-8057 Zurich, Switzerland; [Schreiber, Valerie] Strasbourg Univ, CNRS, Ecole Super Biotechnol Strasbourg, UMR7242 Biotechnol & Cell Signaling,Lab Excellenc, BP10413, F-67412 Illkirch Graffenstaden, France	Technical University of Darmstadt; University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Cardoso, MC (corresponding author), Tech Univ Darmstadt, Dept Biol, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	cardoso@bio.tu-darmstadt.de	Schreiber, Valérie/M-5007-2016; Leonhardt, Heinrich/B-2791-2014; Hottiger, Michael O./J-7747-2013	Schreiber, Valérie/0000-0003-0507-639X; Hottiger, Michael O./0000-0002-7323-2270	Deutsche Forschungsgemeinschaft [DFG CA 198/4]; Chinese Scholarship Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chinese Scholarship Council(China Scholarship Council)	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG CA 198/4 and 7 (to M.C.C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship of the Chinese Scholarship Council.	Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Becker A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053730; Bellini E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00236; Bertulat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047848; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Casas-Delucchi CS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks784; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; De Vos M, 2014, J BIOL CHEM, V289, P16223, DOI 10.1074/jbc.M113.527424; Finch KE, 2012, ACS CHEM BIOL, V7, P563, DOI 10.1021/cb200506t; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Ghosh RP, 2010, BIOCHEMISTRY-US, V49, P4395, DOI 10.1021/bi9019753; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jost KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026499; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Kaufmann U, 1999, J CELL SCI, V112, P55; Kumar A, 2008, J CELL SCI, V121, P1128, DOI 10.1242/jcs.016865; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Marchi M, 2007, EPIGENETICS-US, V2, P187, DOI 10.4161/epi.2.3.5057; Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Rajan M, 2015, FEBS OPEN BIO, V5, P779, DOI 10.1016/j.fob.2015.09.005; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	35	27	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4873	4881		10.1074/jbc.M115.698357	http://dx.doi.org/10.1074/jbc.M115.698357			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26772194	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000371640600003
J	Schalk, AM; Antansijevic, A; Caffrey, M; Lavie, A				Schalk, Amanda M.; Antansijevic, Aleksandar; Caffrey, Michael; Lavie, Arnon			Experimental Data in Support of a Direct Displacement Mechanism for Type I/II l-Asparaginases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme mechanism; enzyme structure; nuclear magnetic resonance (NMR); structural biology	ESCHERICHIA-COLI ASPARAGINASE; CHRYSANTHEMI L-ASPARAGINASE; CRYSTAL-STRUCTURE; SITE; ENZYME; MUTAGENESIS; RESOLUTION; RESIDUES; LEUKEMIA; PROTEASE	Bacterial l-asparaginases play an important role in the treatment of certain types of blood cancers. We are exploring the guinea pig l-asparaginase (gpASNase1) as a potential replacement of the immunogenic bacterial enzymes. The exact mechanism used by l-asparaginases to catalyze the hydrolysis of asparagine into aspartic acid and ammonia has been recently put into question. Earlier experimental data suggested that the reaction proceeds via a covalent intermediate using a ping-pong mechanism, whereas recent computational work advocates the direct displacement of the amine by an activated water. To shed light on this controversy, we generated gpASNase1 mutants of conserved active site residues (T19A, T116A, T19A/T116A, K188M, and Y308F) suspected to play a role in hydrolysis. Using x-ray crystallography, we determined the crystal structures of the T19A, T116A, and K188M mutants soaked in asparagine. We also characterized their steady-state kinetic properties and analyzed the conversion of asparagine to aspartate using NMR. Our structures reveal bound asparagine in the active site that has unambiguously not formed a covalent intermediate. Kinetic and NMR assays detect significant residual activity for all of the mutants. Furthermore, no burst of ammonia production was observed that would indicate covalent intermediate formation and the presence of a ping-pong mechanism. Hence, despite using a variety of techniques, we were unable to obtain experimental evidence that would support the formation of a covalent intermediate. Consequently, our observations support a direct displacement rather than a ping-pong mechanism for l-asparaginases.	[Schalk, Amanda M.; Antansijevic, Aleksandar; Caffrey, Michael; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Lavie, Arnon] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Lavie, A (corresponding author), 900 South Ashland Ave,MBRB Rm 1108, Chicago, IL 60607 USA.	Lavie@uic.edu		Lavie, Arnon/0000-0001-5591-8722	National Institutes of Health [RO1 EB013685]; U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service [I01BX001919]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013685] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grant RO1 EB013685 and by Merit Review Award I01BX001919 from the U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service.	Aghaiypour K, 2001, BIOCHEMISTRY-US, V40, P5655, DOI 10.1021/bi0029595; Aung HP, 2000, BBA-PROTEIN STRUCT M, V1481, P349, DOI 10.1016/S0167-4838(00)00179-5; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; DERST C, 1992, PROTEIN ENG, V5, P785, DOI 10.1093/protein/5.8.785; DERST C, 1994, EUR J BIOCHEM, V224, P533, DOI 10.1111/j.1432-1033.1994.00533.x; DUNLOP PC, 1980, J BIOL CHEM, V255, P1542; EHRMAN M, 1971, J BIOL CHEM, V246, P88; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez CA, 2013, INT J CLIN EXP MED, V6, P478; Gesto DS, 2013, J AM CHEM SOC, V135, P7146, DOI 10.1021/ja310165u; HARMS E, 1991, FEBS LETT, V285, P55, DOI 10.1016/0014-5793(91)80723-G; HARTLEY BS, 1952, BIOCHEM J, V50, P672, DOI 10.1042/bj0500672; Hejazi M, 2002, BIOCHEM J, V364, P129, DOI 10.1042/bj3640129; HOLCENBERG JS, 1978, BIOCHEMISTRY-US, V17, P411, DOI 10.1021/bi00596a005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lubkowski J, 2003, ACTA CRYSTALLOGR D, V59, P84, DOI 10.1107/S0907444902019443; Michalska K, 2006, ACTA BIOCHIM POL, V53, P627, DOI 10.18388/abp.2006_3291; MILLER M, 1993, FEBS LETT, V328, P275, DOI 10.1016/0014-5793(93)80943-O; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; Oteng-Pabi SK, 2013, ANAL BIOCHEM, V441, P169, DOI 10.1016/j.ab.2013.07.014; Palm GJ, 1996, FEBS LETT, V390, P211, DOI 10.1016/0014-5793(96)00660-6; Pedreschi F, 2014, J SCI FOOD AGR, V94, P9, DOI 10.1002/jsfa.6349; ROHM KH, 1986, ARCH BIOCHEM BIOPHYS, V244, P128, DOI 10.1016/0003-9861(86)90101-3; Schalk AM, 2014, J BIOL CHEM, V289, P33175, DOI 10.1074/jbc.M114.609552; Segel I. H., 1975, ENZYME KINETICS BEHA, P342; SWAIN AL, 1993, P NATL ACAD SCI USA, V90, P1474, DOI 10.1073/pnas.90.4.1474; Yao M, 2005, ACTA CRYSTALLOGR D, V61, P294, DOI 10.1107/S0907444904032950; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979	31	21	22	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5088	5100		10.1074/jbc.M115.699884	http://dx.doi.org/10.1074/jbc.M115.699884			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26733195	Green Published, hybrid			2022-12-28	WOS:000371640600022
J	Nyeste, A; Bencsura, P; Vida, I; Hegyi, Z; Homolya, L; Fodor, E; Welker, E				Nyeste, Antal; Bencsura, Petra; Vida, Istvan; Hegyi, Zoltan; Homolya, Laszlo; Fodor, Elfrieda; Welker, Ervin			Expression of the Prion Protein Family Member Shadoo Causes Drug Hypersensitivity That Is Diminished by the Coexpression of the Wild Type Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLEEPING-BEAUTY; CULTURED-CELLS; PRP; TOXICITY; DOPPEL; MICE; MOUSE; KNOCKOUT; NEURONS; ATAXIA	The prion protein (PrP) seems to exert both neuroprotective and neurotoxic activities. The toxic activities are associated with the C-terminal globular parts in the absence of the flexible N terminus, specifically the hydrophobic domain (HD) or the central region (CR). The wild type prion protein (PrP-WT), having an intact flexible part, exhibits neuroprotective qualities by virtue of diminishing many of the cytotoxic effects of these mutant prion proteins (PrP Delta HD and PrP Delta CR) when coexpressed. The prion protein family member Doppel, which possesses a three-dimensional fold similar to the C-terminal part of PrP, is also harmful to neuronal and other cells in various models, a phenotype that can also be eliminated by the coexpression of PrP-WT. In contrast, another prion protein family member, Shadoo (Sho), a natively disordered protein possessing structural features similar to the flexible N-terminal tail of PrP, exhibits PrP-WT-like protective properties. Here, we report that, contrary to expectations, Sho expression in SH-SY5Y or HEK293 cells induces the same toxic phenotype of drug hypersensitivity as PrP Delta CR. This effect is exhibited in a dose-dependent manner and is also counteracted by the coexpression of PrP-WT. The opposing effects of Shadoo in different model systems revealed here may be explored to help discern the relationship of the various toxic activities of mutant PrPs with each other and the neurotoxic effects seen in neurodegenerative diseases, such as transmissible spongiform encephalopathy and Alzheimer disease.	[Nyeste, Antal; Fodor, Elfrieda; Welker, Ervin] Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Temesvari Krt 62, H-6726 Szeged, Hungary; [Bencsura, Petra; Vida, Istvan; Hegyi, Zoltan; Homolya, Laszlo; Welker, Ervin] Hungarian Acad Sci, Res Ctr Nat Sci, H-1117 Budapest, Hungary; [Vida, Istvan] Eotvos Lorand Univ, Inst Chem, H-1117 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Hungarian Academy of Sciences	Welker, E (corresponding author), Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Temesvari Krt 62, H-6726 Szeged, Hungary.	welker.ervin@brc.mta.hu	Welker, Ervin/AAC-6493-2022; Homolya, Laszlo/N-1154-2016	Homolya, Laszlo/0000-0003-1639-8140; Fodor, Elfrieda/0000-0002-5695-6162	Hungarian Scientific Research Fund Grant [K-82090]	Hungarian Scientific Research Fund Grant	This work was supported by Hungarian Scientific Research Fund Grant K-82090. The authors declare that they have no conflicts of interest with the content of this article.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Atarashi R, 2006, J VIROL, V80, P7854, DOI 10.1128/JVI.00424-06; Barton KA, 2011, EMBO J, V30, P1882, DOI 10.1038/emboj.2011.129; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Biasini E, 2013, J NEUROSCI, V33, P2408, DOI 10.1523/JNEUROSCI.3406-12.2013; Biasini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033472; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Christensen HM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-11; Chu NK, 2014, J BIOL CHEM, V289, P30144, DOI 10.1074/jbc.M114.587345; Ciric D, 2015, J VIROL, V89, P6287, DOI 10.1128/JVI.03429-14; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Daude N, 2012, P NATL ACAD SCI USA, V109, P9035, DOI 10.1073/pnas.1202130109; Didonna A, 2012, PRION, V6, P309, DOI 10.4161/pri.20026; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Fukuuchi T, 2006, BIOORG MED CHEM LETT, V16, P5982, DOI 10.1016/j.bmcl.2006.08.115; Izsvak Z, 2004, MOL THER, V9, P147, DOI 10.1016/j.ymthe.2003.11.009; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Kim BH, 2005, NEUROREPORT, V16, P425, DOI 10.1097/00001756-200504040-00002; Kim BH, 2004, MOL BRAIN RES, V124, P40, DOI 10.1016/j.molbrainres.2004.02.005; Kolacsek O, 2014, HUM GENE THER METHOD, V25, P241, DOI 10.1089/hgtb.2013.149; Le Pichon CE, 2009, NAT NEUROSCI, V12, P60, DOI 10.1038/nn.2238; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Nieznanski K, 2014, ACS CHEM NEUROSCI, V5, P340, DOI 10.1021/cn500019c; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; Oh JM, 2008, MOL CELL NEUROSCI, V39, P238, DOI 10.1016/j.mcn.2008.07.003; Premzl M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-1; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Resenberger UK, 2011, TOP CURR CHEM, V305, P101, DOI 10.1007/128_2011_160; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Roucou X, 2004, J NEUROSCI RES, V75, P153, DOI 10.1002/jnr.10864; Sakaguchi Suehiro, 2007, J Med Invest, V54, P211, DOI 10.2152/jmi.54.211; Sakthivelu V, 2011, J BIOL CHEM, V286, P8901, DOI 10.1074/jbc.M110.185470; Salmon Patrick, 2006, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s37; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Solomon IH, 2012, PRION, V6, P40, DOI 10.4161/pri.6.1.18627; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Solomon IH, 2010, CURR ISSUES MOL BIOL, V12, P51; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; Steele AD, 2007, PRION, V1, P83, DOI 10.4161/pri.1.2.4346; Tatrai P, 2013, J MATER SCI-MATER M, V24, P479, DOI 10.1007/s10856-012-4809-x; Toth E, 2013, BBA-MOL CELL RES, V1833, P1199, DOI 10.1016/j.bbamcr.2013.01.020; Turnbaugh JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025675; Wan JY, 2010, MOL BIOL REP, V37, P2295, DOI 10.1007/s11033-009-9722-0; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Watts JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002382; Westaway D, 2011, TOP CURR CHEM, V305, P225, DOI 10.1007/128_2011_190; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011; White AR, 1999, AM J PATHOL, V155, P1723, DOI 10.1016/S0002-9440(10)65487-9	58	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4473	4486		10.1074/jbc.M115.679035	http://dx.doi.org/10.1074/jbc.M115.679035			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26721882	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000371604600019
J	Scavenius, C; Nikolajsen, CL; Stenvang, M; Thogersen, IB; Wyrozemski, L; Wisniewski, HG; Otzen, DE; Sanggaard, KW; Enghild, JJ				Scavenius, Carsten; Nikolajsen, Camilla Lund; Stenvang, Marcel; Thogersen, Ida B.; Wyrozemski, Lukasz; Wisniewski, Hans-Georg; Otzen, Daniel E.; Sanggaard, Kristian W.; Enghild, Jan J.			The Compact and Biologically Relevant Structure of Inter-alpha-inhibitor Is Maintained by the Chondroitin Sulfate Chain and Divalent Cations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL-ELECTROPHORESIS; SHAP-HYALURONAN COMPLEX; COVALENTLY CROSS-LINKS; TRYPSIN-INHIBITOR; HEAVY-CHAINS; BIKUNIN PROTEINS; TSG-6; GLYCOSAMINOGLYCAN; ADHESION; DOMAINS	Inter-alpha-inhibitor is a proteoglycan of unique structure. The protein consists of three subunits, heavy chain 1, heavy chain 2, and bikunin covalently joined by a chondroitin sulfate chain originating at Ser-10 of bikunin. Inter-alpha-inhibitor interacts with an inflammation-associated protein, tumor necrosis factor-inducible gene 6 protein, in the extracellular matrix. This interaction leads to transfer of the heavy chains from the chondroitin sulfate of inter-alpha-inhibitor to hyaluronan and consequently to matrix stabilization. Divalent cations and heavy chain 2 are essential co-factors in this transfer reaction. In the present study, we have investigated how divalent cations in concert with the chondroitin sulfate chain influence the structure and stability of inter-alpha-inhibitor. The results showed that Mg2+ or Mn2+, but not Ca2+, induced a conformational change in inter-alpha-inhibitor as evidenced by a decrease in the Stokes radius and a bikunin chondroitin sulfate-dependent increase of the thermodynamic stability. This structure was shown to be essential for the ability of inter-alpha-inhibitor to participate in extracellular matrix stabilization. In addition, the data revealed that bikunin was positioned adjacent to both heavy chains and that the two heavy chains also were in close proximity. The chondroitin sulfate chain interacted with all protein components and inter-alpha-inhibitor dissociated when it was degraded. Conventional purification protocols result in the removal of the Mg2+ found in plasma and because divalent cations influence the conformation and affect function it is important to consider this when characterizing the biological activity of inter-alpha-inhibitor.	[Scavenius, Carsten; Nikolajsen, Camilla Lund; Stenvang, Marcel; Thogersen, Ida B.; Wyrozemski, Lukasz; Otzen, Daniel E.; Sanggaard, Kristian W.; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, Sci Pk,Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark; [Nikolajsen, Camilla Lund; Stenvang, Marcel; Otzen, Daniel E.; Enghild, Jan J.] Aarhus Univ, Interdisciplinary Nanosci Ctr, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark; [Wisniewski, Hans-Georg] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Aarhus University; Aarhus University; New York University	Enghild, JJ (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Sci Pk,Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	jje@mbg.au.dk	Scavenius, Carsten/Q-5941-2017	Scavenius, Carsten/0000-0002-4304-0681; Wyrozemski, Lukasz/0000-0003-3830-5064; Enghild, Jan Johannes/0000-0001-9292-9172				Blom AM, 1999, J BIOL CHEM, V274, P298, DOI 10.1074/jbc.274.1.298; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Carra JH, 1996, BIOPHYS J, V71, P1994, DOI 10.1016/S0006-3495(96)79397-9; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Flahaut C, 1998, EUR J BIOCHEM, V255, P107, DOI 10.1046/j.1432-1327.1998.2550107.x; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Garantziotis S, 2007, J IMMUNOL, V179, P4187, DOI 10.4049/jimmunol.179.6.4187; Jackson M. B., 2006, MOL CELLULAR BIOPHYS; Kussmann M, 1997, J MASS SPECTROM, V32, P483; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mogensen JE, 2004, BIOCHEMISTRY-US, V43, P3357, DOI 10.1021/bi0358622; MORELLE W, 1994, EUR J BIOCHEM, V221, P881, DOI 10.1111/j.1432-1033.1994.tb18803.x; Okroj M, 2012, J BIOL CHEM, V287, P20100, DOI 10.1074/jbc.M111.324913; Olsen EHN, 1998, BIOCHEMISTRY-US, V37, P408, DOI 10.1021/bi971137d; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Rasmussen MI, 2011, J PROTEOMICS, V74, P1871, DOI 10.1016/j.jprot.2011.04.019; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2010, J BIOL CHEM, V285, P21988, DOI 10.1074/jbc.M109.041046; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; THOGERSEN IB, 1995, J BIOL CHEM, V270, P18700; URIEL J, 1968, NATURE, V218, P578, DOI 10.1038/218578b0; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Xu YB, 1998, J MOL BIOL, V276, P955, DOI 10.1006/jmbi.1997.1582; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	48	5	5	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4658	4670		10.1074/jbc.M115.678748	http://dx.doi.org/10.1074/jbc.M115.678748			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26728454	hybrid, Green Published			2022-12-28	WOS:000371604600033
J	Xie, Q; McGreal, R; Harris, R; Gao, CY; Liu, W; Reneker, LW; Musil, LS; Cvekl, A				Xie, Qing; McGreal, Rebecca; Harris, Raven; Gao, Chun Y.; Liu, Wei; Reneker, Lixing W.; Musil, Linda S.; Cvekl, Ales			Regulation of c-Maf and alpha A-Crystallin in Ocular Lens by Fibroblast Growth Factor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystallin; differentiation; fibroblast growth factor (FGF); lens; signaling; A-crystallin; FGF signaling; c-Maf	FIBER CELL-DIFFERENTIATION; TRANSCRIPTION FACTORS; DNA-BINDING; T-CELLS; EMBRYONIC-DEVELOPMENT; EPITHELIAL-CELLS; HEPARAN-SULFATE; GENE-EXPRESSION; ETS-FAMILY; IN-VIVO	Fibroblast growth factor (FGF) signaling regulates a multitude of cellular processes, including cell proliferation, survival, migration, and differentiation. In the vertebrate lens, FGF signaling regulates fiber cell differentiation characterized by high expression of crystallin proteins. However, a direct link between FGF signaling and crystallin gene transcriptional machinery remains to be established. Previously, we have shown that the bZIP proto-oncogene c-Maf regulates expression of A-crystallin (Cryaa) through binding to its promoter and distal enhancer, DCR1, both activated by FGF2 in cell culture. Herein, we identified and characterized a novel FGF2-responsive region in the c-Maf promoter (-272/-70, FRE). Both c-Maf and Cryaa regulatory regions contain arrays of AP-1 and Ets-binding sites. Chromatin immunoprecipitation (ChIP) assays established binding of c-Jun (an AP-1 factor) and Etv5/ERM (an Ets factor) to these regions in lens chromatin. Analysis of temporal and spatial expression of c-Jun, phospho-c-Jun, and Etv5/ERM in wild type and ERK1/2 deficient lenses supports their roles as nuclear effectors of FGF signaling in mouse embryonic lens. Collectively, these studies show that FGF signaling up-regulates expression of A-crystallin both directly and indirectly via up-regulation of c-Maf. These molecular mechanisms are applicable for other crystallins and genes highly expressed in terminally differentiated lens fibers.	[Xie, Qing; McGreal, Rebecca; Liu, Wei; Cvekl, Ales] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA; [Xie, Qing; Harris, Raven; Liu, Wei; Cvekl, Ales] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Gao, Chun Y.] NEI, Lab Mol & Dev Biol, Bethesda, MD 20892 USA; [Reneker, Lixing W.] Univ Missouri, Mason Eye Inst, Dept Ophthalmol, Columbia, MO 65212 USA; [Musil, Linda S.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Xie, Qing] Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Missouri System; University of Missouri Columbia; Oregon Health & Science University; University of California System; University of California Santa Cruz	Cvekl, A (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ales.cvekl@einstein.yu.edu		McGreal, Rebecca/0000-0002-6069-1566	National Institutes of Health [R01 EY014237, EY016422, EY022113, EY013146, EY022645]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022113, R01EY013146, R01EY022645, R01EY014237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 EY014237 (to A. C.), EY016422 and EY022113 (to L. S. M.), EY013146 (to L. W. R.), EY022645 (to W. L.), and an unrestricted grant from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Boswell BA, 2015, MOL BIOL CELL, V26, P2561, DOI 10.1091/mbc.E15-02-0117; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chang H, 2007, LEUKEMIA, V21, P1572, DOI 10.1038/sj.leu.2404669; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261; Cvekl A, 2014, DEVELOPMENT, V141, P4432, DOI 10.1242/dev.107953; Garcia CM, 2005, DEV DYNAM, V233, P516, DOI 10.1002/dvdy.20356; Golestaneh N, 2004, J BIOL CHEM, V279, P31813, DOI 10.1074/jbc.M403473200; Gotoh N, 2004, P NATL ACAD SCI USA, V101, P17144, DOI 10.1073/pnas.0407577101; Guillemot F, 2011, NEURON, V71, P574, DOI 10.1016/j.neuron.2011.08.002; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Ilagan JG, 1999, J BIOL CHEM, V274, P19973, DOI 10.1074/jbc.274.28.19973; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Iyengar L, 2006, EXP EYE RES, V83, P667, DOI 10.1016/j.exer.2006.03.008; Jaakkola P, 2000, PROG NUCLEIC ACID RE, V63, P109; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kawauchi S, 1999, J BIOL CHEM, V274, P19254, DOI 10.1074/jbc.274.27.19254; Le ACN, 1998, DEV BIOL, V204, P80, DOI 10.1006/dbio.1998.9030; Le ACN, 2001, DEV BIOL, V233, P394, DOI 10.1006/dbio.2001.0194; Li HG, 2014, J CELL SCI, V127, P571, DOI 10.1242/jcs.134478; Li ML, 2011, J GENET GENOMICS, V38, P235, DOI 10.1016/j.jgg.2011.05.004; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Lovicu FJ, 2011, PHILOS T R SOC B, V366, P1204, DOI 10.1098/rstb.2010.0339; Lovicu FJ, 2001, DEVELOPMENT, V128, P5075; MacLean HE, 2003, DEV BIOL, V262, P51, DOI 10.1016/S0012-1606(03)00324-5; Madakashira BP, 2012, DEVELOPMENT, V139, P4601, DOI 10.1242/dev.081737; Maeda A, 2009, DEV DYNAM, V238, P2280, DOI 10.1002/dvdy.22035; MAROULAKOU IG, 1994, ONCOGENE, V9, P1551; Mathelier A., 2015, NUCL ACIDS RES; MCAVOY JW, 1989, DEVELOPMENT, V107, P221; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Musil LS, 2012, J MEMBRANE BIOL, V245, P357, DOI 10.1007/s00232-012-9458-y; NAKAMURA T, 1990, MOL CELL BIOL, V10, P3700, DOI 10.1128/MCB.10.7.3700; Newberry EP, 1997, MOL ENDOCRINOL, V11, P1129, DOI 10.1210/me.11.8.1129; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Qu XX, 2011, DEV BIOL, V355, P12, DOI 10.1016/j.ydbio.2011.04.007; Rani A, 2011, J IMMUNOL, V187, P3721, DOI 10.4049/jimmunol.1002354; Ring BZ, 2000, DEVELOPMENT, V127, P307; Sakai M, 2001, NUCLEIC ACIDS RES, V29, P1228, DOI 10.1093/nar/29.5.1228; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Sun J, 2015, MOL VIS, V21, P955; Sun J, 2015, NUCLEIC ACIDS RES, V43, P6827, DOI 10.1093/nar/gkv589; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Takai S, 2008, J ENDOCRINOL, V197, P131, DOI 10.1677/JOE-07-0560; Tholozan FMD, 2007, MOL BIOL CELL, V18, P4222, DOI 10.1091/mbc.E06-05-0416; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Upadhya D, 2013, DEVELOPMENT, V140, P1573, DOI 10.1242/dev.081042; VERRIJZER CP, 1992, EMBO J, V11, P4993, DOI 10.1002/j.1460-2075.1992.tb05606.x; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; West-Mays JA, 2010, PROG RETIN EYE RES, V29, P135, DOI 10.1016/j.preteyeres.2009.12.001; Weston CR, 2003, GENE DEV, V17, P1271, DOI 10.1101/gad.1087303; Wolf L, 2013, G3-GENES GENOM GENET, V3, P2239, DOI 10.1534/g3.113.008698; Wolf L, 2013, NUCLEIC ACIDS RES, V41, P10199, DOI 10.1093/nar/gkt824; Wolf L, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-88; Wu WJ, 2014, EXP EYE RES, V120, P10, DOI 10.1016/j.exer.2013.12.004; Xie Q, 2011, J BIOL CHEM, V286, P43259, DOI 10.1074/jbc.M111.264580; Yang Y, 2005, J MOL BIOL, V351, P453, DOI 10.1016/j.jmb.2005.05.072; Yang Ying, 2007, Einstein J Biol Med, V23, P2; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; Zelenka P. S., 2009, JOVE-J VIS EXP, DOI [10.3791/1519, DOI 10.3791/1519]; Zhao HT, 2008, DEV BIOL, V318, P276, DOI 10.1016/j.ydbio.2008.03.028	65	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3947	3958		10.1074/jbc.M115.705103	http://dx.doi.org/10.1074/jbc.M115.705103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26719333	hybrid, Green Published			2022-12-28	WOS:000371338400022
J	Bhide, GP; Fernandes, NRJ; Colley, KJ				Bhide, Gaurang P.; Fernandes, Ninoshka R. J.; Colley, Karen J.			Sequence Requirements for Neuropilin-2 Recognition by ST8SiaIV and Polysialylation of Its O-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; HUMAN DENDRITIC CELLS; POLYSIALIC ACID; SWISS-MODEL; III REPEAT; STRUCTURAL BASIS; NERVOUS-SYSTEM; SYNCAM 1; IN-VIVO; POLYSIALYLTRANSFERASE	Polysialic acid is an oncofetal glycopolymer, added to the glycans of a small group of substrates, that controls cell adhesion and signaling. One of these substrates, neuropilin-2, is a VEGF and semaphorin co-receptor that is polysialylated on its O-glycans in mature dendritic cells and macrophages by the polysialyltransferase ST8SiaIV. To understand the biochemical basis of neuropilin-2 polysialylation, we created a series of domain swap chimeras with sequences from neuropilin-1, a protein for which polysialylation had not been previously reported. To our surprise, we found that membrane-associated neuropilin-1 is polysialylated at similar to 50% of the level of neuropilin-2 but not polysialylated when it lacks its cytoplasmic tail and transmembrane region and is secreted from the cell. This was not the case for neuropilin-2, which is polysialylated when either membrane-associated or soluble. Evaluation of the soluble chimeric proteins demonstrated that the meprin A5 antigen-mu tyrosine phosphatase (MAM) domain and the O-glycan-containing linker region of neuropilin-2 are necessary and sufficient for its polysialylation and serve as better recognition and acceptor sites in the polysialylation process than those regions of neuropilin-1. In addition, specific acidic residues on the surface of the MAM domain are critical for neuropilin-2 polysialylation. Based on these data and pull-down experiments, we propose a model where ST8SiaIV recognizes and docks on an acidic surface of the neuropilin-2 MAM domain to polysialylate O-glycans on the adjacent linker region. These results together with those related to neural cell adhesion molecule polysialylation establish a paradigm for the process of protein-specific polysialylation.	[Bhide, Gaurang P.; Fernandes, Ninoshka R. J.; Colley, Karen J.] Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu	FERNANDES, NINOSHKA/AAC-1341-2022	FERNANDES, NINOSHKA/0000-0003-1386-0635; Bhide, Gaurang/0000-0002-6120-3747; Colley, Karen/0000-0002-3801-071X	National Institutes of Health [RO1 GM101949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1 GM101949 (to K. J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Appleton BA, 2007, EMBO J, V26, P4902, DOI 10.1038/sj.emboj.7601906; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; Bae D, 2008, J BIOL CHEM, V283, P28074, DOI 10.1074/jbc.M804203200; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; Berger P, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13318; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Colley KJ, 2014, CRIT REV BIOCHEM MOL, V49, P498, DOI 10.3109/10409238.2014.976606; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; Falconer RA, 2012, CURR CANCER DRUG TAR, V12, P925; FINNE J, 1982, J BIOL CHEM, V257, P1966; Foley DA, 2010, J BIOL CHEM, V285, P35056, DOI 10.1074/jbc.M110.170209; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Grandclement Camille, 2011, Cancers (Basel), V3, P1899, DOI 10.3390/cancers3021899; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; JAMES WM, 1987, BIOCHEM BIOPH RES CO, V148, P817, DOI 10.1016/0006-291X(87)90949-1; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kiermaier E, 2016, SCIENCE, V351, P186, DOI 10.1126/science.aad0512; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Okon IS, 2014, J CLIN INVEST, V124, P4590, DOI 10.1172/JCI75371; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Prud'homme GJ, 2012, ONCOTARGET, V3, P921, DOI 10.18632/oncotarget.626; Rey-Gallardo A, 2011, GLYCOBIOLOGY, V21, P655, DOI 10.1093/glycob/cwq216; Rollenhagen M, 2013, J BIOL CHEM, V288, P22880, DOI 10.1074/jbc.M113.463927; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Sawma P, 2014, J MOL BIOL, V426, P4099, DOI 10.1016/j.jmb.2014.10.007; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Stamatos NM, 2014, GLYCOBIOLOGY, V24, P864, DOI 10.1093/glycob/cwu050; Tanaka F, 2000, CANCER RES, V60, P3072; Thompson MG, 2013, J BIOL CHEM, V288, P7282, DOI 10.1074/jbc.M112.438374; Thompson MG, 2011, J BIOL CHEM, V286, P4525, DOI 10.1074/jbc.M110.200386; Vander Kooi CW, 2007, P NATL ACAD SCI USA, V104, P6152, DOI 10.1073/pnas.0700043104; Werneburg S, 2015, GLIA, V63, P1240, DOI 10.1002/glia.22815; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200	48	15	15	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9444	9457		10.1074/jbc.M116.714329	http://dx.doi.org/10.1074/jbc.M116.714329			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26884342	Green Published, hybrid			2022-12-28	WOS:000375602300006
J	Hodge, CD; Ismail, IH; Edwards, RA; Hura, GL; Xiao, AT; Tainer, JA; Hendzel, MJ; Glover, JNM				Hodge, Curtis D.; Ismail, Ismail H.; Edwards, Ross A.; Hura, Greg L.; Xiao, Andrew T.; Tainer, John A.; Hendzel, Michael J.; Glover, J. N. Mark			RNF8 E3 Ubiquitin Ligase Stimulates Ubc13 E2 Conjugating Activity That Is Essential for DNA Double Strand Break Signaling and BRCA1 Tumor Suppressor Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; DAMAGE RESPONSE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COMPLEX; MDC1; PROTEINS; REVEALS; SAXS; UBIQUITYLATION	DNA double strand break (DSB) responses depend on the sequential actions of the E3 ubiquitin ligases RNF8 and RNF168 plus E2 ubiquitin-conjugating enzyme Ubc13 to specifically generate histone Lys-63-linked ubiquitin chains in DSB signaling. Here, we defined the activated RNF8-Ubc13 similar to ubiquitin complex by x-ray crystallography and its functional solution conformations by x-ray scattering, as tested by separation-offunction mutations imaged in cells by immunofluorescence. The collective results show that the RING E3 RNF8 targets E2 Ubc13 to DSB sites and plays a critical role in damage signaling by stimulating polyubiquitination through modulating conformations of ubiquitin covalently linked to the Ubc13 active site. Structure-guided separation-of-function mutations show that the RNF8 E2 stimulating activity is essential for DSB signaling in mammalian cells and is necessary for down stream recruitment of 53BP1 and BRCA1. Chromatin-targeted RNF168 rescues 53BP1 recruitment involved in non-homologous end joining but not BRCA1 recruitment for homologous recombination. These findings suggest an allosteric approach to targeting the ubiquitin-docking cleft at the E2-E3 interface for possible interventions in cancer and chronic inflammation, and moreover, they establish an independent RNF8 role in BRCA1 recruitment.	[Hodge, Curtis D.; Edwards, Ross A.; Xiao, Andrew T.; Glover, J. N. Mark] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Ismail, Ismail H.; Hendzel, Michael J.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Hura, Greg L.; Tainer, John A.] Lawrence Berkeley Natl Lab, Berkeley, CA 94704 USA; [Tainer, John A.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Ismail, Ismail H.] Cairo Univ, Fac Sci, Dept Biophys, Giza 12613, Egypt	University of Alberta; University of Alberta; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Texas System; UTMD Anderson Cancer Center; Egyptian Knowledge Bank (EKB); Cairo University	Glover, JNM (corresponding author), Univ Alberta, Fac Med & Dent, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	mark.glover@ualberta.ca	Hendzel, Michael/C-3391-2009; Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022	Hendzel, Michael/0000-0002-9603-7945; Tainer, John/0000-0003-1659-2429; Hura, Greg/0000-0003-0501-8464; Hodge, Curtis/0000-0002-7528-4058; Ismail, Ismail Hassan/0000-0002-5526-6063	Integrated Diffraction Analysis Technologies Program (Department of Energy/Biological and Environmental Research); National Institutes of Health MINOS Grant [GM105404]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	Integrated Diffraction Analysis Technologies Program (Department of Energy/Biological and Environmental Research); National Institutes of Health MINOS Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Classen at the Advanced Light Source (SIBYLS) for crystallographic data collections and support. We also thank the Cellular Imaging Facility at the Cross Cancer Institute for the use of microscopes. We thank X. Yu, Division of Molecular Medicine and Genetics, University of Michigan Medical School, Ann Arbor, MI, for the gift of the RNF8 knock-out MEFs. SAXS data collection and analysis at SIBYLS BL12.3.1 at the Advanced Light Source were supported by the Integrated Diffraction Analysis Technologies Program (Department of Energy/Biological and Environmental Research) and by National Institutes of Health MINOS Grant GM105404.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Campbell SJ, 2012, J BIOL CHEM, V287, P23900, DOI 10.1074/jbc.M112.359653; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Carvalho AF, 2012, MOL BIOTECHNOL, V51, P254, DOI 10.1007/s12033-011-9463-x; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; Deshpande RA, 2014, EMBO J, V33, P482, DOI 10.1002/embj.201386100; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Haas AL, 1997, FASEB J, V11, P1257; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hodge CD, 2015, ACS CHEM BIOL, V10, P1718, DOI 10.1021/acschembio.5b00222; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Nordquist KA, 2010, BIOCHEMISTRY-US, V49, P347, DOI 10.1021/bi901620v; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Saito T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012239; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Soss SE, 2013, BIOCHEMISTRY-US, V52, P2991, DOI 10.1021/bi3015949; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	64	22	22	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9396	9410		10.1074/jbc.M116.715698	http://dx.doi.org/10.1074/jbc.M116.715698			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26903517	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000375602300002
J	Yao, LL; Shen, M; Lu, ZK; Ikebe, M; Li, XD				Yao, Lin-Lin; Shen, Mei; Lu, Zekuan; Ikebe, Mitsuo; Li, Xiang-dong			Identification of the Isoform-specific Interactions between the Tail and the Head of Class V Myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; ATPase; intracellular trafficking; molecular motor; myosin; unconventional myosin	CARGO-BINDING DOMAIN; LOW DUTY RATIO; STRUCTURAL BASIS; GLOBULAR TAIL; UNCONVENTIONAL MYOSIN; CONFORMATIONAL-CHANGE; CRYSTAL-STRUCTURE; MESSENGER-RNA; MOTOR; CALMODULIN	Vertebrates have three isoforms of class V myosin (Myo5), Myo5a, Myo5b, and Myo5c, which are involved in transport of multiple cargoes. It is well established that the motor functions of Myo5a and Myo5b are regulated by a tail inhibition mechanism. Here we found that the motor function of Myo5c was also inhibited by its globular tail domain (GTD), and this inhibition was abolished by high Ca2+, indicating that the tail inhibition mechanism is conserved in vertebrate Myo5. Interestingly, we found that Myo5a-GTD and Myo5c-GTD were not interchangeable in terms of inhibition of motor function, indicating isoform-specific interactions between the GTD and the head of Myo5. To identify the isoform-specific interactions, we produced a number of Myo5 chimeras by swapping the corresponding regions of Myo5a and Myo5c. We found that Myo5a-GTD, with its H11-H12 loop being substituted with that of Myo5c, was able to inhibit the ATPase activity of Myo5c and that Myo5a-GTD was able to inhibit the ATPase activity of Myo5c-S1 and Myo5c-HMM only when their IQ1 motif was substituted with that of Myo5a. Those results indicate that the H11-H12 loop in the GTD and the IQ1 motif in the head dictate the isoform-specific interactions between the GTD and head of Myo5. Because the IQ1 motif is wrapped by calmodulin, whose conformation is influenced by the sequence of the IQ1 motif, we proposed that the calmodulin bound to the IQ1 motif interacts with the H11-H12 loop of the GTD in the inhibited state of Myo5.	[Yao, Lin-Lin; Shen, Mei; Lu, Zekuan; Li, Xiang-dong] Chinese Acad Sci, Inst Zool, Grp Cell Motil & Muscle Contract, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China; [Ikebe, Mitsuo] Univ Texas Tyler, Hlth Sci Ctr, Dept Cellular & Mol Biol, Tyler, TX 75708 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Li, XD (corresponding author), Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China.	lixd@ioz.ac.cn			National Basic Research Program of China [2013CB932802, 2012CB114102]; National Natural Science Foundation of China [31171367, 31470791]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2013CB932802 and 2012CB114102 and National Natural Science Foundation of China Grants 31171367 and 31470791. The authors declare that they have no conflicts of interest with the contents of this article.	Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Dunn BD, 2007, J CELL BIOL, V178, P1193, DOI 10.1083/jcb.200707080; Gunther LK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04907; Heuck A, 2010, J CELL BIOL, V189, P497, DOI 10.1083/jcb.201002076; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Ikebe M, 2008, BIOCHEM BIOPH RES CO, V369, P157, DOI 10.1016/j.bbrc.2008.01.057; Ishikawa K, 2003, J CELL BIOL, V160, P887, DOI 10.1083/jcb.200210139; Ji HH, 2015, BIOCHEM J, V469, P135, DOI 10.1042/BJ20141330; Korn ED, 2000, P NATL ACAD SCI USA, V97, P12559, DOI 10.1073/pnas.230441597; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lu Q, 2015, NAT STRUCT MOL BIOL, V22, P81, DOI 10.1038/nsmb.2923; Lu ZK, 2012, J BIOL CHEM, V287, P16530, DOI 10.1074/jbc.M112.343079; Nascimento AFZ, 2013, J BIOL CHEM, V288, P34131, DOI 10.1074/jbc.M113.507202; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Pashkova N, 2005, EUKARYOT CELL, V4, P787, DOI 10.1128/EC.4.4.787-798.2005; Pashkova N, 2005, J CELL BIOL, V168, P359, DOI 10.1083/jcb.200407146; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Rodriguez OC, 2002, J CELL SCI, V115, P991; Sellers JR, 2008, BIOCHEM BIOPH RES CO, V369, P176, DOI 10.1016/j.bbrc.2007.11.109; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Takagi Y, 2008, J BIOL CHEM, V283, P8527, DOI 10.1074/jbc.M709150200; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Velvarska H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082065; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Watanabe S, 2008, J BIOL CHEM, V283, P10581, DOI 10.1074/jbc.M707657200; Wei ZY, 2013, P NATL ACAD SCI USA, V110, P11314, DOI 10.1073/pnas.1306768110; Wu XF, 1997, J CELL SCI, V110, P847; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yao LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10874; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826	40	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8241	8250		10.1074/jbc.M115.693762	http://dx.doi.org/10.1074/jbc.M115.693762			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26912658	Green Published, hybrid			2022-12-28	WOS:000374056700039
J	Jean-Charles, PY; Zhang, LS; Wu, JH; Han, SO; Brian, L; Freedman, NJ; Shenoy, SK				Jean-Charles, Pierre-Yves; Zhang, Lisheng; Wu, Jiao-Hui; Han, Sang-oh; Brian, Leigh; Freedman, Neil J.; Shenoy, Sudha K.			Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of beta-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor kappa B (NF kappa B) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; DOMAIN-CONTAINING PROTEINS; RAT SM22-ALPHA GENE; BETA-ARRESTIN 2; 7-TRANSMEMBRANE RECEPTORS; NEOINTIMAL HYPERPLASIA; DEUBIQUITINATING ENZYMES; APOLIPOPROTEIN-E; DEFICIENT MICE; EXPRESSION	Toll-like receptor 4 (TLR4) promotes vascular inflammatory disorders such as neointimal hyperplasia and atherosclerosis. TLR4 triggers NF kappa B signaling through the ubiquitin ligase TRAF6 (tumor necrosis factor receptor-associated factor 6). TRAF6 activity can be impeded by deubiquitinating enzymes like ubiquitin-specific protease 20 (USP20), which can reverse TRAF6 autoubiquitination, and by association with the multifunctional adaptor protein beta-arrestin2. Although beta-arrestin2 effects on TRAF6 suggest an anti-inflammatory role, physiologic beta-arrestin2 promotes inflammation in atherosclerosis and neointimal hyperplasia. We hypothesized that anti-and proinflammatory dimensions of beta-arrestin2 activity could be dictated by beta-arrestin2's ubiquitination status, which has been linked with its ability to scaffold and localize activated ERK1/2 to signalosomes. With purified proteins and in intact cells, our protein interaction studies showed that TRAF6/USP20 association and subsequent USP20-mediated TRAF6 deubiquitination were beta-arrestin2-dependent. Generation of transgenic mice with smooth muscle cell-specific expression of either USP20 or its catalytically inactive mutant revealed anti-inflammatory effects of USP20 in vivo and in vitro. Carotid endothelial denudation showed that antagonizing smooth muscle cell USP20 activity increased NF kappa B activation and neointimal hyperplasia. We found that beta-arrestin2 ubiquitination was promoted by TLR4 and reversed by USP20. The association of USP20 with beta-arrestin2 was augmented when beta-arrestin2 ubiquitination was prevented and reduced when beta-arrestin2 ubiquitination was rendered constitutive. Constitutive beta-arrestin2 ubiquitination also augmented NF kappa B activation. We infer that pro-and anti-inflammatory activities of beta-arrestin2 are determined by beta-arrestin2 ubiquitination and that changes in USP20 expression and/or activity can therefore regulate inflammatory responses, at least in part, by defining the ubiquitination status of beta-arrestin2.	[Jean-Charles, Pierre-Yves; Zhang, Lisheng; Wu, Jiao-Hui; Han, Sang-oh; Brian, Leigh; Freedman, Neil J.; Shenoy, Sudha K.] Duke Univ, Med Ctr, Dept Med Cardiol, Durham, NC 27710 USA; [Freedman, Neil J.; Shenoy, Sudha K.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Freedman, NJ (corresponding author), Duke Univ, Med Ctr, Box 3187, Durham, NC 27710 USA.; Shenoy, SK (corresponding author), Duke Univ, Med Ctr, Box 103204, Durham, NC 27710 USA.	neil.freedman@dm.duke.edu; skshenoy@dm.duke.edu	Shenoy, Sudha/AAN-4075-2021	Shenoy, Sudha/0000-0002-2565-4663	National Institutes of Health [HL080525, HL118369, T32 HL00710]; American Heart Association [25550051]; Edna and Fred L. Mandel Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080525, R01HL118369, R01HL121689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Edna and Fred L. Mandel Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL080525 (to S. K. S.) and HL118369 (to S. K. S. and N. J. F.) and Grant 25550051 from the American Heart Association (to S. K. S.). We also acknowledge funding support from the Edna and Fred L. Mandel Jr. Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Training Grant T32 HL00710.	Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Cai XJ, 2009, MOL PHARMACOL, V75, P626, DOI 10.1124/mol.108.050278; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fan HK, 2007, MOL IMMUNOL, V44, P3092, DOI 10.1016/j.molimm.2007.02.009; Fan HK, 2010, IMMUNOLOGY, V130, P344, DOI 10.1111/j.1365-2567.2009.03185.x; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Hou BD, 2004, J BIOL CHEM, V279, P18127, DOI 10.1074/jbc.M310438200; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; KEMP PR, 1995, BIOCHEM J, V310, P1037, DOI 10.1042/bj3101037; Keys JR, 2005, CIRCULATION, V112, P1145, DOI 10.1161/CIRCULATIONAHA.104.531657; Kim J, 2008, CIRC RES, V103, P70, DOI 10.1161/CIRCRESAHA.108.172338; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kommaddi RP, 2015, J BIOL CHEM, V290, P8888, DOI 10.1074/jbc.M114.630541; Kommaddi RP, 2013, PROG MOL BIOL TRANSL, V118, P175, DOI 10.1016/B978-0-12-394440-5.00007-3; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Li PF, 2011, MOL IMMUNOL, V49, P64, DOI 10.1016/j.molimm.2011.07.021; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lokeshwar VB, 2008, J BIOL CHEM, V283, P29215, DOI 10.1074/jbc.M801101200; Lovgren AK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001564; Luttrell LM, 2013, PROG MOL BIOL TRANSL, V118, P115, DOI 10.1016/B978-0-12-394440-5.00005-X; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; OSBOURN JK, 1995, GENE, V154, P249, DOI 10.1016/0378-1119(94)00847-L; Poole E, 2006, EMBO J, V25, P4390, DOI 10.1038/sj.emboj.7601287; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Squadrito F, 2003, ATHEROSCLEROSIS, V166, P233, DOI 10.1016/S0021-9150(02)00336-2; Stoll LL, 2006, CURR PHARM DESIGN, V12, P4229, DOI 10.2174/138161206778743501; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Wang XW, 2006, MED SCI MONITOR, V12, pRA177; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Wolfrum S, 2007, P NATL ACAD SCI USA, V104, P18601, DOI 10.1073/pnas.0709011104; Wu JH, 2003, J BIOL CHEM, V278, P44238, DOI 10.1074/jbc.M309450200; Wu JH, 2012, ARTERIOSCL THROM VAS, V32, P308, DOI 10.1161/ATVBAHA.111.239608; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yasunaga J, 2011, J VIROL, V85, P6212, DOI 10.1128/JVI.00079-11; Zernecke A, 2005, BASIC RES CARDIOL, V100, P93, DOI 10.1007/s00395-005-0511-6; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhang LL, 2011, CARDIOVASC RES, V92, P484, DOI 10.1093/cvr/cvr238; Zhang LS, 2007, ARTERIOSCL THROM VAS, V27, P1087, DOI 10.1161/01.ATV.0000261548.49790.63	69	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7450	7464		10.1074/jbc.M115.687129	http://dx.doi.org/10.1074/jbc.M115.687129			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26839314	Green Published, hybrid			2022-12-28	WOS:000383447600021
J	Yun, B; Lee, H; Jayaraja, S; Suram, S; Murphy, RC; Leslie, CC				Yun, Bogeon; Lee, HeeJung; Jayaraja, Sabarirajan; Suram, Saritha; Murphy, Robert C.; Leslie, Christina C.			Prostaglandins from Cytosolic Phospholipase A(2)/Cyclooxygenase-1 Pathway and Mitogen-activated Protein Kinases Regulate Gene Expression in Candida albicans-infected Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						c-Jun N-terminal kinase (JNK); cAMP-response element-binding protein (CREB); Candida albicans; cyclic AMP (cAMP); extracellular signal-regulated kinase (ERK); mitogen-activated protein kinase (MAPK); p38 MAPK; phospholipase A; prostaglandin	RESIDENT PERITONEAL-MACROPHAGES; ARACHIDONIC-ACID RELEASE; AMP RESPONSE ELEMENT; CYCLIC-AMP; CYCLOOXYGENASE-2 EXPRESSION; EICOSANOID PRODUCTION; CELL-DIFFERENTIATION; SIGNALING PATHWAY; NUCLEAR RECEPTORS; LIPID MEDIATORS	In Candida albicans-infected resident peritoneal macrophages, activation of group IVA cytosolic phospholipase A(2) (cPLA(2)) by calcium- and mitogen-activated protein kinases triggers the rapid production of prostaglandins I-2 and E-2 through cyclooxygenase (COX)-1 and regulates gene expression by increasing cAMP. In C. albicans-infected cPLA(2)(-/-) or COX-1(-/-) macrophages, expression of Il10, Nr4a2, and Ptgs2 was lower, and expression of Tnf was higher, than in wild type macrophages. Expression was reconstituted with 8-bromo-cAMP, the PKA activator 6-benzoyl-cAMP, and agonists for prostaglandin receptors IP, EP2, and EP4 in infected but not uninfected cPLA(2)(-/-) or COX-1(-/-) macrophages. In C. albicans-infected cPLA(2)(+/+) macrophages, COX-2 expression was blocked by IP, EP2, and EP4 receptor antagonists, indicating a role for both prostaglandin I-2 and E-2. Activation of ERKs and p38, but not JNKs, by C. albicans acted synergistically with prostaglandins to induce expression of Il10, Nr4a2, and Ptgs2. Tnf expression required activation of ERKs and p38 but was suppressed by cAMP. Results using cAMP analogues that activate PKA or Epacs suggested that cAMP regulates gene expression through PKA. However, phosphorylation of cAMP-response element-binding protein (CREB), the cAMP-regulated transcription factor involved in Il10, Nr4a2, Ptgs2, and Tnf expression, was not mediated by cAMP/PKA because it was similar in C. albicans-infected wild type and cPLA(2)(-/-) or COX-1(-/-) macrophages. CREB phosphorylation was blocked by p38 inhibitors and induced by the p38 activator anisomycin but not by the PKA activator 6-benzoyl-cAMP. Therefore, MAPK activation in C. albicans-infected macrophages plays a dual role by promoting the cPLA(2)/prostaglandin/cAMP/PKA pathway and CREB phosphorylation that coordinately regulate immediate early gene expression.	[Yun, Bogeon; Lee, HeeJung; Jayaraja, Sabarirajan; Suram, Saritha; Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA; [Murphy, Robert C.; Leslie, Christina C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Leslie, Christina C.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Leslie, CC (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	lesliec@njhealth.org	Jayaraja, Sabarirajan/AAC-8653-2022; Murphy, Robert/AAO-5349-2020	Jayaraja, Sabarirajan/0000-0002-2852-4258; Murphy, Robert/0000-0002-9430-6515	National Institutes of Health [HL34303]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL34303 (to C. C. L. and R. C. M.). The authors declare that they have no conflicts of interest with the contents of the article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Alvarez Y, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/201929; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Back M, 2014, BRIT J PHARMACOL, V171, P3551, DOI 10.1111/bph.12665; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; BONNEY RJ, 1978, BIOCHEM J, V176, P433, DOI 10.1042/bj1760433; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bradbury DA, 2003, J BIOL CHEM, V278, P49954, DOI 10.1074/jbc.M307964200; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Casas J, 2009, J IMMUNOL, V183, P2767, DOI 10.4049/jimmunol.0901530; Chinen T, 1999, CLIN EXP IMMUNOL, V115, P491; Darragh J, 2005, BIOCHEM J, V390, P749, DOI 10.1042/BJ20050196; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DECARVALHO MS, 1993, ARCH BIOCHEM BIOPHYS, V306, P534, DOI 10.1006/abbi.1993.1549; Diaz-Munoz MD, 2012, BIOCHEM J, V443, P451, DOI 10.1042/BJ20111052; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Ermert D, 2013, J LEUKOCYTE BIOL, V94, P223, DOI 10.1189/jlb.0213063; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Girotti M, 2004, J BIOL CHEM, V279, P19113, DOI 10.1074/jbc.M313867200; Grewal S, 2003, J CELL SCI, V116, P2303, DOI 10.1242/jcs.00446; Gubern A, 2009, J BIOL CHEM, V284, P32359, DOI 10.1074/jbc.M109.061515; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Haeggstrom JZ, 2002, CELL MOL LIFE SCI, V59, P742, DOI 10.1007/s00018-002-8463-1; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Healy S, 2013, PHARMACOL THERAPEUT, V137, P64, DOI 10.1016/j.pharmthera.2012.09.001; Ishikawa T, 2009, BIOCHEM BIOPH RES CO, V378, P534, DOI 10.1016/j.bbrc.2008.11.099; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Klein T, 2007, BBA-MOL CELL RES, V1773, P1605, DOI 10.1016/j.bbamcr.2007.09.001; Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006; Leslie CC, 2015, J LIPID RES, V56, P1386, DOI 10.1194/jlr.R057588; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahajan S, 2015, J BIOL CHEM, V290, P18304, DOI 10.1074/jbc.M115.638064; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McEvoy AN, 2002, J IMMUNOL, V168, P2979, DOI 10.4049/jimmunol.168.6.2979; Mosenden R, 2011, CELL SIGNAL, V23, P1009, DOI 10.1016/j.cellsig.2010.11.018; Naqvi S, 2014, BIOCHEM J, V458, P469, DOI 10.1042/BJ20131115; Norris PC, 2011, J LEUKOCYTE BIOL, V90, P563, DOI 10.1189/jlb.0311153; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Platzer C, 1999, EUR J IMMUNOL, V29, P3098, DOI 10.1002/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; QIU ZH, 1993, J BIOL CHEM, V268, P24506; QIU ZH, 1994, J BIOL CHEM, V269, P19480; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Rodriguez M, 2014, MOL PHARMACOL, V85, P187, DOI 10.1124/mol.113.089573; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Rouzer CA, 2004, J BIOL CHEM, V279, P34256, DOI 10.1074/jbc.M402594200; Rouzer CA, 2006, BIOCHEM J, V399, P91, DOI 10.1042/BJ20060615; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Sales KJ, 2008, MOL CELL ENDOCRINOL, V285, P51, DOI 10.1016/j.mce.2008.01.016; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schroppel K, 2001, INT J MED MICROBIOL, V290, P659, DOI 10.1016/S1438-4221(01)80003-5; SCOTT WA, 1980, J EXP MED, V152, P324, DOI 10.1084/jem.152.2.324; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Suram S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069002; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; Tam VC, 2013, SEMIN IMMUNOL, V25, P240, DOI 10.1016/j.smim.2013.08.006; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Tang FM, 2009, J EXP MED, V206, P707, DOI 10.1084/jem.20071887; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200; Volakakis N, 2010, P NATL ACAD SCI USA, V107, P12317, DOI 10.1073/pnas.1007088107; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yin F, 2006, J MOL CELL CARDIOL, V40, P384, DOI 10.1016/j.yjmcc.2005.12.005; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517; Zhang JY, 2002, PROSTAG OTH LIPID M, V67, P121, DOI 10.1016/S0090-6980(01)00177-0; Zhong J, 2007, J BIOL CHEM, V282, P24246, DOI 10.1074/jbc.M703422200	96	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7070	7086		10.1074/jbc.M116.714873	http://dx.doi.org/10.1074/jbc.M116.714873			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26841868	hybrid, Green Published			2022-12-28	WOS:000373299700041
J	Bergom, C; Hauser, AD; Rymaszewski, A; Gonyo, P; Prokop, JW; Jennings, BC; Lawton, AJ; Frei, A; Lorimer, EL; Aguilera-Barrantes, I; Mackinnon, AC; Noon, K; Fierke, CA; Williams, CL				Bergom, Carmen; Hauser, Andrew D.; Rymaszewski, Amy; Gonyo, Patrick; Prokop, Jeremy W.; Jennings, Benjamin C.; Lawton, Alexis J.; Frei, Anne; Lorimer, Ellen L.; Aguilera-Barrantes, Irene; Mackinnon, Alexander C.; Noon, Kathleen; Fierke, Carol A.; Williams, Carol L.			The Tumor-suppressive Small GTPase DiRas1 Binds the Noncanonical Guanine Nucleotide Exchange Factor SmgGDS and Antagonizes SmgGDS Interactions with Oncogenic Small GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; glioblastoma; GTPase Kras (KRAS); Ras homolog gene family; member A (RhoA); Ras-related protein 1 (Rap1); Di-Ras1; NF-kappaB (NF-KB); Rap1GDS1; Rig; SmgGDS	NONSMALL CELL LUNG; KAPPA-B ACTIVITY; BREAST CANCERS; RAS ONCOGENES; FORCE-FIELD; ACTIVATION; RAC1; CARCINOMA; PROTEIN; PATHWAY	The small GTPase DiRas1 has tumor-suppressive activities, unlike the oncogenic properties more common to small GTPases such as K-Ras and RhoA. Although DiRas1 has been found to be a tumor suppressor in gliomas and esophageal squamous cell carcinomas, the mechanisms by which it inhibits malignant phenotypes have not been fully determined. In this study, we demonstrate that DiRas1 binds to SmgGDS, a protein that promotes the activation of several oncogenic GTPases. In silico docking studies predict that DiRas1 binds to SmgGDS in a manner similar to other small GTPases. SmgGDS is a guanine nucleotide exchange factor for RhoA, but we report here that SmgGDS does not mediate GDP/GTP exchange on DiRas1. Intriguingly, DiRas1 acts similarly to a dominant-negative small GTPase, binding to SmgGDS and inhibiting SmgGDS binding to other small GTPases, including K-Ras4B, RhoA, and Rap1A. DiRas1 is expressed in normal breast tissue, but its expression is decreased in most breast cancers, similar to its family member DiRas3 (ARHI). DiRas1 inhibits RhoA- and SmgGDS-mediated NF-B transcriptional activity in HEK293T cells. We also report that DiRas1 suppresses basal NF-B activation in breast cancer and glioblastoma cell lines. Taken together, our data support a model in which DiRas1 expression inhibits malignant features of cancers in part by nonproductively binding to SmgGDS and inhibiting the binding of other small GTPases to SmgGDS.	[Bergom, Carmen; Hauser, Andrew D.; Rymaszewski, Amy; Gonyo, Patrick; Frei, Anne; Lorimer, Ellen L.; Mackinnon, Alexander C.; Williams, Carol L.] Med Coll Wisconsin, Canc Ctr, Milwaukee, WI 53226 USA; [Bergom, Carmen; Hauser, Andrew D.; Frei, Anne] Med Coll Wisconsin, Dept Radiat Oncol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Hauser, Andrew D.; Rymaszewski, Amy; Gonyo, Patrick; Lorimer, Ellen L.; Williams, Carol L.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Aguilera-Barrantes, Irene; Mackinnon, Alexander C.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Prokop, Jeremy W.] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Noon, Kathleen] Med Coll Wisconsin, Mass Spect Facil Prote, Milwaukee, WI 53226 USA; [Hauser, Andrew D.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Jennings, Benjamin C.; Lawton, Alexis J.; Fierke, Carol A.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Lawton, Alexis J.] Univ Michigan, Biochem Undergrad Program, Ann Arbor, MI 48109 USA; [Fierke, Carol A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; New York University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bergom, C (corresponding author), Med Coll Wisconsin, Dept Radiat Oncol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	cbergom@mcw.edu	Prokop, Jeremy/AAG-4931-2019	Lawton, Alexis/0000-0002-1065-0846; Mackinnon, Alexander/0000-0002-2036-8529; Prokop, Jeremy/0000-0002-1818-9695; Bergom, Carmen/0000-0002-0886-5055	Medical College of Wisconsin Cancer Center and Research Affairs Committee, Advancing a Healthier Wisconsin; Radiological Society of North America; Robert D. and Patricia E. Kern Family Foundation; National Center for Research Resources; National Center for Advancing Translational Sciences; Office of the Director of the National Institutes of Health [8KL2TR000056]; Nancy Laning Sobczak; Breast Cancer Research Award; Institutional Research from the American Cancer Society [86-004-26]; National Institutes of Health [RO1CA188871, F32GM112317, RO1GM040602]; NATIONAL CANCER INSTITUTE [R01CA188871] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000056, KL2TR001438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES025435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM112317, R01GM040602] Funding Source: NIH RePORTER	Medical College of Wisconsin Cancer Center and Research Affairs Committee, Advancing a Healthier Wisconsin; Radiological Society of North America; Robert D. and Patricia E. Kern Family Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Laning Sobczak; Breast Cancer Research Award; Institutional Research from the American Cancer Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by funding from the Medical College of Wisconsin Cancer Center and Research Affairs Committee, Advancing a Healthier Wisconsin, the Radiological Society of North America, and the Robert D. and Patricia E. Kern Family Foundation (to C. B.). This work was also supported by the National Center for Research Resources, the National Center for Advancing Translational Sciences, and the Office of the Director of the National Institutes of Health through Grant 8KL2TR000056 (to C. B.) and by the Nancy Laning Sobczak, PhD., Breast Cancer Research Award (to C. B. and C. L. W.), Institutional Research Grant 86-004-26 from the American Cancer Society (to C. B.), and National Institutes of Health Grants RO1CA188871 (to C. L. W.), F32GM112317 (to B. C. J.), and RO1GM040602 (to C. A. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alan Jamie K, 2013, Small GTPases, V4, P159, DOI 10.4161/sgtp.26530; Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; BOS JL, 1989, CANCER RES, V49, P4682; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ellis CA, 2002, P NATL ACAD SCI USA, V99, P9876, DOI 10.1073/pnas.142193799; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; Gasper Raphael, 2010, Small GTPases, V1, P133, DOI 10.4161/sgtp.1.3.14742; Gastonguay AJ, 2012, CANCER BIOL THER, V13, P647, DOI 10.4161/cbt.20082; Hamel B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191122; Hauser AD, 2014, MOL CANCER RES, V12, P130, DOI 10.1158/1541-7786.MCR-13-0362; Kang J, 2013, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00206; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kontani K, 2002, J BIOL CHEM, V277, P41070, DOI 10.1074/jbc.M202150200; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Lin G, 2012, ONCOL REP, V27, P1527, DOI 10.3892/or.2012.1669; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Montaner S, 1999, J BIOL CHEM, V274, P8506, DOI 10.1074/jbc.274.13.8506; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nogueira L, 2011, ONCOTARGET, V2, P646, DOI 10.18632/oncotarget.322; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SAKODA T, 1992, ONCOGENE, V7, P1705; Schuld NJ, 2014, CELL CYCLE, V13, P941, DOI 10.4161/cc.27804; Shin EY, 2006, J BIOL CHEM, V281, P35954, DOI 10.1074/jbc.M602399200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Yu YH, 2006, METHOD ENZYMOL, V407, P455, DOI 10.1016/S0076-6879(05)07037-0; Zhang BL, 2004, MOL CELL BIOL, V24, P6205, DOI 10.1128/MCB.24.14.6205-6214.2004; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456; Zhu YH, 2013, CANCER RES, V73, P2298, DOI 10.1158/0008-5472.CAN-12-2663	39	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6534	6545		10.1074/jbc.M115.696831	http://dx.doi.org/10.1074/jbc.M115.696831			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26814130	hybrid, Green Published			2022-12-28	WOS:000372894200039
J	Kim, CH; Kim, YD; Choi, EK; Kim, HR; Na, BR; Im, SH; Jun, CD				Kim, Chang-Hyun; Kim, Young-Dae; Choi, Eun-Kyung; Kim, Hye-Ran; Na, Bo-Ra; Im, Sin-Hyeog; Jun, Chang-Duk			Nuclear Speckle-related Protein 70 Binds to Serine/Arginine-rich Splicing Factors 1 and 2 via an Arginine/Serine-like Region and Counteracts Their Alternative Splicing Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; CD44; dimerization; heterogeneous nuclear ribonucleoprotein (hnRNP); RNA binding protein; NSrp70; RS-like region; SR protein; coiled-coil domain; nuclear speckle	PRE-MESSENGER-RNA; GENOME-WIDE ANALYSIS; SR PROTEINS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; COILED-COILS; RECOGNITION; DOMAINS; CD44; SPECIFICITY	Nuclear speckles are subnuclear storage sites containing pre-mRNA splicing machinery. Proteins assembled in nuclear speckles are known to modulate transcription and pre-mRNA processing. We have previously identified nuclear speckle-related protein 70 (NSrp70) as a novel serine/arginine (SR)-related protein that co-localizes with classical SR proteins such as serine/arginine-rich splicing factor 1 (SRSF1 or ASF/SF2) and SRSF2 (SC35). NSrp70 mediates alternative splice site selection, targeting several pre-mRNAs, including CD44 exon v5. Here we demonstrated that NSrp70 interacts physically with two SR proteins, SRSF1 and SRSF2, and reverses their splicing activity in terms of CD44 exon v5 as exon exclusion. The NSrp70 RS-like region was subdivided into three areas. Deletion of the first arginine/serine-rich-like region (RS1) completely abrogated binding to the SR proteins and to target mRNA and also failed to induce splicing of CD44 exon v5, suggesting that RS1 is critical for NSrp70 functioning. Interestingly, RS1 deletion also resulted in the loss of NSrp70 and SR protein speckle positioning, implying a potential scaffolding role for NSrp70 in nuclear speckles. NSrp70 contains an N-terminal coiled-coil domain that is critical not only for self-oligomerization but also for splicing activity. Consistently, deletion of the coiled-coil domain resulted in indefinite formation of nuclear speckles. Collectively, these results demonstrate that NSrp70 acts as a new molecular counterpart for alternative splicing of target RNA, counteracting SRSF1 and SRSF2 splicing activity.	[Kim, Chang-Hyun; Choi, Eun-Kyung; Kim, Hye-Ran; Na, Bo-Ra; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Immune Synapse Res Ctr, Sch Life Sci, Gwangju 500712, South Korea; [Kim, Young-Dae] Korea Res Inst Biosci & Biotechnol, Stem Cell Res Ctr, 125 Gwahak Ro, Daejeon 3414, South Korea; [Im, Sin-Hyeog] Pohang Univ Sci & Technol, Inst Basic Sci, Acad Immunol & Microbiol Inst, Pohang 790784, South Korea; [Im, Sin-Hyeog] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea	Gwangju Institute of Science & Technology (GIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Jun, CD (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, 123 Cheomdangwagi Ro, Gwangju 500712, South Korea.	cdjun@gist.ac.kr	Im, Sin-Hyeog/AAM-9586-2021; Im, Sin-Hyeog/E-6811-2013	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856	Basic Science Program through National Research Foundation (NRF) - Ministry of Science, ICT, and Future Planning [2015R1 A2A1A15052658]; Creative Research Initiative Program through National Research Foundation (NRF) - Ministry of Science, ICT, and Future Planning [2015R1A3A2066253]; Basic Science Program through NRF - Ministry of Education, Korea [2013R1A6A3A04064259]; Bio Imaging Research Center at the Gwangju Institute of Science and Technology	Basic Science Program through National Research Foundation (NRF) - Ministry of Science, ICT, and Future Planning; Creative Research Initiative Program through National Research Foundation (NRF) - Ministry of Science, ICT, and Future Planning; Basic Science Program through NRF - Ministry of Education, Korea; Bio Imaging Research Center at the Gwangju Institute of Science and Technology	This work was supported by Basic Science Program Grant 2015R1 A2A1A15052658 and Creative Research Initiative Program Grant 2015R1A3A2066253 through National Research Foundation (NRF) grants funded by the Ministry of Science, ICT, and Future Planning; by Basic Science Program Grant 2013R1A6A3A04064259 through NRF grants funded by the Ministry of Education, Korea, and the Bio Imaging Research Center at the Gwangju Institute of Science and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Bell MV, 1998, MOL CELL BIOL, V18, P5930, DOI 10.1128/MCB.18.10.5930; Bradley T, 2015, RNA, V21, P75, DOI 10.1261/rna.043893.113; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; Fakan Stanislav, 1994, Trends in Cell Biology, V4, P86, DOI 10.1016/0962-8924(94)90180-5; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; FU XD, 1995, RNA, V1, P663; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kim YD, 2011, NUCLEIC ACIDS RES, V39, P4300, DOI 10.1093/nar/gkq1267; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lee MW, 2015, NUCLEIC ACIDS RES, V43, P3826, DOI 10.1093/nar/gkv156; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Loh TJ, 2014, ONCOL REP, V31, P273, DOI 10.3892/or.2013.2812; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mahrenholz CC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004994; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Moulton VR, 2010, J BIOL CHEM, V285, P12490, DOI 10.1074/jbc.M109.091660; Oberstrass FC, 2006, NAT STRUCT MOL BIOL, V13, P160, DOI 10.1038/nsmb1038; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Passon DM, 2012, P NATL ACAD SCI USA, V109, P4846, DOI 10.1073/pnas.1120792109; Shen HH, 2004, MOL CELL, V13, P367, DOI 10.1016/S1097-2765(04)00025-5; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Townley-Tilson WHD, 2006, RNA, V12, P1853, DOI 10.1261/rna.76006; Tripathi V, 2012, MOL BIOL CELL, V23, P3694, DOI 10.1091/mbc.E12-03-0206; Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yang C, 2012, EXP THER MED, V4, P79, DOI 10.3892/etm.2012.543; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	43	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6169	6181		10.1074/jbc.M115.689414	http://dx.doi.org/10.1074/jbc.M115.689414			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797131	hybrid, Green Published			2022-12-28	WOS:000372894200011
J	Southern, BD; Grove, LM; Rahaman, SO; Abraham, S; Scheraga, RG; Niese, KA; Sun, HX; Herzog, EL; Liu, F; Tschumperlin, DJ; Egelhoff, TT; Rosenfeld, SS; Olman, MA				Southern, Brian D.; Grove, Lisa M.; Rahaman, Shaik O.; Abraham, Susamma; Scheraga, Rachel G.; Niese, Kathryn A.; Sun, Huanxing; Herzog, Erica L.; Liu, Fei; Tschumperlin, Daniel J.; Egelhoff, Thomas T.; Rosenfeld, Steven S.; Olman, Mitchell A.			Matrix-driven Myosin II Mediates the Pro-fibrotic Fibroblast Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast; fibrosis; lung; myofibroblast; myosin; fibroblast migration; myofibroblast differentiation; non-muscle myosin II	IDIOPATHIC PULMONARY-FIBROSIS; MUSCLE ALPHA-ACTIN; EXTRACELLULAR-MATRIX; MYOFIBROBLAST DIFFERENTIATION; LUNG INJURY; FOCAL ADHESIONS; CELL-MATRIX; MIGRATION; STIFFNESS; RECRUITMENT	Pro-fibrotic mesenchymal cells are known to be the key effector cells of fibroproliferative disease, but the specific matrix signals and the induced cellular responses that drive the fibrogenic phenotype remain to be elucidated. The key mediators of the fibroblast fibrogenic phenotype were characterized using a novel assay system that measures fibroblast behavior in response to actual normal and fibrotic lung tissue. Using this system, we demonstrate that normal lung promotes fibroblast motility and polarization, while fibrotic lung immobilizes the fibroblast and promotes myofibroblast differentiation. These context-specific phenotypes are surprisingly both mediated by myosin II. The role of myosin II is supported by the observation of an increase in myosin phosphorylation and a change in intracellular distribution in fibroblasts on fibrotic lung, as compared with normal lung. Moreover, loss of myosin II activity has opposing effects on protrusive activity in fibroblasts on normal and fibrotic lung. Loss of myosin II also selectively inhibits myofibroblast differentiation in fibroblasts on fibrotic lung. Importantly, these findings are recapitulated by varying the matrix stiffness of polyacrylamide gels in the range of normal and fibrotic lung tissue. Comparison of the effects of myosin inhibition on lung tissue with that of polyacrylamide gels suggests that matrix fiber organization drives the fibroblast phenotype under conditions of normal/soft lung, while matrix stiffness drives the phenotype under conditions of fibrotic/stiff lung. This work defines novel roles for myosin II as a key regulatory effector molecule of the pro-fibrotic phenotype, in response to biophysical properties of the matrix.	[Southern, Brian D.; Grove, Lisa M.; Rahaman, Shaik O.; Abraham, Susamma; Scheraga, Rachel G.; Niese, Kathryn A.; Olman, Mitchell A.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Southern, Brian D.; Scheraga, Rachel G.; Olman, Mitchell A.] Cleveland Clin, Lerner Res Inst, Resp Inst, Cleveland, OH 44195 USA; [Egelhoff, Thomas T.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Rosenfeld, Steven S.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Sun, Huanxing; Herzog, Erica L.] Yale Univ, Sch Med, Yale ILD Ctr Excellence, New Haven, CT 06520 USA; [Liu, Fei] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, 665 Huntington Ave, Boston, MA 02115 USA; [Tschumperlin, Daniel J.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Mayo Clinic	Olman, MA (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	olmanm@ccf.org		Scheraga, Rachel/0000-0001-5113-543X; Southern, Brian/0000-0003-2983-5741	National Institutes of Health [HL-119792, HL-103553, HL-085324]; Genentech Idiopathic Pulmonary Fibrosis Junior Faculty Program Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125850, R01HL085324, R01HL119792, R01HL103553, R01HL109233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech Idiopathic Pulmonary Fibrosis Junior Faculty Program Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-119792, HL-103553, and HL-085324 (to M. A. O.) and a Genentech Idiopathic Pulmonary Fibrosis Junior Faculty Program Award (to B. D. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ajayi IO, 2013, AM J RESP CELL MOL, V49, P86, DOI 10.1165/rcmb.2012-0224OC; Bangasser BL, 2013, BIOPHYS J, V105, P581, DOI 10.1016/j.bpj.2013.06.027; Beach JR, 2014, CURR BIOL, V24, P1160, DOI 10.1016/j.cub.2014.03.071; BITTERMAN PB, 1991, CHEST, V99, pS81, DOI 10.1378/chest.99.3_Supplement.81S; Bond JE, 2011, LAB INVEST, V91, P499, DOI 10.1038/labinvest.2010.181; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Cai GQ, 2010, EXP CELL RES, V316, P1600, DOI 10.1016/j.yexcr.2010.01.021; Chen Y, 1997, SCANNING, V19, P349, DOI 10.1002/sca.4950190505; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Cool CD, 2006, AM J RESP CRIT CARE, V174, P654, DOI 10.1164/rccm.200602-205OC; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200; Ding Q, 2013, AM J PATHOL, V182, P1572, DOI 10.1016/j.ajpath.2013.01.026; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Dugina V, 2001, J CELL SCI, V114, P3285; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Grove LM, 2014, J BIOL CHEM, V289, P12791, DOI 10.1074/jbc.M113.498576; Guo WH, 2012, MOL BIOL CELL, V23, P1657, DOI 10.1091/mbc.E11-06-0556; Hinz B, 2006, EUR J CELL BIOL, V85, P175, DOI 10.1016/j.ejcb.2005.09.004; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Hiromitsu H., 2012, FRONT PHYSIOL, V3, P1; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Johnson LA, 2014, INFLAMM BOWEL DIS, V20, P154, DOI 10.1097/01.MIB.0000437615.98881.31; Johnson LA, 2013, INFLAMM BOWEL DIS, V19, P891, DOI 10.1097/MIB.0b013e3182813297; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; KUHN C, 1991, AM J PATHOL, V138, P1257; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Liu ZA, 2010, BRIT J PHARMACOL, V159, P304, DOI 10.1111/j.1476-5381.2009.00477.x; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Meyer-Ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P4895, DOI 10.1167/iovs.06-0118; Mih JD, 2012, J CELL SCI, V125, P5974, DOI 10.1242/jcs.108886; Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929; Olman MA, 2004, J IMMUNOL, V172, P2668, DOI 10.4049/jimmunol.172.4.2668; Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Pierce EM, 2007, EUR RESPIR J, V29, P1082, DOI 10.1183/09031936.00122806; Rahaman SO, 2014, J CLIN INVEST, V124, P5225, DOI 10.1172/JCI75331; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; SINGER II, 1984, J CELL BIOL, V98, P2091, DOI 10.1083/jcb.98.6.2091; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; SUGANUMA H, 1995, THORAX, V50, P984, DOI 10.1136/thx.50.9.984; Sun HX, 2014, AM J PHYSIOL-LUNG C, V306, pL463, DOI 10.1152/ajplung.00100.2013; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tang XY, 2013, AM J PATHOL, V183, P470, DOI 10.1016/j.ajpath.2013.04.020; Tomasek JJ, 2013, WOUND REPAIR REGEN, V21, P166, DOI 10.1111/wrr.12001; Toshima M, 2004, ARCH HISTOL CYTOL, V67, P31, DOI 10.1679/aohc.67.31; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; White ES, 2003, J PATHOL, V201, P343, DOI 10.1002/path.1446; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700; Zhu S, 2009, AM J PHYSIOL-LUNG C, V297, pL97, DOI 10.1152/ajplung.90283.2008	59	37	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6083	6095		10.1074/jbc.M115.712380	http://dx.doi.org/10.1074/jbc.M115.712380			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26763235	Green Published, hybrid			2022-12-28	WOS:000372894200004
J	Hamamura, K; Matsunaga, N; Ikeda, E; Kondo, H; Ikeyama, H; Tokushige, K; Itcho, K; Furuichi, Y; Yoshida, Y; Matsuda, M; Yasuda, K; Doi, A; Yokota, Y; Amamoto, T; Aramaki, H; Irino, Y; Koyanagi, S; Ohdo, S				Hamamura, Kengo; Matsunaga, Naoya; Ikeda, Eriko; Kondo, Hideaki; Ikeyama, Hisako; Tokushige, Kazutaka; Itcho, Kazufumi; Furuichi, Yoko; Yoshida, Yuya; Matsuda, Masaki; Yasuda, Kaori; Doi, Atsushi; Yokota, Yoshifumi; Amamoto, Toshiaki; Aramaki, Hironori; Irino, Yasuhiro; Koyanagi, Satoru; Ohdo, Shigehiro			Alterations of Hepatic Metabolism in Chronic Kidney Disease via D-box-binding Protein Aggravate the Renal Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian clock; hepatocyte; renal physiology; retinol; transforming growth factor beta (TGF-beta)	OXIDATIVE DRUG-METABOLISM; RETINOIC ACID METABOLISM; CIRCADIAN CLOCK; RESPONSE ELEMENT; GENE-EXPRESSION; MOLECULAR-BASIS; FAILURE; TRANSCRIPTION; ACTIVATION; CELLS	Chronic kidney disease (CKD) is associated with an increase in serum retinol; however, the underlying mechanisms of this disorder are poorly characterized. Here, we found that the alteration of hepatic metabolism induced the accumulation of serum retinol in 5/6 nephrectomy (5/6Nx) mice. The liver is the major organ responsible for retinol metabolism; accordingly, microarray analysis revealed that the hepatic expression of most CYP genes was changed in 5/6Nx mice. In addition, D-box-binding protein (DBP), which controls the expression of several CYP genes, was significantly decreased in these mice. Cyp3a11 and Cyp26a1, encoding key proteins in retinol metabolism, showed the greatest decrease in expression in 5/6Nx mice, a process mediated by the decreased expression of DBP. Furthermore, an increase of plasma transforming growth factor-1 (TGF-1) in 5/6Nx mice led to the decreased expression of the Dbp gene. Consistent with these findings, the alterations of retinol metabolism and renal dysfunction in 5/6Nx mice were ameliorated by administration of an anti-TGF-1 antibody. We also show that the accumulation of serum retinol induced renal apoptosis in 5/6Nx mice fed a normal diet, whereas renal dysfunction was reduced in mice fed a retinol-free diet. These findings indicate that constitutive Dbp expression plays an important role in mediating hepatic dysfunction under CKD. Thus, the aggravation of renal dysfunction in patients with CKD might be prevented by a recovery of hepatic function, potentially through therapies targeting DBP and retinol.	[Hamamura, Kengo; Matsunaga, Naoya; Ikeda, Eriko; Ikeyama, Hisako; Tokushige, Kazutaka; Itcho, Kazufumi; Furuichi, Yoko; Yoshida, Yuya; Matsuda, Masaki; Koyanagi, Satoru; Ohdo, Shigehiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut, Higashi Ku, Fukuoka 8128512, Japan; [Hamamura, Kengo; Ikeda, Eriko; Aramaki, Hironori] Daiichi Univ Pharm, Drug Innovat Res Ctr, Minami Ku, Fukuoka 8158511, Japan; [Aramaki, Hironori] Daiichi Univ Pharm, Dept Mol Biol, Minami Ku, Fukuoka 8158511, Japan; [Kondo, Hideaki] Saiseikai Nagasaki Hosp, Ctr Sleep Med, Nagasaki 8500003, Japan; [Yasuda, Kaori; Doi, Atsushi] Kyushu Univ, Cell Innovator Inc, Higashi Ku, EC Bldg, Fukuoka 8128512, Japan; [Yokota, Yoshifumi] Univ Fukui, Sch Med, Dept Mol Genet, Matsuoka, Fukui 9101193, Japan; [Amamoto, Toshiaki] Neues Corp, Hakata Ku, Tenyamachi Cho, Fukuoka 8120025, Japan; [Irino, Yasuhiro] Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Div Membrane Biol,Chou Ku, Kobe, Hyogo 6500017, Japan; [Irino, Yasuhiro] Kobe Univ, Grad Sch Med, Dept Evidence Based Lab Med, Chuo Ku, Kobe, Hyogo 6500017, Japan	Kyushu University; Kyushu University; University of Fukui; Kobe University; Kobe University	Ohdo, S (corresponding author), Kyushu Univ, Dept Pharmaceut, Fac Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-u.ac.jp	Koyanagi, Satoru/AAE-6843-2020	matsunaga2, naoya2/0000-0001-6226-8473; Hamamura, Kengo/0000-0001-9146-8554; Koyanagi, Satoru/0000-0003-4849-2377	Challenging Exploratory Research Grant [25670079]; Uehara Memorial Foundation [24590196]; Japan Research Foundation for Clinical Pharmacology; Japan Society for the Promotion of Science [25-4175]; Fukuoka Foundation for Sound Health;  [25253038];  [25136716]; Grants-in-Aid for Scientific Research [15H06795] Funding Source: KAKEN	Challenging Exploratory Research Grant; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Research Foundation for Clinical Pharmacology; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fukuoka Foundation for Sound Health(Fukuoka Foundation for Sound Health); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grant-in-Aid for Scientific Research A 25253038 (to S. O.), Scientific Research on Innovative Areas Grant 25136716 (to S. O.), Challenging Exploratory Research Grant 25670079 (to S. O.), a grant from the Uehara Memorial Foundation (to S. O.), Scientific Research C Grant 24590196 (to N. M.), a grant from the Japan Research Foundation for Clinical Pharmacology (to N. M.), Grant-in-Aid for JSPS Fellows 25-4175 (to K. H.) from the Japan Society for the Promotion of Science, and a grant from the Fukuoka Foundation for Sound Health. The authors declare that they have no conflicts of interest with the contents of this article.	Aitken AE, 2007, DRUG METAB DISPOS, V35, P1687, DOI 10.1124/dmd.107.015511; Ali R, 2012, ANAL CHIM ACTA, V725, P57, DOI 10.1016/j.aca.2012.03.003; Arima H, 2010, J CONTROL RELEASE, V146, P106, DOI 10.1016/j.jconrel.2010.05.030; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Cao Y, 2009, ONCOGENE, V28, P1089, DOI 10.1038/onc.2008.456; Chen CH, 2012, J BIOL CHEM, V287, P9694, DOI 10.1074/jbc.M111.301721; Codreanu I, 2005, J AM SOC NEPHROL, V16, pS34, DOI 10.1681/ASN.2004110966; Dreisbach AW, 2003, CLIN PHARMACOL THER, V73, P475, DOI 10.1016/S0009-9236(03)00015-8; Enomoto M, 2008, MOVEMENT DISORD, V23, P811, DOI 10.1002/mds.21882; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hedayati SS, 2008, KIDNEY INT, V74, P930, DOI 10.1038/ki.2008.311; Hou TY, 2009, J BIOL CHEM, V284, P31735, DOI 10.1074/jbc.M109.013961; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Kottgen A, 2008, J AM SOC NEPHROL, V19, P1989, DOI 10.1681/ASN.2007121291; Krishnan AV, 2007, MUSCLE NERVE, V35, P273, DOI 10.1002/mus.20713; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LEBER HW, 1972, KIDNEY INT, V2, P152, DOI 10.1038/ki.1972.85; LEBER HW, 1978, KIDNEY INT, pS43; Leblond F, 2001, J AM SOC NEPHROL, V12, P326, DOI 10.1681/ASN.V122326; Lim C, 2013, NAT NEUROSCI, V16, P1544, DOI 10.1038/nn.3543; Luu L, 2001, ADV ENZYME REGUL, V41, P159, DOI 10.1016/S0065-2571(00)00024-8; Matsunaga N, 2008, HEPATOLOGY, V48, P240, DOI 10.1002/hep.22304; Megyesi J, 1998, J CLIN INVEST, V101, P777, DOI 10.1172/JCI1497; Michaud J, 2005, BRIT J PHARMACOL, V144, P1067, DOI 10.1038/sj.bjp.0706138; Murray AM, 2008, ADV CHRONIC KIDNEY D, V15, P123, DOI 10.1053/j.ackd.2008.01.010; Nakano N, 2010, J BIOL CHEM, V285, P38023, DOI 10.1074/jbc.M110.132209; Ohdo S, 2011, J PHARM SCI-US, V100, P3560, DOI 10.1002/jps.22656; Ohdo S, 2010, ADV DRUG DELIVER REV, V62, P885, DOI 10.1016/j.addr.2010.04.005; Okazaki F, 2010, CANCER RES, V70, P6238, DOI 10.1158/0008-5472.CAN-10-0184; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PATTERSON SE, 1984, BIOCHEM PHARMACOL, V33, P711, DOI 10.1016/0006-2952(84)90451-9; Pichette V, 2003, CURR DRUG METAB, V4, P91, DOI 10.2174/1389200033489532; POPPER H, 1945, AM J CLIN PATHOL, V15, P272; Ripperger JA, 2000, GENE DEV, V14, P679; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Ruster C, 2006, J AM SOC NEPHROL, V17, P2985, DOI 10.1681/ASN.2006040356; Savic D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026897; Singh AK, 2013, CURR OPIN NEPHROL HY, V22, P198, DOI 10.1097/MNH.0b013e32835dda78; SMITH FR, 1971, J CLIN INVEST, V50, P2426, DOI 10.1172/JCI106741; Takiguchi T, 2007, PHARMACOGENET GENOM, V17, P1047, DOI 10.1097/FPC.0b013e3282f12a61; TALBERT RL, 1994, J CLIN PHARMACOL, V34, P99, DOI 10.1002/j.1552-4604.1994.tb03973.x; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; TOUCHETTE MA, 1991, DICP ANN PHARMAC, V25, P1214, DOI 10.1177/106002809102501111; UCHIDA N, 1995, JPN J PHARMACOL, V68, P431, DOI 10.1254/jjp.68.431; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VANPEER AP, 1977, ARCH INT PHARMACOD T, V228, P180; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wang D, 2011, PHARMACOGENOMICS J, V11, P274, DOI 10.1038/tpj.2010.28; Ward SM, 2010, J BIOL CHEM, V285, P38987, DOI 10.1074/jbc.M110.175182; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YATZIDIS H, 1975, BRIT MED J, V3, P352, DOI 10.1136/bmj.3.5979.352; Yu ZL, 2008, J CELL BIOCHEM, V104, P2185, DOI 10.1002/jcb.21773	57	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4913	4927		10.1074/jbc.M115.696930	http://dx.doi.org/10.1074/jbc.M115.696930			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26728457	hybrid, Green Published			2022-12-28	WOS:000371640600008
J	Matsuzawa, T; Mitsuishi, Y; Kameyama, A; Yaoi, K				Matsuzawa, Tomohiko; Mitsuishi, Yasushi; Kameyama, Akihiko; Yaoi, Katsuro			Identification of the Gene Encoding Isoprimeverose-producing Oligoxyloglucan Hydrolase in Aspergillus oryzae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aspergillus; carbohydrate; cloning; glycoside hydrolase; recombinant protein expression; substrate specificity; isoprimeverose; xyloglucan	TROPAEOLUM-MAJUS L; XYLOGLUCAN; PURIFICATION; EXPRESSION; CLONING; OVEREXPRESSION; XYLOSIDASE; ENZYMES; AOXLNR; WALLS	Aspergillus oryzae produces a unique -glucosidase, isoprimeverose-producing oligoxyloglucan hydrolase (IPase), that recognizes and releases isoprimeverose (-d-xylopyranose-(16)-d-glucopyranose) units from the non-reducing ends of oligoxyloglucans. A gene encoding A. oryzae IPase, termed ipeA, was identified and expressed in Pichia pastoris. With the exception of cellobiose, IpeA hydrolyzes a variety of oligoxyloglucans and is a member of the glycoside hydrolase family 3. Xylopyranosyl branching at the non-reducing ends was vital for IPase activity, and galactosylation at a -1,6-linked xylopyranosyl side chain completely abolished IpeA activity. Hepta-oligoxyloglucan saccharide (Xyl(3)Glc(4)) substrate was preferred over tri- (Xyl(1)Glc(2)) and tetra- (Xyl(2)Glc(2)) oligoxyloglucan saccharides substrates. IpeA transferred isoprimeverose units to other saccharides, indicating transglycosylation activity. The ipeA gene was expressed in xylose and xyloglucan media and was strongly induced in the presence of xyloglucan endo-xyloglucanase-hydrolyzed products. This is the first study to report the identification of a gene encoding IPase in eukaryotes.	[Matsuzawa, Tomohiko; Mitsuishi, Yasushi; Yaoi, Katsuro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan; [Kameyama, Akihiko] Natl Inst Adv Ind Sci & Technol, Dept Life Sci & Biotechnol, Tsukuba Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Yaoi, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	k-yaoi@aist.go.jp	Matsuzawa, Tomohiko/M-3308-2018; Kameyama, Akihiko/A-9641-2008; Yaoi, Katsuro/K-1491-2018	Kameyama, Akihiko/0000-0002-8229-4449; Yaoi, Katsuro/0000-0002-4037-0087				Bauer S, 2005, CARBOHYD RES, V340, P2590, DOI 10.1016/j.carres.2005.09.014; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; EDWARDS M, 1986, J BIOL CHEM, V261, P9489; EDWARDS M, 1988, J BIOL CHEM, V263, P4333; Eklof JM, 2012, METHOD ENZYMOL, V510, P97, DOI 10.1016/B978-0-12-415931-0.00006-9; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Grishutin SG, 2004, BBA-GEN SUBJECTS, V1674, P268, DOI 10.1016/j.bbagen.2004.07.001; KATO Y, 1985, J BIOCHEM, V97, P801, DOI 10.1093/oxfordjournals.jbchem.a135120; Kitamoto N, 1999, APPL ENVIRON MICROB, V65, P20; Kudo K, 2015, J BIOSCI BIOENG, V120, P614, DOI 10.1016/j.jbiosc.2015.03.019; Larsbrink J, 2014, MOL MICROBIOL, V94, P418, DOI 10.1111/mmi.12776; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marui J, 2002, FEBS LETT, V528, P279, DOI 10.1016/S0014-5793(02)03328-8; Matsuzawa T, 2014, FEBS LETT, V588, P1731, DOI 10.1016/j.febslet.2014.03.023; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moracci M, 2000, J BIOL CHEM, V275, P22082, DOI 10.1074/jbc.M910392199; Noguchi Y, 2009, APPL MICROBIOL BIOT, V85, P141, DOI 10.1007/s00253-009-2236-9; Okuyama M, 2004, PROTEIN EXPRES PURIF, V37, P170, DOI 10.1016/j.pep.2004.05.008; Ravachol J, 2014, J BIOL CHEM, V289, P7335, DOI 10.1074/jbc.M113.545046; Takeda T, 2002, P NATL ACAD SCI USA, V99, P9055, DOI 10.1073/pnas.132080299; Tuomivaara ST, 2015, CARBOHYD RES, V402, P56, DOI 10.1016/j.carres.2014.06.031; Vincken JP, 1997, PLANT PHYSIOL, V114, P9, DOI 10.1104/pp.114.1.9; Watanabe A, 2016, J BIOSCI BIOENG, V121, P259, DOI 10.1016/j.jbiosc.2015.07.011; Yamagaki T, 1998, BIOSCI BIOTECH BIOCH, V62, P2470, DOI 10.1271/bbb.62.2470; Yaoi K, 2005, APPL ENVIRON MICROB, V71, P7670, DOI 10.1128/AEM.71.12.7670-7678.2005; Yaoi K, 2004, FEBS LETT, V560, P45, DOI 10.1016/S0014-5793(04)00068-7; Yaoi K, 2002, J BIOL CHEM, V277, P48276, DOI 10.1074/jbc.M208443200; Yaoi K., 2007, J APPL GLYCOSCI, V54, P91, DOI DOI 10.5458/JAG.54.91; Yaoi K., 2012, J APPL GLYCOSCI, V59, P83, DOI DOI 10.5458/JAG.JAG.JAG-2011_023; Zabotina OA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00134	32	19	19	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5080	5087		10.1074/jbc.M115.701474	http://dx.doi.org/10.1074/jbc.M115.701474			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26755723	Green Published, hybrid			2022-12-28	WOS:000371640600021
J	Kenche, H; Ye, ZW; Vedagiri, K; Richards, DM; Gao, XH; Tew, KD; Townsend, DM; Blumental-Perry, A				Kenche, Harshavardhan; Ye, Zhi-Wei; Vedagiri, Kokilavani; Richards, Dylan M.; Gao, Xing-Huang; Tew, Kenneth D.; Townsend, Danyelle M.; Blumental-Perry, Anna			Adverse Outcomes Associated with Cigarette Smoke Radicals Related to Damage to Protein-disulfide Isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; OBSTRUCTIVE PULMONARY-DISEASE; THROUGHPUT TURBIDOMETRIC ASSAY; DIMETHYL-SULFOXIDE DMSO; CYSTEINE SULFENIC ACID; II METABOLIC ENZYMES; S-TRANSFERASE P1; ER STRESS; MESSENGER-RNA; IN-VITRO	Identification of factors contributing to the development of chronic obstructive pulmonary disease (COPD) is crucial for developing new treatments. An increase in the levels of protein-disulfide isomerase (PDI), a multifaceted endoplasmic reticulum resident chaperone, has been demonstrated in human smokers, presumably as a protective adaptation to cigarette smoke (CS) exposure. We found a similar increase in the levels of PDI in the murine model of COPD. We also found abnormally high levels (4-6 times) of oxidized and sulfenilated forms of PDI in the lungs of murine smokers compared with non-smokers. PDI oxidation progressively increases with age. We begin to delineate the possible role of an increased ratio of oxidized PDI in the age-related onset of COPD by investigating the impact of exposure to CS radicals, such as acrolein (AC), hydroxyquinones (HQ), peroxynitrites (PN), and hydrogen peroxide, on their ability to induce unfolded protein response (UPR) and their effects on the structure and function of PDIs. Exposure to AC, HQ, PN, and CS resulted in cysteine and tyrosine nitrosylation leading to an altered three-dimensional structure of the PDI due to a decrease in helical content and formation of a more random coil structure, resulting in protein unfolding, inhibition of PDI reductase and isomerase activity in vitro and in vivo, and subsequent induction of endoplasmic reticulum stress response. Addition of glutathione prevented the induction of UPR, and AC and HQ induced structural changes in PDI. Exposure to PN and glutathione resulted in conjugation of PDI possibly at active site tyrosine residues. The findings presented here propose a new role of PDI in the pathogenesis of COPD and its age-dependent onset.	[Kenche, Harshavardhan; Vedagiri, Kokilavani; Richards, Dylan M.; Blumental-Perry, Anna] Mem Hlth Univ Med Ctr, Anderson Canc Inst, 4700 Waters Ave, Savannah, GA 31404 USA; [Blumental-Perry, Anna] Mercer Univ, Sch Med, Dept Biomed Sci, Savannah, GA 31404 USA; [Blumental-Perry, Anna] Case Western Reserve Univ, Dept Surg, 2109 Adelbert Rd,Biomed Res Bldg,Room 821, Cleveland, OH 44106 USA; [Gao, Xing-Huang] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Ye, Zhi-Wei; Tew, Kenneth D.; Townsend, Danyelle M.] Med Univ S Carolina, Coll Pharm, Charleston, SC 29425 USA	Mercer University; Case Western Reserve University; Case Western Reserve University; Medical University of South Carolina	Blumental-Perry, A (corresponding author), Case Western Reserve Univ, Dept Surg, 2109 Adelbert Rd,Biomed Res Bldg,Room 821, Cleveland, OH 44106 USA.	axb811@case.edu	Gao, XingHuang/G-8579-2017		Flight Attendants Medical Research Institute Young Clinical Investigator Award [092207]; National Institutes of Health from NCRR [5P20GM103542]; COBRE in Oxidants, Redox Balance and Stress Signaling [C06 RR015455, R37-DK60596, R01-DK53307]; NATIONAL CANCER INSTITUTE [R01CA085660] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053307, R37DK060596, R01DK060596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER	Flight Attendants Medical Research Institute Young Clinical Investigator Award; National Institutes of Health from NCRR; COBRE in Oxidants, Redox Balance and Stress Signaling; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Flight Attendants Medical Research Institute Young Clinical Investigator Award 092207 (to A. B. P.), National Institutes of Health Grants 5P20GM103542 from NCRR, from COBRE in Oxidants, Redox Balance and Stress Signaling (to D. M. T.), C06 RR015455 (to K. D. T.), and R37-DK60596 and R01-DK53307 (to Maria Hatzoglou). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; [Anonymous], ANAL BIOANAL CHEM; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben Khalaf N, 2011, J BIOMOL SCREEN, V16, P545, DOI 10.1177/1087057111401026; Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439; Bodas M, 2011, AM J PHYSIOL-LUNG C, V300, pL811, DOI 10.1152/ajplung.00408.2010; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chen HC, 2006, DIS MARKERS, V22, P141, DOI 10.1155/2006/436497; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chouchane S, 2006, CHEM RES TOXICOL, V19, P1602, DOI 10.1021/tx060162u; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Da Violante G, 2002, BIOL PHARM BULL, V25, P1600, DOI 10.1248/bpb.25.1600; Dahl JU, 2015, J MOL BIOL, V427, P1549, DOI 10.1016/j.jmb.2015.02.014; Fasman G. D., 1996, CIRCULAR DICHROISM C, P1; Faux SP, 2009, BIOMARKERS, V14, P90, DOI 10.1080/13547500902965047; Gan GX, 2011, CELL PHYSIOL BIOCHEM, V28, P725, DOI 10.1159/000335766; Geraghty P, 2011, INT J CHRONIC OBSTR, V6, P309, DOI 10.2147/COPD.S19599; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Grek C, 2014, ENDOPLASMIC RETICULU, V1, P4, DOI 10.2478/ersc-2013-0001; Gutierrez T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00291; Haendeler J, 2006, ANTIOXID REDOX SIGN, V8, P1723, DOI 10.1089/ars.2006.8.1723; Hakim IA, 2004, CANCER EPIDEM BIOMAR, V13, P242, DOI 10.1158/1055-9965.EPI-03-0193; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hengstermann A, 2008, FREE RADICAL BIO MED, V44, P1097, DOI 10.1016/j.freeradbiomed.2007.12.009; Henson Peter M, 2006, Proc Am Thorac Soc, V3, P713, DOI 10.1513/pats.200605-104SF; Heuck AP, 1997, ANAL BIOCHEM, V248, P94, DOI 10.1006/abio.1997.2123; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Huang CX, 2015, J BIOL CHEM, V290, P5367, DOI 10.1074/jbc.M114.603738; Ishii T, 1999, THORAX, V54, P693, DOI 10.1136/thx.54.8.693; Jacob C, 2012, CHEM RES TOXICOL, V25, P588, DOI 10.1021/tx200342b; Jessop CE, 2004, BIOCHEM SOC T, V32, P655, DOI 10.1042/BST0320655; Jorgensen E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-229; Kabiraj P, 2014, ACS CHEM NEUROSCI, V5, P1209, DOI 10.1021/cn500214k; Kelsen SG, 2008, AM J RESP CELL MOL, V38, P541, DOI 10.1165/rcmb.2007-0221OC; Khositseth S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004036; Krishnan K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-159; Labunskyy VM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004019; Lakhdar R, 2011, EXP LUNG RES, V37, P364, DOI 10.3109/01902148.2011.580416; Lin D, 2008, CHEM RES TOXICOL, V21, P2361, DOI 10.1021/tx800248x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; [卢冰冰 Lu Bingbing], 2002, [中华内科杂志, Chinese Journal of Internal Medicine], V41, P678; Lumb RA, 2002, EMBO J, V21, P6763, DOI 10.1093/emboj/cdf685; Maeda R, 2007, BBA-PROTEINS PROTEOM, V1774, P1619, DOI 10.1016/j.bbapap.2007.08.016; Malhotra D, 2009, AM J RESP CRIT CARE, V180, P1196, DOI 10.1164/rccm.200903-0324OC; Mannino David M, 2006, Int J Chron Obstruct Pulmon Dis, V1, P219; Margittai E, 2015, FREE RADICAL BIO MED, V83, P331, DOI 10.1016/j.freeradbiomed.2015.01.032; Margittai E, 2012, ANTIOXID REDOX SIGN, V16, P1088, DOI 10.1089/ars.2011.4221; Meiners S., 2011, AM THOR SOC INT C DE; Meiners S, 2012, EUR RESPIR J, V40, P1260, DOI 10.1183/09031936.00208511; Mercado N, 2015, THORAX, V70, P482, DOI 10.1136/thoraxjnl-2014-206084; MLB.com, 2013, 1 4 GAM 2013 WORLD S; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Moretto N, 2012, AM J PHYSIOL-LUNG C, V303, pL929, DOI 10.1152/ajplung.00046.2012; Morimoto RI, 2014, J GERONTOL A-BIOL, V69, pS33, DOI 10.1093/gerona/glu049; Morissette Mathieu C, 2009, Int J Chron Obstruct Pulmon Dis, V4, P19; Mota P, 2015, J CANCER RES CLIN, V141, P851, DOI 10.1007/s00432-014-1868-z; Muller C, 2013, ANTIOXID REDOX SIGN, V18, P731, DOI 10.1089/ars.2012.4577; Muller T, 1997, CARCINOGENESIS, V18, P295, DOI 10.1093/carcin/18.2.295; Nagy P, 2012, J BIOL CHEM, V287, P26068, DOI 10.1074/jbc.M112.371690; Nakamura T, 2013, ANTIOXID REDOX SIGN, V18, P239, DOI 10.1089/ars.2012.4703; OHBA H, 1981, J BIOCHEM-TOKYO, V89, P901, DOI 10.1093/oxfordjournals.jbchem.a133273; Parakh S, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00030; Pendyala L, 2001, CANCER EPIDEM BIOMAR, V10, P269; Qi WD, 2008, HEARING RES, V236, P52, DOI 10.1016/j.heares.2007.12.002; Rehder DS, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-25; Rehder DS, 2010, BIOCHEMISTRY-US, V49, P7748, DOI 10.1021/bi1008694; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shao D, 2012, J MOL CELL CARDIOL, V52, P550, DOI 10.1016/j.yjmcc.2011.09.009; Shapiro SD, 2005, AM J RESP CELL MOL, V32, P367, DOI 10.1165/rcmb.F296; Sharma A, 2012, INDIAN J OPHTHALMOL, V60, P189, DOI 10.4103/0301-4738.95869; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Smith AM, 2004, J BIOMOL SCREEN, V9, P614, DOI 10.1177/1087057104265292; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Talhout R, 2011, INT J ENV RES PUB HE, V8, P613, DOI 10.3390/ijerph8020613; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Townsend DM, 2007, MOL INTERV, V7, P313, DOI 10.1124/mi.7.6.7; Townsend DM, 2009, CANCER RES, V69, P7626, DOI 10.1158/0008-5472.CAN-09-0493; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Watanabe MM, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00073; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu SL, 2014, DRUG DISCOV TODAY, V19, P222, DOI 10.1016/j.drudis.2013.10.017; Yan FG, 2010, RESP MED, V104, P473, DOI 10.1016/j.rmed.2010.01.009; Zhao GP, 2015, J BIOL CHEM, V290, P8949, DOI 10.1074/jbc.M114.619353	93	27	28	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4763	4778		10.1074/jbc.M115.712331	http://dx.doi.org/10.1074/jbc.M115.712331			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26728460	hybrid, Green Published			2022-12-28	WOS:000371604600042
J	Chen, Y; Fang, Q; Wang, Z; Zhang, JY; MacLeod, AS; Hall, RP; Liedtke, WB				Chen, Yong; Fang, Quan; Wang, Zilong; Zhang, Jennifer Y.; MacLeod, Amanda S.; Hall, Russell P.; Liedtke, Wolfgang B.			Transient Receptor Potential Vanilloid 4 Ion Channel Functions as a Pruriceptor in Epidermal Keratinocytes to Evoke Histaminergic Itch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRPV4; SKIN; PAIN; ENDOTHELIN-1; INFLAMMATION; RESPONSES; ACTIVATION; DERMATITIS; PRURITUS; BEHAVIOR	TRPV4 ion channels function in epidermal keratinocytes and in innervating sensory neurons; however, the contribution of the channel in either cell to neurosensory function remains to be elucidated. We recently reported TRPV4 as a critical component of the keratinocyte machinery that responds to ultraviolet B (UVB) and functions critically to convert the keratinocyte into a pain-generator cell after excess UVB exposure. One key mechanism in keratinocytes was increased expression and secretion of endothelin-1, which is also a known pruritogen. Here we address the question of whether TRPV4 in skin keratinocytes functions in itch, as a particular form of "forefront" signaling in non-neural cells. Our results support this novel concept based on attenuated scratching behavior in response to histaminergic (histamine, compound 48/80, endothelin-1), not non-histaminergic (chloroquine) pruritogens in Trpv4 keratinocyte-specific and inducible knock-out mice. We demonstrate that keratinocytes rely on TRPV4 for calcium influx in response to histaminergic pruritogens. TRPV4 activation in keratinocytes evokes phosphorylation of mitogen-activated protein kinase, ERK, for histaminergic pruritogens. This finding is relevant because we observed robust anti-pruritic effects with topical applications of selective inhibitors for TRPV4 and also for MEK, the kinase upstream of ERK, suggesting that calcium influx via TRPV4 in keratinocytes leads to ERK-phosphorylation, which in turn rapidly converts the keratinocyte into an organismal itch-generator cell. In support of this concept we found that scratching behavior, evoked by direct intradermal activation of TRPV4, was critically dependent on TRPV4 expression in keratinocytes. Thus, TRPV4 functions as a pruriceptor-TRP in skin keratinocytes in histaminergic itch, a novel basic concept with translational-medical relevance.	[Chen, Yong; Fang, Quan; Wang, Zilong; Liedtke, Wolfgang B.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27710 USA; [Zhang, Jennifer Y.; MacLeod, Amanda S.; Hall, Russell P.] Duke Univ, Med Ctr, Dept Dermatol, Durham, NC 27710 USA; [Liedtke, Wolfgang B.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Liedtke, Wolfgang B.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Liedtke, Wolfgang B.] Duke Univ, Med Ctr, Neurol Clin Headache Head Pain & Trigeminal Senso, Durham, NC 27705 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Chen, Y; Liedtke, WB (corresponding author), Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27710 USA.	yong.chen@duke.edu; wolfgang@neuro.duke.edu	Wang, Zilong/AAB-4143-2019; Wang, Zilong/P-7047-2017; Liedtke, Wolfgang/GNH-1878-2022; Wang, Zilong/AEY-8544-2022	Wang, Zilong/0000-0001-7473-0354; Wang, Zilong/0000-0001-7473-0354; Fang, Quan/0000-0003-0381-6796; Zhang, Jennifer Y./0000-0002-4485-1750	National Institutes of Health [DE018549, UL1TR001117, P30AR066527, F33DE024668, K12DE022793, 5K08AR063729-04]; Department of Defense [W81XWH-13-1-0299]; Harrington Discovery Institute (Cleveland, OH) Scholar-Innovator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066527, K08AR063729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F33DE024668, K12DE022793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Harrington Discovery Institute (Cleveland, OH) Scholar-Innovator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE018549 (to W. B. L.), UL1TR001117 (pilot award to W. B. L.), P30AR066527 (Duke Principal Investigator Russell P. Hall, pilot award to W. B. L.), F33DE024668 (to Y. C.), K12DE022793 (to Y. C.), and 5K08AR063729-04 (to A. S. M.). This work was also supported by Department of Defense Grant W81XWH-13-1-0299 (to W. B. L.) and by a Harrington Discovery Institute (Cleveland, OH) Scholar-Innovator Award (to W. B. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama T, 2015, J NEUROPHYSIOL, V114, P2528, DOI 10.1152/jn.00723.2015; Akiyama T, 2016, J INVEST DERMATOL, V136, P154, DOI 10.1038/JID.2015.388; Alessandri-Haber N, 2005, PAIN, V118, P70, DOI 10.1016/j.pain.2005.07.016; Andoh T, 2012, EUR J PHARMACOL, V686, P16, DOI 10.1016/j.ejphar.2012.04.024; Baumbauer KM, 2015, ELIFE, V4, DOI 10.7554/eLife.09674; Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Biro T, 2007, BBA-MOL BASIS DIS, V1772, P1004, DOI 10.1016/j.bbadis.2007.03.002; Brierley SM, 2008, GASTROENTEROLOGY, V134, P2059, DOI 10.1053/j.gastro.2008.01.074; Burkhart Craig G, 2003, J Drugs Dermatol, V2, P143; Cannon KE, 2007, PAIN, V129, P76, DOI 10.1016/j.pain.2006.09.039; Chen Y, 2014, PAIN, V155, P2662, DOI 10.1016/j.pain.2014.09.033; Chen Y, 2013, PAIN, V154, P1295, DOI 10.1016/j.pain.2013.04.004; Denda M, 2007, J INVEST DERMATOL, V127, P654, DOI 10.1038/sj.jid.5700590; Dhand A, 2014, BRAIN, V137, P313, DOI 10.1093/brain/awt158; Einspahr JG, 2012, CANCER PREV RES, V5, P403, DOI 10.1158/1940-6207.CAPR-11-0427; Elmariah SB, 2013, CELL, V155, P267, DOI 10.1016/j.cell.2013.09.038; Fusi C, 2014, J INVEST DERMATOL, V134, P2408, DOI 10.1038/jid.2014.145; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Greaves MW, 2004, INT ARCH ALLERGY IMM, V135, P166, DOI 10.1159/000080898; Gschwandtner M, 2008, J INVEST DERMATOL, V128, P2783, DOI 10.1038/jid.2008.153; Kashem SW, 2011, EUR J PHARMACOL, V668, P299, DOI 10.1016/j.ejphar.2011.06.027; Katugampola R., 2010, EXP PHYSIOL, V85, P839; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; Lee YM, 2012, J DERMATOL SCI, V65, P81, DOI 10.1016/j.jdermsci.2011.11.003; Li JJ, 2011, ENVIRON HEALTH PERSP, V119, P784, DOI 10.1289/ehp.1002807; Li JJ, 2009, ENVIRON HEALTH PERSP, V117, P400, DOI 10.1289/ehp.0800311; Liang J., 2016, EXP BIOL MED, V235, P1300; Liang JX, 2011, NEUROSCI LETT, V492, P175, DOI 10.1016/j.neulet.2011.02.009; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Liedtke Wolfgang B., 2007, P303; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Macdonald JB, 2015, J AM ACAD DERMATOL, V72, P221, DOI 10.1016/j.jaad.2014.07.033; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; McNulty AL, 2015, N-S ARCH PHARMACOL, V388, P437, DOI 10.1007/s00210-014-1078-x; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Mommert S, 2011, CURR ALLERGY ASTHM R, V11, P21, DOI 10.1007/s11882-010-0162-7; Moore C, 2013, P NATL ACAD SCI USA, V110, pE3225, DOI 10.1073/pnas.1312933110; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2013, EXP DERMATOL, V22, P447, DOI 10.1111/exd.12163; O'Conor CJ, 2013, ANN RHEUM DIS, V72, P300, DOI 10.1136/annrheumdis-2012-202272; OSIFO N G, 1989, African Journal of Medicine and Medical Sciences, V18, P121; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Plant Tim D., 2007, P125; RICCIO MM, 1995, AM J RESP CRIT CARE, V152, P1757, DOI 10.1164/ajrccm.152.6.8520734; Salaga M, 2015, BRIT J PHARMACOL, V172, P4331, DOI 10.1111/bph.13212; Sugimoto Y, 1998, EUR J PHARMACOL, V351, P1, DOI 10.1016/S0014-2999(98)00288-X; Sun SH, 2016, SEMIN IMMUNOPATHOL, V38, P293, DOI 10.1007/s00281-015-0530-4; Tey HL, 2010, ACTA DERM-VENEREOL, V90, P227, DOI 10.2340/00015555-0867; Toth BI, 2015, HANDB EXP PHARMACOL, V226, P89, DOI 10.1007/978-3-662-44605-8_6; Trentin PG, 2006, EXP BIOL MED, V231, P1146; Tsybikov NN, 2015, ALLERGY ASTHMA PROC, V36, P320, DOI 10.2500/aap.2015.36.3846; Turner MJ, 2014, TRENDS IMMUNOL, V35, P49, DOI 10.1016/j.it.2013.12.001; von Banchet GS, 2013, MOL CELL NEUROSCI, V52, P152, DOI 10.1016/j.mcn.2012.11.006; Wenzel RR, 1998, BRIT J CLIN PHARMACO, V45, P441, DOI 10.1046/j.1365-2125.1998.00703.x; Wilson SR, 2014, FRONT NEUROSCI, P281; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Wu Z, 2015, EUR J PAIN, V19, P889, DOI 10.1002/ejp.613; Yamaura K, 2009, J TOXICOL SCI, V34, P427, DOI 10.2131/jts.34.427; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yoshioka T, 2009, J INVEST DERMATOL, V129, P714, DOI 10.1038/jid.2008.245; Zhang XL, 2015, J INVEST DERMATOL, V135, P1016, DOI 10.1038/jid.2014.519; Zhang XM, 2015, N-S ARCH PHARMACOL, V388, P389, DOI 10.1007/s00210-014-1068-z; Zhao PS, 2015, J BIOL CHEM, V290, P13875, DOI 10.1074/jbc.M115.642736; Zhao PS, 2014, J BIOL CHEM, V289, P27215, DOI 10.1074/jbc.M114.599712	68	83	84	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10252	10262		10.1074/jbc.M116.716464	http://dx.doi.org/10.1074/jbc.M116.716464			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26961876	Green Published, hybrid			2022-12-28	WOS:000375602800033
J	Crickard, JB; Fu, JH; Reese, JC				Crickard, J. Brooks; Fu, Jianhua; Reese, Joseph C.			Biochemical Analysis of Yeast Suppressor of Ty 4/5 (Spt4/5) Reveals the Importance of Nucleic Acid Interactions in the Prevention of RNA Polymerase II Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ELONGATION-FACTOR; FACTOR SPT5; SACCHAROMYCES-CEREVISIAE; SPT4-SPT5 COMPLEX; TRIGGER LOOP; PAF1 COMPLEX; NASCENT-RNA; IN-VITRO; CCR4-NOT COMPLEX; STRUCTURAL BASIS	RNA polymerase II (RNAPII) undergoes structural changes during the transitions from initiation, elongation, and termination, which are aided by a collection of proteins called elongation factors. NusG/Spt5 is the only elongation factor conserved in all domains of life. Although much information exists about the interactions between NusG/Spt5 and RNA polymerase in prokaryotes, little is known about how the binding of eukaryotic Spt4/5 affects the biochemical activities of RNAPII. We characterized the activities of Spt4/5 and interrogated the structural features of Spt5 required for it to interact with elongation complexes, bind nucleic acids, and promote transcription elongation. The eukaryotic specific regions of Spt5 containing the Kyrpides, Ouzounis, Woese domains are involved in stabilizing the association with the RNAPII elongation complex, which also requires the presence of the nascent transcript. Interestingly, we identify a region within the conserved NusG N-terminal (NGN) domain of Spt5 that contacts the non-template strand of DNA both upstream of RNAPII and in the transcription bubble. Mutating charged residues in this region of Spt5 did not prevent Spt4/5 binding to elongation complexes, but abrogated the cross-linking of Spt5 to DNA and the anti-arrest properties of Spt4/5, thus suggesting that contact between Spt5 (NGN) and DNA is required for Spt4/5 to promote elongation. We propose that the mechanism of how Spt5/NGN promotes elongation is fundamentally conserved; however, the eukaryotic specific regions of the protein evolved so that it can serve as a platform for other elongation factors and maintain its association with RNAPII as it navigates genomes packaged into chromatin.	[Crickard, J. Brooks; Reese, Joseph C.] Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, 463A North Frear, University Pk, PA 16802 USA; [Fu, Jianhua] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Medical College of Wisconsin	Reese, JC (corresponding author), Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, 463A North Frear, University Pk, PA 16802 USA.	Jcr8@psu.edu			National Institutes of Health [GM058672, GM100997]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058672, R01GM100997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM058672 (to J. C. R.) and GM100997 (to J. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson SJ, 2011, J BIOL CHEM, V286, P18816, DOI 10.1074/jbc.M110.202101; Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Babbarwal V, 2014, J BIOL CHEM, V289, P33125, DOI 10.1074/jbc.C114.601088; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Barnes CO, 2015, MOL CELL, V59, P258, DOI 10.1016/j.molcel.2015.06.034; Belogurov GA, 2010, MOL MICROBIOL, V76, P286, DOI 10.1111/j.1365-2958.2010.07056.x; Bourgeois CF, 2002, MOL CELL BIOL, V22, P1079, DOI 10.1128/MCB.22.4.1079-1093.2002; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; BUROVA E, 1995, J BACTERIOL, V177, P1388, DOI 10.1128/jb.177.5.1388-1392.1995; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Cheng B, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn630; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; DEDRICK RL, 1985, BIOCHEMISTRY-US, V24, P2245, DOI 10.1021/bi00330a019; Ding BJ, 2010, J BIOL CHEM, V285, P5317, DOI 10.1074/jbc.M109.082818; Dutta A, 2015, MOL CELL BIOL, V35, P1915, DOI 10.1128/MCB.00044-15; Gu WG, 1996, P NATL ACAD SCI USA, V93, P6935, DOI 10.1073/pnas.93.14.6935; Guo GR, 2015, J STRUCT BIOL, V192, P418, DOI 10.1016/j.jsb.2015.09.023; Guo M, 2008, STRUCTURE, V16, P1649, DOI 10.1016/j.str.2008.08.013; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Hartzog GA, 2013, BBA-GENE REGUL MECH, V1829, P105, DOI 10.1016/j.bbagrm.2012.08.007; Hartzog GA, 2011, MOL CELL, V43, P161, DOI 10.1016/j.molcel.2011.07.002; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Hein PP, 2014, NAT STRUCT MOL BIOL, V21, P794, DOI 10.1038/nsmb.2867; Herbert KM, 2010, J MOL BIOL, V399, P17, DOI 10.1016/j.jmb.2010.03.051; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; Kim D, 2003, GENES CELLS, V8, P371, DOI 10.1046/j.1365-2443.2003.00638.x; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Kruk JA, 2011, GENE DEV, V25, P581, DOI 10.1101/gad.2020911; Lasko P, 2010, CURR BIOL, V20, pR666, DOI 10.1016/j.cub.2010.05.056; Li WT, 2014, NUCLEIC ACIDS RES, V42, P7069, DOI 10.1093/nar/gku333; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mayekar MK, 2013, MOL CELL BIOL, V33, P3259, DOI 10.1128/MCB.00270-13; Mayer A, 2012, MOL CELL BIOL, V32, P1321, DOI 10.1128/MCB.06310-11; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meyer PA, 2015, MOL CELL BIOL, V35, P3354, DOI 10.1128/MCB.00520-15; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Nayak D, 2013, MOL CELL, V50, P882, DOI 10.1016/j.molcel.2013.05.015; Pei Y, 2002, J BIOL CHEM, V277, P19639, DOI 10.1074/jbc.M200015200; Qiu HF, 2012, EMBO J, V31, P3494, DOI 10.1038/emboj.2012.188; REINES D, 1989, J BIOL CHEM, V264, P10799; Rondon AG, 2003, EMBO J, V22, P612, DOI 10.1093/emboj/cdg047; Saeki H, 2009, MOL CELL, V35, P191, DOI 10.1016/j.molcel.2009.06.009; Sekine S, 2015, MOL CELL, V57, P408, DOI 10.1016/j.molcel.2014.12.014; Sevostyanova A, 2011, MOL CELL, V43, P253, DOI 10.1016/j.molcel.2011.05.026; Sevostyanova A, 2010, NUCLEIC ACIDS RES, V38, P7432, DOI 10.1093/nar/gkq623; SLUDER AE, 1988, J BIOL CHEM, V263, P9917; Suh MH, 2005, P NATL ACAD SCI USA, V102, P17314, DOI 10.1073/pnas.0507987102; SWANSON MS, 1991, MOL CELL BIOL, V11, P3009, DOI 10.1128/MCB.11.6.3009; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Viktorovskaya OV, 2011, J BIOL CHEM, V286, P18825, DOI 10.1074/jbc.M110.202119; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Werner F, 2012, J MOL BIOL, V417, P13, DOI 10.1016/j.jmb.2012.01.031; Wier AD, 2013, P NATL ACAD SCI USA, V110, P17290, DOI 10.1073/pnas.1314754110; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Yakhnin AV, 2016, J BIOL CHEM, V291, P5299, DOI 10.1074/jbc.M115.704189; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Zhang ZQ, 2005, GENE DEV, V19, P1572, DOI 10.1101/gad.1296305; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106; Zhu WY, 2007, NUCLEIC ACIDS RES, V35, P4064, DOI 10.1093/nar/gkm430	74	38	39	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9853	9870		10.1074/jbc.M116.716001	http://dx.doi.org/10.1074/jbc.M116.716001			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26945063	Green Published, hybrid			2022-12-28	WOS:000375602800001
J	Li, YC; Cooper, A; Odibo, IN; Ahmed, A; Murphy, P; Koonce, R; Dajani, NK; Lowery, CL; Roberts, DJ; Maroteaux, L; Kilic, F				Li, Yicong; Cooper, Anthonya; Odibo, Imelda N.; Ahmed, Asli; Murphy, Pamela; Koonce, Ruston; Dajani, Nafisa K.; Lowery, Curtis L.; Roberts, Drucilla J.; Maroteaux, Luc; Kilic, Fusun			Discrepancy in Insulin Regulation between Gestational Diabetes Mellitus (GDM) Platelets and Placenta (Publication with Expression of Concern. See vol. 294, pg. 5208, 2019) (Withdrawn Publication. See vol. 294, pg. 9656, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							HUMAN SEROTONIN TRANSPORTER; HETERO-OLIGOMERIZATION; DOPAMINE TRANSPORTER; HOMO-OLIGOMERIZATION; SURFACE EXPRESSION; GRANULE SECRETION; QUALITY-CONTROL; PREGNANCY; WOMEN; IDENTIFICATION	Earlier findings have identified the requirement of insulin signaling on maturation and the translocation of serotonin (5-HT) transporter, SERT to the plasma membrane of the trophoblast in placenta. Because of the defect on insulin receptor (IR) in the trophoblast of the gestational diabetes mellitus (GDM)-associated placenta, SERT is found entrapped in the cytoplasm of the GDM-trophoblast. SERT is encoded by the same gene expressed in trophoblast and platelets. Additionally, alteration in plasma 5-HT levels and the 5-HT uptake rates are associated with the aggregation rates of platelets. Therefore, here, we investigated a novel hypothesis that GDM-associated defects in platelet IR should change their 5-HT uptake rates, and this should be a leading factor for thrombosis in GDM maternal blood. The maternal blood and the placentas were obtained at the time of cesarean section from the GDM and non-diabetic subjects (n = 6 for each group), and the platelets and trophoblasts were isolated to determine the IR activity, surface level of SERT, and their 5-HT uptake rates. Interestingly, no significant differences were evident in IR tyrosine phosphorylation or the downstream elements, AKT and S6K in platelets and their aggregation rates in both groups. Furthermore, insulin stimulation up-regulated 5-HT uptake rates of GDM-platelets as it does in the control group. However, the phosphorylation of IR and the downstream elements were significantly lower in GDM-trophoblast and showed no response to the insulin stimulation while they showed 4-fold increase to insulin stimulation in control group. Similarly, the 5-HT uptake rates of GDM-trophoblast and the SERT expression on their surface were severalfold lower compared with control subjects. IR is expressed in all tissues, but it is not known if diabetes affects IR in all tissues equally. Here, for the first time, our findings with clinical samples show that in GDM-associated defect on IR is tissue type-dependent. While IR is impaired in GDM-placenta, it is unaffected in GDM-platelet.	[Li, Yicong; Cooper, Anthonya; Ahmed, Asli; Koonce, Ruston; Kilic, Fusun] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Coll Med, Little Rock, AR 72205 USA; [Odibo, Imelda N.; Murphy, Pamela; Dajani, Nafisa K.; Lowery, Curtis L.] Univ Arkansas Med Sci, Dept Obstet & Gynecol, Coll Med, Little Rock, AR 72205 USA; [Roberts, Drucilla J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Maroteaux, Luc] Univ Paris 06, INSERM, UMR S839, Inst Fer Moulin, F-75005 Paris, France	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Harvard University; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Kilic, F (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Coll Med, Little Rock, AR 72205 USA.	kilicfusun@uams.edu	Maroteaux, Luc/H-4585-2019; Roberts, Drucilla/AAB-6379-2022	Maroteaux, Luc/0000-0002-9499-8603; 	National Heart, Lung, and Blood Institute, National Institutes of Health [HL091196]; Eunice Kennedy Shriver NICHHD [058697, 053477]; American Heart Association [13GRNT17240014]; Minnie Merrill Sturgis Diabetes Research Fund; Sturgis Charitable Trust; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie; Fondation pour la Recherche Medicale; French Ministry of Research (Agence Nationale pour la Recherche); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD058697, R03HD053477] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091196] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver NICHHD; American Heart Association(American Heart Association); Minnie Merrill Sturgis Diabetes Research Fund; Sturgis Charitable Trust; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Ministry of Research (Agence Nationale pour la Recherche)(French National Research Agency (ANR)Ministry of Research, France); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute, National Institutes of Health HL091196; Eunice Kennedy Shriver NICHHD 058697 and 053477; American Heart Association (13GRNT17240014); and the Minnie Merrill Sturgis Diabetes Research Fund; and the Sturgis Charitable Trust (to F. K.) This work was also supported by funds from the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the Universite Pierre et Marie Curie, and by grants from the Fondation pour la Recherche Medicale, the French Ministry of Research (Agence Nationale pour la Recherche) (to L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amara S G, 1993, Curr Opin Neurobiol, V3, P337, DOI 10.1016/0959-4388(93)90126-J; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; BALKOVETZ DF, 1989, J BIOL CHEM, V264, P2195; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Barbour LA, 2011, J CLIN ENDOCR METAB, V96, P1431, DOI 10.1210/jc.2010-2116; Basnet KM, 2016, PEDIATR DEVEL PATHOL, V19, P502, DOI 10.2350/15-11-1734-OA.1; Beischer NA, 1996, AUST NZ J OBSTET GYN, V36, P239, DOI 10.1111/j.1479-828X.1996.tb02703.x; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Bonnin A, 2012, NEUROPSYCHOPHARMACOL, V37, P299, DOI 10.1038/npp.2011.194; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Bradley CC, 1997, J NEUROCHEM, V69, P1356; Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x; Brown AJ., 2005, CLIN DIABETES, V23, P17, DOI [10.2337/diaclin.23.1.17, DOI 10.2337/DIACLIN.23.1.17]; Buchanan TA, 2007, DIABETES CARE, V30, pS105, DOI 10.2337/dc07-s201; BULMER JN, 1984, AM J OBSTET GYNECOL, V148, P19, DOI 10.1016/S0002-9378(84)80026-5; CATALANO PM, 1993, AM J PHYSIOL, V264, pE60, DOI 10.1152/ajpendo.1993.264.1.E60; Catalano PM, 2003, J NUTR, V133, p1674S, DOI 10.1093/jn/133.5.1674S; Chamba A, 2008, J NEUROIMMUNOL, V204, P75, DOI 10.1016/j.jneuroim.2008.07.014; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; Clover LN, 2000, PLACENTA, V21, P743, DOI 10.1053/plac.2000.0583; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Crosby David, 2004, Methods Mol Biol, V272, P95; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; FDA Drug Safety Communication, 2011, SEL SER REUPT INH SS; Fraer M, 2015, HYPERTENSION, V65, P942, DOI 10.1161/HYPERTENSIONAHA.114.05061; Freyaldenhoven S, 2012, J BIOL CHEM, V287, P17801, DOI 10.1074/jbc.M112.345058; Greene MF, 2007, NEW ENGL J MED, V356, P2732, DOI 10.1056/NEJMe078079; Holbrook LM, 2010, BRIT J HAEMATOL, V148, P627, DOI 10.1111/j.1365-2141.2009.07994.x; Jansson N, 2013, J CLIN ENDOCR METAB, V98, P105, DOI 10.1210/jc.2012-2667; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Kilic F, 2009, CARDIOL RES CLIN DEV, P219; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kocabas AM, 2003, J NEUROCHEM, V85, P1513, DOI 10.1046/j.1471-4159.2003.01793.x; Lager S, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.242; LAUDER JM, 1976, BRAIN RES, V107, P638, DOI 10.1016/0006-8993(76)90153-0; LAUDER JM, 1988, DEVELOPMENT, V102, P709; LESCH KP, 1993, J NEUROCHEM, V60, P2319, DOI 10.1111/j.1471-4159.1993.tb03522.x; Li YC, 2014, P NATL ACAD SCI USA, V111, pE5697, DOI 10.1073/pnas.1416675112; Maldonado-Estrada J, 2004, J IMMUNOL METHODS, V286, P21, DOI 10.1016/j.jim.2003.03.001; Manoussaka MS, 2005, PLACENTA, V26, P308, DOI 10.1016/j.placenta.2004.06.008; Mercado CP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02795; Mercado CP, 2011, CURR OPIN PHARMACOL, V11, P23, DOI 10.1016/j.coph.2011.01.006; Mercado CP, 2010, MOL INTERV, V10, P231, DOI 10.1124/mi.10.4.6; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Nguyen TT, 1996, J NEUROCHEM, V67, P645; Ozaslan D, 2003, J BIOL CHEM, V278, P43991, DOI 10.1074/jbc.M306360200; Przyklenk K, 2010, J THROMB HAEMOST, V8, P331, DOI 10.1111/j.1538-7836.2009.03693.x; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Reith MEA., 1997, NEUROTRANSMITTER TRA, P29, DOI 10.1007/978-1-59259-470-2_2; Roos S, 2009, BIOCHEM SOC T, V37, P295, DOI 10.1042/BST0370295; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; Shirakawa R, 2000, J BIOL CHEM, V275, P33844, DOI 10.1074/jbc.M002834200; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; TATE CG, 1994, J BIOL CHEM, V269, P26303; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Velasquez JC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00047; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Ziu E, 2012, J MOL CELL CARDIOL, V52, P1112, DOI 10.1016/j.yjmcc.2012.02.004	61	13	13	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9657	9665		10.1074/jbc.M116.713693	http://dx.doi.org/10.1074/jbc.M116.713693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26921319	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000375602300024
J	Druso, JE; Endo, M; Lin, MCJ; Peng, X; Antonyak, MA; Meller, S; Cerione, RA				Druso, Joseph E.; Endo, Makoto; Lin, Miao-chong Joy; Peng, Xu; Antonyak, Marc A.; Meller, Stephanie; Cerione, Richard A.			An Essential Role for Cdc42 in the Functioning of the Adult Mammary Gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL-POLARITY; DIFFERENTIATION; MORPHOGENESIS; EXPRESSION; CADHERIN; ENDOCYTOSIS; TISSUE; STAT5; METASTASIS	The Rho family small GTPase Cdc42 has been implicated in a wide range of cellular functions including the establishment of cell polarity and the remodeling of the actin cytoskeletal architecture, resulting in the tight regulation of cell growth and survival during developmental processes. The complete knock-out of Cdc42 in the mouse is embryonic-lethal, and its targeted deletion in various tissues has been shown to disrupt tissue homeostasis. Thus far, in most studies, the targeted deletion of Cdc42 occurred during embryogenesis. Here, we have used a conditional gene deletion strategy in mice to probe the specific role of Cdc42 during adult mammary gland function. Cdc42 conditional-knock-out females were unable to adequately nourish their pups, due to a disorganized epithelial compartment within their mammary glands. A closer examination showed that their mammary epithelial cells were not able to maintain functional alveolar lumens, due to an inability to establish normal apical/basal epithelial polarity, as well as proper cell-cell contacts. Loss of these essential epithelial characteristics led to a premature sloughing off of the Cdc42-null epithelial cells. Overall our findings demonstrate that Cdc42 plays essential roles in mammary gland function post pregnancy, where it helps to establish proper epithelial cell polarity and tissue homeostasis during lactation.	[Druso, Joseph E.; Endo, Makoto; Lin, Miao-chong Joy; Peng, Xu; Antonyak, Marc A.; Meller, Stephanie; Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Chem & Biol Chem, Baker Lab, Ithaca, NY 14853 USA; [Peng, Xu] Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Med Physiol, Temple, TX 76504 USA	Cornell University; Cornell University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu		Endo, Makoto/0000-0002-2055-5471	National Institutes of Health [GM047458, GM040654]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, P41GM103485, R01GM040654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM047458 and GM040654 (to R. A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhtar N, 2006, J CELL BIOL, V173, P781, DOI 10.1083/jcb.200601059; Bray K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3487; Bray Kristi, 2011, Small GTPases, V2, P247; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gallego MI, 2001, DEV BIOL, V229, P163, DOI 10.1006/dbio.2000.9961; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Lo AT, 2012, J MAMMARY GLAND BIOL, V17, P103, DOI 10.1007/s10911-012-9251-7; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; McHenry PR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2643; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Pedersen E, 2012, EXP CELL RES, V318, P1779, DOI 10.1016/j.yexcr.2012.05.004; Peng X, 2013, PROTEIN CELL, V4, P231, DOI 10.1007/s13238-012-2098-2; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wu XW, 2007, DEV DYNAM, V236, P2767, DOI 10.1002/dvdy.21309; Wu XW, 2006, MATRIX BIOL, V25, P466, DOI 10.1016/j.matbio.2006.09.001; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yuan HX, 2009, HEPATOLOGY, V49, P240, DOI 10.1002/hep.22610	35	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8886	8895		10.1074/jbc.M115.694349	http://dx.doi.org/10.1074/jbc.M115.694349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26912661	Green Published, hybrid			2022-12-28	WOS:000374849000003
J	Jia, ZF; Ikeda, R; Ling, J; Viatchenko-Karpinski, V; Gu, JGG				Jia, Zhanfeng; Ikeda, Ryo; Ling, Jennifer; Viatchenko-Karpinski, Viacheslav; Gu, Jianguo G.			Regulation of Piezo2 Mechanotransduction by Static Plasma Membrane Tension in Primary Afferent Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; MECHANICALLY ACTIVATED CURRENTS; MULTIPLE COMPARISON PROCEDURES; SURFACE-AREA REGULATION; SENSORY NEURONS; MERKEL CELLS; MECHANOSENSITIVE CURRENTS; RAT; CYTOSKELETON; TRPV4	The Piezo2 channel is a newly identified mammalian mechanical transducer that confers rapidly adapting mechanically activated (RA-MA) currents in primary afferent neurons. The Piezo2 channels sense rapid membrane displacement, but it is not clear whether they are sensitive to osmotic swelling, which slowly increases static plasma membrane tension (SPMT). Here, we show that SPMT exerts a profound impact on the mechanical sensitivity of RA-MA channels in primary afferent neurons. RA-MA currents are greatly enhanced, and the mechanical threshold was reduced in both primary afferent neurons of rat dorsal root ganglia (DRG) and HEK293 cells heterologously expressing Piezo2 when these cells undergo osmotic swelling to increase SPMT. Osmotic swelling switches the kinetics of RA-MA currents to the slowly adapting type in both cultured DRG neurons and HEK293 cells heterologously expressing Piezo2. The potentiation of RA-MA currents is abolished when cultured DRG neurons are treated with cytochalasin D, an actin filament disruptor that prevents SPMT of cultured DRG neurons from an increase by osmotic swelling. Osmotic swelling significantly increases DRG neuron mechano-excitability such that a subthreshold mechanical stimulus can result in action potential firing. Behaviorally, the mechanical hind paw withdrawal threshold in rats is reduced following the injection of a hypotonic solution, but this osmotic effect is abolished when cytochalasin D or Gd3+ is co-administered with the hypo-osmotic solution. Taken together, our findings suggest that Piezo2-mediated mechanotransduction is regulated by SPMT in primary afferent neurons. Because SPMT can be changed by multiple biological factors, our findings may have broad implications in mechanical sensitivity under physiological and pathological conditions.	[Ling, Jennifer; Viatchenko-Karpinski, Viacheslav; Gu, Jianguo G.] Univ Alabama Birmingham, Sch Med, Dept Anesthesiol & Perioperat Med, 901 19th St South,BMR II 210, Birmingham, AL 35294 USA; [Jia, Zhanfeng; Ikeda, Ryo; Ling, Jennifer; Gu, Jianguo G.] Univ Cincinnati, Coll Med, Dept Anesthesiol, Cincinnati, OH 45267 USA; [Jia, Zhanfeng] Hebei Med Univ, Dept Pharmacol, 361 East Zhongshan Rd, Shijiazhuang 050017, Hebei Province, Peoples R China; [Ikeda, Ryo] Jikei Univ, Sch Med, Dept Orthoped Surg, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan	University of Alabama System; University of Alabama Birmingham; University System of Ohio; University of Cincinnati; Hebei Medical University; Jikei University	Gu, JGG (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Anesthesiol & Perioperat Med, 901 19th St South,BMR II 210, Birmingham, AL 35294 USA.	gujo@uc.edu		Ikeda, Ryo/0000-0001-6603-7146; Viatchenko-Karpinski, Viacheslav/0000-0001-9828-9081	National Institute of Health [R01 DE018661, R01 DE023090]; Nature Science Foundation of China [81571080]; Hebei Province of China [H2015206240]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023090, R01DE018661] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Province of China; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in whole or part by National Institute of Health Grants R01 DE018661 and R01 DE023090 (to J. G. G.), a scholarship from Nature Science Foundation of China 81571080 (to Z. J.), and Hebei Province of China Grant H2015206240 (to Z. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dai JW, 1998, J NEUROSCI, V18, P6681; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Di Castro A, 2006, P NATL ACAD SCI USA, V103, P4699, DOI 10.1073/pnas.0508005103; Dina OA, 2003, NEURON, V39, P613, DOI 10.1016/S0896-6273(03)00473-2; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Eijkelkamp N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2673; Gilden J, 2010, CYTOSKELETON, V67, P477, DOI 10.1002/cm.20461; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Ikeda R, 2014, NEUROSCI LETT, V583, P210, DOI 10.1016/j.neulet.2014.05.055; Ikeda R, 2014, CELL, V157, P664, DOI 10.1016/j.cell.2014.02.026; Jia ZF, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-57; Jia ZF, 2012, NEUROSCI LETT, V522, P79, DOI 10.1016/j.neulet.2012.06.024; Liedtke W, 2005, J PHYSIOL-LONDON, V567, P53, DOI 10.1113/jphysiol.2005.088963; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; McCarter GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-28; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Oh MJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3886; PAOLETTI P, 1994, NEURON, V13, P645, DOI 10.1016/0896-6273(94)90032-9; Pietuch A, 2013, BBA-MOL CELL RES, V1833, P712, DOI 10.1016/j.bbamcr.2012.11.006; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Reeves D, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041901; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; Saville DJ, 2003, CAN J EXP PSYCHOL, V57, P167, DOI 10.1037/h0087423; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Tanner KD, 1998, J COMP NEUROL, V395, P481; Topp KS, 2000, J COMP NEUROL, V424, P563; Tsujita K, 2015, BBA-MOL CELL BIOL L, V1851, P824, DOI 10.1016/j.bbalip.2014.10.011; Tsuzuki K, 2004, J NEUROSCI, V24, P762, DOI 10.1523/JNEUROSCI.4658-03.2004; Wei XM, 2011, CEPHALALGIA, V31, P1595, DOI 10.1177/0333102411427600; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251	37	26	26	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9087	9104		10.1074/jbc.M115.692384	http://dx.doi.org/10.1074/jbc.M115.692384			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26929410	hybrid, Green Published			2022-12-28	WOS:000374849000022
J	Larmonier, CB; Shehab, KW; Laubitz, D; Jamwal, DR; Ghishan, FK; Kiela, PR				Larmonier, Claire B.; Shehab, Kareem W.; Laubitz, Daniel; Jamwal, Deepa R.; Ghishan, Fayez K.; Kiela, Pawel R.			Transcriptional Reprogramming and Resistance to Colonic Mucosal Injury in Poly(ADP-ribose) Polymerase 1 (PARP1)-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; NF-KAPPA-B; FECAL MICROBIOTA; PARP-1; BINDING; INHIBITION; APOPTOSIS; INFLAMMATION; MODULATION; SYNTHETASE	Poly(ADP-ribose) polymerases (PARPs) synthesize and bind branched polymers of ADP-ribose to acceptor proteins using NAD as a substrate and participate in the control of gene transcription and DNA repair. PARP1, the most abundant isoform, regulates the expression of proinflammatory mediator cytokines, chemokines, and adhesion molecules, and inhibition of PARP1 enzymatic activity reduced or ameliorated autoimmune diseases in several experimental models, including colitis. However, the mechanism(s) underlying the protective effects of PARP1 inhibition in colitis and the cell types in which Parp1 deletion has the most significant impact are unknown. The objective of the current study was to determine the impact of Parp1 deletion on the innate immune response to mucosal injury and on the gut microbiome composition. Parp1 deficiency was evaluated in DSS-induced colitis in WT, Parp1(-/-), Rag2(-/-), and Rag2(-/-)xParp1(-/-) double knock-out mice. Genome-wide analysis of the colonic transcriptome and fecal 16S amplicon profiling was performed. Compared with WT, we demonstrated that Parp1(-/-) were protected from dextran-sulfate sodium-induced colitis and that this protection was associated with a dramatic transcriptional reprogramming in the colon. PARP1 deficiency was also associated with a modulation of the colonic microbiota (increases relative abundance of Clostridia clusters IV and XIVa) and a concomitant increase in the frequency of mucosal CD4(+)CD25(+)Foxp3(+) regulatory T cells. The protective effects conferred by Parp1 deletion were lost in Rag2(-/-) x Parp1(-/-) mice, highlighting the role of the adaptive immune system for full protection.	[Larmonier, Claire B.; Shehab, Kareem W.; Laubitz, Daniel; Jamwal, Deepa R.; Ghishan, Fayez K.; Kiela, Pawel R.] Univ Arizona, Hlth Sci Ctr, Steele Childrens Res Ctr, Dept Pediat, 1501 N Campbell Ave, Tucson, AZ 85724 USA; [Kiela, Pawel R.] Univ Arizona, Hlth Sci Ctr, Dept Immunobiol, 1501 N Campbell Ave, Tucson, AZ 85724 USA; [Larmonier, Claire B.] Ctr Hosp Univ Pellegrin, GRIC, Pole Biol & Pathol, Lab Immunol & Immunogenet, F-33000 Bordeaux, France	University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences; CHU Bordeaux	Kiela, PR (corresponding author), Univ Arizona, Hlth Sci Ctr, Steele Childrens Res Ctr, Dept Pediat, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	pkiela@peds.arizona.edu	Jamwal, Deepa/L-8955-2016; Kiela, Pawel/AAF-5320-2020	Kiela, Pawel/0000-0002-0014-3517; Laubitz, Daniel/0000-0002-7482-8500	National Institutes of Health through the NIDDK [R37DK033209, 1K01DK099268]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK099268, R37DK033209] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R37DK033209 (to F. K. G.) and 1K01DK099268 (to C. B. L.) through the NIDDK. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Boehm F, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-97; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cuzzocrea S, 2000, MOL MED, V6, P766, DOI 10.1007/BF03402192; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Di Paola R, 2005, EUR J PHARMACOL, V527, P163, DOI 10.1016/j.ejphar.2005.09.055; Forsythe RM, 2002, SHOCK, V17, P180, DOI 10.1097/00024382-200203000-00004; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang FC, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/103890; Jijon HB, 2000, AM J PHYSIOL-GASTR L, V279, pG641, DOI 10.1152/ajpgi.2000.279.3.G641; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kim TW, 2006, WORLD J GASTROENTERO, V12, P302, DOI 10.3748/wjg.v12.i2.302; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Lopetuso LR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-23; Mabley JG, 2001, INFLAMM RES, V50, P561, DOI 10.1007/PL00000234; Majewski PM, 2010, J BIOL CHEM, V285, P34828, DOI 10.1074/jbc.M110.152868; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Mazzon E, 2002, BIOCHEM PHARMACOL, V64, P327, DOI 10.1016/S0006-2952(02)01075-4; Nakajima H, 2004, J BIOL CHEM, V279, P42774, DOI 10.1074/jbc.M407923200; Nasta F, 2010, J IMMUNOL, V184, P3470, DOI 10.4049/jimmunol.0901568; Paone G, 2006, J BIOL CHEM, V281, P17054, DOI 10.1074/jbc.M603042200; Peralta-Leal A, 2009, FREE RADICAL BIO MED, V47, P13, DOI 10.1016/j.freeradbiomed.2009.04.008; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Rosado MM, 2013, IMMUNOLOGY, V139, P428, DOI 10.1111/imm.12099; Sanchez-Fidalgo S, 2007, EUR J PHARMACOL, V563, P216, DOI 10.1016/j.ejphar.2007.01.070; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Sodhi RK, 2010, VASC PHARMACOL, V53, P77, DOI 10.1016/j.vph.2010.06.003; SUZUKI H, 1986, J BIOL CHEM, V261, P6048; Szabo C, 2006, TRENDS PHARMACOL SCI, V27, P626, DOI 10.1016/j.tips.2006.10.003; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Welsby I, 2012, BIOCHEM PHARMACOL, V84, P11, DOI 10.1016/j.bcp.2012.02.016; Zhang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071590; Zingarelli B, 1999, GASTROENTEROLOGY, V116, P335, DOI 10.1016/S0016-5085(99)70130-7; Zingarelli B, 2004, IMMUNOLOGY, V113, P509, DOI 10.1111/j.1365-2567.2004.01991.x; Zingarelli B, 2003, EUR J PHARMACOL, V469, P183, DOI 10.1016/S0014-2999(03)01726-6	43	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8918	8930		10.1074/jbc.M116.714386	http://dx.doi.org/10.1074/jbc.M116.714386			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26912654	Green Published, hybrid			2022-12-28	WOS:000374849000006
J	Tayou, J; Wang, Q; Jang, GF; Pronin, AN; Orlandi, C; Martemyanov, KA; Crabb, JW; Slepak, VZ				Tayou, Junior; Wang, Qiang; Jang, Geeng-Fu; Pronin, Alexey N.; Orlandi, Cesare; Martemyanov, Kirill A.; Crabb, John W.; Slepak, Vladlen Z.			Regulator of G Protein Signaling 7 (RGS7) Can Exist in a Homo-oligomeric Form That Is Regulated by G alpha(o) and R7-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC M3 RECEPTOR; BETA-SUBUNIT G-BETA-5; GTPASE ACCELERATING PROTEIN; HETEROTRIMERIC G-PROTEINS; COUPLED RECEPTOR; DEP DOMAIN; TRANSFECTED CELLS; MEMBRANE ANCHOR; MICE LACKING; IN-VIVO	RGS (regulator of G protein signaling) proteins of the R7 subfamily (RGS6, -7, -9, and -11) are highly expressed in neurons where they regulate many physiological processes. R7 RGS proteins contain several distinct domains and form obligatory dimers with the atypical G beta subunit, G beta(5). They also interact with other proteins such as R7-binding protein, R9-anchoring protein, and the orphan receptors GPR158 and GPR179. These interactions facilitate plasma membrane targeting and stability of R7 proteins and modulate their activity. Here, we investigated RGS7 complexes using in situ chemical cross-linking. We found that in mouse brain and transfected cells cross-linking causes formation of distinct RGS7 complexes. One of the products had the apparent molecular mass of similar to 150 kDa on SDS-PAGE and did not contain G beta(5). Mass spectrometry analysis showed no other proteins to be present within the 150-kDa complex in the amount close to stoichiometric with RGS7. This finding suggested that RGS7 could form a homo-oligomer. Indeed, co-immunoprecipitation of differentially tagged RGS7 constructs, with or without chemical cross-linking, demonstrated RGS7 self-association. RGS7-RGS7 interaction required the DEP domain but not the RGS and DHEX domains or the G beta(5) subunit. Using transfected cells and knock-out mice, we demonstrated that R7-binding protein had a strong inhibitory effect on homo-oligomerization of RGS7. In contrast, our data indicated that GPR158 could bind to the RGS7 homo-oligomer without causing its dissociation. Co-expression of constitutively active G alpha(o) prevented the RGS7-RGS7 interaction. These results reveal the existence of RGS protein homo-oligomers and show regulation of their assembly by R7 RGS-binding partners.	[Tayou, Junior; Wang, Qiang; Pronin, Alexey N.; Slepak, Vladlen Z.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Jang, Geeng-Fu; Crabb, John W.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44195 USA; [Orlandi, Cesare; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA	University of Miami; Cleveland Clinic Foundation; Scripps Research Institute	Slepak, VZ (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	VSlepak@med.miami.edu	Orlandi, Cesare/AAK-3180-2020	Orlandi, Cesare/0000-0002-4992-9350	National Institutes of Health [R01DK105427, EY018147, EY14239, DA026405, MH105482];  [P30-EY014801]; NATIONAL EYE INSTITUTE [P30EY014801, R01EY014239, R21EY018147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405, R01DA036596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01DK105427 (to V. Z. S.), EY018147 (to J. W. C.), EY14239 (to J. W. C.), DA026405 (to K. A. M.), MH105482 (to K. A. M.), and Center Grant P30-EY014801 (to Bascom Palmer Eye Institute). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bollinger KE, 2011, INVEST OPHTH VIS SCI, V52, P8287, DOI 10.1167/iovs.11-8218; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chen Qiuyan, 2014, Handb Exp Pharmacol, V219, P205, DOI 10.1007/978-3-642-41199-1_11; Chidiac P, 2003, RECEPTOR CHANNEL, V9, P135, DOI 10.3109/10606820308244; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Gold SJ, 1997, J NEUROSCI, V17, P8024; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Heximer SP, 2003, J CLIN INVEST, V111, P1259, DOI 10.1172/JCI200318099C; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Huang XY, 2006, MOL CELL BIOL, V26, P6870, DOI 10.1128/MCB.00314-06; Hunt RA, 2003, BIOCHEM BIOPH RES CO, V303, P594, DOI 10.1016/S0006-291X(03)00400-5; Jayaraman M, 2009, TRENDS PHARMACOL SCI, V30, P17, DOI 10.1016/j.tips.2008.10.002; Kach J, 2012, AM J PHYSIOL-HEART C, V303, pH19, DOI 10.1152/ajpheart.00764.2011; Karpinsky-Semper D, 2015, BIOCHEMISTRY-US, V54, P1077, DOI 10.1021/bi500980d; Karpinsky-Semper D, 2014, MOL PHARMACOL, V85, P758, DOI 10.1124/mol.114.091843; Klockenbusch C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927585; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Krispel CM, 2003, J NEUROSCI, V23, P6965, DOI 10.1523/JNEUROSCI.23-18-06965.2003; Lan KL, 2000, J BIOL CHEM, V275, P33497, DOI 10.1074/jbc.M005785200; Levay K, 1999, P NATL ACAD SCI USA, V96, P2503, DOI 10.1073/pnas.96.5.2503; Liapis E, 2012, J NEUROCHEM, V122, P568, DOI 10.1111/j.1471-4159.2012.07811.x; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Masuho I, 2013, J BIOL CHEM, V288, P25129, DOI 10.1074/jbc.M113.462283; Masuho I, 2011, J BIOL CHEM, V286, P21806, DOI 10.1074/jbc.M111.241513; Narayanan V, 2007, BIOCHEMISTRY-US, V46, P6859, DOI 10.1021/bi700524w; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Neubig RR, 2015, PROG MOL BIOL TRANSL, V133, P13, DOI 10.1016/bs.pmbts.2015.04.010; Nini L, 2012, ENDOCRINE, V42, P214, DOI 10.1007/s12020-012-9611-5; Orlandi C, 2015, J BIOL CHEM, V290, P13622, DOI 10.1074/jbc.M115.645374; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; Posner BA, 1999, J BIOL CHEM, V274, P31087, DOI 10.1074/jbc.274.43.31087; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Saitoh O, 2003, BIOCHEM BIOPH RES CO, V309, P836, DOI 10.1016/j.bbrc.2003.08.083; Sandiford SL, 2010, BIOCHEMISTRY-US, V49, P4998, DOI 10.1021/bi100080p; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Slepak VZ, 2009, PROG MOL BIOL TRANSL, V86, P157, DOI 10.1016/S1877-1173(09)86006-7; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Stewart A, 2015, PROG MOL BIOL TRANSL, V133, P123, DOI 10.1016/bs.pmbts.2015.03.001; Takida S, 2005, MOL PHARMACOL, V67, P132, DOI 10.1124/mol.104.003418; Wang Q, 2011, FASEB J, V25, P3949, DOI 10.1096/fj.11-190157; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Witherow DS, 2003, J BIOL CHEM, V278, P21307, DOI 10.1074/jbc.M212884200; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Yang Z, 2007, CELL PHYSIOL BIOCHEM, V20, P303, DOI 10.1159/000107516; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200; Zhang JH, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-03-j0004.2000; Zheng B, 1999, TRENDS BIOCHEM SCI, V24, P411, DOI 10.1016/S0968-0004(99)01474-7	71	4	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9133	9147		10.1074/jbc.M115.694075	http://dx.doi.org/10.1074/jbc.M115.694075			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26895961	Green Published, hybrid			2022-12-28	WOS:000374849000025
J	Leyme, A; Marivin, A; Garcia-Marcos, M				Leyme, Anthony; Marivin, Arthur; Garcia-Marcos, Mikel			GIV/Girdin (G alpha-interacting, Vesicle-associated Protein/Girdin) Creates a Positive Feedback Loop That Potentiates Outside-in Integrin Signaling in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; cell migration; heterotrimeric G protein; integrin; metastasis; FAK; GIV; Girdin; PI3K	FOCAL ADHESION KINASE; GROWTH-FACTOR RECEPTOR; G-BETA-GAMMA; G-PROTEINS; PHOSPHOINOSITIDE 3-KINASE; TYROSINE PHOSPHORYLATION; CLINICAL-SIGNIFICANCE; COUPLED RECEPTORS; ACTIVATION; GIV	Activation of the tyrosine kinase focal adhesion kinase (FAK) upon cell stimulation by the extracellular matrix initiates integrin outside-in signaling. FAK is directly recruited to active integrins, which enhances its kinase activity and triggers downstream signaling like activation of PI3K. We recently described that G-interacting, vesicle-associated protein (GIV), a protein up-regulated in metastatic cancers, is also required for outside-in integrin signaling. More specifically, we found that GIV is a non-receptor guanine nucleotide exchange factor that activates trimeric G proteins in response to integrin stimulation to enhance PI3K signaling and tumor cell migration. In contrast, previous reports have established that GIV is involved in phosphotyrosine (Tyr(P))-based signaling in response to growth factor stimulation; i.e. GIV phosphorylation at Tyr-1764 and Tyr-1798 recruits and activates PI3K. Here we show that phosphorylation of GIV at Tyr-1764/Tyr-1798 is also required to enhance PI3K-Akt signaling and tumor cell migration in response to integrin stimulation, indicating that GIV functions in Tyr(P)-dependent integrin signaling. Unexpectedly, we found that activation of FAK, an upstream component of the integrin Tyr(P) signaling cascade, was diminished in GIV-depleted cells, suggesting that GIV is required to establish a positive feedback loop that enhances integrin-FAK signaling. Mechanistically, we demonstrate that this feedback activation of FAK depends on both guanine nucleotide exchange factor and Tyr(P) GIV signaling as well as on their convergence point, PI3K. Taken together, our results provide novel mechanistic insights into how GIV promotes proinvasive cancer cell behavior by working as a signal-amplifying platform at the crossroads of trimeric G protein and Tyr(P) signaling.	[Leyme, Anthony; Marivin, Arthur; Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA	Boston University	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA.	mgm1@bu.edu			National Institutes of Health [GM108733, GM112631]; American Cancer Society [RSG-13-362-01-TBE, IRG-72-001-36]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112631, R01GM108733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM108733 and GM112631 and American Cancer Society Grants RSG-13-362-01-TBE and IRG-72-001-36. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aznar N, 2015, ELIFE, V4, DOI 10.7554/eLife.07091; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; CHEN HC, 1994, J BIOL CHEM, V269, P31229; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dunkel Y, 2012, J BIOL CHEM, V287, P41667, DOI 10.1074/jbc.M112.390781; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Garcia-Marcos M, 2015, J BIOL CHEM, V290, P6697, DOI 10.1074/jbc.R114.613414; Garcia-Marcos M, 2012, P NATL ACAD SCI USA, V109, P1961, DOI 10.1073/pnas.1120538109; Garcia-Marcos M, 2011, J BIOL CHEM, V286, P28138, DOI 10.1074/jbc.M110.204099; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2015, AGING-US, V7, P469, DOI 10.18632/aging.100781; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Higuchi M, 2013, J CELL SCI, V126, P745, DOI 10.1242/jcs.112722; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Leyme A, 2015, J CELL BIOL, V210, P1165, DOI 10.1083/jcb.201506041; Lin CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002049; Ling Y, 2011, CANCER INVEST, V29, P405, DOI 10.3109/07357907.2011.568568; Liu CG, 2012, MED ONCOL, V29, P1554, DOI 10.1007/s12032-011-0087-6; Lopez-Sanchez I, 2015, MOL BIOL CELL, V26, P4313, DOI 10.1091/mbc.E15-07-0496; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Omori K, 2015, BIOCHEM BIOPH RES CO, V458, P934, DOI 10.1016/j.bbrc.2015.02.065; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Rajala RVS, 2002, J BIOL CHEM, V277, P43319, DOI 10.1074/jbc.M206355200; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Shen B, 2015, MOL BIOL CELL, V26, P3658, DOI 10.1091/mbc.E15-05-0274; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Shibata T, 2013, ONCOL REP, V29, P2127, DOI 10.3892/or.2013.2406; Song JY, 2014, ONCOL LETT, V7, P337, DOI 10.3892/ol.2013.1745; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Vadas O, 2013, P NATL ACAD SCI USA, V110, P18862, DOI 10.1073/pnas.1304801110; Wang CH, 2014, MOL CLIN ONCOL, V2, P425, DOI 10.3892/mco.2014.265; Wang SY, 2011, AM J PHYSIOL-CELL PH, V300, pC657, DOI 10.1152/ajpcell.00377.2010; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Zhao LW, 2013, SCI WORLD J, DOI 10.1155/2013/986073	55	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8269	8282		10.1074/jbc.M115.691550	http://dx.doi.org/10.1074/jbc.M115.691550			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26887938	Green Published, hybrid			2022-12-28	WOS:000374056700042
J	Niu, YB; Zhang, LH; Yu, JJ; Wang, CC; Wang, L				Niu, Yingbo; Zhang, Lihui; Yu, Jiaojiao; Wang, Chih-chen; Wang, Lei			Novel Roles of the Non-catalytic Elements of Yeast Protein-disulfide Isomerase in Its Interplay with Endoplasmic Reticulum Oxidoreductin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						disulfide; endoplasmic reticulum (ER); protein-disulfide isomerase; protein-protein interaction; redox regulation; Ero1; oxidative protein folding; regulatory disulfide	BOND FORMATION; OXIDATIVE ACTIVITY; REDOX ENVIRONMENT; FOLDING CATALYST; ERO1-ALPHA; ERO1P; SUBSTRATE; INACTIVATION; SITE; CELL	The formation of disulfide bonds in the endoplasmic reticulum (ER) of eukaryotic cells is catalyzed by the sulfhydryl oxidase, ER oxidoreductin 1 (Ero1), and protein-disulfide isomerase (PDI). PDI is oxidized by Ero1 to continuously introduce disulfides into substrates, and feedback regulates Ero1 activity by manipulating the regulatory disulfides of Ero1. In this study we find that yeast Ero1p is enzymatically active even with its regulatory disulfides intact, and further activation of Ero1p by reduction of the regulatory disulfides requires the reduction of non-catalytic Cys(90)-Cys(97) disulfide in Pdi1p. The principal client-binding site in the Pdi1p b domain is necessary not only for the functional Ero1p-Pdi1p disulfide relay but also for the activation of Ero1p. We also demonstrate by complementary activation assays that the regulatory disulfides in Ero1p are much more stable than those in human Ero1. These new findings on yeast Ero1p-Pdi1p interplay reveal significant differences from our previously identified mode of human Ero1-PDI interplay and provide insights into the evolution of the eukaryotic oxidative protein folding pathway.	[Niu, Yingbo; Zhang, Lihui; Yu, Jiaojiao; Wang, Chih-chen; Wang, Lei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China; [Niu, Yingbo; Zhang, Lihui; Yu, Jiaojiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, CC; Wang, L (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	chihwang@sun5.ibp.ac.cn; wanglei@moon.ibp.ac.cn		Wang, Lei/0000-0002-5071-5800	Chinese Ministry of Science and Technology [2011CB910303, 2012CB911002]; National Natural Science Foundation of China [31370775, 31571163]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Ministry of Science and Technology Grants 2011CB910303 and 2012CB911002 (to C. C. W.) and National Natural Science Foundation of China Grants 31370775 and 31571163 (to L. W.). The authors declare that they have no conflict of interest with the contents of this article.	Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Delic M, 2010, FEMS MICROBIOL LETT, V306, P61, DOI 10.1111/j.1574-6968.2010.01935.x; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Frand AR, 2000, MOL BIOL CELL, V11, P2833, DOI 10.1091/mbc.11.9.2833; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Heldman N, 2010, PROTEIN SCI, V19, P1863, DOI 10.1002/pro.473; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Kim S, 2012, J CELL BIOL, V196, P713, DOI 10.1083/jcb.201110090; Kojer K, 2014, BBA-PROTEINS PROTEOM, V1844, P1383, DOI 10.1016/j.bbapap.2014.02.004; Luz JM, 1998, BIOCHEM BIOPH RES CO, V248, P621, DOI 10.1006/bbrc.1998.8992; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Mares RE, 2011, INT J MOL SCI, V12, P4625, DOI 10.3390/ijms12074625; Oka OBV, 2013, BBA-MOL CELL RES, V1833, P2425, DOI 10.1016/j.bbamcr.2013.02.007; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Ramming T, 2015, FREE RADICAL BIO MED, V83, P361, DOI 10.1016/j.freeradbiomed.2015.02.011; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sevier CS, 2006, MOL BIOL CELL, V17, P2256, DOI 10.1091/mbc.E05-05-0417; Shepherd C, 2014, BIOCHEM J, V461, P107, DOI 10.1042/BJ20140234; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; Wang L, 2015, FREE RADICAL BIO MED, V83, P305, DOI 10.1016/j.freeradbiomed.2015.02.007; Wang L, 2011, BIOCHEM J, V434, P113, DOI 10.1042/BJ20101357; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Wilkinson B, 2005, J BIOL CHEM, V280, P11483, DOI 10.1074/jbc.M414203200; Zhang LH, 2014, J BIOL CHEM, V289, P31188, DOI 10.1074/jbc.M114.602961	37	13	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8283	8294		10.1074/jbc.M115.694257	http://dx.doi.org/10.1074/jbc.M115.694257			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26846856	Green Published, hybrid			2022-12-28	WOS:000374056700043
J	van Meel, E; Lee, WS; Liu, L; Qian, Y; Doray, B; Kornfeld, S				van Meel, Eline; Lee, Wang-Sik; Liu, Lin; Qian, Yi; Doray, Balraj; Kornfeld, Stuart			Multiple Domains of GlcNAc-1-phosphotransferase Mediate Recognition of Lysosomal Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lysosomal glycoprotein; lysosomal storage disease; lysosome; mannose 6-phosphate (Man-6-P); phosphorylation	MANNOSE 6-PHOSPHATE RECEPTOR; SITE-DIRECTED MUTAGENESIS; UDP-N-ACETYLGLUCOSAMINE; CATHEPSIN-D; MRH DOMAIN; BETA-GLUCURONIDASE; ALPHA-SUBUNIT; PHOSPHORYLATION; OLIGOSACCHARIDES; GLYCOSYLATION	The Golgi enzyme UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase (GlcNAc-1-phosphotransferase), an (222) hexamer, mediates the initial step in the addition of the mannose 6-phosphate targeting signal on newly synthesized lysosomal enzymes. This tag serves to direct the lysosomal enzymes to lysosomes. A key property of GlcNAc-1-phosphotransferase is its unique ability to distinguish the 60 or so lysosomal enzymes from the numerous non-lysosomal glycoproteins with identical Asn-linked glycans. In this study, we demonstrate that the two Notch repeat modules and the DNA methyltransferase-associated protein interaction domain of the subunit are key components of this recognition process. Importantly, different combinations of these domains are involved in binding to individual lysosomal enzymes. This study also identifies the -binding site on the subunit and demonstrates that in the majority of instances the mannose 6-phosphate receptor homology domain of the subunit is required for optimal phosphorylation. These findings serve to explain how GlcNAc-1-phosphotransferase recognizes a large number of proteins that lack a common structural motif.	[van Meel, Eline; Lee, Wang-Sik; Liu, Lin; Qian, Yi; Doray, Balraj; Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, Campus Box 8125,660 South Euclid Ave, St Louis, MO 63110 USA; [van Meel, Eline] Leiden Univ, Leiden Inst Chem, Dept Med Biochem, POB 9502, NL-2300 RA Leiden, Netherlands; [Qian, Yi] Shanghai Tech Univ, Shanghai Inst Adv Immunochem Studies, Bldg 6,99 Haike Rd, Shanghai 201210, Peoples R China	Washington University (WUSTL); Leiden University; Leiden University - Excl LUMC; ShanghaiTech University	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Hematol, Campus Box 8125,660 South Euclid Ave, St Louis, MO 63110 USA.	skornfel@dom.wustl.edu		Doray, Balraj/0000-0003-3347-5013; Liu, Lin/0000-0003-4363-1411	National Institutes of Health [CA-008759]; Yash Gandhi Foundation; NATIONAL CANCER INSTITUTE [P30CA091842, R37CA008759, R01CA008759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yash Gandhi Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA-008759 and the Yash Gandhi Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Boldt HB, 2004, J BIOL CHEM, V279, P38525, DOI 10.1074/jbc.M405222200; Canduri F, 1998, BIOCHEM MOL BIOL INT, V45, P797, DOI 10.1080/15216549800203222; CANTOR AB, 1992, J BIOL CHEM, V267, P23357; Castonguay AC, 2011, BBA-GEN SUBJECTS, V1810, P815, DOI 10.1016/j.bbagen.2011.06.016; CUNNINGHAM M, 1976, J BIOL CHEM, V251, P4528; De Pace R, 2015, HUM MOL GENET, V24, P6826, DOI 10.1093/hmg/ddv387; DUSTIN ML, 1995, J BIOL CHEM, V270, P170, DOI 10.1074/jbc.270.1.170; GIESELMANN V, 1992, J BIOL CHEM, V267, P13262; GOLDBERG DE, 1981, J BIOL CHEM, V256, P3060; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Hancock MK, 2002, J BIOL CHEM, V277, P11255, DOI 10.1074/jbc.M109855200; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hu D, 2009, GLYCOBIOLOGY, V19, P1127, DOI 10.1093/glycob/cwp104; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Qian Y, 2015, J BIOL CHEM, V290, P3045, DOI 10.1074/jbc.M114.612507; Qian Y, 2013, P NATL ACAD SCI USA, V110, P10246, DOI 10.1073/pnas.1308453110; Qian Y, 2010, J BIOL CHEM, V285, P3360, DOI 10.1074/jbc.M109.068650; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; REITMAN ML, 1981, J BIOL CHEM, V256, P1977; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; SHIPLEY JM, 1993, J BIOL CHEM, V268, P12193; SONDERFELDFRESKO S, 1989, J BIOL CHEM, V264, P7692; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; TONG PY, 1989, J BIOL CHEM, V264, P7962; VALENZANO KJ, 1995, J BIOL CHEM, V270, P16441, DOI 10.1074/jbc.270.27.16441; VARKI A, 1980, J BIOL CHEM, V255, P8398; Warner JB, 2002, J BIOL CHEM, V277, P41897, DOI 10.1074/jbc.M203097200; WEITZ G, 1992, J BIOL CHEM, V267, P10039; Weyer K, 2007, J BIOL CHEM, V282, P10988, DOI 10.1074/jbc.M607903200	35	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8295	8307		10.1074/jbc.M116.714568	http://dx.doi.org/10.1074/jbc.M116.714568			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26833567	Green Published, hybrid			2022-12-28	WOS:000374056700044
J	Serra-Peinado, C; Sicart, A; Llopis, J; Egea, G				Serra-Peinado, Carla; Sicart, Adria; Llopis, Juan; Egea, Gustavo			Actin Filaments Are Involved in the Coupling of V-0-V-1 Domains of Vacuolar H+-ATPase at the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; YEAST VACUOLAR; V-ATPASE; SECRETORY PATHWAY; BINDING SITE; ORGANELLE ACIDIFICATION; EPITHELIAL-CELLS; MAMMALIAN-CELLS; ANION CHANNEL; PH REGULATION	We previously reported that actin-depolymerizing agents promote the alkalization of the Golgi stack and the trans-Golgi network. The main determinant of acidic pH at the Golgi is the vacuolar-type H+-translocating ATPase (V-ATPase), whose V-1 domain subunits B and C bind actin. We have generated a GFP-tagged subunit B2 construct (GFP-B2) that is incorporated into the V-1 domain, which in turn is coupled to the V-0 sector. GFP-B2 subunit is enriched at distal Golgi compartments in HeLa cells. Subcellular fractionation, immunoprecipitation, and inversal FRAP experiments show that the actin depolymerization promotes the dissociation of V-1-V-0 domains, which entails subunit B2 translocation from Golgi membranes to the cytosol. Moreover, molecular interaction between subunits B2 and C1 and actin were detected. In addition, Golgi membrane lipid order disruption by D-ceramide-C6 causes Golgi pH alkalization. We conclude that actin regulates the Golgi pH homeostasis maintaining the coupling of V-1-V-0 domains of V-ATPase through the binding of microfilaments to subunits B and C and preserving the integrity of detergent-resistant membrane organization. These results establish the Golgi-associated V-ATPase activity as the molecular link between actin and the Golgi pH.	[Serra-Peinado, Carla; Sicart, Adria; Egea, Gustavo] Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, C Casanova 143, E-08036 Barcelona, Spain; [Egea, Gustavo] Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain; [Egea, Gustavo] Inst Nanociencia & Nanotecnol IN2UB, E-08036 Barcelona, Spain; [Llopis, Juan] Univ Castilla La Mancha, Fac Med Albacete, E-0200 Albacete, Spain; [Llopis, Juan] Univ Castilla La Mancha, Ctr Reg Invest Biomed, E-0200 Albacete, Spain; [Sicart, Adria] VIB, Ctr Biol Dis, Campus Gasthuisberg, B-3000 Leuven, Belgium; [Sicart, Adria] Katholieke Univ Leuven, Dept Human Genet, Campus Gasthuisberg, B-3000 Leuven, Belgium	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	Egea, G (corresponding author), Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, C Casanova 143, E-08036 Barcelona, Spain.	gegea@ub.edu	Llopis, Juan/I-2622-2012; Egea, Gustavo/I-2394-2014	Llopis, Juan/0000-0002-9460-0642; Egea, Gustavo/0000-0001-5242-150X; Serra-Peinado, Carla/0000-0003-1413-3990	Ministerio de Economia y Competitividad del Gobierno de Espana [BFU2009-07186, 2012-33932]; Spanish Ministerio de Economia y Competitividad	Ministerio de Economia y Competitividad del Gobierno de Espana(Spanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported in part by Grants BFU2009-07186 and 2012-33932 from Ministerio de Economia y Competitividad del Gobierno de Espana (to G. E.). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a predoctoral fellowship from the Spanish Ministerio de Economia y Competitividad.	BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CHANSON A, 1985, PLANT PHYSIOL, V78, P232, DOI 10.1104/pp.78.2.232; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Drory O, 2006, PHYSIOLOGY, V21, P317, DOI 10.1152/physiol.00017.2006; Duran JM, 2012, EMBO J, V31, P4535, DOI 10.1038/emboj.2012.317; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Egea G, 2013, HISTOCHEM CELL BIOL, V140, P347, DOI 10.1007/s00418-013-1115-8; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; GLICKMAN J, 1983, J CELL BIOL, V97, P1303, DOI 10.1083/jcb.97.4.1303; Gutierrez-Martinez E, 2013, J CELL SCI, V126, P2641, DOI 10.1242/jcs.117705; Holliday LS, 2005, J BIOENERG BIOMEMBR, V37, P419, DOI 10.1007/s10863-005-9483-y; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Huang CJ, 2011, J BIOL CHEM, V286, P10058, DOI 10.1074/jbc.M110.197889; HURLEY D, 1989, PLANT PHYSIOL, V89, P391, DOI 10.1104/pp.89.2.391; Inoue T, 2005, J BIOENERG BIOMEMBR, V37, P393, DOI 10.1007/s10863-005-9478-8; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Lazaro-Dieguez F, 2007, FEBS LETT, V581, P3875, DOI 10.1016/j.febslet.2007.07.015; Lazaro-Dieguez F, 2006, CELL MOTIL CYTOSKEL, V63, P778, DOI 10.1002/cm.20161; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Maeda Y, 2010, METHOD ENZYMOL, V480, P495, DOI 10.1016/S0076-6879(10)80022-9; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; MORIYAMA Y, 1989, J BIOL CHEM, V264, P18445; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nakamura S, 2004, AM J PHYSIOL-CELL PH, V287, pC97, DOI 10.1152/ajpcell.00469.2003; Ono M, 2003, GLYCOCONJUGATE J, V20, P71, DOI 10.1023/B:GLYC.0000018019.22070.7d; PALOKANGAS H, 1994, J BIOL CHEM, V269, P17577; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Perez-Sayans M, 2012, BRAZ J BIOL, V72, P189, DOI 10.1590/S1519-69842012000100023; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rivinoja A, 2012, ANN MED, V44, P542, DOI 10.3109/07853890.2011.579150; Rubenstein EM, 2010, EMBO J, V29, P2473, DOI 10.1038/emboj.2010.161; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; Thompson RJ, 2002, BIOPHYS J, V83, P278, DOI 10.1016/S0006-3495(02)75168-0; Valderrama F, 2001, TRAFFIC, V2, P717, DOI 10.1034/j.1600-0854.2001.21006.x; Valderrama F, 2000, P NATL ACAD SCI USA, V97, P1560, DOI 10.1073/pnas.97.4.1560; van Galen J, 2014, J CELL BIOL, V206, P609, DOI 10.1083/jcb.201405009; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; Vitavska O, 2005, J BIOL CHEM, V280, P1070, DOI 10.1074/jbc.M406797200; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014; Weisz OA, 2003, TRAFFIC, V4, P57, DOI 10.1034/j.1600-0854.2003.40201.x; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Xifro X, 2008, J NEUROCHEM, V105, P1596, DOI 10.1111/j.1471-4159.2008.05252.x; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200; YILLA M, 1993, J BIOL CHEM, V268, P19092; YOUNG GPH, 1988, P NATL ACAD SCI USA, V85, P9590, DOI 10.1073/pnas.85.24.9590; ZHANG F, 1983, BIOCHEM BIOPH RES CO, V114, P620, DOI 10.1016/0006-291X(83)90825-2; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zuo J, 2008, J EXP BIOL, V211, P1102, DOI 10.1242/jeb.013672	66	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7286	7299		10.1074/jbc.M115.675272	http://dx.doi.org/10.1074/jbc.M115.675272			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26872971	Green Published, hybrid			2022-12-28	WOS:000383447600007
J	Zhang, SN; Fitzpatrick, PF				Zhang, Shengnan; Fitzpatrick, Paul F.			Identification of the Allosteric Site for Phenylalanine in Rat Phenylalanine Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-HYDROXYLASE; REGULATORY DOMAIN; SUBSTRATE-BINDING; ACTIVATION; PROTEIN; SYSTEM	Liver phenylalanine hydroxylase (PheH) is an allosteric enzyme that requires activation by phenylalanine for full activity. The location of the allosteric site for phenylalanine has not been established. NMR spectroscopy of the isolated regulatory domain (RDPheH(25-117) is the regulatory domain of PheH lacking residues 1-24) of the rat enzyme in the presence of phenylalanine is consistent with formation of a side-by-side ACT dimer. Six residues in RDPheH(25-117) were identified as being in the phenylalanine-binding site on the basis of intermolecular NOEs between unlabeled phenylalanine and isotopically labeled protein. The location of these residues is consistent with two allosteric sites per dimer, with each site containing residues from both monomers. Site-specific variants of five of the residues (E44Q, A47G, L48V, L62V, and H64N) decreased the affinity of RDPheH(25-117) for phenylalanine based on the ability to stabilize the dimer. Incorporation of the A47G, L48V, and H64N mutations into the intact protein increased the concentration of phenylalanine required for activation. The results identify the location of the allosteric site as the interface of the regulatory domain dimer formed in activated PheH.	[Zhang, Shengnan; Fitzpatrick, Paul F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Fitzpatrick, PF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	fitzpatrickp@uthscsa.edu			Office of the Vice President for Research at University of Texas Health Science Center at San Antonio; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047291, R01GM098140] Funding Source: NIH RePORTER	Office of the Vice President for Research at University of Texas Health Science Center at San Antonio; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Andrew P. Hinck and Dmitri Ivanov for helpful suggestions during the course of this work. The assistance of Virgil Schirf with the analytical ultracentrifugation and Dr. Kristin Cano-McCue with the NMR spectroscopy is gratefully acknowledged. Support for the Center for Macromolecular Interactions and the Center for NMR Spectroscopy from the Office of the Vice President for Research at University of Texas Health Science Center at San Antonio is gratefully acknowledged.	BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Carluccio C, 2016, J BIOMOL STRUCT DYN, V34, P497, DOI 10.1080/07391102.2015.1052016; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doskeland AP, 1996, BIOCHEM J, V313, P409, DOI 10.1042/bj3130409; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; EISENSMITH RC, 1991, MOL BIOL MED, V8, P3; Fitzpatrick PF, 2012, ARCH BIOCHEM BIOPHYS, V519, P194, DOI 10.1016/j.abb.2011.09.012; Fitzpatrick PF, 2003, BIOCHEMISTRY-US, V42, P14083, DOI 10.1021/bi035656u; Flydal MI, 2013, IUBMB LIFE, V65, P341, DOI 10.1002/iub.1150; Flydal MI, 2010, AMINO ACIDS, V39, P1463, DOI 10.1007/s00726-010-0611-6; Gabrielson JP, 2007, ANAL BIOCHEM, V361, P24, DOI 10.1016/j.ab.2006.11.012; Gjetting T, 2001, AM J HUM GENET, V68, P1353, DOI 10.1086/320604; Goodwill KE, 1997, NAT STRUCT BIOL, V4, P578, DOI 10.1038/nsb0797-578; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Jaffe EK, 2013, ARCH BIOCHEM BIOPHYS, V530, P73, DOI 10.1016/j.abb.2012.12.017; Jennings IG, 2001, FEBS LETT, V488, P196, DOI 10.1016/S0014-5793(00)02426-1; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Li J, 2011, ARCH BIOCHEM BIOPHYS, V505, P250, DOI 10.1016/j.abb.2010.10.009; Li J, 2010, BIOCHEMISTRY-US, V49, P3327, DOI 10.1021/bi1001294; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS RS, 1984, BIOCHEMISTRY-US, V23, P3836, DOI 10.1021/bi00312a007; Roberts KM, 2014, BIOCHEMISTRY-US, V53, P7846, DOI 10.1021/bi501183x; Ronau JA, 2013, EUR BIOPHYS J BIOPHY, V42, P691, DOI 10.1007/s00249-013-0919-8; SCHULLER DJ, 1995, NAT STRUCT BIOL, V2, P69, DOI 10.1038/nsb0195-69; SHIMAN R, 1979, J BIOL CHEM, V254, P1300; SHIMAN R, 1994, J BIOL CHEM, V269, P24647; Tan KM, 2008, J STRUCT BIOL, V162, P94, DOI 10.1016/j.jsb.2007.11.009; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Wang L, 2002, BIOCHEMISTRY-US, V41, P12569, DOI 10.1021/bi026561f; Zhang SN, 2015, BIOCHEMISTRY-US, V54, P5167, DOI 10.1021/acs.biochem.5b00616; Zhang SN, 2014, BIOCHEMISTRY-US, V53, P6625, DOI 10.1021/bi501109s; Zhang SN, 2014, J MOL BIOL, V426, P1483, DOI 10.1016/j.jmb.2013.12.015	36	19	20	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7418	7425		10.1074/jbc.M115.709998	http://dx.doi.org/10.1074/jbc.M115.709998			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26823465	hybrid, Green Published			2022-12-28	WOS:000383447600018
J	Drees, SL; Li, C; Prasetya, F; Saleem, M; Dreveny, I; Williams, P; Hennecke, U; Emsley, J; Fetzner, S				Drees, Steffen Lorenz; Li, Chan; Prasetya, Fajar; Saleem, Muhammad; Dreveny, Ingrid; Williams, Paul; Hennecke, Ulrich; Emsley, Jonas; Fetzner, Susanne			PqsBC, a Condensing Enzyme in the Biosynthesis of the Pseudomonas aeruginosa Quinolone Signal: CRYSTAL STRUCTURE, INHIBITION, AND REACTION MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; crystal structure; Pseudomonas aeruginosa (P; aeruginosa); quorum sensing; secondary metabolism; 2-alkyl-4(1H)-quinolones; FabH; Pseudomonas quinolone signal; condensing enzyme	PROTEIN SYNTHASE-III; CATALYTIC CYSTEINE; CHALCONE SYNTHASE; MOLECULES; 2,4-DIHYDROXYQUINOLINE; IDENTIFICATION; COMMUNICATION; ANTHRANILATE; COEFFICIENTS; ABSORPTION	Pseudomonas aeruginosa produces a number of alkylquinolone-type secondary metabolites best known for their antimicrobial effects and involvement in cell-cell communication. In the alkylquinolone biosynthetic pathway, the -ketoacyl-(acyl carrier protein) synthase III (FabH)-like enzyme PqsBC catalyzes the condensation of octanoyl-coenzyme A and 2-aminobenzoylacetate (2-ABA) to form the signal molecule 2-heptyl-4(1H)-quinolone. PqsBC, a potential drug target, is unique for its heterodimeric arrangement and an active site different from that of canonical FabH-like enzymes. Considering the sequence dissimilarity between the subunits, a key question was how the two subunits are organized with respect to the active site. In this study, the PqsBC structure was determined to a 2 angstrom resolution, revealing that PqsB and PqsC have a pseudo-2-fold symmetry that unexpectedly mimics the FabH homodimer. PqsC has an active site composed of Cys-129 and His-269, and the surrounding active site cleft is hydrophobic in character and approximately twice the volume of related FabH enzymes that may be a requirement to accommodate the aromatic substrate 2-ABA. From physiological and kinetic studies, we identified 2-aminoacetophenone as a pathway-inherent competitive inhibitor of PqsBC, whose fluorescence properties could be used for in vitro binding studies. In a time-resolved setup, we demonstrated that the catalytic histidine is not involved in acyl-enzyme formation, but contributes to an acylation-dependent increase in affinity for the second substrate 2-ABA. Introduction of Asn into the PqsC active site led to significant activity toward the desamino substrate analog benzoylacetate, suggesting that the substrate 2-ABA itself supplies the asparagine-equivalent amino function that assists in catalysis.	[Fetzner, Susanne] Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany; [Hennecke, Ulrich] Univ Munster, Inst Organ Chem, D-48149 Munster, Germany; [Li, Chan; Prasetya, Fajar; Saleem, Muhammad; Dreveny, Ingrid; Emsley, Jonas] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England; [Williams, Paul] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England	University of Munster; University of Munster; University of Nottingham; University of Nottingham	Fetzner, S (corresponding author), Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany.; Emsley, J (corresponding author), Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England.	jonas.emsley@nottingham.ac.uk; fetzner@uni-muenster.de	Dreveny, Ingrid/E-8939-2017; emsley, jonas/A-8509-2016; Williams, Paul/P-5224-2019; Drees, Steffen Lorenz/Q-3510-2019; Hennecke, Ulrich/A-7723-2010; Saleem, Muhammad/W-4014-2017	Dreveny, Ingrid/0000-0003-2256-642X; emsley, jonas/0000-0002-8949-8030; Williams, Paul/0000-0002-1920-5036; Drees, Steffen Lorenz/0000-0001-9140-0111; Hennecke, Ulrich/0000-0002-4904-6793; Saleem, Muhammad/0000-0002-0994-9701; Prasetya, Fajar/0000-0002-1020-0423; Fetzner, Susanne/0000-0002-7228-1871	Deutsche Forschungsgemeinschaft [FE 383/23-1]; Directorate General of Indonesia Higher Education	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Directorate General of Indonesia Higher Education	This work was supported by Deutsche Forschungsgemeinschaft Grant FE 383/23-1 (to S. F.) and by a Ph.D. studentship (to F. P.) from the Directorate General of Indonesia Higher Education. The authors declare that they have no conflicts of interest with the contents of this article.	Bandyopadhaya A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003024; Bera AK, 2009, BIOCHEMISTRY-US, V48, P8644, DOI 10.1021/bi9009055; BIRDSALL B, 1983, ANAL BIOCHEM, V132, P353, DOI 10.1016/0003-2697(83)90020-9; Bredenbruch F, 2006, ENVIRON MICROBIOL, V8, P1318, DOI 10.1111/j.1462-2920.2006.01025.x; Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; COX CD, 1979, J CLIN MICROBIOL, V9, P479; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Drees SL, 2015, CHEM BIOL, V22, P611, DOI 10.1016/j.chembiol.2015.04.012; Dulcey CE, 2013, CHEM BIOL, V20, P1481, DOI 10.1016/j.chembiol.2013.09.021; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hansch GM, 2014, J APPL BIOMATER FUNC, V12, P21, DOI 10.5301/jabfm.5000204; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Hooi DSW, 2004, INFECT IMMUN, V72, P6463, DOI 10.1128/IAI.72.11.6463-6470.2004; Huse H, 2011, CHEM REV, V111, P152, DOI 10.1021/cr100063u; Ilangovan A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003508; Jez JM, 2000, J BIOL CHEM, V275, P39640, DOI 10.1074/jbc.M008569200; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kesarwani M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002192; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lepine F, 2007, BIOL CHEM, V388, P839, DOI 10.1515/BC.2007.100; Lu CB, 2014, ANGEW CHEM INT EDIT, V53, P1109, DOI 10.1002/anie.201307547; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Needham ER, 1904, J CHEM SOC, V85, P148, DOI 10.1039/ct9048500148; Niewerth H, 2011, APPL MICROBIOL BIOT, V91, P1399, DOI 10.1007/s00253-011-3378-0; Pan H, 2002, STRUCTURE, V10, P1559, DOI 10.1016/S0969-2126(02)00889-4; Qiu XY, 2001, J MOL BIOL, V307, P341, DOI 10.1006/jmbi.2000.4457; Que YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080140; Rampioni G, 2014, BIOORG CHEM, V55, P60, DOI 10.1016/j.bioorg.2014.04.005; Sachdeva S, 2008, CHEM BIOL, V15, P402, DOI 10.1016/j.chembiol.2008.03.007; Schertzer JW, 2010, MOL MICROBIOL, V77, P1527, DOI 10.1111/j.1365-2958.2010.07303.x; SCHOPF C, 1956, CHEM BER-RECL, V89, P2877, DOI 10.1002/cber.19560891233; Shimada H, 2005, PHOTOCH PHOTOBIO SCI, V4, P367, DOI 10.1039/b416284f; SICKER D, 1988, COLLECT CZECH CHEM C, V53, P839, DOI 10.1135/cccc19880839; Skindersoe ME, 2009, FEMS IMMUNOL MED MIC, V55, P335, DOI 10.1111/j.1574-695X.2008.00533.x; Starkey M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004321; Steinbach A, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-10; Storz MP, 2012, J AM CHEM SOC, V134, P16143, DOI 10.1021/ja3072397; Suh DY, 2000, BIOCHEM BIOPH RES CO, V275, P725, DOI 10.1006/bbrc.2000.3368; Tzika AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074528; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X; Zhang YM, 2008, J BIOL CHEM, V283, P28788, DOI 10.1074/jbc.M804555200; Zhang ZM, 2011, BIOINFORMATICS, V27, P2083, DOI 10.1093/bioinformatics/btr331	56	46	48	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6610	6624		10.1074/jbc.M115.708453	http://dx.doi.org/10.1074/jbc.M115.708453			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26811339	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000373299700001
J	Vershinin, Z; Feldman, M; Chen, A; Levy, D				Vershinin, Zlata; Feldman, Michal; Chen, Ayelet; Levy, Dan			PAK4 Methylation by SETD6 Promotes the Activation of the Wnt/-Catenin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-catenin (-catenin); chromatin; gene transcription; post-translational modification (PTM); S-adenosylmethionine (SAM); Wnt pathway; Wnt signaling; PAK4; SETD6; methylation	LYSINE METHYLATION; HISTONE METHYLATION; STEM-CELLS; CHROMATIN; IDENTIFICATION; MAINTENANCE; MECHANISMS; ENRICHMENT; PROTEINS	Lysine methylation of non-histone proteins has emerged as a key regulator of many cellular functions. Although less studied than other post-translational modifications such as phosphorylation and acetylation, the number of known methylated non-histone proteins is rapidly expanding. We have identified the p21-activated kinase 4 (PAK4) as a new substrate for methylation by the protein lysine methyltransferase SETD6. Our data demonstrate that SETD6 methylates PAK4 both in vitro and at chromatin in cells. Interestingly, depletion of SETD6 in various cellular systems significantly hinders the activation of the Wnt/-catenin target genes. PAK4 was recently shown to regulate -catenin signaling, and we show that SETD6 is a key mediator of this pathway. In the presence of SETD6, the physical interaction between PAK4 and -catenin is dramatically increased, leading to a significant increase in the transcription of -catenin target genes. Taken together, our results uncover a new regulatory layer of the Wnt/-catenin signaling cascade and provide new insight into SETD6 biology.	[Vershinin, Zlata; Feldman, Michal; Chen, Ayelet; Levy, Dan] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel; [Vershinin, Zlata; Feldman, Michal; Chen, Ayelet; Levy, Dan] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Levy, D (corresponding author), Ben Gurion Univ Negev, Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel.	ledan@post.bgu.ac.il	Levy, Dan/A-3226-2013	Levy, Dan/0000-0003-0719-0305; Vershinin, Zlata/0000-0002-0060-693X	Israel Science Foundation [285/14]; Research Career Development Award from the Israel Cancer Research Fund; Marie Curie Career Integration Grant [PCIG12-GA-2012-333242]	Israel Science Foundation(Israel Science Foundation); Research Career Development Award from the Israel Cancer Research Fund; Marie Curie Career Integration Grant	This work was supported by grants (to D. L.) from The Israel Science Foundation (285/14), The Research Career Development Award from the Israel Cancer Research Fund, and a Marie Curie Career Integration Grant (PCIG12-GA-2012-333242). The authors declare that they have no conflicts of interest with the contents of this article.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Alam H, 2015, CELL MOL LIFE SCI, V72, P4577, DOI 10.1007/s00018-015-2023-y; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baskaran Y, 2012, EMBO REP, V13, P653, DOI 10.1038/embor.2012.75; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Binda O, 2013, EPIGENETICS-US, V8, P177, DOI 10.4161/epi.23416; Bremang M, 2013, MOL BIOSYST, V9, P2231, DOI 10.1039/c3mb00009e; Carlson SM, 2014, NAT PROTOC, V9, P37, DOI 10.1038/nprot.2013.164; Chang YQ, 2011, NUCLEIC ACIDS RES, V39, P6380, DOI 10.1093/nar/gkr256; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Ha BH, 2012, P NATL ACAD SCI USA, V109, P16107, DOI 10.1073/pnas.1214447109; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Herbst A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-74; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Levy D, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-19; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Li Y, 2012, BBA-MOL CELL RES, V1823, P465, DOI 10.1016/j.bbamcr.2011.11.013; Lien WH, 2014, GENE DEV, V28, P1517, DOI 10.1101/gad.244772.114; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Moore KE, 2013, MOL CELL, V50, P444, DOI 10.1016/j.molcel.2013.03.005; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; O'Neill DJ, 2014, EPIGENETICS-US, V9, P942, DOI 10.4161/epi.28864; Park MH, 2013, ONCOGENE, V32, P2475, DOI 10.1038/onc.2012.255; Pawson T, 2007, ONCOGENE, V26, P1268, DOI 10.1038/sj.onc.1210255; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Selamat W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129634; Shen CC, 2015, FASEB J, V29, P4313, DOI 10.1096/fj.15-273540; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Whale A, 2011, FRONT BIOSCI-LANDMRK, V16, P849, DOI 10.2741/3724; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Zhang X, 2013, P NATL ACAD SCI USA, V110, P17284, DOI 10.1073/pnas.1307959110	39	46	51	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6786	6795		10.1074/jbc.M115.697292	http://dx.doi.org/10.1074/jbc.M115.697292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26841865	Green Published, hybrid			2022-12-28	WOS:000373299700019
J	Gillmaier, N; Schunder, E; Kutzner, E; Tlapak, H; Rydzewski, K; Herrmann, V; Stammler, M; Lasch, P; Eisenreich, W; Heuner, K				Gillmaier, Nadine; Schunder, Eva; Kutzner, Erika; Tlapak, Hana; Rydzewski, Kerstin; Herrmann, Vroni; Staemmler, Maren; Lasch, Peter; Eisenreich, Wolfgang; Heuner, Klaus			Growth-related Metabolism of the Carbon Storage Poly-3-hydroxybutyrate in Legionella pneumophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; isotopic tracer; lipid metabolism; metabolism; pathogenesis; Legionella; polyhydroxybutyrate	AMINO-ACID-REQUIREMENTS; BACTERIAL POLYHYDROXYALKANOATES; INTRACELLULAR GROWTH; LIQUID-MEDIUM; VIRULENCE; REPLICATION; EXPRESSION; DIFFERENTIATION; BIOSYNTHESIS; MACROPHAGES	Legionella pneumophila, the causative agent of Legionnaires disease, has a biphasic life cycle with a switch from a replicative to a transmissive phenotype. During the replicative phase, the bacteria grow within host cells in Legionella-containing vacuoles. During the transmissive phenotype and the postexponential (PE) growth phase, the pathogens express virulence factors, become flagellated, and leave the Legionella-containing vacuoles. Using C-13 labeling experiments, we now show that, under in vitro conditions, serine is mainly metabolized during the replicative phase for the biosynthesis of some amino acids and for energy generation. During the PE phase, these carbon fluxes are reduced, and glucose also serves as an additional carbon substrate to feed the biosynthesis of poly-3-hydroxybuyrate (PHB), an essential carbon source for transmissive L. pneumophila. Whole-cell FTIR analysis and comparative isotopologue profiling further reveal that a putative 3-ketothiolase (Lpp1788) and a PHB polymerase (Lpp0650), but not enzymes of the crotonyl-CoA pathway (Lpp0931-0933) are involved in PHB metabolism during the PE phase. However, the data also reflect that additional bypassing reactions for PHB synthesis exist in agreement with in vivo competition assays using Acanthamoeba castellannii or human macrophage-like U937 cells as host cells. The data suggest that substrate usage and PHB metabolism are coordinated during the life cycle of the pathogen.	[Gillmaier, Nadine; Kutzner, Erika; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, Lichtenbergstr 4, D-85747 Garching, Germany; [Schunder, Eva; Tlapak, Hana; Rydzewski, Kerstin; Herrmann, Vroni; Heuner, Klaus] Robert Koch Inst, Working Grp Cellular Interact Bacterial Pathogens, ZBS 2,Seestr 10, D-13353 Berlin, Germany; [Staemmler, Maren; Lasch, Peter] Robert Koch Inst, Prote & Spect ZBS 6, Nordufer 20, D-13353 Berlin, Germany	Technical University of Munich; Robert Koch Institute; Robert Koch Institute	Eisenreich, W (corresponding author), Tech Univ Munich, Lehrstuhl Biochem, Lichtenbergstr 4, D-85747 Garching, Germany.; Heuner, K (corresponding author), Robert Koch Inst, Working Grp Cellular Interact Bacterial Pathogens, ZBS 2,Seestr 10, D-13353 Berlin, Germany.	wolfgang.eisenreich@ch.tum.de; heunerk@rki.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279; Lasch, Peter/0000-0001-6193-3144	Deutsche Forschungsgemeinschaft DFG, Bonn, Germany [EI 384/4-2, HE 2845/6-1, SPP 1316]; Robert Koch Institute, Berlin, Germany	Deutsche Forschungsgemeinschaft DFG, Bonn, Germany(German Research Foundation (DFG)); Robert Koch Institute, Berlin, Germany	This work was supported by Grants EI 384/4-2 and HE 2845/6-1 from the Deutsche Forschungsgemeinschaft DFG SPP 1316, Bonn, Germany (to W. E. and K. H., respectively) and the Robert Koch Institute, Berlin, Germany. The authors declare that they have no conflicts of interest with the contents of this article.	ANDERSON AJ, 1990, INT J BIOL MACROMOL, V12, P102, DOI 10.1016/0141-8130(90)90060-N; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Aurass P, 2009, APPL ENVIRON MICROB, V75, P4506, DOI 10.1128/AEM.00187-09; Ayub ND, 2006, FEMS MICROBIOL LETT, V264, P125, DOI 10.1111/j.1574-6968.2006.00446.x; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; Brzuszkiewicz E, 2013, INT J MED MICROBIOL, V303, P514, DOI 10.1016/j.ijmm.2013.07.003; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Edwards RL, 2009, MOL MICROBIOL, V71, P1190, DOI [10.1111/j.1365-2958.2009.06593.x, 10.1111/j.1365-2958.2008.06593.x]; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; Fonseca MV, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00012; Fonseca Maris V., 2008, P213; Garduno RA, 2002, INFECT IMMUN, V70, P6273, DOI 10.1128/IAI.70.11.6273-6283.2002; GEORGE JR, 1980, J CLIN MICROBIOL, V11, P286, DOI 10.1128/JCM.11.3.286-291.1980; Harada E, 2010, J BACTERIOL, V192, P2892, DOI 10.1128/JB.01535-09; Hayashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011718; Herrmann V, 2011, INT J MED MICROBIOL, V301, P133, DOI 10.1016/j.ijmm.2010.08.016; HEUNER K, 1995, INFECT IMMUN, V63, P2499, DOI 10.1128/IAI.63.7.2499-2507.1995; Heuner K, 1999, FEMS MICROBIOL LETT, V175, P69, DOI 10.1016/S0378-1097(99)00160-3; Heuner K., 2016, HOST PATHOGEN INTERA; Hoffman PS, 2008, INFEC AGENT, P113; James BW, 1999, APPL ENVIRON MICROB, V65, P822; Kadouri D, 2005, CRIT REV MICROBIOL, V31, P55, DOI 10.1080/10408410590899228; KEEN MG, 1984, CURR MICROBIOL, V11, P81, DOI 10.1007/BF01567708; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lautner M, 2013, J BACTERIOL, V195, P1583, DOI 10.1128/JB.01739-12; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; MAUCHLINE WS, 1992, J GEN MICROBIOL, V138, P2371, DOI 10.1099/00221287-138-11-2371; Molmeret M, 2010, ENVIRON MICROBIOL, V12, P704, DOI 10.1111/j.1462-2920.2009.02114.x; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Naumann D., 2008, P SPIE, V6853; O'Shaughnessy JB, 2003, BIOTECHNIQUES, V35, P112; OLDHAM LJ, 1985, J GEN MICROBIOL, V131, P697; PINE L, 1979, J CLIN MICROBIOL, V9, P615; Poirier Y, 2002, PROG LIPID RES, V41, P131, DOI 10.1016/S0163-7827(01)00018-2; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; REEVES MW, 1981, J CLIN MICROBIOL, V13, P688, DOI 10.1128/JCM.13.4.688-695.1981; Reich-Slotky R, 2009, J BACTERIOL, V191, P5262, DOI 10.1128/JB.00175-09; RISTROPH JD, 1981, J CLIN MICROBIOL, V13, P115, DOI 10.1128/JCM.13.1.115-119.1981; RISTROPH JD, 1980, J CLIN MICROBIOL, V11, P19, DOI 10.1128/JCM.11.1.19-21.1980; Robertson P, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00670; ROWBOTHAM TJ, 1986, ISRAEL J MED SCI, V22, P678; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sauer JD, 2005, P NATL ACAD SCI USA, V102, P9924, DOI 10.1073/pnas.0502767102; Schulz T, 2012, ARCH MICROBIOL, V194, P977, DOI 10.1007/s00203-012-0833-y; Schunder E, 2014, J BIOL CHEM, V289, P21040, DOI 10.1074/jbc.M114.570085; Stone BJ, 1999, J BACTERIOL, V181, P1395, DOI 10.1128/JB.181.5.1395-1402.1999; TESH MJ, 1981, J CLIN MICROBIOL, V13, P865, DOI 10.1128/JCM.13.5.865-869.1981; TESH MJ, 1983, J BACTERIOL, V154, P1104, DOI 10.1128/JB.154.3.1104-1109.1983; Thi NAN, 2007, ANAL BIOANAL CHEM, V387, P1769, DOI 10.1007/s00216-006-0829-z; Wieland H, 2005, MOL MICROBIOL, V55, P1528, DOI 10.1111/j.1365-2958.2005.04490.x	52	23	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6471	6482		10.1074/jbc.M115.693481	http://dx.doi.org/10.1074/jbc.M115.693481			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26792862	Green Published, hybrid			2022-12-28	WOS:000372894200034
J	Clement, CC; Becerra, A; Yin, LS; Zolla, V; Huang, LL; Merlin, S; Follenzi, A; Shaffer, SA; Stern, LJ; Santambrogio, L				Clement, Cristina C.; Becerra, Aniuska; Yin, Liusong; Zolla, Valerio; Huang, Liling; Merlin, Simone; Follenzi, Antonia; Shaffer, Scott A.; Stern, Lawrence J.; Santambrogio, Laura			The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen presentation; antigen processing; dendritic cell; major histocompatibility complex (MHC); tolerance; lymph; proteomics; immunological tolerance	ANTIGEN-PRESENTING CELLS; RESTRICTED T-CELLS; COLLAGEN-INDUCED ARTHRITIS; ACQUIRED THYMIC TOLERANCE; TANDEM MASS-SPECTROMETRY; HUMAN PLASMA PROTEOME; IN-VIVO; SELF-ANTIGEN; INTRATHYMIC INOCULATION; SOLUBLE ALLOANTIGENS	The repertoire of peptides displayed in vivo by MHC II molecules derives from a wide spectrum of proteins produced by different cell types. Although intracellular endosomal processing in dendritic cells and B cells has been characterized for a few antigens, the overall range of processing pathways responsible for generating the MHC II peptidome are currently unclear. To determine the contribution of non-endosomal processing pathways, we eluted and sequenced over 3000 HLA-DR1-bound peptides presented in vivo by dendritic cells. The processing enzymes were identified by reference to a database of experimentally determined cleavage sites and experimentally validated for four epitopes derived from complement 3, collagen II, thymosin 4, and gelsolin. We determined that self-antigens processed by tissue-specific proteases, including complement, matrix metalloproteases, caspases, and granzymes, and carried by lymph, contribute significantly to the MHC II self-peptidome presented by conventional dendritic cells in vivo. Additionally, the presented peptides exhibited a wide spectrum of binding affinity and HLA-DM susceptibility. The results indicate that the HLA-DR1-restricted self-peptidome presented under physiological conditions derives from a variety of processing pathways. Non-endosomal processing enzymes add to the number of epitopes cleaved by cathepsins, altogether generating a wider peptide repertoire. Taken together with HLA-DM-dependent and-independent loading pathways, this ensures that a broad self-peptidome is presented by dendritic cells. This work brings attention to the role of self-recognition as a dynamic interaction between dendritic cells and the metabolic/catabolic activities ongoing in every parenchymal organ as part of tissue growth, remodeling, and physiological apoptosis.	[Clement, Cristina C.; Zolla, Valerio; Huang, Liling; Follenzi, Antonia; Santambrogio, Laura] Albert Einstein Coll Med, Dept Pathol, New York, NY 10461 USA; [Santambrogio, Laura] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10461 USA; [Becerra, Aniuska; Yin, Liusong; Stern, Lawrence J.] Univ Massachusetts, Dept Pathol, Sch Med, Worcester, MA 01655 USA; [Shaffer, Scott A.; Stern, Lawrence J.] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Sch Med, Worcester, MA 01655 USA; [Shaffer, Scott A.] Univ Massachusetts, Prote & Mass Spectrometry Facil, Sch Med, Worcester, MA 01655 USA; [Follenzi, Antonia] Univ Piemonte Orientale, Sch Med, I-28100 Novara, Italy	Yeshiva University; Yeshiva University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Eastern Piedmont Amedeo Avogadro	Santambrogio, L (corresponding author), Albert Einstein Coll Med, Dept Pathol, Forchheimer Bldg,Rm 140,1300 Morris Pk Ave, Bronx, NY 10461 USA.	laura.santambrogio@einstein.yu.edu	Clement, Cristina/ABG-4525-2021	Clement, Cristina/0000-0003-1464-407X; Follenzi, Antonia/0000-0001-9780-300X; Merlin, Simone/0000-0001-5209-3921	Laboratory for Macromolecular Analysis and Proteomic (under National Institutes of Health) [NIH-1S10RR019352]; Albert Einstein College of Medicine; Proteomics and Mass Spectrometry Facility, University of Massachusetts Medical School; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038996, R37AI038996, R56AI038996, R01AI048833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031782, R01AG045223] Funding Source: NIH RePORTER	Laboratory for Macromolecular Analysis and Proteomic (under National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; Proteomics and Mass Spectrometry Facility, University of Massachusetts Medical School; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge the support of the Laboratory for Macromolecular Analysis and Proteomic (under National Institutes of Health Grant NIH-1S10RR019352), Albert Einstein College of Medicine, and the Proteomics and Mass Spectrometry Facility, University of Massachusetts Medical School.	Adamopoulou E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3039; Ahn SM, 2007, PROTEOM CLIN APPL, V1, P1004, DOI 10.1002/prca.200700217; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Antwi K, 2009, J PROTEOME RES, V8, P4722, DOI 10.1021/pr900414f; Bogunovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010599; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Bozzacco L, 2011, J PROTEOME RES, V10, P5016, DOI 10.1021/pr200503g; Busch R, 1998, J IMMUNOL, V160, P734; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Chou CL, 2008, MOL IMMUNOL, V45, P1935, DOI 10.1016/j.molimm.2007.10.033; CHOWDHURY NC, 1995, J SURG RES, V59, P91, DOI 10.1006/jsre.1995.1137; CLARESALZLER MJ, 1992, J CLIN INVEST, V90, P741, DOI 10.1172/JCI115946; Clement CC, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00424; Clement CC, 2013, J PROTEOMICS, V78, P172, DOI 10.1016/j.jprot.2012.11.013; Clement CC, 2011, TRENDS IMMUNOL, V32, P6, DOI 10.1016/j.it.2010.10.004; Clement CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009863; Collado JA, 2013, EUR J IMMUNOL, V43, P2273, DOI 10.1002/eji.201243280; Costantino CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029805; DAVIS AE, 1984, J IMMUNOL, V132, P1960; DAVIS AE, 1982, BIOCHEMISTRY-US, V21, P5745, DOI 10.1021/bi00266a003; DAVIS AE, 1983, IMMUNOL TODAY, V4, P250, DOI 10.1016/0167-5699(83)90043-9; De Groot AS, 2015, IMMUNOL CELL BIOL, V93, P189, DOI 10.1038/icb.2014.89; DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708; DEBRUIJN MLH, 1991, EUR J IMMUNOL, V21, P2963, DOI 10.1002/eji.1830211210; Delgado JC, 2009, IMMUNOGENETICS, V61, P241, DOI 10.1007/s00251-009-0360-4; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Dongre AR, 2001, EUR J IMMUNOL, V31, P1485, DOI 10.1002/1521-4141(200105)31:5<1485::AID-IMMU1485>3.0.CO;2-A; Donskoy E, 2003, J IMMUNOL, V170, P3514, DOI 10.4049/jimmunol.170.7.3514; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Dzieciatkowska M, 2011, SHOCK, V35, P331, DOI 10.1097/SHK.0b013e318206f654; Espinosa G, 2013, J PROTEOMICS, V94, P23, DOI 10.1016/j.jprot.2013.08.023; Fang JF, 2010, SHOCK, V34, P291, DOI 10.1097/SHK.0b013e3181ceef5e; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; Fissolo N, 2009, MOL CELL PROTEOMICS, V8, P2090, DOI 10.1074/mcp.M900001-MCP200; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Geho DH, 2006, CURR OPIN CHEM BIOL, V10, P50, DOI 10.1016/j.cbpa.2006.01.008; Goldfinch GM, 2008, PROTEOMICS, V8, P1909, DOI 10.1002/pmic.200700531; Goldschneider I, 2003, TRENDS IMMUNOL, V24, P77, DOI 10.1016/S1471-4906(02)00038-8; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Haque MA, 2001, J IMMUNOL, V166, P4543, DOI 10.4049/jimmunol.166.7.4543; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; KHOURY SJ, 1995, J EXP MED, V182, P357, DOI 10.1084/jem.182.2.357; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Leak LV, 2004, PROTEOMICS, V4, P753, DOI 10.1002/pmic.200300573; Li YT, 2011, ONCOL REP, V25, P303, DOI 10.3892/or.2010.1111; Liblau RS, 1996, P NATL ACAD SCI USA, V93, P3031, DOI 10.1073/pnas.93.7.3031; Lindh I, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4605; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Ling Xuefeng B, 2010, Clin Proteomics, V6, P175; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Lovitch SB, 2003, J IMMUNOL, V170, P4155, DOI 10.4049/jimmunol.170.8.4155; Lovitch SB, 2007, J IMMUNOL, V178, P122, DOI 10.4049/jimmunol.178.1.122; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; Marrack P, 1987, Adv Exp Med Biol, V213, P1; Martin S, 1997, EUR J IMMUNOL, V27, P2726, DOI 10.1002/eji.1830271037; Masuno T, 2006, SHOCK, V26, P285, DOI 10.1097/01.shk.0000223132.72135.52; Meng Z, 2007, PROTEOM CLIN APPL, V1, P747, DOI 10.1002/prca.200700243; Mittal A, 2009, J PANCREAS, V10, P130; Morbt N, 2009, PROTEOMICS, V9, P4920, DOI 10.1002/pmic.200800836; Muixi L, 2012, INT IMMUNOL, V24, P59, DOI 10.1093/intimm/dxr096; Muntasesll A, 2002, J IMMUNOL, V169, P5052, DOI 10.4049/jimmunol.169.9.5052; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NYGARD NR, 1994, J IMMUNOL, V152, P1082; Odaka C, 2006, CELL TISSUE RES, V325, P13, DOI 10.1007/s00441-005-0139-3; OLUWOLE SF, 1995, CELL IMMUNOL, V162, P33, DOI 10.1006/cimm.1995.1048; OLUWOLE SF, 1995, TRANSPLANT P, V27, P132; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Pang BX, 2009, J IMMUNOL, V183, P1083, DOI 10.4049/jimmunol.0900861; Peltz ED, 2009, SURGERY, V146, P347, DOI 10.1016/j.surg.2009.02.022; Pieper R, 2004, PROTEOMICS, V4, P1159, DOI 10.1002/pmic.200300661; PLOEGH HL, 1992, COLD SPRING HARB SYM, V57, P565, DOI 10.1101/SQB.1992.057.01.062; Pu Z, 2004, IMMUNITY, V20, P467, DOI 10.1016/S1074-7613(04)00073-1; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Ressom HW, 2005, BIOINFORMATICS, V21, P4039, DOI 10.1093/bioinformatics/bti670; Rohn TA, 2004, NAT IMMUNOL, V5, P909, DOI 10.1038/ni1108; Rosloniec EF, 1997, J EXP MED, V185, P1113, DOI 10.1084/jem.185.6.1113; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15050, DOI 10.1073/pnas.96.26.15050; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Seward RJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002477; Shen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013133; Shen YF, 2010, J PROTEOME RES, V9, P2339, DOI 10.1021/pr901083m; Shen ZX, 2006, J PROTEOME RES, V5, P3154, DOI 10.1021/pr060327k; SHIMOMURA K, 1995, TRANSPLANTATION, V60, P806, DOI 10.1097/00007890-199510270-00008; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Spencer CT, 2013, EUR J IMMUNOL, V43, P1162, DOI 10.1002/eji.201243087; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Strawbridge AB, 2007, CURR OPIN IMMUNOL, V19, P87, DOI 10.1016/j.coi.2006.11.009; Strong BSI, 2011, J IMMUNOL, V187, P2193, DOI 10.4049/jimmunol.1100152; Strug I, 2008, J PROTEOME RES, V7, P2703, DOI 10.1021/pr700780x; Sturm T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2610; TACK BF, 1979, BIOCHEMISTRY-US, V18, P1497, DOI 10.1021/bi00575a017; Takeya K, 1970, Iryo, V24, P684; Tuzun E, 2008, ADV EXP MED BIOL, V632, P265, DOI 10.1007/978-0-387-78952-1_19; Van den Steen PE, 2004, BIOCHEMISTRY-US, V43, P10809, DOI 10.1021/bi0493665; Veenstra TD, 2005, MOL CELL PROTEOMICS, V4, P409, DOI 10.1074/mcp.M500006-MCP200; Villadangos JA, 2000, EMBO J, V19, P882, DOI 10.1093/emboj/19.5.882; Volkmann A, 1997, J IMMUNOL, V158, P693; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Xu X, 2008, PROTEOM CLIN APPL, V2, P1403, DOI 10.1002/prca.200780173; Yin L, 2012, IMMUNOL REV, V250, P49, DOI 10.1111/imr.12004; Yin Liusong, 2014, Curr Protoc Immunol, V106, DOI 10.1002/0471142735.im0510s106; Yin LS, 2014, J IMMUNOL METHODS, V406, P21, DOI 10.1016/j.jim.2014.02.008; Yin LS, 2012, J IMMUNOL, V189, P3983, DOI 10.4049/jimmunol.1200626; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]; Zhao YS, 2009, CANCER EPIDEM BIOMAR, V18, P732, DOI 10.1158/1055-9965.EPI-08-0715; Zhen EY, 2008, ARTHRITIS RHEUM-US, V58, P2420, DOI 10.1002/art.23654; Zheng XY, 2009, J CHROMATOGR A, V1216, P3538, DOI 10.1016/j.chroma.2009.01.063; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866; Zhou Ming, 2005, Briefings in Functional Genomics & Proteomics, V4, P69, DOI 10.1093/bfgp/4.1.69; Zurawel A, 2011, CLIN PROTEOM, V8, P1	126	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5576	5595		10.1074/jbc.M115.655738	http://dx.doi.org/10.1074/jbc.M115.655738			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26740625	hybrid, Green Published			2022-12-28	WOS:000372551800012
J	Kuhlmann, N; Wroblowski, S; Knyphausen, P; de Boor, S; Brenig, J; Zienert, AY; Meyer-Teschendorf, K; Praefcke, GJK; Nolte, H; Kruger, M; Schacherl, M; Baumann, U; James, LC; Chin, JW; Lammers, M				Kuhlmann, Nora; Wroblowski, Sarah; Knyphausen, Philipp; de Boor, Susanne; Brenig, Julian; Zienert, Anke Y.; Meyer-Teschendorf, Katrin; Praefcke, Gerrit J. K.; Nolte, Hendrik; Krueger, Marcus; Schacherl, Magdalena; Baumann, Ulrich; James, Leo C.; Chin, Jason W.; Lammers, Michael			Structural and Mechanistic Insights into the Regulation of the Fundamental Rho Regulator RhoGDI by Lysine Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; acetyltransferase; histone deacetylase (HDAC); post-translational modification (PTM); Ras homolog gene family; member A (RhoA); Rho (Rho GTPase); sirtuin; guanine-nucleotide-dissociation inhibitor alpha; lysine acetylation; lysine acetyltransferase	GDP DISSOCIATION INHIBITOR; STRUCTURE VALIDATION; CELL-MIGRATION; BINDING; GTPASE; PHOSPHORYLATION; PROTEIN; COMPLEX; SIRT2; HDAC6	Rho proteins are small GTP/GDP-binding proteins primarily involved in cytoskeleton regulation. Their GTP/GDP cycle is often tightly connected to a membrane/cytosol cycle regulated by the Rho guanine nucleotide dissociation inhibitor (RhoGDI). RhoGDI has been regarded as a housekeeping regulator essential to control homeostasis of Rho proteins. Recent proteomic screens showed that RhoGDI is extensively lysine-acetylated. Here, we present the first comprehensive structural and mechanistic study to show how RhoGDI function is regulated by lysine acetylation. We discover that lysine acetylation impairs Rho protein binding and increases guanine nucleotide exchange factor-catalyzed nucleotide exchange on RhoA, these two functions being prerequisites to constitute a bona fide GDI displacement factor. RhoGDI acetylation interferes with Rho signaling, resulting in alteration of cellular filamentous actin. Finally, we discover that RhoGDI is endogenously acetylated in mammalian cells, and we identify CBP, p300, and pCAF as RhoGDI-acetyltransferases and Sirt2 and HDAC6 as specific deacetylases, showing the biological significance of this post-translational modification.	[Kuhlmann, Nora; Wroblowski, Sarah; Knyphausen, Philipp; de Boor, Susanne; Brenig, Julian; Nolte, Hendrik; Krueger, Marcus; Lammers, Michael] Univ Cologne, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Kuhlmann, Nora; Wroblowski, Sarah; Knyphausen, Philipp; de Boor, Susanne; Brenig, Julian; Nolte, Hendrik; Krueger, Marcus; Lammers, Michael] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Schacherl, Magdalena; Baumann, Ulrich] Univ Cologne, Inst Biochem, Zulpicher Str 47, D-50674 Cologne, Germany; [Zienert, Anke Y.; Meyer-Teschendorf, Katrin; Praefcke, Gerrit J. K.] Univ Cologne, Inst Genet, Zulpicher Str 47a, D-50674 Cologne, Germany; [Praefcke, Gerrit J. K.] Paul Ehrlich Inst, Paul Ehrlich Str 51-59, D-63225 Langen, Germany; [James, Leo C.; Chin, Jason W.] Med Res Council Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Paul Ehrlich Institute; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Lammers, M (corresponding author), Univ Cologne, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.; Lammers, M (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.	michael.lammers@uni-koeln.de	Baumann, Ulrich/B-1220-2013; Lammers, Michael/AAX-1164-2020; Schacherl, Magdalena/AAT-6362-2021; Schacherl, Magdalena/M-1590-2014	Schacherl, Magdalena/0000-0002-5478-2509; Schacherl, Magdalena/0000-0002-5478-2509; Lammers, Michael/0000-0003-4168-4640; Praefcke, Gerrit/0000-0001-8818-1499	Emmy Noether Grant [LA2984-1/1]; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 635 (SFB635), SPP1365, SPP1580]; European BIOSTRUCTX_5870; MRC [MC_U105181010, MC_U105181009] Funding Source: UKRI; Medical Research Council [MC_U105181010, MC_U105181009] Funding Source: researchfish	Emmy Noether Grant(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European BIOSTRUCTX_5870; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Emmy Noether Grant LA2984-1/1, Sonderforschungsbereich 635 (SFB635; Post-translational Control of Protein Function), and Priority Programs SPP1365 and SPP1580, all from Deutsche Forschungsgemeinschaft. This work was also supported by the European BIOSTRUCTX_5870. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baeza J, 2014, J BIOL CHEM, V289, P21326, DOI 10.1074/jbc.M114.581843; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boulter Etienne, 2010, Small GTPases, V1, P65; Brunet N, 2002, TRAFFIC, V3, P342, DOI 10.1034/j.1600-0854.2002.30504.x; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Boor S, 2015, P NATL ACAD SCI USA, V112, pE3679, DOI 10.1073/pnas.1505995112; de Toledo M, 2003, MOL BIOL CELL, V14, P4846, DOI 10.1091/mbc.E03-04-0254; DeLano W.L, PYMOL MOL GRAPHICS S; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; DerMardirossian CM, 2006, METHOD ENZYMOL, V406, P80, DOI 10.1016/S0076-6879(06)06007-1; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dransart E, 2005, BIOCHEM SOC T, V33, P623, DOI 10.1042/BST0330623; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Euden J, 2013, J BIOL CHEM, V288, P16671, DOI 10.1074/jbc.M113.465310; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fres JM, 2010, J LIPID RES, V51, P2454, DOI 10.1194/jlr.D005397; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Gorvel JP, 1998, FEBS LETT, V422, P269, DOI 10.1016/S0014-5793(98)00020-9; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Gundersen GG, 2005, NOVART FDN SYMP, V269, P116; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han Y, 2009, BIOCHEM BIOPH RES CO, V383, P88, DOI 10.1016/j.bbrc.2009.03.147; Han Y, 2008, BIOCHEM BIOPH RES CO, V375, P576, DOI 10.1016/j.bbrc.2008.08.042; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lammers M, 2010, NAT CHEM BIOL, V6, P331, DOI 10.1038/nchembio.342; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moissoglu K, 2009, CANCER RES, V69, P2838, DOI 10.1158/0008-5472.CAN-08-1397; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; PLATKO JV, 1995, P NATL ACAD SCI USA, V92, P2974, DOI 10.1073/pnas.92.7.2974; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Sawada N, 2009, MOL CELL BIOL, V29, P6018, DOI 10.1128/MCB.00225-09; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Solski PA, 2002, CELL GROWTH DIFFER, V13, P363; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Tnimov Z, 2012, J BIOL CHEM, V287, P26549, DOI 10.1074/jbc.M112.371294; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yu JX, 2012, J BIOL CHEM, V287, P13752, DOI 10.1074/jbc.M111.337469; Zuo QQ, 2012, ONCOL REP, V27, P819, DOI 10.3892/or.2011.1553	64	37	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5484	5499		10.1074/jbc.M115.707091	http://dx.doi.org/10.1074/jbc.M115.707091			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26719334	Green Published, hybrid			2022-12-28	WOS:000372551800004
J	Schutze, S; Orozco, IJ; Jentsch, TJ				Schuetze, Sebastian; Orozco, Ian J.; Jentsch, Thomas J.			KCNQ Potassium Channels Modulate Sensitivity of Skin Down-hair (D-hair) Mechanoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; ion channel; mechanotransduction; mouse genetics; neurobiology; potassium channel; M-current; skin-nerve preparation	SENSORY NEURONS; K+ CHANNELS; DOMINANT DEAFNESS; EPILEPSY; GENE; ACTIVATION; INHIBITION; RECEPTORS; MUTATION; NEUROTROPHIN-4	M-current-mediating KCNQ (K(v)7) channels play an important role in regulating the excitability of neuronal cells, as highlighted by mutations in Kcnq2 and Kcnq3 that underlie certain forms of epilepsy. In addition to their expression in brain, KCNQ2 and -3 are also found in the somatosensory system. We have now detected both KCNQ2 and KCNQ3 in a subset of dorsal root ganglia neurons that correspond to D-hair A-fibers and demonstrate KCNQ3 expression in peripheral nerve endings of cutaneous D-hair follicles. Electrophysiological recordings from single D-hair afferents from Kcnq3(-/-) mice showed increased firing frequencies in response to mechanical ramp-and-hold stimuli. This effect was particularly pronounced at slow indentation velocities. Additional reduction of KCNQ2 expression further increased D-hair sensitivity. Together with previous work on the specific role of KCNQ4 in rapidly adapting skin mechanoreceptors, our results show that different KCNQ isoforms are specifically expressed in particular subsets of mechanosensory neurons and modulate their sensitivity directly in sensory nerve endings.	[Schuetze, Sebastian; Orozco, Ian J.; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, Robert Rossle Str 10, D-13125 Berlin, Germany; [Schuetze, Sebastian; Orozco, Ian J.; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, Robert Rossle Str 10, D-13125 Berlin, Germany; [Jentsch, Thomas J.] Charite, Neurocure Cluster Excellence, D-10117 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jentsch, TJ (corresponding author), Leibniz Inst Mol Pharmakol FMP, Robert Rossle Str 10, D-13125 Berlin, Germany.; Jentsch, TJ (corresponding author), Max Delbruck Ctr Mol Med MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.; Jentsch, TJ (corresponding author), Charite, Neurocure Cluster Excellence, D-10117 Berlin, Germany.	jentsch@fmp-berlin.de		Jentsch, Thomas/0000-0002-3509-2553	Senatsausschuss Wettbewerb (SAW) grant of the Leibniz Gemeinschaft; Deutsche Forschungsgemeinschaft [DFG Exc 257 'Neurocure']	Senatsausschuss Wettbewerb (SAW) grant of the Leibniz Gemeinschaft; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Senatsausschuss Wettbewerb (SAW) grant of the Leibniz Gemeinschaft and by the Deutsche Forschungsgemeinschaft (DFG Exc 257 'Neurocure') ( to T. J. J). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2009, NEUROSCI RES, V63, P138, DOI 10.1016/j.neures.2008.11.005; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; BROWN AG, 1967, J PHYSIOL-LONDON, V193, P707, DOI 10.1113/jphysiol.1967.sp008390; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Cooper EC, 2011, SEMIN CELL DEV BIOL, V22, P185, DOI 10.1016/j.semcdb.2010.10.001; Crozier RA, 2007, J NEUROSCI, V27, P4492, DOI 10.1523/JNEUROSCI.4932-06.2007; Dedek K, 2001, P NATL ACAD SCI USA, V98, P12272, DOI 10.1073/pnas.211431298; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Dry J. W., 1926, J GENET, V16, P287; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Frank JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8118; Hao JZ, 2015, PFLUG ARCH EUR J PHY, V467, P109, DOI 10.1007/s00424-014-1651-7; Heidenreich M, 2012, NAT NEUROSCI, V15, P138, DOI 10.1038/nn.2985; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; JONES S, 1995, NEURON, V14, P399, DOI 10.1016/0896-6273(95)90295-3; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; King CH, 2014, J COMP NEUROL, V522, P3262, DOI 10.1002/cne.23595; King CH, 2012, J COMP NEUROL, V520, P1940, DOI 10.1002/cne.23019; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lechner SG, 2013, PHYSIOLOGY, V28, P142, DOI 10.1152/physiol.00059.2012; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Linley JE, 2008, J NEUROSCI, V28, P11240, DOI 10.1523/JNEUROSCI.2297-08.2008; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Milenkovic N, 2008, J NEUROPHYSIOL, V100, P2771, DOI 10.1152/jn.90799.2008; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Ng FL, 2011, BRIT J PHARMACOL, V162, P42, DOI 10.1111/j.1476-5381.2010.01027.x; Orhan G, 2014, ANN NEUROL, V75, P382, DOI 10.1002/ana.24080; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Passmore GM, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00063; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; Robbins J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071809; Rose K, 2011, PAIN, V152, P742, DOI 10.1016/j.pain.2010.12.028; Rutlin M, 2014, CELL, V159, P1640, DOI 10.1016/j.cell.2014.11.038; Schleifenbaum J, 2014, CIRC RES, V115, P263, DOI 10.1161/CIRCRESAHA.115.302882; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shah MM, 2002, J PHYSIOL-LONDON, V544, P29, DOI 10.1113/jphysiol.2002.028571; Shin JB, 2003, NAT NEUROSCI, V6, P724, DOI 10.1038/nn1076; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Soh H, 2014, J NEUROSCI, V34, P5311, DOI 10.1523/JNEUROSCI.3919-13.2014; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Spitzmaul G, 2013, J BIOL CHEM, V288, P9334, DOI 10.1074/jbc.M112.433383; Stucky CL, 1998, J NEUROSCI, V18, P7040; Stucky CL, 2002, CURR BIOL, V12, P1401, DOI 10.1016/S0960-9822(02)01072-2; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P10232, DOI 10.1073/pnas.1004644107; Vetter I, 2013, J NEUROSCI, V33, P16627, DOI 10.1523/JNEUROSCI.1473-13.2013; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wang R, 2011, J PHYSIOL-LONDON, V589, P2229, DOI 10.1113/jphysiol.2010.203463; Watakabe A, 2007, CEREB CORTEX, V17, P1918, DOI 10.1093/cercor/bhl102; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Zhong XZ, 2010, J PHYSIOL-LONDON, V588, P3277, DOI 10.1113/jphysiol.2010.192823	62	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5566	5575		10.1074/jbc.M115.681098	http://dx.doi.org/10.1074/jbc.M115.681098			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26733196	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000372551800011
J	Mai, JT; Nanayakkara, G; Lopez-Pastrana, J; Li, XY; Li, YF; Wang, X; Song, A; Virtue, A; Shao, Y; Shan, HM; Liu, F; Autieri, MV; Kunapuli, SP; Iwakura, Y; Jiang, XH; Wang, H; Yang, XF				Mai, Jietang; Nanayakkara, Gayani; Lopez-Pastrana, Jahaira; Li, Xinyuan; Li, Ya-Feng; Wang, Xin; Song, Ai; Virtue, Anthony; Shao, Ying; Shan, Huimin; Liu, Fang; Autieri, Michael V.; Kunapuli, Satya P.; Iwakura, Yoichiro; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng			Interleukin-17A Promotes Aortic Endothelial Cell Activation via Transcriptionally and Post-translationally Activating p38 Mitogen-activated Protein Kinase (MAPK) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiovascular disease; endothelial cell; inflammation; interleukin 17A (IL-17 or IL-17A); p38 MAPK; endothelial cell activation; monocyte adhesion	E-DEFICIENT MICE; APOLIPOPROTEIN-E; SEVERE HYPERCHOLESTEROLEMIA; METABOLIC SYNDROME; VASCULAR FUNCTION; ATHEROSCLEROSIS; INFLAMMATION; IL-17; HYPERHOMOCYSTEINEMIA; DYSFUNCTION	Interleukin-17 (IL-17)-secreting T helper 17 cells were recently identified as a CD4(+) T helper subset and implicated in various inflammatory and autoimmune diseases. The issues of whether and by what mechanism hyperlipidemic stress induces IL-17A to activate aortic endothelial cells (ECs) and enhance monocyte adhesion remained largely unknown. Using biochemical, immunological, microarray, experimental data mining analysis, and pathological approaches focused on primary human and mouse aortic ECs (HAECs and MAECs) and our newly generated apolipoprotein E (ApoE)(-/-)/IL-17A(-/-) mice, we report the following new findings. 1) The hyperlipidemia stimulus oxidized low density lipoprotein up-regulated IL-17 receptor(s) in HAECs and MAECs. 2) IL-17A activated HAECs and increased human monocyte adhesion in vitro. 3) A deficiency of IL-17A reduced leukocyte adhesion to endothelium in vivo. 3) IL-17A activated HAECs and MAECs via up-regulation of proinflammatory cytokines IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), chemokine CXC motif ligand 1 (CXCL1), and CXCL2. 4) IL-17A activated ECs specifically via the p38 mitogen-activated protein kinases (MAPK) pathway; the inhibition of p38 MAPK in ECs attenuated IL-17A-mediated activation by ameliorating the expression of the aforementioned proinflammatory cytokines, chemokines, and EC adhesion molecules including intercellular adhesion molecule 1. Taken together, our results demonstrate for the first time that IL-17A activates aortic ECs specifically via p38 MAPK pathway.	[Mai, Jietang; Nanayakkara, Gayani; Lopez-Pastrana, Jahaira; Li, Xinyuan; Li, Ya-Feng; Wang, Xin; Song, Ai; Virtue, Anthony; Shao, Ying; Shan, Huimin; Liu, Fang; Kunapuli, Satya P.; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Ctr Metab Dis Res, MERB 1059,3500 N Broad St, Philadelphia, PA 19140 USA; [Mai, Jietang; Nanayakkara, Gayani; Lopez-Pastrana, Jahaira; Li, Xinyuan; Li, Ya-Feng; Wang, Xin; Song, Ai; Virtue, Anthony; Shao, Ying; Shan, Huimin; Liu, Fang; Kunapuli, Satya P.; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Ctr Cardiovasc Res, MERB 1059,3500 N Broad St, Philadelphia, PA 19140 USA; [Mai, Jietang; Nanayakkara, Gayani; Lopez-Pastrana, Jahaira; Li, Xinyuan; Li, Ya-Feng; Wang, Xin; Song, Ai; Virtue, Anthony; Shao, Ying; Shan, Huimin; Liu, Fang; Kunapuli, Satya P.; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Ctr Thrombosis Res, Philadelphia, PA 19140 USA; [Mai, Jietang; Li, Xinyuan; Virtue, Anthony; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Autieri, Michael V.; Kunapuli, Satya P.] Temple Univ, Lewis Katz Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med, Tokyo 1088639, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Tokyo	Yang, XF (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Metab Dis Res, MERB 1059,3500 N Broad St, Philadelphia, PA 19140 USA.; Yang, XF (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Cardiovasc Res, MERB 1059,3500 N Broad St, Philadelphia, PA 19140 USA.	xfyang@temple.edu	Li, YaFeng/J-6247-2013; Li, Xinyuan/Z-6299-2019; Iwakura, Yoichiro/E-5457-2011; Li, Xinyuan/B-1139-2015	Li, YaFeng/0000-0002-7500-0959; Li, Xinyuan/0000-0002-6746-8367; Iwakura, Yoichiro/0000-0002-9934-5775; Li, Xinyuan/0000-0002-6746-8367	National Institutes of Health Grants [5R01HL108910-05, 5R01HL116917-03, 1R01DK104116-01A1, 5R01HL077288-11, 5R01HL110764-05, 5R01HL117654-03, 1R01HL131460-01]; American Heart Association predoctoral/postdoctoral fellowships; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131460, R01HL108910, R01HL077288, R01HL117654, R01HL110764, R01HL117724, R01HL132399, R01HL141108, R01HL116917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104116] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association predoctoral/postdoctoral fellowships(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grants 5R01HL108910-05, 5R01HL116917-03, 1R01DK104116-01A1, 5R01HL077288-11, 5R01HL110764-05, 5R01HL117654-03, and 1R01HL131460-01 (to X.-F. Y. and H. W.) and American Heart Association predoctoral/postdoctoral fellowships (to J. M., A. V., and Y. L.). The authors declare that they have no conflicts of interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Anter E, 2005, CIRC RES, V96, P1072, DOI 10.1161/01.RES.0000168807.63013.56; Arca M, 2011, INTERN EMERG MED, V6, P571, DOI 10.1007/s11739-011-0550-6; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Bagher P, 2011, JOVE-J VIS EXP, DOI 10.3791/2874; Butcher MJ, 2012, CIRC RES, V110, P675, DOI 10.1161/CIRCRESAHA.111.261784; Chen SA, 2010, J IMMUNOL, V185, P5619, DOI 10.4049/jimmunol.1001879; Cheng ZJ, 2015, DIABETES, V64, P947, DOI 10.2337/db14-0784; CHOWIENCZYK PJ, 1992, LANCET, V340, P1430, DOI 10.1016/0140-6736(92)92621-L; Danzaki K, 2012, ARTERIOSCL THROM VAS, V32, P273, DOI 10.1161/ATVBAHA.111.229997; Dervisoglu E, 2007, ACTA CLIN BELG, V62, P68, DOI 10.1179/acb.2007.013; Fang P, 2014, DIABETES, V63, P4275, DOI 10.2337/db14-0809; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Gong FC, 2015, CELL IMMUNOL, V297, P33, DOI 10.1016/j.cellimm.2015.05.007; Gonzalez-Navarro H, 2007, FRONT BIOSCI, V12, P2291, DOI 10.2741/2231; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Nguyen H, 2013, CARDIOVASC RES, V97, P696, DOI 10.1093/cvr/cvs422; Jiang XH, 2005, ARTERIOSCL THROM VAS, V25, P2515, DOI 10.1161/01.ATV.0000189559.87328.e4; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Ley K, 2008, METHOD ENZYMOL, V445, P255, DOI 10.1016/S0076-6879(08)03011-5; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033628; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lopez-Pastrana J, 2015, J BIOL CHEM, V290, P17485, DOI 10.1074/jbc.M115.641191; Ma XY, 2010, J IMMUNOL, V184, P4898, DOI 10.4049/jimmunol.1000142; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Mai JT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-61; Mai Jietang, 2012, Front Biosci (Elite Ed), V4, P1478; Mai JT, 2010, FRONT BIOSCI-LANDMRK, V15, P986, DOI 10.2741/3657; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Mueller MA, 2008, ATHEROSCLEROSIS, V198, P39, DOI 10.1016/j.atherosclerosis.2007.09.019; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Rocha VZ, 2013, J AM COLL CARDIOL, V61, P2193, DOI 10.1016/j.jacc.2012.11.079; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Sha XJ, 2015, J BIOL CHEM, V290, P19307, DOI 10.1074/jbc.M115.663286; Shalom-Barak T, 1998, J BIOL CHEM, V273, P27467, DOI 10.1074/jbc.273.42.27467; Shao Y, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0080-6; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Surendar J, 2011, METABOLISM, V60, P586, DOI 10.1016/j.metabol.2010.06.003; Szypula Ilona, 2009, Wiad Lek, V62, P64; Taleb S, 2015, ARTERIOSCL THROM VAS, V35, P258, DOI 10.1161/ATVBAHA.114.303567; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; Xiong ZY, 2009, ATHEROSCLEROSIS, V203, P401, DOI 10.1016/j.atherosclerosis.2008.07.041; Yang WY, 2015, BURNS TRAUMA, V3, DOI 10.1186/s41038-015-0001-0; Yang XF, 2001, P NATL ACAD SCI USA, V98, P7492, DOI 10.1073/pnas.131590998; Yang Xiao-Feng, 2008, Drug Discov Today Ther Strateg, V5, P125, DOI 10.1016/j.ddstr.2008.11.003; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Yin Y, 2015, ARTERIOSCL THROM VAS, V35, P804, DOI 10.1161/ATVBAHA.115.305282; Zhang DQ, 2009, CIRCULATION, V120, P1893, DOI 10.1161/CIRCULATIONAHA.109.866889; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	49	46	49	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4939	4954		10.1074/jbc.M115.690081	http://dx.doi.org/10.1074/jbc.M115.690081			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26733204	Green Published, hybrid			2022-12-28	WOS:000371640600010
J	Xu, WY; Wu, LZ; Yu, M; Chen, FJ; Arshad, M; Xia, XY; Ren, H; Yu, JH; Xu, L; Xu, DJ; Li, JZ; Li, P; Zhou, LK				Xu, Wenyi; Wu, Lizhen; Yu, Miao; Chen, Feng-Jung; Arshad, Muhammad; Xia, Xiayu; Ren, Hao; Yu, Jinhai; Xu, Li; Xu, Dijin; Li, John Zhong; Li, Peng; Zhou, Linkang			Differential Roles of Cell Death-inducing DNA Fragmentation Factor-alpha-like Effector (CIDE) Proteins in Promoting Lipid Droplet Fusion and Growth in Subpopulations of Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE ADIPOSE-TISSUE; FATTY LIVER-DISEASE; METABOLIC SYNDROME; TRIACYLGLYCEROL SYNTHESIS; HEPATIC STEATOSIS; VLDL LIPIDATION; DEFICIENT MICE; GENE V115F; FSP27; OBESITY	Lipid droplets (LDs) are dynamic subcellular organelles whose growth is closely linked to obesity and hepatic steatosis. Cell death-inducing DNA fragmentation factor-alpha-like effector (CIDE) proteins, including Cidea, Cideb, and Cidec (also called Fsp27), play important roles in lipid metabolism. Cidea and Cidec are LD-associated proteins that promote atypical LD fusion in adipocytes. Here, we find that CIDE proteins are all localized to LD-LD contact sites (LDCSs) and promote lipid transfer, LD fusion, and growth in hepatocytes. We have identified two types of hepatocytes, one with small LDs (small LD-containing hepatocytes, SLHs) and one with large LDs (large LD-containing hepatocytes, LLHs) in the liver. Cideb is localized to LDCSs and promotes lipid exchange and LD fusion in both SLHs and LLHs, whereas Cidea and Cidec are specifically localized to the LDCSs and promote lipid exchange and LD fusion in LLHs. Cideb-deficient SLHs have reduced LD sizes and lower lipid exchange activities. Fasting dramatically induces the expression of Cidea/Cidec and increases the percentage of LLHs in the liver. The majority of the hepatocytes from the liver of obese mice are Cidea/Cidec-positive LLHs. Knocking down Cidea or Cidec significantly reduced lipid storage in the livers of obese animals. Our data reveal that CIDE proteins play differential roles in promoting LD fusion and lipid storage; Cideb promotes lipid storage under normal diet conditions, whereas Cidea and Cidec are responsible for liver steatosis under fasting and obese conditions.	[Xu, Wenyi; Wu, Lizhen; Yu, Miao; Chen, Feng-Jung; Ren, Hao; Yu, Jinhai; Xu, Dijin; Li, Peng; Zhou, Linkang] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Xu, Wenyi; Wu, Lizhen; Yu, Miao; Chen, Feng-Jung; Ren, Hao; Yu, Jinhai; Xu, Dijin; Li, Peng; Zhou, Linkang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Arshad, Muhammad] Int Islamic Univ, Dept Bioinformat & Biotechnol, Islamabad 44000, Pakistan; [Xia, Xiayu] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100021, Peoples R China; [Xu, Li] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China; [Li, John Zhong] Nanjing Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Jiangsu Prov Key Lab Human Funct Genom, Nanjing 210029, Jiangsu, Peoples R China	Tsinghua University; Tsinghua University; International Islamic University, Pakistan; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Nanjing Medical University	Li, P; Zhou, LK (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.; Li, P; Zhou, LK (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.	li-peng@mail.tsinghua.edu.cn; zhoulinkang@mail.tsinghua.edu.cn	Zhou, Linkang/AAH-9911-2020; Zhou, Linkang/C-8812-2015; Li, Zhong/U-2157-2017; Li, John Zhong/S-2118-2019	Zhou, Linkang/0000-0002-7009-5776; Li, John Zhong/0000-0003-4991-9563; Yu, Jinhai/0000-0002-2992-6785	National Basic Research Program [2013CB530602]; National Natural Science Foundation of China [31430040, 31321003, 31501089, 31271268, 81471079]; China Postdoctoral Science Foundation [2012M520249, 2013T60103]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Basic Research Program Grants 2013CB530602 (to P. L.), National Natural Science Foundation of China Grants 31430040 and 31321003 (to P. L.) and Grant 31501089 (to J. Y.), and Grants 31271268 and 81471079 (to J. Z. L.), and China Postdoctoral Science Foundation Grants 2012M520249 and 2013T60103 (to L. Z.). The authors declare that they have no conflicts of interest regarding the contents of this article.	Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Barneda D, 2015, ELIFE, V4, DOI 10.7554/eLife.07485; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Chen ZM, 2000, J BIOL CHEM, V275, P22619, DOI 10.1074/jbc.C000207200; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Crunk AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067631; Dahlman I, 2005, DIABETES, V54, P3032, DOI 10.2337/diabetes.54.10.3032; Dietrich P, 2014, BEST PRACT RES CL GA, V28, P637, DOI 10.1016/j.bpg.2014.07.008; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Gross DA, 2011, P NATL ACAD SCI USA, V108, P19581, DOI 10.1073/pnas.1110817108; Hall AM, 2010, OBESITY, V18, P417, DOI 10.1038/oby.2009.236; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Langhi C, 2015, HEPATOLOGY, V61, P1227, DOI 10.1002/hep.27607; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Li XH, 2012, J LIPID RES, V53, P1877, DOI 10.1194/jlr.M026591; Liu K, 2009, AM J PHYSIOL-ENDOC M, V297, pE1395, DOI 10.1152/ajpendo.00188.2009; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Nian ZQ, 2010, J BIOL CHEM, V285, P9604, DOI 10.1074/jbc.M109.043786; Okumura T, 2011, J PHYSIOL BIOCHEM, V67, P629, DOI 10.1007/s13105-011-0110-6; Puri V, 2013, J LIPID RES, V54, P569, DOI 10.1194/jlr.E036020; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Vila-Brau A, 2013, J LIPID RES, V54, P592, DOI 10.1194/jlr.M028472; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Wilfling F, 2014, ELIFE, V3, DOI 10.7554/eLife.01607; Wu JJ, 2013, MOL BIOL REP, V40, P5691, DOI 10.1007/s11033-013-2671-7; Wu LZ, 2014, DEV CELL, V30, P378, DOI 10.1016/j.devcel.2014.07.005; Wu LZ, 2014, SCI CHINA LIFE SCI, V57, P107, DOI 10.1007/s11427-013-4585-y; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Xu MJ, 2015, GASTROENTEROLOGY, V149, P1030, DOI 10.1053/j.gastro.2015.06.009; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Yonezawa T, 2011, MOL BIOSYST, V7, P91, DOI 10.1039/c0mb00099j; Zhang L, 2008, METABOLISM, V57, P502, DOI 10.1016/j.metabol.2007.11.011; Zhou LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6949; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611	46	59	63	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4282	4293		10.1074/jbc.M115.701094	http://dx.doi.org/10.1074/jbc.M115.701094			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26733203	Green Published, hybrid			2022-12-28	WOS:000371604600002
J	Kleinboelting, S; Ramos-Espiritu, L; Buck, H; Colis, L; van den Heuvel, J; Glickman, JF; Levin, LR; Buck, J; Steegborn, C				Kleinboelting, Silke; Ramos-Espiritu, Lavoisier; Buck, Hannes; Colis, Laureen; van den Heuvel, Joop; Glickman, J. Fraser; Levin, Lonny R.; Buck, Jochen; Steegborn, Clemens			Bithionol Potently Inhibits Human Soluble Adenylyl Cyclase through Binding to the Allosteric Activator Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BICARBONATE; CAMP; HEXACHLOROPHENE; CATALYSIS; FERTILIZATION; MECHANISMS; EXPRESSION; FORSKOLIN; CALCIUM	The signaling molecule cAMP regulates functions ranging from bacterial transcription to mammalian memory. In mammals, cAMP is synthesized by nine transmembrane adenylyl cyclases (ACs) and one soluble AC (sAC). Despite similarities in their catalytic domains, these ACs differ in regulation. Transmembrane ACs respond to G proteins, whereas sAC is uniquely activated by bicarbonate. Via bicarbonate regulation, sAC acts as a physiological sensor for pH/bicarbonate/CO2, and it has been implicated as a therapeutic target, e.g. for diabetes, glaucoma, and a male contraceptive. Here we identify the bisphenols bithionol and hexachlorophene as potent, sAC-specific inhibitors. Inhibition appears mostly non-competitive with the substrate ATP, indicating that they act via an allosteric site. To analyze the interaction details, we solved a crystal structure of an sAC.bithionol complex. The structure reveals that the compounds are selective for sAC because they bind to the sAC-specific, allosteric binding site for the physiological activator bicarbonate. Structural comparison of the bithionol complex with apo-sAC and other sAC.ligand complexes along with mutagenesis experiments reveals an allosteric mechanism of inhibition; the compound induces rearrangements of substrate binding residues and of Arg(176), a trigger between the active site and allosteric site. Our results thus provide 1) novel insights into the communication between allosteric regulatory and active sites, 2) a novel mechanism for sAC inhibition, and 3) pharmacological compounds targeting this allosteric site and utilizing this mode of inhibition. These studies provide support for the future development of sAC-modulating drugs.	[Kleinboelting, Silke; Steegborn, Clemens] Univ Bayreuth, Dept Biochem, D-95440 Bayreuth, Germany; [Ramos-Espiritu, Lavoisier; Buck, Hannes; Colis, Laureen; Levin, Lonny R.; Buck, Jochen] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Ramos-Espiritu, Lavoisier; Glickman, J. Fraser] Rockefeller Univ, High Throughput Screening & Spect Resource Ctr, New York, NY 10065 USA; [van den Heuvel, Joop] Helmholtz Zentrum Infekt Forsch, D-38124 Braunschweig, Germany; [Kleinboelting, Silke] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA	University of Bayreuth; Cornell University; Rockefeller University; Helmholtz Association; Helmholtz-Center for Infection Research; Stanford University	Steegborn, C (corresponding author), Univ Bayreuth, Dept Biochem, Univ Str 30, D-95447 Bayreuth, Germany.	clemens.steegborn@uni-bayreuth.de	Levin, Lonny R/A-7215-2011; Glickman, Joseph/H-3021-2013	Glickman, Joseph/0000-0002-6706-4039; Levin, Lonny/0000-0002-5204-6356	Helmsley Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY025810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107442] Funding Source: NIH RePORTER	Helmsley Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Berlin Electron Storage Ring Society for Synchrotron Radiation (BESSY) staff for technical assistance, the Helmholtz Protein Sample Production Facility for support in producing sAC protein, and the Helmsley Trust for funding of the Agilent RapidFire mass spectrometry instrument.	Ayyagari VN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-61; Bitterman JL, 2013, J PHARMACOL EXP THER, V347, P589, DOI 10.1124/jpet.113.208496; Buffone MG, 2014, BBA-MOL BASIS DIS, V1842, P2610, DOI 10.1016/j.bbadis.2014.07.013; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Dessauer CW, 1997, J BIOL CHEM, V272, P22272, DOI 10.1074/jbc.272.35.22272; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Gancedo JM, 2013, BIOL REV, V88, P645, DOI 10.1111/brv.12020; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Holz GG, 2014, BBA-MOL BASIS DIS, V1842, P2593, DOI 10.1016/j.bbadis.2014.06.023; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kleinboelting S, 2014, FEBS J, V281, P4151, DOI 10.1111/febs.12913; Kleinboelting S, 2014, ACTA CRYSTALLOGR F, V70, P467, DOI 10.1107/S2053230X14004014; Kleinboelting S, 2014, P NATL ACAD SCI USA, V111, P3727, DOI 10.1073/pnas.1322778111; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Lee YS, 2011, J BIOL CHEM, V286, P41353, DOI 10.1074/jbc.M111.284679; LEOW ACT, 1979, CHEM-BIOL INTERACT, V27, P125, DOI 10.1016/0009-2797(79)90155-8; Levin LR, 2015, ANNU REV PHYSIOL, V77, P347, DOI 10.1146/annurev-physiol-021014-071821; Li M, 2009, J BIOL CHEM, V284, P22988, DOI 10.1074/jbc.M109.020222; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; MAVIER P, 1976, BIOCHEM PHARMACOL, V25, P305, DOI 10.1016/0006-2952(76)90219-7; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Park S, 2006, MOL PHARMACOL, V70, P960, DOI 10.1124/mol.106.024729; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Saalau-Bethell SM, 2014, CHEMMEDCHEM, V9, P823, DOI 10.1002/cmdc.201300480; Schlicker C, 2008, J MED CHEM, V51, P4456, DOI 10.1021/jm800481q; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Steegborn C, 2014, BBA-MOL BASIS DIS, V1842, P2535, DOI 10.1016/j.bbadis.2014.08.012; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Zippin JH, 2013, J BIOL CHEM, V288, P33283, DOI 10.1074/jbc.M113.510073	40	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9776	9784		10.1074/jbc.M115.708255	http://dx.doi.org/10.1074/jbc.M115.708255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26961873	Green Published, hybrid			2022-12-28	WOS:000375602300034
J	Barr, I; Latham, JA; Iavarone, AT; Chantarojsiri, T; Hwang, JD; Klinman, JP				Barr, Ian; Latham, John A.; Iavarone, Anthony T.; Chantarojsiri, Teera; Hwang, Jennifer D.; Klinman, Judith P.			Demonstration That the Radical S-Adenosylmethionine (SAM) Enzyme PqqE Catalyzes de Novo Carbon-Carbon Cross-linking within a Peptide Substrate PqqA in the Presence of the Peptide Chaperone PqqD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRROLOQUINOLINE QUINONE; ESCHERICHIA-COLI; BIOSYNTHESIS; PROTEIN; NOMENCLATURE; FLAVODOXIN; SYNTHASE; DOMAIN; OXYGEN; P450	The radical S-adenosylmethionine (SAM) protein PqqE is predicted to function in the pyrroloquinoline quinone (PQQ) biosynthetic pathway via catalysis of carbon-carbon bond formation between a glutamate and tyrosine side chain within the small peptide substrate PqqA. We report here that PqqE activity is dependent on the accessory protein PqqD, which was recently shown to bind PqqA tightly. In addition, PqqE activity in vitro requires the presence of a flavodoxin-and flavodoxin reductase-based reduction system, with other reductants leading to an uncoupled cleavage of the co-substrate SAM. These results indicate that PqqE, in conjunction with PqqD, carries out the first step in PQQ biosynthesis: a radical-mediated formation of a new carbon-carbon bond between two amino acid side chains on PqqA.	[Barr, Ian; Latham, John A.; Iavarone, Anthony T.; Chantarojsiri, Teera; Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Barr, Ian; Hwang, Jennifer D.; Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Barr, Ian; Latham, John A.; Iavarone, Anthony T.; Klinman, Judith P.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Klinman, JP (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	klinman@berkeley.edu	Chantarojsiri, Teera/C-5238-2018	Chantarojsiri, Teera/0000-0002-4951-9503; Barr, Ian/0000-0003-1805-1415; Latham, John/0000-0002-3034-1768	National Institutes of Health [GM 039296]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118117, R01GM039296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM 039296 (to J. P. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; BADER M, 1980, J CHEM EDUC, V57, P703, DOI 10.1021/ed057p703; Bonnot F, 2013, BIOCHEMISTRY-US, V52, P4667, DOI 10.1021/bi4003315; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Bruender NA, 2015, BIOCHEMISTRY-US, V54, P2903, DOI 10.1021/acs.biochem.5b00210; Burkhart BJ, 2015, NAT CHEM BIOL, V11, P564, DOI 10.1038/nchembio.1856; Chatterjee A, 2010, ANGEW CHEM INT EDIT, V49, P8653, DOI 10.1002/anie.201003419; Crack JC, 2014, METHODS MOL BIOL, V1122, P33, DOI 10.1007/978-1-62703-794-5_4; Duine JA, 1999, J BIOSCI BIOENG, V88, P231, DOI 10.1016/S1389-1723(00)80002-X; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P8519, DOI 10.1073/pnas.1302417110; GOOSEN N, 1987, J BACTERIOL, V169, P303, DOI 10.1128/jb.169.1.303-307.1987; Grell TAJ, 2015, J BIOL CHEM, V290, P3964, DOI 10.1074/jbc.R114.581249; Jenkins CM, 1997, ARCH BIOCHEM BIOPHYS, V347, P93, DOI 10.1006/abbi.1997.0318; Jenkins CM, 1998, BIOCHEMISTRY-US, V37, P6106, DOI 10.1021/bi973076p; Klinman JP, 2014, CHEM REV, V114, P4343, DOI 10.1021/cr400475g; Latham JA, 2015, J BIOL CHEM, V290, P12908, DOI 10.1074/jbc.M115.646521; Link AJ, 2015, NAT CHEM BIOL, V11, P551, DOI 10.1038/nchembio.1862; Magnusson OT, 2004, P NATL ACAD SCI USA, V101, P7913, DOI 10.1073/pnas.0402640101; MEULENBERG JJM, 1989, PQQ AND QUINOPROTEINS, P187; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pandelia ME, 2015, BBA-MOL CELL RES, V1853, P1395, DOI 10.1016/j.bbamcr.2014.12.005; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Saichana N, 2016, J BIOCHEM, V159, P87, DOI 10.1093/jb/mvv073; Schramma KR, 2015, NAT CHEM, V7, P431, DOI [10.1038/NCHEM.2237, 10.1038/nchem.2237]; Schwarzenbacher R, 2004, PROTEINS, V56, P401, DOI 10.1002/prot.20085; Shen YQ, 2012, BIOCHEMISTRY-US, V51, P2265, DOI 10.1021/bi201763d; Shisler KA, 2012, CURR OPIN STRUC BIOL, V22, P701, DOI 10.1016/j.sbi.2012.10.005; van Kleef M A, 1988, Biofactors, V1, P297; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; Wieckowski BM, 2015, FEBS LETT, V589, P1802, DOI 10.1016/j.febslet.2015.05.032; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	31	74	75	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8877	8884		10.1074/jbc.C115.699918	http://dx.doi.org/10.1074/jbc.C115.699918			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26961875	hybrid, Green Published			2022-12-28	WOS:000374849000002
J	Sankaran, SM; Wilkinson, AW; Elias, JE; Gozani, O				Sankaran, Saumya M.; Wilkinson, Alex W.; Elias, Joshua E.; Gozani, Or			A PWWP Domain of Histone-Lysine N-Methyltransferase NSD2 Binds to Dimethylated Lys-36 of Histone H3 and Regulates NSD2 Function at Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-MYELOMA; 36 TRIMETHYLATION; CELL-CYCLE; GENE; DNA; RECOGNITION; MMSET; METHYLATION; PROTEINS; ADHESION	The readout of histone modifications plays a critical role in chromatin-regulated processes. Dimethylation at Lys-36 on histone H3 (H3K36me2) is associated with actively transcribed genes, and global up-regulation of this modification is associated with several cancers. However, the molecular mechanism by which H3K36me2 is sensed and transduced to downstream biological outcomes remains unclear. Here we identify a PWWP domain within the histone lysine methyltransferase and oncoprotein NSD2 that preferentially binds to nucleosomes containing H3K36me2. In cells, the NSD2 PWWP domain interaction with H3K36me2 plays a role in stabilizing NSD2 at chromatin. Furthermore, NSD2's ability to induce global increases in H3K36me2 via its enzymatic activity, and consequently promote cellular proliferation, is compromised by mutations within the PWWP domain that specifically abrogate H3K36me2-recognition. Together, our results identify a pivotal role for NSD2 binding to its catalytic product in regulating its cellular functions, and suggest a model for how this interaction may facilitate epigenetic spreading and propagation of H3K36me2.	[Sankaran, Saumya M.; Wilkinson, Alex W.; Gozani, Or] Stanford Univ, Sch Med, Dept Biol, Stanford, CA 94305 USA; [Elias, Joshua E.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Gozani, O (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA USA.	ogozani@stanford.edu		Gozani, Or/0000-0002-1365-4463	National Institutes of Health [R01 GM079641, T32 GM007276]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or part by National Institutes of Health Grant R01 GM079641 (to O. G.). O. G. is a co-founder of EpiCypher, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Training Grant T32 GM007276.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Brito JLR, 2009, HAEMATOL-HEMATOL J, V94, P78, DOI 10.3324/haematol.13426; Bua DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006789; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Grosso AR, 2015, ELIFE, V4, DOI 10.7554/eLife.09214; Guo R, 2014, MOL CELL, V56, P298, DOI 10.1016/j.molcel.2014.08.022; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Jha D. K., 2014, NAT COMMUN, V5, P1; Jha DK, 2014, NAT STRUCT MOL BIOL, V21, P655, DOI 10.1038/nsmb.2866; Keats JJ, 2003, BLOOD, V101, P1520, DOI 10.1182/blood-2002-06-1675; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Lucio-Eterovic AK, 2010, P NATL ACAD SCI USA, V107, P16952, DOI 10.1073/pnas.1002653107; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Moore KE, 2013, MOL CELL, V50, P444, DOI 10.1016/j.molcel.2013.03.005; Morishita M, 2011, BBA-REV CANCER, V1816, P158, DOI 10.1016/j.bbcan.2011.05.004; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Oyer JA, 2014, LEUKEMIA, V28, P198, DOI 10.1038/leu.2013.204; Pai C. -C., 2014, NAT COMMUN, V5, P1; Qin S, 2014, TRENDS BIOCHEM SCI, V39, P536, DOI 10.1016/j.tibs.2014.09.001; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; van Nuland R, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-12; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045	45	43	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8465	8474		10.1074/jbc.M116.720748	http://dx.doi.org/10.1074/jbc.M116.720748			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26912663	Green Published, hybrid			2022-12-28	WOS:000374773200013
J	Song, X; Ding, YP; Liu, G; Yang, X; Zhao, RF; Zhang, YL; Zhao, X; Anderson, GJ; Nie, GJ				Song, Xiao; Ding, Yanping; Liu, Gang; Yang, Xiao; Zhao, Ruifang; Zhang, Yinlong; Zhao, Xiao; Anderson, Gregory J.; Nie, Guangjun			Cancer Cell-derived Exosomes Induce Mitogen-activated Protein Kinase-dependent Monocyte Survival by Transport of Functional Receptor Tyrosine Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; PERIPHERAL-BLOOD MONOCYTES; SIGNALING PATHWAYS; LYSOSOMAL-ENZYMES; DEATH APOPTOSIS; NECROSIS-FACTOR; IN-VITRO; GROWTH; LIPOPOLYSACCHARIDE; MICROENVIRONMENT	Tumor-associated macrophages (TAM) play pivotal roles in cancer initiation and progression. Monocytes, the precursors of TAMs, normally undergo spontaneous apoptosis within 2 days, but can subsist in the inflammatory tumor microenvironment for continuous survival and generation of sufficient TAMs. The mechanisms underlying tumor-driving monocyte survival remain obscure. Here we report that cancer cell-derived exosomes were crucial mediators for monocyte survival in the inflammatory niche. Analysis of the survival-promoting molecules in monocytes revealed that cancer cell-derived exosomes activated Ras and extracellular signal-regulated kinases in the mitogen-activated protein kinase (MAPK) pathway, resulting in the prevention of caspase cleavage. Phosphorylated receptor tyrosine kinases (RTKs), such as phosphorylated epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER-2), were abundantly expressed in cancer cell-derived exosomes. Knock-out of EGFR or/and HER-2, or alternatively, inhibitors against their phosphorylation significantly disturbed the exosome-mediated activation of the MAPK pathway, inhibition of caspase cleavage, and increase in survival rate in monocytes. Moreover, the deprived survival-stimulating activity of exosomes due to null expression of EGFR and HER-2 could be restored by activation of another RTK, insulin receptor. Overall, our study uncovered a mechanism of tumor-associated monocyte survival and demonstrated that cancer cell-derived exosomes can stimulate the MAPK pathway in monocytes through transport of functional RTKs, leading to inactivation of apoptosis-related caspases. This work provides insights into the long sought question on monocyte survival prior to formation of plentiful TAMs in the tumor microenvironment.	[Song, Xiao; Ding, Yanping; Liu, Gang; Yang, Xiao; Zhao, Ruifang; Zhang, Yinlong; Zhao, Xiao; Nie, Guangjun] Natl Ctr Nanosci & Technol, CAS Key Lab Biomed Effects Nanomat & Nanosafety, 11th Beiyitiao, Beijing 100190, Peoples R China; [Song, Xiao; Ding, Yanping; Liu, Gang; Yang, Xiao; Zhao, Ruifang; Zhang, Yinlong; Zhao, Xiao; Nie, Guangjun] Natl Ctr Nanosci & Technol, CAS Ctr Excellence Nanosci, 11th Beiyitiao, Beijing 100190, Peoples R China; [Yang, Xiao; Zhang, Yinlong] Jilin Univ, Coll Pharmaceut Sci, Changchun 130021, Peoples R China; [Zhao, Xiao] Tianjin Med Univ, Key Lab Canc Prevent & Therapy, Dept Pancreat Carcinoma, Canc Inst & Hosp,Natl Clin Res Ctr Canc, Tianjin 300060, Peoples R China; [Anderson, Gregory J.] Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, Iron Metab Lab, Locked Bag 2000, Brisbane, Qld 4029, Australia	Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Jilin University; Tianjin Medical University; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Nie, GJ (corresponding author), Natl Ctr Nanosci & Technol, 11th Beiyitiao, Beijing 100190, Peoples R China.	niegj@nanoctr.cn	Nie, Guangjun/A-9954-2011; Anderson, Gregory/G-4148-2013	nie, guangjun/0000-0001-5040-9793; Anderson, Gregory/0000-0002-8814-5866	MoST 973 Grant [2012CB934004]; National Natural Science Foundation of China [31325010, 31300822]; Key Research Program of the Chinese Academy of Sciences [KGZD-EW-T06]; Senior Visiting Professorship of Chinese Academy of Sciences	MoST 973 Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Senior Visiting Professorship of Chinese Academy of Sciences	This work was supported in part by MoST 973 Grant 2012CB934004 (to G. N.), National Natural Science Foundation of China Grants 31325010 (to G. N.) and 31300822 (to Y. D.), and Key Research Program of the Chinese Academy of Sciences Grant KGZD-EW-T06 (to G. N.). The authors declare that they have no conflicts of interest with the contents of this article.; Senior Research Fellow of the National Health and Medical Research Council of Australia and a recipient of Senior Visiting Professorship of Chinese Academy of Sciences.	Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Anido J, 2003, CLIN CANCER RES, V9, P1274; BECKER S, 1987, J IMMUNOL, V139, P3703; Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200; Dondi E, 2001, J BIOL CHEM, V276, P47004, DOI 10.1074/jbc.M104316200; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Fahy RJ, 1999, J IMMUNOL, V163, P1755; Goodsell D S, 1999, Oncologist, V4, P263; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Goyal A, 2002, AM J RESP CELL MOL, V26, P224, DOI 10.1165/ajrcmb.26.2.4640; Haile S, 2003, RNA, V9, P1491, DOI 10.1261/rna.5940703; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Heidenreich S, 1997, J IMMUNOL, V159, P3178; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Johnston SRD, 2006, DRUG TODAY, V42, P441, DOI 10.1358/dot.2006.42.7.985637; Kang I, 2014, J BIOL CHEM, V289, P15393, DOI 10.1074/jbc.M113.544338; Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; MANGAN DF, 1992, J IMMUNOL, V148, P1812; MANGAN DF, 1991, J IMMUNOL, V146, P1541; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; MUSSON RA, 1980, J RETICULOENDOTH SOC, V28, P249; MUSSON RA, 1983, AM J PATHOL, V111, P331; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Najib S, 2002, CELL IMMUNOL, V220, P143, DOI 10.1016/S0008-8749(03)00027-3; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; PINK JJ, 1995, CANCER RES, V55, P2583; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Scherle PA, 1998, J IMMUNOL, V161, P5681; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Spector NL, 2005, J CLIN ONCOL, V23, P2502, DOI 10.1200/JCO.2005.12.157; SPIVAKKROIZMAN T, 1992, J BIOL CHEM, V267, P8056; Staubach S, 2009, PROTEOMICS, V9, P2820, DOI 10.1002/pmic.200800793; Tran SEF, 2001, J BIOL CHEM, V276, P16484, DOI 10.1074/jbc.M010384200; TSAKALOS ND, 1984, CELL IMMUNOL, V83, P229, DOI 10.1016/0008-8749(84)90302-2; Twaddle GM, 1999, J SURG ONCOL, V70, P83, DOI 10.1002/(SICI)1096-9098(199902)70:2<83::AID-JSO4>3.0.CO;2-L; WARREN MK, 1986, J IMMUNOL, V137, P2281; Weiss G, 1997, J IMMUNOL, V158, P420; Whiteside TL, 2002, VACCINE, V20, pA46, DOI 10.1016/S0264-410X(02)00387-0; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	49	67	70	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8453	8464		10.1074/jbc.M116.716316	http://dx.doi.org/10.1074/jbc.M116.716316			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26895960	Green Published, hybrid			2022-12-28	WOS:000374773200012
J	Kalamajski, S; Bihan, D; Bonna, A; Rubin, K; Farndale, RW				Kalamajski, Sebastian; Bihan, Dominique; Bonna, Arkadiusz; Rubin, Kristofer; Farndale, Richard W.			Fibromodulin Interacts with Collagen Cross-linking Sites and Activates Lysyl Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; extracellular matrix; fibromodulin; lysyl oxidase; small leucine-rich proteoglycan (SLRP); cross-linking	RICH REPEAT PROTEOGLYCAN; I COLLAGEN; PROTEOLYTIC ACTIVATION; SYNTHETIC PEPTIDES; CRYSTAL-STRUCTURE; DEFICIENT MICE; AMINE OXIDASE; HIGH-AFFINITY; NULL MICE; BINDING	The hallmark of fibrotic disorders is a highly cross-linked and dense collagen matrix, a property driven by the oxidative action of lysyl oxidase. Other fibrosis-associated proteins also contribute to the final collagen matrix properties, one of which is fibromodulin. Its interactions with collagen affect collagen cross-linking, packing, and fibril diameter. We investigated the possibility that a specific relationship exists between fibromodulin and lysyl oxidase, potentially imparting a specific collagen matrix phenotype. We mapped the fibromodulin-collagen interaction sites using the collagen II and III Toolkit peptide libraries. Fibromodulin interacted with the peptides containing the known collagen cross-linking sites and the MMP-1 cleavage site in collagens I and II. Interestingly, the interaction sites are closely aligned within the quarter-staggered collagen fibril, suggesting a multivalent interaction between fibromodulin and several collagen helices. Furthermore, we detected an interaction between fibromodulin and lysyl oxidase (a major collagen cross-linking enzyme) and mapped the interaction site to 12 N-terminal amino acids on fibromodulin. This interaction also increases the activity of lysyl oxidase. Together, the data suggest a fibromodulin-modulated collagen cross-linking mechanism where fibromodulin binds to a specific part of the collagen domain and also forms a complex with lysyl oxidase, targeting the enzyme toward specific cross-linking sites.	[Kalamajski, Sebastian; Rubin, Kristofer] Lund Univ, Dept Lab Med Sci, Medicon Village 406-3, S-22363 Lund, Sweden; [Bihan, Dominique; Bonna, Arkadiusz; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Downing Site, Cambridge CB2 1QW, England	Lund University; University of Cambridge	Kalamajski, S (corresponding author), Lund Univ, Dept Lab Med Sci, Medicon Village 406-3, S-22363 Lund, Sweden.; Farndale, RW (corresponding author), Univ Cambridge, Dept Biochem, Downing Site, Cambridge CB2 1QW, England.	sebastian.kalamajski@med.lu.se; rwf10@cam.ac.uk	Rubin, Kristofer/AAC-1810-2020; Bonna, Arkadiusz/T-3927-2019	Rubin, Kristofer/0000-0003-2789-6276; Bonna, Arkadiusz/0000-0002-3957-7849; Kalamajski, Sebastian/0000-0002-6600-9302	Swedish Cancer Foundation; Swedish Research Council; Alfred Osterlund Foundation; Crafoord Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; Wellcome Trust [094470/Z/10/Z]; British Heart Foundation [RG/15/4/31268]; MRC [G0400701] Funding Source: UKRI; British Heart Foundation [RG/09/003/27122] Funding Source: researchfish; Medical Research Council [G0400701] Funding Source: researchfish	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Alfred Osterlund Foundation; Crafoord Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Swedish Cancer Foundation, the Swedish Research Council, the Alfred Osterlund Foundation, the Crafoord Foundation, the Magnus Bergvall Foundation, and the Ake Wiberg Foundation.; Supported by grants from the Wellcome Trust (094470/Z/10/Z) and British Heart Foundation (RG/15/4/31268).	Atsawasuwan P, 2008, J BIOL CHEM, V283, P34229, DOI 10.1074/jbc.M803142200; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Chen S, 2014, MATRIX BIOL, V35, P103, DOI 10.1016/j.matbio.2014.01.004; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Cox TR, 2013, AM J PHYSIOL-GASTR L, V305, pG659, DOI 10.1152/ajpgi.00425.2012; CRONLUND AL, 1985, CONNECT TISSUE RES, V14, P109, DOI 10.3109/03008208509015017; Eloranta ML, 2010, ANN RHEUM DIS, V69, P1396, DOI 10.1136/ard.2009.121400; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; FUKAE M, 1980, J BIOL CHEM, V255, P6511; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; Grau-Bove X, 2015, SCI REP-UK, V5, DOI 10.1038/srep10568; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Howes JM, 2014, J BIOL CHEM, V289, P24091, DOI 10.1074/jbc.M114.583443; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Kim YM, 2011, MOL BIOL REP, V38, P145, DOI 10.1007/s11033-010-0088-0; KLEINMAN HK, 1978, J BIOL CHEM, V253, P5642; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lucero HA, 2008, J BIOL CHEM, V283, P24103, DOI 10.1074/jbc.M709897200; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Mormone E, 2012, GASTROENTEROLOGY, V142, P612, DOI 10.1053/j.gastro.2011.11.029; Nagan N., 1994, P269; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; PINNELL SR, 1968, P NATL ACAD SCI USA, V61, P708, DOI 10.1073/pnas.61.2.708; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Reyhani V, 2014, BIOCHEM J, V462, P113, DOI 10.1042/BJ20140201; Rydell-Tomaen K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06383; Scott PG, 2006, J BIOL CHEM, V281, P13324, DOI 10.1074/jbc.M513470200; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Shami A, 2013, ARTERIOSCL THROM VAS, V33, P354, DOI 10.1161/ATVBAHA.112.300723; SIEGEL RC, 1976, J BIOL CHEM, V251, P5779; SIEGEL RC, 1974, P NATL ACAD SCI USA, V71, P4826, DOI 10.1073/pnas.71.12.4826; SIEGEL RC, 1970, BIOCHEMISTRY-US, V9, P4486, DOI 10.1021/bi00825a004; SIEGEL RC, 1976, J BIOL CHEM, V251, P5786; SIEGEL RC, 1970, J BIOL CHEM, V245, P1653; Steplewski A, 2007, J STRUCT BIOL, V157, P297, DOI 10.1016/j.jsb.2006.10.009; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Viola M, 2007, CONNECT TISSUE RES, V48, P141, DOI 10.1080/03008200701276133	48	57	57	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7951	7960		10.1074/jbc.M115.693408	http://dx.doi.org/10.1074/jbc.M115.693408			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26893379	Green Published, hybrid			2022-12-28	WOS:000374056700017
J	Mendez-Gonzalez, MP; Kucheryavykh, YV; Zayas-Santiago, A; Velez-Carrasco, W; Maldonado-Martinez, G; Cubano, LA; Nichols, CG; Skatchkov, SN; Eaton, MJ				Mendez-Gonzalez, Miguel P.; Kucheryavykh, Yuriy V.; Zayas-Santiago, Astrid; Velez-Carrasco, Wanda; Maldonado-Martinez, Geronimo; Cubano, Luis A.; Nichols, Colin G.; Skatchkov, Serguei N.; Eaton, Misty J.			Novel KCNJ10 Gene Variations Compromise Function of Inwardly Rectifying Potassium Channel 4.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; GLUTAMATE UPTAKE; KIR4.1 CHANNELS; PH SENSITIVITY; SEIZURE SUSCEPTIBILITY; SENSORINEURAL DEAFNESS; MOLECULAR-MECHANISMS; CORTICAL ASTROCYTES; EXPRESSION; SUBUNIT	The KCNJ10 gene encoding Kir4.1 contains numerous SNPs whose molecular effects remain unknown. We investigated the functional consequences of uncharacterized SNPs (Q212R, L166Q, and G83V) on homomeric (Kir4.1) and heteromeric (Kir4.1-Kir5.1) channel function. We compared these with previously characterized EAST/SeSAME mutants (G77R and A167V) in kidney-derived tsA201 cells and in glial cell-derived C6 glioma cells. The membrane potentials of tsA201 cells expressing G77R and G83V were significantly depolarized as compared with WTKir4.1, whereas cells expressing Q212R, L166Q, and A167V were less affected. Furthermore, macroscopic currents from cells expressing WTKir4.1 and Q212R channels did not differ, whereas currents from cells expressing L166Q, G83V, G77R, and A167V were reduced. Unexpectedly, L166Q current responses were rescued when co-expressed with Kir5.1. In addition, we observed notable differences in channel activity between C6 glioma cells and tsA201 cells expressing L166Q and A167V, suggesting that there are underlying differences between cell lines in terms of Kir4.1 protein synthesis, stability, or expression at the surface. Finally, we determined spermine (SPM) sensitivity of these uncharacterized SNPs and found that Q212R-containing channels displayed reduced block by 1 mu M SPM. At 100 mu M SPM, the block was equal to or greater than WT, suggesting that the greater driving force of SPM allowed achievement of steady state. In contrast, L166Q-Kir5.1 channels achieved a higher block than WT, suggesting a more stable interaction of SPM in the deep pore cavity. Overall, our data suggest that G83V, L166Q, and Q212R residues play a pivotal role in controlling Kir4.1 channel function.	[Mendez-Gonzalez, Miguel P.; Kucheryavykh, Yuriy V.; Velez-Carrasco, Wanda; Skatchkov, Serguei N.; Eaton, Misty J.] Univ Cent Caribe, Dept Biochem, POB 60327, Bayamon, PR 00960 USA; [Zayas-Santiago, Astrid] Univ Cent Caribe, Dept Pathol & Lab Med, Bayamon, PR 00960 USA; [Zayas-Santiago, Astrid; Skatchkov, Serguei N.] Univ Cent Caribe, Dept Physiol, POB 60327, Bayamon, PR 00960 USA; [Maldonado-Martinez, Geronimo] Univ Cent Caribe, Dept Data Management & Stat Res Support Unit, Bayamon, PR 00960 USA; [Cubano, Luis A.] Univ Cent Caribe, Dept Anat & Cell Biol, Bayamon, PR 00960 USA; [Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Mendez-Gonzalez, MP; Skatchkov, SN (corresponding author), Univ Cent Caribe, Dept Biochem, POB 60327, Bayamon, PR 00960 USA.; Skatchkov, SN (corresponding author), Univ Cent Caribe, Dept Physiol, POB 60327, Bayamon, PR 00960 USA.	miguel.mendez3@upr.edu; sergueis50@yahoo.com	Maldonado-Martínez, Gerónimo/AAB-9049-2019	Maldonado-Martínez, Gerónimo/0000-0002-6859-0866; Zayas-Santiago, Astrid/0000-0003-4028-0564	National Institutes of Health [SC1GM088019, R01NS065201, G12MD007583, R25GM110513]; Department of Education [P031M105050]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM110513, SC1GM088019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065201] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education(US Department of Education); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grants SC1GM088019, R01NS065201, G12MD007583, and R25GM110513 and Department of Education Title V Promoting Postbaccalaureate Opportunities for Hispanic Americans Grant P031M105050. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Casamassima M, 2003, J BIOL CHEM, V278, P43533, DOI 10.1074/jbc.M306596200; Chen J, 2014, NEUROSCIENCE, V265, P137, DOI 10.1016/j.neuroscience.2014.01.036; D'Ambrosio R, 1998, J NEUROSCI, V18, P4425; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Heuser K, 2012, J NEUROPATH EXP NEUR, V71, P814, DOI 10.1097/NEN.0b013e318267b5af; Hibino H, 2004, J BIOL CHEM, V279, P44065, DOI 10.1074/jbc.M405985200; Higashi K, 2001, AM J PHYSIOL-CELL PH, V281, pC922, DOI 10.1152/ajpcell.2001.281.3.C922; Higashimori H, 2007, GLIA, V55, P1668, DOI 10.1002/glia.20574; Inyushin M, 2010, EPILEPSIA, V51, P1707, DOI 10.1111/j.1528-1167.2010.02592.x; Ishii M, 1997, J NEUROSCI, V17, P7725; Ishii M, 2003, AM J PHYSIOL-CELL PH, V285, pC260, DOI 10.1152/ajpcell.00560.2002; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Konstas AA, 2003, AM J PHYSIOL-CELL PH, V284, pC910, DOI 10.1152/ajpcell.00479.2002; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Kucheryavykh YV, 2007, CHANNELS, V1, P172, DOI 10.4161/chan.4389; Kucheryavykh YV, 2008, GLIA, V56, P775, DOI 10.1002/glia.20652; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; Kurata HT, 2010, J GEN PHYSIOL, V135, P495, DOI 10.1085/jgp.200910253; Lenzen KP, 2005, EPILEPSY RES, V63, P113, DOI 10.1016/j.eplepsyres.2005.01.002; Li LY, 2001, GLIA, V33, P57, DOI 10.1002/1098-1136(20010101)33:1<57::AID-GLIA1006>3.0.CO;2-0; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; NEWMAN EA, 1984, SCIENCE, V225, P1174, DOI 10.1126/science.6474173; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Olsen ML, 2015, J NEUROSCI, V35, P13827, DOI 10.1523/JNEUROSCI.2603-15.2015; Olsen ML, 2006, GLIA, V53, P516, DOI 10.1002/glia.20312; Olsen ML, 2004, GLIA, V46, P63, DOI 10.1002/glia.10346; Parrock S, 2013, NEPHRON PHYSIOL, V123, P7, DOI 10.1159/000356353; Pattnaik BR, 2012, MOL GENET METAB, V105, P64, DOI 10.1016/j.ymgme.2011.10.004; Paulais M, 2011, P NATL ACAD SCI USA, V108, P10361, DOI 10.1073/pnas.1101400108; Pearson WL, 1999, J PHYSIOL-LONDON, V514, P639, DOI 10.1111/j.1469-7793.1999.639ad.x; Pessia M, 2001, J PHYSIOL-LONDON, V532, P359, DOI 10.1111/j.1469-7793.2001.0359f.x; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; Phani NM, 2014, GENE, V536, P247, DOI 10.1016/j.gene.2013.12.026; Poopalasundaram S, 2000, GLIA, V30, P362, DOI 10.1002/(SICI)1098-1136(200006)30:4<362::AID-GLIA50>3.0.CO;2-4; Raphemot R, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00075; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Skatchkov SN, 2014, PSYCHIAT CLIN N AM, V37, P653, DOI 10.1016/j.psc.2014.08.008; Skatchkov SN, 1999, GLIA, V27, P171, DOI 10.1002/(SICI)1098-1136(199908)27:2<171::AID-GLIA7>3.3.CO;2-6; Tanemoto M, 2000, J PHYSIOL-LONDON, V525, P587, DOI 10.1111/j.1469-7793.2000.00587.x; Tang XF, 2010, BIOCHEM BIOPH RES CO, V399, P537, DOI 10.1016/j.bbrc.2010.07.105; Tucker SJ, 2000, J BIOL CHEM, V275, P16404, DOI 10.1074/jbc.C000127200; Wu J, 2004, J MEMBRANE BIOL, V197, P179, DOI 10.1007/s00232-004-0652-4; Xu HX, 2000, J PHYSIOL-LONDON, V528, P267, DOI 10.1111/j.1469-7793.2000.00267.x; Xu HX, 2000, J PHYSIOL-LONDON, V524, P725, DOI 10.1111/j.1469-7793.2000.00725.x; Yang ZJ, 2000, J GEN PHYSIOL, V116, P33, DOI 10.1085/jgp.116.1.33; Yang ZJ, 1999, J PHYSIOL-LONDON, V520, P921, DOI 10.1111/j.1469-7793.1999.00921.x	54	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7716	7726		10.1074/jbc.M115.679910	http://dx.doi.org/10.1074/jbc.M115.679910			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26867573	Green Published, hybrid			2022-12-28	WOS:000383447600041
J	Noy, T; Vergnolle, O; Hartman, TE; Rhee, KY; Jacobs, WR; Berney, M; Blanchard, JS				Noy, Tahel; Vergnolle, Olivia; Hartman, Travis E.; Rhee, Kyu Y.; Jacobs, William R., Jr.; Berney, Michael; Blanchard, John S.			Central Role of Pyruvate Kinase in Carbon Co-catabolism of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; bacterial metabolism; fatty acid metabolism; microbial pathogenesis; Mycobacterium tuberculosis; pyruvate kinase; tricarboxylic acid cycle (TCA cycle) (Krebs cycle)	ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; METABOLISM; GROWTH; DEHYDROGENASE; METHYLGLYOXAL; BACTERIA; PHOSPHOENOLPYRUVATE; PHOSPHORYLATION; ACETYLATION	Mycobacterium tuberculosis (Mtb) displays a high degree of metabolic plasticity to adapt to challenging host environments. Genetic evidence suggests that Mtb relies mainly on fatty acid catabolism in the host. However, Mtb also maintains a functional glycolytic pathway and its role in the cellular metabolism of Mtb has yet to be understood. Pyruvate kinase catalyzes the last and rate-limiting step in glycolysis and the Mtb genome harbors one putative pyruvate kinase (pykA, Rv1617). Here we show that pykA encodes an active pyruvate kinase that is allosterically activated by glucose 6-phosphate (Glc-6-P) and adenosine monophosphate (AMP). Deletion of pykA prevents Mtb growth in the presence of fermentable carbon sources and has a cidal effect in the presence of glucose that correlates with elevated levels of the toxic catabolite methylglyoxal. Growth attenuation was also observed in media containing a combination of short chain fatty acids and glucose and surprisingly, in media containing odd and even chain fatty acids alone. Untargeted high sensitivity metabolomics revealed that inactivation of pyruvate kinase leads to accumulation of phosphoenolpyruvate (P-enolpyruvate), citrate, and aconitate, which was consistent with allosteric inhibition of isocitrate dehydrogenase by P-enolpyruvate. This metabolic block could be relieved by addition of the -ketoglutarate precursor glutamate. Taken together, our study identifies an essential role of pyruvate kinase in preventing metabolic block during carbon co-catabolism in Mtb.	[Noy, Tahel; Vergnolle, Olivia; Blanchard, John S.] Albert Einstein Coll Med, Dept Biochem, New York, NY 10461 USA; [Jacobs, William R., Jr.; Berney, Michael] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10461 USA; [Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, New York, NY 10461 USA; [Hartman, Travis E.; Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Yeshiva University; Yeshiva University; Howard Hughes Medical Institute; Yeshiva University; Cornell University	Blanchard, JS (corresponding author), Albert Einstein Coll Med, Dept Biochem, New York, NY 10461 USA.; Berney, M (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10461 USA.	michael.berney@einstein.yu.edu; john.blanchard@einstein.yu.edu	Berney, Michael/GQZ-2111-2022	Berney, Michael/0000-0002-4833-0573; Hartman, Travis/0000-0002-3926-6928; Jacobs, William/0000-0003-3321-3080	National Institutes of Health [AI060899, AI26170, AI119573]; Burroughs Wellcome Career Award in the Biomedical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026170, R21AI119573, R01AI026170, R22AI026170, R01AI060899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI060899 (to J. S. B.), AI26170 (to W. R. J.), AI119573 (to M. B.), and a Burroughs Wellcome Career Award in the Biomedical Sciences (to K. Y. R.).	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Berney M, 2015, P NATL ACAD SCI USA, V112, P10008, DOI 10.1073/pnas.1513033112; Berney M, 2012, MOL MICROBIOL, V84, P664, DOI 10.1111/j.1365-2958.2012.08053.x; Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Booth IR, 2003, BIOCHEM SOC T, V31, P1406; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Brzostek A, 2005, MICROBIOL-SGM, V151, P2393, DOI 10.1099/mic.0.27953-0; Chavadi S, 2009, J BACTERIOL, V191, P7545, DOI 10.1128/JB.00619-09; Cheng JH, 2013, J SEP SCI, V36, P1418, DOI 10.1002/jssc.201201158; CORTASSA S, 1995, BIOTECHNOL BIOENG, V47, P193, DOI 10.1002/bit.260470211; de Carvalho LPS, 2010, CHEM BIOL, V17, P323, DOI 10.1016/j.chembiol.2010.03.009; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Ferguson GP, 1999, TRENDS MICROBIOL, V7, P242, DOI 10.1016/S0966-842X(99)01510-3; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Kayne FJ, 1973, ENZYMES, V8, P353, DOI 10.1016/S1874-6047(08)60071-2; Keating LA, 2005, MOL MICROBIOL, V56, P163, DOI 10.1111/j.1365-2958.2005.04524.x; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; Koul A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4369; Kovarova-Kovar K, 1998, MICROBIOL MOL BIOL R, V62, P646; Kremling A, 2008, BIOINFORMATICS, V24, P704, DOI 10.1093/bioinformatics/btn010; Maksymiuk C, 2015, P NATL ACAD SCI USA, V112, pE5834, DOI 10.1073/pnas.1510932112; Marrero J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003116; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Mehra S, 2015, AM J RESP CRIT CARE, V191, P1185, DOI 10.1164/rccm.201408-1502OC; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Nandakumar M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5306; Ogawa T, 2007, J BACTERIOL, V189, P1176, DOI 10.1128/JB.01628-06; Phong WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056037; Ponce E, 1999, J BIOSCI BIOENG, V87, P775, DOI 10.1016/S1389-1723(99)80152-2; Randell E. W., 2005, Journal of Pharmacological and Toxicological Methods, V51, P153, DOI 10.1016/j.vascn.2004.08.005; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Siddiquee KA, 2004, FEMS MICROBIOL LETT, V235, P25, DOI 10.1016/j.femsle.2004.04.004; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Trujillo C, 2014, MBIO, V5, DOI 10.1128/mBio.00085-14; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; Veith N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003159; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; WILSON AJ, 1986, CAN J MICROBIOL, V32, P969, DOI 10.1139/m86-180; Xu YF, 2012, MOL CELL, V48, P52, DOI 10.1016/j.molcel.2012.07.013; Xu YF, 2012, NAT CHEM BIOL, V8, P562, DOI [10.1038/NCHEMBIO.941, 10.1038/nchembio.941]; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhu T, 2001, BIOTECHNOL PROGR, V17, P624, DOI 10.1021/bp0100575; Zoraghi R, 2011, ANTIMICROB AGENTS CH, V55, P2042, DOI 10.1128/AAC.01250-10; Zoraghi R, 2010, BIOCHEMISTRY-US, V49, P7733, DOI 10.1021/bi100780t	57	24	26	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7060	7069		10.1074/jbc.M115.707430	http://dx.doi.org/10.1074/jbc.M115.707430			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26858255	Green Published, hybrid			2022-12-28	WOS:000373299700040
J	Okazaki, F; Matsunaga, N; Okazaki, H; Azuma, H; Hamamura, K; Tsuruta, A; Tsurudome, Y; Ogino, T; Hara, Y; Suzuki, T; Hyodo, K; Ishihara, H; Kikuchi, H; To, H; Aramaki, H; Koyanagi, S; Ohdo, S				Okazaki, Fumiyasu; Matsunaga, Naoya; Okazaki, Hiroyuki; Azuma, Hiroki; Hamamura, Kengo; Tsuruta, Akito; Tsurudome, Yuya; Ogino, Takashi; Hara, Yukinori; Suzuki, Takuya; Hyodo, Kenji; Ishihara, Hiroshi; Kikuchi, Hiroshi; To, Hideto; Aramaki, Hironori; Koyanagi, Satoru; Ohdo, Shigehiro			Circadian Clock in a Mouse Colon Tumor Regulates Intracellular Iron Levels to Promote Tumor Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian; circadian rhythm; iron; iron metabolism; pharmacology	TRANSFERRIN RECEPTOR; MOLECULAR CONTROL; DNA-SYNTHESIS; GROWTH-FACTOR; METABOLISM; CANCER; PROTEINS; RHYTHM; CELL; EXPRESSION	Iron is an important biological catalyst and is critical for DNA synthesis during cell proliferation. Cellular iron uptake is enhanced in tumor cells to support increased DNA synthesis. Circadian variations in DNA synthesis and proliferation have been identified in tumor cells, but their relationship with intracellular iron levels is unclear. In this study, we identified a 24-h rhythm in iron regulatory protein 2 (IRP2) levels in colon-26 tumors implanted in mice. Our findings suggest that IRP2 regulates the 24-h rhythm of transferrin receptor 1 (Tfr1) mRNA expression post-transcriptionally, by binding to RNA stem-loop structures known as iron-response elements. We also found that Irp2 mRNA transcription is promoted by circadian clock genes, including brain and muscle Arnt-like 1 (BMAL1) and the circadian locomotor output cycles kaput (CLOCK) heterodimer. Moreover, growth in colon-26(19) tumors expressing the clock-mutant protein (CLOCK19) was low compared with that in wild-type colon-26 tumor. The time-dependent variation of cellular iron levels, and the proliferation rate in wild-type colon-26 tumor was decreased by CLOCK19 expression. Our findings suggest that circadian organization contributes to tumor cell proliferation by regulating iron metabolism in the tumor.	[Okazaki, Fumiyasu; To, Hideto] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Med Pharmaceut, Toyama 9300194, Japan; [Okazaki, Fumiyasu; Matsunaga, Naoya; Azuma, Hiroki; Tsuruta, Akito; Tsurudome, Yuya; Ogino, Takashi; Hara, Yukinori; Ohdo, Shigehiro] Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Fukuoka 8128582, Japan; [Koyanagi, Satoru] Kyushu Univ, Fac Pharmaceut Sci, Dept Global Healthcare Sci, Fukuoka 8128582, Japan; [Okazaki, Hiroyuki; Hamamura, Kengo; Aramaki, Hironori] Daiichi Univ Pharm, Dept Mol Biol, Fukuoka 8158511, Japan; [Aramaki, Hironori] Daiichi Univ Pharm, Drug Innovat Res Ctr, Fukuoka 8158511, Japan; [Suzuki, Takuya; Hyodo, Kenji; Ishihara, Hiroshi] Pharmaceut Sci & Technol Core Funct Unit, Formulat Res, Ibaraki 3002635, Japan; [Kikuchi, Hiroshi] Eisai & Co Ltd, Eisai Prod Creat Syst, Chief Innovat Officer Grp, Ibaraki 3002635, Japan	University of Toyama; Kyushu University; Kyushu University; Eisai Co Ltd	Ohdo, S (corresponding author), 3-1-1 Maidashi Higashi Ku, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-u.ac.jp	Koyanagi, Satoru/AAE-6843-2020	Koyanagi, Satoru/0000-0003-4849-2377; matsunaga2, naoya2/0000-0001-6226-8473; Hamamura, Kengo/0000-0001-9146-8554; Tsurudome, Yuya/0000-0002-6454-9778	Uehara Memorial Foundation; Japan Research Foundation for Clinical Pharmacology; Japan Society for the Promotion of Science (JSPS) [25-4175]; Fukuoka Foundation for Sound Health; Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology, Japan;  [25253038];  [25136716];  [25670079];  [15K08098];  [26860097];  [15K19167];  [15H06795K]; Grants-in-Aid for Scientific Research [15H06795] Funding Source: KAKEN	Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Research Foundation for Clinical Pharmacology; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fukuoka Foundation for Sound Health(Fukuoka Foundation for Sound Health); Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology, Japan; ; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (A; 25253038) (to S. O.), Scientific Research on Innovative Areas (25136716) (to S. O.), and Challenging Exploratory Research (25670079) (to S. O.), the Uehara Memorial Foundation (to S. O.), Grant-in-Aid for Scientific Research (C; 15K08098) (to N. M.) and Grant-in-Aid for Young Scientists (B; 26860097) (to F. O.), Grant-in-Aid for Young Scientists (B; 15K19167) (to H. O.), and Grant-in-Aid for Young Scientists (Start-up; 15H06795K) (to K. H.), the Japan Research Foundation for Clinical Pharmacology (to N. M.), a Grant-in-Aid for JSPS Fellows (25-4175) (to K. H.) from the Japan Society for the Promotion of Science (JSPS), the Fukuoka Foundation for Sound Health, and the Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abbaspour N, 2014, J RES MED SCI, V19, P164; Alvarez JD, 2002, NATURE, V419, P798, DOI 10.1038/419798a; Arredondo Miguel, 2005, Molecular Aspects of Medicine, V26, P313, DOI 10.1016/j.mam.2005.07.010; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Fairweather-Tait SJ, 2004, P NUTR SOC, V63, P519, DOI 10.1079/PNS2004394; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Henderson BR, 1996, BIOESSAYS, V18, P739, DOI 10.1002/bies.950180909; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Huang X, 2003, MUTAT RES-FUND MOL M, V533, P153, DOI 10.1016/j.mrfmmm.2003.08.023; Koyanagi S, 2003, CANCER RES, V63, P7277; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Nakagawa H, 2008, J PHARMACOL SCI, V107, P401, DOI 10.1254/jphs.08080FP; NIITSU Y, 1987, TOHOKU J EXP MED, V153, P239, DOI 10.1620/tjem.153.239; Okazaki F, 2010, CANCER RES, V70, P6238, DOI 10.1158/0008-5472.CAN-10-0184; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; SMAALAND R, 1991, BLOOD, V77, P2603; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; TROWBRIDGE IS, 1982, P NATL ACAD SCI-BIOL, V79, P1175, DOI 10.1073/pnas.79.4.1175; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wood PA, 2006, MOL CANCER THER, V5, P2023, DOI 10.1158/1535-7163.MCT-06-0177	29	26	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7017	7028		10.1074/jbc.M115.713412	http://dx.doi.org/10.1074/jbc.M115.713412			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26797126	Green Published, hybrid			2022-12-28	WOS:000373299700037
J	Yin, Y; Liu, LR; Yang, CY; Lin, CX; Veith, GM; Wang, CH; Sutovsky, P; Zhou, PB; Ma, L				Yin, Yan; Liu, Liren; Yang, Chenyi; Lin, Congxing; Veith, George Michael; Wang, Caihong; Sutovsky, Peter; Zhou, Pengbo; Ma, Liang			Cell Autonomous and Nonautonomous Function of CUL4B in Mouse Spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mouse genetics; protein degradation; spermatogenesis; ubiquitin; ubiquitin ligase	SPERMATOGONIAL STEM-CELLS; UBIQUITIN LIGASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BULL SPERMATOZOA; SPERM MOTILITY; FLOW-CYTOMETRY; FIBROUS SHEATH; TESTIS; MACROPHAGES; NICHE	CUL4B ubiquitin ligase belongs to the cullin-RING ubiquitin ligase family. Although sharing many sequence and structural similarities, CUL4B plays distinct roles in spermatogenesis from its homologous protein CUL4A. We previously reported that genetic ablation of Cul4a in mice led to male infertility because of aberrant meiotic progression. In the present study, we generated Cul4b germ cell-specific conditional knock-out (Cul4b(Vasa)),as well as Cul4b global knock-out (Cul4b(Sox2)) mouse, to investigate its roles in spermatogenesis. Germ cell-specific deletion of Cul4b led to male infertility, despite normal testicular morphology and comparable numbers of spermatozoa. Notably, significantly impaired sperm mobility caused by reduced mitochondrial activity and glycolysis level were observed in the majority of the mutant spermatozoa, manifested by low, if any, sperm ATP production. Furthermore, Cul4b(Vasa) spermatozoa exhibited defective arrangement of axonemal microtubules and flagella outer dense fibers. Our mass spectrometry analysis identified INSL6 as a novel CUL4B substrate in male germ cells, evidenced by its direct polyubiquination and degradation by CUL4B E3 ligase. Nevertheless, Cul4b global knock-out males lost their germ cells in an age-dependent manner, implying failure of maintaining the spermatogonial stem cell niche in somatic cells. Taken together, our results show that CUL4B is indispensable to spermatogenesis, and it functions cell autonomously in male germ cells to ensure spermatozoa motility, whereas it functions non-cell-autonomously in somatic cells to maintain spermatogonial stemness. Thus, CUL4B links two distinct spermatogenetic processes to a single E3 ligase, highlighting the significance of ubiquitin modification during spermatogenesis.	[Yin, Yan; Lin, Congxing; Veith, George Michael; Ma, Liang] Washington Univ, Sch Med, Dept Med, Div Dermatol, Box 8123,660 S Euclid Ave, St Louis, MO 63110 USA; [Wang, Caihong] Washington Univ, Sch Med, Dept Obstet & Gynecol, Box 8123,660 S Euclid Ave, St Louis, MO 63110 USA; [Liu, Liren; Yang, Chenyi; Zhou, Pengbo] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Liu, Liren; Yang, Chenyi; Zhou, Pengbo] Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA; [Sutovsky, Peter] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Sutovsky, Peter] Univ Missouri, Dept Obstet Gynecol, Columbia, MO 65211 USA; [Sutovsky, Peter] Univ Missouri, Dept Womens Hlth, Columbia, MO 65211 USA	Washington University (WUSTL); Washington University (WUSTL); Cornell University; Cornell University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ma, L (corresponding author), Washington Univ, Dept Med, Box 8123,660 S Euclid Ave, St Louis, MO 63110 USA.	lima@dom.wustl.edu	Liu, Liren/AAX-8645-2021; liu, liren/ABH-6459-2020	Liu, Liren/0000-0001-7786-7874; liu, liren/0000-0001-7786-7874; Sutovsky, Peter/0000-0002-9231-2823	NCI Cancer Center Support Grant [P30 CA91842]; National Institutes of Health [ES016597, 1R01 CA 159925, 1R01 CA098210]; U.S. Department of Agriculture National Institute of Food and Agriculture [2011-67015-20025, 2013-67015-20961]; Food for the 21st Century Program of the University of Missouri; NATIONAL CANCER INSTITUTE [R01CA098210, P30CA091842, R01CA159925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016597] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Food for the 21st Century Program of the University of Missouri; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by NCI Cancer Center Support Grant P30 CA91842 (to the Siteman Cancer Center). This work was supported by National Institutes of Health Grants ES016597 (to L. M.) and 1R01 CA 159925 and 1R01 CA098210 (to P. Z.) and by U.S. Department of Agriculture National Institute of Food and Agriculture Awards 2011-67015-20025 and 2013-67015-20961 and seed funding from the Food for the 21st Century Program of the University of Missouri (to P. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Brugh VM, 2004, MED CLIN N AM, V88, P367, DOI 10.1016/S0025-7125(03)00150-0; Burnicka-Turek O, 2009, ENDOCRINOLOGY, V150, P4348, DOI 10.1210/en.2009-0201; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; de Rooij DG, 1999, BIOL REPROD, V61, P842, DOI 10.1095/biolreprod61.3.842; DeFalco T, 2015, CELL REP, V12, P1107, DOI 10.1016/j.celrep.2015.07.015; EVENSON DP, 1982, J HISTOCHEM CYTOCHEM, V30, P279, DOI 10.1177/30.3.6174566; Frungieri MB, 2002, FERTIL STERIL, V78, P298, DOI 10.1016/S0015-0282(02)03206-5; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Giannessi F, 2005, J MORPHOL, V263, P39, DOI 10.1002/jmor.10287; Goriely A, 2005, P NATL ACAD SCI USA, V102, P6051, DOI 10.1073/pnas.0500267102; Gravance CG, 2000, THERIOGENOLOGY, V53, P1691, DOI 10.1016/S0093-691X(00)00308-3; HALANGK W, 1990, BIOCHIM BIOPHYS ACTA, V1015, P243, DOI 10.1016/0005-2728(90)90026-Z; Hirsh A, 2003, BMJ-BRIT MED J, V327, P669, DOI 10.1136/bmj.327.7416.669; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Hsu SY, 1999, MOL ENDOCRINOL, V13, P2163, DOI 10.1210/me.13.12.2163; Ion R, 1998, HUM GENET, V102, P151, DOI 10.1007/s004390050669; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Krisfalusi M, 2006, BIOL REPROD, V75, P270, DOI 10.1095/biolreprod.105.049684; Lee J, 2013, BLOOD, V121, P4082, DOI 10.1182/blood-2012-09-455204; Lee J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00021; Liu LR, 2012, CELL RES, V22, P1258, DOI 10.1038/cr.2012.48; Lok S, 2000, BIOL REPROD, V62, P1593, DOI 10.1095/biolreprod62.6.1593; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miyazaki S, 2007, J IMMUNOL, V179, P5407, DOI 10.4049/jimmunol.179.8.5407; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; NIEMI M, 1986, CELL TISSUE RES, V243, P337; Oatley MJ, 2011, BIOL REPROD, V84, P639, DOI 10.1095/biolreprod.110.087320; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Perrin RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064314; Pfeiffer JR, 2012, J IMMUNOL, V188, P1828, DOI 10.4049/jimmunol.1102837; Ruiz-Pesini E, 1998, CLIN CHEM, V44, P1616; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Shetty G, 2007, CELL STEM CELL, V1, P361, DOI 10.1016/j.stem.2007.09.013; STOREY BT, 1977, BIOL REPROD, V16, P549; STOREY BT, 1980, J EXP ZOOL, V211, P361, DOI 10.1002/jez.1402110313; STOREY BT, 1980, J EXP ZOOL, V212, P61, DOI 10.1002/jez.1402120109; Sugasawa K, 2009, MOL CELL, V34, P403, DOI 10.1016/j.molcel.2009.05.009; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Westhoff D, 1997, J CELL SCI, V110, P1821; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	47	18	20	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6923	6935		10.1074/jbc.M115.699660	http://dx.doi.org/10.1074/jbc.M115.699660			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26846852	Green Published, hybrid			2022-12-28	WOS:000373299700029
J	Gu, XD; Wu, ZP; Huang, Y; Wagner, MA; Baleanu-Gogonea, C; Mehl, RA; Buffa, JA; DiDonato, AJ; Hazen, LB; Fox, PL; Gogonea, V; Parks, JS; DiDonato, JA; Hazen, SL				Gu, Xiaodong; Wu, Zhiping; Huang, Ying; Wagner, Matthew A.; Baleanu-Gogonea, Camelia; Mehl, Ryan A.; Buffa, Jennifer A.; DiDonato, Anthony J.; Hazen, Leah B.; Fox, Paul L.; Gogonea, Valentin; Parks, John S.; DiDonato, Joseph A.; Hazen, Stanley L.			A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; atherosclerosis; cholesterol; high-density lipoprotein (HDL); post-translational modification (PTM); LCAT	CASSETTE TRANSPORTER 1; APOA-I; TANGIER-DISEASE; NATURAL MUTATIONS; HUMAN ATHEROMA; LECITHIN; HDL; LCAT; DEFICIENCY; ACTIVATION	The interaction of lecithin-cholesterol acyltransferase (LCAT) with apolipoprotein A-I (apoA-I) plays a critical role in high-density lipoprotein (HDL) maturation. We previously identified a highly solvent-exposed apoA-I loop domain (Leu(159)-Leu(170)) in nascent HDL, the so-called solar flare (SF) region, and proposed that it serves as an LCAT docking site (Wu, Z., Wagner, M. A., Zheng, L., Parks, J. S., Shy, J. M., 3rd, Smith, J. D., Gogonea, V., and Hazen, S. L. (2007) Nat. Struct. Mol. Biol. 14, 861-868). The stability and role of the SF domain of apoA-I in supporting HDL binding and activation of LCAT are debated. Here we show by site-directed mutagenesis that multiple residues within the SF region (Pro(165), Tyr(166), Ser(167), and Asp(168)) of apoA-I are critical for both LCAT binding to HDL and LCAT catalytic efficiency. The critical role for possible hydrogen bond interaction at apoA-I Tyr(166) was further supported using reconstituted HDL generated from apoA-I mutants (Tyr(166) Glu or Asn), which showed preservation in both LCAT binding affinity and catalytic efficiency. Moreover, the in vivo functional significance of NO2-Tyr(166)-apoA-I, a specific post-translational modification on apoA-I that is abundant within human atherosclerotic plaque, was further investigated by using the recombinant protein generated from E. coli containing a mutated orthogonal tRNA synthetase/tRNA(CUA) pair enabling site-specific insertion of the unnatural amino acid into apoA-I. NO2-Tyr(166)-apoA-I, after subcutaneous injection into hLCAT(Tg/Tg), apoA-I-/- mice, showed impaired LCAT activation in vivo, with significant reduction in HDL cholesteryl ester formation. The present results thus identify multiple structural features within the solvent-exposed SF region of apoA-I of nascent HDL essential for optimal LCAT binding and catalytic efficiency.	[Gu, Xiaodong; Wu, Zhiping; Huang, Ying; Wagner, Matthew A.; Baleanu-Gogonea, Camelia; Buffa, Jennifer A.; DiDonato, Anthony J.; Hazen, Leah B.; Fox, Paul L.; Gogonea, Valentin; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Gogonea, Valentin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Mehl, Ryan A.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Parks, John S.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Oregon State University; Wake Forest University	Hazen, SL (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, 9500 Euclid Ave,NE-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021		National Institutes of Health [P01 HL076491, R01 HL119962]; Esperion; PG; Abbott; Astra Zeneca; Pfizer Inc.; Roche; Takeda; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, R01HL119962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Esperion; PG(Procter & Gamble); Abbott(Abbott Laboratories); Astra Zeneca(AstraZeneca); Pfizer Inc.(Pfizer); Roche(Roche Holding); Takeda(Takeda Pharmaceutical Company Ltd); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01 HL076491 and R01 HL119962 (to J. S. P.). S. L. H. is named as co-inventor on pending patents held by the Cleveland Clinic relating to cardiovascular and inflammation diagnostics. S. L. H. reports having been paid as a consultant for the following companies: Esperion and P&G. S. L. H. reports receiving research funds from Abbott, Astra Zeneca, P&G, Pfizer Inc., Roche, and Takeda. S. L. H. Hazen reports having the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from the following companies: Cleveland Heart Lab, Siemens, Esperion, Frantz Biomarkers, LLC. All other authors have no relationships to disclose. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander ET, 2005, BIOCHEMISTRY-US, V44, P5409, DOI 10.1021/bi047412v; Bochem AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090967; Bochem AE, 2013, J LIPID RES, V54, P1698, DOI 10.1194/jlr.P033449; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Boes E, 2009, EXP GERONTOL, V44, P136, DOI 10.1016/j.exger.2008.11.003; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Carlson L. A., 1979, LANCET, V2, P922; Chisholm JW, 1999, J LIPID RES, V40, P1512; Cho KH, 2001, J LIPID RES, V42, P379; Daum U, 1999, J LIPID RES, V40, P486; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; Duivenvoorden R, 2011, J AM COLL CARDIOL, V58, P2481, DOI 10.1016/j.jacc.2010.11.092; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; Fotakis P, 2015, BIOCHEMISTRY-US, V54, P3348, DOI 10.1021/acs.biochem.5b00180; Fotakis P, 2013, J LIPID RES, V54, P3293, DOI 10.1194/jlr.M043489; Furbee JW, 2002, ATHEROSCLEROSIS, V165, P89, DOI 10.1016/S0021-9150(02)00201-0; Furbee JW, 2002, J BIOL CHEM, V277, P3511, DOI 10.1074/jbc.M109883200; GLOMSET JA, 1968, J LIPID RES, V9, P155; Gogonea V, 2013, J LIPID RES, V54, P966, DOI 10.1194/jlr.M032763; Gorshkova IN, 2006, BIOCHEMISTRY-US, V45, P1242, DOI 10.1021/bi051669r; Hoang A, 2003, BBA-MOL CELL BIOL L, V1631, P72, DOI 10.1016/S1388-1981(02)00357-8; Holvoet P, 2000, ARTERIOSCL THROM VAS, V20, P459, DOI 10.1161/01.ATV.20.2.459; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Jin LH, 1999, BIOCHEMISTRY-US, V38, P15659, DOI 10.1021/bi9916729; Koukos G, 2007, BIOCHEMISTRY-US, V46, P10713, DOI 10.1021/bi7003203; Kunnen S, 2012, J LIPID RES, V53, P1783, DOI 10.1194/jlr.R024513; Leren TP, 1997, J LIPID RES, V38, P121; Li XM, 2013, ARTERIOSCL THROM VAS, V33, P1696, DOI 10.1161/ATVBAHA.113.301373; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Miettinen HE, 1997, ARTERIOSCL THROM VAS, V17, P3021, DOI 10.1161/01.ATV.17.11.3021; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Roshan B, 2011, J CLIN LIPIDOL, V5, P493, DOI 10.1016/j.jacl.2011.07.002; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Saeedi R, 2015, CLIN BIOCHEM, V48, P472, DOI 10.1016/j.clinbiochem.2014.08.014; Schaefer EJ, 2014, CURR OPIN LIPIDOL, V25, P194, DOI 10.1097/MOL.0000000000000074; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shih AY, 2008, BIOPHYS J, V94, pL87, DOI 10.1529/biophysj.108.131581; Sorci-Thomas MG, 2009, CLIN LIPIDOL, V4, P113, DOI 10.2217/17584299.4.1.113; Sviridov D, 2002, J LIPID RES, V43, P1283, DOI 10.1194/jlr.M100437/JLR200; Sviridov D, 1996, J BIOL CHEM, V271, P33277, DOI 10.1074/jbc.271.52.33277; van den Bogaard B, 2012, ATHEROSCLEROSIS, V225, P481, DOI 10.1016/j.atherosclerosis.2012.09.022; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209130; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	46	14	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6386	6395		10.1074/jbc.M115.696088	http://dx.doi.org/10.1074/jbc.M115.696088			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797122	hybrid, Green Published			2022-12-28	WOS:000372894200027
J	Chhibber-Goel, J; Coleman-Vaughan, C; Agrawal, V; Sawhney, N; Hickey, E; Powell, JC; McCarthy, JV				Chhibber-Goel, Jyoti; Coleman-Vaughan, Caroline; Agrawal, Vishal; Sawhney, Neha; Hickey, Emer; Powell, James C.; McCarthy, Justin V.			gamma-Secretase Activity Is Required for Regulated Intramembrane Proteolysis of Tumor Necrosis Factor (TNF) Receptor 1 and TNF-mediated Pro-apoptotic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; c-Jun N-terminal kinase (JNK); cell death; gamma-secretase; NF-kappaB; presenilin; receptor internalization; tumor necrosis factor (TNF)	NF-KAPPA-B; P75 NEUROTROPHIN RECEPTOR; AMYLOID PRECURSOR PROTEIN; FACTOR-ALPHA; CELL-DEATH; TRANSMEMBRANE ASPARTATES; NUCLEAR TRANSLOCATION; INTRACELLULAR DOMAIN; TRKA RECEPTOR; RIP KINASES	The -secretase protease and associated regulated intramembrane proteolysis play an important role in controlling receptor-mediated intracellular signaling events, which have a central role in Alzheimer disease, cancer progression, and immune surveillance. An increasing number of -secretase substrates have a role in cytokine signaling, including the IL-6 receptor, IL-1 receptor type I, and IL-1 receptor type II. In this study, we show that following TNF-converting enzyme-mediated ectodomain shedding of TNF type I receptor (TNFR1), the membrane-bound TNFR1 C-terminal fragment is subsequently cleaved by -secretase to generate a cytosolic TNFR1 intracellular domain. We also show that clathrin-mediated internalization of TNFR1 C-terminal fragment is a prerequisite for efficient -secretase cleavage of TNFR1. Furthermore, using in vitro and in vivo model systems, we show that in the absence of presenilin expression and -secretase activity, TNF-mediated JNK activation was prevented, assembly of the TNFR1 pro-apoptotic complex II was reduced, and TNF-induced apoptosis was inhibited. These observations demonstrate that TNFR1 is a -secretase substrate and suggest that -secretase cleavage of TNFR1 represents a new layer of regulation that links the presenilins and the -secretase protease to pro-inflammatory cytokine signaling.	[Chhibber-Goel, Jyoti; Coleman-Vaughan, Caroline; Agrawal, Vishal; Sawhney, Neha; Hickey, Emer; Powell, James C.; McCarthy, Justin V.] Natl Univ Ireland Univ Coll Cork, ABCRF, Sch Biochem & Cell Biol, Signal Transduct Lab, 3-41 Western Gateway Bldg,Western Rd, Cork T12 YN60, Ireland	University College Cork	McCarthy, JV (corresponding author), Natl Univ Ireland Univ Coll Cork, ABCRF, Sch Biochem & Cell Biol, Signal Transduct Lab, 3-41 Western Gateway Bldg,Western Rd, Cork T12 YN60, Ireland.	jv.mccarthy@ucc.ie	mccarthy, justin/AAG-7550-2019; Chhibber-Goel, Jyoti/AAC-5735-2020; Goel, Jyoti/L-4510-2019	Chhibber-Goel, Jyoti/0000-0003-4654-5463; Coleman-Vaughan, Caroline/0000-0001-9031-9717; mccarthy, justin/0000-0002-2667-7365	Science Foundation Ireland [02/IN1/B218, 09/IN.1/B2624]; Irish Research Council for Science, Engineering, and Technology [RS/2012/407]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering, and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR)	This work was supported by Science Foundation Ireland Grants 02/IN1/B218 and 09/IN.1/B2624 and Irish Research Council for Science, Engineering, and Technology Grant RS/2012/407. The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bartsch JW, 2010, J NEUROSCI, V30, P12210, DOI 10.1523/JNEUROSCI.1520-10.2010; Berezovska O, 2000, ANN NY ACAD SCI, V920, P223; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chalaris A, 2010, BBA-MOL CELL RES, V1803, P234, DOI 10.1016/j.bbamcr.2009.12.001; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Elzinga BM, 2009, J BIOL CHEM, V284, P1394, DOI 10.1074/jbc.M803108200; Fischer R, 2011, CELL SIGNAL, V23, P161, DOI 10.1016/j.cellsig.2010.08.016; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fritsch J, 2014, MOL CELL BIOL, V34, P3214, DOI 10.1128/MCB.00048-14; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Humphries F, 2015, CELL DEATH DIFFER, V22, P225, DOI 10.1038/cdd.2014.126; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Jurisch-Yaksi N, 2013, BBA-BIOMEMBRANES, V1828, P2815, DOI 10.1016/j.bbamem.2013.04.016; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Kirschenbaum F, 2001, J BIOL CHEM, V276, P30701, DOI 10.1074/jbc.M102849200; Kirschenbaum F, 2001, J BIOL CHEM, V276, P7366, DOI 10.1074/jbc.M004697200; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Lo HM, 2014, ACTA PHARMACOL SIN, V35, P339, DOI 10.1038/aps.2013.182; Lo HM, 2013, INT J MOL SCI, V14, P10090, DOI 10.3390/ijms140510090; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; McElroy B, 2007, BIOCHEM BIOPH RES CO, V358, P1136, DOI 10.1016/j.bbrc.2007.05.062; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Neumeyer J, 2006, EXP CELL RES, V312, P2142, DOI 10.1016/j.yexcr.2006.03.014; Parkhurst CN, 2010, J BIOL CHEM, V285, P5361, DOI 10.1074/jbc.M109.045054; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Powell JC, 2009, J NEUROCHEM, V108, P216, DOI 10.1111/j.1471-4159.2008.05763.x; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Schneider-Brachert W, 2013, INT J MOL SCI, V14, P14475, DOI 10.3390/ijms140714475; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schutze S, 2009, RESULTS PROBL CELL D, V49, P63, DOI 10.1007/400_2008_23; Schulte A, 2007, BIOCHEM BIOPH RES CO, V358, P233, DOI 10.1016/j.bbrc.2007.04.100; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Silke J, 2011, CURR OPIN IMMUNOL, V23, P620, DOI 10.1016/j.coi.2011.08.002; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; TARTAGLIA LA, 1993, CELL, V73, P213, DOI 10.1016/0092-8674(93)90222-C; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; Tchikov V, 2011, EUR J CELL BIOL, V90, P467, DOI 10.1016/j.ejcb.2010.11.002; Tournoy J, 2004, HUM MOL GENET, V13, P1321, DOI 10.1093/hmg/ddh151; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2015, METHODS MOL BIOL, V1280, P269, DOI 10.1007/978-1-4939-2422-6_15; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Wolfe MS, 2008, CURR TOP MED CHEM, V8, P2, DOI 10.2174/156802608783334024; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367	79	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5971	5985		10.1074/jbc.M115.679076	http://dx.doi.org/10.1074/jbc.M115.679076			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26755728	Green Published, hybrid			2022-12-28	WOS:000372551800042
J	Ruan, C; Cui, HC; Lee, CH; Li, S; Li, B				Ruan, Chun; Cui, Haochen; Lee, Chul-Hwan; Li, Sheng; Li, Bing			Homodimeric PHD Domain-containing Rco1 Subunit Constitutes a Critical Interaction Hub within the Rpd3S Histone Deacetylase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; histone deacetylase (HDAC); histone modification; PHD finger; transcription	RNA-POLYMERASE-II; POLYCOMB REPRESSIVE COMPLEX; TRANSCRIPTIONAL ELONGATION; SACCHAROMYCES-CEREVISIAE; NUCLEOSOME RECOGNITION; TRANSCRIBED CHROMATIN; H3K4 METHYLATION; STRUCTURAL BASIS; CODING REGIONS; SET2	Recognition of histone post-translational modifications is pivotal for directing chromatin-modifying enzymes to specific genomic regions and regulating their activities. Emerging evidence suggests that other structural features of nucleosomes also contribute to precise targeting of downstream chromatin complexes, such as linker DNA, the histone globular domain, and nucleosome spacing. However, how chromatin complexes coordinate individual interactions to achieve high affinity and specificity remains unclear. The Rpd3S histone deacetylase utilizes the chromodomain-containing Eaf3 subunit and the PHD domain-containing Rco1 subunit to recognize nucleosomes that are methylated at lysine 36 of histone H3 (H3K36me). We showed previously that the binding of Eaf3 to H3K36me can be allosterically activated by Rco1. To investigate how this chromatin recognition module is regulated in the context of the Rpd3S complex, we first determined the subunit interaction network of Rpd3S. Interestingly, we found that Rpd3S contains two copies of the essential subunit Rco1, and both copies of Rco1 are required for full functionality of Rpd3S. Our functional dissection of Rco1 revealed that besides its known chromatin-recognition interfaces, other regions of Rco1 are also critical for Rpd3S to recognize its nucleosomal substrates and functionin vivo. This unexpected result uncovered an important and understudied aspect of chromatin recognition. It suggests that precisely reading modified chromatin may not only need the combined actions of reader domains but also require an internal signaling circuit that coordinates the individual actions in a productive way.	[Ruan, Chun; Cui, Haochen; Lee, Chul-Hwan; Li, Bing] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	Li, B (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Bing4.Li@utsouthwestern.edu		Lee, Chul-Hwan/0000-0003-0643-0100	National Institutes of Health [GM090077]; Welch Foundation [I-1713]; American Heart Association;  [R01AI081982];  [R01GM020501];  [R01AI101436]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081982, R01AI101436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501, R01GM090077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by National Institutes of Health Grants GM090077 (to B. L.) and R01AI081982, R01GM020501, and R01AI101436 (to S. L.). This work was also supported by the Welch Foundation (I-1713) and the American Heart Association.	Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Burns-Hamuro LL, 2005, PROTEIN SCI, V14, P2982, DOI 10.1110/ps.051687305; Canzio D, 2013, NATURE, V496, P377, DOI 10.1038/nature12032; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen XF, 2012, CURR BIOL, V22, P56, DOI 10.1016/j.cub.2011.11.042; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Dumesic PA, 2015, CELL, V160, P204, DOI 10.1016/j.cell.2014.11.039; Engen JR, 2009, ANAL CHEM, V81, P7870, DOI 10.1021/ac901154s; Gilbert TM, 2014, MOL CELL PROTEOMICS, V13, P2883, DOI 10.1074/mcp.M114.038224; Ginsburg DS, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.585588; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Huerta-Cepas J, 2014, NUCLEIC ACIDS RES, V42, pD897, DOI 10.1093/nar/gkt1177; Huh JW, 2012, EMBO J, V31, P3564, DOI 10.1038/emboj.2012.221; Jelinic P, 2011, MOL CELL BIOL, V31, P54, DOI 10.1128/MCB.00840-10; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim J, 2013, MOL CELL, V49, P1121, DOI 10.1016/j.molcel.2013.01.034; Kim SA, 2015, NUCLEIC ACIDS RES, V43, P4868, DOI 10.1093/nar/gkv388; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lee CH, 2013, MOL CELL, V52, P255, DOI 10.1016/j.molcel.2013.08.024; Lee N, 2009, MOL CELL BIOL, V29, P1401, DOI 10.1128/MCB.01643-08; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Merkera JD, 2008, DNA REPAIR, V7, P1298, DOI 10.1016/j.dnarep.2008.04.009; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; O'Meara MM, 2012, CHROMOSOMA, V121, P221, DOI 10.1007/s00412-012-0361-1; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Ranjan A, 2013, CELL, V154, P1232, DOI 10.1016/j.cell.2013.08.005; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Rossetto D, 2014, EMBO J, V33, P1397, DOI 10.15252/embj.201386433; Ruan C, 2015, CELL REP, V10, P204, DOI 10.1016/j.celrep.2014.12.027; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sardiu ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007310; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Soares LM, 2014, CELL REP, V6, P961, DOI 10.1016/j.celrep.2014.02.017; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tie F, 2007, MOL CELL BIOL, V27, P2014, DOI 10.1128/MCB.01822-06; Wang Y, 2015, NUCLEIC ACIDS RES, V43, P4881, DOI 10.1093/nar/gkv393; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237; Yun M, 2012, METHODS MOL BIOL, V833, P237, DOI 10.1007/978-1-61779-477-3_15	57	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5428	5438		10.1074/jbc.M115.703637	http://dx.doi.org/10.1074/jbc.M115.703637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26747610	Green Published, hybrid			2022-12-28	WOS:000371640600050
J	Torrente, MP; Chuang, E; Noll, MM; Jackrel, ME; Go, MS; Shorter, J				Torrente, Mariana P.; Chuang, Edward; Noll, Megan M.; Jackrel, Meredith E.; Go, Michelle S.; Shorter, James			Mechanistic Insights into Hsp104 Potentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein; fused in sarcoma (FUS); protein engineering; protein misfolding; TAR DNA-binding protein 43 (TDP-43) (TARDBP); hsp104; protein disaggregase	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; ALPHA-SYNUCLEIN; PROTEIN DISAGGREGATION; NEURODEGENERATIVE DISEASE; ATPASE ACTIVITY; BINDING DOMAIN; MIDDLE DOMAIN; CENTRAL PORE; CHAPERONE	Potentiated variants of Hsp104, a protein disaggregase from yeast, can dissolve protein aggregates connected to neurodegenerative diseases such as Parkinson disease and amyotrophic lateral sclerosis. However, the mechanisms underlying Hsp104 potentiation remain incompletely defined. Here, we establish that 2-3 subunits of the Hsp104 hexamer must bear an A503V potentiating mutation to elicit enhanced disaggregase activity in the absence of Hsp70. We also define the ATPase and substrate-binding modalities needed for potentiated Hsp104(A503V) activity in vitro and in vivo. Hsp104(A503V) disaggregase activity is strongly inhibited by the Y257A mutation that disrupts substrate binding to the nucleotide-binding domain 1 (NBD1) pore loop and is abolished by the Y662A mutation that disrupts substrate binding to the NBD2 pore loop. Intriguingly, Hsp104(A503V) disaggregase activity responds to mixtures of ATP and adenosine 5-(-thio)-triphosphate (a slowly hydrolyzable ATP analogue) differently from Hsp104. Indeed, an altered pattern of ATP hydrolysis and altered allosteric signaling between NBD1 and NBD2 are likely critical for potentiation. Hsp104(A503V) variants bearing inactivating Walker A or Walker B mutations in both NBDs are inoperative. Unexpectedly, however, Hsp104(A503V) retains potentiated activity upon introduction of sensor-1 mutations that reduce ATP hydrolysis at NBD1 (T317A) or NBD2 (N728A). Hsp104(T317A/A503V) and Hsp104(A503V/N728A) rescue TDP-43 (TAR DNA-binding protein 43), FUS (fused in sarcoma), and -synuclein toxicity in yeast. Thus, Hsp104(A503V) displays a more robust activity that is unperturbed by sensor-1 mutations that greatly reduce Hsp104 activity in vivo. Indeed, ATPase activity at NBD1 or NBD2 is sufficient for Hsp104 potentiation. Our findings will empower design of ameliorated therapeutic disaggregases for various neurodegenerative diseases.	[Shorter, James] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Chuang, Edward; Shorter, James] Univ Penn, Perelman Sch Med, Pharmacol Grad Grp, Philadelphia, PA 19104 USA; [Go, Michelle S.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Shorter, J (corresponding author), 805B Stellar Chance Labs, 422 Curie Blvd, Philadelphia, PA 19104 USA.	jshorter@mail.med.upenn.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Jackrel, Meredith/0000-0003-4406-9504	PENN-PORT Postdoctoral Fellowship [K12GM081259]; NINDS Advanced Postdoctoral Career Transition Award from the National Institutes of Health (NIH) [K22NS09131401]; NIH Predoctoral Training Grant in Pharmacology [T32GM008076]; American Heart Association; Target ALS Springboard Fellowship; NIH Director's New Innovator Award [DP2OD002177]; NIH [R01GM099836]; Muscular Dystrophy Association Research Award [MDA277268]; Robert Packard Center for ALS Research at Johns Hopkins University; Target ALS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099836, K12GM081259, T32GM008076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K22NS091314] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177] Funding Source: NIH RePORTER	PENN-PORT Postdoctoral Fellowship; NINDS Advanced Postdoctoral Career Transition Award from the National Institutes of Health (NIH); NIH Predoctoral Training Grant in Pharmacology; American Heart Association(American Heart Association); Target ALS Springboard Fellowship; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association Research Award(Muscular Dystrophy Association); Robert Packard Center for ALS Research at Johns Hopkins University; Target ALS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by PENN-PORT Postdoctoral Fellowship K12GM081259 and NINDS Advanced Postdoctoral Career Transition Award K22NS09131401 from the National Institutes of Health (NIH).; Supported by NIH Predoctoral Training Grant in Pharmacology T32GM008076.; Supported by an American Heart Association post-doctoral fellowship and a Target ALS Springboard Fellowship.; Supported by NIH Director's New Innovator Award DP2OD002177, NIH Grant R01GM099836, Muscular Dystrophy Association Research Award MDA277268, the Robert Packard Center for ALS Research at Johns Hopkins University, and Target ALS.	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; Castellano LM, 2015, CHEM BIOL, V22, P1074, DOI 10.1016/j.chembiol.2015.07.007; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DeSantis ME, 2014, J BIOL CHEM, V289, P848, DOI 10.1074/jbc.M113.520759; DeSantis ME, 2012, CHEM BIOL, V19, P1400, DOI 10.1016/j.chembiol.2012.09.013; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Duennwald Martin L, 2012, PLoS Biol, V10, pe1001346, DOI 10.1371/journal.pbio.1001346; Fang YS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5824; Feiler MS, 2015, J CELL BIOL, V211, P897, DOI 10.1083/jcb.201504057; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Grimminger-Marquardt V, 2010, BIOPOLYMERS, V93, P252, DOI 10.1002/bip.21301; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hoppener JWM, 2000, NEW ENGL J MED, V343, P411; Jackrel ME, 2015, ACS CHEM BIOL, V10, P2672, DOI 10.1021/acschembio.5b00765; Jackrel ME, 2015, PRION, V9, P90, DOI 10.1080/19336896.2015.1020277; Jackrel ME, 2014, JOVE-J VIS EXP, DOI 10.3791/52089; Jackrel ME, 2014, DIS MODEL MECH, V7, P1175, DOI 10.1242/dmm.016113; Jackrel ME, 2014, CELL CYCLE, V13, P1379, DOI 10.4161/cc.28709; Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kao PF, 2015, ANN NEUROL, V78, P211, DOI 10.1002/ana.24431; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Li T, 2015, BIOCHEM J, V470, P39, DOI 10.1042/BJ20141457; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liu YH, 2011, INT J BIOCHEM CELL B, V43, P768, DOI 10.1016/j.biocel.2011.01.022; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mahul-Mellier AL, 2015, CELL DEATH DIFFER, V22, P2107, DOI 10.1038/cdd.2015.79; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Narayanan S, 2006, CHEMBIOCHEM, V7, P757, DOI 10.1002/cbic.200500382; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schaupp A, 2007, J MOL BIOL, V370, P674, DOI 10.1016/j.jmb.2007.04.070; Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Shorter J, 2005, NAT STRUCT MOL BIOL, V12, P4, DOI 10.1038/nsmb0105-4; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Shorter J, 2008, NEUROSIGNALS, V16, P63, DOI 10.1159/000109760; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Sweeny EA, 2016, J MOL BIOL, V428, P1870, DOI 10.1016/j.jmb.2015.11.016; Sweeny EA, 2011, JOVE-J VIS EXP, DOI 10.3791/3190; Sweeny EA, 2015, MOL CELL, V57, P836, DOI 10.1016/j.molcel.2014.12.021; Sweeny EA, 2008, PRION, V2, P135, DOI 10.4161/pri.2.4.7952; Takahashi A, 2007, PRION, V1, P69, DOI 10.4161/pri.1.1.4060; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Torrente MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110115; Torrente MP, 2013, PRION, V7, P457, DOI 10.4161/pri.27531; Vashist S, 2010, BIOCHEM CELL BIOL, V88, P1, DOI [10.1139/O09-121, 10.1139/o09-121]; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Yu A, 2014, P NATL ACAD SCI USA, V111, pE1481, DOI 10.1073/pnas.1321811111	85	29	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5101	5115		10.1074/jbc.M115.707976	http://dx.doi.org/10.1074/jbc.M115.707976			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26747608	Green Published, hybrid			2022-12-28	WOS:000371640600023
J	Levenson, R; Bracken, C; Bush, N; Morse, DE				Levenson, Robert; Bracken, Colton; Bush, Nicole; Morse, Daniel E.			Cyclable Condensation and Hierarchical Assembly of Metastable Reflectin Proteins, the Drivers of Tunable Biophotonics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomaterials; intrinsically disordered protein; protein aggregation; protein assembly; protein self-assembly; biophotonics; iridescence; protein metastability; reflectins; tunable	ELASTIN-LIKE POLYPEPTIDES; HYDROPHOBIC MOMENT; SQUID IRIDOPHORES; IRIDESCENCE; PHOSPHORYLATION; ORGANIZATION; MECHANISMS	Reversible changes in the phosphorylation of reflectin proteins have been shown to drive the tunability of color and brightness of light reflected from specialized cells in the skin of squids and related cephalopods. We show here, using dynamic light scattering, electron microscopy, and fluorescence analyses, that reversible titration of the excess positive charges of the reflectins, comparable with that produced by phosphorylation, is sufficient to drive the reversible condensation and hierarchical assembly of these proteins. The results suggest a two-stage process in which charge neutralization first triggers condensation, resulting in the emergence of previously cryptic structures that subsequently mediate reversible, hierarchical assembly. The extent to which cyclability is seen in the in vitro formation and disassembly of complexes estimated to contain several thousand reflectin molecules suggests that intrinsic sequence- and structure-determined specificity governs the reversible condensation and assembly of the reflectins and that these processes are therefore sufficient to produce the reversible changes in refractive index, thickness, and spacing of the reflectin-containing subcellular Bragg lamellae to change the brightness and color of reflected light. This molecular mechanism points to the metastability of reflectins as the centrally important design principle governing biophotonic tunability in this system.	[Levenson, Robert; Bracken, Colton; Bush, Nicole; Morse, Daniel E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Morse, DE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	d_morse@lifesci.ucsb.edu	Bush, Nicole/AAH-4935-2020; Levenson, Robert/AAD-6906-2022	Levenson, Robert/0000-0001-8251-626X; Bracken, Colton/0000-0003-3499-7032	Office of Naval Research via a Multidisciplinary University Research Initiative [N00014-09-1-1053]; Army Research Office [W911NF-10-1-0139]; National Science Foundation; Materials Research Science and Engineering Center Program of the National Science Foundation [1121053]	Office of Naval Research via a Multidisciplinary University Research Initiative; Army Research Office; National Science Foundation(National Science Foundation (NSF)); Materials Research Science and Engineering Center Program of the National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the Office of Naval Research via a Multidisciplinary University Research Initiative award to Duke University (N00014-09-1-1053) and the Army Research Office (W911NF-10-1-0139) (to D. E. M.). Use of the University of California, Santa Barbara, Materials Research Laboratory Shared Experimental Facilities, a member of the National Science Foundation-funded Materials Research Facilities Network, was supported by the Materials Research Science and Engineering Center Program of the National Science Foundation under Materials Research Award 1121053. The authors declare that they have no conflicts of interest with the contents of this article.	Boal JG, 2004, BEHAVIOUR, V141, P837, DOI 10.1163/1568539042265662; COOPER KM, 1990, CELL TISSUE RES, V259, P15, DOI 10.1007/BF00571425; Crookes WJ, 2004, SCIENCE, V303, P235, DOI 10.1126/science.1091288; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeMartini DG, 2015, J BIOL CHEM, V290, P15238, DOI 10.1074/jbc.M115.638254; DeMartini DG, 2013, J EXP BIOL, V216, P3733, DOI 10.1242/jeb.090415; DeMartini DG, 2013, P NATL ACAD SCI USA, V110, P2552, DOI 10.1073/pnas.1217260110; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Fudouzi H, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/6/064704; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Ghoshal A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0106; Ghoshal A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0386; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Izumi M, 2010, J R SOC INTERFACE, V7, P549, DOI 10.1098/rsif.2009.0299; Kramer RM, 2007, NAT MATER, V6, P533, DOI 10.1038/nmat1930; Kundu B, 2002, BIOCHEM BIOPH RES CO, V293, P572, DOI 10.1016/S0006-291X(02)00257-7; Phan L, 2013, ADV MATER, V25, P5621, DOI 10.1002/adma.201301472; MacEwan SR, 2014, J CONTROL RELEASE, V190, P314, DOI 10.1016/j.jconrel.2014.06.028; Mathger LM, 2004, J EXP BIOL, V207, P1759, DOI 10.1242/jeb.00955; McDaniel JR, 2013, BIOMACROMOLECULES, V14, P2866, DOI 10.1021/bm4007166; Ordinario DD, 2014, NAT CHEM, V6, P597, DOI [10.1038/NCHEM.1960, 10.1038/nchem.1960]; Qin GK, 2013, J POLYM SCI POL PHYS, V51, P254, DOI 10.1002/polb.23204; Qin Z, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.198304; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Tao AR, 2010, BIOMATERIALS, V31, P793, DOI 10.1016/j.biomaterials.2009.10.038; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wang Q, 2014, ADV FUNCT MATER, V24, P4303, DOI 10.1002/adfm.201304106; Wardill TJ, 2012, P ROY SOC B-BIOL SCI, V279, P4243, DOI 10.1098/rspb.2012.1374; Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h; Yu CJ, 2014, P NATL ACAD SCI USA, V111, P12998, DOI 10.1073/pnas.1410494111	33	35	35	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4058	4068		10.1074/jbc.M115.686014	http://dx.doi.org/10.1074/jbc.M115.686014			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26719342	Green Published, hybrid			2022-12-28	WOS:000371338400031
J	Vishwanatha, KS; Back, N; Lam, TT; Mains, RE; Eipper, BA				Vishwanatha, Kurutihalli S.; Back, Nils; Lam, TuKiet T.; Mains, Richard E.; Eipper, Betty A.			O-Glycosylation of a Secretory Granule Membrane Enzyme Is Essential for Its Endocytic Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMIDATING MONOOXYGENASE; CLATHRIN-MEDIATED ENDOCYTOSIS; N-ACETYLGALACTOSAMINE; MULTIVESICULAR BODIES; NEUROENDOCRINE CELLS; CONGENITAL DISORDERS; ROUTING DOMAINS; ATT-20 CELLS; PROTEIN; PEPTIDE	Peptidylglycine alpha-amidating monooxygenase (PAM) (EC 1.14.17.3) catalyzes peptide amidation, a crucial post-translational modification, through the sequential actions of its monooxygenase (peptidylglycine alpha-hydroxylating monooxygenase) and lyase (peptidyl-alpha-hydroxyglycine alpha-amidating lyase (PAL)) domains. Alternative splicing generates two different regions that connect the protease-resistant catalytic domains. Inclusion of exon 16 introduces a pair of Lys residues, providing a site for controlled endoproteolytic cleavage of PAM and the separation of soluble peptidylglycine alpha-hydroxylating monooxygenase from membrane-associated PAL. Exon 16 also includes two O-glycosylation sites. PAM-1 lacking both glycosylation sites (PAM-1/OSX; where OSX is O-glycan-depleted mutant of PAM-1) was stably expressed in AtT-20 corticotrope tumor cells. In PAM-1/OSX, a cleavage site for furin-like convertases was exposed, generating a shorter form of membrane-associated PAL. The endocytic trafficking of PAM-1/OSX differed dramatically from that of PAM-1. A soluble fragment of the cytosolic domain of PAM-1 was produced in the endocytic pathway and entered the nucleus; very little soluble fragment of the cytosolic domain was produced from PAM-1/OSX. Internalized PAM-1/OSX was rapidly degraded; unlike PAM-1, very little internalized PAM-1/OSX was detected in multivesicular bodies. Blue native PAGE analysis identified high molecular weight complexes containing PAM-1; the ability of PAM-1/OSX to form similar complexes was markedly diminished. By promoting the formation of high molecular weight complexes, O-glycans may facilitate the recycling of PAM-1 through the endocytic compartment.	[Vishwanatha, Kurutihalli S.; Mains, Richard E.; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA; [Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [Back, Nils] Univ Helsinki, Dept Anat, Fac Med, FIN-00014 Helsinki, Finland; [Lam, TuKiet T.] Yale Univ, WM Keck Fdn, Biotechnol Resource Lab, Yale Keck MS & Prote Resource,Yale NIDA Neuroprot, New Haven, CT 06511 USA	University of Connecticut; University of Connecticut; University of Helsinki; Yale University	Vishwanatha, KS; Eipper, BA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA.	vishwanatha@uchc.edu; eipper@uchc.edu		Rao, Vishwanatha/0000-0001-9471-807X; Back, Nils/0000-0001-9992-3726	National Institutes of Health [DK-032949, DA-018343]; Janice and Rodney Reynolds Endowment; Scoville Endowment; Liv och Halsa Foundation; Finska Lakaresallskapet; Perklen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032949, R01DK032949, R37DK032949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janice and Rodney Reynolds Endowment; Scoville Endowment; Liv och Halsa Foundation; Finska Lakaresallskapet; Perklen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants DK-032949 and DA-018343, the Janice and Rodney Reynolds Endowment, the Scoville Endowment, the Liv och Halsa Foundation, Finska Lakaresallskapet, and the Perklen Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Back N, 2004, EUR J CELL BIOL, V83, P389, DOI 10.1078/0171-9335-00405; Back N, 2010, TRAFFIC, V11, P972, DOI 10.1111/j.1600-0854.2010.01066.x; Bergstrom KSB, 2013, GLYCOBIOLOGY, V23, P1026, DOI 10.1093/glycob/cwt045; Christlet THT, 2001, BIOPHYS J, V80, P952, DOI 10.1016/S0006-3495(01)76074-2; Chufan EE, 2009, STRUCTURE, V17, P965, DOI 10.1016/j.str.2009.05.008; Ciccotosto GD, 1999, J CELL BIOL, V144, P459, DOI 10.1083/jcb.144.3.459; De M, 2007, J BIOL CHEM, V282, P23362, DOI 10.1074/jbc.M702891200; Dillon SL, 2012, J MOL BIOL, V423, P47, DOI 10.1016/j.jmb.2012.06.023; EIPPER BA, 1993, PROTEIN SCI, V2, P489; Francone VP, 2010, MOL ENDOCRINOL, V24, P1543, DOI 10.1210/me.2009-0381; Fricker LD, 2010, MOL BIOSYST, V6, P1355, DOI 10.1039/c003317k; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Hanisch FG, 1999, J BIOL CHEM, V274, P9946, DOI 10.1074/jbc.274.15.9946; HANSEN JE, 1995, BIOCHEM J, V308, P801, DOI 10.1042/bj3080801; Hennet T, 2012, BBA-GEN SUBJECTS, V1820, P1306, DOI 10.1016/j.bbagen.2012.02.001; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Herzog BH, 2014, GLYCOBIOLOGY, V24, P1237, DOI 10.1093/glycob/cwu058; Horynova MS, 2013, CELL MOL LIFE SCI, V70, P829, DOI 10.1007/s00018-012-1082-6; HUSTEN EJ, 1993, J BIOL CHEM, V268, P9709; Ito H, 2009, J ENZYM INHIB MED CH, V24, P279, DOI [10.1080/14756360802166921, 10.1080/14756360802166921 ]; Janetzko J, 2014, J BIOL CHEM, V289, P34424, DOI 10.1074/jbc.R114.604405; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jean-Alphonse F, 2014, J BIOL CHEM, V289, P3960, DOI 10.1074/jbc.M113.526350; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Kadlcikova J, 2004, INT J EXP PATHOL, V85, P365, DOI 10.1111/j.0959-9673.2004.00405.x; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kolhekar AS, 2002, BIOCHEMISTRY-US, V41, P12384, DOI 10.1021/bi0260280; Krishnan N, 2012, MOL CELL BIOL, V32, P4306, DOI 10.1128/MCB.00382-12; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Levery SB, 2015, BBA-GEN SUBJECTS, V1850, P33, DOI 10.1016/j.bbagen.2014.09.026; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Ma XM, 2014, MOL BIOL CELL, V25, P1458, DOI 10.1091/mbc.E13-04-0215; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; MANZELLA SM, 1995, J BIOL CHEM, V270, P21665, DOI 10.1074/jbc.270.37.21665; Milgram SL, 1997, J CELL SCI, V110, P695; Ninkovic T, 2007, J IMMUNOL, V179, P2380, DOI 10.4049/jimmunol.179.4.2380; OUAFIK L, 1992, MOL ENDOCRINOL, V6, P1571, DOI 10.1210/me.6.10.1571; OYARCE AM, 1995, J CELL SCI, V108, P287; Rajagopal C, 2010, J BIOL CHEM, V285, P34632, DOI 10.1074/jbc.M110.145334; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; SCHMIDT WK, 1995, MOL BIOL CELL, V6, P1271, DOI 10.1091/mbc.6.10.1271; Semenov AG, 2009, CLIN CHEM, V55, P489, DOI 10.1373/clinchem.2008.113373; Shirley RB, 2005, NEOPLASIA, V7, P1104, DOI 10.1593/neo.05520; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; STOFFERS DA, 1991, J BIOL CHEM, V266, P1701; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Thiel C, 2013, GLYCOCONJUGATE J, V30, P77, DOI 10.1007/s10719-012-9447-5; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; Vishwanatha K, 2014, J BIOL CHEM, V289, P12404, DOI 10.1074/jbc.M113.545947; Willey KP, 1999, HUM REPROD UPDATE, V5, P330, DOI 10.1093/humupd/5.4.330; YUN HY, 1995, J BIOL CHEM, V270, P30075; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111; ZHOU A, 1994, J BIOL CHEM, V269, P17440	58	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9835	9850		10.1074/jbc.M115.711838	http://dx.doi.org/10.1074/jbc.M115.711838			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26961877	hybrid, Green Published			2022-12-28	WOS:000375602300040
J	Kemp, MG; Sancar, A				Kemp, Michael G.; Sancar, Aziz			ATR Kinase Inhibition Protects Non-cycling Cells from the Lethal Effects of DNA Damage and Transcription Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCISION-REPAIR; DOUBLE-STRAND BREAKS; CANCER-CELLS; ATAXIA-TELANGIECTASIA; CHECKPOINT ACTIVATION; H2AX PHOSPHORYLATION; UV-IRRADIATION; TARGETING ATR; IN-VIVO; ESCHERICHIA-COLI	ATR (ataxia telangiectasia and Rad-3-related) is a protein kinase that maintains genome stability and halts cell cycle phase transitions in response to DNA lesions that block DNA polymerase movement. These DNA replication-associated features of ATR function have led to the emergence of ATR kinase inhibitors as potential adjuvants for DNA-damaging cancer chemotherapeutics. However, whether ATR affects the genotoxic stress response in non-replicating, non-cycling cells is currently unknown. We therefore used chemical inhibition of ATR kinase activity to examine the role of ATR in quiescent human cells. Although ATR inhibition had no obvious effects on the viability of non-cycling cells, inhibition of ATR partially protected non-replicating cells from the lethal effects of UV and UV mimetics. Analyses of various DNA damage response signaling pathways demonstrated that ATR inhibition reduced the activation of apoptotic signaling by these agents in non-cycling cells. The pro-apoptosis/cell death function of ATR is likely due to transcription stress because the lethal effects of compounds that block RNA polymerase movement were reduced in the presence of an ATR inhibitor. These results therefore suggest that whereas DNA polymerase stalling at DNA lesions activates ATR to protect cell viability and prevent apoptosis, the stalling of RNA polymerases instead activates ATR to induce an apoptotic form of cell death in non-cycling cells. These results have important implications regarding the use of ATR inhibitors in cancer chemotherapy regimens.	[Kemp, Michael G.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kemp, MG (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA.; Sancar, A (corresponding author), Univ N Carolina, Sch Med, Campus Box 7260, Chapel Hill, NC 27599 USA.	kemp.2@wright.edu; aziz_sancar@med.unc.edu	Kemp, Michael G./AAT-1545-2021	Kemp, Michael G./0000-0001-8203-0745	National Institutes of Health [R01GM32833]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118102, R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM32833 (to A. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Charrier JD, 2011, J MED CHEM, V54, P2320, DOI 10.1021/jm101488z; CHEN YH, 1991, P NATL ACAD SCI USA, V88, P9583, DOI 10.1073/pnas.88.21.9583; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2015, J BIOL CHEM, V290, P28812, DOI 10.1074/jbc.M115.690354; Choi JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1179; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; Dunkern TR, 2001, ONCOGENE, V20, P6026, DOI 10.1038/sj.onc.1204754; Fokas E, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.181; Gaddameedhi S, 2010, CANCER RES, V70, P4922, DOI 10.1158/0008-5472.CAN-10-0095; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; Hall AB, 2014, ONCOTARGET, V5, P5674, DOI 10.18632/oncotarget.2158; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Heffernan T. P., 2009, J INVEST DERMATOL, V129, P1805; Hess MT, 1996, NUCLEIC ACIDS RES, V24, P824, DOI 10.1093/nar/24.5.824; Hilton BA, 2015, MOL CELL, V60, P35, DOI 10.1016/j.molcel.2015.08.008; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; Jette N, 2015, PROG BIOPHYS MOL BIO, V117, P194, DOI 10.1016/j.pbiomolbio.2014.12.003; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Josse R, 2014, CANCER RES, V74, P6968, DOI 10.1158/0008-5472.CAN-13-3369; Karnitz LM, 2015, CLIN CANCER RES, V21, P4780, DOI 10.1158/1078-0432.CCR-15-0479; Kawasumi M, 2011, P NATL ACAD SCI USA, V108, P13716, DOI 10.1073/pnas.1111378108; Kemp MG, 2014, J BIOL CHEM, V289, P26574, DOI 10.1074/jbc.M114.597088; Kemp MG, 2012, J BIOL CHEM, V287, P22889, DOI 10.1074/jbc.M112.374447; Kemp MG, 2011, J BIOL CHEM, V286, P19237, DOI 10.1074/jbc.M111.235036; Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06; Kim MP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00249; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Lindsey-Boltz LA, 2014, J BIOL CHEM, V289, P5074, DOI 10.1074/jbc.M113.542787; Ljungman M, 2007, CELL CYCLE, V6, P2252, DOI 10.4161/cc.6.18.4751; Llona-Minguez S, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.10; Lu YP, 2008, CANCER RES, V68, P2523, DOI 10.1158/0008-5472.CAN-07-5955; Lu YP, 2011, CANCER PREV RES, V4, P1118, DOI 10.1158/1940-6207.CAPR-11-0116; Marini F, 2006, P NATL ACAD SCI USA, V103, P17325, DOI 10.1073/pnas.0605446103; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moore N, 2012, STEM CELLS DEV, V21, P1822, DOI 10.1089/scd.2011.0477; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; MU D, 1994, NUCLEIC ACIDS RES, V22, P4869, DOI 10.1093/nar/22.23.4869; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Pires IM, 2012, BRIT J CANCER, V107, P291, DOI 10.1038/bjc.2012.265; Prevo R, 2012, CANCER BIOL THER, V13, P1072, DOI 10.4161/cbt.21093; Ray A, 2013, DNA REPAIR, V12, P273, DOI 10.1016/j.dnarep.2013.01.003; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Sancar A, 2004, ADV PROTEIN CHEM, V69, P43; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sertic S, 2011, P NATL ACAD SCI USA, V108, P13647, DOI 10.1073/pnas.1108547108; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Tresini M, 2015, NATURE, V523, P53, DOI 10.1038/nature14512; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; van Gijssel HE, 2003, LIFE SCI, V73, P1759, DOI 10.1016/S0024-3205(03)00506-X; Vavrova J, 2013, RADIAT ENVIRON BIOPH, V52, P471, DOI 10.1007/s00411-013-0486-5; Vendetti FP, 2015, ONCOTARGET, V6, P44289, DOI 10.18632/oncotarget.6247; Vrouwe MG, 2011, J CELL SCI, V124, P435, DOI 10.1242/jcs.075325; Wakasugi M, 2014, J BIOL CHEM, V289, P28730, DOI 10.1074/jbc.M114.589747; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yilmaz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022986; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	82	25	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9330	9342		10.1074/jbc.M116.719740	http://dx.doi.org/10.1074/jbc.M116.719740			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26940878	Green Published, hybrid			2022-12-28	WOS:000374849000041
J	Youngblut, MD; Tsai, CL; Clark, IC; Carlson, HK; Maglaqui, AP; Gau-Pan, PS; Redford, SA; Wong, A; Tainer, JA; Coates, JD				Youngblut, Matthew D.; Tsai, Chi-Lin; Clark, Iain C.; Carlson, Hans K.; Maglaqui, Adrian P.; Gau-Pan, Phonchien S.; Redford, Steven A.; Wong, Alan; Tainer, John A.; Coates, John D.			Perchlorate Reductase Is Distinguished by Active Site Aromatic Gate Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRATE REDUCTASE; CRYSTAL-STRUCTURE; SEQUENCE; DEHYDROGENASE; COORDINATION; PREDICTION; CHEMISTRY; PROTEINS; REVEALS; MARS	Perchlorate is an important ion on both Earth and Mars. Perchlorate reductase (PcrAB), a specialized member of the dimethylsulfoxide reductase superfamily, catalyzes the first step of microbial perchlorate respiration, but little is known about the biochemistry, specificity, structure, and mechanism of PcrAB. Here we characterize the biophysics and phylogeny of this enzyme and report the 1.86-angstrom resolution PcrAB complex crystal structure. Biochemical analysis revealed a relatively high perchlorate affinity (K-m = 6 mu M) and a characteristic substrate inhibition compared with the highly similar respiratory nitrate reductase NarGHI, which has a relatively much lower affinity for perchlorate (K-m = 1.1 mM) and no substrate inhibition. Structural analysis of oxidized and reduced PcrAB with and without the substrate analog SeO32- bound to the active site identified key residues in the positively charged and funnel-shaped substrate access tunnel that gated substrate entrance and product release while trapping transiently produced chlorate. The structures suggest gating was associated with shifts of a Phe residue between open and closed conformations plus an Asp residue carboxylate shift between monodentate and bidentate coordination to the active site molybdenum atom. Taken together, structural and mutational analyses of gate residues suggest key roles of these gate residues for substrate entrance and product release. Our combined results provide the first detailed structural insight into the mechanism of biological perchlorate reduction, a critical component of the chlorine redox cycle on Earth.	[Youngblut, Matthew D.; Clark, Iain C.; Carlson, Hans K.; Maglaqui, Adrian P.; Gau-Pan, Phonchien S.; Redford, Steven A.; Wong, Alan; Coates, John D.] Univ Calif Berkeley, Energy Biosci Inst, 271 Koshland Hall, Berkeley, CA 94720 USA; [Coates, John D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, 271 Koshland Hall, Berkeley, CA 94720 USA; [Tsai, Chi-Lin; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Tainer, John A.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Texas System; UTMD Anderson Cancer Center	Coates, JD (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 271 Koshland Hall, Berkeley, CA 94720 USA.	jdcoates@berkeley.edu	Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429; Tsai, Chi-Lin/0000-0002-0365-2405; Maglaqui, Adrian/0000-0001-8340-5297	Energy Biosciences Institute, University of California, Berkeley; National Institute of Health Project MINOS (Macromolecular INsights Optimized by Scattering) [R01GM105404]; Robert A. Welch Distinguished Chair in Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	Energy Biosciences Institute, University of California, Berkeley(University of California System); National Institute of Health Project MINOS (Macromolecular INsights Optimized by Scattering); Robert A. Welch Distinguished Chair in Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work on perchlorate and chlorate respiration in the laboratory of J. D. C. was supported by the Energy Biosciences Institute, University of California, Berkeley, and structural studies were supported by National Institute of Health Project MINOS (Macromolecular INsights Optimized by Scattering) Grant R01GM105404. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Robert A. Welch Distinguished Chair in Chemistry.	Achenbach L.A, 2006, PERCHLORATE, P279; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banks A. J., 2015, MODELS 360; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Clark IC, 2013, MBIO, V4, DOI 10.1128/mBio.00379-13; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Coates JD, 2004, NAT REV MICROBIOL, V2, P569, DOI 10.1038/nrmicro926; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davila AF, 2013, INT J ASTROBIOL, V12, P321, DOI 10.1017/S1473550413000189; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enemark JH, 1997, J BIOL INORG CHEM, V2, P817, DOI 10.1007/s007750050201; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Garton SD, 1997, J AM CHEM SOC, V119, P12906, DOI 10.1021/ja972109l; Gu B., 2006, PERCHLORATE ENV OCCU; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Heinnickel M, 2011, ENVIRON SCI TECHNOL, V45, P2958, DOI 10.1021/es103715f; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Jackson WA, 2015, EARTH PLANET SC LETT, V430, P470, DOI 10.1016/j.epsl.2015.09.003; Jackson WA, 2015, GEOCHIM COSMOCHIM AC, V164, P502, DOI 10.1016/j.gca.2015.05.016; Jacques JGJ, 2014, BBA-BIOENERGETICS, V1837, P1801, DOI 10.1016/j.bbabio.2014.05.357; Jormakka M, 2004, STRUCTURE, V12, P95, DOI 10.1016/j.str.2003.11.020; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; Kounaves SP, 2014, ICARUS, V229, P206, DOI 10.1016/j.icarus.2013.11.012; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Melnyk RA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2011-5; Melnyk RA, 2014, MBIO, V5, DOI 10.1128/mBio.00769-13; Ming DW, 2014, SCIENCE, V343, DOI 10.1126/science.1245267; MORPETH FF, 1985, BIOCHEMISTRY-US, V24, P40, DOI 10.1021/bi00322a007; Najmudin S, 2008, J BIOL INORG CHEM, V13, P737, DOI 10.1007/s00775-008-0359-6; Novoradovsky A., 2005, 2005 NSTI Nanotechnology Conference and Trade Show. NSTI Nanotech 2005, P532; Ojha L, 2015, NAT GEOSCI, V8, P829, DOI [10.1038/ngeo2546, 10.1038/NGEO2546]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Raaijmakers H, 2002, STRUCTURE, V10, P1261, DOI 10.1016/S0969-2126(02)00826-2; Rajagopaian S, 2009, ENVIRON SCI TECHNOL, V43, P616, DOI 10.1021/es801737u; Romao MJ, 2009, DALTON T, P4053, DOI 10.1039/b821108f; Rothery RA, 1998, BIOCHEM J, V332, P35, DOI 10.1042/bj3320035; Rothery RA, 2010, J BIOL CHEM, V285, P8801, DOI 10.1074/jbc.M109.066027; Sousa SF, 2014, INT J QUANTUM CHEM, V114, P1253, DOI 10.1002/qua.24689; Sparacino-Watkins C, 2014, CHEM SOC REV, V43, P676, DOI 10.1039/c3cs60249d; Thrash JC, 2010, APPL MICROBIOL BIOT, V86, P335, DOI 10.1007/s00253-009-2336-6; Urbansky E.T., 1998, BIOREMEDIAT J, V2, P81, DOI [10.1080/10889869891214231, DOI 10.1080/10889869891214231]; Williams BR, 2015, INORG CHEM, V54, P8214, DOI 10.1021/acs.inorgchem.5b00532; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yan AX, 2009, METHOD ENZYMOL, V463, P787, DOI 10.1016/S0076-6879(09)63042-1	52	45	44	0	39	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9190	9202		10.1074/jbc.M116.714618	http://dx.doi.org/10.1074/jbc.M116.714618			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26940877	Green Published, hybrid			2022-12-28	WOS:000374849000030
J	Jattani, RP; Tritapoe, JM; Pomerantz, JL				Jattani, Rakhi P.; Tritapoe, Julia M.; Pomerantz, Joel L.			Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; lymphoma; NF-kappa B (NF-KB); oncogene; scaffold protein; signal transduction; T-cell receptor; autoinhibitory domain; CARD11; diffuse large B cell lymphoma	NF-KAPPA-B; CELL LYMPHOMA; COMBINED IMMUNODEFICIENCY; KINASE-BETA; ACTIVATION; CARMA1; MUTATIONS; PHOSPHORYLATION; BCL10; PROLIFERATION	The CARD11 signaling scaffold transmits signaling between antigen receptors on B and T lymphocytes and the transcription factor NF-kappa B during the adaptive immune response. CARD11 activity is controlled by an inhibitory domain (ID), which participates in intramolecular interactions and prevents cofactor binding prior to receptor triggering. Oncogenic CARD11 mutations associated with the activated B cell-like subtype of diffuse large B cell lymphoma somehow perturb ID-mediated autoinhibition to confer CARD11 with the dysregulated spontaneous signaling to NF-kappa B that is required for the proliferation and survival of the lymphoma. Here, we investigate how the four repressive elements (REs) we have discovered in the CARD11 ID function to inhibit CARD11 activity with cooperativity and redundancy. We find that each RE contributes to the maintenance of the closed inactive state of CARD11 that predominates in the absence of receptor engagement. Each RE also contributes to the prevention of Bcl10 binding in the basal unstimulated state. RE1, RE2, and RE3 participate in intramolecular interactions with other CARD11 domains and share domain targets for binding. Remarkably, diffuse large B cell lymphoma-associated gain-of-function mutations in the caspase recruitment domain, LATCH, or coiled coil can perturb intramolecular interactions mediated by multiple REs, suggesting how single amino acid oncogenic CARD11 mutations can perturb or bypass the action of redundant inhibitory REs to achieve the level of hyperactive CARD11 signaling required to support lymphoma growth.	[Jattani, Rakhi P.; Tritapoe, Julia M.; Pomerantz, Joel L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Biol Chem, Miller Res Bldg,Rm 607,733 N Broadway, Baltimore, MD 21205 USA	Johns Hopkins University	Pomerantz, JL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Biol Chem, Miller Res Bldg,Rm 607,733 N Broadway, Baltimore, MD 21205 USA.	joel.pomerantz@jhmi.edu		Pomerantz, Joel L./0000-0002-5030-1018	National Institutes of Health [RO1CA177600]; Johns Hopkins University Institute for Cell Engineering; NATIONAL CANCER INSTITUTE [R01CA177600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Institute for Cell Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1CA177600 and funds from The Johns Hopkins University Institute for Cell Engineering. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bu R, 2012, LEUKEMIA LYMPHOMA, V53, P1971, DOI 10.3109/10428194.2012.668286; Chan WP, 2013, MOL CELL BIOL, V33, P429, DOI 10.1128/MCB.00850-12; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Greil J, 2013, J ALLERGY CLIN IMMUN, V131, P1376, DOI 10.1016/j.jaci.2013.02.012; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hara H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6555; Jattani RP, 2016, J BIOL CHEM, V291, P8324, DOI 10.1074/jbc.M115.683714; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Lamason RL, 2010, MOL CELL, V40, P798, DOI 10.1016/j.molcel.2010.11.007; Lamason RL, 2010, BIOCHEMISTRY-US, V49, P8240, DOI 10.1021/bi101052d; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lim KH, 2012, IMMUNOL REV, V246, P359, DOI 10.1111/j.1600-065X.2012.01105.x; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Rui LX, 2011, NAT IMMUNOL, V12, P933, DOI 10.1038/ni.2094; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shinohara H, 2007, J EXP MED, V204, P3285, DOI 10.1084/jem.20070379; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, P477, DOI 10.1016/j.jaci.2012.11.050; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105	31	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8338	8348		10.1074/jbc.M116.717322	http://dx.doi.org/10.1074/jbc.M116.717322			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26884334	Green Published, hybrid			2022-12-28	WOS:000374773200003
J	Jurado-Arjona, J; Llorens-Martin, M; Avila, J; Hernandez, F				Jurado-Arjona, Jeronimo; Llorens-Martin, Maria; Avila, Jesus; Hernandez, Felix			GSK3 Overexpression in Dentate Gyrus Neural Precursor Cells Expands the Progenitor Pool and Enhances Memory Skills	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; glial cell; glycogen synthase kinase 3 (GSK-3); neural stem cell (NSC); transgenic mice	FIBRILLARY ACIDIC PROTEIN; EMBRYONIC STEM-CELLS; NEURONAL DIFFERENTIATION; ADULT NEUROGENESIS; HIPPOCAMPAL NEUROGENESIS; SYNTHASE KINASE-3-BETA; MAMMALIAN HIPPOCAMPUS; GRANULE CELLS; WNT PROTEINS; RAT-BRAIN	In restricted areas of the adult brain, like the subgranular zone of the dentate gyrus (DG), there is continuous production of new neurons. This process, named adult neurogenesis, is involved in important cognitive functions such as memory and learning. It requires the presence of newborn neurons that arise from neuronal stem cells, which divide and differentiate through successive stages in adulthood. In this work, we demonstrate that overexpression of glycogen synthase kinase (GSK) 3 in neural precursor cells (NPCs) using the glial fibrillary acidic protein promoter during DG development produces an increase in the neurogenic process, increasing NPCs numbers. Moreover, the transgenic mice show higher DG volume and increased number of mature granule neurons. In an attempt to compensate for these alterations, glial fibrillary acidic protein/GSK3-overexpressing mice show increased levels of Dkk1 and sFRP3, two inhibitors of the Wnt-frizzled complex. We have also found behavioral differences between wild type and transgenic mice, indicating a higher rating in memory tasks for GSK3-overexpressing mice compared with wild type mice. These data indicate that GSK3 is a crucial kinase in NPC physiology and suggest that this molecule plays a key role in the correct development of DG and adult neurogenesis in this region.	[Jurado-Arjona, Jeronimo; Llorens-Martin, Maria; Avila, Jesus; Hernandez, Felix] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Jurado-Arjona, Jeronimo; Llorens-Martin, Maria; Avila, Jesus; Hernandez, Felix] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED	Hernandez, F (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	fhernandez@cbm.csic.es	Llorens-Martin, Maria/R-4613-2017; Hernandez, Felix/L-2114-2015; Avila, Jesus/I-2610-2015	Llorens-Martin, Maria/0000-0001-9129-5198; Hernandez, Felix/0000-0001-8753-8249; Avila, Jesus/0000-0002-6288-0571	Ministerio de Educacion y Ciencia [SAF2011-24841, BUF2013-40664-P]; Comunidad de Madrid [S2010/BMD-2331]; Fundacion Ramon Areces	Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Fundacion Ramon Areces	This work was supported in part by Ministerio de Educacion y Ciencia Grants SAF2011-24841 and BUF2013-40664-P, Comunidad de Madrid Grant S2010/BMD-2331, and funds from the Fundacion Ramon Areces. The authors declare that they have no conflicts of interest with the contents of this article.	Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BAYER SA, 1974, J COMP NEUROL, V158, P55, DOI 10.1002/cne.901580105; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; BESNARD F, 1991, J BIOL CHEM, V266, P18877; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eom TY, 2009, BIOL PSYCHIAT, V66, P494, DOI 10.1016/j.biopsych.2009.04.015; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Fuster-Matanzo A, 2013, HUM MOL GENET, V22, P1300, DOI 10.1093/hmg/dds533; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Holowacz T, 2013, BIOL OPEN, V2, P812, DOI 10.1242/bio.20131941; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jang MH, 2013, CELL STEM CELL, V12, P215, DOI 10.1016/j.stem.2012.11.021; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kim JS, 2011, J VET SCI, V12, P1, DOI 10.4142/jvs.2011.12.1.1; Kim WY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00044; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lin WS, 2004, J NEUROSCI, V24, P10074, DOI 10.1523/JNEUROSCI.2604-04.2004; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; Llorens-Martin M, 2013, MOL PSYCHIATR, V18, P395, DOI 10.1038/mp.2013.27; Llorens-Martin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012188; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Miki T, 2011, STEM CELL REV REP, V7, P836, DOI 10.1007/s12015-011-9275-1; MUCKE L, 1991, NEW BIOL, V3, P465; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Muroyama Y, 2004, BIOCHEM BIOPH RES CO, V313, P915, DOI 10.1016/j.bbrc.2003.12.023; Okamoto M, 2011, FASEB J, V25, P3570, DOI 10.1096/fj.11-184697; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sirerol-Piquer M, 2011, HIPPOCAMPUS, V21, P910, DOI 10.1002/hipo.20805; Takahashi M, 2000, BRAIN RES, V857, P193, DOI 10.1016/S0006-8993(99)02424-5; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Weber T, 2011, GLIA, V59, P615, DOI 10.1002/glia.21129; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yu Y, 2009, J NEUROCHEM, V108, P1480, DOI 10.1111/j.1471-4159.2009.05882.x	50	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8199	8213		10.1074/jbc.M115.674531	http://dx.doi.org/10.1074/jbc.M115.674531			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26887949	Green Published, hybrid			2022-12-28	WOS:000374056700036
J	Lawrance, W; Banerji, S; Day, AJ; Bhattacharjee, S; Jackson, DG				Lawrance, William; Banerji, Suneale; Day, Anthony J.; Bhattacharjee, Shaumick; Jackson, David G.			Binding of Hyaluronan to the Native Lymphatic Vessel Endothelial Receptor LYVE-1 Is Critically Dependent on Receptor Clustering and Hyaluronan Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; complex; endothelial cell; extracellular matrix; hyaluronan; macrophage; LYVE-1; TSG-6; lymphatic endothelium; transmigration	ALPHA-TRYPSIN INHIBITOR; SMOOTH-MUSCLE-CELLS; EZRIN/RADIXIN/MOESIN ERM PROTEINS; HEAVY-CHAINS; LINK MODULE; HUMAN TSG-6; EXTRACELLULAR-MATRIX; LEUKOCYTE ADHESION; CYTOPLASMIC DOMAIN; DENDRITIC CELLS	The lymphatic endothelial receptor LYVE-1 has been implicated in both uptake of hyaluronan (HA) from tissue matrix and in facilitating transit of leukocytes and tumor cells through lymphatic vessels based largely on in vitro studies with recombinant receptor in transfected fibroblasts. Curiously, however, LYVE-1 in lymphatic endothelium displays little if any binding to HA in vitro, and this has led to the conclusion that the native receptor is functionally silenced, a feature that is difficult to reconcile with its proposed in vivo functions. Nonetheless, as we reported recently, LYVE-1 can function as a receptor for HA-encapsulated Group A streptococci and mediate lymphatic dissemination in mice. Here we resolve these paradoxical findings and show that the capacity of LYVE-1 to bind HA is strictly dependent on avidity, demanding appropriate receptor self-association and/or HA multimerization. In particular, we demonstrate the prerequisite of a critical LYVE-1 threshold density and show that HA binding may be elicited in lymphatic endothelium by surface clustering with divalent LYVE-1 mAbs. In addition, we show that cross-linking of biotinylated HA in streptavidin multimers or supramolecular complexes with the inflammation-induced protein TSG-6 enables binding even in the absence of LYVE-1 cross-linking. Finally, we show that endogenous HA on the surface of macrophages can engage LYVE-1, facilitating their adhesion and transit across lymphatic endothelium. These results reveal LYVE-1 as a low affinity receptor tuned to discriminate between different HA configurations through avidity and establish a new mechanistic basis for the functions ascribed to LYVE-1 in matrix HA binding and leukocyte trafficking in vivo.	[Lawrance, William; Banerji, Suneale; Bhattacharjee, Shaumick; Jackson, David G.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England; [Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Oxford; University of Manchester	Jackson, DG (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England.	david.jackson@imm.ox.ac.uk	Day, Anthony/O-1658-2015	Day, Anthony/0000-0002-1415-3134; banerji, suneale/0000-0002-1179-3152; , david/0000-0002-4133-9364	United Kingdom Medical Research Council; Medical Research Council [1093777, MC_U137884182, MC_UU_12010/2] Funding Source: researchfish; MRC [MC_UU_12010/2, MC_U137884182] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in whole or in part by the United Kingdom Medical Research Council through funding to the MRC Human Immunology Unit (to D. G. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Armstrong SE, 2002, AM J PHYSIOL-HEART C, V283, pH2485, DOI 10.1152/ajpheart.00385.2002; Armstrong SE, 2002, ANAL BIOCHEM, V308, P255, DOI 10.1016/S0003-2697(02)00239-7; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Banerji S, 2010, J BIOL CHEM, V285, P10724, DOI 10.1074/jbc.M109.047647; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Briggs DC, 2015, J BIOL CHEM, V290, P28708, DOI 10.1074/jbc.M115.669838; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Chang MY, 2014, MATRIX BIOL, V34, P1, DOI 10.1016/j.matbio.2014.01.011; Chang MY, 2012, J BIOL CHEM, V287, P14122, DOI 10.1074/jbc.M111.324988; Cueni LN, 2009, EXP CELL RES, V315, P1715, DOI 10.1016/j.yexcr.2009.02.021; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DeGrendele HC, 1997, J IMMUNOL, V159, P2549; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Dubacheva GV, 2015, P NATL ACAD SCI USA, V112, P5579, DOI 10.1073/pnas.1500622112; Dubacheva GV, 2014, J AM CHEM SOC, V136, P1722, DOI 10.1021/ja411138s; English NM, 1998, CANCER RES, V58, P3736; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; FRASER JRE, 1989, CIBA F SYMP, V143, P41; Gee K, 2003, J BIOL CHEM, V278, P37275, DOI 10.1074/jbc.M302309200; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Higman VA, 2014, J BIOL CHEM, V289, P5619, DOI 10.1074/jbc.M113.542357; Hou WH, 2012, FEBS LETT, V586, P1480, DOI 10.1016/j.febslet.2012.04.001; HUANG L, 1993, J BIOL CHEM, V268, P26725; Huang SS, 2003, J BIOL CHEM, V278, P43855, DOI 10.1074/jbc.M306411200; Jackson D. G., 2014, J CLIN CELL IMMUNOL, V5, P255; Jackson DG, 2009, IMMUNOL REV, V230, P216, DOI 10.1111/j.1600-065X.2009.00803.x; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Johnson LA, 2013, J CELL SCI, V126, P5259, DOI 10.1242/jcs.135343; Johnson LA, 2010, INT IMMUNOL, V22, P839, DOI 10.1093/intimm/dxq435; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Katoh S, 2010, CLIN EXP IMMUNOL, V161, P233, DOI 10.1111/j.1365-2249.2010.04165.x; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; LESLEY J, 1993, EUR J IMMUNOL, V23, P1902, DOI 10.1002/eji.1830230826; LESLEY J, 1992, EUR J IMMUNOL, V22, P2719, DOI 10.1002/eji.1830221036; LESLEY J, 1995, J EXP MED, V182, P431, DOI 10.1084/jem.182.2.431; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Levesque MC, 1999, CELL IMMUNOL, V193, P209, DOI 10.1006/cimm.1999.1456; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; Lynskey NN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005137; Mahaffey CL, 2007, J IMMUNOL, V179, P8191, DOI 10.4049/jimmunol.179.12.8191; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; McDonald B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00068; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Monslow J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00231; Mummert ME, 2005, IMMUNOL RES, V31, P189, DOI 10.1385/IR:31:3:189; Mummert ME, 2002, J IMMUNOL, V169, P4322, DOI 10.4049/jimmunol.169.8.4322; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Platt AM, 2013, ADV IMMUNOL, V120, P51, DOI 10.1016/B978-0-12-417028-5.00002-8; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Teijeira A, 2014, SEMIN IMMUNOPATHOL, V36, P261, DOI 10.1007/s00281-013-0410-8; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Tewalt EF, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00305; Thiemann S, 2015, J BIOL CHEM, V290, P22662, DOI 10.1074/jbc.M115.644799; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Wang Y, 2014, J BIOL CHEM, V289, P35159, DOI 10.1074/jbc.M114.600767; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Wu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092857; Yao LC, 2012, AM J PATHOL, V180, P2561, DOI 10.1016/j.ajpath.2012.02.019; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yu MS, 2015, EXP CELL RES, V336, P150, DOI 10.1016/j.yexcr.2015.06.014; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200	95	69	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8014	8030		10.1074/jbc.M115.708305	http://dx.doi.org/10.1074/jbc.M115.708305			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26823460	hybrid, Green Published			2022-12-28	WOS:000374056700022
J	Luff, SA; Papoutsakis, ET				Luff, Stephanie A.; Papoutsakis, Eleftherios T.			Megakaryocytic Maturation in Response to Shear Flow Is Mediated by the Activator Protein 1 (AP-1) Transcription Factor via Mitogen-activated Protein Kinase (MAPK) Mechanotransduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 transcription factor (AP-1); c-Jun N-terminal kinase (JNK); p38 MAPK; shear stress; transcriptomics; Megakaryocyte; megakaryopoiesis; polyploidization	SIGNAL-REGULATED KINASE; N-TERMINAL KINASE; ENDOTHELIAL-CELLS; PLATELET PRODUCTION; STEM-CELLS; DIFFERENTIATION; STRESS; P38; APOPTOSIS; PATHWAYS	Megakaryocytes (MKs) are exposed to shear flow as they migrate from the bone marrow hematopoietic compartment into circulation to release pro/preplatelets into circulating blood. Shear forces promote DNA synthesis, polyploidization, and maturation in MKs, and platelet biogenesis. To investigate mechanisms underlying these MK responses to shear, we carried out transcriptional analysis on immature and mature stem cell-derived MKs exposed to physiological shear. In immature (day (d)9) MKs, shear exposure up-regulated genes related to growth and MK maturation, whereas in mature (d12) MKs, it up-regulated genes involved in apoptosis and intracellular transport. Following shear-flow exposure, six activator protein 1 (AP-1) transcripts (ATF4, JUNB, JUN, FOSB, FOS, and JUND) were up-regulated at d9 and two AP-1 proteins (JunD and c-Fos) were up-regulated both at d9 and d12. We show that mitogen-activated protein kinase (MAPK) signaling is linked to both the shear stress response and AP-1 up-regulation. c-Jun N-terminal kinase (JNK) phosphorylation increased significantly following shear stimulation, whereas JNK inhibition reduced shear-induced JunD expression. Although p38 phosphorylation did not increase following shear flow, its inhibition reduced shear-induced JunD and c-Fos expression. JNK inhibition reduced fibrinogen binding and P-selectin expression of d12 platelet-like particles (PLPs), whereas p38 inhibition reduced fibrinogen binding of d12 PLPs. AP-1 expression correlated with increased MK DNA synthesis and polyploidization, which might explain the observed impact of shear on MKs. To summarize, we show that MK exposure to shear forces results in JNK activation, AP-1 up-regulation, and downstream transcriptional changes that promote maturation of immature MKs and platelet biogenesis in mature MKs.	[Luff, Stephanie A.; Papoutsakis, Eleftherios T.] Univ Delaware, Dept Biol Sci, Newark, DE 19711 USA; [Luff, Stephanie A.; Papoutsakis, Eleftherios T.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; [Papoutsakis, Eleftherios T.] Univ Delaware, Dept Biomol & Chem Engn, Newark, DE 19711 USA	University of Delaware; University of Delaware; University of Delaware	Papoutsakis, ET (corresponding author), 15 Innovat Way, Newark, DE 19711 USA.	epaps@udel.edu		Luff, Stephanie/0000-0003-4259-3839	National Institutes of Health [R21HL106397]; National Institutes of Health Shared Instrumentation Grant [S10 RR0272773]; National Science Foundation Fellowship at the University of Delaware [IGERT SBE2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Fellowship at the University of Delaware; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21HL106397, National Institutes of Health Shared Instrumentation Grant S10 RR0272773, and the National Science Foundation Fellowship IGERT SBE2 program at the University of Delaware (to S. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Apostolidis PA, 2012, PHYSIOL GENOMICS, V44, P638, DOI 10.1152/physiolgenomics.00028.2012; Apostolidis PA, 2012, EXP HEMATOL, V40, P131, DOI 10.1016/j.exphem.2011.10.006; Azuma N, 2001, AM J PHYSIOL-HEART C, V280, pH189, DOI 10.1152/ajpheart.2001.280.1.H189; Baan B, 2006, MOL ENDOCRINOL, V20, P1786, DOI 10.1210/me.2005-0289; Bender M, 2015, BLOOD, V125, P860, DOI 10.1182/blood-2014-09-600858; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bhattacharyya S, 2012, ACTA BIOCH BIOPH SIN, V44, P463, DOI 10.1093/abbs/gms027; Chang Y, 2007, J THROMB HAEMOST, V5, P318, DOI 10.1111/j.1538-7836.2007.02472.x; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Chen C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-384; Clarke MCH, 2003, J CELL BIOL, V160, P577, DOI 10.1083/jcb.200210111; Clichici S, 2012, TOXICOL APPL PHARM, V259, P281, DOI 10.1016/j.taap.2012.01.004; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Damle S, 2006, DEV BIOL, V299, P543, DOI 10.1016/j.ydbio.2006.06.016; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dumas JF, 2009, J BIOL CHEM, V284, P15117, DOI 10.1074/jbc.M900926200; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Dunois-Larde C, 2009, BLOOD, V114, P1875, DOI 10.1182/blood-2009-03-209205; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eriksson M, 2005, EXP CELL RES, V304, P175, DOI 10.1016/j.yexcr.2004.10.017; Ferrara DE, 2006, AM J PHYSIOL-REG I, V290, pR114, DOI 10.1152/ajpregu.00449.2005; Fish KN, 2008, BRAIN RES, V1240, P62, DOI 10.1016/j.brainres.2008.08.060; Fu MM, 2014, TRENDS CELL BIOL, V24, P564, DOI 10.1016/j.tcb.2014.05.002; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Fuhrken PG, 2008, PHYSIOL GENOMICS, V33, P159, DOI 10.1152/physiolgenomics.00127.2007; Fuhrken PG, 2007, EXP HEMATOL, V35, P476, DOI 10.1016/j.exphem.2006.10.017; Go YM, 1998, AM J PHYSIOL-HEART C, V275, pH1898, DOI 10.1152/ajpheart.1998.275.5.H1898; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Hsieh HJ, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-3; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; Jiang JL, 2014, BLOOD, V124, P2094, DOI 10.1182/blood-2014-01-547927; Jo H, 1997, J BIOL CHEM, V272, P1395, DOI 10.1074/jbc.272.2.1395; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kamkin A., 2011, MECHANOSENSITIVITY C; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kaushansky K, 2008, BLOOD, V111, P981, DOI 10.1182/blood-2007-05-088500; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; King SM, 2002, SEMIN CELL DEV BIOL, V13, P293, DOI 10.1016/S1084952102000599; Kodiha M., 2009, PROTOC EXCH, DOI [10. 1038/nprot. 2009. 16, DOI 10.1038/NPROT.2009.16]; Lambert MP, 2013, BLOOD, V121, P3319, DOI 10.1182/blood-2012-09-455428; Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Lordier L, 2008, BLOOD, V112, P3164, DOI 10.1182/blood-2008-03-144956; Meng RH, 2012, BLOOD, V120, P404, DOI 10.1182/blood-2011-11-389551; Mostafa SS, 2000, BRIT J HAEMATOL, V111, P879, DOI 10.1046/j.1365-2141.2000.02457.x; Nagata Y, 1998, BLOOD, V92, P1859, DOI 10.1182/blood.V92.6.1859.418k37_1859_1869; Ordureau A, 2013, J BIOL CHEM, V288, P24569, DOI 10.1074/jbc.M113.479550; Palmieri D, 2010, EXP CELL RES, V316, P789, DOI 10.1016/j.yexcr.2009.12.006; Panuganti S, 2013, TISSUE ENG PT A, V19, P998, DOI [10.1089/ten.tea.2011.0111, 10.1089/ten.TEA.2011.0111]; Patel SR, 2005, BLOOD, V106, P4076, DOI 10.1182/blood-2005-06-2204; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Pereira AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026182; Qin YX, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/863421; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Schlam D, 2013, J BIOL CHEM, V288, P23090, DOI 10.1074/jbc.M113.457606; Severin S, 2010, J THROMB HAEMOST, V8, P17, DOI 10.1111/j.1538-7836.2009.03658.x; Shi ZD, 2011, ANN BIOMED ENG, V39, P1608, DOI 10.1007/s10439-011-0309-2; Shi ZD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012196; Shin JW, 2011, P NATL ACAD SCI USA, V108, P11458, DOI 10.1073/pnas.1017474108; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Shyu KG, 2005, HYPERTENSION, V46, P614, DOI 10.1161/01.HYP.0000175811.79863.e2; SMEAL T, 1994, EMBO J, V13, P6006, DOI 10.1002/j.1460-2075.1994.tb06946.x; Spinier KR, 2015, BLOOD, V125, P525, DOI 10.1182/blood-2014-05-576462; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vittorio O, 2013, INTEGR BIOL-UK, V5, P291, DOI 10.1039/c2ib20152f; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang P, 2015, ONCOGENE, V34, P4558, DOI 10.1038/onc.2014.397; Wang P, 2014, BBA-MOL CELL RES, V1843, P923, DOI 10.1016/j.bbamcr.2014.01.018; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Weyrich AS, 2013, ANNU REV PHYSIOL, V75, P569, DOI 10.1146/annurev-physiol-030212-183752; Whitaker BI, 2013, REPORT US DEP HLTH H; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Wong AKT, 2013, EXPERT REV HEMATOL, V6, P205, DOI [10.1586/ehm.13.5, 10.1586/EHM.13.5]; Yang H, 2003, P NATL ACAD SCI USA, V100, P1122, DOI 10.1073/pnas.0237337100; Zhang W, 2015, BLOOD, V125, P562, DOI 10.1182/blood-2014-07-589507; Zhao Y, 2012, MOL CELL BIOCHEM, V359, P217, DOI 10.1007/s11010-011-1016-x	81	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7831	7843		10.1074/jbc.M115.707174	http://dx.doi.org/10.1074/jbc.M115.707174			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26814129	hybrid, Green Published			2022-12-28	WOS:000374056700007
J	Shilo, BZ				Shilo, Ben-Zion			New Twists in Drosophila Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						bone morphogenetic protein (BMP); cell signaling; development; Drosophila; epidermal growth factor receptor (EGFR); fibroblast growth factor (FGF); transcription; Wnt signaling; cytonemes; morphogen	DEPENDENT TRANSCRIPTION; FGF; TRACHEAL; RANGE; MIGRATION; DYNAMICS; HOMOLOG; EMBRYOS; GROWTH; NICHE	The discovery of a handful of conserved signaling pathways that dictate most aspects of embryonic and post-embryonic development of multicellular organisms has generated a universal view of animal development (Perrimon, N., Pitsouli, C., and Shilo, B. Z. (2012) Cold Spring Harb. Perspect. Biol. 4, a005975). Although we have at hand most of the hardware elements that mediate cell communication events that dictate cell fate choices, we are still far from a comprehensive mechanistic understanding of these processes. One of the next challenges entails an analysis of developmental signaling pathways from the cell biology perspective. Where in the cell does signaling take place, and how do general cellular machineries and structures contribute to the regulation of developmental signaling? Another challenge is to examine these signaling pathways from a quantitative perspective, rather than as crude on/off switches. This requires more precise measurements, and incorporation of the time element to generate a dynamic sequence instead of frozen snapshots of the process. The quantitative outlook also brings up the issue of precision, and the unknown mechanisms that buffer variability in signaling between embryos, to produce a robust and reproducible output. Although these issues are universal to all multicellular organisms, they can be effectively tackled in the Drosophila model, by a combination of genetic manipulations, biochemical analyses, and a variety of imaging techniques. This review will present some of the recent advances that were accomplished by utilizing the versatility of the Drosophila system.	[Shilo, Ben-Zion] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shilo, BZ (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	benny.shilo@weizmann.ac.il		Shilo, Ben Zion/0000-0003-4903-8889	Helen and Martin Kimmel Institute for Stem Cells research	Helen and Martin Kimmel Institute for Stem Cells research	An incumbent of the Hilda and Cecil Lewis chair in Molecular Genetics. Supported by a grant from the Helen and Martin Kimmel Institute for Stem Cells research.	Akiyama T, 2015, NATURE, V527, P375, DOI 10.1038/nature15730; Bothma JP, 2015, ELIFE, V4, DOI 10.7554/eLife.07956; Bothma JP, 2014, P NATL ACAD SCI USA, V111, P10598, DOI 10.1073/pnas.1410022111; Chen F, 2014, SCIENCE, V343, P186, DOI 10.1126/science.1241442; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Dsilva CJ, 2015, DEVELOPMENT, V142, P1717, DOI 10.1242/dev.119396; Gabay L, 1997, DEVELOPMENT, V124, P3535; Hariharan IK, 2015, DEV CELL, V34, P255, DOI 10.1016/j.devcel.2015.07.012; Harmansa S, 2015, NATURE, V527, P317, DOI 10.1038/nature15712; Housden BE, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3729; Inaba M, 2015, NATURE, V523, P329, DOI 10.1038/nature14602; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Kornberg TB, 2014, TRENDS CELL BIOL, V24, P370, DOI 10.1016/j.tcb.2014.01.003; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lim B, 2015, CURR BIOL, V25, P1784, DOI 10.1016/j.cub.2015.05.039; Lucas T, 2013, CURR BIOL, V23, P2135, DOI 10.1016/j.cub.2013.08.053; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Newton FG, 2015, DEVELOPMENT, V142, P3362, DOI 10.1242/dev.123273; Parker J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002274; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Peterson SJ, 2015, CELL, V160, P313, DOI 10.1016/j.cell.2014.11.043; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Roy S, 2014, SCIENCE, V343, P852, DOI 10.1126/science.1244624; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6	26	5	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7805	7808		10.1074/jbc.R115.711473	http://dx.doi.org/10.1074/jbc.R115.711473			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26907691	hybrid, Green Published			2022-12-28	WOS:000374056700004
J	Wennman, A; Oliw, EH; Karkehabadi, S; Chen, Y				Wennman, Anneli; Oliw, Ernst H.; Karkehabadi, Saeid; Chen, Yang			Crystal Structure of Manganese Lipoxygenase of the Rice Blast Fungus Magnaporthe oryzae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme mechanism; fatty acid oxidation; lipoxygenase pathway; metalloenzyme	CYANOTHECE SP; BIOSYNTHESIS; COMPLEX; IRON; HYDROPEROXIDE; EXPRESSION; MECHANISM; SUGGESTS; FEATURES; PRODUCT	Lipoxygenases (LOX) are non-heme metal enzymes, which oxidize polyunsaturated fatty acids to hydroperoxides. All LOX belong to the same gene family, and they are widely distributed. LOX of animals, plants, and prokaryotes contain iron as the catalytic metal, whereas fungi express LOX with iron or with manganese. Little is known about metal selection by LOX and the adjustment of the redox potentials of their protein-bound catalytic metals. Thirteen three-dimensional structures of animal, plant, and prokaryotic FeLOX are available, but none of MnLOX. The MnLOX of the most important plant pathogen, the rice blast fungus Magnaporthe oryzae (Mo), was expressed in Pichia pastoris. Mo-MnLOX was deglycosylated, purified to homogeneity, and subjected to crystal screening and x-ray diffraction. The structure was solved by sulfur and manganese single wavelength anomalous dispersion to a resolution of 2.0 . The manganese coordinating sphere is similar to iron ligands of coral 8R-LOX and soybean LOX-1 but is not overlapping. The Asn-473 is positioned on a short loop (Asn-Gln-Gly-Glu-Pro) instead of an -helix and forms hydrogen bonds with Gln-281. Comparison with FeLOX suggests that Phe-332 and Phe-525 might contribute to the unique suprafacial hydrogen abstraction and oxygenation mechanism of Mo-MnLOX by controlling oxygen access to the pentadiene radical. Modeling suggests that Arg-525 is positioned close to Arg-182 of 8R-LOX, and both residues likely tether the carboxylate group of the substrate. An oxygen channel could not be identified. We conclude that Mo-MnLOX illustrates a partly unique variation of the structural theme of FeLOX.	[Wennman, Anneli; Oliw, Ernst H.; Karkehabadi, Saeid; Chen, Yang] Uppsala Univ, Biomed Ctr, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden; [Karkehabadi, Saeid] Swedish Univ Agr Sci, Dept Chem & Biotechnol, Box 7015, SE-75007 Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences	Oliw, EH (corresponding author), Uppsala Univ, Biomed Ctr, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden.	Ernst.oliw@farmbio.uu.se			Vetenskapsradet Grant [K2013-67X-06523-31-3]; Knut and Alice Wallenberg Foundation [KAW2004.0123]	Vetenskapsradet Grant; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by Vetenskapsradet Grant K2013-67X-06523-31-3 and The Knut and Alice Wallenberg Foundation Grant KAW2004.0123. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andreou A, 2010, J BIOL CHEM, V285, P14178, DOI 10.1074/jbc.M109.094771; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brodhun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064919; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cristea M, 2005, ARCH BIOCHEM BIOPHYS, V434, P201, DOI 10.1016/j.abb.2004.10.026; Cristea M, 2006, J BIOL CHEM, V281, P17612, DOI 10.1074/jbc.M510311200; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Foadi J, 2013, ACTA CRYSTALLOGR D, V69, P1617, DOI 10.1107/S0907444913012274; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Garreta A, 2013, FASEB J, V27, P4811, DOI 10.1096/fj.13-235952; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Goldsmith CR, 2005, J AM CHEM SOC, V127, P9904, DOI 10.1021/ja039283w; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080; Heshof R, 2014, APPL MICROBIOL BIOT, V98, P1261, DOI 10.1007/s00253-013-5392-x; Hornsten L, 2002, EUR J BIOCHEM, V269, P2690, DOI 10.1046/j.1432-1033.2002.02936.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kobe MJ, 2014, J BIOL CHEM, V289, P8562, DOI 10.1074/jbc.M113.543777; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Neau DB, 2014, J BIOL CHEM, V289, P31905, DOI 10.1074/jbc.M114.599662; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; NELSON MJ, 1988, BIOCHEMISTRY-US, V27, P4273, DOI 10.1021/bi00412a011; Newcomer ME, 2015, PROTEIN SCI, V24, P298, DOI 10.1002/pro.2626; Newie J, 2016, J LIPID RES, V57, P276, DOI 10.1194/jlr.M064980; Oliw EH, 2004, LIPIDS, V39, P319, DOI 10.1007/s11745-004-1235-1; Oliw EH, 2008, J LIPID RES, V49, P420, DOI 10.1194/jlr.M700514-JLR200; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sheng YW, 2014, CHEM REV, V114, P3854, DOI 10.1021/cr4005296; SkrzypczakJankun E, 1997, PROTEINS, V29, P15, DOI [10.1002/(SICI)1097-0134(199709)29:1&lt;15::AID-PROT2&gt;3.0.CO;2-E, 10.1002/(SICI)1097-0134(199709)29:1<15::AID-PROT2>3.3.CO;2-F]; Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072; Wennman A, 2015, ARCH BIOCHEM BIOPHYS, V583, P87, DOI 10.1016/j.abb.2015.07.014; Wennman A, 2015, J LIPID RES, V56, P1606, DOI 10.1194/jlr.M060178; Wennman A, 2013, J LIPID RES, V54, P762, DOI 10.1194/jlr.M033787; Wennman A, 2012, J BIOL CHEM, V287, P31757, DOI 10.1074/jbc.M112.364331; Xu S, 2012, STRUCTURE, V20, P1490, DOI 10.1016/j.str.2012.06.003; Youn B, 2006, PROTEINS, V65, P1008, DOI 10.1002/prot.21182	46	47	48	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8130	8139		10.1074/jbc.M115.707380	http://dx.doi.org/10.1074/jbc.M115.707380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26783260	Green Published, hybrid			2022-12-28	WOS:000374056700030
J	Budelli, G; Sun, Q; Ferreira, J; Butler, A; Santi, CM; Salkoff, L				Budelli, Gonzalo; Sun, Qi; Ferreira, Juan; Butler, Alice; Santi, Celia M.; Salkoff, Lawrence			SLO2 Channels Are Inhibited by All Divalent Cations That Activate SLO1 K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; CA-2&-ACTIVATED K; HIGH-CONDUCTANCE; OUTWARD CURRENT; ION CHANNELS; SLACK; NA+; NEURONS; FAMILY; LOCALIZATION	Two members of the family of high conductance K+ channels SLO1 and SLO2 are both activated by intracellular cations. However, SLO1 is activated by Ca2+ and other divalent cations, while SLO2 (Slack or SLO2.2 from rat) is activated by Na+. Curiously though, we found that SLO2.2 is inhibited by all divalent cations that activate SLO1, with Zn2+ being the most effective inhibitor with an IC50 of similar to 8 mu M in contrast to Mg2+, the least effective, with an IC50 of similar to 1.5 mM. Our results suggest that divalent cations are not SLO2 pore blockers, but rather inhibit channel activity by an allosteric modification of channel gating. By site-directed mutagenesis we show that a histidine residue (His-347) downstream of S6 reduces inhibition by divalent cations. An analogous His residue present in some CNG channels is an inhibitory cation binding site. To investigate whether inhibition by divalent cations is conserved in an invertebrate SLO2 channel we cloned the SLO2 channel from Drosophila (dSLO2) and compared its properties to those of rat SLO2.2. We found that, like rat SLO2.2, dSLO2 was also activated by Na+ and inhibited by divalent cations. Inhibition of SLO2 channels in mammals and Drosophila by divalent cations that have second messenger functions may reflect the physiological regulation of these channels by one or more of these ions.	[Budelli, Gonzalo; Sun, Qi; Ferreira, Juan; Butler, Alice; Santi, Celia M.; Salkoff, Lawrence] Washington Univ, Sch Med, Dept Neurosci, 660 S Euclid Ave, St Louis, MO 63110 USA; [Salkoff, Lawrence] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Budelli, Gonzalo] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02458 USA; [Budelli, Gonzalo] Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02458 USA	Washington University (WUSTL); Washington University (WUSTL); Brandeis University; Brandeis University	Salkoff, L (corresponding author), Washington Univ, Sch Med, Dept Neurosci, 660 S Euclid Ave, St Louis, MO 63110 USA.	salkoffl@wustl.edu	Ferreira, Juan/GNW-6445-2022	Budelli, Gonzalo/0000-0002-2157-5511; Ferreira, Juan/0000-0001-8175-9067	National Institutes of Health [R21 NS088611, R21 MH107955, R01 HD069631]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R21 NS088611 and R21 MH107955 (to L. S.) and R01 HD069631 (to C. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2002, J COMP NEUROL, V454, P241, DOI 10.1002/cne.10439; Budelli G, 2009, NAT NEUROSCI, V12, P745, DOI 10.1038/nn.2313; Contreras GF, 2013, CHANNELS, V7, P442, DOI 10.4161/chan.26242; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; EGAN TM, 1992, BRAIN RES, V584, P319, DOI 10.1016/0006-8993(92)90913-T; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; Hage TA, 2012, J NEUROSCI, V32, P2714, DOI 10.1523/JNEUROSCI.5088-11.2012; Henrich M, 2008, AM J PHYSIOL-CELL PH, V294, pC280, DOI 10.1152/ajpcell.00345.2007; Hou SW, 2010, J BIOL CHEM, V285, P6434, DOI 10.1074/jbc.M109.069211; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Jegla T, 1997, J NEUROSCI, V17, P32, DOI 10.1523/JNEUROSCI.17-01-00032.1997; Kaczmarek Leonard K, 2013, ISRN Neurosci, V2013; KAMEYAMA M, 1984, NATURE, V309, P354, DOI 10.1038/309354a0; Lu SQ, 2010, J NEUROPHYSIOL, V103, P3311, DOI 10.1152/jn.00607.2009; MILLER C, 1987, J GEN PHYSIOL, V90, P427, DOI 10.1085/jgp.90.3.427; Nuwer MO, 2010, J NEUROSCI, V30, P14165, DOI 10.1523/JNEUROSCI.3150-10.2010; OBERHAUSER A, 1988, J GEN PHYSIOL, V92, P67, DOI 10.1085/jgp.92.1.67; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Paulais M, 2006, J GEN PHYSIOL, V127, P205, DOI 10.1085/jgp.200509360; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Ruffin VA, 2008, NEUROSCIENCE, V151, P410, DOI 10.1016/j.neuroscience.2007.10.031; SAITO M, 1991, J NEUROSCI, V11, P2135; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Shi JY, 2001, J GEN PHYSIOL, V118, P589, DOI 10.1085/jgp.118.5.589; VERGARA C, 1983, J GEN PHYSIOL, V82, P543, DOI 10.1085/jgp.82.4.543; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Zhang Z, 2010, J NEUROSCI, V30, P7554, DOI 10.1523/JNEUROSCI.0525-10.2010; Zhou Y, 2012, P NATL ACAD SCI USA, V109, P11413, DOI 10.1073/pnas.1204444109	33	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7347	7356		10.1074/jbc.M115.709436	http://dx.doi.org/10.1074/jbc.M115.709436			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26823461	Green Published, hybrid			2022-12-28	WOS:000383447600012
J	Spagnol, G; Kieken, F; Kopanic, JL; Li, HJ; Zach, S; Stauch, KL; Grosely, R; Sorgen, PL				Spagnol, Gaelle; Kieken, Fabien; Kopanic, Jennifer L.; Li, Hanjun; Zach, Sydney; Stauch, Kelly L.; Grosely, Rosslyn; Sorgen, Paul L.			Structural Studies of the Nedd4 WW Domains and Their Selectivity for the Connexin43 (Cx43) Carboxyl Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEIN; SECONDARY STRUCTURE ANALYSES; CIRCULAR-DICHROISM; INTERCELLULAR COMMUNICATION; KINETIC-ANALYSIS; C-SRC; PHOSPHORYLATION; INTERNALIZATION; UBIQUITIN; DEGRADATION	Neuronal precursor cell-expressed developmentally downregulated 4 (Nedd4) was the first ubiquitin protein ligase identified to interact with connexin43 (Cx43), and its suppressed expression results in accumulation of gap junction plaques at the plasma membrane. Nedd4-mediated ubiquitination of Cx43 is required to recruit Eps15 and target Cx43 to the endocytic pathway. Although the Cx43 residues that undergo ubiquitination are still unknown, in this study we address other unresolved questions pertaining to the molecular mechanisms mediating the direct interaction between Nedd4 (WW1-3 domains) and Cx43 (carboxyl terminus (CT)). All three WW domains display a similar three antiparallel beta-strand structure and interact with the same Cx43CT (PPXY286)-P-283 sequence. Although Tyr(286) is essential for the interaction, MAPK phosphorylation of the preceding serine residues (Ser(P)(279) and Ser(P)(282)) increases the binding affinity by 2-fold for the WW domains (WW2 > WW3 >> WW1). The structure of the WW2.Cx43CT(276-289)(Ser(P)(279), Ser(P)(282)) complex reveals that coordination of Ser(P)(282) with the end of beta-strand 3 enables Ser(P)(279) to interact with the back face of beta-strand 3 (Tyr(286) is on the front face) and loop 2, forming a horseshoe-shaped arrangement. The close sequence identity of WW2 with WW1 and WW3 residues that interact with the Cx43CT PPXY motif and Ser(P)(279)/Ser(P)(282) strongly suggests that the significantly lower binding affinity of WW1 is the result of a more rigid structure. This study presents the first structure illustrating how phosphorylation of the Cx43CT domain helps mediate the interaction with a molecular partner involved in gap junction regulation.	[Spagnol, Gaelle; Kieken, Fabien; Kopanic, Jennifer L.; Li, Hanjun; Zach, Sydney; Stauch, Kelly L.; Grosely, Rosslyn; Sorgen, Paul L.] Univ Nebraska Med Ctr, Omaha, NE 68105 USA	University of Nebraska System; University of Nebraska Medical Center	Sorgen, PL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68105 USA.	psorgen@unmc.edu		Spagnol, Gaelle/0000-0002-3201-4840	National Institutes of Health [GM072631, P30CA036727]; American Heart Association [0560050Z]; Nebraska Research Initiative; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Nebraska Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM072631 and P30CA036727, American Heart Association Grant 0560050Z, and the Nebraska Research Initiative funding for the Nebraska Center for Structural Biology. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; AUER HE, 1973, J AM CHEM SOC, V95, P3003, DOI 10.1021/ja00790a046; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bouvier D, 2008, CELL COMMUN ADHES, V15, P107, DOI 10.1080/15419060802014347; Bouvier D, 2009, J BIOL CHEM, V284, P34257, DOI 10.1074/jbc.M109.039594; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Catarino S, 2011, BIOCHEM J, V437, P255, DOI 10.1042/BJ20102059; Cochrane K, 2013, CELL COMMUN ADHES, V20, P53, DOI 10.3109/15419061.2013.784745; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duffy HS, 2004, CIRC RES, V94, P215, DOI 10.1161/01.RES.0000113924.06926.11; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Falk MM, 2012, J MEMBRANE BIOL, V245, P465, DOI 10.1007/s00232-012-9464-0; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Fischer MWF, 1998, P NATL ACAD SCI USA, V95, P8016, DOI 10.1073/pnas.95.14.8016; Fong JT, 2012, AUTOPHAGY, V8, P794, DOI 10.4161/auto.19390; GHOSHROY S, 1995, J MEMBRANE BIOL, V146, P15; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Grosely R, 2013, J BIOL CHEM, V288, P24857, DOI 10.1074/jbc.M113.454389; Gumpert AM, 2008, FEBS LETT, V582, P2887, DOI 10.1016/j.febslet.2008.07.024; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Hirst-Jensen BJ, 2007, J BIOL CHEM, V282, P5801, DOI 10.1074/jbc.M605233200; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jager M, 2009, PROTEIN SCI, V18, P1806, DOI 10.1002/pro.172; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnstone SR, 2012, CIRC RES, V111, P201, DOI 10.1161/CIRCRESAHA.112.272302; Jordan K, 2001, J CELL SCI, V114, P763; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kieken F, 2010, J BIOMOL NMR, V46, P245, DOI 10.1007/s10858-010-9397-9; Kjenseth A, 2010, CELL SIGNAL, V22, P1267, DOI 10.1016/j.cellsig.2010.03.005; Kopanic JL, 2015, BIOCHEM J, V466, P571, DOI 10.1042/BJ20141042; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2009, J CELL SCI, V122, P3883, DOI 10.1242/jcs.053801; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Martins-Marques T, 2015, BIOCHIMIE, V112, P196, DOI 10.1016/j.biochi.2015.02.020; Martins-Marques T, 2015, BIOCHEM J, V467, P231, DOI 10.1042/BJ20141370; Moreno AP, 2002, CIRC RES, V90, P450, DOI 10.1161/hh0402.105667; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Myszka DG, 1997, BIOPHYS CHEM, V64, P127, DOI 10.1016/S0301-4622(96)02230-2; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Nimlamool W, 2015, MOL BIOL CELL, V26, P2755, DOI 10.1091/mbc.E14-06-1105; Oshima A, 2014, FEBS LETT, V588, P1230, DOI 10.1016/j.febslet.2014.01.042; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Salah Z, 2012, FRONT BIOSCI-LANDMRK, V17, P331, DOI 10.2741/3930; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Smith TD, 2012, J MEMBRANE BIOL, V245, P221, DOI 10.1007/s00232-012-9443-5; Smyth JW, 2014, TRAFFIC, V15, P684, DOI 10.1111/tra.12169; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Thevenin AF, 2013, PHYSIOLOGY, V28, P93, DOI 10.1152/physiol.00038.2012; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	68	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7637	7650		10.1074/jbc.M115.701417	http://dx.doi.org/10.1074/jbc.M115.701417			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26841867	hybrid, Green Published			2022-12-28	WOS:000383447600035
J	Zhang, H; Yang, J; Wu, S; Gong, WB; Chen, C; Perrett, S				Zhang, Hong; Yang, Jie; Wu, Si; Gong, Weibin; Chen, Chang; Perrett, Sarah			Glutathionylation of the Bacterial Hsp70 Chaperone DnaK Provides a Link between Oxidative Stress and the Heat Shock Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70 kilodalton heat shock protein (Hsp70); chaperone; chaperone DnaK (DnaK); glutathionylation; oxidative stress; S-glutathionylation; deglutathionylation; thiol modification	NUCLEOTIDE EXCHANGE FACTOR; ESCHERICHIA-COLI; S-NITROSYLATION; ATP HYDROLYSIS; CONFORMATIONAL-CHANGES; SMALL MOLECULES; BINDING DOMAIN; PROTEINS; GRPE; IDENTIFICATION	DnaK is the major bacterial Hsp70, participating in DNA replication, protein folding, and the stress response. DnaK cooperates with the Hsp40 co-chaperone DnaJ and the nucleotide exchange factor GrpE. Under non-stress conditions, DnaK binds to the heat shock transcription factor sigma(32) and facilitates its degradation. Oxidative stress results in temporary inactivation of DnaK due to depletion of cellular ATP and thiol modifications such as glutathionylation until normal cellular ATP levels and a reducing environment are restored. However, the biological significance of DnaK glutathionylation remains unknown, and the mechanisms by which glutathionylation may regulate the activity of DnaK are also unclear. We investigated the conditions under which Escherichia coli DnaK undergoes S-glutathionylation. We observed glutathionylation of DnaK in lysates of E. coli cells that had been subjected to oxidative stress. We also obtained homogeneously glutathionylated DnaK using purified DnaK in the apo state. We found that glutathionylation of DnaK reversibly changes the secondary structure and tertiary conformation, leading to reduced nucleotide and peptide binding ability. The chaperone activity of DnaK was reversibly down-regulated by glutathionylation, accompanying the structural changes. We found that interaction of DnaK with DnaJ, GrpE, or sigma(32) becomes weaker when DnaK is glutathionylated, and the interaction is restored upon deglutathionylation. This study confirms that glutathionylation down-regulates the functions of DnaK under oxidizing conditions, and this down-regulation may facilitate release of sigma(32) from its interaction with DnaK, thus triggering the heat shock response. Such a mechanism provides a link between oxidative stress and the heat shock response in bacteria.	[Zhang, Hong; Yang, Jie; Wu, Si; Gong, Weibin; Chen, Chang; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China; [Yang, Jie] Univ Chinese Acad Sci, 19 Yuquan Rd, Beijing 100049, Peoples R China; [Chen, Chang] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, C; Perrett, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	changchen@moon.ibp.ac.cn; sarah.perrett@cantab.net	Perrett, Sarah/AAS-9483-2020	Perrett, Sarah/0000-0003-0137-0997; chen, chang/0000-0003-1008-1062	Chinese Ministry of Science and Technology 973 Program [2012CB911000, 2013CB910700]; National Natural Science Foundation of China [31270794, 31300631, 31200578, 31030023, 31225012, 31110103914, 31570780]	Chinese Ministry of Science and Technology 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Ministry of Science and Technology 973 Program Grants 2012CB911000 and 2013CB910700 (to S. P.) and National Natural Science Foundation of China Grants 31270794 (to H. Z.), 31300631 (to S. W.), 31200578 (to W. G.), 31030023 and 31225012 (to C. C.), and 31110103914 and 31570780 (to S. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Ansong C, 2013, P NATL ACAD SCI USA, V110, P10153, DOI 10.1073/pnas.1221210110; Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Baler R, 1996, CELL STRESS CHAPERON, V1, P33, DOI 10.1379/1466-1268(1996)001<0033:EFAROH>2.3.CO;2; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Carbone DL, 2004, CHEM RES TOXICOL, V17, P1459, DOI 10.1021/tx049838g; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chi BK, 2013, ANTIOXID REDOX SIGN, V18, P1273, DOI 10.1089/ars.2012.4686; Chirico WJ, 1998, BIOCHEMISTRY-US, V37, P13862, DOI 10.1021/bi980597j; Dahl JU, 2015, J MOL BIOL, V427, P1549, DOI 10.1016/j.jmb.2015.02.014; Fratelli M, 2005, P NATL ACAD SCI USA, V102, P13998, DOI 10.1073/pnas.0504398102; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; GROSSMAN AD, 1987, GENE DEV, V1, P179, DOI 10.1101/gad.1.2.179; GROSSMAN AD, 1984, CELL, V38, P383, DOI 10.1016/0092-8674(84)90493-8; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Han WJ, 2003, BIOCHEM J, V369, P627, DOI 10.1042/BJ20020943; Harrison C, 2003, CELL STRESS CHAPERON, V8, P218, DOI 10.1379/1466-1268(2003)008<0218:GANEFF>2.0.CO;2; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hermawan A, 1999, ARCH BIOCHEM BIOPHYS, V369, P157, DOI 10.1006/abbi.1999.1354; Hoppe G, 2004, EXP EYE RES, V78, P1085, DOI 10.1016/j.exer.2004.02.001; Huang B, 2009, CARDIOVASC RES, V83, P536, DOI 10.1093/cvr/cvp154; HYSLOP PA, 1988, J BIOL CHEM, V263, P1665; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Kang YL, 2008, BIOORG MED CHEM LETT, V18, P3749, DOI 10.1016/j.bmcl.2008.05.046; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; KOBAYASHI N, 1993, MOL CELL BIOL, V13, P248, DOI 10.1128/MCB.13.1.248; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; Lefievre L, 2007, PROTEOMICS, V7, P3066, DOI 10.1002/pmic.200700254; Leichert LIO, 2003, J BACTERIOL, V185, P1967, DOI 10.1128/JB.185.6.1967-1975.2003; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu QL, 1996, J BIOL CHEM, V271, P29937, DOI 10.1074/jbc.271.47.29937; Matagne A, 2000, J MOL BIOL, V297, P193, DOI 10.1006/jmbi.2000.3540; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; Michelet L, 2008, J BIOL CHEM, V283, P21571, DOI 10.1074/jbc.M802331200; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; Miyata Y, 2012, CHEM BIOL, V19, P1391, DOI 10.1016/j.chembiol.2012.07.026; MONTGOMERY D, 1993, J MOL BIOL, V232, P680, DOI 10.1006/jmbi.1993.1418; Muller A, 2013, J BACTERIOL, V195, P2807, DOI 10.1128/JB.00127-13; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Noguchi A, 2014, J BACTERIOL, V196, P1694, DOI 10.1128/JB.01197-13; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; PALLEROS DR, 1993, BIOCHEMISTRY-US, V32, P4314, DOI 10.1021/bi00067a021; PALLEROS DR, 1992, J BIOL CHEM, V267, P5279; Pierpaoli EV, 1998, J BIOL CHEM, V273, P6643, DOI 10.1074/jbc.273.12.6643; Popp S, 2005, J MOL BIOL, V347, P1039, DOI 10.1016/j.jmb.2005.02.026; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Ramsey AJ, 2009, BIOCHEM J, V423, P411, DOI 10.1042/BJ20090543; Reid KL, 1996, CELL STRESS CHAPERON, V1, P127, DOI 10.1379/1466-1268(1996)001<0127:PIBMOT>2.3.CO;2; Revington M, 2004, J BIOL CHEM, V279, P33958, DOI 10.1074/jbc.M313967200; Ricci Laura, 2008, Curr Chem Genomics, V2, P90, DOI 10.2174/1875397300802010090; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Russell R, 1999, BIOCHEMISTRY-US, V38, P4165, DOI 10.1021/bi9824036; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; SPRAGG RG, 1985, J CLIN INVEST, V76, P1471, DOI 10.1172/JCI112126; Swain JF, 2001, BIOCHEM SOC SYMP, V68, P69; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Taylor DM, 2007, CELL STRESS CHAPERON, V12, P151, DOI 10.1379/CSC-254R.1; Thompson AD, 2012, CELL STRESS CHAPERON, V17, P313, DOI 10.1007/s12192-011-0307-1; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Wang YY, 2012, MOL BIOL CELL, V23, P3290, DOI 10.1091/mbc.E12-06-0447; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Wei PC, 2012, MOL CELL, V48, P747, DOI 10.1016/j.molcel.2012.10.007; Westerheide SD, 2012, CURR PROTEIN PEPT SC, V13, P86; Wiktorowicz JE, 2011, BIOCHEMISTRY-US, V50, P5601, DOI 10.1021/bi200008b; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Zhang H, 2009, MOL MICROBIOL, V71, P702, DOI 10.1111/j.1365-2958.2008.06557.x; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zhuravleva A, 2011, P NATL ACAD SCI USA, V108, P6987, DOI 10.1073/pnas.1014448108	77	26	28	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6967	6981		10.1074/jbc.M115.673608	http://dx.doi.org/10.1074/jbc.M115.673608			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26823468	Green Published, hybrid			2022-12-28	WOS:000373299700033
J	Das, A; Fischer, RS; Pan, DJ; Waterman, CM				Das, Arupratan; Fischer, Robert S.; Pan, Duojia; Waterman, Clare M.			YAP Nuclear Localization in the Absence of Cell-Cell Contact Is Mediated by a Filamentous Actin-dependent, Myosin II- and Phospho-YAP-independent Pathway during Extracellular Matrix Mechanosensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; cytoskeleton; Hippo pathway; mechanotransduction; myosin; F-actin; YAP; contact inhibition; contractility	HIPPO SIGNALING PATHWAY; TUMOR-SUPPRESSOR; F-ACTIN; PROMOTES APOPTOSIS; TISSUE-GROWTH; STEM-CELL; PROLIFERATION; DROSOPHILA; PROTEIN; INHIBITION	Cell-cell contact inhibition and the mechanical environment of cells have both been shown to regulate YAP nuclear localization to modulate cell proliferation. Changes in cellular contractility by genetic, pharmacological, and matrix stiffness perturbations regulate YAP nuclear localization. However, because contractility and F-actin organization are interconnected cytoskeletal properties, it remains unclear which of these distinctly regulates YAP localization. Here we show that in the absence of cell-cell contact, actomyosin contractility suppresses YAP phosphorylation at Ser(112), however, neither loss of contractility nor increase in YAP phosphorylation is sufficient for its nuclear exclusion. We find that actin cytoskeletal integrity is essential for YAP nuclear localization, and can override phosphoregulation or contractility-mediated regulation of YAP nuclear localization. This actin-mediated regulation is conserved during mechanotransduction, as substrate compliance increased YAP phosphorylation and reduced cytoskeletal integrity leading to nuclear exclusion of both YAP and Ser(P)(112)-YAP. These data provide evidence for two actin-mediated pathways for YAP regulation; one in which actomyosin contractility regulates YAP phosphorylation, and a second that involves cytoskeletal integrity-mediated regulation of YAP nuclear localization independent of contractility. We suggest that in non-contact inhibited cells, this latter mechanism may be important in low stiffness regimes, such as may be encountered in physiological environments.	[Das, Arupratan; Fischer, Robert S.; Waterman, Clare M.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Das, Arupratan; Pan, Duojia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; Johns Hopkins University	Waterman, CM (corresponding author), NHLBI, Lab Cell & Tissue Morphodynam, NIH, Bldg 50,South Dr.,Rm 4537, Bethesda, MD 20892 USA.	watermancm@nhlbi.nih.gov		Fischer, Robert/0000-0003-0650-2696	NHLBI Division of Intramural Research; NEI through the National Institutes of Health [EY015708]; NATIONAL EYE INSTITUTE [R01EY015708] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005104] Funding Source: NIH RePORTER	NHLBI Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NEI through the National Institutes of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NHLBI Division of Intramural Research (to C. M. W., R. S. F., and A. D.) and Grant EY015708 from the NEI through the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	ABERCROMBIE M, 1970, IN VITRO CELL DEV B, V6, P128; Aoudjit F, 2001, ONCOGENE, V20, P4995, DOI 10.1038/sj.onc.1204554; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chen Q, 2015, GENE DEV, V29, P1285, DOI 10.1101/gad.264234.115; Cheng Y, 2015, FASEB J, V29, P2423, DOI 10.1096/fj.14-267856; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; Codelia VA, 2014, CURR BIOL, V24, P2012, DOI 10.1016/j.cub.2014.07.034; Cramer LP, 2002, CELL MOTIL CYTOSKEL, V51, P27, DOI 10.1002/cm.10013; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kardash E, 2011, NAT PROTOC, V6, P1835, DOI 10.1038/nprot.2011.395; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Rasmussen I, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-44; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shin W.D., 2010, LIVE CELL IMAGING LA, Vsecond; Shutova MS, 2014, CURR BIOL, V24, P1958, DOI 10.1016/j.cub.2014.07.070; Sun YB, 2014, NAT MATER, V13, P599, DOI [10.1038/nmat3945, 10.1038/NMAT3945]; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhong WL, 2013, STEM CELLS DEV, V22, P2083, DOI 10.1089/scd.2012.0685; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	48	120	120	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6096	6110		10.1074/jbc.M115.708313	http://dx.doi.org/10.1074/jbc.M115.708313			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26757814	Green Published, hybrid			2022-12-28	WOS:000372894200005
J	Moore, BD; Jin, RU; Lo, HY; Jung, M; Wang, HY; Battle, MA; Wollheim, CB; Urano, F; Mills, JC				Moore, Benjamin D.; Jin, Ramon U.; Lo, Heiyong; Jung, Min; Wang, Haiyan; Battle, Michele A.; Wollheim, Claes B.; Urano, Fumihiko; Mills, Jason C.			Transcriptional Regulation of X-Box-binding Protein One (XBP1) by Hepatocyte Nuclear Factor 4 (HNF4) Is Vital to Beta-cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); endoplasmic reticulum (ER); hepatocyte nuclear factor 4 (HNF-4); insulin secretion; X-box binding protein 1 (XBP1)	ENDOPLASMIC-RETICULUM STRESS; INSULIN-SECRETION; FACTOR 4-ALPHA; MESSENGER-RNA; TARGET GENES; MODY1 GENE; ER STRESS; EXPRESSION; CA2+; DIFFERENTIATION	The transcription factor, X-box-binding protein-1 (XBP1), controls the development and maintenance of the endoplasmic reticulum (ER) in multiple secretory cell lineages. We show here that Hepatocyte Nuclear Factor 4 (HNF4) directly induces XBP1 expression. Mutations in HNF4 cause Mature-Onset Diabetes of the Young I (MODYI), a subset of diabetes characterized by diminished GSIS. In mouse models, cell lines, and ex vivo islets, using dominant negative and human- disease-allele point mutants or knock-out and knockdown models, we show that disruption of HNF4 caused decreased expression of XBP1 and reduced cellular ER networks. GSIS depends on ER Ca2+ signaling; we show that diminished XBP1 and/or HNF4 in -cells led to impaired ER Ca2+ homeostasis. Restoring XBP1 expression was sufficient to completely rescue GSIS in HNF4- deficient -cells. Our findings uncover a transcriptional relationship between HNF4 and Xbp1 with potentially broader implications about MODYI and the importance of transcription factor signaling in the regulation of secretion.	[Moore, Benjamin D.; Jin, Ramon U.; Lo, Heiyong; Jung, Min; Mills, Jason C.] Washington Univ, Div Gastroenterol, Dept Med, St Louis, MO 63110 USA; [Moore, Benjamin D.; Jin, Ramon U.; Lo, Heiyong; Jung, Min; Mills, Jason C.] Washington Univ, Div Gastroenterol, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Moore, Benjamin D.; Jin, Ramon U.; Lo, Heiyong; Jung, Min; Mills, Jason C.] Washington Univ, Div Gastroenterol, Dept Dev Biol, St Louis, MO 63110 USA; [Wang, Haiyan] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Grenzacherstr 124, CH-4070 Basel, Switzerland; [Battle, Michele A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Wollheim, Claes B.] Lund Univ, Skane Univ Hosp, Ctr Diabet, Dept Clin Sci Diabet & Endocrinol, S-20502 Malmo, Sweden; [Wollheim, Claes B.] Univ Geneva, Univ Med Ctr, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-41211 Geneva, Switzerland; [Urano, Fumihiko] Washington Univ, Sch Med, Div Endocrinol, Dept Med, St Louis, MO 63110 USA; [Urano, Fumihiko] Washington Univ, Sch Med, Div Endocrinol, Dept Metab, St Louis, MO 63110 USA; [Urano, Fumihiko] Washington Univ, Sch Med, Div Endocrinol, Dept Lipid Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Roche Holding; Medical College of Wisconsin; Lund University; Skane University Hospital; University of Geneva; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mills, JC (corresponding author), Washington Univ, Div Gastroenterol, Dept Med, St Louis, MO 63110 USA.; Mills, JC (corresponding author), Washington Univ, Div Gastroenterol, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Mills, JC (corresponding author), Washington Univ, Div Gastroenterol, Dept Dev Biol, St Louis, MO 63110 USA.	jmills@wustl.edu	Mills, Jason/AAA-6688-2021; Urano, Fumihiko/AAF-4492-2020	Mills, Jason/0000-0002-0402-4662; Wollheim, Claes/0000-0002-4570-9879	National Institutes of Health NIDDK [DK094989, DK052574, DK087873]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087873, P30DK020579, R01DK094989, P30DK052574, R56DK087873, R01DK105129] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health NIDDK awards DK094989 and DK052574 (to J. C. M.), DK087873 (to M. A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; ALAM MS, 1995, PHYS REV LETT, V74, P2885, DOI 10.1103/PhysRevLett.74.2905; Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Bagwell AM, 2005, DIABETES, V54, P1185, DOI 10.2337/diabetes.54.4.1185; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cattin AL, 2009, MOL CELL BIOL, V29, P6294, DOI 10.1128/MCB.00939-09; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Furuta H, 1997, DIABETES, V46, P1652, DOI 10.2337/diabetes.46.10.1652; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Hara T, 2014, ENDOCRINOLOGY, V155, P758, DOI 10.1210/en.2013-1519; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hu CCA, 2009, EMBO J, V28, P1624, DOI 10.1038/emboj.2009.117; Huh WJ, 2010, GASTROENTEROLOGY, V139, P2038, DOI 10.1053/j.gastro.2010.08.050; Im Hogune, 2004, Methods Mol Biol, V284, P129; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Jacobo SMP, 2009, J PHARMACOL EXP THER, V331, P724, DOI 10.1124/jpet.109.158519; Leber JH, 2004, PLOS BIOL, V2, P1197, DOI 10.1371/journal.pbio.0020235; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lindner T, 1997, J CLIN INVEST, V100, P1400, DOI 10.1172/JCI119660; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Martino MEB, 2009, J BIOL CHEM, V284, P14904, DOI 10.1074/jbc.M809180200; Mills JC, 2012, BIOESSAYS, V34, P10, DOI 10.1002/bies.201100089; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; Muniappan L, 2009, METHODS MOL BIOL, V590, P131, DOI 10.1007/978-1-60327-378-7_8; Nolan AL, 2009, METHODS MOL BIOL, V560, P43, DOI 10.1007/978-1-59745-448-3_4; Ogawa N, 2004, GENES CELLS, V9, P95, DOI 10.1111/j.1365-2443.2004.00704.x; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Pearson ER, 2005, DIABETOLOGIA, V48, P878, DOI 10.1007/s00125-005-1738-y; Sato Y, 2012, J BIOL CHEM, V287, P23236, DOI 10.1074/jbc.M112.368779; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089; Tian XL, 2010, MOL CELL BIOL, V30, P1269, DOI 10.1128/MCB.01328-09; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Verkhratsky A, 1996, CELL CALCIUM, V19, P1, DOI 10.1016/S0143-4160(96)90009-3; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011621; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	55	22	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6146	6157		10.1074/jbc.M115.685750	http://dx.doi.org/10.1074/jbc.M115.685750			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26792861	hybrid, Green Published			2022-12-28	WOS:000372894200009
J	Romano, FB; Tang, YZ; Rossi, KC; Monopoli, KR; Ross, JL; Heuck, AP				Romano, Fabian B.; Tang, Yuzhou; Rossi, Kyle C.; Monopoli, Kathryn R.; Ross, Jennifer L.; Heuck, Alejandro P.			Type 3 Secretion Translocators Spontaneously Assemble a Hexadecameric Transmembrane Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; membrane transport; oligomer; protein translocation; single-molecule biophysics; type III secretion system (T3SS)	DIPYRROMETHENEBORON DIFLUORIDE BODIPY; MEMBRANE-PROTEIN INSERTION; HOST-CELL MEMBRANES; SYSTEM TIP COMPLEX; TOXIN T-DOMAIN; III SECRETION; PSEUDOMONAS-AERUGINOSA; PORE FORMATION; DIPHTHERIA-TOXIN; SHIGELLA-FLEXNERI	A type 3 secretion system is used by many bacterial pathogens to inject proteins into eukaryotic cells. Pathogens insert a translocon complex into the target eukaryotic membrane by secreting two proteins known as translocators. How these translocators form a translocon in the lipid bilayer and why both proteins are required remains elusive. Pseudomonas aeruginosa translocators PopB and PopD insert pores into membranes forming homo- or hetero-complexes of undetermined stoichiometry. Single-molecule fluorescence photobleaching experiments revealed that PopD formed mostly hexameric structures in membranes, whereas PopB displayed a bi-modal distribution with 6 and 12 subunits peaks. However, individually the proteins are not functional for effector translocation. We have found that when added together, the translocators formed distinct hetero-complexes containing 8 PopB and 8 PopD molecules. Thus, the interaction between PopB and PopD guide the assembly of a unique hetero-oligomer in membranes.	[Romano, Fabian B.; Tang, Yuzhou; Monopoli, Kathryn R.; Ross, Jennifer L.; Heuck, Alejandro P.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Rossi, Kyle C.; Heuck, Alejandro P.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Ross, Jennifer L.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Heuck, AP (corresponding author), 710 N Pleasant St,LGRT 1228, Amherst, MA 01003 USA.	heuck@umass.edu	Romano-Chernac, Fabian B./K-9396-2019; Ross, Jennifer L/D-7208-2012	Ross, Jennifer L/0000-0002-4838-3798; Rossi, Kyle/0000-0003-0607-7802; Heuck, Alejandro/0000-0002-7786-3109	National Institute of General Medical Sciences of the National Institutes of Health [R01GM097414]; National Science Foundation [DMR-1207783]; Direct For Biological Sciences [1344203] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515, R01GM097414] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institute of General Medical Sciences of the National Institutes of Health under award number R01GM097414 (to A. P. H.) and National Science Foundation Grant DMR-1207783 (to J. L. R.). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute of General Medical Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Adam PR, 2014, PROTEINS, V82, P3013, DOI 10.1002/prot.24662; Arant RJ, 2014, CHEMPHYSCHEM, V15, P600, DOI 10.1002/cphc.201301092; Bergstrom F, 2002, J AM CHEM SOC, V124, P196, DOI 10.1021/ja010983f; Chang JH, 2007, MOL MICROBIOL, V66, P1548, DOI 10.1111/j.1365-2958.2007.06024.x; Chenal A, 2002, J BIOL CHEM, V277, P43425, DOI 10.1074/jbc.M204148200; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; Dey S, 2012, PROTEIN J, V31, P401, DOI 10.1007/s10930-012-9416-7; Diaz-Valencia JD, 2011, BIOPHYS J, V100, P2440, DOI 10.1016/j.bpj.2011.03.062; Dickenson NE, 2013, BIOCHEMISTRY-US, V52, P8790, DOI 10.1021/bi400755f; Dunstone MA, 2012, CURR OPIN STRUC BIOL, V22, P342, DOI 10.1016/j.sbi.2012.04.008; Epler CR, 2009, INFECT IMMUN, V77, P2754, DOI 10.1128/IAI.00190-09; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Frithz-Lindsten E, 1998, MOL MICROBIOL, V29, P1155, DOI 10.1046/j.1365-2958.1998.00994.x; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gawrisch K., 2005, STRUCTURE BIOL MEMBR, P147; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Groulx N, 2011, J BIOL CHEM, V286, P42274, DOI 10.1074/jbc.M111.296103; Hume PJ, 2003, MOL MICROBIOL, V49, P425, DOI 10.1046/j.1365-2958.2003.03559.x; Johnson Benjamin B, 2014, Subcell Biochem, V80, P63, DOI 10.1007/978-94-017-8881-6_5; KAROLIN J, 1994, J AM CHEM SOC, V116, P7801, DOI 10.1021/ja00096a042; Kaufman MR, 2000, MICROBIOL-UK, V146, P2531, DOI 10.1099/00221287-146-10-2531; Kaya S, 2003, ANN NY ACAD SCI, V986, P278, DOI 10.1111/j.1749-6632.2003.tb07185.x; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; Mikhalyov I, 2002, PHYS CHEM CHEM PHYS, V4, P5663, DOI 10.1039/b206357n; Montagner C, 2011, J BACTERIOL, V193, P6923, DOI 10.1128/JB.05555-11; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; Mounier J, 2012, CELL HOST MICROBE, V12, P381, DOI 10.1016/j.chom.2012.07.010; Mounier J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000271; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Osiecki JC, 2001, MOL MICROBIOL, V42, P469, DOI 10.1046/j.1365-2958.2001.02654.x; Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; Romano FB, 2011, BIOCHEMISTRY-US, V50, P7117, DOI 10.1021/bi200905x; Rosconi MP, 2004, BIOCHEMISTRY-US, V43, P9127, DOI 10.1021/bi049354j; Ross JL, 2010, METHOD CELL BIOL, V95, P521, DOI 10.1016/S0091-679X(10)95026-7; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Selkrig J, 2014, BBA-MOL CELL RES, V1843, P1542, DOI 10.1016/j.bbamcr.2013.10.009; Senerovic L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.124; Song XD, 2001, ANAL CHIM ACTA, V442, P79, DOI 10.1016/S0003-2670(01)01128-X; TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0; Thuduppathy GR, 2006, BIOCHEMISTRY-US, V45, P14533, DOI 10.1021/bi0616652; Vallis AJ, 1999, INFECT IMMUN, V67, P2040; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Vargas-Uribe M, 2013, BIOCHEMISTRY-US, V52, P7901, DOI 10.1021/bi400926k; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x; Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2; Wang Y, 1997, J BIOL CHEM, V272, P25091, DOI 10.1074/jbc.272.40.25091; WEST SEH, 1995, GENE, V160, P81, DOI 10.1016/0378-1119(95)00236-Y; Yeow EKL, 2007, BIOPHYS J, V92, P3098, DOI [10.1529/biophysj.106.099424, 10.1529/biophysj. 106.099424]; Zhuang XW, 2000, P NATL ACAD SCI USA, V97, P14241, DOI 10.1073/pnas.97.26.14241	62	15	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6304	6315		10.1074/jbc.M115.681031	http://dx.doi.org/10.1074/jbc.M115.681031			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26786106	hybrid, Green Published			2022-12-28	WOS:000372894200021
J	Toorie, AM; Cyr, NE; Steger, JS; Beckman, R; Farah, G; Nillni, EA				Toorie, Anika M.; Cyr, Nicole E.; Steger, Jennifer S.; Beckman, Ross; Farah, George; Nillni, Eduardo A.			The Nutrient and Energy Sensor Sirt1 Regulates the Hypothalamic-Pituitary-Adrenal (HPA) Axis by Altering the Production of the Prohormone Convertase 2 (PC2) Essential in the Maturation of Corticotropin-releasing Hormone (CRH) from Its Prohormone in Male Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypothalamus; obesity; peptides; protein processing; sirtuin 1 (SIRT1); Sirt1 CRH; Sirt1 CRH hypothalamus; energy balance; prohormone convertases	MELANOCYTE-STIMULATING HORMONE; ENZYME CPE PRODUCTION; DIET-INDUCED OBESITY; PEPTIDE ALPHA-MSH; FOOD-INTAKE; BODY-WEIGHT; PARAVENTRICULAR NUCLEUS; MELANOCORTIN SYSTEM; NEURONS; EXPENDITURE	Understanding the role of hypothalamic neuropeptides and hormones in energy balance is paramount in the search for approaches to mitigate the obese state. Increased hypothalamic-pituitary-adrenal axis activity leads to increased levels of glucocorticoids (GC) that are known to regulate body weight. The axis initiates the production and release of corticotropin-releasing hormone (CRH) from the paraventricular nucleus (PVN) of the hypothalamus. Levels of active CRH peptide are dependent on the processing of its precursor pro-CRH by the action of two members of the family of prohormone convertases 1 and 2 (PC1 and PC2). Here, we propose that the nutrient sensor sirtuin 1 (Sirt1) regulates the production of CRH post-translationally by affecting PC2. Data suggest that Sirt1 may alter the preproPC2 gene directly or via deacetylation of the transcription factor Forkhead box protein O1 (FoxO1). Data also suggest that Sirt1 may alter PC2 via a post-translational mechanism. Our results show that Sirt1 levels in the PVN increase in rats fed a high fat diet for 12 weeks. Furthermore, elevated Sirt1 increased PC2 levels, which in turn increased the production of active CRH and GC. Collectively, this study provides the first evidence supporting the hypothesis that PVN Sirt1 activates the hypothalamic-pituitary-adrenal axis and basal GC levels by enhancing the production of CRH through an increase in the biosynthesis of PC2, which is essential in the maturation of CRH from its prohormone, pro-CRH.	[Toorie, Anika M.; Cyr, Nicole E.; Steger, Jennifer S.; Beckman, Ross; Nillni, Eduardo A.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Med,Div Endocrinol, Providence, RI 02903 USA; [Toorie, Anika M.] Brown Univ, Grad Program Pathobiol, Providence, RI 02903 USA; [Nillni, Eduardo A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02903 USA; [Cyr, Nicole E.; Farah, George] Stonehill Coll, Dept Biol, Easton, MA 02357 USA; [Cyr, Nicole E.; Farah, George] Stonehill Coll, Neurosci Program, Easton, MA 02357 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Nillni, EA (corresponding author), Brown Univ, 40 Pine Grove Ave, Sharon, MA 02067 USA.	Eduardo_Nillni@Brown.edu		Toorie, Anika/0000-0002-7235-5519	National Institutes of Health from NIDDK [wR01 DK085916, DK085916S]; Dr. George A. Bray Research Scholars Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085916] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Dr. George A. Bray Research Scholars Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health GrantwR01 DK085916 and DK085916S from NIDDK ( to E. A. N.) and the Dr. George A. Bray Research Scholars Award ( to N. E. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera G, 2008, PROG BRAIN RES, V170, P29, DOI 10.1016/S0079-6123(08)00403-2; Brar B, 1997, J ENDOCRINOL, V154, P431, DOI 10.1677/joe.0.1540431; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; CASTRO M, 1991, BIOCHEM SOC T, V19, pS246, DOI 10.1042/bst019246s; CASTRO MG, 1991, J MOL ENDOCRINOL, V7, P97, DOI 10.1677/jme.0.0070097; Challis BG, 2002, HUM MOL GENET, V11, P1997, DOI 10.1093/hmg/11.17.1997; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Cyr NE, 2015, ENDOCRINOLOGY, V156, P961, DOI 10.1210/en.2014-1970; Cyr NE, 2014, ENDOCRINOLOGY, V155, P2423, DOI 10.1210/en.2013-1998; Cyr NE, 2013, AM J PHYSIOL-ENDOC M, V304, pE640, DOI 10.1152/ajpendo.00448.2012; de Guia RM, 2014, HORM MOL BIOL CLIN I, V19, P117, DOI 10.1515/hmbci-2014-0021; Dhillo WS, 2002, NEUROENDOCRINOLOGY, V75, P209, DOI 10.1159/000054712; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Dong WJ, 1997, J NEUROSCI, V17, P563; EIPPER BA, 1993, PROTEIN SCI, V2, P489; Evanson NK, 2009, PSYCHONEUROENDOCRINO, V34, P1370, DOI 10.1016/j.psyneuen.2009.04.011; Fekete C, 2000, NEUROSCI LETT, V289, P152, DOI 10.1016/S0304-3940(00)01256-8; Ge JF, 2013, PHARMACOL BIOCHEM BE, V114, P64, DOI 10.1016/j.pbb.2013.10.028; HimmsHagen J, 1997, SCIENCE, V276, P1132, DOI 10.1126/science.276.5315.1132; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Jessop DS, 2001, J CLIN ENDOCR METAB, V86, P4109, DOI 10.1210/jc.86.9.4109; Jing EX, 2004, ENDOCRINOLOGY, V145, P1503, DOI 10.1210/en.2003-0834; Kan Y, 2008, FEBS LETT, V582, P2417, DOI 10.1016/j.febslet.2008.06.005; Knight CM, 2011, DIABETES, V60, P2691, DOI 10.2337/db10-0987; Kolthur-Seetharam U, 2009, BIOL REPROD, V80, P384, DOI 10.1095/biolreprod.108.070193; Kong XC, 2015, DIABETES, V64, P393, DOI 10.2337/db14-0395; Korosi A, 2008, EUR J PHARMACOL, V583, P204, DOI 10.1016/j.ejphar.2007.11.066; Kovacs KJ, 2013, J CHEM NEUROANAT, V54, P25, DOI 10.1016/j.jchemneu.2013.05.003; Laryea G, 2013, MOL ENDOCRINOL, V27, P1655, DOI 10.1210/me.2013-1187; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Lloyd DJ, 2006, HUM MOL GENET, V15, P1884, DOI 10.1093/hmg/ddl111; Lovejoy DA, 2014, J MOL ENDOCRINOL, V52, pT43, DOI 10.1530/JME-13-0238; Lu M, 2013, J BIOL CHEM, V288, P10722, DOI 10.1074/jbc.M112.443606; Mastorakos G, 2004, NUTR NEUROSCI, V7, P271, DOI 10.1080/10284150400020516; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Nillni EA, 2002, J BIOL CHEM, V277, P48587, DOI 10.1074/jbc.M206702200; Nillni EA, 2007, ENDOCRINOLOGY, V148, P4191, DOI 10.1210/en.2007-0173; Perello M, 2010, AM J PHYSIOL-ENDOC M, V299, pE976, DOI 10.1152/ajpendo.00448.2010; Perone MJ, 1998, MOL CELL ENDOCRINOL, V142, P191, DOI 10.1016/S0303-7207(98)00104-X; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; RAADSHEER FC, 1993, BRAIN RES, V615, P50, DOI 10.1016/0006-8993(93)91113-7; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Ramadori G, 2010, CELL METAB, V12, P78, DOI 10.1016/j.cmet.2010.05.010; RHO JH, 1987, BRAIN RES, V436, P143, DOI 10.1016/0006-8993(87)91566-6; Richard D, 2000, INT J OBESITY, V24, pS36, DOI 10.1038/sj.ijo.0801275; RIVIER J, 1983, P NATL ACAD SCI-BIOL, V80, P4851, DOI 10.1073/pnas.80.15.4851; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sanchez VC, 2004, J CLIN INVEST, V114, P357, DOI 10.1172/jci200421620; Sasaki T, 2014, DIABETOLOGIA, V57, P819, DOI 10.1007/s00125-013-3140-5; Sasaki T, 2010, ENDOCRINOLOGY, V151, P2556, DOI 10.1210/en.2009-1319; Seimon RV, 2013, HORM MOL BIOL CLIN I, V15, P71, DOI 10.1515/hmbci-2013-0038; Solomon S, 1999, ANN NY ACAD SCI, V885, P22; Sominsky L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00434; Spencer SJ, 2011, STRESS, V14, P233, DOI 10.3109/10253890.2010.534831; SPIESS J, 1981, P NATL ACAD SCI-BIOL, V78, P6517, DOI 10.1073/pnas.78.10.6517; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Tataranni PA, 1996, AM J PHYSIOL-ENDOC M, V271, pE317, DOI 10.1152/ajpendo.1996.271.2.E317; Toriya M, 2010, J NEUROENDOCRINOL, V22, P987, DOI 10.1111/j.1365-2826.2010.02039.x; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Veo K, 2011, GEN COMP ENDOCR, V172, P3, DOI 10.1016/j.ygcen.2011.04.006; Wren MA, 2014, J AM ASSOC LAB ANIM, V53, P44; Xiong SQ, 2011, J BIOL CHEM, V286, P5289, DOI 10.1074/jbc.M110.163667; Ziegler CG, 2007, HORM METAB RES, V39, P106, DOI 10.1055/s-2007-961809	65	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5844	5859		10.1074/jbc.M115.675264	http://dx.doi.org/10.1074/jbc.M115.675264			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26755731	Green Published, hybrid			2022-12-28	WOS:000372551800031
J	Guo, BB; Bellingham, SA; Hill, AF				Guo, Belinda B.; Bellingham, Shayne A.; Hill, Andrew F.			Stimulating the Release of Exosomes Increases the Intercellular Transfer of Prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; exosome (vesicle); extracellular vesicles; prion; prion disease; exosomes; monensin; neutral sphingomy; neutral sphingomyelinase; transwell	PROTEIN; SECRETION; ASSOCIATION; VESICLES; BETA; GLYCOSYLATION; INFECTIVITY; INHIBITION; MECHANISM; COFACTOR	Exosomes are small extracellular vesicles released by cells and play important roles in intercellular communication and pathogen transfer. Exosomes have been implicated in several neurodegenerative diseases, including prion disease and Alzheimer disease. Prion disease arises upon misfolding of the normal cellular prion protein, PrPC, into the disease-associated isoform, PrPSc. The disease has a unique transmissible etiology, and exosomes represent a novel and efficient method for prion transmission. The precise mechanism by which prions are transmitted from cell to cell remains to be fully elucidated, although three hypotheses have been proposed: direct cell-cell contact, tunneling nanotubes, and exosomes. Given the reported presence of exosomes in biological fluids and in the lipid and nucleic acid contents of exosomes, these vesicles represent an ideal mechanism for encapsulating prions and potential cofactors to facilitate prion transmission. This study investigates the relationship between exosome release and intercellular prion dissemination. Stimulation of exosome release through treatment with an ionophore, monensin, revealed a corresponding increase in intercellular transfer of prion infectivity. Conversely, inhibition of exosome release using GW4869 to target the neutral sphingomyelinase pathway induced a decrease in intercellular prion transmission. Further examination of the effect of monensin on PrP conversion revealed that monensin also alters the conformational stability of PrPC, leading to increased generation of proteinase K-resistant prion protein. The findings presented here provide support for a positive relationship between exosome release and intercellular transfer of prion infectivity, highlighting an integral role for exosomes in facilitating the unique transmissible nature of prions.	[Guo, Belinda B.; Bellingham, Shayne A.; Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Guo, Belinda B.; Bellingham, Shayne A.; Hill, Andrew F.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Hill, Andrew F.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3086, Australia	University of Melbourne; University of Melbourne; La Trobe University	Hill, AF (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3086, Australia.	andrew.hill@latrobe.edu.au	Hill, Andrew F./AAH-2854-2020; Hill, Andrew F./GZL-4124-2022; Hill, Andrew F/B-4527-2009	Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Guo, Belinda/0000-0003-2146-8561	Australian National Health and Medical Research Council [628946, 400202]; Australian Postgraduate Award; Faculty of Medicine, Dentistry and Health Sciences; Bellberry Indigenous Health Fellowship (Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne); Australian Research Council [FT100100560]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Faculty of Medicine, Dentistry and Health Sciences; Bellberry Indigenous Health Fellowship (Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne); Australian Research Council(Australian Research Council)	This study was funded by Australian National Health and Medical Research Council Grants 628946 and 400202.; Supported by an Australian Postgraduate Award and Faculty of Medicine, Dentistry and Health Sciences top-up scholarship.; Supported by a Bellberry Indigenous Health Fellowship (Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne).; Supported by Australian Research Council Future Fellowship Grant FT100100560.	Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Back N, 1996, HISTOCHEM J, V28, P591, DOI 10.1007/BF02331379; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cancellotti E, 2013, EMBO J, V32, P756, DOI 10.1038/emboj.2013.6; Cancellotti E, 2010, J VIROL, V84, P3464, DOI 10.1128/JVI.02374-09; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Harrison CF, 2010, J BIOL CHEM, V285, P20213, DOI 10.1074/jbc.M109.093310; Izquierdo-Useros N, 2009, BLOOD, V113, P2732, DOI 10.1182/blood-2008-05-158642; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; KUISMANEN E, 1985, J VIROL, V55, P813, DOI 10.1128/JVI.55.3.813-822.1985; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; LeBlanc AC, 1999, J NEUROCHEM, V72, P1832, DOI 10.1046/j.1471-4159.1999.0721832.x; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Nitrini R, 1997, ANN NEUROL, V42, P138, DOI 10.1002/ana.410420203; O'Neill HC, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.16pe8; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rabesandratana H, 1998, BLOOD, V91, P2573, DOI 10.1182/blood.V91.7.2573.2573_2573_2580; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rasband W., 2006, IMAGEJ; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Schatzl HM, 1997, J VIROL, V71, P8821; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vilette D, 2015, CELL MOL LIFE SCI, V72, P4409, DOI 10.1007/s00018-015-1945-8; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	52	85	89	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5128	5137		10.1074/jbc.M115.684258	http://dx.doi.org/10.1074/jbc.M115.684258			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26769968	Green Published, hybrid			2022-12-28	WOS:000371640600025
J	Kedziora, KM; Leyton-Puig, D; Argenzio, E; Boumeester, AJ; van Butselaar, B; Yin, TF; Wu, YI; van Leeuwen, FN; Innocenti, M; Jalink, K; Moolenaar, WH				Kedziora, Katarzyna M.; Leyton-Puig, Daniela; Argenzio, Elisabetta; Boumeester, Anja J.; van Butselaar, Bram; Yin, Taofei; Wu, Yi I.; van Leeuwen, Frank N.; Innocenti, Metello; Jalink, Kees; Moolenaar, Wouter H.			Rapid Remodeling of Invadosomes by G(i)-coupled Receptors DISSECTING THE ROLE OF Rho GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID RECEPTORS; NUCLEOTIDE EXCHANGE FACTOR; INVADOPODIA FORMATION; CELL INVASION; VASCULAR PHYSIOLOGY; PODOSOME ROSETTES; IN-VIVO; PROTEIN; CANCER; RAC	Invadosomes are actin-rich membrane protrusions that degrade the extracellular matrix to drive tumor cell invasion. Key players in invadosome formation are c-Src and Rho family GTPases. Invadosomes can reassemble into circular rosette-like superstructures, but the underlying signaling mechanisms remain obscure. Here we show that Src-induced invadosomes in human melanoma cells (A375M and MDA-MB-435) undergo rapid remodeling into dynamic extracellular matrix-degrading rosettes by distinct G protein-coupled receptor agonists, notably lysophosphatidic acid (LPA; acting through the LPA1 receptor) and endothelin. Agonist-induced rosette formation is blocked by pertussis toxin, dependent on PI3K activity and accompanied by localized production of phosphatidylinositol 3,4,5-trisphosphate, whereasMAPKand Ca2+ signaling are dispensable. Using FRET-based biosensors, we show that LPA and endothelin transiently activate Cdc42 through G(i), concurrent with a biphasic decrease in Rac activity and differential effects on RhoA. Cdc42 activity is essential for rosette formation, whereas G(12/13)-mediated RhoA-ROCK signaling suppresses the remodeling process. Our results reveal aGi-mediated Cdc42 signaling axis by which G protein-coupled receptors trigger invadosome remodeling, the degree of which is dictated by the Cdc42-RhoA activity balance.	[Kedziora, Katarzyna M.; Leyton-Puig, Daniela; Argenzio, Elisabetta; Boumeester, Anja J.; van Butselaar, Bram; Yin, Taofei; Jalink, Kees; Moolenaar, Wouter H.] Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Innocenti, Metello] Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Yin, Taofei; Wu, Yi I.] Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06030 USA; [van Leeuwen, Frank N.] Radboud Univ Nijmegen, Dept Cell Biol, NL-6525 GA Nijmegen, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; University of Connecticut; Radboud University Nijmegen	Jalink, K (corresponding author), Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	k.jalink@nki.nl	van Leeuwen, Frank/AAQ-6799-2020; Innocenti, Metello/X-2182-2019	van Leeuwen, Frank/0000-0003-1107-6513; Innocenti, Metello/0000-0002-7455-2559; Kedziora, Katarzyna/0000-0001-6524-7731; Jalink, Kees/0000-0001-7019-3440	Dutch Cancer Society [NKI2010-4626]; Stichting Technische Wetenschappen Grant [12150]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Grant [91106027]; National Institutes of Health [NS071216]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071216] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); Stichting Technische Wetenschappen Grant; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by Dutch Cancer Society Grant NKI2010-4626, Stichting Technische Wetenschappen Grant 12150, and Nederlandse Organisatie voor Wetenschappelijk Onderzoek Grant 91106027 (to K. J.) and National Institutes of Health Grant NS071216 (to Y. I. W.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akisaka T, 2001, J BONE MINER RES, V16, P1248, DOI 10.1359/jbmr.2001.16.7.1248; Artym Vira V., 2009, V522, P211, DOI 10.1007/978-1-59745-413-1_15; Asundi J, 2011, CLIN CANCER RES, V17, P965, DOI 10.1158/1078-0432.CCR-10-2340; Bagnato A, 2008, INT J BIOCHEM CELL B, V40, P1443, DOI 10.1016/j.biocel.2008.01.022; Beaty BT, 2014, EUR J CELL BIOL, V93, P438, DOI 10.1016/j.ejcb.2014.07.003; Boateng LR, 2012, EUR J CELL BIOL, V91, P878, DOI 10.1016/j.ejcb.2012.06.003; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; DAVIDPFEUTY T, 1980, P NATL ACAD SCI-BIOL, V77, P6687, DOI 10.1073/pnas.77.11.6687; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Genot E, 2014, EUR J CELL BIOL, V93, P367, DOI 10.1016/j.ejcb.2014.10.002; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hagedorn EJ, 2013, J CELL BIOL, V201, P903, DOI 10.1083/jcb.201301091; Hoshino D, 2013, J CELL SCI, V126, P2979, DOI 10.1242/jcs.079475; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jongsma M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029260; Kocher HM, 2009, GUT, V58, P271, DOI 10.1136/gut.2008.159871; Langeslag M, 2007, J BIOL CHEM, V282, P232, DOI 10.1074/jbc.M605300200; Leong HS, 2014, CELL REP, V8, P1558, DOI 10.1016/j.celrep.2014.07.050; Lepley D, 2005, CANCER RES, V65, P3788, DOI 10.1158/0008-5472.CAN-04-2311; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Marchesin V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121747; Marshall JCA, 2012, JNCI-J NATL CANCER I, V104, P1306, DOI 10.1093/jnci/djs319; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949, DOI 10.1074/jbc.270.22.12949; Moshfegh Y, 2014, NAT CELL BIOL, V16, P571, DOI 10.1038/ncb2972; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nakahara H, 2003, GENES CELLS, V8, P1019, DOI 10.1111/j.1365-2443.2003.00695.x; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Okazawa M, 1998, J BIOL CHEM, V273, P12584, DOI 10.1074/jbc.273.20.12584; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Pan YR, 2011, J CELL BIOL, V195, P113, DOI 10.1083/jcb.201103016; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pignatelli J, 2012, J CELL BIOL, V197, P421, DOI 10.1083/jcb.201108143; Rajadurai CV, 2012, J CELL SCI, V125, P2940, DOI 10.1242/jcs.100834; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Saldana-Caboverde A, 2010, PIGM CELL MELANOMA R, V23, P160, DOI 10.1111/j.1755-148X.2010.00678.x; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sandoval YHG, 2014, CURR VASC PHARMACOL, V12, P202, DOI 10.2174/1570161112666140226122054; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seano G, 2014, NAT CELL BIOL, V16, P931, DOI 10.1038/ncb3036; Sinha S, 2008, CELL SIGNAL, V20, P1927, DOI 10.1016/j.cellsig.2008.05.002; Skoura A, 2009, CARDIOVASC RES, V82, P221, DOI 10.1093/cvr/cvp088; Spuul P, 2014, SMALL GTPASES, V5, DOI [10.4161/sgtp.28713, DOI 10.4161/SGTP.28713]; Sun JW, 2014, J CELL BIOL, V207, P535, DOI 10.1083/jcb.201407082; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	60	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4323	4333		10.1074/jbc.M115.695940	http://dx.doi.org/10.1074/jbc.M115.695940			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26740622	Green Published, hybrid			2022-12-28	WOS:000371604600005
J	Robitaille, K; Rourke, JL; McBane, JE; Fu, A; Baird, S; Du, QJ; Kin, T; Shapiro, AMJ; Screaton, RA				Robitaille, Karine; Rourke, Jillian L.; McBane, Joanne E.; Fu, Accalia; Baird, Stephen; Du, Qiujiang; Kin, Tatsuya; Shapiro, A. M. James; Screaton, Robert A.			High-throughput Functional Genomics Identifies Regulators of Primary Human Beta Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PANCREATIC-ISLETS; INSULIN-SECRETION; TRANSPLANTATION; REPLICATION; EXPANSION; MOLECULE; ORGAN; MICE; REGENERATION; LANGERHANS	The expansion of cells for regenerative therapy will require the genetic dissection of complex regulatory mechanisms governing the proliferation of non-transformed human cells. Here, we report the development of a high-throughput RNAi screening strategy specifically for use in primary cells and demonstrate that silencing the cell cycle-dependent kinase inhibitors CDKN2C/p18 or CDKN1A/p21 facilitates cell cycle entry of quiescent adult human pancreatic beta cells. This work identifies p18 and p21 as novel targets for promoting proliferation of human beta cells and demonstrates the promise of functional genetic screens for dissecting therapeutically relevant state changes in primary human cells.	[Robitaille, Karine; McBane, Joanne E.; Fu, Accalia; Baird, Stephen] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Rourke, Jillian L.; Du, Qiujiang; Screaton, Robert A.] Sunnybrook Res Inst, Rm M7-617,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Fu, Accalia] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Kin, Tatsuya; Shapiro, A. M. James] Univ Alberta, Clin Islet Transplant Program, 8215-112 St, Edmonton, AB T6G 2C8, Canada; [Screaton, Robert A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Ottawa; University of Alberta; University of Toronto	Screaton, RA (corresponding author), Sunnybrook Res Inst, Rm M7-617,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	robert.screaton@sri.utoronto.ca	Kin, Tatsuya/A-3776-2012	Kin, Tatsuya/0000-0002-5179-6067; McBane, Joanne/0000-0002-9053-4668; Fu, Accalia/0000-0002-1110-8039	Juvenile Diabetes Research Foundation; Canadian Institutes of Health Research [MOP 111186]; Banting and Best Diabetes Centre at the University of Toronto; Canadian Diabetes Association; Alberta Innovates-Healthcare Solutions; Canadian Institutes of Health Research; Alberta Innovates [201201154] Funding Source: researchfish	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Centre at the University of Toronto; Canadian Diabetes Association; Alberta Innovates-Healthcare Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This work was supported in part by the Juvenile Diabetes Research Foundation and Canadian Institutes of Health Research Grant MOP 111186. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a postdoctoral fellowship from the Banting and Best Diabetes Centre at the University of Toronto.; Supported by postdoctoral fellowships from the Juvenile Diabetes Research Foundation and the Canadian Diabetes Association.; Holds a Canada Research Chair in Transplantation Surgery and Regenerative Medicine, is supported by a grant from Alberta Innovates-Healthcare Solutions, and is a member of the Canadian Institutes of Health Research-funded Canadian National Transplant Research Project.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Ali F, 2015, CURR OPIN ORGAN TRAN, V20, P152, DOI 10.1097/MOT.0000000000000180; Avrahami D, 2014, J CLIN INVEST, V124, P670, DOI 10.1172/JCI69519; Beattie GM, 1997, J CLIN ENDOCR METAB, V82, P1852, DOI 10.1210/jc.82.6.1852; Beck A, 2013, DIABETOLOGIA, V56, P1317, DOI 10.1007/s00125-013-2889-x; Bernards R, 2014, CURR OPIN GENET DEV, V24, P23, DOI 10.1016/j.gde.2013.11.007; Bruni A, 2014, DIABETES METAB SYNDR, V7, P211, DOI 10.2147/DMSO.S50789; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Cooper DKC, 2013, XENOTRANSPLANTATION, V20, P68, DOI 10.1111/xen.12015; Cozar-Castellano I, 2008, DIABETES, V57, P3056, DOI 10.2337/db08-0393; Eberhard CE, 2013, ENDOCRINOLOGY, V154, P2308, DOI 10.1210/en.2012-2088; Fiaschi-Taesch N, 2009, DIABETES, V58, P882, DOI 10.2337/db08-0631; Fiaschi-Taesch NM, 2013, DIABETES, V62, P2450, DOI 10.2337/db12-0777; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; Fu A, 2015, DIABETOLOGIA, V58, P1513, DOI 10.1007/s00125-015-3579-7; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Jeong JH, 2013, BIOCHEM BIOPH RES CO, V433, P513, DOI 10.1016/j.bbrc.2013.03.015; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kulkarni RN, 2012, DIABETES, V61, P2205, DOI 10.2337/db12-0018; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lakey JRT, 1996, TRANSPLANTATION, V61, P1047, DOI 10.1097/00007890-199604150-00010; Lucidi V, 2015, CURR OPIN CRIT CARE, V21, P163, DOI 10.1097/MCC.0000000000000186; Martin J, 2003, ONCOGENE, V22, P5261, DOI 10.1038/sj.onc.1206506; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; McDonald-Hyman C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa6853; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Moore F, 2012, METHODS MOL BIOL, V820, P179, DOI 10.1007/978-1-61779-439-1_11; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Ruttens D, 2015, ANN MED, V47, P106, DOI 10.3109/07853890.2015.1004359; Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148; Ryan EA, 2001, J INVEST MED, V49, P559, DOI 10.2310/6650.2001.33719; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sakamaki JI, 2014, NAT CELL BIOL, V16, P234, DOI 10.1038/ncb2919; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shen W, 2013, J AM CHEM SOC, V135, P1669, DOI 10.1021/ja309304m; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stein J, 2013, ISLETS, V5, P156, DOI 10.4161/isl.25605; Thomas KA, 2015, TRENDS MOL MED, V21, P319, DOI 10.1016/j.molmed.2015.02.004; Tyrberg B, 2001, DIABETES, V50, P301, DOI 10.2337/diabetes.50.2.301; Walpita Deepika, 2014, Curr Protoc Chem Biol, V6, P157, DOI 10.1002/9780470559277.ch140088; Walpita D, 2012, J BIOMOL SCREEN, V17, P509, DOI 10.1177/1087057111430253; Wang P, 2015, NAT MED, V21, P383, DOI 10.1038/nm.3820; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	49	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4614	4625		10.1074/jbc.M115.683912	http://dx.doi.org/10.1074/jbc.M115.683912			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26740620	hybrid, Green Published			2022-12-28	WOS:000371604600029
J	McLuskey, K; Grewal, JS; Das, D; Godzik, A; Lesley, SA; Deacon, AM; Coombs, GH; Elsliger, MA; Wilson, IA; Mottram, JC				McLuskey, Karen; Grewal, Jaspreet S.; Das, Debanu; Godzik, Adam; Lesley, Scott A.; Deacon, Ashley M.; Coombs, Graham H.; Elsliger, Marc-Andre; Wilson, Ian A.; Mottram, Jeremy C.			Crystal Structure and Activity Studies of the C11 Cysteine Peptidase from Parabacteroides merdae in the Human Gut Microbiome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIPAIN; QUALITY; DIFFRACTION; PROTEINASE; ACTIVATION; ALIGNMENT; FAMILY; ENZYME	Clan CD cysteine peptidases, a structurally related group of peptidases that include mammalian caspases, exhibit a wide range of important functions, along with a variety of specificities and activation mechanisms. However, for the clostripain family (denoted C11), little is currently known. Here, we describe the first crystal structure of a C11 protein from the human gut bacterium, Parabacteroides merdae (PmC11), determined to 1.7-angstrom resolution. PmC11 is a monomeric cysteine peptidase that comprises an extended caspase-like alpha/beta/alpha sandwich and an unusual C-terminal domain. It shares core structural elements with clan CD cysteine peptidases but otherwise structurally differs from the other families in the clan. These studies also revealed a well ordered break in the polypeptide chain at Lys(147), resulting in a large conformational rearrangement close to the active site. Biochemical and kinetic analysis revealed Lys(147) to be an intramolecular processing site at which cleavage is required for full activation of the enzyme, suggesting an autoinhibitory mechanism for self-preservation. PmC11 has an acidic binding pocket and a preference for basic substrates, and accepts substrates with Arg and Lys in P1 and does not require Ca2+ for activity. Collectively, these data provide insights into the mechanism and activity of PmC11 and a detailed framework for studies on C11 peptidases from other phylogenetic kingdoms.	[McLuskey, Karen; Grewal, Jaspreet S.; Mottram, Jeremy C.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland; [Grewal, Jaspreet S.; Mottram, Jeremy C.] Univ York, Dept Biol, Ctr Immunol & Infect, Wentworth Way, York YO10 5DD, N Yorkshire, England; [Das, Debanu; Godzik, Adam; Lesley, Scott A.; Deacon, Ashley M.; Elsliger, Marc-Andre; Wilson, Ian A.] SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA; [Das, Debanu; Godzik, Adam; Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Lesley, Scott A.; Elsliger, Marc-Andre; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Das, Debanu; Godzik, Adam; Deacon, Ashley M.] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Godzik, Adam] Sanford Burnham Prebys Med Discovery Inst, Program Bioinformat & Syst Biol, La Jolla, CA 92037 USA; [Lesley, Scott A.] Novartis Res Fdn, Prot Sci Dept, Genom Inst, San Diego, CA 92121 USA; [Coombs, Graham H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland	University of Glasgow; University of York - UK; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Scripps Research Institute; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Novartis; University of Strathclyde	Mottram, JC (corresponding author), Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland.; Mottram, JC (corresponding author), Univ York, Dept Biol, Ctr Immunol & Infect, Wentworth Way, York YO10 5DD, N Yorkshire, England.; Wilson, IA (corresponding author), SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA.; Wilson, IA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	wilson@scripps.edu; jeremy.mottram@york.ac.uk	Godzik, Adam/AAW-1467-2020; Godzik, Adam/A-7279-2009	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; McLuskey, Karen/0000-0002-9841-4943; Mottram, Jeremy/0000-0001-5574-3766; Elsliger, Marc Andre/0000-0002-1989-7626; Grewal, Jaspreet/0000-0002-2219-7655	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; MRC [MR/K019384/2, MR/K019384/1] Funding Source: UKRI; Medical Research Council [MR/K019384/2, MR/K019384/1] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the JCSG high throughput Structural Biology pipeline for their contribution to this work. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231. Genomic DNA from P. merdae was extracted from cells (ATCC number 43184) obtained from the American Type Culture Collection (ATCC).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Dall E, 2013, P NATL ACAD SCI USA, V110, P10940, DOI 10.1073/pnas.1300686110; Delano W.L, 2002, PYMOL USERS MANUAL; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Elsliger MA, 2010, ACTA CRYSTALLOGR F, V66, P1137, DOI 10.1107/S1744309110038212; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gorman MA, 2015, PROTEIN SCI, V24, P162, DOI 10.1002/pro.2589; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang HJ, 2013, ACTA CRYSTALLOGR D, V69, P1514, DOI 10.1107/S0907444913010196; KEMBHAVI AA, 1991, FEBS LETT, V283, P277, DOI 10.1016/0014-5793(91)80607-5; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Kocholaty W, 1938, BIOCHEM J, V32, P1685, DOI 10.1042/bj0321685; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Labrou NE, 2004, EUR J BIOCHEM, V271, P983, DOI 10.1111/j.1432-1033.2004.04000.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; McLuskey K, 2015, BIOCHEM J, V466, P219, DOI 10.1042/BJ20141324; McLuskey K, 2014, METHODS MOL BIOL, V1133, P203, DOI 10.1007/978-1-4939-0357-3_13; McLuskey K, 2012, P NATL ACAD SCI USA, V109, P7469, DOI 10.1073/pnas.1200885109; Mikolajczyk J, 2003, J BIOL CHEM, V278, P10458, DOI 10.1074/jbc.M210564200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Shen A, 2011, NAT STRUCT MOL BIOL, V18, P364, DOI 10.1038/nsmb.1990; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; ULLMANN D, 1994, EUR J BIOCHEM, V223, P865, DOI 10.1111/j.1432-1033.1994.tb19063.x; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Weiss MS, 1998, FEBS LETT, V423, P291, DOI 10.1016/S0014-5793(98)00098-2; Wiesmann C, 2012, J MOL BIOL, V419, P4, DOI 10.1016/j.jmb.2012.02.018; Witte V, 1996, CURR MICROBIOL, V33, P281, DOI 10.1007/s002849900114; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yu JW, 2011, P NATL ACAD SCI USA, V108, P21004, DOI 10.1073/pnas.1111708108	45	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9482	9491		10.1074/jbc.M115.706143	http://dx.doi.org/10.1074/jbc.M115.706143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26940874	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-28	WOS:000375602300009
J	Teng, L; Bennett, E; Cai, CX				Teng, Lei; Bennett, Edward; Cai, Chuanxi			Preconditioning c-Kit-positive Human Cardiac Stem Cells with a Nitric Oxide Donor Enhances Cell Survival through Activation of Survival Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; OXYGENASE-1 GENE-EXPRESSION; SMOOTH-MUSCLE-CELLS; HEME OXYGENASE-1; ISCHEMIC CARDIOMYOPATHY; INHIBITS APOPTOSIS; REPERFUSION INJURY; ENDOTHELIAL-CELLS; S-NITROSYLATION	Cardiac stem cell therapy has shown very promising potential to repair the infarcted heart but is severely limited by the poor survival of donor cells. Nitric oxide (NO) has demonstrated cytoprotective properties in various cells, but its benefits are unknown specifically for human cardiac stem cells (hCSCs). Therefore, we investigated whether pretreatment of hCSCs with a widely used NO donor, diethylenetriamine nitric oxide adduct (DETA-NO), promotes cell survival. Results from lactate dehydrogenase release assays showed a dose-and time-dependent attenuation of cell death induced by oxidative stress after DETA-NO preconditioning; this cytoprotective effect was abolished by the NO scavenger. Concomitant up-regulation of several cell signaling molecules after DETA-NO preconditioning was observed by Western blotting, including elevated phosphorylation of NRF2, NF kappa B, STAT3, ERK, and AKT, as well as increased protein expression of HO-1 and COX2. Furthermore, pharmaceutical inhibition of ERK, STAT3, and NF kappa B activities significantly diminished NO-induced cytoprotection against oxidative stress, whereas inhibition of AKT or knockdown of NRF2 only produced a minor effect. Blocking PI3K activity or knocking down COX2 expression did not alter the protective effect of DETA-NO on cell survival. The crucial roles of STAT3 and NF kappa B in NO-mediated signaling pathways were further confirmed by stable expression of gene-specific shRNAs in hCSCs. Thus, preconditioning hCSCs with DETA-NO promotes cell survival and resistance to oxidative stress by activating multiple cell survival signaling pathways. These results will potentially provide a simple and effective strategy to enhance survival of hCSCs after transplantation and increase their efficacy in repairing infarcted myocardium.	[Teng, Lei; Cai, Chuanxi] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Teng, Lei; Cai, Chuanxi] Albany Med Coll, Dept Med, Albany, NY 12208 USA; [Bennett, Edward] Albany Med Ctr, Div Cardiothorac Surg, Albany, NY 12208 USA	Albany Medical College; Albany Medical College; Albany Medical College	Cai, CX (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA.; Cai, CX (corresponding author), Albany Med Coll, Dept Med, Albany, NY 12208 USA.	caic@mail.amc.edu	Cai, Chuanxi/AAW-1488-2020		National Institutes of Health [R01HL114951]; American Heart Association [12BGIA9090005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01HL114951 (to C. C.) and American Heart Association Research Grant 12BGIA9090005 (to C. C.). The authors indicate no potential conflicts of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baetz D, 2005, CIRCULATION, V112, P3777, DOI 10.1161/CIRCULATIONAHA.105.573899; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Bolli R, 2013, CIRCULATION, V128, P122, DOI 10.1161/CIRCULATIONAHA.112.001075; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Cai CX, 2015, STEM CELLS, V33, P3596, DOI 10.1002/stem.2198; Cai CX, 2012, J BIOL CHEM, V287, P33720, DOI 10.1074/jbc.M112.385542; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chen K, 2000, CELL MOL BIOL, V46, P609; CORNWELL TL, 1994, AM J PHYSIOL-CELL PH, V267, pC1405, DOI 10.1152/ajpcell.1994.267.5.C1405; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Dawn B, 2002, ANN NY ACAD SCI, V962, P18, DOI 10.1111/j.1749-6632.2002.tb04053.x; Delikouras A, 2001, TRANSPLANTATION, V71, P599, DOI 10.1097/00007890-200103150-00004; DeMeester SL, 1998, CRIT CARE MED, V26, P1500, DOI 10.1097/00003246-199809000-00016; Dhakshinamoorthy S, 2004, J BIOL CHEM, V279, P20096, DOI 10.1074/jbc.M312492200; Durante W, 1997, CIRC RES, V80, P557, DOI 10.1161/01.RES.80.4.557; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Gancz D, 2012, J IMMUNOL, V189, P860, DOI 10.4049/jimmunol.1103451; Grange RW, 2001, PHYSIOL GENOMICS, V5, P35, DOI 10.1152/physiolgenomics.2001.5.1.35; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; He JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027719; Hermann Matthias, 2006, J Clin Hypertens (Greenwich), V8, P17, DOI 10.1111/j.1524-6175.2006.06032.x; Kang-Decker N, 2007, J CELL SCI, V120, P492, DOI 10.1242/jcs.03361; Kanno S, 2000, CIRCULATION, V101, P2742, DOI 10.1161/01.CIR.101.23.2742; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kim YM, 1999, J NEUROSCI, V19, P6740, DOI 10.1523/JNEUROSCI.19-16-06740.1999; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Lee KM, 2004, EUR J NEUROSCI, V19, P3375, DOI 10.1111/j.0953-816X.2004.03441.x; Li CQ, 2009, P NATL ACAD SCI USA, V106, P14547, DOI 10.1073/pnas.0907539106; Li JR, 1999, CELL DEATH DIFFER, V6, P952, DOI 10.1038/sj.cdd.4400579; Li QH, 2007, CIRCULATION, V116, P1577, DOI 10.1161/CIRCULATIONAHA.107.689810; Li QH, 2011, BASIC RES CARDIOL, V106, P1355, DOI 10.1007/s00395-011-0207-7; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Li QH, 2009, CIRCULATION, V120, P1222, DOI 10.1161/CIRCULATIONAHA.108.778688; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Lin L, 2011, BIOCHEM BIOPH RES CO, V416, P246, DOI 10.1016/j.bbrc.2011.10.112; Liu HD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-98; Liu JF, 2014, J CELL MOL MED, V18, P1381, DOI 10.1111/jcmm.12272; Liu XM, 2007, CARDIOVASC RES, V75, P381, DOI 10.1016/j.cardiores.2007.03.004; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; MCCALL TB, 1989, BIOCHEM J, V261, P293, DOI 10.1042/bj2610293; Mujoo K, 2008, P NATL ACAD SCI USA, V105, P18924, DOI 10.1073/pnas.0810230105; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nandagopal K, 2001, J PHARMACOL EXP THER, V297, P474; Napoli C, 2006, NITRIC OXIDE-BIOL CH, V15, P265, DOI 10.1016/j.niox.2006.03.011; Napoli C, 2013, J AM COLL CARDIOL, V62, P89, DOI 10.1016/j.jacc.2013.03.070; Obal D, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0305-1; Park SW, 2003, INT J CANCER, V107, P729, DOI 10.1002/ijc.11498; Patel R, 1999, J IMMUNOL, V162, P4191; Phillips L, 2009, J INVEST SURG, V22, P46, DOI 10.1080/08941930802709470; Sarkar R, 1996, CIRC RES, V78, P225, DOI 10.1161/01.RES.78.2.225; Shen YH, 1998, FEBS LETT, V433, P125, DOI 10.1016/S0014-5793(98)00844-8; Shintani Satoshi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS123, DOI 10.1038/ncpcardio0430; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Shirai T, 1998, J THORAC CARDIOV SUR, V115, P210, DOI 10.1016/S0022-5223(98)70459-3; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Taylor EL, 2003, CELL DEATH DIFFER, V10, P418, DOI 10.1038/sj.cdd.4401152; Um HC, 2011, NITRIC OXIDE-BIOL CH, V25, P161, DOI 10.1016/j.niox.2011.06.001; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Wang GW, 2005, AM J PHYSIOL-HEART C, V288, pH1290, DOI 10.1152/ajpheart.00796.2004; Wang Y, 2002, J MOL CELL CARDIOL, V34, P5, DOI 10.1006/jmcc.2001.1482; Wijayanti N, 2004, ANTIOXID REDOX SIGN, V6, P802, DOI 10.1089/1523086041798132; Yang TX, 2006, AM J PHYSIOL-RENAL, V291, pF891, DOI 10.1152/ajprenal.00512.2005; Zhang XC, 2006, FASEB J, V20, P2156, DOI 10.1096/fj.06-5668fje	70	20	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9733	9747		10.1074/jbc.M115.687806	http://dx.doi.org/10.1074/jbc.M115.687806			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26940876	Green Published, hybrid			2022-12-28	WOS:000375602300031
J	Xie, JS; Dai, CY; Hu, X				Xie, Jiansheng; Dai, Chunyan; Hu, Xun			Evidence That Does Not Support Pyruvate Kinase M2 (PKM2)-catalyzed Reaction as a Rate-limiting Step in Cancer Cell Glycolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; ENZYME-ACTIVITIES; LACTATE-DEHYDROGENASE; GLUCOSE-METABOLISM; PHOSPHOFRUCTOKINASE; HEXOKINASE; PHOSPHORYLATION; DIPHOSPHATE; INHIBITION; ISOMERASE	It has been recognized that the rate-limiting function of pyruvate kinase M2 (PKM2) in glycolysis plays an important role in distributing glycolytic intermediates for anabolic and catabolic purposes in cancer cells. However, after analysis of the catalytic capacity of PKM2 relative to other glycolytic enzymes, the regulation range of PKM2 activity, metabolic flux control, and thermodynamics, we suggest that the PKM2-catalyzed reaction is not a rate-limiting step in cancer cell glycolysis. Hexokinase and phosphofructokinase 1 (PFK1), the first and third enzyme along the pathway, are rate-limiting enzymes that limit the overall glycolytic rate, whereas PKM2 and lactate dehydrogenase, the last two enzymes in the pathway, are for the fast removal of upstream intermediates to prevent the obstruction of the pathway. The argument is in accordance with the catalytic capacity of glycolytic enzymes, regulation range of enzyme activities, metabolic flux control, and thermodynamics.	[Xie, Jiansheng; Dai, Chunyan; Hu, Xun] Second Affiliated Hosp, Inst Canc, Key Lab Canc Prevent & Intervent, China Natl Minist Educ, Hangzhou 310009, Zhejiang, Peoples R China; [Xie, Jiansheng] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Biomed Res Ctr, 88 Jiefang Rd, Hangzhou 310016, Zhejiang, Peoples R China	Zhejiang University	Hu, X (corresponding author), Zhejiang Univ, Sch Med, Inst Canc, 88 Jiefang Rd, Hangzhou 310016, Zhejiang, Peoples R China.	huxun@zju.edu.cn			China National 973 Project [2013CB911303]; China Natural Sciences Foundation [81272456, 81470126, 81502398]; Fundamental Research Funds for the Central Universities, National Ministry of Education, China	China National 973 Project(National Basic Research Program of China); China Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, National Ministry of Education, China	This work was supported in part by China National 973 Project 2013CB911303, China Natural Sciences Foundation Projects 81272456 and 81470126, and the Fundamental Research Funds for the Central Universities, National Ministry of Education, China (to X. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by China Natural Sciences Foundation Project 81502398.	Alberty Robert A, 2006, Methods Biochem Anal, V48, P1; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; BALINSKY D, 1973, CANCER RES, V33, P249; BALINSKY D, 1984, J NATL CANCER I, V72, P217; BALINSKY D, 1984, CANCER RES, V44, P1058; BEEMER FA, 1982, CANCER RES, V42, P4228; BEEMER FA, 1984, EUR J CANCER CLIN ON, V20, P253, DOI 10.1016/0277-5379(84)90192-5; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, VVol. 3., P1196; BUEDING E, 1955, J BIOL CHEM, V215, P507; BURNS JA, 1985, TRENDS BIOCHEM SCI, V10, P16, DOI 10.1016/0968-0004(85)90008-8; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; COWGILL RW, 1956, J BIOL CHEM, V223, P885; Deng HB, 2008, J BIOL CHEM, V283, P20754, DOI 10.1074/jbc.M800024200; FERDINAND W, 1964, BIOCHEM J, V92, P578, DOI 10.1042/bj0920578; GRACY RW, 1969, J BIOL CHEM, V244, P3913; GREGORIOU M, 1986, EUR J BIOCHEM, V161, P171, DOI 10.1111/j.1432-1033.1986.tb10138.x; HENNIPMAN A, 1987, TUMOR BIOL, V8, P251, DOI 10.1159/000217529; HENNIPMAN A, 1988, TUMOR BIOL, V9, P241, DOI 10.1159/000217568; HILF R, 1973, CANCER RES, V33, P2054; HILF R, 1970, CANCER RES, V30, P1874; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Ikeda Y, 1998, J BIOL CHEM, V273, P12227, DOI 10.1074/jbc.273.20.12227; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; KRAAIJENHAGEN RJ, 1982, CLIN CHIM ACTA, V124, P91, DOI 10.1016/0009-8981(82)90323-0; LARNER EH, 1978, CANCER-AM CANCER SOC, V41, P1863, DOI 10.1002/1097-0142(197805)41:5<1863::AID-CNCR2820410530>3.0.CO;2-T; Li X., 2011, DATABASE, V2011; MARSHALL MJ, 1978, BRIT J CANCER, V37, P990, DOI 10.1038/bjc.1978.144; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; MELLATI AA, 1992, CANCER BIOCHEM BIOPH, V13, P33; Mendez E, 2008, BIOCHEM MOL BIOL EDU, V36, P116, DOI 10.1002/bmb.20157; Nelson D.L., 2005, LEHNINGER PRINCIPLES, DOI DOI 10.1002/BMB.2005.494033010419; OLAVARRIA JS, 1986, ENZYME, V35, P34, DOI 10.1159/000469316; PAGLIARO L, 1989, J CELL SCI, V94, P333; PEDERSEN SN, 1975, CANCER-AM CANCER SOC, V35, P469, DOI 10.1002/1097-0142(197502)35:2<469::AID-CNCR2820350226>3.0.CO;2-R; PLAUT B, 1972, BIOCHEM J, V129, P311, DOI 10.1042/bj1290311; SCOPES RK, 1969, BIOCHEM J, V113, P551, DOI 10.1042/bj1130551; SEKINE N, 1994, J BIOL CHEM, V269, P4895; TORNHEIM K, 1976, J BIOL CHEM, V251, P7322; TORRES NV, 1990, MOL CELL BIOCHEM, V93, P21; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; WILSON JE, 1968, J BIOL CHEM, V243, P3640; Wong CCL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115036; Xie JS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04927; Zhao D, 2013, CANCER CELL, V23, P464, DOI 10.1016/j.ccr.2013.02.005	50	25	25	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8987	8999		10.1074/jbc.M115.704825	http://dx.doi.org/10.1074/jbc.M115.704825			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26917721	Green Published, hybrid			2022-12-28	WOS:000374849000014
J	Ghosh, S; Shinogle, HE; Galeva, NA; Dobrowsky, RT; Blagg, BSJ				Ghosh, Suman; Shinogle, Heather E.; Galeva, Nadezhda A.; Dobrowsky, Rick T.; Blagg, Brian S. J.			Endoplasmic Reticulum-resident Heat Shock Protein 90 (HSP90) Isoform Glucose-regulated Protein 94 (GRP94) Regulates Cell Polarity and Cancer Cell Migration by Affecting Intracellular Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cell polarity; heat shock protein 90 (HSP90); intracellular trafficking; survivin; aha1; grp94; integrin	ACTIN CYTOSKELETON; CHAPERONE ACTIVITY; RHO-GTPASES; EXPRESSION; INTEGRIN; STRESS; METASTASIS; SECRETION; MEMBRANE; SURVIVIN	Heat shock protein 90 (HSP90) is a molecular chaperone that is up-regulated in cancer and is required for the folding of numerous signaling proteins. Consequently, HSP90 represents an ideal target for the development of new anti-cancer agents. The human HSP90 isoform, glucose-regulated protein 94 (GRP94), resides in the endoplasmic reticulum and regulates secretory pathways, integrins, and Toll-like receptors, which contribute to regulating immunity and metastasis. However, the cellular function of GRP94 remains underinvestigated. We report that GRP94 knockdown cells are defective in intracellular transport and, consequently, negatively impact the trafficking of F-actin toward the cellular cortex, integrin alpha 2 and integrin alpha L toward the cell membrane and filopodia, and secretory vesicles containing the HSP90 alpha-AHA1-survivin complex toward the leading edge. As a result, GRP94 knockdown cells form a multipolar spindle instead of bipolar morphology and consequently manifest a defect in cell migration and adhesion.	[Ghosh, Suman; Blagg, Brian S. J.] Univ Kansas, Dept Med Chem, 1251 Wescoe Hall Dr,4070 Malott Hall, Lawrence, KS 66045 USA; [Shinogle, Heather E.] Univ Kansas, Microscopy & Analyt Imaging Lab, 1251 Wescoe Hall Dr,4070 Malott Hall, Lawrence, KS 66045 USA; [Galeva, Nadezhda A.] Univ Kansas, Mass Spectrometry Lab, 1251 Wescoe Hall Dr,4070 Malott Hall, Lawrence, KS 66045 USA; [Dobrowsky, Rick T.] Univ Kansas, Dept Pharmacol & Toxicol, 1251 Wescoe Hall Dr,4070 Malott Hall, Lawrence, KS 66045 USA	University of Kansas; University of Kansas; University of Kansas; University of Kansas	Blagg, BSJ (corresponding author), Univ Kansas, Dept Med Chem, 1251 Wescoe Hall Dr,4070 Malott Hall, Lawrence, KS 66045 USA.	bblagg@ku.edu	blagg, brian s j/X-7770-2018; Ghosh, Suman/F-3453-2013	blagg, brian s j/0000-0002-6200-3480; 	National Institutes of Health [CA109265, DK095911]; NATIONAL CANCER INSTITUTE [U01CA109265] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY024232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants CA109265 (to B. S. J. B.) and DK095911 (to R. T. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Altieri DC, 2015, SEMIN CELL DEV BIOL, V39, P91, DOI 10.1016/j.semcdb.2014.12.007; Barnes JA, 1997, ANAT EMBRYOL, V196, P335, DOI 10.1007/s004290050102; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cartwright S, 2014, SEMIN CELL DEV BIOL, V29, P169, DOI 10.1016/j.semcdb.2013.12.010; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chan KT, 2007, METHOD ENZYMOL, V426, P47, DOI 10.1016/S0076-6879(07)26003-3; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CULINE S, 1992, CANCER RES, V52, P3083; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Friederichs JM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002365; Ghosh S, 2015, ACS CHEM BIOL, V10, P577, DOI 10.1021/cb5008713; Ghosh S, 2012, MOL BIOL CELL, V23, P2546, DOI 10.1091/mbc.E11-07-0600; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Hasan N, 2010, EXP CELL RES, V316, P12, DOI 10.1016/j.yexcr.2009.10.007; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Jaspersen SL, 2012, NUCLEUS-PHILA, V3, P226, DOI 10.4161/nucl.20148; Khan S, 2015, HISTOL HISTOPATHOL, V30, P43, DOI 10.14670/HH-30.43; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; KIM KS, 1990, DIFFERENTIATION, V42, P153, DOI 10.1111/j.1432-0436.1990.tb00756.x; King SJ, 2014, CYTOSKELETON, V71, P423, DOI 10.1002/cm.21182; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Luo ML, 2015, CELL REP, V11, P111, DOI 10.1016/j.celrep.2015.03.002; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; MCCORMICK PJ, 1984, DEV BIOL, V105, P530, DOI 10.1016/0012-1606(84)90311-7; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Meng JH, 2015, BBA-REV CANCER, V1856, P1, DOI 10.1016/j.bbcan.2015.04.002; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; Peterson LB, 2012, MOL PHARMACEUT, V9, P1841, DOI 10.1021/mp300138n; Proux-Gillardeaux V, 2005, P NATL ACAD SCI USA, V102, P6362, DOI 10.1073/pnas.0409613102; Rachidi S, 2015, HEPATOLOGY, V61, P1766, DOI 10.1002/hep.27400; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Samadi AK, 2011, CANCER LETT, V312, P158, DOI 10.1016/j.canlet.2011.07.031; Sanz-Pamplona R, 2011, AM J PATHOL, V179, P564, DOI 10.1016/j.ajpath.2011.04.037; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shelton SN, 2009, MOL PHARMACOL, V76, P1314, DOI 10.1124/mol.109.058545; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; Solier S, 2012, P NATL ACAD SCI USA, V109, P12866, DOI 10.1073/pnas.1203617109; Sreedhar AS, 2004, FEBS LETT, V562, P11; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Subramani D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-312; Sung BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8164; Tamm I, 1998, CANCER RES, V58, P5315; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Yamashiro S, 1998, MOL BIOL CELL, V9, P993, DOI 10.1091/mbc.9.5.993; Zhang L, 2012, J PROTEOME RES, V11, P2581, DOI 10.1021/pr300056m; Zhang L, 2010, J PROTEOME RES, V9, P458, DOI 10.1021/pr900818g; Zheng HC, 2008, HUM PATHOL, V39, P1042, DOI 10.1016/j.humpath.2007.11.009	67	25	25	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8309	8323		10.1074/jbc.M115.688374	http://dx.doi.org/10.1074/jbc.M115.688374			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26872972	Green Published, hybrid			2022-12-28	WOS:000374773200001
J	Pandey, S; Modak, A; Phale, PS; Bhaumik, P				Pandey, Suman; Modak, Arnab; Phale, Prashant S.; Bhaumik, Prasenjit			High Resolution Structures of Periplasmic Glucose-binding Protein of Pseudomonas putida CSV86 Reveal Structural Basis of Its Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; glucose transport; protein structure; Pseudomonas; structure-function; substrate specificity; sugar transport; periplasmic glucose-binding protein; x-ray crystallography; sugar binding pocket	CRYSTAL-STRUCTURES; MALTOSE-BINDING; PREFERENTIAL UTILIZATION; CONFORMATIONAL-CHANGES; AROMATIC-COMPOUNDS; ACTIVE-TRANSPORT; RECEPTOR; MECHANISM; CHEMOTAXIS; STABILITY	Periplasmic substrate-binding proteins (SBPs) bind to the specific ligand with high affinity and mediate their transport into the cytoplasm via the cognate inner membrane ATP-binding cassette proteins. Because of low sequence identities, understanding the structural basis of substrate recognition by SBPs has remained very challenging. There are several structures available for the ligand-bound sugar SBPs, but very few unliganded structures are reported. No structural data are available for sugar SBPs from Pseudomonas sp. to date. This study reports the first high resolution crystal structures of periplasmic glucose-binding protein from Pseudomonas putida CSV86 (ppGBP) in unliganded form (2.5 ) and complexed with glucose (1.25 ) and galactose (1.8 ). Asymmetric domain closure of ppGBP was observed upon substrate binding. The ppGBP was found to have an affinity of approximate to 0.3 m for glucose. The structural analysis showed that the sugars are bound to the protein mainly by hydrogen bonds, and the loss of two strong hydrogen bonds between ppGBP and galactose compared with glucose may be responsible for lowering its affinity toward galactose. The higher stability of ppGBP-glucose complex was also indicated by an 8 degrees C increase in the melting temperature compared with unliganded form and ppGBP-galactose complex. ppGBP binds to monosaccharide, but the structural features revealed it to have an oligosaccharide-binding protein fold, indicating that during evolution the sugar binding pocket may have undergone structural modulation to accommodate monosaccharide only.	[Pandey, Suman; Modak, Arnab; Phale, Prashant S.; Bhaumik, Prasenjit] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Modak, Arnab] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Connecticut	Phale, PS; Bhaumik, P (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	pphale@iitb.ac.in; pbhaumik@iitb.ac.in		modak, arnab/0000-0001-7262-0143	Department of Biotechnology, Ministry of Science and Technology, India; Council of Scientific and Industrial Research, India; Department of Science and Technology, Ministry of Science and Technology, India	Department of Biotechnology, Ministry of Science and Technology, India; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Ministry of Science and Technology, India(Department of Science & Technology (India))	This work was supported in part by a Ramalingaswami re-entry fellowship and research grant (to P. B.) from the Department of Biotechnology, Ministry of Science and Technology, India. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Ph.D. fellowship from the Council of Scientific and Industrial Research, India.; Supported by a research grant from the Department of Science and Technology, Ministry of Science and Technology, India.	Adewoye LO, 2000, GENE, V253, P323, DOI 10.1016/S0378-1119(00)00285-7; Basu A, 2006, APPL ENVIRON MICROB, V72, P2226, DOI 10.1128/AEM.72.3.2226-2230.2006; Basu A, 2007, J BACTERIOL, V189, P7556, DOI 10.1128/JB.01235-07; Benson DE, 2002, BIOCHEMISTRY-US, V41, P3262, DOI 10.1021/bi011359i; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Borrok MJ, 2007, PROTEIN SCI, V16, P1032, DOI 10.1110/ps.062707807; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaudhuri BN, 1999, J MOL BIOL, V286, P1519, DOI 10.1006/jmbi.1999.2571; Chekan JR, 2014, J BIOL CHEM, V289, P34965, DOI 10.1074/jbc.M114.579904; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cuneo MJ, 2006, J MOL BIOL, V362, P259, DOI 10.1016/j.jmb.2006.06.084; Cuneo MJ, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-50; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Ejby M, 2013, MOL MICROBIOL, V90, P1100, DOI 10.1111/mmi.12419; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLOCCO MM, 1994, J BIOL CHEM, V269, P8931; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Gestwicki JE, 2001, ANAL CHEM, V73, P5732, DOI 10.1021/ac0105888; Guo ML, 2003, J BIOL CHEM, V278, P2490, DOI 10.1074/jbc.M208776200; Han YJ, 2012, J BIOL CHEM, V287, P34946, DOI 10.1074/jbc.M112.391532; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Heddle J, 2003, J BIOL CHEM, V278, P50322, DOI 10.1074/jbc.M307941200; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hsieh HV, 2004, BIOSENS BIOELECTRON, V19, P653, DOI 10.1016/S0956-5663(03)00271-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lager I, 2003, FEBS LETT, V553, P85, DOI 10.1016/S0014-5793(03)00976-1; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Licht A, 2011, J MOL BIOL, V406, P92, DOI 10.1016/j.jmb.2010.11.048; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; MAO B, 1982, J BIOL CHEM, V257, P1131; Matsumoto N, 2009, FEBS J, V276, P3008, DOI 10.1111/j.1742-4658.2009.07020.x; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER DM, 1980, J BIOL CHEM, V255, P2465; Modak A., 2014, THESIS INDIAN I TECH; Modak A, 2014, FEBS J, V281, P365, DOI 10.1111/febs.12607; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Paliwal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084000; Pandey S., 2015, ADV BIOSCI BIOTECHNO, V6, P164, DOI [10.4236/abb.2015.63016, DOI 10.4236/ABB.2015.63016]; Phale P. S., 2013, GENOME ANNOUNC, V1; PROSSNITZ E, 1988, J BIOL CHEM, V263, P17917; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schafer K, 2004, J MOL BIOL, V335, P261, DOI 10.1016/j.jmb.2003.10.042; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; Shrivastava R, 2011, MICROBIOL-SGM, V157, P1531, DOI 10.1099/mic.0.047191-0; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; Taylor D, 2014, BIOINFORMATICS, V30, P3189, DOI 10.1093/bioinformatics/btu506; Telmer PG, 2003, J BIOL CHEM, V278, P34555, DOI 10.1074/jbc.M301004200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vahedi-Faridi A, 2010, J MOL BIOL, V397, P709, DOI 10.1016/j.jmb.2010.01.054; Wilkinson T., 2003, ABC PROTEINS BACTERI, P187; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	64	17	17	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7844	7857		10.1074/jbc.M115.697268	http://dx.doi.org/10.1074/jbc.M115.697268			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26861882	Green Published, hybrid			2022-12-28	WOS:000374056700008
J	Stewart, MJ; Wang, TF; Koene, JM; Storey, KB; Cummins, SF				Stewart, Michael J.; Wang, Tianfang; Koene, Joris M.; Storey, Kenneth B.; Cummins, Scott F.			A "Love" Dart Allohormone Identified in the Mucous Glands of Hermaphroditic Land Snails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						invertebrate; molecular biology; neuropeptide; peptide hormone; pheromone; proteomics	SMALL CARDIOACTIVE PEPTIDE; CENTRAL-NERVOUS-SYSTEM; HELIX-ASPERSA; SEXUAL SELECTION; APLYSIA-CALIFORNICA; GARDEN SNAIL; BUCCALIN; MUCUS; NEUROPEPTIDES; COURTSHIP	Animals have evolved many ways to enhance their own reproductive success. One bizarre sexual ritual is the love dart shooting of helicid snails, which has courted many theories regarding its precise function. Acting as a hypodermic needle, the dart transfers an allohormone that increases paternity success. Its precise physiological mechanism of action within the recipient snail is to close off the entrance to the sperm digestion organ via a contraction of the copulatory canal, thereby delaying the digestion of most donated sperm. In this study, we used the common garden snail Cornu aspersum to identify the allohormone that is responsible for this physiological change in the female system of this simultaneous hermaphrodite. The love dart allohormone (LDA) was isolated from extracts derived from mucous glands that coat the dart before it is stabbed through the partner's body wall. We isolated LDA from extracts using bioassay-guided contractility measurement of the copulatory canal. LDA is encoded within a 235-amino acid precursor protein containing multiple cleavage sites that, when cleaved, releases multiple bioactive peptides. Synthetic LDA also stimulated copulatory canal contractility. Combined with our finding that the protein amino acid sequence resembles previously described molluscan buccalin precursors, this indicates that LDA is partially conserved in helicid snails and less in other molluscan species. In summary, our study provides the full identification of an allohormone that is hypodermically injected via a love dart. More importantly, our findings have important consequences for understanding reproductive biology and the evolution of alternative reproductive strategies.	[Stewart, Michael J.; Wang, Tianfang; Cummins, Scott F.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, Qld 4558, Australia; [Koene, Joris M.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Ecol Sci, NL-1081 HV Amsterdam, Netherlands; [Storey, Kenneth B.] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada; [Storey, Kenneth B.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	University of the Sunshine Coast; Vrije Universiteit Amsterdam; Carleton University; Carleton University	Cummins, SF (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, Qld 4558, Australia.; Cummins, SF (corresponding author), Univ Sunshine Coast, Dept Sci & Educ, 90 Sippy Downs Dr, Sippy Downs, Qld 4556, Australia.	scummins@usc.edu.au	Wang, Tianfang/GRO-0844-2022; Koene, Joris M./B-4502-2009; Wang, Tianfang/L-5192-2016; Wang, Tianfang/AAG-4290-2020	Wang, Tianfang/0000-0002-4876-7767; Koene, Joris M./0000-0001-8188-3439; Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767	Grains Research and Development Corporation Innovation and Investment Grants [USU00001]; Australian Research Council	Grains Research and Development Corporation Innovation and Investment Grants(Grains R&D Corp); Australian Research Council(Australian Research Council)	This work was supported by Grains Research and Development Corporation Innovation and Investment Grants USU00001 (to M. J. S., T. W., and S. F. C.) and by funds from the Australian Research Council (to S. F. C. and K. B. S.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMO SA, 1990, J EXP ZOOL, V255, P80, DOI 10.1002/jez.1402550111; ADAMO SA, 1990, BEHAV NEURAL BIOL, V54, P115, DOI 10.1016/0163-1047(90)91310-8; ADAMO SA, 1988, CAN J ZOOL, V66, P1446, DOI 10.1139/z88-211; Adamson K. J., 2015, GEN COMP ENDOCRINOL; Adamson KJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1510-8; [Anonymous], 1998, SPERM COMPETITION SE; Baur Bruno, 1998, P255, DOI 10.1016/B978-012100543-6/50033-7; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Bernard A., 1930, R SOC BIOL PARIS, V103, P1110; Birkhead T. R., 2008, SPERM BIOL EVOLUTION, P207; CHARNOV EL, 1979, P NATL ACAD SCI USA, V76, P2480, DOI 10.1073/pnas.76.5.2480; Chase R, 2006, P ROY SOC B-BIOL SCI, V273, P1471, DOI 10.1098/rspb.2006.3474; CHUNG DJD, 1987, VELIGER, V30, P24; Conzelmann M, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-23; CROPPER EC, 1990, BRAIN RES, V512, P175, DOI 10.1016/0006-8993(90)91189-N; CROPPER EC, 1988, P NATL ACAD SCI USA, V85, P6177, DOI 10.1073/pnas.85.16.6177; Gioti A, 2012, P ROY SOC B-BIOL SCI, V279, P4423, DOI 10.1098/rspb.2012.1634; Greenberg MJ, 1997, PEPTIDES, V18, P1099, DOI 10.1016/S0196-9781(97)00149-6; HIGGINS WJ, 1978, EUR J PHARMACOL, V48, P425, DOI 10.1016/0014-2999(78)90170-X; HUNT S, 1979, TISSUE CELL, V11, P51, DOI 10.1016/0040-8166(79)90005-3; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kimura K, 2013, ANIM BEHAV, V85, P631, DOI 10.1016/j.anbehav.2012.12.026; Koene JM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-25; Koene JM, 1998, J EXP BIOL, V201, P2313; Koene JM, 1998, J MOLLUS STUD, V64, P75, DOI 10.1093/mollus/64.1.75; Koene JM, 2001, J COMP PHYSIOL A, V187, P323, DOI 10.1007/s003590100214; Kuanpradit C, 2012, FEBS J, V279, P437, DOI 10.1111/j.1742-4658.2011.08436.x; Leonard JL, 2006, INTEGR COMP BIOL, V46, P349, DOI 10.1093/icb/icj041; LEONARD JL, 1992, J THEOR BIOL, V159, P513, DOI 10.1016/S0022-5193(05)80695-2; LIND H, 1973, J ZOOL, V169, P39; MILLER MW, 1992, J COMP NEUROL, V320, P182, DOI 10.1002/cne.903200204; Morishita F, 2010, CAN J ZOOL, V88, P825, DOI 10.1139/Z10-041; Nakadera Y, 2013, CAN J ZOOL, V91, P367, DOI 10.1139/cjz-2012-0272; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pomiankowski A, 2001, TRENDS ECOL EVOL, V16, P533, DOI 10.1016/S0169-5347(01)02243-1; PRICE DA, 1989, BIOL BULL, V177, P198, DOI 10.2307/1541933; Rogers DW, 2001, BEHAV ECOL SOCIOBIOL, V50, P122, DOI 10.1007/s002650100345; SANTAMA N, 1994, J COMP NEUROL, V342, P335, DOI 10.1002/cne.903420303; Scharer L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0052; Veenstra JA, 2010, GEN COMP ENDOCR, V167, P86, DOI 10.1016/j.ygcen.2010.02.010; VILIM FS, 1994, PEPTIDES, V15, P959, DOI 10.1016/0196-9781(94)90058-2; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a	42	15	15	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7938	7950		10.1074/jbc.M115.704395	http://dx.doi.org/10.1074/jbc.M115.704395			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26817846	Green Published, hybrid			2022-12-28	WOS:000374056700016
J	Forsberg, Z; Nelson, CE; Dalhus, B; Mekasha, S; Loose, JSM; Crouch, LI; Rohr, AK; Gardner, JG; Eijsink, VGH; Vaaje-Kolstad, G				Forsberg, Zarah; Nelson, Cassandra E.; Dalhus, Bjorn; Mekasha, Sophanit; Loose, Jennifer S. M.; Crouch, Lucy I.; Rohr, Asmund K.; Gardner, Jeffrey G.; Eijsink, Vincent G. H.; Vaaje-Kolstad, Gustav			Structural and Functional Analysis of a Lytic Polysaccharide Monooxygenase Important for Efficient Utilization of Chitin in Cellvibrio japonicus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; CELL WALL DEGRADATION; CELLULOSE DEGRADATION; SERRATIA-MARCESCENS; SUBSTRATE-SPECIFICITY; OXIDATIVE CLEAVAGE; PROTEIN CBP21; ALPHA-CHITIN; REFINEMENT; DISCOVERY	Cellvibrio japonicus is a Gram-negative soil bacterium that is primarily known for its ability to degrade plant cell wall polysaccharides through utilization of an extensive repertoire of carbohydrate-active enzymes. Several putative chitin-degrading enzymes are also found among these carbohydrate-active enzymes, such as chitinases, chitobiases, and lytic polysaccharide monooxygenases (LPMOs). In this study, we have characterized the chitin-active LPMO, CjLPMO10A, a tri-modular enzyme containing a catalytic family AA10 LPMO module, a family 5 chitin-binding module, and a C-terminal unclassified module of unknown function. Characterization of the latter module revealed tight and specific binding to chitin, thereby unraveling a new family of chitin-binding modules (classified as CBM73). X-ray crystallographic elucidation of the CjLPMO10A catalytic module revealed that the active site of the enzyme combines structural features previously only observed in either cellulose or chitin-active LPMO10s. Analysis of the copper-binding site by EPR showed a signal signature more similar to those observed for cellulose-cleaving LPMOs. The full-length LPMO shows no activity toward cellulose but is able to bind and cleave both alpha- and beta-chitin. Removal of the chitin-binding modules reduced LPMO activity toward alpha-chitin compared with the full-length enzyme. Interestingly, the full-length enzyme and the individual catalytic LPMO module boosted the activity of an endochitinase equally well, also yielding similar amounts of oxidized products. Finally, gene deletion studies show that CjLPMO10A is needed by C. japonicus to obtain efficient growth on both purified chitin and crab shell particles.	[Forsberg, Zarah; Mekasha, Sophanit; Loose, Jennifer S. M.; Rohr, Asmund K.; Eijsink, Vincent G. H.; Vaaje-Kolstad, Gustav] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Nelson, Cassandra E.; Gardner, Jeffrey G.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA; [Dalhus, Bjorn] Univ Oslo, Inst Clin Med, Dept Med Biochem, POB 4950, N-0424 Oslo, Norway; [Dalhus, Bjorn] Oslo Univ Hosp, Rikshosp, Clin Diagnost & Intervent, Dept Microbiol, POB 4950, N-0424 Oslo, Norway; [Crouch, Lucy I.] Newcastle Univ, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Norwegian University of Life Sciences; University System of Maryland; University of Maryland Baltimore County; University of Oslo; University of Oslo; National Hospital Norway; Newcastle University - UK	Vaaje-Kolstad, G (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway.	gustav.vaaje-kolstad@nmbu.no	Nelson, Cassandra/U-7963-2017; Forsberg, Zarah/AAM-2395-2020; Dalhus, Bjørn/AAK-2895-2020; Kjendseth, Åsmund Røhr/O-2543-2016; Mekasha, Sophanit/AAH-6400-2021	Nelson, Cassandra/0000-0002-7284-5198; Kjendseth, Åsmund Røhr/0000-0002-4956-4865; Forsberg, Zarah/0000-0002-8236-7986	Research Council of Norway [216625/F50]; European Synchrotron Radiation Facility [MX-1468]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); European Synchrotron Radiation Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Beri for providing the C. sapidus shells and for technical assistance. We are grateful for synchrotron travel support from The Research Council of Norway Grant 216625/F50. We also thank the European Synchrotron Radiation Facility staff for help and beamtime at beamline ID30A Project MX-1468.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adav SS, 2010, J PROTEOME RES, V9, P3016, DOI 10.1021/pr901174z; Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Akagi K, 2006, J BIOCHEM, V139, P483, DOI 10.1093/jb/mvj062; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; Book AJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-109; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiu E, 2015, P NATL ACAD SCI USA, V112, P3973, DOI 10.1073/pnas.1418798112; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2014, BIOCHEMISTRY-US, V53, P1647, DOI 10.1021/bi5000433; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frommhagen M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0284-1; Gardner JG, 2014, MOL MICROBIOL, V94, P1121, DOI 10.1111/mmi.12821; Gardner JG, 2012, METHOD ENZYMOL, V510, P331, DOI 10.1016/B978-0-12-415931-0.00018-5; Gardner JG, 2010, APPL ENVIRON MICROB, V76, P5079, DOI 10.1128/AEM.00454-10; GARDNER KH, 1975, BIOPOLYMERS, V14, P1581, DOI 10.1002/bip.1975.360140804; Gudmundsson M, 2014, J BIOL CHEM, V289, P18782, DOI 10.1074/jbc.M114.563494; Hazlewood GP, 1998, PROG NUCLEIC ACID RE, V61, P211, DOI 10.1016/S0079-6603(08)60828-4; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Heuts DPHM, 2008, BIOCHEM J, V413, P175, DOI 10.1042/BJ20071591; Hilden L, 2003, BIOTECHNOL LETT, V25, P553, DOI 10.1023/A:1022846304826; Hori C, 2011, FEMS MICROBIOL LETT, V321, P14, DOI 10.1111/j.1574-6968.2011.02307.x; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Hu JG, 2014, ENERG ENVIRON SCI, V7, P2308, DOI 10.1039/c4ee00891j; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3; Moser F, 2008, BIOTECHNOL BIOENG, V100, P1066, DOI 10.1002/bit.21856; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakagawa YS, 2013, J AGR FOOD CHEM, V61, P11061, DOI 10.1021/jf402743e; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Phillips CM, 2011, J PROTEOME RES, V10, P4177, DOI 10.1021/pr200329b; Rytioja J, 2014, FUNGAL GENET BIOL, V72, P91, DOI 10.1016/j.fgb.2013.12.008; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHNELLMANN J, 1994, MOL MICROBIOL, V13, P807, DOI 10.1111/j.1365-2958.1994.tb00473.x; Selig MJ, 2015, CELLULOSE, V22, P2263, DOI 10.1007/s10570-015-0635-x; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vermaas JV, 2015, J PHYS CHEM B, V119, P6129, DOI 10.1021/acs.jpcb.5b00778; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yakovlev I, 2012, APPL MICROBIOL BIOT, V95, P979, DOI 10.1007/s00253-012-4206-x	72	78	79	3	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7300	7312		10.1074/jbc.M115.700161	http://dx.doi.org/10.1074/jbc.M115.700161			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26858252	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000383447600008
J	Frank, DJ; Zhao, Y; Wong, SH; Basudhar, D; De Voss, JJ; de Montellano, PRO				Frank, Daniel J.; Zhao, Yan; Wong, Siew Hoon; Basudhar, Debashree; De Voss, James J.; de Montellano, Paul R. Ortiz			Cholesterol Analogs with Degradation-resistant Alkyl Side Chains Are Effective Mycobacterium tuberculosis Growth Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-P450 ENZYMES; LIVER-MICROSOMES; MACROPHAGES; CYP125A1; GENES	Cholest-4-en-3-one, whether added exogenously or generated intracellularly from cholesterol, inhibits the growth of Mycobacterium tuberculosis when CYP125A1 and CYP142A1, the cytochrome P450 enzymes that initiate degradation of the sterol side chain, are disabled. Here we demonstrate that a 16-hydroxy derivative of cholesterol, which was previously reported to inhibit growth of M. tuberculosis, acts by preventing the oxidation of the sterol side chain even in the presence of the relevant cytochrome P450 enzymes. The finding that (25R)-cholest-5-en-3 beta,16 beta,26-triol (1) (and its 3-keto metabolite) inhibit growth suggests that cholesterol analogs with non-degradable side chains represent a novel class of anti-mycobacterial agents. In accord with this, two cholesterol analogs with truncated, fluorinated side chains have been synthesized and shown to similarly block the growth in culture of M. tuberculosis.	[Frank, Daniel J.; Zhao, Yan; Basudhar, Debashree; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wong, Siew Hoon; De Voss, James J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia	University of California System; University of California San Francisco; University of Queensland	de Montellano, PRO (corresponding author), 600 16th St,N576D, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu	Frank, Daniel/G-5821-2010	Frank, Daniel/0000-0003-0063-7557; Frank, Daniel/0000-0002-9774-5580	National Institutes of Health [AI074824]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074824. The authors have no conflict of interest.	Alessandrini L, 2004, STEROIDS, V69, P789, DOI 10.1016/j.steroids.2004.09.009; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; HALPERT JR, 1991, METHOD ENZYMOL, V206, P540; Johnston JB, 2012, BIOORGAN MED CHEM, V20, P4064, DOI 10.1016/j.bmc.2012.05.003; Johnston JB, 2010, J BIOL CHEM, V285, P36352, DOI 10.1074/jbc.M110.161117; Klink M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073333; Lal GS, 1999, J ORG CHEM, V64, P7048, DOI 10.1021/jo990566+; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Martin R, 2009, EUR J ORG CHEM, V2009, P3703, DOI 10.1002/ejoc.200900443; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; OMURA T, 1964, J BIOL CHEM, V239, P2379; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Sadhukhan S, 2010, J AM CHEM SOC, V132, P6309, DOI 10.1021/ja100399m; SCHENKMAN JB, 1972, BIOCHEMISTRY-US, V11, P4243, DOI 10.1021/bi00773a008; Schmidt AW, 2013, BIOORG MED CHEM LETT, V23, P6111, DOI 10.1016/j.bmcl.2013.09.013; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Yang XX, 2007, BIOCHEMISTRY-US, V46, P9058, DOI 10.1021/bi700688x	27	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7325	7333		10.1074/jbc.M115.708172	http://dx.doi.org/10.1074/jbc.M115.708172			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26833565	Green Published, hybrid			2022-12-28	WOS:000383447600010
J	Gray, LR; Rauckhorst, AJ; Taylor, EB				Gray, Lawrence R.; Rauckhorst, Adam J.; Taylor, Eric B.			A Method for Multiplexed Measurement of Mitochondrial Pyruvate Carrier Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; TRANSPORT; GLUCONEOGENESIS; CELLS	The discovery that the MPC1 and MPC2 genes encode the protein components of the mitochondrial pyruvate carrier (MPC) has invigorated studies of mitochondrial pyruvate transport and its regulation in normal and disease states. Indeed, recent reports have demonstrated MPC involvement in the control of cell fate in cancer and gluconeogenesis in models of type 2 diabetes. Biochemical measurements of MPC activity are foundational for understanding the role of pyruvate transport in health and disease. We developed a 96-well scaled method of [C-14] pyruvate uptake that markedly decreases sample requirements and increases throughput relative to previous techniques. This method was applied to determine the mouse liver MPC Km (28.0 +/- 3.9 mu M) and V-max (1.08 +/- 0.05 nmol/min/mg), which have not previously been reported. Km and Vmax of the rat liver MPC were found to be 71.2 +/- 17 mu M and 1.42 +/- 0.14 nmol/min/mg, respectively. Additionally, we performed parallel pyruvate uptake and oxidation experiments with the same biological samples and show differential results in response to fasting, demonstrating the continued importance of a direct MPC activity assay. We expect this method will be of value for understanding the contribution of the MPC activity to health and disease states where pyruvate metabolism is expected to play a prominent role.	Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Abboud Cardiovasc Res Ctr, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Pappajohn Biomed Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Taylor, EB (corresponding author), Univ Iowa, Carver Coll Med, 169 Newton Rd,3316 Pappajohn Biomed Res Bldg, Iowa City, IA 52242 USA.	eric-taylor@uiowa.edu		Rauckhorst, Adam/0000-0002-4101-0075; Taylor, Eric/0000-0003-4549-6567	National Institutes of Health [R01 DK104998, R00 AR059190, F32 DK101183, T32 HL007121, T32 HL007638, P30CA086862]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007638, T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR059190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104998, F32DK101183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK104998 (to E. B. T.), R00 AR059190 (to E. B. T.), F32 DK101183 (to L. R. G.), T32 HL007121 to Francois Abboud (to L. R. G.), T32 HL007638 to Michael Welsh (to A. J. R.), and P30CA086862 to George Weiner, which contributed to support of core facilities utilized for this work. The authors declare no conflict of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aires CCP, 2008, FEBS LETT, V582, P3359, DOI 10.1016/j.febslet.2008.08.028; Bender T, 2015, EMBO J, V34, P911, DOI 10.15252/embj.201490197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Compan V, 2015, MOL CELL, V59, P491, DOI 10.1016/j.molcel.2015.06.035; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Fernandez-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; HALESTRAP AP, 1974, BIOCHEM J, V138, P313, DOI 10.1042/bj1380313; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Angaman DM, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-1; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; PAPA S, 1971, FEBS LETT, V12, P285, DOI 10.1016/0014-5793(71)80200-4; PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H; PARADIES G, 1983, CANCER RES, V43, P5068; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Saudek V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030876; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; TITHERADGE MA, 1976, FEBS LETT, V63, P45, DOI 10.1016/0014-5793(76)80191-3; TITHERADGE MA, 1975, BIOCHEM J, V150, P553, DOI 10.1042/bj1500553; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; ZAHLTEN RN, 1972, FEBS LETT, V21, P11, DOI 10.1016/0014-5793(72)80150-9; Zhang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057766; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027553	28	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7409	7417		10.1074/jbc.M115.711663	http://dx.doi.org/10.1074/jbc.M115.711663			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26823462	Green Published, hybrid			2022-12-28	WOS:000383447600017
J	Lin, CS; Uboldi, AD; Epp, C; Bujard, H; Tsuboi, T; Czabotar, PE; Cowman, AF				Lin, Clara S.; Uboldi, Alessandro D.; Epp, Christian; Bujard, Hermann; Tsuboi, Takafumi; Czabotar, Peter E.; Cowman, Alan F.			Multiple Plasmodium falciparum Merozoite Surface Protein 1 Complexes Mediate Merozoite Binding to Human Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBIT PARASITE GROWTH; RED-BLOOD-CELLS; MALARIA PARASITE; BALANCING SELECTION; SERINE-PROTEASE; IN-VITRO; INVASION; ANTIBODIES; IDENTIFICATION; RECEPTOR	Successful invasion of human erythrocytes by Plasmodium falciparum merozoites is required for infection of the host and parasite survival. The early stages of invasion are mediated via merozoite surface proteins that interact with human erythrocytes. The nature of these interactions are currently not well understood, but it is known that merozoite surface protein 1 (MSP1) is critical for successful erythrocyte invasion. Here we show that the peripheral merozoite surface proteins MSP3, MSP6, MSPDBL1, MSPDBL2, and MSP7 bind directly to MSP1, but independently of each other, to form multiple forms of the MSP1 complex on the parasite surface. These complexes have overlapping functions that interact directly with human erythrocytes. We also show that targeting the p83 fragment of MSP1 using inhibitory antibodies inhibits all forms of MSP1 complexes and disrupts parasite growth in vitro.	[Lin, Clara S.; Uboldi, Alessandro D.; Czabotar, Peter E.; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Lin, Clara S.; Czabotar, Peter E.; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Epp, Christian] Heidelberg Univ, Dept Infect Dis, Parasitol, INF 324, D-69120 Heidelberg, Germany; [Bujard, Hermann] Heidelberg Univ, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany; [Tsuboi, Takafumi] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime 7908577, Japan	Walter & Eliza Hall Institute; University of Melbourne; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ehime University	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia.; Cowman, AF (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia.	cowman@wehi.edu.au	Tsuboi, Takafumi/AAK-6145-2021; Cowman, Alan/C-7642-2013	Czabotar, Peter/0000-0002-2594-496X; Tsuboi, Takafumi/0000-0002-7415-1325; Cowman, Alan/0000-0001-5145-9004				Amambua-Ngwa A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002992; Baldwin MR, 2015, BLOOD, V125, P2704, DOI 10.1182/blood-2014-11-611707; BLACKMAN MJ, 1992, MOL BIOCHEM PARASIT, V50, P307, DOI 10.1016/0166-6851(92)90228-C; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; Blackman MJ, 2004, CELL MICROBIOL, V6, P893, DOI 10.1111/j.1462-5822.2004.00437.x; BLACKMAN MJ, 1993, MOL BIOCHEM PARASIT, V62, P103, DOI 10.1016/0166-6851(93)90182-W; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; Campanale N, 2003, J BIOL CHEM, V278, P27354, DOI 10.1074/jbc.M303634200; Chiu CYH, 2015, J INFECT DIS, V212, P406, DOI 10.1093/infdis/jiv057; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; CREWTHER PE, 1990, EXP PARASITOL, V70, P193, DOI 10.1016/0014-4894(90)90100-Q; Das S, 2015, CELL HOST MICROBE, V18, P433, DOI 10.1016/j.chom.2015.09.007; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Gondeau C, 2009, MOL BIOCHEM PARASIT, V165, P153, DOI 10.1016/j.molbiopara.2009.01.015; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Hodder AN, 2012, J BIOL CHEM, V287, P32922, DOI 10.1074/jbc.M112.350504; HOLDER AA, 1987, PARASITOLOGY, V94, P199, DOI 10.1017/S0031182000053889; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Imam M, 2014, J BIOL CHEM, V289, P3856, DOI 10.1074/jbc.M113.520239; Kadekoppala M, 2010, EUKARYOT CELL, V9, P1064, DOI 10.1128/EC.00048-10; Kauth CW, 2006, J BIOL CHEM, V281, P31517, DOI 10.1074/jbc.M604641200; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Lin CS, 2014, J BIOL CHEM, V289, P25655, DOI 10.1074/jbc.M114.586495; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; Mills KE, 2002, MOL MICROBIOL, V43, P1401, DOI 10.1046/j.1365-2958.2002.02834.x; Moss DK, 2012, INFECT IMMUN, V80, P1280, DOI 10.1128/IAI.05887-11; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Ochola LI, 2010, MOL BIOL EVOL, V27, P2344, DOI 10.1093/molbev/msq119; OEUVRAY C, 1994, BLOOD, V84, P1594; Osier FH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008705; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; Pachebat JA, 2007, MOL BIOCHEM PARASIT, V151, P59, DOI 10.1016/j.molbiopara.2006.10.006; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Rodriguez LE, 2005, PROTEIN SCI, V14, P1778, DOI 10.1110/ps.041304505; Sakamoto H, 2012, VACCINE, V30, P1972, DOI 10.1016/j.vaccine.2012.01.010; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; SIM BKL, 1994, EXP PARASITOL, V78, P259, DOI 10.1006/expr.1994.1027; Singh S, 2005, INFECT IMMUN, V73, P1235, DOI 10.1128/IAI.73.2.1235-1238.2005; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; STAFFORD WHL, 1994, MOL BIOCHEM PARASIT, V66, P157, DOI 10.1016/0166-6851(94)90048-5; Stafford WHL, 1996, MOL BIOCHEM PARASIT, V80, P159, DOI 10.1016/0166-6851(96)02696-5; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Tetteh KKA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005568; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9; Van Tyne D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001383; Weedall GD, 2010, TRENDS PARASITOL, V26, P363, DOI 10.1016/j.pt.2010.04.002; Wickramarachchi T, 2009, INT J PARASITOL, V39, P763, DOI 10.1016/j.ijpara.2008.12.004; Woehlbier U, 2006, INFECT IMMUN, V74, P1313, DOI 10.1128/IAI.74.2.1313-1322.2006	56	47	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7703	7715		10.1074/jbc.M115.698282	http://dx.doi.org/10.1074/jbc.M115.698282			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26823464	Green Published, hybrid			2022-12-28	WOS:000383447600040
J	Murase, R; Sato, H; Yamamoto, K; Ushida, A; Nishito, Y; Ikeda, K; Kobayashi, T; Yamamoto, T; Taketomi, Y; Murakami, M				Murase, Remi; Sato, Hiroyasu; Yamamoto, Kei; Ushida, Ayako; Nishito, Yasumasa; Ikeda, Kazutaka; Kobayashi, Tetsuyuki; Yamamoto, Toshinori; Taketomi, Yoshitaka; Murakami, Makoto			Group X Secreted Phospholipase A(2) Releases 3 Polyunsaturated Fatty Acids, Suppresses Colitis, and Promotes Sperm Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arachidonic acid (AA) (ARA); colitis; inflammation; lipid metabolism; membrane; Phospholipase A; polyunsaturated fatty acid (PUFA); prostaglandin; sperm	INFLAMMATORY-BOWEL-DISEASE; PROSTAGLANDIN-E SYNTHASE-1; GROUP-V; DOCOSAHEXAENOIC ACID; LIPID MEDIATORS; GROUP-III; HUMAN MACROPHAGES; ARACHIDONIC-ACID; TRANSGENIC MICE; RESOLVIN D1	Within the secreted phospholipase A(2) (sPLA(2)) family, group X sPLA(2) (sPLA(2)-X) has the highest capacity to hydrolyze cellular membranes and has long been thought to promote inflammation by releasing arachidonic acid, a precursor of pro-inflammatory eicosanoids. Unexpectedly, we found that transgenic mice globally overexpressing human sPLA(2)-X (PLA2G10-Tg) displayed striking immunosuppressive and lean phenotypes with lymphopenia and increased M2-like macrophages, accompanied by marked elevation of free 3 polyunsaturated fatty acids (PUFAs) and their metabolites. Studies using Pla2g10-deficient mice revealed that endogenous sPLA(2)-X, which is highly expressed in the colon epithelium and spermatozoa, mobilized 3 PUFAs or their metabolites to protect against dextran sulfate-induced colitis and to promote fertilization, respectively. In colitis, sPLA(2)-X deficiency increased colorectal expression of Th17 cytokines, and 3 PUFAs attenuated their production by lamina propria cells partly through the fatty acid receptor GPR120. In comparison, cytosolic phospholipase A(2) (cPLA(2)) protects from colitis by mobilizing 6 arachidonic acid metabolites, including prostaglandin E-2. Thus, our results underscore a previously unrecognized role of sPLA(2)-X as an 3 PUFA mobilizer in vivo, segregated mobilization of 3 and 6 PUFA metabolites by sPLA(2)-X and cPLA(2), respectively, in protection against colitis, and the novel role of a particular sPLA(2)-X-driven PUFA in fertilization.	[Murase, Remi; Sato, Hiroyasu; Yamamoto, Kei; Ushida, Ayako; Taketomi, Yoshitaka; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Murase, Remi; Yamamoto, Toshinori] Showa Univ, Sch Pharm, Tokyo 1428555, Japan; [Ushida, Ayako; Kobayashi, Tetsuyuki] Ochanomizu Univ, Fac Sci, Dept Biol, Tokyo 1128610, Japan; [Ikeda, Kazutaka] RIKEN, Ctr Integrat Med Sci, Lab Metabol, Yokohama, Kanagawa 2300045, Japan; [Yamamoto, Kei] PRIME, Tokyo 1000004, Japan; [Murakami, Makoto] Japan Agcy Med Res & Dev, AMED CREST, Tokyo 1000004, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Showa University; Ochanomizu University; RIKEN	Murakami, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	murakami-mk@igakuken.or.jp	Kobayashi, Tetsuyuki/AAH-2985-2020	Kobayashi, Tetsuyuki/0000-0002-9285-0859	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K14957, 15H05905, 15K07959, 25860059, 23591665, 26461671, 24117724, 25460087]; PRIME, Japan Agency for Medical Research and Development; AMED-CREST, Japan Agency for Medical Research and Development; Grants-in-Aid for Scientific Research [16H02613, 15K07959, 16K15122, 26461671] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRIME, Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); AMED-CREST, Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan 15K14957 and 15H05905 (to M. M.), 15K07959 and 25860059 (to H. S.), 23591665 and 26461671 (to K. Y.), and 24117724 and 25460087 (to Y. T.) and by PRIME (to K. Y.) and AMED-CREST (to M. M.), Japan Agency for Medical Research and Development. The authors declare that they have no conflicts of interest with the contents of this article.	Ait-Oufella H, 2013, ARTERIOSCL THROM VAS, V33, P466, DOI 10.1161/ATVBAHA.112.300309; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Calviello G, 2000, J LIPID RES, V41, P182; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Curfs DMJ, 2008, J BIOL CHEM, V283, P21640, DOI 10.1074/jbc.M710584200; Cyster JG, 2009, J EXP MED, V206, P731, DOI 10.1084/jem.20090458; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Diep QN, 2000, HYPERTENSION, V36, P851, DOI 10.1161/01.HYP.36.5.851; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Furimsky A, 2005, BIOL REPROD, V72, P574, DOI 10.1095/biolreprod.104.036095; Hallstrand TS, 2013, AM J RESP CRIT CARE, V188, P42, DOI 10.1164/rccm.201301-0084OC; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Jia Q, 2008, CANCER RES, V68, P3985, DOI 10.1158/0008-5472.CAN-07-6251; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kamei D, 2004, J BIOL CHEM, V279, P33684, DOI 10.1074/jbc.M400199200; Kapoor M, 2006, FASEB J, V20, P2387, DOI 10.1096/fj.06-6366fje; Kaur G, 2011, PROG LIPID RES, V50, P28, DOI 10.1016/j.plipres.2010.07.004; Kelvin AA, 2014, VIROLOGY, V454, P78, DOI 10.1016/j.virol.2014.01.030; Kim W, 2010, PROG LIPID RES, V49, P250, DOI 10.1016/j.plipres.2010.01.002; Kunisawa J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09750; Lai Y, 2010, J BIOL CHEM, V285, P41491, DOI 10.1074/jbc.M110.153338; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lenzi A, 2000, MOL HUM REPROD, V6, P226, DOI 10.1093/molehr/6.3.226; Li X, 2010, FASEB J, V24, P4313, DOI 10.1096/fj.10-154716; Logan RFA, 1998, GUT, V42, P309, DOI 10.1136/gut.42.3.309; Masuda S, 2004, BBA-MOL CELL BIOL L, V1686, P61, DOI 10.1016/j.bbalip.2004.08.017; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Mitsuishi M, 2007, BBA-MOL CELL BIOL L, V1771, P1389, DOI 10.1016/j.bbalip.2007.09.006; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ohta S, 2013, J IMMUNOL, V190, P5927, DOI 10.4049/jimmunol.1203202; Pernet E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6105; Ramon S, 2012, J IMMUNOL, V189, P1036, DOI 10.4049/jimmunol.1103483; Rubio JM, 2015, J IMMUNOL, V194, P3327, DOI 10.4049/jimmunol.1401026; Saleh M, 2011, IMMUNITY, V34, P293, DOI 10.1016/j.immuni.2011.03.008; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Sato H, 2011, J BIOL CHEM, V286, P11632, DOI 10.1074/jbc.M110.206755; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Surrel F, 2009, MOL PHARMACOL, V76, P778, DOI 10.1124/mol.108.053371; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Taylor N, 2010, BLOOD, V115, P1861, DOI 10.1182/blood-2010-01-258848; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Vijay R, 2015, J EXP MED, V212, P1851, DOI 10.1084/jem.20150632; Watanabe K, 2012, AM J PHYSIOL-HEART C, V302, pH95, DOI 10.1152/ajpheart.00695.2011; Yamamoto K, 2015, J EXP MED, V212, P1901, DOI 10.1084/jem.20141904; Yamamoto K, 2011, J BIOL CHEM, V286, P11616, DOI 10.1074/jbc.M110.206714; Zaldumbide A, 2002, J IMMUNOL, V169, P4873, DOI 10.4049/jimmunol.169.9.4873	72	48	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6895	6911		10.1074/jbc.M116.715672	http://dx.doi.org/10.1074/jbc.M116.715672			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26828067	hybrid, Green Published			2022-12-28	WOS:000373299700027
J	Kobayashi, S; Suzuki, T; Kawaguchi, A; Phongphaew, W; Yoshii, K; Iwano, T; Harada, A; Kariwa, H; Orba, Y; Sawa, H				Kobayashi, Shintaro; Suzuki, Tadaki; Kawaguchi, Akira; Phongphaew, Wallaya; Yoshii, Kentaro; Iwano, Tomohiko; Harada, Akihiro; Kariwa, Hiroaki; Orba, Yasuko; Sawa, Hirofumi			Rab8b Regulates Transport of West Nile Virus Particles from Recycling Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavivirus; infection; Rab; transport; vesicles	DENGUE-VIRUS; ENDOPLASMIC-RETICULUM; ENVELOPE PROTEIN; EPITHELIAL-CELLS; HEPG2 CELLS; INFECTION; RAB11; CILIOGENESIS; REPLICATION; PATHOGENESIS	West Nile virus (WNV) particles assemble at and bud into the endoplasmic reticulum (ER) and are secreted from infected cells through the secretory pathway. However, the host factor related to these steps is not fully understood. Rab proteins, belonging to the Ras superfamily, play essential roles in regulating many aspects of vesicular trafficking. In this study, we sought to determine which Rab proteins are involved in intracellular trafficking of nascent WNV particles. RNAi analysis revealed that Rab8b plays a role in WNV particle release. We found that Rab8 and WNV antigen were colocalized in WNV-infected human neuroblastoma cells, and that WNV infection enhanced Rab8 expression in the cells. In addition, the amount of WNV particles in the supernatant of Rab8b-deficient cells was significantly decreased compared with that of wild-type cells. We also demonstrated that WNV particles accumulated in the recycling endosomes in WNV-infected cells. In summary, these results suggest that Rab8b is involved in trafficking of WNV particles from recycling endosomes to the plasma membrane.	[Kobayashi, Shintaro; Kawaguchi, Akira; Phongphaew, Wallaya; Orba, Yasuko; Sawa, Hirofumi] Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan; [Kobayashi, Shintaro; Yoshii, Kentaro; Kariwa, Hiroaki] Hokkaido Univ, Publ Hlth Lab, Grad Sch Vet Med, Kita Ku, N18,W9, Sapporo, Hokkaido 0600818, Japan; [Suzuki, Tadaki] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan; [Iwano, Tomohiko] Univ Yamanashi, Dept Anat & Cell Biol, Interdisciplinary Grad Sch Med & Engn, 1110 Shimo Kateau, Chuo, Yamanashi 4093898, Japan; [Harada, Akihiro] Osaka Univ, Dept Cell Biol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Sawa, Hirofumi] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan; [Sawa, Hirofumi] Hokkaido Univ, GVN, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan	Hokkaido University; Hokkaido University; National Institute of Infectious Diseases (NIID); University of Yamanashi; Osaka University; Hokkaido University; Hokkaido University	Sawa, H (corresponding author), Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Kta Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.	h-sawa@czc.hokudai.ac.jp	Suzuki, Tadaki/ABH-2661-2020; Orba, Yasuko/F-6888-2012; Kobayashi, Shintaro/AFR-4313-2022; YOSHII, Kentaro/A-4808-2012; Sawa, Hirofumi/F-6954-2012; Sawa, Hirofumi/AAW-8816-2021	Kobayashi, Shintaro/0000-0002-8735-5722; Sawa, Hirofumi/0000-0003-2569-2755; 	JSPS [15K19069]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Ministry of Health, Labour, and Welfare of Japan; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Grant from MEXT for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University; Grants-in-Aid for Scientific Research [15K19069] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant from MEXT for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by JSPS KAKENHI Grant Number 15K19069 and grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); the Ministry of Health, Labour, and Welfare of Japan; and the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); as well as by the Grant from MEXT for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University. The authors declare that they have no conflicts of interest with the contents of this article.	Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654; Chen S, 2001, J BIOL CHEM, V276, P13209, DOI 10.1074/jbc.M010798200; Chu JJH, 2002, J GEN VIROL, V83, P2427, DOI 10.1099/0022-1317-83-10-2427; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Das A, 2011, TRENDS CELL BIOL, V21, P383, DOI 10.1016/j.tcb.2011.03.006; de Kreuk BJ, 2012, J BIOL CHEM, V287, P43438, DOI 10.1074/jbc.M112.391078; Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Garg H, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-197; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Guarner J, 2004, HUM PATHOL, V35, P983, DOI 10.1016/j.humpath.2004.04.008; Guichard A, 2014, NAT REV MICROBIOL, V12, P624, DOI 10.1038/nrmicro3325; Hasebe R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-165; Hayes EB, 2005, EMERG INFECT DIS, V11, P1174, DOI 10.3201/eid1108.050289b; Henry L, 2008, MOL BIOL CELL, V19, P2059, DOI 10.1091/mbc.E07-09-0902; KIMURA T, 1994, ARCH VIROL, V139, P239, DOI 10.1007/BF01310788; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Kobayashi S, 2014, VIRUS RES, V191, P83, DOI 10.1016/j.virusres.2014.07.016; Kobayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076668; Kobayashi S, 2012, NEUROPATHOLOGY, V32, P398, DOI 10.1111/j.1440-1789.2011.01275.x; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Ooi YS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003835; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005; Rowe RK, 2008, VIROLOGY, V382, P239, DOI 10.1016/j.virol.2008.09.021; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Sato T, 2014, J CELL SCI, V127, P422, DOI 10.1242/jcs.136903; Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0; Shirato K, 2004, J MED VIROL, V74, P507, DOI 10.1002/jmv.20205; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Xu XF, 2008, INTERVIROLOGY, V51, P182, DOI 10.1159/000151531; Xu XF, 2009, INTERVIROLOGY, V52, P258, DOI 10.1159/000230669; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888	46	20	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6559	6568		10.1074/jbc.M115.712760	http://dx.doi.org/10.1074/jbc.M115.712760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26817838	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000372894200041
J	Tang, C; Tang, LF; Wu, XK; Xiong, WY; Ruan, HF; Hussain, M; Wu, JS; Zou, CC; Wu, XM				Tang, Chao; Tang, Lanfang; Wu, Xiaokai; Xiong, Wenyi; Ruan, Hongfeng; Hussain, Musaddique; Wu, Junsong; Zou, Chaochun; Wu, Ximei			Glioma-associated Oncogene 2 Is Essential for Trophoblastic Fusion by Forming a Transcriptional Complex with Glial Cell Missing-a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						complex; Hedgehog signaling pathway; placenta; protein stability; trophoblast; GCMa; GLI2; cell fusion; transactivation	SONIC HEDGEHOG; HUMAN PLACENTA; DIFFERENTIATION; EXPRESSION; GENE; SYNCYTIALIZATION; CHOLESTEROL; MECHANISMS; SYNCYTIN-1; PATHWAY	Cell-cell fusion of human villous trophoblasts, referred to as a process of syncytialization, acts as a prerequisite for the proper development and functional maintenance of the human placenta. Given the fact that the main components of the Hedgehog signaling pathway are expressed predominantly in the syncytial layer of human placental villi, in this study, we investigated the potential roles and underlying mechanisms of Hedgehog signaling in trophoblastic fusion. Activation of Hedgehog signaling by a variety of approaches robustly induced cell fusion and the expression of syncytial markers, whereas suppression of Hedgehog signaling significantly attenuated cell fusion and the expression of syncytial markers in both human primary cytotrophoblasts and trophoblast-like BeWo cells. Moreover, among glioma-associated oncogene (GLI) family transcriptional factors in Hedgehog signaling, knockdown of GLI2 but not GLI1 and GLI3 significantly attenuated Hedgehog-induced cell fusion, whereas overexpression of the GLI2 activator alone was sufficient to induce cell fusion. Finally, GLI2 not only stabilized glial cell missing-a, a pivotal transcriptional factor for trophoblastic syncytialization, but also formed a transcriptional heterodimer with glial cell missing-a to transactivate syncytin-1, a trophoblastic fusogen, and promote trophoblastic syncytialization. Taken together, this study uncovered a so far uncharacterized role of Hedgehog/GLI2 signaling in trophoblastic fusion, implicating that Hedgehog signaling, through GLI2, could be required for human placental development and pregnancy maintenance.	[Tang, Chao; Wu, Xiaokai; Ruan, Hongfeng; Hussain, Musaddique; Wu, Ximei] Zhejiang Univ, Sch Med, Dept Pharmacol, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Tang, Chao] Univ Tokyo, Sch Med, Dept Microbiol, Tokyo 1130033, Japan; [Tang, Lanfang; Xiong, Wenyi; Zou, Chaochun] Zhejiang Univ, Childrens Hosp, Hangzhou 310006, Zhejiang, Peoples R China; [Wu, Junsong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou 310006, Zhejiang, Peoples R China	Zhejiang University; University of Tokyo; Zhejiang University; Zhejiang University	Wu, XM (corresponding author), Zhejiang Univ, Sch Med, Dept Pharmacol, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.; Zou, CC (corresponding author), Zhejiang Univ, Sch Med, Affiliated Childrens Hosp, 3333 Binsheng Rd, Hangzhou 310003, Zhejiang, Peoples R China.	zcc14@zju.edu.cn; xiwu@zju.edu.cn		Wu, Ximei/0000-0002-3316-893X	973 Program [2011CB944403]; National Natural Science Foundation of China [31271561, 81170016, 81170787, 81370713, 31571493]; Natural Science Foundation of Zhejiang Province Grant [LY13H150002]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province Grant(Natural Science Foundation of Zhejiang Province)	This work was supported by 973 Program Grant 2011CB944403; National Natural Science Foundation of China Grants 31271561, 81170016, 81170787, 81370713, and 31571493; and Natural Science Foundation of Zhejiang Province Grant LY13H150002. The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; Al-Nasiry S, 2006, HUM REPROD, V21, P193, DOI 10.1093/humrep/dei272; Ali SA, 2016, ARTHRITIS RHEUMATOL, V68, P127, DOI 10.1002/art.39337; Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Basyuk E, 1999, DEV DYNAM, V214, P303, DOI 10.1002/(SICI)1097-0177(199904)214:4<303::AID-AJA3>3.3.CO;2-2; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Butler TM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-51; Choudhry Z, 2014, ANN NEUROSCI, V21, P28, DOI 10.5214/ans.0972.7531.210109; Cobourne MT, 2012, FRONT ORAL BIOL, V16, P52, DOI 10.1159/000337543; Cobourne MT, 2004, DEVELOPMENT, V131, P2875, DOI 10.1242/dev.01163; Cocquebert M, 2012, AM J PHYSIOL-ENDOC M, V303, pE950, DOI 10.1152/ajpendo.00087.2012; Drewlo Sascha, 2008, V475, P363, DOI 10.1007/978-1-59745-250-2_21; Gauster M, 2010, PLACENTA, V31, P82, DOI 10.1016/j.placenta.2009.12.007; Gerbaud P, 2015, PLACENTA, V36, pS35, DOI 10.1016/j.placenta.2014.12.015; Guttmacher AE, 2014, PLACENTA, V35, P303, DOI 10.1016/j.placenta.2014.02.012; Honselmann KC, 2015, J PANCREAS, V16, P25, DOI 10.6092/1590-8577/2894; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Huppertz B, 2011, ADV EXP MED BIOL, V713, P81, DOI 10.1007/978-94-007-0763-4_6; Huppertz Berthold, 2008, V475, P135, DOI 10.1007/978-1-59745-250-2_8; INGHAM PW, 1995, CURR OPIN GENET DEV, V5, P492, DOI 10.1016/0959-437X(95)90054-K; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Lee J, 1997, DEVELOPMENT, V124, P2537; Leuchowius K., 2011, CURR PROTOC CYTOM, V56, P9, DOI [10.1002/0471142956.cy0936s56, DOI 10.1002/0471142956.CY0936S56]; Morrish DW, 1998, J REPROD IMMUNOL, V39, P179, DOI 10.1016/S0165-0378(98)00021-7; Pan YB, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.28; Pidoux G, 2012, PLACENTA, V33, pS81, DOI 10.1016/j.placenta.2011.11.007; Pidoux G, 2010, AM J PHYSIOL-CELL PH, V298, pC1517, DOI 10.1152/ajpcell.00484.2008; Shrimali Rajeev K., 2000, Indian Journal of Experimental Biology, V38, P415; Tang C, 2015, BBA-GEN SUBJECTS, V1850, P1438, DOI 10.1016/j.bbagen.2015.04.005; Tang C, 2015, CELL SIGNAL, V27, P487, DOI 10.1016/j.cellsig.2015.01.004; Wich C, 2009, GYNECOL OBSTET INVES, V68, P9, DOI 10.1159/000209396; Wicking C, 1999, ONCOGENE, V18, P7844, DOI 10.1038/sj.onc.1203282; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zhuang XW, 2014, CURR PHARM DESIGN, V20, P1796, DOI 10.2174/13816128113199990541	34	14	14	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5611	5622		10.1074/jbc.M115.700336	http://dx.doi.org/10.1074/jbc.M115.700336			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26769961	hybrid, Green Published			2022-12-28	WOS:000372551800014
J	Yutthanasirikul, R; Nagano, T; Jimbo, H; Hihara, Y; Kanamori, T; Ueda, T; Haruyama, T; Konno, H; Yoshida, K; Hisabori, T; Nishiyama, Y				Yutthanasirikul, Rayakorn; Nagano, Takanori; Jimbo, Haruhiko; Hihara, Yukako; Kanamori, Takashi; Ueda, Takuya; Haruyama, Takamitsu; Konno, Hiroki; Yoshida, Keisuke; Hisabori, Toru; Nishiyama, Yoshitaka			Oxidation of a Cysteine Residue in Elongation Factor EF-Tu Reversibly Inhibits Translation in the Cyanobacterium Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; oxidative stress; redox regulation; translation; translation elongation factor	CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PHOTOSYSTEM-II; THIOREDOXIN; PHOTOINHIBITION; STRESS; TARGETS; PROTEIN; REPAIR; DAMAGE	Translational elongation is susceptible to inactivation by reactive oxygen species (ROS) in the cyanobacterium Synechocystis sp. PCC 6803, and elongation factor G has been identified as a target of oxidation by ROS. In the present study we examined the sensitivity to oxidation by ROS of another elongation factor, EF-Tu. The structure of EF-Tu changes dramatically depending on the bound nucleotide. Therefore, we investigated the sensitivity to oxidation in vitro of GTP- and GDP-bound EF-Tu as well as that of nucleotide-free EF-Tu. Assays of translational activity with a reconstituted translation system from Escherichia coli revealed that GTP-bound and nucleotide-free EF-Tu were sensitive to oxidation by H2O2, whereas GDP-bound EF-Tu was resistant to H2O2. The inactivation of EF-Tu was the result of oxidation of Cys-82, a single cysteine residue, and subsequent formation of both an intermolecular disulfide bond and sulfenic acid. Replacement of Cys-82 with serine rendered EF-Tu resistant to inactivation by H2O2, confirming that Cys-82 was a target of oxidation. Furthermore, oxidized EF-Tu was reduced and reactivated by thioredoxin. Gel-filtration chromatography revealed that some of the oxidized nucleotide-free EF-Tu formed large complexes of >30 molecules. Atomic force microscopy revealed that such large complexes dissociated into several smaller aggregates upon the addition of dithiothreitol. Immunological analysis of the redox state of EF-Tu in vivo showed that levels of oxidized EF-Tu increased under strong light. Thus, resembling elongation factor G, EF-Tu appears to be sensitive to ROS via oxidation of a cysteine residue, and its inactivation might be reversed in a redox-dependent manner.	[Yutthanasirikul, Rayakorn; Nagano, Takanori; Jimbo, Haruhiko; Hihara, Yukako; Nishiyama, Yoshitaka] Saitama Univ, Grad Sch Sci & Engn, Dept Biochem & Mol Biol, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan; [Kanamori, Takashi] GeneFrontier Corp, Todai Kashiwa Venture Plaza,5-4-19 Kashiwanoha, Kashiwa, Chiba 2770882, Japan; [Kanamori, Takashi; Ueda, Takuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778562, Japan; [Haruyama, Takamitsu; Konno, Hiroki] Kanazawa Univ, BioAFM Frontier Res Ctr, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Yoshida, Keisuke; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan	Saitama University; University of Tokyo; Kanazawa University; Tokyo Institute of Technology	Nishiyama, Y (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Dept Biochem & Mol Biol, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	nishiyama@molbiol.saitama-u.ac.jp	Hisabori, Toru/E-5205-2014; Hihara, Yukako/AAO-6742-2020; Hihara, Yukako/E-3461-2010; Ueda, Takuya/K-5217-2014; Hihara, Yukako/AAX-2065-2020; Jimbo, Haruhiko/ABD-6644-2020; Yoshida, Keisuke/E-5231-2014	Hisabori, Toru/0000-0003-2046-0277; Hihara, Yukako/0000-0003-1916-2053; Ueda, Takuya/0000-0002-7760-8271; Yoshida, Keisuke/0000-0001-6542-6254; Jimbo, Haruhiko/0000-0001-9059-7223	Japan Society for the Promotion of Science [24570039, 25119704]; Cooperative Research Program of the Network Joint Research Center for Materials and Devices; Grants-in-Aid for Scientific Research [15H01177] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cooperative Research Program of the Network Joint Research Center for Materials and Devices; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science 24570039 and 25119704 ( to Y. N.) and from the Cooperative Research Program of the Network Joint Research Center for Materials and Devices ( to Y. N. and T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	ANBORGH PH, 1992, EUR J BIOCHEM, V208, P251, DOI 10.1111/j.1432-1033.1992.tb17180.x; Andersen GR, 2000, J MOL BIOL, V297, P421, DOI 10.1006/jmbi.2000.3564; Ando T, 2013, ANNU REV BIOPHYS, V42, P393, DOI 10.1146/annurev-biophys-083012-130324; ARAI KI, 1974, J BIOCHEM-TOKYO, V76, P293, DOI 10.1093/oxfordjournals.jbchem.a130571; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Brandes N, 2007, MOL MICROBIOL, V66, P901, DOI 10.1111/j.1365-2958.2007.05964.x; Cheng Z, 2012, MOL MICROBIOL, V85, P734, DOI 10.1111/j.1365-2958.2012.08135.x; De Laurentiis EI, 2011, BBA-PROTEINS PROTEOM, V1814, P684, DOI 10.1016/j.bbapap.2011.02.007; Ejima K, 2012, FEBS LETT, V586, P778, DOI 10.1016/j.febslet.2012.01.042; Fu J, 2012, J BOT, V2012, P1, DOI DOI 10.1155/2012/835836; Hisabori T, 2005, J EXP BOT, V56, P1463, DOI 10.1093/jxb/eri170; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; Hishiya S, 2008, PLANT CELL PHYSIOL, V49, P11, DOI 10.1093/pcp/pcm158; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Kojima K, 2007, MOL MICROBIOL, V65, P936, DOI 10.1111/j.1365-2958.2007.05836.x; Kojima K, 2009, J BIOL CHEM, V284, P18685, DOI 10.1074/jbc.M109.015131; Krab IM, 1998, BBA-GENE STRUCT EXPR, V1443, P1, DOI 10.1016/S0167-4781(98)00169-9; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Lindhoud S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041363; Mostertz J, 2003, MOL GENET GENOMICS, V269, P640, DOI 10.1007/s00438-003-0877-4; Nagano T, 2015, J BIOCHEM, V158, P165, DOI 10.1093/jb/mvv026; Nagano T, 2012, J BIOL CHEM, V287, P28697, DOI 10.1074/jbc.M112.378067; NAKAMURA S, 1981, J BIOCHEM, V90, P1117, DOI 10.1093/oxfordjournals.jbchem.a133563; Nishiyama Y, 2004, BIOCHEMISTRY-US, V43, P11321, DOI 10.1021/bi036178q; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Nishiyama Y, 2014, APPL MICROBIOL BIOT, V98, P8777, DOI 10.1007/s00253-014-6020-0; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; Rhee KY, 2005, P NATL ACAD SCI USA, V102, P467, DOI 10.1073/pnas.0406133102; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Sedlak E, 2002, BBA-PROTEIN STRUCT M, V1597, P22, DOI 10.1016/S0167-4838(02)00270-4; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Takahashi S, 2007, PLANT PHYSIOL, V144, P487, DOI 10.1104/pp.107.097253; Takahashi S, 2009, PLANT PHYSIOL, V149, P1560, DOI 10.1104/pp.108.134122; Tarrago L, 2010, J BIOL CHEM, V285, P14964, DOI 10.1074/jbc.M110.108373; Uchihashi T, 2012, NAT PROTOC, V7, P1193, DOI 10.1038/nprot.2012.047; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Wu J, 2013, J BIOL CHEM, V288, P4755, DOI 10.1074/jbc.M112.413492; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	45	25	25	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5860	5870		10.1074/jbc.M115.706424	http://dx.doi.org/10.1074/jbc.M115.706424			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786107	Green Published, hybrid			2022-12-28	WOS:000372551800032
J	Jia, SN; Lin, C; Chen, DF; Li, AQ; Dai, L; Zhang, L; Zhao, LL; Yang, JS; Yang, F; Yang, WJ				Jia, Sheng-Nan; Lin, Cheng; Chen, Dian-Fu; Li, An-Qi; Dai, Li; Zhang, Li; Zhao, Ling-Ling; Yang, Jin-Shu; Yang, Fan; Yang, Wei-Jun			The Transcription Factor p8 Regulates Autophagy in Response to Palmitic Acid Stress via a Mammalian Target of Rapamycin (mTOR)-independent Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACIDS; ER STRESS; INDUCED APOPTOSIS; OBESE RATS; PROTEIN; ROLES; LIPOTOXICITY; INDUCTION; PARKIN; CELLS	Autophagy is an evolutionarily conserved degradative process that allows cells to maintain homoeostasis in numerous physiological situations. This process also functions as an essential protective response to endoplasmic reticulum (ER) stress, which promotes the removal and degradation of unfolded proteins. However, little is known regarding the mechanism by which autophagy is initiated and regulated in response to ER stress. In this study, different types of autophagy were identified in human gastric cancer MKN45 cells in response to the stress induced by nutrient starvation or lipotoxicity in which the regulation of these pathways is mammalian target of rapamycin (mTOR)-dependent or -independent, respectively. Interestingly, we found that p8, a stress-inducible transcription factor, was enhanced in MKN45 cells treated with palmitic acid to induce lipotoxicity. Furthermore, an increase in autophagy was observed in MKN45 cells stably overexpressing p8 using a lentivirus system, and autophagy induced by palmitic acid was blocked by p8 RNAi compared with the control. Western blotting analyses showed that autophagy was regulated by p8 or mTORin response to the protein kinase-like endoplasmic reticulum kinase/activating transcription factor 6-mediated ER stress of lipotoxicity or the parkin-mediated mitochondrial stress of nutrient starvation, respectively. Furthermore, our results indicated that autophagy induced by palmitic acid is mTOR-independent, but this autophagy pathway was regulated by p8 via p53-and PKC alpha-mediated signaling in MKN45 cells. Our findings provide insights into the role of p8 in regulating autophagy induced by the lipotoxic effects of excess fat accumulation in cells.	[Jia, Sheng-Nan; Lin, Cheng; Chen, Dian-Fu; Li, An-Qi; Dai, Li; Zhang, Li; Zhao, Ling-Ling; Yang, Jin-Shu; Yang, Fan; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Yang, WJ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	w_jyang@zju.edu.cn		Yang, Wei-Jun/0000-0002-4591-8830; Yang, Jin-Shu/0000-0001-6680-7737	National Natural Science Foundation of China [31370394, 31270424]; National Basic Research Program of China 973 Program [2012CB944903]; 863 Program of China Grant [2012AA092103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); 863 Program of China Grant	This work was supported by National Natural Science Foundation of China Grants 31370394 and 31270424, National Basic Research Program of China 973 Program Grant 2012CB944903, and 863 Program of China Grant 2012AA092103. The authors declare that they have no conflicts of interest with the contents of this article.	Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Cebollero Eduardo, 2012, Int J Cell Biol, V2012, P182834, DOI 10.1155/2012/182834; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Clark DW, 2008, CURR CANCER DRUG TAR, V8, P421, DOI 10.2174/156800908785133196; Deegan S, 2013, CELL MOL LIFE SCI, V70, P2425, DOI 10.1007/s00018-012-1173-4; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; Moruno-Manchon JF, 2013, BIOCHEM J, V449, P497, DOI 10.1042/BJ20121122; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Goruppi S, 2002, EMBO J, V21, P5427, DOI 10.1093/emboj/cdf535; Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887; Han JY, 2015, J BIOL CHEM, V290, P10325, DOI 10.1074/jbc.M114.624767; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jiang YF, 1999, BIOCHEM BIOPH RES CO, V260, P686, DOI 10.1006/bbrc.1999.0953; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Katsuma S, 2005, J BIOL CHEM, V280, P19507, DOI 10.1074/jbc.M412385200; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kong DK, 2010, MOL BIOL CELL, V21, P1335, DOI 10.1091/mbc.E09-09-0818; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Leamy AK, 2014, J LIPID RES, V55, P1478, DOI 10.1194/jlr.M050237; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; Meng N, 2012, INT J BIOCHEM CELL B, V44, P311, DOI 10.1016/j.biocel.2011.11.001; Mizumura K, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00244; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moffitt JH, 2005, DIABETOLOGIA, V48, P1819, DOI 10.1007/s00125-005-1861-9; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Okamoto K, 2014, J CELL BIOL, V205, P435, DOI 10.1083/jcb.201402054; Panda PK, 2015, SEMIN CELL DEV BIOL, V39, P43, DOI 10.1016/j.semcdb.2015.02.013; Park M, 2015, J CELL PHYSIOL, V230, P630, DOI 10.1002/jcp.24781; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sasaki K, 2015, J BIOCHEM, V157, P185, DOI 10.1093/jb/mvv010; Seirafi M, 2015, FEBS J, V282, P2076, DOI 10.1111/febs.13249; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Tu QQ, 2014, ACTA PHARMACOL SIN, V35, P504, DOI 10.1038/aps.2013.170; Tuei VC, 2011, LIFE SCI, V88, P810, DOI 10.1016/j.lfs.2011.02.022; Vasseur S, 2002, ONCOGENE, V21, P1685, DOI 10.1038/sj.onc.1205222; Watanabe-Asano T, 2014, BIOCHEM BIOPH RES CO, V445, P334, DOI 10.1016/j.bbrc.2014.01.180; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Xu K, 2014, BBA-REV CANCER, V1846, P638, DOI 10.1016/j.bbcan.2014.10.007; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976; Zhou ST, 2012, CANCER LETT, V323, P115, DOI 10.1016/j.canlet.2012.02.017; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	64	32	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4462	4472		10.1074/jbc.M115.675793	http://dx.doi.org/10.1074/jbc.M115.675793			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26733200	Green Published, hybrid			2022-12-28	WOS:000371604600018
J	Zoghbi, ME; Cooper, RS; Altenberg, GA				Zoghbi, Maria E.; Cooper, Rebecca S.; Altenberg, Guillermo A.			The Lipid Bilayer Modulates the Structure and Function of an ATP-binding Cassette Exporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-ELECTRON RESONANCE; MULTIDRUG ABC TRANSPORTER; P-GLYCOPROTEIN; ALTERNATING ACCESS; MEMBRANE-PROTEINS; ENERGY-TRANSFER; NUCLEOTIDE; MSBA; MOVEMENT; DOMAIN	ATP-binding cassette exporters use the energy of ATP hydrolysis to transport substrates across membranes by switching between inward-and outward-facing conformations. Essentially all structural studies of these proteins have been performed with the proteins in detergent micelles, locked in specific conformations and/or at low temperature. Here, we used luminescence resonance energy transfer spectroscopy to study the prototypical ATP-binding cassette exporter MsbA reconstituted in nanodiscs at 37 degrees C while it performs ATP hydrolysis. We found major differences when comparing MsbA in these native-like conditions with double electron-electron resonance data and the crystal structure ofMsbAin the open inward-facing conformation. The most striking differences include a significantly smaller separation between the nucleotide-binding domains and a larger fraction of molecules with associated nucleotide- binding domains in the nucleotide-free apo state. These studies stress the importance of studying membrane proteins in an environment that approaches physiological conditions.	[Altenberg, Guillermo A.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, 3601 4th St, Lubbock, TX 79430 USA; Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Altenberg, GA (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, 3601 4th St, Lubbock, TX 79430 USA.	g.altenberg@ttuhsc.edu		Zoghbi, Maria/0000-0002-4206-4673; Altenberg, Guillermo/0000-0002-8932-740X	Cancer Prevention & Research Institute of Texas Grant [RP101073]	Cancer Prevention & Research Institute of Texas Grant	This work was supported by the Cancer Prevention & Research Institute of Texas Grant RP101073. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Shawi MK, 2011, ESSAYS BIOCHEM, V50, P63, DOI [10.1042/BSE0500063, 10.1042/bse0500063]; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Buchaklian AH, 2005, BIOCHEMISTRY-US, V44, P5503, DOI 10.1021/bi047568v; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cooper RS, 2013, J BIOL CHEM, V288, P20785, DOI 10.1074/jbc.M113.477976; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Fribourg PF, 2014, J MOL BIOL, V426, P2059, DOI 10.1016/j.jmb.2014.03.002; George AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059854; Heyduk T, 2001, ANAL BIOCHEM, V289, P60, DOI 10.1006/abio.2000.4925; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; JAMES DR, 1986, CHEM PHYS LETT, V126, P7, DOI 10.1016/0009-2614(86)85107-7; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones PM, 2009, PROTEINS, V75, P387, DOI 10.1002/prot.22250; Kawai T, 2011, FEBS LETT, V585, P3533, DOI 10.1016/j.febslet.2011.10.015; King G, 2012, CRIT REV BIOCHEM MOL, V47, P75, DOI 10.3109/10409238.2011.636505; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; Posson DJ, 2008, NEURON, V59, P98, DOI 10.1016/j.neuron.2008.05.006; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Schultz KM, 2011, BIOCHEMISTRY-US, V50, P3599, DOI 10.1021/bi101666p; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; SIEMIARCZUK A, 1990, J PHYS CHEM-US, V94, P1661, DOI 10.1021/j100367a080; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; Zoghbi ME, 2014, BIOCHEM BIOPH RES CO, V443, P97, DOI 10.1016/j.bbrc.2013.11.050; Zoghbi ME, 2013, J BIOL CHEM, V288, P34259, DOI 10.1074/jbc.M113.500371; Zoghbi ME, 2012, J BIOL CHEM, V287, P14994, DOI 10.1074/jbc.M112.340281; Zoghbi ME, 2012, J BIOL CHEM, V287, P4157, DOI 10.1074/jbc.M111.318378; Zou P, 2010, BIOPHYS J, V98, pL18, DOI 10.1016/j.bpj.2009.12.4193; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	43	50	51	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4453	4461		10.1074/jbc.M115.698498	http://dx.doi.org/10.1074/jbc.M115.698498			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26725230	Green Published, hybrid			2022-12-28	WOS:000371604600017
J	Grewal, JS; McLuskey, K; Das, D; Myburgh, E; Wilkes, J; Brown, E; Lemgruber, L; Gould, MK; Burchmore, RJ; Coombs, GH; Schnaufer, A; Mottram, JC				Grewal, Jaspreet S.; McLuskey, Karen; Das, Debanu; Myburgh, Elmarie; Wilkes, Jonathan; Brown, Elaine; Lemgruber, Leandro; Gould, Matthew K.; Burchmore, Richard J.; Coombs, Graham H.; Schnaufer, Achim; Mottram, Jeremy C.			PNT1 Is a C11 Cysteine Peptidase Essential for Replication of the Trypanosome Kinetoplast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; MULTIPLE SEQUENCE ALIGNMENT; CRITHIDIA-FASCICULATA; BRUCEI METACASPASE; PARASITIC PROTOZOA; DNA-REPLICATION; T-COFFEE; NETWORKS; ROLES; YEAST	The structure of a C11 peptidase PmC11 from the gut bacterium, Parabacteroides merdae, has recently been determined, enabling the identification and characterization of a C11 orthologue, PNT1, in the parasitic protozoon Trypanosoma brucei. A phylogenetic analysis identified PmC11 orthologues in bacteria, archaea, Chromerids, Coccidia, and Kinetoplastida, the latter being the most divergent. A primary sequence alignment of PNT1 with clostripain and PmC11 revealed the position of the characteristic His-Cys catalytic dyad (His(99) and Cys(136)), and an Asp (Asp(134)) in the potential S-1 binding site. Immunofluorescence and cryoelectron microscopy revealed that PNT1 localizes to the kinetoplast, an organelle containing the mitochondrial genome of the parasite (kDNA), with an accumulation of the protein at or near the antipodal sites. Depletion of PNT1 by RNAi in the T. brucei bloodstream form was lethal both in in vitro culture and in vivo in mice and the induced population accumulated cells lacking a kinetoplast. In contrast, overexpression of PNT1 led to cells having mislocated kinetoplasts. RNAi depletion of PNT1 in a kDNA independent cell line resulted in kinetoplast loss but was viable, indicating that PNT1 is required exclusively for kinetoplast maintenance. Expression of a recoded wild-type PNT1 allele, but not of an active site mutant restored parasite viability after induction in vitro and in vivo confirming that the peptidase activity of PNT1 is essential for parasite survival. These data provide evidence that PNT1 is a cysteine peptidase that is required exclusively for maintenance of the trypanosome kinetoplast.	[Grewal, Jaspreet S.; McLuskey, Karen; Myburgh, Elmarie; Wilkes, Jonathan; Brown, Elaine; Lemgruber, Leandro; Burchmore, Richard J.; Mottram, Jeremy C.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland; [Grewal, Jaspreet S.; Myburgh, Elmarie; Brown, Elaine; Mottram, Jeremy C.] Univ York, Dept Biol, Ctr Immunol & Infect, Wentworth Way, York YO10 5DD, N Yorkshire, England; [Das, Debanu] SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA; [Das, Debanu] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Gould, Matthew K.; Schnaufer, Achim] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3FL, Midlothian, Scotland; [Gould, Matthew K.; Schnaufer, Achim] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH9 3FL, Midlothian, Scotland; [Coombs, Graham H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland	University of Glasgow; University of York - UK; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Edinburgh; University of Edinburgh; University of Strathclyde	Mottram, JC (corresponding author), Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland.; Mottram, JC (corresponding author), Univ York, Dept Biol, Ctr Immunol & Infect, Wentworth Way, York YO10 5DD, N Yorkshire, England.	jeremy.mottram@york.ac.uk		Burchmore, Richard/0000-0003-1663-9004; Wilkes, Jonathan/0000-0002-0920-6967; Myburgh, Elmarie/0000-0002-2007-5902; Grewal, Jaspreet/0000-0002-2219-7655; Mottram, Jeremy/0000-0001-5574-3766; Schnaufer, Achim/0000-0003-2132-5560; McLuskey, Karen/0000-0002-9841-4943; Brown, Elaine/0000-0002-6360-9118; Lemgruber, Leandro/0000-0003-2832-6806	Medical Research Council [MR/K019384]; Wellcome Trust [091790, 104111]; National Institutes of Heath [U54 GM094586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586] Funding Source: NIH RePORTER; Medical Research Council [MR/K019384/2, G0600129, MR/K019384/1, MR/L019701/1] Funding Source: researchfish; MRC [MR/L019701/1, MR/K019384/1, MR/K019384/2, G0600129] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant MR/K019384, and Wellcome Trust Grants 091790 and 104111, and National Institutes of Heath Grant U54 GM094586. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alsford S, 2008, MOL BIOCHEM PARASIT, V161, P76, DOI 10.1016/j.molbiopara.2008.05.006; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Baker N, 2015, P NATL ACAD SCI USA, V112, P9112, DOI 10.1073/pnas.1505411112; Beck K, 2013, EUKARYOT CELL, V12, P970, DOI 10.1128/EC.00352-12; Bessat M, 2009, MOL MICROBIOL, V71, P1371, DOI 10.1111/j.1365-2958.2009.06611.x; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Clayton AM, 2011, EUKARYOT CELL, V10, P286, DOI 10.1128/EC.00290-10; Dean S, 2013, P NATL ACAD SCI USA, V110, P14741, DOI 10.1073/pnas.1305404110; ENGLUND PT, 1978, CELL, V14, P157, DOI 10.1016/0092-8674(78)90310-0; FERGUSON M, 1992, CELL, V70, P621, DOI 10.1016/0092-8674(92)90431-B; Helms MJ, 2006, J CELL SCI, V119, P1105, DOI 10.1242/jcs.02809; Hines JC, 2010, MOL CELL BIOL, V30, P1319, DOI 10.1128/MCB.01231-09; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jones NG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003886; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; Klemba M, 2002, ANNU REV BIOCHEM, V71, P275, DOI 10.1146/annurev.biochem.71.090501.145453; Klingbeil MM, 2004, P NATL ACAD SCI USA, V101, P4333, DOI 10.1073/pnas.0401400101; Klingbeil MM, 2002, MOL CELL, V10, P175, DOI 10.1016/S1097-2765(02)00571-3; Kocholaty W, 1938, BIOCHEM J, V32, P1685, DOI 10.1042/bj0321685; Li ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000048; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Liu BY, 2006, MOL CELL BIOL, V26, P5382, DOI 10.1128/mcb.00369-06; Liu BY, 2010, J BIOL CHEM, V285, P7056, DOI 10.1074/jbc.M109.084038; Liu BY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000589; McLuskey K, 2016, J BIOL CHEM, V291, P9482, DOI 10.1074/jbc.M115.706143; McLuskey K, 2012, P NATL ACAD SCI USA, V109, P7469, DOI 10.1073/pnas.1200885109; Monnerat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067327; Moss CX, 2007, FEBS LETT, V581, P5635, DOI 10.1016/j.febslet.2007.11.009; Moss CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123241; Mottram JC, 2003, TRENDS PARASITOL, V19, P182, DOI 10.1016/S1471-4922(03)00038-2; Nolan DP, 2000, J BIOL CHEM, V275, P4072, DOI 10.1074/jbc.275.6.4072; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Peacock L, 2014, CURR BIOL, V24, P181, DOI 10.1016/j.cub.2013.11.044; PEREZMORGA DL, 1993, CELL, V74, P703, DOI 10.1016/0092-8674(93)90517-T; Proto WR, 2011, J BIOL CHEM, V286, P39914, DOI 10.1074/jbc.M111.292334; Saxowsky TT, 2003, J BIOL CHEM, V278, P49095, DOI 10.1074/jbc.M308565200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schnaufer A, 2010, TRENDS PARASITOL, V26, P557, DOI 10.1016/j.pt.2010.08.001; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Steinmann P, 2015, TROP MED INT HEALTH, V20, P707, DOI 10.1111/tmi.12483; Szallies A, 2002, FEBS LETT, V517, P144, DOI 10.1016/S0014-5793(02)02608-X; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Wang JY, 2012, MOL MICROBIOL, V83, P471, DOI 10.1111/j.1365-2958.2011.07938.x; Witte V, 1996, CURR MICROBIOL, V33, P281, DOI 10.1007/s002849900114	45	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9492	9500		10.1074/jbc.M116.714972	http://dx.doi.org/10.1074/jbc.M116.714972			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26940875	Green Accepted, hybrid, Green Published, Green Submitted			2022-12-28	WOS:000375602300010
J	Luo, L; Xue, J; Kwan, A; Gamsjaeger, R; Wielens, J; von Kleist, L; Cubeddu, L; Guo, Z; Stow, JL; Parker, MW; Mackay, JP; Robinson, PJ				Luo, Lin; Xue, Jing; Kwan, Ann; Gamsjaeger, Roland; Wielens, Jerome; von Kleist, Lisa; Cubeddu, Liza; Guo, Zhong; Stow, Jennifer L.; Parker, Michael W.; Mackay, Joel P.; Robinson, Phillip J.			The Binding of Syndapin SH3 Domain to Dynamin Proline-rich Domain Involves Short and Long Distance Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT BULK ENDOCYTOSIS; HERPESVIRAL PROTEIN; STRUCTURAL BASIS; RECOGNITION; DOCKING; IDENTIFICATION; SPECIFICITY; P67(PHOX); CONSENSUS; HADDOCK	Dynamin is a GTPase that mediates vesicle fission during synaptic vesicle endocytosis. Its long C-terminal proline-rich domain contains 13 PXXP motifs, which orchestrate its interactions with multiple proteins. The SH3 domains of syndapin and endophilin bind the PXXP motifs called Site 2 and 3 (Pro-786-Pro-793) at the N-terminal end of the proline-rich domain, whereas the amphiphysin SH3 binds Site 9 (Pro-833-Pro-836) toward the C-terminal end. In some proteins, SH3/peptide interactions also involve short distance elements, which are 5-15 amino acid extensions flanking the central PXXP motif for high affinity binding. Here we found two previously unrecognized elements in the central and the C-terminal end of the dynamin proline-rich domain that account for a significant increase in syndapin binding affinity compared with a previously reported Site 2 and Site 3 PXXP peptide alone. The first new element (Gly-807-Gly-811) is short distance element on the C-terminal side of Site 2 PXXP, which might contact a groove identified under the RT loop of the SH3 domain. The second element (Arg-838-Pro-844) is located about 50 amino acids downstream of Site 2. These two elements provide additional specificity to the syndapin SH3 domain outside of the well described polyproline-binding groove. Thus, the dynamin/syndapin interaction is mediated via a network of multiple contacts outside the core PXXP motif over a previously unrecognized extended region of the proline-rich domain. To our knowledge this is the first example among known SH3 interactions to involve spatially separated and extended long-range elements that combine to provide a higher affinity interaction.	[Luo, Lin; Xue, Jing; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Locked Bag 23, Wentworthville, NSW 2145, Australia; [Luo, Lin; Guo, Zhong; Stow, Jennifer L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Luo, Lin; Stow, Jennifer L.] Univ Queensland, IMB Ctr Inflammat & Dis Res, Brisbane, Qld 4072, Australia; [Kwan, Ann; Gamsjaeger, Roland; Cubeddu, Liza; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Gamsjaeger, Roland; Cubeddu, Liza] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW 2751, Australia; [Wielens, Jerome; Parker, Michael W.] St Vincents Inst Med Res, ACRF Rat Drug Discovery Ctr, 41 Victoria Parade, Fitzroy, Vic 3065, Australia; [von Kleist, Lisa] Free Univ Berlin, Inst Chem & Biochem, Grp Cellular Biochem, Thielallee 63, D-14195 Berlin, Germany; [Parker, Michael W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	Children's Medical Research Institute - Australia; University of Sydney; University of Queensland; University of Queensland; University of Sydney; Western Sydney University; St. Vincent's Institute of Medical Research; Free University of Berlin; University of Melbourne	Robinson, PJ (corresponding author), Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Locked Bag 23, Wentworthville, NSW 2145, Australia.; Mackay, JP (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	joel.mackay@sydney.edu.au; probinson@cmri.org.au	Robinson, Phillip J/G-4008-2011; Mackay, Joel P/D-6834-2011; GUO, Zhong/J-8723-2014; Parker, Michael W/F-9069-2013; Luo, Lin/B-7845-2016; Stow, Jennifer/I-4723-2013	Robinson, Phillip J/0000-0002-7878-0313; Mackay, Joel P/0000-0001-7508-8033; GUO, Zhong/0000-0003-0285-5021; Parker, Michael W/0000-0002-3101-1138; Luo, Lin/0000-0001-5556-7096; Kwan, Ann/0000-0002-1506-2226; Gamsjaeger, Roland/0000-0003-1095-2569; Wielens, Jerome/0000-0003-3406-4136; Stow, Jennifer/0000-0002-5409-9101; von Kleist, Lisa/0000-0001-9938-6510	National Health and Medical Research Council Australia [GNT1047070, GNT633225, GNT1069493]; Children's Medical Research Institute (CMRI); Victorian Government Operational Infrastructure Support Scheme	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Children's Medical Research Institute (CMRI); Victorian Government Operational Infrastructure Support Scheme	This work was supported by National Health and Medical Research Council Australia Grants GNT1047070, GNT633225, and GNT1069493 (to P. J. R.), the Children's Medical Research Institute (CMRI), and the Victorian Government Operational Infrastructure Support Scheme (to St. Vincent's Institute). The authors declare that they have no conflicts of interest with the contents of this article.	Aitio O, 2010, P NATL ACAD SCI USA, V107, P21743, DOI 10.1073/pnas.1010243107; Anggono V, 2007, J NEUROCHEM, V102, P931, DOI 10.1111/j.1471-4159.2007.04574.x; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Bauer F, 2005, PROTEIN SCI, V14, P2487, DOI 10.1110/ps.051563605; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FEENEY J, 1979, J MAGN RESON, V33, P519, DOI 10.1016/0022-2364(79)90163-X; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Graham ME, 2007, J BIOL CHEM, V282, P14695, DOI 10.1074/jbc.M609713200; Harkiolaki M, 2003, EMBO J, V22, P2571, DOI 10.1093/emboj/cdg258; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Luo L, 2014, PROTEOMICS, V14, P19, DOI 10.1002/pmic.201300315; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mott HR, 2005, BIOCHEMISTRY-US, V44, P10977, DOI 10.1021/bi050374a; Musacchio A, 2003, ADV PROTEIN CHEM, V61, P211; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rasmussen RK, 1998, BIOCHEM J, V335, P119, DOI 10.1042/bj3350119; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Schweimer K, 2002, BIOCHEMISTRY-US, V41, P5120, DOI 10.1021/bi015986j; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Solomaha E, 2005, J BIOL CHEM, V280, P23147, DOI 10.1074/jbc.M501745200; Sundborger Anna C, 2014, F1000Prime Rep, V6, P85, DOI 10.12703/P6-85; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; van Dalen J P, 1970, Histochem J, V2, P329; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412	37	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9411	9424		10.1074/jbc.M115.703108	http://dx.doi.org/10.1074/jbc.M115.703108			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26893375	hybrid, Green Published			2022-12-28	WOS:000375602300003
J	Maes, E; Krzewinski, F; Garenaux, E; Lequette, Y; Coddeville, B; Trivelli, X; Ronse, A; Faille, C; Guerardel, Y				Maes, Emmanuel; Krzewinski, Frederic; Garenaux, Estelle; Lequette, Yannick; Coddeville, Bernadette; Trivelli, Xavier; Ronse, Annette; Faille, Christine; Guerardel, Yann			Glycosylation of BclA Glycoprotein from Bacillus cereus and Bacillus anthracis Exosporium Is Domain-specific	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-LIKE REGION; O-POLYSACCHARIDE; MAJOR GLYCOPROTEIN; SURFACE-PROPERTIES; STAINLESS-STEEL; SPORE; TETRASACCHARIDE; ANTHROSE; OLIGOSACCHARIDE; IDENTIFICATION	The spores of the Bacillus cereus group (B. cereus, Bacillus anthracis, and Bacillus thuringiensis) are surrounded by a paracrystalline flexible yet resistant layer called exosporium that plays a major role in spore adhesion and virulence. The major constituent of its hairlike surface, the trimerized glycoprotein BclA, is attached to the basal layer through an N-terminal domain. It is then followed by a repetitive collagen-like neck bearing a globular head (C-terminal domain) that promotes glycoprotein trimerization. The collagen-like region of B. anthracis is known to be densely substituted by unusual O-glycans that may be used for developing species-specific diagnostics of B. anthracis spores and thus targeted therapeutic interventions. In the present study, we have explored the species and domain specificity of BclA glycosylation within the B. cereus group. First, we have established that the collagen-like regions of both B. anthracis and B. cereus are similarly substituted by short O-glycans that bear the species-specific deoxyhexose residues anthrose and the newly observed cereose, respectively. Second we have discovered that the C-terminal globular domains of BclA from both species are substituted by polysaccharide-like O-linked glycans whose structures are also species-specific. The presence of large carbohydrate polymers covering the surface of Bacillus spores may have a profound impact on the way that spores regulate their interactions with biotic and abiotic surfaces and represents potential new diagnostic targets.	[Maes, Emmanuel; Krzewinski, Frederic; Garenaux, Estelle; Coddeville, Bernadette; Trivelli, Xavier; Guerardel, Yann] Univ Lille, CNRS, UMR 8576, UGSF, F-59000 Lille, France; [Lequette, Yannick; Ronse, Annette; Faille, Christine] INRA, UMR8207, F-59650 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); INRAE; Universite de Lille - ISITE; Universite de Lille	Guerardel, Y (corresponding author), Univ Lille, CNRS, UMR 8576, UGSF, F-59000 Lille, France.	yann.guerardel@univ-lille1.fr		Guerardel, Yann/0000-0003-4967-9512; Trivelli, Xavier/0000-0001-6775-9650; Krzewinski, Frederic/0000-0003-1491-6899	Region Nord-Pas de Calais; European Union (Fonds Europeen de Developpement Economique et Regional); Ministere Francais de la Recherche; Universite Lille 1; CNRS	Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); European Union (Fonds Europeen de Developpement Economique et Regional); Ministere Francais de la Recherche(Ministry of Research, France); Universite Lille 1; CNRS(Centre National de la Recherche Scientifique (CNRS))	The 900-MHz NMR spectrometer was funded by Region Nord-Pas de Calais, European Union (Fonds Europeen de Developpement Economique et Regional), Ministere Francais de la Recherche, Universite Lille 1, and CNRS.	Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Bozue JA, 2005, MICROB PATHOGENESIS, V38, P1, DOI 10.1016/j.micpath.2004.10.001; Chen G, 2010, COLLOID SURFACE B, V76, P512, DOI 10.1016/j.colsurfb.2009.12.012; Coddeville B, 2011, BIOMACROMOLECULES, V12, P2064, DOI 10.1021/bm101557v; Crich D, 2007, J ORG CHEM, V72, P6513, DOI 10.1021/jo070750s; Daubenspeck JM, 2004, J BIOL CHEM, V279, P30945, DOI 10.1074/jbc.M401613200; Dhenin SGY, 2008, CARBOHYD RES, V343, P2101, DOI 10.1016/j.carres.2007.11.030; Dong SL, 2008, J BACTERIOL, V190, P2350, DOI 10.1128/JB.01899-07; Dong SL, 2009, J BACTERIOL, V191, P7094, DOI 10.1128/JB.01050-09; Faille C, 2007, J FOOD PROTECT, V70, P2346, DOI 10.4315/0362-028X-70.10.2346; Faille C, 2010, INT J FOOD MICROBIOL, V143, P125, DOI 10.1016/j.ijfoodmicro.2010.07.038; Fox A, 2003, J MICROBIOL METH, V54, P143, DOI 10.1016/S0167-7012(03)00095-2; GERHARDT P, 1964, J BACTERIOL, V88, P1774, DOI 10.1128/JB.88.6.1774-1789.1964; GILLERON M, 1990, EUR J BIOCHEM, V193, P449, DOI 10.1111/j.1432-1033.1990.tb19359.x; Giorno R, 2007, J BACTERIOL, V189, P691, DOI 10.1128/JB.00921-06; GIULIANO RM, 1988, CARBOHYD RES, V183, P277, DOI 10.1016/0008-6215(88)84080-1; Guo HB, 2007, ANGEW CHEM INT EDIT, V46, P5206, DOI 10.1002/anie.200701354; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Kailas L, 2011, P NATL ACAD SCI USA, V108, P16014, DOI 10.1073/pnas.1109419108; Kang TJ, 2005, INFECT IMMUN, V73, P7495, DOI 10.1128/IAI.73.11.7495-7501.2005; KOERNER TAW, 1987, METHOD ENZYMOL, V138, P38; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kubler-Kielb J, 2008, P NATL ACAD SCI USA, V105, P8709, DOI 10.1073/pnas.0803897105; Kuehn A, 2009, CLIN VACCINE IMMUNOL, V16, P1728, DOI 10.1128/CVI.00235-09; Lequette Y, 2011, BIOFOULING, V27, P751, DOI 10.1080/08927014.2011.599842; Lequette Y, 2011, APPL ENVIRON MICROB, V77, P4905, DOI 10.1128/AEM.02872-10; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Mehta AS, 2006, CHEM-EUR J, V12, P9136, DOI 10.1002/chem.200601245; Milhomme O, 2012, ORG BIOMOL CHEM, V10, P8524, DOI 10.1039/c2ob26131f; Milhomme O, 2012, CARBOHYD RES, V356, P115, DOI 10.1016/j.carres.2012.01.007; Oberli MA, 2010, J AM CHEM SOC, V132, P10239, DOI 10.1021/ja104027w; Oliva CR, 2008, P NATL ACAD SCI USA, V105, P1261, DOI 10.1073/pnas.0709321105; PEZARD C, 1993, J GEN MICROBIOL, V139, P2459, DOI 10.1099/00221287-139-10-2459; Pieters RJ, 2011, ADV EXP MED BIOL, V715, P227, DOI 10.1007/978-94-007-0940-9_14; Plomp M, 2005, LANGMUIR, V21, P7892, DOI 10.1021/la050412r; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; Rodenburg CM, 2014, J STRUCT BIOL, V186, P181, DOI 10.1016/j.jsb.2014.02.018; Senchenkova SN, 2002, CARBOHYD RES, V337, P1723, DOI 10.1016/S0008-6215(02)00268-9; Steichen CT, 2005, J BACTERIOL, V187, P5868, DOI 10.1128/JB.187.17.5868-5876.2005; Sylvestre P, 2003, J BACTERIOL, V185, P1555, DOI 10.1128/JB.185.5.1555-1563.2003; Tamborrini M, 2009, J APPL MICROBIOL, V106, P1618, DOI 10.1111/j.1365-2672.2008.04129.x; Tamborrini M, 2006, ANGEW CHEM INT EDIT, V45, P6581, DOI 10.1002/anie.200602048; Tamborrini M, 2011, J BACTERIOL, V193, P3506, DOI 10.1128/JB.00078-11; Tamborrini M, 2010, CLIN VACCINE IMMUNOL, V17, P1446, DOI 10.1128/CVI.00205-10; Toth A, 2003, ARKIVOC, P28, DOI 10.3998/ark.5550190.0004.504; Wang DN, 2007, PROTEOMICS, V7, P180, DOI 10.1002/pmic.200600478; Weaver J, 2007, INFECT IMMUN, V75, P3894, DOI 10.1128/IAI.00283-07; Zdorovenko EL, 2001, CARBOHYD RES, V330, P505, DOI 10.1016/S0008-6215(01)00005-2; Zdorovenko EL, 2012, CARBOHYD RES, V358, P106, DOI 10.1016/j.carres.2012.06.012; Zdorovenko EL, 2009, CARBOHYD RES, V344, P2519, DOI 10.1016/j.carres.2009.08.040	50	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9666	9677		10.1074/jbc.M116.718171	http://dx.doi.org/10.1074/jbc.M116.718171			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26921321	Green Published, hybrid			2022-12-28	WOS:000375602300025
J	Civitelli, L; Sandin, L; Nelson, E; Khattak, SI; Brorsson, AC; Kagedal, K				Civitelli, Livia; Sandin, Linnea; Nelson, Erin; Khattak, Sikander Iqbal; Brorsson, Ann-Christin; Kagedal, Katarina			The Luminescent Oligothiophene p-FTAA Converts Toxic A beta(1-42) Species into Nontoxic Amyloid Fibers with Altered Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE OPTICAL PROBES; ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; CONJUGATED POLYELECTROLYTES; OLIGOMER LEVELS; FIBRILS; CONFORMATION; BINDING; DEPOSITS	Aggregation of the amyloid-(beta) peptide (A beta) in the brain leads to the formation of extracellular amyloid plaques, which is one of the pathological hallmarks of Alzheimer disease (AD). It is a general hypothesis that soluble prefibrillar assemblies of the A beta peptide, rather than mature amyloid fibrils, cause neuronal dysfunction and memory impairment in AD. Thus, reducing the level of these prefibrillar species by using molecules that can interfere with the A beta fibrillation pathway may be a valid approach to reduce A beta cytotoxicity. Luminescent-conjugated oligothiophenes (LCOs) have amyloid binding properties and spectral properties that differ when they bind to protein aggregates with different morphologies and can therefore be used to visualize protein aggregates. In this study, cell toxicity experiments and biophysical studies demonstrated that the LCO p-FTAA was able to reduce the pool of soluble toxic A beta species in favor of the formation of larger insoluble nontoxic amyloid fibrils, there by counteracting A beta-mediated cytotoxicity. Moreover, p-FTAA bound to early formed A beta species and induced a rapid formation of beta-sheet structures. These p-FTAA generated amyloid fibrils were less hydrophobic and more resistant to proteolysis by proteinase K. In summary, our data show that p-FTAA promoted the formation of insoluble and stable A beta species that were nontoxic which indicates that p-FTAA might have therapeutic potential.	[Civitelli, Livia; Sandin, Linnea; Nelson, Erin; Khattak, Sikander Iqbal; Kagedal, Katarina] Linkoping Univ, Dept Clin & Expt Med, Expt Pathol, Linkoping, Sweden; [Brorsson, Ann-Christin] Linkoping Univ, Div Mol Biotechnol, Dept Phys Chem & Biol, Linkoping, Sweden	Linkoping University; Linkoping University	Civitelli, L; Kagedal, K (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Expt Pathol, Linkoping, Sweden.; Brorsson, AC (corresponding author), Linkoping Univ, Div Mol Biotechnol, Dept Phys Chem & Biol, Linkoping, Sweden.	livia.civitelli@liu.se; ann-christin.brorsson@liu.se; katarina.kagedal@liu.se		Civitelli, Livia/0000-0003-2399-1436; Brorsson, Ann-Christin/0000-0001-7651-3556	Swedish Research Council; Torsten Soderberg Foundation; Alzheimer Foundation; Dementia Foundation; Linkoping University Neurobiology Center	Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten Soderberg Foundation; Alzheimer Foundation; Dementia Foundation; Linkoping University Neurobiology Center	This work was supported by the Swedish Research Council, Torsten Soderberg Foundation (to A.-C. B.), the Alzheimer Foundation (to A.-C. B. and K. K.), the Dementia Foundation (to K. K.), and by the Linkoping University Neurobiology Center (to L. C., A.-C. B., and K. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bothra A, 1998, J BIOMOL STRUCT DYN, V15, P959, DOI 10.1080/07391102.1998.10508216; Caesar I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031424; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Gervais F, 2007, NEUROBIOL AGING, V28, P537, DOI 10.1016/j.neurobiolaging.2006.02.015; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Goransson AL, 2012, BIOCHEM BIOPH RES CO, V420, P895, DOI 10.1016/j.bbrc.2012.03.097; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hammarstrom P, 2010, BIOCHEMISTRY-US, V49, P6838, DOI 10.1021/bi100922r; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Herrmann US, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1923; Hirota-Nakaoka N, 2003, J BIOCHEM, V134, P159, DOI 10.1093/jb/mvg124; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Klingstedt T, 2011, ORG BIOMOL CHEM, V9, P8356, DOI 10.1039/c1ob05637a; Klingstedt T, 2011, BBA-GEN SUBJECTS, V1810, P286, DOI 10.1016/j.bbagen.2010.05.003; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Magnusson K, 2014, PRION, V8, P319, DOI 10.4161/pri.29239; Margalith I, 2012, J BIOL CHEM, V287, P18872, DOI 10.1074/jbc.M112.355958; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; Nilsson KPR, 2007, ACS CHEM BIOL, V2, P553, DOI 10.1021/cb700116u; Nilsson KPR, 2006, CHEMBIOCHEM, V7, P1096, DOI 10.1002/cbic.200500550; Nilsson KPR, 2005, BIOCHEMISTRY-US, V44, P3718, DOI 10.1021/bi047402u; Nystrom S, 2013, ACS CHEM BIOL, V8, P1128, DOI 10.1021/cb4000376; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Ries J, 2013, ACS CHEM NEUROSCI, V4, P1057, DOI 10.1021/cn400091m; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Tampellini D, 2010, J NEUROSCI, V30, P14299, DOI 10.1523/JNEUROSCI.3383-10.2010; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Townsend M, 2006, ANN NEUROL, V60, P668, DOI 10.1002/ana.21051; Vernaglia BA, 2004, BIOMACROMOLECULES, V5, P1362, DOI 10.1021/bm0498979; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	46	16	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9233	9243		10.1074/jbc.M115.696229	http://dx.doi.org/10.1074/jbc.M115.696229			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26907684	hybrid, Green Published			2022-12-28	WOS:000374849000033
J	Litvinov, RI; Farrell, DH; Weisel, JW; Bennett, JS				Litvinov, Rustem I.; Farrell, David H.; Weisel, John W.; Bennett, Joel S.			The Platelet Integrin IIb3 Differentially Interacts with Fibrin Versus Fibrinogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; fibrin; fibrinogen; integrin; platelet	GLYCOPROTEIN-IIB; GAMMA-CHAIN; BINDING-SITE; STIMULATED PLATELETS; RECOGNITION SITE; CLOT RETRACTION; FLOWING BLOOD; ALPHA-CHAIN; RECEPTOR; IIIA	Fibrinogen binding to the integrin IIb3 mediates platelet aggregation and spreading on fibrinogen-coated surfaces. However, in vivo IIb3 activation and fibrinogen conversion to fibrin occur simultaneously, although the relative contributions of fibrinogen versus fibrin to IIb3-mediated platelet functions are unknown. Here, we compared the interaction of IIb3 with fibrin and fibrinogen to explore their differential effects. A microscopic bead coated with fibrinogen or monomeric fibrin produced by treating the immobilized fibrinogen with thrombin was captured by a laser beam and repeatedly brought into contact with surface-attached purified IIb3. When IIb3-ligand complexes were detected, the rupture forces were measured and displayed as force histograms. Monomeric fibrin displayed a higher probability of interacting with IIb3 and a greater binding strength. IIb3-fibrin interactions were also less sensitive to inhibition by abciximab and eptifibatide. Both fibrinogen- and fibrin-IIb3 interactions were partially inhibited by RGD peptides, suggesting the existence of common RGD-containing binding motifs. This assumption was supported using the fibrin variants D97E or D574E with mutated RGD motifs. Fibrin made from a fibrinogen / variant lacking the C IIb3-binding motif was more reactive with IIb3 than the parent fibrinogen. These results demonstrate that fibrin is more reactive with IIb3 than fibrinogen. Fibrin is also less sensitive to IIb3 inhibitors, suggesting that fibrin and fibrinogen have distinct binding requirements. In particular, the maintenance of IIb3 binding activity in the absence of the C-dodecapeptide and the -chain RGD sequences suggests that the IIb3-binding sites in fibrin are not confined to its known -chain and RGD motifs.	[Litvinov, Rustem I.; Weisel, John W.; Bennett, Joel S.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Farrell, David H.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA	University of Pennsylvania; Pennsylvania Medicine; Oregon Health & Science University	Bennett, JS (corresponding author), Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, 421 Curie Blvd,814 BRB 2-3, Philadelphia, PA 19104 USA.	bennetts@mail.med.upenn.edu	Pieper, Maja/AAN-8539-2020; Litvinov, Rustem/E-5291-2011	Litvinov, Rustem/0000-0003-0643-1496	National Institutes of Health [PO1 HL40387, RO1 HL090774, UO1 HL116330]; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090774, P01HL040387, U01HL116330, P01HL120846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants PO1 HL40387, RO1 HL090774, and UO1 HL116330 and a grant from the American Society of Hematology. The authors, except for DHF, declare they have no conflicts of interest with the contents of this article. D. H. F. and Oregon Health and Science University have a significant interest in Gamma Therapeutics, a company that may have a commercial interest in the results of this research and technology. This potential individual and institutional conflict of interest has been reviewed and managed by Oregon Health and Science University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bennett JS, 2001, ANN NY ACAD SCI, V936, P340; BENNETT JS, 1988, J BIOL CHEM, V263, P12948; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; Carr ME, 2003, CELL BIOCHEM BIOPHYS, V38, P55, DOI 10.1385/CBB:38:1:55; Cho J, 2005, J BIOL CHEM, V280, P35490, DOI 10.1074/jbc.M506289200; COHEN I, 1982, J CELL BIOL, V93, P775, DOI 10.1083/jcb.93.3.775; Collet JP, 2002, CIRC RES, V90, P428, DOI 10.1161/hh0402.105095; Dai A, 2015, J BIOL CHEM, V290, P27168, DOI 10.1074/jbc.M115.682377; de Willige SU, 2009, BLOOD, V114, P3994, DOI 10.1182/blood-2009-05-217968; Falati Shahrokh, 2004, Methods Mol Biol, V272, P187; Farrell DH, 2004, CURR OPIN HEMATOL, V11, P151, DOI 10.1097/01.moh.0000131440.02397.a4; FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729; FARRELL DH, 1994, J BIOL CHEM, V269, P226; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; GARTNER TK, 1988, THROMB RES, V49, P43; HAMAGUCHI M, 1993, BLOOD, V81, P2348; Hantgan RR, 2010, BIOCHEMISTRY-US, V49, P9217, DOI 10.1021/bi1009858; HANTGAN RR, 1985, BLOOD, V65, P1299, DOI 10.1182/blood.V65.6.1299.bloodjournal6561299; HANTGAN RR, 1988, BIOCHIM BIOPHYS ACTA, V968, P24, DOI 10.1016/0167-4889(88)90040-7; Hantgan RR, 1998, THROMB RES, V89, P271, DOI 10.1016/S0049-3848(98)00021-8; Holmback K, 1996, EMBO J, V15, P5760, DOI 10.1002/j.1460-2075.1996.tb00962.x; Jirouskova M, 1997, THROMB HAEMOSTASIS, V78, P1125; KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028; KLOCZEWIAK M, 1983, THROMB RES, V29, P249, DOI 10.1016/0049-3848(83)90147-0; Litvinov RI, 2005, BLOOD, V106, P2944, DOI 10.1182/blood-2005-05-2039; Litvinov RI, 2005, BIOPHYS J, V89, P2824, DOI 10.1529/biophysj.105.061887; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Litvinov RI, 2007, BLOOD, V109, P130, DOI 10.1182/blood-2006-07-033910; Litvinov RI, 2012, J BIOL CHEM, V287, P35275, DOI 10.1074/jbc.M112.404848; Litvinov RI, 2011, BIOPHYS J, V100, P165, DOI 10.1016/j.bpj.2010.11.019; MARTINEZSALES V, 1995, HAEMOSTASIS, V25, P158; Podolnikova NP, 2009, BIOCHEMISTRY-US, V48, P617, DOI 10.1021/bi801751s; Podolnikova NP, 2005, BIOCHEMISTRY-US, V44, P16920, DOI 10.1021/bi051581d; Podolnikova NP, 2003, J BIOL CHEM, V278, P32251, DOI 10.1074/jbc.M300410200; Remijn JA, 2003, J THROMB HAEMOST, V1, P2245, DOI 10.1046/j.1538-7836.2003.00399.x; Remijn JA, 2002, BRIT J HAEMATOL, V117, P650, DOI 10.1046/j.1365-2141.2002.03467.x; Rooney MM, 1998, BLOOD, V92, P2374, DOI 10.1182/blood.V92.7.2374.2374_2374_2381; Rooney MM, 1996, J BIOL CHEM, V271, P8553, DOI 10.1074/jbc.271.15.8553; SAVAGE B, 1991, J BIOL CHEM, V266, P11227; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Sun JEP, 2012, INTEGR BIOL-UK, V4, P84, DOI 10.1039/c1ib00085c; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; ZAMARRON C, 1991, J BIOL CHEM, V266, P16193	43	40	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7858	7867		10.1074/jbc.M115.706861	http://dx.doi.org/10.1074/jbc.M115.706861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26867579	Green Published, hybrid			2022-12-28	WOS:000374056700009
J	Spoerry, C; Seele, J; Valentin-Weigand, P; Baums, CG; von Pawel-Rammingen, U				Spoerry, Christian; Seele, Jana; Valentin-Weigand, Peter; Baums, Christoph G.; von Pawel-Rammingen, Ulrich			Identification and Characterization of IgdE, a Novel IgG-degrading Protease of Streptococcus suis with Unique Specificity for Porcine IgG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; cysteine protease; immunoglobulin G (IgG); proteolytic enzyme; Streptococcus; substrate specificity	CYSTEINE PROTEINASE; STRICT SPECIFICITY; SIGNAL PEPTIDES; HUMAN PATHOGEN; VIRULENCE; IMMUNOGLOBULINS; CLEAVAGE; IDES; ENDOPEPTIDASE; SEROTYPE-2	Streptococcus suis is a major endemic pathogen of pigs causing meningitis, arthritis, and other diseases. Zoonotic S. suis infections are emerging in humans causing similar pathologies as well as severe conditions such as toxic shock-like syndrome. Recently, we discovered an IdeS family protease of S. suis that exclusively cleaves porcine IgM and represents the first virulence factor described, linking S. suis to pigs as their natural host. Here we report the identification and characterization of a novel, unrelated protease of S. suis that exclusively targets porcine IgG. This enzyme, designated IgdE for immunoglobulin G-degrading enzyme of S. suis, is a cysteine protease distinct from previous characterized streptococcal immunoglobulin degrading proteases of the IdeS family and mediates efficient cleavage of the hinge region of porcine IgG with a high degree of specificity. The findings that all S. suis strains investigated possess the IgG proteolytic activity and that piglet serum samples contain specific antibodies against IgdE strongly indicate that the protease is expressed in vivo during infection and represents a novel and putative important bacterial virulence/colonization determinant, and a thus potential therapeutic target.	[Spoerry, Christian; von Pawel-Rammingen, Ulrich] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Spoerry, Christian; von Pawel-Rammingen, Ulrich] Umea Univ, Umea Ctr Microbial Res, S-90187 Umea, Sweden; [Seele, Jana; Valentin-Weigand, Peter; Baums, Christoph G.] Univ Vet Med Hannover, Ctr Infect Med, Inst Microbiol, D-30173 Hannover, Germany; [Baums, Christoph G.] Univ Leipzig, Coll Vet Med, Ctr Infect Dis, Inst Bacteriol & Mycol, D-04103 Leipzig, Germany	Umea University; Umea University; University of Veterinary Medicine Hannover, Foundation; Leipzig University	von Pawel-Rammingen, U (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.; von Pawel-Rammingen, U (corresponding author), Umea Univ, Umea Ctr Microbial Res, S-90187 Umea, Sweden.	ulrich.von-pawel@molbiol.umu.se		Spoerry, Christian/0000-0001-5763-6542	Carl Tryggers foundation; Insamlingstiftelsen at Umea University; Stiftelsen J.C. Kempes Stipendiefond at Umea University; German Research Foundation [SFB587, BA 4730/1-1]; German Federal Ministry for Research and Education (BMBF) within the Helmholtz-CAS-Joint Research Group ZooStrep [HCJRG-116]	Carl Tryggers foundation; Insamlingstiftelsen at Umea University; Stiftelsen J.C. Kempes Stipendiefond at Umea University; German Research Foundation(German Research Foundation (DFG)); German Federal Ministry for Research and Education (BMBF) within the Helmholtz-CAS-Joint Research Group ZooStrep(Federal Ministry of Education & Research (BMBF))	This work was supported in part by Carl Tryggers foundation, Insamlingstiftelsen at Umea University, and the Stiftelsen J.C. Kempes Stipendiefond at Umea University. The materials from piglets investigated in this work were obtained within a study financed by the German Research Foundation under Grants SFB587 and BA 4730/1-1. A patent application for IgdE has been filed. C. S. and U. v. P. R. are listed as inventors in this application.; Supported by the German Federal Ministry for Research and Education (BMBF) within the Helmholtz-CAS-Joint Research Group ZooStrep (HCJRG-116).	Aarestrup F, 2012, NATURE, V486, P465, DOI 10.1038/486465a; ABRAHAMSON M, 1987, J BIOL CHEM, V262, P9688; Allgaier A, 2001, J CLIN MICROBIOL, V39, P445, DOI 10.1128/JCM.39.2.445-453.2001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baums CG, 2007, APPL ENVIRON MICROB, V73, P711, DOI 10.1128/AEM.01800-06; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BJORCK L, 1989, NATURE, V337, P385, DOI 10.1038/337385a0; Butler JE, 2009, IMMUNOGENETICS, V61, P209, DOI 10.1007/s00251-008-0336-9; Butler JE, 2009, DEV COMP IMMUNOL, V33, P321, DOI 10.1016/j.dci.2008.06.015; Butler JE, 2006, J IMMUNOL, V177, P5480, DOI 10.4049/jimmunol.177.8.5480; DREW MD, 1988, CAN J ANIM SCI, V68, P1277, DOI 10.4141/cjas88-143; Dunn BM., 1989, PROTEOLYTIC ENZYMES, P57; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; GREEN GDJ, 1981, J BIOL CHEM, V256, P1923; Haas B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130528; HIGGINS R, 2005, DIS SWINE; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KLOBASA F, 1981, RES VET SCI, V31, P195, DOI 10.1016/S0034-5288(18)32494-9; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Palmieri C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00235; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PROKESOVA L, 1992, IMMUNOL LETT, V31, P259, DOI 10.1016/0165-2478(92)90124-7; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Seele J, 2015, VET RES, V46, DOI 10.1186/s13567-015-0171-6; Seele J, 2013, J BACTERIOL, V195, P930, DOI 10.1128/JB.01875-12; Smith HE, 1999, INFECT IMMUN, V67, P1750; Smith HJ, 1996, ACTA RADIOL, V37, P2; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Unterweger C, 2014, BERL MUNCH TIERARZTL, V127, P194, DOI 10.2376/0005-9366-127-194; Vincents B, 2004, BIOCHEMISTRY-US, V43, P15540, DOI 10.1021/bi048284d; Vincents B, 2011, FASEB J, V25, P3741, DOI 10.1096/fj.11-187799; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; WALLENFELS K, 1968, EUR J BIOCHEM, V3, P267, DOI 10.1111/j.1432-1033.1968.tb19526.x; Wenig K, 2004, P NATL ACAD SCI USA, V101, P17371, DOI 10.1073/pnas.0407965101; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Wisselink HJ, 2002, J CLIN MICROBIOL, V40, P2922, DOI 10.1128/JCM.40.8.2922-2929.2002; Zhang AD, 2010, VET MICROBIOL, V140, P171, DOI 10.1016/j.vetmic.2009.06.034	43	18	19	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7915	7925		10.1074/jbc.M115.711440	http://dx.doi.org/10.1074/jbc.M115.711440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26861873	hybrid, Green Published			2022-12-28	WOS:000374056700014
J	Wang, TY; Sun, YS; Muthukrishnan, N; Erazo-Oliveras, A; Najjar, K; Pellois, JP				Wang, Ting-Yi; Sun, Yusha; Muthukrishnan, Nandhini; Erazo-Oliveras, Alfredo; Najjar, Kristina; Pellois, Jean-Philippe			Membrane Oxidation Enables the Cytosolic Entry of Polyarginine Cell-penetrating Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell culture; cell-penetrating peptide (CPP); oxidation-reduction (redox); peptide transport; plasma membrane	ARGININE-RICH PEPTIDES; LIPID-PEROXIDATION; CYCLIC-PEPTIDES; LIVE CELLS; DELIVERY; STRESS; INTERNALIZATION; MECHANISM; PERMEABILITY; ANTIBODIES	Arginine-rich peptides can penetrate cells and consequently be used as delivery agents in various cellular applications. The activity of these reagents is often context-dependent, and the parameters that impact cell entry are not fully understood, giving rise to variability and limiting progress toward their usage. Herein, we report that the cytosolic penetration of linear polyarginine peptides is dependent on the oxidation state of the cell. In particular, we find that hypoxia and cellular antioxidants inhibit cell penetration. In contrast, oxidants promote cytosolic cell entry with an efficiency proportional to the level of reactive oxygen species generated within membranes. Moreover, an antibody that binds to oxidized lipids inhibits cell penetration, whereas extracellularly administered pure oxidized lipids enhance peptide transport into cells. Overall, these data indicate that oxidized lipids are capable of mediating the transport of polyarginine peptides across membranes. These data may also explain variability in cell-penetrating peptide performance in different experimental conditions. These new findings therefore provide new opportunities for the rational design of future cell-permeable compounds and for the optimization of delivery protocols.	[Wang, Ting-Yi; Sun, Yusha; Muthukrishnan, Nandhini; Erazo-Oliveras, Alfredo; Najjar, Kristina; Pellois, Jean-Philippe] Texas A&M Univ, Dept Biochem & Biophys, Biochem & Biophys Bldg,Rm 430,300 Olsen Blvd, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Pellois, JP (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, Biochem & Biophys Bldg,Rm 430,300 Olsen Blvd, College Stn, TX 77843 USA.	pellois@tamu.edu	Muthukrishnan, Nandhini/P-8906-2018	Pellois, Jean-Philippe/0000-0001-8528-4652; Sun, Yusha/0000-0003-4835-3000; Wang, Ting-Yi/0000-0001-5536-925X	National Institutes of Health from NIGMS [R01GM110137]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110137] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM110137 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babich H, 2009, IN VITRO CELL DEV-AN, V45, P226, DOI 10.1007/s11626-008-9168-z; Benderitter M, 2003, RADIAT RES, V159, P471, DOI 10.1667/0033-7587(2003)159[0471:TCMAAB]2.0.CO;2; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Cascales L, 2011, J BIOL CHEM, V286, P36932, DOI 10.1074/jbc.M111.264424; Chikazawa M, 2013, J BIOL CHEM, V288, P13204, DOI 10.1074/jbc.M113.452177; Chu Q, 2015, MEDCHEMCOMM, V6, P111, DOI 10.1039/c4md00131a; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; de la Haba C, 2013, BBA-BIOMEMBRANES, V1828, P357, DOI 10.1016/j.bbamem.2012.08.013; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Deshayes S, 2006, BBA-BIOMEMBRANES, V1758, P1846, DOI 10.1016/j.bbamem.2006.08.010; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Drummen GPC, 2002, FREE RADICAL BIO MED, V33, P473, DOI 10.1016/S0891-5849(02)00848-1; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Erazo-Oliveras A, 2014, NAT METHODS, V11, P861, DOI [10.1038/NMETH.2998, 10.1038/nmeth.2998]; Erazo-Oliveras A, 2012, PHARMACEUTICALS-BASE, V5, P1177, DOI 10.3390/ph5111177; FALANGA V, 1993, J CELL PHYSIOL, V154, P506, DOI 10.1002/jcp.1041540308; Friedman P, 2002, J BIOL CHEM, V277, P7010, DOI 10.1074/jbc.M108860200; Frikke-Schmidt H, 2010, ANAL BIOCHEM, V397, P135, DOI 10.1016/j.ab.2009.09.040; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Halliwell Barry, 2014, Biomed J, V37, P99, DOI 10.4103/2319-4170.128725; Herce HD, 2014, J AM CHEM SOC, V136, P17459, DOI 10.1021/ja507790z; Hirose H, 2012, MOL THER, V20, P984, DOI 10.1038/mt.2011.313; Howard AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1594; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Jiang N, 2003, J BIOL CHEM, V278, P21678, DOI 10.1074/jbc.M300286200; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; Kawamoto S, 2012, INT J QUANTUM CHEM, V112, P178, DOI 10.1002/qua.23177; Kawamoto S, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3555531; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kosuge M, 2008, BIOCONJUGATE CHEM, V19, P656, DOI 10.1021/bc700289w; Kotova EA, 2011, BBA-BIOMEMBRANES, V1808, P2252, DOI 10.1016/j.bbamem.2011.05.018; Kwon YU, 2007, J AM CHEM SOC, V129, P1508, DOI 10.1021/ja0668623; Lattig-Tunnemann G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1459; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lehto T, 2012, EXPERT OPIN DRUG DEL, V9, P823, DOI 10.1517/17425247.2012.689285; Liu J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091606, 10.1371/journal.pone.0085755, 10.1371/journal.pone.0089315, 10.1371/journal.pone.0098300]; Long LH, 2009, BIOCHEM BIOPH RES CO, V388, P700, DOI 10.1016/j.bbrc.2009.08.069; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Mandal D, 2011, ANGEW CHEM INT EDIT, V50, P9633, DOI 10.1002/anie.201102572; Melikov K, 2015, BIOCHEM J, V471, P221, DOI 10.1042/BJ20150272; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Muthukrishnan N, 2014, PHOTOCHEM PHOTOBIOL, V90, P1034, DOI 10.1111/php.12288; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Peretto I, 2003, CHEM COMMUN, P2312, DOI 10.1039/b306438g; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Qian ZQ, 2013, ACS CHEM BIOL, V8, P423, DOI 10.1021/cb3005275; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Saito Y, 2003, J BIOL CHEM, V278, P39428, DOI 10.1074/jbc.M305542200; Sakai N, 2003, J AM CHEM SOC, V125, P14348, DOI 10.1021/ja037601l; Schroder T, 2007, BIOCONJUGATE CHEM, V18, P342, DOI 10.1021/bc0602073; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Swiecicki JM, 2014, CHEMBIOCHEM, V15, P884, DOI 10.1002/cbic.201300742; Takahashi M, 2001, FREE RADICAL BIO MED, V31, P164, DOI 10.1016/S0891-5849(01)00575-5; Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m; Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X; Verdurmen WPR, 2010, J CONTROL RELEASE, V147, P171, DOI 10.1016/j.jconrel.2010.06.030; Vernier PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007966; Volinsky R, 2011, BIOPHYS J, V101, P1376, DOI 10.1016/j.bpj.2011.07.051; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wender PA, 2008, ADV DRUG DELIVER REV, V60, P452, DOI 10.1016/j.addr.2007.10.016; Xiao XS, 2007, ANGEW CHEM INT EDIT, V46, P2865, DOI 10.1002/anie.200604485; Yandek LE, 2007, BIOPHYS J, V92, P2434, DOI 10.1529/biophysj.106.100198	66	21	22	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7902	7914		10.1074/jbc.M115.711564	http://dx.doi.org/10.1074/jbc.M115.711564			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26888085	hybrid, Green Published			2022-12-28	WOS:000374056700013
J	Schneider, K; Valdez, J; Nguyen, J; Vawter, M; Galke, B; Kurtz, TW; Chan, JY				Schneider, Kevin; Valdez, Joshua; Nguyen, Janice; Vawter, Marquis; Galke, Brandi; Kurtz, Theodore W.; Chan, Jefferson Y.			Increased Energy Expenditure, Ucp1 Expression, and Resistance to Diet-induced Obesity in Mice Lacking Nuclear Factor-Erythroid-2-related Transcription Factor-2 (Nrf2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; ERYTHROID 2-RELATED FACTOR-2; GAMMA PPAR-GAMMA; INSULIN-RESISTANCE; GENE-EXPRESSION; UNCOUPLING PROTEIN-2; OXIDATIVE STRESS; SKELETAL-MUSCLE; INDUCED THERMOGENESIS; FAT	The NRF2 (also known as NFE2L2) transcription factor is a critical regulator of genes involved in defense against oxidative stress. Previous studies suggest that Nrf2 plays a role in adipogenesis in vitro, and deletion of the Nrf2 gene protects against diet-induced obesity in mice. Here, we demonstrate that resistance to diet-induced obesity in Nrf2(-/-) mice is associated with a 20-30% increase in energy expenditure. Analysis of bioenergetics revealed that Nrf2(-/-) white adipose tissues exhibit greater oxygen consumption. White adipose tissue showed a > 2-fold increase in Ucp1 gene expression. Oxygen consumption is also increased nearly 2.5-fold in Nrf2-deficient fibroblasts. Oxidative stress induced by glucose oxidase resulted in increased Ucp1 expression. Conversely, antioxidant chemicals (such as N-acetylcysteine and Mn(III)tetrakis(4-benzoic acid) porphyrin chloride) and SB203580 (a known suppressor of Ucp1 expression) decreased Ucp1 and oxygen consumption in Nrf2-deficient fibroblasts. These findings suggest that increasing oxidative stress by limiting Nrf2 function in white adipocytes may be a novel means to modulate energy balance as a treatment of obesity and related clinical disorders.	[Schneider, Kevin; Valdez, Joshua; Nguyen, Janice; Chan, Jefferson Y.] Univ Calif Irvine, Dept Lab Med & Pathol, D440 Med Sci 1, Irvine, CA 92697 USA; [Vawter, Marquis; Galke, Brandi] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Kurtz, Theodore W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Francisco	Chan, JY (corresponding author), Univ Calif Irvine, Dept Lab Med & Pathol, D440 Med Sci 1, Irvine, CA 92697 USA.	jchan@uci.edu			National Institute of Health [CA091907]; NATIONAL CANCER INSTITUTE [R01CA091907, R56CA091907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085801] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institute of Health Research Grant CA091907 to J. Y. C. The authors declare that they have no conflicts of interest with the contents of this article.	Anedda A, 2013, FREE RADICAL BIO MED, V61, P395, DOI 10.1016/j.freeradbiomed.2013.04.007; Auffret J, 2012, FASEB J, V26, P3728, DOI 10.1096/fj.12-204958; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; Chutkow WA, 2010, DIABETES, V59, P1424, DOI 10.2337/db09-1212; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Cohade C, 2003, J NUCL MED, V44, P170; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dunham-Snary KJ, 2014, REDOX BIOL, V2, P656, DOI 10.1016/j.redox.2014.04.005; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Garcia-Alonso V, 2013, J BIOL CHEM, V288, P28230, DOI 10.1074/jbc.M113.468603; Giudice A, 2006, BIOESSAYS, V28, P169, DOI 10.1002/bies.20359; He XQ, 2008, CHEM RES TOXICOL, V21, P1375, DOI 10.1021/tx800019a; He XQ, 2007, TOXICOL SCI, V98, P298, DOI 10.1093/toxsci/kfm081; He XQ, 2012, MOL PHARMACOL, V82, P887, DOI 10.1124/mol.112.081133; Hou YY, 2012, FREE RADICAL BIO MED, V52, P462, DOI 10.1016/j.freeradbiomed.2011.10.453; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Kendig EL, 2011, TOXICOL APPL PHARM, V257, P338, DOI 10.1016/j.taap.2011.09.017; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kozak Leslie P, 2011, Front Endocrinol (Lausanne), V2, P64, DOI 10.3389/fendo.2011.00064; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee P., 2013, INT J OBES LOND, V38, P170; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Ma Q, 2006, AM J PATHOL, V168, P1960, DOI 10.2353/ajpath.2006.051113; Mahadik SR, 2012, ADIPOCYTE, V1, P101, DOI 10.4161/adip.19671; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Mexitalia M, 2013, J PEDIATR ENDOCR MET, V26, P441, DOI 10.1515/jpem-2012-0311; More VR, 2013, FREE RADICAL BIO MED, V61, P85, DOI 10.1016/j.freeradbiomed.2013.03.007; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213; Qian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058939; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Ringholm S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064123; Ro SH, 2014, P NATL ACAD SCI USA, V111, P7849, DOI 10.1073/pnas.1401787111; Rolfe DFS, 1999, AM J PHYSIOL-CELL PH, V276, pC692, DOI 10.1152/ajpcell.1999.276.3.C692; Rolo AP, 2009, ANAL BIOCHEM, V385, P176, DOI 10.1016/j.ab.2008.10.002; ROTHWELL NJ, 1983, CLIN SCI, V64, P19, DOI 10.1042/cs0640019; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wang H, 2008, MOL CELL BIOL, V28, P2187, DOI 10.1128/MCB.01479-07; Wang LP, 2013, ARCH BIOCHEM BIOPHYS, V537, P31, DOI 10.1016/j.abb.2013.06.001; Whittle A, 2013, TRENDS PHARMACOL SCI, V34, P347, DOI 10.1016/j.tips.2013.04.004; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Xue P, 2013, DIABETES, V62, P845, DOI 10.2337/db12-0584; Zafrir B, 2013, HORM METAB RES, V45, P774, DOI 10.1055/s-0033-1348264; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	82	51	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7754	7766		10.1074/jbc.M115.673756	http://dx.doi.org/10.1074/jbc.M115.673756			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26841864	Green Published, hybrid			2022-12-28	WOS:000383447600044
J	Muntean, BS; Martemyanov, KA				Muntean, Brian S.; Martemyanov, Kirill A.			Association with the Plasma Membrane Is Sufficient for Potentiating Catalytic Activity of Regulators of G Protein Signaling (RGS) Proteins of the R7 Subfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; G protein; G protein-coupled receptor (GPCR); GTPase-activating protein (GAP); regulator of G protein signaling (RGS); signal transduction	HETEROTRIMERIC G-PROTEINS; NUCLEAR-LOCALIZATION; LIVING CELLS; BETA-SUBUNIT; DEP DOMAIN; COMPLEX; STRIATUM; ANCHOR; FAMILY; BRAIN	Regulators of G protein Signaling (RGS) promote deactivation of heterotrimeric G proteins thus controlling the magnitude and kinetics of responses mediated by G protein-coupled receptors (GPCR). In the nervous system, RGS7 and RGS9-2 play essential role in vision, reward processing, and movement control. Both RGS7 and RGS9-2 belong to the R7 subfamily of RGS proteins that form macromolecular complexes with R7-binding protein (R7BP). R7BP targets RGS proteins to the plasma membrane and augments their GTPase-accelerating protein (GAP) activity, ultimately accelerating deactivation of G protein signaling. However, it remains unclear if R7BP serves exclusively as a membrane anchoring subunit or further modulates RGS proteins to increase their GAP activity. To directly answer this question, we utilized a rapidly reversible chemically induced protein dimerization system that enabled us to control RGS localization independent from R7BP in living cells. To monitor kinetics of G deactivation, we coupled this strategy with measuring changes in the GAP activity by bioluminescence resonance energy transfer-based assay in a cellular system containing -opioid receptor. This approach was used to correlate changes in RGS localization and activity in the presence or absence of R7BP. Strikingly, we observed that RGS activity is augmented by membrane recruitment, in an orientation independent manner with no additional contributions provided by R7BP. These findings argue that the association of R7 RGS proteins with the membrane environment provides a major direct contribution to modulation of their GAP activity.	[Muntean, Brian S.; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA	Scripps Research Institute	Martemyanov, KA (corresponding author), Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA.	kirill@scripps.edu			National Institutes of Health [DA036596, DA026405]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036596, K02DA026405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants DA036596 and DA026405 (to K. A. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Bouhamdan M, 2004, BBA-MOL CELL RES, V1691, P141, DOI 10.1016/j.bbamcr.2004.01.005; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Cao Y, 2012, P NATL ACAD SCI USA, V109, P7905, DOI 10.1073/pnas.1202332109; Carter AM, 2014, J BIOL CHEM, V289, P19737, DOI 10.1074/jbc.M114.564930; Charpentier TH, 2014, J BIOL CHEM, V289, P29545, DOI 10.1074/jbc.M114.586784; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Feng SH, 2014, ANGEW CHEM INT EDIT, V53, P6720, DOI 10.1002/anie.201402294; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; Hillenbrand M, 2015, P NATL ACAD SCI USA, V112, pE1181, DOI 10.1073/pnas.1417573112; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Liapis E, 2012, J NEUROCHEM, V122, P568, DOI 10.1111/j.1471-4159.2012.07811.x; MacNamara A, 2015, BIOORGAN MED CHEM, V23, P2868, DOI 10.1016/j.bmc.2015.04.074; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Masuho I, 2013, J BIOL CHEM, V288, P25129, DOI 10.1074/jbc.M113.462283; Masuho I, 2010, J BIOL CHEM, V285, P4781, DOI 10.1074/jbc.M109.058511; Medina F, 2013, J BIOL CHEM, V288, P11325, DOI 10.1074/jbc.M113.450056; Mitsi V, 2015, P NATL ACAD SCI USA, V112, pE5088, DOI 10.1073/pnas.1504283112; Narayanan V, 2007, BIOCHEMISTRY-US, V46, P6859, DOI 10.1021/bi700524w; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nini Lylia, 2007, BMC Biochemistry, V8, P18, DOI 10.1186/1471-2091-8-18; Orlandi C, 2015, J BIOL CHEM, V290, P13622, DOI 10.1074/jbc.M115.645374; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Ostrovskaya O, 2014, ELIFE, V3, DOI 10.7554/eLife.02053; Posokhova E, 2010, J PROTEOME RES, V9, P1510, DOI 10.1021/pr901022m; Psigfogeorgou K, 2011, J NEUROSCI, V31, P5617, DOI 10.1523/JNEUROSCI.4146-10.2011; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rojkova AM, 2003, J BIOL CHEM, V278, P12507, DOI 10.1074/jbc.M207302200; Rose JJ, 2000, J NEUROCHEM, V75, P2103, DOI 10.1046/j.1471-4159.2000.0752103.x; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Schifferer M, 2015, BIOORGAN MED CHEM, V23, P2862, DOI 10.1016/j.bmc.2015.03.048; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Sutton LP, 2016, BIOL PSYCHIAT, V80, P235, DOI 10.1016/j.biopsych.2015.07.026; Takida S, 2005, MOL PHARMACOL, V67, P132, DOI 10.1124/mol.104.003418; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xie KQ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002922; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang JH, 2001, J BIOL CHEM, V276, P10284, DOI 10.1074/jbc.M009247200; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19977, DOI 10.1073/pnas.1214337109	51	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7195	7204		10.1074/jbc.M115.713446	http://dx.doi.org/10.1074/jbc.M115.713446			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26811338	Green Published, hybrid			2022-12-28	WOS:000373299700051
J	Chavoshi, S; Egorova, O; Lacdao, IK; Farhadi, S; Sheng, Y; Saridakis, V				Chavoshi, Sara; Egorova, Olga; Lacdao, Ira Kay; Farhadi, Sahar; Sheng, Yi; Saridakis, Vivian			Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); DNA viruses; viral protein; virology; X-ray crystallography; KSHV; USP7; vIRF1	UBIQUITIN-SPECIFIC PROTEASE; INTERFERON REGULATORY FACTOR; BINDING DOMAIN; CRYSTAL-STRUCTURE; TUMOR-SUPPRESSOR; STRUCTURAL BASIS; DNA-DAMAGE; HUMAN P53; PHOSPHORYLATION; STABILIZATION	Viral interferon regulatory factor 1 (vIRF1), a Kaposi sarcoma herpesvirus protein, destabilizes p53 by inhibiting p53 acetylation and Hdm2 phosphorylation. This leads to increased ubiquitination and degradation of p53 by Hdm2, which cripples the cellular p53-mediated antiviral response. Ubiquitin-specific protease 7 (USP7) deubiquitinates p53 and Hdm2 and regulates their stability. We identified an EGPS consensus sequence in vIRF1, which is identical to that found in Epstein-Barr virus nuclear antigen 1 (EBNA1) that interacts with the N-terminal domain of USP7 (USP7-NTD). GST pulldown assays demonstrated that vIRF1 interacts with USP7-NTD via its EGPS motif. NMR heteronuclear single quantum correlation (HSQC) analysis revealed chemical perturbations after titration of USP7-NTD with vIRF1 (44)SPGEGPSGTG(53) peptide. In contrast, these perturbations were reduced with a mutant vIRF1 peptide, (44)SPGEGPAGTG(53). Fluorescence polarization analysis indicated that the vIRF1 peptide interacted with USP7-NTD with a K-d of 2.0 m. The crystal structure of the USP7-NTD<bold>vIRF</bold>1 peptide complex revealed an identical mode of binding as that of the EBNA1 peptide to USP7-NTD. We also showed that USP7 interacts with vIRF1 in U2OS cells. Decreased levels of p53, but not Hdm2 or ataxia telangiectasia-mutated (ATM), were seen after expression of vIRF1, but not with a vIRF1 mutant protein. Our results support a new role for vIRF1 through deregulation of the deubiquitinating enzyme USP7 to inhibit p53-mediated antiviral responses.	[Chavoshi, Sara; Egorova, Olga; Lacdao, Ira Kay; Farhadi, Sahar; Sheng, Yi; Saridakis, Vivian] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	York University - Canada	Saridakis, V (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada.	vsaridak@yorku.ca			Canadian Institutes of Health Research (CIHR) [106583]; Canada Foundation for Innovation Leaders Opportunity Fund Program; Ontario Research Fund Research Infrastructure Program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation Leaders Opportunity Fund Program; Ontario Research Fund Research Infrastructure Program	This work was supported by Operating Grant 106583 from the Canadian Institutes of Health Research (CIHR) (to V. S. and Y. S.). Infrastructure was funded by the Canada Foundation for Innovation Leaders Opportunity Fund Program and the Ontario Research Fund Research Infrastructure Program (to V. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alibek K, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-3; Angeletti PC, 2008, ADV PHARMACOL, V56, P509, DOI 10.1016/S1054-3589(07)56016-3; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Boutell C, 2003, J BIOL CHEM, V278, P36596, DOI 10.1074/jbc.M300776200; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen WG, 2010, J VIROL, V84, P3898, DOI 10.1128/JVI.01321-09; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Edelman DC, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-78; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Gillen J, 2015, J VIROL, V89, P4918, DOI 10.1128/JVI.02925-14; Hew K, 2013, NUCLEIC ACIDS RES, V41, P4295, DOI 10.1093/nar/gkt082; Holowaty MN, 2003, J BIOL CHEM, V278, P47753, DOI 10.1074/jbc.M307200200; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Jacobs SR, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00019; Jager W, 2012, J VIROL, V86, P6745, DOI 10.1128/JVI.06840-11; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lee HR, 2011, NAT STRUCT MOL BIOL, V18, P1336, DOI 10.1038/nsmb.2142; Li M, 2000, MOL CELL BIOL, V20, P8254, DOI 10.1128/MCB.20.21.8254-8263.2000; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; MEREDITH M, 1994, VIROLOGY, V200, P457, DOI 10.1006/viro.1994.1209; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Monleon Daniel, 2002, Journal of Structural and Functional Genomics, V2, P93, DOI 10.1023/A:1020499629298; Moore PS, 1998, TRENDS GENET, V14, P144, DOI 10.1016/S0168-9525(98)01408-5; Nakagawa K, 1999, MOL CELL BIOL, V19, P2828; Nakamura H, 2001, J VIROL, V75, P7572, DOI 10.1128/JVI.75.16.7572-7582.2001; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Pfoh R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004950; Pozharskaya VP, 2004, J VIROL, V78, P6621, DOI 10.1128/JVI.78.12.6621-6635.2004; Salsman J, 2012, J VIROL, V86, P806, DOI 10.1128/JVI.05442-11; Salsman J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000100; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Sarkari F, 2013, J BIOL CHEM, V288, P16975, DOI 10.1074/jbc.M113.469262; Sarkari F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016598; Sarkari F, 2010, J MOL BIOL, V402, P825, DOI 10.1016/j.jmb.2010.08.017; Seo T, 2001, J VIROL, V75, P6193, DOI 10.1128/JVI.75.13.6193-6198.2001; Shadfan M, 2012, TRANSL CANCER RES, V1, P88, DOI 10.3978/j.issn.2218-676X.2012.04.02; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shin YC, 2006, J VIROL, V80, P2257, DOI 10.1128/JVI.80.5.2257-2266.2006; Sivachandran N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000170; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; West JA, 2010, FUTURE VIROL, V5, P185, DOI 10.2217/FVL.10.5; Ye T, 2012, ANAL CHEM, V84, P994, DOI 10.1021/ac202548n	51	28	28	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6281	6291		10.1074/jbc.M115.710632	http://dx.doi.org/10.1074/jbc.M115.710632			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26786098	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000372894200019
J	George, CX; Ramaswami, G; Li, JB; Samuel, CE				George, Cyril X.; Ramaswami, Gokul; Li, Jin Billy; Samuel, Charles E.			Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; interferon; protein kinase RNA-activated (PKR); RNA editing; stress granule; adenosine deaminase acting on RNA (ADAR)	DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; SPLICE-SITE VARIANTS; PRE-MESSENGER-RNA; N-TERMINAL REGION; INTERFERON ACTION; MEASLES-VIRUS; HUMAN-CELLS; ENZYME ADAR1; C PROTEIN	Adenosine deaminases acting on double-stranded RNA (ADARs) catalyze the deamination of adenosine (A) to produce inosine (I) in double-stranded (ds) RNA structures, a process known as A-to-I RNA editing. dsRNA is an important trigger of innate immune responses, including interferon (IFN) production and action. We examined the role of A-to-I RNA editing by two ADARs, ADAR1 and ADAR2, in the sensing of self-RNA in the absence of pathogen infection, leading to activation of IFN-induced, RNA-mediated responses in mouse embryo fibroblasts. IFN treatment of Adar1(-/-) cells lacking both the p110 constitutive and p150 IFN-inducible ADAR1 proteins induced formation of stress granules, whereas neither wild-type (WT) nor Adar2(-/-) cells displayed a comparable stress granule response following IFN treatment. Phosphorylation of protein synthesis initiation factor eIF2 at serine 51 was increased in IFN-treated Adar1(-/-) cells but not in either WT or Adar2(-/-) cells following IFN treatment. Analysis by deep sequencing of mouse exonic loci containing A-to-I-editing sites revealed that the majority of editing in mouse embryo fibroblasts was carried out by ADAR1. IFN treatment increased editing in both WT and Adar2(-/-) cells but not in either Adar1(-/-) or Adar1(-/-p150) cells or Stat1(-/-) or Stat2(-/-) cells. Hyper-edited sites found in predicted duplex structures showed strand bias of editing for some RNAs. These results implicate ADAR1 p150 as the major A-to-I editor in mouse embryo fibroblasts, acting as a feedback suppressor of innate immune responses otherwise triggered by self-RNAs possessing regions of double-stranded character.	[George, Cyril X.; Samuel, Charles E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Samuel, Charles E.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Ramaswami, Gokul; Li, Jin Billy] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Stanford University	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.; Samuel, CE (corresponding author), Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			National Institutes of Health [AI-12520]; NIAID [AI-20611]; NIGMS [GM-202484]; Stanford Graduate Fellowship; Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020611, R37AI012520, R01AI012520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102484, T32GM007790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stanford Graduate Fellowship(Stanford University); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Research Grants AI-12520 and AI-20611 from the NIAID (to C. E. S.) and GM-202484 from the NIGMS (to J. B. L.), a Stanford Graduate Fellowship (to G. R.), and by the Ellison Medical Foundation (to J. B. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Barraud P, 2012, CURR TOP MICROBIOL, V353, P35, DOI 10.1007/82_2011_145; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Bevilacqua PC, 1998, BIOCHEMISTRY-US, V37, P6303, DOI 10.1021/bi980113j; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Dalet A, 2015, FEBS LETT, V589, P1539, DOI 10.1016/j.febslet.2015.05.006; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; Das S, 2006, J BIOL CHEM, V281, P3244, DOI 10.1074/jbc.M510612200; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Gelinas JF, 2011, J VIROL, V85, P8460, DOI 10.1128/JVI.00240-11; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; George CX, 2015, VIROLOGY, V485, P363, DOI 10.1016/j.virol.2015.08.001; George CX, 2011, J VIROL, V85, P8338, DOI 10.1128/JVI.02666-10; George CX, 2011, J INTERF CYTOK RES, V31, P99, DOI 10.1089/jir.2010.0097; Goodman RA, 2012, CURR TOP MICROBIOL, V353, P1, DOI 10.1007/82_2011_144; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hood JL, 2012, CURR TOP MICROBIOL, V353, P61, DOI 10.1007/82_2011_157; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; John L, 2014, VIROLOGY, V454, P299, DOI 10.1016/j.virol.2014.02.025; Kedersha N, 2009, PROG MOL BIOL TRANSL, V90, P155, DOI 10.1016/S1877-1173(09)90004-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kuhen KL, 1997, VIROLOGY, V227, P119, DOI 10.1006/viro.1996.8306; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li ZQ, 2012, J VIROL, V86, P3787, DOI 10.1128/JVI.06307-11; Li ZQ, 2010, VIROLOGY, V396, P316, DOI 10.1016/j.virol.2009.10.026; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Liu Y, 1996, J VIROL, V70, P1961, DOI 10.1128/JVI.70.3.1961-1968.1996; Liu Y, 1999, J BIOL CHEM, V274, P5070, DOI 10.1074/jbc.274.8.5070; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Lloyd RE, 2013, WIRES RNA, V4, P317, DOI 10.1002/wrna.1162; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mizrahi RA, 2012, NUCLEIC ACIDS RES, V40, P9825, DOI 10.1093/nar/gks752; Neeman Y, 2006, RNA, V12, P1802, DOI 10.1261/rna.165106; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; PATTERSON JB, 1995, VIROLOGY, V210, P508, DOI 10.1006/viro.1995.1370; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pfaller CK, 2015, J VIROL, V89, P7735, DOI 10.1128/JVI.01017-15; Pfaller CK, 2014, J VIROL, V88, P456, DOI 10.1128/JVI.02572-13; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; RendeFournier R, 1997, VIROLOGY, V238, P410, DOI 10.1006/viro.1997.8824; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1979, P NATL ACAD SCI USA, V76, P600, DOI 10.1073/pnas.76.2.600; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; TANAKA H, 1994, P NATL ACAD SCI USA, V91, P7995, DOI 10.1073/pnas.91.17.7995; THOMIS DC, 1995, J VIROL, V69, P5195, DOI 10.1128/JVI.69.8.5195-5198.1995; Toth AM, 2006, PROG NUCLEIC ACID RE, V81, P369, DOI 10.1016/S0079-6603(06)81010-X; Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146; Toth AM, 2009, J VIROL, V83, P961, DOI 10.1128/JVI.01669-08; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Vazquez C, 2015, J VIROL, V89, P6974, DOI 10.1128/JVI.01918-14; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang R, 2014, NAT METHODS, V11, P51, DOI 10.1038/nmeth.2736	83	81	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6158	6168		10.1074/jbc.M115.709014	http://dx.doi.org/10.1074/jbc.M115.709014			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26817845	hybrid, Green Published			2022-12-28	WOS:000372894200010
J	Kumar, V; Madina, BR; Gulati, S; Vashisht, AA; Kanyumbu, C; Pieters, B; Shakir, A; Wohlschlegel, JA; Read, LK; Mooers, BHM; Cruz-Reyes, J				Kumar, Vikas; Madina, Bhaskara R.; Gulati, Shelly; Vashisht, Ajay A.; Kanyumbu, Chiedza; Pieters, Brittany; Shakir, Afzal; Wohlschlegel, James A.; Read, Laurie K.; Mooers, Blaine H. M.; Cruz-Reyes, Jorge			REH2C Helicase and GRBC Subcomplexes May Base Pair through mRNA and Small Guide RNA in Kinetoplastid Editosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; RNA editing; RNA helicase; RNA processing; Trypanosoma brucei; DEAH; RHA proteins; editosome; REH2; RNP subcomplexes; small guide RNA	INDUCIBLE EXPRESSION SYSTEM; TRYPANOSOMA-BRUCEI; PROTEIN IDENTIFICATIONS; EDITING COMPLEX; BINDING; MITOCHONDRIA; ARCHITECTURE; RECOGNITION; SEARCH; SITES	Mitochondrial mRNAs in Trypanosoma brucei undergo extensive insertion and deletion of uridylates that are catalyzed by the RNA editing core complex (RECC) and directed by hundreds of small guide RNAs (gRNAs) that base pair with mRNA. RECC is largely RNA-free, and accessory mitochondrial RNA-binding complex 1 (MRB1) variants serve as scaffolds for the assembly of mRNA-gRNA hybrids and RECC. However, the molecular steps that create higher-order holoenzymes (editosomes) are unknown. Previously, we identified an RNA editing helicase 2-associated subcomplex (REH2C) and showed that REH2 binds RNA. Here we showed that REH2C is an mRNA-associated ribonucleoprotein (mRNP) subcomplex with editing substrates, intermediates, and products. We isolated this mRNP from mitochondria lacking gRNA-bound RNP (gRNP) subcomplexes and identified REH2-associated cofactors 1 and 2 ((H2)F1 and (H2)F2). (H2)F1 is an octa-zinc finger protein required for mRNP-gRNP docking, pre-mRNA and RECC loading, and RNP formation with a short synthetic RNA duplex. REH2 and other eukaryotic DEAH/RHA-type helicases share a conserved regulatory C-terminal domain cluster that includes an oligonucleotide-binding fold. Recombinant REH2 and (H2)F1 constructs associate in a purified complex in vitro. We propose a model of stepwise editosome assembly that entails controlled docking of mRNP and gRNP modules via specific base pairing between their respective mRNA and gRNA cargo and regulatory REH2 and (H2)F1 subunits of the novel mRNP that may control specificity checkpoints in the editing pathway.	[Kumar, Vikas; Madina, Bhaskara R.; Pieters, Brittany; Cruz-Reyes, Jorge] Texas A&M Univ, Dept Biochem & Biophys, 2128 TAMU, College Stn, TX 77843 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Read, Laurie K.] SUNY Buffalo, Sch Med, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Gulati, Shelly; Kanyumbu, Chiedza; Shakir, Afzal; Mooers, Blaine H. M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Madina, Bhaskara R.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Massachusetts System; University of Massachusetts Amherst	Cruz-Reyes, J (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 2128 TAMU, College Stn, TX 77843 USA.; Cruz-Reyes, J (corresponding author), Texas AgriLife Res, 2128 TAMU, College Stn, TX 77843 USA.	cruzrey@tamu.edu	Mooers, Blaine/S-4383-2017; Cruz-Reyes, Jorge/GQP-1338-2022; Shakir, Afzal/N-5648-2018	Mooers, Blaine/0000-0001-8181-8987; Shakir, Afzal/0000-0001-5093-3616; Cruz-Reyes, Jorge/0000-0003-0545-1508; Kumar, Vikas/0000-0002-2645-2983	National Science Foundation [NSF1122109]; NIAID/National Institutes of Health [R01 AI088011]; NIGMS/National Institutes of Health institutional development award [P20 GM103640]; NIGMS/National Institutes of Health [RO1 GM089778, RO1 AI061580]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061580, R01AI088011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103640, R01GM089778] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIAID/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS/National Institutes of Health institutional development award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant NSF1122109 ( to J. C. R.), NIAID/National Institutes of Health Grant R01 AI088011 ( to B. H. H. M.), a NIGMS/National Institutes of Health institutional development award under Grant P20 GM103640 ( Principal Investigator, Ann West), NIGMS/National Institutes of Health Grant RO1 GM089778 ( to J. A. W.), and NIAID/National Institutes of Health Grant RO1 AI061580 ( to L. K. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Ammerman ML, 2012, NUCLEIC ACIDS RES, V40, P5637, DOI 10.1093/nar/gks211; Ammerman ML, 2010, RNA, V16, P2239, DOI 10.1261/rna.2285510; Aphasizhev R, 2014, BIOCHIMIE, V100, P125, DOI 10.1016/j.biochi.2014.01.003; Aphasizheva I, 2016, TRENDS PARASITOL, V32, P144, DOI 10.1016/j.pt.2015.10.004; Aphasizheva I, 2014, MOL CELL BIOL, V34, P4329, DOI 10.1128/MCB.01075-14; Aphasizheva I, 2011, MOL CELL, V42, P106, DOI 10.1016/j.molcel.2011.02.021; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Burge RG, 2014, BIOCHEMISTRY-US, V53, P1495, DOI 10.1021/bi401675h; Carnes J, 2007, METHOD ENZYMOL, V424, P25, DOI 10.1016/S0076-6879(07)24002-9; Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16; Cruz-Reyes J, 2013, RNA EDITING: CURRENT RESEARCH AND FUTURE TRENDS, P65; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Golas MM, 2009, EMBO J, V28, P766, DOI 10.1038/emboj.2009.19; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hashimi H, 2013, TRENDS PARASITOL, V29, P91, DOI 10.1016/j.pt.2012.11.005; Hernandez A, 2010, J BIOL CHEM, V285, P1220, DOI 10.1074/jbc.M109.051862; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; Kaiser P, 2005, METHOD ENZYMOL, V399, P266, DOI 10.1016/S0076-6879(05)99018-6; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Kruse E, 2013, BBA-GENE REGUL MECH, V1829, P835, DOI 10.1016/j.bbagrm.2013.04.003; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; Li F, 2009, P NATL ACAD SCI USA, V106, P12306, DOI 10.1073/pnas.0901754106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma WK, 2013, J MOL BIOL, V425, P3824, DOI 10.1016/j.jmb.2013.05.016; Madina BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123441; Madina BR, 2014, RNA, V20, P1142, DOI 10.1261/rna.044495.114; Madina BR, 2011, RNA, V17, P1821, DOI 10.1261/rna.2815911; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Masliah G, 2013, CELL MOL LIFE SCI, V70, P1875, DOI 10.1007/s00018-012-1119-x; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Moller HM, 2005, J MOL BIOL, V351, P718, DOI 10.1016/j.jmb.2005.06.032; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Read LK, 2016, WIRES RNA, V7, P33, DOI 10.1002/wrna.1313; Robert-Paganin J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/931857; Rodrigues JPGLM, 2012, NUCLEIC ACIDS RES, V40, pW323, DOI 10.1093/nar/gks376; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; SABATINI R, 1995, J BIOL CHEM, V270, P7233, DOI 10.1074/jbc.270.13.7233; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yang ML, 1999, J BIOL CHEM, V274, P27399, DOI 10.1074/jbc.274.39.27399	52	11	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5753	5764		10.1074/jbc.M115.708164	http://dx.doi.org/10.1074/jbc.M115.708164			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26769962	hybrid, Green Published			2022-12-28	WOS:000372551800024
J	Dong, K; Yan, QS; Lu, M; Wan, LX; Hu, HY; Guo, JH; Boulpaep, E; Wang, WH; Giebisch, G; Hebert, SC; Wang, T				Dong, Ke; Yan, Qingshang; Lu, Ming; Wan, Laxiang; Hu, Haiyan; Guo, Junhua; Boulpaep, Emile; Wang, WenHui; Giebisch, Gerhard; Hebert, Steven C.; Wang, Tong			Romk1 Knockout Mice Do Not Produce Bartter Phenotype but Exhibit Impaired K Excretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						patch clamp; potassium channel; potassium transport; sodium transport; transgenic mice; Bartter syndrome; K channel; ROMK isoforms; sodium and potassium homeostasis	PROTEIN-TYROSINE KINASE; CORTICAL COLLECTING DUCT; THICK ASCENDING LIMB; POTASSIUM CHANNEL; MOUSE MODEL; RAT; ENDOCYTOSIS; EXPRESSION; CLONING; KIDNEY	Romk knock-out mice show a similar phenotype to Bartter syndrome of salt wasting and dehydration due to reduced Na-K-2Cl-cotransporter activity. At least three ROMK isoforms have been identified in the kidney; however, unique functions of any of the isoforms in nephron segments are still poorly understood. We have generated a mouse deficient only in Romk1 by selective deletion of the Romk1-specific first exon using an ES cell Cre-LoxP strategy and examined the renal phenotypes, ion transporter expression, ROMK channel activity, and localization under normal and high K intake. Unlike Romk(-/-) mice, there was no Bartter phenotype with reduced NKCC2 activity and increased NCC expression in Romk1(-/-) mice. The small conductance K channel (SK) activity showed no difference of channel properties or gating in the collecting tubule between Romk1(+/+) and Romk1(-/-) mice. High K intake increased SK channel number per patch and increased the ROMK channel intensity in the apical membrane of the collecting tubule in Romk1(+/+), but such regulation by high K intake was diminished with significant hyperkalemia in Romk1(-/-) mice. We conclude that 1) animal knockouts of ROMK1 do not produce Bartter phenotype. 2) There is no functional linking of ROMK1 and NKCC2 in the TAL. 3) ROMK1 is critical in response to high K intake-stimulated K+ secretion in the collecting tubule.	[Dong, Ke; Yan, Qingshang; Lu, Ming; Wan, Laxiang; Hu, Haiyan; Guo, Junhua; Boulpaep, Emile; Giebisch, Gerhard; Hebert, Steven C.; Wang, Tong] Yale Univ, Dept Cellular & Mol Physiol, Sch Med, New Haven, CT 06520 USA; [Wang, WenHui] New York Med Coll, Dept Pharmacol, New York, NY 10595 USA	Yale University; New York Medical College	Dong, K; Wang, T (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, Sch Med, New Haven, CT 06520 USA.; Wang, T (corresponding author), 333 Cedar St, New Haven, CT 06520 USA.	ke.dong@yale.edu; tong.wang@yale.edu			United States Public Health Service from the National Institutes of Health, NIDDK [RO1-DK54999, RO1-DK099284, DK 54983]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099284, R01DK054983, R01DK054999] Funding Source: NIH RePORTER	United States Public Health Service from the National Institutes of Health, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by United States Public Health Service Grants RO1-DK54999 (to T. W. and S. H.), RO1-DK099284 (to T. W. and L. P.), and DK 54983 (to W. W.) from the National Institutes of Health, NIDDK.	Bailey MA, 2006, KIDNEY INT, V70, P51, DOI 10.1038/sj.ki.5000388; Beesley AH, 1999, AM J PHYSIOL-CELL PH, V276, pC585, DOI 10.1152/ajpcell.1999.276.3.C585; BOIM MA, 1995, AM J PHYSIOL-RENAL, V268, pF1132, DOI 10.1152/ajprenal.1995.268.6.F1132; Cantone A, 2008, AM J PHYSIOL-RENAL, V294, pF1366, DOI 10.1152/ajprenal.00608.2007; Chu PY, 2003, AM J PHYSIOL-RENAL, V285, pF1179, DOI 10.1152/ajprenal.00150.2003; Du ZP, 2012, AM J PHYSIOL-RENAL, V303, pF1507, DOI 10.1152/ajprenal.00277.2012; Dvoryanchikov G, 2009, J COMP NEUROL, V517, P1, DOI 10.1002/cne.22152; Giebisch G, 2001, KIDNEY INT, V60, P436, DOI 10.1046/j.1523-1755.2001.060002436.x; GIEBISCH G, 1993, CARDIOVASC DRUG THER, V7, P11, DOI 10.1007/BF00877954; Gu RM, 2001, AM J PHYSIOL-CELL PH, V281, pC1188, DOI 10.1152/ajpcell.2001.281.4.C1188; Hebert SC, 2003, CURR OPIN NEPHROL HY, V12, P527, DOI 10.1097/00041552-200309000-00008; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Lin DH, 2005, PHYSIOLOGY, V20, P140, DOI 10.1152/physiol.00044.2004; Lin DH, 2004, AM J PHYSIOL-RENAL, V286, pF881, DOI 10.1152/ajprenal.00301.2003; LINAS SL, 1979, KIDNEY INT, V15, P601, DOI 10.1038/ki.1979.79; Lorenz JN, 2002, J BIOL CHEM, V277, P37871, DOI 10.1074/jbc.M205627200; Lu M, 2000, J GEN PHYSIOL, V116, P299, DOI 10.1085/jgp.116.2.299; Lu M, 2004, AM J PHYSIOL-RENAL, V286, pF490, DOI 10.1152/ajprenal.00305.2003; Lu M, 2002, J BIOL CHEM, V277, P37881, DOI 10.1074/jbc.M206644200; Macica CM, 1996, AM J PHYSIOL-RENAL, V271, pF588, DOI 10.1152/ajprenal.1996.271.3.F588; Macica CM, 1998, AM J PHYSIOL-RENAL, V274, pF175, DOI 10.1152/ajprenal.1998.274.1.F175; MALNIC G, 1964, AM J PHYSIOL, V206, P674, DOI 10.1152/ajplegacy.1964.206.4.674; Moral Z, 2001, J BIOL CHEM, V276, P7156, DOI 10.1074/jbc.M008671200; Rapedius M, 2006, EMBO REP, V7, P611, DOI 10.1038/sj.embor.7400678; Seldin D. W., 2000, KIDNEY PHYSL PATHOPH, p[2v, I]; SHUCK ME, 1994, J BIOL CHEM, V269, P24261; Sterling H, 2002, J BIOL CHEM, V277, P4317, DOI 10.1074/jbc.M109739200; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wang T, 2012, CLIN EXP NEPHROL, V16, P49, DOI 10.1007/s10157-011-0495-0; Wang WH, 2006, AM J PHYSIOL-RENAL, V290, pF14, DOI 10.1152/ajprenal.00093.2005; Wang WH, 2004, ANNU REV PHYSIOL, V66, P547, DOI 10.1146/annurev.physiol.66.032102.112025; Wang WH, 2000, AM J PHYSIOL-RENAL, V278, pF165, DOI 10.1152/ajprenal.2000.278.1.F165; Wei Y, 2001, AM J PHYSIOL-RENAL, V281, pF206, DOI 10.1152/ajprenal.2001.281.2.F206; Yan QS, 2008, AM J PHYSIOL-REG I, V295, pR997, DOI 10.1152/ajpregu.00051.2007; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001	35	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5259	5269		10.1074/jbc.M115.707877	http://dx.doi.org/10.1074/jbc.M115.707877			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26728465	Green Published, hybrid			2022-12-28	WOS:000371640600036
J	Lang, I; Fullsack, S; Wyzgol, A; Fick, A; Trebing, J; Arana, JAC; Schafer, V; Weisenberger, D; Wajant, H				Lang, Isabell; Fuellsack, Simone; Wyzgol, Agnes; Fick, Andrea; Trebing, Johannes; Arana, Jose Antonio Carmona; Schaefer, Viktoria; Weisenberger, Daniela; Wajant, Harald			Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; fusion protein; ligand-binding protein; NF-B (NF-KB); protein complex; receptor regulation; TNF receptor-associated factor; tumor necrosis factor (TNF)	TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; HIGH-AFFINITY RECEPTOR; LT-BETA-R; DECOY RECEPTOR; SURFACE IMMOBILIZATION; LIGAND-BINDING; CANCER-THERAPY; WEAK INDUCER; CD40 LIGAND	Ligands of the tumor necrosis factor superfamily (TNFSF) interact with members of the TNF receptor superfamily (TNFRSF). TNFSF ligand-TNFRSF receptor interactions have been intensively evaluated by many groups. The affinities of TNFSF ligand-TNFRSF receptor interactions are highly dependent on the oligomerization state of the receptor, and cellular factors (e.g. actin cytoskeleton and lipid rafts) influence the assembly of ligand-receptor complexes, too. Binding studies on TNFSF ligand-TNFRSF receptor interactions were typically performed using cell-free assays with recombinant fusion proteins that contain varying numbers of TNFRSF ectodomains. It is therefore not surprising that affinities determined for an individual TNFSF ligand-TNFRSF interaction differ sometimes by several orders of magnitude and often do not reflect the ligand activity observed in cellular assays. To overcome the intrinsic limitations of cell-free binding studies and usage of recombinant receptor domains, we performed comprehensive binding studies with Gaussia princeps luciferase TNFSF ligand fusion proteins for cell-bound TNFRSF members on intact cells at 37 degrees C. The affinities of the TNFSF ligand G. princeps luciferase-fusion proteins ranged between 0.01 and 19 nm and offer the currently most comprehensive and best suited panel of affinities for in silico studies of ligand-receptor systems of the TNF family.	[Lang, Isabell; Fuellsack, Simone; Wyzgol, Agnes; Fick, Andrea; Trebing, Johannes; Arana, Jose Antonio Carmona; Schaefer, Viktoria; Weisenberger, Daniela; Wajant, Harald] Univ Hosp Wurzburg, Div Mol Internal Med, Dept Internal Med 2, Rontgenring 11, D-97070 Wurzburg, Germany	University of Wurzburg	Wajant, H (corresponding author), Univ Hosp Wurzburg, Div Mol Internal Med, Dept Internal Med 2, Rontgenring 11, D-97070 Wurzburg, Germany.	harald.wajant@mail.uni-wuerzburg.de	Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949; Lang, Isabell/0000-0002-6369-4973	Deutsche Forschungsgemeinschaft [Wa 1025/19-2, Wa 1025/24-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Wa 1025/19-2 and Wa 1025/24-1. The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; ALDERSON MR, 1994, EUR J IMMUNOL, V24, P2219, DOI 10.1002/eji.1830240943; AlShamkhani A, 1997, J BIOL CHEM, V272, P5275, DOI 10.1074/jbc.272.8.5275; ARMITAGE RJ, 1992, EUR J IMMUNOL, V22, P2071, DOI 10.1002/eji.1830220817; Berg D, 2007, CELL DEATH DIFFER, V14, P2021, DOI 10.1038/sj.cdd.4402213; Bittner S, 2016, FEBS J, V283, P323, DOI 10.1111/febs.13576; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Brown SAN, 2006, BIOCHEM J, V397, P297, DOI 10.1042/BJ20051362; Cao J, 2011, PROTEIN J, V30, P281, DOI 10.1007/s10930-011-9330-4; Chattopadhyay K, 2008, P NATL ACAD SCI USA, V105, P635, DOI 10.1073/pnas.0710529105; Chattopadhyay K, 2007, P NATL ACAD SCI USA, V104, P19452, DOI 10.1073/pnas.0709264104; CORCORAN AE, 1994, EUR J BIOCHEM, V223, P831, DOI 10.1111/j.1432-1033.1994.tb19059.x; Day ES, 2005, BIOCHEMISTRY-US, V44, P1919, DOI 10.1021/bi048227k; Eldredge J, 2006, BIOCHEMISTRY-US, V45, P10117, DOI 10.1021/bi060210+; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Fick A, 2012, J BIOL CHEM, V287, P484, DOI 10.1074/jbc.M111.287656; GRAY PW, 1990, P NATL ACAD SCI USA, V87, P7380, DOI 10.1073/pnas.87.19.7380; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Gupta S, 2015, J VIROL, V89, P4158, DOI 10.1128/JVI.02904-14; Hargreaves PG, 2002, EUR J IMMUNOL, V32, P163, DOI 10.1002/1521-4141(200201)32:1<163::AID-IMMU163>3.0.CO;2-T; Harrop JA, 1998, J BIOL CHEM, V273, P27548, DOI 10.1074/jbc.273.42.27548; Haswell LE, 2001, EUR J IMMUNOL, V31, P3094, DOI 10.1002/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO;2-F; Hendriks J, 2005, CELL DEATH DIFFER, V12, P637, DOI 10.1038/sj.cdd.4401647; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Kanagavelu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090100; Kanagavelu SK, 2012, VACCINE, V30, P691, DOI 10.1016/j.vaccine.2011.11.088; Kanakaraj P, 2001, CYTOKINE, V13, P25, DOI 10.1006/cyto.2000.0793; Krippner-Heidenreich A, 2008, J IMMUNOL, V180, P8176, DOI 10.4049/jimmunol.180.12.8176; Lang I, 2012, J BIOL CHEM, V287, P24026, DOI 10.1074/jbc.M111.328211; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Lin WW, 2011, BIOCHEM PHARMACOL, V81, P838, DOI 10.1016/j.bcp.2011.01.011; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; MARSTERS SA, 1992, J BIOL CHEM, V267, P5747; Morishige T, 2010, BIOMATERIALS, V31, P3357, DOI 10.1016/j.biomaterials.2010.01.022; Muller N, 2008, FEBS J, V275, P2296, DOI 10.1111/j.1742-4658.2008.06382.x; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Patel DR, 2004, J BIOL CHEM, V279, P16727, DOI 10.1074/jbc.M312316200; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Rabu C, 2005, J BIOL CHEM, V280, P41472, DOI 10.1074/jbc.M506881200; Rauert H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.78; Rauert H, 2010, J BIOL CHEM, V285, P7394, DOI 10.1074/jbc.M109.037341; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Rozanov DV, 2009, MOL CANCER THER, V8, P1515, DOI 10.1158/1535-7163.MCT-09-0202; Schneeweis LA, 2005, J BIOL CHEM, V280, P41155, DOI 10.1074/jbc.M506366200; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; Stone GW, 2006, J VIROL, V80, P1762, DOI 10.1128/JVI.80.4.1762-1772.2006; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Sudhamsu J, 2013, P NATL ACAD SCI USA, V110, P19896, DOI 10.1073/pnas.1310838110; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; Trebing J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.555; Truneh A, 2000, J BIOL CHEM, V275, P23319, DOI 10.1074/jbc.M910438199; Vitovski S, 2007, J BIOL CHEM, V282, P31601, DOI 10.1074/jbc.M706078200; Wajant H, 2015, CELL DEATH DIFFER, V22, P1727, DOI 10.1038/cdd.2015.109; Wajant H, 2003, ESSAYS BIOCHEM, V39, P53, DOI 10.1042/bse0390053; Wajant H, 2001, ONCOGENE, V20, P4101, DOI 10.1038/sj.onc.1204558; Wajant H, 2013, CANCER LETT, V332, P163, DOI 10.1016/j.canlet.2010.12.019; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Willard D, 2000, PROTEIN EXPRES PURIF, V20, P48, DOI 10.1006/prep.2000.1278; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004; ZHOU Z, 1995, IMMUNOL LETT, V45, P67, DOI 10.1016/0165-2478(94)00227-I; Zhou ZC, 2008, P NATL ACAD SCI USA, V105, P5465, DOI 10.1073/pnas.0711350105	70	41	45	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5022	5037		10.1074/jbc.M115.683946	http://dx.doi.org/10.1074/jbc.M115.683946			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26721880	hybrid, Green Published			2022-12-28	WOS:000371640600017
J	Niture, SK; Jain, AK; Shelton, PM; Jaiswal, AK				Niture, Suryakant K.; Jain, Abhinav K.; Shelton, Phillip M.; Jaiswal, Anil K.			Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to swtich off Nrf2-mediated antioxidant activation of cytoprotective gene expression (Expression of Concern of Vol 286, Pg 28821, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Niture SK, 2011, J BIOL CHEM, V286, P28821, DOI 10.1074/jbc.M111.255042	1	0	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	191	3					1199	1199		10.1074/jbc.A111.255042	http://dx.doi.org/10.1074/jbc.A111.255042			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	VC7QO	26773125	hybrid, Green Published			2022-12-28	WOS:000434591900003
J	Niture, SK; Jaiswal, AK				Niture, Suryakant K.; Jaiswal, Anil K.			Prothymosin-alpha mediates nuclear import of the INrf2/Cul3 center dot Rbx1 complex to degrade nuclear Nrf2 (Expression of Concern of Vol 284, Pg 13856, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200	1	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	191	3					1199	1199		10.1074/jbc.A109.808084	http://dx.doi.org/10.1074/jbc.A109.808084			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	VC7QO	26773126	Green Published, hybrid			2022-12-28	WOS:000434591900004
J	Huang, Y; Wang, ZJ; Liu, YN; Xiong, HB; Zhao, YY; Wu, L; Yuan, C; Wang, LF; Hou, YX; Yu, G; Huang, ZR; Xu, CQ; Chen, QY; Wang, QK				Huang, Yuan; Wang, Zhijie; Liu, Yinan; Xiong, Hongbo; Zhao, Yuanyuan; Wu, Ling; Yuan, Chao; Wang, Longfei; Hou, Yuxi; Yu, Gang; Huang, Zhengrong; Xu, Chengqi; Chen, Qiuyun; Wang, Qing K.			B-Crystallin Interacts with Na(v)1.5 and Regulates Ubiquitination and Internalization of Cell Surface Na(v)1.5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiovascular disease; electrophysiology; patch clamp; sodium channel; ubiquitylation (ubiquitination); B-crystallin; Nav1; 5; SCN5A	CARDIAC SODIUM-CHANNEL; LONG-QT SYNDROME; IDIOPATHIC VENTRICULAR-FIBRILLATION; ALPHA-A-CRYSTALLIN; MOLECULAR-MECHANISM; ANGIOGENIC FACTOR; MUTATION N1325S; SCN5A MUTATION; GENE SCN5A; PATHOPHYSIOLOGY	Na(v)1.5, the pore-forming subunit of the cardiac voltage-gated Na+ channel complex, is required for the initiation and propagation of the cardiac action potential. Mutations in Na(v)1.5 cause cardiac arrhythmias and sudden death. The cardiac Na+ channel functions as a protein complex; however, its complete components remain to be fully elucidated. A yeast two-hybrid screen identified a new candidate Na(v)1.5-interacting protein, B-crystallin. GST pull-down, co-immunoprecipitation, and immunostaining analyses validated the interaction between Na(v)1.5 and B-crystallin. Whole-cell patch clamping showed that overexpression of B-crystallin significantly increased peak sodium current (I-Na) density, and the underlying molecular mechanism is the increased cell surface expression level of Na(v)1.5 via reduced internalization of cell surface Na(v)1.5 and ubiquitination of Na(v)1.5. Knock-out of B-crystallin expression significantly decreased the cell surface expression level of Na(v)1.5. Co-immunoprecipitation analysis showed that B-crystallin interacted with Nedd4-2; however, a catalytically inactive Nedd4-2-C801S mutant impaired the interaction and abolished the up-regulation of I-Na by B-crystallin. Na(v)1.5 mutation V1980A at the interaction site for Nedd4-2 eliminated the effect of B-crystallin on reduction of Na(v)1.5 ubiquitination and increases of I-Na density. Two disease-causing mutations in B-crystallin, R109H and R151X (nonsense mutation), eliminated the effect of B-crystallin on I-Na. This study identifies B-crystallin as a new binding partner for Na(v)1.5. B-Crystallin interacts with Na(v)1.5 and increases I-Na by modulating the expression level and internalization of cell surface Na(v)1.5 and ubiquitination of Na(v)1.5, which requires the protein-protein interactions between B-crystallin and Na(v)1.5 and between B-crystallin and functionally active Nedd4-2.	[Huang, Yuan; Wang, Zhijie; Liu, Yinan; Xiong, Hongbo; Zhao, Yuanyuan; Yuan, Chao; Wang, Longfei; Yu, Gang; Xu, Chengqi; Wang, Qing K.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, CardioX Ctr, Key Lab Mol Biophys,Minist Educ, 1037 Luoyu Rd, Wuhan 430074, Peoples R China; [Huang, Yuan; Wang, Zhijie; Liu, Yinan; Xiong, Hongbo; Zhao, Yuanyuan; Yuan, Chao; Wang, Longfei; Yu, Gang; Xu, Chengqi; Wang, Qing K.] Huazhong Univ Sci & Technol, Ctr Human Genome Res, 1037 Luoyu Rd, Wuhan 430074, Peoples R China; [Wu, Ling; Chen, Qiuyun; Wang, Qing K.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Ctr Cardiovasc Genet, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Wu, Ling] Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; [Wu, Ling] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Hou, Yuxi; Huang, Zhengrong] Xiamen Univ, Affiliated Hosp 1, Dept Cardiol, 55 Zhenhai Rd, Xiamen 361003, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Xiamen University	Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, 1037 Luoyu Rd, Wuhan 430074, Peoples R China.; Chen, QY (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Ctr Cardiovasc Genet, 9500 Euclid Ave, Cleveland, OH 44195 USA.	chenq3@ccf.org; qkwang@hust.edu.cn	Zhao, Yuanyuan/AAY-6670-2021	Zhao, Yuanyuan/0000-0003-0217-3290; Xu, Chengqi/0000-0002-4269-6830; yuan, huang/0000-0001-6254-5813; Wang, Qing/0000-0002-5639-8519; Chao, Yuan/0000-0003-1315-0166; Wang, Zhijie/0000-0003-4619-0543	Chinese National Basic Research Program (973 Program) [2013CB531101]; China National Natural Science Foundation [31430047, 91439129, NSFC-J1103514]; 973 Program [2012CB517801]; NHLBI, National Institutes of Health [R01 HL121358, R01 HL126729]; Hubei Province's Outstanding Medical Academic Leader Program; Hubei Province Natural Science [2014CFA074]; Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education; and "Innovative Development of New Drugs" Key Scientific Project Grant [2011ZX09307-001-09]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126729, R01HL121358] Funding Source: NIH RePORTER	Chinese National Basic Research Program (973 Program)(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Hubei Province's Outstanding Medical Academic Leader Program; Hubei Province Natural Science; Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education; and "Innovative Development of New Drugs" Key Scientific Project Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Chinese National Basic Research Program (973 Program 2013CB531101); China National Natural Science Foundation Key Program Grant 31430047; 973 Program 2012CB517801; NHLBI, National Institutes of Health, Grants R01 HL121358 and R01 HL126729; Hubei Province's Outstanding Medical Academic Leader Program; Hubei Province Natural Science Key Program Grant 2014CFA074; China National Natural Science Foundation Grant 91439129, NSFC-J1103514; the Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education; and "Innovative Development of New Drugs" Key Scientific Project Grant 2011ZX09307-001-09. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abriel H, 2005, TRENDS CARDIOVAS MED, V15, P35, DOI 10.1016/j.tcm.2005.01.001; Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Chakrabarti S, 2013, CIRC-ARRHYTHMIA ELEC, V6, P392, DOI 10.1161/CIRCEP.111.000206; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Detta N, 2015, BBA-PROTEINS PROTEOM, V1854, P1502, DOI 10.1016/j.bbapap.2015.07.009; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Dumaine R, 1996, CIRC RES, V78, P916, DOI 10.1161/01.RES.78.5.916; Fan C, 2009, J BIOL CHEM, V284, P25653, DOI 10.1074/jbc.M109.041368; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Kase S, 2010, BLOOD, V115, P3398, DOI 10.1182/blood-2009-01-197095; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Li H, 2008, BBA-MOL BASIS DIS, V1782, P303, DOI 10.1016/j.bbadis.2008.01.011; Pilotto A, 2006, BIOCHEM BIOPH RES CO, V346, P1115, DOI 10.1016/j.bbrc.2006.05.203; Reilich P, 2010, NEUROMUSCULAR DISORD, V20, P255, DOI 10.1016/j.nmd.2010.01.012; Tian XL, 2004, CARDIOVASC RES, V61, P256, DOI 10.1016/j.cardiores.2003.11.007; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Veerman CC, 2015, GENE, V573, P177, DOI 10.1016/j.gene.2015.08.062; Wan XP, 2000, J MOL CELL CARDIOL, V32, P1873, DOI 10.1006/jmcc.2000.1223; Wan XP, 2001, AM J PHYSIOL-HEART C, V280, pH354, DOI 10.1152/ajpheart.2001.280.1.H354; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wang Q, 1997, CURR OPIN CARDIOL, V12, P310, DOI 10.1097/00001573-199705000-00013; Wang Q, 1998, ANN MED, V30, P58, DOI 10.3109/07853899808999385; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Wu L, 2008, J BIOL CHEM, V283, P6968, DOI 10.1074/jbc.M709721200; Xu Y, 2014, BBA-MOL BASIS DIS, V1842, P712, DOI 10.1016/j.bbadis.2014.01.007; Yong SRL, 2007, BIOCHEM BIOPH RES CO, V352, P378, DOI 10.1016/j.bbrc.2006.11.019; Zhang T, 2007, BIOCHEM BIOPH RES CO, V355, P444, DOI 10.1016/j.bbrc.2007.01.170; Zhang T, 2011, INT J CARDIOL, V147, P239, DOI 10.1016/j.ijcard.2009.08.047; Zhang XQ, 2008, CELL, V135, P1017, DOI 10.1016/j.cell.2008.10.022; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028; Zhou BS, 2013, FEBS LETT, V587, P724, DOI 10.1016/j.febslet.2013.01.053	33	35	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11030	11041		10.1074/jbc.M115.695080	http://dx.doi.org/10.1074/jbc.M115.695080			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	26961874	hybrid, Green Published			2022-12-28	WOS:000377042100007
J	Walklate, J; Vera, C; Bloemink, MJ; Geeves, MA; Leinwand, L				Walklate, Jonathan; Vera, Carlos; Bloemink, Marieke J.; Geeves, Michael A.; Leinwand, Leslie			The Most Prevalent Freeman-Sheldon Syndrome Mutations in the Embryonic Myosin Motor Share Functional Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN EXPRESSION; ADULT SKELETAL-MUSCLE; SWISS-MODEL; STRUCTURAL MECHANISM; ACTIN; PROTEIN; SLOW; CARDIOMYOPATHY; DIVERSITY; MYOPATHY	The embryonic myosin isoform is expressed during fetal development and rapidly down-regulated after birth. Freeman-Sheldon syndrome (FSS) is a disease associated with missense mutations in the motor domain of this myosin. It is the most severe form of distal arthrogryposis, leading to overcontraction of the hands, feet, and orofacial muscles and other joints of the body. Availability of human embryonic muscle tissue has been a limiting factor in investigating the properties of this isoform and its mutations. Using a recombinant expression system, we have studied homogeneous samples of human motors for the WT and three of the most common FSS mutants: R672H, R672C, and T178I. Our data suggest that the WT embryonic myosin motor is similar in contractile speed to the slow type I/beta cardiac based on the rate constant for ADP release and ADP affinity for actinmyosin. All three FSS mutations show dramatic changes in kinetic properties, most notably the slowing of the apparent ATP hydrolysis step (reduced 5-9-fold), leading to a longer lived detached state and a slowed V-max of the ATPase (2-35-fold), indicating a slower cycling time. These mutations therefore seriously disrupt myosin function.	[Walklate, Jonathan; Bloemink, Marieke J.; Geeves, Michael A.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Vera, Carlos; Leinwand, Leslie] Univ Colorado, Dept Mol & Dev Biol, Boulder, CO 80309 USA; [Bloemink, Marieke J.] Canterbury Christ Church Univ, Sch Human & Life Sci, Biomol Res Grp, Canterbury CT1 1QU, Kent, England	University of Kent; University of Colorado System; University of Colorado Boulder; Canterbury Christ Church University	Geeves, MA (corresponding author), Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.; Leinwand, L (corresponding author), Univ Colorado, Dept Mol & Dev Biol, Boulder, CO 80309 USA.	M.A.Geeves@kent.ac.uk; leslie.leinwand@Colorado.edu	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Bloemink, Marieke Johanna/0000-0001-9441-2783; Walklate, Jonathan/0000-0002-2532-8446; Vera, Carlos/0000-0003-1207-4878	National Institutes of Health [GM29090]; Wellcome Trust [085309]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM29090 (to L. L.) and Wellcome Trust Grant 085309 (to M. A. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAGSHAW CR, 1973, BIOCHEM J, V133, P323, DOI 10.1042/bj1330323; BARBET JP, 1991, MECH DEVELOP, V35, P3, DOI 10.1016/0925-4773(91)90036-6; Beck AE, 2014, AM J MED GENET A, V164, P2808, DOI 10.1002/ajmg.a.36762; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; Bloemink M, 2014, J BIOL CHEM, V289, P5158, DOI 10.1074/jbc.M113.511204; Bloemink MJ, 2013, J BIOL CHEM, V288, P27469, DOI 10.1074/jbc.M113.488130; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; CHO M, 1993, J CELL BIOL, V121, P795, DOI 10.1083/jcb.121.4.795; Clarke NF, 2013, NEUROMUSCULAR DISORD, V23, P432, DOI 10.1016/j.nmd.2013.02.009; COOKE R, 1985, BIOPHYS J, V48, P789, DOI 10.1016/S0006-3495(85)83837-6; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P4239, DOI 10.1007/s00018-012-1111-5; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; DRAEGER A, 1987, J NEUROL SCI, V81, P19, DOI 10.1016/0022-510X(87)90181-X; ECOBPRINCE M, 1989, J NEUROL SCI, V91, P71, DOI 10.1016/0022-510X(89)90076-2; FIDZIANSKA A, 1980, J NEUROPATH EXP NEUR, V39, P476, DOI 10.1097/00005072-198007000-00006; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hamady M, 2010, INT J CARDIOL, V144, P124, DOI 10.1016/j.ijcard.2008.12.199; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; Lamont PJ, 2014, HUM MUTAT, V35, P868, DOI 10.1002/humu.22553; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; Mijailovich SM, 2015, BIOPHYS J, V108, p594A, DOI 10.1016/j.bpj.2014.11.3234; Mijailovich SM, 2015, BIOPHYS J, V108, p337A, DOI 10.1016/j.bpj.2014.11.1843; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Nag S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500511; Oldfors A, 2007, NEUROMUSCULAR DISORD, V17, P355, DOI 10.1016/j.nmd.2007.02.008; ONTELL MP, 1993, DEV DYNAM, V198, P203, DOI 10.1002/aja.1001980306; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Preller M, 2013, CYTOSKELETON, V70, P651, DOI 10.1002/cm.21125; Racca AW, 2015, HUM MOL GENET, V24, P3348, DOI 10.1093/hmg/ddv084; Racca AW, 2013, J PHYSIOL-LONDON, V591, P3049, DOI 10.1113/jphysiol.2013.252650; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Tajsharghi H, 2008, ARCH NEUROL-CHICAGO, V65, P1083, DOI 10.1001/archneur.65.8.1083; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; Wheeler SE, 2014, J PHYS CHEM A, V118, P6133, DOI 10.1021/jp504415p; Yuceyar N, 2015, NEUROMUSCULAR DISORD, V25, P340, DOI 10.1016/j.nmd.2015.01.007	48	27	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10318	10331		10.1074/jbc.M115.707489	http://dx.doi.org/10.1074/jbc.M115.707489			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26945064	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000375602800038
J	Kuo, TY; Kim-Muller, JY; McGraw, TE; Accili, D				Kuo, Taiyi; Kim-Muller, Ja Young; McGraw, Timothy E.; Accili, Domenico			Altered Plasma Profile of Antioxidant Proteins as an Early Correlate of Pancreatic beta Cell Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN LEVELS; INSULIN-RESISTANCE; PROTEOMIC ANALYSIS; DJ-1; SECRETION; GLUCOSE; BLOOD; MICE; QUANTITATION; EXPRESSION	Insulin resistance and beta cell dysfunction contribute to the pathogenesis of type 2 diabetes. Unlike insulin resistance, beta cell dysfunction remains difficult to predict and monitor, because of the inaccessibility of the endocrine pancreas, the integrated relationship with insulin sensitivity, and the paracrine effects of incretins. The goal of our study was to survey the plasma response to a metabolic challenge in order to identify factors predictive of beta cell dysfunction. To this end, we combined (i) the power of unbiased iTRAQ (isobaric tag for relative and absolute quantification) mass spectrometry with (ii) direct sampling of the portal vein following an intravenous glucose/arginine challenge (IVGATT) in (iii) mice with a genetic beta cell defect. By so doing, we excluded the effects of peripheral insulin sensitivity as well as those of incretins on beta cells, and focused on the first phase of insulin secretion to capture the early pathophysiology of beta cell dysfunction. We compared plasma protein profiles with ex vivo islet secretome and transcriptome analyses. We detected changes to 418 plasma proteins in vivo, and detected changes to 262 proteins ex vivo. The impairment of insulin secretion was associated with greater overall changes in the plasma response to IVGATT, possibly reflecting metabolic instability. Reduced levels of proteins regulating redox state and neuronal stress markers, as well as increased levels of coagulation factors, antedated the loss of insulin secretion in diabetic mice. These results suggest that a reduced complement of antioxidants in response to a mixed secretagogue challenge is an early correlate of future beta cell failure.	[Kuo, Taiyi; Kim-Muller, Ja Young; Accili, Domenico] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Kuo, Taiyi; Kim-Muller, Ja Young; Accili, Domenico] Columbia Univ, Coll Phys & Surg, Berrie Diabet Ctr, New York, NY 10032 USA; [McGraw, Timothy E.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Columbia University; Columbia University; Cornell University	Accili, D (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA.; Accili, D (corresponding author), Columbia Univ, Coll Phys & Surg, Berrie Diabet Ctr, New York, NY 10032 USA.	da230@columbia.edu		Kuo, Taiyi/0000-0001-6167-0284	National Institutes of Health [DK63608]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, P30DK063608, P30DK020541, T32DK007328, R01DK064819] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Sheng Zhang (Cornell University) for iTRAQ and MS analysis, Thomas Kolar and Ana Flete-Castro (Columbia University) for excellent technical support, and members of the Accili laboratory for discussions. The Columbia University Diabetes Research Center was supported by National Institutes of Health Grant DK63608.	Abraham TM, 2015, DIABETES CARE, V38, P482, DOI 10.2337/dc14-1432; Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Arntfield ME, 2011, BIOESSAYS, V33, P582, DOI 10.1002/bies.201100015; Atalay M, 1997, ACTA PHYSIOL SCAND, V161, P195, DOI 10.1046/j.1365-201X.1997.00200.x; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Eberhard D, 2013, BIOESSAYS, V35, P584, DOI 10.1002/bies.201300035; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Geng XH, 2011, AM J PHYSIOL-ENDOC M, V300, pE276, DOI 10.1152/ajpendo.00262.2010; Gerich JE, 2002, DIABETES, V51, pS117, DOI 10.2337/diabetes.51.2007.S117; Goth L, 2001, DIABETES CARE, V24, P1839, DOI 10.2337/diacare.24.10.1839; Grimmond SM, 2003, GENOME RES, V13, P1350, DOI 10.1101/gr.983703; Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jain D, 2012, J MOL CELL BIOL, V4, P221, DOI 10.1093/jmcb/mjs025; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kikumoto Y, 2010, BBA-MOL BASIS DIS, V1802, P240, DOI 10.1016/j.bbadis.2009.10.009; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kim-Muller JY, 2014, CELL METAB, V20, P593, DOI 10.1016/j.cmet.2014.08.012; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Levy J, 1998, DIABETIC MED, V15, P290, DOI 10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M; Lin XM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00954; Lo JC, 2014, CELL, V158, P41, DOI 10.1016/j.cell.2014.06.005; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Matsubara J, 2011, CANCER EPIDEM BIOMAR, V20, P160, DOI 10.1158/1055-9965.EPI-10-0397; Mukherjee P, 2013, BBA-PROTEINS PROTEOM, V1834, P2226, DOI 10.1016/j.bbapap.2013.01.022; Obermuller S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008936; Pomero F, 2015, ACTA DIABETOL, V52, P1007, DOI 10.1007/s00592-015-0746-8; Rodriguez-Araujo G, 2015, SCI REP-UK, V5, DOI 10.1038/srep12081; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Shi M, 2010, NEUROSCI LETT, V480, P78, DOI 10.1016/j.neulet.2010.06.009; Steneberg P, 2013, DIABETES, V62, P2004, DOI 10.2337/db12-1045; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stojanovic I, 2012, IMMUNOL RES, V52, P81, DOI 10.1007/s12026-012-8281-y; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Talchai SC, 2015, DIABETES, V64, P2868, DOI 10.2337/db14-1696; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; TRUS M, 1980, DIABETES, V29, P1, DOI 10.2337/diabetes.29.1.1; Tsuboi Y, 2008, FEBS LETT, V582, P2643, DOI 10.1016/j.febslet.2008.06.043; Tsuchiya K, 2013, CIRC RES, V112, P992, DOI 10.1161/CIRCRESAHA.112.300749; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; VANDEWINKEL M, 1983, BIOCHEM BIOPH RES CO, V114, P835, DOI 10.1016/0006-291X(83)90857-4; Vujicic M, 2014, CYTOKINE, V69, P39, DOI 10.1016/j.cyto.2014.05.013; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Wang XD, 2011, ANTIOXID REDOX SIGN, V14, P391, DOI 10.1089/ars.2010.3302; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524; Yang Y, 2011, J PROTEOME RES, V10, P4647, DOI 10.1021/pr200455s; Zemany L, 2015, DIABETES, V64, P1603, DOI 10.2337/db14-0970	56	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9648	9656		10.1074/jbc.M115.702183	http://dx.doi.org/10.1074/jbc.M115.702183			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26917725	Green Published, hybrid			2022-12-28	WOS:000375602300023
J	Boehm, EM; Powers, KT; Kondratick, CM; Spies, M; Houtman, JCD; Washington, MT				Boehm, Elizabeth M.; Powers, Kyle T.; Kondratick, Christine M.; Spies, Maria; Houtman, Jon C. D.; Washington, M. Todd			The Proliferating Cell Nuclear Antigen (PCNA)-interacting Protein (PIP) Motif of DNA Polymerase Mediates Its Interaction with the C-terminal Domain of Rev1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; DNA repair; DNA replication; mutagenesis; translesion synthesis	YEAST REV1; SWISS-MODEL; Y-FAMILY; FUNCTIONAL INTERACTIONS; STRUCTURAL BASIS; REPAIR PROTEINS; MUTL-ALPHA; REPLICATION; BINDING; PCNA	Y-family DNA polymerases, such as polymerase , polymerase , and polymerase , catalyze the bypass of DNA damage during translesion synthesis. These enzymes are recruited to sites of DNA damage by interacting with the essential replication accessory protein proliferating cell nuclear antigen (PCNA) and the scaffold protein Rev1. In most Y-family polymerases, these interactions are mediated by one or more conserved PCNA-interacting protein (PIP) motifs that bind in a hydrophobic pocket on the front side of PCNA as well as by conserved Rev1-interacting region (RIR) motifs that bind in a hydrophobic pocket on the C-terminal domain of Rev1. Yeast polymerase , a prototypical translesion synthesis polymerase, binds both PCNA and Rev1. It possesses a single PIP motif but not an RIR motif. Here we show that the PIP motif of yeast polymerase mediates its interactions both with PCNA and with Rev1. Moreover, the PIP motif of polymerase binds in the hydrophobic pocket on the Rev1 C-terminal domain. We also show that the RIR motif of human polymerase and the PIP motif of yeast Msh6 bind both PCNA and Rev1. Overall, these findings demonstrate that PIP motifs and RIR motifs have overlapping specificities and can interact with both PCNA and Rev1 in structurally similar ways. These findings also suggest that PIP motifs are a more versatile protein interaction motif than previously believed.	[Boehm, Elizabeth M.; Powers, Kyle T.; Kondratick, Christine M.; Spies, Maria; Washington, M. Todd] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Houtman, Jon C. D.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Washington, MT (corresponding author), Univ Iowa, Dept Biochem, 4-403 Bowen Sci Bldg, Iowa City, IA 52242 USA.	todd-washington@uiowa.edu		Spies, Maria/0000-0002-7375-8037; Houtman, Jon/0000-0002-5307-9854; Washington, Todd/0000-0001-8680-2992; Powers, Kyle/0000-0003-3240-6534	National Institutes of Health [R01 GM108027, R01 GM081433, T32 GM067795]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108617, R01GM081433, R01GM108027, T32GM067795, R01GM101167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or part by National Institutes of Health Grants R01 GM108027, R01 GM081433, and T32 GM067795. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Acharya N, 2007, MOL CELL BIOL, V27, P8401, DOI 10.1128/MCB.01478-07; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baldeck N, 2015, NUCLEIC ACIDS RES, V43, P2116, DOI 10.1093/nar/gkv076; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Biesiadecki BJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/421701; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Dherin C, 2009, MOL CELL BIOL, V29, P907, DOI 10.1128/MCB.00945-08; Dieckman LM, 2013, BIOCHEMISTRY-US, V52, P5611, DOI 10.1021/bi400378e; Dieckman Lynne M, 2012, Subcell Biochem, V62, P281, DOI 10.1007/978-94-007-4572-8_15; Freudenthal BD, 2008, BIOCHEMISTRY-US, V47, P13354, DOI 10.1021/bi8017762; Gabel SA, 2013, DNA REPAIR, V12, P1105, DOI 10.1016/j.dnarep.2013.08.015; Gellon L, 2002, J BIOL CHEM, V277, P29963, DOI 10.1074/jbc.M202963200; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Haracska L, 2002, MOL CELL BIOL, V22, P784, DOI 10.1128/MCB.22.3.784-791.2002; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Honda M, 2009, MOL CELL, V35, P694, DOI 10.1016/j.molcel.2009.07.003; Iyer RR, 2010, J BIOL CHEM, V285, P11730, DOI 10.1074/jbc.M110.104125; Jahromi AH, 2013, NUCLEIC ACIDS RES, V41, P6687, DOI 10.1093/nar/gkt330; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Masuda-Ozawa T, 2013, NUCLEIC ACIDS RES, V41, P3576, DOI 10.1093/nar/gkt056; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Milescu LS, 2002, BIOPHYS J, V82, p267A; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ohashi E, 2009, GENES CELLS, V14, P101, DOI 10.1111/j.1365-2443.2008.01255.x; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Pozhidaeva A, 2012, BIOCHEMISTRY-US, V51, P5506, DOI 10.1021/bi300566z; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Pryor JM, 2014, NUCLEIC ACIDS MOL BI, V30, P85, DOI 10.1007/978-3-642-39796-7_4; Pryor JM, 2011, DNA REPAIR, V10, P1138, DOI 10.1016/j.dnarep.2011.08.011; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Vijayakumar S, 2007, NUCLEIC ACIDS RES, V35, P1624, DOI 10.1093/nar/gkm006; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Washington MT, 2004, MOL CELL BIOL, V24, P6900, DOI 10.1128/MCB.24.16.6900-6906.2004; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Wojtaszek J, 2012, J BIOL CHEM, V287, P26400, DOI 10.1074/jbc.M112.380998; Zhou RB, 2011, NANO LETT, V11, P5482, DOI 10.1021/nl2032876	57	37	38	6	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8735	8744		10.1074/jbc.M115.697938	http://dx.doi.org/10.1074/jbc.M115.697938			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26903512	Green Published, hybrid			2022-12-28	WOS:000374773200035
J	Jang, SI; Ong, HL; Liu, X; Alevizos, I; Ambudkar, IS				Jang, Shyh-Ing; Ong, Hwei Ling; Liu, Xibao; Alevizos, Ilias; Ambudkar, Indu S.			Up-regulation of Store-operated Ca2+ Entry and Nuclear Factor of Activated T Cells Promote the Acinar Phenotype of the Primary Human Salivary Gland Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium release-activated calcium channel protein 1 (ORAI1); gene expression; NFAT transcription factor; stromal interaction molecule 1 (STIM1); water channel	NEURAL STEM-CELLS; EPITHELIAL-CELLS; TRANSCRIPTION FACTOR; CALCIUM SIGNALS; GROWTH-FACTOR; NFAT; SECRETION; DIFFERENTIATION; EXPRESSION; FLUID	The signaling pathways involved in the generation and maintenance of exocrine gland acinar cells have not yet been established. Primary human salivary gland epithelial cells, derived from salivary gland biopsies, acquired an acinar-like phenotype when the [Ca2+] in the serum-free medium (keratinocyte growth medium, KGM) was increased from 0.05 mm (KGM-L) to 1.2 mm (KGM-H). Here we examined the mechanism underlying this Ca2+-dependent generation of the acinar cell phenotype. Compared with cells in KGM-L, those in KGM-H display enhancement of Orai1, STIM1, STIM2, and nuclear factor of activated T cells 1 (NFAT1) expression together with an increase in store-operated Ca2+ entry (SOCE), SOCE-dependent nuclear translocation of pGFP-NFAT1, and NFAT-dependent but not NFB-dependent gene expression. Importantly, AQP5, an acinar-specific protein critical for function, is up-regulated in KGM-H via SOCE/NFAT-dependent gene expression. We identified critical NFAT binding motifs in the AQP5 promoter that are involved in Ca2+-dependent up-regulation of AQP5. These important findings reveal that the Ca2+-induced switch of salivary epithelial cells to an acinar-like phenotype involves remodeling of SOCE and NFAT signaling, which together control the expression of proteins critically relevant for acinar cell function. Our data provide a novel strategy for generating and maintaining acinar cells in culture.	[Jang, Shyh-Ing; Ong, Hwei Ling; Liu, Xibao; Alevizos, Ilias; Ambudkar, Indu S.] NIDCR, Secretory & Physiol Sect, NIH, Mol Physiol & Therapeut Branch, Bethesda, MD 20892 USA; [Jang, Shyh-Ing; Ong, Hwei Ling; Liu, Xibao; Alevizos, Ilias; Ambudkar, Indu S.] NIDCR, Sjogrens Syndrome & Salivary Gland Dysfunct Unit, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Alevizos, I; Ambudkar, IS (corresponding author), NIDCR, Secretory & Physiol Sect, NIH, Mol Physiol & Therapeut Branch, Bethesda, MD 20892 USA.; Alevizos, I; Ambudkar, IS (corresponding author), NIDCR, Sjogrens Syndrome & Salivary Gland Dysfunct Unit, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA.	alevizosi@nidcr.nih.gov; indu.ambudkar@nih.gov		Ong, Hwei Ling/0000-0002-7551-6883; Alevizos, Ilias/0000-0001-5331-1652	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000733, ZIADE000438, ZIADE000704] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ambudkar IS, 2014, CELL CALCIUM, V55, P297, DOI 10.1016/j.ceca.2014.02.009; Ambudkar IS, 2000, CRIT REV ORAL BIOL M, V11, P4, DOI 10.1177/10454411000110010301; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Crist SA, 2008, BLOOD, V111, P3553, DOI 10.1182/blood-2007-05-088161; Dimitriou ID, 2002, EUR J ORAL SCI, V110, P21, DOI 10.1034/j.1600-0722.2002.00152.x; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jang SI, 2015, J DENT RES, V94, P304, DOI 10.1177/0022034514559251; Kar P, 2015, MOL CELL, V58, P232, DOI 10.1016/j.molcel.2015.02.027; Kiselyov K, 2006, CELL CALCIUM, V40, P451, DOI 10.1016/j.ceca.2006.08.009; Kudryavtseva O, 2013, FEBS J, V280, P5488, DOI 10.1111/febs.12414; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Maric D, 2003, J NEUROSCI, V23, P240; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Mishra SK, 2006, DEVELOPMENT, V133, P675, DOI 10.1242/dev.02233; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; OKURA M, 1993, DIFFERENTIATION, V54, P143; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Platel JC, 2008, J PHYSIOL-LONDON, V586, P3739, DOI 10.1113/jphysiol.2008.155325; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Redman R. S., 1993, BIOL SALIVARY GLANDS, P285; SABATINI LM, 1991, IN VITRO CELL DEV B, V27, P939; SENS DA, 1985, LAB INVEST, V52, P559; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shukla U, 2009, J BIOL CHEM, V284, P33719, DOI 10.1074/jbc.M109.049999; STAUFFER PL, 1993, J BIOL CHEM, V268, P19769; Yule DI, 2001, J GEN PHYSIOL, V117, P431, DOI 10.1085/jgp.117.5.431; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	37	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8709	8720		10.1074/jbc.M115.701607	http://dx.doi.org/10.1074/jbc.M115.701607			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26903518	hybrid, Green Published			2022-12-28	WOS:000374773200033
J	Lee, SM; Hay, DL; Pioszak, AA				Lee, Sang-Min; Hay, Debbie L.; Pioszak, Augen A.			Calcitonin and Amylin Receptor Peptide Interaction Mechanisms INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cell surface receptor; G protein-coupled receptor (GPCR); glycoprotein; mutagenesis; peptide hormone; structure-function; RAMP	GENE-RELATED PEPTIDE; COUPLED-RECEPTOR; EXTRACELLULAR DOMAIN; SALMON-CALCITONIN; STRUCTURAL BASIS; DIFFERENTIALLY MODULATE; MOLECULAR RECOGNITION; CRYSTAL-STRUCTURE; ALPHA-HELIX; ADRENOMEDULLIN	Receptor activity-modifying proteins (RAMP1-3) determine the selectivity of the class B G protein-coupled calcitonin receptor (CTR) and the CTR-like receptor (CLR) for calcitonin (CT), amylin (Amy), calcitonin gene-related peptide (CGRP), and adrenomedullin (AM) peptides. RAMP1/2 alter CLR selectivity for CGRP/AM in part by RAMP1 Trp-84 or RAMP2 Glu-101 contacting the distinct CGRP/AM C-terminal residues. It is unclear whether RAMPs use a similar mechanism to modulate CTR affinity for CT and Amy, analogs of which are therapeutics for bone disorders and diabetes, respectively. Here, we reproduced the peptide selectivity of intact CTR, AMY(1) (CTRRAMP1), and AMY(2) (CTRRAMP2) receptors using purified CTR extracellular domain (ECD) and tethered RAMP1- and RAMP2-CTR ECD fusion proteins and antagonist peptides. All three proteins bound salmon calcitonin (sCT). Tethering RAMPs to CTR enhanced binding of rAmy, CGRP, and the AMY antagonist AC413. Peptide alanine-scanning mutagenesis and modeling of receptor-bound sCT and AC413 supported a shared non-helical CGRP-like conformation for their TN(T/V)G motif prior to the C terminus. After this motif, the peptides diverged; the sCT C-terminal Pro was crucial for receptor binding, whereas the AC413/rAmy C-terminal Tyr had little or no influence on binding. Accordingly, mutant RAMP1 W84A- and RAMP2 E101A-CTR ECD retained AC413/rAmy binding. ECD binding and cell-based signaling assays with antagonist sCT/AC413/rAmy variants with C-terminal residue swaps indicated that the C-terminal sCT/rAmy residue identity affects affinity more than selectivity. rAmy(8-37) Y37P exhibited enhanced antagonism of AMY(1) while retaining selectivity. These results reveal unexpected differences in how RAMPs determine CTR and CLR peptide selectivity and support the hypothesis that RAMPs allosterically modulate CTR peptide affinity.	[Lee, Sang-Min; Pioszak, Augen A.] Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Hay, Debbie L.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Hay, Debbie L.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Auckland; University of Auckland	Pioszak, AA (corresponding author), Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.	augen-pioszak@ouhsc.edu	Hay, Debbie L/D-4441-2009	Hay, Debbie L/0000-0002-9558-5122; Lee, Sangmin/0000-0002-7262-159X	National Institutes of Health [R01GM104251]; Harold Hamm Diabetes Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold Hamm Diabetes Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM104251 (to A. A. P.) and a training grant from the Harold Hamm Diabetes Center (to S. M. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreassen KV, 2014, AM J PHYSIOL-ENDOC M, V307, pE24, DOI 10.1152/ajpendo.00121.2014; Andreotti G, 2006, J BIOL CHEM, V281, P24193, DOI 10.1074/jbc.M603528200; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Armour SL, 1999, J PHARMACOL TOXICOL, V42, P217, DOI 10.1016/S1056-8719(00)00074-5; Barwell J, 2012, BRIT J PHARMACOL, V166, P51, DOI 10.1111/j.1476-5381.2011.01525.x; Bell IM, 2014, J MED CHEM, V57, P7838, DOI 10.1021/jm500364u; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Brain SD, 2004, PHYSIOL REV, V84, P903, DOI 10.1152/physrev.00037.2003; Chesnut CH, 2008, OSTEOPOROSIS INT, V19, P479, DOI 10.1007/s00198-007-0490-1; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Gingell JJ, 2010, PEPTIDES, V31, P1400, DOI 10.1016/j.peptides.2010.03.027; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hay DL, 2016, ANNU REV PHARMACOL, V56, P469, DOI 10.1146/annurev-pharmtox-010715-103120; Hay DL, 2015, PHARMACOL REV, V67, P564, DOI 10.1124/pr.115.010629; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; Hay DL, 2005, MOL PHARMACOL, V67, P1655, DOI 10.1124/mol.104.008615; Hill HE, 2013, PROTEIN EXPRES PURIF, V88, P107, DOI 10.1016/j.pep.2012.11.019; Hilton JM, 2000, J ENDOCRINOL, V166, P213, DOI 10.1677/joe.0.1660213; Ho HH, 1999, BIOCHEMISTRY-US, V38, P1866, DOI 10.1021/bi981195e; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hong YG, 2012, BRIT J PHARMACOL, V166, P110, DOI 10.1111/j.1476-5381.2011.01530.x; Koth CM, 2010, BIOCHEMISTRY-US, V49, P1862, DOI 10.1021/bi901848m; Kusano S, 2012, PROTEIN SCI, V21, P199, DOI 10.1002/pro.2003; Lee SM, 2015, EUR J PHARMACOL, V763, P196, DOI 10.1016/j.ejphar.2015.05.013; Mack CM, 2010, INT J OBESITY, V34, P385, DOI 10.1038/ijo.2009.238; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Moad HE, 2013, PROTEIN SCI, V22, P1775, DOI 10.1002/pro.2377; Moore EL, 2010, BIOCHEM BIOPH RES CO, V394, P141, DOI 10.1016/j.bbrc.2010.02.131; Morfis M, 2008, ENDOCRINOLOGY, V149, P5423, DOI 10.1210/en.2007-1735; Muff R, 1999, ENDOCRINOLOGY, V140, P2924, DOI 10.1210/en.140.6.2924; Nanga RPR, 2009, J AM CHEM SOC, V131, P8252, DOI 10.1021/ja9010095; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Pioszak AA, 2009, J BIOL CHEM, V284, P28382, DOI 10.1074/jbc.M109.022905; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Purdue BW, 2002, RECEPTOR CHANNEL, V8, P243, DOI 10.1080/10606820213681; Rist B, 1998, J MED CHEM, V41, P117, DOI 10.1021/jm970533r; ROBERTS AN, 1989, P NATL ACAD SCI USA, V86, P9662, DOI 10.1073/pnas.86.24.9662; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Sadry SA, 2013, NAT REV ENDOCRINOL, V9, P425, DOI 10.1038/nrendo.2013.47; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tilakaratne N, 2000, J PHARMACOL EXP THER, V294, P61; Udawela M, 2006, MOL PHARMACOL, V69, P1984, DOI 10.1124/mol.105.021915; Venkatanarayan A, 2015, NATURE, V517, P626, DOI 10.1038/nature13910; Wang YF, 2003, BIOCHEM BIOPH RES CO, V306, P582, DOI 10.1016/S0006-291X(03)01028-3; Warner ML, 2015, MOL PHARMACOL, V87, P410, DOI 10.1124/mol.114.095133; Watkins HA, 2013, BRIT J PHARMACOL, V169, P143, DOI 10.1111/bph.12118; Wong Hoi Kin, 2012, JRSM Cardiovasc Dis, V1, DOI 10.1258/cvd.2012.012003; Wookey PJ, 1996, AM J PHYSIOL-RENAL, V270, pF289, DOI 10.1152/ajprenal.1996.270.2.F289; YOUNG AA, 1994, FEBS LETT, V343, P237, DOI 10.1016/0014-5793(94)80563-6; Younk LM, 2011, EXPERT OPIN PHARMACO, V12, P1439, DOI 10.1517/14656566.2011.581663; Zumpe ET, 2000, BIOCHEM BIOPH RES CO, V267, P368, DOI 10.1006/bbrc.1999.1943	55	48	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8686	8700		10.1074/jbc.M115.713628	http://dx.doi.org/10.1074/jbc.M115.713628			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26895962	Green Published, hybrid			2022-12-28	WOS:000374773200031
J	Nakhaei-Rad, S; Nakhaeizadeh, H; Gotze, S; Kordes, C; Sawitza, I; Hoffmann, MJ; Franke, M; Schulz, WA; Scheller, J; Piekorz, RP; Haussinger, D; Ahmadian, MR				Nakhaei-Rad, Saeideh; Nakhaeizadeh, Hossein; Goetze, Silke; Kordes, Claus; Sawitza, Iris; Hoffmann, Michele J.; Franke, Manuel; Schulz, Wolfgang A.; Scheller, Juergen; Piekorz, Roland P.; Haeussinger, Dieter; Ahmadian, Mohammad R.			The Role of Embryonic Stem Cell-expressed RAS (ERAS) in the Maintenance of Quiescent Hepatic Stellate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; hepatic stellate cell (HSC); Hippo pathway; mammalian target of rapamycin (mTOR); phosphatidylinositide 3-kinase (PI 3-kinase); Raf kinase; signal transduction; embryonic stem cell-expressed RAS; embryonic stem cell-expressed RAS, ERAS; embryonic stem cell-expressed RAS, ERAS, AKT	HEPATOCYTE GROWTH-FACTOR; FAT-STORING CELLS; TYROSINE KINASE; EPIGENETIC REGULATION; MEDIATED REGULATION; SIGNALING PATHWAY; MAMMALIAN TARGET; UP-REGULATION; MAP KINASE; COMPLEX 2	Hepatic stellate cells (HSCs) were recently identified as liver-resident mesenchymal stem cells. HSCs are activated after liver injury and involved in pivotal processes, such as liver development, immunoregulation, regeneration, and also fibrogenesis. To date, several studies have reported candidate pathways that regulate the plasticity of HSCs during physiological and pathophysiological processes. Here we analyzed the expression changes and activity of the RAS family GTPases and thereby investigated the signaling networks of quiescent HSCs versus activated HSCs. For the first time, we report that embryonic stem cell-expressed RAS (ERAS) is specifically expressed in quiescent HSCs and down-regulated during HSC activation via promoter DNA methylation. Notably, in quiescent HSCs, the high level of ERAS protein correlates with the activation of AKT, STAT3, mTORC2, and HIPPO signaling pathways and inactivation of FOXO1 and YAP. Our data strongly indicate that in quiescent HSCs, ERAS targets AKT via two distinct pathways driven by PI3K alpha/delta and mTORC2, whereas in activated HSCs, RAS signaling shifts to RAF-MEK-ERK. Thus, in contrast to the reported role of ERAS in tumor cells associated with cell proliferation, our findings indicate that ERAS is important to maintain quiescence in HSCs.	[Nakhaei-Rad, Saeideh; Nakhaeizadeh, Hossein; Franke, Manuel; Scheller, Juergen; Piekorz, Roland P.; Ahmadian, Mohammad R.] Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany; [Goetze, Silke; Kordes, Claus; Sawitza, Iris; Haeussinger, Dieter] Univ Dusseldorf, Fac Med, Clin Gastroenterol Hepatol & Infect Dis, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany; [Hoffmann, Michele J.; Schulz, Wolfgang A.] Univ Dusseldorf, Fac Med, Dept Urol, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Ahmadian, MR (corresponding author), Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Scheller, Jürgen/K-5290-2015; Hoffmann, Michele J./AAL-1028-2020; Nakhaeirad, Saeideh/AAV-1771-2020; Kordes, Claus/AFM-1775-2022; Schulz, Wolfgang/N-3402-2019	Nakhaeirad, Saeideh/0000-0001-8966-8960; Kordes, Claus/0000-0003-0782-1998; Schulz, Wolfgang/0000-0002-2196-463X	Deutsche Forschungsgemeinschaft through Collaborative Research Center "Communication and System Relevance during Liver Injury and Regeneration" [974, SFB 974]	Deutsche Forschungsgemeinschaft through Collaborative Research Center "Communication and System Relevance during Liver Injury and Regeneration"	This work was supported by the Deutsche Forschungsgemeinschaft through Collaborative Research Center 974 (SFB 974), "Communication and System Relevance during Liver Injury and Regeneration." The authors declare that they have no conflicts of interest with the contents of this article.	Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Aoyama M, 2010, INT J ONCOL, V37, P1011, DOI 10.3892/ijo_00000752; Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; Baier R, 1999, CELL GROWTH DIFFER, V10, P447; Bitencourt S, 2014, CELL BIOCHEM BIOPHYS, V68, P387, DOI 10.1007/s12013-013-9719-0; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Carloni V, 2002, HEPATOLOGY, V36, P582, DOI 10.1053/jhep.2002.35277; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Chiang Jonathan, 2012, Cells, V1, P886, DOI 10.3390/cells1040886; Coll M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11549; de Souza ICC, 2015, J CELL BIOCHEM, V116, P2304, DOI 10.1002/jcb.25181; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Dong S, 2015, CLIN LAB, V61, P537, DOI 10.7754/Clin.Lab.2014.141127; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Fritsch R, 2013, CELL, V154, P940, DOI 10.1016/j.cell.2013.07.045; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Gotze S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128745; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gu XD, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/389807; He JY, 2015, FEBS LETT, V589, P1359, DOI 10.1016/j.febslet.2015.04.010; HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5; Hennig A, 2015, BIOL CHEM, V396, P831, DOI 10.1515/hsz-2014-0257; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Huang KZ, 2014, SEMIN CELL DEV BIOL, V36, P79, DOI 10.1016/j.semcdb.2014.09.011; Hung W, 2001, J BIOL CHEM, V276, P12395, DOI 10.1074/jbc.M010715200; Iwamoto H, 2000, J LAB CLIN MED, V135, P406, DOI 10.1067/mlc.2000.105974; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Kaizaki R, 2009, ANTICANCER RES, V29, P2189; Kang QH, 2009, ENDOCRINOLOGY, V150, P5384, DOI 10.1210/en.2009-0517; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Khadem F, 2016, HEPATOLOGY, V63, P620, DOI 10.1002/hep.28130; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Kordes C, 2008, BIOCHEM BIOPH RES CO, V367, P116, DOI 10.1016/j.bbrc.2007.12.085; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; Kordes C, 2014, J CLIN INVEST, V124, P5503, DOI 10.1172/JCI74119; Kordes C, 2013, J CLIN INVEST, V123, P1874, DOI 10.1172/JCI66027; Kordes C, 2013, CELL PHYSIOL BIOCHEM, V31, P290, DOI 10.1159/000343368; Kwon YW, 2015, STEM CELL RES, V15, P481, DOI 10.1016/j.scr.2015.09.004; Lakner AM, 2010, WORLD J GASTROENTERO, V16, P5047, DOI 10.3748/wjg.v16.i40.5047; Leakey TI, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn210; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu PD, 2014, PROTEIN CELL, V5, P171, DOI 10.1007/s13238-014-0021-8; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; MAHER JJ, 1993, J CLIN INVEST, V91, P2244, DOI 10.1172/JCI116451; Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Nakagawa K, 2013, BBA-MOL CELL RES, V1833, P2988, DOI 10.1016/j.bbamcr.2013.08.004; Nakamura K, 2008, ONCOGENE, V27, P2961, DOI 10.1038/sj.onc.1210956; Nakhaei-Rad S, 2015, J BIOL CHEM, V290, P15892, DOI 10.1074/jbc.M115.640607; Ni LS, 2013, STRUCTURE, V21, P1757, DOI 10.1016/j.str.2013.07.008; Oh HM, 2011, J BIOL CHEM, V286, P30888, DOI 10.1074/jbc.M111.253500; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Paganini S, 2006, BIOCHIMIE, V88, P285, DOI 10.1016/j.biochi.2005.08.007; Parola M, 1998, J CLIN INVEST, V102, P1942, DOI 10.1172/JCI1413; Pereira A, 2013, PROG NEURO-PSYCHOPH, V40, P353, DOI 10.1016/j.pnpbp.2012.10.025; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SB, 2015, CELL ONCOL, V38, P215, DOI 10.1007/s13402-015-0224-x; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Rawat SJ, 2015, TRENDS BIOCHEM SCI, V40, P149, DOI 10.1016/j.tibs.2015.01.001; Reimann T, 1997, FEBS LETT, V403, P57, DOI 10.1016/S0014-5793(97)00024-0; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Saile B, 2001, EUR J CELL BIOL, V80, P554, DOI 10.1078/0171-9335-00182; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; SCHIRMACHER P, 1992, HEPATOLOGY, V15, P5, DOI 10.1002/hep.1840150103; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Soliman EM, 2009, CELL CALCIUM, V45, P284, DOI 10.1016/j.ceca.2008.11.006; Stuhlmann-Laeisz C, 2006, MOL BIOL CELL, V17, P2986, DOI 10.1091/mbc.E05-12-1129; Taha MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091465; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Tomiya T, 2007, BIOCHEM BIOPH RES CO, V358, P176, DOI 10.1016/j.bbrc.2007.04.093; TORTI M, 1994, THROMB HAEMOSTASIS, V71, P533; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wang X, 2002, MOL CELL, V9, P411, DOI 10.1016/S1097-2765(02)00439-2; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925350; Wu JX, 2015, CELL SIGNAL, V27, P1198, DOI 10.1016/j.cellsig.2015.02.026; Xie GH, 2013, HEPATOLOGY, V58, P1801, DOI 10.1002/hep.26511; Yang L, 2008, STEM CELLS, V26, P2104, DOI 10.1634/stemcells.2008-0115; Yashiro M, 2009, INT J ONCOL, V35, P997, DOI 10.3892/ijo_00000414; Yasuda K, 2007, ANTICANCER RES, V27, P4071; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yu Y, 2014, STEM CELLS, V32, P349, DOI 10.1002/stem.1447	97	24	24	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8399	8413		10.1074/jbc.M115.700088	http://dx.doi.org/10.1074/jbc.M115.700088			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26884329	Green Published, hybrid			2022-12-28	WOS:000374773200008
J	Zadeh-Tahmasebi, M; Duca, FA; Rasmussen, BA; Bauer, PV; Cote, CD; Filippi, BM; Lam, TKT				Zadeh-Tahmasebi, Melika; Duca, Frank A.; Rasmussen, Brittany A.; Bauer, Paige V.; Cote, Clemence D.; Filippi, Beatrice M.; Lam, Tony K. T.			Activation of Short and Long Chain Fatty Acid Sensing Machinery in the Ileum Lowers Glucose Production in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid; glucose; glucose metabolism; intestine; lipid signaling	GLUCAGON-LIKE PEPTIDE-1; ENTEROENDOCRINE CELLS; RECEPTOR; PROPIONATE; SECRETION; INTESTINE; RESPONSES; CHOLECYSTOKININ; MICROBIOTA; DIVERSITY	Evidence continues to emerge detailing the myriad of ways the gut microbiota influences host energy homeostasis. Among the potential mechanisms, short chain fatty acids (SCFAs), the byproducts of microbial fermentation of dietary fibers, exhibit correlative beneficial metabolic effects in humans and rodents, including improvements in glucose homeostasis. The underlying mechanisms, however, remain elusive. We here report that one of the main bacterially produced SCFAs, propionate, activates ileal mucosal free fatty acid receptor 2 to trigger a negative feedback pathway to lower hepatic glucose production in healthy rats in vivo. We further demonstrate that an ileal glucagon-like peptide-1 receptor-dependent neuronal network is necessary for ileal propionate and long chain fatty acid sensing to regulate glucose homeostasis. These findings highlight the potential to manipulate fatty acid sensing machinery in the ileum to regulate glucose homeostasis.	[Zadeh-Tahmasebi, Melika; Duca, Frank A.; Rasmussen, Brittany A.; Bauer, Paige V.; Cote, Clemence D.; Filippi, Beatrice M.; Lam, Tony K. T.] UHN, Toronto Gen Res Inst, Toronto, ON M5G 1L7, Canada; [Zadeh-Tahmasebi, Melika; Duca, Frank A.; Rasmussen, Brittany A.; Bauer, Paige V.; Cote, Clemence D.; Filippi, Beatrice M.; Lam, Tony K. T.] UHN, Dept Med, Toronto, ON M5G 1L7, Canada; [Zadeh-Tahmasebi, Melika; Rasmussen, Brittany A.; Bauer, Paige V.; Cote, Clemence D.; Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Zadeh-Tahmasebi, Melika; Rasmussen, Brittany A.; Bauer, Paige V.; Cote, Clemence D.; Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Lam, Tony K. T.] Univ Toronto, Banting & Best Diabet Ctr, 100 Coll St, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Lam, TKT (corresponding author), MaRS Ctr, Toronto Med Discovery Tower Rm 10-705,101 Coll St, Toronto, ON M5G 1L7, Canada.	tony.lam@uhnres.utoronto.ca			Canadian Institutes of Health Research Foundation [FDN-143204]; Banting and Best Diabetes Centre graduate studentship; Vanier Canada scholarship; Ontario Graduate Scholarship	Canadian Institutes of Health Research Foundation(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Centre graduate studentship; Vanier Canada scholarship; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by Canadian Institutes of Health Research Foundation Grant FDN-143204 (to T. K. T. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Banting and Best Diabetes Centre graduate studentship.; Supported by a Vanier Canada scholarship.; Supported by a Ontario Graduate Scholarship and a Banting and Best Diabetes Centre graduate studentship.	Booijink CCGM, 2007, FUTURE MICROBIOL, V2, P285, DOI 10.2217/17460913.2.3.285; BOOTH CC, 1961, GUT, V2, P23, DOI 10.1136/gut.2.1.23; Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cani PD, 2005, J ENDOCRINOL, V185, P457, DOI 10.1677/joe.1.06100; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Cheung GWC, 2009, CELL METAB, V10, P99, DOI 10.1016/j.cmet.2009.07.005; Cote CD, 2015, NAT MED, V21, P498, DOI 10.1038/nm.3821; Cote CD, 2014, J BIOL CHEM, V289, P11642, DOI 10.1074/jbc.O114.556068; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; Dumoulin V, 1998, ENDOCRINOLOGY, V139, P3780, DOI 10.1210/en.139.9.3780; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Gaisano GG, 2010, NEUROGASTROENT MOTIL, V22, P470, DOI 10.1111/j.1365-2982.2009.01430.x; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Hayes MR, 2011, AM J PHYSIOL-REG I, V301, pR1479, DOI 10.1152/ajpregu.00356.2011; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Iakoubov R, 2011, ENDOCRINOLOGY, V152, P1244, DOI 10.1210/en.2010-1352; Kaji I, 2011, J MOL HISTOL, V42, P27, DOI 10.1007/s10735-010-9304-4; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Kokorovic A, 2011, GASTROENTEROLOGY, V141, P1720, DOI 10.1053/j.gastro.2011.06.042; Lal S, 2001, AM J PHYSIOL-GASTR L, V281, pG907, DOI 10.1152/ajpgi.2001.281.4.G907; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Li GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097342; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Nakagawa A, 2004, AUTON NEUROSCI-BASIC, V110, P36, DOI 10.1016/j.autneu.2003.11.001; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Pan XD, 2009, J ZHEJIANG UNIV-SC B, V10, P258, DOI 10.1631/jzus.B0820261; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Randich A, 2000, AM J PHYSIOL-REG I, V278, pR34, DOI 10.1152/ajpregu.2000.278.1.R34; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Richards P, 2014, DIABETES, V63, P1224, DOI 10.2337/db13-1440; Rodriguez MD, 1997, AM J PHYSIOL-REG I, V272, pR1170, DOI 10.1152/ajpregu.1997.272.4.R1170; Schwartz A, 2010, PHYSIOL MEAS, V31, P1147, DOI 10.1088/0967-3334/31/9/006; Tilg H, 2014, GUT, V63, P1513, DOI 10.1136/gutjnl-2014-306928; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; van Avesaat M, 2015, INT J OBESITY, V39, P235, DOI 10.1038/ijo.2014.112; Trung VN, 2014, J INVEST SURG, V27, P332, DOI 10.3109/08941939.2014.929764; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; Woltman T, 1995, AM J PHYSIOL-REG I, V269, pR1420, DOI 10.1152/ajpregu.1995.269.6.R1420; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	43	28	30	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8816	8824		10.1074/jbc.M116.718460	http://dx.doi.org/10.1074/jbc.M116.718460			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26896795	Green Published, hybrid			2022-12-28	WOS:000374773200042
J	Carballal, S; Cuevasanta, E; Yadav, PK; Gherasim, C; Ballou, DP; Alvarez, B; Banerjee, R				Carballal, Sebastian; Cuevasanta, Ernesto; Yadav, Pramod K.; Gherasim, Carmen; Ballou, David P.; Alvarez, Beatriz; Banerjee, Ruma			Kinetics of Nitrite Reduction and Peroxynitrite Formation by Ferrous Heme in Human Cystathionine -Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; kinetics; nitric oxide; oxygen radicals; superoxide ion; hemeprotein; nitrite; oxygen; peroxynitrite	RENAL ISCHEMIA-REPERFUSION; BETA-SYNTHASE; ANAEROBIC CONDITIONS; HYDROGEN-SULFIDE; OXIDATIVE STRESS; CHEMICAL BIOLOGY; REDOX REGULATION; LIGAND SWITCH; HUMAN ENZYME; OXIDE	Cystathionine -synthase (CBS) is a pyridoxal phosphate-dependent enzyme that catalyzes the condensation of homocysteine with serine or with cysteine to form cystathionine and either water or hydrogen sulfide, respectively. Human CBS possesses a noncatalytic heme cofactor with cysteine and histidine as ligands, which in its oxidized state is relatively unreactive. Ferric CBS (Fe(III)-CBS) can be reduced by strong chemical and biochemical reductants to Fe(II)-CBS, which can bind carbon monoxide (CO) or nitric oxide (NO center dot), leading to inactive enzyme. Alternatively, Fe(II)-CBS can be reoxidized by O-2 to Fe(III)-CBS, forming superoxide radical anion (O-2(-center dot)). In this study, we describe the kinetics of nitrite (NO2-) reduction by Fe(II)-CBS to form Fe(II)NO center dot-CBS. The second order rate constant for the reaction of Fe(II)-CBS with nitrite was obtained at low dithionite concentrations. Reoxidation of Fe(II)NO center dot-CBS by O-2 showed complex kinetic behavior and led to peroxynitrite (ONOO-) formation, which was detected using the fluorescent probe, coumarin boronic acid. Thus, in addition to being a potential source of superoxide radical, CBS constitutes a previously unrecognized source of NO center dot and peroxynitrite.	[Carballal, Sebastian] Univ Republica, Fac Med, Dept Bioquim, Avda Gral Flores 2125, Montevideo 11800, Uruguay; [Carballal, Sebastian; Cuevasanta, Ernesto; Alvarez, Beatriz] Univ Republica, Fac Ciencias, Ctr Free Rad & Biomed Res, Montevideo 11800, Uruguay; [Cuevasanta, Ernesto; Alvarez, Beatriz] Univ Republica, Fac Ciencias, Lab Enzimol, Montevideo 11800, Uruguay; [Yadav, Pramod K.; Gherasim, Carmen; Ballou, David P.; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Michigan System; University of Michigan	Carballal, S (corresponding author), Univ Republica, Fac Med, Dept Bioquim, Avda Gral Flores 2125, Montevideo 11800, Uruguay.; Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	scarballal@fmed.edu.uy; rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010	Yadav, Pramod K./0000-0003-0026-1684; Alvarez, Beatriz/0000-0001-6911-3132	Universidad de la Republica (Comision Sectorial de Investigacion Cientifica (CSIC)); Comision Academica de Posgrado (CAP); L'Oreal-Unesco, Uruguay; PROLAB Grant from the American Society for Biochemistry and Molecular Biology; National Institutes of Health [HL58984]; American Heart Association [14POST18760003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	Universidad de la Republica (Comision Sectorial de Investigacion Cientifica (CSIC)); Comision Academica de Posgrado (CAP); L'Oreal-Unesco, Uruguay; PROLAB Grant from the American Society for Biochemistry and Molecular Biology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants and fellowships from Universidad de la Republica (Comision Sectorial de Investigacion Cientifica (CSIC) (to B. A. and E. C.) and Comision Academica de Posgrado (CAP) (to E. C.)), L'Oreal-Unesco, Uruguay (to B. A.), a PROLAB Grant from the American Society for Biochemistry and Molecular Biology (to S. C.), National Institutes of Health Grant HL58984 (to R. B.), and American Heart Association Postdoctoral Fellowship 14POST18760003 (to P. K. Y). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 1996, J NEUROSCI, V16, P1066; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Carballal S, 2008, BIOCHEMISTRY-US, V47, P3194, DOI 10.1021/bi700912k; Carballal S, 2016, BIOCHEMISTRY-US, V55, P238, DOI 10.1021/acs.biochem.5b01326; Carballal S, 2014, BBA-GEN SUBJECTS, V1840, P768, DOI 10.1016/j.bbagen.2013.07.005; Carballal S, 2013, BIOCHEMISTRY-US, V52, P4553, DOI 10.1021/bi4004556; Celano L, 2009, ARCH BIOCHEM BIOPHYS, V491, P96, DOI 10.1016/j.abb.2009.08.022; Cherney MM, 2007, BIOCHEMISTRY-US, V46, P13199, DOI 10.1021/bi701159y; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; CREUTZ C, 1974, INORG CHEM, V13, P2041, DOI 10.1021/ic50138a054; Cuevasanta E., 2013, BIOINORG REACT MECH, V9, P27; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Evande R, 2004, ARCH BIOCHEM BIOPHYS, V427, P188, DOI 10.1016/j.abb.2004.04.027; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gherasim C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085544; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Hannibal L, 2011, J BIOL CHEM, V286, P39224, DOI 10.1074/jbc.M111.286351; Herold S, 2005, BIOCHEMISTRY-US, V44, P6223, DOI 10.1021/bi0475929; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; HUGHES MN, 1968, J CHEM SOC A, P450, DOI 10.1039/j19680000450; Ingi T, 1996, J NEUROSCI, V16, P5621; Kabil O, 2001, J BIOL CHEM, V276, P19350, DOI 10.1074/jbc.M100029200; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kery V, 1998, ARCH BIOCHEM BIOPHYS, V355, P222, DOI 10.1006/abbi.1998.0723; KLUG D, 1972, J BIOL CHEM, V247, P4839; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Kraus JP, 1999, HUM MUTAT, V13, P362; LAMBETH DO, 1973, J BIOL CHEM, V248, P6095; Li HT, 2012, J BIOL CHEM, V287, P36623, DOI 10.1074/jbc.M112.342378; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Michalski R, 2014, J BIOL CHEM, V289, P22536, DOI 10.1074/jbc.M114.553727; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Moller JKS, 2004, CHEM-EUR J, V10, P2291, DOI 10.1002/chem.200305368; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Ojha S, 2000, BIOCHEMISTRY-US, V39, P10542, DOI 10.1021/bi000831h; Pazicni S, 2005, BIOCHEMISTRY-US, V44, P16785, DOI 10.1021/bi051305z; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Prathapasinghe GA, 2008, AM J PHYSIOL-RENAL, V295, pF912, DOI 10.1152/ajprenal.00040.2008; Prathapasinghe GA, 2007, AM J PHYSIOL-RENAL, V292, pF1354, DOI 10.1152/ajprenal.00301.2006; Puranik M, 2006, J BIOL CHEM, V281, P13433, DOI 10.1074/jbc.M600246200; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; SCHELLENBERG KA, 1958, J BIOL CHEM, V231, P547; SCHWARTZ SE, 1981, ATMOS ENVIRON, V15, P1129, DOI 10.1016/0004-6981(81)90303-6; SEBASTIO G, 1995, AM J HUM GENET, V56, P1324; Sen S, 2007, BIOCHEMISTRY-US, V46, P4110, DOI 10.1021/bi602617f; Singh S, 2007, NAT PROD REP, V24, P631, DOI 10.1039/b604182p; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; Smith AT, 2012, BIOCHEMISTRY-US, V51, P6360, DOI 10.1021/bi300421z; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2001, J INORG BIOCHEM, V87, P253, DOI 10.1016/S0162-0134(01)00336-1; Taoka S, 1999, BIOCHEMISTRY-US, V38, P13155, DOI 10.1021/bi990865t; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Tejero J, 2015, BIOCHEMISTRY-US, V54, P722, DOI 10.1021/bi501196k; Tejero J, 2009, FEBS J, V276, P4505, DOI 10.1111/j.1742-4658.2009.07157.x; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Vadon-Le Goff S., 2001, BIOCHEM BIOPH RES CO, V283, P487; Van Doorslaer S, 2003, J BIOL CHEM, V278, P4919, DOI 10.1074/jbc.M210617200; Vicente JB, 2016, J BIOL CHEM, V291, P572, DOI 10.1074/jbc.M115.681221; Vicente JB, 2014, J BIOL CHEM, V289, P8579, DOI 10.1074/jbc.M113.507533; Weeks CL, 2009, J AM CHEM SOC, V131, P12809, DOI 10.1021/ja904468w; Yadav PK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414706; Zeida A, 2013, ARCH BIOCHEM BIOPHYS, V539, P81, DOI 10.1016/j.abb.2013.08.016; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080	77	24	24	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8004	8013		10.1074/jbc.M116.718734	http://dx.doi.org/10.1074/jbc.M116.718734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26867575	hybrid, Green Published			2022-12-28	WOS:000374056700021
J	Ramakrishnan, SK; Khuder, SS; Al-Share, QY; Russo, L; Abdallah, SL; Patel, PR; Heinrich, G; Muturi, HT; Mopidevi, BR; Oyarce, AM; Shah, YM; Sanchez, ER; Najjar, SM				Ramakrishnan, Sadeesh K.; Khuder, Saja S.; Al-Share, Qusai Y.; Russo, Lucia; Abdallah, Simon L.; Patel, Payal R.; Heinrich, Garrett; Muturi, Harrison T.; Mopidevi, Brahma R.; Oyarce, Ana Maria; Shah, Yatrik M.; Sanchez, Edwin R.; Najjar, Sonia M.			PPAR (Peroxisome Proliferator-activated Receptor ) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid metabolism; fatty acid synthase (FAS); gene expression; insulin secretion; peroxisome proliferator-activated receptor (PPAR); CEACAM1; insulin clearance; PPAR response element	CELL-ADHESION MOLECULE-1; INSULIN-CLEARANCE; GENE-EXPRESSION; TYROSINE KINASE; IN-VIVO; ALPHA; METABOLISM; LIVER; SUBSTRATE; DIET	Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is expressed at high levels in the hepatocyte, consistent with its role in promoting insulin clearance in liver. CEACAM1 also mediates a negative acute effect of insulin on fatty acid synthase activity. Western blot analysis reveals lower hepatic CEACAM1 expression during fasting. Treating of rat hepatoma FAO cells with Wy14,643, an agonist of peroxisome proliferator-activated receptor (PPAR), rapidly reduces Ceacam1 mRNA and CEACAM1 protein levels within 1 and 2 h, respectively. Luciferase reporter assay shows a decrease in the promoter activity of both rat and mouse genes by Ppar activation, and 5-deletion and block substitution analyses reveal that the Ppar response element between nucleotides -557 and -543 is required for regulation of the mouse promoter activity. Chromatin immunoprecipitation analysis demonstrates binding of liganded Ppar to Ceacam1 promoter in liver lysates of Ppar(+/+), but not Ppar(-/-) mice fed a Wy14,643-supplemented chow diet. Consequently, Wy14,643 feeding reduces hepatic Ceacam1 mRNA and CEACAM1 protein levels, thus decreasing insulin clearance to compensate for compromised insulin secretion and maintain glucose homeostasis and insulin sensitivity in wild-type mice. Together, the data show that the low hepatic CEACAM1 expression at fasting is mediated by Ppar-dependent mechanisms. Changes in CEACAM1 expression contribute to the coordination of fatty acid oxidation and insulin action in the fasting-refeeding transition.	[Ramakrishnan, Sadeesh K.; Khuder, Saja S.; Al-Share, Qusai Y.; Russo, Lucia; Abdallah, Simon L.; Patel, Payal R.; Heinrich, Garrett; Muturi, Harrison T.; Oyarce, Ana Maria; Sanchez, Edwin R.; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res, Hlth Sci Campus, Toledo, OH 43614 USA; [Ramakrishnan, Sadeesh K.; Khuder, Saja S.; Al-Share, Qusai Y.; Russo, Lucia; Abdallah, Simon L.; Patel, Payal R.; Heinrich, Garrett; Muturi, Harrison T.; Mopidevi, Brahma R.; Oyarce, Ana Maria; Sanchez, Edwin R.; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Hlth Sci Campus, Toledo, OH 43614 USA; [Shah, Yatrik M.] Univ Michigan, Div Gastroenterol & Mol & Integrat Physiol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Najjar, Sonia M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University of Michigan System; University of Michigan; University System of Ohio; Ohio University	Najjar, SM (corresponding author), Univ Toledo, Coll Med & Life Sci, Hlth Sci Campus,3000 Arlington Ave,Mail Stop 10, Toledo, OH 43614 USA.	sonia.najjar@utoledo.edu	Mopidevi, Brahmaraju/D-6003-2015; Najjar, Sonia M/GXW-2217-2022	Mopidevi, Brahmaraju/0000-0003-1231-7796; Al-Share, Qusai/0000-0002-2306-6198; Khuder, Saja/0000-0001-9101-3744	NIH [R01 DK054254, R01 DK083850, R01 HL112248, R01 DK70127]; American Heart Association; Wolfe Innovation Fund (University of Toledo Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070127, R01DK054254, R01DK083850] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Wolfe Innovation Fund (University of Toledo Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH Grants R01 DK054254, R01 DK083850, and R01 HL112248 (to S. M. N.) and R01 DK70127 (to E. R. S.). The authors declare that they have no conflict of interest associated with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a post-doctoral fellowship from the American Heart Association and by the Wolfe Innovation Fund (University of Toledo Foundation).	Ader M, 2014, OBESITY, V22, P1238, DOI 10.1002/oby.20625; Al-Share QY, 2015, DIABETES, V64, P2780, DOI 10.2337/db14-1772; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Cariello NF, 2005, TOXICOL SCI, V88, P250, DOI 10.1093/toxsci/kfi273; DeAngelis AM, 2008, DIABETES, V57, P2296, DOI 10.2337/db08-0379; Durgan DJ, 2006, AM J PHYSIOL-HEART C, V290, pH2480, DOI 10.1152/ajpheart.01344.2005; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; FORMISANO P, 1995, J BIOL CHEM, V270, P24073, DOI 10.1074/jbc.270.41.24073; Goodarzi MO, 2011, AM J PHYSIOL-ENDOC M, V301, pE402, DOI 10.1152/ajpendo.00013.2011; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Gremlich S, 2005, ENDOCRINOLOGY, V146, P375, DOI 10.1210/en.2004-0667; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; IRITANI N, 1992, EUR J BIOCHEM, V205, P433, DOI 10.1111/j.1432-1033.1992.tb16797.x; Kamiya A, 2004, FEBS LETT, V578, P63, DOI 10.1016/j.febslet.2004.10.070; Kane CD, 2009, MOL PHARMACOL, V75, P296, DOI 10.1124/mol.108.051656; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Matveyenko AV, 2012, DIABETES, V61, P2269, DOI 10.2337/db11-1462; MOIR AMB, 1993, BIOCHEM J, V289, P49, DOI 10.1042/bj2890049; Najjar SM, 2005, CELL METAB, V2, P43, DOI 10.1016/j.cmet.2005.06.001; NAJJAR SM, 1995, BIOCHEMISTRY-US, V34, P9341, DOI 10.1021/bi00029a009; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; Najjar SM, 1996, J BIOL CHEM, V271, P8809, DOI 10.1074/jbc.271.15.8809; Park SY, 2006, AM J PHYSIOL-ENDOC M, V291, pE517, DOI 10.1152/ajpendo.00077.2006; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Roden M, 1999, ANNU REV MED, V50, P277, DOI 10.1146/annurev.med.50.1.277; Rubi B, 2002, BIOCHEM J, V364, P219, DOI 10.1042/bj3640219; Shah YA, 2007, MOL CELL BIOL, V27, P4238, DOI 10.1128/MCB.00317-07; Sugden MC, 2002, BIOCHEM J, V364, P361, DOI 10.1042/BJ20011699; WARD GM, 1990, DIABETES, V39, P501, DOI 10.2337/diabetes.39.4.501; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Xu E, 2009, ENDOCRINOLOGY, V150, P3503, DOI 10.1210/en.2008-1439; Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200	35	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8121	8129		10.1074/jbc.M116.714014	http://dx.doi.org/10.1074/jbc.M116.714014			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26846848	hybrid, Green Published			2022-12-28	WOS:000374056700029
J	Liu, YJ; Liu, C; Chang, ZN; Wadas, B; Brower, CS; Song, ZH; Xu, ZL; Shang, YL; Liu, WX; Wang, LN; Dong, W; Varshavsky, A; Hu, RG; Li, W				Liu, Yu-Jiao; Liu, Chao; Chang, ZeNan; Wadas, Brandon; Brower, Christopher S.; Song, Zhen-Hua; Xu, Zhi-Liang; Shang, Yong-Liang; Liu, Wei-Xiao; Wang, Li-Na; Dong, Wen; Varshavsky, Alexander; Hu, Rong-Gui; Li, Wei			Degradation of the Separase-cleaved Rec8, a Meiotic Cohesin Subunit, by the N-end Rule Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; UBIQUITIN LIGASE; CHROMOSOME SEGREGATION; TERMINAL ACETYLATION; PROTEIN-FRAGMENTS; KLEISIN SUBUNIT; SUBSTRATE RECOGNITION; CELLULAR-PROTEINS; STRUCTURAL BASIS; UBR1	The Ate1 arginyltransferase (R-transferase) is a component of the N-end rule pathway, which recognizes proteins containing N-terminal degradation signals called N-degrons, polyubiquitylates these proteins, and thereby causes their degradation by the proteasome. Ate1 arginylates N-terminal Asp, Glu, or (oxidized) Cys. The resulting N-terminal Arg is recognized by ubiquitin ligases of the N-end rule pathway. In the yeast Saccharomyces cerevisiae, the separase-mediated cleavage of the Scc1/Rad21/Mcd1 cohesin subunit generates a C-terminal fragment that bears N-terminal Arg and is destroyed by the N-end rule pathway without a requirement for arginylation. In contrast, the separase-mediated cleavage of Rec8, the mammalian meiotic cohesin subunit, yields a fragment bearing N-terminal Glu, a substrate of the Ate1 R-transferase. Here we constructed and used a germ cell-confined Ate1(-/-) mouse strain to analyze the separase-generated C-terminal fragment of Rec8. We show that this fragment is a short-lived N-end rule substrate, that its degradation requires N-terminal arginylation, and that male Ate1(-/-) mice are nearly infertile, due to massive apoptotic death of Ate1(-/-) spermatocytes during the metaphase of meiosis I. These effects of Ate1 ablation are inferred to be caused, at least in part, by the failure to destroy the C-terminal fragment of Rec8 in the absence of N-terminal arginylation.	[Liu, Yu-Jiao; Liu, Chao; Song, Zhen-Hua; Xu, Zhi-Liang; Shang, Yong-Liang; Liu, Wei-Xiao; Wang, Li-Na; Li, Wei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Liu, Chao; Song, Zhen-Hua; Xu, Zhi-Liang; Shang, Yong-Liang; Wang, Li-Na] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Chang, ZeNan; Wadas, Brandon; Brower, Christopher S.; Varshavsky, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Brower, Christopher S.] Texas Womans Univ, Dept Biol, Denton, TX 76204 USA; [Liu, Yu-Jiao; Dong, Wen] Ocean Univ China, Coll Marine Life, Qingdao 266003, Peoples R China; [Hu, Rong-Gui] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; California Institute of Technology; Texas Womans University; Ocean University of China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, W (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Varshavsky, A (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Dong, W (corresponding author), Ocean Univ China, Coll Marine Life, Qingdao 266003, Peoples R China.; Hu, RG (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	wdong@ouc.edu.cn; avarsh@caltech.edu; coryhu@sibs.ac.cn; leways@ioz.ac.cn	liu, chao/GQZ-6687-2022; Dong, Wen/AAP-4488-2020	Wadas, Brandon/0000-0003-2796-2384; Dong, Wen/0000-0001-5036-8311	National Natural Science Foundation of China [31171374, 31471277]; Major Basic Research Program [2012CB944404]; National Institutes of Health [R01-DK039520, R01-GM031530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China Grants 31171374 and 31471277 and Major Basic Research Program Grant 2012CB944404 (to W. L.) and by National Institutes of Health Grants R01-DK039520 and R01-GM031530 (to A. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksnes H, 2015, INT REV CEL MOL BIO, V316, P267, DOI 10.1016/bs.ircmb.2015.01.001; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1991, P NATL ACAD SCI USA, V88, P1090, DOI 10.1073/pnas.88.4.1090; Bloom KS, 2014, ANNU REV GENET, V48, P457, DOI 10.1146/annurev-genet-120213-092033; Brower CS, 2014, P NATL ACAD SCI USA, V111, pE4936, DOI 10.1073/pnas.1419587111; Brower CS, 2013, MOL CELL, V50, P161, DOI 10.1016/j.molcel.2013.02.009; Brower CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007757; Camdere G, 2015, ELIFE, V4, DOI 10.7554/eLife.11315; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; CHAPMAN DL, 1994, DEV BIOL, V165, P500, DOI 10.1006/dbio.1994.1270; Chen F, 2002, J BIOL CHEM, V277, P16775, DOI 10.1074/jbc.M201322200; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Crawford ED, 2013, MOL CELL PROTEOMICS, V12, P813, DOI 10.1074/mcp.O112.024372; de Boer E, 2007, J CELL SCI, V120, P731, DOI 10.1242/jcs.003186; Dorsett D, 2012, CURR BIOL, V22, pR240, DOI 10.1016/j.cub.2012.02.046; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Haarhuis JHI, 2014, DEV CELL, V31, P7, DOI 10.1016/j.devcel.2014.09.010; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hirano T, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015792; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Humbard MA, 2013, J BIOL CHEM, V288, P28913, DOI 10.1074/jbc.M113.492108; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Hwang CS, 2008, P NATL ACAD SCI USA, V105, P19188, DOI 10.1073/pnas.0808891105; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kouznetsova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028255; Kudo NR, 2009, J CELL SCI, V122, P2686, DOI 10.1242/jcs.035287; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Lee J, 2003, J CELL SCI, V116, P2781, DOI 10.1242/jcs.00495; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Marston AL, 2014, GENETICS, V196, P31, DOI 10.1534/genetics.112.145144; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; McAleenan A, 2013, NATURE, V493, P250, DOI 10.1038/nature11630; McNicoll F, 2013, CURR TOP DEV BIOL, V102, P1, DOI 10.1016/B978-0-12-416024-8.00001-5; Miller MP, 2013, CURR OPIN CELL BIOL, V25, P687, DOI 10.1016/j.ceb.2013.07.009; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Murayama Y, 2015, CELL, V163, P1628, DOI 10.1016/j.cell.2015.11.030; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Ocampo-Hafalla MT, 2007, CHROMOSOMA, V116, P531, DOI 10.1007/s00412-007-0118-4; Ohkura H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015859; Panigrahi AK, 2011, MOL CELL BIOL, V31, P4335, DOI 10.1128/MCB.06075-11; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Pati D, 2002, MOL CELL BIOL, V22, P8267, DOI 10.1128/MCB.22.23.8267-8277.2002; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Peters JM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011130; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Piatkov KI, 2015, MICROB CELL, V2, P376, DOI 10.15698/mic2015.10.231; Piatkov KI, 2014, P NATL ACAD SCI USA, V111, pE817, DOI 10.1073/pnas.1401639111; Piatkov KI, 2012, MOL CELL, V48, P926, DOI 10.1016/j.molcel.2012.10.012; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Rankin S, 2015, FEBS J, V282, P2413, DOI 10.1111/febs.13301; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Rivera-Rivera I, 2014, P NATL ACAD SCI USA, V111, pE3853, DOI 10.1073/pnas.1414933111; Rossitto M, 2015, SEMIN CELL DEV BIOL, V45, P84, DOI 10.1016/j.semcdb.2015.09.014; Rudra S, 2013, J CELL SCI, V126, P31, DOI 10.1242/jcs.116566; Saha S, 2011, DEV BIOL, V358, P1, DOI 10.1016/j.ydbio.2011.06.043; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Singh VP, 2015, CURR OPIN CELL BIOL, V37, P9, DOI 10.1016/j.ceb.2015.08.003; Song ZH, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.559; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; Sullivan M, 2004, J BIOL CHEM, V279, P1191, DOI 10.1074/jbc.M309761200; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tachibana-Konwalski K, 2013, CURR BIOL, V23, P2534, DOI 10.1016/j.cub.2013.10.052; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Varshavsky A, 2012, PROTEIN SCI, V21, P1634, DOI 10.1002/pro.2148; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Wang HN, 2014, CELL RES, V24, P852, DOI 10.1038/cr.2014.70; Wang JL, 2011, CHEM BIOL, V18, P121, DOI 10.1016/j.chembiol.2010.10.016; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Winters T, 2014, EMBO J, V33, P1256, DOI 10.1002/embj.201387330; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681; Zhang NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069458; Zickler D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016626	98	18	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7426	7438		10.1074/jbc.M116.714964	http://dx.doi.org/10.1074/jbc.M116.714964			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26858254	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000383447600019
J	Sarkar, M; Liu, Y; Qi, JP; Peng, HY; Morimoto, J; Rader, C; Chiorazzi, N; Kodadek, T				Sarkar, Mohosin; Liu, Yun; Qi, Junpeng; Peng, Haiyong; Morimoto, Jumpei; Rader, Christoph; Chiorazzi, Nicholas; Kodadek, Thomas			Targeting Stereotyped B Cell Receptors from Chronic Lymphocytic Leukemia Patients with Synthetic Antigen Surrogates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMBINATORIAL LIBRARIES; PEPTIDE; IMMUNOGLOBULIN; DISCOVERY; ANTIBODY; DYNAMICS; LIGANDS	Chronic lymphocytic leukemia (CLL) is a disease in which a single B-cell clone proliferates relentlessly in peripheral lymphoid organs, bone marrow, and blood. DNA sequencing experiments have shown that about 30% of CLL patients have stereotyped antigen-specific B-cell receptors (BCRs) with a high level of sequence homology in the variable domains of the heavy and light chains. These include many of the most aggressive cases that have IGHV-unmutated BCRs whose sequences have not diverged significantly from the germ line. This suggests a personalized therapy strategy in which a toxin or immune effector function is delivered selectively to the pathogenic B-cells but not to healthy B-cells. To execute this strategy, serum-stable, drug-like compounds able to target the antigen-binding sites of most or all patients in a stereotyped subset are required. We demonstrate here the feasibility of this approach with the discovery of selective, high affinity ligands for CLL BCRs of the aggressive, stereotyped subset 7P that cross-react with the BCRs of several CLL patients in subset 7p, but not with BCRs from patients outside this subset.	[Sarkar, Mohosin; Morimoto, Jumpei; Kodadek, Thomas] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Qi, Junpeng; Peng, Haiyong; Rader, Christoph; Kodadek, Thomas] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Rader, Christoph] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Liu, Yun; Chiorazzi, Nicholas] Feinstein Inst Med Res, Hofstra North Shore LIJ Sch Med, Karches Ctr Chron Lymphocyt Leukemia Res, Manhasset, NY 11030 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Hofstra University; Northwell Health	Kodadek, T (corresponding author), Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA.; Kodadek, T (corresponding author), Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	kodadek@scripps.edu	Qi, Junpeng/AAH-5525-2020; Peng, Haiyong/S-8045-2016; Qi, Junpeng/G-6949-2019; Morimoto, Jumpei/D-9024-2017	Morimoto, Jumpei/0000-0002-8393-9616; Rader, Christoph/0000-0001-9955-3454; Kodadek, Thomas/0000-0003-1930-4795	National Institutes of Health [1 DP3 DK094309, CA081554]; NHLBI, Stanford Proteomics Center [NO1-HV-00242]; NATIONAL CANCER INSTITUTE [R01CA181258, R01CA081554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK094309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, Stanford Proteomics Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1 DP3 DK094309 (to T. K.) and CA081554 (to N. C.), and a contract from the NHLBI, Stanford Proteomics Center, NO1-HV-00242 (to T. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Adhikary R, 2015, BIOCHEMISTRY-US, V54, P2085, DOI 10.1021/bi501417q; Adhikary R, 2012, J BIOL CHEM, V287, P27139, DOI 10.1074/jbc.M112.372698; Agathangelidis A, 2014, LEUKEMIA LYMPHOMA, V55, P2252, DOI 10.3109/10428194.2013.879715; Agathangelidis A, 2012, BLOOD, V119, P4467, DOI 10.1182/blood-2011-11-393694; Aquino C, 2012, NAT CHEM, V4, P99, DOI [10.1038/NCHEM.1200, 10.1038/nchem.1200]; Buhl L, 2002, BRIT J HAEMATOL, V116, P549, DOI 10.1046/j.0007-1048.2001.03311.x; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Catera R, 2008, MOL MED, V14, P665, DOI 10.2119/2008-00102.Catera; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; Doran TM, 2014, ACS COMB SCI, V16, P259, DOI 10.1021/co500030f; Esencay M, 2015, NAT REV DRUG DISCOV, V14, P381, DOI 10.1038/nrd4625; Gao Y, 2015, ACS COMB SCI, V17, P49, DOI 10.1021/co500154e; Gao Y, 2014, JOVE-J VIS EXP, DOI 10.3791/51299; Gao Y, 2013, CHEM BIOL, V20, P360, DOI 10.1016/j.chembiol.2013.01.013; Jaglowski SM, 2010, BLOOD, V116, P3705, DOI 10.1182/blood-2010-04-001230; Lian WL, 2013, J AM CHEM SOC, V135, P11990, DOI 10.1021/ja405106u; Liu Y, 2013, MOL MED, V19, P245, DOI 10.2119/molmed.2013.00082; Messmer BT, 2004, J EXP MED, V200, P519, DOI 10.1084/jem.20040544; Morimoto J, 2014, BIOCONJUGATE CHEM, V25, P1479, DOI 10.1021/bc500226j; Olivos HJ, 2002, ORG LETT, V4, P4057, DOI 10.1021/ol0267578; Sarkar M, 2014, CHEM BIOL, V21, P1670, DOI 10.1016/j.chembiol.2014.10.010; Sarkar M, 2013, J AM SOC MASS SPECTR, V24, P1026, DOI 10.1007/s13361-013-0633-x; Seiler T, 2009, BLOOD, V114, P3615, DOI 10.1182/blood-2009-01-197822; Seo JW, 2010, ORG LETT, V12, P492, DOI 10.1021/ol902660p; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Yan XJ, 2006, P NATL ACAD SCI USA, V103, P11713, DOI 10.1073/pnas.0604564103; Yang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021018	28	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7558	7570		10.1074/jbc.M115.701656	http://dx.doi.org/10.1074/jbc.M115.701656			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26851280	Green Published, hybrid			2022-12-28	WOS:000383447600029
J	Yun, T; Yu, KW; Yang, SS; Cui, YF; Wang, ZX; Ren, HY; Chen, S; Li, L; Liu, XY; Fang, M; Jiang, XJ				Yun, Tao; Yu, Kaiwen; Yang, ShuangShuang; Cui, Yifan; Wang, Zixi; Ren, Huiyu; Chen, She; Li, Lin; Liu, Xiaoyun; Fang, Min; Jiang, Xuejun			Acetylation of p53 Protein at Lysine 120 Up-regulates Apaf-1 Protein and Sensitizes the Mitochondrial Apoptotic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; CYTOCHROME-C; TRANSCRIPTIONAL TARGET; CELL-DEATH; CANCER-CELLS; BINDING; ACTIVATION; INDUCTION; RELEASE; PROCASPASE-9	The p53 tumor suppressor controls cell growth, metabolism, and death by regulating the transcription of various target genes. The target-specific transcriptional activity of p53 is highly regulated. Here we demonstrate that acetylation of p53 at Lys-120 up-regulates its transcriptional activity toward Apaf-1, a core component in the mitochondrial apoptotic pathway, and thus sensitizes caspase activation and apoptosis. We found that histone deacetylase (HDAC) inhibitors, including butyrate, augment Lys-120 acetylation of p53 and thus Apaf-1 expression by inhibiting HDAC1. In p53-null cells, transfection of wild-type but not K120R mutant p53 can restore the p53-dependent sensitivity to butyrate. Strikingly, transfection of acetylation-mimicking K120Q mutant p53 is sufficient to up-regulates Apaf-1 in a manner independent of butyrate treatment. Therefore, HDAC inhibitors can induce p53 acetylation at lysine 120, which in turn enhances mitochondrion-mediated apoptosis through transcriptional up-regulation of Apaf-1.	[Yun, Tao; Cui, Yifan; Wang, Zixi; Ren, Huiyu; Fang, Min] Peking Univ, Peking Tsinghua Ctr Life Sci, Yiheyuan Ave 5, Beijing 100875, Peoples R China; [Yun, Tao] Peking Univ, Acad Adv Interdisciplinary Studies, Yiheyuan Ave 5, Beijing 100875, Peoples R China; [Yun, Tao; Cui, Yifan; Wang, Zixi; Ren, Huiyu; Fang, Min] Peking Univ, Sch Life Sci, Div Cell Biol, Yiheyuan Ave 5, Beijing 100875, Peoples R China; [Yu, Kaiwen; Liu, Xiaoyun] Peking Univ, Coll Chem & Mol Engn, Inst Analyt Chem, Yiheyuan Ave 5, Beijing 100875, Peoples R China; [Yu, Kaiwen; Liu, Xiaoyun] Peking Univ, Coll Chem & Mol Engn, Synthet & Funct Biomol Ctr, Yiheyuan Ave 5, Beijing 100875, Peoples R China; [Yang, ShuangShuang] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Yiheyuan Ave 5, Beijing 100875, Peoples R China; [Chen, She; Li, Lin] Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China; [Yun, Tao; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA	Peking University; Peking University; Peking University; Peking University; Peking University; Peking University; National Institute of Biological Sciences, Beijing; Memorial Sloan Kettering Cancer Center	Fang, M (corresponding author), Peking Univ, Sch Life Sci, Div Cell Biol, Yiheyuan Ave 5, Beijing 100875, Peoples R China.; Liu, XY (corresponding author), Peking Univ, Coll Chem & Mol Engn, Inst Analyt Chem, Yiheyuan Ave 5, Beijing 100875, Peoples R China.; Liu, XY (corresponding author), Peking Univ, Coll Chem & Mol Engn, Synthet & Funct Biomol Ctr, Yiheyuan Ave 5, Beijing 100875, Peoples R China.; Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	xiaoyun.liu@pku.edu.cn; min.fang@pku.edu.cn; jiangx@mskcc.org		Wang, Zixi/0000-0002-9354-1206; Yu, Kaiwen/0000-0002-6050-8477	National Basic Program of China 973 Program [2013CB910104]; National Science Foundation of China [31271524]; Peking University; National Institutes of Health [R01CA166413, R01GM113013]; Memorial Sloan Kettering Cancer Center [P30 CA008748]; NATIONAL CANCER INSTITUTE [R01CA166413, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113013] Funding Source: NIH RePORTER	National Basic Program of China 973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University(Peking University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Basic Program of China 973 Program Grant (2013CB910104), National Science Foundation of China Grant 31271524, a startup fund from Peking University, National Institutes of Health Grants R01CA166413 and R01GM113013, and Memorial Sloan Kettering Cancer Center Support Grant/Core Grant P30 CA008748. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Cianfrocca R, 2008, CELL DEATH DIFFER, V15, P354, DOI 10.1038/sj.cdd.4402264; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fortin A, 2001, J CELL BIOL, V155, P207, DOI 10.1083/jcb.200105137; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kraker AJ, 2003, MOL CANCER THER, V2, P401; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lobera M, 2013, NAT CHEM BIOL, V9, P319, DOI [10.1038/nchembio.1223, 10.1038/NCHEMBIO.1223]; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; Marek L, 2013, J MED CHEM, V56, P427, DOI 10.1021/jm301254q; Medina V, 1997, CANCER RES, V57, P3697; Mellert HS, 2011, J BIOL CHEM, V286, P4264, DOI 10.1074/jbc.M110.184663; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Robles AI, 2001, CANCER RES, V61, P6660; Sen N, 2013, MOL CELL, V52, P406, DOI 10.1016/j.molcel.2013.09.003; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Thompson H. J., 1992, CANCER EPIDEM BIOMAR, V1, P697; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang XD, 2001, GENE DEV, V15, P2922; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhang J, 2014, CELL MOL LIFE SCI, V71, P3885, DOI 10.1007/s00018-014-1656-6; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	41	28	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7386	7395		10.1074/jbc.M115.706341	http://dx.doi.org/10.1074/jbc.M115.706341			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26851285	hybrid, Green Published			2022-12-28	WOS:000383447600015
J	Zielonka, J; Zielonka, M; VerPlank, L; Cheng, G; Hardy, M; Ouari, O; Ayhan, MM; Podsiadly, R; Sikora, A; Lambeth, JD; Kalyanaraman, B				Zielonka, Jacek; Zielonka, Monika; VerPlank, Lynn; Cheng, Gang; Hardy, Micael; Ouari, Olivier; Ayhan, Mehmet Menaf; Podsiadly, Radoslaw; Sikora, Adam; Lambeth, J. David; Kalyanaraman, Balaraman			Mitigation of NADPH Oxidase 2 Activity as a Strategy to Inhibit Peroxynitrite Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						high throughput screening (HTS); NADPH oxidase; reactive nitrogen species (RNS); reactive oxygen species (ROS); superoxide ion; NADPH oxidase inhibitors; fluorescence probes	REACTIVE OXYGEN; NITRIC-OXIDE; EXTRACELLULAR-SUPEROXIDE; THERAPEUTIC TARGETS; NOX INHIBITORS; IN-VIVO; CELLS; DISEASE; BIOLOGY; CANCER	Using high throughput screening-compatible assays for superoxide and hydrogen peroxide, we identified potential inhibitors of the NADPH oxidase (Nox2) isoform from a small library of bioactive compounds. By using multiple probes (hydroethidine, hydropropidine, Amplex Red, and coumarin boronate) with well defined redox chemistry that form highly diagnostic marker products upon reaction with superoxide (O2 arrange=stack.), hydrogen peroxide (H2O2), and peroxynitrite (ONOO-), the number of false positives was greatly decreased. Selected hits for Nox2 were further screened for their ability to inhibit ONOO- formation in activated macrophages. A new diagnostic marker product for ONOO- is reported. We conclude that the newly developed high throughput screening/reactive oxygen species assays could also be used to identify potential inhibitors of ONOO- formed from Nox2-derived O2. and nitric oxide synthase-derived nitric oxide.	[Zielonka, Jacek; Zielonka, Monika; Cheng, Gang; Podsiadly, Radoslaw; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Zielonka, Jacek; Zielonka, Monika; Cheng, Gang; Podsiadly, Radoslaw; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Radical Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [VerPlank, Lynn] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Hardy, Micael; Ouari, Olivier; Ayhan, Mehmet Menaf] Aix Marseille Univ, CNRS, ICR UMR 7273, F-13397 Marseille, France; [Sikora, Adam] Lodz Univ Technol, Fac Chem, Inst Appl Radiat Chem, Zeromskiego 116, PL-90924 Lodz, Poland; [Lambeth, J. David] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Podsiadly, Radoslaw] Lodz Univ Technol, Fac Chem, Inst Polymer & Dye Technol, Stefanowskiego 12-16, PL-90924 Lodz, Poland	Medical College of Wisconsin; Medical College of Wisconsin; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Aix-Marseille Universite; Lodz University of Technology; Emory University; Lodz University of Technology	Zielonka, J; Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jzielonk@mcw.edu; balarama@mcw.edu	AYHAN, MEHMET MENAF/AAY-3312-2020; Podsiadly, Radoslaw/P-1732-2019; Hardy, micael/ABF-3357-2020; Zielonka, Jacek/N-9546-2014; Sikora, Adam B/I-2756-2014	AYHAN, MEHMET MENAF/0000-0001-5367-2220; Podsiadly, Radoslaw/0000-0002-7822-8182; Hardy, micael/0000-0003-2976-7785; Zielonka, Jacek/0000-0002-2524-0145; Sikora, Adam B/0000-0002-4962-8945; Ouari, Olivier/0000-0003-4320-4313	National Institutes of Health [R01 HL073056]; Molecular Libraries Probe Development Network [U54 HG005032]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073056] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI102197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Libraries Probe Development Network; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 HL073056 (to B. K.) and in part by Molecular Libraries Probe Development Network Grant U54 HG005032. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Altenhofer S, 2015, ANTIOXID REDOX SIGN, V23, P406, DOI 10.1089/ars.2013.5814; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Beckman JS, 2009, ARCH BIOCHEM BIOPHYS, V484, P114, DOI 10.1016/j.abb.2009.03.013; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Bonner MY, 2012, CELL MOL LIFE SCI, V69, P2435, DOI 10.1007/s00018-012-1017-2; Borbely G, 2010, J MED CHEM, V53, P6758, DOI 10.1021/jm1004368; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Burkhart RA, 2013, MOL CANCER RES, V11, P901, DOI 10.1158/1541-7786.MCR-12-0699; Cifuentes-Pagano E, 2014, ANTIOXID REDOX SIGN, V20, P2741, DOI 10.1089/ars.2013.5620; COHEN HJ, 1980, BLOOD, V56, P23; COOKSON EA, 1966, J CHEM SOC C, P2003, DOI 10.1039/j39660002003; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Daiber A, 2004, FREE RADICAL BIO MED, V36, P101, DOI 10.1016/j.freeradbiomed.2003.10.012; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Goy R, 2013, EUR J INORG CHEM, V2013, P4466, DOI 10.1002/ejic.201300537; Guzik TJ, 2006, DRUG DISCOV TODAY, V11, P524, DOI 10.1016/j.drudis.2006.04.003; Hecker L, 2012, CELL MOL LIFE SCI, V69, P2365, DOI 10.1007/s00018-012-1012-7; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Hirano K, 2015, ANTIOXID REDOX SIGN, V23, P358, DOI 10.1089/ars.2014.6202; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Khan M, 2016, BRAIN RES, V1630, P159, DOI 10.1016/j.brainres.2015.11.015; KUMAR K, 1987, INORG CHEM, V26, P2706, DOI 10.1021/ic00263a030; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Li Y, 2015, ACS MED CHEM LETT, V6, P1047, DOI 10.1021/acsmedchemlett.5b00287; Michalski R, 2013, FREE RADICAL BIO MED, V54, P135, DOI 10.1016/j.freeradbiomed.2012.09.018; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Nisimoto Y, 2014, BIOCHEMISTRY-US, V53, P5111, DOI 10.1021/bi500331y; Oba M, 2001, ORGANOMETALLICS, V20, P4287, DOI 10.1021/om010337p; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; RADI R, 1991, J BIOL CHEM, V266, P4244; Seitz PM, 2010, J BIOMOL SCREEN, V15, P388, DOI 10.1177/1087057109359687; Seredenina T, 2015, FREE RADICAL BIO MED, V86, P239, DOI 10.1016/j.freeradbiomed.2015.05.023; Sikora A, 2013, CHEM RES TOXICOL, V26, P856, DOI 10.1021/tx300499c; Sikora A, 2011, CHEM RES TOXICOL, V24, P687, DOI 10.1021/tx100439a; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Streeter J, 2013, CARDIOVASC THER, V31, P125, DOI 10.1111/j.1755-5922.2011.00310.x; Teufelhofer O, 2003, TOXICOL SCI, V76, P376, DOI 10.1093/toxsci/kfg234; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; Wind S, 2010, BRIT J PHARMACOL, V161, P885, DOI 10.1111/j.1476-5381.2010.00920.x; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Ximenes VF, 2015, J INORG BIOCHEM, V146, P61, DOI 10.1016/j.jinorgbio.2015.02.014; Ye YZ, 2007, J BIOL CHEM, V282, P6324, DOI 10.1074/jbc.M610800200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhao YY, 2010, CANCER RES, V70, P9287, DOI 10.1158/0008-5472.CAN-10-2664; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka Jacek, 2015, Methods Mol Biol, V1264, P171, DOI 10.1007/978-1-4939-2257-4_16; Zielonka J, 2014, J BIOL CHEM, V289, P16176, DOI 10.1074/jbc.M114.548693; Zielonka J, 2013, FREE RADICAL BIO MED, V65, P1310, DOI 10.1016/j.freeradbiomed.2013.09.017; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080	64	48	48	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7029	7044		10.1074/jbc.M115.702787	http://dx.doi.org/10.1074/jbc.M115.702787			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26839313	Green Published, hybrid			2022-12-28	WOS:000373299700038
J	Chavez-Vargas, L; Adame-Garcia, SR; Cervantes-Villagrana, RD; Castillo-Kauil, A; Bruystens, JGH; Fukuhara, S; Taylor, SS; Mochizuki, N; Reyes-Cruz, G; Vazquez-Prado, J				Chavez-Vargas, Lydia; Rafael Adame-Garcia, Sendi; Daniel Cervantes-Villagrana, Rodolfo; Castillo-Kauil, Alejandro; Bruystens, Jessica G. H.; Fukuhara, Shigetomo; Taylor, Susan S.; Mochizuki, Naoki; Reyes-Cruz, Guadalupe; Vazquez-Prado, Jose			Protein Kinase A (PKA) Type I Interacts with P-Rex1, a Rac Guanine Nucleotide Exchange Factor: EFFECT ON PKA LOCALIZATION AND P-Rex1 SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						guanine nucleotide exchange factor (GEF); PDZ domain; protein kinase; protein kinase A (PKA); Rac (Rac GTPase); signal transduction	G-BETA-GAMMA; CANCER-CELL-MIGRATION; ANCHORING PROTEIN; CYCLIC-AMP; BREAST-CANCER; AKAP-LBC; REGULATORY SUBUNITS; MAMMALIAN TARGET; ACTIVATION; CAMP	Morphology of migrating cells is regulated by Rho GTPases and fine-tuned by protein interactions and phosphorylation. PKA affects cell migration potentially through spatiotemporal interactions with regulators of Rho GTPases. Here we show that the endogenous regulatory (R) subunit of type I PKA interacts with P-Rex1, a Rac guanine nucleotide exchange factor that integrates chemotactic signals. Type I PKA holoenzyme interacts with P-Rex1 PDZ domains via the CNB B domain of RI, which when expressed by itself facilitates endothelial cell migration. P-Rex1 activation localizes PKA to the cell periphery, whereas stimulation of PKA phosphorylates P-Rex1 and prevents its activation in cells responding to SDF-1 (stromal cell-derived factor 1). The P-Rex1 DEP1 domain is phosphorylated at Ser-436, which inhibits the DH-PH catalytic cassette by direct interaction. In addition, the P-Rex1 C terminus is indirectly targeted by PKA, promoting inhibitory interactions independently of the DEP1-PDZ(2) region. A P-Rex1 S436A mutant construct shows increased RacGEF activity and prevents the inhibitory effect of forskolin on sphingosine 1-phosphate-dependent endothelial cell migration. Altogether, these results support the idea that P-Rex1 contributes to the spatiotemporal localization of type I PKA, which tightly regulates this guanine exchange factor by a multistep mechanism, initiated by interaction with the PDZ domains of P-Rex1 followed by direct phosphorylation at the first DEP domain and putatively indirect regulation of the C terminus, thus promoting inhibitory intramolecular interactions. This reciprocal regulation between PKA and P-Rex1 might represent a key node of integration by which chemotactic signaling is fine-tuned by PKA.	[Vazquez-Prado, Jose] CINVESTAV IPN, Dept Pharmacol, Av Inst Politecn Nacl 2508, Mexico City 07360, DF, Mexico; [Rafael Adame-Garcia, Sendi; Castillo-Kauil, Alejandro; Reyes-Cruz, Guadalupe] CINVESTAV IPN, Dept Cell Biol, Mexico City 07360, DF, Mexico; [Fukuhara, Shigetomo; Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr, Res Inst NCV, Dept Cell Biol, Osaka 5658565, Japan; [Bruystens, Jessica G. H.; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; National Cerebral & Cardiovascular Center - Japan; University of California System; University of California San Diego; University of California System; University of California San Diego	Vazquez-Prado, J (corresponding author), CINVESTAV IPN, Dept Pharmacol, Av Inst Politecn Nacl 2508, Mexico City 07360, DF, Mexico.	jvazquez@cinvestav.mx	Cervantes-Villagrana, Rodolfo Daniel/E-6804-2019; Cervantes-Villagrana, Rodolfo Daniel/T-6458-2019; VAZQUEZ-PRADO, JOSE/C-1630-2017	Cervantes-Villagrana, Rodolfo Daniel/0000-0002-6599-7994; VAZQUEZ-PRADO, JOSE/0000-0001-5797-6643	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) [152434, 240119]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26670107] Funding Source: KAKEN	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) Grants 152434 (to J. V.-P.) and 240119 (to G. R.-C.).	Ledezma-Sanchez BA, 2010, BIOCHEM BIOPH RES CO, V391, P1647, DOI 10.1016/j.bbrc.2009.12.108; Bachmann VA, 2013, P NATL ACAD SCI USA, V110, P8531, DOI 10.1073/pnas.1215902110; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Barber MA, 2012, BIOCHEM J, V443, P173, DOI 10.1042/BJ20112078; Bracho-Valdes I, 2011, IUBMB LIFE, V63, P896, DOI 10.1002/iub.558; Burdyga A, 2013, BBA-MOL CELL RES, V1833, P2664, DOI 10.1016/j.bbamcr.2013.06.011; Burgers PP, 2012, J BIOL CHEM, V287, P43789, DOI 10.1074/jbc.M112.395970; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Campbell AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053982; Montero JC, 2013, CELL SIGNAL, V25, P2281, DOI 10.1016/j.cellsig.2013.07.018; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Damoulakis G, 2014, J CELL SCI, V127, P2589, DOI 10.1242/jcs.153049; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Di Zazzo E, 2014, SCI WORLD J, DOI 10.1155/2014/565839; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Feng H, 2014, ONCOGENE, V33, P2504, DOI 10.1038/onc.2013.198; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Goicoechea SM, 2014, CELL ADHES MIGR, V8, P535, DOI 10.4161/cam.28721; Guilluy C, 2011, NAT PROTOC, V6, P2050, DOI 10.1038/nprot.2011.411; Hernandez-Garcia R, 2015, VASC PHARMACOL, V74, P60, DOI 10.1016/j.vph.2015.10.003; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hill K, 2006, METHOD ENZYMOL, V406, P26, DOI 10.1016/S0076-6879(06)06003-4; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Johnson KR, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-125; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; Kim EK, 2012, EXP MOL MED, V44, P483, DOI 10.3858/emm.2012.44.8.055; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; Lee JW, 2014, ANTICANCER RES, V34, P3447; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Lissandron V, 2006, J MUSCLE RES CELL M, V27, P399, DOI 10.1007/s10974-006-9077-2; Lu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081220; Lucato CM, 2015, J BIOL CHEM, V290, P20827, DOI 10.1074/jbc.M115.660456; Guzman-Hernandez ML, 2009, J BIOL CHEM, V284, P18334, DOI 10.1074/jbc.M109.008839; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1913, DOI 10.1074/jbc.M506034200; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1921, DOI 10.1074/jbc.M506035200; Means CK, 2011, P NATL ACAD SCI USA, V108, pE1227, DOI 10.1073/pnas.1107182108; Meiri D, 2012, MOL CELL, V45, P642, DOI 10.1016/j.molcel.2012.01.027; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Mizuno R, 2014, J EXP MED, V211, P1123, DOI 10.1084/jem.20132112; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; O'Leary AP, 2015, J CELL PHYSIOL, V230, P356, DOI 10.1002/jcp.24716; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Rivard RL, 2009, CELL MOTIL CYTOSKEL, V66, P693, DOI 10.1002/cm.20399; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Smith FD, 2011, CELL CYCLE, V10, P731, DOI 10.4161/cc.10.5.14902; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Stefan E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1605; Takahashi M, 2013, J BIOL CHEM, V288, P27712, DOI 10.1074/jbc.M113.466904; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Urano D, 2008, CELL SIGNAL, V20, P1545, DOI 10.1016/j.cellsig.2008.04.009; van Buul JD, 2014, CELL ADHES MIGR, V8, P108, DOI 10.4161/cam.27599; Vazquez-Prado J, 2004, METHOD ENZYMOL, V390, P259; Waters JE, 2008, J CELL SCI, V121, P2892, DOI 10.1242/jcs.030353; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Welch Heidi C E, 2015, Small GTPases, V6, P49, DOI 10.4161/21541248.2014.973770; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005; Zimmerman NP, 2015, MOL CARCINOGEN, V54, P203, DOI 10.1002/mc.22091	63	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6182	6199		10.1074/jbc.M115.712216	http://dx.doi.org/10.1074/jbc.M115.712216			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797121	Green Published, hybrid			2022-12-28	WOS:000372894200012
J	Pozzi, N; Chen, ZW; Di Cera, E				Pozzi, Nicola; Chen, Zhiwei; Di Cera, Enrico			How the Linker Connecting the Two Kringles Influences Activation and Conformational Plasticity of Prothrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						coagulation factor; enzyme mechanism; kinetics; protease; structure-function	COAGULATION FACTOR-XA; ALTERNATING-LASER EXCITATION; GAMMA-CARBOXYGLUTAMIC ACID; K-DEPENDENT PROTEINS; FACTOR-VA; BLOOD-COAGULATION; MEMBRANE-BINDING; CRYSTAL-STRUCTURE; ACTIVE-SITE; COMPLEX	A flexible linker (Lnk2) composed of 26 amino acids connects kringle-1 to kringle-2 in the coagulation factor prothrombin. Recent studies point to Lnk2 as a key determinant of the structure and function of this zymogen. Using a combination of mutagenesis, structural biology, and single molecule spectroscopy, we show how Lnk2 influences activation and conformational plasticity of prothrombin. Scrambling the sequence of Lnk2 is inconsequential on activation, and so is extension by as many as 22 residues. On the other hand, below a critical length of 15 residues, the rate of prothrombin activation increases (10-fold) in the absence of cofactor Va and decreases (3-fold) in the presence of cofactor. Furthermore, activation by prothrombinase takes place without preference along the prethrombin-2 (cleavage at Arg(271) first) or meizothrombin (cleavage at Arg(320) first) pathways. Notably, these transitions in the rate and pathway of activation require the presence of phospholipids, pointing to an important physiological role for Lnk2 when prothrombin is anchored to the membrane. Two new crystal structures of prothrombin lacking 22 (ProT146-167) or 14 (ProT154-167) residues of Lnk2 document striking conformational rearrangements of domains located across this linker. FRET measurements of freely diffusing single molecules prove that these structural transitions are genuine properties of the zymogen in solution. These findings support a molecular model of prothrombin activation where Lnk2 presents the sites of cleavage at Arg(271) and Arg(320) to factor Xa in different orientations by pivoting the C-terminal kringle-2/protease domain pair on the N-terminal Gla domain/kringle-1 pair anchored to the membrane.	[Pozzi, Nicola; Chen, Zhiwei; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu	Pozzi, Nicola/AAE-4910-2020; Pozzi, Nicola/AAV-4876-2021	Pozzi, Nicola/0000-0003-2309-7100	American Heart Association [15SDG25550094]; National Institutes of Health Research [HL049413, HL073813, HL112303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112303, R29HL049413, R01HL073813, R01HL049413] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by American Heart Association Grant 15SDG25550094 (to N. P.) and the National Institutes of Health Research Grants HL049413, HL073813, and HL112303 (to E. D. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; BOARD PG, 1983, BRIT J HAEMATOL, V54, P245, DOI 10.1111/j.1365-2141.1983.tb02092.x; Bradford HN, 2013, J BIOL CHEM, V288, P27789, DOI 10.1074/jbc.M113.502005; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Bukys MA, 2008, THROMB HAEMOSTASIS, V99, P511, DOI 10.1160/TH07-08-0532; Bush LA, 2006, J BIOL CHEM, V281, P7183, DOI 10.1074/jbc.M512082200; Chen L, 2003, J BIOL CHEM, V278, P27564, DOI 10.1074/jbc.M302707200; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DANG QD, 1995, P NATL ACAD SCI USA, V92, P5977, DOI 10.1073/pnas.92.13.5977; Dang QD, 1997, NAT BIOTECHNOL, V15, P146, DOI 10.1038/nbt0297-146; DEGEN SJF, 1987, BIOCHEMISTRY-US, V26, P6165, DOI 10.1021/bi00393a033; Deguchi H, 1997, BIOCHEM J, V321, P729, DOI 10.1042/bj3210729; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREEDMAN SJ, 1995, J BIOL CHEM, V270, P7980, DOI 10.1074/jbc.270.14.7980; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; Gopich IV, 2007, J PHYS CHEM B, V111, P12925, DOI 10.1021/jp075255e; HARLOS K, 1987, NATURE, V330, P82, DOI 10.1038/330082a0; Haynes LM, 2012, J BIOL CHEM, V287, P38647, DOI 10.1074/jbc.M112.407791; Huang MD, 2003, NAT STRUCT BIOL, V10, P751, DOI 10.1038/nsb971; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; Joosten RP, 2011, BIOINFORMATICS, V27, P3392, DOI 10.1093/bioinformatics/btr590; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kim PY, 2007, J BIOL CHEM, V282, P32568, DOI 10.1074/jbc.M701781200; Koklic T, 2015, BIOCHEM J, V467, P37, DOI 10.1042/BJ20141177; KOTKOW KJ, 1993, J BIOL CHEM, V268, P15633; KOTKOW KJ, 1995, J BIOL CHEM, V270, P4551, DOI 10.1074/jbc.270.9.4551; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kroh HK, 2011, J BIOL CHEM, V286, P23345, DOI 10.1074/jbc.M111.230292; Lechtenberg BC, 2013, BLOOD, V122, P2777, DOI 10.1182/blood-2013-06-511733; Lee CJ, 2011, J THROMB HAEMOST, V9, P2123, DOI 10.1111/j.1538-7836.2011.04463.x; Lee CJ, 2010, BIOPHYS CHEM, V149, P28, DOI 10.1016/j.bpc.2010.03.011; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Morrissey JH, 2010, THROMB RES, V125, pS23, DOI 10.1016/j.thromres.2010.01.027; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; NAYAL M, 1994, P NATL ACAD SCI USA, V91, P817, DOI 10.1073/pnas.91.2.817; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; Nomura S, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-014-0066-z; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelc LA, 2015, BIOCHEMISTRY-US, V54, P1457, DOI 10.1021/acs.biochem.5b00014; Petrovan RJ, 1998, BIOCHEMISTRY-US, V37, P1185, DOI 10.1021/bi971948h; Pozzi N, 2014, P NATL ACAD SCI USA, V111, P7630, DOI 10.1073/pnas.1403779111; Pozzi N, 2013, J BIOL CHEM, V288, P22734, DOI 10.1074/jbc.M113.466946; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; PRICE PA, 1983, METHOD ENZYMOL, V91, P13; PRZYSIECKI CT, 1987, P NATL ACAD SCI USA, V84, P7856, DOI 10.1073/pnas.84.22.7856; Qureshi SH, 2007, BIOCHEM J, V407, P427, DOI 10.1042/BJ20070735; ROSING J, 1980, J BIOL CHEM, V255, P274; Shim JY, 2015, BIOPHYS CHEM, V199, P46, DOI 10.1016/j.bpc.2015.02.003; Srivasatava KR, 2014, BIOCHEM J, V459, P229, DOI 10.1042/BJ20131099; TANEDA H, 1994, J BIOCHEM-TOKYO, V116, P589, DOI 10.1093/oxfordjournals.jbchem.a124565; TANS G, 1991, J BIOL CHEM, V266, P21864; WALKER RK, 1994, J BIOL CHEM, V269, P27441; Weinreb GE, 2003, J BIOL CHEM, V278, P5679, DOI 10.1074/jbc.M208423200; Whelihan MF, 2012, BLOOD, V120, P3837, DOI 10.1182/blood-2012-05-427856; Wood JP, 2011, BLOOD, V117, P1710, DOI 10.1182/blood-2010-09-311035; WU JR, 1994, THROMB HAEMOSTASIS, V71, P596; Wu JR, 2002, BIOCHEMISTRY-US, V41, P935, DOI 10.1021/bi0116893; Yegneswaran S, 2004, J BIOL CHEM, V279, P49019, DOI 10.1074/jbc.M406645200; Yegneswaran S, 2003, J BIOL CHEM, V278, P33312, DOI 10.1074/jbc.M305906200	63	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6071	6082		10.1074/jbc.M115.700401	http://dx.doi.org/10.1074/jbc.M115.700401			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26763231	Green Published, hybrid			2022-12-28	WOS:000372894200003
J	Puente, C; Hendrickson, RC; Jiang, XJ				Puente, Cindy; Hendrickson, Ronald C.; Jiang, Xuejun			Nutrient-regulated Phosphorylation of ATG13 Inhibits Starvation-induced Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); autophagy; mammalian target of rapamycin (mTOR); phosphorylation; TOR complex (TORC); Macroautophagy; ULK1	SACCHAROMYCES-CEREVISIAE; KINASE COMPLEX; PROTEIN; ULK1; AMPK; MUTANTS; ORGANIZATION; MACHINERY; INDUCTION; MITOPHAGY	Autophagy is a conserved catabolic process that utilizes a defined series of membrane trafficking events to generate a de novo double-membrane vesicle termed the autophagosome, which matures by fusing to the lysosome. Subsequently, the lysosome facilitates the degradation and recycling of the cytoplasmic cargo. In yeast, the upstream signals that regulate the induction of starvation-induced autophagy are clearly defined. The nutrient-sensing kinase Tor inhibits the activation of autophagy by regulating the formation of the Atg1-Atg13-Atg17 complex, through hyperphosphorylation of Atg13. However, in mammals, the ortholog complex ULK1-ATG13-FIP200 is constitutively formed. As such, the molecular mechanism by which mTOR regulates mammalian autophagy is unknown. Here we report the identification and characterization of novel nutrient-regulated phosphorylation sites on ATG13: Ser-224 and Ser-258. mTOR directly phosphorylates ATG13 on Ser-258 while Ser-224 is modulated by the AMPK pathway. In ATG13 knock-out cells reconstituted with an unphosphorylatable mutant of ATG13, ULK1 kinase activity is more potent, and amino acid starvation induced more rapid ATG13 and ULK1 translocation. These events culminated in a more rapid starvation-induced autophagy response. Therefore, ATG13 phosphorylation plays a crucial role in autophagy regulation.	[Puente, Cindy; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10065 USA; [Puente, Cindy] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10065 USA; [Hendrickson, Ronald C.] Mem Sloan Kettering Canc Ctr, Prote & Microchem Facil, 1275 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	jiangx@mskcc.org			National Institutes of Health NCI Cancer Center Support Grant [P30 CA008748]; NIH [F31GM103248, R01GM113013, R01CA166413]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA166413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113013, F31GM103248] Funding Source: NIH RePORTER	National Institutes of Health NCI Cancer Center Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health NCI Cancer Center Support Grant P30 CA008748 to Microchemistry and Proteomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, NIH F31GM103248 (to C. P.), NIH R01GM113013 (to X. J.), and NIH R01CA166413 (to X. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fujioka Y, 2014, NAT STRUCT MOL BIOL, V21, P513, DOI 10.1038/nsmb.2822; Gammoh N, 2013, NAT STRUCT MOL BIOL, V20, P144, DOI 10.1038/nsmb.2475; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Ha J, 2015, MOL ASPECTS MED, V46, P46, DOI 10.1016/j.mam.2015.08.002; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Petherick KJ, 2015, J BIOL CHEM, V290, P28726, DOI [10.1074/jbc.C114.627778, 10.1074/jbc.A114.627778]; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Wong PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9048	33	125	131	5	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					6026	6035		10.1074/jbc.M115.689646	http://dx.doi.org/10.1074/jbc.M115.689646			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26801615	hybrid, Green Published			2022-12-28	WOS:000372551800046
J	Caropreso, V; Darvishi, E; Turbyville, TJ; Ratnayake, R; Grohar, PJ; McMahon, JB; Woldemichael, GM				Caropreso, Vittorio; Darvishi, Emad; Turbyville, Thomas J.; Ratnayake, Ranjala; Grohar, Patrick J.; McMahon, James B.; Woldemichael, Girma M.			Englerin A Inhibits EWS-FLI1 DNA Binding in Ewing Sarcoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHILDRENS ONCOLOGY GROUP; PROTEIN-KINASE-C; TRANSCRIPTION FACTOR; GENE-EXPRESSION; FUSION PROTEINS; GROWTH-FACTOR; TARGET GENE; IQ DOMAIN; CALCIUM; CANCER	High-throughput screening of extracts from plants, marine, and micro-organisms led to the identification of the extract from the plant Phyttanthus engieri as the most potent inhibitor of EWS-FI.I1 induced luciferase reporter expression. Testing of compounds isolated from this extract in turn led to the identification of Englerin A (EA) as the active constituent of the extract. EA induced both necrosis and apoptosis in Ewing cells subsequent to a G2M accumulation of cells in the cell cycle. It also impacted clonogenic survival and anchorage-independent proliferation while also decreasing the proportion of chemotherapy-resistant cells identified by high ALDH activity. EA also caused a sustained increase in cytosolic calcium levels. EA appears to exert its effect on Ewing cells through a decrease in phosphorylation of EWS-FLI1 and its ability to bind DNA. This effect is mediated, at least in part, through a decrease in the levels of the calcium-dependent protein kinase PKC-13I after a transient up-regulation.	[Caropreso, Vittorio; Darvishi, Emad; Ratnayake, Ranjala; McMahon, James B.] NCI, Mol Targets Lab, NIH, Frederick, MD 21702 USA; [Turbyville, Thomas J.] Leidos Biomed Res Inc, Opt Microscopy & Anal Lab, Frederick, MD 21702 USA; [Woldemichael, Girma M.] Leidos Biomed Res Inc, Basic Sci Program, Mol Targets Lab, Frederick Natl Lab, Frederick, MD 21702 USA; [Grohar, Patrick J.] Van Andel Inst, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA; [Grohar, Patrick J.] Helen DeVos Childrens Hosp, Div Hematol Oncol, Grand Rapids, MI 49503 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Van Andel Institute	Woldemichael, GM (corresponding author), Frederick Natl Lab, Mol Targets Lab, Bldg 538,Rm 131,1050 Boyles St, Frederick, MD 21702 USA.	woldemichaelg@mail.nih.gov	Grohar, Patrick/V-2557-2018; Darvishi, Emad/AAQ-2436-2020	Woldemichael, Girma M/0000-0003-1823-1328	National Institutes of Health, Frederick National Lab, Center for Cancer Research; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZICBC010469] Funding Source: NIH RePORTER	National Institutes of Health, Frederick National Lab, Center for Cancer Research; Frederick National Laboratory for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of National Institutes of Health, Frederick National Lab, Center for Cancer Research. It has also been funded in part with federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Dept. of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government. The authors declare that they have no conflicts of interest with the contents of this article.	Akbulut Y, 2015, ANGEW CHEM INT EDIT, V54, P3787, DOI 10.1002/anie.201411511; Awad O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013943; Boro A, 2012, INT J CANCER, V131, P2153, DOI 10.1002/ijc.27472; Chang YS, 2006, J CELL BIOCHEM, V97, P156, DOI 10.1002/jcb.20623; Cironi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002634; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Deloulme JC, 1997, J BIOL CHEM, V272, P27369, DOI 10.1074/jbc.272.43.27369; Esiashvili N, 2008, J PEDIAT HEMATOL ONC, V30, P425, DOI 10.1097/MPH.0b013e31816e22f3; Folmer F, 2008, BIOCHEM PHARMACOL, V75, P603, DOI 10.1016/j.bcp.2007.07.044; Grohar PJ, 2011, JNCI-J NATL CANCER I, V103, P962, DOI 10.1093/jnci/djr156; Guillon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004932; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Joo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007608; Kim J, 1999, P NATL ACAD SCI USA, V96, P14300, DOI 10.1073/pnas.96.25.14300; Kinsey M, 2009, CANCER RES, V69, P9047, DOI 10.1158/0008-5472.CAN-09-1540; Kovar H, 2010, GENOME MED, V2, DOI 10.1186/gm129; Kumar H, 2014, NAT PROD REP, V31, P109, DOI 10.1039/c3np70065h; Leacock SW, 2012, DIS MODEL MECH, V5, P95, DOI 10.1242/dmm.007401; Li YJ, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2011.52; Linabery AM, 2008, CANCER-AM CANCER SOC, V113, P2575, DOI 10.1002/cncr.23866; Maksimenko A, 2005, EXPERT OPIN THER TAR, V9, P825, DOI 10.1517/14728222.9.4.825; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; Miser JS, 2007, PEDIATR BLOOD CANCER, V49, P894, DOI 10.1002/pbc.21233; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; NagamotoCombs K, 1997, J BIOL CHEM, V272, P6051, DOI 10.1074/jbc.272.9.6051; Nagano A, 2010, INT J CANCER, V126, P2790, DOI 10.1002/ijc.24781; Nakatani F, 2003, J BIOL CHEM, V278, P15105, DOI 10.1074/jbc.M211470200; Olsen RJ, 2001, ONCOGENE, V20, P1756, DOI 10.1038/sj.onc.1204268; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Park S, 2013, CELL CALCIUM, V53, P217, DOI 10.1016/j.ceca.2012.12.001; Ratnayake R, 2009, ORG LETT, V11, P57, DOI 10.1021/ol802339w; Rigor RR, 2010, J CEREBR BLOOD F MET, V30, P1373, DOI 10.1038/jcbfm.2010.21; Rios JL, 2009, CURR PHARM DESIGN, V15, P1212, DOI 10.2174/138161209787846874; Schomburg C, 2013, EUR J MED CHEM, V63, P313, DOI 10.1016/j.ejmech.2013.02.018; Scotlandi K, 2011, EUR J CANCER, V47, P1258, DOI 10.1016/j.ejca.2011.01.007; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sourbier C, 2013, CANCER CELL, V23, P228, DOI 10.1016/j.ccr.2012.12.007; Subbiah V, 2012, DISCOV MED, V13, P405; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Takigami I, 2011, INT J CANCER, V128, P216, DOI 10.1002/ijc.25564; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Toretsky JA, 1997, J NEURO-ONCOL, V31, P9, DOI 10.1023/A:1005716926800; Woldemichael GM, 2011, CANCER RES, V71, P134, DOI 10.1158/0008-5472.CAN-10-0757; Womer RB, 2012, J CLIN ONCOL, V30, P4148, DOI 10.1200/JCO.2011.41.5703; YEE D, 1990, J CLIN INVEST, V86, P1806, DOI 10.1172/JCI114910	46	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10058	10066		10.1074/jbc.M115.701375	http://dx.doi.org/10.1074/jbc.M115.701375			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26961871	hybrid, Green Published			2022-12-28	WOS:000375602800018
J	Agrahari, G; Liang, Z; Glinton, K; Lee, SW; Ploplis, VA; Castellino, FJ				Agrahari, Garima; Liang, Zhong; Glinton, Kristofor; Lee, Shaun W.; Ploplis, Victoria A.; Castellino, Francis J.			Streptococcus pyogenes Employs Strain-dependent Mechanisms of C3b Inactivation to Inhibit Phagocytosis and Killing of Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; COMPLEMENT FACTOR-I; M-PROTEIN; PLASMINOGEN-BINDING; STAPHYLOCOCCUS-AUREUS; SURFACE PROTEIN; CLUMPING FACTOR; GLOBAL BURDEN; CLEAVAGE; VIRULENCE	Evasion of complement-mediated opsonophagocytosis enables group A Streptococcus pyogenes (GAS) to establish infection. Different strain-dependent mechanisms are employed by the host to accomplish this goal. In general, GAS inhibits the amplification of the complement cascade on its cell surface by facilitating the degradation of C3b, an opsonin, to an inactive product, inactivated C3b (iC3b), in a step catalyzed by factor I (FI) and its cofactor, factor H (FH), with or without the participation of human host plasmin (hPm). GAS recruits FH to its cell surface via FH receptors, which are transcriptionally controlled by the two-component cluster of virulence responder-sensor system. The manner in which FI-FH and hPm function together on GAS cells is unknown. Using GAS strain AP53, which strongly binds host human plasminogen/plasmin (hPg/hPm) directly via an hPg/hPm surface receptor (PAM), we show that both FI-FH and hPm sequentially cleave C3b. Whereas FI-FH proteolytically cleaves C3b into iC3b, PAM-bound hPm catalyzes cleavage of iC3b into multiple smaller peptides. Unlike AP53, GAS strain M23ND weakly binds FH and recruits hPg/hPm to its cell surface indirectly via fibrinogen bound to M-protein, M23. In this case, FH-FI cleaves C3b into iC3b, with negligible degradation of iC3b by hPm that is bound to fibrinogen on the cells. AP53 and M23ND display similar resistance to human neutrophil-mediated phagocytosis, which results in a corresponding high lethality in mice after injection of these cells. These results suggest that GAS utilizes diverse mechanisms to degrade C3b and thus to protect bacterial cells from the complement response of the host.	[Agrahari, Garima; Liang, Zhong; Glinton, Kristofor; Lee, Shaun W.; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Agrahari, Garima; Liang, Zhong; Glinton, Kristofor; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu		Glinton, Kristofor/0000-0001-9301-7132	American Heart Association [15PRE23080001]; National Institutes of Health [RO1HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Predoctoral Fellowship 15PRE23080001 (to G. A.) and National Institutes of Health Grant RO1HL013423 (to F. J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrahari G, 2013, J BIOL CHEM, V288, P27494, DOI 10.1074/jbc.M113.494864; Bao YJ, 2014, J BACTERIOL, V196, P4089, DOI 10.1128/JB.02131-14; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bisno AL, 2005, CLIN INFECT DIS, V41, P1150, DOI 10.1086/444505; BOKISCH VA, 1975, P NATL ACAD SCI USA, V72, P1989, DOI 10.1073/pnas.72.6.1989; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Chandrahas V, 2015, J BIOL CHEM, V290, P18833, DOI 10.1074/jbc.M115.655365; Christner R, 1997, J INFECT DIS, V175, P1115, DOI 10.1086/516450; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Dale JB, 2013, VACCINE, V31, pB216, DOI 10.1016/j.vaccine.2012.09.045; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Ezekowitz RA, 2002, NAT IMMUNOL, V3, P510, DOI 10.1038/ni0602-510; Foley JH, 2015, J THROMB HAEMOST, V13, P610, DOI 10.1111/jth.12837; Gustafsson MCU, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003323; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hair PS, 2010, INFECT IMMUN, V78, P1717, DOI 10.1128/IAI.01065-09; Hart SP, 2004, CLIN EXP IMMUNOL, V135, P181, DOI 10.1111/j.1365-2249.2003.02330.x; Hong K, 2007, CURR MICROBIOL, V55, P427, DOI 10.1007/s00284-007-9012-9; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Kwinn LA, 2007, FUTURE MICROBIOL, V2, P75, DOI 10.2217/17460913.2.1.75; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Moses AE, 1997, INFECT IMMUN, V65, P64, DOI 10.1128/IAI.65.1.64-71.1997; Pandiripally V, 2002, INFECT IMMUN, V70, P6206, DOI 10.1128/IAI.70.11.6206-6214.2002; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Perez-Caballero D, 2004, J IMMUNOL, V173, P6899, DOI 10.4049/jimmunol.173.11.6899; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Tsiftsoglou SA, 2005, BIOCHEMISTRY-US, V44, P6239, DOI 10.1021/bi047680t; Winram SB, 1996, MICROBIOL-SGM, V142, P2311, DOI 10.1099/13500872-142-8-2311; WISTEDT AC, 1995, MOL MICROBIOL, V18, P569, DOI 10.1111/j.1365-2958.1995.mmi_18030569.x; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420	37	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9181	9189		10.1074/jbc.M115.704221	http://dx.doi.org/10.1074/jbc.M115.704221			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26945067	hybrid, Green Published			2022-12-28	WOS:000374849000029
J	Chu, TW; MacNeil, DE; Autexier, C				Chu, Tsz Wai; MacNeil, Deanna Elise; Autexier, Chantal			Multiple Mechanisms Contribute to the Cell Growth Defects Imparted by Human Telomerase Insertion in Fingers Domain Mutations Associated with Premature Aging Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; DNA damage response; RNA-protein interaction; telomerase; telomerase reverse transcriptase (TERT); telomere	BONE-MARROW FAILURE; RECESSIVE DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; CAJAL BODIES; TEL-PATCH; GERMLINE MUTATION; PROTEIN TPP1; RECRUITMENT; COMPONENT; PROCESSIVITY	Normal human stem cells rely on low levels of active telomerase to sustain their high replicative requirements. Deficiency in telomere maintenance mechanisms leads to the development of premature aging diseases, such as dyskeratosis congenita and aplastic anemia. Mutations in the unique "insertion in fingers domain" (IFD) in the human telomerase reverse transcriptase catalytic subunit (hTERT) have previously been identified and shown to be associated with dyskeratosis congenita and aplastic anemia. However, little is known about the molecular mechanisms impacted by these IFD mutations. We performed comparative functional analyses of disease-associated IFD variants at the molecular and cellular levels. We report that hTERT-P721R- and hTERT-R811C-expressing cells exhibited growth defects likely due to impaired TPP1-mediated recruitment of these variant enzymes to telomeres. We showed that activity and processivity of hTERT-T726M failed to be stimulated by TPP1-POT1 overexpression and that dGTP usage by this variant was less efficient compared with the wild-type enzyme. hTERT-P785L-expressing cells did not show growth defects, and this variant likely confers cell survival through increased DNA synthesis and robust activity stimulation by TPP1-POT1. Altogether, our data suggest that multiple mechanisms contribute to cell growth defects conferred by the IFD variants.	[Chu, Tsz Wai; MacNeil, Deanna Elise; Autexier, Chantal] Jewish Gen Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Chu, Tsz Wai; Autexier, Chantal] McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada; [MacNeil, Deanna Elise; Autexier, Chantal] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada	Lady Davis Institute; McGill University; McGill University; McGill University	Autexier, C (corresponding author), Jewish Gen Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.; Autexier, C (corresponding author), McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada.; Autexier, C (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada.	chantal.autexier@mcgill.ca			Canadian Institute for Health Research Grant [MOP133449]; McGill University Faculty of Medicine internal studentship; Canadian Institute for Health Research McGill Integrated Cancer Research Training Program studentship; Fonds de la Recherche en Sante du Quebec (FRSQ) studentship; McGill Faculty of Medicine Internal Max Stern recruitment fellowship; Canada Graduate Scholarships-Master's Program; Chercheur National of the FRSQ	Canadian Institute for Health Research Grant(Canadian Institutes of Health Research (CIHR)); McGill University Faculty of Medicine internal studentship; Canadian Institute for Health Research McGill Integrated Cancer Research Training Program studentship; Fonds de la Recherche en Sante du Quebec (FRSQ) studentship; McGill Faculty of Medicine Internal Max Stern recruitment fellowship; Canada Graduate Scholarships-Master's Program; Chercheur National of the FRSQ	This work was supported in part by Canadian Institute for Health Research Grant MOP133449 (to C. A.). All authors declare no conflict of interest with the content of this article.; Supported by a McGill University Faculty of Medicine internal studentship, Canadian Institute for Health Research McGill Integrated Cancer Research Training Program studentship, and a Fonds de la Recherche en Sante du Quebec (FRSQ) studentship.; Supported by a McGill Faculty of Medicine Internal Max Stern recruitment fellowship and the Canada Graduate Scholarships-Master's Program.; Supported by Chercheur National of the FRSQ.	Abreu E, 2011, METHODS MOL BIOL, V735, P125, DOI 10.1007/978-1-61779-092-8_12; Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Ballew BJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003695; Ballew BJ, 2013, HUM GENET, V132, P473, DOI 10.1007/s00439-013-1265-8; Cheung DHC, 2012, FEBS LETT, V586, P3166, DOI 10.1016/j.febslet.2012.06.028; Chu TW, 2016, MOL CELL BIOL, V36, P210, DOI 10.1128/MCB.00746-15; Collopy LC, 2015, BLOOD, V126, P176, DOI 10.1182/blood-2015-03-633388; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; D'Souza Y, 2013, MOL BIOL CELL, V24, P1469, DOI 10.1091/mbc.E12-12-0889; D'Souza Y, 2013, J CELL SCI, V126, P676, DOI 10.1242/jcs.119297; Dalby AB, 2015, J MOL BIOL, V427, P1291, DOI 10.1016/j.jmb.2015.01.008; De Lange T, 2005, COLD SH Q B, V70, P197, DOI 10.1101/sqb.2005.70.032; Deng Z, 2013, P NATL ACAD SCI USA, V110, pE3408, DOI 10.1073/pnas.1300600110; Dokal I, 2011, HEMATOL-AM SOC HEMAT, P480, DOI 10.1182/asheducation-2011.1.480; Frank AK, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005410; Guo YR, 2014, BLOOD, V124, P2767, DOI 10.1182/blood-2014-08-596445; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Holohan B, 2014, J CELL BIOL, V205, P289, DOI 10.1083/jcb.201401012; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Kappei D, 2013, EMBO J, V32, P1681, DOI 10.1038/emboj.2013.105; Kaul Z, 2012, EMBO REP, V13, P52, DOI 10.1038/embor.2011.227; Keller RB, 2012, PEDIATR BLOOD CANCER, V59, P311, DOI 10.1002/pbc.24193; Kirwan M, 2009, HUM MUTAT, V30, P1567, DOI 10.1002/humu.21115; Kocak H, 2014, GENE DEV, V28, P2090, DOI 10.1101/gad.248567.114; Kong CM, 2013, FEBS J, V280, P3180, DOI 10.1111/febs.12326; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Le Guen T, 2013, HUM MOL GENET, V22, P3239, DOI 10.1093/hmg/ddt178; Li JR, 2014, NUCLEIC ACIDS RES, V42, P8527, DOI 10.1093/nar/gku541; Liang J, 2006, HAEMATOLOGICA, V91, P656; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Marrone A, 2007, BLOOD, V110, P4198, DOI 10.1182/blood-2006-12-062851; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Moriarty TJ, 2005, RNA, V11, P1448, DOI 10.1261/rna.2910105; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Ourliac-Garnier I, 2010, J BIOL INORG CHEM, V15, P641, DOI 10.1007/s00775-010-0631-4; Robart AR, 2010, J BIOL CHEM, V285, P4375, DOI 10.1074/jbc.M109.088575; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Schmidt JC, 2014, ELIFE, V3, DOI 10.7554/eLife.03563; Shay JW, 2012, SCIENCE, V336, P1388, DOI 10.1126/science.1222394; Snow BE, 2007, MOL CELL BIOL, V27, P1017, DOI 10.1128/MCB.01866-06; Stern JL, 2012, MOL CELL BIOL, V32, P2384, DOI 10.1128/MCB.00379-12; Tomlinson RL, 2008, MOL BIOL CELL, V19, P3793, DOI 10.1091/mbc.E08-02-0184; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Walne AJ, 2013, HAEMATOLOGICA, V98, P334, DOI 10.3324/haematol.2012.071068; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang F, 2011, METHODS MOL BIOL, V735, P173, DOI 10.1007/978-1-61779-092-8_17; Xi LH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0791-1; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin ZT, 2007, BLOOD, V109, P524, DOI 10.1182/blood-2006-07-035089; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Zaug AJ, 2013, NUCLEIC ACIDS RES, V41, P8969, DOI 10.1093/nar/gkt653; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; Zhu SS, 2014, BIOCHIMIE, V101, P93, DOI 10.1016/j.biochi.2013.12.023	67	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8374	8386		10.1074/jbc.M116.714782	http://dx.doi.org/10.1074/jbc.M116.714782			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26887940	hybrid, Green Published			2022-12-28	WOS:000374773200006
J	Crack, JC; Svistunenko, DA; Munnoch, J; Thomson, AJ; Hutchings, MI; Le Brun, NE				Crack, Jason C.; Svistunenko, Dimitri A.; Munnoch, John; Thomson, Andrew J.; Hutchings, Matthew I.; Le Brun, Nick E.			Differentiated, Promoter-specific Response of [4Fe-4S] NsrR DNA Binding to Reaction with Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-protein interaction; iron; iron-sulfur protein; nitric oxide; spectroscopy; DNA-binding protein; regulator	DINITROSYL-IRON COMPLEXES; ESCHERICHIA-COLI; S-NITROSYLATION; NO; PROTEIN; CLUSTER; REGULATORS; REPRESSOR; FNR; HMP	NsrR is an iron-sulfur cluster protein that regulates the nitric oxide (NO) stress response of many bacteria. NsrR from Streptomyces coelicolor regulates its own expression and that of only two other genes, hmpA1 and hmpA2, which encode HmpA enzymes predicted to detoxify NO. NsrR binds promoter DNA with high affinity only when coordinating a [4Fe-4S] cluster. Here we show that reaction of [4Fe-4S] NsrR with NO affects DNA binding differently depending on the gene promoter. Binding to the hmpA2 promoter was abolished at approximate to 2 NO per cluster, although for the hmpA1 and nsrR promoters, approximate to 4 and approximate to 8 NO molecules, respectively, were required to abolish DNA binding. Spectroscopic and kinetic studies of the NO reaction revealed a rapid, multi-phase, non-concerted process involving up to 8-10 NO molecules per cluster, leading to the formation of several iron-nitrosyl species. A distinct intermediate was observed at approximate to 2 NO per cluster, along with two further intermediates at approximate to 4 and approximate to 6 NO. The NsrR nitrosylation reaction was not significantly affected by DNA binding. These results show that NsrR regulates different promoters in response to different concentrations of NO. Spectroscopic evidence indicates that this is achieved by different NO-FeS complexes.	[Crack, Jason C.; Thomson, Andrew J.; Le Brun, Nick E.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Munnoch, John; Hutchings, Matthew I.] Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Svistunenko, Dimitri A.] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England	University of East Anglia; University of East Anglia; University of Essex	Le Brun, NE (corresponding author), Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	n.le-brun@uea.ac.uk	; Hutchings, Matthew/D-1923-2009	Svistunenko, Dimitri/0000-0001-8060-2738; Le Brun, Nick/0000-0001-9780-4061; Crack, Jason C./0000-0002-4979-1910; Munnoch, John Tyson/0000-0002-9018-6026; Hutchings, Matthew/0000-0001-6628-5940	Biotechnology and Biological Sciences Research Council [BB/J003247/1, BB/L007673/1]; Natural Environment Research Council (NERC); BBSRC [BB/J003247/1, BB/L007673/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/J003247/1 (to N. L. B., M. I. H., and A. J. T.) and BB/L007673/1 (to N. L. B., J. C. C., and A. J. T.) and a Natural Environment Research Council (NERC) Ph.D. studentship (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Broillet MC, 1999, CELL MOL LIFE SCI, V55, P1036, DOI 10.1007/s000180050354; Bruckdorfer Richard, 2005, Molecular Aspects of Medicine, V26, P3, DOI 10.1016/j.mam.2004.09.002; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; Costanzo S, 2001, INORG CHIM ACTA, V318, P1, DOI 10.1016/S0020-1693(01)00402-9; Crack JC, 2015, J BIOL CHEM, V290, P12689, DOI 10.1074/jbc.M115.643072; Crack JC, 2014, ACCOUNTS CHEM RES, V47, P3196, DOI 10.1021/ar5002507; Crack JC, 2014, BIOCHEM J, V463, P83, DOI 10.1042/BJ20140169; Crack JC, 2014, METHODS MOL BIOL, V1122, P33, DOI 10.1007/978-1-62703-794-5_4; Crack JC, 2013, J BIOL CHEM, V288, P11492, DOI 10.1074/jbc.M112.439901; Crack JC, 2012, CURR OPIN CHEM BIOL, V16, P35, DOI 10.1016/j.cbpa.2012.02.009; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Drapier JC, 1997, METHODS, V11, P319, DOI 10.1006/meth.1996.0426; Heurlier K, 2008, J BACTERIOL, V190, P2488, DOI 10.1128/JB.01869-07; Isabella VM, 2009, MOL MICROBIOL, V71, P227, DOI 10.1111/j.1365-2958.2008.06522.x; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kommineni S, 2012, J BACTERIOL, V194, P1679, DOI 10.1128/JB.06486-11; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kwon YM, 2009, J BACTERIOL, V191, P5369, DOI 10.1128/JB.00586-09; Lewandowska H, 2011, DALTON T, V40, P8273, DOI 10.1039/c0dt01244k; Partridge JD, 2009, MOL MICROBIOL, V73, P680, DOI 10.1111/j.1365-2958.2009.06799.x; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; Stevanin TM, 2007, GENE, V398, P62, DOI 10.1016/j.gene.2007.03.021; Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004; Svistunenko DA, 2006, BBA-BIOENERGETICS, V1757, P262, DOI 10.1016/j.bbabio.2006.03.007; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tinberg CE, 2010, J AM CHEM SOC, V132, P18168, DOI 10.1021/ja106290p; Tonzetich ZJ, 2010, J AM CHEM SOC, V132, P6914, DOI 10.1021/ja101002f; Tsai ML, 2015, ACCOUNTS CHEM RES, V48, P1184, DOI 10.1021/ar500459j; Tucker NP, 2010, TRENDS MICROBIOL, V18, P149, DOI 10.1016/j.tim.2009.12.009; Tucker NP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003623; VANIN AF, 1977, BIOFIZIKA+, V22, P850; Vine CE, 2011, FEMS MICROBIOL LETT, V325, P99, DOI 10.1111/j.1574-6968.2011.02425.x; Weiss B, 2006, J BACTERIOL, V188, P829, DOI 10.1128/JB.188.3.829-833.2006; Yuki ET, 2008, BIOCHEMISTRY-US, V47, P13084, DOI 10.1021/bi801342x	40	21	21	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8663	8672		10.1074/jbc.M115.693192	http://dx.doi.org/10.1074/jbc.M115.693192			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26887943	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000374773200029
J	Jattani, RP; Tritapoe, JM; Pomerantz, JL				Jattani, Rakhi P.; Tritapoe, Julia M.; Pomerantz, Joel L.			Cooperative Control of Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling by an Unusual Array of Redundant Repressive Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; lymphoma; NF-kappa B (NF-kB); oncogene; scaffold protein; signal transduction; T-cell receptor (TCR); autoinhibitory domain; CARD11; diffuse large B cell lymphoma	NF-KAPPA-B; SECONDARY STRUCTURE PREDICTION; RESPONSIVE INHIBITORY DOMAIN; CELL LYMPHOMA; STRUCTURAL BASIS; COMBINED IMMUNODEFICIENCY; KINASE-BETA; ACTIVATION; CARMA1; AUTOINHIBITION	Several classes of signaling proteins contain autoinhibitory domains that prevent unwarranted signaling and coordinate the induction of activity in response to external cues. CARD11, a scaffold protein critical for antigen receptor signaling to NF-kappa B, undergoes autoregulation by a poorly understood inhibitory domain (ID), which keeps CARD11 inactive in the absence of receptor triggering through inhibitory intramolecular interactions. This autoinhibitory strategy makes CARD11 highly susceptible to gain-of-function mutations that are frequently observed in diffuse large B cell lymphoma (DLBCL) and that disrupt ID-mediated autoinhibition, leading to constitutive NF-kappa B activity, which can promote lymphoma proliferation. Although DLBCL-associated CARD11 mutations in the caspase recruitment domain (CARD), LATCH domain, and coiled coil have been shown to disrupt intramolecular ID binding, surprisingly, no gain-of-function mutations in the ID itself have been reported and validated. In this study, we solve this paradox and report that the CARD11 ID contains an unusual array of four repressive elements that function cooperatively with redundancy to prevent spontaneous NF-kappa B activation. Our quantitative analysis suggests that potent oncogenic CARD11 mutations must perturb autoinhibition by at least three repressive elements. Our results explain the lack of ID mutations in DLBCL and reveal an unusual autoinhibitory domain structure and strategy for preventing unwarranted scaffold signaling to NF-kappa B.	[Jattani, Rakhi P.; Tritapoe, Julia M.; Pomerantz, Joel L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Biol Chem, Miller Res Bldg,Rm 607,733 N Broadway, Baltimore, MD 21205 USA	Johns Hopkins University	Pomerantz, JL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Biol Chem, Miller Res Bldg,Rm 607,733 N Broadway, Baltimore, MD 21205 USA.	joel.pomerantz@jhmi.edu		Pomerantz, Joel L./0000-0002-5030-1018	National Institutes of Health [RO1CA177600]; Johns Hopkins University Institute for Cell Engineering; NATIONAL CANCER INSTITUTE [R01CA177600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Institute for Cell Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1CA177600 and funds from The Johns Hopkins University Institute for Cell Engineering. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Blonska M, 2012, J IMMUNOL, V188, P3160, DOI 10.4049/jimmunol.1102943; Brohl AS, 2015, J CLIN IMMUNOL, V35, P32, DOI 10.1007/s10875-014-0106-4; Bu R, 2012, LEUKEMIA LYMPHOMA, V53, P1971, DOI 10.3109/10428194.2012.668286; Buchbinder D, 2015, J ALLERGY CLIN IMMUN, V136, P819, DOI 10.1016/j.jaci.2015.03.008; Bunney TD, 2012, STRUCTURE, V20, P2062, DOI 10.1016/j.str.2012.09.005; Chan WP, 2013, MOL CELL BIOL, V33, P429, DOI 10.1128/MCB.00850-12; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; DeBell K, 2007, MOL CELL BIOL, V27, P854, DOI 10.1128/MCB.01400-06; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Greil J, 2013, J ALLERGY CLIN IMMUN, V131, P1376, DOI 10.1016/j.jaci.2013.02.012; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jattani RP, 2016, J BIOL CHEM, V291, P8338, DOI 10.1074/jbc.M116.717322; Jiang CY, 2012, IMMUNOL REV, V246, P141, DOI 10.1111/j.1600-065X.2012.01110.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kobashigawa Y, 2011, P NATL ACAD SCI USA, V108, P20579, DOI 10.1073/pnas.1110712108; Lamason RL, 2010, MOL CELL, V40, P798, DOI 10.1016/j.molcel.2010.11.007; Lamason RL, 2010, BIOCHEMISTRY-US, V49, P8240, DOI 10.1021/bi101052d; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lim KH, 2012, IMMUNOL REV, V246, P359, DOI 10.1111/j.1600-065X.2012.01105.x; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; Montesinos-Rongen M, 2010, ACTA NEUROPATHOL, V120, P529, DOI 10.1007/s00401-010-0709-7; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Peterson JR, 2004, J CELL BIOCHEM, V93, P68, DOI 10.1002/jcb.20184; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shinohara H, 2007, J EXP MED, V204, P3285, DOI 10.1084/jem.20070379; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Snow AL, 2012, J EXP MED, V209, P2247, DOI 10.1084/jem.20120831; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, P477, DOI 10.1016/j.jaci.2012.11.050; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Turvey SE, 2014, J ALLERGY CLIN IMMUN, V134, P276, DOI 10.1016/j.jaci.2014.06.015; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Xu J, 2013, NAT STRUCT MOL BIOL, V20, P1047, DOI 10.1038/nsmb.2623; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0	52	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8324	8336		10.1074/jbc.M115.683714	http://dx.doi.org/10.1074/jbc.M115.683714			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26884335	Green Published, hybrid			2022-12-28	WOS:000374773200002
J	Andrusiak, MG; Jin, YS				Andrusiak, Matthew G.; Jin, Yishi			Context Specificity of Stress-activated Mitogen-activated Protein (MAP) Kinase Signaling: The Story as Told by Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						axon; development; innate immunity; Janus kinase (JAK); oxidative stress; p38 MAPK; regeneration; signal transduction; stress; synapse	ODORANT RECEPTOR EXPRESSION; AXON REGENERATION REQUIRES; P GRANULE COMPONENTS; C. ELEGANS; OXIDATIVE STRESS; LIFE-SPAN; PHYSIOLOGICAL-RESPONSES; TRANSDUCTION PATHWAY; INNATE IMMUNITY; JNK	Stress-associated p38 and JNK mitogen-activated protein (MAP) kinase signaling cascades trigger specific cellular responses and are involved in multiple disease states. At the root of MAP kinase signaling complexity is the differential use of common components on a context-specific basis. The roundworm Caenorhabditis elegans was developed as a system to study genes required for development and nervous system function. The powerful genetics of C. elegans in combination with molecular and cellular dissections has led to a greater understanding of how p38 and JNK signaling affects many biological processes under normal and stress conditions. This review focuses on the studies revealing context specificity of different stress-activated MAPK components in C. elegans.	[Andrusiak, Matthew G.; Jin, Yishi] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Jin, Yishi] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Andrusiak, Matthew G.; Jin, Yishi] Howard Hughes Med Inst, Chevy Chase, MD USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute	Jin, YS (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yijin@ucsd.edu		Jin, Yishi/0000-0002-9371-9860	National Institutes of Health [NS 035546]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS 035546 (to Y. J.). This is the second article in the Thematic Minireview series "Cell Signaling in Simple Organisms." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Berman KS, 2001, GENE, V279, P137, DOI 10.1016/S0378-1119(01)00752-1; Bounoutas A, 2011, P NATL ACAD SCI USA, V108, P3982, DOI 10.1073/pnas.1101360108; Brandt JP, 2015, CURR BIOL, V25, P2228, DOI 10.1016/j.cub.2015.07.037; BRENNER S, 1974, GENETICS, V77, P71; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Caffrey DR, 1999, J MOL EVOL, V49, P567, DOI 10.1007/PL00006578; Chen LZ, 2011, NEURON, V71, P1043, DOI 10.1016/j.neuron.2011.07.009; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Ewbank JJ, 2016, CURR OPIN IMMUNOL, V38, P1, DOI 10.1016/j.coi.2015.09.005; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fisk M, 2014, AM J CARDIOVASC DRUG, V14, P155, DOI 10.1007/s40256-014-0063-6; Geoffroy CG, 2014, CURR OPIN NEUROBIOL, V27, P31, DOI 10.1016/j.conb.2014.02.012; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Inoue A, 2013, CELL REP, V3, P808, DOI 10.1016/j.celrep.2013.02.019; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; JANSSON HB, 1994, J NEMATOL, V26, P430; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Kato Y, 2002, BIOCHEM J, V361, P221, DOI 10.1042/0264-6021:3610221; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim AH, 2002, NEURON, V35, P697, DOI 10.1016/S0896-6273(02)00821-8; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kockel L, 1997, GENE DEV, V11, P1748, DOI 10.1101/gad.11.13.1748; Koga M, 2000, EMBO J, V19, P5148, DOI 10.1093/emboj/19.19.5148; Krieg M, 2015, BIOESSAYS, V37, P335, DOI 10.1002/bies.201400154; Kuznicki KA, 2000, DEVELOPMENT, V127, P2907; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LEWIS JA, 1980, GENETICS, V95, P905; Li C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005603; Li C, 2012, NAT NEUROSCI, V15, P551, DOI 10.1038/nn.3052; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Mizuno T, 2004, EMBO J, V23, P2226, DOI 10.1038/sj.emboj.7600226; Mizuno T, 2008, MOL CELL BIOL, V28, P7041, DOI 10.1128/MCB.00938-08; Mohanta TK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1244-7; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Neupane A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.27189; Nix P, 2014, J NEUROSCI, V34, P629, DOI 10.1523/JNEUROSCI.3859-13.2014; Nix P, 2011, P NATL ACAD SCI USA, V108, P10738, DOI 10.1073/pnas.1104830108; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Orsborn AM, 2007, DEVELOPMENT, V134, P3383, DOI 10.1242/dev.005181; Pagano DJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004997; Pastuhov SI, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2136; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Ren M, 2009, IMMUNITY, V30, P521, DOI 10.1016/j.immuni.2009.03.007; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Sakaguchi A, 2004, J BIOCHEM, V136, P7, DOI 10.1093/jb/mvh097; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schwarz Erich M, 2005, WormBook, P1; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Shivers RP, 2009, CELL HOST MICROBE, V6, P321, DOI 10.1016/j.chom.2009.09.001; Smith P, 2002, DEV BIOL, V251, P333, DOI 10.1006/dbio.2002.0832; Solomon A, 2004, GENETICS, V167, P161, DOI 10.1534/genetics.167.1.161; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tanaka-Hino M, 2002, EMBO REP, V3, P56, DOI 10.1093/embo-reports/kvf001; Tong A, 2009, P NATL ACAD SCI USA, V106, P1457, DOI 10.1073/pnas.0809339106; Tournier Cathy, 2013, Genes Cancer, V4, P397, DOI 10.1177/1947601913486349; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Uno M, 2013, CELL REP, V3, P79, DOI 10.1016/j.celrep.2012.12.018; Vadasz I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046696; van der Hoeven R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002453; van der Vaart A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005733; Villanueva A, 2001, EMBO J, V20, P5114, DOI 10.1093/emboj/20.18.5114; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Wu Z, 2007, P NATL ACAD SCI USA, V104, P15132, DOI 10.1073/pnas.0707001104; Xie YS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003324; Yan D, 2012, NEURON, V76, P534, DOI 10.1016/j.neuron.2012.08.043; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Ziegler K, 2009, CELL HOST MICROBE, V5, P341, DOI 10.1016/j.chom.2009.03.006; Zugasti O, 2014, NAT IMMUNOL, V15, P833, DOI 10.1038/ni.2957	100	37	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7796	7804		10.1074/jbc.R115.711101	http://dx.doi.org/10.1074/jbc.R115.711101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26907690	Green Published, hybrid			2022-12-28	WOS:000374056700003
J	Hu, JX; Stern, M; Gimenez, LE; Wanka, L; Zhu, L; Rossi, M; Meister, J; Inoue, A; Beck-Sickinger, AG; Gurevich, VV; Wess, J				Hu, Jianxin; Stern, Matthew; Gimenez, Luis E.; Wanka, Lizzy; Zhu, Lu; Rossi, Mario; Meister, Jaroslawna; Inoue, Asuka; Beck-Sickinger, Annette G.; Gurevich, Vsevolod V.; Wess, Juergen			A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of G(q/11)-dependent Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-helix receptor; arrestin; cell signaling; G protein; G protein-coupled receptor (GPCR); DREADD; biased signaling	IN-VIVO; FUNCTIONAL SELECTIVITY; NONVISUAL ARRESTINS; LIPID-METABOLISM; STRUCTURAL BASIS; INSULIN-RELEASE; ACTIVATION; DESENSITIZATION; RESIDUES; AGONISM	Designer receptors exclusively activated by a designer drug (DREADDs) are clozapine-N-oxide-sensitive designer G protein-coupled receptors (GPCRs) that have emerged as powerful novel chemogenetic tools to study the physiological relevance of GPCR signaling pathways in specific cell types or tissues. Like endogenous GPCRs, clozapine-N-oxide-activated DREADDs do not only activate heterotrimeric G proteins but can also trigger -arrestin-dependent (G protein-independent) signaling. To dissect the relative physiological relevance of G protein-mediated versus -arrestin-mediated signaling in different cell types or physiological processes, the availability of G protein- and -arrestin-biased DREADDs would be highly desirable. In this study, we report the development of a mutationally modified version of a non-biased DREADD derived from the M-3 muscarinic receptor that can activate G(q/11) with high efficacy but lacks the ability to interact with -arrestins. We also demonstrate that this novel DREADD is active in vivo and that cell type-selective expression of this new designer receptor can provide novel insights into the physiological roles of G protein (G(q/11))-dependent versus -arrestin-dependent signaling in hepatocytes. Thus, this novel G(q/11)-biased DREADD represents a powerful new tool to study the physiological relevance of G(q/11)-dependent signaling in distinct tissues and cell types, in the absence of -arrestin-mediated cellular effects. Such studies should guide the development of novel classes of functionally biased ligands that show high efficacy in various pathophysiological conditions but display a reduced incidence of side effects.	[Hu, Jianxin; Stern, Matthew; Zhu, Lu; Rossi, Mario; Meister, Jaroslawna; Wess, Juergen] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bldg 8A,Room B1A-05,8 Ctr Dr MSC 0810, Bethesda, MD 20892 USA; [Gimenez, Luis E.; Gurevich, Vsevolod V.] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Wanka, Lizzy; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University; Leipzig University; Tohoku University; Japan Science & Technology Agency (JST)	Wess, J (corresponding author), NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bldg 8A,Room B1A-05,8 Ctr Dr MSC 0810, Bethesda, MD 20892 USA.	jwess@helix.nih.gov	Zhu, Lu/N-1073-2017; Gurevich, Vsevolod/A-3236-2008	Zhu, Lu/0000-0003-2716-4649; Gurevich, Vsevolod/0000-0002-3950-5351; Diaz Gimenez, Luis Eduardo/0000-0002-0110-2135; Rossi, Mario/0000-0001-7004-0225	National Institutes of Health Intramural Research Program; NIDDK; United States Department of Health and Human Services; Deutsche Forschungsgemeinschaft [DCRC1052-A3]; National Institutes of Health [GM077561, GM109955]; PRESTO, Japan Science and Technology Agency; Office Of Internatl Science &Engineering [1157751] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM109955] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Department of Health and Human Services; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Intramural Research Program, NIDDK, United States Department of Health and Human Services (to J. H., M. S., L. Z., M. R., J. M., and J. W.), Deutsche Forschungsgemeinschaft Grant DCRC1052-A3 (to L. W.), National Institutes of Health RO1 Grants GM077561 and GM109955 (to V. V. G.), and PRESTO, Japan Science and Technology Agency (to A. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez-Curto E, 2011, MOL PHARMACOL, V80, P1033, DOI 10.1124/mol.111.074674; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Budd DC, 2000, J BIOL CHEM, V275, P19667, DOI 10.1074/jbc.M000492200; Estall JL, 2006, CURR PHARM DESIGN, V12, P1731, DOI 10.2174/138161206776873671; EXTON J H, 1987, Diabetes Metabolism Reviews, V3, P163; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Guettier JM, 2009, P NATL ACAD SCI USA, V106, P19197, DOI 10.1073/pnas.0906593106; Gurevich Vsevolod V, 2014, Curr Protoc Pharmacol, V67, DOI 10.1002/0471141755.ph0210s67; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; Kong KC, 2010, P NATL ACAD SCI USA, V107, P21181, DOI 10.1073/pnas.1011651107; Li JH, 2013, ENDOCRINOLOGY, V154, P3539, DOI 10.1210/en.2012-2127; Li P, 2015, CELL METAB, V21, P455, DOI 10.1016/j.cmet.2015.02.004; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Maggio R, 1996, J BIOL CHEM, V271, P31055, DOI 10.1074/jbc.271.49.31055; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Nakajima K, 2012, MOL PHARMACOL, V82, P575, DOI 10.1124/mol.112.080358; Oki T, 2005, MOL BRAIN RES, V133, P6, DOI 10.1016/j.molbrainres.2004.09.012; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Rossi M, 2015, P NATL ACAD SCI USA, V112, pE6818, DOI 10.1073/pnas.1519430112; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Shonberg J, 2014, MED RES REV, V34, P1286, DOI 10.1002/med.21318; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001; Wess J, 2013, TRENDS PHARMACOL SCI, V34, P385, DOI 10.1016/j.tips.2013.04.006; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; White KL, 2015, J PHARMACOL EXP THER, V352, P98, DOI 10.1124/jpet.114.216820; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Zhou L, 2014, CURR OPIN CELL BIOL, V27, P102, DOI 10.1016/j.ceb.2013.11.010	50	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7809	7820		10.1074/jbc.M115.702282	http://dx.doi.org/10.1074/jbc.M115.702282			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26851281	Green Published, hybrid			2022-12-28	WOS:000374056700005
J	Tahimic, CGT; Long, RK; Kubota, T; Sun, MY; Elalieh, H; Fong, C; Menendez, AT; Wang, YM; Vilardaga, JP; Bikle, DD				Tahimic, Candice G. T.; Long, Roger K.; Kubota, Takuo; Sun, Maggie Yige; Elalieh, Hashem; Fong, Chak; Menendez, Alicia T.; Wang, Yongmei; Vilardaga, Jean-Pierre; Bikle, Daniel D.			Regulation of Ligand and Shear Stress-induced Insulin-like Growth Factor 1 (IGF1) Signaling by the Integrin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin-like growth factor (IGF); integrin; mechanotransduction; osteoblast; shear stress; IGF1 receptor; IGF1 signaling	FOCAL ADHESION KINASE; FACTOR-I RECEPTOR; BONE-FORMATION; BED REST; CELLS; OSTEOBLAST; ACTIVATION; OSTEOCYTES; RESISTANCE; MECHANOTRANSDUCTION	Mechanical loading of the skeleton, as achieved during daily movement and exercise, preserves bone mass and stimulates bone formation, whereas skeletal unloading from prolonged immobilization leads to bone loss. A functional interplay between the insulin-like growth factor 1 receptor (IGF1R), a major player in skeletal development, and integrins, mechanosensors, is thought to regulate the anabolic response of osteogenic cells to mechanical load. The mechanistic basis for this cross-talk is unclear. Here we report that integrin signaling regulates activation of IGF1R and downstream targets in response to both IGF1 and a mechanical stimulus. In addition, integrins potentiate responsiveness of IGF1R to IGF1 and mechanical forces. We demonstrate that integrin-associated kinases, Rous sarcoma oncogene (SRC) and focal adhesion kinase (FAK), display distinct actions on IGF1 signaling; FAK regulates IGF1R activation and its downstream effectors, AKT and ERK, whereas SRC controls signaling downstream of IGF1R. These findings linked to our observation that IGF1 assembles the formation of a heterocomplex between IGF1R and integrin 3 subunit indicate that the regulation of IGF1 signaling by integrins proceeds by direct receptor-receptor interaction as a possible means to translate biomechanical forces into osteoanabolic signals.	[Tahimic, Candice G. T.; Sun, Maggie Yige; Elalieh, Hashem; Fong, Chak; Menendez, Alicia T.; Wang, Yongmei; Bikle, Daniel D.] Vet Affairs Med Ctr, Endocrine Res Unit, San Francisco, CA 94121 USA; [Tahimic, Candice G. T.; Sun, Maggie Yige; Elalieh, Hashem; Fong, Chak; Menendez, Alicia T.; Wang, Yongmei; Bikle, Daniel D.] Univ Calif San Francisco, San Francisco, CA 94158 USA; [Long, Roger K.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Kubota, Takuo] Osaka Univ, Dept Pediat, Osaka 5650871, Japan; [Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15213 USA; [Tahimic, Candice G. T.] NASA, Space Biosci Div, Ames Res Ctr, Moffett Field, CA 94035 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Osaka University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Bikle, DD (corresponding author), 1700 Owens St,MB360, San Francisco, CA 94158 USA.	Daniel.Bikle@ucsf.edu		Vilardaga, Jean-Pierre/0000-0002-1217-1435; Tahimic, Candice/0000-0001-5862-2652	National Institutes of Health (NIAMS) [RO1 AR055924]; National Institutes of Health (NIDKK) [R01 DK087688, R01DK102495]; National Space Biomedical Research Institute [NASA NCC 9-58]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055924, P30AR066262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087688, R01DK102495] Funding Source: NIH RePORTER	National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health (NIDKK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Space Biomedical Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants (RO1 AR055924; NIAMS, to D. D. B.) and R01 DK087688 and R01DK102495; NIDKK, to J. P.-V.).; Supported by postdoctoral fellowship awards from the National Space Biomedical Research Institute (NASA NCC 9-58).	Andersson S, 2009, BIOCHEM BIOPH RES CO, V387, P36, DOI 10.1016/j.bbrc.2009.06.088; ARNAUD SB, 1992, AVIAT SPACE ENVIR MD, V63, P14; Basso N, 2002, BONE, V30, P347, DOI 10.1016/S8756-3282(01)00678-0; BIKLE DD, 1994, J BONE MINER RES, V9, P1789; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Chen LM, 2000, J NEUROSCI, V20, P3776, DOI 10.1523/JNEUROSCI.20-10-03776.2000; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Govoni Kristen E, 2012, Curr Mol Pharmacol, V5, P143; Haapasalo H, 2000, BONE, V27, P351, DOI 10.1016/S8756-3282(00)00331-8; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; HUGHES DE, 1993, J BONE MINER RES, V8, P527; HULTENBY K, 1993, EUR J CELL BIOL, V62, P86; Kaneko K, 2014, BIOCHEM BIOPH RES CO, V447, P352, DOI 10.1016/j.bbrc.2014.04.006; KANNUS P, 1994, BONE, V15, P279, DOI 10.1016/8756-3282(94)90289-5; Kapur S, 2005, J BIOL CHEM, V280, P20163, DOI 10.1074/jbc.M501460200; KATO H, 1993, J BIOL CHEM, V268, P2655; Kubota T, 2013, ACTA ASTRONAUT, V92, P73, DOI 10.1016/j.actaastro.2012.08.007; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Le Roith Derek, 2003, Exp Diabesity Res, V4, P205, DOI 10.1155/EDR.2003.205; Liu WG, 2008, CARCINOGENESIS, V29, P1096, DOI 10.1093/carcin/bgn026; Long RK, 2011, J BONE MINER RES, V26, P2948, DOI 10.1002/jbmr.511; McGarry JG, 2004, FASEB J, V18, P482, DOI 10.1096/fj.04-2210fje; Nauman EA, 1999, ANN BIOMED ENG, V27, P194, DOI 10.1114/1.173; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Rittweger J, 2005, BONE, V36, P1019, DOI 10.1016/j.bone.2004.11.014; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; SAITO T, 1994, J ORTHOP RES, V12, P384, DOI 10.1002/jor.1100120311; Sakai K, 1998, CALCIFIED TISSUE INT, V63, P515, DOI 10.1007/s002239900567; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Sakata T, 2003, BONE, V32, P669, DOI 10.1016/S8756-3282(03)00088-7; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Tahimic Candice G T, 2013, Front Endocrinol (Lausanne), V4, P6, DOI 10.3389/fendo.2013.00006; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Vilardaga JP, 2013, METHOD ENZYMOL, V522, P337, DOI 10.1016/B978-0-12-407865-9.00016-9; Wang YM, 2006, J ENDOCRINOL, V189, P279, DOI 10.1677/joe.1.06351; Westbroek I, 2000, BIOCHEM BIOPH RES CO, V268, P414, DOI 10.1006/bbrc.2000.2154; Zheng B, 1998, P NATL ACAD SCI USA, V95, P11217, DOI 10.1073/pnas.95.19.11217	41	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8140	8149		10.1074/jbc.M115.693598	http://dx.doi.org/10.1074/jbc.M115.693598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26865633	hybrid, Green Published			2022-12-28	WOS:000374056700031
J	Gan, Q; Dai, J; Zhou, HX; Wollmuth, LP				Gan, Quan; Dai, Jian; Zhou, Huan-Xiang; Wollmuth, Lonnie P.			The Transmembrane Domain Mediates Tetramerization of -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); ion channel; ionotropic glutamate receptor; protein assembly; synapse; amino-terminal domain; ligand-binding domain; native PAGE	LIGAND-BINDING DOMAIN; IONOTROPIC GLUTAMATE-RECEPTOR; RETICULUM QUALITY-CONTROL; N-TERMINAL DOMAIN; ENDOPLASMIC-RETICULUM; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ION CHANNELS; DESENSITIZATION; ACTIVATION	AMPA receptors (AMPARs) mediate fast excitatory neurotransmission in the central nervous system. Functional AMPARs are tetrameric complexes with a highly modular structure, consisting of four evolutionarily distinct structural domains: an amino-terminal domain (ATD), a ligand-binding domain (LBD), a channel-forming transmembrane domain (TMD), and a carboxyl-terminal domain (CTD). Here we show that the isolated TMD of the GluA1 AMPAR is fully capable of tetramerization. Additionally, removal of the extracellular domains from the receptor did not affect membrane topology or surface delivery. Furthermore, whereas the ATD and CTD contribute positively to tetramerization, the LBD presents a barrier to the process by reducing the stability of the receptor complex. These experiments pinpoint the TMD as the tetramerization domain for AMPARs, with other domains playing modulatory roles. They also raise intriguing questions about the evolution of iGluRs as well as the mechanisms regulating the biogenesis of AMPAR complexes.	[Gan, Quan; Wollmuth, Lonnie P.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Gan, Quan] SUNY Stony Brook, Grad Program Neurosci, Stony Brook, NY 11794 USA; [Wollmuth, Lonnie P.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Wollmuth, Lonnie P.] SUNY Stony Brook, Ctr Nervous Syst Disorders, Stony Brook, NY 11794 USA; [Dai, Jian; Zhou, Huan-Xiang] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Dai, Jian; Zhou, Huan-Xiang] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Wollmuth, LP (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Ctr Nervous Syst Disorders, Stony Brook, NY 11794 USA.; Wollmuth, LP (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Nervous Syst Disorders, Stony Brook, NY 11794 USA.	lonnie.wollmuth@stonybrook.edu	Gan, Quan/P-1902-2015; zhou, huan/GYJ-4398-2022; Zhou, Huan-Xiang/M-5170-2016	Gan, Quan/0000-0003-4234-7785; Zhou, Huan-Xiang/0000-0001-9020-0302	American Heart Association; National Institutes of Health [NS088479]; NINDS; NIGMS [GM0581879]; Thomas Hartman Center for Parkinson's Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088479] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Thomas Hartman Center for Parkinson's Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an American Heart Association Predoctoral Fellowship (to Q. G.), National Institutes of Health RO1 Grants NS088479 (to L. P. W.) from the NINDS and GM0581879 (to H. Y. Z.) from the NIGMS, and a grant from the Thomas Hartman Center for Parkinson's Research (to L. P. W.). The authors declare no conflict of interest.	Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Dai J, 2013, BIOPHYS J, V104, P2170, DOI 10.1016/j.bpj.2013.04.013; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1362; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Gan Q, 2015, J PHYSIOL-LONDON, V593, P39, DOI 10.1113/jphysiol.2014.273755; Gonzalez J, 2010, P NATL ACAD SCI USA, V107, P9891, DOI 10.1073/pnas.0911854107; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Haering SC, 2014, MEMBRANES, V4, P469, DOI 10.3390/membranes4030469; Herring BE, 2013, NEURON, V77, P1083, DOI 10.1016/j.neuron.2013.01.017; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isacoff EY, 2013, NEURON, V80, P658, DOI 10.1016/j.neuron.2013.10.040; Janovjak H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1231; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; Kazi R, 2013, J NEUROSCI, V33, P12052, DOI 10.1523/JNEUROSCI.5780-12.2013; Kim KS, 2010, J NEUROSCI, V30, P1064, DOI 10.1523/JNEUROSCI.3909-09.2010; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mayer ML, 2011, CURR OPIN NEUROBIOL, V21, P283, DOI 10.1016/j.conb.2011.02.001; MEEKER RB, 1989, NEUROSCIENCE, V33, P157, DOI 10.1016/0306-4522(89)90318-7; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Molina ML, 2004, BIOCHEMISTRY-US, V43, P14924, DOI 10.1021/bi048889+; Ojemalm K, 2013, J MOL BIOL, V425, P2813, DOI 10.1016/j.jmb.2013.04.025; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Penn AC, 2012, NEURON, V76, P503, DOI 10.1016/j.neuron.2012.08.010; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Salussolia CL, 2016, NEUROMETHODS, V106, P3, DOI 10.1007/978-1-4939-2812-5_1; Salussolia CL, 2013, J NEUROSCI, V33, P9840, DOI 10.1523/JNEUROSCI.2626-12.2013; Salussolia CL, 2011, J BIOL CHEM, V286, P40205, DOI 10.1074/jbc.M111.268839; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Shanks NF, 2010, J NEUROSCI, V30, P2728, DOI 10.1523/JNEUROSCI.5146-09.2010; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sukumaran M, 2012, ADV EXP MED BIOL, V970, P241, DOI 10.1007/978-3-7091-0932-8_11; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tulumello DV, 2009, BIOCHEMISTRY-US, V48, P12096, DOI 10.1021/bi9013819; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004	55	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6595	6606		10.1074/jbc.M115.686246	http://dx.doi.org/10.1074/jbc.M115.686246			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26839312	hybrid, Green Published			2022-12-28	WOS:000372894200044
J	Qiao, YC; He, H; Jonsson, P; Sinha, I; Zhao, CY; Dahlman-Wright, K				Qiao, Yichun; He, Huan; Jonsson, Philip; Sinha, Indranil; Zhao, Chunyan; Dahlman-Wright, Karin			AP-1 Is a Key Regulator of Proinflammatory Cytokine TNF alpha-mediated Triple-negative Breast Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 transcription factor (AP-1); breast cancer; ChIP-sequencing (ChIP-seq); gene expression; tumor necrosis factor (TNF)	NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; LARGE GENE LISTS; ESTROGEN-RECEPTOR; INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; BINDING-SITES; C-JUN; INFLAMMATION; EXPRESSION	Triple-negative breast cancer (TNBC) represents a highly aggressive form of breast cancer with limited treatment options. Proinflammatory cytokines such as TNF can facilitate tumor progression and metastasis. However, the mechanistic aspects of inflammation mediated TNBC progression remain unclear. Using ChIP-seq, we demonstrate that the cistrome for the AP-1 transcription factor c-Jun is comprised of 13,800 binding regions in TNF-stimulated TNBC cells. In addition, we show that c-Jun regulates nearly a third of the TNF-regulated transcriptome. Interestingly, high expression level of the c-Jun-regulated pro-invasion gene program is associated with poor clinical outcome in TNBCs. We further demonstrate that c-Jun drives TNF-mediated increase of malignant characteristics of TNBC cells by transcriptional regulation of Ninj1. As exemplified by the CXC chemokine genes clustered on chromosome 4, we demonstrate that NF-B might be a pioneer factor required for the regulation of TNF-inducible inflammatory genes, whereas c-Jun has little effect. Together, our results uncover AP-1 as an important determinant for inflammation-induced cancer progression, rather than inflammatory response.	[Qiao, Yichun; He, Huan; Sinha, Indranil; Zhao, Chunyan; Dahlman-Wright, Karin] Karolinska Inst, Dept Biosci & Nutr, Novum, S-14183 Huddinge, Sweden; [Jonsson, Philip] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, Ctr Mol Oncol, New York, NY 10065 USA; [Dahlman-Wright, Karin] Karolinska Inst, Sci Life Lab, S-17121 Solna, Sweden	Karolinska Institutet; Memorial Sloan Kettering Cancer Center; Karolinska Institutet	Zhao, CY; Dahlman-Wright, K (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Novum, S-14183 Huddinge, Sweden.	chunyan.zhao@ki.se; karin.dahlman-wright@ki.se	He, Huan/AAF-9644-2019; Qiao, yichun/Q-6498-2018	Sinha, Indranil/0000-0002-2513-5927; He, Huan/0000-0001-8123-5765; Jonsson, Philip/0000-0002-1537-0624	Swedish Cancer Society (Cancerfonden); Center for Biosciences	Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Center for Biosciences	This work was supported by the Swedish Cancer Society (Cancerfonden) and the Center for Biosciences. The authors declare that they have no conflicts of interest with the contents of this article.	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Arnott CH, 2002, ONCOGENE, V21, P4728, DOI 10.1038/sj.onc.1205588; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen JS, 2001, BLOOD, V97, P2115, DOI 10.1182/blood.V97.7.2115; Cho SJ, 2013, P NATL ACAD SCI USA, V110, P9362, DOI 10.1073/pnas.1221242110; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dahlman-Wright K, 2012, CARCINOGENESIS, V33, P1684, DOI 10.1093/carcin/bgs223; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fanjul AN, 1998, CANCER RES, V58, P4607; Franco HL, 2015, MOL CELL, V58, P21, DOI 10.1016/j.molcel.2015.02.001; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; Halade GV, 2013, PHARMACOL THERAPEUT, V139, P32, DOI 10.1016/j.pharmthera.2013.03.009; Haldosen LA, 2014, MOL CELL ENDOCRINOL, V382, P665, DOI 10.1016/j.mce.2013.08.005; Hochedlinger K, 2002, ONCOGENE, V21, P2441, DOI 10.1038/sj.onc.1205348; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jurida L, 2015, CELL REP, V10, P726, DOI 10.1016/j.celrep.2015.01.001; Kee JY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-949; Kharman-Biz A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-441; Kim JW, 2001, MOL CELLS, V11, P151; Kyriakis JM, 1999, GENE EXPRESSION, V7, P217; Le Du F, 2015, ONCOTARGET, V6, P12890, DOI 10.18632/oncotarget.3849; Lee HJ, 2010, MOL CELLS, V29, P223, DOI 10.1007/s10059-010-0043-x; Li JJ, 1997, CANCER RES, V57, P3569; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Lou YW, 2011, MOL IMMUNOL, V49, P4, DOI 10.1016/j.molimm.2011.08.006; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Qiao YC, 2015, ONCOTARGET, V6, P7804, DOI 10.18632/oncotarget.3158; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Shiohara M, 1999, BLOOD, V93, P2057, DOI 10.1182/blood.V93.6.2057.406k04_2057_2066; Tang GL, 2001, MOL CELL, V8, P1005, DOI 10.1016/S1097-2765(01)00380-X; Wang B, 2015, FEBS OPEN BIO, V5, P147, DOI 10.1016/j.fob.2015.02.003; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Zhao CY, 2007, CANCER RES, V67, P3955, DOI 10.1158/0008-5472.CAN-06-3505; Zhao CY, 2014, CANCER RES, V74, P3983, DOI 10.1158/0008-5472.CAN-13-3396; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	45	63	65	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5068	5079		10.1074/jbc.M115.702571	http://dx.doi.org/10.1074/jbc.M115.702571			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26792858	hybrid, Green Published			2022-12-28	WOS:000371640600020
J	Singh, AB; Kan, CFK; Dong, B; Liu, JW				Singh, Amar Bahadur; Kan, Chin Fung Kelvin; Dong, Bin; Liu, Jingwen			SREBP2 Activation Induces Hepatic Long-chain Acyl-CoA Synthetase 1 (ACSL1) Expression in Vivo and in Vitro through a Sterol Regulatory Element (SRE) Motif of the ACSL1 C-promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid metabolism; lipid metabolism; liver; transcription promoter; transcription regulation; ACSL1; acyl-CoA synthetase; dietary cholesterol; SREBP; statin	FATTY-ACID-METABOLISM; LIVER; TRANSCRIPTION; CHOLESTEROL; PATHWAY; GENE; HOMEOSTASIS; OXIDATION; INSULIN; GLUCOSE	Long-chain acyl-CoA synthetase 1 (ACSL1) plays a key role in fatty acid metabolism. To identify novel transcriptional modulators of ACSL1, we examined ACSL1 expression in liver tissues of hamsters fed a normal diet, a high fat diet, or a high cholesterol and high fat diet (HCHFD). Feeding hamsters HCHFD markedly reduced hepatic Acsl1 mRNA and protein levels as well as acyl-CoA synthetase activity. Decreases in Acsl1 expression strongly correlated with reductions in hepatic Srebp2 mRNA level and mature Srebp2 protein abundance. Conversely, administration of rosuvastatin (RSV) to hamsters increased hepatic Acsl1 expression. These new findings were reproduced in mice treated with RSV or fed the HCHFD. Furthermore, the RSV induction of acyl-CoA activity in mouse liver resulted in increases in plasma and hepatic cholesterol ester concentrations and reductions in free cholesterol amounts. Investigations on different ACSL1 transcript variants in HepG2 cells revealed that the mRNA expression of C-ACSL1 was specifically regulated by the sterol regulatory element (SRE)-binding protein (SREBP) pathway, and RSV treatment increased the C-ACSL1 abundance from a minor mRNA species to an abundant transcript. We analyzed 5-flanking sequence of exon 1C of the human ACSL1 gene and identified one putative SRE site. By performing a promoter activity assay and DNA binding assays, we firmly demonstrated the key role of this SRE motif in SREBP2-mediated activation of C-ACSL1 gene transcription. Finally, we demonstrated that knockdown of endogenous SREBP2 in HepG2 cells lowered ACSL1 mRNA and protein levels. Altogether, this work discovered an unprecedented link between ACSL1 and SREBP2 via the specific regulation of the C-ACSL1 transcript.	[Singh, Amar Bahadur; Kan, Chin Fung Kelvin; Dong, Bin; Liu, Jingwen] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Liu, JW (corresponding author), VA Palo Alto Hlth Care Syst, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	Jingwen.Liu@va.gov	Singh, Amar B/I-2253-2014	Singh, Amar B/0000-0002-7677-2424	Department of Veterans Affairs (Office of Research and Development, Medical Research Service); National Institutes of Health, NCCIH [1R01AT006336-01A1]; National Center for Complementary & Integrative Health [R01AT006336] Funding Source: NIH RePORTER	Department of Veterans Affairs (Office of Research and Development, Medical Research Service)(US Department of Veterans Affairs); National Institutes of Health, NCCIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Department of Veterans Affairs (Office of Research and Development, Medical Research Service). This work was also supported in part by National Institutes of Health, NCCIH, Grant 1R01AT006336-01A1.	Achouri Y, 2005, BIOCHIMIE, V87, P1149, DOI 10.1016/j.biochi.2005.04.015; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Burri L, 2010, PPAR RES, V2010, DOI 10.1155/2010/542359; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Dong B, 2013, J LIPID RES, V54, P1241, DOI 10.1194/jlr.M032599; Dong B, 2010, J LIPID RES, V51, P1486, DOI 10.1194/jlr.M003566; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Ellis JM, 2010, CURR OPIN LIPIDOL, V21, P212, DOI 10.1097/MOL.0b013e32833884bb; Glosli H, 2005, BBA-MOL CELL BIOL L, V1734, P235, DOI 10.1016/j.bbalip.2005.02.011; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Li LO, 2015, DIABETES, V64, P23, DOI 10.2337/db13-1070; Lopes-Marques M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-271; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; SCHOONJANS K, 1995, J BIOL CHEM, V270, P19269, DOI 10.1074/jbc.270.33.19269; Scorletti E, 2013, ANNU REV NUTR, V33, P231, DOI 10.1146/annurev-nutr-071812-161230; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; SUZUKI H, 1995, J BIOL CHEM, V270, P9676, DOI 10.1074/jbc.270.16.9676; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; Wang YL, 2004, OBES RES, V12, P1781, DOI 10.1038/oby.2004.221; Watkins PA, 2012, BBA-MOL BASIS DIS, V1822, P1411, DOI 10.1016/j.bbadis.2012.02.010; Yan S, 2015, WORLD J GASTROENTERO, V21, P3492, DOI 10.3748/wjg.v21.i12.3492	29	19	22	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5373	5384		10.1074/jbc.M115.696872	http://dx.doi.org/10.1074/jbc.M115.696872			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26728456	hybrid, Green Published			2022-12-28	WOS:000371640600045
J	Ren, C; Zhang, J; Yan, WS; Zhang, YH; Chen, XB				Ren, Cong; Zhang, Jin; Yan, Wensheng; Zhang, Yanhong; Chen, Xinbin			RNA-binding Protein PCBP2 Regulates p73 Expression and p73-dependent Antioxidant Defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON CHAPERONES PCBP1; P53 FAMILY; IN-VIVO; POLY(C)-BINDING PROTEINS; CELL-PROLIFERATION; TARGET; TAP73; DELTA-NP73; SENESCENCE; STABILITY	TAp73, a member of the p53 family tumor suppressors, plays a critical rule in tumor suppression and neuronal development. However, how p73 activity is controlled at the posttranscriptional level is not well understood. Here, we showed that TAp73 activity is regulated by RNA-binding protein PCBP2. Specifically, we found that knockdown or knock-out of PCBP2 reduces, whereas ectopic expression of PCBP2 increases, TAp73 expression. We also showed that PCBP2 is necessary for p73 mRNA stability via the CU-rich elements in p73 3'-UTR. To uncover the biological relevance of PCBP2-regulated TAp73 expression, we showed that ectopic expression of PCBP2 inhibits, whereas knockdown or knock-out of PCBP2 increases, the production of reactive oxygen species (ROS) in a TAp73-dependent manner. Additionally, we found that glutaminase 2 (GLS2), a modulator of p73-dependent antioxidant defense, is also involved in PCBP2-regulated ROS production. Moreover, we generated PCBP2-deficient mice and primary mouse embryonic fibroblasts (MEFs) and showed that loss of PCBP2 leads to decreased p73 expression and, subsequently, increased ROS production and accelerated cellular senescence. Together, our data suggest that PCBP2 regulates p73 expression via mRNA stability and p73-dependent biological function in ROS production and cellular senescence.	[Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Sch Med, Davis, CA 95616 USA; Univ Calif Davis, Comparat Oncol Lab, Sch Vet Med, Davis, CA 95616 USA; [Ren, Cong] Jiangnan Univ, Sch Biotechnol, Wuxi 214122, Jiangsu, Peoples R China	University of California System; University of California Davis; University of California System; University of California Davis; Jiangnan University	Zhang, J; Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Sch Med, Davis, CA 95616 USA.	jinzhang@ucdavis.edu; xbchen@ucdavis.edu			National Institutes of Health [CA081237, CA123227, CA121137]; NATIONAL CANCER INSTITUTE [R01CA121137, R01CA123227, R01CA081237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA081237, CA123227, and CA121137.	Afanas'ev I, 2011, AGING DIS, V2, P219; Agostini M, 2011, P NATL ACAD SCI USA, V108, P21093, DOI 10.1073/pnas.1112061109; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Cho SJ, 2012, J BIOL CHEM, V287, P14535, DOI 10.1074/jbc.M111.326827; Du WJ, 2013, NAT CELL BIOL, V15, P991, DOI 10.1038/ncb2789; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Frey AG, 2014, P NATL ACAD SCI USA, V111, P8031, DOI 10.1073/pnas.1402732111; Ghosh D, 2008, P NATL ACAD SCI USA, V105, P11673, DOI 10.1073/pnas.0803182105; Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Kartasheva NN, 2002, ONCOGENE, V21, P4715, DOI 10.1038/sj.onc.1205584; Killilea DW, 2003, ANTIOXID REDOX SIGN, V5, P507, DOI 10.1089/152308603770310158; Lei Yu, 2013, Methods Mol Biol, V1031, P59, DOI 10.1007/978-1-62703-481-4_7; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Ory B, 2011, J CLIN INVEST, V121, P809, DOI 10.1172/JCI43897; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Perrotti D, 2002, ONCOGENE, V21, P8577, DOI 10.1038/sj.onc.1206085; Petrenko O, 2003, MOL CELL BIOL, V23, P5540, DOI 10.1128/MCB.23.16.5540-5555.2003; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren C, 2014, BIOCHEM J, V464, P377, DOI 10.1042/BJ20141164; Rieder E, 2003, J GEN VIROL, V84, P2203, DOI 10.1099/vir.0.19013-0; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; Roychoudhury P, 2007, MOL CARCINOGEN, V46, P198, DOI 10.1002/mc.20265; Rufini A, 2012, GENE DEV, V26, P2009, DOI 10.1101/gad.197640.112; Sean P, 2008, VIROLOGY, V378, P243, DOI 10.1016/j.virol.2008.05.007; Sean P, 2009, VIROLOGY, V389, P45, DOI 10.1016/j.virol.2009.03.012; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tissir F, 2009, P NATL ACAD SCI USA, V106, P16871, DOI 10.1073/pnas.0903191106; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Velletri T, 2015, CELL CYCLE, V14, P1611, DOI 10.1080/15384101.2015.1035968; Waggoner SA, 2009, J BIOL CHEM, V284, P9039, DOI 10.1074/jbc.M806986200; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yan WS, 2012, MOL CELL BIOL, V32, P2336, DOI 10.1128/MCB.00215-12; Zhang J, 2013, ONCOTARGET, V4, P1121, DOI 10.18632/oncotarget.1185	41	13	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9629	9637		10.1074/jbc.M115.712125	http://dx.doi.org/10.1074/jbc.M115.712125			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26907686	hybrid, Green Published			2022-12-28	WOS:000375602300021
J	Blanko, ER; Kadyrova, LY; Kadyrov, FA				Blanko, Elena Rodriges; Kadyrova, Lyudmila Y.; Kadyrov, Farid A.			DNA Mismatch Repair Interacts with CAF-1-and ASF1A-H3-H4-dependent Histone (H3-H4)(2) Tetramer Deposition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI MUTS; CELL NUCLEAR ANTIGEN; SACCHAROMYCES-CEREVISIAE; REPLICATION INVITRO; IN-VITRO; GENETIC INSTABILITY; POLYMERASE-EPSILON; DEFINED SYSTEM; TUMOR-CELLS; CAF-I	DNA mismatch repair (MMR) is required for the maintenance of genome stability and protection of humans from several types of cancer. Human MMR occurs in the chromatin environment, but little is known about the interactions between MMR and the chromatin environment. Previous research has suggested that MMR coincides with replication-coupled assembly of the newly synthesized DNA into nucleosomes. The first step in replication-coupled nucleosome assembly is CAF-1-dependent histone (H3-H4)(2) tetramer deposition, a process that involves ASF1A-H3-H4 complex. In this work we used reconstituted human systems to investigate interactions between MMR and CAF-1- and ASF1A-H3-H4-dependent histone (H3-H4)(2) tetramer deposition. We have found that MutS alpha inhibits CAF-1- and ASF1A-H3-H4-dependent packaging of a DNA mismatch into a tetrasome. This finding supports the idea that MMR occurs before the DNA mismatch is packaged into the tetrasome. Our experiments have also revealed that CAF-1- and ASF1A-H3-H4-dependent deposition of the histone (H3-H4)(2) tetramers does not interfere with MMR reactions. In addition, we have established that unnecessary degradation of the discontinuous strand that takes place in both DNA polymerase delta (Pol delta)- and DNA polymerase epsilon (Pol epsilon)-dependent MMR reactions is suppressed by CAF-1- and ASF1A-H3-H4-dependent deposition of the histone (H3-H4)(2) tetramers. These data suggest that CAF-1- and ASF1A-H3-H4-dependent deposition of the histone (H3-H4)(2) tetramers is compatible with MMR and protects the discontinuous daughter strand from unnecessary degradation by MMR machinery.	[Blanko, Elena Rodriges; Kadyrova, Lyudmila Y.; Kadyrov, Farid A.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA; [Blanko, Elena Rodriges] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Southern Illinois University System; Southern Illinois University; University of Texas System; UTMD Anderson Cancer Center	Kadyrov, FA (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA.	fkadyrov@siumed.edu			National Institutes of Health [R01GM095758]; American Cancer Society, Illinois division [207957]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society, Illinois division(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM095758 (NIGMS). This work was also supported by from the American Cancer Society, Illinois division, Grant 207957. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez F, 2011, J BIOL CHEM, V286, P17714, DOI 10.1074/jbc.M111.223453; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; AU KG, 1992, J BIOL CHEM, V267, P12142; Ben-Shahar TR, 2009, MOL CELL BIOL, V29, P6353, DOI 10.1128/MCB.01051-09; Bermudez VP, 2011, J BIOL CHEM, V286, P28963, DOI 10.1074/jbc.M111.256289; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; COOPER DL, 1993, J BIOL CHEM, V268, P11823; Dao V, 1998, J BIOL CHEM, V273, P9202, DOI 10.1074/jbc.273.15.9202; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; DONG F, 1991, P NATL ACAD SCI USA, V88, P10596, DOI 10.1073/pnas.88.23.10596; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Earley MC, 1998, P NATL ACAD SCI USA, V95, P15487, DOI 10.1073/pnas.95.26.15487; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Iyer RR, 2010, J BIOL CHEM, V285, P11730, DOI 10.1074/jbc.M110.104125; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012633; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kadyrova LY, 2016, DNA REPAIR, V38, P42, DOI 10.1016/j.dnarep.2015.11.023; Kadyrova LY, 2015, J BIOL CHEM, V290, P24051, DOI 10.1074/jbc.M115.660357; Kadyrova LY, 2013, CELL CYCLE, V12, P3286, DOI 10.4161/cc.26310; Kadyrova LY, 2011, P NATL ACAD SCI USA, V108, P2753, DOI 10.1073/pnas.1015914108; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Kunkel TA, 2015, ANNU REV GENET, V49, P291, DOI 10.1146/annurev-genet-112414-054722; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LEE SH, 1991, J BIOL CHEM, V266, P22707; Li F, 2009, J BIOL CHEM, V284, P33056, DOI 10.1074/jbc.M109.049874; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Liu WH, 2012, NUCLEIC ACIDS RES, V40, P11229, DOI 10.1093/nar/gks906; Longley MJ, 1997, J BIOL CHEM, V272, P10917; Lucchini R, 2001, EMBO J, V20, P7294, DOI 10.1093/emboj/20.24.7294; Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Pavlov YI, 2003, CURR BIOL, V13, P744, DOI 10.1016/S0960-9822(03)00284-7; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Russo MT, 2004, MOL CELL BIOL, V24, P465, DOI 10.1128/MCB.24.1.465-474.2004; Schopf B, 2012, P NATL ACAD SCI USA, V109, P1895, DOI 10.1073/pnas.1106696109; Schofield MJ, 2001, J BIOL CHEM, V276, P28291, DOI 10.1074/jbc.M103148200; Shen Y, 2012, NAT STRUCT MOL BIOL, V19, P98, DOI 10.1038/nsmb.2176; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; Surtees JA, 2004, CYTOGENET GENOME RES, V107, P146, DOI 10.1159/000080593; SZANKASI P, 1992, J BIOL CHEM, V267, P3014; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P609, DOI 10.1128/MCB.9.2.609; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Viswanathan M, 2001, J BIOL CHEM, V276, P31053, DOI 10.1074/jbc.M105481200; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	74	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9203	9217		10.1074/jbc.M115.713271	http://dx.doi.org/10.1074/jbc.M115.713271			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26945061	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000374849000031
J	Hong, E; Usiskin, IM; Bergamaschi, C; Hanlon, DJ; Edelson, RL; Justesen, S; Pavlakis, GN; Flavell, RA; Fahmy, TM				Hong, Enping; Usiskin, Ilana M.; Bergamaschi, Cristina; Hanlon, Douglas J.; Edelson, Richard L.; Justesen, Sune; Pavlakis, George N.; Flavell, Richard A.; Fahmy, Tarek M.			Configuration-dependent Presentation of Multivalent IL-15: IL-15R alpha Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DENDRITIC CELLS; TUMOR-INFILTRATING LYMPHOCYTES; IN-VIVO; CROSS-PRESENTATION; ADOPTIVE IMMUNOTHERAPY; TRANS-PRESENTATION; RECEPTOR-ALPHA; BIODEGRADABLE NANOPARTICLES; SOLUBLE IL-15R-ALPHA; HUMAN INTERLEUKIN-15	Here we report a "configuration-dependent" mechanism of action for IL-15:IL-15R alpha (heterodimeric IL-15 or hetIL-15) where the manner by which IL-15:IL-15R alpha molecules are presented to target cells significantly affects its function as a vaccine adjuvant. Although the cellular mechanism of IL-15 trans-presentation via IL-15R alpha and its importance for IL-15 function have been described, the full effect of the IL-15:IL-15R alpha configuration on responding cells is not yet known. We found that trans-presenting IL-15:IL-15R alpha in a multivalent fashion on the surface of antigen-encapsulating nanoparticles enhanced the ability of nanoparticle-treated dendritic cells (DCs) to stimulate antigen-specific CD8(+) T cell responses. Localization of multivalent IL-15:IL-15R alpha and encapsulated antigen to the same DC led to maximal T cell responses. Strikingly, DCs incubated with IL-15:IL-15R alpha coated nanoparticles displayed higher levels of functional IL-15 on the cell surface, implicating a mechanism for nanoparticle-mediated transfer of IL-15 to the DC surface. Using artificial antigen-presenting cells to highlight the effect of IL-15 configuration on DCs, we showed that artificial antigen-presenting cells presenting IL-15:IL-15R alpha increased the sensitivity and magnitude of the T cell response, whereas IL-2 enhanced the T cell response only when delivered in a paracrine fashion. Therefore, the mode of cytokine presentation (configuration) is important for optimal immune responses. We tested the effect of configuration dependence in an aggressive model of murine melanoma and demonstrated significantly delayed tumor progression induced by IL-15:IL-15R alpha-coated nanoparticles in comparison with monovalent IL-15:IL-15R alpha. The novel mechanism of IL-15 transfer to the surface of antigen-processing DCs may explain the enhanced potency of IL-15:IL-15R alpha-coated nanoparticles for antigen delivery.	[Hong, Enping; Usiskin, Ilana M.; Fahmy, Tarek M.] Yale Univ, Dept Biomed Engn, 55 Prospect St, New Haven, CT 06511 USA; [Flavell, Richard A.; Fahmy, Tarek M.] Yale Univ, Sch Med, Dept Immunobiol, 55 Prospect St, New Haven, CT 06511 USA; [Hanlon, Douglas J.; Edelson, Richard L.] Yale Univ, Sch Med, Dept Dermatol, 55 Prospect St, New Haven, CT 06511 USA; [Bergamaschi, Cristina; Pavlakis, George N.] NCI, Vaccine Branch, NIH, Frederick, MD 21702 USA; [Justesen, Sune] Univ Copenhagen, Dept Sci, DK-1017 Copenhagen, Denmark	Yale University; Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Copenhagen	Fahmy, TM (corresponding author), Yale Univ, Dept Biomed Engn, Dept Chem, 55 Prospect St, New Haven, CT 06511 USA.; Fahmy, TM (corresponding author), Yale Univ, Dept Environm Engn, Dept Immunobiol, 55 Prospect St, New Haven, CT 06511 USA.; Fahmy, TM (corresponding author), Yale Univ, Dept Obstet & Gynecol, 55 Prospect St, New Haven, CT 06511 USA.	tarek.fahmy@yale.edu	Edelson, Richard/AAD-4826-2019		NCI NIH HHS [P30 CA016359] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016359, ZIABC010750] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akagi T, 2012, ADV POLYM SCI, V247, P31, DOI 10.1007/12_2011_150; Almeida JPM, 2015, SMALL, V11, P1453, DOI 10.1002/smll.201402179; Arneja A, 2014, J IMMUNOL, V192, P123, DOI 10.4049/jimmunol.1302291; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bandyopadhyay A, 2011, BIOMATERIALS, V32, P3094, DOI 10.1016/j.biomaterials.2010.12.054; Bergamaschi C, 2015, GENE THER, V22, P76, DOI 10.1038/gt.2014.84; Bergamaschi C, 2008, J BIOL CHEM, V283, P4189, DOI 10.1074/jbc.M705725200; Bergamaschi C, 2012, BLOOD, V120, pE1, DOI 10.1182/blood-2011-10-384362; Bergamaschi C, 2009, J IMMUNOL, V183, P3064, DOI 10.4049/jimmunol.0900693; Bessard A, 2009, MOL CANCER THER, V8, P2736, DOI 10.1158/1535-7163.MCT-09-0275; Boyer JD, 2007, P NATL ACAD SCI USA, V104, P18648, DOI 10.1073/pnas.0709198104; Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; Cheng J, 2007, BIOMATERIALS, V28, P869, DOI 10.1016/j.biomaterials.2006.09.047; Chertova E, 2013, J BIOL CHEM, V288, P18093, DOI 10.1074/jbc.M113.461756; Cho NH, 2011, NAT NANOTECHNOL, V6, P675, DOI [10.1038/NNANO.2011.149, 10.1038/nnano.2011.149]; Conlon KC, 2015, J CLIN ONCOL, V33, P74, DOI 10.1200/JCO.2014.57.3329; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; De Koker S, 2009, ANGEW CHEM INT EDIT, V48, P8485, DOI 10.1002/anie.200903769; Demento SL, 2012, BIOMATERIALS, V33, P4957, DOI 10.1016/j.biomaterials.2012.03.041; Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Ding ZL, 2001, NATURE, V411, P59, DOI 10.1038/35075028; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Dubsky P, 2007, EUR J IMMUNOL, V37, P1678, DOI 10.1002/eji.200636329; Elamanchili P, 2004, VACCINE, V22, P2406, DOI 10.1016/j.vaccine.2003.12.032; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; Epardaud M, 2008, CANCER RES, V68, P2972, DOI 10.1158/0008-5472.CAN-08-0045; Fahmy TM, 2005, BIOMATERIALS, V26, P5727, DOI 10.1016/j.biomaterials.2005.02.025; Fehniger TA, 2002, CYTOKINE GROWTH F R, V13, P169, DOI 10.1016/S1359-6101(01)00021-1; Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148; Giron-Michel J, 2005, BLOOD, V106, P2302, DOI 10.1182/blood-2005-01-0064; Hakerud M, 2015, J CONTROL RELEASE, V198, P10, DOI 10.1016/j.jconrel.2014.11.032; Hamdy S, 2008, VACCINE, V26, P5046, DOI 10.1016/j.vaccine.2008.07.035; Hamdy S, 2011, ADV DRUG DELIVER REV, V63, P943, DOI 10.1016/j.addr.2011.05.021; Hansen J, 2012, CANCER IMMUNOL IMMUN, V61, P893, DOI 10.1007/s00262-011-1156-6; Hirosue S, 2010, VACCINE, V28, P7897, DOI 10.1016/j.vaccine.2010.09.077; Ho WY, 2006, J IMMUNOL METHODS, V310, P40, DOI 10.1016/j.jim.2005.11.023; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Jakobisiak M, 2011, CYTOKINE GROWTH F R, V22, P99, DOI 10.1016/j.cytogfr.2011.04.001; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; Kim YS, 1998, J IMMUNOL, V160, P5742; Klippstein R, 2010, NANOMED-NANOTECHNOL, V6, P523, DOI 10.1016/j.nano.2010.01.001; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Kokaji AI, 2008, J IMMUNOL, V180, P4391, DOI 10.4049/jimmunol.180.7.4391; Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112; Labowsky M, 2012, CHEM ENG SCI, V74, P114, DOI 10.1016/j.ces.2012.02.001; Labowsky M, 2015, NANOMED-NANOTECHNOL, V11, P1019, DOI 10.1016/j.nano.2014.12.019; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Mueller K, 2008, EUR J IMMUNOL, V38, P2874, DOI 10.1002/eji.200838426; NopplSimson DA, 1996, BIOPHYS J, V70, P1391, DOI 10.1016/S0006-3495(96)79697-2; Obermaier Bianca, 2003, Biol Proced Online, V5, P197, DOI 10.1251/bpo62; Park J, 2009, NANOMED-NANOTECHNOL, V5, P410, DOI 10.1016/j.nano.2009.02.002; Perdreau H, 2010, EUR CYTOKINE NETW, V21, P297, DOI 10.1684/ecn.2010.0207; Perica K, 2015, ACS NANO, V9, P6861, DOI 10.1021/acsnano.5b02829; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Pulendran B, 2004, EUR J IMMUNOL, V34, P66, DOI 10.1002/eji.200324567; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Rubinstein MP, 2002, J IMMUNOL, V169, P4928, DOI 10.4049/jimmunol.169.9.4928; Ruckert R, 2003, EUR J IMMUNOL, V33, P3493, DOI 10.1002/eji.200324545; Sa Q, 2013, J IMMUNOL, V190, P2199, DOI 10.4049/jimmunol.1202256; Sadat TMF, 2014, ASIAN PAC J CANCER P, V15, P517, DOI DOI 10.7314/APJCP.2014.15.2.517; Saikh KU, 2008, CLIN VACCINE IMMUNOL, V15, P131, DOI 10.1128/CVI.00320-07; Saikh KU, 2001, CLIN EXP IMMUNOL, V126, P447, DOI 10.1046/j.1365-2249.2001.01672.x; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Saluja SS, 2014, INT J NANOMED, V9, P5231, DOI 10.2147/IJN.S66639; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Sato N, 2007, P NATL ACAD SCI USA, V104, P588, DOI 10.1073/pnas.0610115104; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x; Solbrig CM, 2007, MOL PHARMACEUT, V4, P47, DOI 10.1021/mp060107e; Stearns RC, 2001, AM J RESP CELL MOL, V24, P108, DOI 10.1165/ajrcmb.24.2.4081; Steel JC, 2012, TRENDS PHARMACOL SCI, V33, P35, DOI 10.1016/j.tips.2011.09.004; Steenblock ER, 2008, MOL THER, V16, P765, DOI 10.1038/mt.2008.11; Steenblock ER, 2011, J BIOL CHEM, V286, P34883, DOI 10.1074/jbc.M111.276329; Steenblock ER, 2009, EXPERT OPIN BIOL TH, V9, P451, DOI [10.1517/14712590902849216 , 10.1517/14712590902849216]; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Stonier SW, 2010, IMMUNOL LETT, V127, P85, DOI 10.1016/j.imlet.2009.09.009; Swiggard WJ., 2001, CURR PROTOC IMMUNOL, V86, P1, DOI [DOI 10.1002/0471142735.IM0307S25, 10.1002/0471142735.im0307s25]; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359; Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tourkova IL, 2005, J IMMUNOL, V175, P3045, DOI 10.4049/jimmunol.175.5.3045; Tourkova IL, 2002, J LEUKOCYTE BIOL, V72, P1037; Vamosi G, 2004, P NATL ACAD SCI USA, V101, P11082, DOI 10.1073/pnas.0403916101; Viaud S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004942; Villa CH, 2011, ACS NANO, V5, P5300, DOI 10.1021/nn200182x; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Walter E, 2001, J CONTROL RELEASE, V76, P149, DOI 10.1016/S0168-3659(01)00413-8; Xin KQ, 1999, VACCINE, V17, P858, DOI 10.1016/S0264-410X(98)00271-0; Zhang ZP, 2011, BIOMATERIALS, V32, P3666, DOI 10.1016/j.biomaterials.2011.01.067; Zhao YN, 2011, ACS NANO, V5, P1366, DOI 10.1021/nn103077k; Zhu XY, 2009, J IMMUNOL, V183, P3598, DOI 10.4049/jimmunol.0901244; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	106	24	27	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8931	8950		10.1074/jbc.M115.695304	http://dx.doi.org/10.1074/jbc.M115.695304			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26719339	hybrid, Green Published			2022-12-28	WOS:000374849000007
J	Montecinos-Franjola, F; Schuck, P; Sackett, DL				Montecinos-Franjola, Felipe; Schuck, Peter; Sackett, Dan L.			Tubulin Dimer Reversible Dissociation AFFINITY, KINETICS, AND DEMONSTRATION OF A STABLE MONOMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-BETA-TUBULIN; SEDIMENTATION-VELOCITY; PROTEIN INTERACTIONS; ANALYTICAL ULTRACENTRIFUGATION; FLUORESCENCE ANISOTROPY; MICROTUBULE DYNAMICS; COLCHICINE BINDING; POLYMERIZATION; ASSOCIATION; SUBUNITS	Tubulins are evolutionarily conserved proteins that reversibly polymerize and direct intracellular traffic. Of the tubulin family only alpha beta-tubulin forms stable dimers. We investigated the monomer-dimer equilibrium of rat brain alpha beta-tubulin using analytical ultracentrifugation and fluorescence anisotropy, observing tubulin in virtually fully monomeric and dimeric states. Monomeric tubulin was stable for a few hours and exchanged into preformed dimers, demonstrating reversibility of dimer dissociation. Global analysis combining sedimentation velocity and fluorescence anisotropy yielded K-d = 84 (54-123) nM. Dimer dissociation kinetics were measured by analyzing the shape of the sedimentation boundary and by the relaxation of fluorescence anisotropy following rapid dilution of labeled tubulin, yielding k(off) in the range 10(-3)-10(-2) s(-1). Thus, tubulin dimers reversibly dissociate with moderately fast kinetics. Monomer-monomer association is much less sensitive than dimer-dimer association to solution changes (GTP/GDP, urea, and trimethylamine oxide).	[Montecinos-Franjola, Felipe; Sackett, Dan L.] Natl Inst Biomed Imaging & Bioengn NHBLI, Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Schuck, Peter] Natl Inst Biomed Imaging & Bioengn NHBLI, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA	Montecinos-Franjola, F (corresponding author), Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bldg 9,Rm 1E-122,9000 Rockville Pike, Bethesda, MD 20892 USA.; Sackett, DL (corresponding author), Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bldg 9,Rm 1E-129,9000 Rockville Pike, Bethesda, MD 20892 USA.	felipe.montecinos@nih.gov; sackettd@mail.nih.gov	Montecinos, Felipe/HHS-7232-2022; Franjola, Felipe A Montecinos/R-3907-2017; Schuck, Peter/AAA-6888-2020	Montecinos, Felipe/0000-0002-1823-103X; Franjola, Felipe A Montecinos/0000-0002-1823-103X; Schuck, Peter/0000-0002-8859-6966	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Biomedical Imaging and Bioengineering (NHBLI), National Institutes of Health, Bethesda, MD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000008] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Biomedical Imaging and Bioengineering (NHBLI), National Institutes of Health, Bethesda, MD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by funds of the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Biomedical Imaging and Bioengineering (NHBLI), National Institutes of Health, Bethesda, MD. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; ANDREU JM, 1982, BIOCHEMISTRY-US, V21, P6465, DOI 10.1021/bi00268a023; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brautigam CA, 2011, METHODS, V54, P4, DOI 10.1016/j.ymeth.2010.12.029; Brouhard GJ, 2014, J CELL BIOL, V207, P323, DOI 10.1083/jcb.201407095; Brown PH, 2009, EUR BIOPHYS J BIOPHY, V38, P1079, DOI 10.1007/s00249-009-0514-1; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Caplow M, 2002, MOL BIOL CELL, V13, P2120, DOI 10.1091/mbc.E01-10-0089; CORREIA JJ, 1987, J BIOL CHEM, V262, P17278; Cushion TD, 2014, AM J HUM GENET, V94, P634, DOI 10.1016/j.ajhg.2014.03.009; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; DAVIDPFEUTY T, 1977, P NATL ACAD SCI USA, V74, P5372, DOI 10.1073/pnas.74.12.5372; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DETRICH HW, 1978, BIOCHEMISTRY-US, V17, P3900, DOI 10.1021/bi00612a002; DETRICH HW, 1982, BIOCHEMISTRY-US, V21, P2392, DOI 10.1021/bi00539a018; Duggin IG, 2015, NATURE, V519, P362, DOI 10.1038/nature13983; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Hari M, 2003, MOL CANCER THER, V2, P597; Hoyle HD, 2001, MOL BIOL CELL, V12, P2185, DOI 10.1091/mbc.12.7.2185; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Jameson DM, 2010, CHEM REV, V110, P2685, DOI 10.1021/cr900267p; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kar SR, 2000, ANAL BIOCHEM, V285, P135, DOI 10.1006/abio.2000.4748; Lamm O., 1929, ARK MAT ASTR FYS, V21B, P1; LEE JC, 1973, J BIOL CHEM, V248, P7253; Luduena Richard E., 2008, P123, DOI 10.1007/978-1-59745-336-3_6; Luduena RF, 2013, INT REV CEL MOL BIO, V302, P41, DOI 10.1016/B978-0-12-407699-0.00002-9; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; MEJILLANO MR, 1989, BIOCHEMISTRY-US, V28, P6518, DOI 10.1021/bi00441a053; Menendez M., 1998, J BIOL CHEM, V273, P167; Mirigian M, 2013, METHOD CELL BIOL, V115, P215, DOI 10.1016/B978-0-12-407757-7.00014-1; Montecinos-Franjola F, 2012, BIOPHYS J, V102, P2176, DOI 10.1016/j.bpj.2012.03.064; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; Nithianantham S, 2015, ELIFE, V4, DOI 10.7554/eLife.08811; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Nogales E, 1999, CELL MOL LIFE SCI, V56, P133, DOI 10.1007/s000180050012; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; PANDA D, 1992, BIOCHEMISTRY-US, V31, P9709, DOI 10.1021/bi00155a026; PANDA D, 1992, EUR J BIOCHEM, V204, P783, DOI 10.1111/j.1432-1033.1992.tb16695.x; Pollard TD, 2013, MOL BIOL CELL, V24, P1103, DOI 10.1091/mbc.E13-01-0030; Sackett D L, 1991, Protein Expr Purif, V2, P390, DOI 10.1016/1046-5928(91)90099-5; SACKETT DL, 1991, BIOCHEMISTRY-US, V30, P3511, DOI 10.1021/bi00228a023; Sackett DL, 1997, AM J PHYSIOL-REG I, V273, pR669, DOI 10.1152/ajpregu.1997.273.2.R669; SACKETT DL, 1994, BIOCHEMISTRY-US, V33, P12868, DOI 10.1021/bi00209a019; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2010, BIOPHYS J, V98, P2005, DOI 10.1016/j.bpj.2009.12.4336; Serna M, 2015, J CELL SCI, V128, P1824, DOI 10.1242/jcs.167387; SHEARWIN KE, 1994, BIOCHEMISTRY-US, V33, P894, DOI 10.1021/bi00170a007; SHEARWIN KE, 1994, BIOCHEMISTRY-US, V33, P885, DOI 10.1021/bi00170a006; Sontag CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007253; Tian GL, 2013, METHOD CELL BIOL, V115, P155, DOI 10.1016/B978-0-12-407757-7.00011-6; Wickstead B, 2011, J CELL BIOL, V194, P513, DOI 10.1083/jcb.201102065; Wolff J, 1996, PROTEIN SCI, V5, P2020, DOI 10.1002/pro.5560051008; Zhao HY, 2015, ACTA CRYSTALLOGR D, V71, P3, DOI 10.1107/S1399004714010372; Zhao HY, 2014, ANAL CHEM, V86, P3181, DOI 10.1021/ac500093m; Zhao HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077245; Zhao HY, 2012, ANAL CHEM, V84, P9513, DOI 10.1021/ac302357w	61	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9281	9294		10.1074/jbc.M115.699728	http://dx.doi.org/10.1074/jbc.M115.699728			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26934918	hybrid, Green Published			2022-12-28	WOS:000374849000037
J	Salim, M; Knowles, TJ; Hart, R; Mohammed, F; Woodward, MJ; Willcox, CR; Overduin, M; Hayday, AC; Willcox, BE				Salim, Mahboob; Knowles, Timothy J.; Hart, Rosie; Mohammed, Fiyaz; Woodward, Martin J.; Willcox, Carrie R.; Overduin, Michael; Hayday, Adrian C.; Willcox, Benjamin E.			Characterization of a Putative Receptor Binding Surface on Skint-1, a Critical Determinant of Dendritic Epidermal T Cell Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN RESONANCE ASSIGNMENT; ANTIGEN RECEPTOR; REPERTOIRE; EXPRESSION; NMR; CONSERVATION; SURVEILLANCE; MODULATION; EPITHELIUM; HOMOLOGY	Dendritic epidermal T cells (DETC) form a skin-resident gamma delta T cell population that makes key contributions to cutaneous immune stress surveillance, including non-redundant contributions to protection from cutaneous carcinogens. How DETC become uniquely associated with the epidermis was in large part solved by the identification of Skint-1, the prototypic member of a novel B7-related multigene family. Expressed only by thymic epithelial cells and epidermal keratinocytes, Skint-1 drives specifically the development of DETC progenitors, making it the first clear candidate for a selecting ligand for non-MHC/CD1-restricted T cells. However, the molecular mechanisms underpinning Skint-1 activity are unresolved. Here, we provide evidence that DETC selection requires Skint-1 expression on the surface of thymic epithelial cells, and depends upon specific residues on the CDR3-like loop within the membrane-distal variable domain of Skint-1 (Skint-1 DV). Nuclear magnetic resonance of Skint-1 DV revealed a core tertiary structure conserved across the Skint family, but a highly distinct surface charge distribution, possibly explaining its unique function. Crucially, the CDR3-like loop formed an electrostatically distinct surface, featuring key charged and hydrophobic solvent-exposed residues, at the membrane-distal tip of DV. These results provide the first structural insights into the Skint family, identifying a putative receptor binding surface that directly implicates Skint-1 in receptor-ligand interactions crucial for DETC selection.	[Salim, Mahboob; Mohammed, Fiyaz; Willcox, Carrie R.; Willcox, Benjamin E.] Univ Birmingham, Inst Immunol & Immunotherapy, Canc Immunol & Immunotherapy Ctr, Birmingham B15 2TT, W Midlands, England; [Knowles, Timothy J.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Hart, Rosie; Woodward, Martin J.; Hayday, Adrian C.] Lincolns Inn Fields Res Labs, Francis Crick Inst, London WC2A 3LY, England; [Overduin, Michael] Univ Birmingham, Sch Canc Sci, Henry Wellcome Bldg Biomol NMR, Birmingham B15 2TT, W Midlands, England; [Hart, Rosie; Woodward, Martin J.; Hayday, Adrian C.] Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 9RT, England; [Overduin, Michael] Univ Alberta, Fac Med & Dent, Dept Biochem, 356A Med Sci Bldg, Edmonton, AB T6G 2H7, Canada	University of Birmingham; University of Birmingham; Francis Crick Institute; University of Birmingham; University of London; King's College London; University of Alberta	Willcox, BE (corresponding author), Univ Birmingham, Inst Immunol & Immunotherapy, Canc Immunol & Immunotherapy Ctr, Birmingham B15 2TT, W Midlands, England.	b.willcox@bham.ac.uk	Overduin, Michael/AAG-3632-2020	Overduin, Michael/0000-0002-3114-6585; Knowles, Tim/0000-0002-6632-0985	Wellcome Trust; BBSRC [BB/I013865/1, BB/H024697/1, BB/H019383/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H019383/1, BB/H024697/1, BB/I013865/1] Funding Source: researchfish; Wellcome Trust [106292/Z/14/Z] Funding Source: researchfish; The Francis Crick Institute [10093] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute	This work was supported by the Wellcome Trust (to B. E. W.). The authors declare that they have no conflicts of interest with the contents of this article.	ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Boismenu R, 1996, J IMMUNOL, V157, P985; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Chen Y, 2010, PROTEIN CELL, V1, P153, DOI 10.1007/s13238-010-0022-1; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Clements CS, 2003, P NATL ACAD SCI USA, V100, P11059, DOI 10.1073/pnas.1833158100; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Goddard T. D., 2001, SPARKY 3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KYES S, 1991, P NATL ACAD SCI USA, V88, P7830, DOI 10.1073/pnas.88.17.7830; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Mohamed RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123258; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; Roberts NA, 2012, IMMUNITY, V36, P427, DOI 10.1016/j.immuni.2012.01.016; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; ZHANG Y, 1995, IMMUNITY, V3, P439, DOI 10.1016/1074-7613(95)90173-6	42	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9310	9321		10.1074/jbc.M116.722066	http://dx.doi.org/10.1074/jbc.M116.722066			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26917727	Green Published, hybrid			2022-12-28	WOS:000374849000039
J	Shimonaka, S; Nonaka, T; Suzuki, G; Hisanaga, S; Hasegawa, M				Shimonaka, Shotaro; Nonaka, Takashi; Suzuki, Genjiro; Hisanaga, Shin-ichi; Hasegawa, Masato			Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALPHA-SYNUCLEIN; IN-VITRO; FTLD-TDP; MUTATIONS; INCLUSIONS; ALS; CLASSIFICATION; FILAMENTS	TAR DNA-binding protein of 43 kDa (TDP-43) has been identified as the major component of ubiquitin-positive neuronal and glial inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Aggregation of TDP-43 to amyloid-like fibrils and spreading of the aggregates are suggested to account for the pathogenesis and progression of these diseases. To investigate the molecular mechanisms of TDP-43 aggregation, we attempted to identify the amino acid sequence required for the aggregation. By expressing a series of deletion mutants lacking 20 amino acid residues in the C-terminal region in SH-SY5Y cells, we established that residues 274-313 in the glycine-rich region are essential for aggregation. In vitro aggregation experiments using synthetic peptides of 40 amino acids from this sequence and adjacent regions showed that peptides 274-313 and 314-353 formed amyloid-like fibrils. Transduction of these fibrils induced seed-dependent aggregation of TDP-43 in cells expressing wild-type TDP-43 or TDP-43 lacking nuclear localization signal. These cells showed different phosphorylated C-terminal fragments of TDP-43 and different trypsin-resistant bands. These results suggest that residues 274-353 are responsible for the conversion of TDP-43 to amyloid-like fibrils and that templated aggregation of TDP-43 by seeding with different peptides induces various types of TDP-43 pathologies, i.e. the peptides appear to act like prion strains.	[Shimonaka, Shotaro; Nonaka, Takashi; Suzuki, Genjiro; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Tokyo 1568506, Japan; [Shimonaka, Shotaro; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan University	Hasegawa, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, Tokyo 1568506, Japan.	hasegawa-ms@igakuken.or.jp	Nonaka, Takashi/L-8572-2017	Nonaka, Takashi/0000-0002-0830-9403	Ministry of Education, Culture, Sports, Science and Technology KAKENHI [26117005, 26111730]; Japan Society for the Promotion of Science KAKENHI [23228004]; Ministry of Health, Labor, and Welfare of Japan [12946221]; Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development, AMED; Grants-in-Aid for Scientific Research [15H02356] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grants 26117005 (to M. H.) and 26111730 (to T. N.), Japan Society for the Promotion of Science KAKENHI Grant 23228004 (to M. H.), Health and Labor Sciences Research Grant 12946221 from Ministry of Health, Labor, and Welfare of Japan (to M. H.), grant-in-aid for research on rare and intractable diseases, the Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis, and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development, AMED (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bigio EH, 2013, ACTA NEUROPATHOL, V125, P463, DOI 10.1007/s00401-013-1089-6; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Daoud H, 2009, J MED GENET, V46, P112, DOI 10.1136/jmg.2008.062463; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Jiang LL, 2013, J BIOL CHEM, V288, P19614, DOI 10.1074/jbc.M113.463828; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P87, DOI 10.1007/s00401-011-0838-7; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sun CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103644; Tsuji H, 2012, BRAIN, V135, P3380, DOI 10.1093/brain/aws230; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang YT, 2013, J BIOL CHEM, V288, P9049, DOI 10.1074/jbc.M112.438564; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392	32	61	61	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8896	8907		10.1074/jbc.M115.713552	http://dx.doi.org/10.1074/jbc.M115.713552			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26887947	Green Published, hybrid			2022-12-28	WOS:000374849000004
J	Sorokina, EM; Dodia, C; Zhou, SP; Tao, JQ; Gao, L; Raabe, T; Feinstein, SI; Fisher, AB				Sorokina, Elena M.; Dodia, Chandra; Zhou, Suiping; Tao, Jian-Qin; Gao, Ling; Raabe, Tobias; Feinstein, Sheldon I.; Fisher, Aron B.			Mutation of Serine 32 to Threonine in Peroxiredoxin 6 Preserves Its Structure and Enzymatic Function but Abolishes Its Trafficking to Lamellar Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG PHOSPHOLIPID-METABOLISM; MICE OVEREXPRESSING PEROXIREDOXIN-6; 1-CYS PEROXIREDOXIN; GLUTATHIONE-PEROXIDASE; PULMONARY SURFACTANT; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; ANTIOXIDANT ENZYME; PROTEIN-A; RAT LUNG	Peroxiredoxin 6 (Prdx6), a bifunctional protein with phospholipase A(2) (aiPLA(2)) and GSH peroxidase activities, protects lungs from oxidative stress and participates in lung surfactant phospholipid turnover. Prdx6 has been localized to both cytosol and lamellar bodies (LB) in lung epithelium, and its organellar targeting sequence has been identified. We propose that Prdx6 LB targeting facilitates its role in the metabolism of lung surfactant phosphatidylcholine (PC). Ser-32 has been identified as the active site in Prdx6 for aiPLA(2) activity, and this activity was abolished by the mutation of serine 32 to alanine (S32A). However, aiPLA(2) activity was unaffected by mutation of serine 32 in Prdx6 to threonine (S32T). Prdx6 protein expression and aiPLA(2) activity were normal in the whole lung of a "knock-in" mouse model carrying an S32T mutation in the Prdx6 gene but were absent from isolated LB. Analyses by proximity ligation assay in lung sections demonstrated the inability of S32T Prdx6 to bind to the chaperone protein, 14-3-3 epsilon, that is required for LB targeting. The content of total phospholipid, PC, and disaturated PC in lung tissue homogenate, bronchoalveolar lavage fluid, and lung LB was increased significantly in Prdx6-S32T mutant lungs, whereas degradation of internalized [H-3]dipalmitoyl-PC was significantly decreased. Thus, Thr can substitute for Ser for the enzymatic activities of Prdx6 but not for its targeting to LB. These results confirm an important role for LB Prdx6 in the degradation and remodeling of lung surfactant phosphatidylcholine.	[Sorokina, Elena M.; Dodia, Chandra; Zhou, Suiping; Tao, Jian-Qin; Gao, Ling; Feinstein, Sheldon I.; Fisher, Aron B.] Univ Penn, Perelman Sch Med, Dept Physiol, Inst Environm Med, Philadelphia, PA 19104 USA; [Raabe, Tobias] Univ Penn, Perelman Sch Med, Penn Gene Targeting Core & Lab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Fisher, AB (corresponding author), Univ Penn, Inst Environm Med, 3620 Hamilton Walk,1 John Morgan Bldg, Philadelphia, PA 19104 USA.	abf@mail.med.upenn.edu	Raabe, Tobias D/V-5606-2018		National Institutes of Health [HL102016, HL105509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105509, R01HL102016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants HL102016 and HL105509. This work was presented in part at the Experimental Biology Annual Meeting in Boston, MA (April 20-24, 2013), San Diego, CA (April 26-30, 2014), and Boston, MA (March 28 to April 1, 2015). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiba S, 1998, COMP BIOCHEM PHYS B, V120, P393, DOI 10.1016/S0305-0491(98)10046-9; Benipal B, 2015, REDOX BIOL, V4, P321, DOI 10.1016/j.redox.2015.01.011; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buccoliero R, 2007, J INHERIT METAB DIS, V30, P983, DOI 10.1007/s10545-007-0597-8; Buccoliero R, 2004, J INHERIT METAB DIS, V27, P641, DOI 10.1023/B:BOLI.0000042958.22066.6c; CHANDER A, 1986, J BIOL CHEM, V261, P6126; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Fisher A. B., 1985, HDB EXPT PHARM, P109; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; FISHER AB, 1985, ANNU REV PHYSIOL, V47, P789; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V280, pL748, DOI 10.1152/ajplung.2001.280.4.L748; Fisher AB, 1997, AM J PHYSIOL-LUNG C, V272, pL238, DOI 10.1152/ajplung.1997.272.2.L238; Fisher AB, 1996, J LIPID RES, V37, P1057; Fisher AB, 1999, J BIOL CHEM, V274, P21326, DOI 10.1074/jbc.274.30.21326; FISHER AB, 1991, AM J PHYSIOL, V260, pL226, DOI 10.1152/ajplung.1991.260.4.L226; Fisher AB, 2006, BBA-MOL CELL BIOL L, V1761, P785, DOI 10.1016/j.bbalip.2006.05.009; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; Fisher AB, 2010, AM J PHYSIOL-LUNG C, V299, pL51, DOI 10.1152/ajplung.00066.2010; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Goss V, 2013, BBA-MOL CELL BIOL L, V1831, P448, DOI 10.1016/j.bbalip.2012.11.009; Guttentag S. H., 2012, AM J RESP CRIT CARE, V185, pA1984; Kim TS, 1998, AM J PHYSIOL-LUNG C, V274, pL750, DOI 10.1152/ajplung.1998.274.5.L750; Kisselev AF, 2000, J BIOL CHEM, V275, P14831, DOI 10.1074/jbc.275.20.14831; Li H, 2015, FREE RADICAL BIO MED, V87, P356, DOI 10.1016/j.freeradbiomed.2015.06.009; Lien YC, 2012, ANTIOXID REDOX SIGN, V16, P440, DOI 10.1089/ars.2011.3950; Liu G, 2010, FREE RADICAL BIO MED, V49, P1172, DOI 10.1016/j.freeradbiomed.2010.07.002; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Manevich Y, 2002, P NATL ACAD SCI USA, V99, P11599, DOI 10.1073/pnas.182384499; Manevich Y, 2007, J LIPID RES, V48, P2306, DOI 10.1194/jlr.M700299-JLR200; Marks MS, 2013, CURR OPIN CELL BIOL, V25, P495, DOI 10.1016/j.ceb.2013.04.008; Milovanova T, 2006, AM J PHYSIOL-CELL PH, V290, pC66, DOI 10.1152/ajpcell.00094.2005; Orndorff RL, 2014, AM J PHYSIOL-LUNG C, V306, pL260, DOI 10.1152/ajplung.00278.2013; Ralat LA, 2008, ARCH BIOCHEM BIOPHYS, V474, P109, DOI 10.1016/j.abb.2008.02.043; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rivera-Santiago RF, 2015, BIOCHEM J, V468, P87, DOI 10.1042/BJ20141463; Schmidt R, 2002, AM J PHYSIOL-LUNG C, V283, pL1079, DOI 10.1152/ajplung.00484.2001; SCHMITZ G, 1991, J LIPID RES, V32, P1539; Sorokina EM, 2011, AM J PHYSIOL-CELL PH, V300, pC1430, DOI 10.1152/ajpcell.00285.2010; Sorokina EM, 2009, AM J PHYSIOL-LUNG C, V297, pL871, DOI 10.1152/ajplung.00052.2009; Tolomeo AM, 2016, J COMP PHYSIOL B, V186, P59, DOI 10.1007/s00360-015-0935-3; Tripp AE, 1998, J AM CHEM SOC, V120, P5137, DOI 10.1021/ja974129t; Tsien RY, 2010, INTEGR BIOL-UK, V2, P77, DOI 10.1039/b926500g; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; Wang Y, 2006, AM J RESP CELL MOL, V34, P481, DOI 10.1165/rcmb.2005-0333OC; Wang Y, 2008, J CELL BIOCHEM, V104, P1274, DOI 10.1002/jcb.21703; Wei ZH, 2001, AM J PHYSIOL-HEART C, V281, pH2226, DOI 10.1152/ajpheart.2001.281.5.H2226; Whitsett JA, 2015, ANNU REV PATHOL-MECH, V10, P371, DOI 10.1146/annurev-pathol-012513-104644; WIDDICOMBE J G, 1987, European Journal of Respiratory Diseases Supplement, V71, P197	54	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9268	9280		10.1074/jbc.M115.698894	http://dx.doi.org/10.1074/jbc.M115.698894			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26921317	Green Published, hybrid			2022-12-28	WOS:000374849000036
J	Hong, K; Xu, G; Grayson, TB; Shalev, A				Hong, Kyunghee; Xu, Guanlan; Grayson, Truman B.; Shalev, Anath			Cytokines Regulate beta-Cell Thioredoxin-interacting Protein (TXNIP) via Distinct Mechanisms and Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); cytokine; microRNA (miRNA); pancreatic islet; type 1 diabetes; TXNIP	NECROSIS-FACTOR-ALPHA; ENDOPLASMIC-RETICULUM STRESS; CARBOHYDRATE RESPONSE ELEMENT; NITRIC-OXIDE; INDUCED APOPTOSIS; OXIDATIVE STRESS; DEATH; GLUCOSE; EXPRESSION; INTERLEUKIN-1-BETA	Thioredoxin-interacting protein (TXNIP) is a key regulator of diabetic beta-cell apoptosis and dysfunction, and TXNIP inhibition prevents diabetes in mouse models of type 1 and type 2 diabetes. Although we have previously shown that TXNIP is strongly induced by glucose, any regulation by the proinflammatory cytokines tumor necrosis factor alpha (TNF alpha), interleukin-1 beta (IL-1 beta), and interferon gamma (IFN gamma) has remained largely unexplored. Moreover, even though this three-cytokine mixture is widely used to mimic type 1 diabetes in vitro, the mechanisms involved are not fully understood. Interestingly, we have now found that this cytokine mixture increases beta-cell TXNIP expression; however, although TNF alpha had no effect, IL-1 beta surprisingly down-regulated TXNIP transcription, whereas IFN gamma increased TXNIP levels in INS-1 beta-cells and primary islets. Human TXNIP promoter analyses and chromatin immunoprecipitation studies revealed that the IL-1 beta effect was mediated by inhibition of carbohydrate response element binding protein activity. In contrast, IFN gamma increased pro-apoptotic TXNIP post-transcriptionally via induction of endoplasmic reticulum stress, activation of inositol-requiring enzyme 1 alpha (IRE1 alpha), and suppression of miR-17, a microRNA that targets and down-regulates TXNIP. In fact, miR-17 knockdown was able to mimic the IFN gamma effects on TXNIP, whereas miR-17 overexpression blunted the cytokine effect. Thus, our results demonstrate for the first time that the proinflammatory cytokines TNF alpha, IL-1 beta, and IFN gamma each have distinct and in part opposing effects on beta-cell TXNIP expression. These findings thereby provide new mechanistic insight into the regulation of TXNIP and beta-cell biology and reveal novel links between proinflammatory cytokines, carbohydrate response element binding protein-mediated transcription, and microRNA signaling.	Univ Alabama Birmingham, Comprehens Diabet Ctr, 1825 Univ Blvd,SHEL 1206, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, 1825 Univ Blvd,SHEL 1206, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Shalev, A (corresponding author), Univ Alabama Birmingham, 1825 Univ Blvd,SHEL 1206, Birmingham, AL 35294 USA.	shalev@uab.edu			National Institutes of Health [R01DK-078752, UC4DK104204]; JDRF [3-SRA-2014-302-M-R]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104204, P30DK079626, R01DK078752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK-078752 and UC4DK104204. This work was also supported by JDRF Grant 3-SRA-2014-302-M-R. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Allagnat F, 2012, CELL DEATH DIFFER, V19, P1836, DOI 10.1038/cdd.2012.67; Arous C, 2015, J BIOL CHEM, V290, P6653, DOI 10.1074/jbc.M114.611111; Barbu A, 2002, MOL CELL ENDOCRINOL, V190, P75, DOI 10.1016/S0303-7207(02)00009-6; Barthson J, 2011, J BIOL CHEM, V286, P39632, DOI 10.1074/jbc.M111.253591; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chang I, 2004, J IMMUNOL, V172, P7008, DOI 10.4049/jimmunol.172.11.7008; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; CORBETT JA, 1995, J EXP MED, V181, P559, DOI 10.1084/jem.181.2.559; da Silva XG, 2006, J LIPID RES, V47, P2482, DOI DOI 10.1194/JLR.M600289-JLR200; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; DEBRAYSACHS M, 1991, J AUTOIMMUN, V4, P237, DOI 10.1016/0896-8411(91)90021-4; Delaney CA, 1997, ENDOCRINOLOGY, V138, P2610, DOI 10.1210/en.138.6.2610; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Heitmeier MR, 1999, J BIOL CHEM, V274, P29266, DOI 10.1074/jbc.274.41.29266; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Kanari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059026; Kwon G, 1999, J BIOL CHEM, V274, P18702, DOI 10.1074/jbc.274.26.18702; Laffranchi R, 1997, EXP CELL RES, V237, P217, DOI 10.1006/excr.1997.3791; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Loweth AC, 1998, DIABETES, V47, P727, DOI 10.2337/diabetes.47.5.727; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Masson E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1251, DOI 10.1152/ajpendo.90619.2008; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Minn AH, 2005, BIOCHEM BIOPH RES CO, V336, P770, DOI 10.1016/j.bbrc.2005.08.161; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Ortis F, 2010, DIABETES, V59, P358, DOI 10.2337/db09-1159; Pirot P, 2006, DIABETOLOGIA, V49, P1229, DOI 10.1007/s00125-006-0214-7; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Rabinovitch A, 2003, REV ENDOCR METAB DIS, V4, P291, DOI 10.1023/A:1025160614313; Shaked M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028804; Shalev A, 2014, MOL ENDOCRINOL, V28, P1211, DOI 10.1210/me.2014-1095; Stephens LA, 1999, ENDOCRINOLOGY, V140, P3219, DOI 10.1210/en.140.7.3219; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Wali JA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.88; Wali JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113128; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Xiang RL, 2015, BIOMED ENVIRON SCI, V28, P169, DOI 10.3967/bes2015.023; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhuo DX, 2010, J BIOL CHEM, V285, P31491, DOI 10.1074/jbc.M109.068387	54	33	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8428	8439		10.1074/jbc.M115.698365	http://dx.doi.org/10.1074/jbc.M115.698365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26858253	Green Published, hybrid			2022-12-28	WOS:000374773200010
J	Vuillemin, M; Claverie, M; Brison, Y; Severac, E; Bondy, P; Morel, S; Monsan, P; Moulis, C; Remaud-Simeon, M				Vuillemin, Marlene; Claverie, Marion; Brison, Yoann; Severac, Etienne; Bondy, Pauline; Morel, Sandrine; Monsan, Pierre; Moulis, Claire; Remaud-Simeon, Magali			Characterization of the First alpha-(1 -> 3) Branching Sucrases of the GH70 Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 CATALYTIC DOMAINS; LEUCONOSTOC-CITREUM; DSR-E; MOLECULAR CHARACTERIZATION; STRUCTURAL-ANALYSIS; UNUSUAL DEXTRANS; GLUCANSUCRASE; GENE; GLUCOSYLTRANSFERASES; LINKAGES	Leuconostoc citreum NRRL B-742 has been known for years to produce a highly alpha-(1 -> 3)-branched dextran for which the synthesis had never been elucidated. In this work a gene coding for a putative alpha-transglucosylase of the GH70 family was identified in the reported genome of this bacteria and functionally characterized. From sucrose alone, the corresponding recombinant protein, named BRS-B, mainly catalyzed sucrose hydrolysis and leucrose synthesis. However, in the presence of sucrose and a dextran acceptor, the enzyme efficiently transferred the glucosyl residue from sucrose to linear alpha-(1 -> 6) dextrans through the specific formation of alpha-(1 -> 3) linkages. To date, BRS-B is the first reported alpha-(1 -> 3) branching sucrase. Using a suitable sucrose/dextran ratio, a comb-like dextran with 50% of alpha-(1 -> 3) branching was synthesized, suggesting that BRS-B is likely involved in the comb-like dextran produced by L. citreum NRRL B-742. In addition, data mining based on the search for specific sequence motifs allowed the identification of two genes putatively coding for branching sucrases in the genome of Leuconostoc fallax KCTC3537 and Lactobacillus kunkeei EFB6. Biochemical characterization of the corresponding recombinant enzymes confirmed their branching specificity, revealing that branching sucrases are not only found in L. citreum species. According to phylogenetic analyses, these enzymes are proposed to constitute a new subgroup of the GH70 family.	UPS, Univ Toulouse, INSA, INP,LISBP, 135 Ave Rangueil, F-31077 Toulouse, France; CNRS, UMR5504, F-31400 Toulouse, France; INRA, Ingn Syst Biol & Proc UMR792, F-3140 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Moulis, C; Remaud-Simeon, M (corresponding author), INSA, LISBP, 135 Ave Rangueil, F-31077 Toulouse, France.	moulis@insa-toulouse.fr; remaud@insa-toulouse.fr	Vuillemin, Marlène/Q-6203-2016	Vuillemin, Marlène/0000-0002-1776-7844	French National Research Agency [ANR-12-CDII-0005]; Region Midi-Pyrenees (France)	French National Research Agency(French National Research Agency (ANR)); Region Midi-Pyrenees (France)(Region Occitanie)	This work was supported by the French National Research Agency (ANR-12-CDII-0005, Engel 2012-2015) and the Region Midi-Pyrenees (France). The authors declare that they have no conflict of interest with the contents of this article.	Arguello-Morales MA, 2000, FEMS MICROBIOL LETT, V182, P81, DOI 10.1016/S0378-1097(99)00572-8; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bounaix MS, 2009, J AGR FOOD CHEM, V57, P10889, DOI 10.1021/jf902068t; Bozonnet S, 2002, J BACTERIOL, V184, P5753, DOI 10.1128/JB.184.20.5753-5761.2002; Brison Y, 2012, J BIOL CHEM, V287, P7915, DOI 10.1074/jbc.M111.305078; Brison Y, 2010, APPL MICROBIOL BIOT, V86, P545, DOI 10.1007/s00253-009-2241-z; Chung CH, 2004, POULTRY SCI, V83, P1302, DOI 10.1093/ps/83.8.1302; Chung CH, 2002, J IND MICROBIOL BIOT, V29, P196, DOI 10.1038/sj.jim.7000269; COTE GL, 1983, CARBOHYD RES, V119, P141, DOI 10.1016/0008-6215(83)84053-1; De Belder A., 2003, HDB AMERSHAM BIOSCIE; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fabre E, 2005, J BACTERIOL, V187, P296, DOI 10.1128/JB.187.1.296-303.2005; Vidal RF, 2011, CURR MICROBIOL, V62, P1260, DOI 10.1007/s00284-010-9851-7; GIFFARD PM, 1994, J DENT RES, V73, P1133, DOI 10.1177/00220345940730060201; Hucker G., 1930, TECH B N Y AGR EXP S, V167; Irague R, 2011, ANAL CHEM, V83, P1202, DOI 10.1021/ac1032148; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Janecek S, 2000, FEMS MICROBIOL LETT, V192, P53, DOI 10.1016/S0378-1097(00)00408-0; JEANES A, 1954, J AM CHEM SOC, V76, P5041, DOI 10.1021/ja01649a011; JEANES A, 1979, CARBOHYD RES, V74, P31, DOI 10.1016/S0008-6215(00)84763-1; Joucla G, 2006, FEBS LETT, V580, P763, DOI 10.1016/j.febslet.2006.01.001; KIM D, 1995, ENZYME MICROB TECH, V17, P689, DOI 10.1016/0141-0229(94)00021-I; Kim H, 2000, J MICROBIOL BIOTECHN, V10, P559; Kralj S, 2011, APPL ENVIRON MICROB, V77, P8154, DOI 10.1128/AEM.05735-11; Leemhuis H, 2013, APPL MICROBIOL BIOT, V97, P181, DOI 10.1007/s00253-012-3943-1; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MacGregor EA, 1996, FEBS LETT, V378, P263, DOI 10.1016/0014-5793(95)01428-4; Maina NH, 2008, CARBOHYD RES, V343, P1446, DOI 10.1016/j.carres.2008.04.012; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Monchois V, 1996, GENE, V182, P23, DOI 10.1016/S0378-1119(96)00443-X; MOOSER G, 1991, J BIOL CHEM, V266, P8916; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; Olivares-Illana V, 2003, J BACTERIOL, V185, P3606, DOI 10.1128/JB.185.12.3606-3612.2003; Passerini D, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01179-14; Passerini D, 2015, FEBS J, V282, P2115, DOI 10.1111/febs.13261; Pijning T, 2012, ACTA CRYSTALLOGR F, V68, P1448, DOI 10.1107/S1744309112044168; REMAUD M, 1992, J CARBOHYD CHEM, V11, P359, DOI 10.1080/07328309208017999; Robyt J. F., 1985, ENCY POLYM SCI; SEYMOUR FR, 1979, CARBOHYD RES, V74, P41, DOI 10.1016/S0008-6215(00)84764-3; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Van Tieghem P, 1878, ANN SCI NATURELLES, V7, P180; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107	43	37	40	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7687	7702		10.1074/jbc.M115.688044	http://dx.doi.org/10.1074/jbc.M115.688044			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26763236	Green Published, hybrid			2022-12-28	WOS:000383447600039
J	Du, L; Ma, L; Qi, FF; Zheng, XL; Jiang, CY; Li, AL; Wan, XB; Liu, SJ; Li, SY				Du, Lei; Ma, Li; Qi, Feifei; Zheng, Xianliang; Jiang, Chengying; Li, Ailei; Wan, Xiaobo; Liu, Shuang-Jiang; Li, Shengying			Characterization of a Unique Pathway for 4-Cresol Catabolism Initiated by Phosphorylation in Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biodegradation; cytochrome P450; gram-positive bacteria; microbiology; phosphorylation; 4-cresol; Corynebacterium glutamicum	P-CRESOL METHYLHYDROXYLASE; BETA-KETOADIPATE PATHWAY; PSEUDOMONAS-PUTIDA; TRANSCRIPTIONAL REGULATION; GENETIC-CHARACTERIZATION; ANAEROBIC DEGRADATION; AROMATIC-COMPOUNDS; PHENOL METABOLISM; STRAIN; ACID	4-Cresol is not only a significant synthetic intermediate for production of many aromatic chemicals, but also a priority environmental pollutant because of its toxicity to higher organisms. In our previous studies, a gene cluster implicated to be involved in 4-cresol catabolism, creCDEFGHIR, was identified in Corynebacterium glutamicum and partially characterized in vivo. In this work, we report on the discovery of a novel 4-cresol biodegradation pathway that employs phosphorylated intermediates. This unique pathway initiates with the phosphorylation of the hydroxyl group of 4-cresol, which is catalyzed by a novel 4-methylbenzyl phosphate synthase, CreHI. Next, a unique class I P450 system, CreJEF, specifically recognizes phosphorylated intermediates and successively oxidizes the aromatic methyl group into carboxylic acid functionality via alcohol and aldehyde intermediates. Moreover, CreD (phosphohydrolase), CreC (alcohol dehydrogenase), and CreG (aldehyde dehydrogenase) were also found to be required for efficient oxidative transformations in this pathway. Steady-state kinetic parameters (K-m and k(cat)) for each catabolic step were determined, and these results suggest that kinetic controls serve a key role in directing the metabolic flux to the most energy effective route.	[Du, Lei; Ma, Li; Qi, Feifei; Zheng, Xianliang; Li, Shengying] Chinese Acad Sci, CAS Key Lab Biofuels, Shandong Prov Key Lab Synthet Biol, Qingdao 266101, Shandong, Peoples R China; [Li, Ailei; Wan, Xiaobo] Chinese Acad Sci, CAS Key Lab Biobased Mat, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Shandong, Peoples R China; [Du, Lei; Zheng, Xianliang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Jiang, Chengying; Liu, Shuang-Jiang] Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing 100101, Peoples R China; [Jiang, Chengying; Liu, Shuang-Jiang] Chinese Acad Sci, Environm Microbiol & Biotechnol Res Ctr, Inst Microbiol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Li, SY (corresponding author), Chinese Acad Sci, CAS Key Lab Biofuels, Shandong Prov Key Lab Synthet Biol, Qingdao 266101, Shandong, Peoples R China.; Liu, SJ (corresponding author), Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing 100101, Peoples R China.; Liu, SJ (corresponding author), Chinese Acad Sci, Environm Microbiol & Biotechnol Res Ctr, Inst Microbiol, Beijing 100101, Peoples R China.	liusj@im.ac.cn; lishengying@qibebt.ac.cn	Liu, Shuang-Jiang/E-5756-2013		National Natural Science Foundation of China [NSFC 31422002]; Shandong Provincial Natural Science Foundation [JQ201407]; Recruitment Program of Global Experts; 973 Project from Ministry of Science and Technology [2012CB7211-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Recruitment Program of Global Experts; 973 Project from Ministry of Science and Technology(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China under Grant NSFC 31422002 and Shandong Provincial Natural Science Foundation Grant JQ201407, and the funding from Recruitment Program of Global Experts (to S. L.) and 973 Project from Ministry of Science and Technology Grant 2012CB7211-04 (to S.-J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2008, TOX PROF CRES; Anzai Y, 2008, CHEM BIOL, V15, P950, DOI 10.1016/j.chembiol.2008.07.014; Ault A, 2004, J CHEM EDUC, V81, P347, DOI 10.1021/ed081p347; Back K. C., 1972, RECLASSIFICATION MAT; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Bernhardt R, 2014, APPL MICROBIOL BIOT, V98, P6185, DOI 10.1007/s00253-014-5767-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breinig S, 2000, J BACTERIOL, V182, P5849, DOI 10.1128/JB.182.20.5849-5863.2000; Brinkrolf K, 2006, GENET MOL RES, V5, P773; Butler JE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-180; Carlson JC, 2011, NAT CHEM, V3, P628, DOI [10.1038/NCHEM.1087, 10.1038/nchem.1087]; Chaudhry MT, 2007, MICROBIOL-SGM, V153, P857, DOI 10.1099/mic.0.2006/002501-0; Chen YF, 2014, APPL MICROBIOL BIOT, V98, P1349, DOI 10.1007/s00253-013-5001-z; Cho AR, 2011, J MICROBIOL BIOTECHN, V21, P1179, DOI 10.4014/jmh.1104.04006; Cunane LM, 2000, J MOL BIOL, V295, P357, DOI 10.1006/jmbi.1999.3290; CURTIUS HC, 1976, J CHROMATOGR, V126, P569, DOI 10.1016/S0021-9673(01)84102-9; Di Gioia D, 2011, J BIOTECHNOL, V156, P309, DOI 10.1016/j.jbiotec.2011.08.014; Ding W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08044; Efimov I, 2004, BIOCHEMISTRY-US, V43, P6138, DOI 10.1021/bi035772x; Fiege H, 2000, ULLMANNS ENCY IND CH; Green MR, 2012, MOL CLONING LAB MANU, V1; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hanukoglu I., 1996, ADV MOL CELL BIOL; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; HOPPER DJ, 1991, J BACTERIOL, V173, P1298, DOI 10.1128/JB.173.3.1298-1301.1991; Huang Y, 2008, APPL MICROBIOL BIOT, V78, P75, DOI 10.1007/s00253-007-1286-0; Huang Y, 2006, APPL ENVIRON MICROB, V72, P7238, DOI 10.1128/AEM.01494-06; Ikeda M, 2006, J IND MICROBIOL BIOT, V33, P610, DOI 10.1007/s10295-006-0104-5; Joesaar M, 2010, FEMS MICROBIOL ECOL, V72, P464, DOI 10.1111/j.1574-6941.2010.00858.x; Johannes J, 2008, J BACTERIOL, V190, P6493, DOI 10.1128/JB.00790-08; Jojima T, 2010, APPL MICROBIOL BIOT, V87, P159, DOI 10.1007/s00253-010-2493-7; JONES KH, 1993, APPL ENVIRON MICROB, V59, P1125, DOI 10.1128/AEM.59.4.1125-1130.1993; KEAT MJ, 1978, BIOCHEM J, V175, P649, DOI 10.1042/bj1750649; KENNER GW, 1955, J CHEM SOC, P522, DOI 10.1039/jr9550000522; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KIM JH, 1994, J BACTERIOL, V176, P6349, DOI 10.1128/jb.176.20.6349-6361.1994; Li SY, 2009, P NATL ACAD SCI USA, V106, P18463, DOI 10.1073/pnas.0907203106; Li T, 2014, J BIOTECHNOL, V192, P355, DOI 10.1016/j.jbiotec.2014.01.017; Liu Y, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-28; Londry KL, 1999, CAN J MICROBIOL, V45, P458, DOI 10.1139/cjm-45-6-458; MATHEWS FS, 1991, BIOCHEMISTRY-US, V30, P238, DOI 10.1021/bi00215a034; MCKENNA CE, 1977, TETRAHEDRON LETT, P155; Muller JA, 2001, J BACTERIOL, V183, P752, DOI 10.1128/JB.183.2.752-757.2001; OMURA T, 1964, J BIOL CHEM, V239, P2379; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Peters F, 2007, J BACTERIOL, V189, P4729, DOI 10.1128/JB.00260-07; Peters-Wendisch P, 2005, APPL ENVIRON MICROB, V71, P7139, DOI 10.1128/AEM.71.11.7139-7144.2005; POWLOWSKI JB, 1985, J BACTERIOL, V163, P1126, DOI 10.1128/JB.163.3.1126-1135.1985; Qi SW, 2007, PROTEOMICS, V7, P3775, DOI 10.1002/pmic.200700481; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Schmeling S, 2004, J BACTERIOL, V186, P8044, DOI 10.1128/JB.186.23.8044-8057.2004; Schuhle K, 2004, J BACTERIOL, V186, P4556, DOI 10.1128/JB.186.14.4556-4567.2004; Shen X.-H., 2005, MICROB ENV, V20, P160, DOI [10.1264/jsme2.20.160, DOI 10.1264/JSME2.20.160]; Shen XH, 2005, APPL ENVIRON MICROB, V71, P3442, DOI 10.1128/AEM.71.7.3442-3452.2005; Shen XH, 2012, APPL MICROBIOL BIOT, V95, P77, DOI 10.1007/s00253-012-4139-4; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; Stabler N, 2011, J BACTERIOL, V193, P1702, DOI 10.1128/JB.01295-10; Tallur PN, 2006, CURR MICROBIOL, V53, P529, DOI 10.1007/s00284-006-0309-x; Tallur PN, 2009, BIODEGRADATION, V20, P79, DOI 10.1007/s10532-008-9201-7; Tudzynski B, 2001, APPL ENVIRON MICROB, V67, P3514, DOI 10.1128/AEM.67.8.3514-3522.2001; Werck-Reichhart D, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-6-REVIEWS3003; YOKOYAMA MT, 1981, APPL ENVIRON MICROB, V41, P71, DOI 10.1128/AEM.41.1.71-76.1981; Yu L, 2006, BIOCHEMISTRY-US, V45, P9584, DOI 10.1021/bi060840b; Zhao KX, 2010, J BACTERIOL, V192, P1565, DOI 10.1128/JB.01338-09	64	29	33	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6583	6594		10.1074/jbc.M115.695320	http://dx.doi.org/10.1074/jbc.M115.695320			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26817843	Green Published, hybrid			2022-12-28	WOS:000372894200043
J	Nemoto, TK; Ohara-Nemoto, Y; Bezerra, GA; Shimoyama, Y; Kimura, S				Nemoto, Takayuki K.; Ohara-Nemoto, Yuko; Bezerra, Gustavo Arruda; Shimoyama, Yu; Kimura, Shigenobu			A Porphyromonas gingivalis Periplasmic Novel Exopeptidase, Acylpeptidyl Oligopeptidase, Releases N-Acylated Di- and Tripeptides from Oligopeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminopeptidase; microbial pathogenesis; oligomerization; peptidase; periodontal disease; DFP-6; acylaminoacyl peptidase; oligopeptidase B	COMPLETE GENOME SEQUENCE; PEPTIDASE DPP 7; DIPEPTIDYL-PEPTIDASE; CYSTEINE PROTEINASE; TRANSPORT-SYSTEMS; CRYSTAL-STRUCTURE; PURIFICATION; IDENTIFICATION; ASSOCIATION; BACTEROIDES	Exopeptidases, including dipeptidyl- and tripeptidylpeptidase, are crucial for the growth of Porphyromonas gingivalis, a periodontopathic asaccharolytic bacterium that incorporates amino acids mainly as di- and tripeptides. In this study, we identified a novel exopeptidase, designated acylpeptidyl oligopeptidase (AOP), composed of 759 amino acid residues with active Ser(615) and encoded by PGN_1349 in P. gingivalis ATCC 33277. AOP is currently listed as an unassigned S9 family peptidase or prolyl oligopeptidase. Recombinant AOP did not hydrolyze a Pro-Xaa bond. In addition, although sequence similarities to human and archaea-type acylaminoacyl peptidase sequences were observed, its enzymatic properties were apparently distinct from those, because AOP scarcely released an N-acyl-amino acid as compared with di- and tripeptides, especially with N-terminal modification. The k(cat)/K-m value against benzyloxycarbonyl-Val-Lys-Met-4-methycoumaryl-7-amide, the most potent substrate, was 123.3 +/- 17.3 m(-1) s(-1), optimal pH was 7-8.5, and the activity was decreased with increased NaCl concentrations. AOP existed predominantly in the periplasmic fraction as a monomer, whereas equilibrium between monomers and oligomers was observed with a recombinant molecule, suggesting a tendency of oligomerization mediated by the N-terminal region (Met(16)-Glu(101)). Three-dimensional modeling revealed the three domain structures (residues Met(16)-Ala(126), which has no similar homologue with known structure; residues Leu(127)-Met(495) (-propeller domain); and residues Ala(496)-Phe(736) (/-hydrolase domain)) and further indicated the hydrophobic S1 site of AOP in accord with its hydrophobic P1 preference. AOP orthologues are widely distributed in bacteria, archaea, and eukaryotes, suggesting its importance for processing of nutritional and/or bioactive oligopeptides.	[Nemoto, Takayuki K.; Ohara-Nemoto, Yuko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Mol Biol, Course Med & Dent Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan; [Bezerra, Gustavo Arruda] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, Campus Vienna Bioctr 5, A-1030 Vienna, Austria; [Shimoyama, Yu; Kimura, Shigenobu] Iwate Med Univ, Div Mol Microbiol, Morioka, Iwate 0283694, Japan	Nagasaki University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Iwate Medical University	Bezerra, GA (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Mol Biol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	tnemoto@nagasaki-u.ac.jp		Nemoto, Takayuki K./0000-0002-5007-6260; Arruda Bezerra, Gustavo/0000-0003-4471-821X	Japan Society for the Promotion of Science [15K11047, 25462894]; Nagasaki University Graduate School of Biomedical Sciences; Vienna International Postdoctoral Program (VIPS); Grants-in-Aid for Scientific Research [15K11020] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nagasaki University Graduate School of Biomedical Sciences; Vienna International Postdoctoral Program (VIPS); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-aid for Scientific Research 15K11047 ( to T. K. N.) and 25462894 ( to Y. O.- N.) from the Japan Society for the Promotion of Science and a grant from the Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences in 2014 ( to Y. O.- N.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Vienna International Postdoctoral Program (VIPS).	ABIKO Y, 1985, J DENT RES, V64, P106, DOI 10.1177/00220345850640020201; Abraham C. R., 2012, HDB PROTEOLYTIC ENZY, P3401; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; Banbula A, 2001, J BIOL CHEM, V276, P6299, DOI 10.1074/jbc.M008789200; Banbula A, 2000, INFECT IMMUN, V68, P1176, DOI 10.1128/IAI.68.3.1176-1182.2000; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bezerra GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043019; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; Chien CH, 2004, J BIOL CHEM, V279, P52338, DOI 10.1074/jbc.M406185200; Dashper SG, 2001, J BACTERIOL, V183, P4142, DOI 10.1128/JB.183.14.4142-4148.2001; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; GADE W, 1978, J BIOL CHEM, V253, P5012; Griffen AL, 1998, J CLIN MICROBIOL, V36, P3239, DOI 10.1128/JCM.36.11.3239-3242.1998; Ho YC, 2007, J ENDODONT, V33, P437, DOI 10.1016/j.joen.2006.12.022; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Ito K, 2006, J MOL BIOL, V362, P228, DOI 10.1016/j.jmb.2006.06.083; Iwai T, 2005, J VASC SURG, V42, P107, DOI 10.1016/j.jvs.2005.03.016; KANATANI A, 1991, J BIOCHEM-TOKYO, V110, P315, DOI 10.1093/oxfordjournals.jbchem.a123577; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kiss AL, 2007, J MOL BIOL, V368, P509, DOI 10.1016/j.jmb.2007.02.025; Kshirsagar AV, 2007, BLOOD PURIFICAT, V25, P125, DOI 10.1159/000096411; Kurita-Ochiai T, 2008, J DENT RES, V87, P51, DOI 10.1177/154405910808700108; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; LOESCHE WJ, 1985, J PERIODONTOL, V56, P447, DOI 10.1902/jop.1985.56.8.447; McLean JS, 2013, GENOME RES, V23, P867, DOI 10.1101/gr.150433.112; Menyhard DK, 2013, J BIOL CHEM, V288, P17884, DOI 10.1074/jbc.M113.451534; Meuric V, 2010, FUTURE MICROBIOL, V5, P717, DOI 10.2217/FMB.10.32; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; MOORE WEC, 1982, INFECT IMMUN, V38, P651, DOI 10.1128/IAI.38.2.651-667.1982; Morty RE, 1999, MOL BIOCHEM PARASIT, V102, P145, DOI 10.1016/S0166-6851(99)00097-3; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; Oefner C, 2003, ACTA CRYSTALLOGR D, V59, P1206, DOI 10.1107/S0907444903010059; Ohara-Nemoto Y, 2014, J BIOL CHEM, V289, P5436, DOI 10.1074/jbc.M113.527333; Ohara-Nemoto Y, 2011, J BIOL CHEM, V286, P38115, DOI 10.1074/jbc.M111.278572; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; PIPERNO JR, 1968, J BIOL CHEM, V243, P5914; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rouf SMA, 2013, FEBS OPEN BIO, V3, P177, DOI 10.1016/j.fob.2013.03.004; Rouf SMA, 2013, BIOCHIMIE, V95, P824, DOI 10.1016/j.biochi.2012.11.019; SCHELLENBERG GD, 1977, J BIOL CHEM, V252, P9055; SHAH HN, 1990, BIOCHEM SOC T, V18, P578, DOI 10.1042/bst0180578; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; SINGER RE, 1981, INFECT IMMUN, V32, P458, DOI 10.1128/IAI.32.2.458-463.1981; Sykes PA, 1999, FEBS LETT, V455, P159, DOI 10.1016/S0014-5793(99)00872-8; Takahashi N, 2001, J DENT RES, V80, P1425, DOI 10.1177/00220345010800050801; Takahashi N, 2000, J BACTERIOL, V182, P4704, DOI 10.1128/JB.182.17.4704-4710.2000; TANGLARSEN J, 1995, J PERIODONTAL RES, V30, P390, DOI 10.1111/j.1600-0765.1995.tb01292.x; Usuki H, 2009, BBA-PROTEINS PROTEOM, V1794, P1673, DOI 10.1016/j.bbapap.2009.07.024; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Watanabe T, 2011, J BACTERIOL, V193, P4259, DOI 10.1128/JB.05269-11; WHITE D, 1981, J PERIODONTAL RES, V16, P259, DOI 10.1111/j.1600-0765.1981.tb00974.x	59	14	14	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5913	5925		10.1074/jbc.M115.687566	http://dx.doi.org/10.1074/jbc.M115.687566			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26733202	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000372551800037
J	Okuda, H; Yonezawa, Y; Takano, Y; Okamura, Y; Fujiwara, Y				Okuda, Hiroko; Yonezawa, Yasushige; Takano, Yu; Okamura, Yasushi; Fujiwara, Yuichiro			Direct Interaction between the Voltage Sensors Produces Cooperative Sustained Deactivation in Voltage-gated H+ Channel Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; membrane biophysics; oocyte; proton transport; structure-function; channel gating; voltage-gated channel	TRYPTOPHAN-SCANNING MUTAGENESIS; PROTON CHANNEL; MOLECULAR-DYNAMICS; SELECTIVITY FILTER; K+ CHANNEL; 2 PORES; DOMAIN; MEMBRANE; MECHANISM; MOVEMENT	The voltage-gated H+ channel (Hv) is a voltage sensor domain-like protein consisting of four transmembrane segments (S1-S4). The native Hv structure is a homodimer, with the two channel subunits functioning cooperatively. Here we show that the two voltage sensor S4 helices within the dimer directly cooperate via a -stacking interaction between Trp residues at the middle of each segment. Scanning mutagenesis showed that Trp situated around the original position provides the slow gating kinetics characteristic of the dimer's cooperativity. Analyses of the Trp mutation on the dimeric and monomeric channel backgrounds and analyses with tandem channel constructs suggested that the two Trp residues within the dimer are functionally coupled during Hv deactivation but are less so during activation. Molecular dynamics simulation also showed direct -stacking of the two Trp residues. These results provide new insight into the cooperative function of voltage-gated channels, where adjacent voltage sensor helices make direct physical contact and work as a single unit according to the gating process.	[Okuda, Hiroko; Okamura, Yasushi; Fujiwara, Yuichiro] Osaka Univ, Grad Sch Med, Div Integrat Physiol, Yamadaoka 2-2, Suita, Osaka 5650871, Japan; [Takano, Yu] Osaka Univ, Inst Prot Res, Yamadaoka 2-2, Suita, Osaka 5650871, Japan; [Okamura, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 2-2, Suita, Osaka 5650871, Japan; [Yonezawa, Yasushige] Kinki Univ, High Pressure Prot Res Ctr, Inst Adv Technol, Kinokawa, Wakayama 6496493, Japan; [Takano, Yu] Hiroshima City Univ, Grad Sch Informat Sci, Hiroshima, Hiroshima 7313194, Japan	Osaka University; Osaka University; Osaka University; Kindai University (Kinki University)	Fujiwara, Y (corresponding author), Osaka Univ, Grad Sch Med, Div Integrat Physiol, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	fujiwara@phys2.med.osaka-u.ac.jp	Fujiwara, Yuichiro/GOP-2340-2022; Takano, Yu/H-1785-2014	Fujiwara, Yuichiro/0000-0002-9628-4073; Takano, Yu/0000-0002-4165-8672	Uehara Memorial Foundation; Takeda Science Foundation; Naito Foundation; CREST, Japan Science and Technology Agency;  [26291030]; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research, ( 26291030), the Uehara Memorial Foundation, the Takeda Science Foundation, and the Naito Foundation. This work was supported by CREST, Japan Science and Technology Agency. The authors declare that they have no conflicts of interest with the contents of this article.	Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; Berger TK, 2011, NEURON, V72, P991, DOI 10.1016/j.neuron.2011.11.014; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; Chamberlin A, 2014, P NATL ACAD SCI USA, V111, pE273, DOI 10.1073/pnas.1318018111; Choe S, 1995, P NATL ACAD SCI USA, V92, P12046, DOI 10.1073/pnas.92.26.12046; Collins A, 1997, P NATL ACAD SCI USA, V94, P5456, DOI 10.1073/pnas.94.10.5456; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; Deol SS, 2004, BIOPHYS J, V87, P3737, DOI 10.1529/biophysj.104.048397; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fujiwara Y, 2014, J GEN PHYSIOL, V143, P377, DOI 10.1085/jgp.201311082; Fujiwara Y, 2013, J PHYSIOL-LONDON, V591, P627, DOI 10.1113/jphysiol.2012.243006; Fujiwara Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1823; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gonzalez C, 2013, J GEN PHYSIOL, V141, P275, DOI 10.1085/jgp.201210857; Gonzalez C, 2010, NAT STRUCT MOL BIOL, V17, P51, DOI 10.1038/nsmb.1739; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ishii TM, 2007, J PHYSIOL-LONDON, V579, P291, DOI 10.1113/jphysiol.2006.124297; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P244, DOI 10.1038/nsmb.2768; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Musset B, 2011, NATURE, V480, P273, DOI 10.1038/nature10557; Musset B, 2010, J PHYSIOL-LONDON, V588, P1435, DOI 10.1113/jphysiol.2010.188318; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Qiu F, 2013, NEURON, V77, P288, DOI 10.1016/j.neuron.2012.12.021; Ramsey IS, 2010, NAT STRUCT MOL BIOL, V17, P869, DOI 10.1038/nsmb.1826; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Subbiah RN, 2005, J PHYSIOL-LONDON, V569, P367, DOI 10.1113/jphysiol.2005.097386; Takeshita K, 2014, NAT STRUCT MOL BIOL, V21, P352, DOI 10.1038/nsmb.2783; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Tombola F, 2010, NAT STRUCT MOL BIOL, V17, P44, DOI 10.1038/nsmb.1738; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]	47	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5935	5947		10.1074/jbc.M115.666834	http://dx.doi.org/10.1074/jbc.M115.666834			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26755722	Green Published, hybrid			2022-12-28	WOS:000372551800039
J	Yakhnin, AV; Murakami, KS; Babitzke, P				Yakhnin, Alexander V.; Murakami, Katsuhiko S.; Babitzke, Paul			NusG Is a Sequence-specific RNA Polymerase Pause Factor That Binds to the Non-template DNA within the Paused Transcription Bubble	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial transcription; gene regulation; protein-DNA interaction; RNA polymerase; transcription elongation factor; NusG; RNA polymerase pausing	SUBTILIS-TRP OPERON; BACILLUS-SUBTILIS; ATTENUATION PROTEIN; ELONGATION-FACTOR; IN-VITRO; REGULATES TRANSLATION; COMPLEX STRUCTURE; STRUCTURAL BASIS; HAIRPIN; LEADER	NusG, referred to as Spt5 in archaeal and eukaryotic organisms, is the only transcription factor conserved in all three domains of life. This general transcription elongation factor binds to RNA polymerase (RNAP) soon after transcription initiation and dissociation of the RNA polymerase sigma factor. Escherichia coli NusG increases transcription processivity by suppressing RNAP pausing, whereas Bacillus subtilis NusG dramatically stimulates pausing at two sites in the untranslated leader of the trpEDCFBA operon. These two regulatory pause sites participate in transcription attenuation and translational control mechanisms, respectively. Here we report that B. subtilis NusG makes sequence-specific contacts with a T-rich sequence in the non-template DNA (ntDNA) strand within the paused transcription bubble. NusG protects T residues of the recognition sequence from permanganate oxidation, and these T residues increase the affinity of NusG to the elongation complex. Binding of NusG to RNAP does not require interaction with RNA. These results indicate that bound NusG prevents forward movement of RNA polymerase by simultaneously contacting RNAP and the ntDNA strand. Mutational studies indicate that amino acid residues of two short regions within the NusG N-terminal domain are primarily responsible for recognition of the trp operon pause signals. Structural modeling indicates that these two regions are adjacent to each another in the protein. We propose that recognition of specific sequences in the ntDNA and stimulation of RNAP pausing is a conserved function of NusG-like transcription factors.	[Yakhnin, Alexander V.; Murakami, Katsuhiko S.; Babitzke, Paul] Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Babitzke, P (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA.	pxb28@psu.edu	Babitzke, Paul/AAL-3048-2020	Babitzke, Paul/0000-0003-2481-1062; Murakami, Katsuhiko/0000-0003-2244-0501	National Institutes of Health [GM098399, GM087350]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098399, R01GM087350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM098399 (to P. B.) and GM087350 (to K. S. M.).	Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Belogurov GA, 2010, MOL MICROBIOL, V76, P286, DOI 10.1111/j.1365-2958.2010.07056.x; Belogurov GA, 2009, EMBO J, V28, P112, DOI 10.1038/emboj.2008.268; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; Burmann BM, 2012, CELL, V150, P291, DOI 10.1016/j.cell.2012.05.042; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Chan CL, 1997, J MOL BIOL, V268, P54, DOI 10.1006/jmbi.1997.0935; Du HS, 1998, J BIOL CHEM, V273, P20494, DOI 10.1074/jbc.273.32.20494; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; Herbert KM, 2010, J MOL BIOL, V399, P17, DOI 10.1016/j.jmb.2010.03.051; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Landick R, 1996, METHOD ENZYMOL, V274, P334; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; MERINO E, 1995, J BACTERIOL, V177, P6362, DOI 10.1128/jb.177.22.6362-6370.1995; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; Perdue SA, 2011, J MOL BIOL, V412, P782, DOI 10.1016/j.jmb.2011.02.011; Qi Y, 1998, MOL MICROBIOL, V28, P1187, DOI 10.1046/j.1365-2958.1998.00882.x; RING BZ, 1994, CELL, V78, P317, DOI 10.1016/0092-8674(94)90300-X; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Yakhnin AV, 2008, P NATL ACAD SCI USA, V105, P16131, DOI 10.1073/pnas.0808842105; Yakhnin AV, 2006, MOL CELL, V24, P547, DOI 10.1016/j.molcel.2006.09.018; Yakhnin AV, 2010, MOL MICROBIOL, V76, P690, DOI 10.1111/j.1365-2958.2010.07126.x; Yakhnin AV, 2002, P NATL ACAD SCI USA, V99, P11067, DOI 10.1073/pnas.162373299	34	41	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5299	5308		10.1074/jbc.M115.704189	http://dx.doi.org/10.1074/jbc.M115.704189			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26742846	hybrid, Green Published			2022-12-28	WOS:000371640600039
J	Ali, RA; Camick, C; Wiles, K; Walseth, TF; Slama, JT; Bhattacharya, S; Giovannucci, DR; Wall, KA				Ali, Ramadan A.; Camick, Christina; Wiles, Katherine; Walseth, Timothy F.; Slama, James T.; Bhattacharya, Sumit; Giovannucci, David R.; Wall, Katherine A.			Nicotinic Acid Adenine Dinucleotide Phosphate Plays a Critical Role in Naive and Effector Murine T Cells but Not Natural Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; RYANODINE RECEPTOR; TRPM2 CHANNELS; NUCLEAR FACTOR; NAADP; CALCIUM; ACTIVATION; CONNEXIN-43; PROMOTER; IDENTIFICATION	Nicotinic acid adenine dinucleotide phosphate (NAADP), the most potent Ca2+ mobilizing second messenger discovered to date, has been implicated in Ca2+ signaling in some lymphomas and T cell clones. In contrast, the role ofNAADPin Ca2+ signaling or the identity of the Ca2+ stores targeted by NAADP in conventional naive T cells is less clear. In the current study, we demonstrate the importance of NAADP in the generation of Ca2+ signals in murine naive T cells. Combining live-cell imaging methods and a pharmacological approach using theNAADP antagonist Ned-19, we addressed the involvement of NAADP in the generation of Ca2+ signals evoked by TCR stimulation and the role of this signal in downstream physiological end points such as proliferation, cytokine production, and other responses to stimulation. We demonstrated that acidic compartments in addition to the endoplasmic reticulum were the Ca2+ stores that were sensitive to NAADP in naive T cells. NAADP was shown to evoke functionally relevant Ca2+ signals in both naive CD4 and naive CD8 T cells. Furthermore, we examined the role of this signal in the activation, proliferation, and secretion of effector cytokines by Th1, Th2, Th17, and CD8 effector T cells. Overall, NAADP exhibited a similar profile in mediating Ca2+ release in effector T cells as in their counterpart naive T cells and seemed to be equally important for the function of these different subsets of effector T cells. This profile was not observed for natural T regulatory cells.	[Ali, Ramadan A.; Camick, Christina; Wiles, Katherine; Slama, James T.; Wall, Katherine A.] Univ Toledo Hlth Sci Campus, Coll Pharm & Pharmaceut Sci, Dept Med & Biol Chem, Toledo, OH 43614 USA; [Bhattacharya, Sumit; Giovannucci, David R.] Univ Toledo Hlth Sci Campus, Dept Neurosci, Toledo, OH 43614 USA; [Walseth, Timothy F.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University of Minnesota System; University of Minnesota Twin Cities	Wall, KA (corresponding author), 3000 Arlington Ave, Toledo, OH 43614 USA.	Katherine.wall@utoledo.edu	Walseth, Timothy F/F-9518-2010; Giovannucci, David R/A-5657-2018	Walseth, Timothy F/0000-0003-2558-7859; Wall, Katherine/0000-0002-1150-4736; Ali, Ramadan/0000-0003-1507-1517	University of Toledo Interdisciplinary Research Initiation Program Grant; National Institutes of Health [GM100444, DE023418]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE023418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM100444] Funding Source: NIH RePORTER	University of Toledo Interdisciplinary Research Initiation Program Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a University of Toledo Interdisciplinary Research Initiation Program Grant and National Institutes of Health Grants GM100444 (to J. S.) and DE023418 (to D. G.). This work was taken in part from the doctoral dissertation submitted by R. A. A. to the University of Toledo College of Graduate Studies for the Ph.D. degree in Medicinal Chemistry, December 2014. The authors declare that they have no conflicts of interest with the contents of this article.	Ali RA, 2014, CELL CALCIUM, V55, P93, DOI 10.1016/j.ceca.2013.12.004; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Bermudez-Fajardo A, 2007, J LEUKOCYTE BIOL, V82, P608, DOI 10.1189/jlb.0307134; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Billington RA, 2006, FASEB J, V20, P521, DOI 10.1096/fj.05-5058fje; Bruzzone S, 2001, FASEB J, V15, P10; Campbell PM, 1996, TRANSPLANTATION, V61, P933, DOI 10.1097/00007890-199603270-00016; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cordiglieri C, 2010, BRAIN, V133, P1930, DOI 10.1093/brain/awq135; Dammermann W, 2005, J BIOL CHEM, V280, P21394, DOI 10.1074/jbc.M413085200; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Davis LC, 2012, CURR BIOL, V22, P2331, DOI 10.1016/j.cub.2012.10.035; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Guse AH, 2013, CURR TOP MED CHEM, V13, P2978, DOI 10.2174/15680266113136660212; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; Hickman SP, 2006, J IMMUNOL, V177, P2186, DOI 10.4049/jimmunol.177.4.2186; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KIM UH, 1993, BIOCHIM BIOPHYS ACTA, V1178, P121, DOI 10.1016/0167-4889(93)90001-6; Lange I, 2008, CELL CALCIUM, V44, P604, DOI 10.1016/j.ceca.2008.05.001; Langhorst MF, 2004, CELL SIGNAL, V16, P1283, DOI 10.1016/j.cellsig.2004.03.013; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; LIN CS, 1991, CELL IMMUNOL, V133, P269, DOI 10.1016/0008-8749(91)90103-I; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; Moreschi I, 2008, CELL CALCIUM, V43, P344, DOI 10.1016/j.ceca.2007.06.006; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Park KH, 2013, J BIOL CHEM, V288, P35548, DOI 10.1074/jbc.M113.489278; Rah SY, 2010, J BIOL CHEM, V285, P21877, DOI 10.1074/jbc.M109.066290; Robert V, 2011, BIOCHIMIE, V93, P2087, DOI 10.1016/j.biochi.2011.06.016; Rosen D, 2009, J BIOL CHEM, V284, P34930, DOI 10.1074/jbc.M109.016519; Schuh K, 1998, J EXP MED, V188, P1369, DOI 10.1084/jem.188.7.1369; Song EK, 2011, J BIOL CHEM, V286, P44480, DOI 10.1074/jbc.M111.307645; Steen M, 2007, J BIOL CHEM, V282, P18864, DOI 10.1074/jbc.M610925200; Trabbic CJ, 2015, J MED CHEM, V58, P3593, DOI 10.1021/acs.jmedchem.5b00279; Walseth Timothy F, 2012, Messenger (Los Angel), V1, P86; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; Wolf IMA, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0863	43	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4503	4522		10.1074/jbc.M115.681833	http://dx.doi.org/10.1074/jbc.M115.681833			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26728458	Green Published, hybrid			2022-12-28	WOS:000371604600021
J	Samuel, F; Flavin, WP; Iqbal, S; Pacelli, C; Renganathan, SDS; Trudeau, LE; Campbell, EM; Fraser, PE; Tandon, A				Samuel, Filsy; Flavin, William P.; Iqbal, Sobia; Pacelli, Consiglia; Renganathan, Sri Dushyaanthan Sri; Trudeau, Louis-Eric; Campbell, Edward M.; Fraser, Paul E.; Tandon, Anurag			Effects of Serine 129 Phosphorylation on alpha-Synuclein Aggregation, Membrane Association, and Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-LINKED MUTATIONS; MULTIPLE SYSTEM ATROPHY; LEWY BODY DISEASE; PARKINSONS-DISEASE; TRANSGENIC MICE; INCLUSION FORMATION; CELL-DEATH; MEDIATED PHOSPHORYLATION; SER-129 PHOSPHORYLATION; OLIGODENDROGLIAL CELLS	Although trace levels of phosphorylated alpha-synuclein (alpha-syn) are detectable in normal brains, nearly all alpha-syn accumulated within Lewy bodies in Parkinson disease brains is phosphorylated on serine 129 (Ser-129). The role of the phosphoserine residue and its effects on alpha-syn structure, function, and intracellular accumulation are poorly understood. Here, co-expression of alpha-syn and polo-like kinase 2 (PLK2), a kinase that targets Ser-129, was used to generate phosphorylated alpha-syn for biophysical and biological characterization. Misfolding and fibril formation of phosphorylated alpha-syn isoforms were detected earlier, although the fibrils remained phosphatase-and protease-sensitive. Membrane binding of alpha-syn monomers was differentially affected by phosphorylation depending on the Parkinson disease-linked mutation. WT alpha-syn binding to presynaptic membranes was not affected by phosphorylation, whereas A30P alpha-syn binding was greatly increased, and A53T alpha-syn was slightly lower, implicating distal effects of the carboxyl-on amino-terminal membrane binding. Endocytic vesicle-mediated internalization of pre-formed fibrils into non-neuronal cells and dopaminergic neurons matched the efficacy of alpha-syn membrane binding. Finally, the disruption of internalized vesicle membranes was enhanced by the phosphorylated alpha-syn isoforms, a potential means for misfolded extracellular or lumenal alpha-syn to access cytosolic alpha-syn. Our results suggest that the threshold for vesicle permeabilization is evident even at low levels of alpha-syn internalization and are relevant to therapeutic strategies to reduce intercellular propagation of alpha-syn misfolding.	[Samuel, Filsy; Iqbal, Sobia; Renganathan, Sri Dushyaanthan Sri; Fraser, Paul E.; Tandon, Anurag] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, 60 Leonard Ave, Toronto, ON M5T 2S8, Canada; [Flavin, William P.; Campbell, Edward M.] Loyola Univ, Stritch Sch Med, Integrat Cell Biol Program, 2160 S 1st Ave, Maywood, IL 60153 USA; [Campbell, Edward M.] Loyola Univ, Stritch Sch Med, Dept Microbiol & Immunol, 2160 S 1st Ave, Maywood, IL 60153 USA; [Pacelli, Consiglia; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Cent Nervous Syst Res Grp, Dept Pharmacol, Quebec City, PQ H4T 1J4, Canada; [Pacelli, Consiglia; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Cent Nervous Syst Res Grp, Dept Neurosci, Quebec City, PQ H4T 1J4, Canada; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON M5T 2S8, Canada; [Tandon, Anurag] Univ Toronto, Dept Med, Toronto, ON M5T 2S8, Canada	University of Toronto; Loyola University Chicago; Loyola University Chicago; Laval University; Universite de Montreal; Laval University; Universite de Montreal; University of Toronto; University of Toronto	Tandon, A (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, 60 Leonard Ave, Toronto, ON M5T 2S8, Canada.	a.tandon@utoronto.ca	Pacelli, Consiglia/J-9032-2016; Trudeau, Louis-Eric/AAE-4782-2020	Pacelli, Consiglia/0000-0003-4915-5823; Trudeau, Louis-Eric/0000-0003-4684-1377; Flavin, William/0000-0002-5945-7844	Canadian Institutes of Health Research [MOP-84501, MOP-115056]; Edmond J. Safra Foundation fellowships; Illinois Chapter of ARCS(R) Foundation; Parkinson Society of Canada; Krembil Foundation; Brain Canada; Rapid Response Innovation Award from Michael J. Fox Foundation; Alzheimer Society of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Edmond J. Safra Foundation fellowships; Illinois Chapter of ARCS(R) Foundation; Parkinson Society of Canada; Krembil Foundation; Brain Canada; Rapid Response Innovation Award from Michael J. Fox Foundation; Alzheimer Society of Ontario	This work was supported in part by Canadian Institutes of Health Research Operating Grants MOP-84501 (to A. T.) and MOP-115056 (to P. E. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by Edmond J. Safra Foundation fellowships.; Supported by the Illinois Chapter of the ARCS (R) Foundation.; Supported by a fellowship from Parkinson Society of Canada.; Supported by the Krembil Foundation and Brain Canada.; Supported by a Rapid Response Innovation Award from the Michael J. Fox Foundation.; Supported by the Alzheimer Society of Ontario.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Beyer K, 2013, MOL NEUROBIOL, V47, P509, DOI 10.1007/s12035-012-8330-5; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Chau KY, 2009, J NEUROCHEM, V110, P1005, DOI 10.1111/j.1471-4159.2009.06191.x; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; Chen RHC, 2013, J BIOL CHEM, V288, P7438, DOI 10.1074/jbc.M112.439497; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Escobar VD, 2014, NEUROSCI LETT, V563, P96, DOI 10.1016/j.neulet.2014.01.033; Fasano C., 2008, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0321S44; Fiske M, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/392180; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Games D, 2014, J NEUROSCI, V34, P9441, DOI 10.1523/JNEUROSCI.5314-13.2014; Goncalves S, 2013, MOL NEUROBIOL, V47, P1081, DOI 10.1007/s12035-013-8406-x; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Harper CB, 2013, TRENDS CELL BIOL, V23, P90, DOI 10.1016/j.tcb.2012.10.007; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Konno M, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-38; Kragh CL, 2009, J BIOL CHEM, V284, P10211, DOI 10.1074/jbc.M809671200; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Kuwahara T, 2012, J BIOL CHEM, V287, P7098, DOI 10.1074/jbc.M111.237131; Lee G, 2004, J BIOL CHEM, V279, P6834, DOI 10.1074/jbc.M312760200; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Maier O, 2012, J VIROL, V86, P10821, DOI 10.1128/JVI.01428-12; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Neumann M, 2004, J NEUROPATH EXP NEUR, V63, P1225, DOI 10.1093/jnen/63.12.1225; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Nishie M, 2004, ACTA NEUROPATHOL, V107, P292, DOI 10.1007/s00401-003-0811-1; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Potter KJ, 2009, BBA-GEN SUBJECTS, V1790, P566, DOI 10.1016/j.bbagen.2009.02.013; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Reyes JF, 2015, NEUROBIOL DIS, V77, P266, DOI 10.1016/j.nbd.2014.07.003; Reyes JF, 2014, GLIA, V62, P387, DOI 10.1002/glia.22611; Ronzitti G, 2014, J NEUROSCI, V34, P10603, DOI 10.1523/JNEUROSCI.0608-14.2014; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Schreurs S, 2014, INT J MOL SCI, V15, P1040, DOI 10.3390/ijms15011040; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Takahashi M, 2007, EUR J NEUROSCI, V26, P863, DOI 10.1111/j.1460-9568.2007.05736.x; Tenreiro S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004302; Ullman O, 2011, J AM CHEM SOC, V133, P19536, DOI 10.1021/ja208657z; Visanji NP, 2011, J BIOL CHEM, V286, P35863, DOI 10.1074/jbc.M111.253450; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wakamatsu M, 2007, J NEUROSCI RES, V85, P1819, DOI 10.1002/jnr.21310; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Wislet-Gendebien S, 2006, J BIOL CHEM, V281, P32148, DOI 10.1074/jbc.M605965200; Wislet-Gendebien S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-92; Wu B, 2011, ACTA HISTOCHEM, V113, P32, DOI 10.1016/j.acthis.2009.07.007; Yamada M, 2004, J NEUROCHEM, V91, P451, DOI 10.1111/j.1471-4159.2004.02728.x	79	94	94	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4374	4385		10.1074/jbc.M115.705095	http://dx.doi.org/10.1074/jbc.M115.705095			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26719332	hybrid, Green Published			2022-12-28	WOS:000371604600010
J	Yin, FX; Wang, FS; Sheng, JZ				Yin, Feng-Xin; Wang, Feng-Shan; Sheng, Ju-Zheng			Uncovering the Catalytic Direction of Chondroitin AC Exolyase FROM THE REDUCING END TOWARDS THE NON-REDUCING END	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HEPARINS; POLYSACCHARIDE LYASES; CHEMOENZYMATIC SYNTHESIS; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; SULFATE; GLYCOSAMINOGLYCANS; DEGRADATION; PROTEIN; OLIGOSACCHARIDES	Glycosaminoglycans (GAGs) are polysaccharides that play vital functional roles in numerous biological processes, and compounds belonging to this class have been implicated in a wide variety of diseases. Chondroitin AC lyase (ChnAC) (EC 4.2.2.5) catalyzes the degradation of various GAGs, including chondroitin sulfate and hyaluronic acid, to give the corresponding disaccharides containing an Delta(4)-unsaturated uronic acid at their non-reducing terminus. ChnAC has been isolated from various bacteria and utilized as an enzymatic tool for study and evaluating the sequencing of GAGs. Despite its substrate specificity and the fact that its crystal structure has been determined to a high resolution, the direction in which ChnAC catalyzes the cleavage of oligosaccharides remain unclear. Herein, we have determined the structural cues of substrate depolymerization and the cleavage direction of ChnAC using model substrates and recombinant ChnAC protein. Several structurally defined oligosaccharides were synthesized using a chemoenzymatic approach and subsequently cleaved using ChnAC. The degradation products resulting from this process were determined by mass spectrometry. The results revealed that ChnAC cleaved the beta 1,4-glycosidic linkages between glucuronic acid and glucosamine units when these bonds were located on the reducing end of the oligosaccharide. In contrast, the presence of a GlcNAc-alpha-1,4-GlcA unit at the reducing end of the oligosaccharide prevented ChnAC from cleaving the GalNAc-beta 1,4-GlcA moiety located in the middle or at the non-reducing end of the chain. These interesting results therefore provide direct proof that ChnAC cleaves oligosaccharide substrates from their reducing end toward their non-reducing end. This conclusion will therefore enhance our collective understanding of the mode of action of ChnAC.	[Yin, Feng-Xin; Wang, Feng-Shan; Sheng, Ju-Zheng] Shandong Univ, Sch Pharmaceut Sci, Inst Biochem & Biotechnol Drugs, Minist Educ,Key Lab Chem Biol Nat Prod, Jinan 250012, Peoples R China; [Wang, Feng-Shan; Sheng, Ju-Zheng] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250012, Peoples R China	Shandong University; Shandong University	Wang, FS; Sheng, JZ (corresponding author), Shandong Univ, Sch Pharmaceut Sci, Inst Biochem & Biotechnol Drugs, Jinan 250012, Peoples R China.	fswang@sdu.edu.cn; shengjuzheng@sdu.edu.cn	Sheng, Juzheng/G-2693-2013	Sheng, Juzheng/0000-0003-2856-9162	National Natural Science Foundation of China [31300673]; Specialized Research Fund for the Doctoral Program of Higher Education [20130131120046]; Projects of Science and Technology Dept. of Shandong Province [2015GSF121002, 2015ZDJS04002]; Fundamental Research Funds of Shandong University [2014YQ002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Projects of Science and Technology Dept. of Shandong Province; Fundamental Research Funds of Shandong University	This work was supported in part by the National Natural Science Foundation of China (Project no. 31300673), the Specialized Research Fund for the Doctoral Program of Higher Education (Project no. 20130131120046), the Projects of Science and Technology Dept. of Shandong Province (Project no. 2015GSF121002 and 2015ZDJS04002), and the Fundamental Research Funds (Project no. 2014YQ002) of Shandong University. A patent (CN201510289566) has been published relating to this article. Despite this publication, the authors have strictly adhered to all the policies provide by the The Journal of Biological Chemistry regarding the sharing of data and materials.	Bisio A, 2009, THROMB HAEMOSTASIS, V102, P865, DOI 10.1160/TH09-02-0081; Capila I, 2002, BBA-PROTEIN STRUCT M, V1597, P260, DOI 10.1016/S0167-4838(02)00304-7; Chen Y, 2013, ANGEW CHEM INT EDIT, V52, P11852, DOI 10.1002/anie.201305667; DeAngelis PL, 2013, GLYCOBIOLOGY, V23, P764, DOI 10.1093/glycob/cwt016; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Hamai A, 1997, J BIOL CHEM, V272, P9123; Hernaiz M J, 2001, Methods Mol Biol, V171, P363; Huang WJ, 2003, J MOL BIOL, V328, P623, DOI 10.1016/S0022-2836(03)00345-0; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Kale V, 2015, MAR BIOTECHNOL, V17, P479, DOI 10.1007/s10126-015-9629-9; Kawaguchi Y, 2013, FEBS LETT, V587, P3943, DOI 10.1016/j.febslet.2013.10.021; Li L, 2015, CARBOHYD POLYM, V134, P590, DOI 10.1016/j.carbpol.2015.08.028; Li PL, 2013, MED RES REV, V33, P665, DOI 10.1002/med.21263; Li SL, 2001, J BIOL CHEM, V276, P41407, DOI 10.1074/jbc.M106634200; Li YH, 2014, APPL MICROBIOL BIOT, V98, P1127, DOI 10.1007/s00253-013-4947-1; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; Liu CH, 2014, J BIOL CHEM, V289, P13407, DOI 10.1074/jbc.M113.530535; Liu J, 2007, APPL MICROBIOL BIOT, V74, P263, DOI 10.1007/s00253-006-0722-x; Liu J, 2014, NAT PROD REP, V31, P1676, DOI 10.1039/c4np00076e; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Merli Geno J, 2010, P T, V35, P95; Migliore A, 2015, CLIN CASES MINER BON, V12, P31, DOI 10.11138/ccmbm/2015.12.1.031; O'Leary TR, 2013, GLYCOBIOLOGY, V23, P132, DOI 10.1093/glycob/cws136; Pantazaka E, 2014, BBA-GEN SUBJECTS, V1840, P2643, DOI 10.1016/j.bbagen.2014.01.009; Pempe EH, 2012, J BIOL CHEM, V287, P20774, DOI 10.1074/jbc.M111.320069; Peterson S, 2012, J BIOL CHEM, V287, P34836, DOI 10.1074/jbc.M112.390161; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; Sheng JZ, 2011, J BIOL CHEM, V286, P19768, DOI 10.1074/jbc.M111.224311; Shim KW, 2008, PROTEIN EXPRES PURIF, V58, P222, DOI 10.1016/j.pep.2007.11.014; SUTHERLAND IW, 1995, FEMS MICROBIOL REV, V16, P323, DOI 10.1016/0168-6445(95)00020-D; Tao K, 2005, BIOTECHNOL LETT, V27, P489, DOI 10.1007/s10529-005-2538-7; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Varki A., 2009, ESSENTIALS GLYCOBIOL; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Xu YM, 2014, NAT CHEM BIOL, V10, P248, DOI [10.1038/NCHEMBIO.1459, 10.1038/nchembio.1459]; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Zhang Q, 2015, NEUROSCIENCE, V305, P169, DOI 10.1016/j.neuroscience.2015.08.002	41	14	15	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4399	4406		10.1074/jbc.C115.708396	http://dx.doi.org/10.1074/jbc.C115.708396			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26742844	Green Published, hybrid			2022-12-28	WOS:000371604600012
J	Li, YH; Choi, DH; Lee, EH; Seo, SR; Lee, S; Cho, EH				Li, Ying Hui; Choi, Dae Hee; Lee, Eun Hye; Seo, Su Ryeon; Lee, Seungkoo; Cho, Eun-Hee			Sirtuin 3 (SIRT3) Regulates alpha-Smooth Muscle Actin (alpha-SMA) Production through the Succinate Dehydrogenase-G Protein-coupled Receptor 91 (GPR91) Pathway in Hepatic Stellate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; RENIN RELEASE; NONALCOHOLIC STEATOHEPATITIS; DEPENDENT DEACETYLASE; INSULIN-RESISTANCE; HIGH GLUCOSE; RESVERATROL; METABOLISM; ACTIVATION; EXPRESSION	Sirtuin 3 (SIRT3) is an NAD(+)-dependent protein deacetylase. Recent studies have shown that SIRT3 expression is decreased in nonalcoholic fatty liver disease (NAFLD). Moreover, SIRT3 is a key regulator of succinate dehydrogenase (SDH), which catalyzes the oxidation of succinate to fumarate. Increased succinate concentrations and the specific G protein-coupled receptor 91 (GPR91) are involved in the activation of hepatic stellate cells (HSCs). In this study, we aimed to establish whether SIRT3 regulated the SDH activity, succinate, and GPR91 expression in HSCs and an animal model of NAFLD. Our goal was also to determine whether succinate released from hepatocytes regulated HSC activation. Inhibiting SIRT3 using SIRT3 siRNA exacerbated HSC activation via the SDH-succinate-GPR91 pathway, and SIRT3 overexpression or honokiol treatment attenuated HSC activation in vitro. In isolated liver and HSCs from methionine-and choline-deficient (MCD) diet-induced NAFLD, the expression of SIRT3 and SDH activity was decreased, and the succinate concentrations and GPR91 expression were increased. Moreover, we found that GPR91 knockdown or resveratrol treatment improved the steatosis in MCD diet-fed mice. This investigation revealed a novel mechanism of the SIRT3-SDH-GPR91 cascade in MCD diet-induced HSC activation in NAFLD. These findings highlight the biological significance of novel strategies aimed at targeting SIRT3 and GPR91 in HSCs with the goal of improving NAFLD treatment.	[Li, Ying Hui; Choi, Dae Hee; Cho, Eun-Hee] Kangwon Natl Univ, Dept Internal Med, Chunchon 200701, South Korea; [Lee, Seungkoo] Kangwon Natl Univ, Dept Anat Pathol, Sch Med, Chunchon 200701, South Korea; [Lee, Eun Hye; Seo, Su Ryeon] Kangwon Natl Univ, Coll Biomed Sci, Dept Mol Biosci, Chunchon 200701, South Korea; [Lee, Eun Hye; Seo, Su Ryeon] Kangwon Natl Univ, Inst Biosci & Biotechnol, Chunchon 200701, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University	Cho, EH (corresponding author), Kangwon Natl Univ, Sch Med, Dept Internal Med, 26 Kangwondaehak Gil, Chuncheon Si 200701, Gangwon Do, South Korea.	ehcho@kangwon.ac.kr		CHO, EUN-HEE/0000-0002-1349-8894	 [NRF-2013R1A1A1058962]		This work was supported by Grant NRF-2013R1A1A1058962. The authors declare that they have no conflicts of interest with the contents of this article.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ariza Ana Carolina, 2012, Front Endocrinol (Lausanne), V3, P22, DOI 10.3389/fendo.2012.00022; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Barbero-Becerra VJ, 2015, TOXICOL IN VITRO, V29, P1753, DOI 10.1016/j.tiv.2015.07.010; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Cho Eun-Hee, 2014, J Lifestyle Med, V4, P80, DOI 10.15280/jlm.2014.4.2.80; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; COBB MH, 1994, SEMIN CANCER BIOL, V5, P261; Correa PRAV, 2007, J HEPATOL, V47, P262, DOI 10.1016/j.jhep.2007.03.016; Deen PMT, 2011, J AM SOC NEPHROL, V22, P1416, DOI 10.1681/ASN.2010050481; Desquiret-Dumas V, 2013, J BIOL CHEM, V288, P36662, DOI 10.1074/jbc.M113.466490; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Gnana-Prakasam JP, 2011, INVEST OPHTH VIS SCI, V52, P3751, DOI 10.1167/iovs.10-6722; He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hirschey MD, 2011, COLD SH Q B, V76, P267, DOI 10.1101/sqb.2011.76.010850; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ismail MH, 2011, HEPATIC MED-EVID RES, V3, P69, DOI 10.2147/HMER.S9051; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Knittel T, 1996, HEPATOLOGY, V24, P352; Krebs H A, 1970, Adv Enzyme Regul, V8, P335, DOI 10.1016/0065-2571(70)90028-2; Kulkarni SS, 2015, BBA-MOL BASIS DIS, V1852, P1114, DOI 10.1016/j.bbadis.2014.10.005; Lantier L, 2015, DIABETES, V64, P3081, DOI 10.2337/db14-1810; Li YH, 2015, BIOCHEM BIOPH RES CO, V463, P853, DOI 10.1016/j.bbrc.2015.06.023; Lim S, 2014, ENDOCRINOL METAB, V29, P1, DOI 10.3803/EnM.2014.29.1.1; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lukyanova LD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00320; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pan QR, 2015, NUTR RES, V35, P576, DOI 10.1016/j.nutres.2015.05.006; Peti-Peterdi J, 2010, KIDNEY INT, V78, P1214, DOI 10.1038/ki.2010.333; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Qian H, 2015, CELL RES, V25, P930, DOI 10.1038/cr.2015.84; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Robben JH, 2009, KIDNEY INT, V76, P1258, DOI 10.1038/ki.2009.360; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Vargas SL, 2009, J AM SOC NEPHROL, V20, P1002, DOI 10.1681/ASN.2008070740; Wu T, 2014, ANN CLIN LAB SCI, V44, P410; Yoo HJ, 2015, DIABETES METAB J, V39, P10, DOI 10.4093/dmj.2015.39.1.10	55	39	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10277	10292		10.1074/jbc.M115.692244	http://dx.doi.org/10.1074/jbc.M115.692244			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26912655	Green Published, hybrid			2022-12-28	WOS:000375602800035
J	Swenson, S; Cannon, A; Harris, NJ; Taylor, NG; Fox, JL; Khalimonchuk, O				Swenson, Samantha; Cannon, Andrew; Harris, Nicholas J.; Taylor, Nicholas G.; Fox, Jennifer L.; Khalimonchuk, Oleh			Analysis of Oligomerization Properties of Heme a Synthase Provides Insights into Its Function in Eukaryotes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; LEIGH-SYNDROME; ASSEMBLY FACTOR; MITOCHONDRIAL FERREDOXIN; BIOSYNTHETIC-PATHWAY; MISSENSE MUTATIONS; BACILLUS-SUBTILIS; COX15 GENE; O SYNTHASE; YEAST	Heme a is an essential cofactor for function of cytochrome c oxidase in the mitochondrial electron transport chain. Several evolutionarily conserved enzymes have been implicated in the biosynthesis of heme a, including the heme a synthase Cox15. However, the structure of Cox15 is unknown, its enzymatic mechanism and the role of active site residues remain debated, and recent discoveries suggest additional chaperone-like roles for this enzyme. Here, we investigated Cox15 in the model eukaryote Saccharomyces cerevisiae via several approaches to examine its oligomeric states and determine the effects of active site and human pathogenic mutations. Our results indicate that Cox15 exhibits homotypic interactions, forming highly stable complexes dependent upon hydrophobic interactions. This multimerization is evolutionarily conserved and independent of heme levels and heme a synthase catalytic activity. Four conserved histidine residues are demonstrated to be critical for eukaryotic heme a synthase activity and cannot be substituted with other heme-ligating amino acids. The 20-residue linker region connecting the two conserved domains of Cox15 is also important; removal of this linker impairs both Cox15 multimerization and enzymatic activity. Mutations of COX15 causing single amino acid conversions associated with fatal infantile hypertrophic cardiomyopathy and the neurological disorder Leigh syndrome result in impaired stability (S344P) or catalytic function (R217W), and the latter mutation affects oligomeric properties of the enzyme. Structural modeling of Cox15 suggests these two mutations affect protein folding and heme binding, respectively. We conclude that Cox15 multimerization is important for heme a biosynthesis and/or transfer to maturing cytochrome c oxidase.	[Swenson, Samantha; Cannon, Andrew; Khalimonchuk, Oleh] Univ Nebraska, Dept Biochem, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA; [Swenson, Samantha; Cannon, Andrew; Khalimonchuk, Oleh] Univ Nebraska, Nebraska Redox Biol Ctr, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA; [Harris, Nicholas J.; Taylor, Nicholas G.; Fox, Jennifer L.] Coll Charleston, Dept Chem & Biochem, 66 George St, Charleston, SC 29424 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; College of Charleston	Khalimonchuk, O (corresponding author), Univ Nebraska, Dept Biochem, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA.; Khalimonchuk, O (corresponding author), Univ Nebraska, Nebraska Redox Biol Ctr, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA.; Fox, JL (corresponding author), Coll Charleston, Dept Chem & Biochem, 66 George St, Charleston, SC 29424 USA.	foxjl@cofc.edu; okhalimonchuk2@unl.edu	Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678; Swenson, Samantha/0000-0002-5650-3841; Cannon, Andrew/0000-0002-5892-8907	National Institutes of Health [P30GM103335, R01GM108975]; Cottrell College Science Award from Research Corporation for Science Advancement [22643]; National Science Foundation-Major Research Instrumentation Grant [CHE-1229559]; College of Charleston Summer Undergraduate Research; Howard Hughes Medical Institute [52007537]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108975, P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cottrell College Science Award from Research Corporation for Science Advancement; National Science Foundation-Major Research Instrumentation Grant(National Science Foundation (NSF)); College of Charleston Summer Undergraduate Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants P30GM103335 (to the Nebraska Redox Biology Center) and R01GM108975 (to O. K.), Cottrell College Science Award 22643 (to J. L. F.) from Research Corporation for Science Advancement, National Science Foundation-Major Research Instrumentation Grant CHE-1229559 (to J. L. F. as co-principal investigator), College of Charleston Summer Undergraduate Research with Faculty grants (to J. L. F., N. J. H., and N. G. T.), and Howard Hughes Medical Institute Grant 52007537 through the Pre-college and Undergraduate Science Education Program (to the College of Charleston). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfadhel M, 2011, AM J MED GENET A, V155A, P840, DOI 10.1002/ajmg.a.33881; Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Bareth B, 2013, MOL CELL BIOL, V33, P4128, DOI 10.1128/MCB.00747-13; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Barros MH, 2002, J BIOL CHEM, V277, P9997, DOI 10.1074/jbc.M112025200; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bestwick M, 2010, MOL CELL BIOL, V30, P4480, DOI 10.1128/MCB.00228-10; Bestwick M, 2010, MOL CELL BIOL, V30, P172, DOI 10.1128/MCB.00869-09; Bode M, 2013, ANTIOXID REDOX SIGN, V18, P1597, DOI 10.1089/ars.2012.4685; Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101; Brown BM, 2004, BIOCHEMISTRY-US, V43, P13541, DOI 10.1021/bi048469k; Bugiani M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029926; Bundschuh FA, 2009, J BIOL CHEM, V284, P25735, DOI 10.1074/jbc.M109.040295; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Coenen MJH, 2004, ANN NEUROL, V56, P560, DOI 10.1002/ana.20229; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; Cui TZ, 2012, MOL CELL BIOL, V32, P4400, DOI 10.1128/MCB.00441-12; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; GOLLUB EG, 1977, J BIOL CHEM, V252, P2846; Hederstedt L, 2012, BBA-BIOENERGETICS, V1817, P920, DOI 10.1016/j.bbabio.2012.03.025; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P26715, DOI 10.1074/jbc.M112.377200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P7289, DOI 10.1074/jbc.M111.313148; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Kim HJ, 2012, BBA-MOL CELL RES, V1823, P1604, DOI 10.1016/j.bbamcr.2012.04.008; Lewin A, 2006, FEBS LETT, V580, P5351, DOI 10.1016/j.febslet.2006.08.080; Lewin A, 2016, BBA-BIOENERGETICS, V1857, P160, DOI 10.1016/j.bbabio.2015.11.008; Lodi T, 2002, MOL GENET GENOMICS, V266, P838, DOI 10.1007/s00438-001-0604-y; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mogi T, 2009, J BIOCHEM, V145, P625, DOI 10.1093/jb/mvp017; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; Oquendo CE, 2004, J MED GENET, V41, P540, DOI 10.1136/jmg.2003.017426; Piekutowska-Abramczuk D, 2009, CLIN GENET, V76, P195, DOI 10.1111/j.1399-0004.2009.01195.x; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Poyau A, 2000, HUM GENET, V106, P194, DOI 10.1007/s004390051028; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Teraoka M, 1999, HUM GENET, V105, P560, DOI 10.1007/s004390051145; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; Wang ZH, 2009, J BIOL CHEM, V284, P839, DOI 10.1074/jbc.M804167200; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804; Zoppellaro G, 2009, BIOPOLYMERS, V91, P1064, DOI 10.1002/bip.21267	49	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10411	10425		10.1074/jbc.M115.707539	http://dx.doi.org/10.1074/jbc.M115.707539			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26940873	Green Published, hybrid			2022-12-28	WOS:000375602800045
J	Butcher, AJ; Bradley, SJ; Prihandoko, R; Brooke, SM; Mogg, A; Bourgognon, JM; Macedo-Hatch, T; Edwards, JM; Bottrill, AR; Challiss, RAJ; Broad, LM; Felder, CC; Tobin, AB				Butcher, Adrian J.; Bradley, Sophie J.; Prihandoko, Rudi; Brooke, Simon M.; Mogg, Adrian; Bourgognon, Julie-Myrtille; Macedo-Hatch, Timothy; Edwards, Jennifer M.; Bottrill, Andrew R.; Challiss, R. A. John; Broad, Lisa M.; Felder, Christian C.; Tobin, Andrew B.			An Antibody Biosensor Establishes the Activation of the M-1 Muscarinic Acetylcholine Receptor during Learning and Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ANTIPSYCHOTIC-LIKE ACTIVITY; ALLOSTERIC MODULATION; BETA-ARRESTIN; MUTANT MICE; AGONIST; HIPPOCAMPUS; PHOSPHORYLATION; SCOPOLAMINE; XANOMELINE	Establishing the in vivo activation status of G protein-coupled receptors would not only indicate physiological roles of G protein-coupled receptors but would also aid drug discovery by establishing drug/receptor engagement. Here, we develop a phospho-specific antibody-based biosensor to detect activation of the M-1 muscarinic acetylcholine receptor (M-1 mAChR) in vitro and in vivo. Mass spectrometry phosphoproteomics identified 14 sites of phosphorylation on the M-1 mAChR. Phospho-specific antibodies to four of these sites established that serine at position 228 (Ser(228)) on the M-1 mAChR showed extremely low levels of basal phosphorylation that were significantly up-regulated by orthosteric agonist stimulation. In addition, the M-1 mAChR-positive allosteric modulator, 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, enhanced acetylcholine-mediated phosphorylation at Ser(228). These data supported the hypothesis that phosphorylation at Ser(228) was an indicator of M-1 mAChR activation. This was further supported in vivo by the identification of phosphorylated Ser(228) on the M-1 mAChR in the hippocampus of mice following administration of the muscarinic ligands xanomeline and 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. Finally, Ser(228) phosphorylation was seen to increase in the CA1 region of the hippocampus following memory acquisition, a response that correlated closely with up-regulation of CA1 neuronal activity. Thus, determining the phosphorylation status of the M-1 mAChR at Ser(228) not only provides a means of establishing receptor activation following drug treatment both in vitro and in vivo but also allows for the mapping of the activation status of the M-1 mAChR in the hippocampus following memory acquisition thereby establishing a link between M-1 mAChR activation and hippocampus-based memory and learning.	[Butcher, Adrian J.; Bradley, Sophie J.; Prihandoko, Rudi; Brooke, Simon M.; Bourgognon, Julie-Myrtille; Macedo-Hatch, Timothy; Edwards, Jennifer M.; Tobin, Andrew B.] Univ Leicester, MRC, Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England; [Bottrill, Andrew R.] Univ Leicester, Prot & Nucle Acid Chem Lab, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England; [Mogg, Adrian; Broad, Lisa M.] Eli Lilly & Co, Neurosci, Windlesham GU20 6PH, Surrey, England; [Felder, Christian C.] Eli Lilly & Co, Lilly Corp Ctr, Neurosci, Indianapolis, IN 46285 USA; [Challiss, R. A. John] Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England; [Butcher, Adrian J.; Bradley, Sophie J.; Tobin, Andrew B.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Leicester; University of Leicester; Eli Lilly; Eli Lilly; University of Leicester; University of Glasgow	Tobin, AB (corresponding author), Univ Leicester, MRC, Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.; Tobin, AB (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	tba@le.ac.uk	Challiss, R.A. John/A-9412-2008; Bottrill, Andrew/ABD-1459-2021	Bottrill, Andrew/0000-0002-5182-3643; Challiss, John/0000-0001-5506-2848; Felder, Christian/0000-0003-1134-8881	Lilly grants; Lilly LRAP grant; Medical Research Council by Medical Research Council Toxicology Unit; Medical Research Council Integrative Toxicology Training Partnership Ph.D. studentship scheme; Heptares Therapeutics; Biotechnology and Biological Sciences Research Council [BB/L02781X/1]; Medical Research Council [MC_UP_A600_1110, 1382137, G1100712] Funding Source: researchfish; BBSRC [BB/L02781X/1] Funding Source: UKRI; MRC [MC_UP_A600_1110, G1100712] Funding Source: UKRI	Lilly grants; Lilly LRAP grant; Medical Research Council by Medical Research Council Toxicology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Integrative Toxicology Training Partnership Ph.D. studentship scheme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Heptares Therapeutics; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Lilly grants (to C. C. F., L. M. B., and A. M.), a Lilly LRAP grant (to J. M. B.), a Medical Research Council program leader grant provided by the Medical Research Council Toxicology Unit (to A. B. T., S. J. B., A. J. B., T. M. H., and J. M. E.), a Medical Research Council Integrative Toxicology Training Partnership Ph.D. studentship scheme (to S. M. B.), and the Heptares Therapeutics and Biotechnology and Biological Sciences Research Council Grant BB/L02781X/1 (to R. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdul-Ridha A, 2014, J BIOL CHEM, V289, P6067, DOI 10.1074/jbc.M113.539080; Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Anagnostaras SG, 1999, NEUROPSYCHOPHARMACOL, V21, P731, DOI 10.1016/S0893-133X(99)00083-4; Andersen MB, 2003, NEUROPSYCHOPHARMACOL, V28, P1168, DOI 10.1038/sj.npp.1300151; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Digby GJ, 2010, MOL BIOSYST, V6, P1345, DOI 10.1039/c002938f; Eglen R. M., 2006, Autonomic & Autacoid Pharmacology, V26, P219, DOI 10.1111/j.1474-8673.2006.00368.x; Hudson BD, 2012, FASEB J, V26, P4951, DOI 10.1096/fj.12-213314; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kenakin T, 2014, BIOCHEM PHARMACOL, V87, P40, DOI 10.1016/j.bcp.2013.07.033; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; LEVEY AI, 1995, J NEUROSCI, V15, P4077; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Porter AC, 2002, BRAIN RES, V944, P82, DOI 10.1016/S0006-8993(02)02721-X; Poulin B, 2010, P NATL ACAD SCI USA, V107, P9440, DOI 10.1073/pnas.0914801107; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Shannon HE, 2000, SCHIZOPHR RES, V42, P249, DOI 10.1016/S0920-9964(99)00138-3; Shirey JK, 2009, J NEUROSCI, V29, P14271, DOI 10.1523/JNEUROSCI.3930-09.2009; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Van der Zee EA, 1999, PROG NEUROBIOL, V58, P409, DOI 10.1016/S0301-0082(98)00092-6; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Waugh MG, 1999, BIOCHEM J, V338, P175, DOI 10.1042/0264-6021:3380175; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Yeatman HR, 2014, J BIOL CHEM, V289, P15856, DOI 10.1074/jbc.M113.536672; YOUNG SL, 1995, NEUROBIOL LEARN MEM, V63, P174, DOI 10.1006/nlme.1995.1018; Ziegler N, 2011, BIOORGAN MED CHEM, V19, P1048, DOI 10.1016/j.bmc.2010.07.060; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	43	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8862	8875		10.1074/jbc.M115.681726	http://dx.doi.org/10.1074/jbc.M115.681726			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26826123	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000374849000001
J	Noble, CG; Lim, SP; Arora, R; Yokokawa, F; Nilar, S; Seh, CC; Wright, SK; Benson, TE; Smith, PW; Shi, PY				Noble, Christian G.; Lim, Siew Pheng; Arora, Rishi; Yokokawa, Fumiaki; Nilar, Shahul; Seh, Cheah Chen; Wright, S. Kirk; Benson, Timothy E.; Smith, Paul W.; Shi, Pei-Yong			A Conserved Pocket in the Dengue Virus Polymerase Identified through Fragment-based Screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystallography; dengue virus (DENV); enzyme inhibitor; flavivirus; inhibitor; RNA polymerase; viral polymerase	DEPENDENT RNA-POLYMERASE; HEPATITIS-C VIRUS; CRYSTAL-STRUCTURE; INHIBITORS; INITIATION; PROTEIN; DESIGN; DOMAIN	We performed a fragment screen on the dengue virus serotype 3 RNA-dependent RNA polymerase using x-ray crystallography. A screen of 1,400 fragments in pools of eight identified a single hit that bound in a novel pocket in the protein. This pocket is located in the polymerase palm subdomain and conserved across the four serotypes of dengue virus. The compound binds to the polymerase in solution as evidenced by surface plasmon resonance and isothermal titration calorimetry analyses. Related compounds where a phenyl is replaced by a thiophene show higher affinity binding, indicating the potential for rational design. Importantly, inhibition of enzyme activity correlated with the binding affinity, showing that the pocket is functionally important for polymerase activity. This fragment is an excellent starting point for optimization through rational structure-based design.	[Noble, Christian G.; Lim, Siew Pheng; Yokokawa, Fumiaki; Nilar, Shahul; Seh, Cheah Chen; Smith, Paul W.; Shi, Pei-Yong] Novartis Inst Trop Dis, 10 Biopolis Rd,05-01 Chromos, Singapore 138670, Singapore; [Arora, Rishi; Wright, S. Kirk; Benson, Timothy E.] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA; [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	Novartis; Novartis; University of Texas System; University of Texas Medical Branch Galveston	Noble, CG (corresponding author), Novartis Inst Trop Dis, 10 Biopolis Rd,05-01 Chromos, Singapore 138670, Singapore.; Shi, PY (corresponding author), Univ Texas Med Branch, 5-138 Med Res Bldg, Galveston, TX 77555 USA.	christian.noble@novartis.com; peshi@utmb.edu	Pheng, Lim Siew/AAG-4368-2021; Lim, Siew Pheng/P-8528-2016; /AAJ-1244-2020	Pheng, Lim Siew/0000-0002-7377-5662; Benson, Timothy/0000-0001-8633-2142				Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Beno BR, 2015, J MED CHEM, V58, P4383, DOI 10.1021/jm501853m; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Caillet-Saguy C, 2014, ANTIVIR RES, V105, P8, DOI 10.1016/j.antiviral.2014.02.006; Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0; Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010; Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Niyomrattanakit P, 2011, J BIOMOL SCREEN, V16, P201, DOI 10.1177/1087057110389323; Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09; Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13; Nyanguile O, 2010, J VIROL, V84, P2923, DOI 10.1128/JVI.01980-09; Simmons CP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001752; Smith TM, 2015, J BIOMOL SCREEN, V20, P153, DOI 10.1177/1087057114551141; Surana P, 2014, NUCLEIC ACIDS RES, V42, P2758, DOI 10.1093/nar/gkt1106; Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682	20	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8541	8548		10.1074/jbc.M115.710731	http://dx.doi.org/10.1074/jbc.M115.710731			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26872970	Green Published, hybrid			2022-12-28	WOS:000374773200019
J	Wojcik, J; Lamontanara, AJ; Grabe, G; Koide, A; Akin, L; Gerig, B; Hantschel, O; Koide, S				Wojcik, John; Lamontanara, Allan Joaquim; Grabe, Grzegorz; Koide, Akiko; Akin, Louesa; Gerig, Barbara; Hantschel, Oliver; Koide, Shohei			Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABL tyrosine kinase; enzyme inhibitor; protein engineering; protein-protein interaction; Src homology 2 domain (SH2 domain); x-ray crystallography; FN3; PPI inhibitor	BINDING-PROTEINS; C-ABL; III DOMAIN; RESISTANCE; SCAFFOLD; STI571	Bcr-Abl is a constitutively active kinase that causes chronic myelogenous leukemia. We have shown that a tandem fusion of two designed binding proteins, termed monobodies, directed to the interaction interface between the Src homology 2 (SH2) and kinase domains and to the phosphotyrosine-binding site of the SH2 domain, respectively, inhibits the Bcr-Abl kinase activity. Because the latter monobody inhibits processive phosphorylation by Bcr-Abl and the SH2-kinase interface is occluded in the active kinase, it remained undetermined whether targeting the SH2-kinase interface alone was sufficient for Bcr-Abl inhibition. To address this question, we generated new, higher affinity monobodies with single nanomolar K-D values targeting the kinase-binding surface of SH2. Structural and mutagenesis studies revealed the molecular underpinnings of the monobody-SH2 interactions. Importantly, the new monobodies inhibited Bcr-Abl kinase activity in vitro and in cells, and they potently induced cell death in chronic myelogenous leukemia cell lines. This work provides strong evidence for the SH2-kinase interface as a pharmacologically tractable site for allosteric inhibition of Bcr-Abl.	[Wojcik, John; Grabe, Grzegorz; Koide, Akiko; Akin, Louesa; Koide, Shohei] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Lamontanara, Allan Joaquim; Gerig, Barbara; Hantschel, Oliver] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland; [Grabe, Grzegorz] Univ Gdansk, Intercollegiate Fac Biotechnol, Gdansk, Poland; [Grabe, Grzegorz; Hantschel, Oliver] Med Univ Gdansk, Gdansk, Poland	University of Chicago; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Hantschel, O (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland.; Koide, S (corresponding author), NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.	oliver.hantschel@epfl.ch; Shohei.Koide@nyumc.org	Hantschel, Oliver/M-7016-2019; Hantschel, Oliver D/H-4705-2013; Grabe, Grzegorz/CAG-9633-2022	Hantschel, Oliver/0000-0001-8569-8169; Hantschel, Oliver D/0000-0001-8569-8169; Grabe, Grzegorz/0000-0002-0419-491X; Koide, Shohei/0000-0001-5473-4358	National Institutes of Health [P41 GM103403]; National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090324, T32GM007281, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant; DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Georgeon for the gel filtration data and technical support throughout the project. We acknowledge the use of the Northeastern Collaborative Access Team beamlines, which are funded by National Institutes of Health Grant P41 GM103403. The Pilatus 6M detector on the 24-ID-C beamline is funded by National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant S10 RR029205. The Advanced Photon Source is a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlanson DA, 2004, ANNU REV BIOPH BIOM, V33, P199, DOI 10.1146/annurev.biophys.33.110502.140409; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Gilbreth RN, 2012, CURR OPIN STRUC BIOL, V22, P413, DOI 10.1016/j.sbi.2012.06.001; Grebien F, 2011, CELL, V147, P306, DOI 10.1016/j.cell.2011.08.046; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2012, CANCER RES, V72, P4890, DOI 10.1158/0008-5472.CAN-12-1276; Hantschel O, 2008, MOL ONCOL, V2, P272, DOI 10.1016/j.molonc.2008.07.003; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Huang XL, 1998, J MOL BIOL, V281, P61, DOI 10.1006/jmbi.1998.1930; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Koide A, 2012, J MOL BIOL, V415, P393, DOI 10.1016/j.jmb.2011.12.019; Koide A, 2009, PROTEIN ENG DES SEL, V22, P685, DOI 10.1093/protein/gzp053; Koide S, 2012, METHOD ENZYMOL, V503, P135, DOI 10.1016/B978-0-12-396962-0.00006-9; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lamontanara AJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6470; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Sha F, 2013, P NATL ACAD SCI USA, V110, P14924, DOI 10.1073/pnas.1303640110; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2003, ONCOGENE, V22, P7389, DOI 10.1038/sj.onc.1206942; Sherbenou DW, 2010, BLOOD, V116, P3278, DOI 10.1182/blood-2008-10-183665; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; Wylie A, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.398.398	35	23	24	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8836	8847		10.1074/jbc.M115.707901	http://dx.doi.org/10.1074/jbc.M115.707901			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26912659	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000374773200044
J	Algasaier, SI; Exell, JC; Bennet, IA; Thompson, MJ; Gotham, VJB; Shaw, SJ; Craggs, TD; Finger, LD; Grasby, JA				Algasaier, Sana I.; Exell, Jack C.; Bennet, Ian A.; Thompson, Mark J.; Gotham, Victoria J. B.; Shaw, Steven J.; Craggs, Timothy D.; Finger, L. David; Grasby, Jane A.			DNA and Protein Requirements for Substrate Conformational Changes Necessary for Human Flap Endonuclease-1-catalyzed Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circular dichroism (CD); DNA endonuclease; DNA repair; DNA replication; DNA-protein interaction; fluorescence resonance energy transfer (FRET); nucleic acid enzymology	METAL-IONS; MECHANISM; ENDONUCLEASES; SPECIFICITY; FEN1; REPLICATION; RECOGNITION; SUPERFAMILY; CATALYSIS; NUCLEASE	Human flap endonuclease-1 (hFEN1) catalyzes the essential removal of single-stranded flaps arising at DNA junctions during replication and repair processes. hFEN1 biological function must be precisely controlled, and consequently, the protein relies on a combination of protein and substrate conformational changes as a prerequisite for reaction. These include substrate bending at the duplex-duplex junction and transfer of unpaired reacting duplex end into the active site. When present, 5-flaps are thought to thread under the helical cap, limiting reaction to flaps with free 5-termini in vivo. Here we monitored DNA bending by FRET and DNA unpairing using 2-aminopurine exciton pair CD to determine the DNA and protein requirements for these substrate conformational changes. Binding of DNA to hFEN1 in a bent conformation occurred independently of 5-flap accommodation and did not require active site metal ions or the presence of conserved active site residues. More stringent requirements exist for transfer of the substrate to the active site. Placement of the scissile phosphate diester in the active site required the presence of divalent metal ions, a free 5-flap (if present), a Watson-Crick base pair at the terminus of the reacting duplex, and the intact secondary structure of the enzyme helical cap. Optimal positioning of the scissile phosphate additionally required active site conserved residues Tyr(40), Asp(181), and Arg(100) and a reacting duplex 5-phosphate. These studies suggest a FEN1 reaction mechanism where junctions are bound and 5-flaps are threaded (when present), and finally the substrate is transferred onto active site metals initiating cleavage.	[Algasaier, Sana I.; Exell, Jack C.; Bennet, Ian A.; Thompson, Mark J.; Gotham, Victoria J. B.; Shaw, Steven J.; Finger, L. David; Grasby, Jane A.] Univ Sheffield, Ctr Chem Biol, Krebs Inst, Dept Chem, Sheffield S3 7HF, S Yorkshire, England; [Craggs, Timothy D.] Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol BS8 1TD, Avon, England; [Exell, Jack C.] Univ Calif Davis, Dept Microbiol & Mol Genet, Briggs Hall,One Shields Ave, Davis, CA 95616 USA	University of Sheffield; University of Bristol; University of California System; University of California Davis	Grasby, JA (corresponding author), Univ Sheffield, Ctr Chem Biol, Krebs Inst, Dept Chem, Sheffield S3 7HF, S Yorkshire, England.	j.a.grasby@sheffield.ac.uk		Craggs, Timothy/0000-0002-7121-0609; Finger, L. David/0000-0002-2342-9569; Bennet, Ian/0000-0002-2543-2032; Shaw, Steven/0000-0002-1236-1810	Biotechnology and Biological Sciences Research Council [BB/K009079/1, BB/M00404X/1]; Ministry of Higher Education Libya; EPSRC; Astra Zeneca; Biotechnology and Biological Sciences Research Council White Rose Studentship [DTP BB/J014443/1]; BBSRC [BB/K009079/1, BB/M00404X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1477884] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1623361] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Higher Education Libya; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Astra Zeneca(AstraZeneca); Biotechnology and Biological Sciences Research Council White Rose Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/K009079/1 and BB/M00404X/1. This work was also supported by a studentship from the Ministry of Higher Education Libya (to S. I. A.), studentships from the EPSRC and Astra Zeneca (to J. C. E.), and Biotechnology and Biological Sciences Research Council White Rose Studentship DTP BB/J014443/1 (to I. A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Allawi HT, 2003, J MOL BIOL, V328, P537, DOI 10.1016/S0022-2836(03)00351-6; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Beddows A, 2012, CHEM COMMUN, V48, P8895, DOI 10.1039/c2cc33400c; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; CLEGG RM, 1992, BIOCHEMISTRY-US, V31, P4846, DOI 10.1021/bi00135a016; Craggs TD, 2014, NUCLEIC ACIDS RES, V42, P1857, DOI 10.1093/nar/gkt1116; Finger LD, 2013, NUCLEIC ACIDS RES, V41, P9839, DOI 10.1093/nar/gkt737; Finger L David, 2012, Subcell Biochem, V62, P301, DOI 10.1007/978-94-007-4572-8_16; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Grasby JA, 2012, TRENDS BIOCHEM SCI, V37, P74, DOI 10.1016/j.tibs.2011.10.003; Johnson NP, 2004, P NATL ACAD SCI USA, V101, P3426, DOI 10.1073/pnas.0400591101; Jose D, 2009, P NATL ACAD SCI USA, V106, P4231, DOI 10.1073/pnas.0900803106; Kaiser MW, 1999, J BIOL CHEM, V274, P21387, DOI 10.1074/jbc.274.30.21387; Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/nmeth.2222, 10.1038/NMETH.2222]; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Patel N, 2013, J BIOL CHEM, V288, P34239, DOI 10.1074/jbc.M113.509489; Patel N, 2012, NUCLEIC ACIDS RES, V40, P4507, DOI 10.1093/nar/gks051; Sengerova B, 2010, BIOCHEMISTRY-US, V49, P8085, DOI 10.1021/bi100895j; Sobhy MA, 2013, CELL REP, V3, P1785, DOI 10.1016/j.celrep.2013.05.001; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Tomlinson CG, 2011, J BIOL CHEM, V286, P30878, DOI 10.1074/jbc.M111.230391; Tomlinson CG, 2010, BIOCHEM SOC T, V38, P433, DOI 10.1042/BST0380433; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884	25	13	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8258	8268		10.1074/jbc.M115.698993	http://dx.doi.org/10.1074/jbc.M115.698993			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26884332	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000374056700041
J	Kume, A; Kawase, K; Komenoi, S; Usuki, T; Takeshita, E; Sakai, H; Sakane, F				Kume, Aiko; Kawase, Koki; Komenoi, Suguru; Usuki, Takako; Takeshita, Ena; Sakai, Hiromichi; Sakane, Fumio			The Pleckstrin Homology Domain of Diacylglycerol Kinase Strongly and Selectively Binds to Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; diacylglycerol; extracellular signal-regulated kinase (ERK); inositol phospholipid; lipid-binding protein; phosphatidylinositol signaling; phosphatidylinositol 4; 5-bisphosphate; pleckstrin homology domain; diacylglycerol kinase	PHOSPHOLIPASE-C; PHOSPHATIDIC-ACID; ISOZYMES DELTA; SAM DOMAIN; ETA; MEMBRANE; LOCALIZATION; EXPRESSION; IDENTIFICATION; INOSITOL	Type II diacylglycerol kinase (DGK) isozymes (, , and ) have a pleckstrin homology domain (PH) at their N termini. Here, we investigated the lipid binding properties of the PHs of type II DGK isozymes using protein-lipid overlay and liposome binding assays. The PH of DGK showed the most pronounced binding activity to phosphatidylinositol (PI) 4,5-bisphosphate (PI(4,5)P-2) among the various glycero- and sphingolipids including PI 3,4,5-trisphosphate, PI 3,4-bisphosphate, PI 3-phosphate, PI 4-phosphate, and PI 5-phosphate. Moreover, the PI(4,5)P-2 binding activity of the DGK-PH was significantly stronger than that of other type II DGK isozymes. Notably, compared with the PH of phospholipase C (PLC) 1, which is generally utilized as a cellular PI(4,5)P-2- probe, the DGK-PH is equal to or superior than the PLC1-PH in terms of affinity and selectivity for PI(4,5)P-2. Furthermore, in COS-7 cells, GFP-fused wild-type DGK1 and its PH partly translocated from the cytoplasm to the plasma membrane where the PLC1-PH was co-localized in response to hyperosmotic stress in an inositol 5-phosphatase-sensitive manner, whereas a PH deletion mutant did not. Moreover, K74A and R85A mutants of DGK-PH, which lack the conserved basic amino acids thought to ligate PI(4,5)P-2, were indeed unable to bind to PI(4,5)P-2 and co-localize with the PLC1-PH even in osmotically shocked cells. Overexpression of wild-type DGK1 enhanced EGF-dependent phosphorylation of ERK, whereas either K74A or R85A mutant did not. Taken together, these results indicate that the DGK-PH preferentially interacts with PI(4,5)P-2 and has crucial roles in regulating the subcellular localization and physiological function of DGK. Moreover, the DGK-PH could serve as an excellent cellular sensor for PI(4,5)P-2.	[Kume, Aiko; Kawase, Koki; Komenoi, Suguru; Usuki, Takako; Takeshita, Ena; Sakai, Hiromichi; Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan	Chiba University	Sakane, F (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	sakane@faculty.chiba-u.jp	Sakai, Hiromichi/K-8457-2019; Sakane, Fumio/H-2693-2017	Sakane, Fumio/0000-0003-0857-0377	Ministry of Education, Culture, Sports, Science and Technology of Japan [22370047, 23116505, 25116704, 26291017]; Japan Science and Technology Agency [AS221Z00794F, AS231Z00139G, AS251Z01788Q]; Naito Foundation; Hamaguchi Foundation for the Advancement of Biochemistry; Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation; Futaba Electronic Memorial Foundation; Daiwa Securities Health Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Asahi Group Foundation; Grants-in-Aid for Scientific Research [26291017, 16J06865] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Naito Foundation(Naito Memorial Foundation); Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation(Terumo Life Science Foundation); Futaba Electronic Memorial Foundation; Daiwa Securities Health Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Asahi Group Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology of Japan Grants 22370047, 23116505, 25116704, and 26291017; Japan Science and Technology Agency Grants AS221Z00794F, AS231Z00139G, and AS251Z01788Q; the Naito Foundation, the Hamaguchi Foundation for the Advancement of Biochemistry, the Daiichi-Sankyo Foundation of Life Science, the Terumo Life Science Foundation, the Futaba Electronic Memorial Foundation, the Daiwa Securities Health Foundation, the Ono Medical Research Foundation, the Japan Foundation for Applied Enzymology, the Food Science Institute Foundation, the Skylark Food Science Institute; the Food Science Institute Foundation, and the Asahi Group Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Belmaker RH, 1998, NEUROPSYCHOPHARMACOL, V19, P220, DOI 10.1016/S0893-133X(98)00017-7; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; English D, 1996, CELL SIGNAL, V8, P341, DOI 10.1016/0898-6568(95)00076-3; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Goto K, 2006, BBA-MOL CELL BIOL L, V1761, P535, DOI 10.1016/j.bbalip.2006.04.001; Guo YJ, 2003, J BIOL CHEM, V278, P29995, DOI 10.1074/jbc.M301438200; Hagihara H, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/318596; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; Hurley JH, 1997, PROTEIN SCI, V6, P477; Imai S, 2005, J BIOL CHEM, V280, P39870, DOI 10.1074/jbc.M500669200; Imai S, 2004, BIOCHEM J, V382, P957, DOI 10.1042/BJ20040681; Imai S, 2002, J BIOL CHEM, V277, P35323, DOI 10.1074/jbc.M202035200; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Klauck TM, 1996, J BIOL CHEM, V271, P19781, DOI 10.1074/jbc.271.33.19781; Knight MJ, 2010, BIOCHEMISTRY-US, V49, P9667, DOI 10.1021/bi101261x; Leach NT, 2007, AM J HUM GENET, V80, P792, DOI 10.1086/513019; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Maloku E, 2010, P NATL ACAD SCI USA, V107, P4407, DOI 10.1073/pnas.0914483107; Matsutomo D, 2013, J BIOCHEM, V153, P179, DOI 10.1093/jb/mvs130; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miele C, 2007, J BIOL CHEM, V282, P31835, DOI 10.1074/jbc.M702481200; Moya PR, 2010, INT J NEUROPSYCHOPH, V13, P1127, DOI 10.1017/S1461145710000593; Murakami T, 2003, J BIOL CHEM, V278, P34364, DOI 10.1074/jbc.M301542200; Nakano T, 2014, CLIN TRANSL ONCOL, V16, P29, DOI 10.1007/s12094-013-1036-y; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NOH DY, 1995, BBA-REV CANCER, V1242, P99, DOI 10.1016/0304-419X(95)00006-0; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Sakai H, 2012, J BIOCHEM, V152, P397, DOI 10.1093/jb/mvs104; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Shionoya T, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0055-z; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; Tsushima S, 2004, J BIOL CHEM, V279, P28603, DOI 10.1074/jbc.M314031200; Usuki T, 2015, J HISTOCHEM CYTOCHEM, V63, P57, DOI 10.1369/0022155414559130; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; van der Zanden LFM, 2011, NAT GENET, V43, P48, DOI 10.1038/ng.721; Walton NM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.56; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Weber H, 2011, NEUROPSYCHOPHARMACOL, V36, P2076, DOI 10.1038/npp.2011.98; Yamamoto M, 2006, J BIOL CHEM, V281, P32630, DOI 10.1074/jbc.M605928200; Yasuda S, 2009, J BIOL CHEM, V284, P29559, DOI 10.1074/jbc.M109.043604	51	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8150	8161		10.1074/jbc.M115.648717	http://dx.doi.org/10.1074/jbc.M115.648717			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26887948	hybrid, Green Published			2022-12-28	WOS:000374056700032
J	Zhao, WS; Sun, MY; Sun, LF; Liu, Y; Yang, Y; Huang, LD; Fan, YZ; Cheng, XY; Cao, P; Hu, YM; Li, LY; Tian, Y; Wang, R; Yu, Y				Zhao, Wen-Shan; Sun, Meng-Yang; Sun, Liang-Fei; Liu, Yan; Yang, Yang; Huang, Li-Dong; Fan, Ying-Zhe; Cheng, Xiao-Yang; Cao, Peng; Hu, You-Min; Li, Lingyong; Tian, Yun; Wang, Rui; Yu, Ye			A Highly Conserved Salt Bridge Stabilizes the Kinked Conformation of 2,3-Sheet Essential for Channel Function of P2X4 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; conformational change; ion channel; protein expression; protein stability; P2X receptors; salt bridge	ATP-BINDING SITES; ION-CHANNEL; EXTRACELLULAR LOOP; PROTEIN STABILITY; AGONIST BINDING; LEFT-FLIPPER; SURFACE; ANTAGONIST; ACTIVATION; INVOLVEMENT	Significant progress has been made in understanding the roles of crucial residues/motifs in the channel function of P2X receptors during the pre-structure era. The recent structural determination of P2X receptors allows us to reevaluate the role of those residues/motifs. Residues Arg-309 and Asp-85 (rat P2X4 numbering) are highly conserved throughout the P2X family and were involved in loss-of-function polymorphism in human P2X receptors. Previous studies proposed that they participated in direct ATP binding. However, the crystal structure of P2X demonstrated that those two residues form an intersubunit salt bridge located far away from the ATP-binding site. Therefore, it is necessary to reevaluate the role of this salt bridge in P2X receptors. Here, we suggest the crucial role of this structural element both in protein stability and in channel gating rather than direct ATP interaction and channel assembly. Combining mutagenesis, charge swap, and disulfide cross-linking, we revealed the stringent requirement of this salt bridge in normal P2X4 channel function. This salt bridge may contribute to stabilizing the bending conformation of the 2,3-sheet that is structurally coupled with this salt bridge and the 2-helix. Strongly kinked 2,3 is essential for domain-domain interactions between head domain, dorsal fin domain, right flipper domain, and loop 7,8 in P2X4 receptors. Disulfide cross-linking with directions opposing or along the bending angle of the 2,3-sheet toward the 2-helix led to loss-of-function and gain-of-function of P2X4 receptors, respectively. Further insertion of amino acids with bulky side chains into the linker between the 2,3-sheet or the conformational change of the 2-helix, interfering with the kinked conformation of 2,3, led to loss-of-function of P2X4 receptors. All these findings provided new insights in understanding the contribution of the salt bridge between Asp-85 and Arg-309 and its structurally coupled 2,3-sheet to the function of P2X receptors.	[Zhao, Wen-Shan; Sun, Meng-Yang; Wang, Rui] Lanzhou Univ, Sch Basic Med Sci, Sch Life Sci, Lanzhou 730000, Peoples R China; [Zhao, Wen-Shan; Sun, Meng-Yang; Wang, Rui] Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; [Zhao, Wen-Shan; Sun, Meng-Yang; Sun, Liang-Fei; Liu, Yan; Yang, Yang; Huang, Li-Dong; Cheng, Xiao-Yang; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China; [Zhao, Wen-Shan; Sun, Meng-Yang; Sun, Liang-Fei; Liu, Yan; Yang, Yang; Huang, Li-Dong; Cheng, Xiao-Yang; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Shanghai 200025, Peoples R China; [Tian, Yun; Yu, Ye] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China; [Fan, Ying-Zhe] Shanghai Univ Chinese Tradit Med, Putuo Dist Ctr Hosp, Shanghai 200062, Peoples R China; [Li, Lingyong] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Cao, Peng] Nanjing Univ Chinese Med, Hosp Integrated Tradit Chinese & Western Med, Nanjing 210023, Jiangsu, Peoples R China; [Cao, Peng] Jiangsu Prov Acad Tradit Chinese Med, Lab Cellular & Mol Biol, Nanjing 210028, Jiangsu, Peoples R China	Lanzhou University; Lanzhou University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Hunan Agricultural University; Shanghai University of Traditional Chinese Medicine; University of Texas System; UTMD Anderson Cancer Center; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Wang, R (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Sch Life Sci, Lanzhou 730000, Peoples R China.; Wang, R (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.	wangrui@lzu.edu.cn; yuye@shsmu.edu.cn	Cheng, Xiaoyang/N-9970-2019; Cheng, Xiaoyang/M-1257-2017	Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; , Peng/0000-0002-2044-3074; Zhao, Wenshan/0000-0002-8018-5978; Yu, Ye/0000-0002-4054-8543	National Excellent Young Scientist Foundation of China [31222018]; National Program on Key Basic Research Project of China [2014CB910302]; National Natural Science Foundation of China [31570832, 31170787, 31400707, 81473377, 81302694]; Key National S&T Program "Major New Drug Development" Grant [2012ZX09504001-003]; "Shanghai Jiao Tong University-SMC Mutual Funds" for Excellent Young Scholar; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine [13XJ10042]; Shanghai Jiao Tong University School of Medicine-Key Incubation Project; National Key Laboratory of Receptors [SIMM1601KF-02]	National Excellent Young Scientist Foundation of China; National Program on Key Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National S&T Program "Major New Drug Development" Grant; "Shanghai Jiao Tong University-SMC Mutual Funds" for Excellent Young Scholar; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of Medicine-Key Incubation Project; National Key Laboratory of Receptors	This work was supported by National Excellent Young Scientist Foundation of China Grant 31222018, National Program on Key Basic Research Project of China Grant 2014CB910302, National Natural Science Foundation of China Grants 31570832, 31170787, 31400707, 81473377 and 81302694, Key National S&T Program "Major New Drug Development" Grant 2012ZX09504001-003, "Shanghai Jiao Tong University-SMC Mutual Funds" for Excellent Young Scholar, Science and Technology Fund of Shanghai Jiao Tong University School of Medicine Grant 13XJ10042, Shanghai Jiao Tong University School of Medicine-Key Incubation Project, and the Opening Project of National Key Laboratory of Receptors Grant SIMM1601KF-02. The authors declare that they have no conflicts of interest with the contents of this article.	Abdulqawi R, 2015, LANCET, V385, P1198, DOI 10.1016/S0140-6736(14)61255-1; Adriouch S, 2008, FASEB J, V22, P861, DOI 10.1096/fj.07-9294com; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; Ennion S, 2000, J BIOL CHEM, V275, P35656; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Habermacher C, 2016, ELIFE, V5, DOI 10.7554/eLife.11050; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hausmann R, 2013, MOL PHARMACOL, V83, P73, DOI 10.1124/mol.112.081489; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; Huang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097528; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang RT, 2013, TRENDS BIOCHEM SCI, V38, P20, DOI 10.1016/j.tibs.2012.10.006; Jiang R, 2012, EMBO J, V31, P2134, DOI 10.1038/emboj.2012.75; Jiang RT, 2011, P NATL ACAD SCI USA, V108, P9066, DOI 10.1073/pnas.1102170108; Jiang RT, 2010, J BIOL CHEM, V285, P15805, DOI 10.1074/jbc.M110.101980; Jie YL, 2014, NEUROSCI LETT, V582, P1, DOI 10.1016/j.neulet.2014.08.038; Kasuya G, 2016, CELL REP, V14, P932, DOI 10.1016/j.celrep.2015.12.087; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Keystone EC, 2012, ANN RHEUM DIS, V71, P1630, DOI 10.1136/annrheumdis-2011-143578; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Kowalski M, 2014, BRIT J PHARMACOL, V171, P5093, DOI 10.1111/bph.12830; Laha KT, 2011, MOL PHARMACOL, V79, P662, DOI 10.1124/mol.110.068619; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Lorinczi E, 2012, P NATL ACAD SCI USA, V109, P11396, DOI 10.1073/pnas.1118759109; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Roberts JA, 2009, J NEUROCHEM, V109, P1042, DOI 10.1111/j.1471-4159.2009.06035.x; Sackin H, 2009, BIOPHYS J, V97, P1058, DOI 10.1016/j.bpj.2009.05.056; Shaw DE, 2005, J COMPUT CHEM, V26, P1318, DOI 10.1002/jcc.20267; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Takano K, 2000, BIOCHEMISTRY-US, V39, P12375, DOI 10.1021/bi000849s; Turner RD, 2015, LANCET, V386, P244, DOI 10.1016/S0140-6736(15)61274-0; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Wang J, 2016, ACTA PHARMACOL SIN, V37, P44, DOI 10.1038/aps.2015.127; Werner P, 1996, P NATL ACAD SCI USA, V93, P15485, DOI 10.1073/pnas.93.26.15485; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338; Yang Y, 2012, J BIOL CHEM, V287, P14443, DOI 10.1074/jbc.M111.334250; Young MT, 2010, TRENDS BIOCHEM SCI, V35, P83, DOI 10.1016/j.tibs.2009.09.006; Zemkova H, 2007, J NEUROCHEM, V102, P1139, DOI 10.1111/j.1471-4159.2007.04616.x; Zhao WS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5189	52	16	16	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7990	8003		10.1074/jbc.M115.711127	http://dx.doi.org/10.1074/jbc.M115.711127			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26865631	Green Published, hybrid			2022-12-28	WOS:000374056700020
J	Niu, YY; Yang, Y; Liu, Y; Huang, LD; Yang, XN; Fan, YZ; Cheng, XY; Cao, P; Hu, YM; Li, LY; Lu, XY; Tian, Y; Yu, Y				Niu, You-Ya; Yang, Yang; Liu, Yan; Huang, Li-Dong; Yang, Xiao-Na; Fan, Ying-Zhe; Cheng, Xiao-Yang; Cao, Peng; Hu, You-Min; Li, Lingyong; Lu, Xiang-Yang; Tian, Yun; Yu, Ye			Exploration of the Peptide Recognition of an Amiloride-sensitive FMRFamide Peptide-gated Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; EPITHELIAL NA+ CHANNEL; EXTRACELLULAR DOMAIN; HOMOLOGY MODEL; POSITION 552; ACID; ACTIVATION; MODULATION; NEURONS; SITE	FMRFamide (Phe-Met-Arg-Phe-NH2)-activated sodium channel (FaNaC) is an amiloride-sensitive sodium channel activated by endogenous tetrapeptide in invertebrates, and belongs to the epithelial sodium channel/degenerin (ENaC/DEG) superfamily. The ENaC/DEG superfamily differs markedly in its means of activation, such as spontaneously opening or gating by mechanical stimuli or tissue acidosis. Recently, it has been observed that a number of ENaC/DEG channels can be activated by small molecules or peptides, indicating that the ligand-gating may be an important feature of this superfamily. The peptide ligand control of the channel gating might be an ancient ligand-gating feature in this superfamily. Therefore, studying the peptide recognition of FaNaC channels would advance our understanding of the ligand-gating properties of this superfamily of ion channels. Here we demonstrate that Tyr-131, Asn-134, Asp-154, and Ile-160, located in the putative upper finger domain of Helix aspersa FaNaC (HaFaNaC) channels, are key residues for peptide recognition of this ion channel. Two HaFaNaC specific-insertion motifs among the ENaC/DEG superfamily, residing at the putative alpha 4-alpha 5 linker of the upper thumb domain and the alpha 6-alpha 7 linker of the upper knuckle domain, are also essential for the peptide recognition of HaFaNaC channels. Chemical modifications and double mutant cycle analysis further indicated that those two specific inserts and key residues in the upper finger domain together participate in peptide recognition of HaFaNaC channels. This ligand recognition site is distinct from that of acid-sensing ion channels (ASICs) by a longer distance between the recognition site and the channel gate, carrying useful information about the ligand gating and the evolution of the trimeric ENaC/DEG superfamily of ion channels.	[Niu, You-Ya; Yang, Xiao-Na; Lu, Xiang-Yang; Tian, Yun; Yu, Ye] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China; [Niu, You-Ya; Yang, Yang; Liu, Yan; Huang, Li-Dong; Yang, Xiao-Na; Cheng, Xiao-Yang; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China; [Niu, You-Ya; Yang, Yang; Liu, Yan; Huang, Li-Dong; Yang, Xiao-Na; Cheng, Xiao-Yang; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200025, Peoples R China; [Niu, You-Ya; Yang, Yang; Liu, Yan; Huang, Li-Dong; Yang, Xiao-Na; Cheng, Xiao-Yang; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai 200025, Peoples R China; [Fan, Ying-Zhe] Shanghai Univ Chinese Tradit Med, Putuo Dist Ctr Hosp, Shanghai 200062, Peoples R China; [Li, Lingyong] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Cao, Peng] Nanjing Univ Chinese Med, Hosp Integrated Tradit Chinese & Western Med, Nanjing 210023, Jiangsu, Peoples R China; [Cao, Peng] Jiangsu Prov Acad Tradit Chinese Med, Lab Cellular & Mol Biol, Nanjing 210028, Jiangsu, Peoples R China	Hunan Agricultural University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine; University of Texas System; UTMD Anderson Cancer Center; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Tian, Y; Yu, Y (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai 200025, Peoples R China.	tianyun79616@163.com; yuye@shsmu.edu.cn	Cheng, Xiaoyang/N-9970-2019; Cheng, Xiaoyang/M-1257-2017	Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; , Peng/0000-0002-2044-3074; Yu, Ye/0000-0002-4054-8543	National Excellent Young Scientist Foundation of China [31222018]; National Program on Key Basic Research Project of China [2014CB910302]; National Natural Science Foundation of China [31170787, 31570832, 31400707, 81302694, 81473377]; National Key Laboratory of Receptors [SIMM1601KF-02]; Shanghai Jiao Tong University-SMC Mutual Funds for Excellent Young Scholar [2013SMC-A-7]; Shanghai Jiao Tong University School of Medicine-Key Incubation Project [12x190030017]; Key National SAMP;T Program "Major New Drug Development" Grant [2012ZX09504001-003]; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine [13XJ10042]	National Excellent Young Scientist Foundation of China; National Program on Key Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Laboratory of Receptors; Shanghai Jiao Tong University-SMC Mutual Funds for Excellent Young Scholar; Shanghai Jiao Tong University School of Medicine-Key Incubation Project; Key National SAMP;T Program "Major New Drug Development" Grant; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine	This study was supported by grants from the National Excellent Young Scientist Foundation of China (no. 31222018), National Program on Key Basic Research Project of China (2014CB910302), National Natural Science Foundation of China (nos. 31170787, 31570832, 31400707, 81302694, and 81473377), the Opening Project of National Key Laboratory of Receptors (SIMM1601KF-02), Shanghai Jiao Tong University-SMC Mutual Funds for Excellent Young Scholar (2013SMC-A-7), Shanghai Jiao Tong University School of Medicine-Key Incubation Project (12x190030017), Key National S&T Program "Major New Drug Development" Grant (no. 2012ZX09504001-003), and Science and Technology Fund of Shanghai Jiao Tong University School of Medicine (13XJ10042). The authors declare that they have no conflicts of interest with the contents of this article.	Almaca J, 2013, CELL, V154, P1390, DOI 10.1016/j.cell.2013.08.045; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; BELKIN KJ, 1993, J NEUROSCI, V13, P5139, DOI 10.1523/JNEUROSCI.13-12-05139.1993; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Cottrell GA, 2005, PFLUG ARCH EUR J PHY, V450, P168, DOI 10.1007/s00424-005-1385-7; Cottrell GA, 1997, J EXP BIOL, V200, P2377; Cottrell GA, 2001, FEBS LETT, V489, P71, DOI 10.1016/S0014-5793(01)02081-6; Eastwood AL, 2012, PHYSIOLOGY, V27, P282, DOI 10.1152/physiol.00006.2012; Frey EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071733; Furukawa Y, 2006, PFLUG ARCH EUR J PHY, V451, P646, DOI 10.1007/s00424-005-1498-z; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Green KA, 2002, PFLUG ARCH EUR J PHY, V443, P813, DOI 10.1007/s00424-001-0750-4; Grunder S, 2015, J EXP BIOL, V218, P551, DOI 10.1242/jeb.111666; Hong K, 2000, J NEUROSCI, V20, P2575; Horisberger JD., 2004, NEPHRON PHYSIOL, V96, P37, DOI [10.1159/000076406, DOI 10.1159/000076406]; Huang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097528; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jeziorski MC, 2000, J PHYSIOL-LONDON, V526, P13, DOI 10.1111/j.1469-7793.2000.00013.x; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Kodani Y, 2014, J PHYSIOL SCI, V64, P141, DOI 10.1007/s12576-013-0303-6; Kodani Y, 2010, ZOOL SCI, V27, P440, DOI 10.2108/zsj.27.440; Kota P, 2014, J BIOL CHEM, V289, P23029, DOI 10.1074/jbc.M114.570952; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Mercado J, 2008, J BIOL CHEM, V283, P15250, DOI 10.1074/jbc.M708638200; Ostrovskaya O, 2004, J NEUROCHEM, V91, P252, DOI 10.1111/j.1471-4159.2004.02688.x; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Perry SJ, 2001, J NEUROSCI, V21, P5559, DOI 10.1523/JNEUROSCI.21-15-05559.2001; Pietra F, 2011, CHEM BIODIVERS, V8, P816, DOI 10.1002/cbdv.201100060; RUBEN P, 1986, J NEUROSCI, V6, P252; Shi SJ, 2012, J BIOL CHEM, V287, P15439, DOI 10.1074/jbc.M112.346551; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Smith RN, 2014, CHANNELS, V8, P49, DOI 10.4161/chan.26978; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wiemuth D, 2013, CHANNELS, V7, P38, DOI 10.4161/chan.22406; Yang Y, 2012, J BIOL CHEM, V287, P14443, DOI 10.1074/jbc.M111.334250; Yu Y, 2011, J BIOL CHEM, V286, P24996, DOI 10.1074/jbc.M111.239558; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Zhao WS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5189	54	5	6	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7571	7582		10.1074/jbc.M115.710251	http://dx.doi.org/10.1074/jbc.M115.710251			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26867576	Green Published, hybrid			2022-12-28	WOS:000383447600030
J	Varier, RA; Pau, ECD; van der Groep, P; Lindeboom, RGH; Matarese, F; Mensinga, A; Smits, AH; Edupuganti, RR; Baltissen, MP; Jansen, PWTC; ter Hoeve, N; van Weely, DR; Poser, I; van Diest, PJ; Stunnenberg, HG; Vermeulen, M				Varier, Radhika A.; Pau, Enrique Carrillo de Santa; van der Groep, Petra; Lindeboom, Rik G. H.; Matarese, Filomena; Mensinga, Anneloes; Smits, Arne H.; Edupuganti, Raghu Ram; Baltissen, Marijke P.; Jansen, Pascal W. T. C.; ter Hoeve, Natalie; van Weely, Danny R.; Poser, Ina; van Diest, Paul J.; Stunnenberg, Hendrik G.; Vermeulen, Michiel			Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN MODIFICATIONS; BREAST-CANCER; MARKS	Recent work from others and us revealed interactions between the Sin3/HDAC complex, the H3K4me3 demethylase KDM5A, GATAD1, and EMSY. Here, we characterize the EMSY/KDM5A/SIN3B complex in detail by quantitative interaction proteomics and ChIP-sequencing. We identify a novel substoichiometric interactor of the complex, transcription factor ZNF131, which recruits EMSY to a large number of active, H3K4me3 marked promoters. Interestingly, using an EMSY knock-out line and subsequent rescue experiments, we show that EMSY is in most cases positively correlated with transcriptional activity of its target genes and stimulates cell proliferation. Finally, by immunohistochemical staining of primary breast tissue microarrays we find that EMSY/KDM5A/SIN3B complex subunits are frequently overexpressed in primary breast cancer cases in a correlative manner. Taken together, these data open venues for exploring the possibility that sporadic breast cancer patients with EMSY amplification might benefit from epigenetic combination therapy targeting both the KDM5A demethylase and histone deacetylases.	[Varier, Radhika A.; Mensinga, Anneloes; Smits, Arne H.; Jansen, Pascal W. T. C.; van Weely, Danny R.; Vermeulen, Michiel] Univ Med Ctr Utrecht, Dept Mol Canc Res, Univ Weg 100, NL-3584 CG Utrecht, Netherlands; [Pau, Enrique Carrillo de Santa; Lindeboom, Rik G. H.; Matarese, Filomena; Smits, Arne H.; Edupuganti, Raghu Ram; Baltissen, Marijke P.; Jansen, Pascal W. T. C.; Stunnenberg, Hendrik G.; Vermeulen, Michiel] Radboud Inst Mol Life Sci, Dept Mol Biol, Geert Grootepl Zuid 30, NL-6525 GA Nijmegen, Netherlands; [van der Groep, Petra; ter Hoeve, Natalie; van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands; [Poser, Ina] Max Planck Inst Mol Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Varier, Radhika A.] Francis Crick Inst, Cell Fate & Gene Regulat Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England; [Pau, Enrique Carrillo de Santa] BBVA Fdn, CNIO Canc Cell Biol Programme, Spanish Natl Canc Res Ctr CNIO, Epithelial Carcinogenesis Grp, Madrid, Spain; [Mensinga, Anneloes] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Cell Biol, Univ Weg 100, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Max Planck Society; Francis Crick Institute; Centro Nacional de Investigaciones Oncologicas (CNIO); Utrecht University; Utrecht University Medical Center	Vermeulen, M (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.; Vermeulen, M (corresponding author), Radboud Inst Mol Life Sci, Dept Mol Biol, Geert Grootepl Zuid 30, NL-6525 GA Nijmegen, Netherlands.	m.vermeulen@ncmls.ru.nl	Stunnenberg, Hendrik G./D-6875-2012; de Santa Pau, Enrique Carrillo/AAV-7544-2021; Edupuganti, Venkata/AAG-6486-2019; Vermeulen, Michiel/C-8883-2013	Stunnenberg, Hendrik G./0000-0002-0066-1576; de Santa Pau, Enrique Carrillo/0000-0002-2310-2267; Edupuganti, Venkata/0000-0001-9414-2672; Vermeulen, Michiel/0000-0003-0836-6894; Lindeboom, Rik/0000-0002-3660-504X; Varier, Radhika/0000-0003-1302-3159; Smits, Arne H/0000-0001-5011-0898	Dutch Cancer Society [UU2009-4488]; Netherlands Organization for Scientific Research (NWO-VIDI) [864.09.003]; Netherlands Organization for Scientific Research (NWO Gravitation program CGC.nl)	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO Gravitation program CGC.nl)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Grant UU2009-4488 from the Dutch Cancer Society (to K. W. F.) and by grants from the Netherlands Organization for Scientific Research (NWO-VIDI, project number 864.09.003 and the NWO Gravitation program CGC.nl). The authors declare that they have no conflicts of interest with the contents of this article.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chikina MD, 2012, BIOINFORMATICS, V28, P607, DOI 10.1093/bioinformatics/bts009; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Donaldson NS, 2010, EXP CELL RES, V316, P1692, DOI 10.1016/j.yexcr.2010.03.011; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; VANDIEST PJ, 1992, HUM PATHOL, V23, P876, DOI 10.1016/0046-8177(92)90398-M; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vire E, 2014, MOL CELL, V53, P806, DOI 10.1016/j.molcel.2014.01.029; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	29	20	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7313	7324		10.1074/jbc.M115.701227	http://dx.doi.org/10.1074/jbc.M115.701227			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26841866	Green Published, hybrid			2022-12-28	WOS:000383447600009
J	Steidle, EA; Chong, LS; Wu, MX; Crooke, E; Fiedler, D; Resnick, AC; Rolfes, RJ				Steidle, Elizabeth A.; Chong, Lucy S.; Wu, Mingxuan; Crooke, Elliott; Fiedler, Dorothea; Resnick, Adam C.; Rolfes, Ronda J.			A Novel Inositol Pyrophosphate Phosphatase in Saccharomyces cerevisiae: Siw14 PROTEIN SELECTIVELY CLEAVES THE -PHOSPHATE FROM 5-DIPHOSPHOINOSITOL PENTAKISPHOSPHATE (5PP-IP5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dual-specificity phosphoprotein phosphatase; inositol phosphate; phosphatase; phosphatidylinositol; Saccharomyces cerevisiae; second messenger; IP7; Siw14; Vip1	DUAL-SPECIFICITY PHOSPHATASES; INORGANIC POLYPHOSPHATE; ESCHERICHIA-COLI; CONSERVED FAMILY; YEAST; METABOLISM; IDENTIFICATION; COMPLEXES; COATOMER; ENZYMES	Inositol pyrophosphates are high energy signaling molecules involved in cellular processes, such as energetic metabolism, telomere maintenance, stress responses, and vesicle trafficking, and can mediate protein phosphorylation. Although the inositol kinases underlying inositol pyrophosphate biosynthesis are well characterized, the phosphatases that selectively regulate their cellular pools are not fully described. The diphosphoinositol phosphate phosphohydrolase enzymes of the Nudix protein family have been demonstrated to dephosphorylate inositol pyrophosphates; however, the Saccharomyces cerevisiae homolog Ddp1 prefers inorganic polyphosphate over inositol pyrophosphates. We identified a novel phosphatase of the recently discovered atypical dual specificity phosphatase family as a physiological inositol pyrophosphate phosphatase. Purified recombinant Siw14 hydrolyzes the -phosphate from 5-diphosphoinositol pentakisphosphate (5PP-IP5 or IP7) in vitro. In vivo, siw14 yeast mutants possess increased IP7 levels, whereas heterologous SIW14 overexpression eliminates IP7 from cells. IP7 levels increased proportionately when siw14 was combined with ddp1 or vip1, indicating independent activity by the enzymes encoded by these genes. We conclude that Siw14 is a physiological phosphatase that modulates inositol pyrophosphate metabolism by dephosphorylating the IP7 isoform 5PP-IP5 to IP6.	[Steidle, Elizabeth A.; Rolfes, Ronda J.] Georgetown Univ, Dept Biol, Reiss Sci Bldg,Rm 406,37th & O St, Washington, DC 20057 USA; [Chong, Lucy S.; Resnick, Adam C.] Childrens Hosp Philadelphia, Div Neurosurg, 4052 CTRB,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Wu, Mingxuan; Fiedler, Dorothea] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Crooke, Elliott] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Chong, Lucy S.; Fiedler, Dorothea] Leibniz Inst Mol Pharmakol Forschungsverbund Berl, Campus Berlin Buch,Robert Roessle Str 10, D-13125 Berlin, Germany; [Wu, Mingxuan] Johns Hopkins Sch Med, Dept Pharmacol, 316 Hunterian,725 N Wolfe St, Baltimore, MD 21205 USA; [Resnick, Adam C.] Childrens Hosp Philadelphia, 4052 CTRB,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA	Georgetown University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Princeton University; Georgetown University; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Johns Hopkins University; Johns Hopkins Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Rolfes, RJ (corresponding author), Georgetown Univ, Dept Biol, Reiss Sci Bldg,Rm 406,37th & O St, Washington, DC 20057 USA.; Resnick, AC (corresponding author), Childrens Hosp Philadelphia, Div Neurosurg, 4052 CTRB,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	resnick@email.chop.edu; rolfesr@georgetown.edu	Wu, Mingxuan/G-8519-2017	Steidle, Elizabeth/0000-0002-8225-7197; Chong, Lucy/0000-0002-5858-9984	National Science Foundation CAREER Grant [MCB-1253809]; Georgetown University Pilot Grant; Div Of Molecular and Cellular Bioscience [1253809] Funding Source: National Science Foundation	National Science Foundation CAREER Grant(National Science Foundation (NSF)); Georgetown University Pilot Grant; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation CAREER Grant MCB-1253809 (to A. C. R.) and a Georgetown University Pilot Grant (to R. J. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Aceti DJ, 2008, PROTEINS, V73, P241, DOI 10.1002/prot.22041; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; ALI N, 1995, BIOCHEM J, V310, P279, DOI 10.1042/bj3100279; Auger K. R., 1990, METHODS INOSITIDE RE, P159; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Capolicchio S, 2014, ANGEW CHEM INT EDIT, V53, P9508, DOI 10.1002/anie.201404398; Care A, 2004, GENETICS, V166, P707, DOI 10.1534/genetics.166.2.707; Cha-Aim Kamonchai, 2012, Methods Mol Biol, V852, P97, DOI 10.1007/978-1-61779-564-0_8; Dove Stephen K., 2009, V462, P59, DOI 10.1007/978-1-60327-115-8_4; FLEISCHER B, 1994, J BIOL CHEM, V269, P17826; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hatch AJ, 2010, CELL, V143, P1030, DOI 10.1016/j.cell.2010.11.045; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kilari RS, 2013, FEBS LETT, V587, P3464, DOI 10.1016/j.febslet.2013.08.035; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Losito O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005580; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Onnebo SMN, 2009, BIOCHEM J, V423, P109, DOI 10.1042/BJ20090241; Pohlmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004586; Roma-Mateo C, 2007, J MOL BIOL, V374, P899, DOI 10.1016/j.jmb.2007.10.008; Roma-Mateo C, 2011, MOL GENET GENOMICS, V285, P341, DOI 10.1007/s00438-011-0611-6; Safrany ST, 1999, J BIOL CHEM, V274, P21735, DOI 10.1074/jbc.274.31.21735; SIKORSKI RS, 1989, GENETICS, V122, P19; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Thomas MP, 2014, FEBS J, V281, P14, DOI 10.1111/febs.12575; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Worley J, 2013, CELL REP, V3, P1476, DOI 10.1016/j.celrep.2013.03.043; Wu MX, 2014, ANGEW CHEM INT EDIT, V53, P7192, DOI 10.1002/anie.201402905; Wu MX, 2013, CHEM SCI, V4, P405, DOI 10.1039/c2sc21553e; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564	36	36	37	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6772	6783		10.1074/jbc.M116.714907	http://dx.doi.org/10.1074/jbc.M116.714907			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26828065	Green Published, hybrid			2022-12-28	WOS:000373299700016
J	Zhang, XL; Sullivan, E; Scimeca, M; Wu, XZ; Li, YM; Sisodia, SS				Zhang, Xulun; Sullivan, Eric; Scimeca, Maggie; Wu, Xianzhong; Li, Yue-ming; Sisodia, Sangram S.			Evidence That the "Lid" Domain of Nicastrin Is Not Essential for Regulating -Secretase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); gamma-secretase; mutagenesis; Notch protein; nicastrin; lid; substrate binding	GAMMA-SECRETASE; PRESENILIN-1; TRAFFICKING; MUTATIONS; RECEPTOR; PROTEIN	Understanding of the structure of the -secretase complex consisting of presenilin (PS), anterior pharynx-defective 1 (APH-1), nicastrin (NCT), and presenilin enhancer 2 (PEN-2) is of significant therapeutic interest for the design of -secretase modulators for Alzheimer disease. The structure of -secretase revealed by cryo-EM approaches suggested a substrate binding mechanism for NCT, a bilobar structure that involved rotation of the two lobes around a central pivot and opening of a lid region that facilitates substrate recruitment. To validate this proposal, we expressed NCT that lacks the lid entirely, or a variety of NCT variants that harbor mutations at highly conserved residues in the lid region in NCT-deficient cells, and then assessed their impact on -secretase assembly, activity, and stability. In addition, we assessed the impact of mutating a critical residue proposed to be a pivot around which the two lobes of NCT rotate. Our results show that neither the mutations on the lid tested here nor the entire lid deletion has any significant impact on -secretase assembly, activity, and stability, and that NCT with the mutation of the proposed pivot rescues -secretase activity in NCT-deficient cells in a manner indistinguishable from WT NCT. These findings indicate that the NCT lid is not an essential element necessary for -secretase assembly, activity, and stability, and that rotation of the two lobes appears not to be a prerequisite for substrate binding and -secretase function.	[Zhang, Xulun; Sullivan, Eric; Scimeca, Maggie; Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Wu, Xianzhong; Li, Yue-ming] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA	University of Chicago; Memorial Sloan Kettering Cancer Center	Sisodia, SS (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	ssisodia@bsd.uchicago.edu	LI, Yue/GRS-8071-2022		Adler Foundation; Edward H. Levy Fund; Cure Alzheimer's Fund; National Institutes of Health [R01AG026660, 5P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026660] Funding Source: NIH RePORTER	Adler Foundation; Edward H. Levy Fund; Cure Alzheimer's Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by The Adler Foundation, Edward H. Levy Fund, and Cure Alzheimer's Fund (to S. S. S.) and National Institutes of Health Grants R01AG026660 (to Y. L.) and 5P30CA008748 (to C. B. Thompson). The corresponding author (S. S. S.) discloses that he is a paid consultant of Eisai Research Labs Inc., AZ Therapies Inc., and Jannsen Pharmaceutica NV, but is not a shareholder in any company that is a maker or owner of a FDA-regulated drug or device. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Chau DM, 2012, J BIOL CHEM, V287, P17288, DOI 10.1074/jbc.M111.300483; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; Li T, 2003, J NEUROSCI, V23, P3272; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Xie T, 2014, P NATL ACAD SCI USA, V111, P13349, DOI 10.1073/pnas.1414837111; Zhang XL, 2015, J INVEST DERMATOL, V135, P618, DOI 10.1038/jid.2014.399; Zhang XL, 2014, J BIOL CHEM, V289, P34851, DOI 10.1074/jbc.M114.609636; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P8534, DOI 10.1073/pnas.1202691109	16	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6748	6753		10.1074/jbc.C115.701649	http://dx.doi.org/10.1074/jbc.C115.701649			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26887941	Green Published, hybrid			2022-12-28	WOS:000373299700014
J	Cheung, S; Ma, L; Chan, PHW; Hu, HL; Mayor, T; Chen, HT; Measday, V				Cheung, Stephanie; Ma, Lina; Chan, Patrick H. W.; Hu, Hui-Lan; Mayor, Thibault; Chen, Hung-Ta; Measday, Vivien			Ty1 Integrase Interacts with RNA Polymerase III-specific Subcomplexes to Promote Insertion of Ty1 Elements Upstream of Polymerase (Pol) III-transcribed Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						integrase; retrovirus; RNA polymerase III; Saccharomyces cerevisiae; transposable element (TE); Ty1 element; retrotransposon; tRNA gene	NUCLEAR-LOCALIZATION SIGNAL; SACCHAROMYCES-CEREVISIAE; RETROTRANSPOSON TY1; STRUCTURAL BIOLOGY; TARGET PREFERENCE; SILENT CHROMATIN; NUCLEOSOMAL DNA; SUBUNITS; REVEALS; TRANSPOSITION	Retrotransposons are eukaryotic mobile genetic elements that transpose by reverse transcription of an RNA intermediate and are derived from retroviruses. The Ty1 retrotransposon of Saccharomyces cerevisiae belongs to the Ty1/Copia superfamily, which is present in every eukaryotic genome. Insertion of Ty1 elements into the S. cerevisiae genome, which occurs upstream of genes transcribed by RNA Pol III, requires the Ty1 element-encoded integrase (IN) protein. Here, we report that Ty1-IN interacts in vivo and in vitro with RNA Pol III-specific subunits to mediate insertion of Ty1 elements upstream of Pol III-transcribed genes. Purification of Ty1-IN from yeast cells followed by mass spectrometry (MS) analysis identified an enrichment of peptides corresponding to the Rpc82/34/31 and Rpc53/37 Pol III-specific subcomplexes. GFP-Trap purification of multiple GFP-tagged RNA Pol III subunits from yeast extracts revealed that the majority of Pol III subunits co-purify with Ty1-IN but not two other complexes required for Pol III transcription, transcription initiation factors (TF) IIIB and IIIC. In vitro binding studies with bacterially purified RNA Pol III proteins demonstrate that Rpc31, Rpc34, and Rpc53 interact directly with Ty1-IN. Deletion of the N-terminal 280 amino acids of Rpc53 abrogates insertion of Ty1 elements upstream of the hot spot SUF16 tRNA locus and abolishes the interaction of Ty1-IN with Rpc37. The Rpc53/37 complex therefore has an important role in targeting Ty1-IN to insert Ty1 elements upstream of Pol III-transcribed genes.	[Cheung, Stephanie; Mayor, Thibault; Measday, Vivien] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Cheung, Stephanie; Ma, Lina; Measday, Vivien] Univ British Columbia, Wine Res Ctr, Rm 325,2205 East Mall, Vancouver, BC V6T 1Z4, Canada; [Chan, Patrick H. W.; Mayor, Thibault] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Hu, Hui-Lan; Chen, Hung-Ta] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	University of British Columbia; University of British Columbia; University of British Columbia; Academia Sinica - Taiwan	Measday, V (corresponding author), Univ British Columbia, Wine Res Ctr, Rm 325,2205 East Mall, Vancouver, BC V6T 1Z4, Canada.	vmeasday@mail.ubc.ca	Chen, Hung-Ta/ABC-8094-2021	Chen, Hung-Ta/0000-0003-1192-0382	Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery (DG) [RGPIN 355729-11]; CIHR [HOP-131559]; NSERC DG [RPGIN 326924-11]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery (DG)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); NSERC DG(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by the Canadian Institutes of Health Research (CIHR) and Michael Smith Foundation for Health Research new investigator awards and Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery (DG) Grant RGPIN 355729-11.; Supported by CIHR Grant HOP-131559 and NSERC DG Grant RPGIN 326924-11.	Acker J, 2013, BBA-GENE REGUL MECH, V1829, P283, DOI 10.1016/j.bbagrm.2012.10.002; Andrau JC, 1999, J MOL BIOL, V288, P511, DOI 10.1006/jmbi.1999.2724; Aye M, 2001, MOL CELL BIOL, V21, P7839, DOI 10.1128/MCB.21.22.7839-7851.2001; Bachman N, 2005, GENE DEV, V19, P955, DOI 10.1101/gad.1299105; Bachman N, 2004, GENOME RES, V14, P1232, DOI 10.1101/gr.2052904; Baller JA, 2012, GENOME RES, V22, P704, DOI 10.1101/gr.129585.111; Barnes CO, 2015, MOL CELL, V59, P258, DOI 10.1016/j.molcel.2015.06.034; BARTHOLOMEW B, 1993, MOL CELL BIOL, V13, P942, DOI 10.1128/MCB.13.2.942; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Brachmann CB, 1998, YEAST, V14, P115; Bridier-Nahmias A, 2015, SCIENCE, V348, P585, DOI 10.1126/science.1259114; Bridier-Nahmias A, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-22; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; Carter R, 2010, MOL BIOL EVOL, V27, P1035, DOI 10.1093/molbev/msp316; CHALKER DL, 1992, GENE DEV, V6, P117, DOI 10.1101/gad.6.1.117; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Connolly CM, 1997, FEBS LETT, V405, P305, DOI 10.1016/S0014-5793(97)00200-7; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Craigie R, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0026-2014; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Curcio MJ, 2007, MOL CELL BIOL, V27, P8874, DOI 10.1128/MCB.01095-07; Curcio MJ, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0053-2014; CURCIO MJ, 1991, P NATL ACAD SCI USA, V88, P936, DOI 10.1073/pnas.88.3.936; Dakshinamurthy A, 2010, GENETICS, V185, P1193, DOI 10.1534/genetics.110.119115; Devine SE, 1996, GENE DEV, V10, P620, DOI 10.1101/gad.10.5.620; EICHINGER DJ, 1988, CELL, V54, P955, DOI 10.1016/0092-8674(88)90110-9; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Flores A, 1999, P NATL ACAD SCI USA, V96, P7815, DOI 10.1073/pnas.96.14.7815; Gelbart ME, 2005, GENE DEV, V19, P942, DOI 10.1101/gad.1298905; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Griffith JL, 2003, GENETICS, V164, P867; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Ho KL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005109; Hoffmann NA, 2015, NATURE, V528, P231, DOI 10.1038/nature16143; HUET J, 1985, J BIOL CHEM, V260, P5304; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; JI H, 1993, CELL, V73, P1007, DOI 10.1016/0092-8674(93)90278-X; Kassavetis GA, 2010, J BIOL CHEM, V285, P2695, DOI 10.1074/jbc.M109.074013; Kenna MA, 1998, MOL CELL BIOL, V18, P1115, DOI 10.1128/MCB.18.2.1115; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; LALO D, 1993, P NATL ACAD SCI USA, V90, P5524, DOI 10.1073/pnas.90.12.5524; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; Lane LA, 2011, STRUCTURE, V19, P90, DOI 10.1016/j.str.2010.11.009; Lannutti BJ, 1996, BIOCHEMISTRY-US, V35, P9821, DOI 10.1021/bi960525x; Lesage P, 2005, CYTOGENET GENOME RES, V110, P70, DOI 10.1159/000084940; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorenzen K, 2007, STRUCTURE, V15, P1237, DOI 10.1016/j.str.2007.07.016; Moore SP, 1998, MOL CELL BIOL, V18, P1105, DOI 10.1128/MCB.18.2.1105; Mularoni L, 2012, GENOME RES, V22, P693, DOI 10.1101/gr.129460.111; Nyswaner KM, 2008, GENETICS, V178, P197, DOI 10.1534/genetics.107.082602; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Persinger J, 1996, J BIOL CHEM, V271, P33039, DOI 10.1074/jbc.271.51.33039; Qi XJ, 2012, J BIOL CHEM, V287, P18589, DOI 10.1074/jbc.M111.326025; Qi XJ, 2012, GENOME RES, V22, P681, DOI 10.1101/gr.131219.111; Rinckel LA, 1996, GENETICS, V142, P761; Risler JK, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-12; Sandmeyer S, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0057-2014; Scholes DT, 2001, GENETICS, V159, P1449; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sundararajan A, 2003, GENETICS, V163, P55; Tate JJ, 1998, NUCLEIC ACIDS RES, V26, P1421, DOI 10.1093/nar/26.6.1421; THUILLIER V, 1995, EMBO J, V14, P351, DOI 10.1002/j.1460-2075.1995.tb07009.x; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449; Vannini A, 2010, CELL, V143, P59, DOI 10.1016/j.cell.2010.09.002; Wang ZX, 1997, GENE DEV, V11, P1315, DOI 10.1101/gad.11.10.1315; WERNER M, 1993, J BIOL CHEM, V268, P20721; Wu CC, 2012, P NATL ACAD SCI USA, V109, P19232, DOI 10.1073/pnas.1211665109; Wu CC, 2011, MOL CELL BIOL, V31, P2715, DOI 10.1128/MCB.05151-11; Xie WW, 2001, MOL CELL BIOL, V21, P6606, DOI 10.1128/MCB.21.19.6606-6614.2001; Yieh L, 2000, J BIOL CHEM, V275, P29800, DOI 10.1074/jbc.M003149200; Yieh L, 2002, J BIOL CHEM, V277, P25920, DOI 10.1074/jbc.M202729200; Zou S, 1997, P NATL ACAD SCI USA, V94, P7412, DOI 10.1073/pnas.94.14.7412	77	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6396	6411		10.1074/jbc.M115.686840	http://dx.doi.org/10.1074/jbc.M115.686840			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797132	hybrid, Green Published			2022-12-28	WOS:000372894200028
J	Walker, NM; Belloli, EA; Stuckey, L; Chan, KM; Lin, J; Lynch, W; Chang, A; Mazzoni, SM; Fingar, DC; Lama, VN				Walker, Natalie M.; Belloli, Elizabeth A.; Stuckey, Linda; Chan, Kevin M.; Lin, Jules; Lynch, William; Chang, Andrew; Mazzoni, Serina M.; Fingar, Diane C.; Lama, Vibha N.			Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; extracellular matrix protein; fibrosis; mammalian target of rapamycin (mTOR); pulmonary fibrosis; Bronchiolitis obliterans syndrome; Chronic allograft rejection; mesenchymal cell	EUKARYOTIC PROTEIN-SYNTHESIS; TUBEROUS SCLEROSIS COMPLEX; MAMMALIAN TARGET; TRANSLATIONAL CONTROL; ADULT LUNG; GROWTH; AKT; CANCER; INHIBITORS; RAPTOR	Fibrotic diseases display mesenchymal cell (MC) activation with pathologic deposition of matrix proteins such as collagen. Here we investigate the role of mTOR complex 1 (mTORC1) and mTORC2 in regulating MC collagen expression, a hallmark of fibrotic disease. Relative to normal MCs (non-Fib MCs), MCs derived from fibrotic human lung allografts (Fib-MCs) demonstrated increased phosphoinositide-3kinase (PI3K) dependent activation of both mTORC1 and mTORC2, as measured by increased phosphorylation of S6K1 and 4E-BP1 (mTORC1 substrates) and AKT (an mTORC2 substrate). Dual ATP-competitive TORC1/2 inhibitor AZD8055, in contrast to allosteric mTORC1-specific inhibitor rapamycin, strongly inhibited 4E-BP1 phosphorylation and collagen I expression in Fib-MCs. In non-Fib MCs, increased mTORC1 signaling was shown to augment collagen I expression. mTORC1/4E-BP1 pathway was identified as an important driver of collagen I expression in Fib-MCs in experiments utilizing raptor gene silencing and overexpression of dominant-inhibitory 4E-BP1. Furthermore, siRNA-mediated knockdown of rictor, an mTORC2 partner protein, reduced mTORC1 substrate phosphorylation and collagen expression in Fib-, but not non-Fib MCs, revealing a dependence of mTORC1 signaling on mTORC2 function in activated MCs. Together these studies suggest a novel paradigm where fibrotic activation in MCs increases PI3K dependent mTORC1 and mTORC2 signaling and leads to increased collagen I expression via the mTORC1-dependent 4E-BP1/eIF4E pathway. These data provide rationale for targeting specific components of mTORC pathways in fibrotic states and underscore the need to further delineate mTORC2 signaling in activated cell states.	[Walker, Natalie M.; Belloli, Elizabeth A.; Chan, Kevin M.; Mazzoni, Serina M.; Lama, Vibha N.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Stuckey, Linda] Univ Michigan, Coll Pharmacol, Ann Arbor, MI 48109 USA; [Lin, Jules; Lynch, William; Chang, Andrew] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Fingar, Diane C.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lama, VN (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, Div Pulm & Crit Care Med, 6220 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	vlama@umich.edu	Lin, Jules/AAK-3200-2021	Chang, Andrew/0000-0001-9506-0425; Mazzoni-Putman, Serina/0000-0001-7433-9478; Walker, Natalie/0000-0002-7445-3534; Lin, Jules/0000-0003-4733-0659	National Institutes of Health [R01 HL118017, R01 HL094622]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094622, R01HL118017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL118017 and R01 HL094622 (to V. N. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bitterman PB, 2012, MOL CANCER THER, V11, P1051, DOI 10.1158/1535-7163.MCT-11-0530; Chen GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033626; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Gao XM, 2006, J HYPERTENS, V24, P1663, DOI 10.1097/01.hjh.0000239304.01496.83; Garcia-Sanz JA, 1998, FASEB J, V12, P299, DOI 10.1096/fasebj.12.3.299; Goc A, 2011, J CELL PHYSIOL, V226, P3004, DOI 10.1002/jcp.22648; Goncharov DA, 2014, CIRCULATION, V129, P864, DOI 10.1161/CIRCULATIONAHA.113.004581; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh AC, 2010, CLIN CANCER RES, V16, P4914, DOI 10.1158/1078-0432.CCR-10-0433; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; Lama VN, 2006, AM J PATHOL, V169, P47, DOI 10.2353/ajpath.2006.050975; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Larsson O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003220; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044946; Malouf MA, 2011, RESPIROLOGY, V16, P776, DOI 10.1111/j.1440-1843.2011.01955.x; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pham PTT, 2004, TRANSPLANTATION, V77, P1215, DOI 10.1097/01.TP.0000118413.92211.B6; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schenone S, 2011, CURR MED CHEM, V18, P2995, DOI 10.2174/092986711796391651; Shi YJ, 2005, MOL CANCER THER, V4, P1533, DOI 10.1158/1535-7163.MCT-05-0068; Sun SY, 2013, CANCER LETT, V340, P1, DOI 10.1016/j.canlet.2013.06.017; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Walker N, 2011, AM J PATHOL, V178, P2461, DOI 10.1016/j.ajpath.2011.01.058; White ES, 2010, EXP CELL RES, V316, P2644, DOI 10.1016/j.yexcr.2010.06.028; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Yu SY, 2013, THORAC CARDIOV SURG, V61, P223, DOI 10.1055/s-0032-1311548; Yusen RD, 2013, J HEART LUNG TRANSPL, V32, P965, DOI 10.1016/j.healun.2013.08.007	47	35	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6262	6271		10.1074/jbc.M115.672170	http://dx.doi.org/10.1074/jbc.M115.672170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26755732	hybrid, Green Published			2022-12-28	WOS:000372894200017
J	Lu, JS; Isaji, T; Im, S; Fukuda, T; Kameyama, A; Gu, JG				Lu, Jishun; Isaji, Tomoya; Im, Sanghun; Fukuda, Tomohiko; Kameyama, Akihiko; Gu, Jianguo			Expression of N-Acetylglucosaminyltransferase III Suppresses 2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to 2,6-Sialylation Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; glycosyltransferase; integrin; N-linked glycosylation; sialyltransferase; bisecting GlcNAc	CMP-SIALIC ACID; BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; BISECTING GLCNAC; BREAST-CANCER; LINKED OLIGOSACCHARIDES; SPONTANEOUS METASTASIS; BRANCH SPECIFICITY; MEMBRANE-PROTEINS; GENE-EXPRESSION; GLYCANS	N-Acetylglucosaminyltransferase III (GnT-III), which catalyzes the addition of the bisecting GlcNAc branch on N-glycans, is usually described as a metastasis suppressor. Overexpression of GnT-III inhibited migration in multiple types of tumor cells. However, these results seem controversial to the clinical observations for the increased expression of GnT-III in human hepatomas, glioma, and ovarian cancers. Here, we present evidence that these inconsistencies are mainly attributed to the different expression pattern of cell sialylation. In detail, we show that overexpression of GnT-III significantly inhibits 2,3-sialylation but not 2,6-sialylation. The migratory ability of cells without or with a low level of 2,6-sialylation is consistently suppressed after GnT-III overexpression. In contrast, the effects of GnT-III overexpression are variable in tumor cells that are highly 2,6-sialylated. Overexpression of GnT-III promotes the cell migration in glioma cells U-251 and hepatoma cells HepG2, although it has little influence in human breast cancer cell MDA-MB-231 and gastric cancer cell MKN-45. Interestingly, up-regulation of 2,6-sialylation by overexpressing -galactoside 2,6-sialyltranferase 1 in the 2,6-hyposialylated HeLa-S3 cells abolishes the anti-migratory effects of GnT-III. Conversely, depletion of 2,6-sialylation by knock-out of -galactoside 2,6-sialyltranferase 1 in 2,6-hypersialylated HepG2 cells endows GnT-III with the anti-migratory ability. Taken together, our data clearly demonstrate that high expression of 2,6-sialylation on the cell surface could affect the anti-migratory role of GnT-III, which provides an insight into the mechanistic roles of GnT-III in tumor metastasis.	[Lu, Jishun; Isaji, Tomoya; Im, Sanghun; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan; [Kameyama, Akihiko] Natl Inst Adv Ind Sci & Technol, Dept Life Sci & Biotechnol, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan	Tohoku Medical & Pharmaceutical University; National Institute of Advanced Industrial Science & Technology (AIST)	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Isaji, Tomoya/ABC-9285-2021; Kameyama, Akihiko/A-9641-2008; Gu, Jianguo/ABC-9257-2020	Kameyama, Akihiko/0000-0002-8229-4449; 	Japan Society for the Promotion of Science [15H04354, 15K14408]; Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [15K14408] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research 15H04354 ( to J. G.), by Challenging Exploratory Research Grant 15K14408 ( to J. G.) from the Japan Society for the Promotion of Science, and by a Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abelev G I, 1971, Adv Cancer Res, V14, P295, DOI 10.1016/S0065-230X(08)60523-0; Anugraham M, 2014, MOL CELL PROTEOMICS, V13, P2213, DOI 10.1074/mcp.M113.037085; Blidner AG, 2015, FEBS LETT, V589, P3407, DOI 10.1016/j.febslet.2015.08.037; BROCKHAUSEN I, 1988, BIOCHIMIE, V70, P1521, DOI 10.1016/0300-9084(88)90289-1; Bull C, 2014, BBA-REV CANCER, V1846, P238, DOI 10.1016/j.bbcan.2014.07.005; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; Cazet A, 2012, GLYCOBIOLOGY, V22, P806, DOI 10.1093/glycob/cws049; Chen QM, 2008, CLIN EXP METASTAS, V25, P139, DOI 10.1007/s10585-007-9132-4; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Dalziel M, 2004, EUR J BIOCHEM, V271, P3623, DOI 10.1111/j.1432-1033.2004.04284.x; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Elola MT, 2015, BIOCHEM J, V469, P1, DOI 10.1042/BJ20150461; Glavey SV, 2015, BLOOD REV, V29, P269, DOI 10.1016/j.blre.2015.01.003; Gomes C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066737; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Guo HB, 2008, FEBS LETT, V582, P527, DOI 10.1016/j.febslet.2008.01.015; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; HASE S, 1978, BIOCHEM BIOPH RES CO, V85, P257, DOI 10.1016/S0006-291X(78)80037-0; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Isaji T, 2010, METHOD ENZYMOL, V480, P445, DOI 10.1016/S0076-6879(10)80019-9; JOZIASSE DH, 1985, J BIOL CHEM, V260, P714; JOZIASSE DH, 1985, J BIOL CHEM, V260, P4941; JOZIASSE DH, 1987, J BIOL CHEM, V262, P2025; Koyota S, 2001, J BIOL CHEM, V276, P32867, DOI 10.1074/jbc.M102371200; Krzewinski-Recchi MA, 2003, EUR J BIOCHEM, V270, P950, DOI 10.1046/j.1432-1033.2003.03458.x; KURAYA N, 1992, J BIOCHEM, V112, P122, DOI 10.1093/oxfordjournals.jbchem.a123850; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lopez-Morales D, 2009, INVEST CLIN, V50, P45; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Mereiter S, 2016, BBA-GEN SUBJECTS, V1860, P1795, DOI 10.1016/j.bbagen.2015.12.016; Milflores-Flores L, 2012, J BIOSCIENCES, V37, P259, DOI 10.1007/s12038-012-9194-6; Miwa HE, 2012, GLYCOCONJUGATE J, V29, P609, DOI 10.1007/s10719-012-9373-6; Natsuka S, 2011, FEBS J, V278, P452, DOI 10.1111/j.1742-4658.2010.07966.x; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PAULSON JC, 1978, J BIOL CHEM, V253, P5617; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ranjan A, 2013, J BIOSCIENCES, V38, P867, DOI 10.1007/s12038-013-9382-z; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Sethi MK, 2014, J PROTEOME RES, V13, P277, DOI 10.1021/pr400861m; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Song YH, 2010, CANCER RES, V70, P3361, DOI 10.1158/0008-5472.CAN-09-2719; Thomas GJ, 2001, INT J CANCER, V92, P641, DOI 10.1002/1097-0215(20010601)92:5<641::AID-IJC1243>3.0.CO;2-P; Thomas GJ, 2001, J INVEST DERMATOL, V117, P67, DOI 10.1046/j.0022-202x.2001.01379.x; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wang PH, 2002, GYNECOL ONCOL, V86, P45, DOI 10.1006/gyno.2002.6714; WANG X, 1990, Glycobiology, V1, P25, DOI 10.1093/glycob/1.1.25; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; Zhao YF, 2014, MOL CELL PROTEOMICS, V13, P520, DOI 10.1074/mcp.M113.034025; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	64	34	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5708	5720		10.1074/jbc.M115.712836	http://dx.doi.org/10.1074/jbc.M115.712836			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26801611	Green Published, hybrid			2022-12-28	WOS:000372551800021
J	Chandrasekhar, R; Alzayady, KJ; Wagner, LE; Yule, DI				Chandrasekhar, Rahul; Alzayady, Kamil J.; Wagner, Larry E., II; Yule, David I.			Unique Regulatory Properties of Heterotetrameric Inositol 1,4,5-Trisphosphate Receptors Revealed by Studying Concatenated Receptor Constructs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; calcium channel; calcium intracellular release; inositol 1; 4; 5-trisphosphate (IP3); inositol trisphosphate receptor (InsP3R); ATP binding; Concatemer	PANCREATIC ACINAR-CELLS; PROTEIN-KINASE-A; CA2+ RELEASE CHANNELS; LIGAND-BINDING; IP3 RECEPTORS; TRISPHOSPHATE RECEPTOR; MOLECULAR DETERMINANTS; ENDOPLASMIC-RETICULUM; MUTATIONAL ANALYSIS; RAT HEPATOCYTES	The ability of inositol 1,4,5-trisphosphate receptors (IP3R) to precisely initiate and generate a diverse variety of intracellular Ca2+ signals is in part mediated by the differential regulation of the three subtypes (R1, R2, and R3) by key functional modulators (IP3, Ca2+, and ATP). However, the contribution of IP3R heterotetramerization to Ca2+ signal diversity has largely been unexplored. In this report, we provide the first definitive biochemical evidence of endogenous heterotetramer formation. Additionally, we examine the contribution of individual subtypes within defined concatenated heterotetramers to the shaping of Ca2+ signals. Under conditions where key regulators of IP3R function are optimal for Ca2+ release, we demonstrate that individual monomers within heteromeric IP(3)Rs contributed equally toward generating a distinct 'blended' sensitivity to IP3 that is likely dictated by the unique IP3 binding affinity of the heteromers. However, under suboptimal conditions where [ATP] were varied, we found that one subtype dictated the ATP regulatory properties of heteromers. We show that R2 monomers within a heterotetramer were both necessary and sufficient to dictate the ATP regulatory properties. Finally, the ATP-binding site B in R2 critical for ATP regulation was mutated and rendered non-functional to address questions relating to the stoichiometry of IP3R regulation. Two intact R2 monomers were sufficient to maintain ATP regulation in R2 homotetramers. In summary, we demonstrate that heterotetrameric IP3R do not necessarily behave as the sum of the constituent subunits, and these properties likely extend the versatility of IP3-induced Ca2+ signaling in cells expressing multiple IP3R isoforms.	[Chandrasekhar, Rahul; Alzayady, Kamil J.; Wagner, Larry E., II; Yule, David I.] Univ Rochester, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA	University of Rochester	Yule, DI (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	David_Yule@urmc.rochester.edu			National Institutes of Health Grants [RO1 DE014756, DE019245]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756, R01DE019245] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants RO1 DE014756 and DE019245 (to D. I. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alzayady KJ, 2013, J BIOL CHEM, V288, P29772, DOI 10.1074/jbc.M113.502203; Alzayady KJ, 2013, J BIOL CHEM, V288, P11122, DOI 10.1074/jbc.M113.453241; Bansaghi S, 2014, J BIOL CHEM, V289, P8170, DOI 10.1074/jbc.M113.504159; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2010, CURR TOP MEMBR, V66, P273, DOI 10.1016/S1063-5823(10)66012-7; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P16156, DOI 10.1074/jbc.M109.006452; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; CHIN KV, 1987, J BIOL CHEM, V262, P16509; Decuypere JP, 2011, BBA-MOL CELL RES, V1813, P1003, DOI 10.1016/j.bbamcr.2010.11.023; DeSmedt H, 1997, BIOCHEM J, V322, P575; Dufour JF, 1997, J BIOL CHEM, V272, P2675, DOI 10.1074/jbc.272.5.2675; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; Hirata K, 2002, GASTROENTEROLOGY, V122, P1088, DOI 10.1053/gast.2002.32363; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; Joseph SK, 1997, J BIOL CHEM, V272, P1579, DOI 10.1074/jbc.272.3.1579; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; Kruglov EA, 2011, HEPATOLOGY, V54, P1790, DOI 10.1002/hep.24548; Laude AJ, 2005, CELL CALCIUM, V38, P45, DOI 10.1016/j.ceca.2005.04.001; Lee MG, 1997, J BIOL CHEM, V272, P15771, DOI 10.1074/jbc.272.25.15771; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; MARANTO AR, 1994, J BIOL CHEM, V269, P1222; Marchant JS, 1997, CURR BIOL, V7, P510, DOI 10.1016/S0960-9822(06)00222-3; Masuda W, 2010, J BIOL CHEM, V285, P37927, DOI 10.1074/jbc.M110.168989; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; MEYER T, 1988, SCIENCE, V240, P653, DOI 10.1126/science.2452482; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; Nucifora FC, 1996, MOL BIOL CELL, V7, P949, DOI 10.1091/mbc.7.6.949; Onoue H, 2000, BIOCHEM BIOPH RES CO, V267, P928, DOI 10.1006/bbrc.1999.2065; Pantazaka E, 2010, BIOCHEM J, V425, P61, DOI 10.1042/BJ20091051; Park HS, 2008, J BIOL CHEM, V283, P26081, DOI 10.1074/jbc.M804184200; Parker AKT, 2004, J BIOL CHEM, V279, P23797, DOI 10.1074/jbc.M402098200; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; STREB H, 1984, J MEMBRANE BIOL, V81, P241, DOI 10.1007/BF01868717; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wagner LE, 2012, J PHYSIOL-LONDON, V590, P3245, DOI 10.1113/jphysiol.2012.228320; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; WOJCIKIEWICZ RJH, 1995, BIOCHEM BIOPH RES CO, V213, P334, DOI 10.1006/bbrc.1995.2134; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005; Yule DI, 1997, J BIOL CHEM, V272, P9093	63	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4846	4860		10.1074/jbc.M115.705301	http://dx.doi.org/10.1074/jbc.M115.705301			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26755721	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000371640600001
J	Felczak, MM; Sage, JM; Hupert-Kocurek, K; Aykul, S; Kaguni, JM				Felczak, Magdalena M.; Sage, Jay M.; Hupert-Kocurek, Katarzyna; Aykul, Senem; Kaguni, Jon M.			Substitutions of Conserved Residues in the C-terminal Region of DnaC Cause Thermolability in Helicase Loading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; REPLICATION PROTEIN COMPLEX; ESCHERICHIA-COLI; ATP HYDROLYSIS; QUANTITATIVE-ANALYSIS; NUCLEOTIDE COFACTORS; BINDING; INITIATION; DOMAIN; MECHANISM	The DnaB-DnaC complex binds to the unwound DNA within the Escherichia coli replication origin in the helicase loading process, but the biochemical events that lead to its stable binding are uncertain. This study characterizes the function of specific C-terminal residues of DnaC. Genetic and biochemical characterization of proteins bearing F231S and W233L substitutions of DnaC reveals that their activity is thermolabile. Because the mutants remain able to form a complex with DnaB at 30 and 37 degrees C, their thermolability is not explained by an impaired interaction with DnaB. Photo-cross-linking experiments and biosensor analysis show an altered affinity of these mutants compared with wild type DnaC for single-stranded DNA, suggesting that the substitutions affect DNA binding. Despite this difference, their activity in DNA binding is not thermolabile. The substitutions also drastically reduce the affinity of DnaC for ATP as measured by the binding of a fluorescent ATP analogue (MANT-ATP) and by UV cross-linking of radiolabeled ATP. Experiments show that an elevated temperature substantially inhibits both mutants in their ability to load the DnaB-DnaC complex at a DnaA box. Because a decreased ATP concentration exacerbates their thermolabile behavior, we suggest that the F231S and W233L substitutions are thermolabile in ATP binding, which correlates with defective helicase loading at an elevated temperature.	[Felczak, Magdalena M.; Sage, Jay M.; Hupert-Kocurek, Katarzyna; Aykul, Senem; Kaguni, Jon M.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Sage, Jay M.] Nabsys Inc, 60 Clifford St, Providence, RI 02903 USA; [Hupert-Kocurek, Katarzyna] Univ Silesia Katowice, Dept Biochem, Katowice, Poland	Michigan State University; University of Silesia in Katowice	Kaguni, JM (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	kaguni@msu.edu		Hupert-Kocurek, Katarzyna/0000-0003-2821-568X; Kaguni, Jon/0000-0002-3096-4447; AYKUL, SENEM/0000-0001-7250-2913	National Institutes of Health [R01 GM090063]; USDA National Institute of Food and Agriculture, Hatch Project [MICL02370]; Michigan AgBioResearch; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA National Institute of Food and Agriculture, Hatch Project; Michigan AgBioResearch; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant R01 GM090063 from the National Institutes of Health and by the USDA National Institute of Food and Agriculture, Hatch Project MICL02370, and Michigan AgBioResearch. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARAI K, 1981, J BIOL CHEM, V256, P5260; ARAI KI, 1981, P NATL ACAD SCI-BIOL, V78, P707, DOI 10.1073/pnas.78.2.707; Arias-Palomo E, 2013, CELL, V153, P438, DOI 10.1016/j.cell.2013.03.006; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; BAKER TA, 1986, CELL, V45, P53, DOI 10.1016/0092-8674(86)90537-4; Bell SP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010124; Biswas EE, 1999, BIOCHEMISTRY-US, V38, P10929, DOI 10.1021/bi990049l; Biswas SB, 2004, BIOCHEM J, V379, P553, DOI 10.1042/BJ20031255; Biswas SB, 2006, BIOCHEMISTRY-US, V45, P11505, DOI 10.1021/bi060118d; Carr KM, 2002, J BIOL CHEM, V277, P39815, DOI 10.1074/jbc.M205031200; Carr KM, 2001, J BIOL CHEM, V276, P44919, DOI 10.1074/jbc.M107463200; Chodavarapu S, 2008, MOL MICROBIOL, V67, P1331, DOI 10.1111/j.1365-2958.2008.06127.x; Chodavarapu S, 2016, NUCLEIC ACIDS RES, V44, P210, DOI 10.1093/nar/gkv961; Chodavarapu S, 2011, NUCLEIC ACIDS RES, V39, P4180, DOI 10.1093/nar/gkq1203; Chodavarapu S, 2008, MOL MICROBIOL, V67, P781, DOI 10.1111/j.1365-2958.2007.06094.x; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Donate LE, 2000, J MOL BIOL, V303, P383, DOI 10.1006/jmbi.2000.4132; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; Galletto R, 2000, BIOCHEMISTRY-US, V39, P12959, DOI 10.1021/bi0012484; Galletto R, 2003, J MOL BIOL, V329, P441, DOI 10.1016/S0022-2836(03)00435-2; Nhieu GTV, 2013, NAT COMMUN, V4, DOI [10.1038/ncomms3495, 10.1038/ncomms2561]; Hupert-Kocurek K., 2011, COMPUTATIONAL BIOL A; Jezewska MJ, 1997, BIOCHEMISTRY-US, V36, P10320, DOI 10.1021/bi970712a; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; KOONIN EV, 1992, NUCLEIC ACIDS RES, V20, P1997, DOI 10.1093/nar/20.8.1997; Learn BA, 1997, P NATL ACAD SCI USA, V94, P1154, DOI 10.1073/pnas.94.4.1154; Lo YH, 2009, NUCLEIC ACIDS RES, V37, P804, DOI 10.1093/nar/gkn999; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; Marszalek J, 1996, J BIOL CHEM, V271, P18535, DOI 10.1074/jbc.271.31.18535; MARSZALEK J, 1992, J BIOL CHEM, V267, P19334; Meisenheimer KM, 1997, CRIT REV BIOCHEM MOL, V32, P101, DOI 10.3109/10409239709108550; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Neuhard, 1987, ESCHERICHIA COLI SAL, V1, P445; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; WAHLE E, 1989, J BIOL CHEM, V264, P2469; WAHLE E, 1989, J BIOL CHEM, V264, P2463; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8	41	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4803	4812		10.1074/jbc.M115.708586	http://dx.doi.org/10.1074/jbc.M115.708586			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26728455	hybrid, Green Published			2022-12-28	WOS:000371604600045
J	Su, Y; Egli, M; Guengerich, FP				Su, Yan; Egli, Martin; Guengerich, F. Peter			Mechanism of Ribonucleotide Incorporation by Human DNA Polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA enzyme; DNA polymerase; enzyme kinetics; x-ray crystallography; translesion synthesis	STERIC GATE; Y-FAMILY; ABASIC SITE; BYPASS; DISCRIMINATION; REPLICATION; EFFICIENT; EXCISION; SUGAR; INSTABILITY	Ribonucleotides and 2-deoxyribonucleotides are the basic units for RNA and DNA, respectively, and the only difference is the extra 2-OH group on the ribonucleotide sugar. Cellular rNTP concentrations are much higher than those of dNTP. When copying DNA, DNA polymerases not only select the base of the incoming dNTP to form a Watson-Crick pair with the template base but also distinguish the sugar moiety. Some DNA polymerases use a steric gate residue to prevent rNTP incorporation by creating a clash with the 2-OH group. Y-family human DNA polymerase (hpol ) is of interest because of its spacious active site (especially in the major groove) and tolerance of DNA lesions. Here, we show that hpol maintains base selectivity when incorporating rNTPs opposite undamaged DNA and the DNA lesions 7,8-dihydro-8-oxo-2-deoxyguanosine and cyclobutane pyrimidine dimer but with rates that are 10(3)-fold lower than for inserting the corresponding dNTPs. X-ray crystal structures show that the hpol scaffolds the incoming rNTP to pair with the template base (dG) or 7,8-dihydro-8-oxo-2-deoxyguanosine with a significant propeller twist. As a result, the 2-OH group avoids a clash with the steric gate, Phe-18, but the distance between primer end and P of the incoming rNTP increases by 1 , elevating the energy barrier and slowing polymerization compared with dNTP. In addition, Tyr-92 was identified as a second line of defense to maintain the position of Phe-18. This is the first crystal structure of a DNA polymerase with an incoming rNTP opposite a DNA lesion.	[Su, Yan; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, R01ES010546] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Drs. J. M. Harp, P. S. Pallan, and E. A. Kowal for advice on the x-ray crystallography work. We also thank K. Trisler for assistance in the preparation of the manuscript. Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at sector 21 of the Advanced Photon Source, Argonne, IL. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albertella MR, 2005, CANCER RES, V65, P9799, DOI 10.1158/0008-5472.CAN-05-1095; Bassett E, 2004, CANCER RES, V64, P6469, DOI 10.1158/0008-5472.CAN-04-1328; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Carpio RVD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005766; Cavanaugh NA, 2011, J BIOL CHEM, V286, P31650, DOI 10.1074/jbc.M111.253401; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104; Chen YW, 2006, MOL CANCER RES, V4, P257, DOI 10.1158/1541-7786.MCR-05-0118; Clausen AR, 2013, P NATL ACAD SCI USA, V110, P16802, DOI 10.1073/pnas.1309119110; Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; DeLucia AM, 2006, J BIOL CHEM, V281, P27286, DOI 10.1074/jbc.M604393200; Donigan KA, 2015, DNA REPAIR, V35, P1, DOI 10.1016/j.dnarep.2015.07.002; Donigan KA, 2014, J BIOL CHEM, V289, P9136, DOI 10.1074/jbc.M113.545442; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gosavi RA, 2012, NUCLEIC ACIDS RES, V40, P7518, DOI 10.1093/nar/gks413; Gregory MT, 2014, P NATL ACAD SCI USA, V111, P9133, DOI 10.1073/pnas.1405739111; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kirouac KN, 2011, J MOL BIOL, V407, P382, DOI 10.1016/j.jmb.2011.01.037; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Langer GG, 2013, ACTA CRYSTALLOGR D, V69, P635, DOI 10.1107/S0907444913000565; Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Niimi N, 2009, BIOCHEMISTRY-US, V48, P4239, DOI 10.1021/bi900153t; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Su Y, 2015, J BIOL CHEM, V290, P15921, DOI 10.1074/jbc.M115.653691; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; Vaisman A, 2015, DNA REPAIR, V29, P74, DOI 10.1016/j.dnarep.2015.02.008; Vaisman A, 2012, NUCLEIC ACIDS RES, V40, P6144, DOI 10.1093/nar/gks233; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	50	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3747	3756		10.1074/jbc.M115.706226	http://dx.doi.org/10.1074/jbc.M115.706226			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26740629	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000371338400005
J	Friis, S; Madsen, DH; Bugge, TH				Friis, Stine; Madsen, Daniel H.; Bugge, Thomas H.			Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL BARRIER FUNCTION; PROTEOLYTIC CASCADE; PROTEASE; DIFFERENTIATION; LOCALIZATION; HOMEOSTASIS; CHANNELS	The membrane-anchored serine prostasin (CAP1/PRSS8) is essential for barrier acquisition of the interfollicular epidermis and for normal hair follicle development. Consequently, prostasin null mice die shortly after birth. Prostasin is found in two forms in the epidermis: a one-chain zymogen and a two-chain proteolytically active form, generated by matriptase-dependent activation site cleavage. Here we used gene editing to generate mice expressing only activation site cleavage-resistant (zymogen-locked) endogenous prostasin. Interestingly, these mutant mice displayed normal interfollicular epidermal development and postnatal survival, but had defects in whisker and pelage hair formation. These findings identify two distinct in vivo functions of epidermal prostasin: a function in the interfollicular epidermis, not requiring activation site cleavage, that can be mediated by the zymogen-locked version of prostasin and a proteolysis-dependent function of activated prostasin in hair follicles, dependent on zymogen conversion by matriptase.	[Friis, Stine; Madsen, Daniel H.; Bugge, Thomas H.] NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Room 3A-308, Bethesda, MD 20892 USA; [Friis, Stine] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Sect Mol Dis Biol, DK-2100 Copenhagen, Denmark; [Madsen, Daniel H.] Copenhagen Univ Hosp, Ctr Canc Immune Therapy, DK-2730 Herlev, Denmark	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Copenhagen; University of Copenhagen	Bugge, TH (corresponding author), NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Room 3A-308, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov		Madsen, Daniel Hargboel/0000-0002-3183-6201	NIDCR Intramural Research Program; Harboe Foundation; Lundbeck Foundation; Foundation of 17.12.1981; Lundbeck Foundation [R140-2013-13193] Funding Source: researchfish; The Danish Cancer Society [R124-A7599] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	NIDCR Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Harboe Foundation; Lundbeck Foundation(Lundbeckfonden); Foundation of 17.12.1981; Lundbeck Foundation(Lundbeckfonden); The Danish Cancer Society(Danish Cancer Society); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the NIDCR Intramural Research Program (to T. H. B.) and by The Harboe Foundation, The Lundbeck Foundation, and the Foundation of 17.12.1981. (to S. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Crisante G, 2014, FASEB J, V28, P4792, DOI 10.1096/fj.14-253781; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Hummler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055796; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Peters DE, 2014, J BIOL CHEM, V289, P14740, DOI 10.1074/jbc.M113.541318; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; YU JX, 1994, J BIOL CHEM, V269, P18843	16	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2577	2582		10.1074/jbc.C115.706721	http://dx.doi.org/10.1074/jbc.C115.706721			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26719335	Green Published, hybrid			2022-12-28	WOS:000369626900004
J	Yu, WX; Ye, CQ; Greenberg, ML				Yu, Wenxi; Ye, Cunqi; Greenberg, Miriam L.			Inositol Hexakisphosphate Kinase 1 (IP6K1) Regulates Inositol Synthesis in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; MYOINOSITOL 1-PHOSPHATE; 3-PHOSPHATE SYNTHASE; TRANSCRIPTION FACTOR; PHOSPHATIDIC-ACID; CRYSTAL-STRUCTURE; HISTONE H3; PYROPHOSPHATES; METABOLISM; 1,4,5-TRISPHOSPHATE	myo-Inositol, the precursor of all inositol compounds, has pivotal roles in cell metabolism and signaling pathways. Although physiological studies indicate a strong correlation between abnormal intracellular inositol levels and neurological disorders, very little is known about the regulation of inositol synthesis in mammalian cells. In this study, we report that IP6K1, an inositol hexakisphosphate kinase that catalyzes the synthesis of inositol pyrophosphate, regulates inositol synthesis in mammalian cells. Ip6k1 ablation led to profound changes in DNA methylation and expression of Isyna1 (designated mIno1), which encodes the rate-limiting enzyme inositol-3-phosphate synthase. Interestingly, IP6K1 preferentially bound to the phospholipid phosphatidic acid, and this binding was required for IP6K1 nuclear localization and the regulation of mIno1 transcription. This is the first demonstration of IP6K1 as a novel negative regulator of inositol synthesis in mammalian cells.	[Yu, Wenxi; Ye, Cunqi; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Ye, Cunqi] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Wayne State University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	mgreenberg@wayne.edu			National Institutes of Health [DK081367]; Graduate School of Wayne State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate School of Wayne State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK081367 (to M. L. G.) and the Graduate School of Wayne State University (to W. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker RR, 2001, BBA-MOL CELL BIOL L, V1534, P110, DOI 10.1016/S1388-1981(01)00182-2; Bankaitis VA, 2012, CURR BIOL, V22, pR414, DOI 10.1016/j.cub.2012.03.004; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Burton A, 2013, P NATL ACAD SCI USA, V110, P18970, DOI 10.1073/pnas.1309699110; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Choi K, 2008, MOL PHARMACOL, V74, P527, DOI 10.1124/mol.107.044628; Croze ML, 2013, BIOCHIMIE, V95, P1811, DOI 10.1016/j.biochi.2013.05.011; D'Santos CS, 1999, CURR BIOL, V9, P437, DOI 10.1016/S0960-9822(99)80193-6; Deranieh RM, 2013, J BIOL CHEM, V288, P26822, DOI 10.1074/jbc.M113.479121; Dowler S, 2002, SCI STKE, V2002, P6; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; EISENBER.F, 1967, J BIOL CHEM, V242, P1375; Fan L, 1999, PLANT PHYSIOL, V119, P1371, DOI 10.1104/pp.119.4.1371; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Guan GM, 2003, ARCH BIOCHEM BIOPHYS, V417, P251, DOI 10.1016/S0003-9861(03)00388-6; HENRY SA, 1977, J BACTERIOL, V130, P472, DOI 10.1128/JB.130.1.472-484.1977; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Jadav RS, 2013, J BIOL CHEM, V288, P3312, DOI 10.1074/jbc.M112.396556; Ju SL, 2003, MOL MICROBIOL, V49, P1595, DOI 10.1046/j.1365-2958.2003.03641.x; KINDL H, 1964, BIOCHEM Z, V339, P374; Liscovitch M, 1999, BBA-MOL CELL BIOL L, V1439, P245, DOI 10.1016/S1388-1981(99)00098-0; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; LOEWUS FA, 1962, BIOCHEM BIOPH RES CO, V7, P204, DOI 10.1016/0006-291X(62)90175-4; Maslanski J. A., 1990, METHODS INOSITIDE RE, P113; Miller GJ, 2004, MOL CELL, V15, P703, DOI 10.1016/j.molcel.2004.08.005; Newell-Price J, 2000, TRENDS ENDOCRIN MET, V11, P142, DOI 10.1016/S1043-2760(00)00248-4; NIKAWA J, 1991, J BIOL CHEM, V266, P11184; Padmanabhan U, 2009, J BIOL CHEM, V284, P10571, DOI 10.1074/jbc.M900752200; Parthasarathy Latha K., 2006, V39, P293; Popkie AP, 2010, J BIOL CHEM, V285, P41337, DOI 10.1074/jbc.M110.170704; Ryu KH, 2005, DEVELOPMENT, V132, P4765, DOI 10.1242/dev.02055; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi A, 2001, P NATL ACAD SCI USA, V98, P2306, DOI 10.1073/pnas.041614598; Seelan RS, 2011, EPIGENOMICS-UK, V3, P111, DOI 10.2217/EPI.10.73; Seelan RS, 2009, J BIOL CHEM, V284, P9443, DOI 10.1074/jbc.M900206200; Shears SB, 2009, MOL PHARMACOL, V76, P236, DOI 10.1124/mol.109.055897; Shi Yihui, 2006, V39, P265; Shimon H, 1997, AM J PSYCHIAT, V154, P1148; SMITH CD, 1983, J BIOL CHEM, V258, P9368; Stein AJ, 2002, J BIOL CHEM, V277, P9484, DOI 10.1074/jbc.M109371200; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; WHITE MJ, 1991, ADV MICROB PHYSIOL, V32, P1, DOI 10.1016/S0065-2911(08)60004-1; WONG YHH, 1987, J NEUROCHEM, V48, P1434, DOI 10.1111/j.1471-4159.1987.tb05682.x; Yao HY, 2013, PLANT CELL, V25, P5030, DOI 10.1105/tpc.113.120162; Ye CQ, 2015, J NEUROCHEM, V133, P273, DOI 10.1111/jnc.12978; Ye CQ, 2013, J BIOL CHEM, V288, P24898, DOI 10.1074/jbc.M113.493353; Zhu AP, 2009, ANAL BIOCHEM, V388, P97, DOI 10.1016/j.ab.2009.02.009	51	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10437	10444		10.1074/jbc.M116.714816	http://dx.doi.org/10.1074/jbc.M116.714816			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26953345	Green Published, hybrid			2022-12-28	WOS:000377042600001
J	Pereira, JH; Heins, RA; Gall, DL; McAndrew, RP; Deng, K; Holland, KC; Donohue, TJ; Noguera, DR; Simmons, BA; Sale, KL; Ralph, J; Adams, PD				Pereira, Jose Henrique; Heins, Richard A.; Gall, Daniel L.; McAndrew, Ryan P.; Deng, Kai; Holland, Keefe C.; Donohue, Timothy J.; Noguera, Daniel R.; Simmons, Blake A.; Sale, Kenneth L.; Ralph, John; Adams, Paul D.			Structural and Biochemical Characterization of the Early and Late Enzymes in the Lignin beta-Aryl Ether Cleavage Pathway from Sphingobium sp.SYK-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOL-DEHYDROGENASE; STRUCTURE REFINEMENT; DEGRADATION; PHENIX; TRANSFERASES; PROTEINS; BACTERIA; SEQUENCE; GUAIACYL; SDR	There has been great progress in the development of technology for the conversion of lignocellulosic biomass to sugars and subsequent fermentation to fuels. However, plant lignin remains an untapped source of materials for production of fuels or high value chemicals. Biological cleavage of lignin has been well characterized in fungi, in which enzymes that create free radical intermediates are used to degrade this material. In contrast, a catabolic pathway for the stereospecific cleavage of beta-aryl ether units that are found in lignin has been identified in Sphingobium sp.SYK-6 bacteria. beta-Aryl ether units are typically abundant in lignin, corresponding to 50-70% of all of the intermonomer linkages. Consequently, a comprehensive understanding of enzymatic beta-aryl ether (beta-ether) cleavage is important for future efforts to biologically process lignin and its breakdown products. The crystal structures and biochemical characterization of the NAD-dependent dehydrogenases (LigD, LigO, and LigL) and the glutathione-dependent lyase LigG provide new insights into the early and late enzymes in the beta-ether degradation pathway. We present detailed information on the cofactor and substrate binding sites and on the catalytic mechanisms of these enzymes, comparing them with other known members of their respective families. Information on the Lig enzymes provides new insight into their catalysis mechanisms and can inform future strategies for using aromatic oligomers derived from plant lignin as a source of valuable aromatic compounds for biofuels and other bioproducts.	[Pereira, Jose Henrique; Heins, Richard A.; McAndrew, Ryan P.; Deng, Kai; Holland, Keefe C.; Simmons, Blake A.; Sale, Kenneth L.; Adams, Paul D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Pereira, Jose Henrique; McAndrew, Ryan P.; Adams, Paul D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Heins, Richard A.; Deng, Kai; Holland, Keefe C.; Simmons, Blake A.; Sale, Kenneth L.] Sandia Natl Labs, Biol & Engn Sci Ctr, Livermore, CA 94551 USA; [Gall, Daniel L.; Donohue, Timothy J.; Noguera, Daniel R.; Ralph, John] Univ Wisconsin, US Dept, Energy Great Lakes Bioenergy Res Ctr, Wisconsin Energy Inst, Madison, WI 53726 USA; [Gall, Daniel L.; Noguera, Daniel R.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [Donohue, Timothy J.; Ralph, John] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Adams, Paul D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Sandia National Laboratories; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley	Adams, PD (corresponding author), Joint BioEnergy Inst, Emeryville, CA 94608 USA.; Adams, PD (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.; Adams, PD (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	pdadams@lbl.gov	Adams, Paul David/A-1977-2013; Simmons, Blake/N-6022-2016; Ralph, John/C-3161-2009	Adams, Paul David/0000-0001-9333-8219; Simmons, Blake/0000-0002-1332-1810; Ralph, John/0000-0002-6093-4521; Noguera, Daniel/0000-0003-0372-3063	NIGMS, National Institutes of Health; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the staff of the Berkeley Center for Structural Biology at the Advanced Light Source of Lawrence Berkeley National Laboratory. The Berkeley Center for Structural Biology is supported in part by NIGMS, National Institutes of Health. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adler E., 1957, TAPPI, V40, P294; Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAN F, 1991, BIOCHEMISTRY-US, V30, P6397, DOI 10.1021/bi00240a008; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Gall DL, 2014, ENVIRON SCI TECHNOL, V48, P12454, DOI 10.1021/es503886d; Gall DL, 2014, J BIOL CHEM, V289, P8656, DOI 10.1074/jbc.M113.536250; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hishiyama S, 2012, TETRAHEDRON LETT, V53, P842, DOI 10.1016/j.tetlet.2011.12.016; Javidpour P, 2014, APPL ENVIRON MICROB, V80, P497, DOI 10.1128/AEM.03194-13; Lee EH, 2014, ARCH BIOCHEM BIOPHYS, V564, P20, DOI 10.1016/j.abb.2014.09.001; Luo YR, 2012, J BACTERIOL, V194, P907, DOI 10.1128/JB.06476-11; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meux E, 2012, FEBS LETT, V586, P3944, DOI 10.1016/j.febslet.2012.09.036; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Picart P, 2015, GREEN CHEM, V17, P4931, DOI [10.1039/C5GC01078K, 10.1039/c5gc01078k]; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; Reiter J, 2013, GREEN CHEM, V15, P1373, DOI 10.1039/c3gc40295a; Sato Y, 2009, APPL ENVIRON MICROB, V75, P5195, DOI 10.1128/AEM.00880-09; Schlieben NH, 2005, J MOL BIOL, V349, P801, DOI 10.1016/j.jmb.2005.04.029; Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Tashiro S, 2014, BIOCHEMISTRY-US, V53, P2218, DOI 10.1021/bi500294h; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tocheva EI, 2006, J BIOL CHEM, V281, P30933, DOI 10.1074/jbc.M603125200	36	34	35	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10228	10238		10.1074/jbc.M115.700427	http://dx.doi.org/10.1074/jbc.M115.700427			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26940872	Green Published, hybrid			2022-12-28	WOS:000375602800031
J	Natalello, A; Mangione, PP; Giorgetti, S; Porcari, R; Marchese, L; Zorzoli, I; Relini, A; Ami, D; Faravelli, G; Valli, M; Stoppini, M; Doglia, SM; Bellotti, V; Raimondi, S				Natalello, Antonino; Mangione, P. Patrizia; Giorgetti, Sofia; Porcari, Riccardo; Marchese, Loredana; Zorzoli, Irene; Relini, Annalisa; Ami, Diletta; Faravelli, Giulia; Valli, Maurizia; Stoppini, Monica; Doglia, Silvia M.; Bellotti, Vittorio; Raimondi, Sara			Co-fibrillogenesis of Wild-type and D76N beta(2)-Microglobulin THE CRUCIAL ROLE OF FIBRILLAR SEEDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; INFRARED-SPECTROSCOPY; SYSTEMIC AMYLOIDOSIS; IN-VITRO; TRANSTHYRETIN; AGGREGATION; PROTEINS; AMYLOIDOGENESIS; GENERATION	The amyloidogenic variant of beta(2)-microglobulin, D76N, can readily convert into genuine fibrils under physiological conditions and primes in vitro the fibrillogenesis of the wild-type beta(2)-microglobulin. By Fourier transformed infrared spectroscopy, we have demonstrated that the amyloid transformation of wild-type beta(2)-microglobulin can be induced by the variant only after its complete fibrillar conversion. Our current findings are consistent with preliminary data in which we have shown a seeding effect of fibrils formed from D76N or the natural truncated form of beta(2)-microglobulin lacking the first six N-terminal residues. Interestingly, the hybrid wild-type/variant fibrillar material acquired a thermodynamic stability similar to that of homogenous D76N beta(2)-microglobulin fibrils and significantly higher than the wild-type homogeneous fibrils prepared at neutral pH in the presence of 20% trifluoroethanol. These results suggest that the surfaceofD76N beta(2)-microglobulinfibrilscanfavorthetransitionof the wild-type protein into an amyloid conformation leading to a rapid integration into fibrils. The chaperone crystallin, which is a mild modulator of the lag phase of the variant fibrillogenesis, potently inhibits fibril elongation of the wild-type even once it is absorbed on D76N beta(2)-microglobulin fibrils.	[Natalello, Antonino; Ami, Diletta; Doglia, Silvia M.] Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy; [Natalello, Antonino; Ami, Diletta; Doglia, Silvia M.] Consorzio Nazl Interuniv Sci Fis Mat CNISM, UdR Milano Bicocca, I-20126 Milan, Italy; [Mangione, P. Patrizia; Porcari, Riccardo; Bellotti, Vittorio] UCL, Div Med, Ctr Amyloidosis & Acute Phase Prot, Wolfson Drug Discovery Unit, London NW3 2PF, England; [Mangione, P. Patrizia; Giorgetti, Sofia; Marchese, Loredana; Faravelli, Giulia; Valli, Maurizia; Stoppini, Monica; Bellotti, Vittorio; Raimondi, Sara] Univ Pavia, Inst Biochem, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy; [Zorzoli, Irene] Univ Pavia, Dept Internal Med & Therapeut, Via Palestro 3, I-27100 Pavia, Italy; [Relini, Annalisa] Univ Genoa, Dept Phys, I-16146 Genoa, Italy	University of Milano-Bicocca; University of London; University College London; University of Pavia; University of Pavia; University of Genoa	Raimondi, S (corresponding author), Univ Pavia, Inst Biochem, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy.	sara.raimondi@unipv.it	Natalello, Antonino/B-9659-2012; Giorgetti, Sofia/AAD-4341-2019; Relini, Annalisa/AHC-3105-2022; Bellotti, Vittorio/A-6201-2014	Natalello, Antonino/0000-0002-1489-272X; Giorgetti, Sofia/0000-0001-9438-6511; Mangione, Palma/0000-0003-0260-1400; Bellotti, Vittorio/0000-0001-8678-662X; Faravelli, Giulia/0000-0002-7348-9404; RELINI, ANNALISA/0000-0002-4040-9279	United Kingdom Medical Research Council [MR/K000187/1]; Italian Ministry of University and Research Project FIRB [RBFR109EOS]; Telethon Grant [GG14127]; Cariplo Foundation [2013-0964, 2014-0700]; Istituto Nazionale di Biostrutture e Biosistemi; Medical Research Council [MR/K000187/1] Funding Source: researchfish; MRC [MR/K000187/1] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Italian Ministry of University and Research Project FIRB; Telethon Grant(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo); Istituto Nazionale di Biostrutture e Biosistemi; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by United Kingdom Medical Research Council Grant MR/K000187/1, Italian Ministry of University and Research Project FIRB RBFR109EOS (to S. G.), Telethon Grant GG14127 (to V. B.), Cariplo Foundation Projects 2013-0964 (to A. N., S. G., D. A., and S. M. D.) and 2014-0700 (to V. B.), and grants from the Istituto Nazionale di Biostrutture e Biosistemi (to V. B., S. G., and M. S.). Core support for the Wolfson Drug Discovery Unit was provided by the UK National Institute for Health Research Biomedical Research Centre and Unit Funding Scheme. The authors declare that they have no conflicts of interest with the contents of this article.	Aguzzit A, 2016, TRENDS CELL BIOL, V26, P40, DOI 10.1016/j.tcb.2015.08.007; Ami D, 2012, BIOPHYS J, V102, P1676, DOI 10.1016/j.bpj.2012.02.045; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Benson MD, 2012, AMYLOID, V19, P14, DOI 10.3109/13506129.2012.668501; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Cox B, 2003, GENETICS, V165, P23; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Fabian H., 2012, MILLISECOND TO MINUT; Fabian H, 2013, BIOPHYS CHEM, V179, P35, DOI 10.1016/j.bpc.2013.05.001; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Haris PI, 2013, BBA-BIOMEMBRANES, V1828, P2265, DOI 10.1016/j.bbamem.2013.04.008; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; Mangione PP, 2014, P NATL ACAD SCI USA, V111, P1539, DOI 10.1073/pnas.1317488111; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Natalello A., 2015, INSOLUBLE PROTEINS; Natalello A, 2008, J MOL BIOL, V381, P1349, DOI 10.1016/j.jmb.2008.06.063; Natalello A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122449; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Piazza R, 2006, EUR BIOPHYS J BIOPHY, V35, P439, DOI 10.1007/s00249-006-0051-0; Regini JW, 2010, MOL VIS, V16, P2446; Richards DB, 2015, NEW ENGL J MED, V373, P1106, DOI 10.1056/NEJMoa1504942; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sarell CJ, 2013, J BIOL CHEM, V288, P7327, DOI 10.1074/jbc.M112.447524; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Seshadri S, 1999, METHOD ENZYMOL, V309, P559; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Stoppini M, 2015, J BIOL CHEM, V290, P9951, DOI 10.1074/jbc.R115.639799; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030	43	22	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9678	9689		10.1074/jbc.M116.720573	http://dx.doi.org/10.1074/jbc.M116.720573			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26921323	hybrid, Green Published			2022-12-28	WOS:000375602300026
J	Chevalier, C; Le Goffic, R; Jamme, F; Leymarie, O; Refregiers, M; Delmas, B				Chevalier, Christophe; Le Goffic, Ronan; Jamme, Frederic; Leymarie, Olivier; Refregiers, Matthieu; Delmas, Bernard			Synchrotron Infrared and Deep UV Fluorescent Microspectroscopy Study of PB1-F2 beta-Aggregated Structures in Influenza A Virus-infected Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROCHEMICAL DETECTION; FTIR-MICROSPECTROSCOPY; ESCHERICHIA-COLI; AMYLOID FIBRILS; PB1F2 PROTEIN; MEMBRANE; SEQUENCE; TISSUE; OLIGOMERIZATION; PATHOGENICITY	PB1-F2 is a virulence factor of influenza A virus (IAV) whose functions remain misunderstood. The different roles of PB1-F2 may be linked to its structural polymorphism and to its propensity to assemble into oligomers and amyloid fibers in the vicinity of the membrane of IAV-infected cells. Here, we monitored the impact of PB1-F2 on the biochemical composition and protein structures of human epithelial pulmonary cells (A549) and monocytic cells (U937) upon IAV infection using synchrotron Fourier-transform infrared (FTIR) and deep UV (DUV) microscopies at the single-cell level. Cells were infected with a wildtype IAV and its PB1-F2 knock-out mutant for analyses at different times post-infection. IR spectra were recorded in each condition and processed to evaluate the change in the component band of the spectra corresponding to the amide I (secondary structure) and the CH stretching region (membrane). The IR spectra analysis revealed that expression of PB1-F2 in U937 cells, but not in A549 cells, results in the presence of a specific beta-aggregate signature. Furthermore, the lipid membrane composition of U937 cells expressing PB1-F2 was also altered in a cell type-dependent manner. Using DUV microscopy and taking advantage of the high content of tryptophan residues in the sequence of PB1-F2 (5/90 aa), we showed that the increase of the autofluorescent signal recorded in monocytic cells could be correlated with the IR detection of beta-aggregates. Altogether, our results constitute an important step forward in the understanding of the cell type-dependent function of PB1-F2.	[Chevalier, Christophe; Le Goffic, Ronan; Leymarie, Olivier; Delmas, Bernard] Univ PARIS SACLAY, INRA, UR892, VIM, F-78350 Jouy En Josas, France; [Jamme, Frederic; Refregiers, Matthieu] Synchrotron SOLEIL, DISCO & SMIS Beamlines, F-91190 Gif Sur Yvette, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Chevalier, C (corresponding author), Univ PARIS SACLAY, INRA, VIM, Equipe Virus Influenza, F-78350 Jouy En Josas, France.	christophe.chevalier@jouy.inra.fr	Réfrégiers, Matthieu/A-4249-2011; LE GOFFIC, Ronan/B-7649-2008; Réfrégiers, Matthieu/AAE-2075-2022; Chevalier, Christophe/C-2575-2009; JAMME, Frederic/E-2170-2011; Chevalier, Christophe/AAW-5560-2020; LE GOFFIC, Ronan/M-3099-2019; Chevalier, Christophe/AAK-4461-2020	Réfrégiers, Matthieu/0000-0002-3281-2308; LE GOFFIC, Ronan/0000-0002-2012-0064; Chevalier, Christophe/0000-0003-3231-9027; JAMME, Frederic/0000-0002-7398-7868; LE GOFFIC, Ronan/0000-0002-2012-0064; Leymarie, Olivier/0000-0001-8670-3089	Synchrotron SOLEIL; SMIS; DISCO [20110735, 20120904]	Synchrotron SOLEIL; SMIS; DISCO	This work was supported in part by Synchrotron SOLEIL, SMIS, and DISCO beamlines proposals 20110735 and 20120904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study. The authors declare that they have no conflicts of interest with the content of this article.	Alymova IV, 2014, J VIROL, V88, P503, DOI 10.1128/JVI.01373-13; Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Arrondo JLR, 1998, CHEM PHYS LIPIDS, V96, P53, DOI 10.1016/S0009-3084(98)00080-2; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Batard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019440; Blankenberg FG, 1997, BLOOD, V89, P3778, DOI 10.1182/blood.V89.10.3778.3778_3778_3786; Bruns K, 2007, J BIOL CHEM, V282, P353, DOI 10.1074/jbc.M606494200; Bucciantini M, 2012, FASEB J, V26, P818, DOI 10.1096/fj.11-189381; Bucciantini M, 2010, METHODS MOL BIOL, V648, P231, DOI 10.1007/978-1-60761-756-3_15; Chakrabarti AK, 2013, VIROLOGY, V440, P97, DOI 10.1016/j.virol.2013.02.025; Chan FTS, 2013, ANALYST, V138, P2156, DOI 10.1039/c3an36798c; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chevalier C, 2010, J BIOL CHEM, V285, P13233, DOI 10.1074/jbc.M109.067710; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Goormaghtigh E, 2006, BIOPHYS J, V90, P2946, DOI 10.1529/biophysj.105.072017; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; Hastings G, 2009, ANALYST, V134, P1462, DOI 10.1039/b902154j; Hiramatsu H, 2005, BBA-PROTEINS PROTEOM, V1753, P100, DOI 10.1016/j.bbapap.2005.07.008; Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837; Jamme F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074421; Jamme F, 2013, BIOL CELL, V105, P277, DOI 10.1111/boc.201200075; Jamme F, 2010, MICROSC MICROANAL, V16, P507, DOI 10.1017/S1431927610093852; Kawaoka Y., 2006, INFLUENZA VIROLOGY C; Kretlow A, 2006, BBA-BIOMEMBRANES, V1758, P948, DOI 10.1016/j.bbamem.2006.05.026; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Leymarie O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100679; Leymarie O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057894; Loffhagen N, 2007, ENG LIFE SCI, V7, P67, DOI 10.1002/elsc.200620168; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; Miller LM, 2010, CURR OPIN STRUC BIOL, V20, P649, DOI 10.1016/j.sbi.2010.07.007; Miodek A, 2014, ANAL CHEM, V86, P9098, DOI 10.1021/ac5018056; Miodek A, 2014, BIOSENS BIOELECTRON, V59, P6, DOI 10.1016/j.bios.2014.02.037; Moen B, 2009, CAN J MICROBIOL, V55, P714, DOI [10.1139/W09-016, 10.1139/w09-016]; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Pasricha G, 2013, INFLUENZA OTHER RESP, V7, P497, DOI 10.1111/j.1750-2659.2012.00400.x; Penicaud C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111138; Perisic N, 2011, J AGR FOOD CHEM, V59, P10052, DOI 10.1021/jf201578b; Rak M, 2007, BIOPOLYMERS, V87, P207, DOI 10.1002/bip.20820; Romeo M, 2006, BBA-BIOMEMBRANES, V1758, P915, DOI 10.1016/j.bbamem.2006.05.010; Saulou C, 2013, ANAL BIOANAL CHEM, V405, P2685, DOI 10.1007/s00216-013-6725-4; Schmolke M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002186; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrauwen EJA, 2014, EUR J CLIN MICROBIOL, V33, P479, DOI 10.1007/s10096-013-1984-8; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; Trifonov V., 2009, PLOS CURR, V1, P1006; Vidic J., 2013, J ANAL BIOANAL TECH, V4, P169; Vidic J, 2016, J BIOL CHEM, V291, P739, DOI 10.1074/jbc.M115.652917; VidicJ Chevalier C., 2013, J JOURNALOF ANALYTIC, VS7, P6; WHO, 2014, GLOB INFL SURV RESP; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Wood BR, 2008, ANAL CHEM, V80, P9065, DOI 10.1021/ac8015483; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	63	10	10	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9060	9072		10.1074/jbc.M115.710533	http://dx.doi.org/10.1074/jbc.M115.710533			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26896002	Green Published, hybrid			2022-12-28	WOS:000374849000020
J	Baek, JI; Kwon, SH; Zuo, XF; Choi, SY; Kim, SH; Lipschutz, JH				Baek, Jeong-In; Kwon, Sang-Ho; Zuo, Xiaofeng; Choi, Soo Young; Kim, Seok-Hyung; Lipschutz, Joshua H.			Dynamin Binding Protein (Tuba) Deficiency Inhibits Ciliogenesis and Nephrogenesis in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDC42; cilia; guanine nucleotide exchange factor (GEF); kidney; membrane trafficking	NUCLEOTIDE EXCHANGE FACTORS; CDC42 GEF; PRIMARY CILIUM; ZEBRAFISH PRONEPHROS; EXTRACELLULAR-MATRIX; EPITHELIAL POLARITY; SPINDLE ORIENTATION; KUPFFERS VESICLE; LINKS DYNAMIN; WILD-TYPE	Dysfunction of renal primary cilia leads to polycystic kidney disease. We previously showed that the exocyst, a protein trafficking complex, is essential for ciliogenesis and regulated by multiple Rho and Rab family GTPases, such as Cdc42. Cdc42 deficiency resulted in a disruption of renal ciliogenesis and a polycystic kidney disease phenotype in zebrafish and mice. Here we investigate the role of Dynamin binding protein (also known as Tuba), a Cdc42-specific guanine nucleotide exchange factor, in ciliogenesis and nephrogenesis using Tuba knockdown Madin-Darby canine kidney cells and tuba knockdown in zebrafish. Tuba depletion resulted in an absence of cilia, with impaired apical polarization and inhibition of hepatocyte growth factor-induced tubulogenesis in Tuba knockdown Madin-Darby canine kidney cell cysts cultured in a collagen gel. In zebrafish, tuba was expressed in multiple ciliated organs, and, accordingly, tuba start and splice site morphants showed various ciliary mutant phenotypes in these organs. Co-injection of tuba and cdc42 morpholinos at low doses, which alone had no effect, resulted in genetic synergy and led to abnormal kidney development with highly disorganized pronephric duct cilia. Morpholinos targeting two other guanine nucleotide exchange factors not known to be in the Cdc42/ciliogenesis pathway and a scrambled control morpholino showed no phenotypic effect. Given the molecular nature of Cdc42 and Tuba, our data strongly suggest that tuba and cdc42 act in the same ciliogenesis pathway. Our study demonstrates that Tuba deficiency causes an abnormal renal ciliary and morphogenetic phenotype. Tuba most likely plays a critical role in ciliogenesis and nephrogenesis by regulating Cdc42 activity.	[Baek, Jeong-In; Kwon, Sang-Ho; Zuo, Xiaofeng; Choi, Soo Young; Kim, Seok-Hyung; Lipschutz, Joshua H.] Med Univ S Carolina, Dept Med, Clin Sci Bldg 829,96 Jonathan Lucas St, Charleston, SC 29425 USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC 29401 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Lipschutz, JH (corresponding author), Med Univ S Carolina, Dept Med, Clin Sci Bldg 829,96 Jonathan Lucas St, Charleston, SC 29425 USA.	Lipschut@musc.edu		Kwon, Sang-Ho/0000-0001-9074-4641	Department of Veterans Affairs Merit Award [2I01BX000820]; National Institutes of Health [2P30DK074038]; PKD Foundation fellowship award; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000820] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PKD Foundation fellowship award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by Department of Veterans Affairs Merit Award 2I01BX000820 (to J. H. L.), National Institutes of Health Grant 2P30DK074038 (to J. H. L.), and a PKD Foundation fellowship award (to J. I. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bao Q, 1999, GLYCOBIOLOGY, V9, P489, DOI 10.1093/glycob/9.5.489; BAO Q, 1995, J CELL SCI, V108, P2791; Baschieri F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5839; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Cestra G, 2005, METHOD ENZYMOL, V404, P537, DOI 10.1016/S0076-6879(05)04047-4; Cheng HY, 2005, J AM SOC NEPHROL, V16, P1612, DOI 10.1681/ASN.2004121145; Choi SY, 2013, J AM SOC NEPHROL, V24, P1435, DOI 10.1681/ASN.2012121236; Clement A, 2011, DEVELOPMENT, V138, P291, DOI 10.1242/dev.055038; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; Genot E, 2012, J CELL SCI, V125, P3265, DOI 10.1242/jcs.093419; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gudjonsson T, 2002, J CELL SCI, V115, P39; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Hauptmann G, 2000, METH MOL B, V137, P139; Hou P, 2003, HUM MOL GENET, V12, P1981, DOI 10.1093/hmg/ddg209; Jaffe KM, 2010, METHOD CELL BIOL, V97, P415, DOI 10.1016/S0091-679X(10)97022-2; Jurisch-Yaksi N, 2013, J CELL BIOL, V200, P709, DOI 10.1083/jcb.201208175; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kovacs EM, 2006, J CELL SCI, V119, P2715, DOI 10.1242/jcs.03005; Kovacs EM, 2011, CELL ADHES MIGR, V5, P344, DOI 10.4161/cam.5.4.16717; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Liu JL, 2012, PROTOPLASMA, V249, P587, DOI 10.1007/s00709-011-0330-1; Lu Q, 2015, NAT CELL BIOL, V17, P228, DOI 10.1038/ncb3109; Mao ZG, 2011, AM J PHYSIOL-RENAL, V300, pF1375, DOI 10.1152/ajprenal.00482.2010; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Nakanishi H, 2008, J CELL MOL MED, V12, P1169, DOI 10.1111/j.1582-4934.2008.00345.x; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pennekamp Petra, 2015, Cilia, V4, P1, DOI 10.1186/s13630-014-0010-9; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; Pruliere G, 2011, MOL BIOL CELL, V22, P2042, DOI 10.1091/mbc.E10-10-0844; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Raeker MO, 2010, DEV BIOL, V337, P432, DOI 10.1016/j.ydbio.2009.11.018; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Rogers KK, 2003, KIDNEY INT, V63, P1632, DOI 10.1046/j.1523-1755.2003.00902.x; Sakurai H, 1998, KIDNEY INT, V54, P14, DOI 10.1046/j.1523-1755.1998.00969.x; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; SANTOS OFP, 1993, DEV BIOL, V160, P293, DOI 10.1006/dbio.1993.1308; SATO S, 1993, EXP CELL RES, V207, P8, DOI 10.1006/excr.1993.1157; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tobin JL, 2008, PEDIATR NEPHROL, V23, P2095, DOI 10.1007/s00467-008-0898-7; Wakayama Y, 2015, DEV CELL, V32, P109, DOI 10.1016/j.devcel.2014.11.024; Wessely O, 2008, FRONT BIOSCI-LANDMRK, V13, P1866, DOI 10.2741/2806; Wingert RA, 2008, KIDNEY INT, V73, P1120, DOI 10.1038/ki.2008.37; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2008, EMBO REP, V9, P923, DOI 10.1038/embor.2008.135; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zhao CT, 2012, P NATL ACAD SCI USA, V109, P2388, DOI 10.1073/pnas.1116035109; Zuo XF, 2011, J BIOL CHEM, V286, P22469, DOI 10.1074/jbc.M111.238469; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	74	12	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8632	8643		10.1074/jbc.M115.688663	http://dx.doi.org/10.1074/jbc.M115.688663			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26895965	Green Published, hybrid			2022-12-28	WOS:000374773200026
J	Van Calsteren, MR; Goyette-Desjardins, G; Gagnon, F; Okura, M; Takamatsu, D; Roy, R; Gottschalk, M; Segura, M				Van Calsteren, Marie-Rose; Goyette-Desjardins, Guillaume; Gagnon, Fleur; Okura, Masatoshi; Takamatsu, Daisuke; Roy, Rene; Gottschalk, Marcelo; Segura, Mariela			Explaining the Serological Characteristics of Streptococcus suis Serotypes 1 and 1/2 from Their Capsular Polysaccharide Structure and Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate structure; chemical biology; immunochemistry; polysaccharide; sialic acid; Streptococcus	GROUP-B STREPTOCOCCUS; SIALIC-ACID; VIRULENCE FACTOR; GENETIC-ANALYSIS; CELLS; NMR; EXPRESSION; SEQUENCE; LOCUS	The capsular polysaccharide (CPS) is a major virulence factor in many encapsulated pathogens, as it is the case for Streptococcus suis, an important swine pathogen and emerging zoonotic agent. Moreover, the CPS is the antigen at the origin of S. suis classification into serotypes. Hence, analyses of the CPS structure are an essential step to dissect its role in virulence and the serological relations between important serotypes. Here, the CPSs of serotypes 1 and 1/2 were purified and characterized for the first time. Chemical and spectroscopic data gave the following repeating unit sequences: [6)[Neu5Ac(alpha 2-6)GalNAc(beta 1-4)GlcNAc(beta 1-3)]Gal(beta 1-3)Gal(beta 1-4)Glc(beta 1-](n) (serotype 1) and [4)[Neu5Ac(alpha 2-6)GalNAc(beta 1-4)GlcNAc(beta 1-3)]Gal(beta 1-4)[Gal(alpha 1-3)]Rha(beta 1-4)Glc(beta 1-](n) (serotype 1/2). The Sambucus nigra lectin, which recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence, showed binding to both CPSs. Compared with previously characterized serotype 14 and 2 CPSs, N-acetylgalactosamine replaces galactose as the sugar bearing the sialic acid residue in the side chain. Serological analyses of the cross-reaction of serotype 1/2 with serotypes 1 and 2 and that between serotypes 1 and 14 suggested that the side chain, and more particularly the terminal sialic acid, constitutes one important epitope for serotypes 1/2 and 2. The side chain is also an important serological determinant for serotype 1, yet sialic acid seems to play a limited role. In contrast, the side chain does not seem to be part of a major epitope for serotype 14. These results contribute to the understanding of the relationship between S. suis serotypes and provide the basis for improving diagnostic tools.	[Van Calsteren, Marie-Rose; Gagnon, Fleur] Agr & Agri Food Canada, Food Res & Dev Ctr, St Hyacinthe, PQ J2S 8E3, Canada; [Van Calsteren, Marie-Rose; Goyette-Desjardins, Guillaume; Gottschalk, Marcelo; Segura, Mariela] Univ Montreal, Fac Vet Med, Swine & Poultry Infect Dis Res Ctr, St Hyacinthe, PQ J2S 2M2, Canada; [Goyette-Desjardins, Guillaume; Gottschalk, Marcelo; Segura, Mariela] Univ Montreal, Fac Vet Med, Res Grp Infect Dis Swine, St Hyacinthe, PQ J2S 2M2, Canada; [Okura, Masatoshi; Takamatsu, Daisuke] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki 3050856, Japan; [Takamatsu, Daisuke] Gifu Univ, United Grad Sch Vet Sci, Gifu, Gifu 5011193, Japan; [Roy, Rene] Univ Quebec, Dept Chem, Montreal, PQ H3C 3P8, Canada	Agriculture & Agri Food Canada; Universite de Montreal; Universite de Montreal; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Gifu University; University of Quebec; University of Quebec Montreal	Segura, M (corresponding author), Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 2M2, Canada.	mariela.segura@umontreal.ca	Segura, Mariela/AAG-5708-2020; Gottschalk, Marcelo/I-8116-2012; Goyette-Desjardins, Guillaume/I-1881-2019	Goyette-Desjardins, Guillaume/0000-0001-7158-9594	Natural Sciences and Engineering Research Council of Canada (NSERC) [342150]; NSERC fellowship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant 342150 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an NSERC fellowship.	Berti F, 2014, J BIOL CHEM, V289, P23437, DOI 10.1074/jbc.M114.567974; Calzas C, 2013, INFECT IMMUN, V81, P3106, DOI 10.1128/IAI.00113-13; Carpita N. C., 1989, ANAL CARBOHYDRATES G, P157; Chang YC, 2014, GLYCOBIOLOGY, V24, P818, DOI 10.1093/glycob/cwu067; CHARLAND N, 1995, J CLIN MICROBIOL, V33, P2220, DOI 10.1128/JCM.33.8.2220-2221.1995; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; ELLIOTT SD, 1978, J EXP MED, V148, P1699, DOI 10.1084/jem.148.6.1699; GOTTSCHALK M, 1989, J CLIN MICROBIOL, V27, P2633, DOI 10.1128/JCM.27.12.2633-2636.1989; GOTTSCHALK M, 1991, J CLIN MICROBIOL, V29, P2590, DOI 10.1128/JCM.29.11.2590-2594.1991; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; HIGGINS R, 1995, J VET DIAGN INVEST, V7, P405, DOI 10.1177/104063879500700322; Higgins R, 1990, J Vet Diagn Invest, V2, P249; HOUGH L, 1972, CARBOHYD RES, V21, P9, DOI 10.1016/S0008-6215(00)81725-5; Lecours MP, 2012, MICROBES INFECT, V14, P941, DOI 10.1016/j.micinf.2012.03.008; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; MACHYTKA D, 1994, CARBOHYD RES, V254, P289, DOI 10.1016/0008-6215(94)84262-0; Okura M, 2013, APPL ENVIRON MICROB, V79, P2796, DOI 10.1128/AEM.03742-12; PERCH B, 1981, ACTA PATH MICRO IM B, V89, P167; PERCH B, 1983, J CLIN MICROBIOL, V17, P993, DOI 10.1128/JCM.17.6.993-996.1983; Roy D, 2015, CAN J VET RES, V79, P141; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segura M, 2002, INFECT IMMUN, V70, P4312, DOI 10.1128/IAI.70.8.4312-4322.2002; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Smith HE, 1999, INFECT IMMUN, V67, P1750; Van Calsteren MR, 2013, BIOCHEM CELL BIOL, V91, P49, DOI 10.1139/bcb-2012-0036; Van Calsteren MR, 2010, BIOCHEM CELL BIOL, V88, P513, DOI [10.1139/O09-170, 10.1139/o09-170]; Wang KC, 2011, FEMS MICROBIOL LETT, V324, P117, DOI 10.1111/j.1574-6968.2011.02394.x; Wang YC, 2013, INFECT IMMUN, V81, P4498, DOI 10.1128/IAI.00818-13; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu NH, 2015, J GEN VIROL, V96, P2557, DOI 10.1099/jgv.0.000223; ZHU G, 1992, J MAGN RESON, V100, P202, DOI 10.1016/0022-2364(92)90379-L	32	21	21	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8387	8398		10.1074/jbc.M115.700716	http://dx.doi.org/10.1074/jbc.M115.700716			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26912653	Green Published, hybrid			2022-12-28	WOS:000374773200007
J	Zhang, YH; Chen, SR; Laumet, G; Chen, H; Pan, HL				Zhang, Yuhao; Chen, Shao-Rui; Laumet, Geoffroy; Chen, Hong; Pan, Hui-Lin			Nerve Injury Diminishes Opioid Analgesia through Lysine Methyltransferase-mediated Transcriptional Repression of mu-Opioid Receptors in Primary Sensory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHINE-INDUCED ANALGESIA; ROOT GANGLION NEURONS; NEUROPATHIC PAIN; SPINAL-CORD; HISTONE METHYLATION; SUBSTANTIA-GELATINOSA; IDIOPATHIC FORMS; G9A; GENE; CHROMATIN	The mu-opioid receptor (MOR, encoded by Oprm1) agonists are the mainstay analgesics for treating moderate to severe pain. Nerve injury causes down-regulation of MORs in the dorsal root ganglion (DRG) and diminishes the opioid effect on neuropathic pain. However, the epigenetic mechanisms underlying the diminished MOR expression caused by nerve injury are not clear. G9a (encoded by Ehmt2), a histone 3 at lysine 9 methyltransferase, is a key chromatin regulator responsible for gene silencing. In this study, we determined the role of G9a in diminished MOR expression and opioid analgesic effects in animal models of neuropathic pain. We found that nerve injury in rats induced a long-lasting reduction in the expression level of MORs in the DRG but not in the spinal cord. Nerve injury consistently increased the enrichment of the G9a product histone 3 at lysine 9 dimethylation in the promoter of Oprm1 in the DRG. G9a inhibition or siRNA knockdown fully reversed MOR expression in the injured DRG and potentiated the morphine effect on pain hypersensitivity induced by nerve injury. In mice lacking Ehmt2 in DRG neurons, nerve injury failed to reduce the expression level of MORs and the morphine effect. In addition, G9a inhibition or Ehmt2 knockout in DRG neurons normalized nerve injury-induced reduction in the inhibitory effect of the opioid on synaptic glutamate release from primary afferent nerves. Our findings indicate that G9a contributes critically to transcriptional repression of MORs in primary sensory neurons in neuropathic pain. G9a inhibitors may be used to enhance the opioid analgesic effect in the treatment of chronic neuropathic pain.	[Zhang, Yuhao; Chen, Shao-Rui; Laumet, Geoffroy; Chen, Hong; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Houston, TX 77030 USA.; Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Zhang, Yuhao/HHN-6356-2022; Laumet, Geoffroy/O-7480-2019	Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [DE022015, NS073935]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (DE022015 and NS073935) and by the N. G. and Helen T. Hawkins Endowment (to H. L. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARNER S, 1988, PAIN, V33, P11, DOI 10.1016/0304-3959(88)90198-4; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen SR, 2014, J PHARMACOL EXP THER, V350, P301, DOI 10.1124/jpet.114.215855; Chen SR, 2009, J NEUROCHEM, V110, P352, DOI 10.1111/j.1471-4159.2009.06138.x; Chen SR, 2006, BRAIN RES, V1081, P119, DOI 10.1016/j.brainres.2006.01.053; Chen SR, 2006, J NEUROPHYSIOL, V95, P3086, DOI 10.1152/jn.01343.2005; Chen SR, 2002, J NEUROPHYSIOL, V87, P2726, DOI 10.1152/jn.2002.87.6.2726; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jose CC, 2014, P NATL ACAD SCI USA, V111, P14631, DOI 10.1073/pnas.1406923111; Kohno T, 1999, J PHYSIOL-LONDON, V518, P803, DOI 10.1111/j.1469-7793.1999.0803p.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KUPERS RC, 1991, PAIN, V47, P5, DOI 10.1016/0304-3959(91)90004-H; Laedermann CJ, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-19; Laumet G, 2015, NAT NEUROSCI, V18, P1746, DOI 10.1038/nn.4165; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mozzetta C, 2014, MOL CELL, V53, P277, DOI 10.1016/j.molcel.2013.12.005; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; OSSIPOV MH, 1995, NEUROSCI LETT, V199, P87, DOI 10.1016/0304-3940(95)12022-V; Pan HL, 2003, J NEUROSCI, V23, P2911; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Rashid MH, 2004, J PHARMACOL EXP THER, V309, P380, DOI 10.1124/jpet.103.060582; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Ringel AE, 2015, P NATL ACAD SCI USA, V112, pE5461, DOI 10.1073/pnas.1508449112; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sanna MD, 2015, PAIN, V156, P1265, DOI 10.1097/j.pain.0000000000000164; Santos SFA, 2007, J PHYSIOL-LONDON, V581, P241, DOI 10.1113/jphysiol.2006.126912; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Uchida H, 2015, J PHARMACOL SCI, V128, P208, DOI 10.1016/j.jphs.2015.07.040; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Wu ZZ, 2004, J PHARMACOL EXP THER, V311, P939, DOI 10.1124/jpet.104.073429; Zhang X, 1998, NEUROSCIENCE, V82, P223; Zhang YH, 2015, J BIOL CHEM, V290, P14647, DOI 10.1074/jbc.M115.650218; Zhao YL, 2012, J BIOL CHEM, V287, P25073, DOI 10.1074/jbc.M112.378737; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; Zhou XL, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-51	49	36	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8475	8485		10.1074/jbc.M115.711812	http://dx.doi.org/10.1074/jbc.M115.711812			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26917724	Green Published, hybrid			2022-12-28	WOS:000374773200014
J	Badu-Nkansah, A; Mason, AC; Eichman, BF; Cortez, D				Badu-Nkansah, Akosua; Mason, Aaron C.; Eichman, Brandt F.; Cortez, David			Identification of a Substrate Recognition Domain in the Replication Stress Response Protein Zinc Finger Ran-binding Domain-containing Protein 3 (ZRANB3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; DNA-binding protein; DNA damage response; DNA repair; DNA replication; endonuclease; protein domain	SCHIMKE IMMUNOOSSEOUS DYSPLASIA; ANNEALING HELICASE; FORK REVERSAL; HUMAN HLTF; DNA; REPAIR; TRANSLOCASE; MUTATION; RESTART; CANCER	DNA damage and other forms of replication stress can cause replication forks to stall. Replication stress response proteins stabilize and resolve stalled forks by mechanisms that include fork remodeling to facilitate repair or bypass of damaged templates. Several enzymes including SMARCAL1, HLTF, and ZRANB3 catalyze these reactions. SMARCAL1 and HLTF utilize structurally distinct accessory domains attached to an ATPase motor domain to facilitate DNA binding and catalysis of fork remodeling reactions. Here we describe a substrate recognition domain within ZRANB3 that is needed for it to recognize forked DNA structures, hydrolyze ATP, catalyze fork remodeling, and act as a structure-specific endonuclease. Thus, substrate recognition domains are a common feature of fork remodeling, SNF2-family, DNA-dependent ATPases, and our study provides further mechanistic understanding of how these enzymes maintain genome integrity during DNA replication.	[Badu-Nkansah, Akosua; Eichman, Brandt F.; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Mason, Aaron C.; Eichman, Brandt F.] Vanderbilt Univ, Coll Arts & Sci, Dept Biol Sci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [R01CA102729-11A1S1, R01CA160432, P01CA092584];  [3R01CA102729]; NATIONAL CANCER INSTITUTE [R01CA160432, T32CA009582, R01CA102729, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116616, R01GM117299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01CA102729-11A1S1, R01CA160432, and P01CA092584 (to D. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a diversity supplement grant 3R01CA102729.	Achar YJ, 2015, NUCLEIC ACIDS RES, V43, P10277, DOI 10.1093/nar/gkv896; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Baradaran-Heravi A, 2012, AM J MED GENET A, V158A, P2204, DOI 10.1002/ajmg.a.35532; Betous R, 2013, CELL REP, V3, P1958, DOI 10.1016/j.celrep.2013.05.002; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Bhat KP, 2015, J BIOL CHEM, V290, P4110, DOI 10.1074/jbc.M114.627083; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Carroll C, 2015, AM J MED GENET A, V167, P2260, DOI 10.1002/ajmg.a.37146; Carroll C, 2013, PEDIATR BLOOD CANCER, V60, pE88, DOI 10.1002/pbc.24542; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Hishiki A, 2015, J BIOL CHEM, V290, P13215, DOI 10.1074/jbc.M115.643643; Kile AC, 2015, MOL CELL, V58, P1090, DOI 10.1016/j.molcel.2015.05.013; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Mason AC, 2014, P NATL ACAD SCI USA, V111, P7618, DOI 10.1073/pnas.1324143111; Moinova HR, 2002, P NATL ACAD SCI USA, V99, P4562, DOI 10.1073/pnas.062459899; Neelsen KJ, 2015, NAT REV MOL CELL BIO, V16, P207, DOI 10.1038/nrm3935; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Porollo AA, 2004, BIOINFORMATICS, V20, P2460, DOI 10.1093/bioinformatics/bth248; Postow L, 2009, J BIOL CHEM, V284, P35951, DOI 10.1074/jbc.M109.048330; Weston R, 2012, GENE DEV, V26, P1558, DOI 10.1101/gad.193516.112; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Yusufzai T, 2010, P NATL ACAD SCI USA, V107, P20970, DOI 10.1073/pnas.1011196107; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	31	16	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8251	8257		10.1074/jbc.M115.709733	http://dx.doi.org/10.1074/jbc.M115.709733			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26884333	hybrid, Green Published			2022-12-28	WOS:000374056700040
J	Bettoni, S; Bresin, E; Remuzzi, G; Noris, M; Donadelli, R				Bettoni, Serena; Bresin, Elena; Remuzzi, Giuseppe; Noris, Marina; Donadelli, Roberta			Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						complement; convertase; magnesium; manganese; Western blot; alternative pathway complement system; C3 convertase; C3 nephritic factor; C3 proconvertase; factor H	FACTOR-B; PROVIDES INSIGHTS; STRUCTURAL BASIS; BOUND C3B; BINDING; ECULIZUMAB; BETA-1H; IMMUNOLOGY; ACTIVATION; PROPERDIN	The activated fragment of C3 (C3b) and factor B form the C3 proconvertase (C3bB), which is cleaved by factor D to C3 convertase (C3bBb). Older studies (Conrad, D. H., Carlo, J. R., and Ruddy, S. (1978) J. Exp. Med. 147, 1792-1805; Pangburn, M. K., and Muller-Eberhard, H. J. (1978) Proc. Natl. Acad. Sci. U.S.A. 75, 2416-2420; Kazatchkine, M. D., Fearon, D. T., and Austen, K. F. (1979) J. Immunol. 122, 75-81) indicated that the complement alternative pathway regulator factor H (FH) competes with factor B for C3b binding; however, the capability of FH to prevent C3bB assembly has not been formally investigated. Moreover, in the few published studies FH did not favor C3bB dissociation. Whether FH may affect C3bBb formation from C3bB is unknown. We set up user-friendly assays based on combined microplate/Western blotting techniques that specifically detect either C3bB or C3bBb, with the aim of investigating the effect of FH on C3bB assembly and decay and C3bBb formation and decay. We document that FH does not affect C3bB assembly, indicating that FH does not efficiently compete with factor B for C3b binding. We also found that FH does not dissociate C3bB. FH showed a strong C3bBb decay-accelerating activity, as reported previously, and also exerted an apparent inhibitory effect on C3bBb formation. The latter effect was not fully attributable to a rapid FH-mediated dissociation of C3bBb complexes, because blocking decay with properdin and C3 nephritic factor did not restore C3bBb formation. FH almost completely prevented release of the smaller cleavage subunit of FB (Ba), without modifying the amount of C3bB complexes, suggesting that FH inhibits the conversion of C3bB to C3bBb. Thus, the inhibitory effect of FH on C3bBb formation is likely the sum of inhibition of C3bB conversion to C3bBb and of C3bBb decay acceleration. Further studies are required to confirm these findings in physiological cell-based settings.	[Bettoni, Serena; Bresin, Elena; Remuzzi, Giuseppe; Noris, Marina; Donadelli, Roberta] IRCCS Ist Ric Farmacol Mario Negri, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24020 Bergamo, Italy; [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Unit Nephrol & Dialysis, I-24127 Bergamo, Italy; [Remuzzi, Giuseppe] Univ Milan, Dept Biomed & Clin Sci, I-20157 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII; University of Milan	Noris, M (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Clin Res Ctr Rare Dis, Villa Camozzi 3, I-24020 Ranica, BG, Italy.	marina.noris@marionegri.it	Donadelli, Roberta/ABG-8930-2020; Bresin, Elena/ABG-2409-2020; Remuzzi, Giuseppe/V-9766-2017	Bresin, Elena/0000-0003-4198-2891; Remuzzi, Giuseppe/0000-0002-6194-3446	European Union [305608]; Fondazione Aiuti per la Ricerca sulle Malattie Rare A.R.M.R. ONLUS (Bergamo, Italy)	European Union(European Commission); Fondazione Aiuti per la Ricerca sulle Malattie Rare A.R.M.R. ONLUS (Bergamo, Italy)	This work was supported in part by European Union Seventh Framework Programme FP7-EURenOmics Project Number 305608. Part of this work was presented at the 24th International Complement Workshop, October 10-15, 2012, Crete, Greece; at the 14th European Meeting on Complement in Human Disease, August 17-21, 2013, Jena, Germany; and at the 15th European Meeting on Complement in Human Disease, June 26-30, 2015, Uppsala, Sweden. M. N. received honoraria from Alexion Pharmaceuticals for giving lectures and participating in advisory boards. None of these activities has had any influence on the results or interpretation in this article. G. R. has consultancy agreements with the following: AbbVie; Alexion Pharmaceuticals; Bayer Healthcare; Reata Pharmaceuticals; Novartis Pharma; AstraZeneca; Otsuka Pharmaceutical Europe; and Concert Pharmaceuticals. No personal remuneration was accepted, and compensation is paid to his institution for research and educational activities. None of these activities have had any influence on the results or interpretation in this article.; Supported by Fondazione Aiuti per la Ricerca sulle Malattie Rare A.R.M.R. ONLUS (Bergamo, Italy).	Alcorlo M, 2013, P NATL ACAD SCI USA, V110, P13504, DOI 10.1073/pnas.1309618110; Blaum BS, 2015, NAT CHEM BIOL, V11, P77, DOI [10.1038/NCHEMBIO.1696, 10.1038/nchembio.1696]; Bomback AS, 2012, NAT REV NEPHROL, V8, P634, DOI 10.1038/nrneph.2012.213; CONRAD DH, 1978, J EXP MED, V147, P1792, DOI 10.1084/jem.147.6.1792; Daina E, 2012, NEW ENGL J MED, V366, P1161, DOI 10.1056/NEJMc1112273; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; FISHELSON Z, 1982, J IMMUNOL, V129, P2603; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; FREMEAUXBACCHI V, 1994, NEPHROL DIAL TRANSPL, V9, P811; Gruppo RA, 2009, NEW ENGL J MED, V360, P544, DOI 10.1056/NEJMc0809959; Harris CL, 2005, J BIOL CHEM, V280, P2569, DOI 10.1074/jbc.M410179200; HOURCADE DE, 1995, J BIOL CHEM, V270, P19716, DOI 10.1074/jbc.270.34.19716; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Hourcade DE, 2002, J BIOL CHEM, V277, P1107, DOI 10.1074/jbc.M109322200; Hourcade DE, 1999, IMMUNOPHARMACOLOGY, V42, P167, DOI 10.1016/S0162-3109(99)00005-3; Hourcade DE, 2011, J BIOL CHEM, V286, P35725, DOI 10.1074/jbc.M111.263418; Hui KM, 2006, BIOCHEM BIOPH RES CO, V344, P308, DOI 10.1016/j.bbrc.2006.03.101; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2009, EMBO J, V28, P2469, DOI 10.1038/emboj.2009.184; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jelezarova E, 2001, J IMMUNOL METHODS, V251, P45, DOI 10.1016/S0022-1759(01)00295-2; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; Jokiranta TS, 2001, INT IMMUNOPHARMACOL, V1, P495, DOI 10.1016/S1567-5769(00)00042-4; KAZATCHKINE MD, 1979, J IMMUNOL, V122, P75; Kouser L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00093; Lavigne KM, 2015, SCHIZOPHRENIA BULL, V41, P259, DOI 10.1093/schbul/sbu004; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Leslie M, 2012, SCIENCE, V337, P1034, DOI 10.1126/science.337.6098.1034; Makou E, 2013, BIOCHEMISTRY-US, V52, P3949, DOI 10.1021/bi4003452; McHarg S, 2015, MOL IMMUNOL, V67, P43, DOI 10.1016/j.molimm.2015.02.032; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; Mollnes TE, 2007, MOL IMMUNOL, V44, P3838, DOI 10.1016/j.molimm.2007.06.150; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Nester CM, 2013, CURR OPIN NEPHROL HY, V22, P231, DOI 10.1097/MNH.0b013e32835da24c; NILSSON UR, 1993, MOL IMMUNOL, V30, P211, DOI 10.1016/0161-5890(93)90050-L; Noris M, 2013, SEMIN NEPHROL, V33, P479, DOI 10.1016/j.semnephrol.2013.08.001; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Paixao-Cavalcante D, 2012, KIDNEY INT, V82, P1084, DOI 10.1038/ki.2012.250; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; de Cordoba S, 2011, BBA-MOL BASIS DIS, V1812, P12, DOI 10.1016/j.bbadis.2010.09.002; Roumenina LT, 2011, J IMMUNOL METHODS, V365, P8, DOI 10.1016/j.jim.2010.12.020; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Servais A, 2012, KIDNEY INT, V82, P454, DOI 10.1038/ki.2012.63; Sethi S, 2012, KIDNEY INT, V82, P465, DOI 10.1038/ki.2012.212; Torreira E, 2009, J IMMUNOL, V183, P7347, DOI 10.4049/jimmunol.0902310; Torreira E, 2009, P NATL ACAD SCI USA, V106, P882, DOI 10.1073/pnas.0810860106; Tortajada A, 2009, HUM MOL GENET, V18, P3452, DOI 10.1093/hmg/ddp289; Vivarelli M, 2014, SEMIN THROMB HEMOST, V40, P472, DOI 10.1055/s-0034-1375299; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214	61	10	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8214	8230		10.1074/jbc.M115.693119	http://dx.doi.org/10.1074/jbc.M115.693119			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26903516	Green Published, hybrid			2022-12-28	WOS:000374056700037
J	Dohlman, HG				Dohlman, Henrik G.			Thematic Minireview Series: Complexities of Cellular Signaling Revealed by Simple Model Organisms*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						Caenorhabditis elegans (C; elegans); Drosophila; mitogen-activated protein kinase (MAPK); signal transduction; yeast		All cells discriminate environmental signals and generate appropriate intracellular responses. Our understanding of these signal transduction mechanisms has benefitted from studies across the kingdoms of life, from fungi and fish to mice and men. This thematic minireview series examines lessons learned from three of the simplest (and best understood) eukaryotic model organisms. The first article focuses on the mating pheromone pathway in budding yeast Saccharomyces cerevisiae. The second describes stress-mediated signaling in the roundworm Caenorhabditis elegans. The third outlines some of the signaling pathways that dictate growth and development in the fruit fly Drosophila melanogaster. Each system has provided unique insights into hormone and neurotransmitter signaling mechanisms, in particular those mediated by the MAPKs. The advances described in these articles will continue to improve our understanding of human physiology and pharmacology.	[Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hdohlman@asbmb.org		Dohlman, Henrik/0000-0003-2443-0729	NIGMS NIH HHS [R35 GM118105] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvaro CG, 2016, J BIOL CHEM, V291, P7788, DOI 10.1074/jbc.R116.714980; Andrusiak MG, 2016, J BIOL CHEM, V291, P7796, DOI 10.1074/jbc.R115.711101; Shilo BZ, 2016, J BIOL CHEM, V291, P7805, DOI 10.1074/jbc.R115.711473	3	2	2	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7786	7787		10.1074/jbc.R116.722934	http://dx.doi.org/10.1074/jbc.R116.722934			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26907688	Green Published, hybrid			2022-12-28	WOS:000374056700001
J	Nelp, MT; Song, Y; Wysocki, VH; Bandarian, V				Nelp, Micah T.; Song, Yang; Wysocki, Vicki H.; Bandarian, Vahe			A Protein-derived Oxygen Is the Source of the Amide Oxygen of Nitrile Hydratases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; enzyme catalysis; enzyme mechanism; metalloenzyme; post-translational modification (PTM); nitrile hydratase; protein chemical modification	SURFACE-INDUCED DISSOCIATION; NONHEME IRON; CATALYTIC MECHANISM; ACID LIGAND; CRYSTALLOGRAPHY; INTERMEDIATE; NUCLEOPHILE; SUBSTRATE; SUBUNIT; COMPLEX	Nitrile hydratase metalloenzymes are unique and important biocatalysts that are used industrially to produce high value amides from their corresponding nitriles. After more than three decades since their discovery, the mechanism of this class of enzymes is becoming clear with evidence from multiple recent studies that the cysteine-derived sulfenato ligand of the active site metal serves as the nucleophile that initially attacks the nitrile. Herein we describe the first direct evidence from solution phase catalysis that the source of the product carboxamido oxygen is the protein. Using O-18-labeled water under single turnover conditions and native high resolution protein mass spectrometry, we show that the incorporation of labeled oxygen into both product and protein is turnover-dependent and that only a single oxygen is exchanged into the protein even under multiple turnover conditions, lending significant support to proposals that the post-translationally modified sulfenato group serves as the nucleophile to initiate hydration of nitriles.	[Nelp, Micah T.; Bandarian, Vahe] Univ Utah, Dept Chem, 315 South 1400 East,TBBC 3627, Salt Lake City, UT 84112 USA; [Song, Yang; Wysocki, Vicki H.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	Utah System of Higher Education; University of Utah; University System of Ohio; Ohio State University	Bandarian, V (corresponding author), Univ Utah, Dept Chem, 315 South 1400 East,TBBC 3627, Salt Lake City, UT 84112 USA.	vahe@chem.utah.edu		Wysocki, Vicki/0000-0003-0495-2538	NIGMS of the National Institutes of Health [R01GM72623, R01GM113658]; Career Award in Biomedical Sciences from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113658, R01GM072623] Funding Source: NIH RePORTER	NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Career Award in Biomedical Sciences from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS of the National Institutes of Health Grants R01GM72623(to V. B.) and R01GM113658(to V. H. W.), and a Career Award in Biomedical Sciences from the Burroughs Wellcome Fund (to V. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADZAMLI IK, 1979, INORG CHEM, V18, P303, DOI 10.1021/ic50192a019; Arakawa T, 2009, J AM CHEM SOC, V131, P14838, DOI 10.1021/ja903979s; Blackwell AE, 2011, ANAL CHEM, V83, P2862, DOI 10.1021/ac200452b; Hashimoto K, 2008, J BIOL CHEM, V283, P36617, DOI 10.1074/jbc.M806577200; Heinrich L, 2001, EUR J INORG CHEM, P2203; Hopmann KH, 2014, INORG CHEM, V53, P2760, DOI 10.1021/ic500091k; JIN HY, 1993, J AM CHEM SOC, V115, P5290, DOI 10.1021/ja00065a048; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; Kovacs JA, 2004, CHEM REV, V104, P825, DOI 10.1021/cr020619e; Light KM, 2015, CHEM SCI, V6, P6280, DOI 10.1039/c5sc02012c; Lydon J. D., 1981, INORG CHEM, V21, P3180; Martinez S, 2014, J AM CHEM SOC, V136, P1186, DOI 10.1021/ja410462j; McCarty RM, 2008, CHEM BIOL, V15, P790, DOI 10.1016/j.chembiol.2008.07.012; Mitra S, 2007, J BIOL CHEM, V282, P7397, DOI 10.1074/jbc.M604117200; Miyanaga A, 2004, EUR J BIOCHEM, V271, P429, DOI 10.1046/j.1432-1033.2003.03943.x; Miyanaga A, 2001, BIOCHEM BIOPH RES CO, V288, P1169, DOI 10.1006/bbrc.2001.5897; NAGASAWA T, 1987, EUR J BIOCHEM, V162, P691, DOI 10.1111/j.1432-1033.1987.tb10692.x; Nagashima S, 1998, NAT STRUCT BIOL, V5, P347, DOI 10.1038/nsb0598-347; Nelp MT, 2014, BIOCHEMISTRY-US, V53, P3990, DOI 10.1021/bi500260j; Pereira RA, 1998, EXTREMOPHILES, V2, P347, DOI 10.1007/s007920050078; Piersma SR, 2000, J INORG BIOCHEM, V80, P283, DOI 10.1016/S0162-0134(00)00076-3; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Song Y, 2015, ACS CENTRAL SCI, V1, P477, DOI 10.1021/acscentsci.5b00251; SUGIURA Y, 1987, J AM CHEM SOC, V109, P5848, DOI 10.1021/ja00253a046; Takarada H, 2006, BIOSCI BIOTECH BIOCH, V70, P881, DOI 10.1271/bbb.70.881; Tsujimura M, 2003, J AM CHEM SOC, V125, P11532, DOI 10.1021/ja035018z; Yamanaka Y, 2015, ANGEW CHEM INT EDIT, V54, P10763, DOI 10.1002/anie.201502731	28	6	7	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7822	7829		10.1074/jbc.M115.704791	http://dx.doi.org/10.1074/jbc.M115.704791			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26865634	Green Published, hybrid			2022-12-28	WOS:000374056700006
J	Sun, XF; Deng, WB; Li, YJ; Tang, S; Leishman, E; Bradshaw, HB; Dey, SK				Sun, Xiaofei; Deng, Wenbo; Li, Yingju; Tang, Shuang; Leishman, Emma; Bradshaw, Heather B.; Dey, Sudhansu K.			Sustained Endocannabinoid Signaling Compromises Decidual Function and Promotes Inflammation-induced Preterm Birth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anandamide (N-arachidonoylethanolamine) (AEA); cannabinoid receptor type 1 (CB1); fatty acid metabolism; pregnancy; senescence	ONCOGENE-INDUCED SENESCENCE; ACID AMIDE HYDROLASE; CANNABINOID RECEPTOR; MOLECULAR CHARACTERIZATION; ANANDAMIDE; MICE; MOUSE; CB1; IMPLANTATION; ACTIVATION	Recent studies provide evidence that premature maternal decidual senescence resulting from heightened mTORC1 signaling is a cause of preterm birth (PTB). We show here that mice devoid of fatty acid amide hydrolase (FAAH) with elevated levels of N-arachidonyl ethanolamide (anandamide), a major endocannabinoid lipid mediator, were more susceptible to PTB upon lipopolysaccharide (LPS) challenge. Anandamide is degraded by FAAH and primarily works by activating two G-protein-coupled receptors CB1 and CB2, encoded by Cnr1 and Cnr2, respectively. We found that Faah(-/-) decidual cells progressively underwent premature senescence as marked by increased senescence-associated -galactosidase (SA--Gal) staining and H2AX-positive decidual cells. Interestingly, increased endocannabinoid signaling activated MAPK p38, but not p42/44 or mTORC1 signaling, in Faah(-/-) deciduae, and inhibition of p38 halted premature decidual senescence. We further showed that treatment of a long-acting anandamide in wild-type mice at midgestation triggered premature decidual senescence utilizing CB1, since administration of a CB1 antagonist greatly reduced the rate of PTB in Faah(-/-) females exposed to LPS. These results provide evidence that endocannabinoid signaling is critical in regulating decidual senescence and parturition timing. This study identifies a previously unidentified pathway in decidual senescence, which is independent of mTORC1 signaling.	[Sun, Xiaofei; Deng, Wenbo; Li, Yingju; Tang, Shuang; Dey, Sudhansu K.] Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, MLC 7045,3333 Burnet Ave, Cincinnati, OH 45229 USA; [Leishman, Emma; Bradshaw, Heather B.] Indiana Univ, Kinsey Inst Res Sex Gender & Reprod, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	Cincinnati Children's Hospital Medical Center; Indiana University System; Indiana University Bloomington	Sun, XF; Dey, SK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Reprod Sci, MLC 7045,3333 Burnet Ave, Cincinnati, OH 45229 USA.	xiaofei.sun@cchmc.org; sk.dey@cchmc.org	唐, 爽/GXN-4370-2022; Tang, Shuang/G-5604-2016	Tang, Shuang/0000-0002-7078-7289; Tang, Shuang/0000-0002-5967-5593	NIDA/National Institutes of Health [DA006668]; March of Dimes Foundation [21-FY12-127, 22-FY13-543]; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA006668, R01DA006668] Funding Source: NIH RePORTER	NIDA/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in parts by grants from NIDA/National Institutes of Health (DA006668, to S. K. D.) and March of Dimes Foundation (21-FY12-127 and 22-FY13-543). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alam SMK, 2015, REPRODUCTION, V149, P625, DOI 10.1530/REP-15-0107; [Anonymous], 2015, AM CHILDR KEY NAT IN; Behrman RE, 2007, PRETERM BIRTH CAUSES; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Casey ML, 1997, ANN NY ACAD SCI, V828, P273, DOI 10.1111/j.1749-6632.1997.tb48548.x; CAULFIELD MP, 1992, BRIT J PHARMACOL, V106, P231, DOI 10.1111/j.1476-5381.1992.tb14321.x; Cha J, 2013, J CLIN INVEST, V123, P4063, DOI 10.1172/JCI70098; CHAKRABORTY I, 1995, J ENDOCRINOL, V147, P339, DOI 10.1677/joe.0.1470339; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Dennedy MC, 2004, AM J OBSTET GYNECOL, V190, P2, DOI 10.1016/j.ajog.2003.07.013; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, BBA-LIPID LIPID MET, V1392, P153, DOI 10.1016/S0005-2760(98)00042-3; Fidel P I Jr, 1998, J Matern Fetal Med, V7, P222; Hirota Y, 2011, P NATL ACAD SCI USA, V108, P18073, DOI 10.1073/pnas.1108180108; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Houlihan DD, 2010, REPRODUCTION, V139, P783, DOI 10.1530/REP-09-0496; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Maccarrone M, 2002, MOL HUM REPROD, V8, P188, DOI 10.1093/molehr/8.2.188; Maccarrone M, 2000, LANCET, V355, P1326, DOI 10.1016/S0140-6736(00)02115-2; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; PARIA BC, 1995, P NATL ACAD SCI USA, V92, P9460, DOI 10.1073/pnas.92.21.9460; Park B, 2003, PLACENTA, V24, P990, DOI 10.1016/S0143-4004(03)00165-6; Pucci M, 2012, J BIOL CHEM, V287, P15466, DOI 10.1074/jbc.M111.314880; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Rueda D, 2000, MOL PHARMACOL, V58, P814, DOI 10.1124/mol.58.4.814; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; Sun XF, 2012, ACS CHEM NEUROSCI, V3, P349, DOI 10.1021/cn300014e; Sun XF, 2010, P NATL ACAD SCI USA, V107, P16887, DOI 10.1073/pnas.1010892107; Tan J, 1999, ENDOCRINOLOGY, V140, P5310, DOI 10.1210/en.140.11.5310; Thaxton JE, 2010, INFECT DIS OBSTET GY, V2010; Wang HB, 2007, J BIOL CHEM, V282, P37770, DOI 10.1074/jbc.M706577200; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100; Wang JQ, 2011, DEV CELL, V21, P575, DOI 10.1016/j.devcel.2011.07.003; Winchester SK, 2002, ENDOCRINOLOGY, V143, P2593, DOI 10.1210/en.143.7.2593; Wolfson ML, 2015, MOL CELL ENDOCRINOL, V411, P214, DOI 10.1016/j.mce.2015.04.032; Xie HR, 2012, J BIOL CHEM, V287, P32288, DOI 10.1074/jbc.M112.381145; Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	49	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8231	8240		10.1074/jbc.M115.707836	http://dx.doi.org/10.1074/jbc.M115.707836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26900150	Green Published, hybrid			2022-12-28	WOS:000374056700038
J	Collins, JA; Wood, ST; Nelson, KJ; Rowe, MA; Carlson, CS; Chubinskaya, S; Poole, LB; Furdui, CM; Loeser, RF				Collins, John A.; Wood, Scott T.; Nelson, Kimberly J.; Rowe, Meredith A.; Carlson, Cathy S.; Chubinskaya, Susan; Poole, Leslie B.; Furdui, Cristina M.; Loeser, Richard F.			Oxidative Stress Promotes Peroxiredoxin Hyperoxidation and Attenuates Pro-survival Signaling in Aging Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aging; cell signaling; osteoarthritis; oxidative stress; peroxiredoxin; redox signaling	HUMAN ARTICULAR CHONDROCYTES; ISOLATED RAT HEPATOCYTES; OSTEOGENIC PROTEIN-1; THIOL HOMEOSTASIS; DOWN-REGULATION; REDOX STATE; CELL-DEATH; MITOCHONDRIA; OSTEOARTHRITIS; MENADIONE	Oxidative stress-mediated post-translational modifications of redox-sensitive proteins are postulated as a key mechanism underlying age-related cellular dysfunction and disease progression. Peroxiredoxins (PRX) are critical intracellular antioxidants that also regulate redox signaling events. Age-related osteoarthritis is a common form of arthritis that has been associated with mitochondrial dysfunction and oxidative stress. The objective of this study was to determine the effect of aging and oxidative stress on chondrocyte intracellular signaling, with a specific focus on oxidation of cytosolic PRX2 and mitochondrial PRX3. Menadione was used as a model to induce cellular oxidative stress. Compared with chondrocytes isolated from young adult humans, chondrocytes from older adults exhibited higher levels of PRX1-3 hyperoxidation basally and under conditions of oxidative stress. Peroxiredoxin hyperoxidation was associated with inhibition of pro-survival Akt signaling and stimulation of pro-death p38 signaling. These changes were prevented in cultured human chondrocytes by adenoviral expression of catalase targeted to the mitochondria (MCAT) and in cartilage explants from MCAT transgenic mice. Peroxiredoxin hyperoxidation was observed in situ in human cartilage sections from older adults and in osteoarthritic cartilage. MCAT transgenic mice exhibited less age-related osteoarthritis. These findings demonstrate that age-related oxidative stress can disrupt normal physiological signaling and contribute to osteoarthritis and suggest peroxiredoxin hyperoxidation as a potential mechanism.	[Collins, John A.; Wood, Scott T.; Rowe, Meredith A.; Loeser, Richard F.] Univ N Carolina, Div Rheumatol Allergy & Immunol, 3300 Thurston Bldg,CB 7280, Chapel Hill, NC 27599 USA; [Collins, John A.; Wood, Scott T.; Rowe, Meredith A.; Loeser, Richard F.] Univ N Carolina, Thurston Arthrit Res Ctr, 3300 Thurston Bldg,CB 7280, Chapel Hill, NC 27599 USA; [Nelson, Kimberly J.; Poole, Leslie B.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Rowe, Meredith A.; Furdui, Cristina M.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Carlson, Cathy S.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Chubinskaya, Susan] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; Rush University	Loeser, RF (corresponding author), Univ N Carolina, Thurston Arthrit Res Ctr, 3300 Thurston Bldg,CB 7280, Chapel Hill, NC 27599 USA.	Richard_loeser@med.unc.edu	Core UNC, Hooker Imaging/AAE-1484-2022; Wood, Scott/I-6133-2019	Wood, Scott/0000-0002-6747-0547; Furdui, Cristina M./0000-0003-3771-7999; Nelson, Kimberly/0000-0003-2464-7696; Poole, Leslie/0000-0003-0334-7328	National Institute on Aging [RO1 AG044034]; Ciba-Geigy Endowed Chair of Biochemistry from Rush University Medical Center; NATIONAL INSTITUTE ON AGING [R01AG044034] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ciba-Geigy Endowed Chair of Biochemistry from Rush University Medical Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging Grant RO1 AG044034 (to R. F. L.) and the Ciba-Geigy Endowed Chair of Biochemistry from Rush University Medical Center (to S. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn J, 2013, APOPTOSIS, V18, P870, DOI 10.1007/s10495-013-0835-5; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Blanco FJ, 2011, NAT REV RHEUMATOL, V7, P161, DOI 10.1038/nrrheum.2010.213; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Cox AG, 2010, METHOD ENZYMOL, V474, P51, DOI 10.1016/S0076-6879(10)74004-0; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Del Carlo M, 2003, ARTHRITIS RHEUM-US, V48, P3419, DOI 10.1002/art.11338; Del Carlo M, 2002, ARTHRITIS RHEUM, V46, P394, DOI 10.1002/art.10056; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; delPeso L, 1997, SCIENCE, V278, P687; DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P334, DOI 10.1016/0003-9861(84)90206-6; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gavriilidis C, 2013, ARTHRITIS RHEUM-US, V65, P378, DOI 10.1002/art.37782; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Jones DP, 2006, REJUV RES, V9, P169, DOI 10.1089/rej.2006.9.169; Kim SY, 2008, FEBS LETT, V582, P1913, DOI 10.1016/j.febslet.2008.05.015; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Koike M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11722; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Levy YD, 2013, ANN RHEUM DIS, V72, P271, DOI 10.1136/annrheumdis-2012-201730; Loeser RF, 2003, ARTHRITIS RHEUM, V48, P2188, DOI 10.1002/art.11209; Loeser RF, 2002, ARTHRITIS RHEUM, V46, P2349, DOI 10.1002/art.10496; Loeser RF, 2014, ARTHRITIS RHEUMATOL, V66, P2201, DOI 10.1002/art.38641; Loeser RF, 2013, CURR OPIN RHEUMATOL, V25, P108, DOI 10.1097/BOR.0b013e32835a9428; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023; Lowther WT, 2011, ANTIOXID REDOX SIGN, V15, P99, DOI 10.1089/ars.2010.3564; McAmis WC, 2003, BBA-MOL CELL RES, V1641, P43, DOI 10.1016/S0167-4889(03)00063-6; McNulty MA, 2011, CARTILAGE, V2, P354, DOI 10.1177/1947603511402665; Nystrom T, 2012, GENE DEV, V26, P2001, DOI 10.1101/gad.200006.112; Pace PE, 2013, BIOCHEM J, V453, P475, DOI 10.1042/BJ20130030; Pelletier JP, 2001, J RHEUMATOL, V28, P2509; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Randall LM, 2013, METHOD ENZYMOL, V527, P41, DOI 10.1016/B978-0-12-405882-8.00003-9; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Ruiz-Romero C, 2009, MOL CELL PROTEOMICS, V8, P172, DOI 10.1074/mcp.M800292-MCP200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Singh K, 2015, EMBO MOL MED, V7, P59, DOI 10.15252/emmm.201404082; SMITH PF, 1987, TOXICOL APPL PHARM, V89, P190, DOI 10.1016/0041-008X(87)90040-8; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; TOXOPEUS C, 1993, ARCH TOXICOL, V67, P674, DOI 10.1007/BF01973690; Ulici V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008866; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vilela M, 2013, METHOD ENZYMOL, V519, P253, DOI 10.1016/B978-0-12-405539-1.00009-9; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Yin WH, 2009, J BIOL CHEM, V284, P31972, DOI 10.1074/jbc.M109.056838	59	67	70	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6641	6654		10.1074/jbc.M115.693523	http://dx.doi.org/10.1074/jbc.M115.693523			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26797130	Green Published, hybrid			2022-12-28	WOS:000373299700003
J	Fujiwara, S; Kawazoe, T; Ohnishi, K; Kitagawa, T; Popa, C; Valls, M; Genin, S; Nakamura, K; Kuramitsu, Y; Tanaka, N; Tabuchi, M				Fujiwara, Shoko; Kawazoe, Tomoki; Ohnishi, Kouhei; Kitagawa, Takao; Popa, Crina; Valls, Marc; Genin, Stephane; Nakamura, Kazuyuki; Kuramitsu, Yasuhiro; Tanaka, Naotaka; Tabuchi, Mitsuaki			RipAY, a Plant Pathogen Effector Protein, Exhibits Robust -Glutamyl Cyclotransferase Activity When Stimulated by Eukaryotic Thioredoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plant defense; redox regulation; Saccharomyces cerevisiae; thioredoxin; type III secretion system (T3SS)	RALSTONIA-SOLANACEARUM; SACCHAROMYCES-CEREVISIAE; PSEUDOMONAS-AERUGINOSA; GLUTATHIONE; IDENTIFICATION; GENE; REPERTOIRE; ACTIVATION; EXPRESSION; SYSTEM	The plant pathogenic bacterium Ralstonia solanacearum injects more than 70 effector proteins (virulence factors) into the host plant cells via the needle-like structure of a type III secretion system. The type III secretion system effector proteins manipulate host regulatory networks to suppress defense responses with diverse molecular activities. Uncovering the molecular function of these effectors is essential for a mechanistic understanding of R. solanacearum pathogenicity. However, few of the effectors from R. solanacearum have been functionally characterized, and their plant targets remain largely unknown. Here, we show that the ChaC domain-containing effector RipAY/RSp1022 from R. solanacearum exhibits -glutamyl cyclotransferase (GGCT) activity to degrade the major intracellular redox buffer, glutathione. Heterologous expression of RipAY, but not other ChaC family proteins conserved in various organisms, caused growth inhibition of yeast Saccharomyces cerevisiae, and the intracellular glutathione level was decreased to approximate to 30% of the normal level following expression of RipAY in yeast. Although active site mutants of GGCT activity were non-toxic, the addition of glutathione did not reverse the toxicity, suggesting that the toxicity might be a consequence of activity against other -glutamyl compounds. Intriguingly, RipAY protein purified from a bacterial expression system did not exhibit any GGCT activity, whereas it exhibited robust GGCT activity upon its interaction with eukaryotic thioredoxins, which are important for intracellular redox homeostasis during bacterial infection in plants. Our results suggest that RipAY has evolved to sense the host intracellular redox environment, which triggers its enzymatic activity to create a favorable environment for R. solanacearum infection.	[Fujiwara, Shoko; Kawazoe, Tomoki; Tanaka, Naotaka; Tabuchi, Mitsuaki] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, 2393 Ikenobe Miki Cho, Kagawa 7610795, Japan; [Ohnishi, Kouhei] Kochi Univ, Res Inst Mol Genet, Nankoku, Kochi 7830093, Japan; [Kitagawa, Takao; Kuramitsu, Yasuhiro] Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, Ube, Yamaguchi 7558505, Japan; [Popa, Crina; Valls, Marc] Univ Barcelona, Dept Genet, Bellaterra, Catalonia, Spain; [Popa, Crina; Valls, Marc] Ctr Res Agr Genom, Bellaterra, Catalonia, Spain; [Genin, Stephane] INRA CNRS, Lab Interact Plantes Microoganismes, UMR441 2594, Castanet Tolosan, France; [Nakamura, Kazuyuki] Tokuyama Med Assoc Hosp, Ctr Clin Labs, Shunan 7450846, Japan	Kagawa University; Kochi University; Yamaguchi University; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Tabuchi, M (corresponding author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, 2393 Ikenobe Miki Cho, Kagawa 7610795, Japan.	mtabuchi@ag.kagawa-u.ac.jp	Valls, Marc/I-7285-2015; Ohnishi, Kouhei/AAN-9527-2020; Tabuchi, Mitsuaki/AAY-7378-2021; Tabuchi, Mitsuaki/E-9544-2010	Valls, Marc/0000-0003-2312-0091; Tabuchi, Mitsuaki/0000-0002-2042-691X; Tabuchi, Mitsuaki/0000-0002-2042-691X; Popa, Crina Mihaela/0000-0002-4294-9949; Genin, Stephane/0000-0003-2498-2400	Japan Society for the Promotion of Science [22580095, 25450104]; Institute of Fermentation, Osaka	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute of Fermentation, Osaka	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 22580095 and 25450104 and also, in part, by the General Research Grant of the Institute of Fermentation, Osaka. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson DM, 2011, MOL MICROBIOL, V82, P1454, DOI 10.1111/j.1365-2958.2011.07904.x; Angot A, 2006, P NATL ACAD SCI USA, V103, P14620, DOI 10.1073/pnas.0509393103; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; Chi ZK, 2014, CELL REP, V7, P681, DOI 10.1016/j.celrep.2014.03.048; Christen M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000430; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Coll NS, 2013, MICROB BIOTECHNOL, V6, P614, DOI 10.1111/1751-7915.12056; Cunnac S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/j.1365-2958.2004.04118.x; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Deslandes L, 2014, CURR OPIN PLANT BIOL, V20, P110, DOI 10.1016/j.pbi.2014.05.002; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Dubreuil-Maurizi C, 2012, PLANT SIGNAL BEHAV, V7, P210, DOI 10.4161/psb.18831; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gaspar AH, 2014, P NATL ACAD SCI USA, V111, P4560, DOI 10.1073/pnas.1316376111; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Genin S, 2012, ANNU REV PHYTOPATHOL, V50, P67, DOI 10.1146/annurev-phyto-081211-173000; Genin S, 2010, NEW PHYTOL, V187, P920, DOI 10.1111/j.1469-8137.2010.03397.x; Ghanta S, 2011, PLANTA, V233, P895, DOI 10.1007/s00425-011-1349-4; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Kanda A, 2003, MOL PLANT MICROBE IN, V16, P447, DOI 10.1094/MPMI.2003.16.5.447; Kumar A, 2012, EMBO REP, V13, P1095, DOI 10.1038/embor.2012.156; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Kumar S, 2015, BIOCHEM J, V468, P73, DOI 10.1042/BJ20141154; Kuramitsu Y, 2009, PROTEOMICS, V9, P5078, DOI 10.1002/pmic.200800284; Laloi C, 2004, PLANT PHYSIOL, V134, P1006, DOI 10.1104/pp.103.035782; Le Roux C, 2015, CELL, V161, P1074, DOI 10.1016/j.cell.2015.04.025; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Mhamdi A, 2010, PLANT PHYSIOL, V153, P1144, DOI 10.1104/pp.110.153767; Mukaihara T, 2010, MOL PLANT MICROBE IN, V23, P251, DOI 10.1094/MPMI-23-3-0251; Oakley AJ, 2008, J BIOL CHEM, V283, P22031, DOI 10.1074/jbc.M803623200; Parisy V, 2007, PLANT J, V49, P159, DOI 10.1111/j.1365-313X.2006.02938.x; Peeters N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-859; Poueymiro M, 2014, MBIO, V5, DOI 10.1128/mBio.02065-14; Poueymiro M, 2009, CURR OPIN MICROBIOL, V12, P44, DOI 10.1016/j.mib.2008.11.008; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Spoel SH, 2011, CURR OPIN PLANT BIOL, V14, P358, DOI 10.1016/j.pbi.2011.03.007; Tabuchi M, 2009, BIOSCI BIOTECH BIOCH, V73, P2261, DOI 10.1271/bbb.90360; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valdivia RH, 2004, EUKARYOT CELL, V3, P827, DOI 10.1128/EC.3.4.827-834.2004	47	33	33	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6813	6830		10.1074/jbc.M115.678953	http://dx.doi.org/10.1074/jbc.M115.678953			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26823466	Green Published, hybrid			2022-12-28	WOS:000373299700021
J	Li, Q; Lex, RK; Chung, H; Giovanetti, SM; Ji, ZC; Ji, HK; Person, MD; Kim, J; Vokes, SA				Li, Qiang; Lex, Rachel K.; Chung, HaeWon; Giovanetti, Simone M.; Ji, Zhicheng; Ji, Hongkai; Person, Maria D.; Kim, Jonghwan; Vokes, Steven A.			The Pluripotency Factor NANOG Binds to GLI Proteins and Represses Hedgehog-mediated Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						differentiation; embryonic stem cell; Hedgehog signaling pathway; stem cells; transcription repressor; GLI proteins; Nanog; repressor	EMBRYONIC STEM-CELLS; REGULATORY CIRCUITRY; INTERACTION NETWORK; SIGNALING PATHWAY; SELF-RENEWAL; SPINAL-CORD; EXPRESSION; DAX1; GENE; ACTIVATION	The Hedgehog (HH) signaling pathway is essential for the maintenance and response of several types of stem cells. To study the transcriptional response of stem cells to HH signaling, we searched for proteins binding to GLI proteins, the transcriptional effectors of the HH pathway in mouse embryonic stem (ES) cells. We found that both GLI3 and GLI1 bind to the pluripotency factor NANOG. The ectopic expression of NANOG inhibits GLI1-mediated transcriptional responses in a dose-dependent fashion. In differentiating ES cells, the presence of NANOG reduces the transcriptional response of cells to HH. Finally, we found that Gli1 and Nanog are co-expressed in ES cells at high levels. We propose that NANOG acts as a negative feedback component that provides stem cell-specific regulation of the HH pathway.	[Li, Qiang; Lex, Rachel K.; Chung, HaeWon; Giovanetti, Simone M.; Kim, Jonghwan; Vokes, Steven A.] Univ Texas Austin, Dept Mol Biosci, 2500 Speedway Stop A4800, Austin, TX 78712 USA; [Li, Qiang; Lex, Rachel K.; Chung, HaeWon; Giovanetti, Simone M.; Person, Maria D.; Kim, Jonghwan; Vokes, Steven A.] Univ Texas Austin, Inst Cellular & Mol Biol, 2500 Speedway Stop A4800, Austin, TX 78712 USA; [Person, Maria D.] Univ Texas Austin, Prote Facil, 2500 Speedway Stop A4800, Austin, TX 78712 USA; [Ji, Zhicheng; Ji, Hongkai] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Vokes, SA (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, 2500 Speedway Stop A4800, Austin, TX 78712 USA.	svokes@austin.utexas.edu	Ji, Zhicheng/I-5650-2019; Kim, Jonghwan/AAR-2815-2021	Ji, Zhicheng/0000-0002-9457-4704; Kim, Jonghwan/0000-0002-9919-9843; Vokes, Steven/0000-0002-1724-0102	National Institutes of Health [R01HG006282, R01HD073151]; Cancer Prevention Research Institute of Texas [RP120343, RP110782]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073151] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health Grants R01HG006282 (to H. J.) and R01HD073151 (to S. A. V.) and Cancer Prevention Research Institute of Texas Grants RP120343 (to S. A. V.) and RP110782 (to M. D. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Alvarez-Buylla A, 2014, SEMIN CELL DEV BIOL, V33, P105, DOI 10.1016/j.semcdb.2014.05.008; Asaoka Y, 2010, J BIOL CHEM, V285, P4185, DOI 10.1074/jbc.M109.038232; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang DF, 2009, STEM CELLS, V27, P812, DOI 10.1634/stemcells.2008-0657; Choi SC, 2012, J CELL PHYSIOL, V227, P3678, DOI 10.1002/jcp.24076; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Falkenstein KN, 2014, SEMIN CELL DEV BIOL, V33, P73, DOI 10.1016/j.semcdb.2014.05.010; Ferent J, 2014, STEM CELL REP, V3, P312, DOI 10.1016/j.stemcr.2014.05.016; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Ji ZC, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv873; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Lee CF, 2013, J PROTEOME RES, V12, P4302, DOI 10.1021/pr400201d; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Li J, 2011, BIOCHEM BIOPH RES CO, V412, P660, DOI 10.1016/j.bbrc.2011.08.020; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Park HL, 2000, DEVELOPMENT, V127, P1593; Petrova R, 2014, DEVELOPMENT, V141, P3445, DOI 10.1242/dev.083691; Platt KA, 1997, MECH DEVELOP, V62, P121, DOI 10.1016/S0925-4773(96)00648-X; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takata K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3338; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Uranishi K, 2013, MOL CELL BIOL, V33, P2056, DOI 10.1128/MCB.01520-12; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Wu G, 2013, BIOINFORMATICS, V29, P1182, DOI 10.1093/bioinformatics/btt108; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6042	58	16	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7171	7182		10.1074/jbc.M116.714857	http://dx.doi.org/10.1074/jbc.M116.714857			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26797124	Green Published, hybrid			2022-12-28	WOS:000373299700049
J	Fu, WM; Sun, J; Huang, GC; Liu, JC; Kaufman, A; Ryan, RJH; Ramanathan, SY; Venkatesh, T; Singh, B				Fu, Weimin; Sun, Joanne; Huang, Guochang; Liu, Jeffrey C.; Kaufman, Andrew; Ryan, Russell J. H.; Ramanathan, Suresh Y.; Venkatesh, Tadmiri; Singh, Bhuvanesh			Squamous Cell Carcinoma-related Oncogene (SCCRO) Family Members Regulate Cell Growth and Proliferation through Their Cooperative and Antagonistic Effects on Cullin Neddylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						head and neck cancer; lung cancer; oncogene; tumor suppressor gene; ubiquitylation (ubiquitination)	DROSOPHILA-MELANOGASTER; E3 LIGASE; UBIQUITIN-LIGASE; PROTEIN NEDD8; COMPETITION; MECHANISMS; STABILITY; LIGATION; GENE; CUL1	SCCRO (squamous cell carcinoma-related oncogene; also known as DCUN1D1) is a highly conserved gene that functions as an E3 in neddylation. Although inactivation of SCCRO in yeast results in lethality, SCCRO-/- mice are viable. The exclusive presence of highly conserved paralogues in higher organisms led us to assess whether compensation by SCCRO paralogues rescues lethality in SCCRO-/- mice. Using murine and Drosophila models, we assessed the in vivo activities of SCCRO and its paralogues in cullin neddylation. We found that SCCRO family members have overlapping and antagonistic activity that regulates neddylation and cell proliferation activities in vivo. In flies, both dSCCRO and dSCCRO3 promote neddylation and cell proliferation, whereas dSCCRO4 negatively regulates these processes. Analysis of somatic clones showed that the effects that these paralogues have on proliferation serve to promote cell competition, leading to apoptosis in clones with a net decrease in neddylation activity. We found that dSCCRO and, to a lesser extent, dSCCRO3 rescue the neddylation and proliferation defects promoted by expression of SCCRO4. dSCCRO and dSCCRO3 functioned cooperatively, with their coexpression resulting in an increase in both the neddylated cullin fraction and proliferation activity. In contrast, human SCCRO and SCCRO4 promote, and human SCCRO3 inhibits, neddylation and proliferation when expressed in flies. Our findings provide the first insights into the mechanisms through which SCCRO family members cooperatively regulate neddylation and cell proliferation.	[Fu, Weimin; Sun, Joanne; Huang, Guochang; Liu, Jeffrey C.; Kaufman, Andrew; Ryan, Russell J. H.; Ramanathan, Suresh Y.; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Lab Epithelial Canc Biol, Dept Surg, New York, NY 10065 USA; [Venkatesh, Tadmiri] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Liu, Jeffrey C.] Temple Univ, Div Head & Neck Oncol Surg, Philadelphia, PA 19140 USA; [Kaufman, Andrew; Ramanathan, Suresh Y.] Mt Sinai Med Ctr, Dept Thorac Surg, New York, NY 10029 USA; [Ryan, Russell J. H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ryan, Russell J. H.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ryan, Russell J. H.] Broad Inst Harvard Univ & MIT, Cambridge, MA 02142 USA	Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; City College of New York (CUNY); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Singh, B (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	singhb@mskcc.org		Ryan, Russell/0000-0001-8174-3962; Liu, Jeffrey/0000-0001-8377-0905	NCI, National Institutes of Health [P30 CA008748, U54CA137788/U54CA132378]; Hackers for Hope; NATIONAL CANCER INSTITUTE [U54CA132378, U54CA137788, P30CA008748] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hackers for Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grant P30 CA008748, NCI, National Institutes of Health Grant U54CA137788/U54CA132378 (to B. S. and T. V.), and a grant from Hackers for Hope (to B. S.). The authors declare they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amoyel M, 2014, DEVELOPMENT, V141, P988, DOI 10.1242/dev.079129; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Bommelje CC, 2014, CLIN CANCER RES, V20, P372, DOI 10.1158/1078-0432.CCR-13-1252; Dai X, 1998, GENE DEV, V12, P3452, DOI 10.1101/gad.12.21.3452; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Estilo CL, 2003, CLIN CANCER RES, V9, P2300; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Huang GC, 2014, J BIOL CHEM, V289, P34728, DOI 10.1074/jbc.M114.585505; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kim SH, 2010, DEV BIOL, V346, P247, DOI 10.1016/j.ydbio.2010.07.031; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Ma T, 2008, CANCER SCI, V99, P2128, DOI 10.1111/j.1349-7006.2008.00929.x; Meyer-Schaller N, 2009, P NATL ACAD SCI USA, V106, P12365, DOI 10.1073/pnas.0812528106; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Morata G, 2007, DEV CELL, V13, P1, DOI 10.1016/j.devcel.2007.06.002; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Parry G, 2004, SEMIN CELL DEV BIOL, V15, P221, DOI 10.1016/j.semcdb.2003.12.003; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Reynolds PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002918; ROBERTSON HM, 1988, GENETICS, V118, P461; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Vincent JP, 2013, NAT REV MOL CELL BIO, V14, P581, DOI 10.1038/nrm3639; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Wu K, 2011, J BIOL CHEM, V286, P34060, DOI 10.1074/jbc.M111.273045	44	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6200	6217		10.1074/jbc.M115.692756	http://dx.doi.org/10.1074/jbc.M115.692756			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26792857	Green Published, hybrid			2022-12-28	WOS:000372894200013
J	Tetreault, MP; Bourdin, B; Briot, J; Segura, E; Lesage, S; Fiset, C; Parent, L				Tetreault, Marie-Philippe; Bourdin, Benoite; Briot, Julie; Segura, Emilie; Lesage, Sylvie; Fiset, Celine; Parent, Lucie			Identification of Glycosylation Sites Essential for Surface Expression of the Ca-V alpha 2 delta 1 Subunit and Modulation of the Cardiac Ca(V)1.2 Channel Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL N-GLYCOSYLATION; I-KS CHANNELS; CALCIUM-CHANNELS; ALPHA(2)DELTA SUBUNITS; BETA-SUBUNIT; PLASMA-MEMBRANE; POSTNATAL-DEVELOPMENT; QUALITY-CONTROL; CA2+ CURRENTS; ION CHANNELS	Alteration in the L-type current density is one aspect of the electrical remodeling observed in patients suffering from cardiac arrhythmias. Changes in channel function could result from variations in the protein biogenesis, stability, post-translational modification, and/or trafficking in any of the regulatory subunits forming cardiac L-type Ca2+ channel complexes. Ca-V alpha 2 delta 1 is potentially the most heavily N-glycosylated subunit in the cardiac L-type Ca(V)1.2 channel complex. Here, we show that enzymatic removal of N-glycans produced a 50-kDa shift in the mobility of cardiac and recombinant Ca-V alpha 2 delta 1 proteins. This change was also observed upon simultaneous mutation of the 16 Asn sites. Nonetheless, the mutation of only 6/16 sites was sufficient to significantly 1) reduce the steady-state cell surface fluorescence of Ca-V alpha 2 delta 1 as characterized by two-color flow cytometry assays and confocal imaging; 2) decrease protein stability estimated from cycloheximide chase assays; and 3) prevent the Ca-V alpha 2 delta 1-mediated increase in the peak current density and voltage-dependent gating of Ca(V)1.2. Reversing the N348Q and N812Q mutations in the non-operational sextuplet Asn mutant protein partially restored Ca-V alpha 2 delta 1 function. Single mutation N663Q and double mutations N348Q/N468Q, N348Q/N812Q, and N468Q/N812Q decreased protein stability/synthesis and nearly abolished steady-state cell surface density of Ca-V alpha 2 delta 1 as well as the Ca-V alpha 2 delta 1-induced up-regulation of L-type currents. These results demonstrate that Asn-663 and to a lesser extent Asn-348, Asn-468, and Asn-812 contribute to protein stability/synthesis of Ca-V alpha 2 delta 1, and furthermore that N-glycosylation of Ca-V alpha 2 delta 1 is essential to produce functional L-type Ca2+ channels.	[Tetreault, Marie-Philippe; Bourdin, Benoite; Briot, Julie; Segura, Emilie; Parent, Lucie] Univ Montreal, Fac Med, Dept Physiol Mol & Intergrat, Montreal, PQ H3C 3J7, Canada; [Fiset, Celine] Univ Montreal, Inst Cardiol Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Lesage, Sylvie] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Ctr Rech,Hop Maisonneuve Rosemont, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Institut de Cardiologie de Montreal; Universite de Montreal	Parent, L (corresponding author), Univ Montreal, Dept Physiol Mol & Intergrat, POB 6128,Downtown Stn, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca		Fiset, Celine/0000-0003-2309-4823; Parent, Lucie/0000-0002-7932-4264; Briot, Julie/0000-0003-4154-6766; Lesage, Sylvie/0000-0002-0968-2795	Canadian Institutes of Health Research [130256]; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by Canadian Institutes of Health Research Operating Grant 130256 and a grant-in-aid from the Heart and Stroke Foundation of Canada (to L. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Andrade A, 2007, EUR J NEUROSCI, V25, P1705, DOI 10.1111/j.1460-9568.2007.05454.x; [Anonymous], 2009, ESSENTIALS GLYCOBIOL; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Aschar-Sobbi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7018; Bannister JP, 2012, HYPERTENSION, V60, P1006, DOI 10.1161/HYPERTENSIONAHA.112.199661; Bas T, 2011, J BIOL CHEM, V286, P28150, DOI 10.1074/jbc.M111.235168; Berrou L, 2002, BIOPHYS J, V83, P1429, DOI 10.1016/S0006-3495(02)73914-3; Berrou L, 2005, J BIOL CHEM, V280, P494, DOI 10.1074/jbc.M410859200; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bourdin B, 2015, J BIOL CHEM, V290, P2854, DOI 10.1074/jbc.M114.597930; Bourdin B, 2010, J BIOL CHEM, V285, P22851, DOI 10.1074/jbc.M110.111062; Brundel BJJM, 1999, CARDIOVASC RES, V42, P443, DOI 10.1016/S0008-6363(99)00045-0; Buraei Z, 2013, BBA-BIOMEMBRANES, V1828, P1530, DOI 10.1016/j.bbamem.2012.08.028; Burashnikov E, 2010, HEART RHYTHM, V7, P1872, DOI 10.1016/j.hrthm.2010.08.026; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; CARL SL, 1995, J CELL BIOL, V129, P673, DOI 10.1083/jcb.129.3.673; Cassidy JS, 2014, P NATL ACAD SCI USA, V111, P8979, DOI 10.1073/pnas.1403731111; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CHANG FC, 1988, J BIOL CHEM, V263, P18929; Clark RB, 2001, J PHYSIOL-LONDON, V537, P979; COHEN SA, 1993, CIRC RES, V73, P735, DOI 10.1161/01.RES.73.4.735; Comyn SA, 2014, J PROTEOMICS, V100, P92, DOI 10.1016/j.jprot.2013.08.005; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Davies A, 2006, J NEUROSCI, V26, P8748, DOI 10.1523/JNEUROSCI.2764-06.2006; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Douglas L, 2006, BIOCHEM SOC T, V34, P894, DOI 10.1042/BST0340894; Du DP, 2014, IEEE J BIOMED HEALTH, V18, P205, DOI 10.1109/JBHI.2013.2260864; Freeze H. H., 2010, CURR PROTOC PROTEIN; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Grandy SA, 2007, AM J PHYSIOL-HEART C, V293, pH2168, DOI 10.1152/ajpheart.00521.2007; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; Hebert DN, 2012, TRENDS BIOCHEM SCI, V37, P404, DOI 10.1016/j.tibs.2012.07.005; Hendrich J, 2008, P NATL ACAD SCI USA, V105, P3628, DOI 10.1073/pnas.0708930105; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; JAY SD, 1991, J BIOL CHEM, V266, P3287; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kasturi L, 1997, BIOCHEM J, V323, P415, DOI 10.1042/bj3230415; Laedermann CJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00137; Lee GH, 2000, CIRC RES, V87, P489; Lizotte E, 2005, ANAL BIOCHEM, V345, P47, DOI 10.1016/j.ab.2005.07.001; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Lugenbiel P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116395; Marais E, 2001, MOL PHARMACOL, V59, P1243, DOI 10.1124/mol.59.5.1243; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; Mercier A, 2015, BBA-GEN SUBJECTS, V1850, P1215, DOI 10.1016/j.bbagen.2015.02.009; Mukherjee R, 1998, J MOL CELL CARDIOL, V30, P1899, DOI 10.1006/jmcc.1998.0755; Muthusamy S, 2015, AM J PHYSIOL-CELL PH, V308, pC964, DOI 10.1152/ajpcell.00023.2015; Nagae M, 2012, INT J MOL SCI, V13, P8398, DOI 10.3390/ijms13078398; Nakagawa H, 2009, FEBS J, V276, P7237, DOI 10.1111/j.1742-4658.2009.07423.x; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Parent L, 1997, J MEMBRANE BIOL, V160, P127, DOI 10.1007/s002329900302; Park KH, 2003, FASEB J, V17, DOI 10.1096/fj.03-0577fje; Pertusa M, 2012, J BIOL CHEM, V287, P18218, DOI 10.1074/jbc.M111.312645; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Plant LD, 2014, P NATL ACAD SCI USA, V111, pE1438, DOI 10.1073/pnas.1323548111; Richard S, 1998, CARDIOVASC RES, V37, P300, DOI 10.1016/S0008-6363(97)00273-3; Richard S, 2006, PROG BIOPHYS MOL BIO, V90, P118, DOI 10.1016/j.pbiomolbio.2005.05.005; Robinson P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019802; Rougier JS, 2015, PFLUG ARCH EUR J PHY, V467, P1919, DOI 10.1007/s00424-014-1636-6; Ruscic KJ, 2013, P NATL ACAD SCI USA, V110, pE559, DOI 10.1073/pnas.1222616110; Sandoval A, 2004, FEBS LETT, V576, P21, DOI 10.1016/j.febslet.2004.08.054; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Scott H, 2014, GLYCOBIOLOGY, V24, P407, DOI 10.1093/glycob/cwu015; Shakeri B, 2012, J BIOL CHEM, V287, P32835, DOI 10.1074/jbc.M112.387233; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Song L, 2015, CURR MOL PHARMACOL, V8, P169, DOI 10.2174/1874467208666150507104555; Suzuki S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04258; Templin C, 2011, EUR HEART J, V32, P1077, DOI 10.1093/eurheartj/ehr076; Trepanier-Boulay V, 2004, CARDIOVASC RES, V64, P84, DOI 10.1016/j.cardiores.2004.06.002; Vacher H, 2012, EPILEPSIA, V53, P21, DOI 10.1111/epi.12032; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; Walsh CP, 2009, J BIOL CHEM, V284, P22310, DOI 10.1074/jbc.M109.017152; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Weng TY, 2013, BBA-MOL CELL RES, V1833, P1133, DOI 10.1016/j.bbamcr.2013.01.018; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yue LX, 1997, CIRC RES, V81, P512, DOI 10.1161/01.RES.81.4.512; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x	95	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4826	4843		10.1074/jbc.M115.692178	http://dx.doi.org/10.1074/jbc.M115.692178			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26742847	hybrid, Green Published			2022-12-28	WOS:000371604600047
J	Isakova, A; Berset, Y; Hatzimanikatis, V; Deplancke, B				Isakova, Alina; Berset, Yves; Hatzimanikatis, Vassily; Deplancke, Bart			Quantification of Cooperativity in Heterodimer-DNA Binding Improves the Accuracy of Binding Specificity Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; BHLH TRANSCRIPTION FACTORS; GENE REGULATORY NETWORKS; PPAR-GAMMA-RXR; NUCLEAR RECEPTOR; TARGET GENES; ADIPOCYTE DIFFERENTIATION; ESCHERICHIA-COLI; GENOME-WIDE; ADIPOGENESIS	Many transcription factors (TFs) have the ability to cooperate on DNA elements as heterodimers. Despite the significance of TF heterodimerization for gene regulation, a quantitative understanding of cooperativity between various TF dimer partners and its impact on heterodimer DNA binding specificity models is still lacking. Here, we used a novel integrative approach, combining microfluidics-steered measurements of dimer-DNA assembly with mechanistic modeling of the implicated protein-protein-DNA interactions to quantitatively interrogate the cooperative DNA binding behavior of the adipogenic peroxisome proliferator-activated receptor gamma (PPAR gamma): retinoid X receptor alpha (RXR alpha) heterodimer. Using the high throughput MITOMI (mechanically induced trapping of molecular interactions) platform, we derived equilibrium DNA binding data for PPAR gamma, RXR alpha, as well as the PPAR gamma: RXR alpha heterodimer to more than 300 target DNA sites and variants thereof. We then quantified cooperativity underlying heterodimer-DNA binding and derived an integrative heterodimer DNA binding constant. Using this cooperativity-inclusive constant, we were able to build a heterodimer-DNA binding specificity model that has superior predictive power than the one based on a regular one-site equilibrium. Our data further revealed that individual nucleotide substitutions within the target site affect the extent of cooperativity in PPAR gamma:RXR alpha-DNA binding. Our study therefore emphasizes the importance of assessing cooperativity when generating DNA binding specificity models for heterodimers.	[Isakova, Alina; Berset, Yves; Deplancke, Bart] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Berset, Yves; Hatzimanikatis, Vassily] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Isakova, Alina; Berset, Yves; Hatzimanikatis, Vassily; Deplancke, Bart] SIB, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Deplancke, B (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland.; Hatzimanikatis, V (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.; Hatzimanikatis, V; Deplancke, B (corresponding author), SIB, CH-1015 Lausanne, Switzerland.	vassily.hatzimanikatis@epfl.ch; bart.deplancke@epfl.ch	Hatzimanikatis, Vassily/G-6505-2010	Hatzimanikatis, Vassily/0000-0001-6432-4694; Isakova, Alina/0000-0003-1113-6889; Deplancke, Bart/0000-0001-9935-843X	Swiss National Science Foundation [SNSF 31003A_122552]; Ecole Polytechnique Federale de Lausanne; SystemsX.ch (Swiss Initiative in Systems Biology); Swiss National Science Foundation within the initiative SystemsX.ch	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne; SystemsX.ch (Swiss Initiative in Systems Biology); Swiss National Science Foundation within the initiative SystemsX.ch	This work was supported in part by Swiss National Science Foundation Grant SNSF 31003A_122552, the Ecole Polytechnique Federale de Lausanne, and SystemsX.ch (i.e. the Swiss Initiative in Systems Biology). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by an Interdisciplinary Ph.D. grant from the Swiss National Science Foundation within the initiative SystemsX.ch.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Ben-Naim A., 2010, COOPERATIVITY REGULA, P67; Boggy GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012355; Castelein H, 1996, MOL CELL ENDOCRINOL, V119, P11, DOI 10.1016/0303-7207(96)03794-X; Chakrabarti A, 2013, BIOTECHNOL J, V8, P1043, DOI 10.1002/biot.201300091; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Deplancke Bart, 2009, Briefings in Functional Genomics & Proteomics, V8, P12, DOI 10.1093/bfgp/elp001; Ecevit O, 2010, BIOCHEMISTRY-US, V49, P2627, DOI 10.1021/bi901913a; Ethayathulla AS, 2013, J BIOL CHEM, V288, P4744, DOI 10.1074/jbc.M112.408039; Fordyce PM, 2012, P NATL ACAD SCI USA, V109, pE3084, DOI 10.1073/pnas.1212457109; Funnell APW, 2012, ADV EXP MED BIOL, V747, P105, DOI 10.1007/978-1-4614-3229-6_7; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; Griggs AJ, 2012, BIOTECHNOL BIOENG, V109, P665, DOI 10.1002/bit.23355; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Gubelmann C, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.38; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hill T. L., 1985, COOPERATIVITY THEORY, P167; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; IJpenberg A, 2004, EMBO J, V23, P2083, DOI 10.1038/sj.emboj.7600209; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2011, SUBCELL BIOCHEM, V52, P155, DOI 10.1007/978-90-481-9069-0_7; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Kohler JJ, 2001, BIOCHEMISTRY-US, V40, P130, DOI 10.1021/bi001881p; LEE SB, 1984, BIOTECHNOL BIOENG, V26, P1372, DOI 10.1002/bit.260261115; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Maerkl SJ, 2009, P NATL ACAD SCI USA, V106, P18650, DOI 10.1073/pnas.0907688106; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Metallo SJ, 1997, NAT STRUCT BIOL, V4, P115, DOI 10.1038/nsb0297-115; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Ng CKL, 2012, NUCLEIC ACIDS RES, V40, P4933, DOI 10.1093/nar/gks153; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Okuno M, 2001, BIOCHEM J, V353, P193, DOI 10.1042/0264-6021:3530193; Orenstein Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku117; Osz J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08216; Park S, 2004, BBA-GEN SUBJECTS, V1670, P217, DOI 10.1016/j.bbagen.2003.12.007; Perlmann T, 1996, MOL ENDOCRINOL, V10, P958, DOI 10.1210/me.10.8.958; Raghav SK, 2012, MOL CELL, V46, P335, DOI 10.1016/j.molcel.2012.03.017; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Reginato MJ, 1996, J BIOL CHEM, V271, P28199, DOI 10.1074/jbc.271.45.28199; Shultzaberger RK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002614; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Siggers T, 2014, NUCLEIC ACIDS RES, V42, P2099, DOI 10.1093/nar/gkt1112; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Simicevic J, 2013, NAT METHODS, V10, P570, DOI [10.1038/NMETH.2441, 10.1038/nmeth.2441]; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Todorov VT, 2008, ENDOCRINOLOGY, V149, P4647, DOI 10.1210/en.2008-0127; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; WAHLI W, 1995, CHEM BIOL, V2, P261, DOI 10.1016/1074-5521(95)90045-4; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; ZECHEL C, 1994, EMBO J, V13, P1414, DOI 10.1002/j.1460-2075.1994.tb06395.x; Zhao Y, 2012, GENETICS, V191, P781, DOI 10.1534/genetics.112.138685; Zhou J, 2006, P NATL ACAD SCI USA, V103, P9238, DOI 10.1073/pnas.0603324103	65	18	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10293	10306		10.1074/jbc.M115.691154	http://dx.doi.org/10.1074/jbc.M115.691154			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26912662	hybrid, Green Published			2022-12-28	WOS:000375602800036
J	de Candia, P; De Rosa, V; Casiraghi, M; Matarese, G				de Candia, Paola; De Rosa, Veronica; Casiraghi, Maurizio; Matarese, Giuseppe			Extracellular RNAs: A Secret Arm of Immune System Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CIRCULATING NUCLEIC-ACIDS; T-CELLS; MICRORNA SIGNATURES; EXOSOMES; VESICLES; BIOMARKERS; PLASMA; LYMPHOCYTES; ACTIVATION; ANTIGEN	The immune system has evolved to protect multicellular organisms from the attack of a variety of pathogens. To exert this function efficiently, the system has developed the capacity to coordinate the function of different cell types and the ability to down-modulate the response when the foreign attack is over. For decades, immunologists believed that these two characteristics were primarily related to cytokine/chemokine-based communication and cell-to-cell direct contact. More recently, it has been shown that immune cells also communicate by transferring regulatory RNAs, microRNAs in particular, from one cell to the other. Several studies have suggested a functional role of extracellular regulatory RNAs in cell-to-cell communication in different cellular contexts. This minireview focuses on the potential role of extracellular RNA transfer in the regulation of adaptive immune response, also contextualizing it in a broader field of what is known of cell-free RNAs in communication among different organisms in the evolutionary scale.	[de Candia, Paola] IRCCS MultiMed, I-20138 Milan, Italy; [De Rosa, Veronica] CNR, IEOS, Lab Immunol, I-80131 Naples, Italy; [De Rosa, Veronica] IRCCS Fdn Santa Lucia, Unita NeuroImmunol, I-00142 Rome, Italy; [Casiraghi, Maurizio] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, ZooPlantLab, I-20126 Milan, Italy; [Matarese, Giuseppe] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy	IRCCS Multimedica; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); IRCCS Santa Lucia; University of Milano-Bicocca; University of Naples Federico II	de Candia, P (corresponding author), IRCCS MultiMed, I-20138 Milan, Italy.; Matarese, G (corresponding author), Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy.	paola.decandia@multimedica.it; giuseppe.matarese@unina.it	Casiraghi, Maurizio/E-7273-2011; de Candia, Paola/Z-1498-2019; de Candia, Paola/HGC-8826-2022; Matarese, Giuseppe/AAO-4077-2021	Casiraghi, Maurizio/0000-0002-2733-2094; de Candia, Paola/0000-0003-4767-446X; de Candia, Paola/0000-0003-4767-446X; Matarese, Giuseppe/0000-0001-9429-0616	European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation (EFSD/JDRF)/Lilly Programme; Italian Space Agency (ASI) [2014-033-RO]; Ministero della Salute [GR-2010-2315414]; Fondo per gli Investimenti della Ricerca di Base (FIRB) [RBFR12I3UB_004]; Fondazione Italiana Sclerosi Multipla (FISM) [2014/R/21]; European Foundation for the Study of Diabetes [JDRF Lilly 2015_4] Funding Source: researchfish	European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation (EFSD/JDRF)/Lilly Programme; Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI)); Ministero della Salute(Ministry of Health, Italy); Fondo per gli Investimenti della Ricerca di Base (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); European Foundation for the Study of Diabetes	This work was supported by grants from the European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation (EFSD/JDRF)/Lilly Programme 2015 and the Italian Space Agency (ASI) RadioEBV Grant 2014-033-RO (to G. M.). This work was also supported by the Ministero della Salute Grant GR-2010-2315414, the Fondo per gli Investimenti della Ricerca di Base (FIRB) Grant RBFR12I3UB_004, and the Fondazione Italiana Sclerosi Multipla (FISM) Grant 2014/R/21 (to V. D. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Admyre C, 2008, ALLERGY, V63, P404, DOI 10.1111/j.1398-9995.2007.01600.x; Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; ANKER P, 1975, CANCER RES, V35, P2375; ANKER P, 1980, J IMMUNOGENET, V7, P475; ARCHER SJ, 1978, IMMUNOLOGY, V34, P123; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batagov AO, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-12; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Bronevetsky Y, 2013, IMMUNOL REV, V253, P304, DOI 10.1111/imr.12059; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Butt AN, 2008, ANN NY ACAD SCI, V1137, P236, DOI 10.1196/annals.1448.002; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066577; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; de Candia P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075348; Divekar AA, 2011, J IMMUNOL, V186, P924, DOI 10.4049/jimmunol.1002218; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Forterre A, 2014, CELL CYCLE, V13, P78, DOI 10.4161/cc.26808; FRIEDMAN H, 1973, ANN NY ACAD SCI, V207, P5, DOI 10.1111/j.1749-6632.1973.tb47471.x; Garcia-Silva MR, 2014, PARASITOL RES, V113, P285, DOI 10.1007/s00436-013-3655-1; Goretti E, 2013, INT J CARDIOL, V168, P4548, DOI 10.1016/j.ijcard.2013.06.092; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Gulinelli S, 2012, EUR J IMMUNOL, V42, P3334, DOI 10.1002/eji.201142268; Gutierrez-Vazquez C, 2013, IMMUNOL REV, V251, P125, DOI 10.1111/imr.12013; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kandere-Grzybowska K, 2003, J IMMUNOL, V171, P4830, DOI 10.4049/jimmunol.171.9.4830; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Kim SH, 2007, J IMMUNOL, V179, P2235, DOI 10.4049/jimmunol.179.4.2235; Knip M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004602; Koshland DE, 2002, SCIENCE, V295, P2215, DOI 10.1126/science.1068489; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Liu HJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2071; Lo YMD, 2001, ANN NY ACAD SCI, V945, P1; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Melnik BC, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-43; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; MINDELL DP, 1992, BIOSYSTEMS, V27, P53, DOI 10.1016/0303-2647(92)90046-2; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Morel L, 2013, J BIOL CHEM, V288, P7105, DOI 10.1074/jbc.M112.410944; Moussay E, 2011, P NATL ACAD SCI USA, V108, P6573, DOI 10.1073/pnas.1019557108; NAKAMURA K, 1979, IMMUNOL COMMUN, V8, P511, DOI 10.3109/08820137909063250; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Peche H, 2006, AM J TRANSPLANT, V6, P1541, DOI 10.1111/j.1600-6143.2006.01344.x; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Salvucci O, 2012, HAEMATOL-HEMATOL J, V97, P818, DOI 10.3324/haematol.2011.056945; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; STROUN M, 1978, CANCER RES, V38, P3546; Svenningsen SL, 2009, EMBO J, V28, P429, DOI 10.1038/emboj.2008.300; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tu KC, 2010, MOL CELL, V37, P567, DOI 10.1016/j.molcel.2010.01.022; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wahlgren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049723; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Zhang GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077966; Zhang HG, 2006, J IMMUNOL, V176, P7385, DOI 10.4049/jimmunol.176.12.7385; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang RW, 2015, NEUROMOL MED, V17, P24, DOI 10.1007/s12017-014-8335-5; Zhang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-381; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	98	36	36	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7221	7228		10.1074/jbc.R115.708842	http://dx.doi.org/10.1074/jbc.R115.708842			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26887954	hybrid, Green Published			2022-12-28	WOS:000383447600001
J	Young, SK; Palam, LR; Wu, C; Sachs, MS; Wek, RC				Young, Sara K.; Palam, Lakshmi Reddy; Wu, Cheng; Sachs, Matthew S.; Wek, Ronald C.			Ribosome Elongation Stall Directs Gene-specific Translation in the Integrated Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); eukaryotic initiation factor 2 (eIF2); stress response; translation control; translation initiation; CHOP; DDIT3; GADD153	UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA TRANSLATION; OPEN READING FRAME; ER-STRESS; ENDOPLASMIC-RETICULUM; NEUROSPORA-CRASSA; CELL-DEATH; CHOP; TRANSCRIPTION; PHOSPHORYLATION	Upon exposure to environmental stress, phosphorylation of the subunit of eIF2 (eIF2-P) represses global protein synthesis, coincident with preferential translation of gene transcripts that mitigate stress damage or alternatively trigger apoptosis. Because there are multiple mammalian eIF2 kinases, each responding to different stress arrangements, this translational control scheme is referred to as the integrated stress response (ISR). Included among the preferentially translated mRNAs induced by eIF2-P is that encoding the transcription factor CHOP (DDIT3/GADD153). Enhanced levels of CHOP promote cell death when ISR signaling is insufficient to restore cell homeostasis. Preferential translation of CHOP mRNA occurs by a mechanism involving ribosome bypass of an inhibitory upstream ORF (uORF) situated in the 5-leader of the CHOP mRNA. In this study, we used biochemical and genetic approaches to define the inhibitory features of the CHOP uORF and the biological consequences of loss of the CHOP uORF on CHOP expression during stress. We discovered that specific sequences within the CHOP uORF serve to stall elongating ribosomes and prevent ribosome reinitiation at the downstream CHOP coding sequence. As a consequence, deletion of the CHOP uORF substantially increases the levels and modifies the pattern of induction of CHOP expression in the ISR. Enhanced CHOP expression leads to increased expression of key CHOP target genes, culminating in increased cell death in response to stress.	[Young, Sara K.; Palam, Lakshmi Reddy; Wek, Ronald C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA; [Wu, Cheng; Sachs, Matthew S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station	Wek, RC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iu.edu		Young-Baird, Sara/0000-0002-8915-3139; Sachs, Matthew/0000-0001-9891-9223	National Institutes of Health [GM049164]; Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R29GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM049164 (to R. C. W.) and the Ralph W. and Grace M. Showalter Research Trust Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Fang P, 2004, P NATL ACAD SCI USA, V101, P4059, DOI 10.1073/pnas.0400554101; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fawcett TW, 1996, J BIOL CHEM, V271, P14285, DOI 10.1074/jbc.271.24.14285; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oslowski Christine M, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P107, DOI 10.1097/MED.0b013e3283372843; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Teske BF, 2013, MOL BIOL CELL, V24, P2477, DOI 10.1091/mbc.E13-01-0067; Teske BF, 2011, METHOD ENZYMOL, V490, P333, DOI 10.1016/B978-0-12-385114-7.00019-2; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang Z, 1997, J BIOL CHEM, V272, P255; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; Young SK, 2015, J BIOL CHEM, V290, P28257, DOI 10.1074/jbc.M115.693184; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	31	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6546	6558		10.1074/jbc.M115.705640	http://dx.doi.org/10.1074/jbc.M115.705640			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26817837	hybrid, Green Published			2022-12-28	WOS:000372894200040
J	Douglas, ME; Diffley, JFX				Douglas, Max E.; Diffley, John F. X.			Recruitment of Mcm10 to Sites of Replication Initiation Requires Direct Binding to the Minichromosome Maintenance (MCM) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA polymerase; DNA replication; DNA synthesis; protein-DNA interaction; mcm10; replication origin	EUKARYOTIC DNA-REPLICATION; IN-VITRO; CHROMATIN ASSOCIATION; POLYMERASE-ALPHA; ORIGIN DNA; HELICASE; YEAST; PROTEINS; ARCHITECTURE; CEREVISIAE	Mcm10 is required for the initiation of eukaryotic DNA replication and contributes in some unknown way to the activation of the Cdc45-MCM-GINS (CMG) helicase. How Mcm10 is localized to sites of replication initiation is unclear, as current models indicate that direct binding to minichromosome maintenance (MCM) plays a role, but the details and functional importance of this interaction have not been determined. Here, we show that purified Mcm10 can bind both DNA-bound double hexamers and soluble single hexamers of MCM. The binding of Mcm10 to MCM requires the Mcm10 C terminus. Moreover, the binding site for Mcm10 on MCM includes the Mcm2 and Mcm6 subunits and overlaps that for the loading factor Cdt1. Whether Mcm10 recruitment to replication origins depends on CMG helicase assembly has been unclear. We show that Mcm10 recruitment occurs via two modes: low affinity recruitment in the absence of CMG assembly (G(1)-like) and high affinity recruitment when CMG assembly takes place (S-phase-like). Mcm10 that cannot bind directly to MCM is defective in both modes of recruitment and is unable to support DNA replication. These findings indicate that Mcm10 is localized to replication initiation sites by directly binding MCM through the Mcm10 C terminus.	[Douglas, Max E.; Diffley, John F. X.] Francis Crick Inst, Clare Hall Lab, S Mimms EN6 3LD, Herts, England		Diffley, JFX (corresponding author), Francis Crick Inst, Clare Hall Lab, S Mimms EN6 3LD, Herts, England.	john.diffley@crick.ac.uk		Diffley, John/0000-0001-5184-7680; Douglas, Max/0000-0003-1186-7163	Cancer Research UK; Francis Crick Institute; Wellcome Senior Investigator Award [106252/Z/14/Z]; Cancer Research UK [15669] Funding Source: researchfish; Wellcome Trust [106252/Z/14/Z] Funding Source: researchfish; Worldwide Cancer Research [10-0270] Funding Source: researchfish; The Francis Crick Institute [10273, 10066] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Francis Crick Institute; Wellcome Senior Investigator Award; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Worldwide Cancer Research; The Francis Crick Institute	This work was supported by Cancer Research UK, the Francis Crick Institute, and a Wellcome Senior Investigator Award (106252/Z/14/Z) ( to J. F. X. D.) The authors declare that they have no conflicts of interest with the contents of this article.	Apger J, 2010, GENETICS, V185, P1151, DOI 10.1534/genetics.110.117234; Costa A, 2013, ANNU REV BIOCHEM, V82, P25, DOI 10.1146/annurev-biochem-052610-094414; Coster G, 2014, MOL CELL, V55, P666, DOI 10.1016/j.molcel.2014.06.034; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Du WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070518; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fernandez-Cid A, 2013, MOL CELL, V50, P577, DOI 10.1016/j.molcel.2013.03.026; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Gros J, 2014, EMBO J, V33, P621, DOI 10.1002/embj.201387278; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kanke M, 2012, EMBO J, V31, P2182, DOI 10.1038/emboj.2012.68; Lee C, 2010, MOL CELL BIOL, V30, P423, DOI 10.1128/MCB.01240-09; Li NN, 2015, NATURE, V524, P186, DOI 10.1038/nature14685; MAINE GT, 1984, GENETICS, V106, P365; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; On KF, 2014, EMBO J, V33, P605, DOI 10.1002/embj.201387369; Raveendranathan M, 2006, EMBO J, V25, P3627, DOI 10.1038/sj.emboj.7601251; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Ticau S, 2015, CELL, V161, P513, DOI 10.1016/j.cell.2015.03.012; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Watase G, 2012, CURR BIOL, V22, P343, DOI 10.1016/j.cub.2012.01.023; Wei Z, 2010, J BIOL CHEM, V285, P12469, DOI 10.1074/jbc.C109.094599; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Zhang JJ, 2010, CELL CYCLE, V9, P4848, DOI 10.4161/cc.9.24.14136	33	31	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5879	5888		10.1074/jbc.M115.707802	http://dx.doi.org/10.1074/jbc.M115.707802			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26719337	Green Published, hybrid			2022-12-28	WOS:000372551800034
J	Mita, T; Mayanagi, T; Ichijo, H; Fukumoto, K; Otsuka, K; Sakai, A; Sobue, K				Mita, Toshinari; Mayanagi, Taira; Ichijo, Hiroshi; Fukumoto, Kentaro; Otsuka, Kotaro; Sakai, Akio; Sobue, Kenji			Docosahexaenoic Acid Promotes Axon Outgrowth by Translational Regulation of Tau and Collapsin Response Mediator Protein 2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurite outgrowth; neurodevelopment; neuron; PUFA; S6 kinase; translation control	POLYUNSATURATED FATTY-ACIDS; HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH; BRAIN-DEVELOPMENT; TERM INFANTS; RAT; SUPPLEMENTATION; MICROTUBULES; GROWTH; AKT	n-3 PUFAs are essential for neuronal development and brain function. However, the molecular mechanisms underlying their biological effects remain unclear. Here we examined the mechanistic action of docosahexaenoic acid (DHA), the most abundant n-3 polyunsaturated fatty acids in the brain. We found that DHA treatment of cortical neurons resulted in enhanced axon outgrowth that was due to increased axon elongation rates. DHA-mediated axon outgrowth was accompanied by the translational up-regulation of Tau and collapsin response mediator protein 2 (CRMP2), two important axon-related proteins, and the activation of Akt and p70 S6 kinase. Consistent with these findings, rapamycin, a potent inhibitor of mammalian target of rapamycin (mTOR), prevented DHA-mediated axon outgrowth and up-regulation of Tau and CRMP2. In addition, DHA-dependent activation of the Akt-mTOR-S6K pathway enhanced 5-terminal oligopyrimidine tract-dependent translation of Tau and CRMP2. Therefore, our results revealed an important role for the Akt-mTOR-S6K pathway in DHA-mediated neuronal development.	[Mita, Toshinari; Mayanagi, Taira; Ichijo, Hiroshi; Fukumoto, Kentaro; Sobue, Kenji] Iwate Med Univ, Inst Biomed Sci, Dept Neurosci, Yahaba, Iwate 0283694, Japan; [Mita, Toshinari; Fukumoto, Kentaro; Otsuka, Kotaro; Sakai, Akio] Iwate Med Univ, Sch Med, Dept Neuropsychiat, Morioka, Iwate 0208505, Japan	Iwate Medical University; Iwate Medical University	Sobue, K (corresponding author), Iwate Med Univ, Inst Biomed Sci, Dept Neurosci, Yahaba, Iwate 0283694, Japan.	ksobue@iwate-med.ac.jp			Japan Society for the Promotion of Science KAKENHI Grants [20240038, 23110510, 25110728, 21700352, 15K21319, 22791124, 24791229]	Japan Society for the Promotion of Science KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 20240038, 23110510, and 25110728 (to K. S.); 21700352 and 15K21319 (to T. M.); and 22791124 and 24791229 (to K. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; AVELDANO MI, 1973, BIOCHIM BIOPHYS ACTA, V296, P1, DOI 10.1016/0005-2760(73)90038-6; Black MM, 1996, J NEUROSCI, V16, P3601; Calderon F, 2004, J NEUROCHEM, V90, P979, DOI 10.1111/j.1471-4159.2004.02520.x; Cao DH, 2005, J NUTR BIOCHEM, V16, P538, DOI 10.1016/j.jnutbio.2005.02.002; Chung WL, 2008, J NUTR, V138, P1165, DOI 10.1093/jn/138.6.1165; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Fukumoto K, 2009, MOL PSYCHIATR, V14, P1119, DOI 10.1038/mp.2009.60; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Gawrisch K, 2003, LIPIDS, V38, P445, DOI 10.1007/s11745-003-1082-0; Green P, 1998, J NEUROSCI RES, V52, P129, DOI 10.1002/(SICI)1097-4547(19980415)52:2<129::AID-JNR1>3.0.CO;2-C; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Innis SM, 2001, J PEDIATR-US, V139, P532, DOI 10.1067/mpd.2001.118429; Jorgensen MH, 2001, J PEDIATR GASTR NUTR, V32, P293, DOI 10.1097/00005176-200103000-00011; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; McNamara RK, 2010, AM J CLIN NUTR, V91, P1060, DOI 10.3945/ajcn.2009.28549; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Morse NL, 2012, NUTRIENTS, V4, P799, DOI 10.3390/nu4070799; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; SINCLAIR AJ, 1975, LIPIDS, V10, P175, DOI 10.1007/BF02534156; WAINWRIGHT PE, 1994, DEV PSYCHOBIOL, V27, P467, DOI 10.1002/dev.420270705; Xiao Y, 2005, BRIT J NUTR, V94, P544, DOI 10.1079/BJN20051539; Ye T, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00217; Yoshida S, 1997, J NEUROCHEM, V68, P1261; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	37	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4955	4965		10.1074/jbc.M115.693499	http://dx.doi.org/10.1074/jbc.M115.693499			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26763232	hybrid, Green Published			2022-12-28	WOS:000371640600011
J	Gorski, JP; Huffman, NT; Vallejo, J; Brotto, L; Chittur, SV; Breggia, A; Stern, A; Huang, J; Mo, CL; Seidah, NG; Bonewald, L; Brotto, M				Gorski, Jeff P.; Huffman, Nichole T.; Vallejo, Julian; Brotto, Leticia; Chittur, Sridar V.; Breggia, Anne; Stern, Amber; Huang, Jian; Mo, Chenglin; Seidah, Nabil G.; Bonewald, Lynda; Brotto, Marco			Deletion of Mbtps1 (Pcsk8, S1p, Ski-1) Gene in Osteocytes Stimulates Soleus Muscle Regeneration and Increased Size and Contractile Force with Age	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SATELLITE CELL ACTIVATION; SKELETAL-MUSCLE; PROPROTEIN CONVERTASE; TRANSGENIC OVEREXPRESSION; TRANSCRIPTION FACTOR; SITE-1 PROTEASE; MYOSIN; EXPRESSION; MICE; KNOCKOUT	Conditional deletion of Mbtps1 (cKO) protease in bone osteocytes leads to an age-related increase in mass (12%) and in contractile force (30%) in adult slow twitch soleus muscles (SOL) with no effect on fast twitch extensor digitorum longus muscles. Surprisingly, bone from 10-12-month-old cKO animals was indistinguishable from controls in size, density, and morphology except for a 25% increase in stiffness. cKO SOL exhibited increased expression of Pax7, Myog, Myod1, Notch, and Myh3 and 6-fold more centralized nuclei, characteristics of postnatal regenerating muscle, but only in type I myosin heavy chain-expressing cells. Increased expression of gene pathways mediating EGF receptor signaling, circadian exercise, striated muscle contraction, and lipid and carbohydrate oxidative metabolism were also observed in cKO SOL. This muscle phenotype was not observed in 3-month-old mice. Although Mbtps1 mRNA and protein expression was reduced in cKO bone osteocytes, no differences in Mbtps1 or cre recombinase expression were observed in cKO SOL, explaining this age-related phenotype. Understanding bone-muscle cross-talk may provide a fresh and novel approach to prevention and treatment of age-related muscle loss.	[Gorski, Jeff P.; Huffman, Nichole T.; Bonewald, Lynda] Univ Missouri, Sch Dent, Ctr Excellence Study Dent & Musculoskeletal Tissu, Dept Oral & Craniofacial Sci, Kansas City, MO 64108 USA; [Vallejo, Julian; Brotto, Leticia; Huang, Jian; Mo, Chenglin; Brotto, Marco] Univ Missouri, Sch Nursing & Hlth Studies, Muscle Biol Res Grp, Kansas City, MO 64108 USA; [Stern, Amber] Univ Missouri, Sch Comp & Engn, Kansas City, MO 64108 USA; [Chittur, Sridar V.] SUNY Albany, Ctr Funct Gen, Albany, NY 12144 USA; [Breggia, Anne] Maine Med Ctr, Portland, ME 04102 USA; [Stern, Amber] Engn Syst Inc, Charlotte, NC 28277 USA; [Seidah, Nabil G.] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Brotto, Leticia; Huang, Jian; Mo, Chenglin; Brotto, Marco] Univ Texas Arlington, Coll Nursing & Hlth Innovat, Bone Muscle Collaborat Sci, Arlington, TX 76019 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Maine Medical Center; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Texas System; University of Texas Arlington	Gorski, JP (corresponding author), Univ Missouri, Sch Dent, Ctr Excellence Study Dent & Musculoskeletal Tissu, Dept Oral & Craniofacial Sci, Kansas City, MO 64108 USA.	gorskij@umkc.edu	/W-2676-2019; Bonewald, Lynda/Q-3638-2019; Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342; Stern, Amber/0000-0002-1013-8818	National Institutes of Health [AR052775, P01 AG039355, RC2 AR058962]; Canada Research Chair [216684]; University of Missouri Research Board bridging grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR058962, R01AR052775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG039355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); University of Missouri Research Board bridging grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AR052775 (to J. P. G.), P01 AG039355 (to L. B. and M. B.), and RC2 AR058962 (to L. B. and M. B.); Canada Research Chair 216684 (to N. G. S.); and a University of Missouri Research Board bridging grant (to J. P. G.). The authors have no conflict of interest to disclose regarding the work presented in this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharjee S, 2014, J CELL SCI, V127, P599, DOI 10.1242/jcs.136648; Achilleos A, 2015, HUM MOL GENET, V24, P2884, DOI 10.1093/hmg/ddv050; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; APPELL HJ, 1988, INT J SPORTS MED, V9, P297, DOI 10.1055/s-2007-1025026; Asmussen G, 2003, EXP NEUROL, V184, P758, DOI 10.1016/S0014-4886(03)00294-2; BLANAR MA, 1995, P NATL ACAD SCI USA, V92, P5870, DOI 10.1073/pnas.92.13.5870; Brotto MAP, 2004, CELL RES, V14, P373, DOI 10.1038/sj.cr.7290237; Brotto M, 2014, CURR OSTEOPOROS REP, V12, P135, DOI 10.1007/s11914-014-0209-0; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Chatterjee S, 2015, EXP CELL RES, V331, P200, DOI 10.1016/j.yexcr.2014.08.041; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Deb C, 2012, GROWTH HORM IGF RES, V22, P173, DOI 10.1016/j.ghir.2012.05.003; Del Prete Z, 2008, ANN BIOMED ENG, V36, P1281, DOI 10.1007/s10439-008-9496-x; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Fougerousse F, 2003, MUSCLE NERVE, V27, P616, DOI 10.1002/mus.10368; Galbiati F, 2000, P NATL ACAD SCI USA, V97, P9689, DOI 10.1073/pnas.160249097; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gorski JP, 2011, J BIOL CHEM, V286, P1836, DOI 10.1074/jbc.M110.151647; GROUNDS MD, 1992, CELL TISSUE RES, V267, P99, DOI 10.1007/BF00318695; Hamaguchi H, 2004, BIOCHEM J, V382, P43, DOI 10.1042/BJ20031760; Herzog W, 2014, J EXP BIOL, V217, P2825, DOI 10.1242/jeb.099127; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Huffman NT, 2007, J BIOL CHEM, V282, P26002, DOI 10.1074/jbc.M701332200; Jahn K, 2012, EUR CELLS MATER, V24, P197; Jahn K, 2012, EUR CELLS MATER, V24, P209; Kalhovde JM, 2005, J PHYSIOL-LONDON, V562, P847, DOI 10.1113/jphysiol.2004.073684; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Lagord C, 1998, CELL TISSUE RES, V291, P455, DOI 10.1007/s004410051015; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Leroy MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071770; Li Y, 2011, J NEUROSCI, V31, P13191, DOI 10.1523/JNEUROSCI.2953-11.2011; Li ZL, 1997, J CELL BIOL, V139, P129, DOI 10.1083/jcb.139.1.129; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; Mangner N, 2012, MUSCLE NERVE, V45, P544, DOI 10.1002/mus.22318; Mathes AL, 2011, MUSCLE NERVE, V43, P733, DOI 10.1002/mus.21959; MATSUDA R, 1983, DEV BIOL, V100, P478, DOI 10.1016/0012-1606(83)90240-3; Matsuura T, 2007, J ORTHOP RES, V25, P1534, DOI 10.1002/jor.20451; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mo Chenglin, 2012, Recent Pat Biotechnol, V6, P223; MOORE BJ, 1993, J APPL PHYSIOL, V75, P522, DOI 10.1152/jappl.1993.75.2.522; Newlands S, 1998, GENE DEV, V12, P2748, DOI 10.1101/gad.12.17.2748; Norman B, 2014, J APPL PHYSIOL, V116, P1197, DOI 10.1152/japplphysiol.00557.2013; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Park KH, 2012, JOVE-J VIS EXP, DOI 10.3791/4198; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Personius KE, 2010, J APPL PHYSIOL, V109, P886, DOI 10.1152/japplphysiol.00300.2010; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Pullikotil P, 2007, J BIOL CHEM, V282, P27402, DOI 10.1074/jbc.M703200200; Rassier DE, 2005, BIOL LETTERS, V1, P342, DOI 10.1098/rsbl.2005.0337; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; SARTORE S, 1982, NATURE, V298, P294, DOI 10.1038/298294a0; SCHMALBRUCH H, 1976, TISSUE CELL, V8, P673, DOI 10.1016/0040-8166(76)90039-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Shen H, 2015, J BONE MINER RES, V30, P596, DOI 10.1002/jbmr.2389; Shen JH, 2009, NAT CELL BIOL, V11, P769, DOI 10.1038/ncb1884; Sun H, 2007, J CELL BIOL, V177, P647, DOI 10.1083/jcb.200609007; Thornton AM, 2011, AGING-US, V3, P621, DOI 10.18632/aging.100335; WARHOL MJ, 1985, AM J PATHOL, V118, P331; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; Weiss A, 1999, J MOL BIOL, V290, P61, DOI 10.1006/jmbi.1999.2865; Wu T, 2010, PHYSIOL RES, V59, P581, DOI 10.33549/physiolres.931818; Xiao ZS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104154; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Yang N, 2009, MED SPORT SCI, V54, P88, DOI 10.1159/000235698; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005	80	24	25	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4308	4322		10.1074/jbc.M115.686626	http://dx.doi.org/10.1074/jbc.M115.686626			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26719336	Green Published, hybrid			2022-12-28	WOS:000371604600004
J	Wang, Y; Pannuri, AA; Ni, DC; Zhou, HZ; Cao, XO; Lu, XM; Romeo, T; Huang, YH				Wang, Yan; Pannuri, Archana Andole; Ni, Dongchun; Zhou, Haizhen; Cao, Xiou; Lu, Xiaomei; Romeo, Tony; Huang, Yihua			Structural Basis for Translocation of a Biofilm-supporting Exopolysaccharide across the Bacterial Outer Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSACCHARIDE ADHESIN; MOLECULAR-DYNAMICS; PROTEIN; PGAABCD; SELECTIVITY; PERMEATION; MECHANISMS; PROTECTION; TRANSPORT; COMPONENT	The partially de-N-acetylated poly-beta-1,6-N-acetyl-D-glucosamine (dPNAG) polymer serves as an intercellular biofilm adhesin that plays an essential role for the development and maintenance of integrity of biofilms of diverse bacterial species. Translocation of dPNAG across the bacterial outer membrane is mediated by a tetratricopeptide repeat-containing outer membrane protein, PgaA. To understand the molecular basis of dPNAG translocation, we determined the crystal structure of the C-terminal transmembrane domain of PgaA (residues 513807). The structure reveals that PgaA forms a 16-strand trans membrane beta-barrel, closed by four loops on the extracellular surface. Half of the interior surface of the barrel that lies parallel to the translocation pathway is electronegative, suggesting that the corresponding negatively charged residues may assist the secretion of the positively charged dPNAG polymer. In vivo complementation assays in a pgaA deletion bacterial strain showed that a cluster of negatively charged residues proximal to the periplasm is necessary for biofilm formation. Biochemical analyses further revealed that the tetratricopeptide repeat domain of PgaA binds directly to the N-deacetylase PgaB and is critical for biofilm formation. Our studies support a model in which the positively charged PgaB-bound dPNAG polymer is delivered to PgaA through the PgaA-PgaB interaction and is further targeted to the beta-barrel lumen of PgaA potentially via a charge complementarity mechanism, thus priming the translocation of dPNAG across the bacterial outer membrane.	[Wang, Yan; Zhou, Haizhen; Huang, Yihua] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wang, Yan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Pannuri, Archana Andole; Romeo, Tony] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Ni, Dongchun] Tianjin Xiqing Hosp, Dept Cardiovasc Dis, Tianjin 300380, Peoples R China; [Cao, Xiou] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Lu, Xiaomei] Eighth Peoples Hosp Dongguan, Dongguan Inst Pediat, Dongguan 523325, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; State University System of Florida; University of Florida; Peking University	Huang, YH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Romeo, T (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	tromeo@ufl.edu; yihuahuang@sun5.ibp.ac.cn	Cao, Xiou/K-4619-2019	Cao, Xiou/0000-0001-7202-6582	National Institutes of Health [GM059969, GM066794]; National Natural Science Foundation of China [31470743, 31170698]; Ministry of Science and Technology (China) "973" Project [2013CB910603, 2012CB917302]; Chinese Academy of Sciences [XDB08020302]; University of Florida CHRIS Project [FLA-MCS-004949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059969, R01GM066794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (China) "973" Project; Chinese Academy of Sciences(Chinese Academy of Sciences); University of Florida CHRIS Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM059969 and GM066794 (to T. R.). This work was also supported by National Natural Science Foundation of China Grants 31470743 and 31170698 (to Y. H.), Ministry of Science and Technology (China) "973" Project Grants 2013CB910603 and 2012CB917302 (to Y. H.), Chinese Academy of Sciences Grant XDB08020302 (to Y. H.), and University of Florida CHRIS Project FLA-MCS-004949 (to T. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amini S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000432; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bentancor LV, 2012, INFECT IMMUN, V80, P651, DOI 10.1128/IAI.05653-11; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Cerca N, 2007, P NATL ACAD SCI USA, V104, P7528, DOI 10.1073/pnas.0700630104; Chen KM, 2014, MICROB PATHOGENESIS, V77, P89, DOI 10.1016/j.micpath.2014.11.005; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figueroa-Bossi N, 2014, GENE DEV, V28, P1239, DOI 10.1101/gad.240192.114; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gening ML, 2010, INFECT IMMUN, V78, P764, DOI 10.1128/IAI.01093-09; Gruss F, 2013, NAT STRUCT MOL BIOL, V20, P1318, DOI 10.1038/nsmb.2689; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7; Irie Y, 2012, P NATL ACAD SCI USA, V109, P20632, DOI 10.1073/pnas.1217993109; Itoh Y, 2005, J BACTERIOL, V187, P382, DOI 10.1128/JB.187.1.382-387.2005; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Keiski CL, 2010, STRUCTURE, V18, P265, DOI 10.1016/j.str.2009.11.015; Kutzner C, 2011, BIOPHYS J, V101, P809, DOI 10.1016/j.bpj.2011.06.010; Little DJ, 2014, P NATL ACAD SCI USA, V111, P11013, DOI 10.1073/pnas.1406388111; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Lu X, 2014, MBIO, V5, DOI 10.1128/mBio.00974-14; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Messiaen AS, 2014, J CYST FIBROS, V13, P56, DOI 10.1016/j.jcf.2013.07.004; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannuri A, 2012, J BACTERIOL, V194, P79, DOI 10.1128/JB.06209-11; Russo TA, 1998, J BACTERIOL, V180, P338, DOI 10.1128/JB.180.2.338-349.1998; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315; Subbarao GV, 2006, J MOL BIOL, V360, P750, DOI 10.1016/j.jmb.2006.05.045; Tan JQ, 2014, ACTA CRYSTALLOGR D, V70, P2054, DOI 10.1107/S1399004714001850; Tanabe M, 2010, P NATL ACAD SCI USA, V107, P6811, DOI 10.1073/pnas.0912115107; Venketaraman V, 2008, MICROB PATHOGENESIS, V45, P173, DOI 10.1016/j.micpath.2008.05.007; Wan Z, 2013, MOL MICROBIOL, V88, P486, DOI 10.1111/mmi.12199; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108; WUNDER DE, 1994, J BACTERIOL, V176, P4025, DOI 10.1128/JB.176.13.4025-4033.1994; Yakandawala N, 2011, APPL ENVIRON MICROB, V77, P8303, DOI 10.1128/AEM.05814-11	48	28	28	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10046	10057		10.1074/jbc.M115.711762	http://dx.doi.org/10.1074/jbc.M115.711762			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26957546	hybrid, Green Published			2022-12-28	WOS:000375602800017
J	Puntambekar, SS; Nyayanit, D; Saxena, P; Gadgil, CJ				Puntambekar, Shraddha S.; Nyayanit, Dimpal; Saxena, Priyanka; Gadgil, Chetan J.			Identification of Unintuitive Features of Sumoylation through Mathematical Modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO PATHWAY; UBIQUITIN; CONJUGATION; REGULATOR; ENZYMES; ROLES; UBC9; E1	Sumoylation is a multistep, multienzymatic post-translational modification in which a small ubiquitin-like modifier protein (SUMO) is attached to the target. We present the first mathematical model for sumoylation including enzyme mechanism details such as autosumoylation of E2 and multifunctional nature of SENP. Simulations and analysis reveal three nonobvious properties for the long term response, modeled as an open system: (i) the steady state sumoylation level is robust to variation in several enzyme properties; (ii) even when autosumoylation of E2 results in equal or higher activity, the target sumoylation levels are lower; and (iii) there is an optimal SENP concentration at which steady state target sumoylation level is maximum. These results are qualitatively different for a short term response modeled as a closed system, where e.g. sumoylation always decreases with increasing SENP levels. Simulations with multiple targets suggest that the available SUMO is limiting, indicating a possible explanation for the experimentally observed low fractional sumoylation. We predict qualitative differences in system responses at short post-translational and longer transcriptional time scales. We thus use this mechanism-based model to explain system properties and generate testable hypotheses for existence and mechanism of unexpected responses.	[Puntambekar, Shraddha S.; Nyayanit, Dimpal; Gadgil, Chetan J.] CSIR Natl Chem Lab, Chem Engn & Proc Dev Div, Pune 411008, Maharashtra, India; [Puntambekar, Shraddha S.; Nyayanit, Dimpal; Saxena, Priyanka; Gadgil, Chetan J.] Acad Sci & Innovat Res AcSIR, CSIR NCL Campus, Pune 411008, Maharashtra, India; [Saxena, Priyanka; Gadgil, Chetan J.] CSIR Inst Genom & Integrat Biol, New Delhi 110020, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Gadgil, CJ (corresponding author), CSIR Natl Chem Lab, Chem Engn & Proc Dev Div, Pune 411008, Maharashtra, India.	cj.gadgil@ncl.res.in			Department of Biotechnology-Bioinformatics National Certification (DBT-BINC) fellowship; University Grants Commission fellowship; Council of Scientific and Industrial Research fellowship; NCL-IGIB Joint Research Initiative project [BSC0124]	Department of Biotechnology-Bioinformatics National Certification (DBT-BINC) fellowship; University Grants Commission fellowship(University Grants Commission, India); Council of Scientific and Industrial Research fellowship(Council of Scientific & Industrial Research (CSIR) - India); NCL-IGIB Joint Research Initiative project	This work was supported by a Department of Biotechnology-Bioinformatics National Certification (DBT-BINC) fellowship (to S. S. P.), a University Grants Commission fellowship (to D. N.), a Council of Scientific and Industrial Research fellowship (to P. S.), and funds from the BSC0124 NCL-IGIB Joint Research Initiative project. The authors declare that they have no conflicts of interest with the contents of this article.	Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bawa-Khalfe T, 2010, SUBCELL BIOCHEM, V54, P170, DOI 10.1007/978-1-4419-6676-6_14; Bhaskar V, 2002, MOL CELL BIOL, V22, P492, DOI 10.1128/MCB.22.2.492-504.2002; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Denuc A, 2010, BIOCHEM SOC T, V38, P34, DOI 10.1042/BST0380034; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Lee D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05573; Liu JL, 2005, BIOPHYS J, V88, P3212, DOI 10.1529/biophysj.104.056085; Lopez-Canovas F. J., 2010, J BIOMED SCI ENG, V3, P274; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Reverter David, 2009, V497, P225, DOI 10.1007/978-1-59745-566-4_15; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Truong K, 2011, BIOCHEMISTRY-US, V50, P5757, DOI 10.1021/bi2001856; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; Wang JH, 2010, J BIOL CHEM, V285, P23732, DOI 10.1074/jbc.M110.114660; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; Wang YE, 2012, BIOL CELL, V104, P121, DOI 10.1111/boc.201100105; Watts FZ, 2013, CHROMOSOMA, V122, P451, DOI 10.1007/s00412-013-0422-0; Xu LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034616; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	26	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9458	9468		10.1074/jbc.M115.676122	http://dx.doi.org/10.1074/jbc.M115.676122			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26861881	Green Published, hybrid			2022-12-28	WOS:000375602300007
J	Lamas-Maceiras, M; Singh, BN; Hampsey, M; Freire-Picos, MA				Lamas-Maceiras, Monica; Singh, Badri Nath; Hampsey, Michael; Freire-Picos, Maria A.			Promoter-Terminator Gene Loops Affect Alternative 3 '-End Processing in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; MESSENGER-RNA; TRANSCRIPTION TERMINATION; KLUYVEROMYCES-LACTIS; POLYADENYLATION; PHOSPHATASE; EXPRESSION; COMPLEX; SSU72; CONSEQUENCES	Many eukaryotic genes undergo alternative 3'-end poly(A)site selection producing transcript isoforms with 3'-UTRs of different lengths and post-transcriptional fates. Gene loops are dynamic structures that juxtapose the 3'-ends of genes with their promoters. Several functions have been attributed to looping, including memory of recent transcriptional activity and polarity of transcription initiation. In this study, we investigated the relationship between gene loops and alternative poly(A)site. Using the KlCYC1 gene of the yeast Kluyveromyces lactis, which includes a single promoter and two poly(A) sites separated by 394 nucleotides, we demonstrate in two yeast species the formation of alternative gene loops (L1 and L2) that juxtapose the KlCYC1 promoter with either proximal or distal 3'-end processing sites, resulting in the synthesis of short and long forms of KlCYC1 mRNA. Furthermore, synthesis of short and long mRNAs and formation of the L1 and L2 loops are growth phase-dependent. Chromatin immunoprecipitation experiments revealed that the Ssu72 RNA polymerase II carboxyl-terminal domain phosphatase, a critical determinant of looping, peaks in early log phase at the proximal poly(A) site, but as growth phase advances, it extends to the distal site. These results define a cause-and-effect relationship between gene loops and alternative poly(A) site selection that responds to different physiological signals manifested by RNA polymerase II carboxyl-terminal domain phosphorylation status.	[Lamas-Maceiras, Monica; Freire-Picos, Maria A.] Univ A Coruna, Fac Ciencias, Dept Biol Celular & Mol, Campus A Coruna,Rua Fraga 10, La Coruna 15008, Spain; [Singh, Badri Nath; Hampsey, Michael] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Universidade da Coruna; Rutgers State University New Brunswick; Rutgers State University Medical Center	Freire-Picos, MA (corresponding author), Univ A Coruna, Fac Ciencias, Dept Biol Celular & Mol, Campus A Coruna,Rua Fraga 10, La Coruna 15008, Spain.	mafreire@udc.es	Singh, Badri/P-5848-2015	Singh, Badri/0000-0002-6100-7092; Lamas, Monica/0000-0001-8025-2838	Spanish Ministerio de Ciencia y Tecnologia; National Institutes of Health [R01 GM39484]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039484] Funding Source: NIH RePORTER	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Jose Castillejo fellowship from the Spanish Ministerio de Ciencia y Tecnologia (to M. L.-M.) and by National Institutes of Health Grant R01 GM39484 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Di Giammartino DC, 2014, GENE DEV, V28, P2248, DOI 10.1101/gad.245787.114; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; El Kaderi B, 2009, J BIOL CHEM, V284, P25015, DOI 10.1074/jbc.M109.007948; Freire-Picos MA, 2001, YEAST, V18, P1347, DOI 10.1002/yea.787; FREIREPICOS MA, 1995, FEBS LETT, V360, P39, DOI 10.1016/0014-5793(95)00016-3; FREIREPICOS MA, 1994, GENE, V139, P43, DOI 10.1016/0378-1119(94)90521-5; Gruber AR, 2014, WIRES RNA, V5, P183, DOI 10.1002/wrna.1206; Guisbert KSK, 2007, PLOS BIOL, V5, P15, DOI 10.1371/journal.pbio.0050006; Hall-Pogar T, 2005, NUCLEIC ACIDS RES, V33, P2565, DOI 10.1093/nar/gki544; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Hoopes BC, 2000, NUCLEIC ACIDS RES, V28, P4435, DOI 10.1093/nar/28.22.4435; Jimeno S, 2011, MOL CELL BIOL, V31, P674, DOI 10.1128/MCB.01188-10; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Liu DL, 2008, J BIOL CHEM, V283, P28010, DOI 10.1074/jbc.M804895200; Lutz CS, 2011, WIRES RNA, V2, P22, DOI 10.1002/wrna.47; Mischo HE, 2013, BBA-GENE REGUL MECH, V1829, P174, DOI 10.1016/j.bbagrm.2012.10.003; Miura P, 2014, BIOESSAYS, V36, P766, DOI 10.1002/bies.201300174; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Rosado-Lugo JD, 2014, J BIOL CHEM, V289, P33916, DOI 10.1074/jbc.M114.608695; Schwartz GG, 1998, CANCER EPIDEM BIOMAR, V7, P391; Seoane S, 2005, J BIOTECHNOL, V118, P149, DOI 10.1016/j.jbiotec.2005.03.003; Seoane S, 2009, FEBS LETT, V583, P2843, DOI 10.1016/j.febslet.2009.07.042; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Singh BN, 2009, METHODS, V48, P361, DOI 10.1016/j.ymeth.2009.02.018; Sparks KA, 1998, NUCLEIC ACIDS RES, V26, P4676, DOI 10.1093/nar/26.20.4676; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Xiang KH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1947; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Yu LJ, 2013, NUCLEIC ACIDS RES, V41, P3104, DOI 10.1093/nar/gkt020; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhang DW, 2012, J BIOL CHEM, V287, P8541, DOI 10.1074/jbc.M111.335687; Zhang Y, 2011, BIOCHEM J, V434, P435, DOI 10.1042/BJ20101471; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	46	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8960	8968		10.1074/jbc.M115.687491	http://dx.doi.org/10.1074/jbc.M115.687491			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26929407	Green Published, hybrid			2022-12-28	WOS:000374849000009
J	Singh, G; Zhang, JW; Ma, YL; Cerione, RA; Antonyak, MA				Singh, Garima; Zhang, Jingwen; Ma, Yilun; Cerione, Richard A.; Antonyak, Marc A.			The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; DOXORUBICIN-INDUCED APOPTOSIS; HUNTINGTONS-DISEASE BRAIN; GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; BIOLOGICAL MACROMOLECULES; TRANSAMIDATION ACTIVITY; ALZHEIMERS-DISEASE; CROSS-LINKING	Tissue transglutaminase (tTG) is an acyltransferase/GTP-binding protein that contributes to the development of various diseases. In human cancer cells, tTG activates signaling pathways that promote cell growth and survival, whereas in other disorders (i.e. neurodegeneration), overexpression of tTG enhances cell death. Therefore, it is important to understand how tTG is differentially regulated and functioning to promote diametrically distinct cellular outcomes. Previous structural studies revealed that tTG adopts either a nucleotide-bound closed conformation or a transamidation-competent open conformation. Here we provide evidence showing that these different conformational states determine whether tTG promotes, or is detrimental to, cell survival, with the open conformation of the protein being responsible for inducing cell death. First, we demonstrate that a nucleotide binding-defective form of tTG, which has previously been shown to induce cell death, assumes an open conformation in solution as assessed by an enhanced sensitivity to trypsin digestion and by small angle x-ray scattering (SAXS) analysis. We next identify two pairs of intramolecular hydrogen bonds that, based on existing x-ray structures, are predicted to form between the most C-terminal beta-barrel domain and the catalytic core domain of tTG. By disrupting these hydrogen bonds, we are able to generate forms of tTG that constitutively assume an open conformation and induce apoptosis. These findings provide important insights into how tTG participates in the pathogenesis of neurodegenerative diseases, particularly with regard to the actions of a C-terminal truncated form of tTG (TG-Short) that has been linked to such disorders and induces apoptosis by assuming an open-like conformation.	[Singh, Garima; Zhang, Jingwen; Ma, Yilun; Cerione, Richard A.; Antonyak, Marc A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Zhang, Jing/GWZ-7332-2022	Ma, Yilun/0000-0002-2297-9980	National Institutes of Health [P41 GM103485]; NATIONAL CANCER INSTITUTE [R01CA201402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485, R01GM040654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Richard Gillilan and MacCHESS (National Institutes of Health Grant P41 GM103485) for SAXS data collection and help with the analyses and Cindy Westmiller for expert secretarial assistance.	AESCHLIMANN D, 1993, J CELL BIOL, V120, P1461, DOI 10.1083/jcb.120.6.1461; Antonyak MA, 2004, J BIOL CHEM, V279, P41461, DOI 10.1074/jbc.M404976200; Antonyak MA, 2006, P NATL ACAD SCI USA, V103, P18609, DOI 10.1073/pnas.0604844103; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; AUGER KR, 1992, J BIOL CHEM, V267, P5408; Bernardi P., 2007, V45, P481; Boroughs LK, 2014, J BIOL CHEM, V289, P10115, DOI 10.1074/jbc.M113.464693; Caccamo D, 2010, EXPERT OPIN THER TAR, V14, P989, DOI 10.1517/14728222.2010.510134; Chen QC, 2015, ONCOL LETT, V10, P17, DOI 10.3892/ol.2015.3184; Citron BA, 2002, NEUROCHEM INT, V40, P69, DOI 10.1016/S0197-0186(01)00062-6; Citron BA, 2001, J BIOL CHEM, V276, P3295, DOI 10.1074/jbc.M004776200; Datta S, 2007, BIOCHEMISTRY-US, V46, P14819, DOI 10.1021/bi701422h; Datta S, 2006, BIOCHEMISTRY-US, V45, P13163, DOI 10.1021/bi0606795; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Eckert RL, 2015, MOL CARCINOGEN, V54, P947, DOI 10.1002/mc.22375; Festoff BW, 2002, J NEUROCHEM, V81, P708, DOI 10.1046/j.1471-4159.2002.00850.x; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; Gundemir S, 2013, BBA-MOL CELL RES, V1833, P1, DOI 10.1016/j.bbamcr.2012.10.011; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Jeitner TM, 2009, FUTUR NEUROL, V4, P449, DOI 10.2217/FNL.09.17; Karpuj MV, 1999, P NATL ACAD SCI USA, V96, P7388, DOI 10.1073/pnas.96.13.7388; Katt WP, 2015, MOL PHARMACEUT, V12, P46, DOI 10.1021/mp500405h; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kim SY, 1999, J BIOL CHEM, V274, P30715, DOI 10.1074/jbc.274.43.30715; Lai TS, 2013, FRONT BIOSCI-LANDMRK, V18, P504, DOI 10.2741/4117; LEE KN, 1993, BIOCHIM BIOPHYS ACTA, V1202, P1, DOI 10.1016/0167-4838(93)90055-V; Lesort M, 1999, J NEUROCHEM, V73, P2018; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li B, 2010, P NATL ACAD SCI USA, V107, P1408, DOI 10.1073/pnas.0907907107; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LIU XQ, 1993, MOL CELL BIOL, V13, P5225, DOI 10.1128/MCB.13.9.5225; MEHTA K, 1986, CANCER RES, V46, P1388; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Polivka J, 2014, PHARMACOL THERAPEUT, V142, P164, DOI 10.1016/j.pharmthera.2013.12.004; Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003; Singer CF, 2006, CLIN EXP METASTAS, V23, P33, DOI 10.1007/s10585-006-9015-0; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1991, J APPL CRYSTALLOGR, V24, P485, DOI 10.1107/S0021889891001280; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang Z, 2011, EXP CELL RES, V317, P367, DOI 10.1016/j.yexcr.2010.10.015; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Zhang JW, 2013, CELL REP, V3, P2008, DOI 10.1016/j.celrep.2013.05.021	51	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9119	9132		10.1074/jbc.M115.699108	http://dx.doi.org/10.1074/jbc.M115.699108			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26893378	Green Published, hybrid			2022-12-28	WOS:000374849000024
J	Chuang, TW; Lee, KM; Lou, YC; Lu, CC; Tarn, WY				Chuang, Tzu-Wei; Lee, Kuo-Ming; Lou, Yuan-Chao; Lu, Chia-Chen; Tarn, Woan-Yuh			A Point Mutation in the Exon Junction Complex Factor Y14 Disrupts Its Function in mRNA Cap Binding and Translation Enhancement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; mRNA decay; translation; translation control; translation regulation; decapping; exon-junction complex; mRNA cap; mRNA stability	DECAPPING PROTEIN; MAMMALIAN-CELLS; YEAST-CELLS; DECAY; INTERACTS; EXPORT; RECOGNITION; CYTOPLASM; CORE; DCP1	Eukaryotic mRNA biogenesis involves a series of interconnected steps mediated by RNA-binding proteins. The exon junction complex core protein Y14 is required for nonsense-mediated mRNA decay (NMD) and promotes translation. Moreover, Y14 binds the cap structure of mRNAs and inhibits the activity of the decapping enzyme Dcp2. In this report, we show that an evolutionarily conserved tryptophan residue (Trp-73) of Y14 is critical for its binding to the mRNA cap structure. A Trp-73 mutant (W73V) bound weakly to mRNAs and failed to protect them from degradation. However, this mutant could still interact with the NMD and mRNA degradation factors and retained partial NMD activity. In addition, we found that the W73V mutant could not interact with translation initiation factors. Overexpression of W73V suppressed reporter mRNA translation in vitro and in vivo and reduced the level of a set of nascent proteins. These results reveal a residue of Y14 that confers cap-binding activity and is essential for Y14-mediated enhancement of translation. Finally, we demonstrated that Y14 may selectively and differentially modulate protein biosynthesis.	[Chuang, Tzu-Wei; Lee, Kuo-Ming; Lou, Yuan-Chao; Lu, Chia-Chen; Tarn, Woan-Yuh] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	Academia Sinica - Taiwan	Tarn, WY (corresponding author), 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	wtarn@ibms.sinica.edu.tw	Tarn, Woan-Yuh/N-8464-2018	Lee, Kuo-Ming/0000-0002-3215-8342	Ministry of Science and Technology, Taiwan [MOST 102-2311-B-001-025-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grant MOST 102-2311-B-001-025-MY3 from the Ministry of Science and Technology, Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	Bono F, 2004, EMBO REP, V5, P304, DOI 10.1038/sj.embor.7400091; Chang WL, 2009, NUCLEIC ACIDS RES, V37, P6600, DOI 10.1093/nar/gkp717; Chuang TW, 2013, MOL BIOL CELL, V24, P1, DOI 10.1091/mbc.E12-03-0217; Chuang TW, 2011, J BIOL CHEM, V286, P8722, DOI 10.1074/jbc.M110.190587; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gong PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084842; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Hsu IW, 2005, J BIOL CHEM, V280, P34507, DOI 10.1074/jbc.M507658200; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Khanna R, 2004, EMBO J, V23, P1968, DOI 10.1038/sj.emboj.7600213; Kshirsagar M, 2004, GENETICS, V166, P729, DOI 10.1534/genetics.166.2.729; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; LARIMER FW, 1992, GENE, V120, P51, DOI 10.1016/0378-1119(92)90008-D; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee HC, 2009, BIOCHEM BIOPH RES CO, V384, P334, DOI 10.1016/j.bbrc.2009.04.123; Lee KM, 2010, NUCLEIC ACIDS RES, V38, P3340, DOI 10.1093/nar/gkq017; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Li Y, 2008, MOL CELL BIOL, V28, P939, DOI 10.1128/MCB.01727-07; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Mazza C, 2001, MOL CELL, V8, P383, DOI 10.1016/S1097-2765(01)00299-4; Mohr SE, 2001, GENE DEV, V15, P2886; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Schwartz DC, 2000, MOL CELL BIOL, V20, P7933, DOI 10.1128/MCB.20.21.7933-7942.2000; Singh G, 2007, MOL CELL, V27, P780, DOI 10.1016/j.molcel.2007.06.030; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Vilela C, 2000, EMBO J, V19, P4372, DOI 10.1093/emboj/19.16.4372	36	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8565	8574		10.1074/jbc.M115.704544	http://dx.doi.org/10.1074/jbc.M115.704544			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26887951	hybrid, Green Published			2022-12-28	WOS:000374773200021
J	Eichmann, C; Campioni, S; Kowal, J; Maslennikov, I; Gerez, J; Liu, XX; Verasdonck, J; Nespovitaya, N; Choe, S; Meier, BH; Picotti, P; Rizo, J; Stahlberg, H; Riek, R				Eichmann, Cedric; Campioni, Silvia; Kowal, Julia; Maslennikov, Innokentiy; Gerez, Juan; Liu, Xiaoxia; Verasdonck, Joeri; Nespovitaya, Nadezhda; Choe, Senyon; Meier, Beat H.; Picotti, Paola; Rizo, Josep; Stahlberg, Henning; Riek, Roland			Preparation and Characterization of Stable -Synuclein Lipoprotein Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein (-synuclein); apolipoprotein; high-density lipoprotein (HDL); lipid; membrane bilayer; Parkinson disease	BOUND ALPHA-SYNUCLEIN; PHOSPHOLIPID-BILAYER NANODISCS; SOLID-STATE NMR; SECONDARY STRUCTURE; PARKINSONS-DISEASE; CROSS-LINKING; IN-VIVO; BIOLOGICAL MACROMOLECULES; MEMBRANE INTERACTIONS; UNILAMELLAR VESICLES	Multiple neurodegenerative diseases are caused by the aggregation of the human -Synuclein (-Syn) protein. -Syn possesses high structural plasticity and the capability of interacting with membranes. Both features are not only essential for its physiological function but also play a role in the aggregation process. Recently it has been proposed that -Syn is able to form lipid-protein particles reminiscent of high-density lipoproteins. Here, we present a method to obtain a stable and homogeneous population of nanometer-sized particles composed of -Syn and anionic phospholipids. These particles are called -Syn lipoprotein (nano)particles to indicate their relationship to high-density lipoproteins formed by human apolipoproteins in vivo and of in vitro self-assembling phospholipid bilayer nanodiscs. Structural investigations of the -Syn lipoprotein particles by circular dichroism (CD) and magic angle solid-state nuclear magnetic resonance (MAS SS-NMR) spectroscopy establish that -Syn adopts a helical secondary structure within these particles. Based on cryo-electron microscopy (cryo-EM) and dynamic light scattering (DLS) -Syn lipoprotein particles have a defined size with a diameter of approximate to 23 nm. Chemical cross-linking in combination with solution-state NMR and multiangle static light scattering (MALS) of -Syn particles reveal a high-order protein-lipid entity composed of approximate to 8-10 -Syn molecules. The close resemblance in size between cross-linked in vitro-derived -Syn lipoprotein particles and a cross-linked species of endogenous -Syn from SH-SY5Y human neuroblastoma cells indicates a potential functional relevance of -Syn lipoprotein nanoparticles.	[Eichmann, Cedric; Campioni, Silvia; Verasdonck, Joeri; Nespovitaya, Nadezhda; Meier, Beat H.; Riek, Roland] ETH Honggerberg, Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Gerez, Juan; Picotti, Paola] ETH Honggerberg, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland; [Kowal, Julia; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, Mattenstr 26, CH-4058 Basel, Switzerland; [Maslennikov, Innokentiy; Choe, Senyon; Riek, Roland] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Liu, Xiaoxia; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Salk Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Riek, R (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA.	roland.riek@phys.chem.ethz.ch	Eichmann, Cédric/U-1360-2018; Meier, Beat H/K-4066-2016; Stahlberg, Henning/H-1868-2011	Eichmann, Cédric/0000-0002-8476-1936; Meier, Beat H/0000-0002-9107-4464; Stahlberg, Henning/0000-0002-1185-4592; Kowal, Julia/0000-0003-4694-1896; Riek, Roland/0000-0002-6333-066X; Maslennikov, Innokentiy/0000-0003-4292-5821	Swiss National Foundation Sinergia grant	Swiss National Foundation Sinergia grant	This work was supported by a Swiss National Foundation Sinergia grant. The authors declare that they have no conflicts of interest with the contents of this article.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Barcelo-Coblijn G, 2007, J NEUROCHEM, V101, P132, DOI 10.1111/j.1471-4159.2006.04348.x; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayrhuber M, 2011, J MAGN RESON, V209, P310, DOI 10.1016/j.jmr.2011.01.031; Bisaglia M, 2005, BIOCHEMISTRY-US, V44, P329, DOI 10.1021/bi048448q; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bockmann A, 2009, J BIOMOL NMR, V45, P319, DOI 10.1007/s10858-009-9374-3; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Braun AR, 2012, J AM CHEM SOC, V134, P2613, DOI 10.1021/ja208316h; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cabin DE, 2002, J NEUROSCI, V22, P8797; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Cavanagh J., 2010, PROTEIN NMR SPECTROS; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Gath J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090659; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Golovko MY, 2009, MOL CELL BIOCHEM, V326, P55, DOI 10.1007/s11010-008-0008-y; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Halliday GM, 2005, BRAIN, V128, P2654, DOI 10.1093/brain/awh584; Haque F, 2010, J PHYS CHEM B, V114, P4070, DOI 10.1021/jp1006704; Hartman VN, 2001, NEUROREPORT, V12, P943, DOI 10.1097/00001756-200104170-00016; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hogen T, 2012, BIOPHYS J, V102, P1646, DOI 10.1016/j.bpj.2012.01.059; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Lai Y, 2014, BIOCHEMISTRY-US, V53, P3889, DOI 10.1021/bi5002536; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee HJ, 2011, BIOCHEM BIOPH RES CO, V412, P526, DOI 10.1016/j.bbrc.2011.07.028; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Maslennikov Innokentiy, 2009, Journal of Structural and Functional Genomics, V10, P25, DOI 10.1007/s10969-009-9061-3; Melcher K, 2004, CURR PROTEIN PEPT SC, V5, P287, DOI 10.2174/1389203043379701; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Mishra VK, 1998, BIOCHEMISTRY-US, V37, P10313, DOI 10.1021/bi980042o; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Pandey AP, 2011, J PHYS CHEM B, V115, P5886, DOI 10.1021/jp1121917; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Petrache HI, 2004, BIOPHYS J, V86, P1574, DOI 10.1016/S0006-3495(04)74225-3; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Ulusoy A, 2013, MOL NEUROBIOL, V47, P484, DOI 10.1007/s12035-012-8329-y; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Varkey J, 2013, J BIOL CHEM, V288, P17620, DOI 10.1074/jbc.M113.476697; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200	85	39	39	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8516	8527		10.1074/jbc.M115.707968	http://dx.doi.org/10.1074/jbc.M115.707968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26846854	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000374773200017
J	Smith, GA; Howell, GJ; Phillips, C; Muench, SP; Ponnambalam, S; Harrison, MA				Smith, Gina A.; Howell, Gareth J.; Phillips, Clair; Muench, Stephen P.; Ponnambalam, Sreenivasan; Harrison, Michael A.			Extracellular and Luminal pH Regulation by Vacuolar H+-ATPase Isoform Expression and Targeting to the Plasma Membrane and Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; membrane trafficking; receptor internalization; receptor recycling; vacuolar ATPase	BREAST-CANCER CELLS; ACCESSORY SUBUNIT AC45; PROTON-TRANSLOCATING ATPASE; HUMAN PANCREATIC-CANCER; RENAL TUBULAR-ACIDOSIS; IN-VIVO DISSOCIATION; V-ATPASE; A3 ISOFORM; OSTEOCLAST DIFFERENTIATION; NEUROTRANSMITTER RELEASE	Plasma membrane vacuolar H+-ATPase (V-ATPase) activity of tumor cells is a major factor in control of cytoplasmic and extracellular pH and metastatic potential, but the isoforms involved and the factors governing plasma membrane recruitment remain uncertain. Here, we examined expression, distribution, and activity of V-ATPase isoforms in invasive prostate adenocarcinoma (PC-3) cells. Isoforms 1 and 3 were the most highly expressed forms of membrane subunit a, with a(1) and a(3) the dominant plasma membrane isoforms. Correlation between plasma membrane V-ATPase activity and invasiveness was limited, but RNAi knockdown of either a isoform did slow cell proliferation and inhibit invasion in vitro. Isoform a(1) was recruited to the cell surface from the early endosome-recycling complex pathway, its knockdown arresting transferrin receptor recycling. Isoform a(3) was associated with the late endosomal/lysosomal compartment. Both a isoforms associated with accessory protein Ac45, knockdown of which stalled transit of a(1) and transferrin-transferrin receptor, decreased proton efflux, and reduced cell growth and invasiveness; this latter effect was at least partly due to decreased delivery of the membrane-bound matrix metalloproteinase MMP-14 to the plasma membrane. These data indicate that in prostatic carcinoma cells, a(1) and a(3) isoform populations predominate in different compartments where they maintain different luminal pH. Ac45 plays a central role in navigating the V-ATPase to the plasma membrane, and hence it is an important factor in expression of the invasive phenotype.	[Smith, Gina A.; Howell, Gareth J.; Ponnambalam, Sreenivasan] Univ Leeds, Fac Biol Sci, Endothelial Cell Biol Unit, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Phillips, Clair; Muench, Stephen P.; Harrison, Michael A.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; [Howell, Gareth J.] Univ Manchester, Manchester Collaborat Ctr Inflammat Res Flow Cyto, Oxford Rd, Manchester M13 9PT, Lancs, England	University of Leeds; University of Leeds; University of Manchester	Harrison, MA (corresponding author), Univ Leeds, Sch Biomed Sci, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.	m.a.harrison@leeds.ac.uk	Muench, Stephen/AAI-9529-2020	Muench, Stephen/0000-0001-6869-4414; Harrison, Michael/0000-0002-7826-7472; Ponnambalam, Sreenivasan/0000-0002-4452-7619; Smith, Gina/0000-0003-3601-3025	British Heart Foundation [FS/12/20/29462]; Medical Research Council [G1000567]; Heart Research UK; British Heart Foundation; Leverhulme Trust; MRC [G1000567] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Heart Research UK; British Heart Foundation(British Heart Foundation); Leverhulme Trust(Leverhulme Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Recipient of British Heart Foundation Ph.D. Studentship FS/12/20/29462.; Medical Research Council Career Development Fellow supported by Grant G1000567.; Supported by grants from Heart Research UK, British Heart Foundation, and Leverhulme Trust.	Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Chung C, 2010, PANCREAS, V39, P1315; Chung CH, 2011, LAB INVEST, V91, P732, DOI 10.1038/labinvest.2011.8; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Cotter K, 2015, J BIOL CHEM, V290, P3680, DOI 10.1074/jbc.M114.611210; De Milito A, 2012, CURR PHARM DESIGN, V18, P1395, DOI 10.2174/138161212799504911; Di Giovanni J, 2010, NEURON, V67, P268, DOI 10.1016/j.neuron.2010.06.024; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Feng HT, 2008, J BIOL CHEM, V283, P13194, DOI 10.1074/jbc.M709712200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GILLIES RJ, 1990, P NATL ACAD SCI USA, V87, P7414, DOI 10.1073/pnas.87.19.7414; Gleize V, 2012, GLIA, V60, P1004, DOI 10.1002/glia.22332; Hernandez A, 2012, CURR PHARM DESIGN, V18, P1383, DOI 10.2174/138161212799504821; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Ishisaki A, 1999, BIOL CELL, V91, P507, DOI 10.1016/S0248-4900(00)88207-6; Jansen EJR, 1998, J CELL SCI, V111, P2999; Jansen EJR, 2012, J BIOL CHEM, V287, P27537, DOI 10.1074/jbc.M112.356105; Jansen EJR, 2008, BBA-MOL CELL RES, V1783, P2301, DOI 10.1016/j.bbamcr.2008.06.020; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P17941, DOI 10.1074/jbc.M010790200; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Kozik P, 2013, NAT CELL BIOL, V15, P50, DOI 10.1038/ncb2652; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Martinez-Zaguilan R, 1999, BIOCHEM PHARMACOL, V57, P1037, DOI 10.1016/S0006-2952(99)00022-2; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; Montcourrier P, 1997, CLIN EXP METASTAS, V15, P382, DOI 10.1023/A:1018446104071; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Niikura K, 2004, BRIT J PHARMACOL, V142, P558, DOI 10.1038/sj.bjp.0705812; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Nyman JKE, 2010, CALCIFIED TISSUE INT, V87, P273, DOI 10.1007/s00223-010-9395-7; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Paunescu TG, 2007, AM J PHYSIOL-RENAL, V293, pF1915, DOI 10.1152/ajprenal.00160.2007; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; ROZHIN J, 1994, CANCER RES, V54, P6517; Sabbota AL, 2010, CANCER RES, V70, P5558, DOI 10.1158/0008-5472.CAN-09-4416; Sabeh F, 2009, J BIOL CHEM, V284, P23001, DOI 10.1074/jbc.M109.002808; Sasazawa Y, 2009, CANCER SCI, V100, P1460, DOI 10.1111/j.1349-7006.2009.01194.x; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Saw NMN, 2011, MOL BIOL CELL, V22, P3394, DOI 10.1091/mbc.E11-02-0155; Sennoune SR, 2007, J BIOENERG BIOMEMBR, V39, P427, DOI 10.1007/s10863-007-9108-8; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Sun-Wada GH, 2010, HISTOL HISTOPATHOL, V25, P1611, DOI 10.14670/HH-25.1611; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Towler MC, 2000, EXP CELL RES, V259, P167, DOI 10.1006/excr.2000.4958; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; VANWEERT AWM, 1995, J CELL BIOL, V130, P821, DOI 10.1083/jcb.130.4.821; Wang D, 2014, J CELL BIOL, V205, P21, DOI 10.1083/jcb.201312109; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; Xu XY, 2012, J CELL BIOCHEM, V113, P2356, DOI 10.1002/jcb.24106; You HY, 2009, CANCER LETT, V280, P110, DOI 10.1016/j.canlet.2009.02.023	80	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8500	8515		10.1074/jbc.M116.723395	http://dx.doi.org/10.1074/jbc.M116.723395			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26912656	hybrid, Green Published			2022-12-28	WOS:000374773200016
J	Sun, JJ; Lan, JF; Shi, XZ; Yang, MC; Niu, GJ; Ding, D; Zhao, XF; Yu, XQ; Wang, JX				Sun, Jie-Jie; Lan, Jiang-Feng; Shi, Xiu-Zhen; Yang, Ming-Chong; Niu, Guo-Juan; Ding, Ding; Zhao, Xiao-Fan; Yu, Xiao-Qiang; Wang, Jin-Xing			beta-Arrestins Negatively Regulate the Toll Pathway in Shrimp by Preventing Dorsal Translocation and Inhibiting Dorsal Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME VIRUS-INFECTION; SIGNALING PATHWAY; FENNEROPENAEUS-CHINENSIS; ANTIMICROBIAL PEPTIDES; GENE-EXPRESSION; INNATE IMMUNITY; CHINESE SHRIMP; DROSOPHILA; RECEPTOR; DEFENSE	The Toll signaling pathway plays an important role in the innate immunity of Drosophila melanogaster and mammals. The activation and termination of Toll signaling are finely regulated in these animals. Although the primary components of the Toll pathway were identified in shrimp, the functions and regulation of the pathway are seldom studied. We first demonstrated that the Toll signaling pathway plays a central role in host defense against Staphylococcus aureus by regulating expression of antimicrobial peptides in shrimp. We then found that beta-arrestins negatively regulate Toll signaling in two different ways. beta-Arrestins interact with the C-terminal PEST domain of Cactus through the arrestin-N domain, and Cactus interacts with the RHD domain of Dorsal via the ankyrin repeats domain, forming a heterotrimeric complex of beta-arrestin.Cactus.Dorsal, with Cactus as the bridge. This complex prevents Cactus phosphorylation and degradation, as well as Dorsal translocation into the nucleus, thus inhibiting activation of the Toll signaling pathway. beta-Arrestins also interact withn on-phosphorylated ERK (extracellular signal-regulated protein kinase) through the arrestin-C domain to inhibit ERK phosphorylation, which affects Dorsal translocation into the nucleus and phosphorylation of Dorsal at Ser(276) that impairs Dorsal transcriptional activity. Our study suggests that beta-arrestins negatively regulate the Toll signaling pathway by preventing Dorsal translocation and inhibiting Dorsal phosphorylation and transcriptional activity.	[Sun, Jie-Jie; Lan, Jiang-Feng; Shi, Xiu-Zhen; Yang, Ming-Chong; Niu, Guo-Juan; Ding, Ding; Zhao, Xiao-Fan; Wang, Jin-Xing] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Shandong, Peoples R China; [Yu, Xiao-Qiang] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA	Shandong University; University of Missouri System; University of Missouri Kansas City	Wang, JX (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	jxwang@sdu.edu.cn	Zhao, Xiao-Fan/AGW-9886-2022; YU, XiaoQiang/GRJ-1077-2022; Yang, Mingchong/AAW-4529-2021; YU, XIAO-QIANG/AAL-1797-2021; Wang, Jin-Xing/AAU-1514-2021	Yang, Mingchong/0000-0003-0912-8417; YU, XIAO-QIANG/0000-0003-1419-9009; Zhao, Xiao-Fan/0000-0003-1809-4730; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31130056, 31472303]; National Basic Research Program of China 973 Program [2012CB114405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 31130056 and 31472303 and National Basic Research Program of China 973 Program Grant 2012CB114405. The authors declare that they have no conflicts of interest with the contents of this article.	Anjum SG, 2013, GENETICS, V195, P1307, DOI 10.1534/genetics.113.157859; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Charroux B, 2010, FLY, V4, P40, DOI 10.4161/fly.4.1.10810; Crozatier M, 2007, CELL MICROBIOL, V9, P1117, DOI 10.1111/j.1462-5822.2007.00930.x; Deepika A, 2014, FISH SHELLFISH IMMUN, V41, P441, DOI 10.1016/j.fsi.2014.09.026; Destoumieux D, 2000, CELL MOL LIFE SCI, V57, P1260, DOI 10.1007/PL00000764; Ding D, 2014, DEV COMP IMMUNOL, V46, P246, DOI 10.1016/j.dci.2014.04.016; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Haghayeghi A, 2010, MECH DEVELOP, V127, P301, DOI 10.1016/j.mod.2010.01.004; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Huang HR, 2010, P NATL ACAD SCI USA, V107, P8322, DOI 10.1073/pnas.1004031107; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Ji SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4458; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li FH, 2013, FISH SHELLFISH IMMUN, V34, P973, DOI 10.1016/j.fsi.2012.08.023; Li XP, 2013, FISH SHELLFISH IMMUN, V35, P1882, DOI 10.1016/j.fsi.2013.09.021; Li YX, 2015, J IMMUNOL, V194, P168, DOI 10.4049/jimmunol.1401080; Lindsay SA, 2014, DEV COMP IMMUNOL, V42, P16, DOI 10.1016/j.dci.2013.04.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luttrell LM, 2002, J CELL SCI, V115, P455; Marullo Stefano, 2014, Handb Exp Pharmacol, V219, P361, DOI 10.1007/978-3-642-41199-1_18; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Ren Q, 2014, DEV COMP IMMUNOL, V45, P198, DOI 10.1016/j.dci.2014.02.020; Shi H, 2014, J ORAL PATHOL MED, V43, P785, DOI 10.1111/jop.12209; Shi XZ, 2009, FISH SHELLFISH IMMUN, V27, P610, DOI 10.1016/j.fsi.2009.07.005; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Tamouza H, 2012, KIDNEY INT, V82, P1284, DOI 10.1038/ki.2012.192; Tipping M, 2010, EMBO J, V29, P3222, DOI 10.1038/emboj.2010.202; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Valanne S, 2010, J IMMUNOL, V184, P6188, DOI 10.4049/jimmunol.1000261; Wang DD, 2013, DEV COMP IMMUNOL, V39, P352, DOI 10.1016/j.dci.2012.12.005; Wang PH, 2013, DEV COMP IMMUNOL, V40, P266, DOI 10.1016/j.dci.2013.02.011; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2012, DEV COMP IMMUNOL, V36, P39, DOI 10.1016/j.dci.2011.06.002; Wang XW, 2014, J IMMUNOL, V193, P2106, DOI 10.4049/jimmunol.1400552; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Wang Z, 2015, FISH SHELLFISH IMMUN, V43, P219, DOI 10.1016/j.fsi.2014.12.038; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Yang XH, 2012, APOPTOSIS, V17, P1019, DOI 10.1007/s10495-012-0741-2; Zhang S., 2012, PLOS ONE, V7	50	43	45	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7488	7504		10.1074/jbc.M115.698134	http://dx.doi.org/10.1074/jbc.M115.698134			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26846853	Green Published, hybrid			2022-12-28	WOS:000383447600024
J	Hanke-Gogokhia, C; Wu, ZJ; Gerstner, CD; Frederick, JM; Zhang, HB; Baehr, W				Hanke-Gogokhia, Christin; Wu, Zhijian; Gerstner, Cecilia D.; Frederick, Jeanne M.; Zhang, Houbin; Baehr, Wolfgang			Arf-like Protein 3 (ARL3) Regulates Protein Trafficking and Ciliogenesis in Mouse Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; gene knock-out; lipid-binding protein; photoreceptor; protein trafficking (Golgi); retinal degeneration	CYCLIC-GMP PHOSPHODIESTERASE; ROD OUTER SEGMENTS; PDE-DELTA; CGMP PHOSPHODIESTERASE; RETINAL DEGENERATION; SMALL GTPASES; GENE; TRANSPORT; INPP5E; ARL13B	Arf-like protein 3 (ARL3) is a ubiquitous small GTPase expressed in ciliated cells of plants and animals. Germline deletion of Arl3 in mice causes multiorgan ciliopathy reminiscent of Bardet-Biedl or Joubert syndromes. As photoreceptors are elegantly compartmentalized and have cilia, we probed the function of ARL3 (ADP-ribosylation factor (Arf)-like 3 protein) by generating rod photoreceptor-specific (prefix (rod)) and retina-specific (prefix (ret)) Arl3 deletions. In predegenerate (rod)Arl3(-/-) mice, lipidated phototransduction proteins showed trafficking deficiencies, consistent with the role of ARL3 as a cargo displacement factor for lipid-binding proteins. By contrast, (ret)Arl3(-/-) rods and cones expressing Cre recombinase during embryonic development formed neither connecting cilia nor outer segments and degenerated rapidly. Absence of cilia infers participation of ARL3 in ciliogenesis and axoneme formation. Ciliogenesis was rescued, and degeneration was reversed in part by subretinal injection of adeno-associated virus particles expressing ARL3-EGFP. The conditional knock-out phenotypes permitted identification of two ARL3 functions, both in the GTP-bound form as follows: one as a regulator of intraflagellar transport participating in photoreceptor ciliogenesis and the other as a cargo displacement factor transporting lipidated protein to the outer segment. Surprisingly, a farnesylated inositol polyphosphate phosphatase only trafficked from the endoplasmic reticulum to the Golgi, thereby excluding it from a role in photoreceptor cilia physiology.	[Hanke-Gogokhia, Christin; Gerstner, Cecilia D.; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Sch Med, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Sch Med, Dept Neurobiol & Anat, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA; [Hanke-Gogokhia, Christin] Univ Potsdam, Dept Biol & Biochem, D-14476 Golm, Germany; [Wu, Zhijian] NEI, NIH, Bethesda, MD 20892 USA; [Zhang, Houbin] Hosp Univ Elect Sci & Technol China, Inst Lab Med, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu 610072, Sichuan, Peoples R China; [Zhang, Houbin] Sichuan Prov Peoples Hosp, Chengdu 610072, Sichuan, Peoples R China; [Zhang, Houbin] Univ Elect Sci & Technol China, Sch Med, Chengdu 610072, Sichuan, Peoples R China; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Potsdam; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Utah System of Higher Education; University of Utah	Zhang, HB (corresponding author), Hosp Univ Elect Sci & Technol China, Inst Lab Med, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu 610072, Sichuan, Peoples R China.; Zhang, HB (corresponding author), Sichuan Prov Peoples Hosp, Chengdu 610072, Sichuan, Peoples R China.; Baehr, W (corresponding author), Univ Utah, Moran Eye Ctr, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	houbin.zhang@gmail.com; wbaehr@hsc.utah.edu	wu, zhi/GXH-3041-2022; Zhang, Houbin/A-8887-2012	Zhang, Houbin/0000-0002-2968-7454	National Institutes of Health [EY08123, EY019298]; NEI Core [EY014800-039003]; Research to Prevent Blindness (New York); National Science Foundation of China [81371030]; Science and Technology Department of Sichuan [2014HH0009]; NATIONAL EYE INSTITUTE [ZIAEY000443, R01EY008123, P30EY014800, R01EY019298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI Core; Research to Prevent Blindness (New York)(Research to Prevent Blindness (RPB)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Sichuan; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grants EY08123 and EY019298 (to W. B.) and NEI Core Grant EY014800-039003, unrestricted grants to the University of Utah Department of Ophthalmology from Research to Prevent Blindness (New York), National Science Foundation of China Grant 81371030, and Science and Technology Department of Sichuan Grant 2014HH0009 (to H. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANANT JS, 1992, J BIOL CHEM, V267, P687; ANDERSON DH, 1978, INVEST OPHTH VIS SCI, V17, P117; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; BAEHR W, 1979, J BIOL CHEM, V254, P1669; BAEHR W, 1982, J BIOL CHEM, V257, P6452; Baehr W, 2014, INVEST OPHTH VIS SCI, V55, P8653, DOI 10.1167/iovs.14-16066; Barabas P, 2011, INVEST OPHTH VIS SCI, V52, P6766, DOI 10.1167/iovs.10-7147; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Bouabe H, 2013, METHODS MOL BIOL, V1064, P315, DOI 10.1007/978-1-62703-601-6_23; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; CAVENAGH MM, 1994, J BIOL CHEM, V269, P18937; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Conduit SE, 2012, FEBS LETT, V586, P2846, DOI 10.1016/j.febslet.2012.07.037; Cuvillier A, 2000, J CELL SCI, V113, P2065; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022; Friedel RH, 2011, METHODS MOL BIOL, V693, P205, DOI 10.1007/978-1-60761-974-1_12; FUNG BKK, 1983, J BIOL CHEM, V258, P495; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gotthardt K, 2015, ELIFE, V4, DOI 10.7554/eLife.11859; Grayson C, 2002, HUM MOL GENET, V11, P3065, DOI 10.1093/hmg/11.24.3065; Grimm D, 2003, BLOOD, V102, P2412, DOI 10.1182/blood-2003-02-0495; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; INGLESE J, 1992, J BIOL CHEM, V267, P1422; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; Ishiba Y, 2007, EXP EYE RES, V84, P473, DOI 10.1016/j.exer.2006.10.016; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jiang L, 2015, J BIOL CHEM, V290, P12765, DOI 10.1074/jbc.M115.638437; Kobayashi A, 2000, INVEST OPHTH VIS SCI, V41, P3268; Kobayashi A, 2003, FEBS LETT, V534, P26, DOI 10.1016/S0014-5793(02)03766-3; Kong AM, 2000, J BIOL CHEM, V275, P24052, DOI 10.1074/jbc.M000874200; LAI RK, 1990, P NATL ACAD SCI USA, V87, P7673, DOI 10.1073/pnas.87.19.7673; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Lerea C L, 1987, Prog Clin Biol Res, V249, P31; Li LJ, 2013, INVEST OPHTH VIS SCI, V54, P4503, DOI 10.1167/iovs.13-12140; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Li YJ, 2010, J CELL BIOL, V189, P1039, DOI 10.1083/jcb.200912001; LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457; Linari M, 1999, FEBS LETT, V458, P55, DOI 10.1016/S0014-5793(99)01117-5; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Nakatsu F, 2015, DEV CELL, V34, P379, DOI 10.1016/j.devcel.2015.08.008; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; QIN N, 1992, J BIOL CHEM, V267, P8458; Renault L, 2001, ACTA CRYSTALLOGR D, V57, P1167, DOI 10.1107/S0907444901009556; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Schwarz N, 2012, VISION RES, V75, P2, DOI 10.1016/j.visres.2012.07.016; Su CY, 2012, DEVELOPMENT, V139, P4062, DOI 10.1242/dev.082321; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Thomas S, 2014, HUM MUTAT, V35, P137, DOI 10.1002/humu.22470; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; YANG ZH, 1992, J BIOL CHEM, V267, P23197; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835; Zhang JM, 2008, INVEST OPHTH VIS SCI, V49, P5561, DOI 10.1167/iovs.08-2226; Zhang Q, 2013, EXP CELL RES, V319, P2316, DOI 10.1016/j.yexcr.2013.03.024	75	66	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7142	7155		10.1074/jbc.M115.710954	http://dx.doi.org/10.1074/jbc.M115.710954			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26814127	Green Published, hybrid			2022-12-28	WOS:000373299700047
J	Lafond, M; Sulzenbacher, G; Freyd, T; Henrissat, B; Berrin, JG; Garron, ML				Lafond, Mickael; Sulzenbacher, Gerlind; Freyd, Thibaud; Henrissat, Bernard; Berrin, Jean-Guy; Garron, Marie-Line			The Quaternary Structure of a Glycoside Hydrolase Dictates Specificity toward -Glucans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystallography; enzyme; glycobiology; glycoside hydrolase; oligomerization; CAZyme; Saccharophagus degradans; endoglucanase; lichenase	ENDOGLUCANASE CEL5A; CRYSTAL-STRUCTURE; CELLULASE; COMPLEX; ENDOCELLULASE	In the Carbohydrate-Active Enzyme (CAZy) database, glycoside hydrolase family 5 (GH5) is a large family with more than 6,000 sequences. Among the 51 described GH5 subfamilies, subfamily GH5_26 contains members that display either endo-(1,4)-glucanase or (1,3;1,4)-glucanase activities. In this study, we focused on the GH5_26 enzyme from Saccharophagus degradans (SdGluc5_26A), a marine bacterium known for its capacity to degrade a wide diversity of complex polysaccharides. SdGluc5_26A displays lichenase activity toward (1,3;1,4)-glucans with a side cellobiohydrolase activity toward (1,4)-glucans. The three-dimensional structure of SdGluc5_26A adopts a stable trimeric quaternary structure also observable in solution. The N-terminal region of SdGluc5_26A protrudes into the active site of an adjacent monomer. To understand whether this occupation of the active site could influence its activity, we conducted a comprehensive enzymatic characterization of SdGluc5_26A and of a mutant truncated at the N terminus. Ligand complex structures and kinetic analyses reveal that the N terminus governs the substrate specificity of SdGluc5_26A. Its deletion opens the enzyme cleft at the -3 subsite and turns the enzyme into an endo-(1,4)-glucanase. This study demonstrates that experimental approaches can reveal structure-function relationships out of reach of current bioinformatic predictions.	[Lafond, Mickael] Aix Marseille Univ, CNRS UMR7313, Inst Sci Mol Marseille BiosCiences, F-13284 Marseille, France; [Lafond, Mickael; Berrin, Jean-Guy] Aix Marseille Univ, Polytech Marseille, INRA, Biodivers & Biotechnol Fong,UMR1163, F-13288 Marseille, France; [Sulzenbacher, Gerlind; Freyd, Thibaud; Henrissat, Bernard; Garron, Marie-Line] Aix Marseille Univ, CNRS UMR7257, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard; Garron, Marie-Line] INRA, Architecture & Fonct Macromol Biol USC1408, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21589, Saudi Arabia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; King Abdulaziz University	Berrin, JG (corresponding author), UMR1163 INRA, Biodivers & Biotechnol Fong, F-13288 Marseille, France.	jean-guy.berrin@univ-amu.fr	BERRIN, Jean-Guy/AAF-3107-2021; Sulzenbacher, Gerlind/A-6801-2018; Henrissat, Bernard/J-2475-2012; BERRIN, Jean-Guy/E-1460-2014	Sulzenbacher, Gerlind/0000-0003-4844-2820; Henrissat, Bernard/0000-0002-3434-8588; BERRIN, Jean-Guy/0000-0001-7570-3745; Garron, Marie-Line/0000-0001-5846-1246	French National Research Agency (Funlock project) [ANR-13-BIME-0002-01]; French National Research Agency (Microbio-E A*MIDEX project ) [ANR-11-IDEX-0001-02]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]	French National Research Agency (Funlock project)(French National Research Agency (ANR)); French National Research Agency (Microbio-E A*MIDEX project )(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI)	This work was supported by the French National Research Agency (Funlock project ANR-13-BIME-0002-01 and the Microbio-E A*MIDEX project number ANR-11-IDEX-0001-02). This work was also supported by a grant from the French Infrastructure for Integrated Structural Biology (FRISBI) (ANR-10-INSB-05-01). The authors declare that they have no conflicts of interest with the contents of this article.	Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao L, 2011, J MOL CATAL B-ENZYM, V73, P104, DOI 10.1016/j.molcatb.2011.08.006; BARRAS F, 1992, FEBS LETT, V300, P145, DOI 10.1016/0014-5793(92)80183-H; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burton RA, 2009, MOL PLANT, V2, P873, DOI 10.1093/mp/ssp063; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Chapon V, 2001, J MOL BIOL, V310, P1055, DOI 10.1006/jmbi.2001.4787; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; DOMINGUEZ R, 1995, NAT STRUCT BIOL, V2, P569, DOI 10.1038/nsb0795-569; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Duan CJ, 2009, J APPL MICROBIOL, V107, P245, DOI 10.1111/j.1365-2672.2009.04202.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hutcheson SW, 2011, MAR DRUGS, V9, P645, DOI 10.3390/md9040645; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lafond M, 2012, APPL ENVIRON MICROB, V78, P8540, DOI 10.1128/AEM.02572-12; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MATSUI I, 1991, J BIOCHEM-TOKYO, V109, P566, DOI 10.1093/oxfordjournals.jbchem.a123420; Mckee LS, 2012, P NATL ACAD SCI USA, V109, P6537, DOI 10.1073/pnas.1117686109; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarro D, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-58; Pereira JH, 2010, J STRUCT BIOL, V172, P372, DOI 10.1016/j.jsb.2010.06.018; Planas N, 2000, BBA-PROTEIN STRUCT M, V1543, P361, DOI 10.1016/S0167-4838(00)00231-4; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; Santos CR, 2012, BIOCHEM J, V441, P95, DOI 10.1042/BJ20110869; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Telke AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065727; Varrot A, 2003, J AM CHEM SOC, V125, P7496, DOI 10.1021/ja034917k; Varrot A, 2001, ACTA CRYSTALLOGR D, V57, P1739, DOI 10.1107/S0907444901013993; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Voget S, 2006, J BIOTECHNOL, V126, P26, DOI 10.1016/j.jbiotec.2006.02.011; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087	40	8	8	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7183	7194		10.1074/jbc.M115.695999	http://dx.doi.org/10.1074/jbc.M115.695999			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26755730	Green Published, hybrid			2022-12-28	WOS:000373299700050
J	Pintscher, S; Kuleta, P; Cieluch, E; Borek, A; Sarewicz, M; Osyczka, A				Pintscher, Sebastian; Kuleta, Patryk; Cieluch, Ewelina; Borek, Arkadiusz; Sarewicz, Marcin; Osyczka, Artur			Tuning of Hemes b Equilibrium Redox Potential Is Not Required for Cross-Membrane Electron Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome; electron transfer; oxidation-reduction (redox); photosynthesis; respiratory chain; heme iron ligation	CYTOCHROME B(6)F COMPLEX; BACILLUS-SUBTILIS SUCCINATE; PROTON MOTIVE FORCE; RHODOBACTER-CAPSULATUS; BC(1) COMPLEX; AXIAL LIGATION; WOLINELLA-SUCCINOGENES; PARAMAGNETIC-RESONANCE; MENAQUINONE REDUCTASE; STRUCTURAL-ANALYSIS	In biological energy conversion, cross-membrane electron transfer often involves an assembly of two hemes b. The hemes display a large difference in redox midpoint potentials (E(m_)b), which in several proteins is assumed to facilitate cross-membrane electron transfer and overcome a barrier of membrane potential. Here we challenge this assumption reporting on heme b ligand mutants of cytochrome bc(1) in which, for the first time in transmembrane cytochrome, one natural histidine has been replaced by lysine without loss of the native low spin type of heme iron. With these mutants we show that E(m_)b can be markedly increased, and the redox potential of one of the hemes can stay above the level of quinone pool, or E(m_)b can be markedly decreased to the point that two hemes are almost isopotential, yet the enzyme retains catalytically competent electron transfer between quinone binding sites and remains functional in vivo. This reveals that cytochrome bc(1) can accommodate large changes in E(m_)b without hampering catalysis, as long as these changes do not impose overly endergonic steps on downhill electron transfer from substrate to product. We propose that hemes b in this cytochrome and in other membranous cytochromes b act as electronic connectors for the catalytic sites with no fine tuning in E(m_)b required for efficient cross-membrane electron transfer. We link this concept with a natural flexibility in occurrence of several thermodynamic configurations of the direction of electron flow and the direction of the gradient of potential in relation to the vector of the electric membrane potential.	[Pintscher, Sebastian; Kuleta, Patryk; Cieluch, Ewelina; Borek, Arkadiusz; Sarewicz, Marcin; Osyczka, Artur] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Mol Biophys, 7 Gronostajowa St, PL-30387 Krakow, Poland	Jagiellonian University	Osyczka, A (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Mol Biophys, 7 Gronostajowa St, PL-30387 Krakow, Poland.	artur.osyczka@uj.edu.pl		Sarewicz, Marcin/0000-0001-6813-5997	Wellcome Trust; Ministry of Science and Higher Education	Wellcome Trust(Wellcome Trust); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by The Wellcome Trust International Senior Research Fellowship (to A. O.). The Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education. The authors declare that they have no conflicts of interest with the contents of this article.	Alric J, 2005, P NATL ACAD SCI USA, V102, P15860, DOI 10.1073/pnas.0508102102; ATTAASAFOADJEI E, 1991, P NATL ACAD SCI USA, V88, P492, DOI 10.1073/pnas.88.2.492; Battistuzzi G, 2002, J AM CHEM SOC, V124, P5315, DOI 10.1021/ja017479v; Berczi A, 2010, EUR BIOPHYS J BIOPHY, V39, P1129, DOI 10.1007/s00249-009-0564-4; Berry EA, 2008, J BIOL INORG CHEM, V13, P481, DOI 10.1007/s00775-008-0372-9; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Bewley KD, 2013, BBA-BIOENERGETICS, V1827, P938, DOI 10.1016/j.bbabio.2013.03.010; Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5; CHEESMAN MR, 1990, NATURE, V346, P771, DOI 10.1038/346771a0; Cieluch E, 2010, BBA-BIOENERGETICS, V1797, P296, DOI 10.1016/j.bbabio.2009.11.003; Czapla M, 2012, BIOCHEMISTRY-US, V51, P829, DOI 10.1021/bi2016316; Czapla M, 2012, PROTEIN ENG DES SEL, V25, P15, DOI 10.1093/protein/gzr055; Desmet F, 2011, FEBS LETT, V585, P545, DOI 10.1016/j.febslet.2011.01.006; Dutton P L, 1978, Methods Enzymol, V54, P411; Ekiert R, 2014, BIOCHEM BIOPH RES CO, V451, P270, DOI 10.1016/j.bbrc.2014.07.117; Farid TA, 2013, NAT CHEM BIOL, V9, P826, DOI [10.1038/NCHEMBIO.1362, 10.1038/nchembio.1362]; Finnegan MG, 1996, BBA-BIOENERGETICS, V1274, P9, DOI 10.1016/0005-2728(95)00155-7; Frielingsdorf S, 2011, BIOCHEMISTRY-US, V50, P10836, DOI 10.1021/bi201594m; Fufezan C, 2008, PROTEINS, V73, P690, DOI 10.1002/prot.22097; Garcia LM, 2008, CAN J MICROBIOL, V54, P456, DOI [10.1139/W08-037, 10.1139/w08-037]; GARTNER P, 1991, EUR J BIOCHEM, V200, P215, DOI 10.1111/j.1432-1033.1991.tb21070.x; Gross R, 2004, J BIOL CHEM, V279, P274, DOI 10.1074/jbc.M310610200; Haas AH, 2004, BIOPHYS J, V87, P4298, DOI 10.1529/biophysj.104.042945; HAGERHALL C, 1995, BIOCHEMISTRY-US, V34, P11080; Hasan SS, 2013, BBA-BIOENERGETICS, V1827, P1295, DOI 10.1016/j.bbabio.2013.03.002; Jensen LMR, 2012, J BIOL INORG CHEM, V17, P1241, DOI 10.1007/s00775-012-0939-3; Jensen LMR, 2010, SCIENCE, V327, P1392, DOI 10.1126/science.1182492; Jormakka M, 2003, FEBS LETT, V545, P25, DOI 10.1016/S0014-5793(03)00389-2; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Kamensky Y, 2007, BIOCHEMISTRY-US, V46, P8647, DOI 10.1021/bi700054g; Kappler U, 2004, J BIOL CHEM, V279, P6252, DOI 10.1074/jbc.M310644200; Kilmartin JR, 2011, J BIOL CHEM, V286, P24872, DOI 10.1074/jbc.M110.212183; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; Koch H.G., 2007, CURR CHEM BIOL, V1, P59; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; KROGER A, 1979, EUR J BIOCHEM, V94, P465, DOI 10.1111/j.1432-1033.1979.tb12914.x; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Lanciano P, 2013, BIOCHEMISTRY-US, V52, P7196, DOI 10.1021/bi400561e; Lanciano P, 2011, BIOCHEMISTRY-US, V50, P1651, DOI 10.1021/bi101736v; Lu PL, 2014, P NATL ACAD SCI USA, V111, P1813, DOI 10.1073/pnas.1323931111; Mao JJ, 2003, BIOCHEMISTRY-US, V42, P9829, DOI 10.1021/bi027288k; MATHEWS FS, 1979, J BIOL CHEM, V254, P1699; Matsson M, 2000, BIOCHEMISTRY-US, V39, P8617, DOI 10.1021/bi000271m; Mileni M, 2006, BIOCHEM J, V395, P191, DOI 10.1042/BJ20051675; NICHOLLS DG, 2013, BIOENERGETICS; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Osyczka A, 2001, BIOCHEMISTRY-US, V40, P14547, DOI 10.1021/bi011630w; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; ROBERTSON DE, 1993, BIOCHEMISTRY-US, V32, P1310, DOI 10.1021/bi00056a016; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Rodrigues ML, 2006, EMBO J, V25, P5951, DOI 10.1038/sj.emboj.7601439; Rothery RA, 2001, J MOL MICROB BIOTECH, V3, P273; Rotsaert FAJ, 2003, J BIOL CHEM, V278, P33224, DOI 10.1074/jbc.M302653200; Rotsaert FAJ, 2008, BBA-BIOENERGETICS, V1777, P239, DOI 10.1016/j.bbabio.2007.08.005; Sarewicz M, 2015, PHYSIOL REV, V95, P219, DOI 10.1152/physrev.00006.2014; Sarewicz M, 2013, BIOCHEMISTRY-US, V52, P6388, DOI 10.1021/bi400624m; Shinkarev VP, 2001, BIOCHEMISTRY-US, V40, P12584, DOI 10.1021/bi011334j; Stoffels L, 2012, J BACTERIOL, V194, P475, DOI 10.1128/JB.06014-11; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Suga M, 2013, FEBS LETT, V587, P3267, DOI 10.1016/j.febslet.2013.08.023; Swierczek M, 2010, SCIENCE, V329, P451, DOI 10.1126/science.1190899; TAKAMIYA KI, 1979, BIOCHIM BIOPHYS ACTA, V546, P1, DOI 10.1016/0005-2728(79)90166-X; Valkova-Valchanova MB, 1998, BIOCHEMISTRY-US, V37, P16242, DOI 10.1021/bi981651z; Volkmer T, 2006, BBA-BIOMEMBRANES, V1758, P1815, DOI 10.1016/j.bbamem.2006.05.009; WALLACE CJA, 1992, J BIOL CHEM, V267, P3852; Xia D, 2013, BBA-BIOENERGETICS, V1827, P1278, DOI 10.1016/j.bbabio.2012.11.008; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; YUN CH, 1991, BIOCHEMISTRY-US, V30, P6747, DOI 10.1021/bi00241a017; Zhang HB, 2008, J BIOENERG BIOMEMBR, V40, P493, DOI 10.1007/s10863-008-9174-6; Zoppellaro G, 2009, BIOPOLYMERS, V91, P1064, DOI 10.1002/bip.21267	71	12	12	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6872	6881		10.1074/jbc.M115.712307	http://dx.doi.org/10.1074/jbc.M115.712307			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26858251	Green Published, hybrid			2022-12-28	WOS:000373299700025
J	Tsubota, T; Tomita, S; Uchino, K; Kimoto, M; Takiya, S; Kajiwara, H; Yamazaki, T; Sezutsu, H				Tsubota, Takuya; Tomita, Shuichiro; Uchino, Keiro; Kimoto, Mai; Takiya, Shigeharu; Kajiwara, Hideyuki; Yamazaki, Toshimasa; Sezutsu, Hideki			A Hox Gene, Antennapedia, Regulates Expression of Multiple Major Silk Protein Genes in the Silkworm Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bombyx mori; development; gene regulation; proteomics; silkworm; transcription regulation; transgenic; Antennapedia; Hox; silk gland	SERICIN-1 GENE; DROSOPHILA-MELANOGASTER; DOWNSTREAM GENES; LIM-HOMEODOMAIN; FIBROIN; GLAND; IDENTIFICATION; ULTRABITHORAX; PROMOTER; HALTERE	Hox genes play a pivotal role in the determination of anteroposterior axis specificity during bilaterian animal development. They do so by acting as a master control and regulating the expression of genes important for development. Recently, however, we showed that Hox genes can also function in terminally differentiated tissue of the lepidopteran Bombyx mori. In this species, Antennapedia (Antp) regulates expression of sericin-1, a major silk protein gene, in the silk gland. Here, we investigated whether Antp can regulate expression of multiple genes in this tissue. By means of proteomic, RT-PCR, and in situ hybridization analyses, we demonstrate that misexpression of Antp in the posterior silk gland induced ectopic expression of major silk protein genes such as sericin-3, fhxh4, and fhxh5. These genes are normally expressed specifically in the middle silk gland as is Antp. Therefore, the evidence strongly suggests that Antp activates these silk protein genes in the middle silk gland. The putative sericin-1 activator complex (middle silk gland-intermolt-specific complex) can bind to the upstream regions of these genes, suggesting that Antp directly activates their expression. We also found that the pattern of gene expression was well conserved between B. mori and the wild species Bombyx mandarina, indicating that the gene regulation mechanism identified here is an evolutionarily conserved mechanism and not an artifact of the domestication of B. mori. We suggest that Hox genes have a role as a master control in terminally differentiated tissues, possibly acting as a primary regulator for a range of physiological processes.	[Tsubota, Takuya; Tomita, Shuichiro; Uchino, Keiro; Sezutsu, Hideki] Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, 1-2 Owashi, Tsukuba, Ibaraki 3058634, Japan; [Kimoto, Mai; Takiya, Shigeharu] Hokkaido Univ, Fac Sci, Grad Sch Life Sci, Kita Ku, North 10,West 8, Sapporo, Hokkaido 0600810, Japan; [Takiya, Shigeharu] Hokkaido Univ, Fac Sci, Div Biol Sci, Kita Ku, North 10,West 8, Sapporo, Hokkaido 0600810, Japan; [Takiya, Shigeharu] Hokkaido Univ, Fac Sci, Ctr Genome Dynam, Kita Ku, North 10,West 8, Sapporo, Hokkaido 0600810, Japan; [Kajiwara, Hideyuki; Yamazaki, Toshimasa] Natl Inst Agrobiol Sci, Biomol Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan	National Institute of Agrobiological Sciences - Japan; Hokkaido University; Hokkaido University; Hokkaido University; National Institute of Agrobiological Sciences - Japan	Tsubota, T; Sezutsu, H (corresponding author), Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, 1-2 Owashi, Tsukuba, Ibaraki 3058634, Japan.	tsubota@affrc.go.jp; hsezutsu@affrc.go.jp		Uchino, Keiro/0000-0003-3650-7359; Sezutsu, Hideki/0000-0001-8886-1611; Tsubota, Takuya/0000-0002-5839-4570	National Institute of Agrobiological Sciences technical support system	National Institute of Agrobiological Sciences technical support system	We are grateful to Kaoru Nakamura, Koji Hashimoto, and Toshihiko Misawa for maintaining the silkworms and Dr. Natuo Komoto for providing B. mandarina. We also thank Satoko Kawamoto for technical assistances and Dr. Takao K. Suzuki for helpful discussion. This work was supported by the National Institute of Agrobiological Sciences technical support system.	Agrawal P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00205; BELLO B, 1994, B I PASTEUR, V92, P81; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; de Navas LF, 2006, DEVELOPMENT, V133, P4495, DOI 10.1242/dev.02609; Dhawan S, 2003, DEV GENES EVOL, V213, P523, DOI 10.1007/s00427-003-0357-1; FUKUTA M, 1993, J BIOL CHEM, V268, P19471; Hersh BM, 2007, DEV BIOL, V302, P717, DOI 10.1016/j.ydbio.2006.11.011; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; Imamura M, 2003, GENETICS, V165, P1329; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.ibmb.2004.10.002; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; Kajiwara H., 2009, J ELECTROPHOR, V53, P19; KAUFMAN TC, 1980, GENETICS, V94, P115; Kimoto M, 2015, INSECT BIOCHEM MOLEC, V56, P29, DOI 10.1016/j.ibmb.2014.11.003; Kimoto M, 2014, DEV BIOL, V386, P64, DOI 10.1016/j.ydbio.2013.12.002; Kimoto M, 2012, DEV GENES EVOL, V222, P351, DOI 10.1007/s00427-012-0418-4; Kobayashi I, 2011, ARCH INSECT BIOCHEM, V76, P195, DOI 10.1002/arch.20402; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MACH V, 1995, J BIOL CHEM, V270, P9340, DOI 10.1074/jbc.270.16.9340; Makhijani K, 2007, DEV BIOL, V302, P243, DOI 10.1016/j.ydbio.2006.09.029; Mohit P, 2003, DEVELOPMENT, V130, P1537, DOI 10.1242/dev.00393; Ohno K, 2013, J BIOL CHEM, V288, P31581, DOI 10.1074/jbc.M113.514471; Pallavi SK, 2006, DEV BIOL, V296, P340, DOI 10.1016/j.ydbio.2006.05.035; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prochiantz A, 2015, NEURON, V85, P911, DOI 10.1016/j.neuron.2015.01.019; Robertson L.K., 2009, INSECT DEV, P1; Rohrschneider MR, 2007, DEV BIOL, V309, P358, DOI 10.1016/j.ydbio.2007.06.012; Schwab K, 2006, DEV BIOL, V293, P540, DOI 10.1016/j.ydbio.2006.02.023; Sezutsu Hideki, 2009, Journal of Insect Biotechnology and Sericology, V78, P1; Slattery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014686; Takasu Y, 2007, INSECT BIOCHEM MOLEC, V37, P1234, DOI 10.1016/j.ibmb.2007.07.009; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P339, DOI 10.1016/j.ibmb.2010.02.010; Takiya S, 1997, BIOCHEM J, V321, P645, DOI 10.1042/bj3210645; Takiya S, 2011, INSECT BIOCHEM MOLEC, V41, P592, DOI 10.1016/j.ibmb.2011.03.011; Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0; Tatematsu K, 2010, TRANSGENIC RES, V19, P473, DOI 10.1007/s11248-009-9328-2; Tsubota T., 2016, INSECT SCI IN PRESS; Tsubota T, 2014, G3-GENES GENOM GENET, V4, P1347, DOI 10.1534/g3.114.011643; Uchino Keiro, 2006, Journal of Insect Biotechnology and Sericology, V75, P89; Uchino K, 2008, INSECT BIOCHEM MOLEC, V38, P1165, DOI 10.1016/j.ibmb.2008.09.009; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Zhang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123403	45	11	11	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7087	7096		10.1074/jbc.M115.699819	http://dx.doi.org/10.1074/jbc.M115.699819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26814126	Green Published, hybrid			2022-12-28	WOS:000373299700042
J	Windheim, M; Honing, S; Leppard, KN; Butler, L; Seed, C; Ponnambalam, S; Burgert, HG				Windheim, Mark; Hoening, Stefan; Leppard, Keith N.; Butler, Larissa; Seed, Christina; Ponnambalam, Sreenivasan; Burgert, Hans-Gerhard			Sorting Motifs in the Cytoplasmic Tail of the Immunomodulatory E3/49K Protein of Species D Adenoviruses Modulate Cell Surface Expression and Ectodomain Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenovirus; intracellular trafficking; protein sorting; shedding; viral immunology; Adenovirus E3 proteins; CD45; E3; 49K; Epidemic Keratoconjunctivitis; Immune evasion	AMYLOID PRECURSOR PROTEIN; CLASS-I ANTIGENS; EPIDEMIC KERATOCONJUNCTIVITIS; MOLECULAR EVOLUTION; E3/19K PROTEIN; INFECTED-CELLS; INTRACELLULAR SEQUESTRATION; CLATHRIN ADAPTERS; DOWN-MODULATE; E3 PROTEIN	The E3 transcription unit of human species C adenoviruses (Ads) encodes immunomodulatory proteins that mediate direct protection of infected cells. Recently, we described a novel immunomodulatory function for E3/49K, an E3 protein uniquely expressed by species D Ads. E3/49K of Ad19a/Ad64, a serotype that causes epidemic keratokonjunctivitis, is synthesized as a highly glycosylated type I transmembrane protein that is subsequently cleaved, resulting in secretion of its large ectodomain (sec49K). sec49K binds to CD45 on leukocytes, impairing activation and functions of natural killer cells and T cells. E3/49K is localized in the Golgi/trans-Golgi network (TGN), in the early endosomes, and on the plasma membrane, yet the cellular compartment where E3/49K is cleaved and the protease involved remained elusive. Here we show that TGN-localized E3/49K comprises both newly synthesized and recycled molecules. Full-length E3/49K was not detected in late endosomes/lysosomes, but the C-terminal fragment accumulated in this compartment at late times of infection. Inhibitor studies showed that cleavage occurs in a post-TGN compartment and that lysosomotropic agents enhance secretion. Interestingly, the cytoplasmic tail of E3/49K contains two potential sorting motifs, YXX phi (where phi represents a bulky hydrophobic amino acid) and LL, that are important for binding the clathrin adaptor proteins AP-1 and AP-2 in vitro. Surprisingly, mutating the LL motif, either alone or together with YXX phi, did not prevent proteolytic processing but increased cell surface expression and secretion. Upon brefeldin A treatment, cell surface expression was rapidly lost, even for mutants lacking all known endocytosis motifs. Together with immunofluorescence data, we propose a model for intracellular E3/49K transport whereby cleavage takes place on the cell surface by matrix metalloproteases.	[Windheim, Mark; Leppard, Keith N.; Butler, Larissa; Seed, Christina; Burgert, Hans-Gerhard] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Windheim, Mark] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany; [Hoening, Stefan] Inst Biochem 1, D-50931 Cologne, Germany; [Hoening, Stefan] Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Ponnambalam, Sreenivasan] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University of Warwick; Hannover Medical School; University of Cologne; University of Cologne; University of Leeds	Burgert, HG (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	H-G.Burgert@warwick.ac.uk	Leppard, Keith N/A-1853-2009; Burgert, Hans-Gerhard/AAE-6668-2020; Windheim, Mark/HHR-9135-2022	Leppard, Keith N/0000-0003-2155-7919; Burgert, Hans-Gerhard/0000-0002-1650-9878; Ponnambalam, Sreenivasan/0000-0002-4452-7619; Windheim, Mark/0000-0001-6734-0905	Deutsche Forschungsgemeinschaft [BU 642/1, SFB455]; BBSRC [BB/D002877/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D002877/1] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutsche Forschungsgemeinschaft Grants BU 642/1 and SFB455 (to H.-G. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; Arnberg N, 2012, TRENDS PHARMACOL SCI, V33, P442, DOI 10.1016/j.tips.2012.04.005; ARNOLD B, 1984, CELL, V38, P79, DOI 10.1016/0092-8674(84)90528-2; Banting G, 1997, BBA-MOL CELL RES, V1355, P209, DOI 10.1016/S0167-4889(96)00146-2; Blusch JH, 2002, VIROLOGY, V296, P94, DOI 10.1006/viro.2002.1404; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Burgert HG, 2000, VIRUS GENES, V21, P13, DOI 10.1023/A:1008135928310; BURGERT HG, 1985, CELL, V41, P987, DOI 10.1016/S0092-8674(85)80079-9; BURGERT HG, 1987, P NATL ACAD SCI USA, V84, P1356, DOI 10.1073/pnas.84.5.1356; Burgert HG, 2002, CURR TOP MICROBIOL, V269, P273; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CHODOSH J, 1995, CORNEA, V14, P167; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Davison AJ, 2003, J GEN VIROL, V84, P657, DOI 10.1099/vir.0.18856-0; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Deryckere F, 1996, J VIROL, V70, P2832, DOI 10.1128/JVI.70.5.2832-2841.1996; Diettrich O, 1996, EUR J CELL BIOL, V69, P99; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; Dosso AA, 2008, CORNEA, V27, P263, DOI 10.1097/ICO.0b013e31815b7d7d; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Elsing A, 1998, P NATL ACAD SCI USA, V95, P10072, DOI 10.1073/pnas.95.17.10072; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fallon PG, 2006, TRENDS IMMUNOL, V27, P470, DOI 10.1016/j.it.2006.08.002; FOX JP, 1977, AM J EPIDEMIOL, V105, P362, DOI 10.1093/oxfordjournals.aje.a112394; Frietze KM, 2010, J VIROL, V84, P11310, DOI 10.1128/JVI.00512-10; Gabaev I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002432; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; GINSBERG HS, 1989, P NATL ACAD SCI USA, V86, P3823, DOI 10.1073/pnas.86.10.3823; Gregory SM, 2011, FUTURE VIROL, V6, P357, DOI 10.2217/FVL.11.6; Heilker R, 1999, BIOESSAYS, V21, P558, DOI 10.1002/(SICI)1521-1878(199907)21:7<558::AID-BIES4>3.0.CO;2-R; Hendrickx R, 2014, HUM GENE THER, V25, P265, DOI 10.1089/hum.2014.001; Hilgendorf A, 2003, J BIOL CHEM, V278, P51872, DOI 10.1074/jbc.M310038200; Honing S, 1997, J BIOL CHEM, V272, P19884, DOI 10.1074/jbc.272.32.19884; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; Kaneko H, 2011, BRIT J OPHTHALMOL, V95, P32, DOI 10.1136/bjo.2009.178772; KEMP MC, 1983, J INFECT DIS, V148, P24, DOI 10.1093/infdis/148.1.24; King A. M. Q., 2012, VIRUS TAXONOMY CLASS, P213; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KORNER H, 1992, P NATL ACAD SCI USA, V89, P11857, DOI 10.1073/pnas.89.24.11857; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Mallet WG, 1999, J CELL BIOL, V146, P345, DOI 10.1083/jcb.146.2.345; McNees AL, 2002, VIRUS RES, V88, P87, DOI 10.1016/S0168-1702(02)00122-3; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; Meyer-Rusenberg B, 2011, DTSCH ARZTEBL INT, V108, P475, DOI 10.3238/arztebl.2011.0475; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nilsson EC, 2011, NAT MED, V17, P105, DOI 10.1038/nm.2267; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Ponnambalam S, 1996, J CELL SCI, V109, P675; Robinson CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01812; Robinson CM, 2011, VIRUS RES, V160, P120, DOI 10.1016/j.virusres.2011.05.022; Robinson CM, 2011, INFECT GENET EVOL, V11, P1208, DOI 10.1016/j.meegid.2011.04.031; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Ruzsics Z, 2006, J VIROL, V80, P8100, DOI 10.1128/JVI.00687-06; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; SESTER M, 1994, J VIROL, V68, P5423, DOI 10.1128/JVI.68.9.5423-5432.1994; Sester M, 2013, J VIROL, V87, P6104, DOI 10.1128/JVI.03391-12; Sester M, 2010, J IMMUNOL, V184, P255, DOI 10.4049/jimmunol.0902343; Simonsen A, 1998, EUR J CELL BIOL, V76, P25, DOI 10.1016/S0171-9335(98)80014-9; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Tikkanen R, 2000, TRAFFIC, V1, P631, DOI 10.1034/j.1600-0854.2000.010807.x; Tollefson AE, 1996, J VIROL, V70, P2296, DOI 10.1128/JVI.70.4.2296-2306.1996; Tollefson AE, 1998, NATURE, V392, P726, DOI 10.1038/33712; Tortorella LL, 2007, TRAFFIC, V8, P402, DOI 10.1111/j.1600-0854.2007.00541.x; Towler MC, 2000, EXP CELL RES, V259, P167, DOI 10.1006/excr.2000.4958; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Uchino J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087342; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; Windheim M, 2004, CURR TOP MICROBIOL, V273, P29; Windheim M, 2002, J VIROL, V76, P755, DOI 10.1128/JVI.76.2.755-766.2002; Windheim M, 2013, P NATL ACAD SCI USA, V110, pE4884, DOI 10.1073/pnas.1312420110; WOLD WSM, 2007, FIELD VIROLOGY, P02395; Wu HY, 2003, J BIOL CHEM, V278, P40425, DOI 10.1074/jbc.C300225200; Zhou XH, 2012, INVEST OPHTH VIS SCI, V53, P2804, DOI 10.1167/iovs.12-9656	78	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6796	6812		10.1074/jbc.M115.684787	http://dx.doi.org/10.1074/jbc.M115.684787			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26841862	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000373299700020
J	Kusevic, D; Kudithipudi, S; Jeltsch, A				Kusevic, Denis; Kudithipudi, Srikanth; Jeltsch, Albert			Substrate Specificity of the HEMK2 Protein Glutamine Methyltransferase and Identification of Novel Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; enzyme catalysis; post-translational modification (PTM); protein methylation; S-adenosylmethionine (SAM); enzyme specificity; methylglutamine	ESCHERICHIA-COLI; LYSINE METHYLTRANSFERASE; RELEASE FACTORS; PEPTIDE ARRAYS; GGQ MOTIF; METHYLATION; TRANSLATION; TERMINATION; GENE; CARCINOMA	Bacterial HEMK2 homologs initially had been proposed to be involved in heme biogenesis or to function as adenine DNA methyltransferase. Later it was shown that this family of enzymes has protein glutamine methyltransferase activity, and they methylate the glutamine residue in the GGQ motif of ribosomal translation termination factors. The murine HEMK2 enzyme methylates Gln(185) of the eukaryotic translation termination factor eRF1. We have employed peptide array libraries to investigate the peptide sequence recognition specificity of murine HEMK2. Our data show that HEMK2 requires a GQX(3)R motif for methylation activity. In addition, amino acid preferences were observed between the -3 and +7 positions of the peptide substrate (considering the target glutamine as 0), including a preference for Ser, Arg, and Gly at the +1 and a preference for Arg at the +7 position. Based on our specificity profile, we identified several human proteins that contain putative HEMK2 methylation sites and show that HEMK2 methylates 58 novel peptide substrates. After cloning, expression, and purification of the corresponding protein domains, we confirmed methylation for 11 of them at the protein level. Transfected CHD5 (chromodomain helicase DNA-binding protein 5) and NUT (nuclear protein in testis) were also demonstrated to be methylated by HEMK2 in human HEK293 cells. Our data expand the range of proteins potentially subjected to glutamine methylation significantly, but further investigation will be required to understand the function of HEMK2-mediated methylation in proteins other than eRF1.	[Kusevic, Denis; Kudithipudi, Srikanth; Jeltsch, Albert] Univ Stuttgart, Inst Biochem, Fac Chem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany	University of Stuttgart	Jeltsch, A (corresponding author), Univ Stuttgart, Inst Biochem, Fac Chem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	albert.jeltsch@ibc.uni-stuttgart.de	Jeltsch, Albert/O-7404-2014	Jeltsch, Albert/0000-0001-6113-9290	Deutsche Forschungsgemeinschaft [JE 252/25-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant JE 252/25-1. The authors declare that they have no conflicts of interest with the contents of this article.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Bujnicki JM, 1999, IUBMB LIFE, V48, P247, DOI 10.1080/713803519; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Clarke S, 1993, CURR OPIN CELL BIOL, V5, P977, DOI 10.1016/0955-0674(93)90080-A; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; French CA, 2010, CANCER GENET CYTOGEN, V203, P16, DOI 10.1016/j.cancergencyto.2010.06.007; Graille M, 2005, MOL CELL, V20, P917, DOI 10.1016/j.molcel.2005.10.025; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Heurgue-Hamard V, 2006, J BIOL CHEM, V281, P36140, DOI 10.1074/jbc.M608571200; Ishizawa T, 2008, BIOCHEM BIOPH RES CO, V373, P99, DOI 10.1016/j.bbrc.2008.05.176; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Kolla V, 2014, CANCER RES, V74, P652, DOI 10.1158/0008-5472.CAN-13-3056; Kudithipudi S, 2014, JOVE-J VIS EXP, DOI 10.3791/52203; Kudithipudi S, 2014, CHEM BIOL, V21, P226, DOI 10.1016/j.chembiol.2013.10.016; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Le Guen L, 1999, FEMS MICROBIOL LETT, V173, P175, DOI 10.1016/S0378-1097(99)00067-1; LHOEST J, 1977, MOL GEN GENET, V154, P175, DOI 10.1007/BF00330833; Liger D, 2011, NUCLEIC ACIDS RES, V39, P6249, DOI 10.1093/nar/gkr176; Liu P, 2010, MOL CELL BIOL, V30, P4245, DOI 10.1128/MCB.00218-10; Nakahigashi K, 2002, P NATL ACAD SCI USA, V99, P1473, DOI 10.1073/pnas.032488499; NAKAYASHIKI T, 1995, GENE, V153, P67, DOI 10.1016/0378-1119(94)00805-3; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Rathert P, 2008, CHEM BIOL, V15, P5, DOI 10.1016/j.chembiol.2007.11.013; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schubert HL, 2003, BIOCHEMISTRY-US, V42, P5592, DOI 10.1021/bi034026p; Tessarz P, 2014, NATURE, V505, P564, DOI 10.1038/nature12819; Yang Z, 2004, J MOL BIOL, V340, P695, DOI 10.1016/j.jmb.2004.05.019	39	23	24	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6124	6133		10.1074/jbc.M115.711952	http://dx.doi.org/10.1074/jbc.M115.711952			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26797129	Green Published, hybrid			2022-12-28	WOS:000372894200007
J	Crowder, RN; Dicker, DT; El-Deiry, WS				Crowder, Roslyn N.; Dicker, David T.; El-Deiry, Wafik S.			The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caspase; cell death; deubiquitylation (deubiquitination); fibroblast; TRAIL	TRAIL-INDUCED APOPTOSIS; BREAST-CANCER CELLS; CASPASE-8 EXPRESSION; MEDIATED APOPTOSIS; DECOY RECEPTORS; CARCINOMA CELLS; DOWN-REGULATION; C-MYC; RESISTANCE; A20	TNF-related apoptosis-inducing ligand (TRAIL) is a potential cancer therapy that selectively targets cancer cell death while non-malignant cells remain viable. Using a panel of normal human fibroblasts, we characterized molecular differences in human foreskin fibroblasts and WI-38 TRAIL-resistant cells and marginally sensitive MRC-5 cells compared with TRAIL-sensitive human lung and colon cancer cells. We identified decreased caspase-8 protein expression and protein stability in normal fibroblasts compared with cancer cells. Additionally, normal fibroblasts had incomplete TRAIL-induced caspase-8 activation compared with cancer cells. We found that normal fibroblasts lack the ubiquitin modification of caspase-8 required for complete caspase-8 activation. Treatment with the deubiquitinase inhibitor PR-619 increased caspase-8 ubiquitination and caspase-8 enzymatic activity and sensitized normal fibroblasts to TRAIL-mediated apoptosis. Therefore, posttranslational regulation of caspase-8 confers resistance to TRAIL-induced cell death in normal cells through blockade of initiation of the extrinsic cell death pathway.	[Crowder, Roslyn N.; Dicker, David T.; El-Deiry, Wafik S.] Penn State Canc Inst, Penn State Milton S Hershey Med Ctr, Dept Med, Div Hematol Oncol, Hershey, PA 17033 USA; [Dicker, David T.; El-Deiry, Wafik S.] Fox Chase Canc Ctr, Dept Hematol Oncol, Philadelphia, PA 19111 USA; [Dicker, David T.; El-Deiry, Wafik S.] Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA; [Crowder, Roslyn N.] Stetson Univ, Dept Biol, 421 N Woodland Blvd, Deland, FL 32720 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Fox Chase Cancer Center; Fox Chase Cancer Center; Stetson University	El-Deiry, WS (corresponding author), Penn State Canc Inst, Penn State Milton S Hershey Med Ctr, Dept Med, Div Hematol Oncol, Hershey, PA 17033 USA.; El-Deiry, WS (corresponding author), Fox Chase Canc Ctr, Dept Hematol Oncol, Philadelphia, PA 19111 USA.; El-Deiry, WS (corresponding author), Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA.	wafik.eldeiry@fccc.edu	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266	National Institute of Health [R01 CA135273-05S1]; NATIONAL CANCER INSTITUTE [R01CA135273, P30CA006927] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health Grant R01 CA135273-05S1, including a minority supplement (to R. N. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Allen JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059380; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bellail AC, 2012, CANCER DISCOV, V2, P140, DOI 10.1158/2159-8290.CD-11-0172; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; Dong BF, 2012, BIOCHEM BIOPH RES CO, V418, P433, DOI 10.1016/j.bbrc.2012.01.056; Duiker EW, 2011, BRIT J CANCER, V104, P1278, DOI 10.1038/bjc.2011.84; Eggert A, 2001, CANCER RES, V61, P1314; Elrod HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012178; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Falschlehner C, 2009, ADV EXP MED BIOL, V647, P195, DOI 10.1007/978-0-387-89520-8_14; Grotzer MA, 2000, ONCOGENE, V19, P4604, DOI 10.1038/sj.onc.1203816; Hacker S, 2009, ONCOGENE, V28, P3097, DOI 10.1038/onc.2009.161; Hopkins-Donaldson S, 2003, CELL DEATH DIFFER, V10, P356, DOI 10.1038/sj.cdd.4401157; Hopkins-Donaldson S, 2000, CANCER RES, V60, P4315; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jia SH, 2008, J BIOL CHEM, V283, P5402, DOI 10.1074/jbc.M706462200; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Jin ZY, 2004, J BIOL CHEM, V279, P35829, DOI 10.1074/jbc.M405538200; Kim KH, 2000, CLIN CANCER RES, V6, P335; Kim SH, 2004, J BIOL CHEM, V279, P40044, DOI 10.1074/jbc.M404541200; Kim YS, 2002, HEPATOLOGY, V36, P1498, DOI 10.1053/jhep.2002.36942; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Li Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.464; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Ozoren N, 2000, INT J ONCOL, V16, P917; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Ramakrishna S, 2011, CELL MOL LIFE SCI, V68, P15, DOI 10.1007/s00018-010-0504-6; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Richter C, 1996, FEBS LETT, V378, P107, DOI 10.1016/0014-5793(95)01431-4; Rossin A, 2009, BIOCHEM J, V419, P185, DOI 10.1042/BJ20081212; Sarhan D, 2013, CANCER IMMUNOL IMMUN, V62, P1359, DOI 10.1007/s00262-013-1439-1; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; Tian XF, 2011, ASSAY DRUG DEV TECHN, V9, P165, DOI 10.1089/adt.2010.0317; van Dijk M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.214; van Noesel MM, 2002, CANCER RES, V62, P2157; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wang X, 2008, MOL CANCER THER, V7, P1156, DOI 10.1158/1535-7163.MCT-07-2183; Wang X, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-36; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yang XW, 2001, CANCER RES, V61, P7025; Zhang LD, 2005, NEOPLASIA, V7, P594, DOI 10.1593/neo.04688; Zhang XD, 2000, FEBS LETT, V482, P193, DOI 10.1016/S0014-5793(00)02042-1; Zhang Y, 2007, CELL RES, V17, P363, DOI 10.1038/cr.2007.11; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	59	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5960	5970		10.1074/jbc.M115.713545	http://dx.doi.org/10.1074/jbc.M115.713545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26757822	hybrid, Green Published			2022-12-28	WOS:000372551800041
J	Shin, HR; Islam, R; Yoon, WJ; Lee, T; Cho, YD; Bae, HS; Kim, BS; Woo, KM; Baek, JH; Ryoo, HM				Shin, Hye-Rim; Islam, Rabia; Yoon, Won-Joon; Lee, Taegyung; Cho, Young-Dan; Bae, Han-sol; Kim, Bong-Su; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo			Pin1-mediated Modification Prolongs the Nuclear Retention of -Catenin in Wnt3a-induced Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-catenin; cell differentiation; nuclear translocation; osteoblast; Wnt signaling; peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1); adenomatous polyposis coli (APC); osteogenesis; peptidyl prolyl cis-trans isomerization	PROLYL ISOMERASE PIN1; TRANSCRIPTION FACTOR LEF-1; BETA-CATENIN; WNT/BETA-CATENIN; SUBCELLULAR-LOCALIZATION; STEM-CELLS; SIGNALING PATHWAY; MESSENGER-RNA; FISSION YEAST; LEPTOMYCIN-B	The canonical Wnt signaling pathway, in which -catenin nuclear localization is a crucial step, plays an important role in osteoblast differentiation. Pin1, a prolyl isomerase, is also known as a key enzyme in osteogenesis. However, the role of Pin1 in canonical Wnt signal-induced osteoblast differentiation is poorly understood. We found that Pin1 deficiency caused osteopenia and reduction of -catenin in bone lining cells. Similarly, Pin1 knockdown or treatment with Pin1 inhibitors strongly decreased the nuclear -catenin level, TOP flash activity, and expression of bone marker genes induced by canonical Wnt activation and vice versa in Pin1 overexpression. Pin1 interacts directly with and isomerizes -catenin in the nucleus. The isomerized -catenin could not bind to nuclear adenomatous polyposis coli, which drives -catenin out of the nucleus for proteasomal degradation, which consequently increases the retention of -catenin in the nucleus and might explain the decrease of -catenin ubiquitination. These results indicate that Pin1 could be a critical target to modulate -catenin-mediated osteogenesis.	[Shin, Hye-Rim; Islam, Rabia; Yoon, Won-Joon; Lee, Taegyung; Cho, Young-Dan; Bae, Han-sol; Kim, Bong-Su; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo] Seoul Natl Univ, Sch Dent, Dept Mol Genet, 28 Yeongeon Dong, Seoul 110749, South Korea; [Shin, Hye-Rim; Islam, Rabia; Yoon, Won-Joon; Lee, Taegyung; Cho, Young-Dan; Bae, Han-sol; Kim, Bong-Su; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo] Seoul Natl Univ, Dent Res Inst, Program BK21, Seoul 110749, South Korea; [Cho, Young-Dan] Seoul Natl Univ, Sch Dent, Dept Periodontol, Seoul 110749, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Ryoo, HM (corresponding author), Seoul Natl Univ, Sch Dent, Dept Mol Genet, 28 Yeongeon Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr	Ryoo, Hyun-Mo/D-5839-2012; Cho, Young-Dan/AAR-4573-2021; Woo, Kyung Mi/A-2793-2009	Ryoo, Hyun-Mo/0000-0001-6769-8341; Woo, Kyung Mi/0000-0002-2782-1189; Islam, Rabia/0000-0001-7378-9071	National Research Foundation of Korea [20100030015, 20100010590]; Ministry of Health and Welfare of Korea [860-20120107, HI12C1154]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Health and Welfare of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Bio and Medical Technology Development Program Grant 20100030015 and General Researcher Program Grant 20100010590 of the National Research Foundation of Korea. Funding was also provided by Ministry of Health and Welfare Projects 860-20120107 and HI12C1154 of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Attisano L, 2004, CANCER METAST REV, V23, P53, DOI 10.1023/A:1025811012690; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Caliceti C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/318714; Chen SY, 2006, MOL CELL BIOL, V26, P929, DOI 10.1128/MCB.26.3.929-939.2006; Cho YD, 2014, J BIOL CHEM, V289, P20120, DOI 10.1074/jbc.M114.558064; Chocarro-Calvo A, 2013, MOL CELL, V49, P474, DOI 10.1016/j.molcel.2012.11.022; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Driver Jane A, 2010, Curr Aging Sci, V3, P158; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Inoue T, 2006, STEM CELLS, V24, P95, DOI 10.1634/stemcells.2005-0124; Islam R, 2014, J CELL PHYSIOL, V229, P2166, DOI 10.1002/jcp.24679; Islam R, 2014, J CELL PHYSIOL, V229, P443, DOI 10.1002/jcp.24462; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Kolpakova E, 2005, DEV CELL, V8, P626, DOI 10.1016/j.devcel.2005.04.008; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Kuersten S, 2001, TRENDS CELL BIOL, V11, P497, DOI 10.1016/S0962-8924(01)02144-4; Lim JN, 2005, BBA-MOL BASIS DIS, V1739, P311, DOI 10.1016/j.bbadis.2004.10.003; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Luu HH, 2004, CURR CANCER DRUG TAR, V4, P653, DOI 10.2174/1568009043332709; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nakamura K, 2012, MOL CELL BIOL, V32, P2966, DOI 10.1128/MCB.05688-11; Neufeld KL, 2000, EMBO REP, V1, P519; NISHI K, 1994, J BIOL CHEM, V269, P6320; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Shen ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079443, 10.1371/journal.pone.0054520]; Suizu F, 2006, MOL CELL BIOL, V26, P1463, DOI 10.1128/MCB.26.4.1463-1479.2006; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Warner DR, 2005, FEBS LETT, V579, P3539, DOI 10.1016/j.febslet.2005.05.024; Watanabe M, 1999, GENES CELLS, V4, P291, DOI 10.1046/j.1365-2443.1999.00259.x; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Wulf G, 2003, BREAST CANCER RES, V5, P76, DOI 10.1186/bcr572; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yoon WJ, 2015, J CELL PHYSIOL, V230, P640, DOI 10.1002/jcp.24787; Yoon WJ, 2014, J BIOL CHEM, V289, P8828, DOI 10.1074/jbc.M113.516237; Yoon WJ, 2013, J CELL PHYSIOL, V228, P2377, DOI 10.1002/jcp.24403; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zhang M, 2010, J BIOL CHEM, V285, P8703, DOI 10.1074/jbc.M109.093526	57	21	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5555	5565		10.1074/jbc.M115.698563	http://dx.doi.org/10.1074/jbc.M115.698563			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26740630	hybrid, Green Published			2022-12-28	WOS:000372551800010
J	Eroglu, A; Gentleman, S; Poliakov, E; Redmond, TM				Eroglu, Abdulkerim; Gentleman, Susan; Poliakov, Eugenia; Redmond, T. Michael			Inhibition of RPE65 Retinol Isomerase Activity by Inhibitors of Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme inhibitor; liposome; retinal metabolism; retinoid; vision; RPE65; triacsin C; visual cycle; fatty acyl:CoA ligase	ACYL-COA SYNTHETASE; VISUAL CYCLE; TRIACSIN-C; ISOMEROHYDROLASE ACTIVITY; ARACHIDONIC-ACID; ISOMERIZATION; VASODILATORS; DEGENERATION; WS-1228-A; MECHANISM	RPE65 is the isomerase catalyzing conversion of all-trans-retinyl ester (atRE) into 11-cis-retinol in the retinal visual cycle. Crystal structures of RPE65 and site-directed mutagenesis reveal aspects of its catalytic mechanism, especially retinyl moiety isomerization, but other aspects remain to be determined. To investigate potential interactions between RPE65 and lipid metabolism enzymes, HEK293-F cells were transfected with expression vectors for visual cycle proteins and co-transfected with either fatty acyl:CoA ligases (ACSLs) 1, 3, or 6 or the SLC27A family fatty acyl-CoA synthase FATP2/SLCA27A2 to test their effect on isomerase activity. These experiments showed that RPE65 activity was reduced by co-expression of ACSLs or FATP2. Surprisingly, however, in attempting to relieve the ACSL-mediated inhibition, we discovered that triacsin C, an inhibitor of ACSLs, also potently inhibited RPE65 isomerase activity in cellulo. We found triacsin C to be a competitive inhibitor of RPE65 (IC50 = 500 nm). We confirmed that triacsin C competes directly with atRE by incubating membranes prepared from chicken RPE65-transfected cells with liposomes containing 0-1 m atRE. Other inhibitors of ACSLs had modest inhibitory effects compared with triascin C. In conclusion, we have identified an inhibitor of ACSLs as a potent inhibitor of RPE65 that competes with the atRE substrate of RPE65 for binding. Triacsin C, with an alkenyl chain resembling but not identical to either acyl or retinyl chains, may compete with binding of the acyl moiety of atRE via the alkenyl moiety. Its inhibitory effect, however, may reside in its nitrosohydrazone/triazene moiety.	[Eroglu, Abdulkerim; Gentleman, Susan; Poliakov, Eugenia; Redmond, T. Michael] NEI, Lab Retinal Cell & Mol Biol, Natl Inst Hlth, Bldg 6,Rm 117A,6 Ctr Dr,MSC 0608, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Redmond, TM (corresponding author), NEI, Lab Retinal Cell & Mol Biol, Natl Inst Hlth, Bldg 6,Rm 117A,6 Ctr Dr,MSC 0608, Bethesda, MD 20892 USA.	redmondd@helix.nih.gov	Eroglu, Abdulkerim/J-5862-2019	Eroglu, Abdulkerim/0000-0001-5350-450X; Redmond, T. Michael/0000-0002-1813-5291	Intramural Research Program of National Eye Institute, National Institutes of Health (U.S. Department of Health and Human Services); NATIONAL EYE INSTITUTE [ZIAEY000260] Funding Source: NIH RePORTER	Intramural Research Program of National Eye Institute, National Institutes of Health (U.S. Department of Health and Human Services); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Intramural Research Program of the National Eye Institute, National Institutes of Health (U.S. Department of Health and Human Services). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chander P, 2012, J BIOL CHEM, V287, P30552, DOI 10.1074/jbc.M112.364596; CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Guignard TJP, 2010, J BIOL CHEM, V285, P18759, DOI 10.1074/jbc.M109.064329; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kim Y, 2012, EUR J MED CHEM, V50, P311, DOI 10.1016/j.ejmech.2012.02.010; Kiser PD, 2015, NAT CHEM BIOL, V11, P409, DOI [10.1038/NCHEMBIO.1799, 10.1038/nchembio.1799]; Kiser PD, 2012, P NATL ACAD SCI USA, V109, pE2747, DOI 10.1073/pnas.1212025109; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; KNOLL LJ, 1995, J BIOL CHEM, V270, P20090, DOI 10.1074/jbc.270.34.20090; LANDERS GM, 1988, J CHROMATOGR, V438, P383, DOI 10.1016/S0021-9673(00)90269-3; LAPOSATA M, 1987, PROSTAGLANDINS, V33, P603, DOI 10.1016/0090-6980(87)90284-X; Li SH, 2013, J NEUROSCI, V33, P3178, DOI 10.1523/JNEUROSCI.2428-12.2013; Matsuda D, 2008, J ANTIBIOT, V61, P318, DOI 10.1038/ja.2008.45; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2008, J BIOL CHEM, V283, P8110, DOI 10.1074/jbc.M703654200; Nikolaeva O, 2009, FEBS J, V276, P3020, DOI 10.1111/j.1742-4658.2009.07021.x; OMURA S, 1986, J ANTIBIOT, V39, P1211, DOI 10.7164/antibiotics.39.1211; Poliakov E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049975; Poliakov E, 2011, BIOCHEMISTRY-US, V50, P6739, DOI 10.1021/bi200532m; Redmond TM, 2010, J BIOL CHEM, V285, P1919, DOI 10.1074/jbc.M109.027458; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SOLTYSIAK RM, 1984, BIOCHIM BIOPHYS ACTA, V792, P214, DOI 10.1016/0005-2760(84)90225-X; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; SUN FF, 1981, PROSTAGLANDINS, V21, P333, DOI 10.1016/0090-6980(81)90151-9; TANAKA H, 1982, J ANTIBIOT, V35, P157, DOI 10.7164/antibiotics.35.157; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vessey DA, 2004, J BIOCHEM MOL TOXIC, V18, P100, DOI 10.1002/jbt.20009; YOSHIDA K, 1982, J ANTIBIOT, V35, P151, DOI 10.7164/antibiotics.35.151; Zhang JY, 2015, J CLIN INVEST, V125, P2781, DOI 10.1172/JCI80950	33	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4966	4973		10.1074/jbc.M115.685651	http://dx.doi.org/10.1074/jbc.M115.685651			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26719343	Green Published, hybrid			2022-12-28	WOS:000371640600012
J	Lai, SS; Safaei, J; Pelech, S				Lai, Shenshen; Safaei, Javad; Pelech, Steven			Evolutionary Ancestry of Eukaryotic Protein Kinases and Choline Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; protein evolution; protein kinase; protein phosphorylation; signal transduction; choline kinase; glutaminyl aminoacyl tRNA synthetase; phosphatidylcholine biosynthesis	HORIZONTAL GENE-TRANSFER; RNA SYNTHETASE FAMILY; CRYSTAL-STRUCTURE; DATABASE; SUPERFAMILY; PROKARYOTES; PREDICTION; BACTERIA; DOMAIN; YEAST	The reversible phosphorylation of proteins catalyzed by protein kinases in eukaryotes supports an important role for eukaryotic protein kinases (ePKs) in the emergence of nucleated cells in the third superkingdom of life. Choline kinases (ChKs) could also be critical in the early evolution of eukaryotes, because of their function in the biosynthesis of phosphatidylcholine, which is unique to eukaryotic membranes. However, the genomic origins of ePKs and ChKs are unclear. The high degeneracy of protein sequences and broad expansion of ePK families have made this fundamental question difficult to answer. In this study, we identified two class-I aminoacyl-tRNA synthetases with high similarities to consensus amino acid sequences of human protein-serine/threonine kinases. Comparisons of primary and tertiary structures supported that ePKs and ChKs evolved from a common ancestor related to glutaminyl aminoacyl-tRNA synthetases, which may have been one of the key factors in the successful of emergence of ancient eukaryotic cells from bacterial colonies.	[Lai, Shenshen; Pelech, Steven] Univ British Columbia, Div Neurol, Dept Med, Vancouver, BC V6T 2B5, Canada; [Safaei, Javad] Univ British Columbia, Dept Comp Sci, Vancouver, BC V6T 1Z4, Canada; [Pelech, Steven] Kinexus Bioinformat Corp, Vancouver, BC V6P 6T3, Canada	University of British Columbia; University of British Columbia	Pelech, S (corresponding author), Ste 1,8755 Ash St, Vancouver, BC V6P 6T3, Canada.	spelech@kinexus.ca		Pelech, Steven/0000-0003-1112-903X	Kinexus; University of British Columbia; Kinexus Bioinformatics Corporation	Kinexus; University of British Columbia; Kinexus Bioinformatics Corporation	This work was supported by Kinexus. S. P. is the president, chief scientific officer and majority shareholder of Kinexus Bioinformatics Corporation, which offers proteomics services and products for sale.; Supported by University Graduate Fellowships from the University of British Columbia and Kinexus Bioinformatics Corporation.	Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CARLING D, 1994, J BIOL CHEM, V269, P11442; Daigle DM, 1999, CHEM BIOL, V6, P11, DOI 10.1016/S1074-5521(99)80016-7; Darnell JE, 1997, P NATL ACAD SCI USA, V94, P11767, DOI 10.1073/pnas.94.22.11767; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; LAMOUR V, 1994, P NATL ACAD SCI USA, V91, P8670, DOI 10.1073/pnas.91.18.8670; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Middelbeek J, 2010, CELL MOL LIFE SCI, V67, P875, DOI 10.1007/s00018-009-0215-z; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Peisach D, 2003, STRUCTURE, V11, P703, DOI 10.1016/S0969-2126(03)00094-7; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Safaei J, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S6; Saha R, 2009, BIOCHEM J, V417, P449, DOI 10.1042/BJ20080747; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Siatecka M, 1998, EUR J BIOCHEM, V256, P80, DOI 10.1046/j.1432-1327.1998.2560080.x; SMITH RF, 1995, PROTEIN SCI, V4, P126; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; Theobald DL, 2010, NATURE, V465, P219, DOI 10.1038/nature09014; Tyagi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010608; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086	35	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5199	5205		10.1074/jbc.M115.691428	http://dx.doi.org/10.1074/jbc.M115.691428			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26742849	Green Published, hybrid			2022-12-28	WOS:000371640600031
J	Magin, RS; March, ZM; Marmorstein, R				Magin, Robert S.; March, Zachary M.; Marmorstein, Ronen			The N-terminal Acetyltransferase Naa10/ARD1 Does Not Acetylate Lysine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl-CoA; acetylation; acetyltransferase; posttranslational modification (PTM); transcription factor; ARD1; NAT; Naa10p; chemical acetylation	METHIONINE SULFOXIDE REDUCTASE; MOLECULAR-BASIS; PROTEIN ACETYLATION; COMPLEX; HIF-1-ALPHA; DESTABILIZATION; PEPTIDE; HARD1; YEAST; NATA	The N-terminal acetyltransferase NatA is a heterodimeric complex consisting of a catalytic subunit (Naa10/ARD1) and an auxiliary subunit (Naa15). NatA co-translationally acetylates the N termini of a wide variety of nascent polypeptides. In addition, Naa10 can act independently to posttranslationally acetylate a distinct set of substrates, notably actin. Recent structural studies of Naa10 have also revealed the molecular basis for N-terminal acetylation specificity. Surprisingly, recent reports claim that Naa10 may also acetylate lysine residues of diverse targets, including methionine sulfoxide reductase A, myosin light chain kinase, and Runt-related transcription factor 2. Here we used recombinant proteins to reconstitute and assess lysine acetylation events catalyzed by Naa10 in vitro. We show that there is no difference in lysine acetylation of substrate proteins with or without Naa10, suggesting that the substrates may be acetylated chemically rather than enzymatically. Together, our data argue against a role for Naa10 in lysine acetylation.	[Magin, Robert S.; March, Zachary M.; Marmorstein, Ronen] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Magin, Robert S.; Marmorstein, Ronen] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Magin, Robert S.; March, Zachary M.] Univ Penn, Grad Grp Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Marmorstein, R (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Dept Biochem & Biophys, 421 Curie Blvd, Philadelphia, PA 19104 USA.	marmor@mail.med.upenn.edu		March, Zachary/0000-0003-2441-899X; Magin, Robert/0000-0002-8480-8511	DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania (National Institutes of Health) [P30 CA016520]; NATIONAL CANCER INSTITUTE [P30CA010815, P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293, T32GM071339, R35GM118090] Funding Source: NIH RePORTER	DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the support of the DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania (National Institutes of Health Grant P30 CA016520).	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Arnesen T, 2005, FEBS LETT, V579, P6428, DOI 10.1016/j.febslet.2005.10.036; Baeza J, 2015, ACS CHEM BIOL, V10, P122, DOI 10.1021/cb500848p; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dorfel MJ, 2015, GENE, V567, P103, DOI 10.1016/j.gene.2015.04.085; Forte GMA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001073; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Li Y, 2014, GENE DEV, V28, P1217, DOI 10.1101/gad.240531.114; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Liszczak G, 2013, P NATL ACAD SCI USA, V110, P14652, DOI 10.1073/pnas.1310365110; Liszczak G, 2011, J BIOL CHEM, V286, P37002, DOI 10.1074/jbc.M111.282863; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Magin RS, 2015, STRUCTURE, V23, P332, DOI 10.1016/j.str.2014.10.025; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; Murray-Rust TA, 2006, FEBS LETT, V580, P1911, DOI 10.1016/j.febslet.2006.02.012; Olia AS, 2015, ACS CHEM BIOL, V10, P2034, DOI 10.1021/acschembio.5b00342; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Ricketts MD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8711; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Shin DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007451; Shin SH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.456; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Van Damme P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004580; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Vetting MW, 2008, PROTEIN SCI, V17, P1781, DOI 10.1110/ps.035899.108; Yoon H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6176; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382	31	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5270	5277		10.1074/jbc.M115.709428	http://dx.doi.org/10.1074/jbc.M115.709428			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26755727	Green Published, hybrid			2022-12-28	WOS:000371640600037
J	Wu, ZX; Guo, W; Xie, YT; Zhou, ST				Wu, Zhongxia; Guo, Wei; Xie, Yingtian; Zhou, Shutang			Juvenile Hormone Activates the Transcription of Cell-division-cycle 6 (Cdc6) for Polyploidy-dependent Insect Vitellogenesis and Oogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; gene regulation; insect; juvenile hormone (JH); reproduction	KRUPPEL-HOMOLOG 1; LOCUST FAT-BODY; METHOPRENE-TOLERANT; DNA-REPLICATION; ANDROGEN RECEPTOR; MOLECULAR ACTIONS; MESSENGER-RNA; MCM PROTEINS; S-PHASE; COMPLEX	Although juvenile hormone (JH) is known to prevent insect larval metamorphosis and stimulate adult reproduction, the molecular mechanisms of JH action in insect reproduction remain largely unknown. Earlier, we reported that the JH-receptor complex, composed of methoprene-tolerant and steroid receptor co-activator, acts on mini-chromosome maintenance (Mcm) genes Mcm4 and Mcm7 to promote DNA replication and polyploidy for the massive vitellogenin (Vg) synthesis required for egg production in the migratory locust (Guo, W., Wu, Z., Song, J., Jiang, F., Wang, Z., Deng, S., Walker, V. K., and Zhou, S. (2014) PLoS Genet. 10, e1004702). In this study we have investigated the involvement of cell-division-cycle 6 (Cdc6) in JH-dependent vitellogenesis and oogenesis, as Cdc6 is essential for the formation of prereplication complex. We demonstrate here that Cdc6 is expressed in response to JH and methoprene-tolerant, and Cdc6 transcription is directly regulated by the JH-receptor complex. Knockdown of Cdc6 inhibits polyploidization of fat body and follicle cells, resulting in the substantial reduction of Vg expression in the fat body as well as severely impaired oocyte maturation and ovarian growth. Our data indicate the involvement of Cdc6 in JH pathway and a pivotal role of Cdc6 in JH-mediated polyploidization, vitellogenesis, and oogenesis.	[Wu, Zhongxia] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Guo, Wei] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China; [Xie, Yingtian] Jilin Univ, Coll Life Sci, Changchun 30012, Jilin, Peoples R China; [Zhou, Shutang] Henan Univ, Inst Plant Stress Biol, Sch Life Sci, State Key Lab Cotton Biol, Kaifeng 475004, Henan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Jilin University; Henan University	Zhou, ST (corresponding author), Henan Univ, Inst Plant Stress Biol, Sch Life Sci, State Key Lab Cotton Biol, Kaifeng 475004, Henan, Peoples R China.	szhou@henu.edu.cn	Guo, Wei/A-7089-2008	Guo, Wei/0000-0001-9081-9754	National Natural Science Foundation of China [31172149]; National Basic Research Program of China [2012CB114101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grant 31172149 and National Basic Research Program of China Grant 2012CB114101.	Ayad NG, 2005, CELL, V122, P825, DOI 10.1016/j.cell.2005.09.001; Belles X, 2005, REPRO BIOL, V12, P157; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; BOWNES M, 1989, J INSECT PHYSIOL, V35, P409, DOI 10.1016/0022-1910(89)90115-7; Buntrock L, 2012, GENOME, V55, P755, DOI 10.1139/g2012-060; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; CHINZEI Y, 1982, CAN J BIOCHEM CELL B, V60, P243, DOI 10.1139/o82-029; Crevel G, 2005, J CELL SCI, V118, P2451, DOI 10.1242/jcs.02361; Cruz J, 2003, INSECT BIOCHEM MOLEC, V33, P1219, DOI 10.1016/j.ibmb.2003.06.004; DALE JF, 1986, J INSECT PHYSIOL, V32, P763, DOI 10.1016/0022-1910(86)90079-X; DEAN RL, 1980, J INSECT PHYSIOL, V26, P267, DOI 10.1016/0022-1910(80)90073-6; DHADIALLA TS, 1987, DEV BIOL, V123, P108, DOI 10.1016/0012-1606(87)90432-5; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Evrin C, 2014, NUCLEIC ACIDS RES, V42, P2257, DOI 10.1093/nar/gkt1148; Evrin C, 2013, NUCLEIC ACIDS RES, V41, P3162, DOI 10.1093/nar/gkt043; GLINKA AV, 1995, INSECT BIOCHEM MOLEC, V25, P775, DOI 10.1016/0965-1748(94)00098-3; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Guo W, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004702; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Jacobson AL, 2013, INSECT MOL BIOL, V22, P12, DOI 10.1111/j.1365-2583.2012.01165.x; Jin F, 2009, NUCLEIC ACIDS RES, V37, P4826, DOI 10.1093/nar/gkp510; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Koyama T, 2004, MOL CELL ENDOCRINOL, V213, P155, DOI 10.1016/j.mce.2003.10.063; LAPOINTE MC, 1985, J INSECT PHYSIOL, V31, P187, DOI 10.1016/0022-1910(85)90119-2; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lei M, 2001, J CELL SCI, V114, P1447; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Mallik I, 2008, BBA-MOL CELL RES, V1783, P1737, DOI 10.1016/j.bbamcr.2008.05.006; NAIR KK, 1981, DEV BIOL, V81, P356, DOI 10.1016/0012-1606(81)90300-6; Nordman J, 2012, DEVELOPMENT, V139, P455, DOI 10.1242/dev.061838; OISHI M, 1985, CAN J BIOCHEM CELL B, V63, P1064, DOI 10.1139/o85-132; Okayama H, 2012, CELL SIGNAL, V24, P1599, DOI 10.1016/j.cellsig.2012.04.005; Parthasarathy R, 2011, INSECT BIOCHEM MOLEC, V41, P294, DOI 10.1016/j.ibmb.2011.01.006; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P429, DOI 10.1016/j.ibmb.2010.04.002; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; Petrakis TG, 2012, TRANSCR-AUSTIN, V3, P124, DOI 10.4161/trns.20301; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; PRATT GE, 1972, J EXP BIOL, V56, P201; Raikhel A.S., 2005, P433; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Ren D, 2014, INSECT MOL BIOL, V23, P175, DOI 10.1111/imb.12074; Richard DS, 2001, J INSECT PHYSIOL, V47, P905, DOI 10.1016/S0022-1910(01)00063-4; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Riera A, 2015, CELL CYCLE, V14, P6, DOI 10.4161/15384101.2014.987624; Riera A, 2013, CELL CYCLE, V12, P2917, DOI 10.4161/cc.26132; Schoenfelder KP, 2015, J CELL BIOL, V209, P485, DOI 10.1083/jcb.201502016; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; Song JS, 2014, INSECT BIOCHEM MOLEC, V52, P94, DOI 10.1016/j.ibmb.2014.07.001; Sun JJ, 2008, J CELL BIOL, V182, P885, DOI 10.1083/jcb.200802084; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Takara TJ, 2011, EMBO J, V30, P4885, DOI 10.1038/emboj.2011.394; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; WIELGUS JJ, 1979, J INSECT PHYSIOL, V25, P9, DOI 10.1016/0022-1910(79)90030-1; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zhou S, 2002, INSECT BIOCHEM MOLEC, V32, P1567, DOI 10.1016/S0965-1748(02)00077-2; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110	68	41	49	2	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5418	5427		10.1074/jbc.M115.698936	http://dx.doi.org/10.1074/jbc.M115.698936			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26728459	Green Published, hybrid			2022-12-28	WOS:000371640600049
J	Fernandez-Caggiano, M; Schroder, E; Cho, HJ; Burgoyne, J; Barallobre-Barreiro, J; Mayr, M; Eaton, P				Fernandez-Caggiano, Mariana; Schroeder, Ewald; Cho, Hyun-Ju; Burgoyne, Joseph; Barallobre-Barreiro, Javier; Mayr, Manuel; Eaton, Philip			Oxidant-induced Interprotein Disulfide Formation in Cardiac Protein DJ-1 Occurs via an Interaction with Peroxiredoxin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CRYSTAL-STRUCTURE; IN-VIVO; GENE; ANTIOXIDANT; DAMAGE; ACID; REGULATOR; APOPTOSIS; CHAPERONE	The role and responses of the dimeric DJ-1 protein to cardiac oxidative stress is incompletely understood. H2O2 induces a 50-kDa DJ-1 interprotein homodimer disulfide, known to form between Cys-53 on each subunit. A trimeric 75-kDa DJ-1 complex that mass spectrometry shows contained 2-Cys peroxiredoxin also formed and precedes the appearance of the disulfide dimer. These observations may represent peroxiredoxin sensing and transducing the oxidant signal to DJ-1. The dimeric disulfide DJ-1 complex was stabilized by auranofin, suggesting that thioredoxin recycles it in cells. Higher concentrations of H2O2 concomitantly induce DJ-1 Cys-106 hyperoxidation (sulfination or sulfonation) in myocytes, perfused heart, or HEK cells. An oxidation-resistant C53A DJ-1 shows potentiated H2O2-induced Cys-106 hyperoxidation. DJ-1 also forms multiple disulfides with unknown target proteins during H2O2 treatment, the formation of which is also potentiated in cells expressing the C53A mutant. This suggests that the intersubunit disulfide induces a conformational change that limits Cys-106 forming heterodisulfide protein complexes or from hyperoxidizing. High concentrations of H2O2 also induce cell death, with DJ-1 Cys-106 sulfonation appearing causal in these events, as expression of C53A DJ-1 enhanced both Cys-106 sulfonation and cell death. Nonetheless, expression of the DJ-1 C106A mutant, which fully prevents hyperoxidation, also showed exacerbated cell death responses to H2O2. A rational explanation for these findings is that DJ-1 Cys-106 forms disulfides with target proteins to limit oxidant induced cell death. However, when Cys-106 is hyperoxidized, formation of these potentially protective heterodimeric disulfide complexes is limited, and so cell death is exacerbated.	[Fernandez-Caggiano, Mariana; Schroeder, Ewald; Cho, Hyun-Ju; Burgoyne, Joseph; Eaton, Philip] Kings Coll London, Rayne Inst, St Thomas Hosp, Cardiovasc Div,British Heart Fdn,Ctr Excellence, London SE1 7EH, England; [Barallobre-Barreiro, Javier; Mayr, Manuel] Kings Coll London, Kings Coll Hosp London, James Black Ctr, Cardiovasc Div,British Heart Fdn,Ctr Excellence, London SE5 9NU, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University College London	Eaton, P (corresponding author), Kings Coll London, Rayne Inst, St Thomas Hosp, Cardiovasc Div,British Heart Fdn,Ctr Excellence, London SE1 7EH, England.	philip.eaton@kcl.ac.uk	Eaton, Philip/I-5444-2015	Eaton, Philip/0000-0003-0748-2367; Mayr, Manuel/0000-0002-0597-829X; Barallobre-Barreiro, Javier/0000-0001-6236-2304; Fernandez-Caggiano, Mariana/0000-0001-5180-0866	European Research Council (ERC); British Heart Foundation; Medical Research Council; Fondation Leducq; Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre; Biotechnology and Biological Sciences Research Council [BB/C503646/1] Funding Source: researchfish; British Heart Foundation [RG/12/12/29872, PG/15/26/31373, PG/10/98/28655, FS/11/45/28859, FS/13/2/29892, PG/13/13/30018] Funding Source: researchfish; Medical Research Council [G1000458, G0600785, G0700320, 998501, MR/L009684/1, MR/K003232/1] Funding Source: researchfish; MRC [G0600785, MR/K003232/1, G1000458, MR/L009684/1, G0700320] Funding Source: UKRI	European Research Council (ERC)(European Research Council (ERC)European Commission); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fondation Leducq(Leducq Foundation); Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Research Council (ERC Advanced award), British Heart Foundation, Medical Research Council and Fondation Leducq, and the Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre award to Guy's and St. Thomas' National Health Service Foundation Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Basak I, 2014, J BIOL CHEM, V289, P14458, DOI 10.1074/jbc.M114.548156; Billia F, 2013, P NATL ACAD SCI USA, V110, P6085, DOI 10.1073/pnas.1303444110; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cao J, 2014, ANTIOXID REDOX SIGN, V21, P1443, DOI 10.1089/ars.2013.5446; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Culleton BA, 2015, CELL STRESS CHAPERON, V20, P121, DOI 10.1007/s12192-014-0531-6; Duan XB, 2008, J PROTEOME RES, V7, P4955, DOI 10.1021/pr800295j; Dubuisson M, 2004, FEBS LETT, V571, P161, DOI 10.1016/j.febslet.2004.06.080; Fu CX, 2009, MOL CELL PROTEOMICS, V8, P1674, DOI 10.1074/mcp.M800580-MCP200; Gautier CA, 2014, REV NEUROL-FRANCE, V170, P339, DOI 10.1016/j.neurol.2013.06.003; Girotto S, 2014, J BIOL CHEM, V289, P10887, DOI 10.1074/jbc.M113.535112; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; HARRISON WH, 1968, BIOCHEMISTRY-US, V7, P3089, DOI 10.1021/bi00849a010; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Im JY, 2010, NEUROSCI RES, V67, P203, DOI 10.1016/j.neures.2010.04.002; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Klawitter J, 2013, CARDIOVASC RES, V97, P66, DOI 10.1093/cvr/cvs302; Knobbe CB, 2011, J PROTEOME RES, V10, P4388, DOI 10.1021/pr200225c; Lee H, 2012, ONCOL LETT, V3, P507, DOI 10.3892/ol.2011.522; Lev N, 2009, J MOL NEUROSCI, V38, P94, DOI 10.1007/s12031-008-9138-7; Liu CL, 2014, INVEST OPHTH VIS SCI, V55, P5551, DOI 10.1167/iovs.14-14580; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Matte A, 2015, ANTIOXID REDOX SIGN, V23, P1284, DOI 10.1089/ars.2014.6237; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Milani P, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/836760; Mitsugi H, 2013, FEBS LETT, V587, P2493, DOI 10.1016/j.febslet.2013.06.032; Mitsumoto A, 2001, FREE RADICAL RES, V35, P301, DOI 10.1080/10715760100300831; Miyajima Y, 2010, ANTICANCER RES, V30, P265; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Niki T, 2003, MOL CANCER RES, V1, P247; Pantcheva P, 2014, NEURAL REGEN RES, V9, P1430, DOI 10.4103/1673-5374.139458; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Poynton RA, 2014, BBA-GEN SUBJECTS, V1840, P906, DOI 10.1016/j.bbagen.2013.08.001; Rehder DS, 2010, BIOCHEMISTRY-US, V49, P7748, DOI 10.1021/bi1008694; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhu ZM, 2014, ONCOL REP, V31, P1489, DOI 10.3892/or.2013.2961; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	52	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10399	10410		10.1074/jbc.M115.699850	http://dx.doi.org/10.1074/jbc.M115.699850			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26945066	hybrid, Green Published			2022-12-28	WOS:000375602800044
J	Ranatunga, W; Gakh, O; Galeano, BK; Smith, DY; Soderberg, CAG; Al-Karadaghi, S; Thompson, JR; Isaya, G				Ranatunga, Wasantha; Gakh, Oleksandr; Galeano, Belinda K.; Smith, Douglas Y.; Soderberg, Christopher A. G.; Al-Karadaghi, Salam; Thompson, James R.; Isaya, Grazia			Architecture of the Yeast Mitochondrial Iron-Sulfur Cluster Assembly Machinery THE SUB-COMPLEX FORMED BY THE IRON DONOR, Yfh1 PROTEIN, AND THE SCAFFOLD, Isu1 PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL CROSS-LINKING; N-HYDROXYSUCCINIMIDE ESTERS; X-RAY CRYSTALLOGRAPHY; BINDING PROTEIN; CYSTEINE DESULFURASE; FERROXIDASE ACTIVITY; ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; FRIEDREICH ATAXIA; FRATAXIN	The biosynthesis of Fe-S clusters is a vital process involving the delivery of elemental iron and sulfur to scaffold proteins via molecular interactions that are still poorly defined. We reconstituted a stable, functional complex consisting of the iron donor, Yfh1 (yeast frataxin homologue 1), and the Fe-S cluster scaffold, Isu1, with 1: 1 stoichiometry, [Yfh1](24).[Isu1](24). Using negative staining transmission EM and single particle analysis, we obtained a three-dimensional reconstruction of this complex at a resolution of similar to 17 angstrom. In addition, via chemical cross-linking, limited proteolysis, and mass spectrometry, we identified protein-protein interaction surfaces within the complex. The data together reveal that [Yfh1](24).[Isu1](24) is a roughly cubic macromolecule consisting of one symmetric Isu1 trimer binding on top of one symmetric Yfh1 trimer at each of its eight vertices. Furthermore, molecular modeling suggests that two subunits of the cysteine desulfurase, Nfs1, may bind symmetrically on top of two adjacent Isu1 trimers in a manner that creates two putative [2Fe-2S] cluster assembly centers. In each center, conserved amino acids known to be involved in sulfur and iron donation by Nfs1 and Yfh1, respectively, are in close proximity to the Fe-S cluster-coordinating residues of Isu1. We suggest that this architecture is suitable to ensure concerted and protected transfer of potentially toxic iron and sulfur atoms to Isu1 during Fe-S cluster assembly.	[Ranatunga, Wasantha; Gakh, Oleksandr; Galeano, Belinda K.; Smith, Douglas Y.; Isaya, Grazia] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Ranatunga, Wasantha; Gakh, Oleksandr; Galeano, Belinda K.; Smith, Douglas Y.; Isaya, Grazia] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ranatunga, Wasantha; Gakh, Oleksandr; Galeano, Belinda K.; Smith, Douglas Y.; Isaya, Grazia] Mayo Clin, Mayo Clin Childrens Res Ctr, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Soderberg, Christopher A. G.; Al-Karadaghi, Salam] Lund Univ, Ctr Mol Prot Sci, Inst Chem & Chem Engn, POB 124, SE-22100 Lund, Sweden	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Lund University	Isaya, G (corresponding author), Mayo Clin, 200 First St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health from NIA [AG15709-19]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health from NIA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant AG15709-19 from NIA (to G. I. and J. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Adrover M, 2015, BBA-MOL CELL RES, V1853, P1448, DOI 10.1016/j.bbamcr.2014.10.023; Amela I, 2013, PROTEIN J, V32, P183, DOI 10.1007/s10930-013-9475-4; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Blanc B, 2015, BBA-MOL CELL RES, V1853, P1436, DOI 10.1016/j.bbamcr.2014.12.009; Blow DM, 2002, ACTA CRYSTALLOGR D, V58, P792, DOI 10.1107/S0907444902003931; Bonomi F, 2011, BIOCHEMISTRY-US, V50, P9641, DOI 10.1021/bi201123z; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Bridwell-Rabb J, 2012, BIOCHEMISTRY-US, V51, P2506, DOI 10.1021/bi201628j; Chan KY, 2011, STRUCTURE, V19, P1211, DOI 10.1016/j.str.2011.07.017; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury UR, 2010, INVEST OPHTH VIS SCI, V51, P4921, DOI 10.1167/iovs.10-5531; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gakh O, 2008, J BIOL CHEM, V283, P31500, DOI 10.1074/jbc.M805415200; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Isaya G, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00029; Jones KA, 2013, J PROTEOME RES, V12, P4351, DOI 10.1021/pr400307u; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Kim JH, 2015, BBA-MOL CELL RES, V1853, P1416, DOI 10.1016/j.bbamcr.2014.11.020; Kim JH, 2009, BIOCHEMISTRY-US, V48, P6062, DOI 10.1021/bi9002277; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Ludtke SJ, 2013, CURR OPIN STRUC BIOL, V23, P755, DOI 10.1016/j.sbi.2013.06.003; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Madler S, 2010, ANAL BIOCHEM, V398, P123, DOI 10.1016/j.ab.2009.11.020; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Majewska J, 2013, J BIOL CHEM, V288, P29134, DOI 10.1074/jbc.M113.503524; Manicki M, 2014, J BIOL CHEM, V289, P30268, DOI 10.1074/jbc.M114.596726; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Markley JL, 2013, FEBS LETT, V587, P1172, DOI 10.1016/j.febslet.2013.01.003; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Parent A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6686; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Pastore C, 2007, FEBS J, V274, P4199, DOI 10.1111/j.1742-4658.2007.05946.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Seguin A, 2010, BBA-MOL BASIS DIS, V1802, P531, DOI 10.1016/j.bbadis.2010.03.008; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Soderberg CAG, 2013, J BIOL CHEM, V288, P8156, DOI 10.1074/jbc.M112.442285; Soderberg CAG, 2011, J MOL BIOL, V414, P783, DOI 10.1016/j.jmb.2011.10.034; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thuku RN, 2007, FEBS J, V274, P2099, DOI 10.1111/j.1742-4658.2007.05752.x; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Webert H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6013; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang XK, 1999, BIOCHEM J, V338, P615, DOI 10.1042/0264-6021:3380615	64	12	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10378	10398		10.1074/jbc.M115.712414	http://dx.doi.org/10.1074/jbc.M115.712414			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26941001	Green Published, hybrid			2022-12-28	WOS:000375602800043
J	Schrotter, S; Leondaritis, G; Eickholt, BJ				Schroetter, Sandra; Leondaritis, George; Eickholt, Britta J.			Capillary Isoelectric Focusing of Akt Isoforms Identifies Highly Dynamic Phosphorylation in Neuronal Cells and Brain Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-B-GAMMA; PHOSPHOINOSITIDE 3-KINASE; GLUCOSE-HOMEOSTASIS; TUMOR-SUPPRESSOR; GROWTH; PI3K; ACTIVATION; MICE; CANCER; SPECIFICITY	The PI3K/PTEN/Akt pathway has been established as a core signaling pathway that is crucial for the integration of neurons into neuronal circuits and the maintenance of the architecture and function of neurons in the adult brain. Akt1-3 kinases are specifically activated by two phosphorylation events on residues The(308) and Ser(473) upon growth factor signaling, which subsequently phosphorylate a vast cohort of downstream targets. However, we still lack a clear understanding of the complexity and regulation of isoform specificity within the PI3K/PTEN/Akt pathway. We utilized a capillary-based isoelectric focusing method to study dynamics of Akt phosphorylation in neuronal cells and the developing brain and identify previously undescribed features of Akt phosphorylation and activation. First, we show that the accumulation of multiple phosphorylation events on Akt forms occur concurrently with Ser(473) and Thr(308) phosphorylation upon acute PI3K activation and provide evidence for uncoupling of Ser(473) and Thr(308) phosphorylation, as well as differential sensitivities of Akt1 forms upon PI3K inhibition. Second, we detect a transient shift in Akt isoform phosphorylation and activation pattern during early postnatal brain development, at stages corresponding to synapse development and maturation. Third, we show differential sensitivities of Ser(473)-Akt species to PTEN deletion in mature neurons, which suggests inherent differences in the Akt pools that are accessible to growth factors as compared with the pools that are controlled by PTEN. Our study demonstrates the presence of complex phosphorylation events of Akt in a time- and signal-dependent manner in neurons.	Charite, Cluster Excellence NeuroCure, D-10117 Berlin, Germany; Charite, Inst Biochem, D-10117 Berlin, Germany; [Leondaritis, George] Univ Ioannina, Pharmacol Lab, GR-45110 Ioannina, Greece	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Ioannina	Eickholt, BJ (corresponding author), ChariteCrossOver, Inst Biochem, Virchowweg 6, D-10117 Berlin, Germany.	Britta.Eickholt@charite.de		Schroetter, Sandra/0000-0001-6891-6910; Eickholt, Britta/0000-0001-7873-8687	Deutsche Forschungsgemeinschaft [SFB958, EXC 257 NeuroCure]; Biotechnology and Biological Sciences Research Council [BB/I022392/1]; BBSRC [BB/I022392/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB958 and EXC 257 NeuroCure, and Biotechnology and Biological Sciences Research Council Grant BB/I022392/1. The authors declare that they have no conflicts of interest with the contents of this article.	Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Berenjeno IM, 2012, BIOCHEM J, V442, P151, DOI 10.1042/BJ20111741; Beurel E, 2012, BIPOLAR DISORD, V14, P822, DOI 10.1111/bdi.12023; Braccini L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8400; Brodbeck D, 2001, J BIOL CHEM, V276, P29550, DOI 10.1074/jbc.M104633200; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; Chen JQ, 2013, MOL CANCER THER, V12, P2601, DOI 10.1158/1535-7163.MCT-13-0074; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cohen MM, 2013, AM J MED GENET A, V161, P2931, DOI 10.1002/ajmg.a.36101; Cosker KE, 2008, J CELL SCI, V121, P796, DOI 10.1242/jcs.019166; Dajas-Bailador F, 2014, J CELL SCI, V127, P230, DOI 10.1242/jcs.137208; Diez H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032715; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Eickholt BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000869; Endersby R, 2011, CANCER RES, V71, P4106, DOI 10.1158/0008-5472.CAN-10-3597; Fan AC, 2009, NAT MED, V15, P566, DOI 10.1038/nm.1903; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Guo H, 2014, ONCOGENE, V33, P3463, DOI 10.1038/onc.2013.301; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Iacovides DC, 2013, MOL CELL PROTEOMICS, V12, P3210, DOI 10.1074/mcp.M112.023119; Islam O, 2009, CURR NEUROVASC RES, V6, P42, DOI 10.2174/156720209787466028; Kreis P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00023; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lin C, 2016, ONCOGENE, V35, P595, DOI 10.1038/onc.2015.115; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mester J, 2013, AM J MED GENET C, V163C, P114, DOI 10.1002/ajmg.c.31364; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Najafov A, 2012, BIOCHEM J, V448, P285, DOI 10.1042/BJ20121287; O'Neill RA, 2006, P NATL ACAD SCI USA, V103, P16153, DOI 10.1073/pnas.0607973103; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Sabnis H, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-166; Schmit F, 2014, P NATL ACAD SCI USA, V111, P6395, DOI 10.1073/pnas.1323004111; Schwartz S, 2015, CANCER CELL, V27, P109, DOI 10.1016/j.ccell.2014.11.008; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Waite K, 2010, CURR TOP MICROBIOL, V346, P245, DOI 10.1007/82_2010_82; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037427; Xue MS, 2009, NEURON, V64, P367, DOI 10.1016/j.neuron.2009.09.043; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	47	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10239	10251		10.1074/jbc.M115.700138	http://dx.doi.org/10.1074/jbc.M115.700138			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26945062	Green Published, hybrid			2022-12-28	WOS:000375602800032
J	Rakete, S; Nagaraj, RH				Rakete, Stefan; Nagaraj, Ram H.			Identification of Kynoxazine, a Novel Fluorescent Product of the Reaction between 3-Hydroxykynurenine and Erythrulose in the Human Lens, and Its Role in Protein Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DICARBONYL COMPOUNDS; ADVANCED GLYCATION ENDPRODUCTS; CATARACTOUS HUMAN LENSES; FREE UV FILTERS; ASCORBIC-ACID; VITAMIN-C; MONOCLONAL-ANTIBODY; NUCLEAR CATARACT; END-PRODUCTS; AMINO-ACIDS	Kynurenine pathway metabolites and ascorbate degradation products are present in human lenses. In this study, we showed that erythrulose, a major ascorbate degradation product, reacts spontaneously with 3-hydroxykynurenine to form a fluorescent product. Structural characterization of the product revealed it to be 2-amino-4-(2-hydroxy-3-(2-hydroxyethyl)-2H-benzo[b][1,4]oxazin-5-yl)-4-oxobutanoic acid, which we named kynoxazine. Unlike 3-hydroxykynurenine, 3-hydroxykynurenine glucoside and kynurenine were unable to form a kynoxazine-like compound, which suggested that the aminophenol moiety in 3-hydroxykynurenine is essential for the formation of kynoxazine. This reasoning was confirmed using a model compound, 1-(2-amino-3-hydroxyphenyl)ethan-1-one, which is an aminophenol lacking the amino acid moiety of 3-hydroxykynurenine. Ultra-performance liquid chromatography-tandem mass spectrometry analyses showed that kynoxazine is present in the human lens at levels ranging from 0 to 64 pmol/mg lens. Kynoxazine as well as erythrulose degraded under physiological conditions to generate 3-deoxythreosone, which modified and cross-linked proteins through the formation of an arginine adduct, 3-deoxythreosone-derived hydroimidazolone, and a lysine-arginine cross-linking adduct, 3-deoxythreosone-derived hydroimidazolimine cross-link. Ultra-performance liquid chromatography-tandem mass spectrometry quantification showed that 32-169 pmol/mg protein of 3-deoxythreosone-derived hydroimidazolone and 1.1-11.2 pmol/mg protein of 3-deoxythreosone-derived hydroimidazolimine cross-link occurred in aging lenses. Taken together, these results demonstrate a novel biochemical mechanism by which ascorbate oxidation and the kynurenine pathway intertwine, which could promote protein modification and cross-linking in aging human lenses.	[Rakete, Stefan; Nagaraj, Ram H.] Univ Colorado, Sch Med, Dept Ophthalmol, 12800 E 19th Ave,RC-1 North 5102, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Nagaraj, RH (corresponding author), Univ Colorado, Sch Med, Dept Ophthalmol, 12800 E 19th Ave,RC-1 North 5102, Aurora, CO 80045 USA.	nagaraj@ucdenver.edu			National Institutes of Health [EY022061, EY023286]; NATIONAL EYE INSTITUTE [R01EY023286, R01EY022061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY022061 and EY023286 (to R. H. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed N, 2002, BIOCHEM J, V364, P1; Ahmed N, 2003, INVEST OPHTH VIS SCI, V44, P5287, DOI 10.1167/iovs.03-0573; Aquilina JA, 1999, BIOCHEMISTRY-US, V38, P11455, DOI 10.1021/bi990458h; Aquilina JA, 2000, BIOCHEMISTRY-US, V39, P16176, DOI 10.1021/bi001230t; BELGODERE E, 1977, J HETEROCYCLIC CHEM, V14, P997, DOI 10.1002/jhet.5570140610; Biemel KM, 2002, J BIOL CHEM, V277, P24907, DOI 10.1074/jbc.M202681200; Chen YC, 1997, EXP EYE RES, V65, P835, DOI 10.1006/exer.1997.0393; Cheng RZ, 2006, BBA-MOL BASIS DIS, V1762, P533, DOI 10.1016/j.bbadis.2006.01.009; Cheng RZ, 2001, BBA-MOL BASIS DIS, V1537, P14, DOI 10.1016/S0925-4439(01)00051-5; Coote S. C., 2010, SCI SYNTHESIS, P417; Fan XJ, 2009, J BIOL CHEM, V284, P34618, DOI 10.1074/jbc.M109.032094; Fu SL, 1998, J BIOL CHEM, V273, P28603, DOI 10.1074/jbc.273.44.28603; Gobert J, 2009, J AGR FOOD CHEM, V57, P8591, DOI 10.1021/jf9019085; Henning C, 2014, J BIOL CHEM, V289, P28676, DOI 10.1074/jbc.M114.563593; Korlimbinis A, 2007, INVEST OPHTH VIS SCI, V48, P1718, DOI 10.1167/iovs.06-1134; Linetsky M, 2014, J BIOL CHEM, V289, P17111, DOI 10.1074/jbc.M114.554410; Manthey MK, 1999, J ORG CHEM, V64, P3930, DOI 10.1021/jo982321n; McNulty R, 2004, J PHYSIOL-LONDON, V559, P883, DOI 10.1113/jphysiol.2004.068619; Nagaraj RH, 2012, BBA-MOL BASIS DIS, V1822, P120, DOI 10.1016/j.bbadis.2011.11.011; Nagaraj RH, 2012, AMINO ACIDS, V42, P1205, DOI 10.1007/s00726-010-0778-x; Nagaraj RH, 2010, BBA-PROTEINS PROTEOM, V1804, P829, DOI 10.1016/j.bbapap.2009.12.008; Nemet I, 2011, J BIOL CHEM, V286, P37128, DOI 10.1074/jbc.M111.245100; ORTWERTH BJ, 1988, BIOCHIM BIOPHYS ACTA, V956, P10, DOI 10.1016/0167-4838(88)90292-0; ORTWERTH BJ, 1988, EXP EYE RES, V47, P737, DOI 10.1016/0014-4835(88)90041-3; Reihl O, 2004, CARBOHYD RES, V339, P483, DOI 10.1016/j.carres.2003.12.004; ROGERS KM, 1978, EXP EYE RES, V27, P719, DOI 10.1016/0014-4835(78)90041-6; Schleicher E, 1990, ANGEW CHEM, V102, P597; Simpson GLW, 2000, BBA-MOL BASIS DIS, V1501, P12, DOI 10.1016/S0925-4439(00)00009-0; Smuda M, 2015, BIOCHEMISTRY-US, V54, P2500, DOI 10.1021/bi5013194; Smuda M, 2013, ANGEW CHEM INT EDIT, V52, P4887, DOI 10.1002/anie.201300399; Staniszewska M, 2007, J IMMUNOL METHODS, V324, P63, DOI 10.1016/j.jim.2007.05.002; Staniszewska MM, 2005, J BIOL CHEM, V280, P22154, DOI 10.1074/jbc.M501419200; Streete IM, 2004, INVEST OPHTH VIS SCI, V45, P4091, DOI 10.1167/iovs.04-0178; Tessier F, 1998, INT J VITAM NUTR RES, V68, P309; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Tsentalovich YP, 2015, EXP EYE RES, V134, P15, DOI 10.1016/j.exer.2015.03.008; Tsentalovich YP, 2011, INVEST OPHTH VIS SCI, V52, P7687, DOI 10.1167/iovs.11-8120; Usui T, 2007, BIOSCI BIOTECH BIOCH, V71, P2465, DOI 10.1271/bbb.70229; VARMA SD, 1988, OPHTHALMIC RES, V20, P164, DOI 10.1159/000266579; Vazquez S, 2002, J BIOL CHEM, V277, P4867, DOI 10.1074/jbc.M107529200; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; WOOD AM, 1993, EXP EYE RES, V56, P317, DOI 10.1006/exer.1993.1041; Yamada K., 2011, Patent No. [JP2011231022 (A), 2011231022]; ZIGLER JS, 1989, FREE RADICAL BIO MED, V7, P499	45	9	9	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9596	9609		10.1074/jbc.M116.716621	http://dx.doi.org/10.1074/jbc.M116.716621			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26941078	Green Published, hybrid			2022-12-28	WOS:000375602300018
J	Elagabani, MN; Brisevac, D; Kintscher, M; Pohle, J; Kohr, G; Schmitz, D; Kornau, HC				Elagabani, Mohammad Nael; Brisevac, Dusica; Kintscher, Michael; Pohle, Joerg; Koehr, Georg; Schmitz, Dietmar; Kornau, Hans-Christian			Subunit-selective N-Methyl-D-aspartate (NMDA) Receptor Signaling through Brefeldin A-resistant Arf Guanine Nucleotide Exchange Factors BRAG1 and BRAG2 during Synapse Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILENT SYNAPSES; POSTSYNAPTIC DENSITY; AMPA RECEPTORS; EXPRESSION; MECHANISM; PLASTICITY; ROLES; BRAIN; NR2B; ACTIVATION	The maturation of glutamatergic synapses in the CNS is regulated by NMDA receptors (NMDARs) that gradually change from a GluN2B- to a GluN2A-dominated subunit composition during postnatal development. Here we show that NMDARs control the activity of the small GTPase ADP-ribosylation factor 6 (Arf6) by consecutively recruiting two related brefeldin A-resistant Arf guanine nucleotide exchange factors, BRAG1 and BRAG2, in a GluN2 subunit-dependent manner. In young cortical cultures, GluN2B and BRAG1 tonically activated Arf6. In mature cultures, Arf6 was activated through GluN2A and BRAG2 upon NMDA treatment, whereas the tonic Arf6 activation was not detectable any longer. This shift in Arf6 regulation and the associated drop in Arf6 activity were reversed by a knockdown of BRAG2. Given their sequential recruitment during development, we examined whether BRAG1 and BRAG2 influence synaptic currents in hippocampal CA1 pyramidal neurons using patch clamp recordings in acute slices from mice at different ages. The number of AMPA receptor (AMPAR) miniature events was reduced by depletion of BRAG1 but not by depletion of BRAG2 during the first 2 weeks after birth. In contrast, depletion of BRAG2 during postnatal weeks 4 and 5 reduced the number of AMPAR miniature events and compromised the quantal sizes of both AMPAR and NMDAR currents evoked at Schaffer collateral synapses. We conclude that both Arf6 activation through GluN2B-BRAG1 during early development and the transition from BRAG1- to BRAG2-dependent Arf6 signaling induced by the GluN2 subunit switch are critical for the development of mature glutamatergic synapses.	[Elagabani, Mohammad Nael; Brisevac, Dusica; Kintscher, Michael; Schmitz, Dietmar; Kornau, Hans-Christian] Charite, Neurosci Res Ctr NWFZ, Charite Pl 1, D-10117 Berlin, Germany; [Elagabani, Mohammad Nael; Brisevac, Dusica; Kornau, Hans-Christian] Charite, Inst Biochem, Charite Pl 1, D-10117 Berlin, Germany; [Pohle, Joerg; Koehr, Georg] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Kintscher, Michael] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Synapt Mech, CH-1015 Lausanne, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Kornau, HC (corresponding author), Charite, Neurosci Res Ctr NWFZ, Charite Pl 1, D-10117 Berlin, Germany.	hckornau@charite.de		Schmitz, Dietmar/0000-0003-2741-5241; Kintscher, Michael/0000-0003-2355-1369; Brisevac, Dusica/0000-0003-1439-5333; Elagabani, Mohammad Nael/0000-0002-8611-3975	Deutsche Forschungsgemeinschaft [KO 2290/2-1, EXC 257 NeuroCure, KO 2290/1-1]; CHS Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CHS Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (KO 2290/2-1 and EXC 257 NeuroCure). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Chica and Heinz Schaller (CHS) short term fellowship from the CHS Stiftung and a Heisenberg fellowship (KO 2290/1-1) from the Deutsche Forschungsgemeinschaft.	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4182-05.2006; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Hanse E, 2013, NAT REV NEUROSCI, V14, P839, DOI 10.1038/nrn3642; Humphreys D, 2013, P NATL ACAD SCI USA, V110, P16880, DOI 10.1073/pnas.1311680110; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kim Y, 2015, J BIOL CHEM, V290, P7323, DOI 10.1074/jbc.M114.634527; Kiraly DD, 2011, J NEUROSCI, V31, P12554, DOI 10.1523/JNEUROSCI.3143-11.2011; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lowenthal MS, 2015, J PROTEOME RES, V14, P2528, DOI 10.1021/acs.jproteome.5b00109; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Murphy JA, 2006, BRAIN RES, V1120, P35, DOI 10.1016/j.brainres.2006.08.096; Myers KR, 2012, J NEUROSCI, V32, P11716, DOI 10.1523/JNEUROSCI.1942-12.2012; Oku Y, 2013, J NEUROSCI, V33, P12586, DOI 10.1523/JNEUROSCI.0341-13.2013; Palmer I., 2004, CURRENT PROTOCOLS PR, DOI DOI 10.1002/0471140864.PS0603S38.UNIT6.3; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; Ryan TJ, 2013, NAT NEUROSCI, V16, P25, DOI 10.1038/nn.3277; Sakagami H, 2008, NEUROSCI RES, V60, P199, DOI 10.1016/j.neures.2007.10.013; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Schwechter B, 2013, P NATL ACAD SCI USA, V110, P14462, DOI 10.1073/pnas.1304340110; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shoubridge C, 2010, NAT GENET, V42, P486, DOI 10.1038/ng.588; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Um K, 2014, DEV CELL, V29, P701, DOI 10.1016/j.devcel.2014.05.011; Xu XM, 2009, NAT PROTOC, V4, P1338, DOI 10.1038/nprot.2009.145; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Zheng N, 2015, ELIFE, V4, DOI 10.7554/eLife.06878	48	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9105	9118		10.1074/jbc.M115.691717	http://dx.doi.org/10.1074/jbc.M115.691717			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26884337	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000374849000023
J	Golnik, R; Lehmann, A; Kloetzel, PM; Ebstein, F				Golnik, Richard; Lehmann, Andrea; Kloetzel, Peter-Michael; Ebstein, Frederic			Major Histocompatibility Complex (MHC) Class I Processing of the NY-ESO-1 Antigen Is Regulated by Rpn10 and Rpn13 Proteins and Immunoproteasomes following Non-lysine Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen processing; proteasome; protein degradation; tumor immunology; ubiquitin	26S PROTEASOME; MEDIATED PROTEOLYSIS; STANDARD PROTEASOME; DRIP HYPOTHESIS; DENDRITIC CELLS; DEGRADATION; SITE; UBIQUITYLATION; RECOGNITION; MECHANISMS	The supply of MHC class I-restricted peptides is primarily ensured by the degradation of intracellular proteins via the ubiquitin-proteasome system. Depending on the target and the enzymes involved, ubiquitination is a process that may dramatically vary in terms of linkages, length, and attachment sites. Here we identified the unique lysine residue at position 124 of the NY-ESO-1 cancer/testis antigen as the acceptor site for the formation of canonical Lys-48-linkages. Interestingly, a lysine-less form of NY-ESO-1 was as efficient as its wild-type counterpart in supplying the HLA-A*0201-restricted NY-ESO-1(157-165) antigenic peptide. In fact, we show that the regulation of NY-ESO-1 processing by the ubiquitin receptors Rpn10 and Rpn13 as a well as by the standard and immunoproteasome is governed by non-canonical ubiquitination on non-lysine sites. In summary, our data underscore the significance of atypical ubiquitination in the modulation of MHC class I antigen processing.	[Golnik, Richard; Lehmann, Andrea; Kloetzel, Peter-Michael; Ebstein, Frederic] Charite, Inst Biochem, Charite Pl 1-Virchowweg 6, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ebstein, F (corresponding author), Charite, Inst Biochem, Charite Pl 1-Virchowweg 6, D-10117 Berlin, Germany.	frederic.ebstein@charite.de			Berlin Institute of Health (CRG Project); Einstein Foundation Berlin	Berlin Institute of Health (CRG Project); Einstein Foundation Berlin	This work was supported by grants from the Berlin Institute of Health (CRG Project) (to P. M. K.) and from the Einstein Foundation Berlin (to P. M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Batchu RB, 2005, CANCER RES, V65, P10041, DOI 10.1158/0008-5472.CAN-05-1383; Bedford L, 2011, NEUROSCI LETT, V491, P44, DOI 10.1016/j.neulet.2010.12.064; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Chapiro J, 2006, J IMMUNOL, V176, P1053, DOI 10.4049/jimmunol.176.2.1053; Chen JL, 2000, J IMMUNOL, V165, P948, DOI 10.4049/jimmunol.165.2.948; Ciechanover A, 2014, BBA-MOL CELL RES, V1843, P86, DOI 10.1016/j.bbamcr.2013.07.007; Dammer EB, 2011, J BIOL CHEM, V286, P10457, DOI 10.1074/jbc.M110.149633; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; DEVERAUX Q, 1995, J BIOL CHEM, V270, P29660; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Ebstein F, 2012, CELL MOL LIFE SCI, V69, P2443, DOI 10.1007/s00018-012-0933-5; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Livnat-Levanon N, 2014, CELL REP, V7, P1371, DOI 10.1016/j.celrep.2014.04.030; McDowell GS, 2010, BIOCHEM BIOPH RES CO, V400, P655, DOI 10.1016/j.bbrc.2010.08.122; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Myung J, 2001, MOL CELL, V7, P411, DOI 10.1016/S1097-2765(01)00188-5; Rock KL, 2014, TRENDS IMMUNOL, V35, P144, DOI 10.1016/j.it.2014.01.002; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shin EC, 2006, J CLIN INVEST, V116, P3006, DOI 10.1172/JCI29832; Sijts EJAM, 2011, CELL MOL LIFE SCI, V68, P1491, DOI 10.1007/s00018-011-0657-y; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; vanNocker S, 1996, P NATL ACAD SCI USA, V93, P856, DOI 10.1073/pnas.93.2.856; Vosper JMD, 2009, J BIOL CHEM, V284, P15458, DOI 10.1074/jbc.M809366200; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008	32	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8805	8815		10.1074/jbc.M115.705178	http://dx.doi.org/10.1074/jbc.M115.705178			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26903513	Green Published, hybrid			2022-12-28	WOS:000374773200041
J	Sivanesan, D; Beauchamp, C; Quinou, C; Lee, J; Lesage, S; Chemtob, S; Rioux, JD; Michnick, SW				Sivanesan, Durga; Beauchamp, Claudine; Quinou, Christiane; Lee, Jonathan; Lesage, Sylvie; Chemtob, Sylvain; Rioux, John D.; Michnick, Stephen W.			IL23R (Interleukin 23 Receptor) Variants Protective against Inflammatory Bowel Diseases (IBD) Display Loss of Function due to Impaired Protein Stability and Intracellular Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						genetic polymorphism; glycosylation; inflammatory bowel disease (IBD); protein trafficking (Golgi); receptor; interleukin 23 receptor	GENOME-WIDE ASSOCIATION; AMYLOID PRECURSOR PROTEIN; MEMBRANE-PROXIMAL REGION; CROHNS-DISEASE; ERYTHROPOIETIN RECEPTOR; AUTOIMMUNE INFLAMMATION; PROPROTEIN CONVERTASES; ENDOPLASMIC-RETICULUM; SUSCEPTIBILITY LOCI; FLUORESCENT PROTEIN	Genome-wide association studies as well as murine models have shown that the interleukin 23 receptor (IL23R) pathway plays a pivotal role in chronic inflammatory diseases such as Crohn disease (CD), ulcerative colitis, psoriasis, and type 1 diabetes. Genome-wide association studies and targeted re-sequencing studies have revealed the presence of multiple potentially causal variants of the IL23R. Specifically the G149R, V362I, and R381Q IL23R chain variants are linked to protection against the development of Crohn disease and ulcerative colitis in humans. Moreover, the exact mechanism of action of these receptor variants has not been elucidated. We show that all three of these IL23R variants cause a reduction in IL23 receptor activation-mediated phosphorylation of the signal-transducing activator of transcription 3 (STAT3) and phosphorylation of signal transducing activator of transcription 4 (STAT4). The reduction in signaling is due to lower levels of cell surface receptor expression. For G149R, the receptor retention in the endoplasmic reticulum is due to an impairment of receptor maturation, whereas the R381Q and V362I variants have reduced protein stability. Finally, we demonstrate that the endogenous expression of IL23R protein from V362I and R381Q variants in human lymphoblastoid cell lines exhibited lower expression levels relative to susceptibility alleles. Our results suggest a convergent cause of IL23R variant protection against chronic inflammatory disease.	[Sivanesan, Durga; Michnick, Stephen W.] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Claudine; Rioux, John D.] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Beauchamp, Claudine; Rioux, John D.] Res Ctr, Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lesage, Sylvie] Univ Montreal, Ctr Rech, Hosp Maisonneuve Rosemont, Montreal, PQ H1T 2M4, Canada; [Lesage, Sylvie] Univ Montreal, Dept Microbiol Infect & Immunol, Montreal, PQ H1T 2M4, Canada; [Quinou, Christiane; Chemtob, Sylvain] CHU Sainte Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Sivanesan, Durga; Lee, Jonathan] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Ottawa	Michnick, SW (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.	stephen.michnick@umontreal.ca	Rioux, John D/A-9599-2015	Rioux, John D/0000-0001-7560-8326; Lesage, Sylvie/0000-0002-0968-2795	NIDDK, National Institutes of Health	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Debasmita Talapatra for assisting with experiments. We also thank the laboratory of Dr. Gerardo Ferberye for the pLpC binary vector and Monique Vasseur for help with microscopy. We extend our appreciation to Veronique Bourdeau, Emmanuelle Quierdo, Jacqueline Kowarzyk Moreno, Vincent Messier, and Jean-Francois Paradis for discussions. We also thank Dr. Nabil G. Sediah for identifying the possibility of G149R as a substrate for convertase in Golgi. We thank Katherine Harding for help with editing of the manuscript and discussion. The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) study was conducted by the IBDGC Investigators and supported by the NIDDK, National Institutes of Health. The lymphoblastoid cell lines and related data from the Inflammatory Bowel Disease Genetics Consortium reported here were supplied by the NIDDK Central Repositories.	Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Ali BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026206; Amre DK, 2008, AM J GASTROENTEROL, V103, P615, DOI 10.1111/j.1572-0241.2007.01661.x; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Bonaventure J, 2007, FEBS J, V274, P3078, DOI 10.1111/j.1742-4658.2007.05835.x; Budarf ML, 2009, TRENDS GENET, V25, P137, DOI 10.1016/j.tig.2009.01.001; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Chognard G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089092; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; Eugene E, 2007, J NEUROSCI, V27, P14108, DOI 10.1523/JNEUROSCI.2618-07.2007; Floss DM, 2013, J BIOL CHEM, V288, P19386, DOI 10.1074/jbc.M112.432153; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Glosson-Byers Nicole L, 2014, JAKSTAT, V3, pe955393, DOI 10.4161/21623988.2014.955393; Guo W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045625; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Heim EN, 2015, P NATL ACAD SCI USA, V112, pE4717, DOI 10.1073/pnas.1514230112; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Kizhakkedath P, 2014, BBA-MOL CELL RES, V1843, P2871, DOI 10.1016/j.bbamcr.2014.08.013; Lamon S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00176; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Niederreiter L, 2013, CURR DRUG TARGETS, V14, P1379, DOI 10.2174/13894501113146660229; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang W, 2008, MUCOSAL IMMUNOL, V1, P335, DOI 10.1038/mi.2008.26; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pidasheva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025038; Quiniou C, 2014, AM J PHYSIOL-REG I, V307, pR1216, DOI 10.1152/ajpregu.00540.2013; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Reshetnyak AV, 2013, P NATL ACAD SCI USA, V110, P17832, DOI 10.1073/pnas.1317118110; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roy S, 2007, MOL ENDOCRINOL, V21, P1656, DOI 10.1210/me.2007-0041; Roy S, 2010, ENDOCRINOLOGY, V151, P660, DOI 10.1210/en.2009-0826; Sarin R, 2011, P NATL ACAD SCI USA, V108, P9560, DOI 10.1073/pnas.1017854108; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Spoerri L, 2012, J BIOL CHEM, V287, P26840, DOI 10.1074/jbc.M112.355743; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Stefan E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1605; Tchekanda E, 2014, NAT METHODS, V11, P641, DOI [10.1038/nmeth.2934, 10.1038/NMETH.2934]; Tong W, 2006, J BIOL CHEM, V281, P38930, DOI 10.1074/jbc.M607524200; van Geest M, 2000, MICROBIOL MOL BIOL R, V64, P13, DOI 10.1128/MMBR.64.1.13-33.2000; Vogt G, 2008, J EXP MED, V205, P1729, DOI 10.1084/jem.20071987; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wheatley M, 1999, HUM REPROD UPDATE, V5, P356, DOI 10.1093/humupd/5.4.356; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhao XQ, 2011, J MATER CHEM, V21, P7240, DOI 10.1039/c1jm10277j; Zwiers A, 2012, J IMMUNOL, V188, P1573, DOI 10.4049/jimmunol.1101494	64	46	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8673	8685		10.1074/jbc.M116.715870	http://dx.doi.org/10.1074/jbc.M116.715870			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26887945	hybrid, Green Published			2022-12-28	WOS:000374773200030
J	Harada, Y; Huang, CC; Yamaki, S; Dohmae, N; Suzuki, T				Harada, Yoichiro; Huang, Chengcheng; Yamaki, Satoshi; Dohmae, Naoshi; Suzuki, Tadashi			Non-lysosomal Degradation of Singly Phosphorylated Oligosaccharides Initiated by the Action of a Cytosolic Endo--N-acetylglucosaminidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; endoplasmic reticulum (ER); glycobiology; N-linked glycosylation; oligosaccharide; dolichol-linked oligosaccharides; endo--N-acetylglucosaminidase; non-lysosomal glycan degradation; phosphorylated oligosaccharides	POLYMANNOSE-TYPE OLIGOSACCHARIDES; DOLICHOL-LINKED OLIGOSACCHARIDES; GLUCOSE STARVATION; SACCHAROMYCES-CEREVISIAE; GLYCOSYLATION; IDENTIFICATION; GENE; ER; FIBROBLASTS; GENERATION	Phosphorylated oligosaccharides (POSs) are produced by the degradation of dolichol-linked oligosaccharides (DLOs) by an unclarified mechanism in mammalian cells. Although POSs are exclusively found in the cytosol, their intracellular fates remain unclear. Our findings indicate that POSs are catabolized via a non-lysosomal glycan degradation pathway that involves a cytosolic endo--N-acetylglucosaminidase (ENGase). Quantitative and structural analyses of POSs revealed that ablation of the ENGase results in the significant accumulation of POSs with a hexasaccharide structure composed of Man1,2Man1,3(Man1,6)Man1,4GlcNAc1,4GlcNAc. In vitro ENGase assays revealed that the presence of an 1,2-linked mannose residue facilitates the hydrolysis of POSs by the ENGase. Liquid chromatography-mass spectrometric analyses and fluorescent labeling experiments show that such POSs contain one phosphate group at the reducing end. These results indicate that ENGase efficiently hydrolyzes POSs that are larger than Man(4)GlcNAc(2)-P, generating GlcNAc-1-P and neutral Gn1-type free oligosaccharides. These results provide insight into important aspects of the generation and degradation of POSs.	[Harada, Yoichiro; Huang, Chengcheng; Suzuki, Tadashi] RIKEN, Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Glycometabolome Team,Syst Glycobiol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Yamaki, Satoshi] Shimadzu Co Ltd, Analyt & Measuring Instruments Div, Global Applicat Dev Ctr, Hadano, Kanagawa 2591304, Japan; [Dohmae, Naoshi] RIKEN Global Res Cluster, Collaborat Promot Unit, Wako, Saitama 3510198, Japan; [Harada, Yoichiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Sakuragaoka, Kagoshima 8908544, Japan	RIKEN; Shimadzu Corporation; RIKEN; Kagoshima University	Suzuki, T (corresponding author), RIKEN, Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Glycometabolome Team,Syst Glycobiol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	Dohmae, Naoshi/C-2040-2011; Suzuki, Tadashi/AAX-5707-2021; Suzuki, Tadashi/I-4536-2014; huang, chengcheng/GRX-5340-2022	Dohmae, Naoshi/0000-0002-5242-9410; Suzuki, Tadashi/0000-0003-1030-7631; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24770134, 26650040, 25291030]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan 24770134 and 26650040 (to Y. H.) and 25291030 (to T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Absmanner B, 2010, BIOCHEM J, V426, P205, DOI 10.1042/BJ20091121; Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; Albrecht S, 2014, BRIT J NUTR, V111, P1313, DOI 10.1017/S0007114513003772; BAUMANN H, 1983, J BIOL CHEM, V258, P3942; BELARD M, 1988, BIOCHEM J, V255, P235; CACAN R, 1980, EUR J BIOCHEM, V106, P473, DOI 10.1111/j.1432-1033.1980.tb04594.x; Chantret I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011734; Cipollo JF, 2001, J BIOL CHEM, V276, P21828, DOI 10.1074/jbc.M010896200; Doerrler WT, 1999, P NATL ACAD SCI USA, V96, P13050, DOI 10.1073/pnas.96.23.13050; Dwivedi R, 2013, BIOPOLYMERS, V99, P772, DOI 10.1002/bip.22296; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; GERSHMAN H, 1981, J BIOL CHEM, V256, P7774; Haga Y, 2009, GLYCOBIOLOGY, V19, P987, DOI 10.1093/glycob/cwp075; Harada Y, 2015, GLYCOBIOLOGY, V25, P1196, DOI 10.1093/glycob/cwv055; Harada Y, 2015, CELL MOL LIFE SCI, V72, P2509, DOI 10.1007/s00018-015-1881-7; Harada Y, 2013, P NATL ACAD SCI USA, V110, P19366, DOI 10.1073/pnas.1312187110; Harada Y, 2013, J BIOL CHEM, V288, P32673, DOI 10.1074/jbc.M113.486985; HASE S, 1979, J BIOCHEM-TOKYO, V85, P989, DOI 10.1093/oxfordjournals.jbchem.a132431; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hirayama H, 2015, SEMIN CELL DEV BIOL, V41, P110, DOI 10.1016/j.semcdb.2014.11.009; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Huang CC, 2015, P NATL ACAD SCI USA, V112, P1398, DOI 10.1073/pnas.1414593112; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Kato T, 1997, J BIOCHEM, V122, P1167, DOI 10.1093/oxfordjournals.jbchem.a021877; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Peric D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011675; REARICK JI, 1981, J BIOL CHEM, V256, P6255; Reiss G, 1996, GLYCOBIOLOGY, V6, P493, DOI 10.1093/glycob/6.5.493; Rose MD., 1990, METHODS YEAST GENETI; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; Seino J, 2013, J BIOL CHEM, V288, P26898, DOI 10.1074/jbc.M113.464503; Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Suzuki T, 2008, ANAL BIOCHEM, V381, P224, DOI 10.1016/j.ab.2008.07.002; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; Suzuki T, 2015, J BIOCHEM, V157, P23, DOI 10.1093/jb/mvu068; Suzuki T, 2014, BIOCHEM BIOPH RES CO, V453, P213, DOI 10.1016/j.bbrc.2014.05.075; TURCO SJ, 1982, J BIOL CHEM, V257, P8674; Vleugels W, 2011, BIOCHIMIE, V93, P823, DOI 10.1016/j.biochi.2011.01.016	41	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8048	8058		10.1074/jbc.M115.685313	http://dx.doi.org/10.1074/jbc.M115.685313			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26858256	hybrid, Green Published			2022-12-28	WOS:000374056700024
J	Bah, A; Forman-Kay, JD				Bah, Alaji; Forman-Kay, Julie D.			Modulation of Intrinsically Disordered Protein Function by Post-translational Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						intrinsically disordered protein; post-translational modification (PTM); protein conformation; protein-DNA interaction; protein-protein interaction; regulation	GAMMA-CARBOXYGLUTAMIC ACID; ETS-1 DNA-BINDING; MOLECULAR RECOGNITION; STRUCTURAL DISORDER; INTERMOLECULAR INTERACTIONS; MULTISITE PHOSPHORYLATION; TRANSLATION INITIATION; UNSTRUCTURED PROTEINS; PHASE-TRANSITIONS; CRYSTAL-STRUCTURE	Post-translational modifications (PTMs) produce significant changes in the structural properties of intrinsically disordered proteins (IDPs) by affecting their energy landscapes. PTMs can induce a range of effects, from local stabilization or destabilization of transient secondary structure to global disorder-to-order transitions, potentially driving complete state changes between intrinsically disordered and folded states or dispersed monomeric and phase-separated states. Here, we discuss diverse biological processes that are dependent on PTM regulation of IDPs. We also present recent tools for generating homogenously modified IDPs for studies of PTM-mediated IDP regulatory mechanisms.	[Bah, Alaji; Forman-Kay, Julie D.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Bah, Alaji; Forman-Kay, Julie D.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Bah, A; Forman-Kay, JD (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada.; Bah, A; Forman-Kay, JD (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	alaji.bah@sickkids.ca; forman@sickkids.ca		Forman-Kay, Julie/0000-0001-8265-972X	Canadian Institutes of Health Research (CIHR); Canadian Cancer Society; Cystic Fibrosis Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Cystic Fibrosis Canada	This work was supported by grants from the Canadian Institutes of Health Research (CIHR), Canadian Cancer Society, and Cystic Fibrosis Canada (to J. D. F. K.). This is the third article in the Thematic Minireview series "Intrinsically Disordered Proteins." The authors declare that they have no conflicts of interest with the contents of this article.	Andrew CD, 2002, BIOCHEMISTRY-US, V41, P1897, DOI 10.1021/bi0113216; Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Balazs A, 2009, FEBS J, V276, P3744, DOI 10.1111/j.1742-4658.2009.07090.x; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Bozoky Z, 2013, FEBS J, V280, P4407, DOI 10.1111/febs.12422; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; Burai R, 2015, J AM CHEM SOC, V137, P5041, DOI 10.1021/ja5131726; BURNIER JP, 1981, MOL CELL BIOCHEM, V39, P191, DOI 10.1007/BF00232574; Carlson ED, 2012, BIOTECHNOL ADV, V30, P1185, DOI 10.1016/j.biotechadv.2011.09.016; Chalker JM, 2011, ACCOUNTS CHEM RES, V44, P730, DOI 10.1021/ar200056q; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Das RK, 2015, CURR OPIN STRUC BIOL, V32, P102, DOI 10.1016/j.sbi.2015.03.008; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Desjardins G, 2014, P NATL ACAD SCI USA, V111, P11019, DOI 10.1073/pnas.1401891111; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Evans TC, 1999, J BIOL CHEM, V274, P3923, DOI 10.1074/jbc.274.7.3923; FREEDMAN SJ, 1995, BIOCHEMISTRY-US, V34, P12126, DOI 10.1021/bi00038a005; Fukuyo A, 2011, J PEPT SCI, V17, P650, DOI 10.1002/psc.1384; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Gandhi NS, 2015, ANGEW CHEM INT EDIT, V54, P6819, DOI 10.1002/anie.201501898; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; Gosselin P, 2011, NUCLEIC ACIDS RES, V39, P3496, DOI 10.1093/nar/gkq1306; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hazy E, 2009, CHEMPHYSCHEM, V10, P1415, DOI 10.1002/cphc.200900205; He YN, 2015, J BIOL CHEM, V290, P25090, DOI 10.1074/jbc.M115.658583; Hegyi H, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-65; Hejjaoui M, 2012, J AM CHEM SOC, V134, P5196, DOI 10.1021/ja210866j; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hofmann H, 2012, P NATL ACAD SCI USA, V109, P16155, DOI 10.1073/pnas.1207719109; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Huang MD, 2003, NAT STRUCT BIOL, V10, P751, DOI 10.1038/nsb971; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jensen MR, 2014, CHEM REV, V114, P6632, DOI 10.1021/cr400688u; Jensen ON, 2004, CURR OPIN CHEM BIOL, V8, P33, DOI 10.1016/j.cbpa.2003.12.009; Jin J, 2012, PHILOS T R SOC B, V367, P2540, DOI 10.1098/rstb.2012.0106; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Kowalski A, 2015, COMPUT BIOL CHEM, V59, P16, DOI 10.1016/j.compbiolchem.2015.08.011; Langst G, 2015, GENES-BASEL, V6, P299, DOI 10.3390/genes6020299; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Latysheva NS, 2015, PROTEIN SCI, V24, P909, DOI 10.1002/pro.2674; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Lee GM, 2008, J MOL BIOL, V382, P1014, DOI 10.1016/j.jmb.2008.07.064; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Lukhele S, 2013, STRUCTURE, V21, P2186, DOI 10.1016/j.str.2013.08.030; Mandell DJ, 2007, J AM CHEM SOC, V129, P820, DOI 10.1021/ja063019w; Mann KG, 2003, CHEST, V124, p4S, DOI 10.1378/chest.124.3_suppl.4S; Mao AH, 2010, P NATL ACAD SCI USA, V107, P8183, DOI 10.1073/pnas.0911107107; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; Mitrea DM, 2014, P NATL ACAD SCI USA, V111, P4466, DOI 10.1073/pnas.1321007111; Mitrea DM, 2013, FEBS LETT, V587, P1081, DOI 10.1016/j.febslet.2013.02.024; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Ou L, 2011, J BIOL CHEM, V286, P30142, DOI 10.1074/jbc.M111.244095; Oulhen N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005070; Pappu RV, 2008, ARCH BIOCHEM BIOPHYS, V469, P132, DOI 10.1016/j.abb.2007.08.033; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Perez Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01295; Peter D, 2015, MOL CELL, V57, P1074, DOI 10.1016/j.molcel.2015.01.017; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Radhakrishnan I, 1998, FEBS LETT, V430, P317, DOI 10.1016/S0014-5793(98)00680-2; Robinson NE, 2004, MECH AGEING DEV, V125, P259, DOI 10.1016/j.mad.2004.01.001; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schwalbe M, 2013, BIOCHEMISTRY-US, V52, P9068, DOI 10.1021/bi401266n; Siman P, 2012, ORG BIOMOL CHEM, V10, P5684, DOI 10.1039/c2ob25149c; Sivakolundu SG, 2005, J MOL BIOL, V353, P1118, DOI 10.1016/j.jmb.2005.08.074; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Theillet FX, 2012, J BIOMOL NMR, V54, P217, DOI 10.1007/s10858-012-9674-x; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Toretsky JA, 2014, J CELL BIOL, V206, P579, DOI 10.1083/jcb.201404124; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; van Kasteren S, 2012, BIOCHEM SOC T, V40, P929, DOI 10.1042/BST20120144; Venditti V, 2012, J BIOMOL NMR, V52, P191, DOI 10.1007/s10858-012-9606-9; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xiang SQ, 2013, STRUCTURE, V21, P2162, DOI 10.1016/j.str.2013.09.014; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Zhu L, 2015, CURR OPIN CELL BIOL, V34, P23, DOI 10.1016/j.ceb.2015.04.003	100	269	271	34	211	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6696	6705		10.1074/jbc.R115.695056	http://dx.doi.org/10.1074/jbc.R115.695056			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26851279	Green Published, hybrid			2022-12-28	WOS:000373299700009
J	Rowe, ER; Mimmack, ML; Barbosa, AD; Haider, A; Isaac, I; Ouberai, MM; Thiam, AR; Patel, S; Saudek, V; Siniossoglou, S; Savage, DB				Rowe, Emily R.; Mimmack, Michael L.; Barbosa, Antonio D.; Haider, Afreen; Isaac, Iona; Ouberai, Myriam M.; Thiam, Abdou Rachid; Patel, Satish; Saudek, Vladimir; Siniossoglou, Symeon; Savage, David B.			Conserved Amphipathic Helices Mediate Lipid Droplet Targeting of Perilipins 1-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid droplet; lipodystrophy; lipolysis; membrane; phospholipid; 11-mer repeat; amphipathic helix; membrane targeting; monolayer; perilipin	DIFFERENTIATION-RELATED PROTEIN; SECONDARY STRUCTURE ANALYSES; ADIPOSE TRIGLYCERIDE LIPASE; HORMONE-SENSITIVE LIPASE; CELLULAR FAT STORES; POSTTRANSLATIONAL REGULATION; ENDOPLASMIC-RETICULUM; PARTIAL LIPODYSTROPHY; ALPHA-SYNUCLEIN; LIPOLYSIS	Perilipins (PLINs) play a key role in energy storage by orchestrating the activity of lipases on the surface of lipid droplets. Failure of this activity results in severe metabolic disease in humans. Unlike all other lipid droplet-associated proteins, PLINs localize almost exclusively to the phospholipid monolayer surrounding the droplet. To understand how they sense and associate with the unique topology of the droplet surface, we studied the localization of human PLINs in Saccharomyces cerevisiae, demonstrating that the targeting mechanism is highly conserved and that 11-mer repeat regions are sufficient for droplet targeting. Mutations designed to disrupt folding of this region into amphipathic helices (AHs) significantly decreased lipid droplet targeting in vivo and in vitro. Finally, we demonstrated a substantial increase in the helicity of this region in the presence of detergent micelles, which was prevented by an AH-disrupting missense mutation. We conclude that highly conserved 11-mer repeat regions of PLINs target lipid droplets by folding into AHs on the droplet surface, thus enabling PLINs to regulate the interface between the hydrophobic lipid core and its surrounding hydrophilic environment.	[Rowe, Emily R.; Mimmack, Michael L.; Haider, Afreen; Isaac, Iona; Patel, Satish; Saudek, Vladimir; Savage, David B.] Univ Cambridge, Inst Metab Sci, Wellcome Trust Med Res Council, Metab Res Labs, Cambridge CB2 0QQ, England; [Barbosa, Antonio D.; Siniossoglou, Symeon] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Ouberai, Myriam M.] Univ Cambridge, Nanosci Ctr, Dept Engn, Cambridge CB3 0FF, England; [Thiam, Abdou Rachid] Univ Paris 06, Univ Paris Diderot, CNRS, Ecole Normale Super Paris,Lab Phys Stat, 24 Rue Lhomond, F-75005 Paris, France	University of Cambridge; University of Cambridge; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite	Savage, DB (corresponding author), Univ Cambridge, Inst Metab Sci, Wellcome Trust Med Res Council, Metab Res Labs, Cambridge CB2 0QQ, England.	dbs23@medschl.cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; Barbosa, Antonio Daniel/N-8248-2019	O'Rahilly, Stephen/0000-0003-2199-4449; Barbosa, Antonio Daniel/0000-0002-5555-3230; Savage, David Bousfield/0000-0002-7857-7032; Haider, Afreen/0000-0003-4768-0499	Wellcome Trust [091551, 107064]; UKNIHR Cambridge Biomedical Research Centre; Medical Research Council [G0701446]; MRC Metabolic Diseases Unit [MC_UU_12012/5]; Innovative Medicines Initiative Joint Undertaking, EMIF-Metabolism award; Medical Research Council [1125163, MC_UU_12012/5] Funding Source: researchfish; MRC [MC_UU_12012/5, G0701446] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); UKNIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Metabolic Diseases Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Innovative Medicines Initiative Joint Undertaking, EMIF-Metabolism award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Wellcome Trust (091551 and 107064 to DBS), the UKNIHR Cambridge Biomedical Research Centre, the Medical Research Council (G0701446 to SS and a Doctoral training grant awarded to the University of Cambridge for ERR), core facilities at the MRC Metabolic Diseases Unit (MC_UU_12012/5) and by the Innovative Medicines Initiative Joint Undertaking, EMIF-Metabolism award. The authors declare that they have no conflicts of interest with the contents of this article.	Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bouvet S, 2013, J CELL SCI, V126, P4794, DOI 10.1242/jcs.134254; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Chong BM, 2011, J BIOL CHEM, V286, P23254, DOI 10.1074/jbc.M110.217091; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; DYSON HJ, 1988, J MOL BIOL, V201, P201, DOI 10.1016/0022-2836(88)90447-0; Gandotra S, 2011, J BIOL CHEM, V286, P34998, DOI 10.1074/jbc.M111.278853; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Garcia A, 2003, J BIOL CHEM, V278, P625, DOI 10.1074/jbc.M206602200; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Horchani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113484; Hynson RMG, 2012, PROTEINS, V80, P2046, DOI 10.1002/prot.24095; Jacquier N, 2013, J CELL SCI, V126, P5198, DOI 10.1242/jcs.131896; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Kory N, 2015, DEV CELL, V34, P351, DOI 10.1016/j.devcel.2015.06.007; Kozusko K, 2015, DIABETES, V64, P299, DOI 10.2337/db14-0104; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; McManaman JL, 2003, J LIPID RES, V44, P668, DOI 10.1194/jlr.C200021-JLR200; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Najt CP, 2014, BIOCHEMISTRY-US, V53, P7051, DOI 10.1021/bi500918m; Nakamura N, 2003, BIOCHEM BIOPH RES CO, V306, P333, DOI 10.1016/S0006-291X(03)00979-3; Ohsaki Y, 2006, BIOCHEM BIOPH RES CO, V347, P279, DOI 10.1016/j.bbrc.2006.06.074; Orlicky DJ, 2008, J CELL SCI, V121, P2921, DOI 10.1242/jcs.026153; Patel S, 2014, P NATL ACAD SCI USA, V111, P9163, DOI 10.1073/pnas.1318791111; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Robbins AL, 2015, TRENDS MOL MED, V21, P433, DOI 10.1016/j.molmed.2015.04.004; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sampaio-Marques B, 2012, AUTOPHAGY, V8, P1494, DOI 10.4161/auto.21275; Shen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008119; Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stevanovic A, 2013, J LIPID RES, V54, P503, DOI 10.1194/jlr.M033852; Subramanian V, 2004, J LIPID RES, V45, P1983, DOI 10.1194/jlr.M400291-JLR200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Thiam AR, 2013, P NATL ACAD SCI USA, V110, P13244, DOI 10.1073/pnas.1307685110; Vanni S, 2013, BIOPHYS J, V104, P575, DOI 10.1016/j.bpj.2012.11.3837; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wei P, 2005, J BIOCHEM, V138, P399, DOI 10.1093/jb/mvi136; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200	81	65	65	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6664	6678		10.1074/jbc.M115.691048	http://dx.doi.org/10.1074/jbc.M115.691048			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26742848	Green Published, hybrid			2022-12-28	WOS:000373299700005
J	Thaler, R; Maurizi, A; Roschger, P; Sturmlechner, I; Khani, F; Spitzer, S; Rumpler, M; Zwerina, J; Karlic, H; Dudakovic, A; Klaushofer, K; Teti, A; Rucci, N; Varga, F; van Wijnen, AJ				Thaler, Roman; Maurizi, Antonio; Roschger, Paul; Sturmlechner, Ines; Khani, Farzaneh; Spitzer, Silvia; Rumpler, Monika; Zwerina, Jochen; Karlic, Heidrun; Dudakovic, Amel; Klaushofer, Klaus; Teti, Anna; Rucci, Nadia; Varga, Franz; van Wijnen, Andre J.			Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; epigenetics; osteoblast; osteoclast; osteoporosis	CELL-CYCLE ARREST; MINERALIZATION DENSITY DISTRIBUTION; GROUP PROTEIN-LEVEL; COLON-CANCER CELLS; SERUM AMYLOID A3; FACTOR-KAPPA-B; HISTONE DEACETYLASE; DIMETHYL-SULFOXIDE; OSTEOCLAST DIFFERENTIATION; OXIDATIVE STRESS	Bone degenerative pathologies like osteoporosis may be initiated by age-related shifts in anabolic and catabolic responses that control bone homeostasis. Here we show that sulforaphane (SFN), a naturally occurring isothiocyanate, promotes osteoblast differentiation by epigenetic mechanisms. SFN enhances active DNA demethylation via Tet1 and Tet2 and promotes preosteoblast differentiation by enhancing extracellular matrix mineralization and the expression of osteoblastic markers (Runx2, Col1a1, Bglap2, Sp7, Atf4, and Alpl). SFN decreases the expression of the osteoclast activator receptor activator of nuclear factor-B ligand (RANKL) in osteocytes and mouse calvarial explants and preferentially induces apoptosis in preosteoclastic cells via up-regulation of the Tet1/Fas/Caspase 8 and Caspase 3/7 pathway. These mechanistic effects correlate with higher bone volume (approximate to 20%) in both normal and ovariectomized mice treated with SFN for 5 weeks compared with untreated mice as determined by microcomputed tomography. This effect is due to a higher trabecular number in these mice. Importantly, no shifts in mineral density distribution are observed upon SFN treatment as measured by quantitative backscattered electron imaging. Our data indicate that the food-derived compound SFN epigenetically stimulates osteoblast activity and diminishes osteoclast bone resorption, shifting the balance of bone homeostasis and favoring bone acquisition and/or mitigation of bone resorption in vivo. Thus, SFN is a member of a new class of epigenetic compounds that could be considered for novel strategies to counteract osteoporosis.	[Thaler, Roman; Roschger, Paul; Sturmlechner, Ines; Spitzer, Silvia; Rumpler, Monika; Zwerina, Jochen; Karlic, Heidrun; Klaushofer, Klaus; Varga, Franz] Hanusch Hosp Social Hlth Insurance Vienna WGKK, Ludwig Boltzmann Inst Osteol, A-1140 Vienna, Austria; [Thaler, Roman; Roschger, Paul; Sturmlechner, Ines; Spitzer, Silvia; Rumpler, Monika; Zwerina, Jochen; Karlic, Heidrun; Klaushofer, Klaus; Varga, Franz] Hanusch Hosp, Dept Med 1, Austrian Social Insurance Occupat Risks AUVA Trau, A-1140 Vienna, Austria; [Thaler, Roman; Khani, Farzaneh; Dudakovic, Amel; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg & Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA; [Maurizi, Antonio; Teti, Anna; Rucci, Nadia] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy	Ludwig Boltzmann Institute; WGKK - Hanusch Hospital; WGKK - Hanusch Hospital; Mayo Clinic; University of L'Aquila	Varga, F (corresponding author), Hanusch Hosp Social Hlth Insurance Vienna WGKK, Ludwig Boltzmann Inst Osteol, A-1140 Vienna, Austria.; Varga, F (corresponding author), Hanusch Hosp, Dept Med 1, Austrian Social Insurance Occupat Risks AUVA Trau, A-1140 Vienna, Austria.; van Wijnen, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg & Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.; Rucci, N (corresponding author), Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.	rucci@univaq.it; franz.varga@osteologie.at; vanwijnen.andre@mayo.edu	Maurizi, Antonio/AAI-7728-2020; van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946; Sturmlechner, Ines/0000-0003-1272-5618; Maurizi, Antonio/0000-0002-7027-4694; Rucci, Nadia/0000-0002-1371-8252; Dudakovic, Amel/0000-0002-8850-3977	NIAMS, National Institutes of Health [AR049069]; Center of Regenerative Medicine at Mayo Clinic; Austrian Science Fund (FWF) [P24370-B19]; Austrian Social Insurance for Occupational Risks (AUVA); Social Health Insurance Vienna (WGKK); Austrian Science Fund (FWF) [P 24370] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Center of Regenerative Medicine at Mayo Clinic; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Social Insurance for Occupational Risks (AUVA); Social Health Insurance Vienna (WGKK); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health Grant AR049069 (to A. J. v. W.), a fellowship grant from the Center of Regenerative Medicine at Mayo Clinic (to R. T.), the Austrian Science Fund (FWF; Project P24370-B19 to F. V. and K. K.), Austrian Social Insurance for Occupational Risks (AUVA; to F. V. and K. K.), Social Health Insurance Vienna (WGKK; to F. V. and K. K.), and generous philanthropic support of William H. and Karen J. Eby and the charitable foundation in their names. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen ML, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-51; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Balasubramanian S, 2012, J BIOL CHEM, V287, P36179, DOI 10.1074/jbc.M112.359281; Balasubramanian S, 2011, MOL PHARMACOL, V80, P870, DOI 10.1124/mol.111.072363; Barutcu AR, 2014, NUCLEIC ACIDS RES, V42, P10360, DOI 10.1093/nar/gku712; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; BONSER RW, 1981, BIOCHEM BIOPH RES CO, V98, P614, DOI 10.1016/0006-291X(81)91158-X; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Clarke JD, 2011, MOL NUTR FOOD RES, V55, P999, DOI 10.1002/mnfr.201000547; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; Davidson RK, 2013, ARTHRITIS RHEUM-US, V65, P3130, DOI 10.1002/art.38133; Dinsmore J, 1996, CELL TRANSPLANT, V5, P131, DOI 10.1016/0963-6897(95)02040-3; Do DP, 2010, INT J PHARMACEUT, V386, P114, DOI 10.1016/j.ijpharm.2009.11.009; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Dudakovic A, 2015, J CELL PHYSIOL, V230, P52, DOI 10.1002/jcp.24680; Enomoto H, 2003, J BIOL CHEM, V278, P23971, DOI 10.1074/jbc.M302457200; Facchini A, 2011, J CELL PHYSIOL, V226, P1771, DOI 10.1002/jcp.22506; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fan HT, 2012, EPIGENETICS-US, V7, P1379, DOI 10.4161/epi.22609; Fratzl-Zelman N, 2009, BONE, V44, P1043, DOI 10.1016/j.bone.2009.02.021; Fratzl-Zelman N, 1998, BONE, V23, P511, DOI 10.1016/S8756-3282(98)00139-2; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Gambari L, 2014, PHARMACOL RES, V87, P99, DOI 10.1016/j.phrs.2014.06.014; Gamet-Payrastre L, 2006, CURR CANCER DRUG TAR, V6, P135, DOI 10.2174/156800906776056509; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Gordon JAR, 2015, BONE, V81, P739, DOI 10.1016/j.bone.2015.03.011; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Hyeon S, 2013, FREE RADICAL BIO MED, V65, P789, DOI 10.1016/j.freeradbiomed.2013.08.005; Iwatani M, 2006, STEM CELLS, V24, P2549, DOI 10.1634/stemcells.2005-0427; Jiang X, 2014, TOXICOL APPL PHARM, V279, P198, DOI 10.1016/j.taap.2014.06.009; Kim SJ, 2005, MOL CELLS, V20, P364; Ko JY, 2013, BIOMATERIALS, V34, P5359, DOI 10.1016/j.biomaterials.2013.03.066; Kong JS, 2010, ARTHRITIS RHEUM-US, V62, P159, DOI 10.1002/art.25017; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Li XL, 2006, ANN NY ACAD SCI, V1068, P26, DOI 10.1196/annals.1346.006; Liang H, 2013, NAT PROD RES, V27, P194, DOI 10.1080/14786419.2012.662649; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Marie PJ, 2015, CELL MOL LIFE SCI, V72, P1347, DOI 10.1007/s00018-014-1801-2; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Meeran SM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0011-5; Misof BM, 2013, J BONE MINER RES, V28, P442, DOI 10.1002/jbmr.1780; Molvik H, 2015, OSTEOPOROSIS INT, V26, P1251, DOI 10.1007/s00198-014-3007-8; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Nian H, 2008, CARCINOGENESIS, V29, P1816, DOI 10.1093/carcin/bgn165; Nian H, 2009, ENVIRON MOL MUTAGEN, V50, P213, DOI 10.1002/em.20454; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRATT AJ, 1991, IEEE T BIO-MED ENG, V38, P306, DOI 10.1109/10.133215; Rajendran P, 2013, EPIGENETICS-US, V8, P612, DOI 10.4161/epi.24710; Reid IR, 2015, NAT REV ENDOCRINOL, V11, P418, DOI 10.1038/nrendo.2015.71; Roschger P, 1998, BONE, V23, P319, DOI 10.1016/S8756-3282(98)00112-4; Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021; Roschger P, 2014, CURR OSTEOPOROS REP, V12, P338, DOI 10.1007/s11914-014-0218-z; Schilcher J, 2015, ACTA ORTHOP, V86, P100, DOI 10.3109/17453674.2015.1004149; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Shiotani A, 2002, ANAT REC, V268, P137, DOI 10.1002/ar.10121; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Stephens AS, 2011, J BIOL CHEM, V286, P30071, DOI 10.1074/jbc.M111.253518; Teufel S, 2014, J IMMUNOL, V193, P223, DOI 10.4049/jimmunol.1302713; Thaler R, 2013, BIOCHEM PHARMACOL, V85, P173, DOI 10.1016/j.bcp.2012.10.016; Thaler R, 2015, FASEB J, V29, P1344, DOI 10.1096/fj.14-265512; Thaler R, 2013, FASEB J, V27, P446, DOI 10.1096/fj.12-208058; Thaler R, 2012, EPIGENETICS-US, V7, P635, DOI 10.4161/epi.20163; Thaler R, 2009, BRIT J NUTR, V101, P743, DOI 10.1017/S0007114508047685; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; Venturelli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073097; Watson GW, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.47; Xue MZ, 2008, DIABETES, V57, P2809, DOI 10.2337/db06-1003; Yara S, 2015, EPIGENOMICS-UK, V7, P283, DOI [10.2217/EPI.14.84, 10.2217/epi.14.84]; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang ZG, 2014, J MOL CELL CARDIOL, V77, P42, DOI 10.1016/j.yjmcc.2014.09.022	70	44	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6754	6771		10.1074/jbc.M115.678235	http://dx.doi.org/10.1074/jbc.M115.678235			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26757819	hybrid, Green Published			2022-12-28	WOS:000373299700015
J	Ago, H; Adachi, H; Umena, Y; Tashiro, T; Kawakami, K; Kamiya, N; Tian, LR; Han, GY; Kuang, TY; Liu, ZY; Wang, FJ; Zou, HF; Enami, I; Miyano, M; Shen, JR				Ago, Hideo; Adachi, Hideyuki; Umena, Yasufumi; Tashiro, Takayoshi; Kawakami, Keisuke; Kamiya, Nobuo; Tian, Lirong; Han, Guangye; Kuang, Tingyun; Liu, Zheyi; Wang, Fangjun; Zou, Hanfa; Enami, Isao; Miyano, Masashi; Shen, Jian-Ren			Novel Features of Eukaryotic Photosystem II Revealed by Its Crystal Structure Analysis from a Red Alga	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; crystallography; cyanobacteria; electron transfer complex; membrane protein; photosynthesis; photosystem II; x-ray crystallography	EXTRINSIC PROTEINS; FUNCTIONAL-PROPERTIES; CYANIDIUM-CALDARIUM; CROSS-LINKING; PSBQ PROTEIN; ANGSTROM RESOLUTION; 12-KDA PROTEIN; CYANOBACTERIAL; BINDING; MECHANISM	Photosystem II (PSII) catalyzes light-induced water splitting, leading to the evolution of molecular oxygen indispensible for life on the earth. The crystal structure of PSII from cyanobacteria has been solved at an atomic level, but the structure of eukaryotic PSII has not been analyzed. Because eukaryotic PSII possesses additional subunits not found in cyanobacterial PSII, it is important to solve the structure of eukaryotic PSII to elucidate their detailed functions, as well as evolutionary relationships. Here we report the structure of PSII from a red alga Cyanidium caldarium at 2.76 resolution, which revealed the structure and interaction sites of PsbQ, a unique, fourth extrinsic protein required for stabilizing the oxygen-evolving complex in the lumenal surface of PSII. The PsbQ subunit was found to be located underneath CP43 in the vicinity of PsbV, and its structure is characterized by a bundle of four up-down helices arranged in a similar way to those of cyanobacterial and higher plant PsbQ, although helices I and II of PsbQ were kinked relative to its higher plant counterpart because of its interactions with CP43. Furthermore, two novel transmembrane helices were found in the red algal PSII that are not present in cyanobacterial PSII; one of these helices may correspond to PsbW found only in eukaryotic PSII. The present results represent the first crystal structure of PSII from eukaryotic oxygenic organisms, which were discussed in comparison with the structure of cyanobacterial PSII.	[Ago, Hideo; Miyano, Masashi] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan; [Adachi, Hideyuki; Umena, Yasufumi; Shen, Jian-Ren] Okayama Univ, Fac Sci, Grad Sch Nat Sci & Technol, Photosynthesis Res Ctr, Okayama 7008530, Japan; [Umena, Yasufumi; Kawakami, Keisuke; Kamiya, Nobuo] Osaka City Univ, Adv Res Inst Nat Sci & Technol OCARNA, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 7008530, Japan; [Umena, Yasufumi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Tokyo 1020076, Japan; [Tashiro, Takayoshi; Kamiya, Nobuo] Osaka City Univ, Grad Sch Sci, Dept Chem, Sumiyoshi Ku, Osaka 5588585, Japan; [Tian, Lirong; Han, Guangye; Kuang, Tingyun; Shen, Jian-Ren] Chinese Acad Sci, Inst Bot, Key Lab Photobiol, Photosynthesis Res Ctr, Beijing 100093, Peoples R China; [Liu, Zheyi; Wang, Fangjun; Zou, Hanfa] Chinese Acad Sci, Dalian Inst Chem Phys, Natl Chromatog R&A Ctr, Key Lab Separat Sci Analyt Chem, Dalian 116023, Peoples R China; [Enami, Isao] Tokyo Univ Sci, Fac Sci, Dept Biol, Shinjuku Ku, Tokyo 1628601, Japan; [Miyano, Masashi] Aoyama Gakuin Univ, Dept Chem & Biol Sci, Sagamihara, Kanagawa 2525258, Japan	RIKEN; Okayama University; Osaka Metropolitan University; Japan Science & Technology Agency (JST); Osaka Metropolitan University; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Tokyo University of Science; Aoyama Gakuin University	Shen, JR (corresponding author), Okayama Univ, Fac Sci, Grad Sch Nat Sci & Technol, Photosynthesis Res Ctr, Okayama 7008530, Japan.; Shen, JR (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photobiol, Photosynthesis Res Ctr, Beijing 100093, Peoples R China.	shen@cc.okayama-u.ac.jp	Miyano, Masashi/R-2785-2016; Shen, Jian-Ren/B-2558-2011; LIU, zhe/HGD-6875-2022; Umena, Yasufumi/AAD-5472-2019	Miyano, Masashi/0000-0003-2253-6175; Ago, Hideo/0000-0002-9040-488X; Fangjun, Wang/0000-0002-8118-7019	JSPS [24000018]; MEXT of Japan; Chinese Academy of Sciences [KGZD-EW-T05]; China State Key Basic Research Program Grant [2013CB911203]; Creative Research Group Project by NSFC [21321064]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chinese Academy of Sciences(Chinese Academy of Sciences); China State Key Basic Research Program Grant; Creative Research Group Project by NSFC	This work was supported by a Grant-in-Aid for Specially Promoted Research No. 24000018 from JSPS, a Special Project on Photosynthesis Research in Okayama University, a Program for Promoting the Enhancement of Research Universities, from MEXT of Japan, a Key Research Program of the Chinese Academy of Sciences ( Grant No. KGZD-EW-T05), the China State Key Basic Research Program Grant ( 2013CB911203) and the financial supports from the Creative Research Group Project by NSFC ( 21321064). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi H, 2009, BBA-BIOENERGETICS, V1787, P121, DOI 10.1016/j.bbabio.2008.11.004; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen JF, 2011, TRENDS PLANT SCI, V16, P645, DOI 10.1016/j.tplants.2011.10.004; Balsera M, 2005, J MOL BIOL, V350, P1051, DOI 10.1016/j.jmb.2005.05.044; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Bricker TM, 2002, PHOTOSYNTH RES, V72, P131, DOI 10.1023/A:1016128715865; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Calderone V, 2003, EMBO REP, V4, P900, DOI 10.1038/sj.embor.embor923; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enami I, 2005, FEBS J, V272, P5020, DOI 10.1111/j.1742-4658.2005.04912.x; Enami I, 1998, BIOCHEMISTRY-US, V37, P2787, DOI 10.1021/bi9724624; Enami I, 2000, PLANT CELL PHYSIOL, V41, P1354, DOI 10.1093/pcp/pcd069; Enami I, 1995, BBA-BIOENERGETICS, V1232, P208, DOI 10.1016/0005-2728(95)00122-0; Enami I, 2008, PHOTOSYNTH RES, V98, P349, DOI 10.1007/s11120-008-9343-9; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Garcia-Cerdan JG, 2011, PLANT J, V65, P368, DOI 10.1111/j.1365-313X.2010.04429.x; Gardian Z, 2007, BBA-BIOENERGETICS, V1767, P725, DOI 10.1016/j.bbabio.2007.01.021; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Ido K, 2014, J BIOL CHEM, V289, P20150, DOI 10.1074/jbc.M114.574822; Ifuku K, 2015, BIOSCI BIOTECH BIOCH, V79, P1223, DOI 10.1080/09168451.2015.1031078; Ifuku K, 2014, PLANT PHYSIOL BIOCH, V81, P108, DOI 10.1016/j.plaphy.2014.01.001; Jackson SA, 2010, BIOCHEMISTRY-US, V49, P2765, DOI 10.1021/bi100217h; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kawakami K, 2007, FEBS LETT, V581, P4983, DOI 10.1016/j.febslet.2007.09.036; Kawakami K, 2011, J PHOTOCH PHOTOBIO B, V104, P9, DOI 10.1016/j.jphotobiol.2011.03.017; Kawakami K, 2009, P NATL ACAD SCI USA, V106, P8567, DOI 10.1073/pnas.0812797106; Koua FHM, 2013, P NATL ACAD SCI USA, V110, P3889, DOI 10.1073/pnas.1219922110; Krupnik T, 2013, J BIOL CHEM, V288, P23529, DOI 10.1074/jbc.M113.484659; Liu HJ, 2014, P NATL ACAD SCI USA, V111, P4638, DOI 10.1073/pnas.1323063111; Michoux F, 2014, PHOTOSYNTH RES, V122, P57, DOI 10.1007/s11120-014-0010-z; Mummadisetti MP, 2014, P NATL ACAD SCI USA, V111, P16178, DOI 10.1073/pnas.1415165111; Murray JW, 2008, ENERG ENVIRON SCI, V1, P161, DOI 10.1039/b810067p; Nagao R, 2010, J BIOL CHEM, V285, P29191, DOI 10.1074/jbc.M110.146092; Ohta H, 2003, EUR J BIOCHEM, V270, P4156, DOI 10.1046/j.1432-1033.2003.03810.x; Rokka A, 2005, BIOCHEM J, V388, P159, DOI 10.1042/BJ20042098; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Shen JR, 2015, ANNU REV PLANT BIOL, V66, P23, DOI 10.1146/annurev-arplant-050312-120129; SHEN JR, 1992, FEBS LETT, V301, P145, DOI 10.1016/0014-5793(92)81235-E; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Shi LX, 2012, BBA-BIOENERGETICS, V1817, P13, DOI 10.1016/j.bbabio.2011.08.008; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	49	77	78	3	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5676	5687		10.1074/jbc.M115.711689	http://dx.doi.org/10.1074/jbc.M115.711689			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26757821	Green Published, hybrid			2022-12-28	WOS:000372551800019
J	Shankar, E; Song, K; Corum, SL; Bane, KL; Wang, H; Kao, HY; Danielpour, D				Shankar, Eswar; Song, Kyung; Corum, Sarah L.; Bane, Kara L.; Wang, Hui; Kao, Hung-Ying; Danielpour, David			A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; androgen; androgen receptor; c-Fos; c-Jun transcription factor; MAPK; p38 MAPK; phorbol ester; prostate cancer; PKC	RAT VENTRAL PROSTATE; GROWTH-FACTOR-BETA; SERUM RESPONSE ELEMENT; CANCER-CELLS; KINASE-C; INDUCED APOPTOSIS; EPITHELIAL-CELLS; PHORBOL ESTER; TRANSFORMING GROWTH-FACTOR-BETA-1; TRANSCRIPTIONAL ACTIVITY	The transcription factor c-Fos controls many important cellular processes, including cell growth and apoptosis. c-Fos expression is rapidly elevated in the prostate upon castration-mediated androgen withdrawal through an undefined mechanism. Here we show that androgens (5-dihydrotestosterone and R1881) suppress c-Fos protein and mRNA expression induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) or EGF in human prostate cancer (PCa) cell lines. Such suppression transpires through a transcriptional mechanism, predominantly at the proximal serum response element of the c-fos promoter. We show that androgen signaling suppresses TPA-induced c-Fos expression through repressing a PKC/MEK/ERK/ELK-1 signaling pathway. Moreover, our results support the hypothesis that p38(MAPK), PI3K, and PKC are involved in the androgenic regulation of c-Fos through controlling MEK/ERK. Stable silencing of c-Fos and PKC with shRNAs suggests that R1881 promotes cell death induced by low-dose TPA through a mechanism that is dependent on both PKC and loss of c-Fos expression. Reciprocally, loss of either PKC or c-Fos activates p38(MAPK) while suppressing the activation of ERK1/2. We also provide the first demonstration that R1881 permits cell death induced by low-dose TPA in the LNCaP androgen-dependent PCa cell line and that TPA-induced cell death is independent of exogenous androgen in the castration-resistant variants of LNCaP, C4-2 and C4-2B. Acquisition of androgen-independent killing by TPA correlates with activation of p38(MAPK), suppression of ERK1/2, and loss of c-Fos. These results provide new insights into androgenic control of c-Fos and use of PKC inhibitors in PCa therapy.	[Kao, Hung-Ying; Danielpour, David] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Shankar, Eswar; Song, Kyung; Corum, Sarah L.; Bane, Kara L.; Danielpour, David] Case Western Reserve Univ, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA; [Wang, Hui; Danielpour, David] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Danielpour, David] Univ Hosp Cleveland, Dept Urol, Cleveland, OH 44106 USA; [Song, Kyung] Wonkwang Univ, Coll Pharm, Iksan 570749, South Korea; [Wang, Hui] Athenex, Cranford, NJ 07016 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Wonkwang University	Danielpour, D (corresponding author), Div Gen Med Sci Oncol, Wolstein Res Bldg,Rm 3-532,2103 Cornell Ave, Cleveland, OH 44106 USA.	dxd49@case.edu	Shankar, Eswar/E-5139-2015	Shankar, Eswar/0000-0001-8968-838X	NCI/National Institutes of Health [R01CA092102, R01CA102074, R01CA134878]; NATIONAL CANCER INSTITUTE [R01CA134878, R01CA092102, R01CA102074] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NCI/National Institutes of Health Grants R01CA092102, R01CA102074, and R01CA134878 ( to D. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler J, 2010, MOL CELL BIOL, V30, P3767, DOI 10.1128/MCB.00899-09; Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; BIRCHENALLROBERTS MC, 1990, MOL CELL BIOL, V10, P4978, DOI 10.1128/MCB.10.9.4978; BLUMBERG PM, 1988, CANCER RES, V48, P1; BUTTYAN R, 1988, MOL ENDOCRINOL, V2, P650, DOI 10.1210/mend-2-7-650; Buttyan R, 1999, TRENDS ENDOCRIN MET, V10, P47, DOI 10.1016/S1043-2760(98)00104-0; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; Chmura SJ, 1996, CANCER RES, V56, P2711; COOKE PS, 1991, ENDOCRINOLOGY, V128, P2867, DOI 10.1210/endo-128-6-2867; Cui XX, 2002, ONCOL RES, V13, P169; Culig Z, 2005, ENDOCR-RELAT CANCER, V12, P229, DOI 10.1677/erc.1.00775a; David JP, 2005, J CLIN INVEST, V115, P664, DOI 10.1172/JCI200522877; DAY ML, 1994, CELL GROWTH DIFFER, V5, P735; Engedal N, 2002, ONCOGENE, V21, P1017, DOI 10.1038/sj.onc.1205167; Fang BJ, 2007, LEUKEMIA RES, V31, P1441, DOI 10.1016/j.leukres.2007.02.004; Feng ZW, 1998, ONCOGENE, V17, P2593, DOI 10.1038/sj.onc.1202195; Fronsdal K, 1998, J BIOL CHEM, V273, P31853, DOI 10.1074/jbc.273.48.31853; Garzotto M, 1999, CANCER RES, V59, P5194; Gavrielides MV, 2006, CANCER RES, V66, P11792, DOI 10.1158/0008-5472.CAN-06-1139; GRANT S, 1992, CANCER RES, V52, P6270; Gschwendt M, 1999, EUR J BIOCHEM, V259, P555, DOI 10.1046/j.1432-1327.1999.00120.x; HAIMOVITZFRIEDMAN A, 1994, CANCER RES, V54, P2591; Han ZT, 1998, P NATL ACAD SCI USA, V95, P5362, DOI 10.1073/pnas.95.9.5362; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; Hsu CC, 2013, MOL CELL ENDOCRINOL, V372, P12, DOI 10.1016/j.mce.2013.03.004; Huggins C, 1972, CA Cancer J Clin, V22, P232, DOI 10.3322/canjclin.22.4.232; Ito Y, 2005, BONE, V37, P842, DOI 10.1016/j.bone.2005.04.030; IVANOVIC V, 1995, NAT MED, V1, P282, DOI 10.1038/nm0495-282; JARVIS WD, 1994, CANCER RES, V54, P1707; JOHANSEN FE, 1993, MOL CELL BIOL, V13, P4640, DOI 10.1128/MCB.13.8.4640; Johnson CM, 1997, J NEUROSCI, V17, P6189; Kim DW, 1998, MOL CELL BIOL, V18, P3310, DOI 10.1128/MCB.18.6.3310; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; KRONGRAD A, 1994, CANCER RES, V54, P6073; KYPRIANOU N, 1989, MOL ENDOCRINOL, V3, P1515, DOI 10.1210/mend-3-10-1515; Latinkic BV, 1996, NUCLEIC ACIDS RES, V24, P1345, DOI 10.1093/nar/24.7.1345; Leach DA, 2014, MOL CELL ENDOCRINOL, V384, P185, DOI 10.1016/j.mce.2014.01.004; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Liu GM, 2006, MOL CARCINOGEN, V45, P582, DOI 10.1002/mc.20189; Lucia MS, 1998, J CELL PHYSIOL, V175, P184, DOI 10.1002/(SICI)1097-4652(199805)175:2<184::AID-JCP8>3.0.CO;2-K; LUCIBELLO FC, 1989, CELL, V59, P999, DOI 10.1016/0092-8674(89)90756-3; MERZ VW, 1994, WORLD J UROL, V12, P96; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Mora GR, 1996, MOL CELL ENDOCRINOL, V124, P111, DOI 10.1016/S0303-7207(96)03939-1; Mora LB, 2002, CANCER RES, V62, P6659; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Patki M, 2013, J BIOL CHEM, V288, P11047, DOI 10.1074/jbc.M112.438473; PAVELIC K, 1991, International Journal of Developmental Biology, V35, P209; Perry KT, 1997, PROSTATE, V33, P133, DOI 10.1002/(SICI)1097-0045(19971001)33:2<133::AID-PROS7>3.0.CO;2-L; PIECHACZYK M, 1994, CRIT REV ONCOL HEMAT, V17, P93, DOI 10.1016/1040-8428(94)90021-3; RAO VN, 1992, ONCOGENE, V7, P2335; Sato N, 1997, J BIOL CHEM, V272, P17485, DOI 10.1074/jbc.272.28.17485; Schaar D, 2006, CANCER CHEMOTH PHARM, V57, P789, DOI 10.1007/s00280-005-0125-1; Schweizer L, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-4; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; Smith PC, 2001, CYTOKINE GROWTH F R, V12, P33, DOI 10.1016/S1359-6101(00)00021-6; Sng JCG, 2004, BIOL PHARM BULL, V27, P606, DOI 10.1248/bpb.27.606; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Song K, 2008, CANCER RES, V68, P8173, DOI 10.1158/0008-5472.CAN-08-2290; Song K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061896; STANCOVSKI I, 1995, MOL CELL BIOL, V15, P7106; Stewart LMV, 2003, EXP CELL RES, V284, P303, DOI 10.1016/S0014(02)00037-X; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P742, DOI 10.1021/bi00147a029; Wen Y, 2000, CANCER RES, V60, P6841; Xiao LQ, 2009, MOL CARCINOGEN, V48, P187, DOI 10.1002/mc.20476; Zhang XP, 2007, CLIN CANCER RES, V13, P7181, DOI 10.1158/1078-0432.CCR-07-1133; Zhang XP, 2007, CANCER RES, V67, P9425, DOI 10.1158/0008-5472.CAN-07-1310	74	14	17	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5512	5526		10.1074/jbc.M115.694877	http://dx.doi.org/10.1074/jbc.M115.694877			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26786102	hybrid, Green Published			2022-12-28	WOS:000372551800006
J	So, EC; Schroeder, GN; Carson, D; Mattheis, C; Mousnier, A; Broncel, M; Tate, EW; Frankel, G				So, Ernest C.; Schroeder, Gunnar N.; Carson, Danielle; Mattheis, Corinna; Mousnier, Aurelie; Broncel, Malgorzata; Tate, Edward W.; Frankel, Gad			The Rab-binding Profiles of Bacterial Virulence Factors during Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; mass spectrometry (MS); protein complex; protein cross-linking; protein purification; Legionella pneumophila; LidA; Rab GTPases; SidM; Type IV secretion system effectors	PATHOGEN LEGIONELLA-PNEUMOPHILA; EFFECTOR; PROTEOME; DRRA; DISPLACEMENT; PROTEINS; SYSTEMS; LIDA	Legionella pneumophila, the causative agent of Legionnaire's disease, uses its type IV secretion system to translocate over 300 effector proteins into host cells. These effectors subvert host cell signaling pathways to ensure bacterial proliferation. Despite their importance for pathogenesis, the roles of most of the effectors are yet to be characterized. Key to understanding the function of effectors is the identification of host proteins they bind during infection. We previously developed a novel tandem-affinity purification (TAP) approach using hexahistidine and BirA-specific biotinylation tags for isolating translocated effector complexes from infected cells whose composition were subsequently deciphered by mass spectrometry. Here we further advanced the workflow for the TAP approach and determined the infection-dependent interactomes of the effectors SidM and LidA, which were previously reported to promiscuously bind multiple Rab GTPases in vitro. In this study we defined a stringent subset of Rab GTPases targeted by SidM and LidA during infection, comprising of Rab1A, 1B, 6, and 10; in addition, LidA targets Rab14 and 18. Taken together, this study illustrates the power of this approach to profile the intracellular interactomes of bacterial effectors during infection.	[So, Ernest C.; Schroeder, Gunnar N.; Carson, Danielle; Mattheis, Corinna; Mousnier, Aurelie; Frankel, Gad] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Mol Bacteriol & Infect, Dept Life Sci, Flowers Bldg, London SW7 2AZ, England; [So, Ernest C.; Broncel, Malgorzata; Tate, Edward W.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, South Kensington Campus, London SW7 2AZ, England; [So, Ernest C.; Tate, Edward W.; Frankel, Gad] Univ London Imperial Coll Sci Technol & Med, Inst Chem Biol, Dept Chem, South Kensington Campus, London SW7 2AZ, England; [Mousnier, Aurelie] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Infect Sect, South Kensington Campus, London SW7 2AZ, England; [Broncel, Malgorzata] Inst Canc Res, Div Canc Biol, 237 Fulham Rd, London SW3 6JB, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Frankel, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Ctr Mol Bacteriol & Infect, Flowers Bldg, London SW7 2AZ, England.	g.frankel@imperial.ac.uk	Schroeder, Gunnar Neels/AAJ-2591-2020	Schroeder, Gunnar Neels/0000-0002-0412-7741; Carson, Danielle/0000-0003-1200-2022; Mousnier, Aurelie/0000-0002-7317-1009; Broncel, Malgorzata/0000-0003-2991-3500; Tate, Edward/0000-0003-2213-5814	Medical Research Council at Imperial College; German Academic Exchange Service; UK Engineering and Physical Sciences Research Council (Institute of Chemical Biology studentship); European Union (Marie Curie Intra European Fellowship) [PEF-GA-2011-299740]; Engineering and Physical Sciences Research Council [1234574, EP/J021199/1] Funding Source: researchfish; Medical Research Council [MR/L018225/1, MR/J006874/1] Funding Source: researchfish; EPSRC [EP/J021199/1] Funding Source: UKRI; MRC [MR/J006874/1, MR/L018225/1] Funding Source: UKRI	Medical Research Council at Imperial College(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); UK Engineering and Physical Sciences Research Council (Institute of Chemical Biology studentship)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union (Marie Curie Intra European Fellowship); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council at Imperial College, the German Academic Exchange Service ( to C. M.), the UK Engineering and Physical Sciences Research Council (Institute of Chemical Biology studentship, to E. C. S.), and the European Union (Marie Curie Intra European Fellowship ( to M. B.) (PEF-GA-2011-299740)). The authors declare that they have no conflicts of interest with the contents of this article.	Arasaki K, 2012, CELL HOST MICROBE, V11, P46, DOI 10.1016/j.chom.2011.11.009; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Broncel M, 2015, ANGEW CHEM INT EDIT, V54, P5948, DOI 10.1002/anie.201500342; Capmany A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014084; Chen Y, 2013, INFECT IMMUN, V81, P2226, DOI 10.1128/IAI.00157-13; Cheng W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002528; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Gerondopoulos A, 2014, J CELL BIOL, V205, P707, DOI 10.1083/jcb.201403026; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Hoffmann C, 2014, CELL MICROBIOL, V16, P1034, DOI 10.1111/cmi.12256; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Jeong KC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004695; Kubori T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001216; Kuijl C, 2013, EMBO J, V32, P713, DOI 10.1038/emboj.2013.10; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Mousnier A, 2014, MBIO, V5, DOI 10.1128/mBio.01148-14; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Neunuebel MR, 2011, SCIENCE, V333, P453, DOI 10.1126/science.1207193; Schoebel S, 2011, P NATL ACAD SCI USA, V108, P17945, DOI 10.1073/pnas.1113133108; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Schroeder GN, 2015, INFECT IMMUN, V83, P3989, DOI 10.1128/IAI.00785-15; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; So EC, 2015, CAN J MICROBIOL, V61, P617, DOI 10.1139/cjm-2015-0166; Tan YH, 2011, NATURE, V475, P506, DOI 10.1038/nature10307; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Yu XB, 2015, J PROTEOME RES, V14, P1920, DOI 10.1021/pr5013015; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	32	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5832	5843		10.1074/jbc.M115.700930	http://dx.doi.org/10.1074/jbc.M115.700930			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26755725	Green Published, hybrid			2022-12-28	WOS:000372551800030
J	Melchior, JT; Walker, RG; Morris, J; Jones, MK; Segrest, JP; Lima, DB; Carvalho, PC; Gozzo, FC; Castleberry, M; Thompson, TB; Davidson, WS				Melchior, John T.; Walker, Ryan G.; Morris, Jamie; Jones, Martin K.; Segrest, Jere P.; Lima, Diogo B.; Carvalho, Paulo C.; Gozzo, Fabio C.; Castleberry, Mark; Thompson, Thomas B.; Davidson, W. Sean			An Evaluation of the Crystal Structure of C-terminal Truncated Apolipoprotein A-I in Solution Reveals Structural Dynamics Related to Lipid Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; mass spectrometry (MS); oligomerization; small-angle x-ray scattering (SAXS); structural biology; structural model	CHOLESTEROL ACYLTRANSFERASE ACTIVATION; HIGH-DENSITY-LIPOPROTEINS; X-RAY-SCATTERING; CROSS-LINKING; PHOSPHOLIPID-BINDING; PLASMA LIPOPROTEINS; AMPHIPATHIC HELIXES; MOLECULAR-DYNAMICS; TANGIER-DISEASE; LECITHIN	Apolipoprotein (apo) A-I mediates many of the anti-atherogenic functions attributed to high density lipoprotein. Unfortunately, efforts toward a high resolution structure of full-length apoA-I have not been fruitful, although there have been successes with deletion mutants. Recently, a C-terminal truncation (apoA-I185-243) was crystallized as a dimer. The structure showed two helical bundles connected by a long, curved pair of swapped helical domains. To compare this structure to that existing under solution conditions, we applied small angle x-ray scattering and isotope-assisted chemical cross-linking to apoA-I185-243 in its dimeric and monomeric forms. For the dimer, we found evidence for the shared domains and aspects of the N-terminal bundles, but not the molecular curvature seen in the crystal. We also found that the N-terminal bundles equilibrate between open and closed states. Interestingly, this movement is one of the transitions proposed during lipid binding. The monomer was consistent with a model in which the long shared helix doubles back onto the helical bundle. Combined with the crystal structure, these data offer an important starting point to understand the molecular details of high density lipoprotein biogenesis.	[Melchior, John T.; Morris, Jamie; Davidson, W. Sean] Univ Cincinnati, Dept Pathol & Lab Med, 2120 Galbraith Rd, Cincinnati, OH 45237 USA; [Walker, Ryan G.; Castleberry, Mark; Thompson, Thomas B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45237 USA; [Jones, Martin K.; Segrest, Jere P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Jones, Martin K.; Segrest, Jere P.] Univ Alabama Birmingham, Atherosclerosis Res Unit, Birmingham, AL 35294 USA; [Lima, Diogo B.; Carvalho, Paulo C.] Fiocruz MS, Carlos Chagas Inst, Lab Prote & Prot Engn, BR-81350010 Curitiba, Parana, Brazil; [Gozzo, Fabio C.] Univ Estadual Campinas, Dalton Mass Spectrometry Lab, BR-13083970 Sao Paulo, Brazil	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Fundacao Oswaldo Cruz; Universidade Estadual de Campinas	Davidson, WS (corresponding author), Univ Cincinnati, Dept Pathol & Lab Med, 2120 Galbraith Rd, Cincinnati, OH 45237 USA.; Thompson, TB (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45237 USA.	Tom.Thompson@uc.edu; Sean.Davidson@UC.edu		Thompson, Thomas/0000-0002-7041-5047; Walker, Ryan/0000-0001-6160-8026; Davidson, William/0000-0003-2756-2989; Borges Lima, Diogo/0000-0001-6056-0825	National Institutes of Health [R01 GM098458, HL67093]; National Institute of Health Project MINOS [R01GM105404]; Department of Energy Office of Basic Energy Sciences through the Integrated Diffraction Analysis Technologies program; Department of Energy Office of Biological and Environmental Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098458, R01GM105404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health Project MINOS; Department of Energy Office of Basic Energy Sciences through the Integrated Diffraction Analysis Technologies program(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM098458 (to W. S. D. and T. B. T.) and HL67093 (to W. S. D.), National Institute of Health Project MINOS R01GM105404, and the Department of Energy Office of Basic Energy Sciences through the Integrated Diffraction Analysis Technologies program, supported by Department of Energy Office of Biological and Environmental Research.	Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Borrell B, 2009, NATURE, V462, P970, DOI 10.1038/462970a; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Deng XD, 2015, J BIOL CHEM, V290, P10689, DOI 10.1074/jbc.M115.637058; Deng XD, 2013, J BIOL CHEM, V288, P4854, DOI 10.1074/jbc.M112.436709; Deng XD, 2012, STRUCTURE, V20, P767, DOI 10.1016/j.str.2012.02.020; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; HOLVOET P, 1995, BIOCHEMISTRY-US, V34, P13334, DOI 10.1021/bi00041a009; Jones MK, 2009, BIOCHEMISTRY-US, V48, P11196, DOI 10.1021/bi901242k; Laccotripe M, 1997, J BIOL CHEM, V272, P17511, DOI 10.1074/jbc.272.28.17511; Leavell MD, 2004, J AM SOC MASS SPECTR, V15, P1604, DOI 10.1016/j.jasms.2004.07.018; LEROY A, 1994, BBA-LIPID LIPID MET, V1212, P285, DOI 10.1016/0005-2760(94)90202-X; Li L, 2004, J MOL BIOL, V343, P1293, DOI 10.1016/j.jmb.2004.09.017; Lima DB, 2015, J PROTEOMICS, V129, P51, DOI 10.1016/j.jprot.2015.01.013; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; MINNICH A, 1992, J BIOL CHEM, V267, P16553; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Pollard RD, 2013, BIOCHEMISTRY-US, V52, P9470, DOI 10.1021/bi401080k; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; REIJNGOUD DJ, 1982, BIOCHEMISTRY-US, V21, P2969, DOI 10.1021/bi00541a026; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Segrest JP, 2015, STRUCTURE, V23, P1214, DOI 10.1016/j.str.2015.05.010; Segrest JP, 2014, BIOCHEMISTRY-US, V53, P7625, DOI 10.1021/bi501111j; Segrest JP, 2012, J LIPID RES, V53, P1851, DOI 10.1194/jlr.M026229; SEGREST JP, 1977, CHEM PHYS LIPIDS, V18, P7, DOI 10.1016/0009-3084(77)90023-8; SEGREST JP, 1977, BIOPOLYMERS, V16, P2053, DOI 10.1002/bip.1977.360160916; Shah AS, 2013, J LIPID RES, V54, P2575, DOI 10.1194/jlr.R035725; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; SOUTAR AK, 1975, BIOCHEMISTRY-US, V14, P3057, DOI 10.1021/bi00685a003; Swaim CL, 2004, J AM SOC MASS SPECTR, V15, P736, DOI 10.1016/j.jasms.2004.01.011; Tubb MR, 2009, J LIPID RES, V50, P1497, DOI 10.1194/jlr.D900003-JLR200; Walker RG, 2014, J BIOL CHEM, V289, P5596, DOI 10.1074/jbc.M113.541037; Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109	46	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5439	5451		10.1074/jbc.M115.706093	http://dx.doi.org/10.1074/jbc.M115.706093			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26755744	hybrid, Green Published			2022-12-28	WOS:000371640600051
